0001755672-22-000005.txt : 20220210 0001755672-22-000005.hdr.sgml : 20220210 20220210160953 ACCESSION NUMBER: 0001755672-22-000005 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 196 CONFORMED PERIOD OF REPORT: 20211231 FILED AS OF DATE: 20220210 DATE AS OF CHANGE: 20220210 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Corteva, Inc. CENTRAL INDEX KEY: 0001755672 STANDARD INDUSTRIAL CLASSIFICATION: AGRICULTURE PRODUCTION - CROPS [0100] IRS NUMBER: 824979096 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-38710 FILM NUMBER: 22613986 BUSINESS ADDRESS: STREET 1: 9330 ZIONSVILLE ROAD CITY: INDIANAPOLIS STATE: IN ZIP: 46268 BUSINESS PHONE: (833) 267-8382 MAIL ADDRESS: STREET 1: 9330 ZIONSVILLE ROAD CITY: INDIANAPOLIS STATE: IN ZIP: 46268 FILER: COMPANY DATA: COMPANY CONFORMED NAME: DUPONT E I DE NEMOURS & CO CENTRAL INDEX KEY: 0000030554 STANDARD INDUSTRIAL CLASSIFICATION: PLASTIC MATERIAL, SYNTH RESIN/RUBBER, CELLULOS (NO GLASS) [2820] IRS NUMBER: 510014090 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-00815 FILM NUMBER: 22613987 BUSINESS ADDRESS: STREET 1: 9330 ZIONSVILLE ROAD CITY: INDIANAPOLIS STATE: IN ZIP: 46268 BUSINESS PHONE: 8332678382 MAIL ADDRESS: STREET 1: 9330 ZIONSVILLE ROAD CITY: INDIANAPOLIS STATE: IN ZIP: 46268 10-K 1 ctva-20211231.htm 10-K ctva-20211231
10-K10-KFALSEFALSEDecember 31, 2021December 31, 202100017556720000030554December 31December 3120212021FYFYYesYesNoNoYesYesLarge Accelerated FilerNon-accelerated FilerFalseFalseFalseFalse20falsefalse0.010.011,666,667,0001,666,667,000726,527,000743,458,0000.540.520.261251254.6253.6254.2502.8006.5005.6004.9004.15012012010210233330.300.301,800,000,0001,800,000,00020020023,000,00023,000,0001,673,0001,673,00012012023,000,00023,000,000700,000700,0001021024.504.504.503.503.503.509200017556722021-01-012021-12-310001755672ctva:EIDMember2021-01-012021-12-310001755672us-gaap:CommonStockMember2021-01-012021-12-310001755672ctva:A3.50SeriesPreferredStockMemberctva:EIDMember2021-01-012021-12-310001755672ctva:EIDMemberctva:A4.50SeriesPreferredStockMember2021-01-012021-12-3100017556722022-02-03xbrli:sharesiso4217:USDxbrli:shares0001755672ctva:EIDMember2022-02-0300017556722021-06-30iso4217:USD0001755672us-gaap:AllowanceForCreditLossMember2020-12-310001755672us-gaap:AllowanceForCreditLossMember2019-12-310001755672us-gaap:AllowanceForCreditLossMember2018-12-310001755672us-gaap:AllowanceForCreditLossMember2021-01-012021-12-310001755672us-gaap:AllowanceForCreditLossMember2020-01-012020-12-310001755672us-gaap:AllowanceForCreditLossMember2019-01-012019-12-310001755672us-gaap:AllowanceForCreditLossMember2021-12-310001755672us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember2020-12-310001755672us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember2019-12-310001755672us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember2018-12-310001755672us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember2021-01-012021-12-310001755672us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember2020-01-012020-12-310001755672us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember2019-01-012019-12-310001755672us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember2021-12-3100017556722020-01-012020-12-3100017556722019-01-012019-12-310001755672ctva:EIDMember2019-01-012019-12-310001755672us-gaap:PensionPlansDefinedBenefitMember2021-01-012021-12-310001755672us-gaap:PensionPlansDefinedBenefitMember2020-01-012020-12-310001755672us-gaap:PensionPlansDefinedBenefitMember2019-01-012019-12-310001755672us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2021-01-012021-12-310001755672us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2020-01-012020-12-310001755672us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2019-01-012019-12-3100017556722021-12-3100017556722020-12-310001755672ctva:TotalcompanyMember2021-01-012021-12-310001755672ctva:TotalcompanyMember2020-01-012020-12-310001755672ctva:TotalcompanyMember2019-01-012019-12-3100017556722019-12-3100017556722018-12-310001755672us-gaap:CommonStockMember2018-12-310001755672us-gaap:AdditionalPaidInCapitalMember2018-12-310001755672ctva:DivisionalEquityMember2018-12-310001755672us-gaap:RetainedEarningsMember2018-12-310001755672us-gaap:AccumulatedOtherComprehensiveIncomeMember2018-12-310001755672us-gaap:NoncontrollingInterestMember2018-12-310001755672ctva:DivisionalEquityMember2019-01-012019-12-310001755672us-gaap:RetainedEarningsMember2019-01-012019-12-310001755672us-gaap:NoncontrollingInterestMember2019-01-012019-12-310001755672us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-01-012019-12-310001755672us-gaap:AdditionalPaidInCapitalMember2019-01-012019-12-310001755672ctva:DowDuPontMemberctva:DivisionalEquityMember2019-01-012019-12-310001755672ctva:DowDuPontMember2019-01-012019-12-310001755672us-gaap:CommonStockMember2019-01-012019-12-310001755672us-gaap:CommonStockMember2019-12-310001755672us-gaap:AdditionalPaidInCapitalMember2019-12-310001755672ctva:DivisionalEquityMember2019-12-310001755672us-gaap:RetainedEarningsMember2019-12-310001755672us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-12-310001755672us-gaap:NoncontrollingInterestMember2019-12-310001755672us-gaap:RetainedEarningsMember2020-01-012020-12-310001755672us-gaap:NoncontrollingInterestMember2020-01-012020-12-310001755672us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-01-012020-12-310001755672us-gaap:AdditionalPaidInCapitalMember2020-01-012020-12-310001755672us-gaap:CommonStockMember2020-12-310001755672us-gaap:AdditionalPaidInCapitalMember2020-12-310001755672us-gaap:RetainedEarningsMember2020-12-310001755672us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-12-310001755672us-gaap:NoncontrollingInterestMember2020-12-310001755672us-gaap:RetainedEarningsMember2021-01-012021-12-310001755672us-gaap:NoncontrollingInterestMember2021-01-012021-12-310001755672us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-01-012021-12-310001755672us-gaap:AdditionalPaidInCapitalMember2021-01-012021-12-310001755672us-gaap:CommonStockMember2021-12-310001755672us-gaap:AdditionalPaidInCapitalMember2021-12-310001755672us-gaap:RetainedEarningsMember2021-12-310001755672us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-12-310001755672us-gaap:NoncontrollingInterestMember2021-12-310001755672ctva:CortevaMember2021-01-012021-12-31xbrli:pure0001755672ctva:CortevaMember2019-06-260001755672ctva:DowMember2019-04-010001755672ctva:SharesofCortevaStockMemberctva:CortevaMember2019-06-010001755672ctva:SharesofDowDuPontCommonStockHeldMemberctva:CortevaMember2019-06-010001755672ctva:CortevaMember2019-06-030001755672ctva:EIDMemberctva:CortevaMember2021-01-012021-12-310001755672ctva:InternalReorganizationMember2020-01-012020-03-310001755672ctva:ECPDisposalMember2021-01-012021-12-310001755672ctva:SpecialtyProductsDisposalMember2021-01-012021-12-310001755672us-gaap:OtherCurrentAssetsMember2021-12-310001755672us-gaap:OtherCurrentAssetsMember2020-12-310001755672srt:MinimumMember2021-01-012021-12-310001755672srt:MaximumMember2021-01-012021-12-310001755672us-gaap:OtherAssetsMember2021-12-310001755672ctva:AccountsandNotesReceivableMemberctva:DuPontdeNemoursMember2021-12-310001755672us-gaap:OtherAssetsMemberctva:DuPontdeNemoursMember2021-12-310001755672us-gaap:OtherNoncurrentLiabilitiesMemberctva:DuPontdeNemoursMember2021-12-310001755672ctva:DowMemberctva:AccruedandOtherCurrentLiabilitiesMember2021-12-310001755672ctva:DowMemberus-gaap:OtherNoncurrentLiabilitiesMember2021-12-310001755672ctva:IncomeStatementMemberctva:ECPDisposalMember2021-01-012021-12-310001755672ctva:ECPDisposalMember2020-01-012020-12-310001755672ctva:ECPDisposalMemberctva:CashFlowMember2021-01-012021-12-310001755672ctva:IncomeStatementMemberctva:SpecialtyProductsDisposalMember2021-01-012021-12-310001755672ctva:SpecialtyProductsDisposalMember2020-01-012020-12-310001755672ctva:SpecialtyProductsDisposalMemberctva:CashFlowMember2021-01-012021-12-310001755672ctva:DivestedAgBusinessMemberctva:FavorableSupplyContractMember2017-11-010001755672ctva:DivestedAgBusinessMember2020-01-012020-12-310001755672ctva:OtherdiscontinuedoperationsMember2021-01-012021-12-310001755672ctva:OtherdiscontinuedoperationsMember2020-01-012020-12-310001755672srt:MinimumMember2021-12-310001755672srt:MaximumMember2021-12-310001755672us-gaap:OtherNoncurrentLiabilitiesMember2021-12-310001755672us-gaap:OtherNoncurrentLiabilitiesMember2020-12-310001755672ctva:SeedMemberctva:CornMember2021-01-012021-12-310001755672ctva:SeedMemberctva:CornMember2020-01-012020-12-310001755672ctva:SeedMemberctva:CornMember2019-01-012019-12-310001755672ctva:SeedMemberctva:SoybeanMember2021-01-012021-12-310001755672ctva:SeedMemberctva:SoybeanMember2020-01-012020-12-310001755672ctva:SeedMemberctva:SoybeanMember2019-01-012019-12-310001755672ctva:SeedMemberctva:OtheroilseedsMember2021-01-012021-12-310001755672ctva:SeedMemberctva:OtheroilseedsMember2020-01-012020-12-310001755672ctva:SeedMemberctva:OtheroilseedsMember2019-01-012019-12-310001755672ctva:SeedMemberctva:OtherMember2021-01-012021-12-310001755672ctva:SeedMemberctva:OtherMember2020-01-012020-12-310001755672ctva:SeedMemberctva:OtherMember2019-01-012019-12-310001755672ctva:SeedMember2021-01-012021-12-310001755672ctva:SeedMember2020-01-012020-12-310001755672ctva:SeedMember2019-01-012019-12-310001755672ctva:CropProtectionMemberctva:HerbicidesMember2021-01-012021-12-310001755672ctva:CropProtectionMemberctva:HerbicidesMember2020-01-012020-12-310001755672ctva:CropProtectionMemberctva:HerbicidesMember2019-01-012019-12-310001755672ctva:InsecticidesMemberctva:CropProtectionMember2021-01-012021-12-310001755672ctva:InsecticidesMemberctva:CropProtectionMember2020-01-012020-12-310001755672ctva:InsecticidesMemberctva:CropProtectionMember2019-01-012019-12-310001755672ctva:FungicidesMemberctva:CropProtectionMember2021-01-012021-12-310001755672ctva:FungicidesMemberctva:CropProtectionMember2020-01-012020-12-310001755672ctva:FungicidesMemberctva:CropProtectionMember2019-01-012019-12-310001755672ctva:CropProtectionMemberctva:OtherMember2021-01-012021-12-310001755672ctva:CropProtectionMemberctva:OtherMember2020-01-012020-12-310001755672ctva:CropProtectionMemberctva:OtherMember2019-01-012019-12-310001755672ctva:CropProtectionMember2021-01-012021-12-310001755672ctva:CropProtectionMember2020-01-012020-12-310001755672ctva:CropProtectionMember2019-01-012019-12-310001755672ctva:GeographyMember2021-01-012021-12-310001755672srt:NorthAmericaMemberctva:SeedMember2021-01-012021-12-310001755672srt:NorthAmericaMemberctva:SeedMember2020-01-012020-12-310001755672srt:NorthAmericaMemberctva:SeedMember2019-01-012019-12-310001755672us-gaap:EMEAMemberctva:SeedMember2021-01-012021-12-310001755672us-gaap:EMEAMemberctva:SeedMember2020-01-012020-12-310001755672us-gaap:EMEAMemberctva:SeedMember2019-01-012019-12-310001755672ctva:SeedMembersrt:LatinAmericaMember2021-01-012021-12-310001755672ctva:SeedMembersrt:LatinAmericaMember2020-01-012020-12-310001755672ctva:SeedMembersrt:LatinAmericaMember2019-01-012019-12-310001755672srt:AsiaPacificMemberctva:SeedMember2021-01-012021-12-310001755672srt:AsiaPacificMemberctva:SeedMember2020-01-012020-12-310001755672srt:AsiaPacificMemberctva:SeedMember2019-01-012019-12-310001755672srt:NorthAmericaMemberctva:CropProtectionMember2021-01-012021-12-310001755672srt:NorthAmericaMemberctva:CropProtectionMember2020-01-012020-12-310001755672srt:NorthAmericaMemberctva:CropProtectionMember2019-01-012019-12-310001755672us-gaap:EMEAMemberctva:CropProtectionMember2021-01-012021-12-310001755672us-gaap:EMEAMemberctva:CropProtectionMember2020-01-012020-12-310001755672us-gaap:EMEAMemberctva:CropProtectionMember2019-01-012019-12-310001755672ctva:CropProtectionMembersrt:LatinAmericaMember2021-01-012021-12-310001755672ctva:CropProtectionMembersrt:LatinAmericaMember2020-01-012020-12-310001755672ctva:CropProtectionMembersrt:LatinAmericaMember2019-01-012019-12-310001755672srt:AsiaPacificMemberctva:CropProtectionMember2021-01-012021-12-310001755672srt:AsiaPacificMemberctva:CropProtectionMember2020-01-012020-12-310001755672srt:AsiaPacificMemberctva:CropProtectionMember2019-01-012019-12-310001755672ctva:A2021RestructuringActionsMember2021-01-012021-12-310001755672ctva:SeedMemberctva:A2021RestructuringActionsMember2020-01-012020-12-310001755672ctva:A2021RestructuringActionsMemberctva:CropProtectionMember2020-01-012020-12-310001755672ctva:A2021RestructuringActionsMemberus-gaap:CorporateNonSegmentMember2020-01-012020-12-310001755672ctva:A2021RestructuringActionsMember2020-01-012020-12-310001755672us-gaap:EmployeeSeveranceMemberctva:A2021RestructuringActionsMember2020-01-012020-12-310001755672ctva:AssetRelatedChargesMemberctva:A2021RestructuringActionsMember2021-01-012021-12-310001755672ctva:A2021RestructuringActionsMemberus-gaap:ContractTerminationMember2021-01-012021-12-310001755672us-gaap:EmployeeSeveranceMemberctva:A2021RestructuringActionsMember2020-12-310001755672ctva:AssetRelatedChargesMemberctva:A2021RestructuringActionsMember2020-12-310001755672ctva:A2021RestructuringActionsMemberus-gaap:ContractTerminationMember2020-12-310001755672ctva:A2021RestructuringActionsMember2020-12-310001755672us-gaap:EmployeeSeveranceMemberctva:A2021RestructuringActionsMember2021-01-012021-12-310001755672us-gaap:EmployeeSeveranceMemberctva:A2021RestructuringActionsMember2021-12-310001755672ctva:AssetRelatedChargesMemberctva:A2021RestructuringActionsMember2021-12-310001755672ctva:A2021RestructuringActionsMemberus-gaap:ContractTerminationMember2021-12-310001755672ctva:A2021RestructuringActionsMember2021-12-310001755672ctva:ExecuteToWinProductivityProgramMember2021-12-310001755672ctva:AssetRelatedChargesMemberctva:ExecuteToWinProductivityProgramMember2021-12-310001755672us-gaap:EmployeeSeveranceMemberctva:ExecuteToWinProductivityProgramMember2021-12-310001755672ctva:ExecuteToWinProductivityProgramMember2021-01-012021-12-310001755672ctva:SeedMemberctva:ExecuteToWinProductivityProgramMember2021-01-012021-12-310001755672ctva:SeedMemberctva:ExecuteToWinProductivityProgramMember2020-01-012020-12-310001755672ctva:CropProtectionMemberctva:ExecuteToWinProductivityProgramMember2021-01-012021-12-310001755672ctva:CropProtectionMemberctva:ExecuteToWinProductivityProgramMember2020-01-012020-12-310001755672us-gaap:CorporateNonSegmentMemberctva:ExecuteToWinProductivityProgramMember2021-01-012021-12-310001755672us-gaap:CorporateNonSegmentMemberctva:ExecuteToWinProductivityProgramMember2020-01-012020-12-310001755672ctva:ExecuteToWinProductivityProgramMember2020-01-012020-12-310001755672us-gaap:EmployeeSeveranceMemberctva:ExecuteToWinProductivityProgramMember2021-01-012021-12-310001755672us-gaap:EmployeeSeveranceMemberctva:ExecuteToWinProductivityProgramMember2020-01-012020-12-310001755672ctva:AssetRelatedChargesMemberctva:ExecuteToWinProductivityProgramMember2021-01-012021-12-310001755672ctva:AssetRelatedChargesMemberctva:ExecuteToWinProductivityProgramMember2020-01-012020-12-310001755672ctva:AssetRelatedChargesMember2020-01-012020-12-310001755672us-gaap:EmployeeSeveranceMemberctva:ExecuteToWinProductivityProgramMember2020-12-310001755672ctva:AssetRelatedChargesMemberctva:ExecuteToWinProductivityProgramMember2020-12-310001755672ctva:ExecuteToWinProductivityProgramMember2020-12-310001755672ctva:DowDuPontCostSynergyProgramMember2021-12-310001755672us-gaap:EmployeeSeveranceMemberctva:DowDuPontCostSynergyProgramMember2021-12-310001755672ctva:CostsRelatedToContractTerminationMemberctva:DowDuPontCostSynergyProgramMember2021-12-310001755672ctva:AssetRelatedChargesMemberctva:DowDuPontCostSynergyProgramMember2021-12-310001755672ctva:DowDuPontCostSynergyProgramMember2021-01-012021-12-310001755672ctva:SeedMemberctva:DowDuPontCostSynergyProgramMember2021-01-012021-12-310001755672ctva:SeedMemberctva:DowDuPontCostSynergyProgramMember2020-01-012020-12-310001755672ctva:SeedMemberctva:DowDuPontCostSynergyProgramMember2019-01-012019-12-310001755672ctva:CropProtectionMemberctva:DowDuPontCostSynergyProgramMember2021-01-012021-12-310001755672ctva:CropProtectionMemberctva:DowDuPontCostSynergyProgramMember2020-01-012020-12-310001755672ctva:CropProtectionMemberctva:DowDuPontCostSynergyProgramMember2019-01-012019-12-310001755672us-gaap:CorporateMemberctva:DowDuPontCostSynergyProgramMember2021-01-012021-12-310001755672us-gaap:CorporateMemberctva:DowDuPontCostSynergyProgramMember2020-01-012020-12-310001755672us-gaap:CorporateMemberctva:DowDuPontCostSynergyProgramMember2019-01-012019-12-310001755672ctva:DowDuPontCostSynergyProgramMember2020-01-012020-12-310001755672ctva:DowDuPontCostSynergyProgramMember2019-01-012019-12-310001755672us-gaap:EmployeeSeveranceMemberctva:DowDuPontCostSynergyProgramMember2021-01-012021-12-310001755672us-gaap:EmployeeSeveranceMemberctva:DowDuPontCostSynergyProgramMember2020-01-012020-12-310001755672us-gaap:EmployeeSeveranceMemberctva:DowDuPontCostSynergyProgramMember2019-01-012019-12-310001755672ctva:CostsRelatedToContractTerminationMemberctva:DowDuPontCostSynergyProgramMember2021-01-012021-12-310001755672ctva:CostsRelatedToContractTerminationMemberctva:DowDuPontCostSynergyProgramMember2020-01-012020-12-310001755672ctva:CostsRelatedToContractTerminationMemberctva:DowDuPontCostSynergyProgramMember2019-01-012019-12-310001755672ctva:AssetRelatedChargesMemberctva:DowDuPontCostSynergyProgramMember2021-01-012021-12-310001755672ctva:AssetRelatedChargesMemberctva:DowDuPontCostSynergyProgramMember2020-01-012020-12-310001755672ctva:AssetRelatedChargesMemberctva:DowDuPontCostSynergyProgramMember2019-01-012019-12-310001755672ctva:OtherAssetRelatedMember2021-01-012021-12-310001755672ctva:OtherAssetRelatedMember2020-01-012020-12-310001755672us-gaap:InProcessResearchAndDevelopmentMember2019-01-012019-12-310001755672us-gaap:MaterialReconcilingItemsMemberctva:LaPorteMemberctva:CropProtectionMember2021-01-012021-12-310001755672ctva:APACBusinessMemberus-gaap:MaterialReconcilingItemsMemberctva:CropProtectionMember2021-01-012021-12-310001755672ctva:HedgingProgramMemberctva:ArgentinepesodevaluationMember2021-01-012021-12-310001755672ctva:HedgingProgramMemberctva:ArgentinepesodevaluationMember2020-01-012020-12-310001755672ctva:HedgingProgramMemberctva:ArgentinepesodevaluationMember2019-01-012019-12-310001755672us-gaap:MaterialReconcilingItemsMember2021-01-012021-12-310001755672us-gaap:MaterialReconcilingItemsMemberctva:SeedMember2021-01-012021-12-310001755672srt:SubsidiariesMember2021-01-012021-12-310001755672srt:SubsidiariesMember2020-01-012020-12-310001755672srt:SubsidiariesMember2019-01-012019-12-310001755672ctva:HedgingProgramMember2021-01-012021-12-310001755672ctva:HedgingProgramMember2020-01-012020-12-310001755672ctva:HedgingProgramMember2019-01-012019-12-310001755672us-gaap:SegmentContinuingOperationsMember2021-01-012021-12-310001755672us-gaap:SegmentContinuingOperationsMember2020-01-012020-12-310001755672us-gaap:SegmentContinuingOperationsMember2019-01-012019-12-310001755672ctva:ChangeInAccountingMethodMemberus-gaap:SegmentContinuingOperationsMember2020-01-012020-12-310001755672ctva:SwissTaxReformMemberus-gaap:SegmentContinuingOperationsMember2020-01-012020-12-310001755672ctva:SwissTaxReformMemberus-gaap:SegmentContinuingOperationsMember2019-01-012019-12-310001755672ctva:ExpiringwithinFiveYearsMember2021-12-310001755672ctva:ExpiringwithinFiveYearsMember2020-12-310001755672ctva:ExpiringAfterFiveYearsOrHavingIndefiniteExpirationMember2021-12-310001755672ctva:ExpiringAfterFiveYearsOrHavingIndefiniteExpirationMember2020-12-310001755672ctva:CortevaMember2019-06-010001755672ctva:RoundedAmountMemberctva:CortevaMember2019-06-010001755672ctva:FactoringAgreementMember2021-01-012021-12-310001755672ctva:FactoringAgreementMember2020-01-012020-12-310001755672ctva:FactoringAgreementMember2019-01-012019-12-310001755672ctva:FactoringAgreementMember2021-12-310001755672ctva:FactoringAgreementMember2020-12-310001755672ctva:MergerwithDowMember2017-09-010001755672ctva:MergerwithDowMember2019-01-012019-12-310001755672us-gaap:LandAndLandImprovementsMember2021-12-310001755672us-gaap:LandAndLandImprovementsMember2020-12-310001755672us-gaap:BuildingMember2021-12-310001755672us-gaap:BuildingMember2020-12-310001755672us-gaap:MachineryAndEquipmentMember2021-12-310001755672us-gaap:MachineryAndEquipmentMember2020-12-310001755672us-gaap:ConstructionInProgressMember2021-12-310001755672us-gaap:ConstructionInProgressMember2020-12-310001755672srt:MinimumMemberus-gaap:BuildingMember2021-01-012021-12-310001755672srt:MaximumMemberus-gaap:BuildingMember2021-01-012021-12-310001755672us-gaap:ComputerSoftwareIntangibleAssetMembersrt:MinimumMember2021-01-012021-12-310001755672us-gaap:ComputerSoftwareIntangibleAssetMembersrt:MaximumMember2021-01-012021-12-310001755672srt:MinimumMemberus-gaap:MachineryAndEquipmentMember2021-01-012021-12-310001755672srt:MaximumMemberus-gaap:MachineryAndEquipmentMember2021-01-012021-12-310001755672srt:MinimumMemberus-gaap:LandImprovementsMember2021-01-012021-12-310001755672srt:MaximumMemberus-gaap:LandImprovementsMember2021-01-012021-12-310001755672ctva:CropProtectionMember2019-12-310001755672ctva:SeedMember2019-12-310001755672ctva:CropProtectionMember2020-12-310001755672ctva:SeedMember2020-12-310001755672ctva:CropProtectionMember2021-12-310001755672ctva:SeedMember2021-12-310001755672ctva:GermplasmMember2021-12-310001755672ctva:GermplasmMember2020-12-310001755672us-gaap:CustomerRelatedIntangibleAssetsMember2021-12-310001755672us-gaap:CustomerRelatedIntangibleAssetsMember2020-12-310001755672ctva:DevelopedTechnologyMember2021-12-310001755672ctva:DevelopedTechnologyMember2020-12-310001755672us-gaap:TrademarksAndTradeNamesMember2021-12-310001755672us-gaap:TrademarksAndTradeNamesMember2020-12-310001755672ctva:FavorableSupplyContractMember2021-12-310001755672ctva:FavorableSupplyContractMember2020-12-310001755672us-gaap:OtherIntangibleAssetsMember2021-12-310001755672us-gaap:OtherIntangibleAssetsMember2020-12-310001755672us-gaap:InProcessResearchAndDevelopmentMember2021-12-310001755672us-gaap:InProcessResearchAndDevelopmentMember2020-12-310001755672us-gaap:InProcessResearchAndDevelopmentMember2019-07-012019-09-300001755672us-gaap:InProcessResearchAndDevelopmentMember2019-10-012019-12-310001755672us-gaap:SegmentContinuingOperationsMember2021-12-310001755672ctva:ResidualValueGuaranteeMember2021-12-310001755672us-gaap:PropertyPlantAndEquipmentMember2021-12-310001755672us-gaap:PropertyPlantAndEquipmentMember2020-12-310001755672us-gaap:ShortTermDebtMember2021-12-310001755672us-gaap:ShortTermDebtMember2020-12-310001755672us-gaap:LongTermDebtMember2021-12-310001755672us-gaap:LongTermDebtMember2020-12-310001755672us-gaap:LoansPayableMemberctva:NotesMaturing2025Domain2021-12-310001755672us-gaap:LoansPayableMemberctva:NotesMaturing2025Domain2020-12-310001755672us-gaap:LoansPayableMemberctva:NotesMaturing2030Domain2021-12-310001755672us-gaap:LoansPayableMemberctva:NotesMaturing2030Domain2020-12-310001755672ctva:ForeignCurrencyLoansMemberus-gaap:LoansPayableMember2021-12-310001755672ctva:ForeignCurrencyLoansMemberus-gaap:LoansPayableMember2020-12-310001755672us-gaap:MediumTermNotesMember2021-12-310001755672us-gaap:MediumTermNotesMember2020-12-310001755672ctva:NotesMaturing2025Domain2021-01-012021-12-310001755672us-gaap:FairValueInputsLevel2Member2021-12-310001755672us-gaap:FairValueInputsLevel2Member2020-12-310001755672ctva:SeniorNotesDue2025Member2020-05-310001755672ctva:SeniorNotesDue2030Member2020-05-310001755672ctva:RevolvingCreditFacilitiesdue2024Member2021-12-310001755672ctva:RevolvingCreditFacilitiesdue2022Member2021-12-310001755672ctva:RevolvingCreditFacilitiesdue2024Member2018-11-130001755672ctva:RevolvingCreditFacilitiesdue2024Member2018-11-132023-11-130001755672ctva:RevolvingCreditFacilitiesdue2022Member2018-11-130001755672ctva:RevolvingCreditFacilitiesdue2022Member2018-11-132021-11-130001755672ctva:RevolvingCreditFacilitiesdue2022Member2018-11-130001755672ctva:RevolvingCreditFacilitiesdue2022Member2021-03-310001755672ctva:A4.625Notesdue2020Member2019-03-220001755672ctva:A3.625Notesdue2021Member2019-03-220001755672ctva:A4.250Notesdue2021Member2019-03-220001755672ctva:A2.800Notesdue2023Member2019-03-220001755672ctva:A6.500Debenturesdue2028Member2019-03-220001755672ctva:A5.600SeniorNotesdue2036Member2019-03-220001755672ctva:A4.900Notesdue2041Member2019-03-220001755672ctva:A4.150Notesdue2043Member2019-03-2200017556722019-03-220001755672ctva:TermLoanFacilitydue2020Member2016-03-012019-03-310001755672ctva:EIDMemberctva:TermLoanFacilitydue2020Member2016-03-2200017556722019-05-0200017556722019-05-022019-05-020001755672ctva:SeniorNote2.20PercentDue2020Member2019-05-170001755672ctva:SeniorNoteFloatingRateDue2020Member2019-05-170001755672ctva:SMRnotesMember2019-05-170001755672ctva:FactoringAgreementMember2021-12-310001755672ctva:FactoringAgreementMember2020-12-310001755672ctva:AgreementsWithLendersToProvideFinancingForSelectCustomersMember2021-12-310001755672ctva:AgreementsWithLendersToProvideFinancingForSelectCustomersMember2020-12-310001755672ctva:PFOAMattersMultiDistrictLitigationMember2018-12-31ctva:lawsuits0001755672srt:MaximumMemberctva:PFASMember2021-01-012021-12-310001755672srt:MaximumMemberctva:PFASMember2021-12-310001755672ctva:CortevaMemberctva:DuPontdeNemoursMemberctva:PFASMember2021-12-310001755672srt:MaximumMemberctva:CortevaMemberctva:DuPontdeNemoursMemberctva:PFASMember2021-12-310001755672ctva:DuPontdeNemoursMember2021-12-310001755672ctva:DuPontdeNemoursMember2021-12-310001755672ctva:CortevaMember2021-12-310001755672ctva:ChemoursMemberctva:PFASMember2023-09-300001755672ctva:CortevaMemberctva:DuPontdeNemoursMemberctva:PFASMember2023-09-300001755672ctva:ChemoursMemberctva:PFASMember2029-09-300001755672ctva:CortevaMemberctva:DuPontdeNemoursMemberctva:PFASMember2029-09-300001755672ctva:ChemoursMembersrt:MaximumMemberctva:PFASMember2029-09-300001755672srt:MaximumMemberctva:CortevaMemberctva:DuPontdeNemoursMemberctva:PFASMember2029-09-300001755672ctva:PFASMember2028-12-310001755672ctva:ChemoursMemberctva:PFASMember2021-12-310001755672ctva:PFASMember2021-12-310001755672ctva:PerformanceChemicalsMember2021-01-012021-12-310001755672ctva:PerformanceChemicalsMember2020-01-012020-12-310001755672ctva:CortevaMemberctva:DuPontdeNemoursMember2021-12-310001755672ctva:DuPontdeNemoursMemberctva:DuPontdeNemoursMember2021-12-310001755672ctva:CortevaMemberctva:PFASMember2021-12-310001755672ctva:PFASMemberctva:DuPontdeNemoursMember2021-12-310001755672srt:MinimumMemberctva:PFASMember2021-12-310001755672srt:MinimumMemberctva:Once300millionthresholdismetMemberctva:PFASMember2021-12-310001755672ctva:PFOAMattersDrinkingWaterActionsMember2004-01-012004-12-310001755672ctva:PFOAMattersDrinkingWaterActionsMember2012-01-010001755672ctva:PFOAMattersDrinkingWaterActionsMember2004-12-310001755672ctva:PFOAMattersDrinkingWaterActionsMember2012-01-012020-12-310001755672ctva:PFOAMattersDrinkingWaterActionsMember2021-12-310001755672ctva:PFOAMattersMultiDistrictLitigationMember2021-12-310001755672ctva:PFOAMattersMultiDistrictLitigationMember2017-04-012017-06-300001755672ctva:PFOAMattersDrinkingWaterActionsMemberctva:PostMDLSettlementPFOAPersonalInjuryClaimsDomainctva:CompensatoryDamagesMember2021-01-012021-12-310001755672ctva:LossOfConsortiumMemberctva:PFOAMattersDrinkingWaterActionsMemberctva:PostMDLSettlementPFOAPersonalInjuryClaimsDomain2021-01-012021-12-310001755672ctva:PFOAMattersDrinkingWaterActionsMemberus-gaap:SettledLitigationMemberctva:PostMDLSettlementPFOAPersonalInjuryClaimsDomain2021-12-310001755672ctva:MDLSettlementMember2021-01-012021-12-310001755672ctva:ChemoursContributionToMDLSettlementMember2021-01-012021-12-310001755672ctva:DuPontDeNemoursAndCortevaContributionToMDLSettlementMember2021-01-012021-12-310001755672ctva:PFOAMattersDrinkingWaterActionsMemberstpr:NY2021-12-310001755672ctva:PFOAMattersDrinkingWaterActionsMemberstpr:NJ2021-12-310001755672ctva:NaturalResourcesDamagesMemberstpr:NJ2021-12-310001755672stpr:OHctva:PFOAMattersDrinkingWaterActionsMember2021-12-310001755672stpr:DEctva:NaturalResourcesDamagesMemberctva:CortevaMemberctva:DuPontdeNemoursMember2021-12-310001755672ctva:ChemoursMemberstpr:DEctva:NaturalResourcesDamagesMember2021-12-310001755672stpr:DEctva:NaturalResourcesDamagesMemberctva:CortevaMember2021-12-310001755672ctva:SettlementAgreementMember2021-01-012021-12-310001755672ctva:FirefightingFoamMember2021-12-310001755672ctva:PersonalinjurycasesMemberctva:FirefightingFoamMember2021-12-310001755672ctva:PFOAMattersDrinkingWaterActionsMemberstpr:NC2021-01-012021-12-310001755672ctva:ChemoursrelatedobligationsubjecttoindemnificationMember2021-12-310001755672us-gaap:SegmentDiscontinuedOperationsMember2021-12-310001755672ctva:OtherDiscontinuedOrDivestedBusinessObligationsMember2021-12-310001755672ctva:EnvironmentalremediationliabilitiesprimarilyrelatedtoDuPontsubjecttoindemnityfromDuPontMember2021-12-310001755672ctva:NotsubjecttoindemnificationMember2021-12-310001755672ctva:SuperfundSitesMemberctva:ChemoursMemberus-gaap:IndemnificationGuaranteeMember2021-12-310001755672ctva:NonPFASMember2022-01-280001755672ctva:CortevaMember2019-06-0100017556722019-06-0100017556722019-06-260001755672ctva:CortevaMember2021-01-012021-12-310001755672ctva:CortevaMember2020-01-012020-12-310001755672ctva:A2019ShareRepurchasePlanMember2021-01-012021-12-310001755672ctva:A2019ShareRepurchasePlanMember2020-01-012020-12-310001755672ctva:EIDMemberctva:A4.50SeriesPreferredStockMember2021-12-310001755672ctva:A3.50SeriesPreferredStockMemberctva:EIDMember2021-12-310001755672us-gaap:AccumulatedTranslationAdjustmentMember2018-12-310001755672us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2018-12-310001755672us-gaap:PensionPlansDefinedBenefitMember2018-12-310001755672us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2018-12-310001755672us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2018-12-310001755672us-gaap:AccumulatedTranslationAdjustmentMember2019-01-012019-12-310001755672us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2019-01-012019-12-310001755672us-gaap:PensionPlansDefinedBenefitMember2019-01-012019-12-310001755672us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2019-01-012019-12-310001755672us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2019-01-012019-12-310001755672ctva:InternalReorganizationMemberus-gaap:AccumulatedTranslationAdjustmentMember2019-01-012019-12-310001755672us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMemberctva:InternalReorganizationMember2019-01-012019-12-310001755672us-gaap:PensionPlansDefinedBenefitMemberctva:InternalReorganizationMember2019-01-012019-12-310001755672ctva:InternalReorganizationMemberus-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2019-01-012019-12-310001755672ctva:InternalReorganizationMemberus-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2019-01-012019-12-310001755672ctva:InternalReorganizationMemberus-gaap:AccumulatedOtherComprehensiveIncomeMember2019-01-012019-12-310001755672us-gaap:AccumulatedTranslationAdjustmentMember2019-12-310001755672us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2019-12-310001755672us-gaap:PensionPlansDefinedBenefitMember2019-12-310001755672us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2019-12-310001755672us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2019-12-310001755672us-gaap:AccumulatedTranslationAdjustmentMember2020-01-012020-12-310001755672us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2020-01-012020-12-310001755672us-gaap:PensionPlansDefinedBenefitMember2020-01-012020-12-310001755672us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2020-01-012020-12-310001755672us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2020-01-012020-12-310001755672us-gaap:AccumulatedTranslationAdjustmentMember2020-12-310001755672us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2020-12-310001755672us-gaap:PensionPlansDefinedBenefitMember2020-12-310001755672us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2020-12-310001755672us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2020-12-310001755672us-gaap:AccumulatedTranslationAdjustmentMember2021-01-012021-12-310001755672us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2021-01-012021-12-310001755672us-gaap:PensionPlansDefinedBenefitMember2021-01-012021-12-310001755672us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2021-01-012021-12-310001755672us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2021-01-012021-12-310001755672us-gaap:AccumulatedTranslationAdjustmentMember2021-12-310001755672us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2021-12-310001755672us-gaap:PensionPlansDefinedBenefitMember2021-12-310001755672us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2021-12-310001755672us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2021-12-310001755672us-gaap:PensionPlansDefinedBenefitMemberus-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember2021-01-012021-12-310001755672us-gaap:PensionPlansDefinedBenefitMemberus-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember2020-01-012020-12-310001755672us-gaap:PensionPlansDefinedBenefitMemberus-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember2019-01-012019-12-310001755672us-gaap:PensionPlansDefinedBenefitMemberus-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember2021-01-012021-12-310001755672us-gaap:PensionPlansDefinedBenefitMemberus-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember2020-01-012020-12-310001755672us-gaap:PensionPlansDefinedBenefitMemberus-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember2019-01-012019-12-310001755672us-gaap:PensionPlansDefinedBenefitMemberctva:AccumulatedDefinedBenefitPlansAdjustmentSettlementGainLossMember2021-01-012021-12-310001755672us-gaap:PensionPlansDefinedBenefitMemberctva:AccumulatedDefinedBenefitPlansAdjustmentSettlementGainLossMember2020-01-012020-12-310001755672us-gaap:PensionPlansDefinedBenefitMemberctva:AccumulatedDefinedBenefitPlansAdjustmentSettlementGainLossMember2019-01-012019-12-310001755672us-gaap:PensionPlansDefinedBenefitMemberus-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2021-01-012021-12-310001755672us-gaap:PensionPlansDefinedBenefitMemberus-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2020-01-012020-12-310001755672us-gaap:PensionPlansDefinedBenefitMemberus-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2019-01-012019-12-310001755672us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMemberus-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember2021-01-012021-12-310001755672us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMemberus-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember2020-01-012020-12-310001755672us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMemberus-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember2019-01-012019-12-310001755672us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMemberus-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember2021-01-012021-12-310001755672us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMemberus-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember2020-01-012020-12-310001755672us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMemberus-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember2019-01-012019-12-310001755672us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMemberus-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2021-01-012021-12-310001755672us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMemberus-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2020-01-012020-12-310001755672us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMemberus-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2019-01-012019-12-310001755672us-gaap:GainLossOnInvestmentsMember12021-01-012021-12-310001755672us-gaap:GainLossOnInvestmentsMember12020-01-012020-12-310001755672us-gaap:GainLossOnInvestmentsMember12017-09-012017-12-310001755672ctva:EIDMemberctva:A4.50SeriesPreferredStockMember2020-12-310001755672ctva:A3.50SeriesPreferredStockMemberctva:EIDMember2020-12-310001755672us-gaap:OtherPensionPlansDefinedBenefitMember2021-01-012021-12-310001755672us-gaap:OtherPensionPlansDefinedBenefitMember2020-01-012020-12-310001755672us-gaap:OtherPensionPlansDefinedBenefitMember2019-01-012019-12-310001755672us-gaap:OtherPensionPlansDefinedBenefitMember2022-12-310001755672us-gaap:PensionPlansDefinedBenefitMember2021-12-310001755672us-gaap:PensionPlansDefinedBenefitMember2020-12-310001755672us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2022-12-310001755672us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2021-12-310001755672us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2020-12-310001755672us-gaap:PensionPlansDefinedBenefitMember2020-12-310001755672us-gaap:PensionPlansDefinedBenefitMember2019-12-310001755672us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2019-12-310001755672us-gaap:PensionPlansDefinedBenefitMember2021-12-310001755672us-gaap:PensionPlansDefinedBenefitMemberctva:U.S.PlanswithPlanAssetsMember2021-12-310001755672us-gaap:PensionPlansDefinedBenefitMemberctva:U.S.PlanswithPlanAssetsMember2020-12-310001755672ctva:U.S.PlanswithPlanAssetsMemberus-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2021-12-310001755672ctva:U.S.PlanswithPlanAssetsMemberus-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2020-12-310001755672ctva:NonU.S.planswithplanassetsMemberus-gaap:PensionPlansDefinedBenefitMember2021-12-310001755672ctva:NonU.S.planswithplanassetsMemberus-gaap:PensionPlansDefinedBenefitMember2020-12-310001755672ctva:NonU.S.planswithplanassetsMemberus-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2021-12-310001755672ctva:NonU.S.planswithplanassetsMemberus-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2020-12-310001755672ctva:AllotherplansMemberus-gaap:PensionPlansDefinedBenefitMember2021-12-310001755672ctva:AllotherplansMemberus-gaap:PensionPlansDefinedBenefitMember2020-12-310001755672ctva:AllotherplansMemberus-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2021-12-310001755672ctva:AllotherplansMemberus-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2020-12-310001755672ctva:TrustAgreementMember2021-12-310001755672ctva:TrustAgreementMember2020-12-310001755672us-gaap:OtherAssetsMemberus-gaap:PensionPlansDefinedBenefitMember2021-12-310001755672us-gaap:OtherAssetsMemberus-gaap:PensionPlansDefinedBenefitMember2020-12-310001755672us-gaap:OtherAssetsMemberus-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2021-12-310001755672us-gaap:OtherAssetsMemberus-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2020-12-310001755672us-gaap:PensionPlansDefinedBenefitMemberctva:AccruedandOtherCurrentLiabilitiesMember2021-12-310001755672us-gaap:PensionPlansDefinedBenefitMemberctva:AccruedandOtherCurrentLiabilitiesMember2020-12-310001755672ctva:AccruedandOtherCurrentLiabilitiesMemberus-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2021-12-310001755672ctva:AccruedandOtherCurrentLiabilitiesMemberus-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2020-12-310001755672ctva:PensionandotherpostemploymentbenefitsnoncurrentMemberus-gaap:PensionPlansDefinedBenefitMember2021-12-310001755672ctva:PensionandotherpostemploymentbenefitsnoncurrentMemberus-gaap:PensionPlansDefinedBenefitMember2020-12-310001755672ctva:PensionandotherpostemploymentbenefitsnoncurrentMemberus-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2021-12-310001755672ctva:PensionandotherpostemploymentbenefitsnoncurrentMemberus-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2020-12-310001755672us-gaap:PensionPlansDefinedBenefitMemberus-gaap:SegmentDiscontinuedOperationsMember2021-01-012021-12-310001755672us-gaap:PensionPlansDefinedBenefitMemberus-gaap:SegmentDiscontinuedOperationsMember2020-01-012020-12-310001755672us-gaap:PensionPlansDefinedBenefitMemberus-gaap:SegmentDiscontinuedOperationsMember2019-01-012019-12-310001755672us-gaap:SegmentDiscontinuedOperationsMemberus-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2021-01-012021-12-310001755672us-gaap:SegmentDiscontinuedOperationsMemberus-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2020-01-012020-12-310001755672us-gaap:SegmentDiscontinuedOperationsMemberus-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2019-01-012019-12-310001755672us-gaap:SegmentContinuingOperationsMemberus-gaap:PensionPlansDefinedBenefitMember2021-01-012021-12-310001755672us-gaap:SegmentContinuingOperationsMemberus-gaap:PensionPlansDefinedBenefitMember2020-01-012020-12-310001755672us-gaap:SegmentContinuingOperationsMemberus-gaap:PensionPlansDefinedBenefitMember2019-01-012019-12-310001755672us-gaap:SegmentContinuingOperationsMemberus-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2021-01-012021-12-310001755672us-gaap:SegmentContinuingOperationsMemberus-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2020-01-012020-12-310001755672us-gaap:SegmentContinuingOperationsMemberus-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2019-01-012019-12-310001755672us-gaap:EquitySecuritiesMembercountry:US2021-12-310001755672us-gaap:EquitySecuritiesMembercountry:US2020-12-310001755672us-gaap:EquitySecuritiesMemberus-gaap:NonUsMember2021-12-310001755672us-gaap:EquitySecuritiesMemberus-gaap:NonUsMember2020-12-310001755672us-gaap:FixedIncomeSecuritiesMember2021-12-310001755672us-gaap:FixedIncomeSecuritiesMember2020-12-310001755672us-gaap:HedgeFundsMember2021-12-310001755672us-gaap:HedgeFundsMember2020-12-310001755672us-gaap:PrivateEquityFundsMember2021-12-310001755672us-gaap:PrivateEquityFundsMember2020-12-310001755672us-gaap:RealEstateMember2021-12-310001755672us-gaap:RealEstateMember2020-12-310001755672us-gaap:CashAndCashEquivalentsMember2021-12-310001755672us-gaap:CashAndCashEquivalentsMember2020-12-310001755672us-gaap:PensionPlansDefinedBenefitMemberus-gaap:RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember2021-12-310001755672us-gaap:FairValueInputsLevel1Memberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember2021-12-310001755672us-gaap:FairValueInputsLevel2Memberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember2021-12-310001755672us-gaap:FairValueInputsLevel3Memberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember2021-12-310001755672us-gaap:EquitySecuritiesMemberus-gaap:PensionPlansDefinedBenefitMembercountry:US2021-12-310001755672us-gaap:EquitySecuritiesMemberus-gaap:FairValueInputsLevel1Memberus-gaap:PensionPlansDefinedBenefitMembercountry:US2021-12-310001755672us-gaap:FairValueInputsLevel2Memberus-gaap:EquitySecuritiesMemberus-gaap:PensionPlansDefinedBenefitMembercountry:US2021-12-310001755672us-gaap:EquitySecuritiesMemberus-gaap:FairValueInputsLevel3Memberus-gaap:PensionPlansDefinedBenefitMembercountry:US2021-12-310001755672us-gaap:EquitySecuritiesMemberus-gaap:NonUsMemberus-gaap:PensionPlansDefinedBenefitMember2021-12-310001755672us-gaap:EquitySecuritiesMemberus-gaap:NonUsMemberus-gaap:FairValueInputsLevel1Memberus-gaap:PensionPlansDefinedBenefitMember2021-12-310001755672us-gaap:FairValueInputsLevel2Memberus-gaap:EquitySecuritiesMemberus-gaap:NonUsMemberus-gaap:PensionPlansDefinedBenefitMember2021-12-310001755672us-gaap:EquitySecuritiesMemberus-gaap:NonUsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:PensionPlansDefinedBenefitMember2021-12-310001755672us-gaap:USTreasuryAndGovernmentMemberus-gaap:PensionPlansDefinedBenefitMember2021-12-310001755672us-gaap:USTreasuryAndGovernmentMemberus-gaap:FairValueInputsLevel1Memberus-gaap:PensionPlansDefinedBenefitMember2021-12-310001755672us-gaap:FairValueInputsLevel2Memberus-gaap:USTreasuryAndGovernmentMemberus-gaap:PensionPlansDefinedBenefitMember2021-12-310001755672us-gaap:USTreasuryAndGovernmentMemberus-gaap:FairValueInputsLevel3Memberus-gaap:PensionPlansDefinedBenefitMember2021-12-310001755672us-gaap:PensionPlansDefinedBenefitMemberus-gaap:CorporateDebtSecuritiesMember2021-12-310001755672us-gaap:FairValueInputsLevel1Memberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:CorporateDebtSecuritiesMember2021-12-310001755672us-gaap:FairValueInputsLevel2Memberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:CorporateDebtSecuritiesMember2021-12-310001755672us-gaap:FairValueInputsLevel3Memberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:CorporateDebtSecuritiesMember2021-12-310001755672us-gaap:AssetBackedSecuritiesMemberus-gaap:PensionPlansDefinedBenefitMember2021-12-310001755672us-gaap:AssetBackedSecuritiesMemberus-gaap:FairValueInputsLevel1Memberus-gaap:PensionPlansDefinedBenefitMember2021-12-310001755672us-gaap:FairValueInputsLevel2Memberus-gaap:AssetBackedSecuritiesMemberus-gaap:PensionPlansDefinedBenefitMember2021-12-310001755672us-gaap:FairValueInputsLevel3Memberus-gaap:AssetBackedSecuritiesMemberus-gaap:PensionPlansDefinedBenefitMember2021-12-310001755672us-gaap:PrivateEquityFundsMemberus-gaap:PensionPlansDefinedBenefitMember2021-12-310001755672us-gaap:PrivateEquityFundsMemberus-gaap:FairValueInputsLevel1Memberus-gaap:PensionPlansDefinedBenefitMember2021-12-310001755672us-gaap:PrivateEquityFundsMemberus-gaap:FairValueInputsLevel2Memberus-gaap:PensionPlansDefinedBenefitMember2021-12-310001755672us-gaap:PrivateEquityFundsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:PensionPlansDefinedBenefitMember2021-12-310001755672us-gaap:RealEstateMemberus-gaap:PensionPlansDefinedBenefitMember2021-12-310001755672us-gaap:FairValueInputsLevel1Memberus-gaap:RealEstateMemberus-gaap:PensionPlansDefinedBenefitMember2021-12-310001755672us-gaap:FairValueInputsLevel2Memberus-gaap:RealEstateMemberus-gaap:PensionPlansDefinedBenefitMember2021-12-310001755672us-gaap:FairValueInputsLevel3Memberus-gaap:RealEstateMemberus-gaap:PensionPlansDefinedBenefitMember2021-12-310001755672us-gaap:OtherInvestmentsMemberus-gaap:PensionPlansDefinedBenefitMember2021-12-310001755672us-gaap:OtherInvestmentsMemberus-gaap:FairValueInputsLevel1Memberus-gaap:PensionPlansDefinedBenefitMember2021-12-310001755672us-gaap:OtherInvestmentsMemberus-gaap:FairValueInputsLevel2Memberus-gaap:PensionPlansDefinedBenefitMember2021-12-310001755672us-gaap:OtherInvestmentsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:PensionPlansDefinedBenefitMember2021-12-310001755672us-gaap:FairValueInputsLevel1Memberus-gaap:PensionPlansDefinedBenefitMember2021-12-310001755672us-gaap:FairValueInputsLevel2Memberus-gaap:PensionPlansDefinedBenefitMember2021-12-310001755672us-gaap:FairValueInputsLevel3Memberus-gaap:PensionPlansDefinedBenefitMember2021-12-310001755672us-gaap:HedgeFundsMemberus-gaap:PensionPlansDefinedBenefitMember2021-12-310001755672us-gaap:PensionPlansDefinedBenefitMemberus-gaap:CommonStockMember2021-12-310001755672us-gaap:CommonStockMember2021-12-310001755672us-gaap:PensionPlansDefinedBenefitMemberus-gaap:RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember2020-12-310001755672us-gaap:FairValueInputsLevel1Memberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember2020-12-310001755672us-gaap:FairValueInputsLevel2Memberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember2020-12-310001755672us-gaap:FairValueInputsLevel3Memberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember2020-12-310001755672us-gaap:EquitySecuritiesMemberus-gaap:PensionPlansDefinedBenefitMembercountry:US2020-12-310001755672us-gaap:EquitySecuritiesMemberus-gaap:FairValueInputsLevel1Memberus-gaap:PensionPlansDefinedBenefitMembercountry:US2020-12-310001755672us-gaap:FairValueInputsLevel2Memberus-gaap:EquitySecuritiesMemberus-gaap:PensionPlansDefinedBenefitMembercountry:US2020-12-310001755672us-gaap:EquitySecuritiesMemberus-gaap:FairValueInputsLevel3Memberus-gaap:PensionPlansDefinedBenefitMembercountry:US2020-12-310001755672us-gaap:EquitySecuritiesMemberus-gaap:NonUsMemberus-gaap:PensionPlansDefinedBenefitMember2020-12-310001755672us-gaap:EquitySecuritiesMemberus-gaap:NonUsMemberus-gaap:FairValueInputsLevel1Memberus-gaap:PensionPlansDefinedBenefitMember2020-12-310001755672us-gaap:FairValueInputsLevel2Memberus-gaap:EquitySecuritiesMemberus-gaap:NonUsMemberus-gaap:PensionPlansDefinedBenefitMember2020-12-310001755672us-gaap:EquitySecuritiesMemberus-gaap:NonUsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:PensionPlansDefinedBenefitMember2020-12-310001755672us-gaap:USTreasuryAndGovernmentMemberus-gaap:PensionPlansDefinedBenefitMember2020-12-310001755672us-gaap:USTreasuryAndGovernmentMemberus-gaap:FairValueInputsLevel1Memberus-gaap:PensionPlansDefinedBenefitMember2020-12-310001755672us-gaap:FairValueInputsLevel2Memberus-gaap:USTreasuryAndGovernmentMemberus-gaap:PensionPlansDefinedBenefitMember2020-12-310001755672us-gaap:USTreasuryAndGovernmentMemberus-gaap:FairValueInputsLevel3Memberus-gaap:PensionPlansDefinedBenefitMember2020-12-310001755672us-gaap:PensionPlansDefinedBenefitMemberus-gaap:CorporateDebtSecuritiesMember2020-12-310001755672us-gaap:FairValueInputsLevel1Memberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:CorporateDebtSecuritiesMember2020-12-310001755672us-gaap:FairValueInputsLevel2Memberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:CorporateDebtSecuritiesMember2020-12-310001755672us-gaap:FairValueInputsLevel3Memberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:CorporateDebtSecuritiesMember2020-12-310001755672us-gaap:AssetBackedSecuritiesMemberus-gaap:PensionPlansDefinedBenefitMember2020-12-310001755672us-gaap:AssetBackedSecuritiesMemberus-gaap:FairValueInputsLevel1Memberus-gaap:PensionPlansDefinedBenefitMember2020-12-310001755672us-gaap:FairValueInputsLevel2Memberus-gaap:AssetBackedSecuritiesMemberus-gaap:PensionPlansDefinedBenefitMember2020-12-310001755672us-gaap:FairValueInputsLevel3Memberus-gaap:AssetBackedSecuritiesMemberus-gaap:PensionPlansDefinedBenefitMember2020-12-310001755672us-gaap:PrivateEquityFundsMemberus-gaap:PensionPlansDefinedBenefitMember2020-12-310001755672us-gaap:PrivateEquityFundsMemberus-gaap:FairValueInputsLevel1Memberus-gaap:PensionPlansDefinedBenefitMember2020-12-310001755672us-gaap:PrivateEquityFundsMemberus-gaap:FairValueInputsLevel2Memberus-gaap:PensionPlansDefinedBenefitMember2020-12-310001755672us-gaap:PrivateEquityFundsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:PensionPlansDefinedBenefitMember2020-12-310001755672us-gaap:RealEstateMemberus-gaap:PensionPlansDefinedBenefitMember2020-12-310001755672us-gaap:FairValueInputsLevel1Memberus-gaap:RealEstateMemberus-gaap:PensionPlansDefinedBenefitMember2020-12-310001755672us-gaap:FairValueInputsLevel2Memberus-gaap:RealEstateMemberus-gaap:PensionPlansDefinedBenefitMember2020-12-310001755672us-gaap:FairValueInputsLevel3Memberus-gaap:RealEstateMemberus-gaap:PensionPlansDefinedBenefitMember2020-12-310001755672us-gaap:OtherInvestmentsMemberus-gaap:PensionPlansDefinedBenefitMember2020-12-310001755672us-gaap:OtherInvestmentsMemberus-gaap:FairValueInputsLevel1Memberus-gaap:PensionPlansDefinedBenefitMember2020-12-310001755672us-gaap:OtherInvestmentsMemberus-gaap:FairValueInputsLevel2Memberus-gaap:PensionPlansDefinedBenefitMember2020-12-310001755672us-gaap:OtherInvestmentsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:PensionPlansDefinedBenefitMember2020-12-310001755672us-gaap:FairValueInputsLevel1Memberus-gaap:PensionPlansDefinedBenefitMember2020-12-310001755672us-gaap:FairValueInputsLevel2Memberus-gaap:PensionPlansDefinedBenefitMember2020-12-310001755672us-gaap:FairValueInputsLevel3Memberus-gaap:PensionPlansDefinedBenefitMember2020-12-310001755672us-gaap:HedgeFundsMemberus-gaap:PensionPlansDefinedBenefitMember2020-12-310001755672us-gaap:PensionPlansDefinedBenefitMemberus-gaap:CommonStockMember2020-12-310001755672us-gaap:EquitySecuritiesMemberus-gaap:FairValueInputsLevel3Memberus-gaap:PensionPlansDefinedBenefitMembercountry:US2019-12-310001755672us-gaap:EquitySecuritiesMemberus-gaap:NonUsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:PensionPlansDefinedBenefitMember2019-12-310001755672us-gaap:FairValueInputsLevel3Memberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:CorporateDebtSecuritiesMember2019-12-310001755672us-gaap:PrivateEquityFundsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:PensionPlansDefinedBenefitMember2019-12-310001755672us-gaap:FairValueInputsLevel3Memberus-gaap:RealEstateMemberus-gaap:PensionPlansDefinedBenefitMember2019-12-310001755672us-gaap:OtherInvestmentsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:PensionPlansDefinedBenefitMember2019-12-310001755672us-gaap:FairValueInputsLevel3Memberus-gaap:PensionPlansDefinedBenefitMember2019-12-310001755672us-gaap:EquitySecuritiesMemberus-gaap:FairValueInputsLevel3Memberus-gaap:PensionPlansDefinedBenefitMembercountry:US2020-01-012020-12-310001755672us-gaap:EquitySecuritiesMemberus-gaap:NonUsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:PensionPlansDefinedBenefitMember2020-01-012020-12-310001755672us-gaap:FairValueInputsLevel3Memberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:CorporateDebtSecuritiesMember2020-01-012020-12-310001755672us-gaap:PrivateEquityFundsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:PensionPlansDefinedBenefitMember2020-01-012020-12-310001755672us-gaap:FairValueInputsLevel3Memberus-gaap:RealEstateMemberus-gaap:PensionPlansDefinedBenefitMember2020-01-012020-12-310001755672us-gaap:OtherInvestmentsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:PensionPlansDefinedBenefitMember2020-01-012020-12-310001755672us-gaap:FairValueInputsLevel3Memberus-gaap:PensionPlansDefinedBenefitMember2020-01-012020-12-310001755672us-gaap:EquitySecuritiesMemberus-gaap:FairValueInputsLevel3Memberus-gaap:PensionPlansDefinedBenefitMembercountry:US2021-01-012021-12-310001755672us-gaap:EquitySecuritiesMemberus-gaap:NonUsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:PensionPlansDefinedBenefitMember2021-01-012021-12-310001755672us-gaap:FairValueInputsLevel3Memberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:CorporateDebtSecuritiesMember2021-01-012021-12-310001755672us-gaap:PrivateEquityFundsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:PensionPlansDefinedBenefitMember2021-01-012021-12-310001755672us-gaap:FairValueInputsLevel3Memberus-gaap:RealEstateMemberus-gaap:PensionPlansDefinedBenefitMember2021-01-012021-12-310001755672us-gaap:OtherInvestmentsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:PensionPlansDefinedBenefitMember2021-01-012021-12-310001755672us-gaap:FairValueInputsLevel3Memberus-gaap:PensionPlansDefinedBenefitMember2021-01-012021-12-310001755672ctva:TrustAgreementMemberus-gaap:NonqualifiedPlanMember2017-11-012017-11-300001755672ctva:TrustAgreementMemberus-gaap:NonqualifiedPlanMember2019-01-012019-06-010001755672ctva:TrustAgreementMemberus-gaap:NonqualifiedPlanMember2021-01-012021-12-310001755672ctva:TrustAgreementMemberus-gaap:NonqualifiedPlanMember2020-01-012020-12-310001755672ctva:TrustAgreementMemberus-gaap:NonqualifiedPlanMember2021-12-310001755672ctva:TrustAgreementMemberus-gaap:NonqualifiedPlanMember2020-12-310001755672ctva:U.S.RetirementSavingsPlanMember2021-01-012021-12-310001755672ctva:U.S.RetirementSavingsPlanMember2020-01-012020-12-310001755672ctva:U.S.RetirementSavingsPlanMember2019-01-012019-12-310001755672ctva:CortevaOtherContributionPlansMember2021-01-012021-12-310001755672ctva:CortevaOtherContributionPlansMember2020-01-012020-12-310001755672ctva:CortevaOtherContributionPlansMember2019-01-012019-12-310001755672ctva:CortevaOtherContributionPlansMemberus-gaap:SegmentDiscontinuedOperationsMember2019-01-012019-12-310001755672ctva:OIPMember2021-12-310001755672us-gaap:EmployeeStockOptionMember2021-01-012021-12-310001755672us-gaap:EmployeeStockOptionMember2020-01-012020-12-310001755672us-gaap:EmployeeStockOptionMember2019-01-012019-12-310001755672ctva:OIPMemberus-gaap:StockOptionMemberctva:GrantsBetweenJune2019And2020Member2021-01-012021-12-310001755672ctva:Grantsbetween2013and2015Memberus-gaap:StockOptionMemberctva:EIPMember2021-01-012021-12-310001755672us-gaap:StockOptionMemberctva:EIPMemberctva:Grantsbetween2016and2018Member2021-01-012021-12-310001755672ctva:DowMember2021-01-012021-12-310001755672ctva:OIPMemberus-gaap:EmployeeStockMember2021-01-012021-12-310001755672ctva:OIPMemberus-gaap:EmployeeStockMember2020-01-012020-12-310001755672us-gaap:EmployeeStockMemberctva:EIPMember2020-01-012020-12-310001755672ctva:OIPMember2021-01-012021-12-310001755672ctva:OIPMember2020-01-012020-12-310001755672ctva:EIPMember2019-01-012019-12-310001755672us-gaap:StockOptionMember2020-12-310001755672us-gaap:StockOptionMember2020-01-012020-12-310001755672us-gaap:StockOptionMember2021-01-012021-12-310001755672us-gaap:StockOptionMember2021-12-310001755672ctva:OIPMember2021-01-012021-12-310001755672ctva:OIPMember2020-01-012020-12-310001755672ctva:EIPMember2020-01-012020-12-310001755672us-gaap:RestrictedStockUnitsRSUMemberctva:EIPMember2021-01-012021-12-310001755672srt:MinimumMemberus-gaap:RestrictedStockUnitsRSUMemberctva:DowMember2021-01-012021-12-310001755672us-gaap:RestrictedStockUnitsRSUMemberctva:DowMembersrt:MaximumMember2021-01-012021-12-310001755672ctva:OIPMemberus-gaap:RestrictedStockUnitsRSUMember2021-01-012021-12-310001755672us-gaap:RestrictedStockUnitsRSUMember2021-01-012021-12-310001755672us-gaap:PerformanceSharesMember2021-01-012021-12-310001755672srt:MinimumMemberus-gaap:RestrictedStockUnitsRSUMembersrt:ManagementMember2021-01-012021-12-310001755672us-gaap:RestrictedStockUnitsRSUMembersrt:ManagementMembersrt:MaximumMember2021-01-012021-12-310001755672ctva:PerformanceShareUnitsMember2021-01-012021-12-310001755672ctva:RestrictedStockUnitsAndPerformanceShareUnitsMember2020-12-310001755672ctva:RestrictedStockUnitsAndPerformanceShareUnitsMember2021-01-012021-12-310001755672ctva:RestrictedStockUnitsAndPerformanceShareUnitsMember2021-12-310001755672ctva:RSUsAndPSUsOIPMember2021-01-012021-12-310001755672ctva:RSUsAndPSUsOIPMember2020-01-012020-12-310001755672ctva:RSUsAndPSUsEIPMember2020-01-012020-12-310001755672ctva:RSUsAndPSUsOIPMember2021-12-310001755672us-gaap:CashEquivalentsMember2021-12-310001755672us-gaap:CashEquivalentsMember2020-12-310001755672ctva:MarketableSecuritiesMember2021-12-310001755672ctva:MarketableSecuritiesMember2020-12-310001755672us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeContractMember2021-12-310001755672us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeContractMember2020-12-310001755672us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CommodityContractMember2021-12-310001755672us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CommodityContractMember2020-12-310001755672us-gaap:NondesignatedMemberus-gaap:ForeignExchangeContractMember2021-12-310001755672us-gaap:NondesignatedMemberus-gaap:ForeignExchangeContractMember2020-12-310001755672us-gaap:NondesignatedMemberus-gaap:CommodityContractMember2021-12-310001755672us-gaap:NondesignatedMemberus-gaap:CommodityContractMember2020-12-310001755672us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CommodityContractMember2021-01-012021-12-310001755672us-gaap:CommodityContractMember2021-01-012021-12-310001755672us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CommodityContractMember2019-12-310001755672us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CommodityContractMember2018-12-310001755672us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CommodityContractMember2020-01-012020-12-310001755672us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CommodityContractMember2019-01-012019-12-310001755672us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeContractMember2021-01-012021-12-310001755672us-gaap:ForeignExchangeContractMember2021-01-012021-12-310001755672us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeContractMember2019-12-310001755672us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeContractMember2020-01-012020-12-310001755672us-gaap:ForeignExchangeContractMemberus-gaap:NetInvestmentHedgingMember2021-12-31iso4217:EUR0001755672us-gaap:OtherCurrentAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeContractMember2021-12-310001755672us-gaap:NondesignatedMemberus-gaap:OtherCurrentAssetsMemberus-gaap:ForeignExchangeContractMember2021-12-310001755672us-gaap:NondesignatedMemberus-gaap:OtherCurrentAssetsMemberus-gaap:CommodityContractMember2021-12-310001755672us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeContractMemberctva:AccruedandOtherCurrentLiabilitiesMember2021-12-310001755672us-gaap:NondesignatedMemberus-gaap:ForeignExchangeContractMemberctva:AccruedandOtherCurrentLiabilitiesMember2021-12-310001755672us-gaap:NondesignatedMemberctva:AccruedandOtherCurrentLiabilitiesMemberus-gaap:CommodityContractMember2021-12-310001755672us-gaap:OtherCurrentAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeContractMember2020-12-310001755672us-gaap:NondesignatedMemberus-gaap:OtherCurrentAssetsMemberus-gaap:ForeignExchangeContractMember2020-12-310001755672us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeContractMemberctva:AccruedandOtherCurrentLiabilitiesMember2020-12-310001755672us-gaap:NondesignatedMemberus-gaap:ForeignExchangeContractMemberctva:AccruedandOtherCurrentLiabilitiesMember2020-12-310001755672us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeContractMemberus-gaap:NetInvestmentHedgingMember2021-01-012021-12-310001755672us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeContractMemberus-gaap:NetInvestmentHedgingMember2020-01-012020-12-310001755672us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeContractMemberus-gaap:NetInvestmentHedgingMember2019-01-012019-12-310001755672us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeContractMemberus-gaap:CashFlowHedgingMember2021-01-012021-12-310001755672us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeContractMemberus-gaap:CashFlowHedgingMember2020-01-012020-12-310001755672us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeContractMemberus-gaap:CashFlowHedgingMember2019-01-012019-12-310001755672us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CommodityContractMemberus-gaap:CashFlowHedgingMember2021-01-012021-12-310001755672us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CommodityContractMemberus-gaap:CashFlowHedgingMember2020-01-012020-12-310001755672us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CommodityContractMemberus-gaap:CashFlowHedgingMember2019-01-012019-12-310001755672us-gaap:DesignatedAsHedgingInstrumentMember2021-01-012021-12-310001755672us-gaap:DesignatedAsHedgingInstrumentMember2020-01-012020-12-310001755672us-gaap:DesignatedAsHedgingInstrumentMember2019-01-012019-12-310001755672us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeContractMemberus-gaap:CashFlowHedgingMemberus-gaap:CostOfSalesMember2021-01-012021-12-310001755672us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeContractMemberus-gaap:CashFlowHedgingMemberus-gaap:CostOfSalesMember2020-01-012020-12-310001755672us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeContractMemberus-gaap:CashFlowHedgingMemberus-gaap:CostOfSalesMember2019-01-012019-12-310001755672us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CommodityContractMemberus-gaap:CashFlowHedgingMemberus-gaap:CostOfSalesMember2021-01-012021-12-310001755672us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CommodityContractMemberus-gaap:CashFlowHedgingMemberus-gaap:CostOfSalesMember2020-01-012020-12-310001755672us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CommodityContractMemberus-gaap:CashFlowHedgingMemberus-gaap:CostOfSalesMember2019-01-012019-12-310001755672us-gaap:NondesignatedMemberus-gaap:ForeignExchangeContractMemberus-gaap:OtherNonoperatingIncomeExpenseMember2021-01-012021-12-310001755672us-gaap:NondesignatedMemberus-gaap:ForeignExchangeContractMemberus-gaap:OtherNonoperatingIncomeExpenseMember2020-01-012020-12-310001755672us-gaap:NondesignatedMemberus-gaap:ForeignExchangeContractMemberus-gaap:OtherNonoperatingIncomeExpenseMember2019-01-012019-12-310001755672us-gaap:NondesignatedMemberus-gaap:ForeignExchangeContractMemberus-gaap:CostOfSalesMember2021-01-012021-12-310001755672us-gaap:NondesignatedMemberus-gaap:ForeignExchangeContractMemberus-gaap:CostOfSalesMember2020-01-012020-12-310001755672us-gaap:NondesignatedMemberus-gaap:ForeignExchangeContractMemberus-gaap:CostOfSalesMember2019-01-012019-12-310001755672us-gaap:NondesignatedMemberus-gaap:CommodityContractMemberus-gaap:CostOfSalesMember2021-01-012021-12-310001755672us-gaap:NondesignatedMemberus-gaap:CommodityContractMemberus-gaap:CostOfSalesMember2020-01-012020-12-310001755672us-gaap:NondesignatedMemberus-gaap:CommodityContractMemberus-gaap:CostOfSalesMember2019-01-012019-12-310001755672us-gaap:NondesignatedMember2021-01-012021-12-310001755672us-gaap:NondesignatedMember2020-01-012020-12-310001755672us-gaap:NondesignatedMember2019-01-012019-12-310001755672us-gaap:AvailableforsaleSecuritiesMember2021-01-012021-12-310001755672us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2021-12-310001755672us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Memberus-gaap:ForeignExchangeContractMember2021-12-310001755672us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2021-12-310001755672us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2020-12-310001755672us-gaap:FairValueMeasurementsRecurringMemberus-gaap:USTreasurySecuritiesMemberus-gaap:FairValueInputsLevel1Member2020-12-310001755672us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Memberus-gaap:ForeignExchangeContractMember2020-12-310001755672us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2020-12-310001755672us-gaap:TechnologyBasedIntangibleAssetsMember2020-12-310001755672us-gaap:FairValueMeasurementsNonrecurringMemberus-gaap:TechnologyBasedIntangibleAssetsMember2020-01-012020-12-310001755672us-gaap:OtherIntangibleAssetsMember2020-12-310001755672us-gaap:FairValueMeasurementsNonrecurringMemberus-gaap:OtherIntangibleAssetsMember2020-01-012020-12-310001755672us-gaap:InProcessResearchAndDevelopmentMember2020-12-310001755672us-gaap:FairValueMeasurementsNonrecurringMemberus-gaap:InProcessResearchAndDevelopmentMember2020-01-012020-12-310001755672country:US2021-01-012021-12-310001755672country:US2020-01-012020-12-310001755672country:US2019-01-012019-12-310001755672country:CA2021-01-012021-12-310001755672country:CA2020-01-012020-12-310001755672country:CA2019-01-012019-12-310001755672us-gaap:EMEAMember2021-01-012021-12-310001755672us-gaap:EMEAMember2020-01-012020-12-310001755672us-gaap:EMEAMember2019-01-012019-12-310001755672srt:LatinAmericaMember2021-01-012021-12-310001755672srt:LatinAmericaMember2020-01-012020-12-310001755672srt:LatinAmericaMember2019-01-012019-12-310001755672srt:AsiaPacificMember2021-01-012021-12-310001755672srt:AsiaPacificMember2020-01-012020-12-310001755672srt:AsiaPacificMember2019-01-012019-12-310001755672country:BR2021-01-012021-12-310001755672country:BR2020-01-012020-12-310001755672country:BR2019-01-012019-12-310001755672country:US2021-12-310001755672country:US2020-12-310001755672country:US2019-12-310001755672country:CA2021-12-310001755672country:CA2020-12-310001755672country:CA2019-12-310001755672us-gaap:EMEAMember2021-12-310001755672us-gaap:EMEAMember2020-12-310001755672us-gaap:EMEAMember2019-12-310001755672srt:AsiaPacificMember2021-12-310001755672srt:AsiaPacificMember2020-12-310001755672srt:AsiaPacificMember2019-12-310001755672srt:LatinAmericaMember2021-12-310001755672srt:LatinAmericaMember2020-12-310001755672srt:LatinAmericaMember2019-12-310001755672us-gaap:OperatingSegmentsMember2021-01-012021-12-310001755672us-gaap:OperatingSegmentsMember2021-12-310001755672us-gaap:OperatingSegmentsMember2020-01-012020-12-310001755672us-gaap:OperatingSegmentsMember2020-12-310001755672us-gaap:OperatingSegmentsMember2019-01-012019-12-310001755672us-gaap:OperatingSegmentsMember2019-12-310001755672ctva:ReallocationofgoodwillMember2019-06-010001755672us-gaap:MaterialReconcilingItemsMember2020-01-012020-12-310001755672us-gaap:MaterialReconcilingItemsMember2019-01-012019-12-310001755672ctva:HedgingProgramMemberus-gaap:MaterialReconcilingItemsMemberctva:ArgentinepesodevaluationMember2020-01-012020-12-310001755672us-gaap:SegmentDiscontinuedOperationsMember2019-01-012019-12-310001755672us-gaap:MaterialReconcilingItemsMemberctva:CropProtectionMember2021-01-012021-12-310001755672us-gaap:MaterialReconcilingItemsMemberus-gaap:CorporateNonSegmentMember2021-01-012021-12-310001755672us-gaap:MaterialReconcilingItemsMemberctva:SeedMember2020-01-012020-12-310001755672us-gaap:MaterialReconcilingItemsMemberctva:CropProtectionMember2020-01-012020-12-310001755672us-gaap:MaterialReconcilingItemsMemberus-gaap:CorporateNonSegmentMember2020-01-012020-12-310001755672us-gaap:MaterialReconcilingItemsMemberctva:CropProtectionMemberctva:SaleofJVMember2020-01-012020-12-310001755672us-gaap:MaterialReconcilingItemsMemberctva:SeedMember2019-01-012019-12-310001755672us-gaap:MaterialReconcilingItemsMemberctva:CropProtectionMember2019-01-012019-12-310001755672us-gaap:MaterialReconcilingItemsMemberus-gaap:CorporateNonSegmentMember2019-01-012019-12-310001755672us-gaap:MaterialReconcilingItemsMemberctva:AssetsaleMemberctva:SeedMember2019-01-012019-12-310001755672us-gaap:MaterialReconcilingItemsMemberctva:AssetsaleMember2019-01-012019-12-310001755672us-gaap:MaterialReconcilingItemsMemberctva:SeedMemberctva:DeconsolidationofasubsidiaryMember2019-01-012019-12-310001755672us-gaap:MaterialReconcilingItemsMemberctva:DeconsolidationofasubsidiaryMember2019-01-012019-12-310001755672us-gaap:MaterialReconcilingItemsMemberctva:SeedMemberctva:OtherlossonsaleMember2019-01-012019-12-310001755672us-gaap:MaterialReconcilingItemsMemberctva:OtherlossonsaleMember2019-01-012019-12-310001755672ctva:HedgingProgramMemberus-gaap:MaterialReconcilingItemsMemberctva:TaxReformForeignCurrencyExchangeImpactMemberus-gaap:CorporateNonSegmentMember2019-01-012019-12-310001755672ctva:HedgingProgramMemberus-gaap:MaterialReconcilingItemsMemberctva:TaxReformForeignCurrencyExchangeImpactMember2019-01-012019-12-310001755672ctva:HedgingProgramMemberctva:ArgentinepesodevaluationMember2020-07-012020-09-300001755672us-gaap:SecuritiesSoldUnderAgreementsToRepurchaseMember2021-02-090001755672ctva:EIDMember2020-01-012020-12-310001755672ctva:EIDMemberus-gaap:PensionPlansDefinedBenefitMember2021-01-012021-12-310001755672ctva:EIDMemberus-gaap:PensionPlansDefinedBenefitMember2020-01-012020-12-310001755672ctva:EIDMemberus-gaap:PensionPlansDefinedBenefitMember2019-01-012019-12-310001755672ctva:EIDMemberus-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2021-01-012021-12-310001755672ctva:EIDMemberus-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2020-01-012020-12-310001755672ctva:EIDMemberus-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2019-01-012019-12-310001755672ctva:EIDMember2021-12-310001755672ctva:EIDMember2020-12-310001755672ctva:TotalcompanyMemberctva:EIDMember2021-01-012021-12-310001755672ctva:TotalcompanyMemberctva:EIDMember2020-01-012020-12-310001755672ctva:TotalcompanyMemberctva:EIDMember2019-01-012019-12-310001755672ctva:EIDMember2019-12-310001755672ctva:EIDMember2018-12-310001755672us-gaap:PreferredStockMemberctva:EIDMember2018-12-310001755672ctva:EIDMemberus-gaap:CommonStockMember2018-12-310001755672ctva:EIDMemberus-gaap:AdditionalPaidInCapitalMember2018-12-310001755672ctva:DivisionalEquityMemberctva:EIDMember2018-12-310001755672ctva:EIDMemberus-gaap:RetainedEarningsMember2018-12-310001755672ctva:EIDMemberus-gaap:AccumulatedOtherComprehensiveIncomeMember2018-12-310001755672us-gaap:NoncontrollingInterestMemberctva:EIDMember2018-12-310001755672ctva:DivisionalEquityMemberctva:EIDMember2019-01-012019-12-310001755672ctva:EIDMemberus-gaap:RetainedEarningsMember2019-01-012019-12-310001755672us-gaap:NoncontrollingInterestMemberctva:EIDMember2019-01-012019-12-310001755672ctva:EIDMemberus-gaap:AccumulatedOtherComprehensiveIncomeMember2019-01-012019-12-310001755672ctva:EIDMemberus-gaap:AdditionalPaidInCapitalMember2019-01-012019-12-310001755672ctva:DivisionalEquityMemberctva:DowDuPontMemberctva:EIDMember2019-01-012019-12-310001755672ctva:DowDuPontMemberctva:EIDMember2019-01-012019-12-310001755672us-gaap:PreferredStockMemberctva:EIDMember2019-01-012019-12-310001755672us-gaap:PreferredStockMemberctva:EIDMember2019-12-310001755672ctva:EIDMemberus-gaap:CommonStockMember2019-12-310001755672ctva:EIDMemberus-gaap:AdditionalPaidInCapitalMember2019-12-310001755672ctva:EIDMemberus-gaap:RetainedEarningsMember2019-12-310001755672ctva:EIDMemberus-gaap:AccumulatedOtherComprehensiveIncomeMember2019-12-310001755672us-gaap:NoncontrollingInterestMemberctva:EIDMember2019-12-310001755672ctva:EIDMemberus-gaap:RetainedEarningsMember2020-01-012020-12-310001755672us-gaap:NoncontrollingInterestMemberctva:EIDMember2020-01-012020-12-310001755672ctva:EIDMemberus-gaap:AccumulatedOtherComprehensiveIncomeMember2020-01-012020-12-310001755672ctva:EIDMemberus-gaap:AdditionalPaidInCapitalMember2020-01-012020-12-310001755672us-gaap:PreferredStockMemberctva:EIDMember2020-12-310001755672ctva:EIDMemberus-gaap:CommonStockMember2020-12-310001755672ctva:EIDMemberus-gaap:AdditionalPaidInCapitalMember2020-12-310001755672ctva:EIDMemberus-gaap:RetainedEarningsMember2020-12-310001755672ctva:EIDMemberus-gaap:AccumulatedOtherComprehensiveIncomeMember2020-12-310001755672us-gaap:NoncontrollingInterestMemberctva:EIDMember2020-12-310001755672ctva:EIDMemberus-gaap:RetainedEarningsMember2021-01-012021-12-310001755672ctva:EIDMemberus-gaap:AccumulatedOtherComprehensiveIncomeMember2021-01-012021-12-310001755672ctva:EIDMemberus-gaap:AdditionalPaidInCapitalMember2021-01-012021-12-310001755672us-gaap:PreferredStockMemberctva:EIDMember2021-12-310001755672ctva:EIDMemberus-gaap:CommonStockMember2021-12-310001755672ctva:EIDMemberus-gaap:AdditionalPaidInCapitalMember2021-12-310001755672ctva:EIDMemberus-gaap:RetainedEarningsMember2021-12-310001755672ctva:EIDMemberus-gaap:AccumulatedOtherComprehensiveIncomeMember2021-12-310001755672us-gaap:NoncontrollingInterestMemberctva:EIDMember2021-12-310001755672ctva:EIDMemberctva:A4.50SeriesPreferredStockMember2020-01-012020-12-310001755672ctva:EIDMemberctva:A4.50SeriesPreferredStockMember2019-01-012019-12-310001755672ctva:A3.50SeriesPreferredStockMemberctva:EIDMember2020-01-012020-12-310001755672ctva:A3.50SeriesPreferredStockMemberctva:EIDMember2019-01-012019-12-310001755672ctva:CortevaMemberctva:EIDMember2021-12-310001755672ctva:CortevaMemberctva:EIDMember2020-12-310001755672ctva:CortevaMemberctva:EIDMember2021-01-012021-12-310001755672ctva:CortevaMemberctva:EIDMember2020-01-012020-12-310001755672ctva:CortevaMemberctva:EIDMemberctva:AccruedandOtherCurrentLiabilitiesMember2020-12-310001755672us-gaap:OtherNoncurrentLiabilitiesMemberctva:CortevaMemberctva:EIDMember2020-12-310001755672ctva:CortevaMemberctva:EIDMemberctva:AccruedandOtherCurrentLiabilitiesMember2021-12-310001755672us-gaap:OtherNoncurrentLiabilitiesMemberctva:CortevaMemberctva:EIDMember2021-12-310001755672us-gaap:SegmentContinuingOperationsMemberctva:EIDMember2021-01-012021-12-310001755672us-gaap:SegmentContinuingOperationsMemberctva:EIDMember2020-01-012020-12-310001755672us-gaap:SegmentContinuingOperationsMemberctva:EIDMember2019-01-012019-12-310001755672us-gaap:SegmentContinuingOperationsMemberctva:TaxChargeBenefitRelatedToTheActMemberctva:EIDMember2021-01-012021-12-310001755672ctva:SwissTaxReformMemberus-gaap:SegmentContinuingOperationsMemberctva:EIDMember2021-01-012021-12-310001755672ctva:SwissTaxReformMemberus-gaap:SegmentContinuingOperationsMemberctva:EIDMember2020-01-012020-12-310001755672us-gaap:MaterialReconcilingItemsMemberctva:EIDMember2021-01-012021-12-310001755672us-gaap:MaterialReconcilingItemsMemberctva:EIDMember2020-01-012020-12-310001755672us-gaap:MaterialReconcilingItemsMemberctva:EIDMember2019-01-012019-12-310001755672ctva:HedgingProgramMemberctva:EIDMemberctva:ArgentinepesodevaluationMember2020-01-012020-12-31

2021

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-K
(Mark One)
 ANNUAL REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the fiscal year ended December 31, 2021
OR
 TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

____________________________________________________________________________
Commission File Number 001-38710
Corteva, Inc.
(Exact Name of Registrant as Specified in Its Charter)
Delaware 82-4979096
(State or other Jurisdiction of Incorporation or Organization) (I.R.S. Employer Identification No.)
9330 Zionsville Road,Indianapolis,Indiana46268 (833)267-8382
(Address of Principal Executive Offices) (Zip Code)(Registrant’s Telephone Number, including area code)
Commission File Number 1-815
E. I. du Pont de Nemours and Company
(Exact Name of Registrant as Specified in Its Charter)
Delaware 51-0014090
(State or other Jurisdiction of Incorporation or Organization) (I.R.S. Employer Identification No.)
9330 Zionsville Road,Indianapolis,Indiana46268 (833)267-8382
(Address of Principal Executive Offices) (Zip Code)(Registrant’s Telephone Number, including area code)


Securities registered pursuant to Section 12(b) of the Act for Corteva, Inc.:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, par value $0.01 per shareCTVANew York Stock Exchange

Securities registered pursuant to Section 12(b) of the Act for E. I. du Pont de Nemours and Company:
Title of each classTrading Symbol(s)Name of each exchange on which registered
$3.50 Series Preferred Stock CTAPrANew York Stock Exchange
$4.50 Series Preferred StockCTAPrBNew York Stock Exchange


No securities are registered pursuant to Section 12(g) of the Act.
_____________________________________________________
        Indicate by check mark if the registrant is a well-known seasoned issuer (as defined in Rule 405 of the Securities Act).    
Corteva, Inc.                                      Yes  x   No  o
E. I. du Pont de Nemours and Company                          Yes  x   No  o


        Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.   
Corteva, Inc.                                      Yes  o   No  x
E. I. du Pont de Nemours and Company                          Yes  o   No  x




        Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. 
Corteva, Inc.                                           Yes  x   No  o
E. I. du Pont de Nemours and Company                               Yes  x   No  o

        Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit files). 
Corteva, Inc.                                                 Yes ý   No  o
E. I. du Pont de Nemours and Company                                 Yes ý   No  o

        Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definition of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

Corteva, Inc.Large Accelerated Filerx
Accelerated Filer o
Non-Accelerated Filero
Smaller reporting company o
Emerging growth company o
E. I. du Pont de Nemours and CompanyLarge Accelerated Filero
Accelerated Filer o
Non-Accelerated Filerx
Smaller reporting company o
Emerging growth company o

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Corteva, Inc.                                             o
E. I. du Pont de Nemours and Company                                  o
  
      Indicate by check mark whether the registrant has filed a report on and attestation to its management's assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C.7262(b)) by the registered public accounting firm that prepared or issued its audit report.
Corteva, Inc.                                             Yes ý No o
E. I. du Pont de Nemours and Company                                  Yes ý No o

        Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).    
Corteva, Inc.                                             Yes o No ý
E. I. du Pont de Nemours and Company                                  Yes o No ý

        The aggregate market value of voting stock of Corteva, Inc. held by non-affiliates of the registrant (excludes outstanding shares beneficially owned by directors and officers and treasury shares) as of June 30, 2021 was $32.5 billion.

As of February 3, 2022, 727,021,000 shares of Corteva, Inc's common stock, $0.01 par value, were outstanding.

As of February 3, 2022, all of E. I. du Pont de Nemours and Company’s issued and outstanding common stock, comprised of 200 shares, $0.30 par value per share, is held by Corteva, Inc.

E.I. du Pont de Nemours and Company meets the conditions set forth in General Instruction I(1)(a), (b) and (d) of Form 10-K (as modified by a grant of no-action relief dated February 12, 2018) and is therefore filing this form with reduced disclosure format.

Documents Incorporated by Reference
Information pertaining to certain Items in Part III of this report is incorporated herein by reference to portions of Corteva, Inc.'s definitive 2022 Annual Meeting Proxy Statement to be filed within 120 days after the end of the year covered by this Annual Report on Form 10-K, pursuant to Regulation 14A (the Proxy).



CORTEVA, INC.
Form 10-K
Table of Contents
  Page
  
 
 
 
 
 
  
 
 
 
 
 
 
 
 
  
 
 
 
 
 
  
 
F-93
 
F-83

1


Explanatory Note

This Annual Report on Form 10-K is a combined report being filed separately by Corteva, Inc. and EID. Corteva, Inc. owns all of the common equity interests in EID, and EID meets the conditions set forth in General Instruction I(1)(a), (b) and (d) of Form 10-K and is therefore filing its information within this Form 10-K with the reduced disclosure format. Each of Corteva, Inc. and EID is filing on its own behalf the information contained in this report that relates to itself, and neither company makes any representation as to information relating to the other company. Where information or an explanation is provided that is substantially the same for each company, such information or explanation has been combined in this report. Where information or an explanation is not substantially the same for each company, separate information and explanation has been provided. In addition, separate consolidated financial statements for each company, along with notes to the consolidated financial statements, are included in this report. 

The primary differences between Corteva and EID's financial statements relate to EID's Preferred Stock - $4.50 Series and EID's Preferred Stock - $3.50 Series, a related party loan between EID and Corteva, Inc. and the associated tax deductible interest expense for EID, and the capital structure of Corteva. Inc. (See EID's Note 1 - Basis of Presentation to EID's Consolidated Financial Statements, for additional information for above items). The separate EID financial statements and footnotes for areas that differ from Corteva, are included within this Annual Report on Form 10-K and begin on page F-83. Footnotes of EID that are identical to that of Corteva are cross-referenced accordingly.

2


Part I


ITEM 1.  BUSINESS
Unless otherwise indicated or the context otherwise requires, references in this Annual Report on Form 10-K to:

"Corteva" or "the company" refers to Corteva, Inc. and its consolidated subsidiaries (including EID);
"EID" refers to E. I. du Pont de Nemours and Company and its consolidated subsidiaries or E. I. du Pont de Nemours and Company excluding its consolidated subsidiaries, as the context may indicate;
"DowDuPont" refers to DowDuPont Inc. and its subsidiaries prior to the Separation (as defined below) of Corteva;
"Historical Dow" refers to The Dow Chemical Company and its consolidated subsidiaries prior to the Internal Reorganization as defined on page 4;
"Historical DuPont" and "Historical EID" refers to EID prior to the Internal Reorganization (as defined on page 4);
"Dow" refers to Dow Inc. after The Dow Distribution (as defined below);
"DuPont" refers to DuPont de Nemours, Inc. after the Separation of Corteva;
"DAS" refers to the agriculture business of Historical Dow, Dow AgroSciences; and
"Merger" refers to the all-stock merger of equals strategic combination between Historical Dow and Historical DuPont.

Background
Corteva is a leading global provider of seed and crop protection solutions focused on the agriculture industry and contributing to a healthier, more secure and sustainable food supply. Corteva was incorporated in Delaware in March 2018 and maintains its business headquarters in Indianapolis, Indiana. The company is focused on advancing its science-based innovation, which aims to deliver a wide range of improved products and services to its customers. Corteva has one of the broadest and most productive new product pipelines in the agriculture industry. The company intends to leverage its rich heritage of scientific achievement to advance its robust innovation pipeline and continue to shape the future of responsible agriculture. New products are crucial to solving farmers’ productivity challenges amid a growing global population while addressing natural resistance, regulatory changes, safety requirements and competitive dynamics. The company’s investment in technology-based and solution-based product offerings allows it to meet farmers’ evolving needs while ensuring that its investments generate sufficient returns. Meanwhile, through Corteva’s unique routes to market, the company continues to work face-to-face with farmers around the world to understand their needs.

The company's broad portfolio of agriculture solutions fuels farmer productivity in approximately 140 countries. See Note 24 - Geographic Information, to the Consolidated Financial Statements for details on the location of the company's sales and property.

On June 1, 2019, Corteva, Inc. became an independent, publicly traded company through the completed separation (the “Separation”) of the agriculture business of DuPont de Nemours, Inc. (formerly known as DowDuPont Inc.) (“DuPont” or "DowDuPont"). The separation was effectuated through a pro rata distribution (the “Corteva Distribution”) of all of the then- issued and outstanding shares of common stock of Corteva, Inc.

As a result of the Internal Reorganization (defined below), on May 31, 2019, EID was contributed to Corteva, Inc. and, as a result, Corteva, Inc. owns 100% of the outstanding common stock of EID. Prior to March 31, 2019, Corteva, Inc. had engaged in no business operations and had no assets or liabilities of any kind, other than those incident to its formation.

EID continues to be a reporting company and is deemed to be the predecessor to Corteva, Inc., with the historical results of EID to be deemed the historical results of Corteva for periods prior to and including May 31, 2019. Shares of EID preferred stock, $3.50 Series and $4.50 Series, issued and outstanding immediately prior to the Separation remain issued and outstanding and were unaffected by the Separation.

Internal Reorganizations and Business Separations
Subsequent to the Merger, Historical Dow and EID engaged in a series of internal reorganization and realignment steps to realign their businesses into three subgroups: agriculture, materials science and specialty products (collectively, the "Business Separations”). On April 1, 2019, DowDuPont completed the separation of its materials science business into a separate and independent public company by way of a distribution of Dow through a pro rata dividend in-kind of all of the then-issued and outstanding shares of Dow’s common stock, to holders of DowDuPont's common stock, as of the close of business on March 21, 2019 (the “Dow Distribution” and together with the Corteva Distribution, the “Distributions”).

3


Part I
ITEM 1.  BUSINESS, continued

Prior to the Dow Distribution, Historical Dow conveyed or transferred the assets and liabilities aligned with Historical Dow’s agriculture business to separate legal entities (“Dow Ag Entities”) and the assets and liabilities associated with its specialty products business to separate legal entities (the “Dow SP Entities”). On April 1, 2019, Dow Ag Entities and the Dow SP Entities were transferred and conveyed to DowDuPont.

In furtherance of the Business Separations, EID engaged in a series of internal reorganization and realignment steps (the “Internal Reorganization” and the "Business Realignment," respectively) to realign its businesses into three subgroups: agriculture, materials science and specialty products. As part of the Internal Reorganization:

the assets and liabilities aligned with EID’s materials science business ("EID ECP"), were transferred or conveyed to separate legal entities that were ultimately conveyed by DowDuPont to Dow on April 1, 2019;

the assets and liabilities aligned with EID’s specialty products business were transferred or conveyed to separate legal entities that were ultimately distributed to DowDuPont ("EID Specialty Products Entities") on May 1, 2019;

on May 2, 2019, DowDuPont conveyed Dow Ag Entities to EID and in connection with the foregoing, EID issued additional shares of its common stock to DowDuPont; and

on May 31, 2019, DowDuPont contributed EID to Corteva, Inc.

On May 6, 2019, the Board of Directors of DowDuPont approved the distribution of all the then issued and outstanding shares of common stock of Corteva, Inc., then a wholly-owned subsidiary of DowDuPont, to DowDuPont stockholders. On June 1, 2019, DowDuPont completed the Separation. Corteva, Inc.'s common stock began trading on the New York Stock Exchange under the ticker symbol "CTVA" on June 3, 2019.

As a result of the Business Realignment and the Internal Reorganization discussed above, Corteva owns 100% of the outstanding common stock of EID. EID is a subsidiary of Corteva, Inc. and continues to be a reporting company, subject to the requirements of the Securities Exchange Act of 1934, as amended.

Separation Agreements
In connection with the Distributions, DuPont, Corteva, and Dow (together, the “Parties” and each a “Party”) have entered into certain agreements to effect the separation, provide for the allocation of DowDuPont’s assets, employees, liabilities and obligations (including its investments, property and employee benefits and tax-related assets and liabilities) among the Parties, and provide a framework for Corteva's relationship with Dow and DuPont following the separations and Distributions. Effective April 1, 2019, the Parties entered into the following agreements:

Separation and Distribution Agreement - Effective April 1, 2019, the Parties entered into an agreement that sets forth, among other things, the agreements among the Parties regarding the principal transactions necessary to effect the Distributions. It also sets forth other agreements that govern certain aspects of the Parties’ ongoing relationships after the completion of the Distributions (the "Corteva Separation Agreement").

Tax Matters Agreement - The Parties entered into an agreement effective as of April 1, 2019, as amended on June 1, 2019, that governs their respective rights, responsibilities and obligations with respect to tax liabilities and benefits, tax attributes, the preparation and filing of tax returns, the control of audits and other tax proceedings and other matters regarding taxes.

Employee Matters Agreement - The Parties entered into an agreement that identifies employees and employee-related liabilities (and attributable assets) to be allocated (either retained, transferred and accepted, or assigned and assumed, as applicable) to the Parties as part of the Distributions and describes when and how the relevant transfers and assignments would occur.

Intellectual Property Cross-License Agreement - Effective as of April 1, 2019 Corteva and Dow, and effective June 1, 2019, Corteva and DuPont, entered into Intellectual Property Cross-License Agreements. The Intellectual Property Cross-License Agreements set forth the terms and conditions under which the applicable Parties may use in their respective businesses, following each of the Distributions, certain know-how (including trade secrets), copyrights, and software, and certain patents and standards, allocated to another Party pursuant to the Corteva Separation Agreement.
4


Part I
ITEM 1.  BUSINESS, continued


Letter Agreement - Effective as of June 1, 2019 DuPont and Corteva entered into a Letter Agreement. The Letter Agreement sets forth certain additional terms and conditions related to the Separation, including certain limitations on each party’s ability to transfer certain businesses and assets to third parties without assigning certain of such party’s indemnification obligations under the Corteva Separation Agreement to the other party to the transferee of such businesses and assets or meeting certain other alternative conditions.

Business Segments
The company’s operations are managed through two reportable segments: seed and crop protection. The seed segment develops and supplies commercial seed combining superior germplasm with advanced traits to produce high yield potential for farmers around the world. The crop protection segment supplies products to protect crop yields against weeds, insects and disease, enabling farmers to achieve optimal results. The combination of these leading platforms creates one of the broadest portfolios of agriculture solutions in the industry. Additional information with respect to business segment results is included in Item 7, Management’s Discussion and Analysis of Financial Condition and Results of Operations, on page 47 of this report and Note 25 - Segment Information, to the Consolidated Financial Statements.

Seed
The seed segment is a global leader in developing and supplying commercial seed combining advanced germplasm and traits that produce optimum yield for farms around the world. The company’s seed segment is a leader in many key seed markets, including North America corn and soybeans, Europe corn and sunflower, as well as Brazil, India, South Africa and Argentina corn. The company offers trait technologies that improve resistance to weather, disease, insects and herbicides used to control weeds, and trait technologies that enhance food and nutritional characteristics. In addition, the company provides digital solutions that assist farmer decision-making with a view to optimize product selection and, ultimately, help maximize yield and profitability.

Details on the seed segment’s net sales by major product line and geographic region (based on customer location) are as follows:
ctva-20211231_g1.jpg ctva-20211231_g2.jpg

5


Part I
ITEM 1.  BUSINESS, continued

Products and Brands
The seed segment’s major brands and technologies, by key product line, are listed below:
Seed Solutions Brands
Pioneer®; Brevant® seeds; Dairyland Seed®; Hoegemeyer®; Nutech®; Seed Consultants®; AgVenture®; Alforex®; PhytoGen®; Pannar®; VP Maxx®; HPT®; G2®; Supreme EX®; XL®; Power Plus®
Seed Solutions Traits and Technologies
ENLIST E3® soybeans; ENLIST® cotton; EXZACT™ Precision Technology; HERCULEX® Insect Protection; Pioneer® brand hybrids with Leptra® insect protection technology offering protection against above ground pests; POWERCORE® trait technology family of products; Pioneer® brand Optimum® AcreMax® family of products offering above and below ground insect protection; REFUGE ADVANCED® trait technology; SMARTSTAX® trait technology; NEXERA® canola trait; Omega-9 Oils; Pioneer® brand Optimum® AQUAmax® hybrids; Pioneer® brand A-Series soybeans; Pioneer® brand Plenish® high oleic soybeans; ExpressSun® herbicide tolerant trait; Pioneer Protector® products for canola, sunflower and sorghum; Pioneer MAXIMUS® rapeseed hybrids; Qrome® products for corn; Pioneer® brand canola hybrids with Clearfield® trait; PROPOUND™ advanced canola meal; Conkesta E3® soybeans; WideStrike® insect protection trait; WideStrike® 3 insect protection trait.
Other
LumiGEN® seed treatments, LUMIDERM®, LUMIVIA® and LUMIALZA™; GRANULAR®; Granular® Insights™ (e.g. LANDVisor™)

U.S. federal regulatory authorizations have been obtained for the commercialization of ENLIST™ corn, ENLIST E3® soybeans and ENLIST® cotton, including the U.S. Environmental Protection Agency's registration of ENLIST DUO® and ENLIST ONE® for use with ENLIST™ corn, soybeans and cotton in 34 states. The company has also secured cultivation authorizations of ENLIST E3® soybeans and ENLIST™ corn in Argentina, Brazil, and North America

In 2020, Corteva signed an agreement with J.G. Boswell Company to purchase the remaining 46.5 percent interest in PhytoGen® Seed Company, LLC – a joint venture between the two companies. With a 100% ownership position in PhytoGen® Seed Company, LLC, Corteva became the sole owner of the intellectual property, including patents, trademarks, proprietary germplasm and information, as well as know-how.

In 2020, Corteva announced the launch of Brevant™ seeds in the U.S. for sale exclusively through retail locations in the Midwest and Eastern Corn Belt starting with 2021 planting. As a global brand, Brevant™ seeds, which was originally launched in Latin America, Canada, and select European countries in 2018, provides farmers a greater choice with a high-performance retail solution. Brevant™ provides multiple seed offerings including corn, soybeans, sunflowers and canola.

In connection with the validation of breeding plans and large-scale product development timelines focused on rapidly ramping up differentiated technology solutions, during the fourth quarter of 2019, the company began accelerating the ramp up of the Enlist E3TM trait platform in the company’s soybean portfolio mix across all brands, including Pioneer® brands, over the subsequent five years. During the ramp-up period, the company is expected to significantly reduce the volume of products with the Roundup Ready 2 Yield® and Roundup Ready 2 Xtend® herbicide tolerance traits beginning in 2021, with expected minimal use of the Roundup Ready 2 Yield® and Roundup Ready 2 Xtend® traits thereafter for the remaining term of the non-exclusive license with the Monsanto Company. Refer to Prepaid Royalties within the Critical Accounting Estimates section on page 63 for additional information.

In 2019, Corteva received import authorization from China for the Conkesta® soybean insect control trait, which was a necessary step for commercialization of Conkesta E3® soybeans in Latin America. Conkesta E3® soybeans received regulatory approvals and was commercialized in the second half of 2021.

In 2019, the company launched Qrome® corn products in U.S. Pioneer® brands. Qrome® products offer growers high yield potential insect control options to help drive productivity for their operations by combining top-tier genetics and strong defensive traits. In 2020, Qrome® products were expanded to the U.S. multi-channel and Canada Pioneer® brands.
6


Part I
ITEM 1.  BUSINESS, continued

The company acquired exclusive rights to the Clearfield® canola production system in North America from BASF in 2019. The Clearfield® canola trait provides non-genetically modified tolerance to imidazolinone herbicides. Clearfield® canola in the Pioneer® and Nexera® brands were already highly established in the market and integrated into the company’s breeding, production and commercial processes.

In addition, the company creates digital tools that provide both farmers and internal sales resources with platforms to support agronomic and operational decision-making, particularly in the areas of product selection, targeted crop protection application, and financial analysis, designed to help maximize yield and profitability.

Distribution
The seed segment has a diverse worldwide network which markets and distributes the company’s brands to customers, primarily through the company’s multi-channel, multi-brand strategy, which includes four differentiated channels: Pioneer agency model, regional brands, retail brands, as well as third parties through licensing and distribution channels.

The Pioneer agency model is unique to Corteva and represents sales made directly to farmers via independent sales representatives. Through this agency model, the company interacts directly with farmers at multiple points in the growing season, from prior to planting all the way through harvest. These regular interactions enable the company to provide the advice and service farmers need while giving the company real-time insights into the customers’ future ordering decisions. The company’s regional brands connect to customers through regional brand employees and farmer-dealer networks. Retail brands provide a one-stop shop for seed and chemistry solutions and may include sales to distributors, agricultural cooperatives, and dealers. Finally, Corteva out-licenses traits and germplasm to third parties.

Key Raw Materials
The key raw materials for seed include corn and soybean seeds. To produce high-quality seeds, the company contracts with third-party growers globally. Corteva focuses on production close to the customer to provide the seed product, which is suitable for that region and its weed, insect and disease challenges, weather, soil and other conditions. The company conditions and packages the seeds using its own plants and third-party contract manufacturers. By striking a balance between owning production facility assets directly and contracting with third-party growers, the company believes it is best able to maintain flexibility to react to demand changes unique to each geography while minimizing costs. The company seeks to collaborate with strategic seed growers and share its digital agronomy and product management knowledge with them. The company’s third-party growers are an important part of its supply chain. Corteva provides them with rigorous training, planning tools and access to a system that tests and advances products matched to specific geographic needs.

The seed segment's R&D and supply chain groups work seamlessly to select and maintain product characteristics that enhance the quality of its seed products and solutions. Corteva focuses on customer-driven innovation to deliver superior germplasm and trait technologies. With its large sets of digitized data and its seed field management solution, the company can manage its field operations efficiently and draw insights from data quickly and effectively. This allows the company’s supply chain to react quickly to changing customer needs and provides R&D with tremendous amounts of data to analyze and incorporate into resource allocation decisions. The company continues to invest in and build capabilities that drive value via data digitization and analytics that enable it to create an even more responsive and efficient answer to customer needs.

Crop Protection
The crop protection segment serves the global agricultural input industry with products that protect against weeds, insects and other pests, and disease, and that improve overall crop health both above and below ground via nitrogen management and seed-applied technologies. The company offers crop protection solutions that provide farmers the tools they need to improve productivity and profitability, and help keep fields free of weeds, insects and diseases. The company is a leader in global herbicides, insecticides, nitrogen stabilizers and pasture and range management herbicides.

7


Part I
ITEM 1.  BUSINESS, continued

Details on the crop protection segment’s net sales by major product line and geographic region (based on customer location) are as follows:
ctva-20211231_g3.jpg ctva-20211231_g4.jpg
Products and Brands
The crop protection segment’s major brands and technologies, by key product line, are listed below:
Insect and Nematode Management
CLOSER™; DELEGATE™; INTREPID®; ISOCLAST™; LANNATE®; EXALT™; PEXALON™; TRANSFORM™; VYDATE®; OPTIMUM®; RADIANT™; SENTRICON™; ENTRUST® SC; GF-120™; and TRACER™
Disease Management
APROACH PRIMA®; VESSARYA®; APROACH™, APROACH POWER®; TALENDO™; TALIUS®; EQUATION PRO®; EQUATION CONTACT®; ZORVEC™; INATREQ™; CURZATE™; TANOS®, FONTELIS™; ACANTO™; and GALILEO®
Weed Control
ARIGO®; ARYLEX®; ENLIST™ weed control system; ENLIST ONE™; BROADWAY™; RINSKOR™; ZYPAR™; MUSTANG™; GALLANT™; VERDICT®; LANCET®; KERB™; PIXXARO®; QUELEX™; GALLERY®; CENT-7®; SNAPSHOT®; TRELLIS®; CITADEL™; CLIPPER™; GRANITE®; RAINBOW™; PINDAR® GT; VIPER®; WIDEATTACK®; BELKAR®; WIDEMATCH®; PERFECTMATCH®; CLINCHER™; DURANGO™; FENCER®; GARLON™; SONIC®; TEXARO®; KEYSTONE®; PACTO®; LIGATE®; DIMENSION®; TOPSHOT™; RICER™; LOYANT™; CLASSIC®; REALM® Q; TRIVENCE®; LONTREL®; GRAZON®; PANZER®; PRIMUS®; RESICORE™; SPIDER®; STARANE®; SURESTART®; and TORDON®
Nitrogen ManagementINSTINCT™; N-LOCK™; N-SERVE® Nitrogen Stabilizer

Key Raw Materials
The key raw materials and supplies for crop protection include chlorinated pyridines derivatives, specialty intermediates and technical grade active ingredients, chlorine, and seed treatments. Typically, the company purchases major raw materials through long-term contracts with multiple suppliers, which sometimes require minimum purchase commitments. Certain important raw materials are supplied by a few major suppliers. The company expects the markets for its raw materials to remain balanced, though pricing may be volatile given the current state of the global economy. The company relies on contract manufacturers, both domestically and internationally, to produce certain inputs or key components for its product formulations. These inputs are typically sourced close to where the company ultimately formulates and sells its products. Shifts in customer demand, reduced local availability of raw materials, and/or production capacity constraints may, at times, necessitate sourcing from an alternative geography. The company strives to maintain multiple high-quality supply sources for each input.

Corteva’s supply chain strategy will involve managing global supplies of active and intermediate ingredients sourced regionally with global best practices and oversight. Corteva’s supply strategy includes a robust and flexible global footprint to meet future
8


Part I
ITEM 1.  BUSINESS, continued

portfolio growth. The company’s supply chain also provides competitive advantages including reducing time to meet customer requirements in regions while minimizing costs through the value chain.

Seasonality
Corteva’s sales are generally strongest in the first half of the calendar year, which aligns with the planting and growing season in the northern hemisphere. The company typically generates about 65 percent of its sales in the first half of the calendar year, driven by northern hemisphere seed and crop protection sales. The company generates about 35 percent of its sales in the second half of the calendar year, led by seed sales in the southern hemisphere. The seasonality in sales impacts both the seed and crop protection segments. The company’s direct distribution channel, where products are shipped to farmers, is more affected by planting delays than its competitors. Generally speaking, unfavorable weather slows the planting season and can affect the company’s quarterly results and sales mix. Severe unfavorable weather, however, can impact overall sales. Accounts receivable tends to be higher during the first half of the year, consistent with the peak sales period in the northern hemisphere, with cash collection focused in the fourth quarter.

Human Capital Management
Corteva aims to attract the best employees, to retain those employees through offering career development and training opportunities while also prioritizing their safety and wellness in an inclusive and productive work environment. The company’s strong employee base of approximately 21,000 employees, along with its commitment to Corteva’s core values, is a key element to the success of its business.

Workforce Composition. As of December 31, 2021, the company globally employs approximately 21,000 employees. In order to address regional specific customer needs within its global business, the company has a geographically diverse employee base with 48%, 18%, 17%, 13% and 4% located in North America, Latin America, Europe, Asia-Pacific and Africa regions, respectively.

Approximately 1% of the workforce is unionized in the United States and another 11% participate in work councils and collective bargaining arrangements outside the United States. In 2021, the company did not experience any work stoppages due to strike or lockouts.

Safety. Living safely is one of the company’s core values by which the company manages its business. The company has implemented safety programs and management practices to promote a culture of safety to protect its employees, as well as the environment. This includes required trainings for employees, as well as specific qualifications and certifications for certain operational employees.

Diversity. The company has a robust inclusion, diversity, and equity (“ID&E”) vision and strategy, based upon the belief that embracing diversity and inclusion benefits the company by creating a workforce with a greater variety of skills and perspectives as a result of their differentiated backgrounds and experiences. Specific ID&E initiatives are identified and tracked to create a culture of belonging where a diverse population of employees are attracted, retained, and engaged. Management is expected to support specific diversity initiatives for their respective geographies and business, as applicable, in order to build a more representative workforce. Critical to creating this environment are company-sponsored employee business resource groups (“BRGs”) that support and promote certain mutual objectives of both the employee and the company, including community engagement and the professional development of employees. The BRGs provide a space where employees can foster connections within a supportive environment. As of the 2021 year end, the company had eight global BRGs, each led by a member of the company’s senior leadership: Disability Awareness Network; Global African Heritage Alliance; Growing Asian Impact Network; Latin Network; Pride (LGBTQ+); Professional Learning Acceleration Network; Veteran’s Network; and Women’s Inclusion Network.

The company is focused on recruitment of diverse candidates and on internal talent development of its diverse leaders so that they can advance their careers and move into leadership positions within the company. The company monitors its diversity and inclusion efforts through periodic engagement surveys and other measures. The results of the company’s efforts, along with its ID&E strategy, are reviewed periodically with the company’s management, and through regular reviews of the company’s leadership pipelines with the People and Compensation Committee of the Board of Directors.

Experienced Management. The company believes its management team has the experience necessary to effectively execute its strategy and advance its product pipelines and technology. The company's chief executive officer and executive vice presidents have an average of approximately 26 years of agriculture experience and are supported by an experienced and talented management team who is dedicated to maintaining and expanding its position as a global force in the agriculture industry.
9


Part I
ITEM 1.  BUSINESS, continued

Intellectual Property
Corteva considers its intellectual property estate, which includes patents, trade secrets, trademarks and copyrights, in the aggregate, to constitute a valuable asset of Corteva and actively seeks to secure intellectual property rights as part of an overall strategy to protect its investment in innovations and maximize the results of its research and development program. While the company believes that its intellectual property estate, taken as a whole, provides a competitive advantage in many of its businesses, no single patent, trademark, license or group of related patents or licenses is in itself essential to the company as a whole or to any of the company’s segments.

Trade secrets are an important element of the company's intellectual property. Many of the processes used to make Corteva products are kept as trade secrets which, from time to time, may be licensed to third parties. Corteva vigilantly protects all of its intellectual property including its trade secrets. When the company discovers that its trade secrets have been unlawfully taken, it reports the matter to governmental authorities for investigation and potential criminal action, as appropriate. In addition, the company takes measures to mitigate any potential impact, which may include civil actions seeking redress, restitution and/or damages based on loss to the company and/or unjust enrichment.

Patents & Trademarks: Corteva continually applies for and obtains U.S. and foreign patents and has access to a large patent portfolio, both owned and licensed. Corteva’s rights under these patents and licenses, as well as the products made and sold under them, are important to the company in the aggregate. The protection afforded by these patents varies based on country, scope of individual patent coverage, as well as the availability of legal remedies in each country. This significant patent estate may be leveraged to align with the company’s strategic priorities within and across product lines. At December 31, 2021, the company owned about 5,600 U.S. patents and about 11,100 active patents outside of the U.S.

Remaining life of granted patents owned as of December 31, 2021:
Approximate U.S.Approximate Other Countries
Within 5 years7001,300
6 to 10 years1,7004,300
11 to 16 years2,1005,100
16 to 20 years1,100400
Total5,60011,100

In addition to its owned patents, the company owns over 5,500 patent applications.

The company also owns or has licensed a substantial number of trade names, trademarks and trademark registrations in the United States and other countries, including approximately 14,500 registrations and pending trademark applications in a number of jurisdictions.

In addition, the company holds multiple long-term biotechnology trait licenses from third parties in the normal course of business. Most corn hybrids and soybean varieties sold to customers contain biotechnology traits licensed from third parties under these long-term licenses.

Competition
The company competes with producers of seed germplasm, trait developers, and crop protection products on a global basis. The global market for products within the industry is highly competitive and the company believes competition has and will continue to intensify. Corteva competes based on germplasm and trait leadership, price, quality and cost competitiveness and the offering of a holistic solution. The company’s key competitors include BASF, Bayer, FMC and ChemChina, as well as companies trading in generic crop protection chemicals and regional seed companies.

Environmental Matters
Information related to environmental matters is included in several areas of this report: (1) Environmental Proceedings beginning on page 28, (2) Management's Discussion and Analysis of Financial Condition and Results of Operations beginning on pages 61, 66-68 and (3) Note 2 - Summary of Significant Accounting Policies, and Note 18 - Commitments and Contingent Liabilities, to the Consolidated Financial Statements.


10


Part I
ITEM 1.  BUSINESS, continued

Regulatory Considerations
Our seed and crop protection products and operations are subject to certain approval procedures, manufacturing requirements and environmental protection laws and regulations in the jurisdictions in which we operate. We evaluate and test products throughout the research and development phases, and each new technology undergoes further rigorous scientific studies and tests to validate that the product can be used effectively and that use of the technology is safe for humans and animals and does not cause undue harm to the environment when used in accordance with the directions for use.

The regulatory approval processes and procedures globally are becoming increasingly more complex, which has resulted in additional testing needs, difficult to predict and longer approval timelines, and higher development and maintenance costs. We continue to invest on an ongoing basis to keep dossiers current, respond to regulators and meet evolving regulatory standards required by global regulatory frameworks. Failure to comply with these regulations or future regulatory bans and requirements related to our products and their use may materially impact our financial performance. The increase in timelines for regulatory approvals may result in the company not achieving its sustainability targets, or its anticipated returns on research and development investments.

Regulation of Genetically Modified Organisms (“GMOs”)
Genetically modified seed products are subject to regulatory approval processes and procedures. For example, in the United States, the Coordinated Framework for Regulation of Biotechnology governs genetically modified organisms, using existing U.S. legislation and legal authorities on food, feed and environmental safety. Plant GMOs are regulated by the U.S. Department of Agriculture’s (the “USDA”) Animal and Plant Health Inspection Service (the “APHIS”) under the Plant Protection Act. The APHIS assesses the trait to ensure that the trait will not pose a plant pest and is not a noxious weed. GMOs in food are regulated by the Food and Drug Administration (the “FDA”) under the Federal Food, Drug, and Cosmetic Act (the “FFDCA”). The FDA ensures that the food is safe for food and feed. Pesticides and microorganisms containing GMOs are regulated by the Environmental Protection Agency (the “EPA”) pursuant to the Federal Insecticide, Fungicide and Rodenticide Act (the “FIFRA”) and the Toxic Substances Control Act. The EPA assesses the trait or the stack containing the traits to ensure that there is no unreasonable adverse effect to the environment.

Other countries also have rigorous approval processes, procedures, and scientific testing requirements for the cultivation or import of genetically modified seed products. In the United States and other countries that have functioning regulatory systems, a rigorous scientific review is conducted by these agencies to demonstrate that genetically modified products are as safe as traditionally bred, non-biotech/GMO counterparts for food, feed and the environment. Various countries in EMEA, Latin America, and Asia have banned GMOs entirely.

Regulation of Crop Protection Products
Globally, manufacturers of crop protection products, including herbicides, fungicides and insecticides are required to submit an application/dossier and obtain government regulatory approval prior to selling products in a particular country. In the United States, the EPA is responsible for registering and overseeing the approval and marketing of pesticides, pursuant to the FIFRA, the FFDCA and the Food Quality Protection Act. Also, the USDA and the FDA monitor levels of pesticide residue that is allowed on or in crops. Already registered pesticides are required to be re-registered every 15 years to ensure that those products continue to meet the rigorous safety standards set by the regulators. The EPA reevaluates pesticide tolerances at least every 10 years, taking into account ecological and human health risks, in addition to cumulative risks as a result of multiple routes of and sources of exposure.

As of January 2022, before registering any new conventional pesticide active ingredient, the EPA will evaluate the potential effects on listed species and their designated critical habitats under the Endangered Species Act (the “ESA”). EPA also has initiated such evaluations for certain other active ingredients in response to existing or threatened litigation. Where the EPA determines that a pesticide in the registration and re-evaluation processes “may affect” a listed species, the EPA must consult with the U.S. Fish and Wildlife Service and the National Marine Fisheries Service. As part of its approval, registration, and reevaluation processes, the EPA may impose certain use restrictions on crop protection products under the ESA. Under the citizen suit provisions, the ESA also includes citizen suit provisions that allow the public to bring suit in court against federal agencies when they believe a listed species is not being adequately protected by the EPA.

The company's European operations are subject to the European chemical regulation REACH (“Registration, Evaluation, Authorisation, and Restriction of Chemicals”) and the CLP (“Classification, Labeling, and Packaging of Substances and Mixtures”). Other jurisdictions also have rigorous approval processes, procedures and scientific testing requirements for the approval of crop protection products. We continue to monitor legislative and regulatory developments related to pollution and other environmental health and safety matters.

European Farm to Fork Strategy
In October 2021, a majority of the European Parliament adopted the Farm to Fork Strategy setting forth the European Union’s plans to increase organic farming. As part of this strategy, the E.U. Commission has set aggressive 2030 targets to reduce by 50% the use and risk of chemical pesticides and the use of more hazardous pesticides by 50%. Additionally, as part of this strategy, the E.U. Commission is targeting having 25% of the European Union’s agricultural land under organic farming by
11


Part I
ITEM 1.  BUSINESS, continued

2030. The E.U. Commission is also expected to propose mandatory front-of-pack nutrition labelling and develop a food labelling framework covering the nutritional, climate, environmental and social aspects of food products. While the company has a growing product portfolio supportive to organic agriculture, the implementation of this strategy may decrease the size of the market for its products within the European Union.

Available Information
The company's annual report on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, and amendments to those reports are accessible on Corteva's website at http://investors.corteva.com by clicking on the section labeled "Financial Information", then on "SEC Filings." These reports are made available, without charge, as soon as is reasonably practicable after the company files or furnishes them electronically with the Securities and Exchange Commission. No portion of the company's website mentioned in this report, or the materials contained on it, have been made part of this annual report on Form 10-K or incorporated herein by reference, unless such incorporation is specifically mentioned herein.

12


Part I
ITEM 1A.  RISK FACTORS

Risks Related to our Industry

The successful development and commercialization of Corteva's pipeline products will be necessary for Corteva's growth.

Corteva uses advanced breeding technologies to produce hybrids and varieties with superior performance in farmers’ fields and uses biotechnology to introduce traits that enhance specific characteristics of its crops. Corteva also uses advanced analytics, software tools, mobile communications and new planting and monitoring equipment to provide agronomic recommendations to growers. Additionally, Corteva conducts research into biological and chemical products to protect farmers’ crops from pests and diseases and enhance plant productivity.

New product concepts may be abandoned for many reasons, including greater anticipated development costs, technical difficulties, lack of efficacy, regulatory obstacles or inability to market under regulatory frameworks, competition, inability to prove the original concept, lack of demand and the need to divert focus, from time to time, to other initiatives with perceived opportunities for better returns. The processes of active ingredient development or discovery, breeding, biotechnology trait discovery and development and trait integration are lengthy, and a very small percentage of the chemicals, genes and germplasm Corteva tests is selected for commercialization. Furthermore, the length of time and the risk associated with the breeding and biotech pipelines are interlinked because both are required as a package for commercial success in markets where biotech traits are approved for growers. For example, the commercial transition to the company’s Enlist E3™ and Conkesta E3® soybean technologies, which are packaged with its Enlist One® and Enlist Duo® herbicides, is expected to take the company several years to complete. In countries where biotech traits are not approved for widespread use, Corteva’s seed sales depend on the quality of its germplasm. While initial commercialization efforts have been promising, there are no guarantees that anticipated levels of product acceptability within Corteva's markets will be achieved or that higher quality products will not be developed by Corteva's competitors in the future.

Speed in discovering, developing, protecting and responding to new technologies, including new technology-based distribution channels that could facilitate Corteva’s ability to engage with customers and end users, and bringing related products to market is a significant competitive advantage. Commercial success frequently depends on being the first company to the market, and many of Corteva’s competitors are also making considerable investments in similar new biotechnology products, improved germplasm products, biological and chemical products and agronomic recommendation products.

Corteva may not be able to obtain or maintain the necessary regulatory approvals for some of its products, including its seed and crop protection products, which could restrict its ability to sell those products in some markets.

Regulatory and legislative requirements affect the development, manufacture and distribution of Corteva’s products, including the testing and planting of seeds containing Corteva’s biotechnology traits and the import of crops grown from those seeds, and non-compliance can harm Corteva’s sales and profitability.

Seed products incorporating biotechnology derived traits and crop protection products must be extensively tested for safety, efficacy and environmental impact before they can be registered for production, use, sale or commercialization in a given market. In certain jurisdictions, Corteva must periodically renew its approvals for both biotechnology and crop protection products, which typically require Corteva to demonstrate compliance with then-current standards which generally are more stringent since the prior registration. The regulatory approvals process is lengthy, costly, complex and in some markets unpredictable, with requirements that can vary by product, technology, industry and country. The regulatory approvals process for products that incorporate novel modes of action or new technologies can be particularly unpredictable and uncertain due to the then-current state of regulatory guidelines and objectives, as well as governmental policy considerations and non- governmental organization and other stakeholder considerations. The uncertainty and increased length of regulatory approvals may reduce Corteva’s return on its research and development investments, and impede its ability to meet sales, profitability, or sustainability metrics.

Furthermore, the detection of biotechnology traits or chemical residues from a crop protection product not approved in the country in which Corteva sells or cultivates its product, or in a country to which Corteva imports its product, may affect Corteva’s ability to supply its products or export its products, or even result in crop destruction, product recalls or trade disruption, which could result in lawsuits and termination of licenses related to biotechnology traits and raw material supply agreements. Delays in obtaining regulatory approvals to import, including those related to the importation of crops grown from
13


Part I
ITEM 1A.  RISK FACTORS, continued

seeds containing certain traits or treated with specific chemicals, may influence the rate of adoption of new products in globally traded crops.

Additionally, the regulatory environment may be impacted by the activities of non-governmental organizations and special interest groups and stakeholder reaction to actual or perceived impacts of new and existing technology, products or processes on safety, health and the environment. Obtaining and maintaining regulatory approvals requires submitting a significant amount of information and data, which may require participation from technology providers. Regulatory standards and trial procedures are continuously changing. In addition, Corteva has seen an increase in recent years in the number of lawsuits filed by those who identify themselves as public or environmental interest groups seeking to invalidate pesticide product registrations and/or challenge the way federal or state governmental entities apply the rules and regulations governing pesticide produce use. The pace of change together with the lack of regulatory harmony could result in unintended noncompliance. Responding to these changes and meeting existing and new requirements may involve significant costs or capital expenditures or require changes in business practice that could result in reduced profitability. The failure to receive necessary permits or approvals could have near- and long-term effects on Corteva’s ability to produce and sell some current and future products.

The degree of public understanding and acceptance or perceived public acceptance of Corteva’s biotechnology and other agricultural products and technologies can affect Corteva’s sales and results of operations by affecting planting approvals, regulatory requirements and customer purchase decisions.

Concerns and claims regarding the safe use of seeds with biotechnology traits and crop protection products in general, their potential impact on health and the environment, and the perceived impacts of biotechnology on health and the environment, reflect a growing trend in societal demands for increasing levels of product safety and environmental protection. These include concerns and claims that increased use of crop protection products, drift, inversion, volatilization and the use of biotechnology traits meant to reduce the resistance of weeds or pests to control by crop protection products, could increase or accelerate such resistance and otherwise negatively impact health and the environment. These and other concerns could manifest themselves in stockholder proposals, preferred purchasing, delays or failures in obtaining or retaining regulatory approvals, delayed product launches, lack of market acceptance, product discontinuation, continued pressure for and adoption of more stringent regulatory intervention and litigation, termination of raw material supply agreements and legal claims. These and other concerns could also influence public perceptions, the viability or continued sales of certain of Corteva’s products, Corteva’s reputation and the cost to comply with regulations. As a result, such concerns could have a material adverse effect Corteva’s business, results of operations, financial condition and cash flows.

Changes in agricultural and related policies of governments and international organizations may prove unfavorable.

In many markets there are various pressures to reduce government subsidies to farmers, which may inhibit the growth in these markets of products used in agriculture. In addition, government programs that create incentives for farmers may be modified or discontinued. However, it is difficult to predict accurately whether, and if so when, such changes will occur. Corteva expects that the policies of governments and international organizations will continue to affect the planting choices made by growers as well as the income available to growers to purchase products used in agriculture and, accordingly, the operating results of the agriculture industry.

Corteva participates in an industry that is highly competitive and has undergone consolidation, which could increase competitive pressures.

Corteva currently faces significant competition in the markets in which it operates. In most segments of the market, the number of products available to the grower is steadily increasing as new products are introduced. At the same time, certain products are coming off patent and are thus available to generic manufacturers for production and commercialization. Additionally, data analytic tools and web-based new direct purchase models offer increased transparency and comparability, which creates price pressures. Corteva cannot predict the pricing or promotional actions of its competitors. Aggressive marketing or pricing by Corteva’s competitors could adversely affect Corteva’s business, results of operations and financial conditions. As a result, Corteva continues to face significant competitive challenges.

Corteva’s business may be materially affected by competition from manufacturers of generic products.

Competition from manufacturers of generic products is a challenge for Corteva’s branded products around the world, and the loss or expiration of intellectual property rights can have a significant adverse effect on Corteva’s revenues. The date at which
14


Part I
ITEM 1A.  RISK FACTORS, continued

generic competition commences may be different from the date that the patent or regulatory exclusivity expires. However, upon the loss or expiration of patent protection for one of Corteva’s products or of a product that Corteva licenses, or upon the “at- risk” launch (despite pending patent infringement litigation against the generic product) by a generic manufacturer of a generic version of one of Corteva’s patented products or of a product that Corteva licenses, Corteva can lose a major portion of revenues for that product, which can have a material adverse effect on Corteva’s business.

The costs of complying with evolving regulatory requirements could negatively impact Corteva’s business, results of operations and financial condition. Actual or alleged violations of environmental laws or permit requirements could result in restrictions or prohibitions on plant operations, substantial civil or criminal sanctions, as well as the assessment of strict liability and/or joint and several liability.

Corteva is subject to extensive federal, state, local and foreign laws, regulations, rules and ordinances relating to pollution, protection of the environment, waste water discharges, the generation, storage, handling, transportation, treatment, disposal and remediation of hazardous substances and waste materials and the use of genetically modified seeds and crop protection active ingredients by growers.

Environmental and health and safety laws, regulations and standards expose Corteva to the risk of substantial costs and liabilities, including liabilities associated with Corteva’s business and the discontinued and divested businesses and operations of EID. As is typical for businesses like Corteva’s, soil and groundwater contamination has occurred in the past at certain sites and may be identified at other sites in the future. Disposal of waste from Corteva’s business at off-site locations also exposes it to potential remediation costs. Consistent with past practice, Corteva is continuing to monitor, investigate and remediate soil and groundwater contamination at several of these sites.

Costs and capital expenditures relating to environmental, health or safety matters are subject to evolving regulatory requirements and depend on the timing of the promulgation and enforcement of specific standards which impose the requirements. Moreover, changes in environmental regulations, including those related to climate change, could inhibit or interrupt Corteva’s operations, or require modifications to its facilities in the future. Accordingly, environmental, health or safety regulatory matters could result in significant unanticipated costs or liabilities, which may be materially higher than Corteva’s accruals.

Climate change and unpredictable seasonal and weather factors could impact Corteva’s sales and earnings.

The agriculture industry is subject to seasonal and weather factors, which can vary unpredictably from period to period. Weather factors can affect the presence of disease and pests on a regional basis and, accordingly, can positively or adversely affect the demand for crop protection products, including the mix of products used or the level of returns. The weather also can affect the quality, volume and cost of seed produced for sale as well as demand and product mix. Seed yields can be higher or lower than planned, which could lead to higher inventory and related write-offs. Climate change may increase the frequency or intensity of extreme weather such as storms, floods, heat waves, droughts and other events that could affect the quality, volume and cost of seed produced for sale as well as demand and product mix. Climate change may also affect the availability and suitability of arable land and contribute to unpredictable shifts in the average growing season and types of crops produced.

Corteva’s business is subject to various competition and antitrust, rules and regulations around the world, and as the size of its business grows, scrutiny of its business by legislators and regulators in these areas may intensify.

On July 9, 2021, President Biden issued an executive order promoting competition in the American economy. The order encouraged further examination and efforts by U.S. regulatory agencies to avoid market concentrations for agricultural inputs, that could challenge the survival of family farms. The executive order also directs the U.S. Secretary of Agriculture to take action to ensure that the intellectual property system, while still incentivizing innovation, does not also unnecessarily reduce competition in seed and other agricultural input markets beyond what is reasonably contemplated by the U.S. Patent Act and propose strategies for addressing those concerns across intellectual property, antitrust, and other relevant laws. While the ultimate impact of the executive order will depend on the actions ultimately resulting from the U.S. regulatory authorities, actions taken by such authorities may increase the regulation and regulatory costs associated with the agriculture industry in the future and restrict the company from pursuing certain growth opportunities, including mergers and acquisitions.

Scrutiny from regulators in the U.S. and abroad may intensify as Corteva’s business presence grows. This scrutiny and related investigations, even when not resulting in an enforcement action, may result in damage to a company’s reputation, significant
15


Part I
ITEM 1A.  RISK FACTORS, continued

defense expense, as well as become a distraction to management. Antitrust and competition enforcement actions may result in regulators imposing fines, penalties, or restrictions on a company’s business practices in a manner that may significantly impact its results of operations.

Corteva’s sales to its customers may be adversely affected should a company successfully establish an intermediary platform for the sale of Corteva’s products or otherwise position itself between Corteva and its customers.

Corteva services customers primarily through the Pioneer direct sales channel in key agricultural geographies, including the United States. In addition, Corteva supplements this approach with strong retail channels, including distributors, agricultural cooperatives and dealers, and with digital solutions that assist farmer decision-making with a view to optimize their product selection and maximize their yield and profitability. While Corteva expects the indirect channels and its digital platform will extend its reach and increase exposure of its products to other potential customers, including smaller farmers or farmers in less concentrated areas, there can be no assurance that Corteva will be successful in this regard. If a competitor were to successfully establish an intermediary platform for distribution of Corteva’s products, especially with respect to Corteva’s digital platform, it may disrupt Corteva’s distribution model and inhibit Corteva’s ability to provide a complete go-to-market strategy covering the direct, dealer and retail channels. In such a circumstance, Corteva’s sales may be adversely affected.

Risks Related to Our Operations

Corteva is dependent on its relationships or contracts with third parties with respect to certain of its raw materials or licenses and commercialization.

Corteva is dependent on third parties in the research, development and commercialization of its products and enters into transactions including, but not limited to, supply agreements and licensing agreements in connection with Corteva’s business. The majority of Corteva’s corn hybrids and soybean varieties sold to customers contain biotechnology traits that Corteva licenses from third parties under long-term licenses. If Corteva loses its rights under such licenses, it could negatively impact Corteva’s ability to obtain future licenses on competitive terms, commercialize new products and generate sales from existing products. To maintain such licenses, Corteva may elect to out-license its technology, including germplasm. There can be no guarantee that such out-licensing will not ultimately strengthen Corteva’s competition thereby adversely impacting Corteva’s results of operations.

While Corteva relies heavily on third parties for multiple aspects of its business and commercialization activities, Corteva does not control many aspects of such third parties’ activities. Third parties may not complete activities on schedule or in accordance with Corteva’s expectations. Failure by one or more of these third parties to meet their contractual or other obligations to Corteva or to comply with applicable laws or regulations, or any disruption in the relationship between Corteva and one or more of these third parties could delay or prevent the development, approval or commercialization of Corteva’s products and could also result in non-compliance or reputational harm, all with potential negative implications for Corteva’s business.

In addition, Corteva’s agreements with third parties may obligate it to meet certain contractual or other obligations to third parties. For example, Corteva may be obligated to meet certain thresholds or abide by certain boundary conditions. If Corteva were to fail to meet such obligations to the third parties, its relationship with such third parties may be disrupted. Such a disruption could negatively impact certain of Corteva’s licenses on which it depends, could cause reputational harm, and could negatively affect Corteva’s business, results of operations and financial condition.

Corteva’s business, results of operations and financial condition could be adversely affected by industrial espionage and other disruptions to its supply chain, information technology or network systems.

Business and/or supply chain disruptions, plant and/or power outages and information technology system and/or network disruptions, regardless of cause including acts of sabotage, employee error or other actions, geo-political activity, military conflict, local epidemics or pandemics, weather events and natural disasters could seriously harm Corteva’s operations as well as the operations of its customers and suppliers. For example, a pandemic in locations where Corteva has significant operations, sales, or key suppliers could have a material adverse effect on Corteva’s results of operations. In addition, terrorist attacks and natural disasters have increased stakeholder concerns about the security and safety of chemical production and distribution.

Business and/or supply chain disruptions may also be caused by security breaches, which could include, for example, ransomware attacks and attacks on information technology and infrastructure by hackers, viruses, breaches due to employee
16


Part I
ITEM 1A.  RISK FACTORS, continued

error or actions or other disruptions. Corteva and/or its suppliers may fail to effectively prevent, detect and recover from these or other security breaches and, as a consequence, such breaches could result in misuse of Corteva’s assets, business disruptions, loss of property including trade secrets and confidential business information, legal claims or proceedings, reporting errors, processing inefficiencies, negative media attention, loss of sales and interference with regulatory and data privacy compliance.

Like most major corporations, Corteva is the target of industrial espionage, including cyber-attacks, from time to time. Corteva has determined that these incidents have resulted, and could result in the future, in unauthorized parties gaining access to certain confidential business information. However, to date, Corteva has not experienced any material financial impact, changes in the competitive environment or impact on business operations from these events. Although management does not believe that Corteva has experienced any material losses to date related to industrial espionage and security breaches, including cybersecurity incidents, there can be no assurance that Corteva will not suffer such losses in the future.

Corteva actively manages the risks within its control that could lead to business disruptions and security breaches. As these threats continue to evolve, particularly around cybersecurity, Corteva may be required to expend significant resources to enhance its control environment, processes, practices and other protective measures. Despite these efforts, such events could also have a material adverse effect on Corteva’s business, financial condition, results of operations and reputation. Additionally, any losses from such an event may be excluded from, or in excess of the coverages provided by Corteva's insurance policies.

Volatility in Corteva’s input costs, which include raw materials and production costs, could have a significant impact on Corteva’s business, results of operations and financial condition.

Corteva’s input costs are variable based on the costs associated with production or with raw materials Corteva uses. For example, Corteva’s production costs vary, especially on a seasonal basis where changes in weather influence supply and demand. In addition, Corteva’s manufacturing processes consume significant amounts of raw materials, the costs of which are subject to worldwide supply and demand as well as other factors beyond Corteva’s control. Corteva refers to these costs collectively as input costs. Significant variations in input costs affect Corteva’s operating results from period to period.

When possible, Corteva purchases raw materials through negotiated long-term contracts to minimize the impact of price fluctuations. Corteva also enters into over-the-counter and exchange traded derivative commodity instruments to hedge its exposure to price fluctuations on certain raw material purchases. In addition, Corteva takes actions to offset the effects of higher input costs through selling price increases, productivity improvements and cost reduction programs. Success in offsetting higher input costs with price increases is largely influenced by competitive and economic conditions and could vary significantly depending on the market served. If Corteva is not able to fully offset the effects of higher input costs, it could have a significant impact on its financial results.

Corteva’s liquidity, business, results of operations and financial condition could be impaired if it is unable to raise capital through the capital markets or short-term debt borrowings.

Any limitation on Corteva’s ability to raise money in the capital markets or through short-term debt borrowings could have a substantial negative effect on Corteva’s liquidity. Corteva’s ability to affordably access the capital markets and/or borrow short- term debt in amounts adequate to finance its activities could be impaired as a result of a variety of factors, including factors that are not specific to Corteva, such as a severe disruption of the financial markets and, in the case of debt securities or borrowings, interest rate fluctuations. Due to the seasonality of Corteva’s business and the credit programs Corteva may offer its customers, net working capital investment and corresponding debt levels will fluctuate over the course of the year.

Corteva regularly extends credit to its customers to enable them to purchase seeds or crop protection products at the beginning of the growing season. The customer receivables may be used as collateral for short-term financing programs. Any material adverse effect upon Corteva’s ability to own or sell such customer receivables, including seasonal factors that may impact the amount of customer receivables Corteva owns, may materially impact Corteva’s access to capital.

Corteva has additional agreements with financial institutions to establish programs that provide financing for select customers of Corteva’s seed and crop protection products in the United States, Latin America, Europe and Asia. The programs are renewed on an annual basis. In most cases, Corteva guarantees the extension of such credit to such customers. If Corteva is unable to renew these agreements or access the debt markets to support customer financing, Corteva’s sales may be negatively impacted, which could result in increased borrowing needs to fund working capital.

17


Part I
ITEM 1A.  RISK FACTORS, continued

Corteva’s earnings, operations and business, among other things, will impact its credit ratings, costs and availability of financing. There can be no assurance that Corteva or EID will maintain its current or prospective credit ratings. A decrease in the ratings assigned to Corteva or EID by the ratings agencies may negatively impact Corteva’s liquidity, access to the debt capital markets and increase Corteva’s cost of borrowing and the financing of its seasonal working capital.

Corteva’s customers may be unable to pay their debts to Corteva, which could adversely affect Corteva’s results.

Corteva offers its customers financing programs with credit terms generally less than one year from invoicing in alignment with the growing season. Due to these credit practices as well as the seasonality of Corteva’s operations, Corteva may need to issue short-term debt at certain times of the year to fund its cash flow requirements. Corteva’s customers may be exposed to a variety of conditions that could adversely affect their ability to pay their debts. For example, customers in economies experiencing an economic downturn or in a region experiencing adverse growing conditions may be unable to repay their obligations to Corteva, which could adversely affect Corteva’s results.

Increases in pension and other post-employment benefit plan funding obligations may adversely affect Corteva’s results of operations, liquidity or financial condition.

Through Corteva's ownership of EID, Corteva maintains EID defined benefit pension and other post-employment benefit plans. For some of these plans, including EID’s principal U.S. pension plan, Corteva continues as sponsor for the entire plan regardless of whether participants, including retirees, are or were associated with EID’s agriculture business. Corteva uses many assumptions in calculating its expected future payment obligations under these plans. Significant adverse changes in credit or market conditions could result in actual rates of returns on pension investments being lower than assumed. In addition, expected future payment obligations may be adversely impacted by changes in assumptions regarding participants, including retirees. In 2022, Corteva expects to contribute approximately $60 million to its pension plans other than the principal U.S. pension plan, and about $140 million for its other post-employment benefit ("OPEB") plans. While not anticipated for 2022, Corteva may make potential discretionary contributions to the principal U.S. pension plan. Corteva, furthermore, may be required to make significant contributions to its pension plans in the future, which could adversely affect Corteva’s results of operations, liquidity and financial condition.

Corteva’s business, results of operations and financial condition could be adversely affected by environmental, litigation and other commitments and contingencies.

As a result of Corteva’s operations, including past operations and those related to divested businesses and discontinued operations of EID, Corteva incurs environmental operating costs for pollution abatement activities including waste collection and disposal, installation and maintenance of air pollution controls and wastewater treatment, emissions testing and monitoring and obtaining permits. Corteva also incurs environmental operating costs related to environmental related research and development activities including environmental field and treatment studies as well as toxicity and degradation testing to evaluate the environmental impact of products and raw materials. In addition, Corteva maintains and periodically reviews and adjusts its accruals for probable environmental remediation and restoration costs.

Corteva expects to continue to incur environmental operating costs since it will operate global manufacturing, product handling and distribution facilities that are subject to a broad array of environmental laws and regulations. These rules are subject to change by the implementing governmental agency, which Corteva monitors closely. Corteva’s policy requires that its operations fully meet or exceed legal and regulatory requirements. In addition, Corteva expects to continue certain voluntary programs, and could consider additional voluntary actions, to reduce air emissions, minimize the generation of hazardous waste, decrease the volume of water use and discharges, increase the efficiency of energy use and reduce the generation of persistent, bioaccumulative and toxic materials. Costs to comply with complex environmental laws and regulations, as well as internal voluntary programs and goals, are significant and Corteva expects these costs will continue to be significant for the foreseeable future. Over the long term, such expenditures are subject to considerable uncertainty and could fluctuate significantly.

Corteva accrues for environmental matters when it is probable that a liability has been incurred and the amount can be reasonably estimated. As remediation activities vary substantially in duration and cost from site to site, it is difficult to develop precise estimates of future site remediation costs. Corteva expects to base such estimates on several factors, including the complexity of the geology, the nature and extent of contamination, the type of remedy, the outcome of discussions with regulatory agencies and other Potentially Responsible Parties (“PRPs”) at multi-party sites and the number of, and financial
18


Part I
ITEM 1A.  RISK FACTORS, continued

viability of, other PRPs. Considerable uncertainty exists with respect to environmental remediation costs and, under adverse changes in circumstances, the potential liability may be materially higher than Corteva’s accruals.

Corteva faces risks arising from various unasserted and asserted litigation matters arising out of the normal course of its current and former business operations, including intellectual property, commercial, product liability, environmental and antitrust lawsuits. Corteva has noted a trend in public and private suits being filed on behalf of states, counties, cities and utilities alleging harm to the general public and the environment, including waterways and watersheds. Claims alleging harm to the public and the environment may be brought against Corteva, notwithstanding years of scientific evidence and regulatory determinations supporting the safety of crop protection products. The litigation involving Monsanto’s Roundup® non-selective glyphosate containing weedkiller products has resulted in negative publicity and sentiment and may lead to similar suits with respect to glyphosate-containing products and/or other established crop protection products. Claims and allegations that Corteva’s products or products that Corteva manufactures or markets on behalf of third parties are not safe could result in litigation, damage to Corteva’s reputation and have a material adverse effect on Corteva’s business. It is not possible to predict the outcome of these various proceedings and any potential impact on Corteva. An adverse outcome in any one or more of these matters may result in losses not fully covered by Corteva's insurance policies, and could be material to Corteva's financial results. Various factors or developments can lead to changes in current estimates of liabilities. Such factors and developments may include, but are not limited to, additional data, safety or risk assessments, as well as a final adverse judgment, significant settlement or changes in applicable law. A future adverse ruling or unfavorable development could result in future charges that could have a material adverse effect on Corteva.

The company, pursuant to the respective Separation Agreements, is entitled to cost sharing and indemnification from Chemours, Dow and DuPont, as applicable, for certain litigation, environmental, workers’ compensation and other liabilities related to its historical operations. In connection with the recognition of liabilities related to these matters, Corteva records an indemnification asset when recovery is deemed probable. These estimates of recovery are subject to various factors and developments that could result in differences from future estimates or the actual recovery. As of December 31, 2021, the indemnification assets pursuant to the Chemours Separation Agreement and the Corteva Separation Agreement are in aggregate $72 million within accounts and notes receivable - net and $254 million within other assets in the company’s Consolidated Balance Sheet. Any failure by, or inability to pay, these liabilities in line with the indemnification provisions of the Separation Agreements may have a material adverse effect on Corteva and its financial condition and results of operations.

In the ordinary course of business, Corteva may make certain commitments, including representations, warranties and indemnities relating to current and past operations, including those related to divested businesses and issue guarantees of third-party obligations. If Corteva were required to make payments as a result, they could exceed the amounts accrued, thereby adversely affecting Corteva’s financial condition and results of operations.

Corteva’s operations outside the United States are subject to risks and restrictions, which could negatively affect Corteva’s business, results of operations and financial condition.

Corteva’s operations outside the United States are subject to risks and restrictions, including fluctuations in foreign-currency exchange rates; inflation; exchange and price control regulations; corruption risks; competitive restrictions; changes in local political or economic conditions; import and trade restrictions; import or export licensing requirements and trade policy; and other potentially detrimental domestic and foreign governmental practices or policies affecting U.S. companies doing business abroad. In addition, Corteva’s international operations are sometimes in countries with unstable governments, economic or fiscal challenges, military or political conflicts, local epidemics or pandemics, significant levels of crime and organized crime, or developing legal systems. This may increase the risk to the company's employees, subcontractors or other parties, and to other liabilities, such as property loss or damage to the company's products, and may affect Corteva's ability to safely operate in, or import into, or receive raw materials from these countries.

Additionally, Corteva’s ability to export its products and its sales outside the United States has been, and may continue to be adversely affected by significant changes in trade, tax or other policies, including the risk that other countries may retaliate through the imposition of their own trade restrictions and/or increased tariffs in response to substantial changes to U.S. trade and tax policies.

Although Corteva has operations throughout the world, Corteva’s sales outside the United States in 2021 were principally to customers in Brazil, Eurozone countries, and Canada. Further, Corteva’s largest currency exposures are the Brazilian Real, Swiss franc, European Euro ("EUR"), and Canadian dollar. Inflation, market uncertainty or an economic downturn in these
19


Part I
ITEM 1A.  RISK FACTORS, continued

geographic areas could reduce demand for Corteva’s products and result in decreased sales volume, which could have a negative impact on Corteva’s results of operations. In addition, changes in exchange rates may affect Corteva’s results of operations, financial condition and cash flows in future periods. Corteva actively manages currency exposures that are associated with net monetary asset positions and committed purchases.

Failure to effectively manage acquisitions, divestitures, alliances, restructurings, cost savings initiatives and other portfolio actions may not have the results anticipated.

From time to time Corteva evaluates acquisition candidates that may strategically fit Corteva’s business and/or growth objectives. If Corteva is unable to successfully integrate and develop acquired businesses, Corteva could fail to achieve anticipated synergies and cost savings, including any expected increases in revenues and operating results, which could have a material adverse effect on Corteva’s financial results. Corteva continually reviews its portfolio of assets for contributions to its objectives and alignment with its growth strategy. However, Corteva may not be successful in separating underperforming or non-strategic assets and gains or losses on the divestiture of, or lost operating income from, such assets may affect Corteva’s earnings. Moreover, Corteva might incur asset impairment charges related to acquisitions or divestitures that reduce its earnings. In addition, if the execution of these transactions, initiatives, or portfolio actions is not successful, it could adversely impact Corteva’s financial condition, cash flows and results of operations.

Sentiment towards climate change and other environmental, social and governance (“ESG”) matters could adversely affect our stock price, results of operations, and access to capital.

Since 2020, Corteva has announced sustainability goals, including adopting its greenhouse gas emission reduction strategy and targets for 2030 and inclusion, diversity and equity goals for 2026. Execution of these strategies and the achievements of Corteva’s sustainability goals is subject to risk and uncertainties, many of which are out of its control. Failure to achieve its sustainability goals within the currently projected costs and expected timeframes could damage Corteva’s reputation, customer and investor relationships, or its access to financing. Further, given investors' increased focus related to ESG matters, such a failure could cause stockholders to reduce their ownership holdings, all of which, in turn could adversely affect Corteva’s business, financial condition, results of operations and cash flows and reduce its stock price.

Global or regional health pandemics or epidemics, including COVID-19, could negatively impact the company's business, financial condition and results of operations.

Corteva's business, financial condition, and results of operations could be negatively impacted by COVID-19 or other pandemics or epidemics. The severity, magnitude and duration of the current COVID-19 pandemic and future outbreaks is uncertain, rapidly changing and difficult to predict. To date, the COVID-19 pandemic has negatively impacted foreign currency exchange rates, as a result of a generally stronger U.S. dollar relative to other currencies in the countries in which the company operates, which has adversely affected the company's reported results of operations. These relative differences could widen and further adversely impact our results of operations and financial condition. Increased market volatility resulting from COVID-19 disruptions has also limited the availability of certain manufacturing inputs. Current and future COVID-19 outbreaks and resulting illness, travel restrictions and workforce disruptions could impact Corteva's global supply chain, its operations and its routes to market or those of its suppliers, co-manufacturers, or customers/distributors. These disruptions or the company's failure to effectively respond to them could increase product or distribution costs, alter the timing of recognizing manufacturing costs, or impact the delivery of products to customers.

COVID-19 and the related government-imposed restrictions, including stay at home orders, has significantly impacted other economic activity and markets around the world. Future outbreaks or pandemics could negatively impact the company's business, financial condition, and results of operations in numerous ways, including but not limited to those outlined below:

Government or regulatory responses to pandemics could negatively impact the company's business. Mandatory lockdowns or other restrictions on operations in certain countries have temporarily disrupted the company's ability to operate or distribute its products in these markets. Continuation or expansion of these disruptions could materially adversely impact the company's operations and results.
Reductions to the company’s forecasted profitability and continued global economic decline could trigger potential impairment of the carrying value of goodwill or other indefinite and definite-lived intangible assets.
The instability or unavailability of a farm workforce to harvest agricultural products could impact the company's customers’ ability to monetize their crop and potentially impact the collection of the company's customer receivables.
20


Part I
ITEM 1A.  RISK FACTORS, continued

Continued commodity cost volatility is expected and the company's commodity hedging activities may not sufficiently offset this volatility. Depressed commodity prices may increase the insolvency risk of Corteva's customers in the longer-term, along with reducing the demand for Corteva's products.
Disruptions or uncertainties related to the COVID-19 outbreak for a sustained period of time could result in delays or modifications to the company's strategic plans and productivity initiatives.
Increased volatility and pricing in the capital and commercial paper markets may re-occur and impact the company's access to preferred sources of liquidity resulting in higher borrowing costs. The company cannot assure investors that additional liquidity will be readily available or available on favorable terms.
Increased market volatility may bring unprecedented market conditions making it difficult for the company to adequately forecast customer demand or price its products.

Therefore, the result of the company’s consolidated results of operations in face of the ongoing COVID-19 outbreak, or another pandemic, and the unprecedented economic conditions which can result therefrom may negatively impact the company's business operations, financial performance and results of operations in the future.

If we are unable to recruit and retain key personnel, our business may be harmed.

Much of Corteva’s future success depends on the continued service, availability and performance of our senior management and highly-skilled personnel across all levels of the organization. Corteva’s senior management has acquired specialized knowledge and skills with respect to its business, and the loss of any of these individuals could harm its business, especially if we are not successful in developing adequate succession plans. Our efforts to attract, develop, integrate and retain highly skilled employees with appropriate qualifications may be compounded by difficulties in recruiting, hiring and retaining urgently needed specialized employees at a regional level where there may be significant competition between employers. If we are unable to continue to successfully attract, retain, and develop key personnel, our business may be harmed.

Risks Related to Our Intellectual Property

Enforcing Corteva’s intellectual property rights, or defending against intellectual property claims asserted by others, could materially affect Corteva’s business, results of operations and financial condition.

Intellectual property rights, including patents, plant variety protection, trade secrets, confidential information, trademarks, trade names and other forms of trade dress, are important to Corteva’s business. Corteva endeavors to protect its intellectual property rights in jurisdictions in which its products are produced or used and in jurisdictions into which its products are imported. However, Corteva may be unable to obtain protection for its intellectual property in key jurisdictions. Further, changes in government policies and regulations, including changes made in reaction to pressure from non-governmental organizations, or the public generally, could impact the extent of intellectual property protection afforded by such jurisdictions.

Corteva has designed and implemented internal controls to restrict use of, access to and distribution of its intellectual property. Despite these precautions, Corteva’s intellectual property is vulnerable to infringement, misappropriation and other unauthorized access, including through employee or licensee error or actions, theft and cybersecurity incidents, and other security breaches. When unauthorized access and use or counterfeit products are discovered, Corteva reports such situations to governmental authorities for investigation, as appropriate, and takes measures to mitigate any potential impact. Protecting intellectual property related to biotechnology is particularly challenging because theft is difficult to detect and biotechnology can be self-replicating.

Competitors are increasingly challenging intellectual property positions and the outcomes can be highly uncertain. Third parties may claim Corteva’s products violate their intellectual property rights. Defending such claims, even those without merit, could be time-consuming and expensive. In addition, any such claim could result in Corteva’s having to enter into license agreements, develop non-infringing products or engage in litigation that could be costly. If challenges are resolved adversely, it could negatively impact Corteva’s ability to obtain licenses on competitive terms, develop and commercialize new products and generate sales from existing products.

In addition, because of the rapid pace of technological change, the confidentiality of patent applications in some jurisdictions and/or the uncertainty in predicting the outcome of complex proceedings relating to ownership and the scope of patents relating to certain emerging technologies, competitors may be issued patents related to Corteva’s business unexpectedly. These patents could reduce the value of Corteva’s commercial or pipeline products or, to the extent they cover key technologies on which
21


Part I
ITEM 1A.  RISK FACTORS, continued

Corteva has relied, require Corteva to seek to obtain licenses (and Corteva cannot ensure it would be able to obtain such a license on acceptable terms) or cease using the technology, no matter how valuable to Corteva’s business.

Legislation and jurisprudence on patent protection is evolving and changes in laws could affect Corteva’s ability to obtain or maintain patent protection for, and otherwise enforce Corteva’s patents related to, its products.

Corteva’s business may be adversely affected by the availability of counterfeit products.

A counterfeit product is one that has been deliberately and fraudulently mislabeled as to its identity and source. A counterfeit Corteva product, therefore, is one manufactured by someone other than Corteva, but which appears to be the same as an authentic Corteva product. The prevalence of counterfeit products is a significant and growing industry-wide issue due to a variety of factors, including, but not limited to, the following: the widespread use of the Internet, which has greatly facilitated the ease by which counterfeit products can be advertised, purchased and delivered to individual consumers; the availability of sophisticated technology that makes it easier for counterfeiters to make counterfeit products; and the relatively modest risk of penalties faced by counterfeiters compared to the large profits that can be earned by them from the sale of counterfeit products. Further, laws against counterfeiting vary greatly from country to country, and the enforcement of existing laws varies greatly from jurisdiction to jurisdiction. For example, in some countries, counterfeiting is not a crime; in others, it may result in only minimal sanctions. In addition, those involved in the distribution of counterfeit products use complex transport routes to evade customs controls by disguising the true source of their products.

Corteva’s global reputation makes its products prime targets for counterfeiting organizations. Counterfeit products pose a risk to consumer health and safety because of the conditions under which they are manufactured (often in unregulated, unlicensed, uninspected and unsanitary sites) as well as the lack of regulation of their contents. Failure to mitigate the threat of counterfeit products, which is exacerbated by the complexity of the supply chain, could adversely impact Corteva’s business by, among other things, causing the loss of consumer confidence in Corteva’s name and in the integrity of its products, potentially resulting in lost sales and an increased threat of litigation.

Corteva undertakes significant efforts to counteract the threats associated with counterfeit products, including, among other things, working with regulatory authorities and multinational coalitions to combat the counterfeiting of products and supporting efforts by law enforcement authorities to prosecute counterfeiters; assessing new and existing technologies to seek to make it more difficult for counterfeiters to copy Corteva’s products and easier for consumers to distinguish authentic from counterfeit products; working diligently to raise public awareness about the dangers of counterfeit products; working collaboratively with wholesalers, customs offices and law enforcement agencies to increase inspection coverage, monitor distribution channels and improve surveillance of distributors; and working with other members of an international trade association of agrochemical companies to promote initiatives to combat counterfeiting activity. No assurance can be given, however, that Corteva’s efforts and the efforts of others will be entirely successful, and the presence of counterfeit products may continue to increase.

Restrictions under the intellectual property cross-license agreements limit Corteva’s ability to develop and commercialize certain products and services and/or prosecute, maintain and enforce certain intellectual property.

The company is dependent to a certain extent on DuPont and Dow to maintain and enforce certain of the intellectual property licensed under the Intellectual Property Cross-License Agreements. For example, DuPont and Dow are responsible for filing, prosecuting and maintaining (at their respective discretion) patents on trade secrets and know-how that they each respectively license to Corteva. They also have the first right to enforce their respective trade secrets and know-how licensed to Corteva. If DuPont or Dow, as applicable, fails to fulfill its obligations or chooses to not enforce the licensed patents, trade secrets or know-how under the Intellectual Property Cross-License Agreements, the company may not be able to prevent competitors from making, using and selling competitive products and services.

In addition, Corteva’s use of the intellectual property licensed to it under the Intellectual Property Cross-License Agreements is restricted to certain fields, which could limit Corteva’s ability to develop and commercialize certain products and services. For example, the licenses granted to Corteva under the agreement will not extend to all fields of use that the company may decide to enter into in the future. These restrictions may make it more difficult, time consuming and/or expensive for Corteva to develop and commercialize certain new products and services, or may result in certain of its products or services being later to market than those of its competitors.


22


Part I
ITEM 1A.  RISK FACTORS, continued

Risks Related to The Separation

In connection with the Separation the company has assumed, and agreed to indemnify DuPont and Dow for, certain liabilities. If the company is required to make payments pursuant to these indemnities, the company may need to divert cash to meet those obligations and its financial results could be negatively impacted. In addition, DuPont and Dow will indemnify Corteva for certain liabilities. These indemnities may not be sufficient to insure the company against the full amount of liabilities it incurs, and DuPont and/or Dow, and/or their historical separated businesses, may not be able to satisfy their indemnification obligations in the future.

Pursuant to the Separation Agreement, the Employee Matters Agreement and the Tax Matters Agreement with DuPont and Dow, the company agreed to assume, and indemnify DuPont and Dow for, certain liabilities for uncapped amounts, which may include, among other items, associated defense costs, settlement amounts and judgments, as discussed further in Note 18 - Commitments and Contingent Liabilities, to the Consolidated Financial Statements and Part I - Item 3 - Legal Proceedings. Payments pursuant to these indemnities may be significant and could negatively impact the company’s business, particularly indemnities relating to certain litigation for Historical DuPont operations or its actions that could impact the tax-free nature of the Corteva Distribution. Third parties could also seek to hold the company responsible for any of the liabilities allocated to DuPont and Dow, including those related to DowDuPont’s specialty products and/or materials science businesses, respectively, and those related to discontinued and/or divested businesses and operations of Historical Dow, which have been allocated to Dow. DuPont and/or Dow, as applicable, will agree to indemnify Corteva for such liabilities, but such indemnities may not be sufficient to protect the company against the full amount of such liabilities. In addition, DuPont and/or Dow, as applicable, may not be able to fully satisfy their indemnification obligations with respect to the liabilities the company incurs. Even if the company ultimately succeeds in recovering from DuPont and/or Dow, as applicable, any amounts for which the company is held liable, the company may be temporarily required to bear these losses itself. Each of these risks could negatively affect the company’s business, financial condition, results of operations and cash flows.

Additionally, the company generally has assumed and is responsible for the payment of its share of (i) certain liabilities of DowDuPont relating to, arising out of or resulting from certain general corporate matters of DowDuPont, (ii) certain liabilities of Historical DuPont relating to, arising out of or resulting from general corporate matters of Historical DuPont and discontinued and/or divested businesses and operations of Historical DuPont, including its spin-off of Chemours, and (iii) certain separation expenses not otherwise allocated to DuPont or Dow (or allocated specifically to Corteva) pursuant to the Corteva Separation Agreement, and third parties could seek to hold Corteva responsible for DuPont’s or Dow’s share of any such liabilities. For more information, see Note 18 - Commitments and Contingent Liabilities, to the Consolidated Financial Statements and Part I - Item 3 - Legal Proceedings. DuPont and/or Dow, as applicable, will indemnify Corteva for their share of any such liabilities; however, such indemnities may not be sufficient to protect Corteva against the full amount of such liabilities, and/or DuPont and/or Dow may not be able to fully satisfy their respective indemnification obligations. In addition, even if the company ultimately succeeds in recovering from DuPont and/or Dow any amounts for which the company is held liable in excess of its agreed share, the company may be temporarily required to bear these losses itself and may not be able to fully insure itself to cover these risks. Each of these risks could materially affect the company’s business, financial condition, results of operations and cash flows.

The Separation and related transactions may expose Corteva to potential liabilities arising out of state and federal fraudulent conveyance laws

Although the company received a solvency opinion from an investment bank confirming that the company and DuPont were each adequately capitalized following the Distribution, the Separation could be challenged under various state and federal fraudulent conveyance laws. In connection with fraudulent conveyances or transfers are generally defined to include transfers made or obligations incurred with the actual intent to hinder, delay or defraud current or future creditors or transfers made or obligations incurred for less than reasonably equivalent value when the debtor was insolvent, or that rendered the debtor insolvent, inadequately capitalized or unable to pay its debts as they become due. Any unpaid creditor could claim that DuPont did not receive fair consideration or reasonably equivalent value in the Separation and Corteva Distribution, and that the Separation and Corteva Distribution left DuPont insolvent or with unreasonably small capital or that DuPont intended or believed it would incur debts beyond its ability to pay such debts as they matured. Additionally, under its indemnity provisions of the Separation Agreement, the company could find its liabilities increased as a result of a court concluding that Historical DuPont, Historical Dow or DowDuPont executed a fraudulent conveyance in connection with divestitures and spin-offs of any one of their historical operations, including Chemours. If a court were to agree with such a plaintiff, then such court could void the Separation and Distribution as a fraudulent transfer or impose substantial liabilities on Corteva, which could materially
23


Part I
ITEM 1A.  RISK FACTORS, continued

adversely affect its financial condition and results of operations. Among other things, the court could return some of Corteva’s assets or shares of Corteva common stock to DuPont, provide DuPont with a claim for money damages against Corteva in an amount equal to the difference between the consideration received by DuPont and the fair market value of Corteva at the time of the Corteva Distribution, or require Corteva to fund liabilities of other companies involved in the Internal Reorganization and Business Realignment for the benefit of creditors.

The Distribution is also subject to review under state corporate Distribution statutes. Under the Delaware General Corporation Law (the “DGCL”), a corporation may only pay dividends to its stockholders either (i) out of its surplus (net assets minus capital) or (ii) if there is no such surplus, out of its net profits for the fiscal year in which the dividend is declared and/or the preceding fiscal year. Although the Distribution was made out of DowDuPont’s surplus and the company received an opinion that DowDuPont has adequate surplus under Delaware law to declare the dividend of Corteva common stock in connection with the Corteva Distribution, there can be no assurance that a court will not later determine that some or all of the Corteva Distribution was unlawful.

If the Corteva Distribution, together with certain related transactions, were to fail to qualify for non-recognition treatment for U.S. federal income tax purposes, then the company could be subject to significant tax and indemnification liability and stockholders receiving Corteva common stock in the Corteva Distribution could be subject to significant tax liability.

DowDuPont received an IRS Tax Ruling and tax opinion that, among other things, the Corteva Distribution and certain related transactions will qualify as a tax-free transaction under Section 355 and Section 368(a)(1)(D) of the Internal Revenue Code (the "Code). The IRS Ruling and tax opinion relied on certain facts, assumptions, and undertakings, and certain representations from DowDuPont and Corteva, regarding the past and future conduct of both respective businesses and other matters. Despite the tax opinion and the IRS Ruling, the IRS could determine on audit that the Distribution or certain related transactions should be treated as a taxable transaction if it determines that any of these facts, assumptions, representations or undertakings are not correct or have been violated, or that the Distribution should be taxable for other reasons, including if the IRS were to disagree with the conclusions of the tax opinion.

If the Corteva Distribution ultimately is determined to be taxable, then a stockholder of DuPont that received shares of Corteva common stock would be treated as having received a distribution of property in an amount equal to the fair market value of such shares (including any fractional shares sold on behalf of such stockholder) on the distribution date and could incur significant income tax liabilities. Such distribution would be taxable to such stockholder as a dividend to the extent of DuPont’s current and accumulated earnings and profits, which would include any earnings and profits attributable to the gain recognized by DuPont on the taxable distribution and could include earnings and profits attributable to certain internal transactions preceding the Corteva Distribution. Any amount that exceeded DuPont’s earnings and profits would be treated first as a non- taxable return of capital to the extent of such stockholder’s tax basis in its shares of DuPont stock with any remaining amount being taxed as a gain on the DuPont stock. In the event the Distribution is ultimately determined to be taxable, DuPont would recognize corporate level taxable gain on the Distribution in an amount equal to the excess, if any, of the fair market value of Corteva common stock distributed to DuPont stockholders on the distribution date over DuPont’s tax basis in such stock. In addition, if certain related transactions fail to qualify for tax-free treatment under U.S. federal, state, local tax and/or foreign tax law, Corteva and DuPont could incur significant tax liabilities under U.S. federal, state, local and/or foreign tax law.

Generally, taxes resulting from the failure of the Separation and Distributions to qualify for non-recognition treatment for U.S. federal income tax purposes would be imposed on DuPont or DuPont stockholders. Under the Tax Matters Agreement that the company entered into with DuPont and Dow, subject to the exceptions described below, the company is generally obligated to indemnify DuPont against such taxes imposed on DuPont. However, if the Distributions fail to qualify for non-recognition treatment for U.S. federal income tax purposes for certain reasons relating to the overall structure of the Merger and the Distributions, then under the Tax Matters Agreement, DuPont and Dow would share the tax liability resulting from such failure in accordance with their relative equity values on the first full trading day following the Dow Distribution. The company and DuPont would share any liabilities of DuPont described in the preceding sentence in accordance with its relative equity values on the first full trading day following the Corteva Distribution. Furthermore, under the terms of the Tax Matters Agreement, the company also generally will be responsible for any taxes imposed on DuPont or Dow that arise from the failure of the Corteva Distribution to qualify as tax-free for U.S. federal income tax purposes within the meaning of Section 355 of the Code or the failure of certain related transactions to qualify for tax-free treatment, to the extent such failure to qualify is attributable to actions, events or transactions relating to its, or its affiliates’, stock, assets or business, or any breach of its representations made in any representation letter provided to its counsel in connection with the tax opinion. DuPont and Dow will be separately
24


Part I
ITEM 1A.  RISK FACTORS, continued

responsible for any taxes imposed on Corteva that arise from the failure of the Corteva Distribution to qualify as tax-free for U.S. federal income tax purposes within the meaning of Section 355 of the Code or the failure of certain related transactions to qualify for tax-free treatment, to the extent such failure to qualify is attributable to actions, events or transactions relating to such company’s or its affiliates’ stock, assets or business, or any breach of such company’s representations made in connection with the IRS Ruling or in the representation letter provided to counsel in connection with the tax opinion. Events triggering an indemnification obligation under the tax matters agreement include events occurring after the Corteva Distribution that cause DuPont to recognize a gain under Section 355(e) of the Code, as discussed further below. Such tax amounts could be significant. To the extent that the company is responsible for any liability under the tax matters agreement, there could be a material adverse impact on Corteva’s business, financial condition, results of operations and cash flows in future reporting periods.

The IRS may assert that the Merger causes the Distributions and other related transactions to be taxable to DuPont, in which case the company could be subject to significant indemnification liability.

Even if the Distributions otherwise constitutes a tax-free transaction to stockholders under Section 355 of the Code, DuPont may be required to recognize corporate level tax on the Distributions and certain related transactions under Section 355(e) of the Code if, as a result of the Merger or other transactions considered part of a plan with the Distributions, there is a 50 percent or greater change of ownership in DuPont or Corteva. In connection with the Merger, DowDuPont received a private letter ruling from the IRS regarding the proper time, manner and methodology for measuring common ownership in the stock of DowDuPont, Historical DuPont and Historical Dow for purposes of determining whether there has been a 50 percent or greater change of ownership under Section 355(e) of the Code as a result of the Merger. The tax opinion relied on the continued validity of the private letter ruling, as well as certain factual representations from DowDuPont as to the extent of common ownership in the stock of Historical DuPont and Historical Dow immediately prior to the Merger. Based on the representations made by DowDuPont as to the common ownership in the stock of Historical DuPont and Historical Dow immediately prior to the Merger and assuming the continued validity of the IRS Ruling, the tax opinion concluded that there was not a 50 percent or greater change of ownership in DowDuPont, Historical DuPont or Historical Dow for purposes of Section 355(e) as a result of the Merger. Notwithstanding the tax opinion and the IRS Ruling, the IRS could determine that the Distributions or a related transaction should nevertheless be treated as a taxable transaction to DuPont if it determines that any of the facts, assumptions, representations or undertakings of DowDuPont is not correct or that the Distributions should be taxable for other reasons, including if the IRS were to disagree with the conclusions in the tax opinion that are not covered by the private letter ruling. If DuPont is required to recognize corporate level tax on either of the Distributions and certain related transactions under Section 355(e) of the Code, then under the Tax Matters Agreement, the company may be required to indemnify DuPont and/or Dow for all or a portion of such taxes, which could be a material amount, if such taxes were the result of either direct or indirect transfers of Corteva common stock or certain reasons relating to the overall structure of the Merger and the Distributions.

The company is subject to continuing contingent tax-related liabilities of DowDuPont following the Distribution.

There are several significant areas where the liabilities of DowDuPont may become Corteva’s obligations either in whole or in part. For example, under the Code and the related rules and regulations, each corporation that was a member of DowDuPont’s consolidated tax reporting group during any taxable period or portion of any taxable period ending on or before the effective time of the Distribution is jointly and severally liable for the U.S. federal income tax liability of the entire consolidated tax reporting group for such taxable period. Additionally, to the extent that any subsidiary of Corteva was included in the consolidated tax reporting group of either Historical DuPont or Historical Dow for any taxable period or portion of any taxable period ending on or before the effective date of the Merger, such subsidiary is jointly and severally liable for the U.S. federal income tax liability of the entire consolidated tax reporting group of Historical DuPont or Historical Dow, as applicable, for such taxable period. In connection with the Distributions, on April 1, 2019, the company entered into the Tax Matters Agreement with DuPont and Dow that allocates the responsibility for prior period consolidated taxes among Corteva, DuPont and Dow. If DuPont or Dow were unable to pay any prior period taxes for which it is responsible, however, the company could be required to pay the entire amount of such taxes, and such amounts could be significant. Other provisions of federal, state, local, or foreign law may establish similar liability for other matters, including laws governing tax-qualified pension plans, as well as other contingent liabilities.

25


Part I

ITEM 1B.  UNRESOLVED STAFF COMMENTS

None.


ITEM 2.  PROPERTIES
The company moved its headquarters from Wilmington, Delaware to Indianapolis, Indiana effective February 8, 2022. It also maintains a global business center in Johnston, Iowa, for its seed business. Its manufacturing, processing, marketing and research and development facilities, as well as regional purchasing offices and distribution centers, are located throughout the world. The company has 92 manufacturing sites in the following geographic regions:
Number of Sites
CropSeedTotal
North America1
42 48 
EMEA2
15 19 
Latin America10 17 
Asia Pacific
Total21 71 92 
1.    North America consists of U.S. & Canada.
2.    Europe, Middle East, and Africa ("EMEA").
The company's principal sites include facilities which, in the opinion of management, are suitable and adequate for their use and have sufficient capacity for the company's current needs and expected near-term growth. In 2019, the company announced an expansion to increase its Spinosyns fermentation capacity (refer to page 56 for further discussion). Properties are primarily owned by the company; however, certain properties are leased. No title examination of the properties has been made for the purpose of this report and certain properties are shared with other tenants under long-term leases.

26



Part I
ITEM 3.  LEGAL PROCEEDINGS
The company is subject to various legal proceedings, including, but not limited to, product liability, intellectual property, antitrust, commercial, property damage, personal injury, environmental and regulatory matters arising out of the normal course of its current businesses or legacy EID businesses unrelated to Corteva’s current businesses but allocated to Corteva as part of the Separation of Corteva from DuPont. Information regarding certain of these matters is set forth below and in Note 18 - Commitments and Contingent Liabilities, to the Consolidated Financial Statements. Even when the Company believes liabilities are not expected to be material or the probability of loss or an adverse unappealable final judgment is remote, the Company may consider settlement of these matters, and may enter into settlement agreements, if it believes settlement is in the best interest of the Company, including avoidance of future distraction and litigation defense cost, and its shareholders.

Litigation related to Corteva’s current businesses
Canadian Competition Bureau Formal Inquiry
On January 30, 2020, the Canadian Competition Bureau (the “Bureau”) filed a court order for the company to produce records and information as part of a formal inquiry under civil sections of Canada’s competition laws. The inquiry is in response to allegations by the Farmers Business Network ("FBN") that Corteva and other seeds and crop protection manufacturers and wholesalers unilaterally or in coordination refused, restricted and/or impaired supply of products to FBN in western Canada. This inquiry follows an informal request for information from the Bureau pursuant to which the company voluntarily provided documents and engaged in discussions with the Bureau outlining how its conduct was and continues to be compliant with Canadian competition laws. In February 2022, the Commissioner of the Bureau notified Corteva that the Bureau had discontinued the inquiry. The Bureau made no final determination with respect to Corteva’s conduct, thereby retaining discretion to investigate or to take enforcement action in the future. Corteva believes the likelihood of material liability is remote.

Federal Trade Commission Investigation
On May 26, 2020, Corteva received a subpoena from the Federal Trade Commission (“FTC”) directing it to submit documents pertaining to its crop protection products generally, as well as business plans, rebate programs, offers, pricing and marketing materials specifically related to its acetochlor, oxamyl, rimsulfuron and other related products in order to determine whether Corteva engaged in unfair methods of competition through anticompetitive conduct. Corteva has cooperated with the FTC’s subpoena, and continues to believe the likelihood of material liability is remote.

Chlorpyrifos Lawsuits
As of December 31, 2021, there were pending personal injury and remediation lawsuits filed against the former Dow Agrosciences LLC in California alleging injuries related to exposure to, or contamination by, chlorpyrifos, the active ingredient in Lorsban®, an insecticide used by commercial farms for field fruit, nut and vegetable crops. Corteva ended its production of Lorsban® in 2020. Further information with respect to these proceedings is set forth under “Chlorpyrifos Lawsuits” in Note 18 – Commitments and Contingent Liabilities, to the Consolidated Financial Statements.

Litigation related to legacy EID businesses unrelated to Corteva’s current businesses

As discussed below and in Note 18 - Commitments and Contingent Liabilities, to the Consolidated Financial Statements, certain of the environmental proceedings and litigation allocated to Corteva as part of the Separation from DuPont relate to the legacy EID businesses, including their use of PFOA, which, for purposes of this report, means collectively perfluorooctanoic acid and its salts, including the ammonium salt and does not distinguish between the two forms, and PFAS, which means per- and polyfluoroalkyl substances, including PFOA, PFOS (perfluorooctanesulfonic acid), GenX and other perfluorinated chemicals and compounds ("PFCs"). Management believes that it is reasonably possible that EID could incur liabilities related to PFOA in excess of amounts accrued. However, any such losses are not estimable at this time due to various reasons, including, among others, that the underlying matters are in their early stages and have significant factual issues to be resolved.

On January 22, 2021, Chemours, DuPont, Corteva and EID entered into a binding memorandum of understanding containing a settlement to resolve legal disputes related to Chemours' responsibility for litigation and environmental liabilities allocated to it, and to establish a cost sharing arrangement and escrow account to be used to support and manage potential future legacy PFAS liabilities arising out of pre-July 1, 2015 conduct (the “MOU”). See Note 18 - Commitments and Contingent Liabilities, to the Consolidated Financial Statements for further discussion.





27


Part I
ITEM 3.  LEGAL PROCEEDINGS, continued

Environmental Proceedings
The company believes it is remote that the following matters will have a material impact on its financial position, liquidity or results of operations. The matters below involve the potential for $1 million or more in monetary fines and are included per Item 103(3)(c)(iii) of Regulation S-K of the Securities Exchange Act of 1934, as amended.

Related to Corteva’s current businesses

La Porte Plant, La Porte, Texas - Crop Protection - Release Incident Investigations
On November 15, 2014, there was a release of methyl mercaptan at EID's La Porte, Texas, facility. The release occurred at the site’s crop protection unit resulting in four employee fatalities inside the unit. The Chemical Safety Board (“CSB”) issued its final report on June 18, 2019, which included recommendations related to the emergency response program at La Porte. Corteva responded to the CSB on September 30, 2019 outlining the actions it has taken to date to address the recommendations for the site and providing its plan to address the CSB’s remaining recommendations. After the conclusion of the CSB investigation, criminal U.S. Environmental Protection Agency ("EPA") and the Department of Justice ("DOJ") investigations related to the incident continued.

On January 8, 2021, EID and the facility's former unit operations leader were indicted by the DOJ on two felony and one misdemeanor charges of violations of the Clean Air Act related to the release. On January 18, 2022, the U.S. District Court of the Southern District of Texas dismissed the felony charge for failing to implement a safety practice. The maximum statutory penalties per charge are $500,000, or twice the gross gain or loss derived from the incident, as well as up to three years of probation and related ongoing reporting obligations. The company intends to move to dismiss the remaining charges and the trial is currently scheduled for October 2022.

Related to legacy EID businesses unrelated to Corteva’s current businesses

Sabine Plant, Orange, Texas - EPA Multimedia Inspection
In June 2012, EID began discussions with the EPA and the DOJ related to a multimedia inspection that the EPA conducted at the Sabine facility in March 2009 and December 2015. The discussions involve the management of materials in the facility's wastewater treatment system, hazardous waste management, flare and air emissions, including leak detection and repair. A final consent decree was approved by the federal court in January 2022, pursuant to which EID agreed to pay a civil penalty of $3.1 million and attorney’s fees to the State of Texas. Under the Separation Agreement, Corteva and DuPont will share liabilities under the decree proportionally on the basis of 29% and 71%, respectively.

Divested Neoprene Facility, La Place, Louisiana - EPA Compliance Inspection
In 2016, the EPA conducted a focused compliance investigation at the Denka Performance Elastomer LLC (“Denka”) neoprene manufacturing facility in La Place, Louisiana. EID sold the neoprene business, including this manufacturing facility, to Denka in the fourth quarter of 2015. In the spring of 2017, the EPA, the DOJ, the Louisiana Department of Environmental Quality, EID and Denka began discussions relating to the inspection conclusions and allegations of noncompliance arising under the Clean Air Act, including leak detection and repair. These discussions, which include potential settlement options, continue. Under the Separation Agreement, DuPont is defending and indemnifying the company in this matter.

New Jersey Directive PFAS
On March 25, 2019, the New Jersey Department of Environmental Protection (“NJDEP”) issued a Statewide PFAS Directive to several companies, including Chemours, DuPont, and EID. The Directive seeks information relating to the use and environmental release of PFAS and PFAS-replacement chemicals at and from two former EID sites in New Jersey, Chambers Works and Parlin, and a funding source for costs related to the NJDEP’s investigation of PFAS issues and PFAS testing and remediation.

New Jersey Directive Pompton Lakes
On March 27, 2019, the NJDEP issued to Chemours and EID a Natural Resource Damages Directive relating to chemical contamination (non-PFAS) at and around EID’s former Pompton Lakes facility in New Jersey. The Directive alleges that this contamination has harmed the natural resources of New Jersey. It seeks $125,000 as reimbursement for the cost of preparing a natural resource damages assessment, which the State will use to determine the extent of such damage and the amount it expects to seek to restore the affected natural resources to their pre-damage state.


28


Part I
ITEM 3.  LEGAL PROCEEDINGS, continued

Natural Resource Damage Cases
Since May 2017, several municipal water districts and state attorneys general have filed lawsuits against EID, Corteva, Chemours, 3M, and others, claiming contamination of public water systems by PFCs, including but not limited to PFOA. These actions with the municipalities and states seeking economic impact damages for alleged harm to natural resources, punitive damages, present and future costs to cleanup PFOA contamination and the abatement of alleged nuisance with filtration systems. Further information with respect to these proceedings is set forth under "Other PFOA Matters" in Note 18 - Commitments and Contingent Liabilities, to the Consolidated Financial Statements.

Netherlands Municipality Cases
In April 2021, four municipalities in the Netherlands filed complaints alleging contamination of land and groundwater resulting from the emission of PFOA and GenX by Corteva, DuPont and Chemours. Further information with respect to these proceedings is set forth under "Other PFOA Matters" in Note 18 - Commitments and Contingent Liabilities, to the Consolidated Financial Statements.

Settlement with the State of Delaware
On July 13, 2021, Chemours, DuPont, EID and Corteva entered into a settlement agreement with the State of Delaware reflecting the companies’ and the State’s agreement to settle and fully resolve claims alleged against the companies regarding their historical Delaware operations, manufacturing, use and disposal of all chemical compounds, including PFAS. Further information with respect to this settlement is set forth under "Other PFOA Matters" in Note 18 - Commitments and Contingent Liabilities, to the Consolidated Financial Statements.

Nebraska Department of Environment and Energy, AltEn Facility
The Environmental Protection Agency (“EPA”) and the Nebraska Department of the Environmental and Energy (“NDEE”) are pursuing investigations, response and removal actions, litigation and enforcement action related to an ethanol plant located near Mead, Nebraska and owned and operated by AltEn LLC (“AltEn”). The agencies have alleged violations under the Resource Conservation and Recovery Act (“RCRA”) and other federal and state laws stemming from AltEn’s lack of compliance with the terms and conditions of its operating permits and other regulatory requirements. Corteva is one of six seed companies, who were customers of AltEn, participating in the NDEE’s Voluntary Cleanup Program to address certain interim remediation needs at the site.


ITEM 4.  MINE SAFETY DISCLOSURES

Not applicable.

29


Part II

ITEM 5.  MARKET FOR REGISTRANT'S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES
Market for Registrant's Common Equity and Related Stockholder Matters
The company's common stock is listed on the New York Stock Exchange, Inc. (symbol: CTVA). The number of record holders of common stock was approximately 76,000 at January 31, 2022.

During 2021 and 2020, the company paid four quarterly dividends on its common stock. See the below table for dividend information for each quarter during 2021 and 2020.

20212020
Fourth Quarter$0.14 $0.13 
Third Quarter$0.14 $0.13 
Second Quarter$0.13 $0.13 
First Quarter$0.13 $0.13 
Total$0.54 $0.52 

See Part III, Item 11. Executive Compensation for information relating to the company’s equity compensation plans.

Issuer Purchases of Equity Securities
The following table summarizes information with respect to the company's purchase of its common stock during the three months ended December 31, 2021:

MonthTotal Number of Shares PurchasedAverage Price Paid per Share
Total Number of Shares Purchased as Part of the Company's Publicly Announced Share Buyback Program1
Approximate Value of Shares that May Yet Be Purchased Under the Program1
(Dollars in millions)
October 20211,461,297$42.91 1,461,297$1,387 
November 20211,484,41046.68 1,484,4101,318 
December 20211,458,66846.621,458,6681,250 
Fourth quarter 20214,404,375 $45.41 4,404,375 $1,250 
1 On August 5, 2021, Corteva, Inc. announced that its Board of Directors authorized a $1.5 billion share repurchase program to purchase Corteva, Inc.'s common stock, par value $0.01 per share, without an expiration date. The timing, price and volume of purchases will be based on market conditions, relevant securities laws and other factors.


30


Part II
ITEM 5.  MARKET FOR REGISTRANT'S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES, continued


Stock Performance Graph
The following graph illustrates the cumulative total return to Corteva stockholders following the completion of the Separation and beginning as of the closing price of its first NYSE listing date, June 3, 2019. The Chart compares the cumulative total return of Corteva’ s common stock with the S&P 500 Stock Index and the S&P 500 Chemicals Index.
ctva-20211231_g5.gif


6/3/201912/31/201912/31/202012/31/2021
Corteva$100 $120 $161 $198 
S&P 500 Index100 119 141 181 
S&P 500 Chemicals Index100 112 129 160 

The chart depicts a hypothetical $100 investment in each of the Corteva common stock, the S&P 500 Index and the S&P 500 Chemicals Index as of the closing price on June 3, 2019 and illustrates the value of each investment over time (assuming the reinvestment of dividends) until December 31, 2021.


ITEM 6.  [RESERVED]
Not applicable.





31


Part II

ITEM 7.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

CAUTIONARY STATEMENTS ABOUT FORWARD-LOOKING STATEMENTS

This report contains certain estimates and forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and Section 27A of the Securities Act of 1933, as amended, which are intended to be covered by the safe harbor provisions for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995, and may be identified by their use of words like “plans,” “expects,” “will,” “anticipates,” “believes,” “intends,” “projects,” “estimates,” “outlook,” or other words of similar meaning. All statements that address expectations or projections about the future, including statements about Corteva’s financial results or outlook; strategy for growth; product development; regulatory approvals; market position; capital allocation strategy; liquidity; environmental, social and governance (“ESG”) targets; the anticipated benefits of acquisitions, restructuring actions, or cost savings initiatives; and the outcome of contingencies, such as litigation and environmental matters, are forward-looking statements.

Forward-looking statements and other estimates are based on certain assumptions and expectations of future events which may not be accurate or realized. Forward-looking statements and other estimates also involve risks and uncertainties, many of which are beyond Corteva’s control. While the list of factors presented below is considered representative, no such list should be considered to be a complete statement of all potential risks and uncertainties. Unlisted factors may present significant additional obstacles to the realization of forward-looking statements. Consequences of material differences in results as compared with those anticipated in the forward-looking statements could include, among other things, business disruption, operational problems, financial loss, legal liability to third parties and similar risks, any of which could have a material adverse effect on Corteva’s business, results of operations and financial condition. Some of the important factors that could cause Corteva’s actual results to differ materially from those projected in any such forward-looking statements include: (i) failure to successfully develop and commercialize Corteva’s pipeline; (ii) failure to obtain or maintain the necessary regulatory approvals for some of Corteva’s products; (iii) effect of the degree of public understanding and acceptance or perceived public acceptance of Corteva’s biotechnology and other agricultural products; (iv) effect of changes in agricultural and related policies of governments and international organizations; (v) effect of competition and consolidation in Corteva’s industry; (vi) effect of competition from manufacturers of generic products; (vii) costs of complying with evolving regulatory requirements and the effect of actual or alleged violations of environmental laws or permit requirements; (viii) effect of climate change and unpredictable seasonal and weather factors; (ix) failure to comply with competition and antitrust laws; (x) competitor’s establishment of an intermediary platform for distribution of Corteva's products; (xi) impact of Corteva's dependence on third parties with respect to certain of its raw materials or licenses and commercialization; (xii) effect of industrial espionage and other disruptions to Corteva’s supply chain, information technology or network systems; (xiii) effect of volatility in Corteva’s input costs; (xiv) failure to raise capital through the capital markets or short-term borrowings on terms acceptable to Corteva; (xv) failure of Corteva’s customers to pay their debts to Corteva, including customer financing programs; (xvi) increases in pension and other post-employment benefit plan funding obligations; (xvii) risks related to environmental litigation and the indemnification obligations of legacy EID liabilities in connection with the separation of Corteva; (xviii) risks related to Corteva’s global operations; (xix) failure to effectively manage acquisitions, divestitures, alliances, restructurings, cost savings initiatives, and other portfolio actions; (xx) capital markets sentiment towards ESG matters; (xxi) risks related to COVID-19; (xxii) Corteva’s ability to recruit and retain key personnel; (xxiii) Corteva’s intellectual property rights or defend against intellectual property claims asserted by others; (xxiv) effect of counterfeit products; (xxv) Corteva’s dependence on intellectual property cross-license agreements; and (xxvi) other risks related to the Separation from DowDuPont.

Additionally, there may be other risks and uncertainties that Corteva is unable to currently identify or that Corteva does not currently expect to have a material impact on its business. Where, in any forward-looking statement or other estimate, an expectation or belief as to future results or events is expressed, such expectation or belief is based on the current plans and expectations of Corteva’s management and expressed in good faith and believed to have a reasonable basis, but there can be no assurance that the expectation or belief will result or be achieved or accomplished. Corteva disclaims and does not undertake any obligation to update or revise any forward-looking statement, except as required by applicable law. A detailed discussion of some of the significant risks and uncertainties which may cause results and events to differ materially from such forward-looking statements is included in the section titled “Risk Factors” (Part I, Item 1A of this Form 10-K).
32


Part II

ITEM 7.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS, continued

Overview
Refer to pages 3 - 5 for a discussion of the DowDuPont Merger, the Internal Reorganizations, and the Business Separations.

Basis of Presentation
Dow AgroSciences ("DAS") Common Control Combination
The transfer or conveyance of DAS to Corteva was treated as a transfer of entities under common control. As such, the company recorded the assets, liabilities, and equity of DAS on its balance sheet at their historical basis. Transfers of businesses between entities under common control requires the financial statements to be presented as if the transaction had occurred at the point at which common control first existed (the "Merger Effectiveness Time," or August 31, 2017 at 11:59 pm ET). As a result, the accompanying Consolidated Financial Statements and Notes thereto include the results of DAS as of the Merger Effectiveness Time. See Note 1 - Background and Basis of Presentation and Note 4 - Common Control Business Combination, to the Consolidated Financial Statements for additional information.

Divestiture of EID ECP and EID Specialty Products Entities
The transfer of EID ECP and EID Specialty Products Entities meets the criteria for discontinued operations and as such, results of operations are presented as discontinued operations and have been excluded from continuing operations for all periods presented. The comprehensive income (loss), stockholder's equity and cash flows related to EID ECP and EID Specialty Products Entities, respectively, have not been segregated and are included in the Consolidated Statements of Comprehensive Income (Loss), Consolidated Statements of Equity and Consolidated Statements of Cash Flows, respectively, for 2019. Amounts related to EID ECP and EID Specialty Products Entities are consistently included or excluded from the Notes to the Consolidated Financial Statements based on the respective financial statement line item. See Note 5 - Divestitures and Other Transactions, to the Consolidated Financial Statements for additional information.

Items Affecting Comparability of Financial Results
In addition to the Analysis of Operations discussion based on GAAP as reported results, the following includes a supplemental Analysis of Operations discussion reflecting unaudited pro forma financial information, prepared in accordance with Article 11 of Regulation S-X that was in effect prior to recent amendments. This unaudited pro forma financial information, for the year ended December 31, 2019 assumes the Merger, the debt retirement transactions related to paying off or retiring portions of EID’s existing debt liabilities (as discussed in Note 17 - Long-Term Debt and Available Credit Facilities, to the Consolidated Financial Statements), and the separation and distribution to DowDuPont stockholders of all the outstanding shares of Corteva common stock as if they had been consummated on January 1, 2016. For additional information, see the Supplemental Unaudited Pro Forma Combined Financial Information in this section.
33


Part II

ITEM 7.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS, continued

Overview
The following is a summary of results from continuing operations for the year ended December 31, 2021:

The company reported net sales of $15,655 million, an increase of 10 percent versus the year ended December 31, 2020, reflecting a 5 percent increase in volume, a 4 percent increase in price, and a 1 percent favorable impact from currency. Volume and price gains were driven by continued penetration of new products, continued focus on the company's price for value strategy and pricing for higher raw material and logistical costs.

Cost of goods sold ("COGS") totaled $9,220 million, up from $8,507 million for the year ended December 31, 2020, primarily driven by increased volumes, higher input costs, freight and logistics, which are primarily market-driven, and unfavorable currency, partially offset by ongoing cost and productivity actions.

Restructuring and asset related charges - net were $289 million, a decrease from $335 million for the year ended December 31, 2020. The year ended December 31, 2021 primarily included $167 million related to severance and related benefit costs, asset related charges, and contract termination charges associated with 2021 Restructuring Activities and $125 million of non-cash accelerated prepaid royalty amortization expense related to Roundup Ready 2 Yield® and Roundup Ready 2 Xtend® herbicide tolerance traits.

Income from continuing operations after income taxes was $1,822 million, as compared to $756 million for the year ended December 31, 2020.

Operating EBITDA was $2,576 million, up from $2,087 million for the year ended December 31, 2020, driven by strong price execution and volume gains in all regions and both segments.

In addition to the financial highlights above, the following events occurred during or subsequent to the year ended December 31, 2021:

The company returned approximately $1.3 billion to shareholders during the year ended December 31, 2021 under its previously announced share repurchase programs and through common stock dividends.

On July 21, 2021, the company's Board of Directors approved an increase in the common stock dividend of $0.13 per share to $0.14 per share.

Priorities
The company believes the following priorities will enable it to create significant value for its customers while delivering strong financial returns to its shareholders over the mid-term:

Deliver sales and earnings growth by continuing to leverage an industry-leading innovation pipeline to introduce new proprietary seed traits and crop protection formulations that anticipate and meet evolving customer needs and utilizing a comprehensive multi-channel, multi-brand strategy to align brands and capabilities across different sales channels.

Drive actions to expand margins through pricing for high value technology and new products and operational excellence, which includes integrating its operations and continuing to drive operating efficiencies and creating a strong culture based on accountability.

Generate cash flow growth reflecting operating discipline of working capital, including net working capital turns appropriate across the cycle.

Deploy capital in a balanced and disciplined way investing in high return organic and inorganic growth opportunities as well as providing attractive returns to shareholders via dividends and share repurchases.
34


Part II

ITEM 7.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS, continued

Analysis of Operations

Global Economic Conditions
On March 11, 2020, the World Health Organization (“WHO”) declared the novel coronavirus disease (“COVID-19”) a pandemic. The global health crisis caused by COVID-19 and the related government actions and stay at home orders have negatively impacted economic activity and increased political instability across the globe. Since the crisis began, Corteva has engaged its global Integrated Health Services Pandemic & Infectious Disease Team to take actions and implement guidelines and protocols in response to the COVID-19 pandemic.

As COVID-19 becomes more contained, a rebound in economic activity has occurred, although varying regionally depending on government policies and regulations and the rate, pace, and effectiveness of the containment efforts deployed by various national, state, and local governments, vaccination rates, and the ability of COVD-19 variants to overcome containment efforts, available vaccines, and medical treatments. These varying levels of recovery have created a misalignment of supply and demand for labor, transportation and logistic services, energy, raw materials and other inputs, which have been exasperated in certain regions by one-time events, including extreme weather events. Corteva will continue to actively monitor the situation and may take further actions altering its business operations that it determines are in the best interests of its stakeholders, or as required by federal, state, or local authorities. These alterations or modifications may impact the company's business, including the effects on its customers, employees, and prospects, or on its financial results through at least 2022. With the ongoing volatility in global markets, the company will continue to monitor various factors that could impact earnings and cash flows of the business, including, but not limited to the inflation of, or unavailability of raw material inputs and transportation and logistics services, currency fluctuations, expectations of future planted area (as influenced by consumer demand, ethanol markets and government policies and regulations), trade and purchasing of commodities globally and relative commodity prices.

2021 Restructuring Actions
During the first quarter of 2021, Corteva approved restructuring actions designed to right-size and optimize footprint and organizational structure according to the business needs in each region with the focus on driving continued cost improvement and productivity. During the year ended December 31, 2021, the company recorded net pre-tax restructuring charges of approximately $167 million, comprised of $74 million of severance and related benefit costs, $45 million of asset related charges, $6 million of asset retirement obligations and $42 million of costs related to contract terminations (contract terminations includes early lease terminations). The company does not anticipate any additional material charges from the 2021 Restructuring Activities as actions associated with this charge are substantially complete.

Future cash payments related to this charge are anticipated to be approximately $70 million, primarily related to the payment of severance and related benefits, asset retirement obligations, and costs related to contract terminations.

The 2021 Restructuring Actions are expected to contribute to the company’s ongoing cost and productivity improvement efforts
through achieving an estimated $70 million of savings on a run rate basis by 2023. See Note 7 - Restructuring and Asset Related Charges - Net, to the Consolidated Financial Statements, for additional information.

Share Buyback Plan
On August 5, 2021, Corteva, Inc. announced that its Board of Directors authorized a $1.5 billion share repurchase program to purchase Corteva, Inc.'s common stock, par value $0.01 per share, without an expiration date ("2021 Share Buyback Plan"). The timing, price and volume of purchases will be based on market conditions, relevant securities laws and other factors. In connection with the 2021 Share Buyback Plan, the company repurchased and retired 5,572,000 shares during the year ended December 31, 2021 in the open market for a total cost of $250 million.

On June 26, 2019, Corteva, Inc. announced that its Board of Directors authorized a $1 billion share repurchase program to purchase Corteva, Inc.'s common stock, par value $0.01 per share, without an expiration date ("2019 Share Buyback Plan"). The company completed the 2019 Share Buyback Plan during the third quarter of 2021. In connection with the 2019 Share Buyback Plan, the company repurchased and retired 15,378,000 shares, 8,503,000 shares, and 824,000 shares during the years ended December 31, 2021, 2020, and 2019, respectively, in the open market for a total cost of $700 million, $275 million, and $25 million, respectively.


35


Part II

ITEM 7.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS, continued

Execute to Win Productivity Program
During the first quarter of 2020, Corteva approved restructuring actions designed to improve productivity through optimizing certain operational and organizational structures primarily related to the Execute to Win Productivity Program. The company recorded net pre-tax restructuring charges of $185 million from inception-to-date under the Execute to Win Productivity Program, consisting of $124 million of asset related charges and $61 million of severance and related benefit costs. Actions associated with the Execute to Win Productivity Program were substantially complete by the end of 2020.

DowDuPont Cost Synergy Program
In September and November 2017, DowDuPont and EID approved post-merger restructuring actions under the DowDuPont Cost Synergy Program (the “Synergy Program”), adopted at the time by the DowDuPont Board of Directors. The Synergy Program was designed to integrate and optimize the organization following the Merger and in preparation for the Business Separations. The company recorded net pre-tax restructuring charges of $833 million from inception-to-date under the Synergy Program, consisting of severance and related benefit costs of $316 million, contract termination costs of $190 million, and asset-related charges of $327 million. Actions associated with the Synergy Program, including employee separations, were substantially complete in 2019.

The company included cumulative savings associated with these actions within its cost synergy commitment of approximately $1.2 billion through 2021. See Note 7 - Restructuring and Asset Related Charges - Net, to the Consolidated Financial Statements, for additional information.
36


Part II

ITEM 7.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS, continued

Net Sales
For the Year Ended December 31,
(In millions) 202120202019
Net Sales$15,655 $14,217 $13,846 

2021 versus 2020
Net sales were $15,655 million for the year ended December 31, 2021, compared to $14,217 million for the year ended December 31, 2020. Volume increased 5 percent versus the year-ago period with increases in all regions, led by Latin America. The volume increases were primarily driven by strong demand, the continued penetration of new and differentiated products and increased planted area. Price increased 4 percent versus prior year, driven by a continued focus on the company's price for value strategy and pricing for higher raw material and logistical costs.

2020 versus 2019
Net sales were $14,217 million for the year ended December 31, 2020, compared to $13,846 million for the year ended December 31, 2019. Volume increased 5 percent versus the year-ago period, primarily driven by sales of new and differentiated products globally and across both segments. Price grew 3 percent on a full-year basis, with higher prices in all regions, led by Latin America partly to offset currency. Currency represented a headwind of 5 percent, led by the impact of the Brazilian Real.

 For the Year Ended December 31,
(In millions) 202120202019
Net Sales% of Net SalesNet Sales% of Net SalesNet Sales% of Net Sales
Worldwide$15,655 100 %$14,217 100 %$13,846 100 %
North America
7,536 48 %7,168 50 %6,929 50 %
EMEA
3,123 20 %2,842 20 %2,740 20 %
Latin America3,545 23 %2,805 20 %2,889 21 %
Asia Pacific1,451 %1,402 10 %1,288 %
Year Ended December 31, 2021 vs. 2020Percent Change Due To:
Net Sales ChangePrice &Portfolio /
(in millions)$%Product MixVolumeCurrencyOther
North America$368 %%%%— %
EMEA281 10 %%%%— %
Latin America740 26 %10 %17 %(1)%— %
Asia Pacific49 %%%%(2)%
Total$1,438 10 %%%%— %

Year Ended December 31, 2020 vs. 2019Percent Change Due To:
Net Sales ChangePrice &Portfolio /
(in millions)$%Product MixVolumeCurrencyOther
North America$239 %%%(1)%— %
EMEA102 %%%(4)%— %
Latin America(84)(3)%%10 %(20)%— %
Asia Pacific114 %%11 %(3)%(1)%
Total$371 %%%(5)%— %
37


Part II

ITEM 7.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS, continued


COGS
For the Year Ended December 31,
(In millions) 202120202019
COGS$9,220 $8,507 $8,575 
(In millions)For the Year Ended December 31, 2019
Pro Forma COGS$8,386 

2021 versus 2020
COGS was $9,220 million (59 percent of net sales) for the year ended December 31, 2021 compared to $8,507 million (60 percent of net sales) for the year ended December 31, 2020. The increase was primarily driven by increased volumes in both seed and crop protection, higher input costs, freight and logistics, which are primarily market-driven, and unfavorable currency, partially offset by ongoing cost and productivity actions. The market driven trends are expected to continue as global supply chains and logistics remain constrained across industries.

2020 versus 2019
COGS was $8,507 million (60 percent of net sales) for the year ended December 31, 2020 compared to $8,575 million (62 percent of net sales) for the year ended December 31, 2019. The decrease was primarily driven by currency benefits, lack of inventory step-up in 2020 as compared to $272 million recognized in 2019, and ongoing cost and productivity actions. The decrease was partially offset by increased volumes, higher input costs in both seed and crop protection and higher royalties in seed. Amortization of inventory step-up was 2 percent of net sales for the year ended December 31, 2019.

COGS was $8,507 million (60 percent of net sales) on an as reported basis for the year ended December 31, 2020 compared to $8,386 million (61 percent of net sales) on a pro forma basis for the year ended December 31, 2019. The increase was driven by increased volumes, higher input costs in both seed and crop protection and higher royalties in seed, partially offset by the above noted currency benefits and ongoing cost and productivity actions.

Research and Development Expense ("R&D")
For the Year Ended December 31,
(In millions) 202120202019
R&D$1,187 $1,142 $1,147 

2021 versus 2020
R&D expense was $1,187 million (8 percent of net sales) for the year ended December 31, 2021 and $1,142 million (8 percent of net sales) for the year ended December 31, 2020. The increase was primarily driven by increases in contract labor, variable
compensation and unfavorable currency, partially offset by ongoing cost and productivity actions.

2020 versus 2019
R&D expense was $1,142 million (8 percent of net sales) for the year ended December 31, 2020 and $1,147 million (8 percent of net sales) for the year ended December 31, 2019. The decrease was primarily driven by currency benefits and ongoing cost and productivity actions, partially offset by increased investments to support new products in crop protection.

38


Part II

ITEM 7.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS, continued

Selling, General and Administrative Expenses ("SG&A")
For the Year Ended December 31,
(In millions) 202120202019
SG&A$3,209 $3,043 $3,065 
(In millions)For the Year Ended December 31, 2019
Pro Forma SG&A$3,068 

2021 versus 2020
SG&A was $3,209 million (20 percent of net sales) for the year ended December 31, 2021 and $3,043 million (21 percent of net sales) for the year ended December 31, 2020. The increase was driven primarily by increases in commission expense, employee related benefit costs, salaries and wages, variable compensation, enterprise resource planning ("ERP") costs and unfavorable currency, partially offset by a decrease in bad debt expense and ongoing cost and productivity actions.

2020 versus 2019
SG&A was $3,043 million (21 percent of net sales) for the year ended December 31, 2020 and $3,065 million (22 percent of net sales) for the year ended December 31, 2019. The decrease was primarily driven by currency benefits and ongoing cost and productivity actions taken to curtail spending, partially offset by higher commissions and selling expenses due to higher volumes, higher ERP costs and higher product launch costs.

Amortization of Intangibles
For the Year Ended December 31,
(In millions) 202120202019
Amortization of Intangibles$722 $682 $475 

2021 versus 2020
Intangible asset amortization was $722 million for the year ended December 31, 2021 and $682 million for the year ended December 31, 2020. The increase was primarily driven by the full year impact of the trade name asset, which changed from an indefinite lived intangible asset to definite lived with a useful life of 25 years in the fourth quarter of 2020. See Note 15 - Goodwill and Other Intangible Assets, to the Consolidated Financial Statements, for additional information for the above items.

2020 versus 2019
Intangible asset amortization was $682 million for the year ended December 31, 2020 and $475 million for the year ended December 31, 2019. The increase was primarily driven by the full year impact of germplasm assets, which changed from an indefinite lived intangible asset to a definite lived with a useful life of 25 years in the fourth quarter of 2019. The remaining increase in amortization expense is primarily due to amortization of the trade name asset that was changed from an indefinite lived intangible asset to definite lived in the fourth quarter of 2020.

39


Part II

ITEM 7.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS, continued

Restructuring and Asset Related Charges - Net            
For the Year Ended December 31,
(In millions) 202120202019
Restructuring and Asset Related Charges - Net$289 $335 $222 

2021
Restructuring and asset related charges - net were $289 million for the year ended December 31, 2021, which was primarily comprised of a $167 million net charge related to the 2021 Restructuring Actions and $125 million of restructuring and asset related charges - net from non-cash accelerated prepaid royalty amortization expense related to the Roundup Ready 2 Yield® and Roundup Ready 2 Xtend® herbicide tolerance traits. The $167 million net charge associated with the 2021 Restructuring Actions was comprised of $74 million of severance and related benefit costs, $45 million of asset related charges, $6 million of asset retirement obligations and $42 million of costs related to contract terminations (contract terminations includes early lease terminations).

2020
Restructuring and asset related charges - net were $335 million for the year ended December 31, 2020, which was comprised of a $176 million net charge related to the Execute to Win Productivity Program and $159 million of restructuring and asset related charges - net from non-cash accelerated prepaid royalty amortization expense related to the Roundup Ready 2 Yield® and Roundup Ready 2 Xtend® herbicide tolerance traits. The $176 million net charge associated with the Execute to Win Productivity Program was comprised of $113 million of asset related charges and $63 million of severance and related benefit costs.

2019
Restructuring and asset related charges - net were $222 million for the year ended December 31, 2019, which was comprised of $144 million of asset related charges (discussed in the "Asset Impairment" section, below) and a $92 million net charge related to the Synergy Program, offset by a net benefit of $14 million related to the DowDuPont Agriculture Division Restructuring Program. The $92 million net charge associated with the Synergy Program was comprised of $69 million of contract termination charges and $30 million of asset related charges, partially offset by a $7 million benefit on the reduction of severance and related benefit costs. The $14 million net benefit associated with the DowDuPont Agriculture Division Restructuring Program included a $17 million benefit on the reduction of severance and related benefit costs, partially offset by $3 million of asset related charges.

Asset Impairment
For the year ended December 31, 2019, the company recognized a $144 million pre-tax ($110 million after-tax) non-cash impairment charge in restructuring and asset related charges - net in the company's Consolidated Statements of Operations related to certain IPR&D assets within the seed segment. See Note 7 - Restructuring and Asset Related Charges - Net, and Note 23 - Fair Value Measurements, to the Consolidated Financial Statements for additional information.

40


Part II

ITEM 7.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS, continued

Integration and Separation Costs
For the Year Ended December 31,
(In millions) 202120202019
Integration and Separation Costs$— $— $744 
(In millions)For the Year Ended December 31, 2019
Pro Forma Integration and Separation Costs$632 

Integration and separation costs were $744 million for the year ended December 31, 2019. These costs consisted primarily of financial advisory, information technology, legal, accounting, consulting, and other professional advisory fees associated with the preparation and execution of activities related to the Business Separations and the integration of EID’s Pioneer and Crop Protection businesses with DAS. Pro forma integration and separation costs were $632 million for the year ended December 31, 2019. These costs were primarily driven by financial advisory, information technology, legal, accounting, consulting, and other professional advisory fees associated with the preparation and execution of activities related to the Business Separations and the integration of EID’s Pioneer and Crop Protection businesses with DAS.

Other Income - Net
For the Year Ended December 31,
(In millions) 202120202019
Other Income - Net$1,348 $212 $215 
2021 versus 2020
Other income - net was income of $1,348 million for the year ended December 31, 2021 and income of $212 million for the year ended December 31, 2020. The increase was primarily driven by an increase in non-operating pension and other post-employment benefit credits, driven by the 2020 OPEB Plan Amendments, a decrease in net exchange losses, and the Employee Retention Credit pursuant to the Coronavirus Aid, Relief, and Economic Security (“CARES”) Act as enhanced by the Consolidated Appropriations Act (“CAA”) and American Rescue Plan Act (“ARPA”). The increases are partially offset by the 2021 officer indemnification payment and a charge related to a contract termination with a third-party service provider. See Note 9 - Supplementary Information, to the Consolidated Financial Statements for additional information.

2020 versus 2019
Other income - net was income of $212 million for the year ended December 31, 2020 and income of $215 million for the year ended December 31, 2019. The increase in non-operating pension and other post-employment benefit credits was offset by higher net exchange losses as well as net losses on sales of businesses and other assets for the year ended December 31, 2020, compared to net gains in 2019 and a change in miscellaneous income. Other income - net for the year ended December 31, 2020 includes a $(53) million loss on the expected sale of the La Porte site. See Note 9 - Supplementary Information, to the Consolidated Financial Statements for additional information.

The company routinely uses forward exchange contracts to offset its net exposures, by currency denominated monetary assets and liabilities of its operations. The objective of this program is to maintain an approximately balanced position in foreign currencies in order to minimize, on an after-tax basis, the effects of exchange rate changes. The net pre-tax exchange gains and losses are recorded in other income - net and the related tax impact is recorded in provision for (benefit from) income taxes on continuing operations in the Consolidated Statement of Operations. See Note 9 - Supplementary Information, to the Consolidated Financial Statements for additional information.

41


Part II

ITEM 7.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS, continued

Interest Expense
For the Year Ended December 31,
(In millions) 202120202019
Interest Expense$30 $45 $136 

(In millions)For the Year Ended December 31, 2019
Pro Forma Interest Expense$91 

2021 versus 2020
Interest expense was $30 million and $45 million for the years ended December 31, 2021 and 2020, respectively. The change was primarily driven by lower average short-term borrowings and lower interest rates, partially offset by higher average long-term borrowings.

2020 versus 2019
Interest expense was $45 million and $136 million for the years ended December 31, 2020 and 2019, respectively. The change was primarily driven by lower average debt balances as a result of the redemption/repayment transactions in the second quarter of 2019 related to paying off or retiring portions of EID’s existing debt liabilities (refer to Note 17 - Long-Term Debt and Available Credit Facilities, to the Consolidated Financial Statements) and lower average interest rates.

Provision for (Benefit from) Income Taxes on Continuing Operations
For the Year Ended December 31,
(In millions) 202120202019
Provision for (Benefit from) Income Taxes on Continuing Operations$524 $(81)$(46)
Effective Tax Rate22.3 %(12.0)%14.6 %
(In millions)For the Year Ended December 31, 2019
Pro Forma Provision for (Benefit from) Income Taxes on Continuing Operations$
Pro Forma Effective Tax Rate3.7 %

2021
For the year ended December 31, 2021, the company’s effective tax rate of 22.3 percent on pre-tax income from continuing operations of 2,346 million was unfavorably impacted by the tax impact of certain net exchange losses recognized on the re-measurement of the net monetary asset positions which were not deductible in their local jurisdictions, the tax impact of income from pension and other post employment benefits, and a $23 million charge associated with repatriation of cash held outside of the U.S. These items were partially offset by the impacts of favorable geographic mix of earnings and a $(57) million benefit related to U.S. tax credits for increasing research activities.

2020
For the year ended December 31, 2020, the company’s effective tax rate of (12.0) percent on pre-tax income from continuing operations of $675 million was favorably impacted by a $(182) million tax benefit associated with the recognition of an elective cantonal component of the recent enactment of the Federal Act on Tax Reform and AHV Financing (“Swiss Tax Reform”), a $(51) million tax benefit related to a return to accrual adjustment associated with an elective change in accounting method for the 2019 tax year impact of The Act's foreign tax provisions, a $(14) million tax benefit related to a return to accrual adjustment to reflect a change in estimate on the impact of a tax law enactment in a foreign jurisdiction, as well as an additional $(14) million of net tax benefits associated with changes in accruals for certain prior year tax positions in various other jurisdictions. These benefits were partially offset by the impacts of unfavorable geographic mix of earnings, the tax impact of certain net exchange losses recognized on the re-measurement of the net monetary asset positions which were not deductible in their local jurisdictions, and a $19 million tax charge associated with a state tax valuation allowance in the U.S. based on a change in judgment about the realizability of a deferred tax asset.

42


Part II

ITEM 7.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS, continued

2019
For the year ended December 31, 2019, the company’s effective tax rate of 14.6 percent on pre-tax loss from continuing operations of $(316) million was unfavorably impacted by a tax charge of $146 million related to the U.S. state blended tax rate changes associated with the Business Separations and a tax charge of $35 million related to application of foreign tax provisions. Other net unfavorable effective tax rate impacts included those related to the Argentine peso devaluation, integration and separation costs, non-tax-deductible amortization of the fair value step-up in inventories as a result of the Merger, the tax impact of certain net exchange losses recognized on the re-measurement of the net monetary asset positions which were not deductible in their local jurisdictions, as well as geographic mix of earnings. Those unfavorable impacts were partially offset by a tax benefit of $(102) million related to an internal legal entity restructuring associated with the Business Separations, tax benefits of $(38) million associated with the enactment of the Federal Act on Tax Reform and AHV Financing (“Swiss Tax Reform”), a $(34) million tax benefit associated with the release of a valuation allowance recorded against the net deferred tax asset position of a legal entity in Switzerland, as well as $(19) million of tax benefits associated with changes in accruals for certain prior year tax positions and reductions in the company’s unrecognized tax benefits due to the closure of various tax statutes of limitations.

For the year ended December 31, 2019, the company’s effective tax rate was 3.7 percent on pro forma pre-tax income from continuing operations of $27 million. The pro forma pre-tax income from continuing operations excludes pre-tax charges of $205 million, $45 million and $93 million primarily related to the removal of amortization of the fair value-step-up of inventories as a result of the Merger, removal of interest expense related to paying off or retiring portions of EID’s existing debt liabilities (as discussed in Note 17 - Long-Term Debt and Available Credit Facilities, to the Consolidated Financial Statements), and removal of expenses directly attributable to the Separation, respectively. The pro forma provision for income taxes on continuing operations excludes net tax benefits of $(36) million, $(10) million and $(1) million related to the above items, respectively.

(Loss) Income from Discontinued Operations After Tax
For the Year Ended December 31,
(In millions) 202120202019
(Loss) Income from Discontinued Operations After Income Taxes$(53)$(55)$(671)

2021 versus 2020
(Loss) income from discontinued operations after income taxes was $(53) million for the year ended December 31, 2021 and $(55) million for the year ended December 31, 2020. The year ended December 31, 2021 primarily reflects charges relating to PFAS environmental remediation activities at the Chemours Fayetteville Works facility and the settlement with the State of Delaware for PFAS related natural resource damage claims. See Note 18 - Commitments and Contingent Liabilities, to the Consolidated Financial Statements, for further discussion. See below for discussion of discontinued operations for the year ended December 31, 2020.

2020 versus 2019
(Loss) income from discontinued operations after income taxes was $(55) million for the year ended December 31, 2020 and $(671) million for the year ended December 31, 2019. The year ended December 31, 2020 primarily reflects an after-tax charge of $(65) million as a result of the MOU, and the settlement of approximately 95 matters, as well as unfiled matters remaining in the Ohio MDL. See Note 18 - Commitments and Contingent Liabilities, to the Consolidated Financial Statements, for further discussion. The year ended December 31, 2019 reflects the financial results recognized for the EID Specialty Entities of $(859) million, which includes a non-cash goodwill impairment charge of $(1,102) million and impairment charge relating to equity method investment of $(63) million, partially offset by changes in accruals for certain prior tax positions relating to the Divested Ag Business of $80 million, adjustments of certain unrecognized tax benefits for positions taken on items from prior years from previously divested businesses of $89 million and the financial results recognized for EID ECP of $19 million.

EID Analysis of Operations
As discussed in Note 1 - Basis of Presentation, to the EID Consolidated Financial Statements, EID is a subsidiary of Corteva, Inc. and continues to be a reporting company, subject to the requirements of the Exchange Act. The below relates to EID only and is presented to provide an Analysis of Operations, only for the differences between EID and Corteva, Inc.


43


Part II

ITEM 7.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS, continued

Interest Expense
2021 versus 2020
EID’s interest expense was $80 million for the year ended December 31, 2021 and $145 million for the year ended December 31, 2020. The change was primarily driven by the items noted on page 42, under the header “Interest Expense – 2021 versus 2020,” and by lower interest expense incurred on the related party loan between EID and Corteva, Inc. See Note 2 - Related Party Transactions, to the EID Consolidated Financial Statements for further information.

2020 versus 2019
EID’s interest expense was $145 million for the year ended December 31, 2020 and $242 million for the year ended December 31, 2019. The change was primarily driven by the items noted on page 42, under the header "Interest Expense - 2020 versus 2019," and by lower interest expense incurred on the related party loan between EID and Corteva, Inc. See Note 2 - Related Party Transactions, to the EID Consolidated Financial Statements for further information.

Provision for (Benefit from) Income Taxes
2021
For the year ended December 31, 2021, EID had an effective tax rate of 22.2 percent on pre-tax income from continuing operations of $2,296 million, driven by the items noted on page 42, under the header “Provision for Income Taxes - 2021” and a tax benefit related to the interest expense incurred on the related party loan between EID and Corteva, Inc. See Note 3 - Income Taxes, to the EID Consolidated Financial Statements for further information.

2020
For the year ended December 31, 2020, EID had an effective tax rate of (18.3) percent on pre-tax income from continuing operations of $575 million, driven by the items noted on page 42, under the header “Provision for Income Taxes - 2020” and a tax benefit related to the interest expense incurred on the related party loan between EID and Corteva, Inc. See Note 3 - Income Taxes, to the EID Consolidated Financial Statements for further information.

2019
For the year ended December 31, 2019, EID had an effective tax rate of 16.8 percent on pre-tax loss from continuing operations of $(422) million, driven by the items noted on page 43, under the header "Provision for Income Taxes - 2019" and a tax benefit related to the interest expense incurred on a related party loan between EID and Corteva, Inc. See Note 3 - Income Taxes, to the EID Consolidated Financial Statements for further information.

Corporate Outlook - 2022
Global demand for agricultural products continues to be strong with an expected record demand for grain and oilseeds. The company anticipates total U.S. corn and soybean planted area to be flat, with a modest shift towards soybeans.

The company expects net sales to be in the range of $16.7 billion and $17.0 billion, driven by new product sales and continued focus on the company’s price for value strategy, partially offset by currency headwinds.

The company expects Operating EBITDA to be in the range of $2.8 billion and $3.0 billion with new product sales, pricing and ongoing cost savings actions offsetting the expected increased input costs. Operating Earnings Per Share is expected to be in the range of $2.30 and $2.50 per share. Refer to further discussion of Non-GAAP metrics on pages 52 - 54.

The above outlook does not contemplate any extreme weather events, operational disruptions, significant changes in customers' demand or ability to pay, or further acceleration of currency and inflation impacts resulting from global economic conditions. Corteva is not able to reconcile its forward-looking non-GAAP financial measures to its most comparable U.S. GAAP financial measures, as it is unable to predict with reasonable certainty items outside of the company’s control, such as Significant Items, without unreasonable effort (refer to page 53 for Significant Items recorded in the years ended December 31, 2021, 2020 and 2019). However, the company expects non-operating benefits to be approximately $1 billion lower, as a result of the 2020 OPEB Plan Amendments, an increase in the discount rates, and a change in the expected long-term rate of return on plan assets. Refer to the company's discussion on Long-term Employee Benefits on page 65. Additionally, beginning January 1, 2020, the company recognizes non-cash accelerated prepaid royalty amortization expense as a restructuring and asset related charge. For further discussion of accelerated prepaid royalty amortization refer to the Company's Critical Accounting Estimates for Prepaid Royalties on page 63.


44


Part II

ITEM 7.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS, continued

Supplemental Unaudited Pro Forma Financial Information
The supplemental unaudited pro forma statements of operations (the "unaudited pro forma statements of operations") for Corteva for the year ended December 31, 2019 gives effect to the Merger, the debt retirement transactions related to paying off or retiring portions of EID’s existing debt liabilities (as discussed in Note 17 - Long-Term Debt and Available Credit Facilities, to the Consolidated Financial Statements), and the separation and distribution to DowDuPont stockholders of all the outstanding shares of Corteva common stock as if they had been consummated on January 1, 2016.

For the periods presented below, Corteva’s results for all periods prior to the Business Realignment and Internal Reorganization consist of the combined results of operations for Historical EID and DAS, and Corteva’s results for all periods after the Business Realignment and Internal Reorganization represent the consolidated balances of the company. The unaudited pro forma statements of operations below were prepared in accordance with Article 11 of Regulation S-X that was in effect prior to recent amendments, and events that are not expected to have a continuing impact on the combined results (e.g., amortization of inventory step-up costs) are excluded. One-time transaction-related costs incurred prior to, or concurrent with, the closing of the Merger, the debt redemptions/repayments, and the Corteva Distribution are not included in the unaudited pro forma combined statements of operations through March 31, 2019. The unaudited pro forma combined statements of operations do not reflect restructuring or integration activities or other costs, that were not already reflected in GAAP results, following the separation and distribution transactions that may be incurred to achieve cost or growth synergies of Corteva. As no assurance can be made that these costs will be incurred or the growth synergies will be achieved, no adjustment has been made.

The unaudited pro forma statements of operations have been presented for informational purposes only and are not necessarily indicative of what Corteva’s results of operations actually would have been had the above transactions been completed on January 1, 2016. In addition, the unaudited pro forma statements of operations do not purport to project the future operating results of the company. The unaudited pro forma statements of operations were based on and should be read in conjunction with the audited Consolidated Financial Statements and Notes contained within this Annual Report on Form 10-K. 

45


Part II

ITEM 7.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS, continued

Unaudited Pro Forma Statement of OperationsFor the Year Ended December 31, 2019
(In millions, except per share amounts) Corteva (As Reported - GAAP)
Merger 1
Debt Retirement 2
Separations Related 3
Pro Forma
Net sales$13,846 $— $— $— $13,846 
Cost of goods sold
8,575 (205)— 16 8,386 
Research and development expense
1,147 — — — 1,147 
Selling, general and administrative expenses
3,065 — — 3,068 
Amortization of intangibles
475 — — — 475 
Restructuring and asset related charges - net
222 — — — 222 
Integration and separation costs
744 — — (112)632 
Other income - net
215 — — — 215 
Loss on early extinguishment of debt
13 — — — 13 
Interest expense
136 — (45)— 91 
Income (loss) from continuing operations before income taxes(316)205 45 93 27 
Provision for (benefit from) income taxes on continuing operations(46)36 10 
Income (loss) from continuing operations after income taxes(270)169 35 92 26 
Net income (loss) from continuing operations attributable to noncontrolling interests13 — — — 13 
Net income (loss) attributable to Corteva$(283)$169 $35 $92 $13 
Per share common data
Earnings (loss) per share of common stock from continuing operations - basic$0.02 
Earnings (loss) per share of common stock from continuing operations - diluted$0.02 
Weighted-average common shares outstanding - basic
749.5 
Weighted-average common shares outstanding - diluted
749.5 
1.Represents the removal of amortization of EID’s agriculture business’ inventory step-up recognized in connection with the Merger, as the incremental amortization is directly attributable to the Merger and will not have a continuing impact.
2.Represents removal of interest expense related to the debt redemptions/repayments.
3.Adjustments directly attributable to the separations and distributions of Corteva, Inc. include the following: removal of Telone® Soil Fumigant business (“Telone®”) results (as Telone® did not transfer to Corteva as part of the common control combination of DAS); impact from the distribution agreement entered into between Corteva and Dow that allows for Corteva to become the exclusive distributor of Telone® products for Dow; elimination of one-time transaction costs directly attributable to the Corteva Distribution; the impact of certain manufacturing, leasing and supply agreements entered into in connection with the Corteva Distribution; and the related tax impacts of these items.

46


Part II

ITEM 7.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS, continued

Recent Accounting Pronouncements
See Note 3 - Recent Accounting Guidance, to the Consolidated Financial Statements for a description of recent accounting pronouncements.

Segment Reviews
The company operates in two reportable segments: seed and crop protection. The company’s seed segment is a global leader in developing and supplying advanced germplasm and traits that produce optimum yield for farms around the world. The segment offers trait technologies that improve resistance to weather, disease, insects and herbicides used to control weeds, and trait technologies that enhance food and nutritional characteristics, and also provides digital solutions that assist farmer decision-making with a view to optimize product selection and, ultimately, help maximize yield and profitability. The segment competes in a wide variety of agricultural markets. The crop protection segment serves the global agricultural input industry with products that protect against weeds, insects and other pests, and disease, and that improve overall crop health both above and below ground via nitrogen management and seed-applied technologies. The segment is a leader in global herbicides, insecticides, nitrogen stabilizers and pasture and range management herbicides.

Summarized below are comments on individual segment net sales and segment operating EBITDA for the years ended December 31, 2021, 2020 and 2019. For the year ended December 31, 2019, segment operating EBITDA is calculated on a pro forma basis, as this is the manner in which the chief operating decision maker ("CODM") assesses performance and allocates resources. Pro forma adjustments used in the calculation of pro forma segment operating EBITDA were determined in accordance with Article 11 of Regulation S-X that was in effect prior to recent amendments. For the year ended December 31, 2019, these adjustments give effect to the Merger, the debt retirement transactions related to paying off or retiring portions of EID’s existing debt liabilities (as discussed in Note 17 - Long-Term Debt and Available Credit Facilities, to the Consolidated Financial Statements), and the separation and distribution to DowDuPont stockholders of all the outstanding shares of Corteva common stock as if they had been consummated on January 1, 2016 (refer to supplemental unaudited pro forma financial statements on page 45). The company defines segment operating EBITDA as earnings (loss) (i.e., income (loss) from continuing operations before income taxes) before interest, depreciation, amortization, corporate expenses, non-operating benefits (costs), foreign exchange gains (losses), and net unrealized gain or loss from mark-to-market activity for certain foreign currency derivative instruments that do not qualify for hedge accounting, excluding the impact of significant items. Non-operating benefits (costs) consists of non-operating pension and OPEB benefit (costs), tax indemnification adjustments, environmental remediation and legal costs associated with legacy EID businesses and sites, and the 2021 officer indemnification payment. Tax indemnification adjustments relate to changes in indemnification balances, as a result of the application of the terms of the Tax Matters Agreement, between Corteva and Dow and/or DuPont that are recorded by the company as pre-tax income or expense. See Note 25 - Segment Information, to the Consolidated Financial Statements for details related to significant pre-tax benefits (costs) excluded from segment operating EBITDA. All references to prices are based on local price unless otherwise specified.

A reconciliation of segment operating EBITDA to income (loss) from continuing operations after income taxes for the years ended December 31, 2021, 2020 and 2019 is included in Note 25 - Segment Information, to the Consolidated Financial Statements.
47


Part II

ITEM 7.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS, continued

SeedFor the Year Ended December 31,
In millions20212020
20191
Net sales$8,402 $7,756 $7,590 
Segment operating EBITDA$1,512 $1,208 $1,040 
1.The year ended December 31, 2019 is presented on a Pro Forma Basis, prepared in accordance with Article 11 of Regulation S-X that was in effect prior to recent amendments.

Seed2021 vs. 2020Percent Change Due To:
Net Sales ChangePrice &Portfolio /
In millions$%Product MixVolumeCurrencyOther
North America
$209 %%%%— %
EMEA
131 %%%%— %
Latin America303 27 %16 %14 %(3)%— %
Asia Pacific%%(2)%%— %
Total$646 %%%— %— %
Seed2021 vs. 2020Percent Change Due To:
Net Sales ChangePrice &Portfolio /
In millions$%Product MixVolumeCurrencyOther
Corn$436 %%%— %— %
Soybeans123 %— %%%— %
Other oilseeds133 21 %%14 %%— %
Other(46)(9)%(2)%(8)%%— %
Total$646 %%%— %— %
Seed2020 vs. 2019Percent Change Due To:
Net Sales ChangePrice &Portfolio /
In millions$%Product MixVolumeCurrencyOther
North America
$71 %— %%— %— %
EMEA
90 %%%(5)%— %
Latin America(13)(1)%%13 %(18)%— %
Asia Pacific18 %%%(5)%— %
Total$166 %%%(4)%— %
Seed2020 vs. 2019Percent Change Due To:
Net Sales ChangePrice &Portfolio /
In millions$%Product MixVolumeCurrencyOther
Corn$56 %%%(5)%— %
Soybeans58 %%%(2)%— %
Other oilseeds26 %— %%(4)%— %
Other26 %%%(3)%— %
Total$166 %%%(4)%— %

48


Part II

ITEM 7.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS, continued

Seed
Seed net sales were $8,402 million in 2021, up 8 percent from $7,756 million in 2020. The increase was driven by a 4 percent increase in price and a 4 percent increase in volume. Local price gains were driven by strong adoption of new Seed technology, including price execution in Latin America and EMEA, with corn price up 5 percent globally. These gains were partially offset by competitive pricing pressure in North America soybeans, where price was down 2 percent. The increase in volume was driven by strong demand for corn in Brazil, coupled with higher soybean and corn sales in North America.

Seed operating EBITDA was $1,512 million in 2021, up 25 percent from $1,208 million in 2020. Continued price execution, volume gains, ongoing cost and productivity actions, lower royalties, and lower bad debt expense more than offset higher input costs, higher freight and warehousing costs, and higher variable compensation costs.

Seed net sales were $7,756 million in 2020, up 2 percent from $7,590 million in 2019. The increase was driven by a 5 percent increase in volume and 1 percent increase in price, partially offset by a 4 percent unfavorable impact from currency. Volume growth was driven by the recovery of soybean planted area in North America and strong summer and Safrinha sales in Brazil. Global corn price grew 2 percent year over year, primarily driven by continued penetration from products such as Qrome® and PowerCore ULTRATM. North America soybean price increased 2 percent versus the year-ago period due to superior product performance and strong execution. Unfavorable currency impacts were led by the Brazilian Real.

Seed operating EBITDA was $1,208 million in 2020, up 16 percent from pro forma operating EBITDA of $1,040 million in 2019. Favorable mix, volume gains and ongoing cost and productivity actions more than offset the unfavorable impact of currency, higher input costs and higher royalties.

49


Part II

ITEM 7.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS, continued

Crop ProtectionFor the Year Ended December 31,
In millions20212020
20191
Net sales$7,253 $6,461 $6,256 
Segment operating EBITDA$1,202 $1,004 $1,066 
1.The year ended December 31, 2019 is presented on a Pro Forma Basis, prepared in accordance with Article 11 of Regulation S-X that was in effect prior to recent amendments.
Crop Protection2021 vs. 2020Percent Change Due To:
Net Sales ChangePrice &Portfolio /
In millions$%Product MixVolumeCurrencyOther
North America
$159 %%— %%— %
EMEA
150 11 %%%%— %
Latin America437 26 %%19 %— %— %
Asia Pacific46 %%%%(3)%
Total$792 12 %%%%(1)%
Crop Protection2021 vs. 2020Percent Change Due To:
Net Sales ChangePrice &Portfolio /
In millions$%Product MixVolumeCurrencyOther
Herbicides$535 16 %%%%— %
Insecticides(34)(2)%%(5)%%— %
Fungicides278 27 %%22 %%(2)%
Other13 %(8)%11 %— %— %
Total$792 12 %%%%(1)%
Crop Protection2020 vs. 2019Percent Change Due To:
Net Sales ChangePrice &Portfolio /
In millions$%Product MixVolumeCurrencyOther
North America
$168 %%%— %— %
EMEA
12 %%%(2)%(1)%
Latin America(71)(4)%%%(21)%— %
Asia Pacific96 10 %%13 %(2)%(2)%
Total$205 %%%(7)%(1)%
Crop Protection2020 vs. 2019Percent Change Due To:
Net Sales ChangePrice &Portfolio /
In millions$%Product MixVolumeCurrencyOther
Herbicides$74 %%%(5)%(1)%
Insecticides112 %%%(7)%— %
Fungicides(40)(4)%%%(12)%(2)%
Other1
59 18 %24 %%(7)%— %
Total$205 %%%(7)%(1)%
50


Part II

ITEM 7.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS, continued


Crop Protection
Crop protection net sales were $7,253 million in 2021, up 12 percent from $6,461 million in 2020. The increase was due to a 6 percent increase in volume, a 5 percent increase in price and a 2 percent favorable impact from currency, partially offset by a 1 percent unfavorable portfolio impact.

Volume gains were led by continued penetration of new products globally, with combined sales of over $1.4 billion in 2021, up nearly $450 million compared to the prior-year period, led by EnlistTM and ArylexTM herbicides and IsoclastTM insecticide. These volume gains were partially offset by an approximate $275 million impact from the company's decision to phase out select low-margin products.

The increase in price was primarily driven by gains in North America and Latin America, including pricing for higher raw material and logistical costs. Favorable currency impacts were primarily from the Euro. The portfolio impact was driven by a divestiture in Asia Pacific.

Crop protection operating EBITDA was $1,202 million in 2021, up 20 percent from $1,004 million from 2020. Pricing execution, continued penetration of new products, ongoing cost and productivity actions, and a favorable impact from currency more than offset higher input costs, including raw material and logistical costs, and higher variable compensation costs.

Crop protection net sales were $6,461 million in 2020, up from $6,256 million in 2019. Sales gains were driven by a 7 percent increase in volume and a 4 percent increase in price, which was partially offset by a 7 percent impact from currency and a 1 percent impact from portfolio.

The increase in volume was driven by continued penetration of new products globally, with combined sales of $1 billion in 2020, up $265 million compared to the prior-year period, led by EnlistTM, ArylexTM, and RinskorTM herbicides and IsoclastTM insecticide. Local price growth was driven by increases in Latin America to offset currency, coupled with favorable mix globally from new product launches. Unfavorable currency impacts were led by the Brazilian Real. The Company has recognized approximately $150 million in pricing to offset the weakening Brazilian Real for the full year. The portfolio impact was driven by divestitures in Asia Pacific and North America.

Crop Protection operating EBITDA was $1,004 million in 2020, down from pro forma segment operating EBITDA of $1,066 million in 2019. Favorable mix, ongoing cost and productivity actions, together with volume gains, were more than offset by the negative impact of currency, increased investment to fund growth and higher input costs. Currency net of pricing was a $70 million headwind, inclusive of $150 million in pricing actions.
51


Part II

ITEM 7.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS, continued

Non-GAAP Financial Measures
The company presents certain financial measures that do not conform to U.S. GAAP and are considered non-GAAP measures. These measures include Operating EBITDA and operating earnings (loss) per share. Management uses these measures internally for planning and forecasting, including allocating resources and evaluating incentive compensation. Management believes that these non-GAAP measures best reflect the ongoing performance of the company during the periods presented and provide more relevant and meaningful information to investors as they provide insight with respect to ongoing operating results of the company and a more useful comparison of year over year results. These non-GAAP measures supplement the company's U.S. GAAP disclosures and should not be viewed as an alternative to U.S. GAAP measures of performance. Furthermore, such non-GAAP measures may not be consistent with similar measures provided or used by other companies. Reconciliations for these non-GAAP measures to U.S. GAAP are provided below. For the year ended December 31, 2019, information is on a pro forma basis and these non-GAAP measures are being reconciled to a pro forma GAAP financial measure prepared and presented in accordance with Article 11 of Regulation S-X that was in effect prior to recent amendments, which are reconciled to the GAAP reported figures. See Article 11 Pro Forma Combined Statements of Operations on page 46.

Operating EBITDA is defined as earnings (loss) (i.e., income (loss) from continuing operations before income taxes) before interest, depreciation, amortization, non-operating benefits (costs), foreign exchange gains (losses), and net unrealized gain or loss from mark-to-market activity for certain foreign currency derivative instruments that do not qualify for hedge accounting, excluding the impact of significant items. Effective January 1, 2021, on a prospective basis, the company excludes from segment operating EBITDA net unrealized gain or loss from mark-to-market activity for certain foreign currency derivative instruments that do not qualify for hedge accounting. Non-operating benefits (costs) consists of non-operating pension and OPEB benefits (costs), tax indemnification adjustments, environmental remediation and legal costs associated with legacy EID businesses and sites, and the 2021 officer indemnification payment. Tax indemnification adjustments relate to changes in indemnification balances, as a result of the application of the terms of the Tax Matters Agreement, between Corteva and Dow and/or DuPont that are recorded by the company as pre-tax income or expense. Operating earnings (loss) per share is defined as "earnings (loss) per common share from continuing operations - diluted" excluding the after-tax impact of significant items, the after-tax impact of non-operating benefits (costs), the after-tax impact of amortization expense associated with intangible assets existing as of the Separation from DowDuPont, and the after-tax impact of net unrealized gain or loss from mark-to-market activity for certain foreign currency derivative instruments that do not qualify for hedge accounting. Although amortization of the company's intangible assets is excluded from these non-GAAP measures, management believes it is important for investors to understand that such intangible assets contribute to revenue generation. Amortization of intangible assets that relate to past acquisitions will recur in future periods until such intangible assets have been fully amortized. Any future acquisitions may result in amortization of additional intangible assets. Net unrealized gain or loss from mark-to-market activity for certain foreign currency derivative instruments that do not qualify for hedge accounting represents the non-cash net gain (loss) from changes in fair value of certain undesignated foreign currency derivative contracts. Upon settlement, which is within the same calendar year of execution of the contract, the realized gain (loss) from the changes in fair value of the non-qualified foreign currency derivative contracts will be reported in the relevant non-GAAP financial measures, allowing quarterly results to reflect the economic effects of the foreign currency derivative contracts without the resulting unrealized mark to fair value volatility.


52


Part II

ITEM 7.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS, continued

Reconciliation of Income (Loss) from Continuing Operations after Income Taxes to Operating EBITDA
Year Ended December 31,
202120202019
(In millions)As ReportedAs ReportedPro Forma
Income (loss) from continuing operations after income taxes $1,822 $756 $26 
Provision for (benefit from) income taxes on continuing operations524 (81)
Income (loss) from continuing operations before income taxes 2,346 675 27 
Depreciation and amortization1,243 1,177 1,000 
Interest income(77)(56)(59)
Interest expense30 45 91 
Exchange (gains) losses54 174 66 
Non-operating (benefits) costs(1,256)(316)(129)
Mark-to-market (gains) losses on certain foreign currency contracts not designated as hedges1
— 
Significant items (benefit) charge236 388 991 
Operating EBITDA (Non-GAAP)$2,576 $2,087 $1,987 
1.Effective January 1, 2021, on a prospective basis, the company excludes net unrealized gains or losses from mark-to-market activity for certain foreign currency derivative instruments that do not qualify for hedge accounting. There were no unrealized mark-to-market (gains) losses for the years ended December 31, 2020 and 2019.

Significant Items
Year Ended December 31,
202120202019
(In millions)As ReportedAs ReportedPro Forma
Integration and separation costs$— $— $632 
Restructuring and asset related charges - net289 335 222 
Equity securities mark-to-market gain(47)— — 
Loss on divestiture— 53 24 
Amortization of inventory step-up— — 67 
Argentina currency devaluation— — 33 
Loss on early extinguishment of debt— — 13 
Employee Retention Credit(60)— — 
Contract termination54 — — 
Total pretax significant items (benefit) charge236 388 991 
Total tax (benefit) charge impact of significant items1
(51)(86)(135)
Tax only significant item (benefit) charge2
(9)(192)(72)
Total significant items (benefit) charge, net of tax$176 $110 $784 
1.The tax benefit impact of significant items for the year ended December 31, 2019 includes a net tax charge of $35 million related to application of foreign tax provisions, a net tax charge of $146 million related to U.S. state blended tax rate changes associated with the Internal Reorganizations, and a net tax benefit of $(102) million related to an internal legal entity restructuring associated with the Internal Reorganizations. Unless specifically addressed above, the income tax effect on significant items was calculated based upon the enacted tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment.
2.The tax only significant item benefit for the year ended December 31, 2021 reflects a net benefit for the impact of changes in valuation allowances recorded against the net deferred tax asset positions of two legal entities in Brazil of $(57) million and $44 million, as well as an adjustment related to the impacts of Swiss Tax Reform of $4 million. The tax only significant item benefit for the year ended December 31, 2020 reflects the impacts of the recognition of an elective cantonal component of the recent enactment of the Federal Act on Tax Reform and AHV Financing ("Swiss Tax Reform") ($(182) million benefit) and a benefit due to an elective change in accounting method that alters the 2019 impact of the business separation on foreign tax provisions ($(29) million benefit), partially offset by a state tax valuation allowance in the U.S. based on a change in judgment about the realizability of a deferred tax asset ($19 million charge). The tax only significant item benefit for the year ended December 31, 2019 reflects the impacts of Swiss Tax Reform ($(38) million
53


Part II

ITEM 7.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS, continued

benefit) and the release of a tax valuation allowance recorded against the net deferred tax asset position of a Swiss legal entity ($(34) million benefit).

Reconciliation of Income (Loss) from Continuing Operations Attributable to Corteva and Earnings (Loss) Per Share of Common Stock from Continuing Operations - Diluted to Operating Earnings (Loss) and Operating Earnings (Loss) Per Share
Year Ended December 31,
202120202019
(In millions)As ReportedAs ReportedPro Forma
Income (loss) from continuing operations attributable to Corteva$1,812 $736 $13 
Less: Non-operating benefits (costs), after tax955 237 100 
Less: Amortization of intangibles (existing as of Separation), after tax(562)(518)(376)
Less: Mark-to-market gains (losses) on certain foreign currency contracts not designated as hedges1
— 
Less: Significant items benefit (charge), after tax(176)(110)(784)
Operating Earnings (Loss) (Non-GAAP)$1,595 $1,127 $1,073 
Year Ended December 31,
202120202019
As ReportedAs ReportedPro Forma
Earnings (loss) per share of common stock from continuing operations - diluted$2.44 $0.98 $0.02 
Less: Non-operating benefits (costs), after tax1.29 0.32 0.13 
Less: Amortization of intangibles (existing as of Separation), after tax(0.76)(0.69)(0.50)
Less: Mark-to-market gains (losses) on certain foreign currency contracts not designated as hedges, after tax1
— 
Less: Significant items benefit (charge), after tax(0.24)(0.15)(1.04)
Operating Earnings (Loss) Per Share (Non-GAAP)$2.15 $1.50 $1.43 
Diluted Shares Outstanding (in millions)
741.6 751.2 749.5 
1.Effective January 1, 2021, on a prospective basis, the company excludes net unrealized gain or loss from mark-to-market activity for certain foreign currency derivative instruments that do not qualify for hedge accounting. There were no unrealized mark-to-market (gains) losses for the years ended December 31, 2020 and 2019.


Liquidity & Capital Resources
The company continually reviews its sources of liquidity and debt portfolio and occasionally may make adjustments to one or both to ensure adequate liquidity.
(Dollars in millions)December 31, 2021December 31, 2020
Cash, cash equivalents and marketable securities$4,545 $3,795 
Total debt$1,117 $1,105 

The company's cash, cash equivalents and marketable securities at December 31, 2021 and December 31, 2020 were $4.5 billion, and $3.8 billion respectively. Total debt at December 31, 2021 and 2020 was $1.1 billion, respectively. See further information under Note 17 - Long-Term Debt and Available Credit Facilities, to the Consolidated Financial Statements.
54


Part II

ITEM 7.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS, continued

The company's credit ratings impact its access to the debt capital markets and cost of capital. The company remains committed to a strong financial position and strong investment-grade rating. The company's long-term and short-term credit ratings assigned to EID are as follows:
 Long-termShort-termOutlook
Standard & Poor's1
A-A-2Stable
Moody’s Investors ServiceA3P-2Stable
Fitch Ratings1
AF1Stable
1.In addition, Corteva, Inc. has been assigned a long-term issuer credit rating of A- with Stable outlook by Standard & Poor's and an Issuer Default Rating of A with Stable outlook by Fitch Ratings.

The company believes its ability to generate cash from operations and access to capital markets and commercial paper markets will be adequate to meet anticipated cash requirements to fund its operations, including seasonal working capital, capital spending, dividend payments, share repurchases and pension obligations. Corteva's strong financial position, liquidity and credit ratings will provide access as needed to capital markets and commercial paper markets to fund seasonal working capital needs. The company's liquidity needs can be met through a variety of sources, including cash provided by operating activities, commercial paper, syndicated credit lines, bilateral credit lines, long-term debt markets, bank financing and committed receivable repurchase facilities. Corteva considers the borrowing costs and lending terms when selecting the source to fund its operations and working capital needs.

The company had access to approximately $6.4 billion in committed and uncommitted unused credit lines at December 31, 2021 and 2020, respectively. These facilities provide support to meet the company’s short-term liquidity needs and for general corporate purposes which may include funding of discretionary and non-discretionary contributions to certain benefit plans, severance payments, repayment and refinancing of debt, working capital, capital expenditures, repurchases and redemptions of securities and funding Corteva's costs and expenses.

On January 22, 2021, Chemours, DuPont, Corteva and EID entered into a binding memorandum of understanding containing a settlement to resolve legal disputes originating from the Delaware Litigation and Pending Arbitration, and to establish a cost sharing arrangement and escrow account to be used to support and manage potential future legacy per- and polyfluoroalkyl substances (“PFAS”) liabilities arising out of pre-July 1, 2015 conduct (the “MOU”). The MOU replaces the 2017 amendment to the Chemours Separation Agreement. According to the terms of the cost sharing arrangement within the MOU, Corteva and DuPont together, on one hand, and Chemours, on the other hand, agreed to a 50-50 split of certain qualified expenses related to PFAS liabilities incurred over a term not to exceed twenty years or $4 billion of qualified spend and escrow account contributions in the aggregate. DuPont’s and Corteva’s 50% share under the MOU will be limited to $2 billion, including qualified expenses and escrow contributions (see below for discussion of escrow contributions). These expenses and escrow account contributions will be subject to the existing Letter Agreement, under which DuPont and Corteva will each bear 50% of the first $300 million (up to $150 million each), and thereafter DuPont bears 71% and Corteva bears the remaining 29%.

In order to support and manage any potential future PFAS liabilities, the parties have also agreed to establish an escrow account. The MOU provides that (1) no later than each of September 30, 2021 and September 30, 2022, Chemours shall deposit $100 million into an escrow account and DuPont and Corteva shall together deposit $100 million in the aggregate into an escrow account and (2) no later than September 30 of each subsequent year through and including 2028, Chemours shall deposit $50 million into an escrow account and DuPont and Corteva shall together deposit $50 million in the aggregate into an escrow account. Subject to the terms and conditions set forth in the MOU, each party may be permitted to defer funding in any year (excluding 2021). Over this period, Chemours will deposit a total of $500 million in the account and DuPont and Corteva will deposit an additional $500 million pursuant to the terms of the Letter Agreement. Additionally, if on December 31, 2028, the balance of the escrow account (including interest) is less than $700 million, Chemours will make 50% of the deposits and DuPont and Corteva together will make 50% of the deposits necessary to restore the balance of the escrow account to $700 million. Such payments will be made in a series of consecutive annual equal installments commencing on September 30, 2029 pursuant to the escrow account replenishment terms as set forth in the MOU. During 2021, the company contributed is initial deposit into the MOU Escrow Account, which is classified as noncurrent restricted cash equivalents and is included in other assets in the Consolidated Balance Sheets. Refer to Note 18 - Commitments and Contingent Liabilities, to the Consolidated Financial Statements for further details on the MOU and Letter Agreement.

55


Part II

ITEM 7.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS, continued

In November 2018, EID entered into a $3.0 billion five-year revolving credit facility and a $3.0 billion three-year revolving credit facility (the “Revolving Credit Facilities”). The 2018 Revolving Credit Facilities became effective May 2019. Corteva, Inc. became a party at the time of the Corteva Distribution. In May 2021, the company entered into an amendment that extended the maturity date of the 3-year revolving credit facility from May 2022 to May 2023. Other than the change in maturity date, there were no material modifications to the terms of the credit facility. The Revolving Credit Facilities may serve as a substitute to the company's commercial paper program, and can be used, from time to time, for general corporate purposes including, but not limited to, the funding of seasonal working capital needs. The Revolving Credit Facilities contain customary representations and warranties, affirmative and negative covenants and events of default that are typical for companies with similar credit ratings. The Revolving Credit Facilities also contain a financial covenant requiring that the ratio of total indebtedness to total capitalization for Corteva and its consolidated subsidiaries not exceed 0.60. At December 31, 2021 the company was in compliance with these covenants.

In March 2020, the company drew down $500 million under the three-year revolving credit facility to finance its short term liquidity needs as a result of the volatility and increased borrowing costs of commercial paper resulting from the unstable market conditions caused by the COVID-19 pandemic, and repaid that borrowing in full in June 2020.

In May 2020, EID issued $500 million of 1.70 percent Senior Notes due 2025 and $500 million of 2.30 percent Senior Notes due 2030 (the May 2020 Debt Offering). The proceeds of this offering are intended to be used for general corporate purposes.

The company's indenture covenants include customary limitations on liens, sale and leaseback transactions, and mergers and consolidations affecting manufacturing plants, mineral producing properties or research facilities located in the U.S. and the consolidated subsidiaries owning such plants, properties and facilities subject to certain limitations. The outstanding long-term debt also contains customary default provisions.
The company has meaningful seasonal working capital needs based in part on providing financing to its customers. Working capital is funded through multiple methods including cash, commercial paper, a receivable repurchase facility, the Revolving Credit Facilities, and factoring.

In February 2021, the company entered into a committed receivable repurchase facility of up to $1 billion (the "2021 Repurchase Facility") which expired in December 2021. Under the 2021 Repurchase Facility, Corteva sold a portfolio of available and eligible outstanding customer notes receivables to participating institutions and simultaneously agreed to repurchase at a future date.

In February 2022, the company entered into a new committed receivable repurchase facility of up to $500 million (the "2022 Repurchase Facility") which expires in December 2022. See further discussion of the 2022 Repurchase Facility in Note 26 - Subsequent Events, to the Consolidated Financial Statements.
The company has factoring agreements with third-party financial institutions to sell its trade receivables under both recourse and non-recourse agreements in exchange for cash proceeds in an effort to reduce its receivables risk. For arrangements that include an element of recourse, the company provides a guarantee of the trade receivables in the event of customer default. Refer to Note 12 - Accounts and Notes Receivable - Net, to the Consolidated Financial Statements for more information.
The company also organizes agreements with third-party financial institutions who directly provide financing for select customers of its seed and crop protection products in each region. Terms of the third-party loans are less than a year and programs are renewed on an annual basis. In some cases, the company guarantees a portion of the extension of such credit to such customers. Refer to Note 18 - Commitments and Contingent Liabilities, to the Consolidated Financial Statements, for more information on the company’s guarantees.

Capacity Expansion
During 2021, the company's Board of Directors authorized a $113 million increase in the capital investment (approximately $260 million in total) for the previously announced expansion of Spinosyns fermentation capacity. The 30 percent increase in capacity is staged to come online over the next several years. Higher capital investment is primarily due to updated design requirements impacting materials, labor and engineering costs.


56


Part II

ITEM 7.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS, continued

Debt Redemptions/Repayments

On March 22, 2019, EID issued notices of redemption in full of all of its outstanding notes (the “Make Whole Notes”) listed in the table below:

(in millions)Amount
4.625% Notes due 2020$474 
3.625% Notes due 2021296
4.250% Notes due 2021163
2.800% Notes due 2023381
6.500% Debentures due 202857
5.600% Senior Notes due 203642
4.900% Notes due 204148
4.150% Notes due 204369
Total$1,530 

The Make Whole Notes were redeemed on April 22, 2019 at the make-whole redemption prices set forth in the respective Make Whole Notes. On and after the date of redemption, the Make Whole Notes were no longer deemed outstanding, interest on the Make Whole Notes ceased to accrue and all rights of the holders of the Make Whole Notes were terminated. For further information on the Make Whole Notes, see Note 17 - Long-Term Debt and Available Credit Facilities, to the Consolidated Financial Statements.

In March 2016, EID entered into a credit agreement that provides for a three-year, senior unsecured term loan facility in the aggregate principal amount of $4.5 billion (as amended, from time to time, the "Term Loan Facility") under which EID could make up to seven term loan borrowings and amounts repaid or prepaid were not available for subsequent borrowings. On May 2, 2019, EID terminated its Term Loan Facility and repaid the aggregate outstanding principal amount of $3 billion plus accrued and unpaid interest through and including May 1, 2019. For further information on the termination of the Term Loan Facility, see Note 17 - Long-Term Debt and Available Credit Facilities, to the Consolidated Financial Statements.

In connection with the repayment of the Make Whole Notes and the Term Loan Facility, EID paid a total of $4.6 billion in the second quarter 2019, which included breakage fees and accrued and unpaid interest on the Make Whole Notes and Term Loan Facility. The repayment of the Make Whole Notes and Term Loan Facility was funded with cash from operations and a contribution from DowDuPont.

On May 7, 2019, DowDuPont publicly announced the record date in connection with the Corteva Distribution. In connection with such announcement, EID was required to redeem $1.25 billion aggregate principal amount of 2.200% Notes due 2020 and $750 million aggregate principal amount of Floating Rate Notes due 2020 (collectively, the Special Mandatory Redemption or “SMR Notes”) setting forth the date of redemption of the SMR Notes. The date of redemption was May 17, 2019 and EID paid a total of $2.0 billion, which included accrued and unpaid interest on the SMR Notes. The company funded the payment with a contribution from DowDuPont. Following the redemption, the SMR Notes are no longer outstanding and no longer bear interest and all rights of the holders of the SMR Notes have terminated.

The company's cash, cash equivalents and marketable securities at December 31, 2021 and December 31, 2020 are $4.5 billion and $3.8 billion, respectively, of which $2.9 billion and $3.1 billion at December 31, 2021 and 2020, respectively, was held by subsidiaries in foreign countries, including United States territories. Upon actual repatriation, such earnings could be subject to withholding taxes, foreign and/or U.S. state income taxes, and taxes resulting from the impact of foreign currency movements. The cash held by foreign subsidiaries is generally used to finance the subsidiaries' operational activities and future foreign investments. At December 31, 2021, management believed that sufficient liquidity is available in the U.S. with global operating cash flows, borrowing capacity from existing committed credit facilities, and access to capital markets and commercial paper markets.

57


Part II

ITEM 7.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS, continued

For the Year Ended December 31,
(Dollars in millions)202120202019
Cash provided by (used for) operating activities$2,727 $2,064 $1,070 

Cash provided by (used for) operating activities for the year ended December 31, 2021 was $2,727 million compared to $2,064 million for the year ended December 31, 2020. The increase in cash provided by (used for) operating activities was driven by an increase in net income, and improvement in working capital primarily driven by higher customer prepayments and higher accounts payable.

Cash provided by (used for) operating activities for the year ended December 31, 2020 was $2,064 million compared to $1,070 million for the year ended December 31, 2019. The increase in cash provided by (used for) operating activities was driven by an increase in net income, including a decrease in integration and separation costs, and improvement in working capital, partially offset by the absence of the net impact of cash earnings from EID ECP and EID Specialty Products entities, as a result of the Internal Reorganizations and Business Realignments in 2019.

For the Year Ended December 31,
(Dollars in millions)202120202019
Cash provided by (used for) investing activities$(362)$(674)$(904)

Cash provided by (used for) investing activities was $(362) million for the year ended December 31, 2021 compared to $(674) million for the year ended December 31, 2020. The change was primarily due to lower purchases of investments and proceeds of marketable securities, partially offset by higher capital expenditures.

Cash provided by (used for) investing activities was $(674) million for the year ended December 31, 2020 compared to $(904) million for the year ended December 31, 2019. The change was primarily due to lower capital expenditures driven by the Internal Reorganizations and Business Realignments in 2019, partially offset by higher net purchases of investments and lower proceeds from sales of property, businesses, and consolidated companies.

Capital expenditures totaled $573 million, $475 million, and $1,163 million for the years ended December 31, 2021, 2020 and 2019, respectively. The year ended December 31, 2019 includes capital expenditures of $497 million, related to the EID Specialty Products and EID ECP (i.e., ethylene copolymers business, excluding its ethylene acrylic elastomers business) Entities. The company expects 2022 capital expenditures to be approximately $645 million.

For the Year Ended December 31,
(Dollars in millions)202120202019
Cash provided by (used for) financing activities$(1,266)$303 $(2,929)

Cash provided by (used for) financing activities was $(1,266) million for the year ended December 31, 2021 compared to $303 million for the year ended December 31, 2020. The change was primarily due to lower borrowings and higher repurchases of Corteva common stock.

Cash provided by (used for) financing activities was $303 million for the year ended December 31, 2020 compared to $(2,929) million for the year ended December 31, 2019. The change was primarily due to lower payments on long-term debt, due to the 2019 debt retirement transactions related to paying off or retiring portions of EID’s existing debt liabilities (using a portion of the contributions from DowDuPont), lower net payment on borrowings (less than 90 days), the May 2020 Debt Offering, and the absence of distributions to DowDuPont (which in 2019 were used primarily to fund a portion of DowDuPont’s dividend payments). This was partially offset by dividends to Corteva stockholders, repurchases of Corteva common stock and payments for the acquisition of noncontrolling interests. In addition, during the year ended December 31, 2019 there was a transfer of cash to DowDuPont as part of the Internal Reorganizations.

58


Part II

ITEM 7.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS, continued

During 2021, the company's Board of Directors authorized and paid quarterly dividends on its common stock of $0.13, $0.13, $0.14, and $0.14 in the first, second, third and fourth quarters, respectively.

On August 5, 2021, the company's Board of Directors authorized a $1.5 billion share repurchase program to purchase Corteva, Inc.'s common stock, par value $0.01 per share, without an expiration date (“2021 Share Buyback Plan”). In connection with the 2021 Share Buyback Plan, the company repurchased and retired 5,572,000 shares during the year ended December 31, 2021 in the open market for a total cost of $250 million.

On June 26, 2019, the company's Board of Directors authorized a $1 billion share repurchase program to purchase Corteva, Inc.'s common stock, par value $0.01 per share, without an expiration date ("2019 Share BuyBack Plan"). The company completed the 2019 Share Buyback Plan during the third quarter of 2021. In connection with the 2019 Share Buyback Plan, the company repurchased and retired 15,378,000 shares, 8,503,000 shares, and 824,000 shares during the years ended December 31, 2021, 2020, and 2019, respectively, in the open market for a total cost of $700 million, $275 million, and $25 million, respectively. See Note 19 - Stockholders' Equity, to the Consolidated Financial Statements, for additional information related to the share buyback plans.

EID Liquidity Discussion
As discussed in Note 1 - Basis of Presentation, to the EID Consolidated Financial Statements, EID is a subsidiary of Corteva, Inc. and continues to be a reporting company, subject to the requirements of the Exchange Act. The below relates to EID only and is presented to provide a Liquidity discussion, only for the differences between EID and Corteva, Inc.

Cash provided by (used for) operating activities
EID’s cash provided by (used for) operating activities for the year ended December 31, 2021 was $2,689 million compared to $1,986 million for the year ended December 31, 2020. The change was primarily driven by the items noted on page 58, under the header "Cash provided by (used for) operating activities."

EID’s cash provided by (used for) operating activities for the year ended December 31, 2020 was $1,986 million compared to $996 million for the year ended December 31, 2019. The change was primarily driven by the items noted on page 58, under the header "Cash provided by (used for) operating activities."

Cash provided by (used for) financing activities
EID’s cash provided by (used for) financing activities was $(1,228) million for the year ended December 31, 2021 compared to $381 million for the year ended December 31, 2020. The change was primarily driven by lower proceeds from issuance of long-term debt partially offset by lower payments on long-term debt on related party debt.

EID’s cash provided by (used for) financing activities was $381 million for the year ended December 31, 2020 compared to $(2,855) million for the year ended December 31, 2019. The change was due to lower payments on long-term debt due to the 2019 debt retirement transactions related to paying off or retiring portions of EID's existing debt liabilities (using a portion of the contributions from DowDuPont and proceeds from related party debt), lower net payment on borrowings (less than 90 days), the May 2020 Debt Offering, and the absence of distributions to DowDuPont (which in 2019 were used primarily to fund a portion of DowDuPont's dividend payments). This activity was partially offset by lower proceeds from related party debt and higher payments on related party debt, and payments for the acquisition of noncontrolling interests. In addition, during 2019 there was a transfer of cash to DowDuPont as part of the Internal Reorganizations.

See Note 2 - Related Party Transactions, to the EID Consolidated Financial Statements for further information on the related party loan between EID and Corteva, Inc.

Critical Accounting Estimates
The company's significant accounting policies are more fully described in Note 2 - Summary of Significant Accounting Policies, to the Consolidated Financial Statements. Management believes that the application of these policies on a consistent basis enables the company to provide the users of the financial statements with useful and reliable information about the company's operating results and financial condition.

The preparation of the Consolidated Financial Statements in conformity with generally accepted accounting principles ("GAAP") in the United States of America requires management to make estimates and assumptions that affect the reported
59


Part II

ITEM 7.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS, continued

amounts, including, but not limited to, receivable and inventory valuations, impairment of tangible and intangible assets, long-term employee benefit obligations, income taxes, environmental matters and litigation. Management's estimates are based on historical experience, facts and circumstances available at the time and various other assumptions that are believed to be reasonable. The company reviews these matters and reflects changes in estimates as appropriate. Management believes that the following represent some of the more critical judgment areas in the application of the company's accounting policies which could have a material effect on the company's financial position, liquidity or results of operations.

Pension Plans and Other Post Employment Benefits
Accounting for employee benefit plans involves numerous assumptions and estimates. Discount rate and expected long-term rate of return on plan assets are two critical assumptions in measuring the cost and benefit obligation of the company's pension and OPEB plans. Management reviews these two key assumptions when plans are re-measured. These and other assumptions are updated periodically to reflect the actual experience and expectations on a plan specific basis as appropriate. As permitted by GAAP, actual results that differ from the assumptions are accumulated on a plan by plan basis and to the extent that such differences exceed 10 percent of the greater of the plan's benefit obligation or the applicable plan assets, the excess is amortized over the average remaining service period of active employees or the average remaining life expectancy of plan participants if all or almost all of a plan’s participants are inactive.

Substantially all of the company's benefit obligation for pensions and OPEB are attributable to the benefit plans in the U.S. In the U.S., the single equivalent discount rate is developed by matching the expected cash flow of the benefit plans to a yield curve constructed from a portfolio of high quality fixed-income instruments provided by the plans' actuaries as of the measurement date. The company measures the service and interest cost components utilizing a full yield curve approach by applying the specific spot rates along the yield curve used in the determination of the benefit obligation to the relevant projected cash flows. For non-U.S. benefit plans, historically the company utilized prevailing long-term high quality corporate bond indices to determine the discount rate, applicable to each country, at the measurement date. The weighted average discount rates used in developing the 2022 net periodic pension and OPEB costs are expected to be 2.82 percent and 2.59 percent, respectively.

Within the U.S., the company establishes strategic asset allocation percentage targets and appropriate benchmarks for significant asset classes with the aim of achieving a prudent balance between return and risk. Strategic asset allocations in other countries are selected in accordance with the laws and practices of those countries. Where appropriate, asset-liability studies are also taken into consideration. The expected long-term rate of return on plan assets in the U.S. is based upon historical real returns (net of inflation) for the asset classes covered by the investment policy, expected performance, and projections of inflation and interest rates over the long-term period during which benefits are payable to plan participants. In determining the 2021 net periodic pension cost in the U.S., 5.75 percent of expected long-term rate of return on plan assets assumption was used. After re-evaluating the current strategic asset allocation and recent market conditions, the company lowered the expected long-term rate of return on plan assets assumption to 4.50 percent to be used in determining the 2022 net periodic pension cost in the U.S. Consistent with prior years, the expected long-term rate of return on plan assets in the U.S. reflects the asset allocation of the plan and the effect of the company's active management of the plan's assets.

In determining annual expense for the principal U.S. pension plan, the company uses a market-related value of assets rather than its fair value. Accordingly, there may be a lag in recognition of changes in market valuation. As a result, changes in the fair value of assets are not immediately reflected in the company's calculation of net periodic pension cost. For the years ended December 31, 2021 and 2020, the market-related value of assets is calculated by averaging market returns over 36 months, however, as a result of the Merger, the market-related value of assets was calculated by averaging market returns from September 1, 2017 through the year ended December 31, 2019.

The following table shows the market-related value and fair value of plan assets for the principal U.S. pension plan:
(Dollars in billions)December 31, 2021December 31, 2020December 31, 2019
Market-related value of assets$17.2 $16.3 $16.4 
Fair value of plan assets
17.5 17.5 16.6 

For plans other than the principal U.S. pension plan, pension expense is determined using the fair value of assets.

60


Part II

ITEM 7.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS, continued

The following table highlights the potential impact on the company's pre-tax earnings due to changes in certain key assumptions with respect to the company's pension and OPEB plans, based on assets and liabilities at December 31, 2021:
Pre-tax Earnings Benefit (Charge)

(Dollars in millions)
1/4 Percentage
Point
Increase
1/4 Percentage
Point
Decrease
Discount rate$(33)$36 
Expected rate of return on plan assets42 (42)
Additional information with respect to pension and OPEB expenses, liabilities and assumptions is discussed under "Long-term Employee Benefits" beginning on page 65 and in Note 20 - Pension Plans and Other Post Employment Benefits, to the Consolidated Financial Statements.

Environmental Matters
Accruals for environmental matters are recorded when it is probable that a liability has been incurred and the amount of the liability can be reasonably estimated. At December 31, 2021, the company had accrued obligations of $452 million for probable environmental remediation and restoration costs, including $68 million for the remediation of Superfund sites. As remediation activities vary substantially in duration and cost from site to site, it is difficult to develop precise estimates of future site remediation costs. The company's estimates are based on a number of factors, including the complexity of the geology, the nature and extent of contamination, the type of remedy, the outcome of discussions with regulatory agencies and other Potentially Responsible Parties ("PRPs") at multi-party sites and the number of and financial viability of other PRPs. Therefore, considerable uncertainty exists with respect to environmental remediation and costs, and, under adverse changes in circumstances, it is reasonably possible that the ultimate cost with respect to these particular matters could range up to $592 million above that amount. Consequently, it is reasonably possible that environmental remediation and restoration costs in excess of amounts accrued could have a material impact on the company’s results of operations, financial condition and cash flows. It is the opinion of the company’s management, however, that the possibility is remote that costs in excess of the range disclosed will have a material impact on the company’s results of operations, financial condition or cash flows. For further discussion, see Environmental Matters in Management’s Discussion and Analysis of Financial Condition and Results of Operations and Note 18 - Commitments and Contingent Liabilities, to the Consolidated Financial Statements.

Legal Contingencies
The company's results of operations could be affected by significant litigation adverse to the company, including product liability claims, patent infringement and antitrust claims, and claims for third-party property damage or personal injury stemming from alleged environmental torts. The company records accruals for legal matters when the information available indicates that it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. Management makes adjustments to these accruals to reflect the impact and status of negotiations, settlements, rulings, advice of counsel and other information and events that may pertain to a particular matter. Predicting the outcome of claims and lawsuits and estimating related costs and exposure involves substantial uncertainties that could cause actual costs to vary materially from estimates. In making determinations of likely outcomes of litigation matters, management considers many factors. These factors include, but are not limited to, the nature of specific claims including unasserted claims, the company's experience with similar types of claims, the jurisdiction in which the matter is filed, input from outside legal counsel, the likelihood of resolving the matter through alternative dispute resolution mechanisms, and the matter's current status. Considerable judgment is required in determining whether to establish a litigation accrual when an adverse judgment is rendered against the company in a court proceeding. In such situations, the company will not recognize a loss if, based upon a thorough review of all relevant facts and information, management believes that it is probable that the pending judgment will be successfully overturned on appeal. A detailed discussion of significant litigation matters is contained in Note 18 - Commitments and Contingent Liabilities, to the Consolidated Financial Statements.

Indemnification Assets
The company has entered into various agreements where the company is indemnified for certain liabilities by DuPont, Dow, and Chemours. The term of this indemnification is generally indefinite and includes defense costs and expenses, as well as monetary and non-monetary settlements and judgments. In connection with the recognition of liabilities related to these matters, the company records an indemnification asset when recovery is deemed probable. In assessing the probability of recovery, the company considers the contractual rights under the separation agreements and any potential credit risk. Future events, such as potential disputes related to recovery as well as the solvency of DuPont, Dow, and / or Chemours, could cause the indemnification assets to have a lower value than anticipated and recorded. The company evaluates the recovery of the
61


Part II

ITEM 7.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS, continued

indemnification assets recorded when events or changes in circumstances indicate the carrying values may not be fully recoverable. See Note 5 - Divestitures and Other Transactions and Note 18 - Commitments and Contingent Liabilities, to the Consolidated Financial Statements, for additional information related to indemnifications.

Income Taxes
The breadth of the company's operations and the global complexity of tax regulations require assessments of uncertainties and judgments in estimating taxes the company will ultimately pay. The final taxes paid are dependent upon many factors, including negotiations with taxing authorities in various jurisdictions, outcomes of tax litigation and resolution of disputes arising from federal, state and international tax audits in the normal course of business. The resolution of these uncertainties may result in adjustments to the company's tax assets and tax liabilities. It is reasonably possible that changes to the company’s global unrecognized tax benefits could be significant; however, due to the uncertainty regarding the timing of completion of audits and possible outcomes, a current estimate of the range of increases or decreases that may occur within the next twelve months cannot be made.

Deferred income taxes result from differences between the financial and tax basis of the company's assets and liabilities and are adjusted for changes in tax rates and tax laws when changes are enacted. Valuation allowances are recorded to reduce deferred tax assets when it is more likely than not that a tax benefit will not be realized. Significant judgment is required in evaluating the need for and magnitude of appropriate valuation allowances against deferred tax assets. The realization of these assets is dependent on generating future taxable income, as well as successful implementation of various tax planning strategies. For example, changes in facts and circumstances that alter the probability that the company will realize deferred tax assets could result in recording a valuation allowance, thereby reducing the deferred tax asset and generating a deferred tax expense in the relevant period. In some situations, these changes could be material. See Note 10 - Income Taxes, to the Consolidated Financial Statements for additional information.

At December 31, 2021, the company had a net deferred tax liability balance of $782 million, inclusive of a valuation allowance of $366 million. Realization of deferred tax assets is expected to occur over an extended period of time. As a result, changes in tax laws, assumptions with respect to future taxable income, and tax planning strategies could result in adjustments to deferred tax assets. See Note 10 - Income Taxes, to the Consolidated Financial Statements for additional details related to the deferred tax liability balance.

Valuation of Assets and Impairment Considerations
The assets and liabilities of acquired businesses are measured at their estimated fair values at the dates of acquisition. The excess of the purchase price over the estimated fair value of the net assets acquired, including identified intangibles, is recorded as goodwill. The determination and allocation of fair value to the assets acquired and liabilities assumed is based on various assumptions and valuation methodologies requiring considerable management judgment, including estimates based on historical information, current market data and future expectations. The principal assumptions utilized in the company's valuation methodologies include revenue growth rates, operating margin estimates, royalty rates, and discount rates. Although the estimates are deemed reasonable by management based on information available at the dates of acquisition, those estimates are inherently uncertain.

Assessment of the potential impairment of goodwill, other intangible assets, property, plant and equipment, investments in nonconsolidated affiliates, and other assets is an integral part of the company's normal ongoing review of operations. Testing for potential impairment of these assets is significantly dependent on numerous assumptions and reflects management's best estimates at a particular point in time. The dynamic economic environment in which the company's segments operate, and key economic and business assumptions with respect to projected selling prices, market growth and inflation rates, can significantly affect the outcome of impairment tests. Estimates based on these assumptions may differ significantly from actual results. Changes in factors and assumptions used in assessing potential impairments can have a significant impact on the existence and magnitude of impairments, as well as the time in which such impairments are recognized. In addition, the company continually reviews its portfolio of assets to ensure they are achieving their greatest potential and are aligned with the company's growth strategy. Strategic decisions involving a particular group of assets may trigger an assessment of the recoverability of the related assets. Such an assessment could result in impairment losses.

The company performs its annual goodwill impairment assessment during the fourth quarter at the reporting unit level which is defined as the operating segment or one level below the operating segment. One level below the operating segment, or component, is a business in which discrete financial information is available and regularly reviewed by segment management.
62


Part II

ITEM 7.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS, continued

The company aggregates certain components into reporting units based on economic similarities. The company’s reporting units include seed, crop protection and digital.

For purposes of the annual goodwill impairment test, the company has the option to first perform qualitative testing to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying value. Qualitative factors assessed at the company level include, but are not limited to, GDP growth rates, long-term commodity prices, equity and credit market activity, discount rates, foreign exchange rates, and overall financial performance. Qualitative factors assessed at the reporting unit level include, but are not limited to, changes in industry and market structure, competitive environments, planned capacity and new product launches, cost factors such as raw material prices, and financial performance of the reporting unit. If the company chooses not to complete a qualitative assessment for a given reporting unit or if the initial assessment indicates that it is more likely than not that the carrying value of a reporting unit exceeds its estimated fair value, additional quantitative testing is required.

If additional quantitative testing is required, the reporting unit’s fair value is compared with its carrying amount, and an impairment charge, if any, is recognized for the amount by which the carrying amount exceeds the reporting unit’s fair value, limited to the amount of goodwill associated with the reporting unit. The company determines fair values for each of the reporting units using a discounted cash flow model (a form of the income approach), utilizing Level 3 unobservable inputs, or the market approach.

Under the income approach, fair value is determined based on the present value of estimated future cash flows, discounted at an appropriate risk-adjusted rate. The company’s significant assumptions in these analyses include future cash flow projections, weighted average cost of capital, the terminal growth rate and the tax rate. The company’s estimates of future cash flows are based on current regulatory and economic climates, recent operating results, and planned business strategy and includes an estimate of long-term future growth rates based on its most recent views of the long-term outlook for each reporting unit. Actual results may differ from those assumed in the company’s forecasts. The company derives its discount rates using a capital asset pricing model and analyzes published rates for industries relevant to its reporting units to estimate the cost of equity financing. The company uses discount rates that are commensurate with the risks and uncertainty inherent in the respective reporting units and in its internally developed forecasts. Discount rates used in the company’s valuations ranged from 9.25 percent to 16.5 percent. Under the market approach, the company uses metrics of publicly traded companies or historically completed transactions for comparable companies.

Estimating the fair value of reporting units requires the use of estimates and significant judgments that are based on a number of factors including actual operating results. It is reasonably possible that the judgments and estimates described above could change in future periods. The company believes the current assumptions and estimates utilized are both reasonable and appropriate. Based on the goodwill impairment analyses performed in the fourth quarter 2021, the company concluded the fair value of each of the reporting units exceeded their respective carrying values by more than 20 percent, and no goodwill impairment charge was necessary.

Prepaid Royalties
The company’s seed segment currently has certain third-party biotechnology trait license agreements, which require up-front and variable payments subject to the licensor meeting certain conditions. These payments are reflected as other current assets and other assets and are amortized to cost of goods sold as seeds containing the respective trait technology are utilized over the term of the license. The rate of royalty amortization expense recognized is based on the company’s strategic plans which include various assumptions and estimates including product portfolio, market dynamics, farmer preferences, growth rates and projected planted acres. Changes in factors and assumptions included in the strategic plans, including potential changes to the product portfolio in favor of internally developed biotechnology, could impact the rate of recognition of the relevant prepaid royalty.

At December 31, 2021, the balance of prepaid royalties reflected in other current assets and other assets was $303 million and $256 million, respectively. The majority of the balance of prepaid royalties relates to the company’s wholly owned subsidiary, Pioneer Hi-Bred International, Inc.’s (“Pioneer”) non-exclusive license in the United States and Canada for the Monsanto Company's Genuity® Roundup Ready 2 Yield® glyphosate tolerance trait and Roundup Ready 2 Xtend® glyphosate and dicamba tolerance trait for soybeans (“Roundup Ready 2 License Agreement”). The prepaid royalty asset relates to a series of up-front, fixed and variable royalty payments to utilize the traits in Pioneer’s soybean product mix. The company’s historical expectation has been that the technology licensed under the Roundup Ready 2 License Agreement would be used as the primary herbicide tolerance trait platform in the Pioneer® brand soybean through the term of the agreement. DAS and MS Technologies,
63


Part II

ITEM 7.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS, continued

L.L.C. jointly developed and own the Enlist E3TM herbicide tolerance trait for soybeans which provides tolerance to 2, 4-D choline in Enlist Duo® and Enlist One® herbicides, as well as glyphosate and glufosinate herbicides. In connection with the validation of breeding plans and large-scale product development timelines, during the fourth quarter of 2019, the company accelerated the ramp up of the Enlist E3TM trait platform in the company’s soybean portfolio mix across all brands, including Pioneer® brands, over the subsequent five years. During the ramp-up period, the company is expected to significantly reduce the volume of products with the Roundup Ready 2 Yield® and Roundup Ready 2 Xtend® herbicide tolerance traits beginning in 2021, with expected minimal use of the trait platform thereafter for the remainder of the Roundup Ready 2 License Agreement (the “Transition Plan”). The rate of royalty expense is therefore expected to significantly increase through higher amortization of the prepaid royalty as fewer seeds containing the respective trait are expected to be utilized.

In connection with the departure from these traits in the company's product portfolio, beginning January 1, 2020 the company presents and discloses the accelerated prepaid royalty amortization expense as a component of restructuring and asset related charges - net in the Consolidated Statement of Operations. The accelerated prepaid royalty amortization expense represents the difference between the rate of amortization based on the revised number of units expected to contain the Roundup Ready 2 Yield® and Roundup Ready 2 Xtend® trait technology and the per unit cash rate per the Roundup Ready 2 License Agreement. For the year ended December 31, 2021, the company recognized $125 million in restructuring and asset related charges - net in the Consolidated Statement of Operations from non-cash accelerated prepaid royalty amortization expense. The expected non-cash accelerated prepaid royalty amortization expense estimated for 2022 is approximately $102 million, aggregating to approximately $235 million over the next 3 years.

Further changes in factors and assumptions associated with usage of the trait platform licensed under the Roundup Ready 2 License Agreement, including the Transition Plan, could further impact the rate of recognition of the prepaid royalty and statement of operations presentation of the accelerated prepaid royalty amortization expense.

Off-Balance Sheet Arrangements
Certain Guarantee Contracts
Information with respect to the company's guarantees is included in Note 18 - Commitments and Contingent Liabilities, to the Consolidated Financial Statements. Historically, the company has not made significant payments to satisfy guarantee obligations; however, the company believes it has the financial resources to satisfy these guarantees.

Contractual Obligations
Our principal commitments consist of long-term debt, operating and finance lease obligations and environmental remediation obligations. Refer to further discussion on long-term debt and operating and finance lease obligations in Note 17 - Long-Term Debt and Available Credit Facilities and Note 16 – Leases, to the Consolidated Financial Statements, respectively. Refer to discussion on environmental remediation obligations on page 68 of this report.

Information related to the company's other significant contractual obligations are summarized in the following table:
  Payments Due In
(Dollars in millions)Total at
December 31, 2021
20222023 and
beyond
Expected cumulative cash requirements for interest payments
     through maturity
$138 $20 $118 
Purchase obligations1
1,363 741622
License agreements2, 3
307 121 186 
Other liabilities2, 4
285 53 232 
Total 5
$2,093 $935 $1,158 
1.Represents enforceable and legally binding agreements in excess of $1 million to purchase goods or services that specify fixed or minimum quantities; fixed, minimum or variable price provisions; and the approximate timing of the agreement.
2.Included in the Consolidated Financial Statements.
3.    Represents undiscounted remaining payments under Pioneer license agreements ($305 million on a discounted basis).
4.    Includes liabilities related to employee-related benefits other than pension and other post employment benefits, asset retirement obligations and other noncurrent liabilities.
5.    Due to uncertainty regarding the completion of tax audits and possible outcomes, the timing of certain payments of obligations related to unrecognized tax benefits cannot be made and have been excluded from the table above. See Note 10 - Income Taxes, to the Consolidated Financial Statements for additional detail.

64


Part II

ITEM 7.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS, continued

The company expects to meet its contractual obligations through its normal sources of liquidity and believes it has the financial resources to satisfy the contractual obligations that arise in the ordinary course of business.

Long-term Employee Benefits
The company has various obligations to its employees and retirees. The company maintains retirement-related programs in many countries that have a long-term impact on the company's earnings and cash flows. These plans are typically defined benefit pension plans, as well as medical, dental and life insurance benefits for pensioners and survivors and disability benefits for employees ("other post employment benefits" or "OPEB"). Substantially all of the company's worldwide benefit obligation for pensions and essentially all of the company's worldwide OPEB obligations are attributable to the U.S. benefit plans.

Pension coverage for employees of the company's non-U.S. consolidated subsidiaries is provided, to the extent deemed appropriate, through separate plans. The company regularly explores alternative solutions to meet its global pension obligations in the most cost effective manner possible as demographics, life expectancy and country-specific pension funding rules change. Where permitted by applicable law, the company reserves the right to change, modify or discontinue its plans that provide pension, medical, dental, life insurance and disability benefits.

Benefits under defined benefit pension plans are based primarily on years of service and employees' pay near retirement. In November 2016, the company announced changes to the U.S. pension and OPEB plans. The company froze the pay and service amounts used to calculate pension benefits for active employees who participate in the U.S. pension plans on November 30, 2018, resulting in the participants no longer accruing additional benefits. In addition to the changes to the U.S. pension plans, OPEB eligible employees who were under the age of 50 as of November 30, 2018 will not receive post-retirement medical, dental and life insurance benefits. The majority of employees hired in the U.S. on or after January 1, 2007 are not eligible to participate in the pension and post-retirement medical, dental and life insurance plans, but receive benefits in the defined contribution plans.

In September 2021, the company transferred approximately $250 million of certain benefit obligations and related assets associated with the principal U.S. pension plan to an insurance company through the purchase of nonparticipating group annuity contracts. The company may consider additional annuity purchases in the future.

In December 2020, the company amended its retiree medical, dental and life insurance plans resulting in the company no longer providing retiree dental and life insurance benefits effective January 1, 2022 and Corteva’s portion of the cost of non-Medicare retiree medical coverage no longer being adjusted for cost increases, which capped the Corteva cost at the level as of December 31, 2021 ("2020 OPEB Plan Amendments"). As a result of these changes, the company recorded a $(939) million decrease in OPEB benefit obligations as of December 31, 2020 with a corresponding prior service benefit within other comprehensive income (loss) for the year ended December 31, 2020. During 2021, a substantial amount of the prior service benefit within other comprehensive income (loss) in 2020 was recognized in other income - net in the Consolidated Statement of Operations.

Pension benefits are paid primarily from trust funds established to comply with applicable laws and regulations. The actuarial assumptions and procedures utilized are reviewed periodically by the plans' actuaries to provide reasonable assurance that there will be adequate funds for the payment of benefits. The company did not make contributions to the principal U.S. pension plan for the years ended December 31, 2021, 2020 or 2019.

Funding for each pension plan other than the principal U.S. pension plan is governed by the rules of the sovereign country in which it operates. Thus, there is not necessarily a direct correlation between pension funding and pension expense. In general, however, improvements in plans' funded status tends to moderate subsequent funding needs. The company contributed $8 million, $9 million, and $39 million to its funded pension plans other than the principal U.S. pension plan for the years ended December 31, 2021, 2020 and 2019, respectively.
U.S. pension benefits that exceed federal limitations are covered by separate unfunded plans and these benefits are paid to pensioners and survivors from operating cash flows. The company's remaining pension plans with no plan assets are paid from operating cash flows. The company made benefit payments of $41 million, $53 million, and $82 million to its unfunded plans for the years ended December 31, 2021, 2020 and 2019, respectively.
The company's OPEB plans are unfunded and the cost of the approved claims is paid from operating cash flows. Pre-tax cash requirements to cover actual net claims costs and related administrative expenses were $198 million, $207 million, and $202 million for the years ended December 31, 2021, 2020 and 2019, respectively. Changes in cash requirements reflect the net
65


Part II

ITEM 7.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS, continued

impact of per capita health care cost, demographic changes, plan amendments and changes in participant premiums, co-pays and deductibles.

In 2022, the company expects to contribute approximately $60 million to its pension plans other than the principal U.S. pension plan and approximately $140 million to its OPEB plans. The company does not anticipate making contributions to its principal U.S. pension plan in 2022.

The company's income can be significantly affected by pension and defined contribution benefits as well as OPEB costs. The following table summarizes the extent to which the company's income (loss) from continuing operations before income taxes for the years ended December 31, 2021, 2020 and 2019 was affected by pre-tax charges related to long-term employee benefits:
For the Year Ended December 31,
(Dollars in millions)202120202019
Net periodic benefit (credit) cost - pension and OPEB$(1,292)$(340)$(163)
Defined contributions1
125 127 115 
Long-term employee benefit plan (credit) charges - continuing operations$(1,167)$(213)$(48)
1.The year ended December 31, 2021 includes a charge of $33 million for the company contributions to be paid in 2022, which was included in accrued and other current liabilities in the Consolidated Balance Sheet.

The above (credit) charges for pension and OPEB are determined as of the beginning of each period. Long-term employee benefit plan credits were $(1,167) million and $(213) million for the years ended December 31, 2021 and 2020, respectively. The change is due to the 2020 OPEB Plan Amendments and lower discount rates. See "Pension Plans and Other Post Employment Benefits" under the Critical Accounting Estimates section beginning on page 60 of this report for additional information on determining annual expense.

For 2022, long-term employee benefits credit is expected to decrease by about $1 billion. The decrease is mainly due to the 2020 OPEB Plan Amendments, an increase in the discount rates, and a change in the expected long-term rate of return on plan assets from 5.75 percent to 4.50 percent.
Environmental Matters
The company operates global manufacturing, product handling and distribution facilities that are subject to a broad array of environmental laws and regulations. Such rules are subject to change by the implementing governmental agency, and the company monitors these changes closely. Company policy requires that all operations fully meet or exceed legal and regulatory requirements. In addition, the company implements voluntary programs to reduce air emissions, minimize the generation of hazardous waste, decrease the volume of water use and discharges, increase the efficiency of energy use and reduce the generation of persistent, bioaccumulative and toxic materials. Management has noted a global upward trend in the amount and complexity of proposed chemicals regulation. The costs to comply with complex environmental laws and regulations, as well as internal voluntary programs and goals, are significant and will continue to be significant for the foreseeable future.
Pre-tax environmental expenses charged to income (loss) from continuing operations before income taxes are summarized below:
For the Year Ended December 31,
(Dollars in millions)202120202019
Environmental operating costs$144 $138 $136 
Environmental remediation costs1
46 63 29 
            $190 $201 $165 
1.Environmental remediation costs include costs that are subject to the $200 million threshold and sharing arrangements as discussed in Note 18 - Commitments and Contingent Liabilities, to the Consolidated Financial Statements, under the header Corteva Separation Agreement.

Environmental Operating Costs
As a result of its operations, the company incurs costs for pollution abatement activities including waste collection and disposal, installation and maintenance of air pollution controls and wastewater treatment, emissions testing and monitoring, and obtaining permits. The company also incurs costs related to environmental related research and development activities including
66


Part II

ITEM 7.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS, continued

environmental field and treatment studies as well as toxicity and degradation testing to evaluate the environmental impact of products and raw materials.

About 85 percent of total pre-tax environmental operating costs charged to income (loss) from continuing operations for the year ended December 31, 2021 resulted from operations in the U.S. Based on existing facts and circumstances, management does not believe that year-over-year changes, if any, in environmental operating costs charged to current operations will have a material impact on the company's financial position, liquidity or results of operations. Annual expenditures in the near term are not expected to vary significantly from the range of such expenditures experienced in the past few years. Longer term, expenditures are subject to considerable uncertainty and may fluctuate significantly.

Remediation Accrual
Changes in the remediation accrual balance are summarized below:
(Dollars in millions) 
Balance at December 31, 2019$336 
Remediation payments(57)
Net increase in remediation accrual 1
63 
Net change, indemnification 2
(13)
Balance at December 31, 2020$329 
Remediation payments(35)
Net increase in remediation accrual 1
46 
Net change, indemnification 2
112 
Balance at December 31, 2021$452 
1.Excludes indemnified remediation obligations.
2.Represents the net change in indemnified remediation obligations based on activity as well as the removal from EID's accrued remediation liabilities of obligations that have been fully transferred to Chemours and DuPont. Pursuant to the Chemours Separation Agreement and subsequent MOU, and the Corteva Separation Agreement, as discussed in Note 5 - Divestitures and Other Transactions, and Note 18 - Commitments and Contingent Liabilities, to the Consolidated Financial Statements, EID is indemnified by Chemours and DuPont for certain environmental matters.

Considerable uncertainty exists with respect to environmental remediation costs and, under adverse changes in circumstances, the potential liability may range up to $592 million above the amount accrued as of December 31, 2021. However, based on existing facts and circumstances, management does not believe that any loss, in excess of amounts accrued, related to remediation activities at any individual site will have a material impact on the financial position, liquidity or results of operations of the company.

67


Part II

ITEM 7.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS, continued

The above noted $452 million accrued obligations includes the following:
As of December 31, 2021
(In millions)Indemnification Asset
Accrual balance3,5
Potential exposure above amount accrued3
Environmental Remediation Stray Liabilities
Chemours related obligations - subject to indemnity1,2
$159 $159 $262 
Other discontinued or divested businesses obligations1
15 75 187 
Environmental remediation liabilities primarily related to DuPont - subject to indemnity from DuPont2
37 37 66 
Environmental remediation liabilities not subject to indemnity— 82 49 
Indemnification liabilities related to the MOU4
99 28 
Total$220 $452 $592 
1.Represents liabilities that are subject to the $200 million threshold and sharing arrangements as discussed in Note 18 - Commitments and Contingent Liabilities, to the Consolidated Financial Statements, under the header "Corteva Separation Agreement."
2.The company has recorded an indemnification asset related to these accruals, including $40 million related to the Superfund sites.
3.Accrual balance represents management’s best estimate of the costs of remediation and restoration, although it is reasonably possible that the potential exposure, as indicated, could range above the amounts accrued, as there are inherent uncertainties in these estimates. Accrual balance includes $68 million for remediation of Superfund sites. Amounts do not include possible impacts from the remediation elements of the EPAs October 2021 PFAS Strategic Roadmap (as applicable) or possible revisions to Chemours’ Consent Order with the North Carolina Department of Environmental Quality, as any possible impacts, to the extent such items would be reimbursable under the MOU, are not yet determinable.
4.Represents liabilities that are subject to the $150 million threshold and sharing agreements as discussed in Note 18 - Commitments and Contingent Liabilities, to the Consolidated Financial Statements, under the header "Chemours/ Performance Chemicals."
5.Included accrued obligations of $133 million due in the next twelve months with the remainder being due subsequent to 2022.

As of December 31, 2021, the company has been notified of potential liability under the Comprehensive Environmental Response, Compensation and Liability Act ("Superfund") or similar state laws at about 500 sites around the U.S., including approximately 130 sites for which the company does not believe it has liability based on current information. Active remediation is under way at approximately 70 of the 500 sites. In addition, the company has resolved its liability at approximately 210 sites, either by completing remedial actions with other PRPs or by participating in "de minimis buyouts" with other PRPs whose waste, like the company's, represented only a small fraction of the total waste present at a site. There were no new notices in 2021 or 2020.

Environmental Capital Expenditures
Capital expenditures for environmental projects, either required by law or necessary to meet the company’s internal environmental goals, were approximately $9 million for the year ended December 31, 2021. The company currently estimates expenditures for environmental-related capital projects to be approximately $9 million in 2022.

Climate Change
The company believes that climate change is an important global environmental concern that presents risks and opportunities. The Board of Directors maintains oversight of these risks and opportunities. Management regularly assesses and manages climate-related issues. Across its business, individuals who are responsible for climate-related initiatives may have annual performance goals tied to the delivery of projects related to these initiatives.

Continuing political and social attention to climate change and its impacts has resulted in regulatory and market-based approaches to limit greenhouse gas emissions. The company believes there is a way forward for sustainable climate change mitigation that both enables farmers to meet the demands of a growing population and secures the economic future for the vast majority of the world’s population who depend on agriculture for their livelihoods. 

Extreme and volatile weather due to climate change may have an adverse impact on our customers’ ability to use the company's products, potentially reducing sales volumes, revenues and margins. The company continuously evaluates opportunities for
68


Part II

ITEM 7.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS, continued

existing and new product and service offerings to meet the anticipated demands of climate-smart agriculture and mitigate the impact of extreme and volatile weather. The company integrates processes for identifying, assessing and managing climate-related risk into its overall risk management.

The company completed a non-financial materiality assessment and identified short-, medium- and long-term climate-related risks and opportunities. The results of this assessment are integrated into the company's businesses, strategy and financial planning and are presented in the 14 ten-year sustainability goals that were set in 2020. For each goal, the company established key performance indicators and criteria to achieve the goals, which are provided on the company's website at: https://www.corteva.com/sustainability.html. The information contained on the company’s website is not part of, nor incorporated by reference into, this Annual Report on Form 10-K or the company’s other SEC filings.

As demonstrated by the goals, Corteva is working to shrink its role in the emission of greenhouse gasses while enabling a more resilient agriculture value chain. Corteva has an established climate strategy, including appropriate Scopes 1, 2 and 3 greenhouse gas reduction targets. The company is seeking ways to reduce its impact and providing tools and incentives for customers to do the same. Corteva champions climate positive agriculture, utilizing carbon storage and other means to remove more carbon from the atmosphere than it emits without sacrificing farmer productivity or ongoing profitability.

The company is committed to engaging with multiple stakeholders and partners around the globe who have innovative and actionable ideas to help safeguard the health and well-being of the planet and its people. By doing more to address climate change today, the company is fortifying its ability to grow food, grow progress and build a sustainable industry that will help humanity thrive for generations to come.






69


Part II



ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

The company’s global operations are exposed to financial market risks relating to fluctuations in foreign currency exchange rates, commodity prices, and interest rates. The company has established a variety of programs including the use of derivative instruments and other financial instruments to manage the exposure to financial market risks as to minimize volatility of financial results. In the ordinary course of business, the company enters into derivative instruments to hedge its exposure to foreign currency and commodity price risks under established procedures and controls. For additional information on these derivatives and related exposures, see Note 22 - Financial Instruments, to the Consolidated Financial Statements. Decisions regarding whether or not to hedge a given commitment are made on a case-by-case basis, taking into consideration the amount and duration of the exposure, market volatility and economic trends. Foreign currency exchange contracts may be used, from time to time, to manage near-term foreign currency cash requirements.

Foreign Currency Exchange Rate Risks
The company has significant international operations resulting in a large number of currency transactions that result from international sales, purchases, investments and borrowings. The primary currencies for which the company has an exchange rate exposure are the Brazilian Real, Swiss franc, Canadian dollar and European Euro ("EUR"). The company uses foreign exchange contracts to offset its net exposures, by currency, related to the foreign currency denominated monetary assets and liabilities of its operations. The company also uses foreign currency exchange contracts to offset a portion of the company's exposure to certain forecasted transactions, investment in foreign subsidiaries, as well as the translation of foreign currency-denominated earnings and uses commodity contracts to offset risks associated with foreign currency devaluation in certain countries. In addition to the contracts disclosed in Note 22 - Financial Instruments, to the Consolidated Financial Statements, from time to time, the company will enter into foreign currency exchange contracts to establish with certainty the U.S. dollar ("USD") amount of future firm commitments denominated in a foreign currency.

Certain foreign entities of the company held USD denominated marketable securities, mainly U.S. government securities, at December 31, 2020. The USD/EUR was the primary foreign exchange exposure for these nonfunctional currency denominated marketable securities. These debt securities were classified as available-for-sale marketable securities and as such, fluctuations in foreign exchange were recorded in accumulated other comprehensive income (loss) within the Consolidated Statements of Equity. These fluctuations were subsequently reclassified from accumulated other comprehensive income (loss) to earnings during 2021, which was the period in which the marketable securities were sold. At December 31, 2021, the company no longer held these USD denominated marketable securities.

The following table illustrates the fair values of outstanding foreign currency contracts at December 31, 2021 and 2020, and the effect on fair values of a hypothetical adverse change in the foreign exchange rates that existed at December 31, 2021 and 2020. The sensitivities for foreign currency contracts are based on a 10 percent adverse change in foreign exchange rates.
 Fair Value
(Liability)/Asset
Fair Value
Sensitivity
(Dollars in millions)2021202020212020
Foreign currency contracts$44 $(80)$(211)$(388)
Marketable securities$— $226 $— $(36)

Since the company's risk management programs are highly effective, the potential loss in value for each risk management portfolio described above would be largely offset by changes in the value of the underlying exposure.

Concentration of Credit Risk
The company maintains cash and cash equivalents, marketable securities, derivatives and certain other financial instruments with various financial institutions. These financial institutions are generally highly rated and geographically dispersed and the company has a policy to limit the dollar amount of credit exposure with any one institution.

As part of the company's financial risk management processes, it continuously evaluates the relative credit standing of all of the financial institutions that service Corteva and monitors actual exposures versus established limits. The company has not sustained credit losses from instruments held at financial institutions.

The company's sales are not materially dependent on any single customer. Credit risk associated with its receivables balance is representative of the geographic, industry and customer diversity associated with the company's global product lines.
70


Part II



ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK, continued

The company also maintains strong credit controls in evaluating and granting customer credit. As a result, it may require that customers provide some type of financial guarantee in certain circumstances. Length of terms for customer credit varies by region.


ITEM 8.  FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

The financial statements and supplementary data required by this Item are included herein, commencing on page F-1 of this report.


ITEM 9.  CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE

None.

71


Part II

ITEM 9A.  CONTROLS AND PROCEDURES

Corteva, Inc.

a)        Evaluation of Disclosure Controls and Procedures
 
The company maintains a system of disclosure controls and procedures to give reasonable assurance that information required to be disclosed in the company's reports filed or submitted under the Securities Exchange Act of 1934 ("Exchange Act") is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the Securities and Exchange Commission. These controls and procedures also give reasonable assurance that information required to be disclosed in such reports is accumulated and communicated to management to allow timely decisions regarding required disclosures.

As of December 31, 2021, the company's Chief Executive Officer ("CEO") and Chief Financial Officer ("CFO"), together with management, conducted an evaluation of the effectiveness of the company's disclosure controls and procedures pursuant to Rules 13a-15(e) and 15d-15(e) of the Exchange Act. Based on that evaluation, the CEO and CFO concluded that these disclosure controls and procedures are effective.
 
b)                         Changes in Internal Control over Financial Reporting
 
There have been no changes in the company's internal control over financial reporting that occurred during the quarter ended December 31, 2021 that have materially affected, or are reasonably likely to materially affect, the company's internal control over financial reporting.

E. I. du Pont de Nemours and Company

a)        Evaluation of Disclosure Controls and Procedures
 
EID maintains a system of disclosure controls and procedures to give reasonable assurance that information required to be disclosed in EID's reports filed or submitted under the Securities Exchange Act of 1934 ("Exchange Act") is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the Securities and Exchange Commission. These controls and procedures also give reasonable assurance that information required to be disclosed in such reports is accumulated and communicated to management to allow timely decisions regarding required disclosures.

As of December 31, 2021, EID's CEO and CFO, together with management, conducted an evaluation of the effectiveness of EID's disclosure controls and procedures pursuant to Rules 13a-15(e) and 15d-15(e) of the Exchange Act. Based on that evaluation, the CEO and CFO concluded that these disclosure controls and procedures are effective.
 
b)                         Changes in Internal Control over Financial Reporting
 
There have been no changes in EID's internal control over financial reporting that occurred during the quarter ended December 31, 2021 that have materially affected, or are reasonably likely to materially affect, EID's internal control over financial reporting.


ITEM 9B.  OTHER INFORMATION

None.


ITEM 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections.

Not applicable.
72


Part III


ITEM 10.  DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE
Information with respect to this Item is incorporated herein by reference to the Proxy, including information within the sections entitled, "Election of Directors," "Corporate Governance," and "Delinquent Section 16(a) Reports".

The company has adopted a Code of Financial Ethics for its CEO, CFO, and Controller that may be accessed from the company's website at www.corteva.com by clicking on "Investors" and then "Corporate Governance." Any amendments to, or waiver from, any provision of the code will be posted on the company's website at the above address.

Executive Officers of the Registrant
Each of the executive officers became officers of the company in May 2019 with the exception of Mr. Charles Magro, Mr. David Anderson, and Dr. Sam Eathington who became an executive officer in November 2021, April 2021 and January 2021, respectively.

Charles V. Magro, age 52, is the Chief Executive Officer of Corteva. Prior to joining Corteva on November 1, 2021, he served as President and chief executive officer of Nutrien Ltd. ("Nutrien") from the company’s launch in 2018 until April 2021. From 2014 to 2018, Mr. Magro served as President and chief executive officer of Agrium Inc., which merged with Potash Corporation of Saskatchewan to create Nutrien. As President and CEO of Nutrien, Mr. Magro led more than 27,000 employees to achieve best-in-class engagement, top safety performance and exceptional business results. He also led the company through numerous M&A transactions, expanding globally and restructuring the industry. Prior to this role, he held a variety of other key leadership positions with the company, including Chief Operating Officer, Chief Risk Officer, Executive Vice President of Corporate Development, and Vice President of Manufacturing. He joined Agrium in 2009 following a productive career with NOVA Chemicals. Since 2018, Mr. Magro has served on the Canada Pension Plan Investment Board and will continue to serve on the board through March 2022. Previously, he served as Vice Chairman of the International Fertilizer Association and past Chair and Board Member of The Fertilizer Institute. He also served as a Board Steward for the World Economic Forum’s Food Systems Initiative, providing strategic leadership to build inclusive, sustainable, efficient, and healthy global food systems, as well as on the Boards of the International Plant Nutrition Institute, Nutrients for Life Foundation, the Business Council of Canada, and the Business Council of Alberta. Ingredion Inc., a global provider of ingredient solutions to the food and beverage manufacturing industry, elected Mr. Magro to its board of directors effective May 1, 2022.

David J. Anderson, age 72, is Executive Vice President and Chief Financial Officer of Corteva. Mr. Anderson is an experienced Chief Financial Officer, with a career spanning a number of diverse global companies across a range of industries. Prior to joining Corteva in April 2021, Mr. Anderson was interim chief financial officer at Criteo S.A., which he joined after serving as chief financial officer and chief operating officer at Nielsen Holdings plc. He previously served as executive vice president and chief financial officer of Alexion Pharmaceuticals, which he joined following his tenure of more than a decade as the chief financial officer for Honeywell. Prior to that, Mr. Anderson was the chief financial officer for ITT, Inc., Newport News Shipbuilding Inc., and RJR Nabisco, Inc. Mr. Anderson is currently a Board member of American Electric Power and previously a Board member of Cardinal Health.

Rajan Gajaria, age 54, is Executive Vice President, Business Platforms of Corteva. Mr. Gajaria previously served as vice president, global crop protection business platform, of DowDuPont Inc. Prior to this, he served as Vice President, Latin America and North America, for Dow AgroSciences since 2015. He was selected to lead Dow AgroSciences’ Latin America and Asia Pacific geographies in 2012 after being named marketing director for the company’s U.S. business in 2009. Mr. Gajaria advanced through leadership roles at Dow AgroSciences in corporate strategy, marketing, and e-business before serving as global supply chain director. He joined Dow AgroSciences’ Indian joint venture partner in Mumbai in 1993, where he served in sales and marketing roles as well as in human resources before moving to the company’s global headquarters in Indianapolis, Indiana. Effective February 18, 2022, Mr. Gajaria will retire from the company.

Timothy P. Glenn, age 55, is Executive Vice President, Chief Commercial Officer of Corteva. Mr. Glenn previously served as Vice President, Global Seed Business Platform of DowDuPont Inc. Prior to this, he served as President, DuPont Crop Protection since 2015, and from 2014 to 2015 served as vice president, integrated operations and commercial effectiveness for DuPont Pioneer. He previously held other leadership positions at DuPont Pioneer, including regional business director, Latin America and Canada, after rejoining DuPont Pioneer in 2006 as director, North America Marketing. In 1997, he joined Dow AgroSciences as corn product manager, Mycogen Seeds, and served in sales and business leadership roles in the crop protection and seeds businesses of Dow AgroSciences. He first joined Pioneer Hi-Bred International, Inc. in 1991, and held a variety of marketing roles in seed markets around the world.
73


Part III

Meghan Cassidy, age 46, is Senior Vice President, Chief Human Resources and Diversity Officer of Corteva. In February 2021, Ms. Cassidy became Chief Diversity Officer in addition to her human resources duties at Corteva. Prior to joining Corteva, Ms. Cassidy served as the head of human resources of the agriculture division of DowDuPont Inc. since September 2017. Prior to this, Ms. Cassidy was director, global talent management and leadership development for DuPont since 2015. From 2011 to 2015, she served as chief human resources officer for Sunoco Logistics after joining Sunoco in 2010 as director, corporate human resources. Ms. Cassidy’s early career was spent at Aramark, where she held progressive human resources roles before serving as vice president, executive development and corporate human resources.

Dr. Sam Eathington, age 53, joined Corteva in November 2020 and became Senior Vice President, Chief Technology Officer of Corteva in January 2021, where he is responsible for leading the company’s global research and development organization, building and expanding its industry-leading pipeline, and sustainability. A recognized leader in agricultural innovation, Dr. Eathington most recently served as chief science officer of The Climate Corporation (part of the crop science division of Bayer AG) from December 2015 until April 2020. Prior to assuming that role, Dr. Eathington spent 19 years with Monsanto Corporation, rising through the ranks in quantitative traits and molecular breeding to become vice president, global plant breeding beginning in February 2011.

Cornel B. Fuerer, age 55, is Senior Vice President, General Counsel and Secretary of Corteva, where he is responsible for legal, compliance, enterprise risk management, and government affairs. Mr. Fuerer previously served as general counsel of the agriculture division of DowDuPont Inc. since June 2018 and prior to that served as associate general counsel supporting the agriculture division of DowDuPont after the Merger in September 2017. From 2013 to 2017, he served as associate general counsel of DuPont with responsibility for the legal affairs of DuPont’s agriculture business and from 2012 to 2013 he served as the corporate secretary of DuPont. From 2007 to 2012, Mr. Fuerer served as the vice president, general counsel and company secretary of Solae, a food ingredients joint venture between DuPont and Bunge. After joining DuPont in 1995 as an attorney in Geneva, Switzerland, he served in various legal roles around the world until his appointment at Solae in 2007.

Brian Titus, age 49, is Vice President, Controller and Principal Accounting Officer of Corteva. Mr. Titus previously served as the controller and principal accounting officer of the agriculture division of DowDuPont Inc. since February 2019. Prior to this, he was general auditor of DuPont since August 2015 and previously served as the director of corporate accounting from 2014 to 2015 and global finance leader of DuPont Crop Protection from 2013 to 2014. Prior to joining DuPont’s corporate accounting group in 2010, he spent 14 years in public accounting, primarily with PricewaterhouseCoopers LLP, providing audit and transactional support services.

74

Part III


ITEM 11.  EXECUTIVE COMPENSATION

Information related to executive compensation and the company's equity compensation plans is contained in the definitive Proxy Statement for the 2022 Annual Meeting of Stockholders of Corteva, Inc. and is incorporated herein by reference.


ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS

Information with respect to beneficial ownership of Corteva, Inc. common stock by each director, executive officer, and all directors and executive officers of the Company as a group is contained in the definitive Proxy Statement for the 2022 Annual Meeting of Stockholders of Corteva, Inc. and is incorporated herein by reference.

Information relating to any person who beneficially owns in excess of 5 percent of the total outstanding shares of Corteva, Inc. common stock is contained in the definitive Proxy Statement for the 2022 Annual Meeting of Stockholders of Corteva, Inc. and is incorporated herein by reference.

Information with respect to compensation plans under which equity securities are authorized for issuance is contained in the definitive Proxy Statement for the 2022 Annual Meeting of Stockholders of Corteva, Inc. and is incorporated herein by reference.


ITEM 13.  CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE
Information with respect to this Item is incorporated herein by reference to the definitive Proxy Statement for the 2022 Annual Meeting of Stockholders of Corteva, Inc., including information within the sections entitled, "Certain Relationships and Related Transactions", and "Director Independence."

ITEM 14.  PRINCIPAL ACCOUNTANT FEES AND SERVICES
Information with respect to this Item is incorporated herein by reference to the definitive Proxy Statement for the 2022 Annual Meetings of Stockholders of Corteva, Inc., including information within the section entitled, “Ratification of Independent Registered Public Accounting Firm.”


75


Part IV

ITEM 15.  EXHIBITS AND CONSOLIDATED FINANCIAL STATEMENT SCHEDULES

(a)Financial Statements, Financial Statement Schedules and Exhibits:
1.Corteva Financial Statements (See the Index to the Consolidated Financial Statements on page F-1 of this report).
2.Corteva Financial Statement Schedule (presented below)
3.EID Financial Statements (Starting on page F-79 of this report).
4.EID Financial Statement Schedule (presented below)
Schedule II—Valuation and Qualifying Accounts (EID and Corteva, Inc.)
(Dollars in millions)
For the Year Ended December 31,
202120202019
Accounts Receivable—Allowance for Doubtful Receivables 
Balance at beginning of period$208 $174 $127 
Additions charged to expenses1
6 52 69 
Deductions from reserves1,2
(4)(18)(22)
Balance at end of period$210 $208 $174 
Deferred Tax Assets—Valuation Allowance  
Balance at beginning of period$453 $457 $669 
Additions charged to expenses97 56 20 
Deductions from reserves3
(184)(60)(232)
Balance at end of period$366 $453 $457 
1.    Classifications in the changes in the allowance for doubtful receivables for the period ended December 31, 2020 have been adjusted from their previous presentation. Adjustments did not impact the amount of the provision or the allowance for doubtful receivables recorded in the Consolidated Statements of Operations or the Consolidated Balance Sheets.
2.    Deductions include write-offs, recoveries collected and currency translation adjustments.
3.     Deductions include currency translation adjustments.


Financial Statement Schedules listed under the Securities and Exchange Commission ("SEC") rules but not included in this report are omitted because they are not applicable or the required information is shown in the Consolidated Financial Statements or notes thereto.

76


Part IV
ITEM 15.  EXHIBITS AND FINANCIAL STATEMENT SCHEDULES, continued

3.Exhibits

The following list of exhibits includes both exhibits submitted with this Form 10-K as filed with the SEC and those incorporated by reference to other filings:
Exhibit
Number
 Description
   
Separation and Distribution Agreement by and among DuPont Inc., Dow Inc. and Corteva, Inc. (incorporated by reference to Exhibit No. 2.1 to Amendment 3 to Corteva’s Registration Statement on Form 10 (Commission file number 001-38710), filed on April 16, 2019).
   
 Amended and Restated Certificate of Incorporation of Corteva, Inc. (incorporated by reference to Exhibit No. 3.1 to Corteva’s Current Report on Form 8-K (Commission file number 001-38710), filed on June 3, 2019.
   
 Amended and Restated Bylaws of Corteva, Inc. (incorporated by reference to Exhibit No. 3.1 to Corteva’s Current Report on Form 8-K (Commission file number 001-38710), filed on October 10, 2019.
   
Amended and Restated Certificate of Incorporation of E.I. du Pont de Nemours and Company (incorporated by reference to Exhibit 3.1 to E. I. du Pont de Nemours and Company’s Current Report on Form 8-K (Commission file number 1-815) dated September 1, 2017).
Amended and Restated Bylaws of E.I. du Pont de Nemours and Company (incorporated by reference to Exhibit 3.2 to E. I. du Pont de Nemours and Company's Current Report on Form 8-K (Commission file number 1-815) dated September 1, 2017).
 
Description of Corteva, Inc. registered securities (incorporated by reference from Exhibit 4.1 to the Company’s Annual Report on Form 10-K (Commission file number 001-38710) filed February 14, 2020).
   
Description of E. I. du Pont de Nemours and Company registered securities (incorporated by reference from Exhibit 4.2 to the Company’s Annual Report on Form 10-K (Commission file number 001-38710) filed February 14, 2020).
Amended and Restated Tax Matters Agreement, effective as of June 1, 2019 by and among DowDuPont Inc., Corteva, Inc. and Dow Inc. (incorporated by reference to Exhibit 10.3 of Corteva’s Current Report on Form 8-K (Commission file number 001-38710) filed on June 3, 2019).
Employee Matters Agreement by and among DowDuPont Inc., Corteva, Inc. and Dow Inc. (incorporated by reference to Exhibit No. 10.2 to Amendment 3 to Corteva’s Registration Statement on Form 10 (Commission file number 001-38710), filed on April 16, 2019).
SpecCo/AgCo Intellectual Property Cross-License Agreement, effective as of June 1, 2019, by and among DowDuPont Inc., Corteva, Inc. and the other parties identified therein (incorporated by reference to Exhibit 10.1 to Corteva’s Current Report on Form 8-K (Commission file number 001-38710), filed on June 3, 2019).
Intellectual Property Cross-License Agreement by and between Corteva, Inc. and Dow Inc. (incorporated by reference to Exhibit No. 10.4 to Amendment 3 to Corteva’s Registration Statement on Form 10 (Commission file number 001-38710), filed on April 16, 2019).
Corteva, Inc. 2019 Omnibus Incentive Plan. (incorporated by reference to Exhibit No. 10.5 to Corteva’s Registration Statement on Form 10 (Commission file number 001-38710), filed on May 6, 2019).
Fondation de Prevoyance en Faveur du Personnel de DuPont de Nemours International SÁRL. (incorporated by reference to Exhibit No. 10.6 to Corteva’s Registration Statement on Form 10 (Commission file number 001-38710), filed on May 6, 2019).
Separation Agreement by and between E. I. du Pont de Nemours and Company and The Chemours Company (incorporated by reference to Exhibit 2.1 to E. I. du Pont de Nemours and Company's Current Report on Form 8-K (Commission file number 1-815) dated July 8, 2015).
Amendment No. 1 to Separation Agreement by and between E. I. du Pont de Nemours and Company and The Chemours Company, dated August 24, 2017 (incorporated by reference to Exhibit 2.1 to E. I. du Pont de Nemours and Company's Current Report on Form 8-K (Commission file number 1-815) dated August 25, 2017).
Tax Matters Agreement by and between E. I. du Pont de Nemours and Company and The Chemours Company (incorporated by reference to Exhibit 2.2 to E. I. du Pont de Nemours and Company's Current Report on Form 8-K (Commission file number 1-815) dated July 8, 2015).
The E. I. du Pont de Nemours and Company Management Deferred Compensation Plan, incorporated by reference to Exhibit 4.3 to DowDuPont Inc. Registration Statement on Form S-8 (Commission file number 333-220324) filed September 1, 2017.
The E. I. du Pont de Nemours and Company Stock Accumulation and Deferred Compensation Plan for Directors, (incorporated by reference to Exhibit 4.4 to DowDuPont Inc. Registration Statement on Form S-8 (Commission file number 333-220324) filed September 1, 2017.)
E. I. du Pont de Nemours and Company's Pension Restoration Plan, as last amended effective June 29, 2015 (incorporated by reference to Exhibit 10.3 to E. I. du Pont de Nemours and Company’s Quarterly Report on Form 10-Q (Commission file number 1-815) for the period ended June 30, 2015).
E. I. du Pont de Nemours and Company’s Rules for Lump Sum Payments, as last amended effective May 15, 2014 (incorporated by reference to Exhibit 10.4 to E. I. du Pont de Nemours and Company’s Quarterly Report on Form 10-Q (Commission file number 1-815) for the period ended June 30, 2015).
77


Part IV
ITEM 15.  EXHIBITS AND FINANCIAL STATEMENT SCHEDULES, continued

E. I. du Pont de Nemours and Company’s Retirement Savings Restoration Plan, as last amended effective May 15, 2014. (incorporated by reference to Exhibit 10.08 to E. I. du Pont de Nemours and Company’s Quarterly Report on Form 10-Q (Commission file number 1-815) for the period ended June 30, 2014).
E. I. du Pont de Nemours and Company’s Retirement Income Plan for Directors, as last amended January 2011 (incorporated by reference to Exhibit 10.9 to E. I. du Pont de Nemours and Company’s Quarterly Report on Form 10-Q (Commission file number 1-815) for the period ended March 31, 2012).
Letter Agreement between Charles Victor Magro and Corteva, Inc., dated October 25, 2021 (incorporated by reference to Exhibit 10.1 to Corteva’s Current Report on Form 8-K (Commission file number 001-38710), filed on October 28, 2021).
Letter Agreement between James C. Collins, Jr. and Corteva, Inc., dated June 21, 2021 (incorporated by reference to Exhibit 10.1 to Corteva’s Current Report on Form 8-K (Commission file number 001-38710), filed on June 23, 2021).
Corteva, Inc. Severance Plan (incorporated by reference to Exhibit 10.2 to Corteva’s Current Report on Form 8-K (Commission file number 001-38710), filed on October 28, 2021).
Letter Agreement effective as of June 1, 2019 by and between DowDuPont Inc. and Corteva, Inc. (incorporated by reference to Exhibit 10.2 to Corteva's Current Report on Form 8-K (Commission file number 001-38710) filed June 3, 2019)
Memorandum of Understanding, dated January 22, 2021, by and among The Chemours Company, Corteva, Inc., E. I. du Pont de Nemours and Company and DuPont de Nemours, Inc. (incorporated by reference from the Form 8-K (Commission file number 001-38710) filed January 22, 2021)
Form of Award Terms for Options granted under the Corteva, Inc. 2019 Omnibus Incentive Plan for U.S. grantees (incorporated by reference from Exhibit 10.3 to the Company’s Quarterly Report Form 10-Q (Commission file number 001-38710) filed May 7, 2020).
Form of Award Terms for Performance Stock Units granted under the Corteva, Inc. 2019 Omnibus Incentive Plan for U.S. grantees (incorporated by reference from Exhibit 10.4 to the Company’s Quarterly Report Form 10-Q (Commission file number 001-38710) filed May 7, 2020).
Form of Award Terms for Restricted Stock Units granted under the Corteva, Inc. 2019 Omnibus Incentive Plan for U.S. grantees (incorporated by reference from Exhibit 10.5 to the Company’s Quarterly Report Form 10-Q (Commission file number 001-38710) filed May 7, 2020).
Form of Special CFO RSU Agreement (incorporated by reference from Exhibit 10.1 to Corteva’s Current Report on Form 8-K (Commission file number 001-38710) filed April 6, 2021).
Agreement dated March 18, 2021, among Corteva, Inc., Starboard Value LP and certain of its affiliates. (incorporated by reference from Exhibit 10.1 to Corteva’s Current Report on Form 8-K (Commission file number 001-38710) filed March 19, 2021).

Corteva, Inc. Global Omnibus Employee Stock Purchase Plan (incorporated by reference from Exhibit 4.3 to Corteva’s Registration Statement on Form S-8 (Commission file number 333-249887), filed November 5, 2020).
Subsidiaries of the Registrant.
Consent of Independent Registered Public Accounting Firm, PricewaterhouseCoopers LLP - Corteva, Inc.
Consent of Independent Registered Public Accounting Firm, PricewaterhouseCoopers LLP - E. I. du Pont de Nemours and Company.
 Rule 13a-14(a)/15d-14(a) Certification of the company’s and EID’s Principal Executive Officer.
   
 Rule 13a-14(a)/15d-14(a) Certification of the company’s and EID’s Principal Financial Officer.
  
 Section 1350 Certification of the company’s and EID’s Principal Executive Officer. The information contained in this Exhibit shall not be deemed filed with the Securities and Exchange Commission nor incorporated by reference in any registration statement filed by the registrant under the Securities Act of 1933, as amended.
   
 Section 1350 Certification of the company’s and EID’s Principal Financial Officer. The information contained in this Exhibit shall not be deemed filed with the Securities and Exchange Commission nor incorporated by reference in any registration statement filed by the registrant under the Securities Act of 1933, as amended.
101.INS XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
   
101.SCH Inline XBRL Taxonomy Extension Schema Document
   
101.CAL Inline XBRL Taxonomy Extension Calculation Linkbase Document
   
101.DEF Inline XBRL Taxonomy Extension Definition Linkbase Document
   
101.LAB Inline XBRL Taxonomy Extension Label Linkbase Document
   
101.PRE Inline XBRL Taxonomy Extension Presentation Linkbase Document
104Cover Page Interactive Data File – The Cover Page XBRL tags are embedded within the Inline XBRL document (included in Exhibit 101.INS)
`
78




Corteva 

Pursuant to the requirements of Section 13 of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
February 10, 2022  
 Corteva, Inc.
 By:/s/ Brian Titus
Brian Titus
Vice President, Controller
(Principal Accounting Officer)

_____________________________________________

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant in the capacities and on the dates indicated:
79




Signature Title(s) Date
     
/s/ Charles V. Magro Chief Executive Officer and Director
(Principal Executive Officer)
 February 10, 2022
Charles V. Magro
/s/ Gregory R. Page Non-Executive Chairman of the Board of Directors and Director February 10, 2022
Gregory R. Page
/s/ Lamberto Andreotti Director February 10, 2022
Lamberto Andreotti
/s/ David C. Everitt Director February 10, 2022
David C. Everitt
/s/ Klaus Engel Director February 10, 2022
Klaus Engel
/s/ Michael O. Johanns Director February 10, 2022
Michael O. Johanns
/s/ Janet P. Giesselman Director February 10, 2022
Janet P. Giesselman
/s/ Karen H. GrimesDirectorFebruary 10, 2022
Karen H. Grimes
/s/ Rebecca B. Liebert Director February 10, 2022
Rebecca B. Liebert
/s/ Marcos M. Lutz Director February 10, 2022
Marcos M. Lutz
/s/ Nayaki NayyarDirector February 10, 2022
Nayaki Nayyar
/s/ Kerry J. PreeteDirector February 10, 2022
Kerry J. Preete
/s/ Patrick J. WardDirector February 10, 2022
Patrick J. Ward
/s/ David J. AndersonExecutive Vice President and Chief Financial Officer
(Principal Financial Officer)
February 10, 2022
David J. Anderson
80




E. I. du Pont de Nemours and Company

Pursuant to the requirements of Section 13 of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
February 10, 2022  
 E. I. DU PONT DE NEMOURS AND COMPANY
 By:/s/ Brian Titus
Brian Titus
Vice President, Controller
(Principal Accounting Officer)

_____________________________________________

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant in the capacities and on the dates indicated:
Signature Title(s) Date
     
/s/ Charles V. Magro Chief Executive Officer and Director
(Principal Executive Officer)
 February 10, 2022
Charles V. Magro
/s/ David J. AndersonExecutive Vice President,
Chief Financial Officer and Director
(Principal Financial Officer)
February 10, 2022
David J. Anderson

81


Corteva, Inc.
Index to the Consolidated Financial Statements


F-1


Management's Reports on Responsibility for Financial Statements and
Internal Control over Financial Reporting

Management's Report on Responsibility for Financial Statements
Management is responsible for the Consolidated Financial Statements and the other financial information contained in this Annual Report on Form 10-K. The financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America ("GAAP") and are considered by management to present fairly the company's financial position, results of operations and cash flows. The financial statements include some amounts that are based on management's best estimates and judgments. The financial statements have been audited by the company's independent registered public accounting firm, PricewaterhouseCoopers LLP. The purpose of their audit is to express an opinion as to whether the Consolidated Financial Statements included in this Annual Report on Form 10-K present fairly, in all material respects, the company's financial position, results of operations and cash flows in conformity with GAAP. Their report is presented on the following pages.
Management's Report on Internal Control over Financial Reporting
Management is responsible for establishing and maintaining an adequate system of internal control over financial reporting as defined in Rules 13a-15(f) and 15d-15(f) under the Securities Exchange Act of 1934. The company's internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with GAAP. The company's internal control over financial reporting includes those policies and procedures that:
i.pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company;
ii.provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles and that receipts and expenditures of the company are being made only in accordance with authorization of management and directors of the company; and
iii.provide reasonable assurance regarding prevention or timely detection of unauthorized acquisitions, use or disposition of the company's assets that could have a material effect on the financial statements.
Internal control over financial reporting has certain inherent limitations which may not prevent or detect misstatements. In addition, changes in conditions and business practices may cause variation in the effectiveness of internal controls.
Management assessed the effectiveness of the company's internal control over financial reporting as of December 31, 2021, based on criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission ("COSO") in Internal Control-Integrated Framework (2013). Based on its assessment and those criteria, management concluded that the company maintained effective internal control over financial reporting as of December 31, 2021.
PricewaterhouseCoopers LLP, an independent registered public accounting firm, has audited the effectiveness of the company's internal control over financial reporting as of December 31, 2021, as stated in their report, which is presented on the following pages.
ctva-20211231_g6.jpg ctva-20211231_g7.jpg
Charles V. Magro
Chief Executive Officer and Director
 David J. Anderson
Executive Vice President and
Chief Financial Officer
February 10, 2022
F-2


Report of Independent Registered Public Accounting Firm

To the Stockholders and Board of Directors of Corteva, Inc.

Opinions on the Financial Statements and Internal Control over Financial Reporting

We have audited the accompanying consolidated balance sheets of Corteva, Inc. and its subsidiaries (the “Company”) as of December 31, 2021 and 2020, and the related consolidated statements of operations, comprehensive income (loss), equity and cash flows for each of the three years in the period ended December 31, 2021, including the related notes and schedule of valuation and qualifying accounts for each of the three years in the period ended December 31, 2021 appearing under Item 15(a) (collectively referred to as the “consolidated financial statements”). We also have audited the Company's internal control over financial reporting as of December 31, 2021, based on criteria established in Internal Control - Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).

In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of the Company as of December 31, 2021 and 2020, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2021 in conformity with accounting principles generally accepted in the United States of America. Also in our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2021, based on criteria established in Internal Control - Integrated Framework (2013) issued by the COSO.

Basis for Opinions

The Company's management is responsible for these consolidated financial statements, for maintaining effective internal control over financial reporting, and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Management’s Report on Internal Control over Financial Reporting. Our responsibility is to express opinions on the Company’s consolidated financial statements and on the Company's internal control over financial reporting based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud, and whether effective internal control over financial reporting was maintained in all material respects.

Our audits of the consolidated financial statements included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audits also included performing such other procedures as we considered necessary in the circumstances. We believe that our audits provide a reasonable basis for our opinions.

Definition and Limitations of Internal Control over Financial Reporting

A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

F-3


Critical Audit Matters

The critical audit matter communicated below is a matter arising from the current period audit of the consolidated financial statements that was communicated or required to be communicated to the audit committee and that (i) relates to accounts or disclosures that are material to the consolidated financial statements and (ii) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.

Goodwill (Seed Reporting Unit) Impairment Assessment

As described in Notes 2 and 15 to the consolidated financial statements, the Company’s consolidated goodwill balance was $10.1 billion as of December 31, 2021, and the goodwill associated with the seed reporting unit was $5.4 billion. Management tests goodwill for impairment at the reporting unit level at least annually, or more frequently when events or changes in circumstances indicate it is more likely than not that the fair value of a reporting unit has declined below its carrying value. Management performs an annual goodwill impairment test in the fourth quarter. If management chooses not to complete a qualitative assessment for a given reporting unit or if the initial assessment indicates that it is more likely than not that the carrying value of a reporting unit exceeds its estimated fair value, additional quantitative testing is required. Management performed quantitative testing on its seed reporting unit and determined that no goodwill impairment existed in 2021. Management determined fair value for the seed reporting unit using a discounted cash flow model. Management’s significant assumptions in this analysis included future cash flow projections, the weighted average cost of capital, the terminal growth rate, and the tax rate.

The principal considerations for our determination that performing procedures relating to the seed reporting unit goodwill impairment assessment is a critical audit matter are (i) the significant judgment by management when developing the fair value of the seed reporting unit; (ii) a high degree of auditor judgment, subjectivity, and effort in performing procedures and evaluating management’s significant assumptions related to projected revenue, the weighted average cost of capital, and the terminal value; and (iii) the audit effort involved the use of professionals with specialized skill and knowledge.

Addressing the matter involved performing procedures and evaluating audit evidence in connection with forming our overall opinion on the consolidated financial statements. These procedures included testing the effectiveness of controls relating to management’s goodwill impairment assessment, including controls over the valuation of the seed reporting unit. These procedures also included, among others, (i) testing management’s process for developing the fair value estimate; (ii) evaluating the appropriateness of the discounted cash flow model; (iii) testing the completeness, accuracy, and relevance of underlying data used in the discounted cash flow model; and (iv) evaluating the reasonableness of significant assumptions used by management related to projected revenue, the weighted average cost of capital, and the terminal value. Evaluating management’s assumptions related to projected revenue and the terminal value involved evaluating whether the assumptions used by management were reasonable considering (i) the current and past performance of the reporting unit; (ii) the consistency with external market and industry data; and (iii) whether the assumptions were consistent with evidence obtained in other areas of the audit. Professionals with specialized skill and knowledge were used to assist in the evaluation of the Company’s discounted cash flow model and the weighted average cost of capital and terminal value assumptions.




/s/PricewaterhouseCoopers LLP
Philadelphia, Pennsylvania
February 10, 2022

We have served as the Company’s or its predecessor’s auditor since 1946.
F-4

Corteva, Inc.
Consolidated Financial Statements

CONSOLIDATED STATEMENTS OF OPERATIONS
(In millions, except per share amounts) For the Year Ended December 31,
202120202019
Net sales$15,655 $14,217 $13,846 
Cost of goods sold9,220 8,507 8,575 
Research and development expense1,187 1,142 1,147 
Selling, general and administrative expenses3,209 3,043 3,065 
Amortization of intangibles722 682 475 
Restructuring and asset related charges - net289 335 222 
Integration and separation costs  744 
Other income - net1,348 212 215 
Loss on early extinguishment of debt  13 
Interest expense30 45 136 
Income (loss) from continuing operations before income taxes2,346 675 (316)
Provision for (benefit from) income taxes on continuing operations524 (81)(46)
Income (loss) from continuing operations after income taxes1,822 756 (270)
(Loss) income from discontinued operations after income taxes(53)(55)(671)
Net income (loss)1,769 701 (941)
Net income (loss) attributable to noncontrolling interests10 20 18 
Net income (loss) attributable to Corteva$1,759 $681 $(959)
Basic earnings (loss) per share of common stock:
Basic earnings (loss) per share of common stock from continuing operations$2.46 $0.98 $(0.38)
Basic earnings (loss) per share of common stock from discontinued operations(0.07)(0.07)(0.90)
Basic earnings (loss) per share of common stock$2.39 $0.91 $(1.28)
Diluted earnings (loss) per share of common stock:
Diluted earnings (loss) per share of common stock from continuing operations$2.44 $0.98 $(0.38)
Diluted earnings (loss) per share of common stock from discontinued operations(0.07)(0.07)(0.90)
Diluted earnings (loss) per share of common stock$2.37 $0.91 $(1.28)


See Notes to the Consolidated Financial Statements beginning on page F-11.
F-5

Corteva, Inc.
Consolidated Financial Statements

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
(In millions) For the Year Ended December 31,
202120202019
Net income (loss)$1,769 $701 $(941)
Other comprehensive income (loss) - net of tax:
Cumulative translation adjustments(573)(26)(274)
Adjustments to pension benefit plans1,037 (186)(718)
Adjustments to other benefit plans(621)671 (160)
Unrealized gain (loss) on investments10 (10) 
Derivative instruments139 (69)28 
Total other comprehensive income (loss) (8)380 (1,124)
Comprehensive income (loss) 1,761 1,081 (2,065)
Comprehensive income (loss) attributable to noncontrolling interests - net of tax10 20 18 
Comprehensive income (loss) attributable to Corteva$1,751 $1,061 $(2,083)

See Notes to the Consolidated Financial Statements beginning on page F-11.
F-6

Corteva, Inc.
Consolidated Financial Statements

CONSOLIDATED BALANCE SHEETS
(In millions, except share and per share amounts)December 31, 2021December 31, 2020
Assets  
Current assets  
Cash and cash equivalents$4,459 $3,526 
Marketable securities86 269 
Accounts and notes receivable - net4,811 4,926 
Inventories5,180 4,882 
Other current assets1,010 1,165 
Total current assets15,546 14,768 
Investment in nonconsolidated affiliates76 66 
Property, plant and equipment8,364 8,253 
Less: Accumulated depreciation4,035 3,857 
Net property, plant and equipment4,329 4,396 
Goodwill10,107 10,269 
Other intangible assets10,044 10,747 
Deferred income taxes438 464 
Other assets1,804 1,939 
Total Assets$42,344 $42,649 
Liabilities and Equity  
Current liabilities  
Short-term borrowings and finance lease obligations$17 $3 
Accounts payable4,126 3,615 
Income taxes payable146 123 
Deferred revenue3,201 2,662 
Accrued and other current liabilities2,068 2,145 
Total current liabilities9,558 8,548 
Long-term debt1,100 1,102 
Other noncurrent liabilities
Deferred income tax liabilities1,220 893 
Pension and other post employment benefits - noncurrent3,124 5,176 
Other noncurrent obligations1,719 1,867 
Total noncurrent liabilities7,163 9,038 
Commitments and contingent liabilities
Stockholders’ equity  
Common stock, $0.01 par value; 1,666,667,000 shares authorized;
issued at December 31, 2021 - 726,527,000 and December 31, 2020 - 743,458,000
7 7 
Additional paid-in capital27,751 27,707 
Retained earnings (accumulated deficit)524  
Accumulated other comprehensive income (loss)(2,898)(2,890)
Total Corteva stockholders’ equity25,384 24,824 
Noncontrolling interests239 239 
Total equity25,623 25,063 
Total Liabilities and Equity$42,344 $42,649 

See Notes to the Consolidated Financial Statements beginning on page F-11.
F-7

Corteva, Inc.
Consolidated Financial Statements

CONSOLIDATED STATEMENTS OF CASH FLOWS
(In millions)For the Year Ended December 31,
20212020
20191
Operating activities
Net income (loss)$1,769 $701 $(941)
Adjustments to reconcile net income (loss) to cash provided by (used for) operating activities:
Depreciation and amortization1,243 1,177 1,599 
Provision for (benefit from) deferred income tax174 (330)(477)
Net periodic pension and OPEB benefit, net(1,292)(340)(177)
Pension and OPEB contributions(247)(269)(323)
Net (gain) loss on sales of property, businesses, consolidated companies, and investments(21)3 (142)
Restructuring and asset related charges - net289 335 339 
Amortization of inventory step-up  272 
Goodwill impairment charge  1,102 
Loss on early extinguishment of debt  13 
Other net loss156 290 246 
Changes in assets and liabilities, net
Accounts and notes receivable(113)187 (361)
Inventories(422)104 74 
Accounts payable524 (118)149 
Deferred revenue574 71 632 
Other assets and liabilities93 253 (935)
Cash provided by (used for) operating activities2,727 2,064 1,070 
Investing activities  
Capital expenditures(573)(475)(1,163)
Proceeds from sales of property, businesses, and consolidated companies - net of cash divested75 83 249 
Acquisitions of businesses - net of cash acquired  (10)
Investments in and loans to nonconsolidated affiliates(4)(1)(10)
Proceeds from sale of ownership interest in nonconsolidated affiliates  21 
Purchases of investments(204)(995)(138)
Proceeds from sales and maturities of investments345 721 160 
Other investing activities, net(1)(7)(13)
Cash provided by (used for) investing activities(362)(674)(904)
Financing activities  
Net change in borrowings (less than 90 days)13  (1,868)
Proceeds from debt419 2,439 1,001 
Payments on debt(421)(1,441)(6,804)
Repurchase of common stock(950)(275)(25)
Proceeds from exercise of stock options100 56 47 
Dividends paid to stockholders(397)(388)(194)
Payment for acquisition of subsidiary's interest from the noncontrolling interest (60) 
Distributions to DowDuPont  (317)
Cash transferred to DowDuPont at Internal Reorganizations  (2,053)
Contributions from Dow and DowDuPont  7,396 
Debt extinguishment costs   (79)
Other financing activities, net(30)(28)(33)
Cash provided by (used for) financing activities(1,266)303 (2,929)
Effect of exchange rate changes on cash, cash equivalents and restricted cash equivalents(136)7 (88)
F-8

Corteva, Inc.
Consolidated Financial Statements

(In millions)For the Year Ended December 31,
20212020
20191
 Increase (decrease) on cash, cash equivalents and restricted cash equivalents963 1,700 (2,851)
Cash, cash equivalents and restricted cash equivalents at beginning of period3,873 2,173 5,024 
Cash, cash equivalents and restricted cash equivalents at end of period2
$4,836 $3,873 $2,173 
Supplemental cash flow information
Cash paid during the period for
Interest, net of amounts capitalized$30 $36 $263 
Income taxes341 229 234 
1.The cash flows for the year ended December 31, 2019 includes cash flows of EID's ECP and Specialty Products Entities.
2. See page F-30 for reconciliation of cash and cash equivalents and restricted cash equivalents presented in the Consolidated Balance Sheets to total cash, cash equivalents and restricted cash equivalents presented in the Consolidated Statements of Cash Flows.

See Notes to the Consolidated Financial Statements beginning on page F-11.

F-9

Corteva, Inc.
Consolidated Financial Statements

CONSOLIDATED STATEMENTS OF EQUITY
(In millions)Common StockAdditional Paid-in Capital "APIC"Divisional EquityRetained Earnings (Accum Deficit)Accumulated Other Comp Income (Loss)Non-controlling InterestsTotal Equity
Balance at January 1, 2019$ $ $78,020 $ $(3,360)$493 $75,153 
Net income (loss)(641)(318)18 (941)
Other comprehensive income (loss)(1,124)(1,124)
Common dividends ($0.26 per share)(97)(97)(194)
Distributions to Dow and DowDuPont(317)(317)
Issuance of DowDuPont stock39 39 
Issuance of Corteva stock88 
Share-based compensation41 62 103 
Common Stock Repurchase(25)(25)
Contributions from Dow and DowDuPont7,396 7,396 
Impact of Internal Reorganizations(56,479)1,214 (231)(55,496)
Reclassification of Divisional Equity to Additional Paid-in Capital7 28,070 (28,077)— 
Other - net(3)(10)(34)(47)
Balance at December 31, 2019$7 $27,997 $ $(425)$(3,270)$246 $24,555 
Net income (loss) 681 20 701 
Other comprehensive income (loss)380 380 
Share-based compensation60 (1)59 
Common dividends ($0.52 per share)(194)(194)(388)
Repurchase of common stock(216)(59)(275)
Issuance of Corteva stock56 56 
Acquisition of a noncontrolling interest in consolidated subsidiaries(37)(15)(52)
Other - net41 (2)(12)27 
Balance at December 31, 2020$7 $27,707 $ $(2,890)$239 $25,063 
Net income (loss) 1,759 10 1,769 
Other comprehensive income (loss)(8)(8)
Share-based compensation59 (3)56 
Common dividends ($0.54 per share)(97)(300)(397)
Repurchase of common stock(18)(932)(950)
Issuance of Corteva stock100 100 
Other - net(10)(10)
Balance at December 31, 2021$7 $27,751 $524 $(2,898)$239 $25,623 


See Notes to the Consolidated Financial Statements beginning on page F-11.
F-10

Corteva, Inc.
Notes to the Consolidated Financial Statements

Table of Contents

NotePage
1
F-12
2
F-14
3
F-19
4
F-19
5
F-20
6
F-24
7
F-26
8
F-28
9
F-29
10
F-31
11
F-35
12
F-36
13
F-37
14
F-37
15
F-38
16
F-40
17
F-42
18
F-44
19
F-51
20
F-54
21
F-63
22
F-65
23F-71
24
F-73
25
F-74
26
F-78


F-11

Corteva, Inc.
Notes to the Consolidated Financial Statements (continued)
NOTE 1 - BACKGROUND AND BASIS OF PRESENTATION

Corteva, Inc. is a leading global provider of seed and crop protection solutions focused on the agriculture industry. The company intends to leverage its rich heritage of scientific achievement to advance its robust innovation pipeline and continue to shape the future of responsible agriculture. The company's broad portfolio of agriculture solutions fuels farmer productivity around the globe. Corteva has two reportable segments: seed and crop protection. See Note 25 - Segment Information, to the Consolidated Financial Statements, for additional information on the company's reportable segments.

Throughout these financial statements, except as otherwise noted by the context, the terms "Corteva" or "company" used herein mean Corteva, Inc. and its consolidated subsidiaries (including EID) and the term “EID” used herein means E. I. du Pont de Nemours and Company and its consolidated subsidiaries or E. I. du Pont de Nemours and Company excluding its consolidated subsidiaries, as the context may indicate. Additionally, on June 1, 2019, DowDuPont Inc. changed its registered name to DuPont de Nemours, Inc. (“DuPont”), for certain events prior to, or on, June 1, 2019, DuPont may be referred to as DowDuPont.

Principles of Consolidation and Basis of Presentation
On June 1, 2019, Corteva, Inc. became an independent, publicly traded company through the completed separation (the “Separation”) of the agriculture business of DuPont de Nemours, Inc. (formerly known as DowDuPont Inc.) (“DowDuPont” or “DuPont”). The separation was effectuated through a pro rata distribution (the “Corteva Distribution”) of all of the then-issued and outstanding shares of common stock, par value $0.01 per share, of Corteva, Inc., which was then a wholly-owned subsidiary of DowDuPont, to holders of record of DowDuPont common stock as of the close of business on May 24, 2019.

Previously, DowDuPont was formed on December 9, 2015, to effect an all-stock merger of equals strategic combination between The Dow Chemical Company ("Historical Dow") and EID. On August 31, 2017 at 11:59 pm ET (the “Merger Effectiveness Time”) pursuant to the Agreement and Plan of Merger, dated as of December 11, 2015, as amended March 31, 2017 (the "Merger Agreement"), Historical Dow and EID each merged with wholly-owned subsidiaries of DowDuPont and became subsidiaries of DowDuPont (the “Merger”). Prior to the Merger, DowDuPont did not conduct any business activities other than those required for its formation and matters contemplated by the Merger Agreement.

Subsequent to the Merger, Historical Dow and EID engaged in a series of internal reorganization and realignment steps to realign their businesses into three subgroups: agriculture, materials science and specialty products through a series of tax-efficient transactions (collectively, the "Business Separations”). Effective as of 5:00 pm ET on April 1, 2019, DowDuPont completed the separation of its materials science business into a separate and independent public company by way of a distribution of Dow Inc. (“Dow”) through a pro rata dividend in-kind of all of the then-issued and outstanding shares of Dow’s common stock, par value $0.01 per share, to holders of DowDuPont's common stock, as of the close of business on March 21, 2019 (the “Dow Distribution” and together with the Corteva Distribution, the “Distributions”).

Prior to the Dow Distribution, Historical Dow conveyed or transferred the assets and liabilities aligned with Historical Dow’s agriculture business to separate legal entities (“Dow Ag Entities”) and the assets and liabilities associated with its specialty products business to separate legal entities (the “Dow SP Entities”). On April 1, 2019, Dow Ag Entities and the Dow SP Entities were transferred and conveyed to DowDuPont.

In furtherance of the Business Separations, EID engaged in a series of internal reorganization and realignment steps (the “Internal Reorganization” and the "Business Realignment," respectively) to realign its businesses into three subgroups: agriculture, materials science and specialty products. As part of the Internal Reorganization:

the assets and liabilities aligned with EID’s materials science business (“EID ECP”) were transferred or conveyed to separate legal entities that were ultimately conveyed by DowDuPont to Dow on April 1, 2019;

the assets and liabilities aligned with EID’s specialty products business were transferred or conveyed to separate legal entities (“EID Specialty Products Entities”) that were ultimately distributed to DowDuPont on May 1, 2019;

on May 2, 2019, DowDuPont conveyed Dow Ag Entities to EID and in connection with the foregoing, EID issued additional shares of its Common Stock to DowDuPont; and

on May 31, 2019, DowDuPont contributed EID to Corteva, Inc.

On May 6, 2019, the Board of Directors of DowDuPont approved the distribution of all the then issued and outstanding shares of common stock of Corteva, Inc., then a wholly-owned subsidiary of DowDuPont, to DowDuPont stockholders. On June 1,
F-12

Corteva, Inc.
Notes to the Consolidated Financial Statements (continued)
2019, DowDuPont completed the Separation. Each DowDuPont stockholder received one share of Corteva common stock for every three shares of DowDuPont common stock held at the close of business on May 24, 2019, the record date of distribution. Corteva, Inc.'s common stock began trading the "regular way" under the ticker symbol "CTVA" on June 3, 2019, the first business day after June 1, 2019. Upon becoming an independent company, the capital structure of Corteva consisted of 748,815,000 authorized shares of common stock (par value of $0.01 per share), which represents the number of common shares issued on June 3, 2019. Information related to the Corteva Distribution and its effect on the company's financial statements is discussed throughout these Notes to the Consolidated Financial Statements.

As a result of the Business Realignment and the Internal Reorganization discussed above, Corteva owns 100% of the outstanding common stock of EID. EID is a subsidiary of Corteva, Inc. and continues to be a reporting company, subject to the requirements of the Securities Exchange Act of 1934, as amended.

DAS Common Control Business Combination
The transfer or conveyance of DAS to Corteva was treated as a transfer of entities under common control. As such, the company recorded the assets, liabilities, and equity of DAS on its balance sheet at their historical basis. Transfers of businesses between entities under common control requires the financial statements to be presented as if the transaction had occurred at the point at which common control first existed (the Merger Effectiveness Time). As a result, the accompanying Consolidated Financial Statements and Notes thereto include the results of DAS as of the Merger Effectiveness Time. See Note 4 - Common Control Business Combination, to the Consolidated Financial Statements, for additional information.

For periods prior to the Corteva Distribution, the combined results of operations and assets and liabilities of EID and DAS were derived from the Consolidated Financial Statements and accounting records of EID as well as the carve-out financial statements of DAS. The DAS carve-out financial statements reflect the historical results of operations, financial position, and cash flows of Historical Dow's Agricultural Sciences Business and include allocations of certain expenses for services from Historical Dow, including, but not limited to, general corporate expenses related to finance, legal, information technology, human resources, ethics and compliance, shared services, employee benefits and incentives, insurance, and stock-based compensation. These expenses were allocated on the basis of direct usage when identifiable, with the remainder allocated under the basis of headcount or other measures.

The company's Consolidated Balance Sheets for all periods presented consist of Corteva, Inc. and its consolidated subsidiaries.

The company's Consolidated Statements of Operations (the "Consolidated Statements of Operations") for all periods prior to the Corteva Distribution consist of the combined results of operations for Historical EID and DAS. The Consolidated Statements of Operations for all periods after the Corteva Distribution represent the consolidated balances of the company. Intercompany balances and transactions with Historical EID and DAS have been eliminated.

During the first quarter 2020, the company recorded an increase of $40 million to APIC relating to net assets recorded as
transferred as part of the 2019 Internal Reorganizations that were retained.

Divestiture of EID ECP and EID Specialty Products Entities
The transfer of EID ECP and EID Specialty Products Entities meets the criteria for discontinued operations and as such, results of operations are presented as discontinued operations and have been excluded from continuing operations for all periods presented. The comprehensive income (loss), stockholder's equity and cash flows related to EID ECP and EID Specialty Products Entities have not been segregated and are included in the Consolidated Statements of Comprehensive Income (Loss), Consolidated Statements of Equity and Consolidated Statements of Cash Flows, respectively, for 2019. Amounts related to EID ECP and EID Specialty Products Entities are consistently included or excluded from the Notes to the Consolidated Financial Statements based on the respective financial statement line item. See Note 5 - Divestitures and Other Transactions, to the Consolidated Financial Statements, for additional information.

Certain reclassifications of prior year's data have been made to conform to current year's presentation.

Since 2018, Argentina has been considered a hyper-inflationary economy under U.S. GAAP and therefore the U.S. Dollar (“USD”) is the functional currency for our related subsidiaries. Argentina contributes approximately 5 percent to both the company's annual Sales and EBITDA. We remeasure net monetary assets and translate our financial statements utilizing the official Argentine Peso (“Peso”) to USD exchange rate. The ability to draw down Peso cash balances is limited at this time due to government restrictions and market availability of U.S. Dollars. The devaluation of the Peso relative to the USD over the last several years has resulted in the recognition of exchange losses (refer to Note 9 – Supplementary Information, to the Consolidated Financial Statements). As of December 31, 2021, a further 10 percent deterioration in the official Peso to USD
F-13

Corteva, Inc.
Notes to the Consolidated Financial Statements (continued)
exchange rate would reduce the USD value of our net monetary assets and negatively impact pre-tax earnings by approximately $15 million. We will continue to assess the implications to our operations and financial reporting.

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

The Consolidated Financial Statements include the accounts of the company and subsidiaries in which a controlling interest is maintained. For those consolidated subsidiaries in which the company's ownership is less than 100 percent, the outside stockholders' interests are shown as noncontrolling interests. Investments in affiliates over which the company has the ability to exercise significant influence but does not have a controlling interest are accounted for under the equity method.

The company is also involved with certain joint ventures accounted for under the equity method of accounting that are variable interest entities ("VIEs"). The company is not the primary beneficiary, as the nature of the company's involvement with the VIEs does not provide it the power to direct the VIEs significant activities. Future events may require these VIEs to be consolidated if the company becomes the primary beneficiary. At December 31, 2021 and 2020, the maximum exposure to loss related to the nonconsolidated VIEs is not considered material to the Consolidated Financial Statements.

Use of Estimates in Financial Statement Preparation
The preparation of financial statements in accordance with U.S. GAAP requires the use of estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. The company’s consolidated financial statements include amounts that are based on management’s best estimates and judgments. Actual results could differ from those estimates.

Cash and Cash Equivalents
Cash equivalents represent investments with maturities of three months or less from time of purchase. They are carried at cost plus accrued interest.
 
Restricted Cash Equivalents
Restricted cash equivalents primarily consist of trust assets and contributions to the MOU Escrow Account of $377 million and $347 million as of December 31, 2021 and 2020, respectively. The trust assets are classified as current and the contributions to the MOU Escrow Account are classified as noncurrent and included within other current assets and other assets, respectively, in the Consolidated Balance Sheets. See Note 9 - Supplementary Information, to the Consolidated Financial Statements, for further information.

Marketable Securities
Marketable securities represent investments in fixed and floating rate financial instruments with maturities greater than three months and up to twelve months at time of purchase. Investments classified as held-to-maturity are recorded at amortized cost. The carrying value approximates fair value due to the short-term nature of the investments. Investments classified as debt securities that are available-for-sale are carried at estimated fair value with unrealized gains and losses recorded as a component of accumulated other comprehensive income (loss) or current period earnings if an allowance for credit losses has been established. The cost of investments sold is determined by specific identification.

Fair Value Measurements
Under the accounting guidance for fair value measurements and disclosures, a fair value hierarchy was established that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). A financial instrument's level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement.


F-14

Corteva, Inc.
Notes to the Consolidated Financial Statements (continued)
The company uses the following valuation techniques to measure fair value for its assets and liabilities:
Level 1Quoted market prices in active markets for identical assets or liabilities;
Level 2Significant other observable inputs (e.g. quoted prices for similar items in active markets, quoted prices for identical or similar items in markets that are not active, inputs other than quoted prices that are observable such as interest rate and yield curves, and market-corroborated inputs);
Level 3Unobservable inputs for the asset or liability, which are valued based on management's estimates of assumptions that market participants would use in pricing the asset or liability.

Foreign Currency Translation
The company's worldwide operations utilize the U.S. dollar ("USD") or a related foreign currency as the functional currency, where applicable. The company identifies its separate and distinct foreign entities and groups the foreign entities into two categories: 1) extension of the parent or foreign subsidiaries operating in a hyper-inflationary environment (USD functional currency) and 2) self-contained (related foreign functional currency). If a foreign entity does not align with either category, factors are evaluated and a judgment is made to determine the functional currency. 

For foreign entities where the USD is the functional currency, all foreign currency-denominated asset and liability amounts are re-measured into USD at end-of-period exchange rates, except for inventories, prepaid expenses, property, plant and equipment, goodwill and other intangible assets, which are re-measured at historical rates. Foreign currency income and expenses are re-measured at average exchange rates in effect during each month, except for expenses related to balance sheet amounts re-measured at historical exchange rates. Exchange gains and losses arising from re-measurement of foreign currency-denominated monetary assets and liabilities are included in income in the period in which they occur.

For foreign entities where a related foreign currency is the functional currency, assets and liabilities denominated in the related foreign currencies are translated into USD at end-of-period exchange rates and the resultant translation adjustments are reported, net of their related tax effects, as a component of accumulated other comprehensive income (loss) in equity. Assets and liabilities denominated in other than the functional currency are re-measured into the functional currency prior to translation into USD and the resultant exchange gains or losses are included in income in the period in which they occur. Income and expenses are translated into USD at average exchange rates in effect during each month.

The company changes the functional currency of its separate and distinct foreign entities only when significant changes in economic facts and circumstances indicate clearly that the functional currency has changed.

Inventories
The company's inventories are valued at the lower of cost or net realizable value. Elements of cost in inventories include raw materials, direct labor and manufacturing overhead. Stores and supplies are valued at cost or net realizable value, whichever is lower; cost is generally determined by the average cost method.

As of December 31, 2021 and December 31, 2020, approximately 60% and 40% of the company's inventories were accounted for under the first-in, first-out ("FIFO") and average cost methods, respectively. Inventories accounted for under the FIFO method are primarily comprised of products with shorter shelf lives such as seeds. See Note 13 - Inventories, to the Consolidated Financial Statements, for further information.

The company establishes an obsolescence reserve for inventory based upon quality considerations and assumptions about future demand and market conditions.

Property, Plant and Equipment
Property, plant and equipment are carried at cost less accumulated depreciation. In connection with the Merger, the fair value of property, plant and equipment was determined using a market approach and a replacement cost approach. Depreciation is based on the estimated service lives of depreciable assets and is calculated using the straight-line method. Fully depreciated assets are retained in property and accumulated depreciation accounts until they are removed from service. When assets are surrendered, retired, sold, or otherwise disposed of, their gross carrying values and related accumulated depreciation are removed from the Consolidated Balance Sheets and included in determining gain or loss on such disposals.



F-15

Corteva, Inc.
Notes to the Consolidated Financial Statements (continued)
Goodwill and Other Intangible Assets
The company records goodwill when the purchase price of a business acquisition exceeds the estimated fair value of net identified tangible and intangible assets acquired. Goodwill is tested for impairment at the reporting unit level at least annually, or more frequently when events or changes in circumstances indicate that the fair value of a reporting unit has more likely than not declined below its carrying value. The company performs an annual goodwill impairment test in the fourth quarter.

When testing goodwill for impairment, the company has the option to first perform qualitative testing to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying value. If the company chooses not to complete a qualitative assessment for a given reporting unit or if the initial assessment indicates that it is more likely than not that the carrying value of a reporting unit exceeds its estimated fair value, additional quantitative testing is required. If additional quantitative testing is required, the reporting unit's fair value is compared with its carrying amount, and an impairment charge, if any, is recognized for the amount by which the carrying amount exceeds the reporting unit's fair value, limited to the amount of goodwill associated with the reporting unit. The company determines fair values for each of the reporting units using a discounted cash flow model (a form of the income approach) or the market approach. Under the income approach, fair value is determined based on the present value of estimated future cash flows, discounted at an appropriate risk-adjusted rate. The company's significant assumptions in this analysis included future cash flow projections, weighted average cost of capital, the terminal growth rate, and the tax rate. Under the market approach, the company uses metrics of publicly traded companies or historically completed transactions for comparable companies. See Note 15 - Goodwill and Other Intangible Assets, to the Consolidated Financial Statements, for further information on goodwill.

Indefinite-lived intangible assets are tested for impairment at least annually; however, these tests are performed more frequently when events or changes in circumstances indicate that the asset may be impaired. Impairment exists when carrying value exceeds fair value. The company performs an impairment assessment using the relief from royalty method (a form of the income approach) using Level 3 inputs within the fair value hierarchy. The significant assumptions used in the calculation included projected revenue, the royalty rate, the discount rate, and the terminal growth rate. These significant assumptions involve management judgment and estimates relating to future operating performance and economic conditions that may differ from actual cash flows.

Definite-lived intangible assets are amortized over their estimated useful lives, generally on a straight-line basis for periods ranging primarily from 2 years to 25 years. The company continually evaluates the reasonableness of the useful lives of these assets. Once these assets are fully amortized, they are removed from the Consolidated Balance Sheets.

Leases
The company determines whether an arrangement is a lease at the inception of the arrangement based on the terms and conditions in the contract. A contract contains a lease if there is an identified asset and the company has the right to control the asset. Operating lease right-of-use ("ROU") assets are included in other assets on the company’s Consolidated Balance Sheets. Operating lease liabilities are included in accrued and other current liabilities and other noncurrent obligations on the company’s Consolidated Balance Sheets. Finance lease assets are included in property, plant and equipment on the company’s Consolidated Balance Sheets. Finance lease liabilities are included in short-term borrowings and finance lease obligations and long-term debt on the company’s Consolidated Balance Sheets.  

Operating lease ROU assets represent the company’s right to use an underlying asset for the lease term and lease liabilities represent the company’s obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at the commencement date based on the present value of lease payments over the lease term. As most of the company’s leases do not provide the lessor's implicit rate, the company uses its incremental borrowing rate at the commencement date in determining the present value of lease payments. Lease terms include options to extend the lease when it is reasonably certain those options will be exercised. Leases with an initial term of 12 months or less are not recorded on the balance sheet. The company recognizes lease expense for these leases on a straight-line basis over the lease term.

The company has lease agreements with lease and non-lease components, which are accounted for as a single lease component for all asset classes. In the Consolidated Statements of Operations, lease expense for operating leases is recognized on a straight-line basis over the lease term. For finance leases, interest expense is recognized on the lease liability and the ROU asset is amortized over the lease term. See Note 16 - Leases, to the Consolidated Financial Statements, for further information.

Impairment of Long-Lived Assets
The company evaluates the carrying value of long-lived assets to be held and used when events or changes in circumstances indicate the carrying value may not be recoverable. The carrying value of a long-lived asset group is considered impaired when the total projected undiscounted cash flows from the assets are separately identifiable and are less than its carrying value. In that event, a loss is recognized based on the amount by which the carrying value exceeds the fair value of the long-lived asset. The
F-16

Corteva, Inc.
Notes to the Consolidated Financial Statements (continued)
company's fair value methodology is an estimate of fair market value which is made based on prices of similar assets or other valuation methodologies including present value techniques. Long-lived assets to be disposed of by sale, if material, are classified as held for sale and reported at the lower of carrying amount or fair value less cost to sell, and depreciation is ceased. Long-lived assets to be disposed of other than by sale are classified as held and used until they are disposed of and reported at the lower of carrying amount or fair value. Depreciation is recognized over the remaining useful life of the assets.

Derivative Instruments
Derivative instruments are reported in the Consolidated Balance Sheets at their fair values. The company utilizes derivatives to manage exposures to foreign currency exchange rates and commodity prices. Changes in the fair values of derivative instruments that are not designated as hedges are recorded in current period earnings. For derivative instruments designated as cash flow hedges, the gain (loss) is reported in accumulated other comprehensive income (loss) until it is cleared to earnings during the same period in which the hedged item affects earnings. For derivative instruments designated as net investment hedges, the gain (loss) is reported within accumulated other comprehensive income (loss) until the subsidiary is divested.

In the event that a derivative designated as a hedge of a firm commitment or an anticipated transaction is terminated prior to the maturation of the hedged transaction, the net gain or loss in accumulated other comprehensive income (loss) generally remains in accumulated other comprehensive income (loss) until the item that was hedged affects earnings. If a hedged transaction matures, or is sold, extinguished, or terminated prior to the maturity of a derivative designated as a hedge of such transaction, gains or losses associated with the derivative through the date the transaction matured are included in the measurement of the hedged transaction and the derivative is reclassified as for trading purposes. Derivatives designated as hedges of anticipated transactions are reclassified as for trading purposes if the anticipated transaction is no longer probable.

The company included foreign currency exchange contract settlements within cash flows from operating activities, regardless of hedge accounting qualification. See Note 22 - Financial Instruments, to the Consolidated Financial Statements, for additional discussion regarding the company's objectives and strategies for derivative instruments.

Environmental Matters
Accruals for environmental matters are recorded when it is probable that a liability has been incurred and the amount of the liability can be reasonably estimated. These accruals are adjusted periodically as assessment and remediation efforts progress or as additional technical or legal information becomes available. Accruals for environmental liabilities are included in the Consolidated Balance Sheets in accrued and other current liabilities and other noncurrent obligations at undiscounted amounts. Accruals for related insurance or other third-party recoveries for environmental liabilities are recorded when it is probable that a recovery will be realized and are included in the Consolidated Balance Sheets as accounts and notes receivable - net.

Environmental costs are capitalized if the costs extend the life of the property, increase its capacity, and/or mitigate or prevent contamination from future operations. Environmental costs are also capitalized in recognition of legal asset retirement obligations resulting from the acquisition, construction and/or normal operation of a long-lived asset. Costs related to environmental contamination treatment and cleanup are charged to expense. Estimated future incremental operations, maintenance and management costs directly related to remediation are accrued when such costs are probable and reasonably estimable.

Revenue Recognition
The company recognizes revenue when its customer obtains control of promised goods or services, in an amount that reflects the consideration which the company expects to receive in exchange for those goods or services. To determine revenue recognition for the arrangements that the company determines are within the scope of FASB ASU No. 2014-09, Revenue from Contracts with Customers (Topic 606), the company performs the following five steps: (1) identify the contract(s) with a customer, (2) identify the performance obligations in the contract, (3) determine the transaction price, (4) allocate the transaction price to the performance obligations in the contract, and (5) recognize revenue when (or as) the entity satisfies a performance obligation. See Note 6 - Revenue, to the Consolidated Financial Statements, for additional information on revenue recognition.

Prepaid Royalties
The company currently has certain third-party biotechnology trait license agreements, which require up-front and variable payments subject to the licensor meeting certain conditions. These payments are reflected as other current assets and other assets and are amortized to cost of goods sold as seeds containing the respective trait technology are utilized over the life of the license. The rate of royalty amortization expense recognized is based on the company’s strategic plans which include various assumptions and estimates including product portfolio, market dynamics, farmer preferences, growth rates and projected planted acres. Changes in factors and assumptions included in the strategic plans, including potential changes to the product portfolio in favor of internally developed biotechnology, could impact the rate of recognition of the relevant prepaid royalty.
F-17

Corteva, Inc.
Notes to the Consolidated Financial Statements (continued)
At December 31, 2021, the balance of prepaid royalties reflected in other current assets and other assets was $303 million and $256 million, respectively. The majority of the balance of prepaid royalties relates to the company’s wholly owned subsidiary, Pioneer Hi-Bred International, Inc.’s (“Pioneer”) non-exclusive license in the United States and Canada for the Monsanto Company's Genuity® Roundup Ready 2 Yield® glyphosate tolerance trait and Roundup Ready 2 Xtend® glyphosate and dicamba tolerance trait for soybeans (“Roundup Ready 2 License Agreement”). Each of these licensed technologies are now trademarks of the Bayer Group, which acquired the Monsanto Company in 2018. The prepaid royalty asset relates to a series of up-front, fixed and variable royalty payments to utilize the traits in Pioneer’s soybean product mix.The company’s historical expectation has been that the technology licensed under the Roundup Ready 2 License Agreement would be used as the primary herbicide tolerance trait platform in the Pioneer® brand soybean through the term of the agreement. DAS and MS Technologies, L.L.C. jointly developed and own the Enlist E3TM herbicide tolerance trait for soybeans which provides tolerance to 2, 4-D choline in Enlist Duo® and Enlist One® herbicides, as well as glyphosate and glufosinate herbicides. In connection with the validation of breeding plans and large-scale product development timelines, during the fourth quarter of 2019, the company accelerated the ramp up of the Enlist E3TM trait platform in the company’s soybean portfolio mix across all brands, including Pioneer® brands, over the subsequent five years. During the ramp-up period, the company is expected to significantly reduce the volume of products with the Roundup Ready 2 Yield® and Roundup Ready 2 Xtend® herbicide tolerance traits beginning in 2021, with expected minimal use of the trait platform thereafter for the remainder of the Roundup Ready 2 License Agreement (the “Transition Plan”). The rate of royalty expense has therefore increased significantly through higher amortization of the prepaid royalty as fewer seeds containing the respective trait are expected to be utilized.

In connection with the departure from these traits, beginning January 1, 2020 the company presents and discloses the non-cash accelerated prepaid royalty amortization expense as a component of restructuring and asset related charges - net, in the Consolidated Statement of Operations. The accelerated prepaid royalty amortization expense represents the difference between the rate of amortization based on the revised number of units expected to contain the Roundup Ready 2 Yield® and Roundup Ready 2 Xtend® trait technology and the variable cash rate per the Roundup Ready 2 License Agreement.

Further changes in factors and assumptions associated with usage of the trait platform licensed under the Roundup Ready 2 License Agreement, including the Transition Plan, could further impact the rate of recognition of the prepaid royalty and Consolidated Statement of Operations presentation of the accelerated prepaid royalty amortization expense.

Cost of Goods Sold
Cost of goods sold primarily includes the cost of manufacture and delivery, ingredients or raw materials, direct salaries, wages and benefits and overhead, non-capitalizable costs associated with capital projects, royalties and other operational expenses. No amortization of intangibles is included within cost of goods sold.

Research and Development
Research and development costs are expensed as incurred. Research and development expense includes costs (primarily consisting of employee costs, materials, contract services, research agreements, and other external spend) relating to the discovery and development of new products.

Selling, General and Administrative Expenses
Selling, general and administrative expenses primarily include selling and marketing expenses, commissions, functional costs, and business management expenses.

Integration and Separation Costs
Integration and separation costs includes costs incurred to prepare for and close the Merger, post-Merger integration expenses, and costs incurred to prepare for the Business Separations. These costs primarily consist of financial advisory, information technology, legal, accounting, consulting and other professional advisory fees associated with preparation and execution of these activities.

Litigation and Other Contingencies
Accruals for legal matters and other contingencies are recorded when it is probable that a liability has been incurred and the amount of the liability can be reasonably estimated. Legal costs, such as outside counsel fees and expenses, are charged to expense in the period incurred.

Severance Costs
Severance benefits are provided to employees under the company's ongoing benefit arrangements. Severance costs are accrued when management commits to a plan of termination and it becomes probable that employees will be entitled to benefits at amounts that can be reasonably estimated.

F-18

Corteva, Inc.
Notes to the Consolidated Financial Statements (continued)
Insurance/Self-Insurance
The company self-insures certain risks where permitted by law or regulation, including workers' compensation, vehicle liability and employee related benefits. Liabilities associated with these risks are estimated in part by considering historical claims experience, demographic factors and other actuarial assumptions. For other risks, the company uses a combination of insurance and self-insurance, reflecting comprehensive reviews of relevant risks. A receivable for an insurance recovery is generally recognized when the loss has occurred and collection is considered probable.

Income Taxes
The company accounts for income taxes using the asset and liability method. Under this method, deferred tax assets and liabilities are recognized for the future tax consequences of temporary differences between the carrying amounts and tax bases of assets and liabilities using enacted tax rates. The effect of a change in tax rates on deferred tax assets or liabilities is recognized in income in the period that includes the enactment date.

The company recognizes the financial statement effects of an uncertain income tax position when it is more likely than not, based on the technical merits, that the position will be sustained upon examination. The current portion of uncertain income tax positions is included in income taxes payable or income tax receivable, and the long-term portion is included in other noncurrent obligations or other noncurrent assets in the Consolidated Balance Sheets.

Income tax related penalties are included in the provision for (benefit from) income taxes in the Consolidated Statements of Operations. Interest accrued related to unrecognized tax benefits is included within the provision for (benefit from) income taxes from continuing operations in the Consolidated Statements of Operations.

Earnings per Common Share
The calculation of earnings per common share is based on the weighted-average number of the company’s common shares outstanding for the applicable period. The calculation of diluted earnings per common share reflects the effect of all potential common shares that were outstanding during the respective periods, unless the effect of doing so is antidilutive.


NOTE 3 - RECENT ACCOUNTING GUIDANCE

Recently Adopted Accounting Guidance
In January 2021, the FASB issued ASU 2021-01, Reference Rate Reform (Topic 848): Scope, which provides certain optional expedients that allow derivative instruments impacted by changes in the interest rate used for margining, discounting or contract price alignment to qualify for certain optional relief. The amendments in this Update are effective immediately for all entities and may be applied retrospectively as of any date from the beginning of any interim period that includes March 12, 2020 or prospectively to new modifications subsequent to the issuance of this Update. The adoption of ASU 2021-01 did not have a material impact on the company’s financial position, results of operation or cash flows.

In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes, which is part of the FASB’s Simplification Initiative to identify, evaluate, and improve areas of U.S. GAAP for which cost and complexity can be reduced, while maintaining or improving the usefulness of the information provided to users of financial statements. This ASU amends ASC 740, Income Taxes, by removing certain exceptions to the general principles, and clarifying and amending current guidance. The new standard is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020. The company adopted this guidance on January 1, 2021 and it did not have a material impact on the company’s financial position, results of operation or cash flows.

Accounting Guidance Issued But Not Adopted as of December 31, 2021
In November 2021, the FASB issued ASU 2021-10, Government Assistance (Topic 832): Disclosures by Business Entities about Government Assistance, which requires business entities to disclose transactions with a governmental entity for which a grant or contribution accounting model is used in recognizing and measuring such transactions. This standard is effective for fiscal years beginning after December 15, 2021, and early adoption is permitted. The company is currently evaluating the impact of adopting this guidance.

NOTE 4 - COMMON CONTROL BUSINESS COMBINATIONS

DAS Common Control Combination
Based on an evaluation of the provisions of ASC 805 (Business Combinations), Corteva and DAS represented entities under common control, as both shared DowDuPont as their parent company. As a result, the assets, liabilities and operations of
F-19

Corteva, Inc.
Notes to the Consolidated Financial Statements (continued)
Corteva and DAS were combined at their historical carrying amounts, and periods prior to the Internal Reorganizations are adjusted as if Corteva and DAS had been combined since the Merger Effectiveness Time, when the entities were first under common control. Accordingly, in 2019, the accompanying Consolidated Financial Statements and Notes thereto were retrospectively revised to include the transferred net assets and results of operations of DAS beginning on September 1, 2017. Refer to Note 1 - Background and Basis of Presentation, for additional information on the common control combination.

Intercompany balances and transactions with Historical EID and DAS have been eliminated.

NOTE 5 - DIVESTITURES AND OTHER TRANSACTIONS

Separation Agreements
In connection with the Distributions, DuPont, Corteva, and Dow (together, the “Parties” and each a “Party”) entered into certain agreements to effect the separation, provide for the allocation of DowDuPont’s assets, employees, liabilities and obligations (including its investments, property and employee benefits and tax-related assets and liabilities) among the Parties, and provide a framework for Corteva's relationship with Dow and DuPont following the separations and Distributions (collectively, the "Separation Agreements"). Effective April 1, 2019, the Parties entered into the following agreements referred to herein as: the Separation and Distribution Agreement (the “Corteva Separation Agreement”); the Tax Matters Agreement; the Employee Matters Agreement; and the Intellectual Property Cross-License Agreement.

Effective June 1, 2019, in connection with the Corteva Distribution, Corteva and DuPont entered into the following agreements: the Intellectual Property Cross-License Agreement (the “Corteva-DuPont IP Cross-License Agreement”); the Letter Agreement; and the Amended and Restated Tax Matters Agreement.

DuPont
Pursuant to the Separation Agreements, DuPont and Corteva indemnifies the other against certain litigation, environmental, tax, workers' compensation and other liabilities that arose prior to the Corteva Distribution. The term of this indemnification is generally indefinite and includes defense costs and expenses, as well as monetary and non-monetary settlements and judgments. In connection with the recognition of liabilities related to these matters, the company records an indemnification asset when recovery is deemed probable. At December 31, 2021, the indemnification assets are $25 million within accounts and notes receivable - net and $75 million within other assets in the Consolidated Balance Sheet. At December 31, 2021, the indemnification liabilities are $75 million within other noncurrent obligations in the Consolidated Balance Sheet.

Dow
Pursuant to the Separation Agreements, Dow and Corteva indemnifies the other against certain litigation, environmental, tax and other liabilities that arose prior to the Corteva Distribution. The term of this indemnification is generally indefinite and includes defense costs and expenses, as well as monetary and non-monetary settlements and judgments. In connection with the recognition of liabilities related to these matters, the company records an indemnification asset when recovery is deemed probable. At December 31, 2021, the indemnification liabilities are $20 million within accrued and other current liabilities and $42 million within other noncurrent obligations in the Consolidated Balance Sheet.
F-20

Corteva, Inc.
Notes to the Consolidated Financial Statements (continued)

EID ECP Divestiture
As discussed in Note 1 - Background and Basis of Presentation, on April 1, 2019, EID completed the transfer of the entities and related assets and liabilities of EID ECP to DowDuPont.

As a result, the financial results of EID ECP are reflected as discontinued operations, as summarized below:
(In millions)For the Year Ended December 31, 2019
Net sales$362 
Cost of goods sold
259 
Research and development expense
4 
Selling, general and administrative expenses
9 
Amortization of intangibles
23 
Restructuring and asset related charges - net
2 
Integration and separation costs
44 
Other income - net
2 
(Loss) income from discontinued operations before income taxes23 
Provision for (benefit from) income taxes on discontinued operations4 
(Loss) income from discontinued operations after income taxes$19 

The following table presents the depreciation, amortization of intangibles, and capital expenditures of the discontinued operations related to EID ECP:
(In millions)For the Year Ended December 31, 2019
Depreciation$28 
Amortization of intangibles23 
Capital expenditures16 

F-21

Corteva, Inc.
Notes to the Consolidated Financial Statements (continued)
EID Specialty Products Divestiture
As discussed in Note 1 - Background and Basis of Presentation, on May 1, 2019, the company completed the transfer of the entities and related assets and liabilities of the EID Specialty Products Entities to DowDuPont.

As a result, the financial results of the EID Specialty Products Entities are reflected as discontinued operations, as summarized below:
(In millions)For the Year Ended December 31, 2019
Net sales$5,030 
Cost of goods sold3,352 
Research and development expense204 
Selling, general and administrative expenses573 
Amortization of intangibles267 
Restructuring and asset related charges - net115 
Integration and separation costs253 
Goodwill impairment1,102 
Other income - net57 
(Loss) income from discontinued operations before income taxes(779)
Provision for (benefit from) income taxes on discontinued operations80 
(Loss) income from discontinued operations after income taxes$(859)

EID Specialty Products Impairment    
As a result of the Merger and related acquisition method of accounting, Historical DuPont's assets and liabilities were measured at fair value resulting in increases to the company’s goodwill and other intangible assets. The fair value valuation increased the risk that any declines in financial projections, including changes to key assumptions, could have a material, negative impact on the fair value of the company’s reporting units and assets, and therefore could result in an impairment.

As a result of the Internal Reorganization, in the second quarter of 2019, EID assessed the recoverability of the goodwill within the electronics and communications, protection solutions, nutrition and health, transportation and advanced polymers, packaging and specialty plastics, industrial biosciences, and clean technologies reporting units, and the overall carrying value of the net assets in the disposal group that was distributed to DowDuPont on May 1, 2019. As a result of this analysis, the company determined that the fair value of certain reporting units related to the EID specialty products businesses were below carrying value resulting in pre-tax, non-cash goodwill impairment charges totaling $1,102 million reflected in (loss) income from discontinued operations after income taxes. Revised financial projections reflect unfavorable market conditions, driven by slowed demand in the biomaterials business unit, coupled with challenging conditions in U.S. bioethanol markets. These revised financial projections resulted in a reduction in the long-term forecasts of sales and profitability as compared to prior projections.

F-22

Corteva, Inc.
Notes to the Consolidated Financial Statements (continued)
The company’s analyses above using discounted cash flow models (a form of the income approach) utilized Level 3 unobservable inputs. The company’s significant assumptions in these analyses include, but are not limited to, future cash flow projections, the weighted average cost of capital, the terminal growth rate, and the tax rate. The company’s estimates of future cash flows are based on current regulatory and economic climates, recent operating results, and planned business strategies. These estimates could be negatively affected by changes in federal, state, or local regulations or economic downturns. Future cash flow estimates are, by their nature, subjective and actual results may differ materially from the company’s estimates. The company also used a form of the market approach (utilizes Level 3 unobservable inputs), which is derived from metrics of publicly traded companies or historically completed transactions of comparable businesses. The selection of comparable businesses is based on the markets in which the reporting units operate giving consideration to risk profiles, size, geography, and diversity of products and services. As such, the company believes the current assumptions and estimates utilized are both reasonable and appropriate.

In addition, the company performed an impairment analysis related to the equity method investments held by the EID specialty products businesses, as of May 1, 2019. The company applied the net asset value method under the cost approach to determine the fair value of the equity method investments in the EID specialty products businesses. Based on updated projections, the company determined the fair value of an equity method investment was below the carrying value and had no expectation the fair value would recover in the short-term due to the current economic environment. As a result, management concluded the impairment was other-than-temporary and recorded an impairment charge of $63 million, reflected in (loss) income from discontinued operations after income taxes. Additionally, this impairment is reflected within restructuring and asset related charges - net in the year ended December 31, 2019, within the table above.

The following table presents the depreciation, amortization of intangibles, and capital expenditures of the discontinued operations related to the EID Specialty Products Entities:
For the Year Ended December 31,
(In millions)2019
Depreciation$281 
Amortization of intangibles267 
Capital expenditures
481 

Merger Remedy - Divested Ag Business
As a condition of the regulatory approval for the Merger, including by the European Commission, EID was required to divest (the “Divested Ag Business”) certain assets related to its crop protection business and research and development ("R&D") organization, specifically EID’s Cereal Broadleaf Herbicides and Chewing Insecticides portfolios, including Rynaxypyr®, Cyazypyr® and Indoxacarb as well as the crop protection R&D pipeline and organization, excluding seed treatment, nematicides, and late-stage R&D programs. On March 31, 2017, EID and FMC Corporation (“FMC”) entered into a definitive agreement (the "FMC Transaction Agreement"), and on November 1, 2017 FMC acquired the Divested Ag Business. As a result of the agreement, EID entered into favorable contracts with FMC of $495 million, which were recorded as intangible assets recognized at the fair value of off-market contracts.

For the year ended December 31, 2019, the company recorded income from discontinued operations after income taxes related to the Divested Ag Business of $80 million related to changes in accruals for certain prior year tax positions.

Other Discontinued Operations Activity
For the year ended December 31, 2020, the company recorded income from discontinued operations after income taxes of $10 million related to the adjustment of certain prior year tax positions for previously divested businesses. For the year ended December 31, 2019, the company recorded income from discontinued operations after income taxes of $89 million related to the adjustment of certain unrecognized tax benefits for positions taken on items from prior years from previously divested businesses.

F-23

Corteva, Inc.
Notes to the Consolidated Financial Statements (continued)

NOTE 6 - REVENUE

Revenue Recognition
Products
Substantially all of Corteva's revenue is derived from product sales. Product sales consist of sales of Corteva's products to farmers, distributors, and manufacturers. Corteva considers purchase orders, which in some cases are governed by master supply agreements, to be a contract with a customer. Contracts with customers are considered to be short-term when the time between order confirmation and satisfaction of the performance obligations is equal to or less than one year. However, the company has some long-term contracts which can span multiple years.

Revenue from product sales is recognized when the customer obtains control of the company's product, which occurs at a point in time according to shipping terms. Payment terms are generally less than one year from invoicing. The company elected the practical expedient and does not adjust the promised amount of consideration for the effects of a significant financing component when the company expects it will be one year or less between when a customer obtains control of the company's product and when payment is due. When the company performs shipping and handling activities after the transfer of control to the customer (e.g., when control transfers prior to or at shipment), these are considered fulfillment activities, and accordingly, the costs are accrued when the related revenue is recognized. Taxes collected from customers relating to product sales and remitted to governmental authorities are excluded from revenues. In addition, the company elected the practical expedient to expense any costs to obtain contracts as incurred, as the amortization period for these costs would have been one year or less.

The transaction price includes estimates of variable consideration, such as rights of return, rebates, and discounts, that are reductions in revenue. All estimates are based on the company's historical experience, anticipated performance, and the company's best judgment at the time the estimate is made. Estimates of variable consideration included in the transaction price primarily utilize the expected value method based on historical experience. These estimates are reassessed each reporting period and are included in the transaction price to the extent it is probable that a significant reversal of cumulative revenue recognized will not occur upon resolution of uncertainty associated with the variable consideration. The majority of contracts have a single performance obligation satisfied at a point in time and the transaction price is stated in the contract, usually as quantity times price per unit. For contracts with multiple performance obligations, the company allocates the transaction price to each performance obligation based on the relative standalone selling price. The standalone selling price is the observable price which depicts the price as if sold to a similar customer in similar circumstances.

Licenses of Intellectual Property
Corteva enters into licensing arrangements with customers under which it licenses its intellectual property. Revenue from the majority of intellectual property licenses is derived from sales-based royalties. Revenue for licensing agreements that contain sales-based royalties is recognized at the later of (i) when the subsequent sale occurs or (ii) when the performance obligation to which some or all of the royalty has been allocated is satisfied.

Remaining Performance Obligations
Remaining performance obligations represent the transaction price allocated to unsatisfied or partially unsatisfied performance obligations. The company applies the practical expedient to disclose the transaction price allocated to remaining performance obligations for only those contracts with an original duration of one year or more. The transaction price allocated to remaining performance obligations with an original duration of more than one year related to material rights granted to customers for contract renewal options were $123 million and $115 million at December 31, 2021 and December 31, 2020, respectively. The company expects revenue to be recognized for the remaining performance obligations evenly over the period of 1 year to 6 years.

Contract Balances
Contract liabilities primarily reflect deferred revenue from prepayments under contracts with customers where the company receives advance payments for products to be delivered in future periods. Corteva classifies deferred revenue as current or noncurrent based on the timing of when the company expects to recognize revenue. Contract assets primarily include amounts related to conditional rights to consideration for completed performance not yet invoiced. Accounts receivable are recorded when the right to consideration becomes unconditional.

F-24

Corteva, Inc.
Notes to the Consolidated Financial Statements (continued)
Contract BalancesDecember 31, 2021December 31, 2020
(In millions)
Accounts and notes receivable - trade1
$3,561 $3,917 
Contract assets - current2
$24 $22 
Contract assets - noncurrent3
$58 $54 
Deferred revenue - current$3,201 $2,662 
Deferred revenue - noncurrent4
$120 $116 
1.Included in accounts and notes receivable - net in the Consolidated Balance Sheets.
2.Included in other current assets in the Consolidated Balance Sheets.
3.Included in other assets in the Consolidated Balance Sheets.
4.Included in other noncurrent obligations in the Consolidated Balance Sheets.

Revenue recognized during the year ended December 31, 2021, December 31, 2020, and December 31, 2019 from amounts included in deferred revenue at the beginning of the period was $2,613 million, $2,540 million, and $2,146 million, respectively.

Disaggregation of Revenue
Corteva's operations are classified into two reportable segments: Seed and Crop Protection. The company disaggregates its revenue by major product line and geographic region, as the company believes it best depicts the nature, amount and timing of its revenue and cash flows. Net sales by major product line are included below:

For the Year Ended December 31,
(In millions)202120202019
    Corn$5,618 $5,182 $5,126 
    Soybean1,568 1,445 1,387 
    Other oilseeds752 619 593 
    Other464 510 484 
Seed8,402 7,756 7,590 
    Herbicides3,815 3,280 3,206 
    Insecticides1,730 1,764 1,652 
    Fungicides1,310 1,032 1,072 
    Other398 385 326 
Crop Protection7,253 6,461 6,256 
Total$15,655 $14,217 $13,846 
F-25

Corteva, Inc.
Notes to the Consolidated Financial Statements (continued)
Sales are attributed to geographic regions based on customer location. Net sales by geographic region and segment are included below:
SeedFor the Year Ended December 31,
(In millions)202120202019
North America1
$5,004 $4,795 $4,724 
EMEA2
1,599 1,468 1,378 
Latin America1,420 1,117 1,130 
Asia Pacific379 376 358 
Total$8,402 $7,756 $7,590 
Crop ProtectionFor the Year Ended December 31,
(In millions)202120202019
North America1
$2,532 $2,373 $2,205 
EMEA2
1,524 1,374 1,362 
Latin America2,125 1,688 1,759 
Asia Pacific1,072 1,026 930 
Total$7,253 $6,461 $6,256 
1.Represents U.S. & Canada.
2.Europe, Middle East, and Africa ("EMEA").

Refer to Note 24 - Geographic Information, for the breakout of consolidated net sales by geographic area.

NOTE 7 - RESTRUCTURING AND ASSET RELATED CHARGES - NET

2021 Restructuring Actions
During the first quarter of 2021, Corteva approved restructuring actions designed to right-size and optimize its footprint and organizational structure according to the business needs in each region with the focus on driving continued cost improvement and productivity. The company recorded net pre-tax restructuring charges in 2021 under the 2021 Restructuring Actions, as disclosed in the tables below. The company does not anticipate any additional material charges from the 2021 Restructuring Actions as actions associated with this charge are substantially complete.

The charges related to the 2021 Restructuring Actions related to the segments, as well as corporate expenses, were as follows:
(In millions)For the Year Ended December 31, 2021
Seed$31 
Crop Protection55 
Corporate expenses81 
Total$167 

The following table is a summary of charges incurred related to 2021 Restructuring Actions for the year ended December 31, 2021:
(In millions)For the Year Ended December 31, 2021
Severance and related benefit costs$74 
Asset related charges51 
Contract termination charges42 
Total restructuring and asset charges - net$167 

F-26

Corteva, Inc.
Notes to the Consolidated Financial Statements (continued)
A reconciliation of the December 31, 2020 to the December 31, 2021 liability balances related to the 2021 Restructuring Actions is summarized below:
(In millions)Severance and Related Benefit Costs
Asset Related1
Contract Termination2
Total
Balance at December 31, 2020$ $ $ $ 
Charges to income from continuing operations74 51 42 167 
Payments(22) (30)(52)
Asset write-offs (51) (51)
Balance at December 31, 2021$52 $ $12 $64 
1.In addition, the company has a liability recorded for asset retirement obligations of $6 million as of December 31, 2021.
2.The liability for contract terminations includes lease obligations. The cash impact of these obligations will be substantially complete by the end of 2022.

Execute to Win Productivity Program
During the first quarter of 2020, Corteva approved restructuring actions designed to improve productivity through optimizing certain operational and organizational structures primarily related to the Execute to Win Productivity Program. The company recorded net pre-tax restructuring charges of $185 million inception-to-date under the Execute to Win Productivity Program, consisting of $124 million of asset related charges and $61 million of severance and related benefit costs. Actions associated with the Execute to Win Productivity Program were substantially complete by the end of 2020.

The Execute to Win Productivity Program charges related to the segments, as well as corporate expenses, were as follows:
For the Year Ended December 31,
(In millions)20212020
Seed$ $15 
Crop Protection11 98 
Corporate expenses(2)63 
Total$9 $176 
The below is a summary of charges incurred related to the Execute to Win Productivity Program for the year ended December 31, 2020:
For the Year Ended December 31,
(In millions)20212020
Severance and related benefit costs - net$(2)$63 
Asset related charges11 113 
Total restructuring and asset related charges - net$9 $176 

A reconciliation of the December 31, 2020 to the December 31, 2021 liability balances related to the Execute to Win Productivity Program is summarized below:
(In millions)Severance and Related Benefit (Credits) Costs
Asset Related1
Total
Balance at December 31, 2020$53 $3 $56 
Charges to income from continuing operations for the year ended December 31, 2021(2)11 9 
Payments(27)(3)(30)
Asset write-offs (11)(11)
Balance at December 31, 2021$24 $ $24 
1.In addition, the company has a liability recorded for asset retirement obligations of $13 million as of December 31, 2021.


F-27

Corteva, Inc.
Notes to the Consolidated Financial Statements (continued)
DowDuPont Cost Synergy Program
In September and November 2017, DowDuPont and EID approved post-merger restructuring actions under the DowDuPont Cost Synergy Program (the “Synergy Program”), adopted at the time by the DowDuPont Board of Directors. The Synergy Program was designed to integrate and optimize the organization following the Merger and in preparation for the Business Separations. The company recorded net pre-tax restructuring charges of $833 million inception-to-date under the Synergy Program, consisting of severance and related benefit costs of $316 million, contract termination costs of $190 million, and asset related charges of $327 million. Actions associated with the Synergy Program, including employee separations, were substantially complete by the end of 2019.

The Synergy Program net charges (benefits) related to the segments, as well as corporate expenses, were as follows:
For the Year Ended December 31,
(In millions)202120202019
Seed$(8)$(9)$66 
Crop Protection(3)11 27 
Corporate expenses(1)(2)(1)
Total$(12)$ $92 

The below is a summary of net charges (benefits) incurred related to the Synergy Program for the years ended December 31, 2021, 2020 and 2019:
For the Year Ended December 31,
(In millions)202120202019
Severance and related benefit (credits) costs - net$(1)$(2)$(7)
Contract termination charges(3) 69 
Asset related charges(8)2 30 
Total restructuring and asset related charges - net$(12)$ $92 

Other Asset Related Charges
For the years ended December 31, 2021 and 2020, the company recognized $125 million and $159 million, respectively, in restructuring and asset related charges - net in the Consolidated Statements of Operations, from non-cash accelerated prepaid royalty amortization expense related to Roundup Ready 2 Yield® and Roundup Ready 2 Xtend® herbicide tolerance traits.

Asset Impairment
During the year ended December 31, 2019, the company recognized non-cash impairment charges of $144 million pre-tax ($110 million after-tax) in restructuring and asset related charges - net in the company's Consolidated Statements of Operations related to certain in-process research and development ("IPR&D") assets within the seed segment. Refer to Note 15 - Goodwill and Other Intangible Assets, and Note 23 - Fair Value Measurements, for further information.

NOTE 8 - RELATED PARTY TRANSACTIONS

Services Provided by and to Historical Dow and its affiliates
Following the Merger and prior to the Dow Distribution, Corteva reported transactions with Historical Dow and its affiliates as related party transactions.

Transactions with DowDuPont
In 2019 DowDuPont contributed cash to Corteva to fund portions of the company's debt redemption/repayment transactions. See Note 17 - Long-Term Debt and Available Credit Facilities, to the Consolidated Financial Statements, for additional information.

In February 2019, the DowDuPont Board declared first quarter dividends per share of DowDuPont common stock payable on March 15, 2019. EID declared and paid distributions to DowDuPont of about $317 million for the year ended December 31, 2019 to fund a portion of DowDuPont’s dividend payments.

F-28

Corteva, Inc.
Notes to the Consolidated Financial Statements (continued)

NOTE 9 - SUPPLEMENTARY INFORMATION

Other Income - NetFor the Year Ended December 31,
(In millions)202120202019
Interest income$77 $56 $59 
Equity in earnings (losses) of affiliates - net14  (9)
Net gain (loss) on sales of businesses and other assets1
21 (2)64 
Net exchange gains (losses)2
(54)(174)(99)
Non-operating pension and other post employment benefit credit (costs)3
1,318 368 191 
Miscellaneous income (expenses) - net4
(28)(36)9 
Other income - net$1,348 $212 $215 
1.    The year ended December 31, 2021 includes a gain of $19 million relating to the sale of a business in Asia Pacific in the crop protection segment. The year ended December 31, 2020 includes a loss of $(53) million and a gain of $27 million relating to the expected sale of the La Porte site, for which the company signed an agreement in 2020, and the sale of a business in Asia Pacific in the crop protection segment, respectively.
2.    Includes net pre-tax exchange gains (losses) of $(67) million, $(82) million and $(51) million associated with the devaluation of the Argentine peso for the years ended December 31, 2021, 2020 and 2019, respectively.
3.    Includes non-service related components of net periodic benefit credits (costs) (interest cost, expected long-term rate of return on plan assets, amortization of unrecognized gain (loss), amortization of prior service benefit and settlement gain (loss)). 
4.    Miscellaneous income (expenses) - net, includes losses from sale of receivables, tax indemnification adjustments related to changes in indemnification balances as a result of the application of the terms of the Tax Matters Agreement between Corteva and Dow and/or DuPont, and other items. The year ended December 31, 2021 also includes the Employee Retention Credit of $60 million pursuant to the Coronavirus Aid, Relief, and Economic Security (“CARES”) Act as enhanced by the Consolidated Appropriations Act (“CAA”) and American Rescue Plan Act (“ARPA”), a gain from the remeasurement of an equity investment of $47 million, a charge related to a contract termination with a third-party service provider of $(54) million and the 2021 officer indemnification payment. 

F-29

Corteva, Inc.
Notes to the Consolidated Financial Statements (continued)
The following table summarizes the impacts of the company's foreign currency hedging program on the company's results of operations. The company routinely uses foreign currency exchange contracts to offset its net exposures, by currency, related to the foreign currency-denominated monetary assets and liabilities. The objective of this program is to maintain an approximately balanced position in foreign currencies in order to minimize, on an after-tax basis, the effects of exchange rate changes on net monetary asset positions. The hedging program gains (losses) are largely taxable (tax deductible) in the United States (U.S.), whereas the offsetting exchange gains (losses) on the remeasurement of the net monetary asset positions are often not taxable (tax deductible) in their local jurisdictions. The net pre-tax exchange gains (losses) are recorded in other income - net and the related tax impact is recorded in provision for (benefit from) income taxes on continuing operations in the Consolidated Statements of Operations.
For the Year Ended December 31,
(In millions)202120202019
Subsidiary Monetary Position Gain (Loss)
Pre-tax exchange gain (loss) $(72)$(263)$(41)
Local tax (expenses) benefits (30)34 2 
Net after-tax impact from subsidiary exchange gain (loss) $(102)$(229)$(39)
Hedging Program Gain (Loss)
Pre-tax exchange gain (loss) $18 $89 $(58)
Tax (expenses) benefits (4)(21)13 
Net after-tax impact from hedging program exchange gain (loss) $14 $68 $(45)
Total Exchange Gain (Loss)
Pre-tax exchange gain (loss) $(54)$(174)$(99)
Tax (expenses) benefits(34)13 15 
Net after-tax exchange gain (loss) $(88)$(161)$(84)


Cash, cash equivalents and restricted cash equivalents
The following table provides a reconciliation of cash and cash equivalents and restricted cash equivalents presented in the Consolidated Balance Sheets to the total cash, cash equivalents and restricted cash equivalents presented in the Consolidated Statements of Cash Flows. Corteva classifies restricted cash equivalents as current or noncurrent based on the nature of the restrictions, which are included in other current assets and other assets, respectively, in the Consolidated Balance Sheets.
(In millions)December 31, 2021December 31, 2020
Cash and cash equivalents$4,459 $3,526 
Restricted cash equivalents377 347 
Total cash, cash equivalents and restricted cash equivalents$4,836 $3,873 

Restricted cash equivalents primarily relates to (i) a trust funded by EID for cash obligations under certain non-qualified benefit and deferred compensation plans due to the Merger, which was a change in control event, and is classified as current; and (ii) contributions to the MOU Escrow Account as further described in Note 18 - Commitments and Contingent Liabilities, to the Consolidated Financial Statements, which is classified as noncurrent.

Accounts payable
Accounts payable was $4,126 million and $3,615 million at December 31, 2021 and December 31, 2020, respectively. Accounts payable - trade, which is a component of accounts payable, was $3,023 million and $2,557 million at December 31, 2021 and December 31, 2020, respectively. Accounts payable - other, which is a component of accounts payable, was $1,103 million and $1,058 million at December 31, 2021 and December 31, 2020, respectively. No other components of accounts payable were more than 5 percent of total current liabilities.





F-30

Corteva, Inc.
Notes to the Consolidated Financial Statements (continued)
NOTE 10 - INCOME TAXES
Domestic and foreign components of the income (loss) from continuing operations before income taxes and the provision for (benefit from) current and deferred tax expense (benefit) are shown below:
Geographic Allocation of Income (Loss) and Provision for (Benefit from) Income Taxes For the Year Ended December 31,
(In millions)202120202019
Income (loss) from continuing operations before income taxes
Domestic$941 $(83)$(1,352)
Foreign1,405 758 1,036 
Income (loss) from continuing operations before income taxes$2,346 $675 $(316)
Current tax expense (benefit)
Federal$(13)$28 $(11)
State and local6 9 1 
Foreign329 222 317 
Total current tax expense (benefit)$322 $259 $307 
Deferred tax expense (benefit)
Federal$164 $(116)$(392)
State and local55 27 156 
Foreign(17)(251)(117)
Total deferred tax expense (benefit)$202 $(340)$(353)
Provision for (benefit from) income taxes on continuing operations524 (81)(46)
Net income (loss) from continuing operations after taxes$1,822 $756 $(270)

The effective income tax rate applicable to income (loss) from continuing operations before income taxes was different from the statutory U.S. federal income tax rate due to the factors listed in the following table:
Reconciliation to U.S. Statutory RateFor the Year Ended December 31,
202120202019
Statutory U.S. federal income tax rate21.0 %21.0 %21.0 %
Effective tax rates on international operations - net 1
(2.5)(13.9)(18.4)
Acquisitions, divestitures and ownership restructuring activities 2
(0.1)(0.3)(10.7)
U.S. research and development credit(2.4)(2.9)7.0 
Exchange gains/losses 3
1.9 3.5 (1.8)
State and local incomes taxes - net2.1 4.0 3.2 
Impact of Swiss Tax Reform4
0.2 (27.0)11.9 
Excess tax benefits/deficiencies from stock compensation(0.2)1.0 (0.6)
Tax settlements and expiration of statute of limitations 0.4 3.9 
Other - net2.3 2.2 (0.9)
Effective tax rate on income from continuing operations22.3 %(12.0)%14.6 %
1.    Includes the effects of local and U.S. taxes related to earnings of non-U.S. subsidiaries, changes in the amount of unrecognized tax benefits associated with these earnings, losses at non-U.S. subsidiaries without local tax benefits due to valuation allowances, and other permanent differences between tax and U.S. GAAP results. Includes a tax benefit of $(51) million for the year ended December 31, 2020, related to a return to accrual adjustment associated with an elective change in accounting method for the 2019 tax year impact of foreign tax provisions.
2.    See Notes 4 - Common Control Business Combination, and Note 5 - Divestitures and Other Transactions, to the Consolidated Financial Statements, for additional information.
3.    Principally reflects the impact of foreign exchange gains and losses on net monetary assets for which no corresponding tax impact is realized. Further information about the company's foreign currency hedging program is included in Note 9 - Supplementary Information, and Note 22 - Financial Instruments, under the heading Foreign Currency Risk.
4.    Reflects tax benefits of $(182) million primarily driven by the recognition of an elective cantonal component of the recent enactment of the Federal Act on Tax Reform and AHV Financing ("Swiss Tax Reform") for the year ended December 31, 2020. Reflects tax benefits of $(38) million associated with the enactment of the Federal Act on Tax Reform and AHV Financing ("Swiss Tax Reform"), for the year ended December 31, 2019.


F-31

Corteva, Inc.
Notes to the Consolidated Financial Statements (continued)
Significant components of our net deferred tax asset (liability) were attributable to:
Deferred Tax Balances at December 31,20212020
(In millions)AssetsLiabilitiesAssetsLiabilities
Property1
$— $341 $— $297 
Tax loss and credit carryforwards2,3
464 — 497 — 
Accrued employee benefits904 — 1,415 — 
Other accruals and reserves1
309 — 365 — 
Intangibles— 2,260 — 2,418 
Inventory153 — 127 — 
Research and development capitalization224 — 186 — 
Investments36 — 56 — 
Unrealized exchange gains/losses 10 2  
Other – net105  91  
Subtotal$2,195 $2,611 $2,739 $2,715 
Valuation allowances3
(366)— (453)— 
Total$1,829 $2,611 $2,286 $2,715 
Net Deferred Tax Asset (Liability)$(782)$(429)
1.    Prior year classifications in property and other accruals and reserves have been adjusted from their previous presentation. Adjustments did not impact the amount of the net deferred tax asset (liability) recorded in the Consolidated Balance Sheets.    
2.    Primarily related to the realization of recorded tax benefits on tax loss and credit carryforwards from operations in the United States, Brazil, and Spain.    
3.    In connection with the company's 2021 internal legal entity restructuring, the company reduced various state net operating loss carryforwards and corresponding full valuation allowances by $61 million. There was no impact on the statement of operations. During the year ended December 31, 2020, the company established a $19 million state tax valuation allowance in the U.S. based on a change in judgement about the realizability of a deferred tax asset.

Details of the company’s operating loss and tax credit carryforwards are shown in the following table:
Operating Loss and Tax Credit CarryforwardsDeferred Tax Asset
(In millions)20212020
Operating loss carryforwards
Expire within 5 years$123 $99 
Expire after 5 years or indefinite expiration210 343 
Total operating loss carryforwards$333 $442 
Tax credit carryforwards
Expire within 5 years$14 $14 
Expire after 5 years or indefinite expiration117 41 
Total tax credit carryforwards$131 $55 
Total Operating Loss and Tax Credit Carryforwards$464 $497 


F-32

Corteva, Inc.
Notes to the Consolidated Financial Statements (continued)
A reconciliation of the beginning and ending amount of gross unrecognized tax benefits is as follows:
Total Gross Unrecognized Tax BenefitsFor the Year Ended December 31,
(In millions)202120202019
Total unrecognized tax benefits as of beginning of period$395 $426 $749 
Decreases related to positions taken on items from prior years(7)(14)(167)
Increases related to positions taken on items from prior years13 5 77 
Increases related to positions taken in the current year9 6 54 
Settlement of uncertain tax positions with tax authorities(17)(18)(9)
Impact of Internal Reorganizations  (278)
Decreases due to expiration of statutes of limitations(16)(7) 
Exchange (gain) loss (3) 
Total unrecognized tax benefits as of end of period$377 $395 $426 
Total unrecognized tax benefits that, if recognized, would impact the effective tax rate$157 $156 $188 
Total amount of interest and penalties (benefits) recognized in provision for (benefit from) income taxes on continuing operations$1 $(2)$(4)
Total accrual for interest and penalties associated with unrecognized tax benefits at end of period$11 $18 $24 

Each year the company files hundreds of tax returns in the various national, state and local income taxing jurisdictions in which it operates. These tax returns are subject to examination and possible challenge by the tax authorities. Positions challenged by the tax authorities may be settled or appealed by the company. As a result, there is an uncertainty in income taxes recognized in the company's financial statements in accordance with accounting for income taxes and accounting for uncertainty in income taxes. It is reasonably possible that changes to the company’s global unrecognized tax benefits could be significant; however, due to the uncertainty regarding the timing of completion of audits and possible outcomes, a current estimate of the range of increases or decreases that may occur within the next twelve months cannot be made. As of December 31, 2021, the company has made advance deposits of approximately $102 million to a foreign taxing authority, partially as a prerequisite to petition the court related to an open tax examination. These payments are accounted for as a prepaid asset, included in other assets in the Consolidated Balance Sheets.

Tax years that remain subject to examination for the company’s major tax jurisdictions are shown below:
Tax Years Subject to Examination by Major Tax Jurisdiction at December 31, 2021Earliest Open Year
Jurisdiction
Argentina2015
Brazil2014
Canada2012
China2014
France2019
India2015
Italy2016
Switzerland2016
United States:
Federal income tax2012
State and local income tax2008

Undistributed earnings of foreign subsidiaries and related companies that are deemed to be indefinitely invested amounted to $3,681 million at December 31, 2021. Distributions of profits from non-U.S. subsidiaries are not expected to cause a significant incremental U.S. tax impact in the future; however, those distributions may still be subject to certain taxes upon repatriation, primarily where foreign withholding taxes apply. The company is asserting indefinite reinvestment related to certain investments in foreign subsidiaries. Determination of the amount of unrecognized deferred tax liability related to indefinitely reinvested profits is not feasible primarily due to our legal entity structure and the complexity of U.S. and local tax laws.

For periods between the Merger Effectiveness Time and the Corteva Distribution, Corteva and its subsidiaries were included in DowDuPont's consolidated federal income tax group and consolidated tax return. Generally, the consolidated tax liability of the
F-33

Corteva, Inc.
Notes to the Consolidated Financial Statements (continued)
DowDuPont U.S. tax group for each year was apportioned among the members of the consolidated group based on each member’s separate taxable income. Corteva, DuPont and Dow intend that to the extent Federal and/or State corporate income tax liabilities are reduced through the utilization of tax attributes of the other, settlement of any receivable and payable generated from the use of the other party’s sub-group attributes will be in accordance with a tax sharing agreement and/or tax matters agreement. See Note 5 - Divestitures and Other Transactions, to the Consolidated Financial Statements for further information related to indemnifications between Corteva, Dow and DuPont.

F-34

Corteva, Inc.
Notes to the Consolidated Financial Statements (continued)

NOTE 11 - EARNINGS PER SHARE OF COMMON STOCK

On June 1, 2019, the date of the Corteva Distribution, 748,815,000 shares of the company’s common stock were distributed to DowDuPont shareholders of record as of May 24, 2019.

The following tables provide earnings per share calculations for the periods indicated below:
Net Income (Loss) for Earnings Per Share Calculations - Basic and DilutedFor the Year Ended December 31,
(In millions)202120202019
Income (loss) from continuing operations after income taxes$1,822 $756 $(270)
Net income (loss) attributable to continuing operations noncontrolling interests10 20 13 
Income (loss) from continuing operations attributable to Corteva common stockholders1,812 736 (283)
(Loss) income from discontinued operations, net of tax(53)(55)(671)
Net income (loss) attributable to discontinued operations noncontrolling interests  5 
(Loss) income from discontinued operations attributable to Corteva common stockholders(53)(55)(676)
Net income (loss) attributable to common stockholders$1,759 $681 $(959)

Earnings (Loss) Per Share Calculations - BasicFor the Year Ended December 31,
(Dollars per share)202120202019
Earnings (loss) per share of common stock from continuing operations$2.46 $0.98 $(0.38)
(Loss) earnings per share of common stock from discontinued operations(0.07)(0.07)(0.90)
Earnings (loss) per share of common stock$2.39 $0.91 $(1.28)

Earnings (Loss) Per Share Calculations - DilutedFor the Year Ended December 31,
(Dollars per share)202120202019
Earnings (loss) per share of common stock from continuing operations$2.44 $0.98 $(0.38)
(Loss) earnings per share of common stock from discontinued operations(0.07)(0.07)(0.90)
Earnings (loss) per share of common stock$2.37 $0.91 $(1.28)

Share Count InformationFor the Year Ended December 31,
(Shares in millions)202120202019
Weighted-average common shares - basic1
735.9 748.7 749.5 
Plus dilutive effect of equity compensation plans2
5.7 2.5  
Weighted-average common shares - diluted741.6 751.2 749.5 
Potential shares of common stock excluded from EPS calculations3
2.8 9.4 14.4 
1.Share amounts for all periods prior to the Corteva Distribution were based on 748.8 million shares of Corteva, Inc. common stock distributed to holders of DowDuPont's common stock on June 1, 2019, plus 0.6 million of additional shares in which accelerated vesting conditions have been met.
2.Diluted earnings (loss) per share considers the impact of potentially dilutive securities except in periods in which there is a loss because the inclusion of the potential common shares would have an anti-dilutive effect.
3.These outstanding potential shares of common stock relating to stock options, restricted stock units and performance-based restricted stock units were excluded from the calculation of diluted earnings (loss) per share because (i) the effect of including stock options and restricted stock units would have been anti-dilutive; and (ii) the performance metrics have not yet been achieved for the outstanding potential shares relating to performance-based restricted stock units, which are deemed to be contingently issuable.

F-35

Corteva, Inc.
Notes to the Consolidated Financial Statements (continued)

NOTE 12 - ACCOUNTS AND NOTES RECEIVABLE - NET

(In millions)December 31, 2021December 31, 2020
Accounts receivable – trade1
$3,441 $3,754 
Notes receivable – trade1,2
120 163 
Other3
1,250 1,009 
Total accounts and notes receivable - net$4,811 $4,926 
1.Accounts receivable – trade and notes receivable – trade are net of allowances of $210 million and $208 million at December 31, 2021 and December 31, 2020, respectively. Allowances are equal to the estimated uncollectible amounts and are based on the expected credit losses and were developed using a loss-rate method.
2.Notes receivable – trade primarily consists of receivables for deferred payment loan programs for the sale of seed products to customers. These loans have terms of one year or less and are primarily concentrated in North America. The company maintains a rigid pre-approval process for extending credit to customers in order to manage overall risk and exposure associated with credit losses. As of December 31, 2021 and 2020, there were no significant impairments related to current loan agreements.
3.Other includes receivables in relation to indemnification assets, value added tax, general sales tax and other taxes. No individual group represents more than 10 percent of total receivables. In addition, Other includes amounts due from nonconsolidated affiliates of $104 million and $106 million as of December 31, 2021 and 2020, respectively.

Accounts and notes receivable are carried at the expected amount to be collected, which approximates fair value. The company establishes the allowance for doubtful receivables using a loss-rate method where the loss rate is developed using past events, historical experience, current conditions and forecasts that affect the collectability of the financial assets.

The following table summarizes changes in the allowance for doubtful receivables for the year ended December 31, 2021 and 2020, respectively:
(In millions)
2020
Balance at December 31, 2019$174 
Net provision for credit losses1
52 
Write-offs charged against allowance / other1
(18)
Balance at December 31, 2020$208 
2021
Balance at December 31, 2020$208 
Net provision for credit losses1 
Write-offs charged against allowance / other1 
Balance at December 31, 2021$210 
1. Prior year classifications in the changes in the allowance for doubtful receivables have been adjusted from their previous presentation. Adjustments did not impact the amount of the provision or the allowance for doubtful receivables recorded in the Consolidated Statements of Operations or the Consolidated Balance Sheets.

The company enters into various factoring agreements with third-party financial institutions to sell its trade receivables under both recourse and non-recourse agreements in exchange for cash proceeds. These financing arrangements result in a transfer of the company's receivables and risks to the third-party. As these transfers qualify as true sales under the applicable accounting guidance, the receivables are derecognized from the Consolidated Balance Sheets upon transfer, and the company receives a payment for the receivables from the third-party within a mutually agreed upon time period. For arrangements involving an element of recourse, which is typically provided through a guarantee of accounts in the event of customer default, the guarantee obligation is measured using market data from similar transactions and reported as a current liability in the Consolidated Balance Sheets.

Trade receivables sold under these agreements were $272 million, $255 million, and $328 million for the years ended December 31, 2021, 2020 and 2019, respectively. The trade receivables sold that remained outstanding under these agreements which include an element of recourse as of December 31, 2021 and December 31, 2020 were $166 million and $157 million, respectively. The net proceeds received were included in cash provided by (used for) operating activities in the Consolidated
F-36

Corteva, Inc.
Notes to the Consolidated Financial Statements (continued)
Statements of Cash Flows. The difference between the carrying amount of the trade receivables sold and the sum of the cash received is recorded as a loss on sale of receivables in other income - net in the Consolidated Statements of Operations. The loss on sale of receivables were $54 million, $55 million, and $44 million for the years ended December 31, 2021, 2020 and 2019, respectively. See Note 18 - Commitments and Contingent Liabilities, to the Consolidated Financial Statements, for additional information on the company’s guarantees.

NOTE 13 - INVENTORIES

(In millions)December 31, 2021December 31, 2020
Finished products$2,497 $2,584 
Semi-finished products2,076 1,813 
Raw materials and supplies607 485 
Total inventories$5,180 $4,882 

As a result of the Merger, a fair value step-up of $2,297 million was recorded for inventories. This fair value step-up was fully
amortized, as of December 31, 2019. During the year ended December 31, 2019, the company recognized $272 million in cost of goods sold in the Consolidated Statements of Operations related to the amortization of the step-up.


NOTE 14 - PROPERTY, PLANT AND EQUIPMENT

(In millions)December 31, 2021December 31, 2020
Land and land improvements$420 $451 
Buildings1,487 1,525 
Machinery and equipment5,729 5,556 
Construction in progress728 721 
Total property, plant and equipment8,364 8,253 
Accumulated depreciation(4,035)(3,857)
Total property, plant and equipment - net$4,329 $4,396 

Buildings, machinery and equipment and land improvements are depreciated over useful lives on a straight-line basis ranging from 2 to 25 years. Capitalizable costs associated with computer software for internal use are amortized on a straight-line basis over 2 to 7 years.

For the Year Ended December 31,
(In millions)202120202019
Depreciation expense$521 $495 $525 

F-37

Corteva, Inc.
Notes to the Consolidated Financial Statements (continued)

NOTE 15 - GOODWILL AND OTHER INTANGIBLE ASSETS

Goodwill
The following table summarizes changes in the carrying amount of goodwill by segment for the years ended December 31, 2021 and 2020, respectively.
(In millions)Crop ProtectionSeedTotal
Balance as of December 31, 2019$4,743 $5,486 $10,229 
Currency translation adjustment31 38 69 
Other goodwill adjustments and acquisitions1
(29) (29)
Balance as of December 31, 2020$4,745 $5,524 $10,269 
Currency translation adjustment(73)(87)(160)
Other goodwill adjustments and acquisitions2
 (2)(2)
Balance as of December 31, 2021$4,672 $5,435 $10,107 
1.Primarily consists of the goodwill included in the sale of businesses in the crop protection segment.
2.Consists of the goodwill included in the sale of a business in the seed segment.

The company tests goodwill for impairment annually (during the fourth quarter), or more frequently when events or changes in circumstances indicate it is more likely than not that the fair value of a reporting unit has declined below its carrying value. As mentioned in Note 2 - Summary of Significant Accounting Policies, as a result of the Internal Reorganizations and Business Realignments, the company changed its reportable segments to seed and crop protection to reflect the manner in which the company's chief operating decision maker assesses performance and allocates resources. The change in reportable segments resulted in changes to the company's reporting units for goodwill impairment testing to align with the level at which discrete financial information is available for review by management. The company’s reporting units include seed, crop protection and digital.

During the second quarter of 2020, the company determined a triggering event had occurred as a result of changes in the company's long-term projections driven largely by the impacts of the COVID-19 pandemic on the mid-term forecasted cash flows of the business, including, but not limited to currency fluctuations, expectations of future planted area (as influenced by consumer demand, ethanol markets and government policies and regulations) and relative commodity prices, which required an interim impairment assessment for its seed and crop protection reporting units and trade name indefinite lived intangible asset. Based on the impairment analysis performed over the company’s trade name indefinite lived intangible asset it was determined that the fair value approximated the carrying value, and no impairment charge was necessary.

The company performed quantitative testing on all of its reporting units and determined that no goodwill impairments existed in 2021 and 2020. As of December 31, 2021, accumulated impairment losses on goodwill were $4,503 million.


F-38

Corteva, Inc.
Notes to the Consolidated Financial Statements (continued)
Other Intangible Assets
The gross carrying amounts and accumulated amortization of other intangible assets by major class are as follows: 
(In millions)December 31, 2021December 31, 2020
 GrossAccumulated
Amortization
NetGrossAccumulated
Amortization
Net
Intangible assets subject to amortization (Definite-lived):
      
Germplasm$6,265 $(571)$5,694 $6,265 $(317)$5,948 
Customer-related
1,953 (487)1,466 1,984 (380)1,604 
Developed technology1,485 (679)806 1,451 (525)926 
Trademarks/trade names1
2,012 (172)1,840 2,019 (99)1,920 
Favorable supply contracts
475 (396)79 475 (302)173 
Other2
405 (256)149 405 (239)166 
Total other intangible assets with finite lives
12,595 (2,561)10,034 12,599 (1,862)10,737 
Intangible assets not subject to amortization (Indefinite-lived):
      
IPR&D10 — 10 10 — 10 
Total other intangible assets
10 — 10 10 — 10 
Total$12,605 $(2,561)$10,044 $12,609 $(1,862)$10,747 
1.Beginning on October 1, 2020, the company changed its indefinite life assertion of its trade name asset to definite lived with a useful life of 25 years. This change is the result of the launch of BrevantTM seed in the retail channel in the U.S. Prior to changing the useful life of the trade name asset, the company tested the asset for impairment under ASC 350 - Intangibles, Goodwill and Other, concluding the asset was not impaired.
2.Primarily consists of sales and farmer networks, marketing and manufacturing alliances and noncompetition agreements.

During the third quarter of 2019, and in connection with strategic product and portfolio reviews, the company determined that the fair value of certain intangible assets classified as developed technology, other intangible assets and IPR&D within the seed segment that primarily relate to heritage DAS intangibles previously acquired from Cooperativa Central de Pesquisa Agrícola's ("Coodetec") was less than the carrying value due to the company’s focus on advancing more competitive products and eliminating redundancy and complexity across the breeding programs. For IPR&D and developed technology, the company concluded these projects were abandoned. For other intangible assets, the company performed an impairment assessment using the relief from royalty method (a form of the income approach) using Level 3 inputs within the fair value hierarchy. The significant assumptions used in the calculation included projected revenue, royalty rates and discount rates. These significant assumptions involve management judgment and estimates relating to future operating performance and economic conditions that may differ from actual cash flows. As a result, the company recorded a pre-tax, non-cash intangible asset impairment charge of $54 million ($41 million after-tax), which is reflected in restructuring and asset related charges - net, in the company's Consolidated Statements of Operations for the year ended December 31, 2019.

There were no indicators of impairment for the company’s other intangible assets that suggested that the fair value was less than its carrying value at December 31, 2019, except for IPR&D. As a result of the company’s decision, during the fourth quarter of 2019, to accelerate the ramp up of the Enlist E3TM trait platform in the company’s soybean portfolio mix across all brands over the subsequent five years with minimal use of the Roundup Ready 2 Yield® and Roundup Ready 2 Xtend® traits thereafter for the remainder of the Roundup Ready 2 License Agreement, the company determined that certain IPR&D projects associated with Roundup Ready 2 Xtend® were not recoverable and were impaired. These IPR&D projects were either abandoned or tested for impairment using the relief from royalty method (a form of the income approach) using Level 3 inputs within the fair value hierarchy. The key assumptions used in the relief from royalty method calculation included projected revenue, royalty rates and discount rates. These key assumptions involve management judgment and estimates relating to future operating performance and economic conditions that may differ from actual cash flows. As a result, the company recorded a pre-tax, non-cash intangible asset charge of $90 million ($69 million after-tax), which is reflected in restructuring and asset related charges - net, in the company's Consolidated Statements of Operations for the year ended December 31, 2019.

The aggregate pre-tax amortization expense from continuing operations for definite-lived intangible assets was $722 million, $682 million, and $475 million, for the year ended December 31, 2021, December 31, 2020, and December 31, 2019, respectively.

F-39

Corteva, Inc.
Notes to the Consolidated Financial Statements (continued)

Total estimated amortization expense for the next five fiscal years is as follows:
(In millions)
2022$700 
2023$620 
2024$606 
2025$569 
2026$558 

NOTE 16 - LEASES

The company has operating and finance leases for real estate, transportation, certain machinery and equipment, and information technology assets. The company’s leases have remaining lease terms of 1 to 50 years. For purposes of calculating operating lease liabilities, lease terms may be deemed to include options to extend the lease when it is reasonably certain that the company will exercise that option. Some leasing arrangements require variable payments that are dependent on usage, output, or may vary for other reasons, such as insurance and tax payments. The variable lease payments are not presented as part of the initial ROU asset or lease liability.

Certain of the company's leases include residual value guarantees. These residual value guarantees are based on a percentage of the lessor's asset acquisition price and the amount of such guarantee declines over the course of the lease term. The portion of residual value guarantees that are probable of payment are included in the related lease liability. At December 31, 2021, the company has future maximum payments for residual value guarantees in operating leases of $193 million with final expirations through 2028. The company's lease agreements do not contain any material restrictive covenants. The components of lease cost are as follows:
For the Year Ended December 31,
(In millions)20212020
Operating lease cost$158 $197 
Finance lease cost
Amortization of right-of-use assets12 
Interest on lease liabilities  
Total finance lease cost12 
Short-term lease cost1414 
Variable lease cost87 
Total lease cost$181 $220 

New leases entered into during the years ended December 31, 2021 and December 31, 2020 were not material, on an individual basis.

Supplemental cash flow information related to leases is as follows:
For the Year Ended December 31,
(In millions)20212020
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash outflows from operating leases$169 $202 
Operating cash outflows from finance leases$ $ 
Financing cash outflows from finance leases$1 $1 







F-40

Corteva, Inc.
Notes to the Consolidated Financial Statements (continued)
Supplemental balance sheet information related to leases is as follows:
(In millions)December 31, 2021December 31, 2020
Operating Leases
 
Operating lease right-of-use assets1
$458 $521 
Current operating lease liabilities2
121 138 
Noncurrent operating lease liabilities3
338 391 
Total operating lease liabilities
$459 $529 
Finance Leases
 
Property, plant, and equipment, gross
$15 $15 
Accumulated depreciation
(11)(10)
Property, plant, and equipment, net
4 5 
Short-term borrowings and finance lease obligations1 1 
Long-Term Debt3 4 
Total finance lease liabilities$4 $5 
1.Included in other assets in the Consolidated Balance Sheet.
2.Included in accrued and other current liabilities in the Consolidated Balance Sheet.
3.Included in other noncurrent obligations in the Consolidated Balance Sheet.

The company utilizes the incremental borrowing rate in determining the present value of lease payments unless the implicit rate is readily determinable.
Lease Term and Discount RateDecember 31, 2021December 31, 2020
Weighted-average remaining lease term (years)
Operating leases7.417.71
Financing leases3.364.26
Weighted average discount rate
Operating leases2.75 %3.06 %
Financing leases3.29 %3.28 %

Maturities of lease liabilities are as follows:
Maturity of Lease Liabilities at December 31, 2021Operating LeasesFinancing Leases
(In millions)
2022$132 $1 
202394 1 
202471 1 
202560 1 
202649  
2027 and thereafter106  
Total lease payments512 4 
Less: Interest53  
Present value of lease liabilities$459 $4 
F-41

Corteva, Inc.
Notes to the Consolidated Financial Statements (continued)
Maturity of Lease Liabilities at December 31, 2020Operating LeasesFinancing Leases
(In millions)
2021$152 $1 
2022114 1 
202383 1 
202461 1 
202551 1 
2026 and thereafter137  
Total lease payments598 5 
Less: Interest69  
Present value of lease liabilities$529 $5 

NOTE 17 - LONG-TERM DEBT AND AVAILABLE CREDIT FACILITIES

Long-Term Debt
December 31, 2021December 31, 2020
(In millions)AmountWeighted Average RateAmountWeighted Average Rate
Promissory notes and debentures:
  Maturing in 2025500 1.70 %500 1.70 %
  Maturing in 2030500 2.30 %500 2.30 %
Other loans:
Foreign currency loans, various rates and maturities1 1 
Medium-term notes, varying maturities through 2041107  %109  %
Finance lease obligations3 4 
Less: Unamortized debt discount and issuance costs10 11 
Less: Long-term debt due within one year1 1 
Total$1,100 $1,102 

Principal payments of long-term debt are $500 million for long-term debt maturing in 2025.

The estimated fair value of the company's long-term borrowings, was determined using Level 2 inputs within the fair value hierarchy, as described in Note 2 - Summary of Significant Accounting Policies. Based on quoted market prices for the same or similar issues, or on current rates offered to the company for debt of the same remaining maturities, the fair value of the company's long-term borrowings, not including long-term debt due within one year, was $1,120 million and $1,166 million at December 31, 2021 and 2020, respectively.

Debt Offering
In May 2020, EID issued $500 million of 1.70 percent Senior Notes due 2025 and $500 million of 2.30 percent Senior Notes due 2030 (the May 2020 Debt Offering). The proceeds of this offering are intended to be used for general corporate purposes.

Available Committed Credit Facilities
The following table summarizes the company's credit facilities:
Committed and Available Credit Facilities at December 31, 2021
(In millions)Effective DateCommitted CreditCredit AvailableMaturity DateInterest
Revolving Credit FacilityMay 2019$3,000 $3,000 May 2024Floating Rate
Revolving Credit FacilityMay 20193,000 3,000 May 2023Floating Rate
Total Committed and Available Credit Facilities$6,000 $6,000 


F-42

Corteva, Inc.
Notes to the Consolidated Financial Statements (continued)
Revolving Credit Facilities
In November 2018, EID entered into a $3.0 billion, 5 year revolving credit facility and a $3.0 billion, 3-year revolving credit facility (the "Revolving Credit Facilities”). The Revolving Credit Facilities became effective May 2019. Corteva, Inc. became a party at the time of the Corteva Distribution. In May 2021, the company entered into an amendment that extended the maturity date of the 3-year revolving credit facility from May 2022 to May 2023. Other than the change in maturity date, there were no material modifications to the terms of the credit facility. The Revolving Credit Facilities may serve as a substitute to the company's commercial paper program, and can be used from time to time, for general corporate purposes including, but not limited to, the funding of seasonal working capital needs. The Revolving Credit Facilities contain customary representations and warranties, affirmative and negative covenants and events of default that are typical for companies with similar credit ratings. Additionally, the Revolving Credit Facilities contain a financial covenant requiring that the ratio of total indebtedness to total capitalization for Corteva and its consolidated subsidiaries not exceed 0.60.

In March 2020, the company drew down $500 million under the $3.0 billion 3-year revolving credit facility as a result of the volatility and increased borrowing costs of commercial paper resulting from the unstable market conditions caused by the COVID-19 pandemic and repaid that borrowing in full in June 2020. There were no additional borrowings and the unused commitments under the 3-year revolving credit facility were $3.0 billion as of December 31, 2021.

Debt Redemptions/Repayments
On March 22, 2019, EID issued notices of redemption in full of all of its outstanding notes (the “Make Whole Notes”) listed in the table below:
(in millions)Amount
4.625% Notes due 2020$474 
3.625% Notes due 2021296 
4.250% Notes due 2021163 
2.800% Notes due 2023381 
6.500% Debentures due 202857 
5.600% Senior Notes due 203642 
4.900% Notes due 204148 
4.150% Notes due 204369 
Total$1,530 

The Make Whole Notes were redeemed on April 22, 2019 at the make-whole redemption prices set forth in the respective Make Whole Notes. On and after the date of redemption, the Make Whole Notes were no longer deemed outstanding, interest on the Make Whole Notes ceased to accrue and all rights of the holders of the Make Whole Notes were terminated.

In March 2016, EID entered into a credit agreement that provided for a 3-year, senior unsecured term loan facility in the aggregate principal amount of $4.5 billion (as amended, from time to time, the "Term Loan Facility") under which EID could make up to seven term loan borrowings and amounts repaid or prepaid were not available for subsequent borrowings. On May 2, 2019, EID terminated its Term Loan Facility and repaid the aggregate outstanding principal amount of $3 billion plus accrued and unpaid interest through and including May 1, 2019.

In connection with the repayment of the Make Whole Notes and the Term Loan Facility, EID paid a total of $4.6 billion in the second quarter 2019, which included breakage fees and accrued and unpaid interest on the Make Whole Notes and Term Loan Facility. The repayment of the Make Whole Notes and Term Loan Facility was funded with cash from operations and a contribution from DowDuPont.

On May 7, 2019, DowDuPont publicly announced the record date in connection with the Corteva Distribution. In connection with such announcement, EID was required to redeem $1.25 billion aggregate principal amount of 2.20% Notes due 2020 and $750 million aggregate principal amount of Floating Rate Notes due 2020 (collectively, the Special Mandatory Redemption, or “SMR Notes”) setting forth the date of redemption of the SMR Notes. On May 17, 2019 EID redeemed and paid a total of $2 billion, which included accrued and unpaid interest on the SMR Notes. EID funded the payment with a contribution from DowDuPont. Following the redemption, the SMR Notes are no longer outstanding and no longer bear interest, and all rights of the holders of the SMR Notes have terminated.

F-43

Corteva, Inc.
Notes to the Consolidated Financial Statements (continued)
EID recorded a loss on the early extinguishment of debt of $13 million for the year ended December 31, 2019, related to the difference between the redemption price and the par value of the Make Whole Notes, the Term Loan Facility, and the SMR Notes, partially offset by the write-off of unamortized step-up related to the fair value step-up of EID’s debt.

Uncommitted Credit Facilities and Outstanding Letters of Credit
Unused bank credit lines on uncommitted credit facilities were $389 million at December 31, 2021. These lines are available to support short-term liquidity needs and general corporate purposes, including letters of credit. Outstanding letters of credit were $127 million at December 31, 2021. These letters of credit support commitments made in the ordinary course of business.

NOTE 18 - COMMITMENTS AND CONTINGENT LIABILITIES

Guarantees
Indemnifications
In connection with acquisitions and divestitures, the company has indemnified respective parties against certain liabilities that may arise in connection with these transactions and business activities prior to the completion of the transactions. The term of these indemnifications, which typically pertain to environmental, tax and product liabilities, is generally indefinite. In addition, the company indemnifies its duly elected or appointed directors and officers to the fullest extent permitted by Delaware law, against liabilities incurred as a result of their activities for the company, such as adverse judgments relating to litigation matters. If the indemnified party were to incur a liability or have a liability increase as a result of a successful claim, pursuant to the terms of the indemnification, the company would be required to reimburse the indemnified party. The maximum amount of potential future payments is generally unlimited. See below for additional information relating to the indemnification obligations under the Corteva Separation Agreement and the Chemours Separation Agreement.

Obligations for Customers and Other Third Parties
The company has directly guaranteed various debt obligations under agreements with third parties related to customers and other third parties. At December 31, 2021 and December 31, 2020, the company had directly guaranteed $105 million and $94 million, respectively, of such obligations. These amounts represent the maximum potential amount of future (undiscounted) payments that the company could be required to make under the guarantees in the event of default by the guaranteed party. All of the maximum future payments at December 31, 2021, had terms less than one year. The maximum future payments include $21 million and $17 million of guarantees related to the various factoring agreements that the company enters into with third-party financial institutions to sell its trade receivables at December 31, 2021 and December 31, 2020, respectively. See Note 12 - Accounts and Notes Receivable - Net, to the Consolidated Financial Statements, for additional information.

The maximum future payments also include agreements with lenders to establish programs that provide financing for select customers. The terms of the guarantees are equivalent to the terms of the customer loans that are primarily made to finance customer invoices. The total amounts owed from customers to the lenders relating to these agreements was $15 million and $16 million at December 31, 2021 and December 31, 2020, respectively.

The company assesses the payment/performance risk by assigning default rates based on the duration of the guarantees. These default rates are assigned based on the external credit rating of the counterparty or through internal credit analysis and historical default history for counterparties that do not have published credit ratings. For counterparties without an external rating or available credit history, a cumulative average default rate is used.

Indemnifications under Separation Agreements
The company has entered into various agreements where the company is indemnified for certain liabilities. In connection with the recognition of liabilities related to these matters, the company records an indemnification asset when recovery is deemed probable. See Note 5 - Divestitures and Other Transactions, to the Consolidated Financial Statements, for additional information related to indemnifications between Corteva, DuPont and Dow.

Chemours/Performance Chemicals
Pursuant to the Chemours Separation Agreement resulting from the 2015 spin-off of the Performance Chemicals segment from Historical DuPont, Chemours indemnifies the company against certain litigation, environmental, workers' compensation and other liabilities that arose prior to the distribution. The term of this indemnification is generally indefinite and includes defense costs and expenses, as well as monetary and non-monetary settlements and judgments. In connection with the recognition of liabilities related to these matters, the company records an indemnification asset when recovery is deemed probable.

In 2017, the Chemours Separation Agreement was amended to provide for a limited sharing of potential future liabilities related to alleged historical releases of perfluorooctanoic acids and its ammonium salts (“PFOA”) for a five-year period that began on
F-44

Corteva, Inc.
Notes to the Consolidated Financial Statements (continued)
July 6, 2017. In addition, in 2017, Chemours and EID settled multi-district litigation in the U.S. District Court for the Southern District of Ohio (“Ohio MDL”), resolving claims of about 3,550 plaintiffs alleging injury from exposure to PFOA in drinking water as a result of the historical manufacture or use of PFOA at the Washington Works plant outside Parkersburg, West Virginia. This plant was previously owned and/or operated by the performance chemicals segment of EID and is now owned and/or operated by Chemours.

On May 13, 2019, Chemours filed suit in the Delaware Court of Chancery against DuPont, EID, and Corteva, seeking, among other things, to limit its responsibility for the litigation and environmental liabilities allocated to and assumed by Chemours under the Chemours Separation Agreement (the “Delaware Litigation”). On March 30, 2020, the Court of Chancery granted a motion to dismiss. On December 15, 2020, the Delaware Supreme Court affirmed the judgment of the Court of Chancery. Meanwhile, a confidential arbitration process regarding the same and other claims has proceeded (the “Pending Arbitration”).

On January 22, 2021, Chemours, DuPont, Corteva and EID entered into a binding memorandum of understanding containing a settlement to resolve legal disputes originating from the Delaware Litigation and Pending Arbitration, and to establish a cost sharing arrangement and escrow account to be used to support and manage potential future legacy per- and polyfluoroalkyl substances (“PFAS”) liabilities arising out of pre-July 1, 2015 conduct (the “MOU”). The MOU replaces the 2017 amendment to the Chemours Separation Agreement. According to the terms of the cost sharing arrangement within the MOU, Corteva and DuPont together, on one hand, and Chemours, on the other hand, agreed to a 50-50 split of certain qualified expenses related to PFAS liabilities incurred over a term not to exceed twenty years or $4 billion of qualified spend and escrow account contributions (see below for discussion of escrow account) in the aggregate. DuPont’s and Corteva’s 50% share under the MOU will be limited to $2 billion, including qualified expenses and escrow contributions. These expenses and escrow account contributions will be subject to the existing Letter Agreement, under which DuPont and Corteva will each bear 50% of the first $300 million (up to $150 million each), and thereafter DuPont bears 71% and Corteva bears the remaining 29%.

In order to support and manage any potential future PFAS liabilities, the parties have also agreed to establish an escrow account ("MOU Escrow Account"). The MOU provides that (1) no later than each of September 30, 2021 and September 30, 2022, Chemours shall deposit $100 million into an escrow account and DuPont and Corteva shall together deposit $100 million in the aggregate into an escrow account and (2) no later than September 30 of each subsequent year through and including 2028, Chemours shall deposit $50 million into an escrow account and DuPont and Corteva shall together deposit $50 million in the aggregate into an escrow account. Subject to the terms and conditions set forth in the MOU, each party may be permitted to defer funding in any year (excluding 2021). Over this period, Chemours will deposit a total of $500 million in the account and DuPont and Corteva will deposit an additional $500 million pursuant to the terms of the Letter Agreement. Additionally, if on December 31, 2028, the balance of the escrow account (including interest) is less than $700 million, Chemours will make 50% of the deposits and DuPont and Corteva together will make 50% of the deposits necessary to restore the balance of the escrow account to $700 million. Such payments will be made in a series of consecutive annual equal installments commencing on September 30, 2029 pursuant to the escrow account replenishment terms as set forth in the MOU. The MOU provides that no withdrawals from the MOU Escrow Account can be made before year six, except to fund mutually agreed upon third-party settlements in excess of $125 million. Starting with year six, withdrawals can only be made to fund qualified spend if the parties’ aggregate qualified spend in that particular year is greater than $200 million. Beginning with year 11, the amounts in the MOU Escrow Account can be used to fund any qualified spend.

During 2021, the company contributed its initial deposit into the MOU Escrow Account, which is classified as noncurrent restricted cash equivalents and is included in other assets in the interim Consolidated Balance Sheets.

After the term of this arrangement, Chemours’ indemnification obligations under the original 2015 Chemours Separation Agreement, would continue unchanged, subject in each case to certain exceptions set out in the MOU. Under the MOU, Chemours waived specified claims regarding the construct of its 2015 spin-off transaction, and the parties will dismiss the Pending Arbitration regarding those claims. Additionally, the parties have agreed to resolve the Ohio MDL PFOA personal injury litigation (as discussed below). The parties are expected to cooperate in good faith to enter into additional agreements reflecting the terms set forth in the MOU.

During the years ended December 31, 2021 and 2020, the company recorded charges of $48 million and $65 million to (loss) income from discontinued operations after income taxes in the Consolidated Statement of Operations, related to the MOU. The charges recorded for the year ended December 31, 2021 primarily relate to an increase in the environmental remediation accrual for Chemours' Fayetteville Works facility for estimated costs for on-site surface water and groundwater remediation to address and abate PFAS discharges arising out of pre-July 1, 2015 conduct. The increase is the result of further detailed engineering and design work related to Chemours’ environmental remediation activities at the site under the Consent Order between Chemours and the North Carolina Department of Environmental Quality. The charges recorded for the year ended December 31, 2020
F-45

Corteva, Inc.
Notes to the Consolidated Financial Statements (continued)
primarily related to the execution of the MOU and the settlement of the Ohio MDL PFOA personal injury litigation (as discussed below).

Corteva Separation Agreement
On April 1, 2019, in connection with the Dow Distribution, Corteva, DuPont and Dow entered into the Corteva Separation Agreement, the Tax Matters Agreement, the Employee Matters Agreement, and certain other agreements (collectively, the “Corteva Separation Agreements”). The Corteva Separation Agreements allocate among Corteva, DuPont and Dow certain liabilities and obligations among the parties and provides for indemnification obligation among the parties. Under the Corteva Separation Agreements, DuPont will indemnify Corteva against certain litigation, environmental, workers' compensation and other liabilities that arose prior to the Corteva Distribution and (ii) Dow indemnifies Corteva against certain litigation and other liabilities that relate to the Historical Dow business, but were transferred over as part of the common control combination with DAS, and Corteva indemnifies DuPont and Dow for certain liabilities. The term of this indemnification is generally indefinite with exceptions, and includes defense costs and expenses, as well as monetary and non-monetary settlements and judgments. See Note 1 - Background and Basis of Presentation, and Note 5 - Divestitures and Other Transactions, to the Consolidated Financial Statements, for additional information relating to the Separation.

Under the Corteva Separation Agreement, certain legacy EID liabilities from discontinued and/or divested operations and businesses of EID (including Performance Chemicals) (a “stray liability”) were allocated to Corteva or DuPont. For those stray liabilities allocated to Corteva (which may include a specified amount of liability associated with that liability), Corteva is responsible for liabilities in an amount up to that specified amount plus an additional $200 million and, for those stray liabilities allocated to DuPont (which may include a specified amount of liability associated with that liability), DuPont is responsible for liabilities up to a specified amount plus an additional $200 million. Once each company has met the $200 million threshold, Corteva and DuPont will share future liabilities proportionally on the basis of 29% and 71%, respectively; provided, however, that for PFAS, DuPont will manage such liabilities with Corteva and DuPont sharing the costs on a 50% - 50% basis starting from $1 and up to $300 million (with such amount, up to $150 million, to be credited to each company’s $200 million threshold) and once the $300 million threshold is met, then the companies will share proportionally on the basis of 29% and 71% respectively, subject to a $1 million de minimis requirement. During the second quarter of 2021, the aggregate amount of the Company’s cash spent and liabilities accrued exceeded the stray liability thresholds, including PFAS, noted above. Therefore, liabilities recognized subsequent to the second quarter of 2021 will be shared at the reduced rates noted above.

Litigation
The company is subject to various legal proceedings, including, but not limited to, product liability, intellectual property, antitrust, commercial, property damage, personal injury, environmental and regulatory matters arising out of the normal course of its current businesses or legacy EID businesses unrelated to Corteva’s current businesses but allocated to Corteva as part of the separation of Corteva from DuPont. It is not possible to predict the outcome of these various proceedings, as considerable uncertainty exists. The company records accruals for legal matters when the information available indicates that it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. Accruals may reflect the impact and status of negotiations, settlements, rulings, advice from counsel and other information and events that may pertain to a particular matter. For the litigation matters discussed below, management believes that it is reasonably possible that the company could incur liabilities in excess of amounts accrued, the ultimate liability for which could be material to the results of operations and the cash flows in the period recognized. However, the company is unable to estimate the possible loss beyond amounts accrued due to various reasons, including, among others, that the underlying matters are either in early stages and/or have significant factual issues to be resolved. In addition, even when the company believes it has substantial defenses, the company may consider settlement of matters if it believes it is in the best interest of the company.

Chlorpyrifos Lawsuits
As of December 31, 2021, there were pending personal injury lawsuits filed and additional asserted claims against the former Dow Agrosciences LLC, alleging injuries related to chlorpyrifos exposure, the active ingredient in Lorsban®, an insecticide used by commercial farms for field fruit, nut and vegetable crops. Corteva ended its production of Lorsban® in 2020. Chlorpyrifos products are restricted-use pesticides, which are not available for purchase or use by the general public, and may only be sold to, and used by, certified applicators or someone under the certified applicator's direct supervision. These lawsuits do not relate to Dursban®, a residential type chlorpyrifos product that was authorized for indoor purposes, which was discontinued over two decades ago prior to the Merger and Corteva’s formation and Separation. Claimants allege personal injury, including autism, developmental delays and/or decreased neurologic function, resulting from farm worker exposure and bystander drift and in utero exposure to chlorpyrifos. Certain claimants have also put forth remediation claims due to alleged property contamination from chlorpyrifos. Discovery is expected to continue through 2022.


F-46

Corteva, Inc.
Notes to the Consolidated Financial Statements (continued)
Litigation related to legacy EID businesses unrelated to Corteva’s current businesses

PFAS, PFOA, PFOS and Other Related Liabilities
For purposes of this report, the term PFOA means collectively perfluorooctanoic acid and its salts, including the ammonium salt and does not distinguish between the two forms, and PFAS, including PFOA, PFOS (perfluorooctanesulfonic acid), GenX and other perfluorinated chemicals and compounds ("PFCs").

EID is a party to various legal proceedings relating to the use of PFOA by its former Performance Chemicals segment for which potential liabilities would be subject to the cost sharing arrangement under the MOU as long as it remains effective.

Leach Settlement and Ohio MDL Settlement
EID has residual liabilities under its 2004 settlement of a West Virginia state court class action, Leach v. EID, which alleged that PFOA from EID’s former Washington Works facility had contaminated area drinking water supplies and affected the health of area residents. The settlement class has about 80,000 members. In addition to relief that was provided to class members years ago, the settlement requires EID to continue providing PFOA water treatment to six area water districts and private well users and to fund, through an escrow account, up to $235 million for a medical monitoring program for eligible class members. As of December 31, 2021, approximately $2 million had been disbursed from the account since its establishment in 2012 and the remaining balance is approximately $1 million.

The Leach settlement permits class members to pursue personal injury claims for six health conditions (and no others) that an expert panel appointed under the settlement reported in 2012 had a “probable link” (as defined in the settlement) with PFOA: pregnancy-induced hypertension, including preeclampsia; kidney cancer; testicular cancer; thyroid disease; ulcerative colitis; and diagnosed high cholesterol. After the panel reported its findings, approximately 3,550 personal injury lawsuits were filed in federal and state courts in Ohio and West Virginia and consolidated in multi-district litigation in the U.S. District Court for the Southern District of Ohio (“Ohio MDL”). Ohio MDL was settled in early 2017 for $670.7 million in cash, with Chemours and EID (without indemnification from Chemours) each paying half.

Post-MDL Settlement PFOA Personal Injury Claims
The 2017 Ohio MDL settlement did not resolve claims of plaintiffs who did not have claims in the Ohio MDL or whose claims are based on diseases first diagnosed after February 11, 2017. The first was a consolidated trial of two cases; the first, a kidney cancer case, which resulted in a hung jury, while the second, Travis and Julie Abbot v. E.I du Pont de Nemours and Company (the “Abbot Case”), a testicular cancer case, resulted in a jury verdict of $40 million in compensatory damages and $10 million for loss of consortium. The loss of consortium award was subsequently reduced to $250,000 in accordance with state law limitations. Following entry of the judgment by the court, EID filed post-trial motions to reduce the verdict, and to appeal the verdict on the basis of procedural and substantive legal errors made by the trial court. The company believes the merits of the appeal will be successful in reducing the jury verdict or eliminating its liability, in whole or part.

In January 2021, Chemours, DuPont and Corteva agreed to settle the remaining approximately 95 matters, as well as unfiled matters, remaining in the Ohio MDL, with the exception of the Abbot case, for $83 million, with Chemours contributing $29 million to the settlement, and DuPont and Corteva contributing $27 million each. The company recorded a liability for its share of the settlement, with a charge to (loss) income from discontinued operations after income taxes in the Consolidated Statement of Operations, during the year ended December 31, 2020, and paid $27 million during the year ended December 31, 2021. As agreed to in the settlement, the plaintiffs' counsel filed a motion to dissolve the MDL.

Other PFOA Matters
EID is a party to other PFOA lawsuits that do not involve claims for personal injury. Defense costs and any future liabilities that may arise out of these lawsuits are subject to the MOU and the cost sharing arrangement disclosed above. Under the MOU, fraudulent conveyance claims associated with these matters are not qualified expenses, unless Corteva, Inc. and EID would prevail on the merits of these claims.

New York. EID is a defendant in about 50 lawsuits, including a putative class action, brought by persons who live in and around Hoosick Falls, New York. These lawsuits assert claims for medical monitoring and property damage based on alleged PFOA releases from manufacturing facilities owned and operated by co-defendants in Hoosick Falls and allege that EID and 3M supplied some of the materials used at these facilities. EID is also one of more than ten defendants in a lawsuit brought by the Town of East Hampton, New York alleging PFOA and PFOS contamination of the town’s well water. Additionally, EID, along with 3M, Chemours and Dyneon, have been named defendants in complaints filed by eleven water districts in Nassau County, New York alleging that the drinking water they provide to
F-47

Corteva, Inc.
Notes to the Consolidated Financial Statements (continued)
customers is contaminated with PFAS and seeking reimbursement for clean-up costs. The water district complaints also include allegations of fraudulent transfer.

New Jersey. At December 31, 2021, two lawsuits were pending, one brought by a local water utility and the second a putative class action, against EID alleging that PFOA from EID’s former Chambers Works facility contaminated drinking water sources. The putative class action was voluntarily dismissed without prejudice by the plaintiff.

In late March of 2019, the New Jersey State Attorney General filed four lawsuits against EID, Chemours, 3M and others alleging that operations at and discharges from former EID sites in New Jersey (Chambers Works, Pompton Lakes, Parlin and Repauno) damaged the State’s natural resources. Two of these lawsuits (those involving the Chambers Works and Parlin sites) allege contamination from PFAS. The Ridgewood Water District in New Jersey filed suit in the first quarter 2019 against EID, 3M, Chemours, and Dyneon alleging losses related to the investigation, remediation and monitoring of polyfluorinated surfactants, including PFOA, in water supplies. DuPont and Corteva were subsequently added as defendants to these lawsuits. These lawsuits include claims under the New Jersey Industrial Site Recovery Act (“ISRA”) and for fraudulent conveyance.

Alabama / Others. EID is one of more than thirty defendants in a lawsuit by the Alabama water utility alleging contamination from PFCs, including PFOA, used by co-defendant carpet manufacturers to make their products more stain and grease resistant. In addition, the states of Michigan, Mississippi, New Hampshire, South Dakota, and Vermont recently filed lawsuits against EID, Chemours, 3M and others, claiming, among other things, PFC (including PFOA) contamination of groundwater and drinking water. The complaints seek reimbursement for past and future costs to investigate and remediate the alleged contamination and compensation for the loss of value and use of the state’s natural resources. Motions to dismiss the Michigan, Vermont and New Hampshire cases have been denied.

Ohio. EID is a defendant in three lawsuits: an action by the State of Ohio based on alleged damage to natural resources, a putative nationwide class action brought on behalf of anyone who has detectable levels of PFAS in their blood serum, and an action by the City of Dayton claiming losses related to the investigation, remediation and monitoring of PFAS in water supplies. The trial with respect to the natural resources lawsuit is scheduled for April 2023.

Netherlands. In April 2021, four municipalities in the Netherlands filed complaints alleging contamination of land and groundwater resulting from the emission of PFOA and GenX by Corteva, DuPont and Chemours. The municipalities seek to recover costs incurred due to the alleged emissions, including damages for investigation costs, construction project delays, depreciation of land, soil remediation, liabilities to contractors, and attorneys’ fees.

Delaware. On July 13, 2021, Chemours, DuPont, EID and Corteva entered into a settlement agreement with the State of Delaware reflecting the companies' and the State's agreement to settle and fully resolve claims alleged against the companies regarding their historical Delaware operations, manufacturing, use and disposal of all chemical compounds, including PFAS. Under the settlement, the companies will collectively pay $50 million to fund environmental projects, including sampling and community environmental justice and equity grants, which shall be utilized to fund the Natural Resources and Sustainability Trust (the “NRST Trust”). If the companies, individually or jointly, within 8 years of the settlement, enter into a proportionally similar agreement to settle or resolve claims of another state for PFAS-related natural resource damages, for an amount greater than $50 million, the companies shall make a supplemental payment directly to the NRST Trust (“Supplemental Payment”) in an amount equal to such other states’ recovery in excess of $50 million. Supplemental Payment(s), if any, will not exceed $25 million in the aggregate. All amounts paid by the companies under the settlement are subject to the MOU and the Corteva Separation Agreement with Chemours bearing responsibility for 50%, or $25 million, of the $50 million payment due to the NRST and DuPont and Corteva each bearing $12.5 million of the remaining amount, which Corteva paid in January 2022. As of December 31, 2021, an accrual has been established in relation to this settlement and during the year ended December 31, 2021, the company recorded a charge of $11 million to (loss) income from discontinued operations after income taxes in the Consolidated Statement of Operations. Under the settlement, if the state sues other parties and those parties seek contribution from the companies, the companies will have protection from contribution up to the amounts previously paid under the settlement agreement. The companies will also receive a credit up to the amount of the payment if the state seeks natural resource damage claims against the companies outside the scope of the settlement’s release of claims.

Aqueous Firefighting Foams. Approximately 2,050 cases have been filed against 3M and other defendants, including EID and Chemours, and more recently also including Corteva and DuPont, alleging PFOS or PFOA contamination of soil and groundwater from the use of aqueous firefighting foams. Most of those cases claim some form of property damage and seek to recover the costs of responding to this contamination and damages for the loss of use and
F-48

Corteva, Inc.
Notes to the Consolidated Financial Statements (continued)
enjoyment of property and diminution in value. Most of these cases have been transferred to a multidistrict litigation proceeding in federal district court in South Carolina. Approximately 1,860 of these cases were filed on behalf of firefighters who allege personal injuries (primarily kidney and testicular cancer) as a result of aqueous firefighting foams. Approximately 140 of these cases were filed by water utility or municipal water districts. Most of these recent cases assert claims that the EID and Chemours separation constituted a fraudulent conveyance. Discovery for these cases is expected to continue through 2022, with a water district “bellwether” trial expected for early 2023.

EID did not make firefighting foams, PFOS, or PFOS products. While EID made surfactants and intermediaries that some manufacturers used in making foams, which may have contained PFOA as an unintended byproduct or an impurity, EID’s products were not formulated with PFOA, nor was PFOA an ingredient of these products. EID has never made or sold PFOA as a commercial product.

Fayetteville Works Facility, North Carolina
Prior to the separation of Chemours, EID introduced GenX as a polymerization processing aid and a replacement for PFOA at the Fayetteville Works facility in Bladen County, North Carolina. The facility is now owned and operated by Chemours, which continues to manufacture and use GenX.

At December 31, 2021, several actions are pending in federal court against Chemours and EID relating to PFC discharges from the Fayetteville Works facility. One of these is a consolidated putative class action that asserts claims for medical monitoring and property damage on behalf of putative classes of property owners and residents in areas near or who draw drinking water from the Cape Fear River. Another action is a consolidated action brought by various North Carolina water authorities, including the Cape Fear Public Utility Authority and Brunswick County, that seek actual and punitive damages as well as injunctive relief. In another action over approximately 100 property owners near the Fayetteville Works facility filed a complaint against Chemours and EID in May 2020. The plaintiffs seek compensatory and punitive damages for their claims of private nuisance, trespass, and negligence allegedly caused by release of PFAS.

In addition to the federal court actions, there is an action on behalf of about 100 plaintiffs who own wells and property near the Fayetteville Works facility. The plaintiffs seek damages for nuisance allegedly caused by releases of certain PFCs from the site.

Generally, site-related expenses related GenX claims are subject to the cost sharing arrangements as defined in the MOU.


F-49

Corteva, Inc.
Notes to the Consolidated Financial Statements (continued)
Environmental
Accruals for environmental matters are recorded when it is probable that a liability has been incurred and the amount of the liability can be reasonably estimated based on current law and existing technologies. These obligations are included in accrued and other current liabilities and other noncurrent obligations in the Consolidated Balance Sheet. It is reasonably possible that environmental remediation and restoration costs in excess of amounts accrued could have a material impact on the company’s results of operations, financial condition and cash flows. Inherent uncertainties exist in these estimates primarily due to unknown conditions, changing governmental regulations and legal standards regarding liability, and emerging remediation
technologies for handling site remediation and restoration.
For a discussion of the allocation of environmental liabilities under the Chemours Separation Agreement and the Corteva Separation Agreement, see the previous discussion on page F-46.

As of December 31, 2021
(In millions)Indemnification Asset
Accrual balance3
Potential exposure above amount accrued3
Environmental Remediation Stray Liabilities
Chemours related obligations - subject to indemnity1,2
$159 $159 $262 
Other discontinued or divested businesses obligations1
15 75 187 
Environmental remediation liabilities primarily related to DuPont - subject to indemnity from DuPont2
37 37 66 
Environmental remediation liabilities not subject to indemnity— 82 49 
Indemnification liabilities related to the MOU4
9 99 28 
Total$220 $452 $592 
1.Represents liabilities that are subject the $200 million threshold and sharing arrangements as discussed on page F-46, under Corteva Separation Agreement.
2.The company has recorded an indemnification asset related to these accruals, including $40 million related to the Superfund sites.
3.Accrual balance represents management’s best estimate of the costs of remediation and restoration, although it is reasonably possible that the potential exposure, as indicated, could range above the amounts accrued, as there are inherent uncertainties in these estimates. Accrual balance includes $68 million for remediation of Superfund sites. Amounts do not include possible impacts from the remediation elements of the EPAs October 2021 PFAS Strategic Roadmap (as applicable) or possible revisions to Chemours’ Consent Order with the North Carolina Department of Environmental Quality, as any possible impacts, to the extent such items would be reimbursable under the MOU, are not yet determinable.
4.Represents liabilities that are subject to the $150 million threshold and sharing agreements as discussed on page F-44, under the header "Chemours / Performance Chemicals.

Chambers Works, New Jersey
On January 28, 2022, the State of New Jersey filed a request for a preliminary injunction against EID and Chemours seeking the establishment of a Remediation Funding Source (“RFS”) in an amount exceeding $900 million for environmental remediation at EID’s former Chambers Work facility in New Jersey. The RFS primarily relates to non-PFAS remediation, which is not subject to the MOU. Chemours has accepted indemnity and defense for these matters, while reserving rights and declining EID’s demand relating to the ISRA and fraudulent transfer matters as alleged under the existing New Jersey natural resource lawsuits discussed on page F-48.
F-50

Corteva, Inc.
Notes to the Consolidated Financial Statements (continued)

NOTE 19 - STOCKHOLDERS' EQUITY

Common Stock
As discussed in Note 1 - Background and Basis of Presentation, on June 1, 2019, Corteva, Inc.'s common stock was distributed to DowDuPont stockholders by way of a pro rata distribution. Each DowDuPont stockholder received one share of Corteva, Inc. common stock for every three shares of DowDuPont common stock held at the close of business on May 24, 2019, the record date of distribution. Corteva, Inc.'s common stock began trading the "regular way" under the ticker symbol "CTVA" on June 3, 2019, the first business day after June 1, 2019. The number of Corteva, Inc. common shares issued on June 1, 2019 was 748,815,000 (par value of $0.01 per share). Information related to the Corteva Distribution and its effect on the company's financial statements are discussed throughout these Notes to the Consolidated Financial Statements.

Set forth below is a reconciliation of common stock share activity for the years ended December 31, 2021, 2020, and 2019:
Shares of common stockIssued
Balance June 1, 2019748,815,000 
Issued586,000 
Repurchased and retired(824,000)
Balance December 31, 2019748,577,000 
Issued3,384,000 
Repurchased and retired(8,503,000)
Balance December 31, 2020743,458,000 
Issued4,019,000 
Repurchased and retired(20,950,000)
Balance December 31, 2021726,527,000 

Share Buyback Plan
On August 5, 2021, Corteva, Inc. announced that its Board of Directors authorized a $1.5 billion share repurchase program to purchase Corteva, Inc.'s common stock, par value $0.01 per share, without an expiration date ("2021 Share Buyback Plan"). The timing, price and volume of purchases will be based on market conditions, relevant securities laws and other factors. In connection with the 2021 Share Buyback Plan, the company purchased and retired 5,572,000 shares during the year ended December 31, 2021 in the open market for a total cost of $250 million.

On June 26, 2019, Corteva, Inc. announced that its Board of Directors authorized a $1 billion share repurchase program to purchase Corteva, Inc.'s common stock, par value $0.01 per share, without an expiration date ("2019 Share Buyback Plan").

In connection with the 2019 Share Buyback Plan, the company repurchased and retired 15,378,000 shares, 8,503,000 shares, and 824,000 shares in the open market for a total cost of $700 million, $275 million, and $25 million during the years ended December 31, 2021, 2020, and 2019, respectively. Repurchases under the 2019 Share Buyback Plan were completed during the third quarter of 2021.

Shares repurchased pursuant to Corteva's share buyback plan are immediately retired upon repurchase. Repurchased common stock is reflected as a reduction of stockholders' equity. The company's accounting policy related to its share repurchases is to reduce its common stock based on the par value of the shares and to reduce its retained earnings for the excess of the repurchase price over the par value. When Corteva has an accumulated deficit balance, the excess over the par value is applied to APIC. When Corteva has retained earnings, the excess is charged entirely to retained earnings.

Noncontrolling Interest
In June 2020, the company completed the acquisition of the remaining 46.5 percent interest in the Phytogen Seed Company, LLC joint venture from J. G. Boswell Company. As the purchase of the remaining interest did not result in a change of control, the difference between the carrying value of the noncontrolling interest and the consideration paid, net of taxes was recorded within equity.

Corteva, Inc. owns 100 percent of the outstanding common shares of EID. However, EID has preferred stock outstanding to third parties which is accounted for as a noncontrolling interest in Corteva's Consolidated Balance Sheets. Each share of EID
F-51

Corteva, Inc.
Notes to the Consolidated Financial Statements (continued)
Preferred Stock - $4.50 Series and EID Preferred Stock - $3.50 Series issued and outstanding at the effective date of the Corteva Distribution remains issued and outstanding as to EID and was unaffected by the Corteva Distribution.

Below is a summary of the EID Preferred Stock at December 31, 2021 and December 31, 2020 which is classified as noncontrolling interests in the Corteva Consolidated Balance Sheets.

(Shares in thousands)Number of Shares
Authorized23,000
$4.50 Series, callable at $1201,673
$3.50 Series, callable at $102700

Other Comprehensive Income (Loss)
The changes and after-tax balances of components comprising accumulated other comprehensive income (loss) are summarized below:
(In millions)
Cumulative Translation Adjustment1
Derivative InstrumentsPension Benefit PlansOther Benefit PlansUnrealized Gain (Loss) on InvestmentsTotal
2019
Balance January 1, 2019$(2,793)$(26)$(620)$79 $ $(3,360)
Other comprehensive income (loss) before reclassifications(274)16 (723)(159) (1,140)
Amounts reclassified from accumulated other comprehensive income (loss) 12 5 (1) 16 
Net other comprehensive income (loss) (274)28 (718)(160) (1,124)
Impact of Internal Reorganizations
1,123  91   1,214 
Balance December 31, 2019$(1,944)$2 $(1,247)$(81)$ $(3,270)
2020
Other comprehensive income (loss) before reclassifications$(26)$(81)$(191)$670 $(10)$362 
Amounts reclassified from accumulated other comprehensive income (loss) 12 5 1  18 
Net other comprehensive income (loss) (26)(69)(186)671 (10)380 
Balance December 31, 2020$(1,970)$(67)$(1,433)$590 $(10)$(2,890)
2021
Other comprehensive income (loss) before reclassifications$(573)$143 $996 $25 $3 $594 
Amounts reclassified from accumulated other comprehensive income (loss) (4)41 (646)7 (602)
Net other comprehensive income (loss)(573)139 1,037 (621)10 (8)
Balance December 31, 2021$(2,543)$72 $(396)$(31)$ $(2,898)
1.The cumulative translation adjustment losses for the year ended December 31, 2021 was primarily driven by the strengthening of the U.S. Dollar ("USD") against the European Euro ("EUR"), Swiss franc ("CHF") and Turkish Lira (“TRY”). The cumulative translation adjustment losses for the year ended December 31, 2020 was primarily driven by the strengthening of the U.S. Dollar ("USD") against the Brazilian Real ("BRL"), partially offset by the weakening of the U.S. Dollar against the Swiss franc ("CHF") and European Euro ("EUR").

The tax (expense) benefit on the net activity related to each component of other comprehensive income (loss) was as follows:
For the Year Ended December 31,
(In millions)202120202019
Derivative instruments$(41)$24 $(8)
Pension benefit plans - net(319)54 231 
Other benefit plans - net188 (211)52 
(Provision for) benefit from income taxes related to other comprehensive income (loss) items$(172)$(133)$275 
F-52

Corteva, Inc.
Notes to the Consolidated Financial Statements (continued)

A summary of the reclassifications out of accumulated other comprehensive loss is provided as follows:
(In millions)For the Year Ended December 31,
202120202019
Derivative Instruments1:
$(13)$18 $13 
Tax (benefit) expense2
9 (6)(1)
After-tax$(4)$12 $12 
Amortization of pension benefit plans:
  Prior service (benefit) cost3,4
$(2)$(1)$(1)
  Actuarial (gains) losses3,4,5
55 4 2 
  Settlement (gain) loss3,4,5
1 3 4 
Total before tax54 6 5 
Tax (benefit) expense2
(13)(1) 
After-tax$41 $5 $5 
Amortization of other benefit plans:
  Prior service (benefit) cost3,4
$(922)$ $ 
  Actuarial (gains) losses3,4
81 1 (1)
  Curtailment (gain) loss(1)— — 
Total before tax(842)1 (1)
Tax (benefit) expense2
196   
After-tax$(646)$1 $(1)
Unrealized (Gain) Loss on Investments4
$7 $ $ 
Tax (benefit) expense2
   
After-tax
$$— $— 
Total reclassifications for the period, after-tax$(602)$18 $16 
1.Reflected in cost of goods sold in the Consolidated Statements of Operations.
2.Reflected in provision for (benefit from) income taxes from continuing operations in the Consolidated Statements of Operations.
3.These accumulated other comprehensive (loss) income components are included in the computation of net periodic benefit (credit) cost of the company's pension and other benefit plans. See Note 20 - Pension Plans and Other Post Employment Benefits, to the Consolidated Financial Statements, for additional information.
4.Reflected in other income - net in the Consolidated Statements of Operations.
5.A portion reflected in (loss) income from discontinued operations after income taxes for the year ended December 31, 2019.
F-53

Corteva, Inc.
Notes to the Consolidated Financial Statements (continued)
NOTE 20 - PENSION PLANS AND OTHER POST EMPLOYMENT BENEFITS

The company offers various long-term benefits to its employees. Where permitted by applicable law, the company reserves the right to change, modify or discontinue the plans.

Defined Benefit Pension Plans
The company has both funded and unfunded noncontributory defined benefit pension plans covering a majority of the U.S. employees and employees in a number of other countries. The principal U.S. pension plan is the largest pension plan held by Corteva. Effective January 1, 2007, a majority of new hires are not eligible to participate in the U.S. defined benefit pension plans. The company froze the pay and service amounts used to calculate the pension benefits for active employees who participate in these plans on November 30, 2018, resulting in the participants no longer accruing additional benefits.

The company's funding policy is consistent with the funding requirements of federal laws and regulations. Pension coverage for employees of the company's non-U.S. consolidated subsidiaries is provided, to the extent deemed appropriate, through separate plans. Obligations under such plans are funded by depositing funds with trustees, covered by insurance contracts, or remain unfunded.

The company made total contributions of $49 million, $62 million, and $121 million to its pension plans other than the principal U.S. pension plan for the years ended December 31, 2021, 2020 and 2019, respectively. Corteva expects to contribute approximately $60 million to its pension plans other than the principal U.S. pension plan in 2022. The company does not anticipate making contributions to its principal U.S pension plan in 2022.

The weighted-average assumptions used to determine pension plan obligations for all pension plans are summarized in the table below:
Weighted-Average Assumptions used to Determine Benefit ObligationsDecember 31, 2021December 31, 2020
Discount rate
2.82 %2.44 %
Rate of increase in future compensation levels1
2.55 %2.54 %
1.The rate of compensation increase excludes U.S. pension plans since the employees who participate in the U.S. pension plans no longer accrue additional benefits for future service and eligible compensation.

The weighted-average assumptions used to determine net periodic benefit costs for all pension plans are summarized in the table below:
Weighted-Average Assumptions used to Determine Net Periodic Benefit CostFor the Year Ended December 31,
202120202019
Discount rate
2.44 %3.19 %4.19 %
Rate of increase in future compensation levels1
2.54 %2.60 %2.84 %
Expected long-term rate of return on plan assets
5.73 %6.25 %6.24 %
1.The rate of compensation increase excludes U.S. pension plans since the employees who participate in the U.S. pension plans no longer accrue additional benefits for future service and eligible compensation.

Other Post Employment Benefits
The company has historically provided medical, dental and life insurance benefits to certain pensioners and survivors. The majority of U.S. employees hired on or after January 1, 2007, and eligible employees under the age of 50 as of November 30, 2018, are not eligible to participate in the post-employment medical, dental and life insurance plans. Substantially all of the cost and liabilities for these retiree benefit plans are attributable to the U.S. benefit plans. The non-Medicare eligible retiree medical plan is contributory with costs shared between the company and pensioners and survivors. For Medicare eligible pensioners and survivors, Corteva provides a company-funded Health Reimbursement Arrangement ("HRA"). In December 2020, the company amended its retiree medical, dental and life insurance plans resulting in the company no longer providing retiree dental and life insurance benefits effective January 1, 2022 and Corteva’s portion of the cost of non-Medicare retiree medical coverage no longer being adjusted for cost increases, which capped the Corteva cost at the level in effect as of December 31, 2021 ("2020 OPEB Plan Amendments"). As a result of these changes, the company recorded a $(939) million decrease in OPEB benefit obligations as of December 31, 2020 with a corresponding prior service benefit within other comprehensive income for the year ended December 31, 2020. During 2021, a substantial amount of the prior service benefit within other comprehensive income (loss) in 2020 was recognized in other income - net in the Consolidated Statement of Operations.

F-54

Corteva, Inc.
Notes to the Consolidated Financial Statements (continued)
The company also provides disability benefits to employees. Employee disability benefit plans are insured in many countries. However, primarily in the U.S., such plans are generally self-insured. Obligations and expenses for self-insured plans are reflected in the change in projected benefit obligations table on page F-56.

The company's OPEB plans are unfunded and the cost of the approved claims is paid from operating cash flows. Pre-tax cash requirements to cover actual net claims costs and related administrative expenses were $198 million, $207 million, and $202 million for the years ended December 31, 2021, 2020 and 2019, respectively. Changes in cash requirements reflect the net impact of per capita health care costs, demographic changes, plan amendments and changes in participant premiums, co-pays and deductibles. In 2022, the company expects to contribute approximately $140 million for its OPEB plans.

The weighted-average assumptions used to determine benefit obligations for OPEB plans are summarized in the table below:
Weighted-Average Assumptions used to Determine Benefit ObligationsDecember 31, 2021December 31, 2020
Discount rate
2.59 %2.09 %

The weighted-average assumptions used to determine net periodic benefit costs for the OPEB plans are summarized in the two tables below:
Weighted-Average Assumptions used to Determine Net Periodic Benefit CostFor the Year Ended December 31,
202120202019
Discount rate
2.09 %3.07 %3.93 %

As of December 31, 2021, health care cost trend rates do not impact the benefit obligations for the OPEB plans because of the 2020 OPEB Plan Amendments. For the year ended December 31, 2020 and 2019, the health care cost trend rate was assumed to be 7.0 percent and 7.2 percent for next year, respectively.

Assumptions
Within the U.S., the company determines the expected long-term rate of return on plan assets by performing a detailed analysis of key economic and market factors driving historical returns for each asset class and formulating a projected return based on factors in the current environment. Factors considered include, but are not limited to, inflation, real economic growth, interest rate yield, interest rate spreads, and other valuation measures and market metrics. The expected long-term rate of return for each asset class is then weighted based on the strategic asset allocation approved by the governing body for the plan. The company's historical experience with the pension fund asset performance is also considered. For non-U.S. plans, assumptions reflect economic assumptions applicable to each country.

In the U.S., Corteva calculates service costs and interest costs by applying individual spot rates from a yield curve (based on high-quality corporate bond yields) to the separate expected cash flows components of service cost and interest cost. Service cost and interest cost for all other plans are determined on the basis of the single equivalent discount rates derived in determining those plan obligations.

The discount rates utilized to measure the pension and other post employment benefit obligations are based on the yield on high-quality corporate fixed income investments at the measurement date. Future expected actuarially determined cash flows are individually discounted at the spot rates under the Aon AA_Above Median yield curve (based on high-quality corporate bond yields) to arrive at the plan’s obligations as of the measurement date. For non-U.S. benefit plans, historically the company utilized prevailing long-term high quality corporate bond indices to determine the discount rate, applicable to each country, at the measurement date.

The company adopts the most recently published mortality tables and mortality improvement scale released by the Society of Actuaries in measuring its U.S. pension and other post employment benefit obligations. The effect of these adoptions is amortized into net periodic benefit cost for the years following the adoption.
F-55

Corteva, Inc.
Notes to the Consolidated Financial Statements (continued)


Summarized information on the company's pension and other post employment benefit plans is as follows:
Change in Projected Benefit Obligations, Plan Assets and Funded Status
Defined Benefit Pension PlansOther Post Employment Benefits
(In millions)For the Year Ended December 31, 2021For the Year Ended December 31, 2020For the Year Ended December 31, 2021For the Year Ended December 31, 2020
Change in benefit obligations:
Benefit obligation at beginning of the period$21,682 $21,004 $1,571 $2,591 
Service cost25 26 1 2 
Interest cost364 559 21 66 
Plan participants' contributions3 2 35 34 
Actuarial (gain) loss(524)1,659 (33)59 
Benefits paid(1,490)(1,538)(233)(241)
Plan amendments(15)(3) (939)
Other1
(240)   
Effect of foreign exchange rates(30)(27) (1)
Benefit obligations at end of the period$19,775 $21,682 $1,362 $1,571 
Change in plan assets:
Fair value of plan assets at beginning of the period$17,835 $16,941 $ $ 
Actual return on plan assets1,685 2,404   
Employer contributions49 62 198 207 
Plan participants' contributions3 2 35 34 
Benefits paid(1,490)(1,538)(233)(241)
Other1
(240)   
Effect of foreign exchange rates(15)(36)  
Fair value of plan assets at end of the period$17,827 $17,835 $ $ 
Funded status    
U.S. plan with plan assets$(1,471)$(3,301)$ $ 
Non-U.S. plans with plan assets(62)(98)  
All other plans 2,3
(415)(448)(1,362)(1,571)
Funded status at end of the period$(1,948)$(3,847)$(1,362)$(1,571)
1.Relates to the transfer of certain benefit obligations and related assets associated with the principal U.S. pension plan to an insurance company through the purchase of nonparticipating group annuity contracts.
2.As of December 31, 2021 and December 31, 2020, $219 million and $249 million, respectively, of the benefit obligations are supported by funding under the Trust agreement, defined in the "Trust Assets" section below.
3.Includes pension plans maintained around the world where funding is not customary.

F-56

Corteva, Inc.
Notes to the Consolidated Financial Statements (continued)
Defined Benefit Pension PlansOther Post Employment Benefits
(In millions)December 31, 2021December 31, 2020December 31, 2021December 31, 2020
Amounts recognized in the Consolidated Balance Sheets:
Other Assets$4 $7 $ $ 
Accrued and other current liabilities(46)(32)(144)(217)
Pension and other post employment benefits - noncurrent (1,906)(3,822)(1,218)(1,354)
Net amount recognized$(1,948)$(3,847)$(1,362)$(1,571)
Pretax amounts recognized in accumulated other comprehensive income (loss):
Net gain (loss)$(543)$(1,886)$(50)$(163)
Prior service benefit (cost)27 14 17 939 
Pretax balance in accumulated other comprehensive income (loss) at end of year$(516)$(1,872)$(33)$776

The gain related to the change in pension and OPEB plan benefit obligations for the period ended December 31, 2021 is mainly due to an increase in discount rates.

The accumulated benefit obligation for all pensions plans was $19.7 billion and $21.6 billion at December 31, 2021 and 2020, respectively.

Pension Plans with Projected Benefit Obligations in Excess of Plan AssetsDecember 31, 2021December 31, 2020
(In millions)
Projected benefit obligations$19,519 $21,513 
Fair value of plan assets17,567 17,659 

Pension Plans with Accumulated Benefit Obligations in Excess of Plan AssetsDecember 31, 2021December 31, 2020
(In millions)
Accumulated benefit obligations$19,501 $21,369 
Fair value of plan assets17,567 17,550 


F-57

Corteva, Inc.
Notes to the Consolidated Financial Statements (continued)
(In millions)Defined Benefit Pension PlansOther Post Employment Benefits
For the Year Ended December 31,For the Year Ended December 31,
Components of net periodic benefit (credit) cost and amounts recognized in other comprehensive income (loss)202120202019202120202019
Net Periodic Benefit (Credit) Cost:
Service cost$25 $26 $41 $1 $2 $4 
Interest cost364 559 769 21 66 84 
Expected return on plan assets(915)(1,000)(1,078)   
Amortization of unrecognized loss (gain)55 4 3 81 1 (1)
Amortization of prior service (benefit) cost(2)(1)(1)(922)  
Curtailment loss (gain)   (2)(1)  
Settlement loss1 3 4    
Net periodic benefit (credit) cost - Total$(472)$(409)$(264)$(820)$69 $87 
Less: Discontinued operations1
  (14)   
Net periodic benefit (credit) cost - continuing operations$(472)$(409)$(250)$(820)$69 $87 
Changes in plan assets and benefit obligations recognized in other comprehensive income (loss):
Net gain (loss)$1,284 $(247)$(970)$33 $(59)$(211)
Amortization of unrecognized (gain) loss55 4 2 81 1 (1)
Prior service benefit (cost)15 3 11  939  
Amortization of prior service (benefit) cost(2)(1)(1)(922)  
Curtailment (gain) loss— — — (1)  
Settlement loss1 3 4    
Effect of foreign exchange rates3 (2)5  1  
Total benefit (loss) recognized in other comprehensive income (loss), attributable to Corteva$1,356 $(240)$(949)$(809)$882 $(212)
Total recognized in net periodic benefit (credit) cost and other comprehensive income (loss)$1,828 $169 $(685)$11 $813 $(299)
1.Includes non-service related components of net periodic benefit credit of $(31) million for the year ended December 31, 2019.

Estimated Future Benefit Payments
The estimated future benefit payments, reflecting expected future service, as appropriate, are presented in the following table:
Estimated Future Benefit Payments at December 31, 2021Defined Benefit Pension PlansOther Post Employment Benefits
(In millions)
2022$1,459 $144 
20231,409 134 
20241,378 126 
20251,341 118 
20261,305 112 
Years 2027-20315,913 399 
Total$12,805 $1,033 

F-58

Corteva, Inc.
Notes to the Consolidated Financial Statements (continued)
Plan Assets
All pension plan assets in the U.S. are invested through a single master trust fund. The strategic asset allocation for this trust fund is approved by the Pension Investment Committee. The general principles guiding U.S. pension asset investment policies are those embodied in the Employee Retirement Income Security Act of 1974 ("ERISA"). These principles include discharging Corteva's investment responsibilities for the exclusive benefit of plan participants and in accordance with the "prudent expert" standard and other ERISA rules and regulations. Corteva establishes strategic asset allocation percentage targets and appropriate benchmarks for significant asset classes with the aim of achieving a prudent balance between return and risk. Strategic asset allocations in other countries are selected in accordance with the laws and practices of those countries. Where appropriate, asset liability studies are utilized in this process. U.S. plan assets are managed by investment professionals employed by Corteva. The remaining assets are managed by professional investment firms unrelated to the company. Corteva's pension investment professionals have discretion to manage the assets within established asset allocation ranges approved by the Pension Investment Committee. Additionally, pension trust funds are permitted to enter into certain contractual arrangements generally described as "derivatives." Derivatives are primarily used to reduce specific market risks, hedge currency and adjust portfolio duration and asset allocation in a cost-effective manner.

The weighted-average target allocation for plan assets of the company's pension plans is summarized as follows:
Target Allocation for Plan AssetsDecember 31, 2021December 31, 2020
Asset Category
U.S. equity securities11 %20 %
Non-U.S. equity securities11 16 
Fixed income securities58 51 
Hedge funds2 2 
Private market securities8 6 
Real estate5 4 
Cash and cash equivalents5 1 
Total 100 %100 %

U.S. equity investments are primarily large-cap companies. Global equity securities include varying market capitalization levels. Global fixed income investments include corporate-issued, government-issued and asset-backed securities. Corporate debt investments include a range of credit risk and industry diversification. U.S. fixed income investments are weighted heavier than non-U.S. fixed income securities. Other investments include cash and cash equivalents, hedge funds, real estate and private market securities such as interests in private equity and venture capital partnerships.

Fair value calculations may not be indicative of net realizable value or reflective of future fair values. Furthermore, although the company believes its valuation methods are appropriate and consistent with other market participants, the use of different methodologies or assumptions to determine the fair value of certain financial instruments could result in a different fair value measurement at the reporting date.

For pension plan assets classified as Level 1 measurements (measured using quoted prices in active markets), total fair value is either the price of the most recent trade at the time of the market close or the official close price, as defined by the exchange on which the asset is most actively traded on the last trading day of the period, multiplied by the number of units held without consideration of transaction costs.

For pension plan assets classified as Level 2 measurements, where the security is frequently traded in less active markets, fair value is based on the closing price at the end of the period; where the security is less frequently traded, fair value is based on the price a dealer would pay for the security or similar securities, adjusted for any terms specific to that asset or liability. Market inputs are obtained from well-established and recognized vendors of market data and subjected to tolerance and quality checks. For derivative assets and liabilities, standard industry models are used to calculate the fair value of the various financial instruments based on significant observable market inputs, such as foreign exchange rates, commodity prices, swap rates, interest rates and implied volatilities obtained from various market sources.

F-59

Corteva, Inc.
Notes to the Consolidated Financial Statements (continued)
For pension plan assets classified as Level 3 measurements, total fair value is based on significant unobservable inputs including assumptions where there is little, if any, market activity for the investment. Investment managers, fund managers, or investment contract issuers provide valuations of the investment on a monthly or quarterly basis. These valuations are reviewed for reasonableness based on applicable sector, benchmark and company performance. Adjustments to valuations are made where appropriate. Where available, audited financial statements are obtained and reviewed for the investments as support for the manager’s investment valuation.

The tables below present the fair values of the company's pension assets by level within the fair value hierarchy, as described in Note 2 - Summary of Significant Accounting Policies:
Basis of Fair Value MeasurementsTotalLevel 1Level 2Level 3
For the year ended December 31, 2021
(In millions)
Cash and cash equivalents$2,543 $2,543 $ $ 
U.S. equity securities 1
2,400 2,394 2 4 
Non-U.S. equity securities1,523 1,523   
Debt – government-issued3,271  3,271  
Debt – corporate-issued4,591  4,589 2 
Debt – asset-backed682  682  
Private market securities3   3 
Real estate26   26 
Other78  3 75 
     Subtotal $15,117 $6,460 $8,547 $110 
Investments measured at net asset value
     Debt - government issued37 
     Debt - corporate issued7 
     U.S. equity securities33 
     Non-U.S. equity securities34 
     Hedge funds394 
     Private market securities1,822 
     Real estate funds759 
Total investments measured at net asset value$3,086 
Other items to reconcile to fair value of plan assets
     Pension trust receivables 2
655    
     Pension trust payables 3
(1,031)   
Total$17,827    
1.The Corteva pension plans directly held $201 million (approximately 1 percent of total plan assets) of Corteva, Inc. common stock at December 31, 2021.
2.Primarily receivables for investments securities sold.
3.Primarily payables for investment securities purchased.


F-60

Corteva, Inc.
Notes to the Consolidated Financial Statements (continued)
Basis of Fair Value Measurements
For the year ended December 31, 2020
(In millions)TotalLevel 1Level 2Level 3
Cash and cash equivalents$2,616 $2,616 $ $ 
U.S. equity securities1
3,905 3,898 2 5 
Non-U.S. equity securities2,194 2,189 2 3 
Debt – government-issued3,569  3,569  
Debt – corporate-issued2,579  2,576 3 
Debt – asset-backed616  616  
Private market securities3   3 
Real estate28   28 
Other76  3 73 
     Subtotal $15,586 $8,703 $6,768 $115 
Investments measured at net asset value
     Debt - government issued36 
     Debt - corporate issued7 
     U.S. equity securities32 
     Non-U.S. equity securities32 
     Hedge funds391 
     Private market securities1,381 
     Real estate funds590 
Total investments measured at net asset value$2,469 
Other items to reconcile to fair value of plan assets
     Pension trust receivables2
214 
     Pension trust payables3
(434)   
Total$17,835    
1.The Corteva pension plans directly held $165 million (approximately 1 percent of total plan assets) of Corteva, Inc. at December 31, 2020.
2.Primarily receivables for investments securities sold.
3.Primarily payables for investment securities purchased.



F-61

Corteva, Inc.
Notes to the Consolidated Financial Statements (continued)
The following table summarizes the changes in fair value of Level 3 pension plan assets for the years ended December 31, 2020 and 2019:
Fair Value Measurement of Level 3 Pension Plan AssetsU.S. equity securitiesNon-U.S. equity securitiesDebt – corporate-issuedPrivate market securitiesReal estateOtherTotal
(In millions)
Balance at January 1, 2020$9 $4 $4 $2 $33 $ $52 
Actual return on assets:
Relating to assets sold during the year ended December 31, 2020(25)(6)(7)   (38)
Relating to assets held at December 31, 202021 5 5 1 (5)7 34 
Purchases, sales and settlements, net     5 5 
Transfers in or out of Level 3, net  1   61 62 
Balance at December 31, 2020$5 $3 $3 $3 $28 $73 $115 
Actual return on assets:
Relating to assets sold during the year ended December 31, 20211 (1)(5)   (5)
Relating to assets held at December 31, 2021(3)(1)6  (2)(2)(2)
Purchases, sales and settlements, net1 (1)(2)  4 2 
Balance at December 31, 2021$4 $ $2 $3 $26 $75 $110 

Trust Assets
EID entered into a trust agreement in 2013 (as amended and restated in 2017) that established and requires EID to fund the Trust for cash obligations under certain non-qualified benefit and deferred compensation plans upon a change in control event as defined in the Trust agreement. Under the Trust agreement, the consummation of the Merger was a change in control event. As a result, in November 2017, EID contributed $571 million to the Trust. At the Separation, Corteva transferred $39 million to DuPont. During the years ended December 31, 2021 and 2020, $43 million and $65 million, respectively, was distributed to EID according to the Trust agreement, and at December 31, 2021 and 2020, the balance in the Trust was $304 million and $347 million, respectively. The Trust Assets are classified as current restricted cash equivalents and included within other current assets in the Consolidated Balance Sheets. See Note 9 - Supplementary Information, to the Consolidated Financial Statements, for further information.

Defined Contribution Plans
Corteva provides defined contribution benefits to its employees. The most significant is the U.S. Retirement Savings Plan ("the Plan"), which covers almost all of the U.S. full-service employees. This Plan includes a non-leveraged Employee Stock Ownership Plan ("ESOP"). Employees are not required to participate in the ESOP and those who do are free to diversify out of the ESOP. The purpose of the Plan is to provide retirement savings benefits for employees and to provide employees an opportunity to become stockholders of the company. The Plan is a tax qualified contributory profit sharing plan, with cash or deferred arrangement and any eligible employee of Corteva may participate. Currently, Corteva contributes 100 percent of the first 6 percent of the employee's contribution election and also contributes 3 percent of each eligible employee's eligible compensation regardless of the employee's contribution.

Corteva's contributions to the Plan were $63 million, $94 million, and $142 million for the years ended December 31, 2021, 2020 and 2019, respectively. Corteva's matching contributions vest immediately upon contribution. The 3 percent nonmatching company contribution vests after employees complete three years of service. In addition, Corteva made contributions to other defined contribution plans of $29 million, $33 million, and $46 million for the years ended December 31, 2021, 2020 and 2019, respectively. Included in Corteva's contributions are amounts related to discontinued operations of $73 million for the year ended December 31, 2019.
F-62

Corteva, Inc.
Notes to the Consolidated Financial Statements (continued)
NOTE 21 - STOCK-BASED COMPENSATION

Prior to the Corteva Distribution, Corteva employees held equity awards, including stock options, share appreciation rights (“SARs”), restricted stock units (“RSUs”) and performance-based restricted stock units (“PSUs”), which were denominated in DowDuPont common stock and, in some cases, in Dow Inc. common stock, and which had originally been issued under the DuPont Equity and Incentive Plan ("EIP"), the Dow Chemical Company 2012 Stock Incentive Plan or the Dow Chemical Company 1988 Award and Option Plan.

As discussed in Note 18 - Commitment and Contingent Liabilities, on April 1, 2019 the company entered into an employee matters agreement (the "EMA") with DuPont and Dow that identifies employees and employee-related liabilities (and attributable assets) to be allocated (either retained, transferred and accepted, or assigned and assumed, as applicable) to the Parties as part of the Distributions and describes when and how the relevant transfers and assignments will occur. With some exceptions, the EMA provides for the equitable adjustment of existing equity incentive compensation awards denominated in the common stock of DowDuPont to reflect the occurrence of the Distributions.

In connection with the Separation on June 1, 2019, outstanding DowDuPont-denominated stock options, SARs, RSU and PSU awards were converted into Corteva-denominated awards under the “Employer Method,” or into both DuPont-denominated awards and Corteva-denominated awards under the “Shareholder Method,” using a formula designed to preserve the intrinsic value of the awards immediately prior to and subsequent to the Corteva Separation. The awards have the same terms and conditions under the applicable plans and award agreements prior to the Separation transactions. The conversions of equity awards did not have a material impact to the company’s consolidated financial statements.

On June 1, 2019 (“Adoption Date”), in connection with the Separation, the Omnibus Incentive Plan (the "OIP") became effective. Under the OIP, the company may grant incentive awards, including stock options (both “incentive stock options” and nonqualified stock options), share appreciation rights, restricted shares, restricted stock units, other share-based awards and cash awards, to its and its subsidiaries’ eligible employees, non-employee directors, independent contractors and consultants following the Separation until the tenth anniversary of the Adoption Date, subject to an aggregate limit and annual individual limits. Under the OIP, the maximum number of shares reserved for the grant or settlement of awards is 20 million shares, excluding shares underlying certain exempt awards, such as the awards converted to Corteva-denominated awards pursuant to the Separation. At December 31, 2021, approximately 12 million shares were authorized for future grants under the OIP. The company generally satisfies stock option exercises and the vesting of RSUs and PSUs with newly issued shares of Corteva common stock, although RSU awards granted under Historical Dow plans in certain countries are settled in cash.

The compensation committee determines the long-term incentive mix, including stock options, RSUs and PSUs and may authorize new grants annually. The company estimates expected forfeitures.

The total stock-based compensation cost included in income (loss) from continuing operations before income taxes within the Consolidated Statement of Operations was $79 million, $73 million, and $84 million for the years ended December 31, 2021, 2020 and 2019, respectively. The income tax benefits related to stock-based compensation arrangements were $(15) million, $(15) million, and $(17) million for the years ended December 31, 2021, 2020 and 2019, respectively.

Stock Options

The exercise price of shares subject to option is equal to the market price of the company's stock on the date of grant. All options vest serially over a period of three years. Stock option awards granted under the OIP between June 2019 and 2020 expire 10 years after the grant date. Stock option awards granted under the EIP (previous plan) between 2014 and 2015 expire seven years after the grant date and options granted between 2016 and May 2019 expire 10 years after the grant date. Stock option awards granted under the Historical Dow plans subsequent to 2010 expire 10 years after the grant date.

To measure the fair value of the awards on the date of grant, the company used the Black-Scholes option pricing model and the assumptions set forth in the below table. Under the OIP, the weighted-average grant-date fair value of options granted for the years ended December 31, 2021 and 2020 was $11.77 and $6.06, respectively. Under the EIP, the weighted-average grant-date fair value of options granted for the years ended December 31, 2019 was $7.29.
F-63

Corteva, Inc.
Notes to the Consolidated Financial Statements (continued)
Weighted-Average AssumptionsOIPEIP
For the year ended December 31, 2021For the year ended December 31, 2020For the year ended December 31, 2019
Dividend yield1.14 %1.67 %1.55 %
Expected volatility29.44 %23.14 %19.80 %
Risk-free interest rate1.0 %1.3 %2.4 %
Expected life of stock options granted during period (years)6.06.06.1

Under the OIP, the company determined the dividend yield by dividing the annualized dividend on Corteva’ s Common Stock by the option exercise price. A historical daily measurement of volatility is determined based on the expected life of the option granted. For the years ended December 31, 2021 and 2020, the measurement of volatility is based on the average volatility of eight of Corteva's peer companies. Corteva's peer volatility is based on the historical volatility of each business respectively. The risk-free interest rate is determined by reference to the yield on an outstanding U.S. Treasury note with a term equal to the expected life of the option granted. Expected life is determined by utilizing the simplified method for estimating expected term as referenced under ASC 718 – Share based Payments.

Under the EIP, the company determined the dividend yield by dividing the annualized dividend on DowDuPont's Common Stock by the option exercise price.

A historical daily measurement of volatility is determined based on the expected life of the option granted. For the year ended December 31, 2019, the measurement of volatility is based on weighted average of the individual peer volatilities of DuPont and Corteva based on the size of each business respectively. DuPont and Corteva peer volatility are based on a 50/50 blend of historical volatility and implied volatility. Both volatility measures are based on the average of five peer companies for DuPont and eight peer companies for Corteva.

The risk-free interest rate is determined by reference to the yield on an outstanding U.S. Treasury note with a term equal to the expected life of the option granted. Expected life is determined by reference to the company's historical experience.

The following table summarizes stock option activity for year ended December 31, 2021 under the OIP:
Stock OptionsFor the Year Ended December 31, 2021
Number of Shares
(in thousands)
Weighted Average Exercise Price (per share)Weighted Average Remaining Contractual Term (in years)Aggregate Intrinsic Value
(in thousands)
Outstanding at January 1, 20218,998 $34.21 5.27$50,077 
Granted849 45.37 
Exercised(3,206)32.44 
Forfeited/Expired(218)33.39 
Outstanding at December 31, 20216,423 $36.65 5.69$68,219 
Exercisable at December 31, 20214,739 $36.15 4.76$52,726 

The aggregate intrinsic values in the table above represent the total pre-tax intrinsic value (the difference between the closing stock price on the last trading day of the December 31, 2021 and the exercise price, multiplied by the number of in-the-money options) that would have been received by the option holders had all option holders exercised their in-the-money options at period end. Under the OIP, the total intrinsic value of options exercised for the years ended December 31, 2021 and 2020 were $43 million, and $21 million, respectively. The company recognized tax benefits from options exercised for the years ended December 31, 2021 and 2020 of $(8) million and $(4) million, respectively.

Under the EIP, the total intrinsic value of options exercised for the year ended December 31, 2019 was $16 million. The company recognized tax benefits from options exercised for the year ended December 31, 2019 of $(3) million.

As of December 31, 2021, $4 million of total unrecognized pre-tax compensation expense related to nonvested stock options is expected to be recognized over a weighted-average period of about 1.20 years.


F-64

Corteva, Inc.
Notes to the Consolidated Financial Statements (continued)
Restricted Stock Units and Performance Share Units

RSUs granted under the EIP serially vest over 3 years. RSUs granted under the Historical Dow plans vest after a designated period, generally 1 year to 3 years. RSUs granted under the OIP serially vest over 3 years. Upon vesting, these RSUs convert one-for-one to Corteva Common Stock. A retirement-eligible employee retains any granted awards upon retirement provided the employee has rendered at least six months of service following the grant date. Additional RSUs are also granted periodically to key senior management employees. These RSUs generally vest over periods ranging from 3 years to 5 years. The fair value of all stock-settled RSUs is based upon the market price of the underlying common stock as of the grant date.

The company grants PSUs to senior leadership. In 2021, there were 343,632 PSUs granted. Vesting for PSUs granted in 2021 and 2020 is partially based on the realization of the Company’s improvement of its Return on Invested Capital (“ROIC”) and Operating Earnings Per Share (EPS) during the Performance Period. Vesting for PSUs granted in 2019 is partially based on the realization of the Company’s improvement of its Return on Invested Capital (“ROIC”) and Operating EBITDA during the Performance Period. Performance and payouts are determined independently for each metric. The actual award, delivered in Corteva Common Stock, can range from zero percent to 200 percent of the original grant. The weighted-average grant date fair value of the PSUs granted in 2021 of $45.37 was based upon the market price of the underlying common stock as of the grant date.

Nonvested awards of RSUs and PSUs are shown below.
RSUs & PSUsFor the Year Ended December 31, 2021
Number of Shares
(in thousands)
Weighted Average Grant Date Fair Value
(per share)
Nonvested at January 1, 20215,883 $31.54 
Granted1,536 $45.30 
Vested(1,583)$35.59 
Forfeited(234)$32.99 
Nonvested at December 31, 20215,602 $34.11 

The total fair value of stock units vested under the OIP for the years ended December 31, 2021 and 2020 was $56 million and $49 million, respectively. The weighted-average grant-date fair value of stock units granted under the OIP for the years ended December 31, 2021 and 2020 was $45.30 and $31.15, respectively.

The total fair value of stock units vested under the EIP during the years ended December 31, 2019 was $79 million. The weighted-average grant-date fair value of stock units granted under the EIP for the year ended December 31, 2019 was $52.19.

As of December 31, 2021, $45 million of total unrecognized pre-tax compensation expense related to RSUs and PSUs is expected to be recognized over a weighted average period of 1.13 years.

NOTE 22 - FINANCIAL INSTRUMENTS

At December 31, 2021 and 2020, the company had $3,400 million and $2,511 million, respectively, of held-to-maturity securities (primarily time deposits and money market funds) classified as cash equivalents, as these securities had maturities of three months or less at the time of purchase; and $86 million and $43 million at December 31, 2021 and 2020, respectively, of held-to-maturity securities (primarily time deposits) classified as marketable securities as these securities had maturities of more than three months to less than one year at the time of purchase. The company’s investments in held-to-maturity securities are held at amortized cost, which approximates fair value. Additionally, at December 31, 2020, the company had $226 million of available-for-sale securities (see below "Debt Securities" for further discussion). The above noted securities are included in cash and cash equivalents, marketable securities, and other current assets in the Consolidated Balance Sheets.

Derivative Instruments
Objectives and Strategies for Holding Derivative Instruments
In the ordinary course of business, the company enters into contractual arrangements (derivatives) to reduce its exposure to foreign currency and commodity price risks. The company has established a variety of derivative programs to be utilized for financial risk management. These programs reflect varying levels of exposure coverage and time horizons based on an assessment of risk.

F-65

Corteva, Inc.
Notes to the Consolidated Financial Statements (continued)
Derivative programs have procedures and controls and are approved by the Corporate Financial Risk Management Committee, consistent with the company's financial risk management policies and guidelines. Derivative instruments used are forwards, options, futures and swaps. The company has not designated any non-derivatives as hedging instruments.

The company's financial risk management procedures also address counterparty credit approval, limits and routine exposure monitoring and reporting. The counterparties to these contractual arrangements are major financial institutions and major commodity exchanges, and multinational grain exporters. The company is exposed to credit loss in the event of nonperformance by these counterparties. The company utilizes collateral support annex agreements with certain counterparties to limit its exposure to credit losses. The company anticipates performance by counterparties to these contracts and therefore no material loss is expected. Market and counterparty credit risks associated with these instruments are regularly reported to management.

The notional amounts of the company's derivative instruments were as follows:
Notional Amounts
(In millions)
December 31, 2021December 31, 2020
Derivatives designated as hedging instruments:
Foreign currency contracts$1,252 $1,164 
Commodity contracts
$845 $383 
Derivatives not designated as hedging instruments:
Foreign currency contracts
$103 $647 
Commodity contracts
$4 $ 

Foreign Currency Risk
The company's objective in managing exposure to foreign currency fluctuations is to reduce earnings and cash flow volatility associated with foreign currency rate changes and to mitigate the exposure of certain investments in foreign subsidiaries against
changes in the Euro/USD exchange rate. Accordingly, the company enters into various contracts that change in value as foreign exchange rates change to protect the value of its existing foreign currency-denominated assets, liabilities, commitments, investments and cash flows.

The company uses foreign exchange contracts to offset its net exposures, by currency, related to the foreign currency denominated monetary assets and liabilities of its operations. The primary business objective of this hedging program is to maintain an approximately balanced position in foreign currencies so that exchange gains and losses resulting from exchange rate changes, after related tax effects, are minimized. The company also uses foreign currency exchange contracts to offset a portion of the company's exposure to certain forecasted transactions as well as the translation of foreign currency-denominated earnings. The company also uses commodity contracts to offset risks associated with foreign currency devaluation in certain
countries.

Commodity Price Risk
Commodity price risk management programs serve to reduce exposure to price fluctuations on purchases of inventory such as corn and soybeans. The company enters into over-the-counter and exchange-traded derivative commodity instruments to hedge the commodity price risk associated with agricultural commodity exposures.

Derivatives Designated as Cash Flow Hedges
Commodity Contracts
The company enters into over-the-counter and exchange-traded derivative commodity instruments, including options, futures and swaps, to hedge the commodity price risk associated with agriculture commodity exposures.

While each risk management program has a different time maturity period, most programs currently do not extend beyond the next two years. Cash flow hedge results are reclassified into earnings during the same period in which the related exposure impacts earnings. Reclassifications are made sooner if it appears that a forecasted transaction is probable of not occurring.

F-66

Corteva, Inc.
Notes to the Consolidated Financial Statements (continued)
The following table summarizes the after-tax effect of commodity contract cash flow hedges on accumulated other comprehensive loss:
For the Year Ended December 31,
(In millions)202120202019
Beginning balance$(16)$2 $(26)
Additions and revaluations of derivatives designated as cash flow hedges92 (44)16 
Clearance of hedge results to earnings(29)26 12 
Ending balance$47 $(16)$2 

At December 31, 2021, an after-tax net gain of $36 million is expected to be reclassified from accumulated other comprehensive loss into earnings over the next twelve months.

Foreign Currency Contracts
The company enters into forward contracts to hedge the foreign currency risk associated with forecasted transactions within certain foreign subsidiaries.

While each risk management program has a different time maturity period, most programs currently do not extend beyond the next two years. Cash flow hedge results are reclassified into earnings during the same period in which the related exposure impacts earnings. Reclassifications are made sooner if it appears that a forecasted transaction is not probable of occurring.

The following table summarizes the after-tax effect of foreign currency cash flow hedges on accumulated other comprehensive
loss:
(In millions)For the Year Ended December 31, 2021For the Year Ended December 31, 2020
Beginning balance$(17)$ 
Additions and revaluations of derivatives designated as cash flow hedges24 (3)
Clearance of hedges results to earnings25 (14)
Ending balance$32 $(17)

At December 31, 2021, an after-tax net gain of $32 million is expected to be reclassified from accumulated other comprehensive loss into earnings over the next twelve months.

Derivatives Designated as Net Investment Hedges
Foreign Currency Contracts
The company has designated €450 million of forward contracts to exchange EUR as net investment hedges. The purpose of these forward contracts is to mitigate FX exposure related to a portion of the company’s Euro net investments in certain foreign subsidiaries against changes in Euro/USD exchange rates. These hedges will expire and be settled in 2023, unless terminated early at the discretion of the company.

The company elected to apply the spot method in testing for effectiveness of the hedging relationship.

Derivatives not Designated in Hedging Relationships
Foreign Currency Contracts
The company uses foreign exchange contracts to reduce its net exposure, by currency, related to foreign currency-denominated monetary assets and liabilities of its operations so that exchange gains and losses resulting from exchange rate changes are minimized. The netting of such exposures precludes the use of hedge accounting; however, the required revaluation of the forward contracts and the associated foreign currency-denominated monetary assets and liabilities intends to achieve a minimal earnings impact, after taxes. The company also uses foreign currency exchange contracts to offset a portion of the company’s exposure to the translation of certain foreign currency-denominated earnings so that gains and losses on the contracts offset changes in the USD value of the related foreign currency-denominated earnings over the relevant aggregate period.

Commodity Contracts
The company utilizes options, futures and swaps that are not designated as hedging instruments to reduce exposure to commodity price fluctuations on purchases of inventory such as corn and soybeans. The company uses forward agreements,
F-67

Corteva, Inc.
Notes to the Consolidated Financial Statements (continued)
with durations less than one year, to buy and sell USD priced commodities in order to reduce its exposure to currency devaluation for a portion of its local currency cash balances. Counterparties to the forward sales agreements are multinational grain exporters and subject to the company’s financial risk management procedures.

Fair Value of Derivative Instruments
Asset and liability derivatives subject to an enforceable master netting arrangement with the same counterparty are presented on a net basis in the Consolidated Balance Sheets. The presentation of the company's derivative assets and liabilities is as follows:
December 31, 2021
(In millions)Balance Sheet LocationGross
Counterparty and Cash Collateral Netting1
Net Amounts Included in the Consolidated Balance Sheet
Asset derivatives:   
Derivatives designated as hedging instruments:
Foreign currency contractsOther current assets$37 $ $37 
Derivatives not designated as hedging instruments:  
Foreign currency contracts
Other current assets31 (20)11 
Commodity contractsOther current assets3  3 
Total asset derivatives
 $71 $(20)$51 
Liability derivatives:  
Derivatives designated as hedging instruments:
Foreign currency contractsAccrued and other current liabilities$1 $ $1 
Derivatives not designated as hedging instruments:  
Foreign currency contracts
Accrued and other current liabilities23 $(20)3 
Commodity contractsAccrued and other current liabilities2  2 
Total liability derivatives
 $26 $(20)$6 

F-68

Corteva, Inc.
Notes to the Consolidated Financial Statements (continued)
December 31, 2020
(In millions)Balance Sheet LocationGross
Counterparty and Cash Collateral Netting1
Net Amounts Included in the Consolidated Balance Sheet
Asset derivatives:   
Derivatives designated as hedging instruments:
Foreign currency contractsOther current assets$15 $ $15 
Derivatives not designated as hedging instruments:  
Foreign currency contracts
Other current assets40 (40) 
Total asset derivatives
 $55 $(40)$15 
Liability derivatives:  
Derivatives designated as hedging instruments:
Foreign currency contractsAccrued and other current liabilities$38 $ $38 
Derivatives not designated as hedging instruments:  
Foreign currency contracts
Accrued and other current liabilities97 (40)57 
Total liability derivatives
 $135 $(40)$95 
1.    Counterparty and cash collateral amounts represent the estimated net settlement amount when applying netting and set-off rights included in master netting arrangements between the company and its counterparties and the payable or receivable for cash collateral held or placed with the same counterparty.

Effect of Derivative Instruments
Amount of Gain (Loss) Recognized in OCI1 - Pre-Tax
For the Year Ended December 31,
(In millions)202120202019
Derivatives designated as hedging instruments:
Net investment hedges:
Foreign currency contracts$37 $(45)$ 
Cash flow hedges:
Foreign currency contracts27 (4) 
Commodity contracts129 (62)23 
Total derivatives designated as hedging instruments$193 $(111)$23 
1.OCI is defined as other comprehensive income (loss).

F-69

Corteva, Inc.
Notes to the Consolidated Financial Statements (continued)
(in millions)
Amount of (Loss) Gain Recognized in Income - Pre-Tax1
For the Year Ended December 31,
202120202019
Derivatives designated as hedging instruments:
Cash flow hedges:
Foreign currency contracts2
$(29)$17 $ 
Commodity contracts2
42 (35)(13)
Total derivatives designated as hedging instruments
13 (18)(13)
Derivatives not designated as hedging instruments:
Foreign currency contracts3
18 89 (58)
Foreign currency contracts2
(14)14  
Commodity contracts2
(18)9 9 
Total derivatives not designated as hedging instruments
(14)112 (49)
Total derivatives$(1)$94 $(62)
1.For cash flow hedges, this represents the portion of the gain (loss) reclassified from accumulated OCI into income during the period.
2.Recorded in cost of goods sold.
3.Gain recognized in other income - net was partially offset by the related gain on the foreign currency-denominated monetary assets and liabilities of the company's operations. See Note 9 - Supplementary Information, to the Consolidated Financial Statements for additional information.

Debt Securities
The estimated fair value of the available-for-sale securities as of December 31, 2020 was determined using Level 1 inputs within the fair value hierarchy. Level 1 measurements were based on quoted market prices in active markets for identical assets and liabilities. The available-for-sale securities at of December 31, 2020 are held by certain foreign subsidiaries in which the USD is not the functional currency. The fluctuations in foreign exchange are recorded in accumulated other comprehensive loss within the Consolidated Statements of Equity. These fluctuations are subsequently reclassified from accumulated other comprehensive income (loss) to earnings in the period in which the marketable securities are sold and the gains and losses on these securities offset a portion of the foreign exchange fluctuations in earnings for the company.

The following table provides the investing results from available-for-sale securities for the year ended December 31,2021:
Investing ResultsFor the Year Ended December 31,
(In millions)2021
Proceeds from sales of available-for-sale securities$226 
Gross realized losses$(7)

F-70

Corteva, Inc.
Notes to the Consolidated Financial Statements (continued)

NOTE 23 - FAIR VALUE MEASUREMENTS

The following tables summarize the basis used to measure certain assets and liabilities at fair value on a recurring basis:
December 31, 2021Significant Other Observable Inputs
(In millions)Level 1Level 2
Assets at fair value:
Marketable securities
$— $86 
Derivatives relating to:1
Foreign currency
— 68 
Equity securities2
48 — 
Total assets at fair value$48 $154 
Liabilities at fair value:
Derivatives relating to:1
Foreign currency
— 24 
Total liabilities at fair value$ $24 

December 31, 2020Significant Other Observable Inputs
(In millions)Level 1Level 2
Assets at fair value:
Marketable securities
$— $43 
Debt securities:
U.S. treasuries3
226 — 
Derivatives relating to:1
Foreign currency
— 55 
Total assets at fair value$226 $98 
Liabilities at fair value:
Derivatives relating to:1
Foreign currency
$— $135 
Total liabilities at fair value$ $135 
1.See Note 22 - Financial Instruments, to the Consolidated Financial Statements, for the classification of derivatives in the Consolidated Balance Sheets.
2.    The company's equity securities are included in "other assets" in the Consolidated Balance Sheets.
3.    The company's investments in U.S. treasuries, which are primarily available-for-sale, are included in "marketable securities" in the Consolidated Balance Sheets.

For assets and liabilities classified as Level 1 measurements (measured using quoted prices in active markets), total fair value is either the price of the most recent trade at the time of the market close or the official close price, as defined by the exchange on which the asset is most actively traded on the last trading day of the period, multiplied by the number of units held without consideration of transaction costs.

For assets and liabilities classified as Level 2 measurements, where the security is frequently traded in less active markets, fair value is based on the closing price at the end of the period; where the security is less frequently traded, fair value is based on the price a dealer would pay for the security or similar securities, adjusted for any terms specific to that asset or liability, or by using observable market data points of similar, more liquid securities to imply the price. For time deposits classified as held-to-maturity investments and reported at amortized cost, fair value is based on an observable interest rate for similar securities. Market inputs are obtained from well-established and recognized vendors of market data and subjected to tolerance and quality checks.

F-71

Corteva, Inc.
Notes to the Consolidated Financial Statements (continued)
For derivative assets and liabilities, standard industry models are used to calculate the fair value of the various financial instruments based on significant observable market inputs, such as foreign exchange rates, commodity prices, swap rates and implied volatilities obtained from various market sources. Market inputs are obtained from well-established and recognized vendors of market data and subjected to tolerance/quality checks.

For all other assets and liabilities for which observable inputs are used, fair value is derived through the use of fair value models, such as a discounted cash flow model or other standard pricing models. See Note 22 - Financial Instruments, to the Consolidated Financial Statements, for further information on the types of instruments used by the company for risk management.

There were no transfers between Levels 1 and 2 during the years ended December 31, 2021 and 2020.

For assets classified as Level 3 measurements, the fair value is based on significant unobservable inputs including assumptions where there is little, if any, market activity. The fair value of the company’s interests held in trade receivable conduits is determined by calculating the expected amount of cash to be received using the key input of anticipated credit losses in the portfolio of receivables sold that have not yet been collected. Given the short-term nature of the underlying receivables, discount rate and prepayments are not factors in determining the fair value of the interests.

Fair Value Measurements on a Nonrecurring Basis
The following table summarizes the basis used to measure certain assets at fair value on a nonrecurring basis:
Basis of Fair Value Measurements on a Nonrecurring BasisSignificant Other Unobservable Inputs
(Level 3)
Total Losses
(In millions)
2019
Assets at fair value:
Developed technology
$ $(1)
Other intangible assets
$ $(6)
IPR&D
$ $(137)

During the third and fourth quarter of 2019, the company recorded impairment charges to developed technology, other intangible assets, and IPR&D. See Note 7 - Restructuring and Asset Related Charges - Net, and Note 15 - Goodwill and Other Intangible Assets, to the Consolidated Financial Statements, for further discussion of these fair value measurements.


F-72

Corteva, Inc.
Notes to the Consolidated Financial Statements (continued)

NOTE 24 - GEOGRAPHIC INFORMATION

Sales are attributed to geographic areas based on customer location; long-lived assets are attributed to geographic areas based on asset location.
 Net Sales
For the Year Ended December 31,
(In millions)202120202019
United States$6,782 $6,510 $6,255 
Canada754 658 674 
EMEA3,123 2,842 2,740 
Latin America1
3,545 2,805 2,889 
Asia Pacific1,451 1,402 1,288 
Total$15,655 $14,217 $13,846 
1.Net sales for Brazil for the years ended December 31, 2021, 2020 and 2019 were $2,315 million, $1,724 million and $1,794 million, respectively.

 Net Property
(In millions)202120202019
United States$3,051 $3,014 $3,069 
Canada114 122 125 
EMEA566 601 566 
Latin America468 510 608 
Asia Pacific130 149 178 
Total$4,329 $4,396 $4,546 

F-73

Corteva, Inc.
Notes to the Consolidated Financial Statements (continued)
NOTE 25 - SEGMENT INFORMATION
Corteva’s reportable segments reflects the manner in which its chief operating decision maker ("CODM") allocates resources and assesses performance, which is at the operating segment level (seed and crop protection). For purposes of allocating resources to the segments and assessing segment performance, segment operating EBITDA is the primary measure used by Corteva’s CODM. The company defines segment operating EBITDA as earnings (loss) (i.e., income (loss) from continuing operations before income taxes) before interest, depreciation, amortization, corporate expenses, non-operating (benefits) costs, foreign exchange gains (losses), and net unrealized gain or loss from mark-to-market activity for certain foreign currency derivative instruments that do not qualify for hedge accounting, excluding the impact of significant items. Effective January 1, 2021, on a prospective basis, the company excludes from segment operating EBITDA net unrealized gain or loss from mark-to- market activity for certain foreign currency derivative instruments that do not qualify for hedge accounting. Non-operating (benefits) costs consists of non-operating pension and other post-employment benefit (OPEB) costs, tax indemnification adjustments, environmental remediation and legal costs associated with legacy EID businesses and sites, and the 2021 officer indemnification payment. Tax indemnification adjustments relate to changes in indemnification balances, as a result of the application of the terms of the Tax Matters Agreement, between Corteva and Dow and/or DuPont that are recorded by the company as pre-tax income or expense. Net unrealized gain or loss from mark-to-market activity for certain foreign currency derivative instruments that do not qualify for hedge accounting represents the non-cash net gain (loss) from changes in fair value of certain undesignated foreign currency derivative contracts. Upon settlement, which is within the same calendar year of execution of the contract, the realized gain (loss) from the changes in fair value of the non-qualified foreign currency derivative contracts will be reported in the respective segment results to reflect the economic effects of the foreign currency derivative contracts without the resulting unrealized mark to fair value volatility. For the year ended December 31, 2019, segment operating EBITDA is calculated on a pro forma basis, as this is the manner in which the CODM assesses performance and allocates resources or expense.

Pro forma adjustments used in the calculation of pro forma segment operating EBITDA for the year ended December 31, 2019 were determined in accordance with Article 11 of Regulation S-X that was in effect prior to recent amendments. These adjustments give effect to the Merger, the debt retirement transactions related to paying off or retiring portions of EID’s existing debt liabilities (as discussed in Note 17 - Long-Term Debt and Available Credit Facilities, to the Consolidated Financial Statements), and the separation and distribution to DowDuPont stockholders of all the outstanding shares of Corteva common stock as if they had been consummated on January 1, 2016.

Corporate Profile
The company conducts its global operations through the following reportable segments:

Seed
The company’s seed segment is a global leader in developing and supplying advanced germplasm and traits that produce optimum yield for farms around the world. The segment is a leader in many of the company’s key seed markets, including North America corn and soybeans, Europe corn and sunflower, as well as Brazil, India, South Africa and Argentina corn. The segment offers trait technologies that improve resistance to weather, disease, insects and herbicides used to control weeds, and trait technologies that enhance food and nutritional characteristics. In addition, the segment provides digital solutions that assist farmer decision-making with a view to optimize product selection and, ultimately, help maximize yield and profitability.

Crop Protection
The crop protection segment serves the global agricultural input industry with products that protect against weeds, insects and other pests, and disease, and that improve overall crop health both above and below ground via nitrogen management and seed-applied technologies. The segment is a leader in global herbicides, insecticides, nitrogen stabilizers and pasture and range management herbicides.

F-74

Corteva, Inc.
Notes to the Consolidated Financial Statements (continued)

(In millions)
SeedCrop ProtectionTotal
As of and for the Year Ended December 31, 2021   
Net sales$8,402 $7,253 $15,655 
Segment operating EBITDA$1,512 $1,202 $2,714 
Depreciation and amortization$866 $377 $1,243 
Segment assets$23,270 $12,428 $35,698 
Investments in nonconsolidated affiliates$29 $47 $76 
Purchases of property, plant and equipment$237 $336 $573 
As of and for the Year Ended December 31, 2020   
Net sales$7,756 $6,461 $14,217 
Segment operating EBITDA$1,208 $1,004 $2,212 
Depreciation and amortization$798 $379 $1,177 
Segment assets$23,751 $13,099 $36,850 
Investments in nonconsolidated affiliates$22 $44 $66 
Purchases of property, plant and equipment$225 $250 $475 
As of and for the Year Ended December 31, 2019
Net sales$7,590 $6,256 $13,846 
Pro forma segment operating EBITDA$1,040 $1,066 $2,106 
Depreciation and amortization$628 $372 $1,000 
Segment assets1
$25,387 $13,492 $38,879 
Investments in nonconsolidated affiliates$27 $39 $66 
Purchase of property, plant and equipment$373 $293 $666 
1.On June 1, 2019, as a result of changes in reportable segments, $3,382 million of goodwill was reallocated from the seed reportable segment to the crop protection reportable segment. This change was not reflected in segment assets prior to June 1, 2019.

Reconciliation to Consolidated Financial Statements
Income (loss) from continuing operations after income taxes to segment operating EBITDA
For the Year Ended December 31,
(In millions)202120202019
Income (loss) from continuing operations after income taxes$1,822 $756 $(270)
Provision for (benefit from) income taxes on continuing operations524 (81)(46)
Income (loss) from continuing operations before income taxes2,346 675 (316)
Depreciation and amortization1,243 1,177 1,000 
Interest income(77)(56)(59)
Interest expense30 45 136 
Exchange (gains) losses - net 1
54 174 66 
Non-operating (benefits) costs - net(1,256)(316)(129)
Mark-to-market (gains) losses on certain foreign currency contracts not designated as hedges2
— 
Significant items236 388 991 
Pro forma adjustments298 
Corporate expenses138 125 119 
Segment operating EBITDA3
$2,714 $2,212 $2,106 
1.Excludes a $(33) million foreign exchange loss for the year ended December 31, 2019 associated with the devaluation of the Argentine peso. See Note 9 - Supplementary Information, to the Consolidated Financial Statements, for additional information.
2.Effective January 1, 2021, on a prospective basis, the company excludes net unrealized gain or loss from mark-to-market activity for certain foreign currency derivative instruments that do not qualify for hedge accounting. There were no unrealized mark-to-market (gains) losses for the years ended December 31, 2020 and 2019.
3.The year ended December 31, 2019 is presented on a pro forma basis, prepared in accordance with Article 11 of Regulation S-X that was in effect prior to recent amendments.
F-75

Corteva, Inc.
Notes to the Consolidated Financial Statements (continued)


Segment assets to total assets (in millions)
December 31, 2021December 31, 2020
Total segment assets$35,698 $36,850 
Corporate assets6,646 5,799 
Total assets$42,344 $42,649 


Other Items (in millions)
Segment Totals
Adjustments 1
Consolidated Totals
For the Year Ended December 31, 2019
Depreciation and amortization$1,000 $599 $1,599 
Purchase of property, plant and equipment$666 $497 $1,163 
1.See Note 5 - Divestitures and Other Transactions, to the Consolidated Financial Statements, for additional information.

F-76

Corteva, Inc.
Notes to the Consolidated Financial Statements (continued)

Significant Pre-tax (Charges) Benefits Not Included in Segment Operating EBITDA
The years ended December 31, 2021, 2020 and 2019, respectively, included the following significant pre-tax (charges) benefits which are excluded from segment operating EBITDA:
(In millions)SeedCrop ProtectionCorporateTotal
For the Year Ended December 31, 2021
Restructuring and Asset Related Charges - Net 1
$(152)$(59)$(78)$(289)
Equity securities mark-to-market gain (loss)47 — — 47 
Employee Retention Credit37 23 — 60 
Contract termination(30)(24)— (54)
Total$(98)$(60)$(78)$(236)
(In millions)SeedCrop ProtectionCorporateTotal
For the Year Ended December 31, 2020
Restructuring and Asset Related Charges - Net 1
$(165)$(109)$(61)$(335)
Loss on Divestiture 2
— (53) (53)
Total$(165)$(162)$(61)$(388)
(In millions)SeedCrop ProtectionCorporateTotal
For the Year Ended December 31, 20193
Restructuring and Asset Related Charges - Net 1
$(213)$(23)$14 $(222)
Integration and Separation Costs 4
— — (632)(632)
Loss on Divestiture 5
(24)— — (24)
Amortization of Inventory Step Up 6
(67)— — (67)
Loss on Early Extinguishment of Debt 7
 — (13)(13)
Argentina Currency Devaluation 8
— — (33)(33)
Total$(304)$(23)$(664)$(991)
1.Includes Board approved restructuring plans and asset related charges as well as accelerated prepaid amortization. See Note 7 - Restructuring and Asset Related Charges - Net, to the Consolidated Financial Statements, for additional information.
2.Includes a loss recorded in other income - net related to the sale of the La Porte site.
3.The year ended December 31, 2019 is presented on a pro forma basis, prepared in accordance with Article 11 of Regulation S-X that was in effect prior to recent amendments.
4.Integration and separation costs include costs incurred to prepare for and close the Merger, post-Merger integration expenses, and costs incurred to prepare for the Internal Reorganizations. Beginning in the second quarter of 2019, this includes both integration and separation costs.
5.Includes a loss recorded in other income - net related to DAS's sale of a joint venture related to synergy actions.
6.Includes a charge related to the amortization of the inventory that was stepped up to fair value in connection with the Merger.
7.Includes a loss on early extinguishment of debt related to the difference between the redemption price and the par value of the Make Whole Notes and Term Loan Facility, partially offset by the write-off of unamortized step-up related to the fair value step-up of EID's debt.
8.Includes a charge included in other income - net associated with remeasuring the company’s Argentine Peso net monetary assets, resulting from an unexpected August primary election result in Argentina. Throughout the three months ended September 30, 2019, the Argentine Peso dropped approximately a third of its value against the US dollar and in September of 2019, the country’s central bank announced new restrictions on foreign currency transactions.


F-77

Corteva, Inc.
Notes to the Consolidated Financial Statements (continued)
NOTE 26 - SUBSEQUENT EVENTS

In February 2022, the company entered into a new committed receivable repurchase facility of up to $500 million (the "2022 Repurchase Facility"), which expires in December 2022. Under the 2022 Repurchase Facility, Corteva may sell a portfolio of available and eligible outstanding customer notes receivables to participating institutions and simultaneously agree to repurchase at a future date. The 2022 Repurchase Facility is considered a secured borrowing with the customer notes receivables inclusive of those that are sold and repurchased, equal to 105 percent of the outstanding amounts borrowed utilized as collateral. Borrowings under the 2022 Repurchase Facility will have an interest rate equal to the Adjusted Term Secured Overnight Financing Rate ("SOFR") plus a margin of 0.75 percent.


F-78


E. I. du Pont de Nemours and Company
Index to the Consolidated Financial Statements


F-79






Management's Reports on Responsibility for Financial Statements and
Internal Control over Financial Reporting

Management's Report on Responsibility for Financial Statements
Management is responsible for the Consolidated Financial Statements and the other financial information contained in this Annual Report on Form 10-K. The financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America ("GAAP") and are considered by management to present fairly EID's financial position, results of operations and cash flows. The financial statements include some amounts that are based on management's best estimates and judgments. The financial statements have been audited by EID's independent registered public accounting firm, PricewaterhouseCoopers LLP. The purpose of their audit is to express an opinion as to whether the Consolidated Financial Statements included in this Annual Report on Form 10-K present fairly, in all material respects, EID's financial position, results of operations and cash flows in conformity with GAAP. Their report is presented on the following pages.
Management's Report on Internal Control over Financial Reporting
Management is responsible for establishing and maintaining an adequate system of internal control over financial reporting as defined in Rules 13a-15(f) and 15d-15(f) under the Securities Exchange Act of 1934. EID's internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with GAAP. EID's internal control over financial reporting includes those policies and procedures that:
i.pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of EID;
ii.provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles and that receipts and expenditures of EID are being made only in accordance with authorization of management and directors of EID; and
iii.provide reasonable assurance regarding prevention or timely detection of unauthorized acquisitions, use or disposition of EID's assets that could have a material effect on the financial statements.
Internal control over financial reporting has certain inherent limitations which may not prevent or detect misstatements. In addition, changes in conditions and business practices may cause variation in the effectiveness of internal controls.
Management assessed the effectiveness of EID's internal control over financial reporting as of December 31, 2021, based on criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission ("COSO") in Internal Control-Integrated Framework (2013). Based on its assessment and those criteria, management concluded that EID maintained effective internal control over financial reporting as of December 31, 2021.
PricewaterhouseCoopers LLP, an independent registered public accounting firm, has audited the effectiveness of EID's internal control over financial reporting as of December 31, 2021, as stated in their report, which is presented on the following pages.

ctva-20211231_g6.jpg ctva-20211231_g7.jpg
Charles V. Magro
Chief Executive Officer and Director
 David J. Anderson
Executive Vice President,
Chief Financial Officer and Director
February 10, 2022
F-80







Report of Independent Registered Public Accounting Firm


To the Stockholders and Board of Directors of E. I. du Pont de Nemours and Company

Opinions on the Financial Statements and Internal Control over Financial Reporting

We have audited the accompanying consolidated balance sheets of E. I. du Pont de Nemours and Company and its subsidiaries (the “Company”) as of December 31, 2021 and 2020, and the related consolidated statements of operations, comprehensive income (loss), equity and cash flows for each of the three years in the period ended December 31, 2021, including the related notes and schedule of valuation and qualifying accounts for each of the three years in the period ended December 31, 2021 appearing under Item 15(a) (collectively referred to as the “consolidated financial statements”). We also have audited the Company's internal control over financial reporting as of December 31, 2021, based on criteria established in Internal Control - Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).

In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of the Company as of December 31, 2021 and 2020, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2021 in conformity with accounting principles generally accepted in the United States of America. Also in our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2021, based on criteria established in Internal Control - Integrated Framework (2013) issued by the COSO.

Basis for Opinions

The Company's management is responsible for these consolidated financial statements, for maintaining effective internal control over financial reporting, and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Management’s Report on Internal Control over Financial Reporting. Our responsibility is to express opinions on the Company’s consolidated financial statements and on the Company's internal control over financial reporting based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud, and whether effective internal control over financial reporting was maintained in all material respects.

Our audits of the consolidated financial statements included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audits also included performing such other procedures as we considered necessary in the circumstances. We believe that our audits provide a reasonable basis for our opinions.

Definition and Limitations of Internal Control over Financial Reporting

A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.

F-81






Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

Critical Audit Matters

The critical audit matter communicated below is a matter arising from the current period audit of the consolidated financial statements that was communicated or required to be communicated to the audit committee and that (i) relates to accounts or disclosures that are material to the consolidated financial statements and (ii) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.

Goodwill (Seed Reporting Unit) Impairment Assessment

As described in Notes 2 and 15 to the Corteva, Inc. consolidated financial statements, the Company’s consolidated goodwill balance was $10.1 billion as of December 31, 2021, and the goodwill associated with the seed reporting unit was $5.4 billion. Management tests goodwill for impairment at the reporting unit level at least annually, or more frequently when events or changes in circumstances indicate it is more likely than not that the fair value of a reporting unit has declined below its carrying value. Management performs an annual goodwill impairment test in the fourth quarter. If management chooses not to complete a qualitative assessment for a given reporting unit or if the initial assessment indicates that it is more likely than not that the carrying value of a reporting unit exceeds its estimated fair value, additional quantitative testing is required. Management performed quantitative testing on its seed reporting unit and determined that no goodwill impairment existed in 2021. Management determined fair value for the seed reporting unit using a discounted cash flow model. Management’s significant assumptions in this analysis included future cash flow projections, the weighted average cost of capital, the terminal growth rate, and the tax rate.

The principal considerations for our determination that performing procedures relating to the seed reporting unit goodwill impairment assessment is a critical audit matter are (i) the significant judgment by management when developing the fair value of the seed reporting unit; (ii) a high degree of auditor judgment, subjectivity, and effort in performing procedures and evaluating management’s significant assumptions related to projected revenue, the weighted average cost of capital, and the terminal value; and (iii) the audit effort involved the use of professionals with specialized skill and knowledge.

Addressing the matter involved performing procedures and evaluating audit evidence in connection with forming our overall opinion on the consolidated financial statements. These procedures included testing the effectiveness of controls relating to management’s goodwill impairment assessment, including controls over the valuation of the seed reporting unit. These procedures also included, among others, (i) testing management’s process for developing the fair value estimate; (ii) evaluating the appropriateness of the discounted cash flow model; (iii) testing the completeness, accuracy, and relevance of underlying data used in the discounted cash flow model; and (iv) evaluating the reasonableness of significant assumptions used by management related to projected revenue, the weighted average cost of capital, and the terminal value. Evaluating management’s assumptions related to projected revenue and the terminal value involved evaluating whether the assumptions used by management were reasonable considering (i) the current and past performance of the reporting unit; (ii) the consistency with external market and industry data; and (iii) whether the assumptions were consistent with evidence obtained in other areas of the audit. Professionals with specialized skill and knowledge were used to assist in the evaluation of the Company’s discounted cash flow model and the weighted average cost of capital and terminal value assumptions.




/s/PricewaterhouseCoopers LLP
Philadelphia, Pennsylvania
February 10, 2022

We have served as the Company’s auditor since 1946.

F-82

E. I. du Pont de Nemours and Company
Consolidated Financial Statements


CONSOLIDATED STATEMENTS OF OPERATIONS
(In millions, except per share amounts) For the Year Ended December 31,
202120202019
Net sales$15,655 $14,217 $13,846 
Cost of goods sold9,220 8,507 8,575 
Research and development expense1,187 1,142 1,147 
Selling, general and administrative expenses3,209 3,043 3,065 
Amortization of intangibles722 682 475 
Restructuring and asset related charges - net289 335 222 
Integration and separation costs  744 
Other income - net1,348 212 215 
Loss on early extinguishment of debt  13 
Interest expense80 145 242 
Income (loss) from continuing operations before income taxes2,296 575 (422)
Provision for (Benefit from) income taxes on continuing operations512 (105)(71)
Income (loss) from continuing operations after income taxes1,784 680 (351)
Loss (income) from discontinued operations after income taxes(53)(55)(671)
Net income (loss)1,731 625 (1,022)
Net income (loss) attributable to noncontrolling interests 10 8 
Net income (loss) attributable to E. I. du Pont de Nemours and Company$1,731 $615 $(1,030)

See Notes to the Consolidated Financial Statements beginning on page F-89.

F-83

E. I. du Pont de Nemours and Company
Consolidated Financial Statements

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
(In millions) For the Year Ended December 31,
202120202019
Net income (loss)$1,731 $625 $(1,022)
Other comprehensive income (loss) - net of tax:
Cumulative translation adjustments(573)(26)(274)
Adjustments to pension benefit plans1,037 (186)(718)
Adjustments to other benefit plans(621)671 (160)
Unrealized gain (loss) on investments10 (10) 
Derivative instruments139 (69)28 
Total other comprehensive income (loss) (8)380 (1,124)
Comprehensive income (loss) 1,723 1,005 (2,146)
Comprehensive income (loss) attributable to noncontrolling interests - net of tax 10 8 
Comprehensive income (loss) attributable to E. I. du Pont de Nemours and Company$1,723 $995 $(2,154)

See Notes to the Consolidated Financial Statements beginning on page F-89.

F-84

E. I. du Pont de Nemours and Company
Consolidated Financial Statements

CONSOLIDATED BALANCE SHEETS
(In millions, except share and per share amounts)December 31, 2021December 31, 2020
Assets  
Current assets  
Cash and cash equivalents$4,459 $3,526 
Marketable securities86 269 
Accounts and notes receivable - net4,811 4,926 
Inventories5,180 4,882 
Other current assets1,010 1,165 
Total current assets15,546 14,768 
Investment in nonconsolidated affiliates76 66 
Property, plant and equipment8,364 8,253 
Less: Accumulated depreciation4,035 3,857 
Net property, plant and equipment4,329 4,396 
Goodwill10,107 10,269 
Other intangible assets10,044 10,747 
Deferred income taxes438 464 
Other assets1,804 1,939 
Total Assets$42,344 $42,649 
Liabilities and Equity  
Current liabilities  
Short-term borrowings and finance lease obligations$17 $3 
Accounts payable4,126 3,615 
Income taxes payable146 123 
Deferred Revenue3,201 2,662 
Accrued and other current liabilities2,070 2,148 
Total current liabilities9,560 8,551 
Long-term debt1,100 1,102 
Long-term debt - Related party2,162 3,459 
Other noncurrent liabilities
Deferred income tax liabilities1,220 893 
Pension and other post employment benefits - noncurrent3,124 5,176 
Other noncurrent obligations1,719 1,867 
Total noncurrent liabilities9,325 12,497 
Commitments and contingent liabilities
Stockholders’ equity  
Preferred stock, without par value – cumulative; 23,000,000 shares authorized;
     issued at December 31, 2021, December 31, 2020:
$4.50 Series – 1,673,000 shares (callable at $120)169 169 
$3.50 Series – 700,000 shares (callable at $102)70 70 
Common stock, $0.30 par value; 1,800,000,000 shares authorized; 200
issued at December 31, 2021 and December 31, 2020
  
Additional paid-in capital24,196 24,049 
Retained earnings (accumulated deficit)1,922 203 
Accumulated other comprehensive income (loss)(2,898)(2,890)
Total E. I. du Pont de Nemours and Company stockholders’ equity23,459 21,601 
Noncontrolling interests  
Total equity23,459 21,601 
Total Liabilities and Equity$42,344 $42,649 
See Notes to the Consolidated Financial Statements beginning on page F-89.
F-85

E. I. du Pont de Nemours and Company
Consolidated Financial Statements

CONSOLIDATED STATEMENTS OF CASH FLOWS
(In millions)For the Year Ended December 31,
20212020
20191
Operating activities
Net income (loss)$1,731 $625 $(1,022)
Adjustments to reconcile net income (loss) to cash provided by (used for) operating activities:
Depreciation and amortization1,243 1,177 1,599 
Provision for (benefit from) deferred income tax174 (330)(477)
Net periodic pension and OPEB benefit, net(1,292)(340)(177)
Pension and OPEB contributions(247)(269)(323)
Net (gain) loss on sales of property, businesses, consolidated companies, and investments(21)3 (142)
Restructuring and asset related charges - net289 335 339 
Amortization of inventory step-up  272 
Goodwill impairment charge  1,102 
Loss on early extinguishment of debt  13 
Other net loss156 290 246 
Changes in assets and liabilities, net
Accounts and notes receivable(113)187 (361)
Inventories(422)104 74 
Accounts payable524 (118)149 
Deferred Revenue574 71 632 
Other assets and liabilities93 251 (928)
Cash provided by (used for) operating activities2,689 1,986 996 
Investing activities  
Capital expenditures(573)(475)(1,163)
Proceeds from sales of property, businesses, and consolidated companies - net of cash divested75 83 249 
Acquisitions of businesses - net of cash acquired  (10)
Investments in and loans to nonconsolidated affiliates(4)(1)(10)
Proceeds from sale of ownership interest in nonconsolidated affiliates  21 
Purchases of investments(204)(995)(138)
Proceeds from sales and maturities of investments345 721 160 
Other investing activities, net(1)(7)(13)
Cash provided by (used for) investing activities(362)(674)(904)
Financing activities  
Net change in borrowings (less than 90 days) 13  (1,868)
Proceeds from related party debt52 103 4,240 
Payments on related party debt(1,349)(665)(219)
Proceeds from debt419 2,439 1,001 
Payments on debt(421)(1,441)(6,804)
Proceeds from exercise of stock options100 56 47 
Payment for acquisition of subsidiary's interest from the noncontrolling interest (60) 
Distributions to DowDuPont  (317)
Cash transferred to DowDuPont at Internal Reorganization  (2,053)
Contributions from Dow and DowDuPont  3,255 
Debt extinguishment costs  (79)
Other financing activities, net(42)(51)(58)
Cash provided by (used for) financing activities(1,228)381 (2,855)
Effect of exchange rate changes on cash, cash equivalents and restricted cash equivalents(136)7 (88)
Increase (decrease) in cash, cash equivalents and restricted cash equivalents963 1,700 (2,851)
Cash, cash equivalents and restricted cash equivalents at beginning of period3,873 2,173 5,024 
Cash, cash equivalents and restricted cash equivalents at end of period$4,836 $3,873 $2,173 
F-86

E. I. du Pont de Nemours and Company
Consolidated Financial Statements

(In millions)For the Year Ended December 31,
20212020
20191
Supplemental cash flow information
Cash paid during the period for
Interest, net of amounts capitalized2
$30 $36 $263 
Income taxes341 229 234 
1..The cash flows for the year ended December 31, 2019 includes cash flows of EID's ECP and Specialty Products Entities.
2.Reflects interest, net of amounts capitalized, paid to external parties. For information associated with interest paid on related party debt refer to EID's Note 2 - Related Party Transactions, of the EID Consolidated Financial Statements.

See Notes to the Consolidated Financial Statements beginning on page F-89.

F-87

E. I. du Pont de Nemours and Company
Consolidated Financial Statements

CONSOLIDATED STATEMENTS OF EQUITY
(In millions)Preferred StockCommon StockAdditional Paid-in Capital "APIC"Divisional EquityRetained Earnings (Accum Deficit)Accumulated Other Comp Income (Loss)Non-controlling InterestsTotal Equity
Balance at January 1, 2019$ $ $ $78,259 $ $(3,360)$254 $75,153 
Net (loss) income(640)(390)8 (1,022)
Other comprehensive income (loss)(1,124)(1,124)
Preferred dividends ($4.50 Series - $4.50 per share, $3.50 Series - $3.50 per share)(2)(2)(6)(10)
Distributions to DowDuPont(317)(317)
Contributions from DowDuPont3,255 3,255 
Issuance of DowDuPont stock39 39 
Issuance of Corteva stock8 8 
Share-based compensation41 62 103 
Impact of Internal Reorganizations(56,479)1,214 (231)(55,496)
Reclassification of Divisional Equity to Additional Paid-in Capital23923,936 (24,175) 
Other - net(25)(2)(10)(24)(61)
Balance at December 31, 2019$239 $ $23,958 $(406)$(3,270)$7 $20,528 
Net income (loss)615 10 625 
Other comprehensive income (loss)380 380 
Issuance of Corteva Stock56 56 
Preferred dividends ($4.50 Series - $4.50 per share, $3.50 Series - $3.50 per share)(5)(5)(10)
Share-based compensation60 (1)59 
Acquisition of noncontrolling interest in consolidated subsidiaries(37)(15)(52)
Other - net17 (2)15 
Balance at December 31, 2020$239 $ $24,049 $203 $(2,890)$ $21,601 
Net income (loss)1,731 1,731 
Other comprehensive income (loss)(8)(8)
Issuance of Corteva Stock100 100 
Preferred dividends ($4.50 Series - $4.50 per share, $3.50 Series - $3.50 per share)(10)(10)
Share-based compensation59 (3)56 
Other - net(12)1 (11)
Balance at December 31, 2021$239 $ $24,196 $1,922 $(2,898)$ $23,459 

See Notes to the Consolidated Financial Statements beginning on page F-89.
F-88

E. I. du Pont de Nemours and Company
Notes to the Consolidated Financial Statements
Table of Contents


F-89

E. I. du Pont de Nemours and Company
Notes to the Consolidated Financial Statements (continued)

NOTE 1 - BASIS OF PRESENTATION

As a result of the Business Realignment and the Internal Reorganization, Corteva, Inc. owns 100% of the outstanding common stock of EID. EID is a subsidiary of Corteva, Inc. and continues to be a reporting company, subject to the requirements of the Exchange Act. The primary differences between Corteva, Inc. and EID are outlined below:

Preferred Stock - EID has preferred stock outstanding to third parties which is accounted for as a noncontrolling interest at the Corteva, Inc. level. Each share of EID Preferred Stock - $4.50 Series and EID Preferred Stock - $3.50 Series issued and outstanding at the effective date of the Corteva Distribution remains issued and outstanding as to EID and was unaffected by the Corteva Distribution.
Related Party Loan - EID engaged in a series of debt redemptions during the second quarter of 2019 that were partially funded through an intercompany loan from Corteva, Inc. This was eliminated in consolidation at the Corteva, Inc. level but remains on EID's financial statements at the standalone level (including the associated interest).
Capital Structure - At December 31, 2021, Corteva, Inc.'s capital structure consists of 726,527,000 issued shares of common stock, par value $0.01 per share.

The accompanying footnotes relate to EID only, and not to Corteva, Inc., and are presented to show differences between EID and Corteva, Inc.

For the footnotes listed below, refer to the footnotes from the Corteva 10-K:
Note 1 - Background and Basis of Presentation - refer to page F-12 of the Corteva, Inc. Consolidated Financial Statements
Note 2 - Summary of Significant Accounting Policies - refer to page F-14 of the Corteva, Inc. Consolidated Financial Statements
Note 3 - Recent Accounting Guidance - refer to page F-19 of the Corteva, Inc. Consolidated Financial Statements
Note 4 - Common Control Business Combination - refer to page F-19 of the Corteva, Inc. Consolidated Financial Statements
Note 5 - Divestitures and Other Transactions - refer to page F-20 of the Corteva, Inc. Consolidated Financial Statements
Note 6 - Revenue - refer to page F-24 of the Corteva, Inc. Consolidated Financial Statements
Note 7 - Restructuring and Asset Related Charges - Net - refer to page F-26 of the Corteva, Inc. Consolidated Financial Statements
Note 8 - Related Party Transactions - Differences exist between Corteva, Inc. and EID; refer to EID Note 2 - Related Party Transactions, of the EID Consolidated Financial Statements, below
Note 9 - Supplementary Information - refer to page F-29 of the Corteva, Inc. Consolidated Financial Statements
Note 10 - Income Taxes - Differences exist between Corteva, Inc. and EID; refer to EID Note 3 - Income Taxes, of the EID Consolidated Financial Statements, below
Note 11 - Earnings Per Share of Common Stock - Not applicable for EID
Note 12 - Accounts and Notes Receivable - Net - refer to page F-36 of the Corteva, Inc. Consolidated Financial Statements
Note 13 - Inventories - refer to page F-37 of the Corteva, Inc. Consolidated Financial Statements
Note 14 - Property, Plant and Equipment - refer to page F-37 of the Corteva, Inc. Consolidated Financial Statements
Note 15 - Goodwill and Other Intangible Assets - refer to page F-38 of the Corteva, Inc. Consolidated Financial Statements
Note 16 - Leases - refer to page F-40 of the Corteva, Inc. Consolidated Financial Statements
Note 17 - Long-Term Debt and Available Credit Facilities - refer to page F-42 of the Corteva, Inc. Consolidated Financial Statements. In addition, EID has a related party loan payable to Corteva, Inc.; refer to EID Note 2 - Related Party Transactions, of the EID Consolidated Financial Statements, below
Note 18 - Commitments and Contingent Liabilities - refer to page F-44 of the Corteva, Inc. Consolidated Financial Statements
Note 19 - Stockholders' Equity - refer to page F-51 of the Corteva, Inc. Consolidated Financial Statements
Note 20 - Pension Plans and Other Post Employment Benefits - refer to page F-54 of the Corteva, Inc. Consolidated Financial Statements
Note 21 - Stock-Based Compensation - refer to page F-63 of the Corteva, Inc. Consolidated Financial Statements
Note 22 - Financial Instruments - refer to page F-65 of the Corteva, Inc. Consolidated Financial Statements
Note 23 - Fair Value Measurements - refer to page F-71 of the Corteva, Inc. Consolidated Financial Statements
Note 24 - Geographic Information - refer to page F-73 of the Corteva, Inc. Consolidated Financial Statements
Note 25 - Segment Information - Differences exist between Corteva, Inc. and EID; refer to EID Note 4 - Segment Information, of the EID Consolidated Financial Statements, below
F-90

E. I. du Pont de Nemours and Company
Notes to the Consolidated Financial Statements (continued)

Note 26 - Subsequent Events - Refers to page F-78 of the Corteva, Inc. Consolidated Financial Statements

NOTE 2 - RELATED PARTY TRANSACTIONS

Refer to page F-28 of the Corteva, Inc. Consolidated Financial Statements for discussion of related party transactions with Historical Dow and DowDuPont.

Transactions with Corteva
In the second quarter of 2019, EID entered into a related party revolving loan from Corteva, Inc., with a maturity date in 2024. As of December 31, 2021 and December 31, 2020, the outstanding related party loan balance was $2,162 million and $3,459 million respectively (which approximates fair value), with interest rates of 1.67% and 1.62%, respectively, and is reflected as long-term debt - related party on EID's Consolidated Balance Sheet. Additionally, EID has incurred tax deductible interest expense of $50 million and $100 million and paid interest of $51 million and $105 million for the years ended December 31, 2021 and 2020, respectively, associated with the related party loan to Corteva, Inc.

As of December 31, 2021, EID had payables to Corteva, Inc. of $27 million and $117 million included in accrued and other current liabilities and other noncurrent obligations, respectively, and $92 million included in both accrued and other current liabilities and other noncurrent obligations, respectively, at December 31, 2020, in the Consolidated Balance Sheet, related to Corteva's indemnification liabilities to Dow and DuPont per the Separation Agreements (refer to page F-20 of the Corteva, Inc. Consolidated Financial Statements for further details of the Separation Agreements).

NOTE 3 - INCOME TAXES

Refer to page F-31 of the Corteva, Inc. Consolidated Financial Statements for discussion of tax items that do not differ between Corteva, Inc. and EID.
Geographic Allocation of Income (Loss) and Provision for (Benefit from) Income Taxes For the Year Ended December 31,
(In millions)202120202019
Income (loss) from continuing operations before income taxes
Domestic$892 $(183)$(1,458)
Foreign1,404 758 1,036 
Income (loss) from continuing operations before income taxes$2,296 $575 $(422)
Current tax expense (benefit)
Federal$(23)$8 $(11)
State and local4 5 1 
Foreign329 222 317 
Total current tax expense (benefit)$310 $235 $307 
Deferred tax (benefit) expense
Federal$164 $(116)$(417)
State and local55 27 156 
Foreign(17)(251)(117)
Total deferred tax expense (benefit)$202 $(340)$(378)
Provision for (benefit from) income taxes on continuing operations512 (105)(71)
Net income (loss) from continuing operations$1,784 $680 $(351)

F-91

E. I. du Pont de Nemours and Company
Notes to the Consolidated Financial Statements (continued)

Reconciliation to U.S. Statutory RateFor the Year Ended December 31,
202120202019
Statutory U.S. federal income tax rate21.0 %21.0 %21.0 %
Effective tax rates on international operations - net 1
(2.6)(16.4)(13.8)
Acquisitions, divestitures and ownership restructuring activities 2
(0.1)(0.3)(8.0)
U.S. research and development credit(2.5)(3.4)5.2 
Exchange gains/losses 3
1.9 4.1 (1.3)
State and local income taxes - net2.2 4.2 3.0 
Impact of Swiss Tax Reform 4
0.2 (31.7)8.9 
Excess tax benefits/deficiencies from stock compensation(0.2)1.2 (0.5)
Tax settlements and expiration of statute of limitations 0.4 2.9 
Other - net2.3 2.6 (0.6)
Effective tax rate22.2 %(18.3)%16.8 %
1.    Includes the effects of local and U.S. taxes related to earnings of non-U.S. subsidiaries, changes in the amount of unrecognized tax benefits associated with these earnings, losses at non-U.S. subsidiaries without local tax benefits due to valuation allowances, and other permanent differences between tax and U.S. GAAP results. Includes a tax benefit of $(51) million for the year ended December 31, 2020, related to a return to accrual adjustment associated with an elective change in accounting method that alters the 2019 impact of foreign tax provisions.
2.    See Notes 4 - Common Control Business Combination, and Note 5 - Divestitures and Other Transactions, of the Corteva, Inc. Consolidated Financial Statements for additional information.
3.    Principally reflects the impact of foreign exchange gains and losses on net monetary assets for which no corresponding tax impact is realized. Further information about the company's foreign currency hedging program is included in Note 9 - Supplementary Information, and Note 22 - Financial Instruments, of the Corteva, Inc. Consolidated Financial Statements under the heading Foreign Currency Risk.
4.    Reflects tax benefits of $(182) million primarily driven by the recognition of an elective cantonal component of the recent enactment of the Federal Act on Tax Reform and AHV Financing ("Swiss Tax Reform") for the year ended December 31, 2020. Reflects tax benefits of $(38) million associated with the enactment of the Federal Act on Tax Reform and AHV Financing ("Swiss Tax Reform"), for the year ended December 31, 2019.

F-92

E. I. du Pont de Nemours and Company
Notes to the Consolidated Financial Statements (continued)


NOTE 4 - SEGMENT INFORMATION

There are no differences in reporting structure or segments between Corteva, Inc. and EID. In addition, there are no differences between Corteva, Inc. and EID segment net sales, segment operating EBITDA or pro forma segment operating EBITDA, segment assets, or significant items by segment; refer to page F-74 of the Corteva, Inc. Consolidated Financial Statements for background information on the segments as well as further details regarding segment metrics. The tables below reconcile income (loss) from continuing operations after income taxes to segment operating EBITDA, as differences exist between Corteva, Inc. and EID.

Reconciliation to Consolidated Financial Statements
Income (loss) from continuing operations after income taxes to segment operating EBITDA
(In millions)
For the Year Ended December 31,
202120202019
Income (loss) from continuing operations after income taxes$1,784 $680 $(351)
Provision for (benefit from) income taxes on continuing operations512 (105)(71)
Income (loss) from continuing operations before income taxes2,296 575 (422)
Depreciation and amortization1,243 1,177 1,000 
Interest income(77)(56)(59)
Interest expense80 145 242 
Exchange losses - net1
54 174 66 
Non-operating (benefits) costs - net(1,256)(316)(129)
Mark-to-market (gains) losses on certain foreign currency contracts not designated as hedges2
— 
Significant items236 388 991 
Pro forma adjustments298 
Corporate expenses138 125 119 
Segment operating EBITDA3
$2,714 $2,212 $2,106 
1.Excludes a $(33) million foreign exchange loss for the year ended December 31, 2019 associated with the devaluation of the Argentine peso. See Note 9 - Supplementary Information, of the Corteva, Inc. Consolidated Financial Statements for additional information.
2.Effective January 1, 2021, on a prospective basis, the company excludes net unrealized gain or loss from mark-to-market activity for certain foreign currency derivative instruments that do not qualify for hedge accounting. There were no unrealized mark-to-market (gains) losses for the years ended December 31, 2020 and 2019.
3.The year ended December 31, 2019 is presented on a pro forma basis, prepared in accordance with Article 11 of Regulation S-X that was in effect prior to recent amendments.


ITEM 16.  FORM 10-K SUMMARY

Not applicable.

F-93
EX-21 2 ctva-12312021xex21.htm EX-21 Document

Exhibit 21


SUBSIDIARIES OF THE REGISTRANT

Set forth below are certain subsidiaries of
Corteva, Inc.

Name
Organized Under
Laws Of
Ag HoldCo Mexico S. de R.L. de C.VMéxico
AG MX 2, Inc.Delaware
Agar Cross Paraguaya S.A.Paraguay
Agricor LtdZimbabwe
Agrigenetics Molokai LLCHawaii
Agrigenetics, Inc.Delaware
AgSurf CorporationDelaware
AgVenture, Inc.Indiana
Alforex Seeds LLCDelaware
Ambito Das S.A.Argentina
Cal/West Seeds S.R.L.Argentina
ChacoDAS S.A.Argentina
Christiana Insurance LLCDelaware
Corteva (China) Investment Co., Ltd.China
Corteva (China), LLCDelaware
Corteva Agriscience (Cambodia) Co., Ltd.Cambodia
Corteva Agriscience (Malaysia) Sdn. Bhd.Malaysia
Corteva Agriscience (Myanmar) Company LimitedMyanmar
Corteva Agriscience (Thailand) Co., Ltd.Thailand
Corteva Agriscience ABStockholm
Corteva Agriscience Argentina S.R.L.Argentina
Corteva Agriscience Austria GmbHEisenstadt
Corteva Agriscience Belgium B.V.Belgium
Corteva Agriscience Bolivia S.A.Bolivia
Corteva Agriscience Bulgaria EOODBulgaria
Corteva Agriscience Canada CompanyCanada
Corteva Agriscience Chile LimitadaChile
Corteva Agriscience Costa Rica S.A.Costa Rica
Corteva Agriscience Croatia LLCCroatia
Corteva Agriscience Czech s.r.o.Czech Republic
Corteva Agriscience de Colombia S.A.S.Colombia
Corteva Agriscience de Ecuador S.A.Ecuador
Corteva Agriscience Denmark A/SCopenhagen
Corteva Agriscience Denmark A/S (Estonian Branch)Tallinn
Corteva Agriscience Denmark A/S (Latvian Branch)Riga
Corteva Agriscience do Brasil Ltda.Brazil
Corteva Agriscience Egypt LLCEgypt
Corteva Agriscience eSwatini Proprietary LimitedSwaziland
Corteva Agriscience Finland OYVantaa



Corteva Agriscience FoundationIowa
Corteva Agriscience France S.A.S.Versailles
Corteva Agriscience Germany GmbHMuenchen
Corteva Agriscience Guatemala S.A.Guatemala
Corteva Agriscience Hellas S.A.Greece
Corteva Agriscience Holding LLCDelaware
Corteva Agriscience Holding Sàrl/LLCGeneva
Corteva Agriscience Holding Spain, S.L.Spain
Corteva Agriscience Hungary Zrt.Hungary
Corteva Agriscience India Private LimitedIndia
Corteva Agriscience International SàrlGeneva
Corteva Agriscience Italia S.r.l.Cremona
Corteva Agriscience Japan LimitedDelaware
Corteva Agriscience Japan LimitedJapan
Corteva Agriscience Kazakhstan Limited Liability PartnershipKazakhstan
Corteva Agriscience Kenya LimitedKenya
Corteva Agriscience Korea Ltd.Korea
Corteva Agriscience Lithuania UABVilnius
Corteva Agriscience LLCDelaware
Corteva Agriscience Maroc SARLMorocco
Corteva Agriscience MCS LLCIowa
Corteva Agriscience Mexico S. de R. L. de C. V.México
Corteva Agriscience MW LimitedMalawi
Corteva Agriscience Netherlands B.V.Netherlands
Corteva Agriscience New Zealand LtdNew Zealand
Corteva Agriscience Nigeria LimitedNigeria
Corteva Agriscience Pacific LimitedHong Kong
Corteva Agriscience Pakistan LimitedPakistan
Corteva Agriscience Paraguay S.A.Paraguay
Corteva Agriscience Perú SACPeru
Corteva Agriscience Philippines, Inc.Philippines
Corteva Agriscience Poland Sp. z o.o.Warsaw
Corteva Agriscience Portugal, S.A.Portugal
Corteva Agriscience Puerto Rico, Inc.Iowa
Corteva Agriscience Romania S.R.L.Romania
Corteva Agriscience RSA Proprietary LimitedSouth Africa
Corteva Agriscience Rus LLCRussia
Corteva Agriscience S. de R.L. de C.V.México
Corteva Agriscience Seeds Private LimitedIndia
Corteva Agriscience Services India Private LimitedIndia
Corteva Agriscience SLO d.o.o.Slovenia
Corteva Agriscience Slovakia s.r.oSlovakia
Corteva Agriscience Spain, S.L.U.Asturias
Corteva Agriscience SRB d.o.o.Serbia
Corteva Agriscience Taiwan Co., Ltd.Taiwan
Corteva Agriscience Tanzania LimitedTanzania
Corteva Agriscience UK LimitedUnited Kingdom



Corteva Agriscience Ukraine LLCUkraine
Corteva Agriscience Uruguay S.A.Uruguay
Corteva Agriscience Vietnam Co., Ltd.Vietnam
Corteva Agriscience Worldwide, LLCDelaware
Corteva Agriscience Zambia LimitedZambia
Corteva Finance Company B.V.Netherlands
Corteva Global Holding Inc.Delaware
Corteva Holding France S.A.S.Versailles
Corteva Holding Mauritius LimitedMauritius
Corteva Holding Netherlands 1 B.V.Hoek
Corteva Holding Netherlands 2 B.V.Netherlands
Corteva Holding Netherlands 3 B.V.Netherlands
Corteva Holding Switzerland SàrlGeneva
Corteva Holding Zimbabwe (Private) LimitedZimbabwe
Corteva India Limited, LLCDelaware
Corteva International Holding CorporationDelaware
Corteva ITA Holding B.V.Netherlands
Corteva Seeds RSA Proprietary LimitedSouth Africa
Corteva Services SàrlGeneva
Corteva Turkey Tarim A.S.Istanbul
Corteva Turkey Tohumculuk A.S.Adana
Corteva US Feedstocks Company, LLCDelaware
Corteva, Inc.Delaware
Dairyland Seed Co., Inc.Wisconsin
Daser Agro S.A.Argentina
DDP AgroSciences Kenya LimitedKenya
DDP AgroSciences Nigeria LimitedNigeria
DDP AgroSciences S.R.L.Peru
DDP AgroSciences Switzerland GmbHGeneva
DDP AgroSciences US DCOMCO, Inc.Delaware
Desab S.A.Argentina
Dikanka Nasinnia LLCUkraine
Doeblers' Pennsylvania Hybrids, Inc.Pennsylvania
Dow AgroSciences (China) Company Limited Beijing BranchChina
Dow AgroSciences (China) Company Limited Shanghai BranchChina
Dow AgroSciences (China) Company LimitedChina
Dow AgroSciences (Jiangsu) Co., Ltd.China
Dow AgroSciences (Thailand) LimitedThailand
Dow AgroSciences Asia Sdn. Bhd.Malaysia
Dow AgroSciences Australia LimitedAustralia
Dow AgroSciences B.V. (Belgium Branch Office)Brussels
Dow AgroSciences B.V. (Philippines Branch Office)Philippines
Dow AgroSciences B.V. (Vietnam Representative Office) VAN PHONG DAI DIEN DOW AGROSCIENCES B.V TAI TP HO CHI MINHVietnam
Dow AgroSciences Chile S.A.Chile
Dow AgroSciences China Ltd. Beijing Representative OfficeChina
Dow Agrosciences de Mexico S.A. de C.V.México
Dow AgroSciences Distribution S.A.S.Versailles



Dow AgroSciences Export S.A.S.Versailles
Dow AgroSciences Export S.A.S. (Bulgaria Rep Office)Bulgaria
Dow AgroSciences Export S.A.S. (Romanian Representative Office)Romania
Dow AgroSciences Export SAS (Egypt Rep. Office)Egypt
Dow AgroSciences Export SAS (Ivory Coast Representative Office)Ivory Coast
Dow AgroSciences Hungary Kft (Szolnok Branch Office)Hungary
Dow AgroSciences Hungary Kft.Hungary
Dow AgroSciences Hungary Kft. (Szeged Branch Office)Hungary
Dow Agrosciences Iberica S.A.Spain
Dow AgroSciences India Pvt. Ltd.India
Dow AgroSciences Industrial Ltda.Brazil
Dow AgroSciences International Ltd.Delaware
Dow AgroSciences International Ltd. (Republic of Korea Branch Office)Korea
Dow AgroSciences Japan LimitedJapan
Dow AgroSciences OOORussia
Dow AgroSciences Singapore Pte. Ltd.Singapore
Dow AgroSciences Southern Africa (Proprietary) LimitedSouth Africa
Dow AgroSciences Sverige A/BStockholm
Dow AgroSciences Switzerland S.A.Geneva
Dow AgroSciences Taiwan Ltd.Taiwan
Dow AgroSciences Ukraine LLCUkraine
Dow AgroSciences Vertriebsgesellschaft m.b.H.Eisenstadt
Dow AgroSciences Vertriebsgesellschaft m.b.H. (Russian Representative Office)Russia
Dow AgroSciences Vertriebsgesellschaft m.b.H. (Ukraine Representative Office)Ukraine
Dow Venezuela, C.A.Venezuela
Du Pont Company (Singapore) Pte. Ltd.Singapore
Du Pont de Nemours (France) S.A.S.Versailles
Du Pont de Nemours Italiana S.r.l.Italy
Du Pont do Brasil S.A.Brazil
Du Pont Far East Inc - Philippines (Branch)Philippines
Du Pont Far East Inc.Delaware
Du Pont Production Agriscience (Malaysia) Sdn. Bdh.Malaysia
Ducoragro S.A. de C.V.México
Dunhuang Seed Pioneer Hi-Bred Company LimitedChina
DuPont (New Zealand) LimitedNew Zealand
DuPont Argentina SrlArgentina
DuPont Asturias S.L.Spain
DuPont Bangladesh LimitedBangladesh
DuPont Bulgaria EOODBulgaria
DuPont Capital Management CorporationDelaware
DuPont Chile S.A.Chile
DuPont Conid S.P.A.Delaware
DuPont Conid S.p.A.Italy
DuPont CZ s.r.o.Czech Republic
DuPont Danmark ApSDenmark
DuPont de Colombia, S.A.Colombia
DuPont de Nemours Investments Sàrl, en liquidationGeneva



DuPont de Nemours South Africa (Pty) Ltd.South Africa
DuPont de Nemours, Inc.Delaware
DuPont Deutschland Real Estate Partner GmbHOffenbach am Main
DuPont Global Operations, LLCDelaware
DuPont Hellas S.A.Greece
DuPont Magyarorszag KftHungary
DuPont Mexicana, S de RL de CVMéxico
DuPont Pioneer Investment Co., Ltd.China
DuPont Poland Sp z.o.o.Poland
DuPont Portugal Unipessoal Lda.Portugal
DuPont Production Agriscience Deutschland GmbHMuenchen
DuPont Quimica de Venezuela C.A.Venezuela
DuPont Romania S.R.L.Romania
DuPont Science and Technologies LLCRussia
DuPont Solutions (France) S.A.S.Versailles
DuPont South Africa Holdco (Pty) LtdSouth Africa
DuPont SRB d.o.o. BeogradSerbia
DuPont Turkey Endustri Urunleri Limited SirketiIstanbul
DuPont Ukraine LLCUkraine
E. I. du Pont de Nemours and CompanyDelaware
E. I. du Pont de Nemours and Company Inc.Delaware
Fedea S.A.Argentina
Grainit S.R.L.Italy
Granular Australia Pty LtdAustralia
Granular Brasil Licenciamento e Distribuição de Software de Agricultura Ltda.Brazil
Granular Canada CompanyCanada
Granular, Inc.Delaware
Griffin L.L.C. Valdosta, GeorgiaDelaware
Guang An LiVa Chemical Co., Ltd.China
Hoegemeyer Hybrids, Inc.Nebraska
MISR Pioneer Seeds Company S.A.E.Egypt
Mycogen Seeds-Puerto Rico CorporationDelaware
Nutech Seed, LLCDelaware
Orion Mexico, LLCDelaware
Pannar Industrial Holdings (Pty) Ltd.South Africa
Pannar International (Pty) Ltd.South Africa
Pannar Ltd.United Kingdom
Pannar Properties Zambia LimitedZambia
Pannar Research Farms (Pty) Ltd.South Africa
Pannar Seed (Pty) Ltd.South Africa
Pannar Seed (Zimbabwe) Private LimitedZimbabwe
Pannar Seed Kenya Ltd.Kenya
Pannar Seed LdaMozambique
PD Glycol LPTexas
PHI Financial Services Canada LimitedCanada
PHI Financial Services, Inc.Iowa
PHI Mexico, S.A. de C.V.México



PhPhilippines Holdings Inc.Philippines
Phytogen Seed Company, LLCDelaware
Pioneer Argentina, S.R.L.Argentina
Pioneer DuPont Zambia LimitedZambia
Pioneer Génétique SàrlToulouse
Pioneer Hi-Bred (Switzerland) S.A.Geneva
Pioneer Hi-Bred (Thailand) Co. LimitedThailand
Pioneer Hi-Bred (Zimbabwe) (Private) LimitedZimbabwe
Pioneer Hi-Bred Australia, Pty Ltd.Australia
Pioneer Hi-Bred Canada CompanyCanada
Pioneer Hi-Bred International Production LimitedTurks And Caicos Islands
Pioneer Hi-Bred International, Inc.Iowa
Pioneer Hi-Bred Italia S.r.l.Italy
Pioneer Hi-Bred Italia Sementi S.r.l.Italy
Pioneer Hi-Bred Italia Servizi Agronomici S.r.l.Italy
Pioneer Hi-Bred Magyarorszag KftBudapest
Pioneer Hi-Bred Northern Europe Sales Division GmbHMuenchen
Pioneer Hi-Bred Northern Europe Sales Division GmbH (Austria Branch)Austria
Pioneer Hi-Bred Northern Europe Sales Division GmbH (Belgium Branch)Belgium
Pioneer Hi-Bred Northern Europe Sales Division GmbH (Czech Republic Branch)Prague
Pioneer Hi-Bred Northern Europe Sales Division GmbH (Netherlands Branch)Netherlands
Pioneer Hi-Bred Northern Europe Sales Division GmbH (Poland Branch)Poland
Pioneer Hi-Bred Northern Europe Sales Division GmbH (UK Branch)United Kingdom
Pioneer Hi-Bred Northern Europe Service Division GmbHMuenchen
Pioneer Hi-Bred Poland Sp z.o.o.Warsaw
Pioneer HI-Bred Private LimitedIndia
Pioneer Hi-Bred Production CompanyCanada
Pioneer Hi-Bred Romania S.R.L.Romania
Pioneer Hi-Bred Seeds Ethiopia PLCEthiopia
Pioneer Hi-Bred Spain, S.L.Spain
Pioneer HI-Bred Vietnam Limited CÔNG TY TNHH PIONEER HI-BRED VIETNAMVietnam
Pioneer Mexico Holdings LLCIowa
Pioneer Overseas CorporationIowa
Pioneer Overseas Corporation (Branch in Belgium)Brussels
Pioneer Overseas Corporation (Branch in Egypt)Egypt
Pioneer Overseas Corporation (Branch in India)India
Pioneer Overseas Corporation (Branch in Zimbabwe)Zimbabwe
Pioneer Overseas Corporation (Hong Kong) Holdings No 1 LimitedHong Kong
Pioneer Overseas Corporation (Hong Kong) Holdings No 2 LimitedHong Kong
Pioneer Overseas Corporation (Hong Kong) LimitedHong Kong
Pioneer Overseas Corporation (Singapore) Pte LtdSingapore
Pioneer Overseas Corporation Merkezi Amerika Lüleburgaz Merkez ŞubesiLuleburgaz
Pioneer Seeds, Inc.Iowa
Pioneer Semences S.A.SToulouse
Pioneer Tohumculuk Distribution and MarketingAdana
Pioneer Turks & Caicos, LLCIowa
Pitt-Consol Chemical CompanyNew Jersey



Prochrom International S.A.Uruguay
Production Agriscience (Australia) Pty LtdAustralia
Production Agriscience Netherlands B.V.Netherlands
Production Agriscience UK LtdUnited Kingdom
PT Corteva Agriscience IndonesiaIndonesia
PT Corteva Agriscience Manufacturing IndonesiaIndonesia
PT Corteva Agriscience Seeds IndonesiaIndonesia
PT Dow AgroSciences Commerce IndonesiaIndonesia
Rindes y Cultivos DAS S.A.Argentina
Seed Consultants Inc.Ohio
Semillas Pioneer de Venezuela C.A.Venezuela
Shandong Denghai Pioneer Seeds Company LimitedChina
Sporting Goods Properties, Inc.Delaware
Stasi Nasinnia LLCUkraine
SUMIDAS JV S.A.Argentina
Terral Seed, Inc.Louisiana
Terramar JV S.A.Argentina
The Rep Office of DuPont Far East Inc, in Ho Chi Minh CityVietnam
Tieling Pioneer Seed Research Co., Ltd.China
Ubajay DAS S.A.Argentina


EX-23.1 3 ctva-12312021xex231.htm EX-23.1 Document

Exhibit 23.1







CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM


We hereby consent to the incorporation by reference in the Registration Statements on Form S‑3 (No. 333-231871) and Form S-8 (Nos. 333-231869 and 333-249887) of Corteva, Inc. of our report dated February 10, 2022 relating to the financial statements and financial statement schedule and the effectiveness of internal control over financial reporting of Corteva, Inc., which appears in this Form 10‑K.


/s/PricewaterhouseCoopers LLP
Philadelphia, Pennsylvania
February 10, 2022





EX-23.2 4 ctva-12312021xex232.htm EX-23.2 Document

Exhibit 23.2







CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM


We hereby consent to the incorporation by reference in the Registration Statement on Form S‑3 (No. 333-231871) of E. I. du Pont de Nemours and Company of our report dated February 10, 2022 relating to the financial statements and financial statement schedule and the effectiveness of internal control over financial reporting of E. I. du Pont de Nemours and Company, which appears in this Form 10‑K.


/s/PricewaterhouseCoopers LLP
Philadelphia, Pennsylvania
February 10, 2022





EX-31.1 5 ctva-12312021xex311.htm EX-31.1 Document

Exhibit 31.1
CERTIFICATIONS
I, Charles V. Magro, certify that:
1.I have reviewed this report on Form 10-K for the period ended December 31, 2021 of Corteva, Inc.;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c)Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d)Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
5.The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

  Date: February 10, 2022
  By: /s/ Charles V. Magro
Charles V. Magro
Chief Executive Officer



I, Charles V. Magro, certify that:
1.I have reviewed this report on Form 10-K for the period ended December 31, 2021 of E. I. du Pont de Nemours and Company;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c)Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d)Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
5.The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

  Date: February 10, 2022
  By: /s/ Charles V. Magro
Charles V. Magro
Chief Executive Officer


EX-31.2 6 ctva-12312021xex312.htm EX-31.2 Document

Exhibit 31.2
CERTIFICATIONS
I, David J. Anderson, certify that:
1.I have reviewed this report on Form 10-K for the period ended December 31, 2021 of Corteva, Inc.;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c)Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d)Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
5.The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date:February 10, 2022
By:/s/ David J. Anderson
David J. Anderson
Executive Vice President and
Chief Financial Officer



I, David J. Anderson, certify that:
1.I have reviewed this report on Form 10-K for the period ended December 31, 2021 of E. I. du Pont de Nemours and Company;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c)Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d)Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
5.The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date:February 10, 2022
By:
/s/ David J. Anderson
David J. Anderson
Executive Vice President and
Chief Financial Officer


EX-32.1 7 ctva-12312021xex321.htm EX-32.1 Document

Exhibit 32.1

Certification of CEO Pursuant to
18 U.S.C. Section 1350,
As Adopted Pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002
In connection with the Annual Report of Corteva, Inc. (the "Company") on Form 10-K for the period ending December 31, 2021 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), Charles V. Magro, as Chief Executive Officer of the Company, hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
(1)The Report fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934; and
(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ Charles V. Magro
Charles V. Magro
Chief Executive Officer
February 10, 2022



Certification of CEO Pursuant to
18 U.S.C. Section 1350,
As Adopted Pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002
In connection with the Annual Report of E. I. du Pont de Nemours and Company on Form 10-K for the period ending December 31, 2021 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), Charles V. Magro, as Chief Executive Officer of E. I. du Pont de Nemours and Company, hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
(1)The Report fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934; and
(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of E. I. du Pont de Nemours and Company.

/s/ Charles V. Magro
Charles V. Magro
Chief Executive Officer
February 10, 2022




EX-32.2 8 ctva-12312021xex322.htm EX-32.2 Document

Exhibit 32.2

Certification of CFO Pursuant to
18 U.S.C. Section 1350,
As Adopted Pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002
In connection with the Annual Report of Corteva, Inc. (the "Company") on Form 10-K for the period ending December 31, 2021 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), David J. Anderson, as Chief Financial Officer of the Company, hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
(1)The Report fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934; and
(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ David J. Anderson
David J. Anderson
Chief Financial Officer
February 10, 2022




Certification of CFO Pursuant to
18 U.S.C. Section 1350,
As Adopted Pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002
In connection with the Annual Report of E. I. du Pont de Nemours and Company on Form 10-K for the period ending December 31, 2021 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), David J. Anderson, as Chief Financial Officer of E. I. du Pont de Nemours and Company, hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
(1)The Report fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934; and
(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of E. I. du Pont de Nemours and Company.

/s/ David J. Anderson
David J. Anderson
Chief Financial Officer
February 10, 2022


EX-101.SCH 9 ctva-20211231.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 000010001 - Document - DEI Document link:presentationLink link:calculationLink link:definitionLink 000020002 - Document - Audit Information link:presentationLink link:calculationLink link:definitionLink 100010003 - Statement - Consolidated Statements of Income link:presentationLink link:calculationLink link:definitionLink 100020004 - Statement - Consolidated Statements of Comprehensive Income link:presentationLink link:calculationLink link:definitionLink 100030005 - Statement - Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 100040006 - Statement - Consolidated Balance Sheets (Parentheticals) link:presentationLink link:calculationLink link:definitionLink 100050007 - Statement - Consolidated Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 100060008 - Statement - Consolidated Statements of Equity link:presentationLink link:calculationLink link:definitionLink 100070009 - Statement - Consolidated Statements of Equity (Parentheticals) link:presentationLink link:calculationLink link:definitionLink 210011001 - Disclosure - Schedule II - Valuation and Qualifying Accounts (Notes) link:presentationLink link:calculationLink link:definitionLink 240024001 - Disclosure - Schedule II - Valuation and Qualifying Accounts (Details) link:presentationLink link:calculationLink link:definitionLink 210031002 - Disclosure - Background and Basis of Presentation (Notes) link:presentationLink link:calculationLink link:definitionLink 220042001 - Disclosure - Background and Basis of Presentation (Policies) link:presentationLink link:calculationLink link:definitionLink 240054002 - Disclosure - Background and Basis of Presentation (Details) link:presentationLink link:calculationLink link:definitionLink 210061003 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 220072002 - Disclosure - Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 240084003 - Disclosure - Summary of Significant Accounting Policies (Details) link:presentationLink link:calculationLink link:definitionLink 210091004 - Disclosure - Recent Accounting Guidance link:presentationLink link:calculationLink link:definitionLink 220102003 - Disclosure - Recent Accounting Guidance Recent Accounting Guidance (Policies) link:presentationLink link:calculationLink link:definitionLink 230113001 - Disclosure - Recent Accounting Guidance Accounting Pronouncements (Tables) link:presentationLink link:calculationLink link:definitionLink 210121005 - Disclosure - Common Control Business Combinations link:presentationLink link:calculationLink link:definitionLink 230133002 - Disclosure - Common Control Business Combinations (Tables) link:presentationLink link:calculationLink link:definitionLink 240144004 - Disclosure - Business Combinations DAS Common Control Transfer Income Statement (Details) link:presentationLink link:calculationLink link:definitionLink 210151006 - Disclosure - Divestitures and Other Transactions link:presentationLink link:calculationLink link:definitionLink 230163003 - Disclosure - Divestitures and Other Transactions (Tables) link:presentationLink link:calculationLink link:definitionLink 240174005 - Disclosure - Divestitures and Other Transactions Divestitures and Other Transactions - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 240184006 - Disclosure - Divestitures and Other Transactions ECP Divestiture (Details) link:presentationLink link:calculationLink link:definitionLink 240194007 - Disclosure - Divestitures and Other Transactions SP Divestiture (Details) link:presentationLink link:calculationLink link:definitionLink 240204008 - Disclosure - Divestitures and Other Transactions Divestitures and Other Transactions - Divested Ag Business Results of Operations (Details) link:presentationLink link:calculationLink link:definitionLink 240214009 - Disclosure - Divestitures and Other Transactions Divestitures and Other Transactions - PChem Results of Operations (Details) link:presentationLink link:calculationLink link:definitionLink 210221007 - Disclosure - Revenue (Notes) link:presentationLink link:calculationLink link:definitionLink 220232004 - Disclosure - Revenue from Contract with Customer (Policies) link:presentationLink link:calculationLink link:definitionLink 230243004 - Disclosure - Revenue (Tables) link:presentationLink link:calculationLink link:definitionLink 240254010 - Disclosure - Revenue Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 240264011 - Disclosure - Revenue Contract Balances (Details) link:presentationLink link:calculationLink link:definitionLink 240274012 - Disclosure - Revenue Disaggregation of Revenue - Products (Details) link:presentationLink link:calculationLink link:definitionLink 240284013 - Disclosure - Revenue Disaggregation of Revenue - Geo (Details) link:presentationLink link:calculationLink link:definitionLink 210291008 - Disclosure - Restructuring and Asset Related Charges link:presentationLink link:calculationLink link:definitionLink 230303005 - Disclosure - Restructuring and Asset Related Charges (Tables) link:presentationLink link:calculationLink link:definitionLink 240314014 - Disclosure - Restructuring and Asset Related Charges 2021 Restructuring Actions (Details) link:presentationLink link:calculationLink link:definitionLink 240324015 - Disclosure - Restructuring and Asset Related Charges Execute to Win Productivity Program (Details) link:presentationLink link:calculationLink link:definitionLink 240334016 - Disclosure - Restructuring and Asset Related Charges DowDuPont Cost Synergy Program (Details) link:presentationLink link:calculationLink link:definitionLink 240344017 - Disclosure - Restructuring and Asset Related Charges DowDuPont Agriculture Division Restructuring Program (Details) link:presentationLink link:calculationLink link:definitionLink 240354018 - Disclosure - Restructuring and Asset Related Charges Asset Impairments (Details) link:presentationLink link:calculationLink link:definitionLink 210361009 - Disclosure - Related Parties (Notes) link:presentationLink link:calculationLink link:definitionLink 240374019 - Disclosure - Related Parties Services Provided by and to Dow (Details) link:presentationLink link:calculationLink link:definitionLink 240384020 - Disclosure - Related Parties Transactions with DowDuPont (Details) link:presentationLink link:calculationLink link:definitionLink 210391010 - Disclosure - Supplementary Information link:presentationLink link:calculationLink link:definitionLink 230403006 - Disclosure - Supplementary Information (Tables) link:presentationLink link:calculationLink link:definitionLink 240414021 - Disclosure - Supplementary Information Other Income (Expense) - Net (Details) link:presentationLink link:calculationLink link:definitionLink 240424022 - Disclosure - Supplementary Information Foreign Currency Exchange Gain (Loss) (Details) link:presentationLink link:calculationLink link:definitionLink 240434023 - Disclosure - Supplementary Information Reconciliation of Cash, Cash Equivalents and Restricted Cash (Details) link:presentationLink link:calculationLink link:definitionLink 240444024 - Disclosure - Supplementary Information Supplementary Information (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 210451011 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 230463007 - Disclosure - Income Taxes (Tables) link:presentationLink link:calculationLink link:definitionLink 240474025 - Disclosure - Income Taxes Income Taxes - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 240484026 - Disclosure - Income Taxes Income Taxes - Geographic Allocation of Income and Provision for Income Taxes (Details) link:presentationLink link:calculationLink link:definitionLink 240494027 - Disclosure - Income Taxes Income Taxes - Reconciliation to US Statutory Rate (Details) link:presentationLink link:calculationLink link:definitionLink 240504028 - Disclosure - Income Taxes Income Taxes - Deferred Tax Balances (Details) link:presentationLink link:calculationLink link:definitionLink 240514029 - Disclosure - Income Taxes Income Taxes - Operating Loss and Tax Credit Carryforwards (Details) link:presentationLink link:calculationLink link:definitionLink 240524030 - Disclosure - Income Taxes Income Taxes - Gross Unrecognized Tax Benefits (Details) link:presentationLink link:calculationLink link:definitionLink 210531012 - Disclosure - Earnings Per Share of Common Stock (Notes) link:presentationLink link:calculationLink link:definitionLink 230543008 - Disclosure - Earnings Per Share of Common Stock (Tables) link:presentationLink link:calculationLink link:definitionLink 240554031 - Disclosure - Earnings Per Share Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 240564032 - Disclosure - Earnings Per Share Net Income for Earnings Per Share Calculations - Basic and Diluted (Details) link:presentationLink link:calculationLink link:definitionLink 240574033 - Disclosure - Earnings Per Share of Common Stock EPS Calculation - Basic (Details) link:presentationLink link:calculationLink link:definitionLink 240584034 - Disclosure - Earnings Per Share of Common Stock EPS Calculation - Diluted (Details) link:presentationLink link:calculationLink link:definitionLink 240594035 - Disclosure - Earnings Per Share Share Count Information (Details) link:presentationLink link:calculationLink link:definitionLink 210601013 - Disclosure - Accounts and Notes Receivable, Net link:presentationLink link:calculationLink link:definitionLink 230613009 - Disclosure - Accounts and Notes Receivable, Net (Tables) link:presentationLink link:calculationLink link:definitionLink 240624036 - Disclosure - Accounts and Notes Receivable, Net (Schedule of Accounts and Notes Receivable, Net) (Details) link:presentationLink link:calculationLink link:definitionLink 240634037 - Disclosure - Accounts and Notes Receivable Allowance Rollforward (Details) link:presentationLink link:calculationLink link:definitionLink 240644038 - Disclosure - Accounts and Notes Receivable, Net Customer Financing (Details) link:presentationLink link:calculationLink link:definitionLink 210651014 - Disclosure - Inventories link:presentationLink link:calculationLink link:definitionLink 230663010 - Disclosure - Inventories (Tables) link:presentationLink link:calculationLink link:definitionLink 240674039 - Disclosure - Inventories Schedule of Inventory (Details) link:presentationLink link:calculationLink link:definitionLink 240684040 - Disclosure - Inventories Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 210691015 - Disclosure - Property, Plant and Equipment link:presentationLink link:calculationLink link:definitionLink 230703011 - Disclosure - Property, Plant and Equipment (Tables) link:presentationLink link:calculationLink link:definitionLink 240714041 - Disclosure - Property, Plant and Equipment Schedule of Property, Plant and Equipment (Details) link:presentationLink link:calculationLink link:definitionLink 240724042 - Disclosure - Property, Plant and Equipment Schedule of Depreciation (Details) link:presentationLink link:calculationLink link:definitionLink 210731016 - Disclosure - Goodwill and Other Intangible Assets link:presentationLink link:calculationLink link:definitionLink 230743012 - Disclosure - Goodwill and Other Intangible Assets (Tables) link:presentationLink link:calculationLink link:definitionLink 240754043 - Disclosure - Goodwill and Other Intangible Assets Goodwill by Segment (Details) link:presentationLink link:calculationLink link:definitionLink 240764044 - Disclosure - Goodwill and Other Intangible Assets Other Intangible Assets (Details) link:presentationLink link:calculationLink link:definitionLink 240774045 - Disclosure - Goodwill and Other Intangible Assets Amortization Expense (Details) link:presentationLink link:calculationLink link:definitionLink 210781017 - Disclosure - Leases (Notes) link:presentationLink link:calculationLink link:definitionLink 230793013 - Disclosure - Leases (Tables) link:presentationLink link:calculationLink link:definitionLink 240804046 - Disclosure - Leases Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 240814047 - Disclosure - Leases Lease Costs (Details) link:presentationLink link:calculationLink link:definitionLink 240824048 - Disclosure - Leases Supplemental Cash Flow Information (Details) link:presentationLink link:calculationLink link:definitionLink 240834049 - Disclosure - Leases Supplemental Balance Sheet Information (Details) link:presentationLink link:calculationLink link:definitionLink 240844050 - Disclosure - Leases Lease Term and Discount Rate (Details) link:presentationLink link:calculationLink link:definitionLink 240854051 - Disclosure - Leases Maturity of Lease Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 240864052 - Disclosure - Leases Future Minimum Lease Commitments (Details) link:presentationLink link:calculationLink link:definitionLink 210871018 - Disclosure - Long-Term Debt and Available Credit Facilities link:presentationLink link:calculationLink link:definitionLink 230883014 - Disclosure - Long-Term Debt and Available Credit Facilities (Tables) link:presentationLink link:calculationLink link:definitionLink 240894053 - Disclosure - Long-Term Debt and Available Credit Facilities Long Term Debt (Details) link:presentationLink link:calculationLink link:definitionLink 240904054 - Disclosure - Long-Term Debt and Available Credit Facilities Available Committed Credit Facilities (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 240914055 - Disclosure - Long-Term Debt and Available Credit Facilities Debt Redemptions/Repayments (Details) link:presentationLink link:calculationLink link:definitionLink 240924056 - Disclosure - Long-Term Debt and Available Credit Facilities Uncommitted Credit Facilities and Outstanding Letters of Credit (Details) link:presentationLink link:calculationLink link:definitionLink 210931019 - Disclosure - Commitments and Contingent Liabilities link:presentationLink link:calculationLink link:definitionLink 230943015 - Disclosure - Commitments and Contingent Liabilities (Tables) link:presentationLink link:calculationLink link:definitionLink 240954057 - Disclosure - Commitments and Contingent Liabilities Guarantee Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 240964058 - Disclosure - Commitments and Contingent Liabilities Litigation - Chemours (Details) link:presentationLink link:calculationLink link:definitionLink 240974059 - Disclosure - Commitments and Contingent Liabilities Litigation - DuPont (Details) link:presentationLink link:calculationLink link:definitionLink 240984060 - Disclosure - Commitments and Contingent Liabilities Litigation - Leach and MDL Settlement (Details) link:presentationLink link:calculationLink link:definitionLink 240994061 - Disclosure - Commitments and Contingent Liabilities Litigation - Other PFOA Matters / Fayatteville (Details) link:presentationLink link:calculationLink link:definitionLink 241004062 - Disclosure - Commitments and Contingent Liabilities Environmental (Details) link:presentationLink link:calculationLink link:definitionLink 211011020 - Disclosure - Stockholders' Equity link:presentationLink link:calculationLink link:definitionLink 231023016 - Disclosure - Stockholders' Equity (Tables) link:presentationLink link:calculationLink link:definitionLink 241034063 - Disclosure - Stockholders' Equity Common Stock (Details) link:presentationLink link:calculationLink link:definitionLink 241044064 - Disclosure - Stockholders' Equity Noncontrolling Interest (Details) link:presentationLink link:calculationLink link:definitionLink 241054065 - Disclosure - Stockholders' Equity Other Comprehensive Income (Loss) (Details) link:presentationLink link:calculationLink link:definitionLink 241064066 - Disclosure - Stockholders' Equity Tax Benefit (Expense) on Net Activity (Details) link:presentationLink link:calculationLink link:definitionLink 241074067 - Disclosure - Stockholders' Equity Reclassifications out of AOCI (Details) link:presentationLink link:calculationLink link:definitionLink 211081021 - Disclosure - Pension Plans and Other Post Employment Benefit Plans link:presentationLink link:calculationLink link:definitionLink 231093017 - Disclosure - Pension Plans and Other Post Employment Benefit Plans (Tables) link:presentationLink link:calculationLink link:definitionLink 241104068 - Disclosure - Pension Plans and Other Post Employment Benefit Plans Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 241114069 - Disclosure - Pension Plans and Other Post Employment Benefit Plans Weighted Average Assumptions used to Determine Benefit Obligations - Pension (Details) link:presentationLink link:calculationLink link:definitionLink 241124070 - Disclosure - Pension Plans and Other Post Employment Benefit Plans Weighted Average Assumptions used to Determine Net Periodic Benefit Cost - Pension (Details) link:presentationLink link:calculationLink link:definitionLink 241134071 - Disclosure - Pension Plans and Other Post Employment Benefit Plans Weighted Average Assumptions used to Determine Benefit Obligations and Periodic Benefit Cost - OPEB (Details) link:presentationLink link:calculationLink link:definitionLink 241144072 - Disclosure - Pension Plans and Other Post Employment Benefit Plans Assumed Health Care Cost Trend Rates (Details) link:presentationLink link:calculationLink link:definitionLink 241154073 - Disclosure - Pension Plans and Other Post Employment Benefit Plans Change in Projected Benefit Obligations, Plan Assets and Funded Status (Details) link:presentationLink link:calculationLink link:definitionLink 241164074 - Disclosure - Pension Plans and Other Post Employment Benefit Plans Amounts Recognized in Consolidated Balance Sheets (Details) link:presentationLink link:calculationLink link:definitionLink 241174075 - Disclosure - Pension Plans and Other Post Employment Benefit Plans Pension Plans with Projected Benefit Obligations in Excess of Plan Assets (Details) link:presentationLink link:calculationLink link:definitionLink 241184076 - Disclosure - Pension Plans and Other Post Employment Benefit Plans Pension Plans with Accumulated Benefit Obligations in Excess of Plan Assets (Details) link:presentationLink link:calculationLink link:definitionLink 241194077 - Disclosure - Pension Plans and Other Post Employment Benefit Plans Components of net periodic benefit cost (credit) and amounts recognized in other comprehensive loss (Details) link:presentationLink link:calculationLink link:definitionLink 241204078 - Disclosure - Pension Plans and Other Post Employment Benefit Plans Estimated Future Benefit Payments (Details) link:presentationLink link:calculationLink link:definitionLink 241214079 - Disclosure - Pension Plans and Other Post Employment Benefit Plans Target Allocation for Plan Assets (Details) link:presentationLink link:calculationLink link:definitionLink 241224080 - Disclosure - Pension Plans and Other Post Employment Benefit Plans Basis of Fair Value Measurement (Details) link:presentationLink link:calculationLink link:definitionLink 241234081 - Disclosure - Pension Plans and Other Post Employment Benefit Plans Summary of Fair Value Measurement of Level 3 Pension Plan Assets (Details) link:presentationLink link:calculationLink link:definitionLink 211241022 - Disclosure - Stock-Based Compensation link:presentationLink link:calculationLink link:definitionLink 231253018 - Disclosure - Stock-Based Compensation (Tables) link:presentationLink link:calculationLink link:definitionLink 241264082 - Disclosure - Stock-Based Compensation Stock Compensation (Details) link:presentationLink link:calculationLink link:definitionLink 241274083 - Disclosure - Stock-Based Compensation Weighted Average Assumptions - Stock Options (Details) link:presentationLink link:calculationLink link:definitionLink 241284084 - Disclosure - Stock-Based Compensation Stock Options (Details) link:presentationLink link:calculationLink link:definitionLink 241294085 - Disclosure - Stock-Based Compensation Restricted Stock Units and Performance Deferred Stock (Details) link:presentationLink link:calculationLink link:definitionLink 211301023 - Disclosure - Financial Instruments link:presentationLink link:calculationLink link:definitionLink 231313019 - Disclosure - Financial Instruments (Tables) link:presentationLink link:calculationLink link:definitionLink 241324086 - Disclosure - Financial Instruments Financial Instruments (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 241334087 - Disclosure - Financial Instruments Notional Amounts (Details) link:presentationLink link:calculationLink link:definitionLink 241344088 - Disclosure - Financial Instruments Cash Flow Hedges Included in AOCI (Details) link:presentationLink link:calculationLink link:definitionLink 241354089 - Disclosure - Financial Instruments Fair Value of Derivatives (Details) link:presentationLink link:calculationLink link:definitionLink 241364090 - Disclosure - Financial Instruments Effect of Derivative Instruments (Details) link:presentationLink link:calculationLink link:definitionLink 241374091 - Disclosure - Financial Instruments Debt Securities (Details) link:presentationLink link:calculationLink link:definitionLink 241384092 - Disclosure - Financial Instruments Fair Value and Gross Unrealized Losses of investments (Details) link:presentationLink link:calculationLink link:definitionLink 211391024 - Disclosure - Fair Value Measurements link:presentationLink link:calculationLink link:definitionLink 231403020 - Disclosure - Fair Value Measurements (Tables) link:presentationLink link:calculationLink link:definitionLink 241414093 - Disclosure - Fair Value Measurements Fair Value Measurement Recurring Basis (Details) link:presentationLink link:calculationLink link:definitionLink 241424094 - Disclosure - Fair Value Measurements Fair Value Measurement Nonrecurring Basis (Details) link:presentationLink link:calculationLink link:definitionLink 211431025 - Disclosure - Geographic Information link:presentationLink link:calculationLink link:definitionLink 231443021 - Disclosure - Geographic Information (Tables) link:presentationLink link:calculationLink link:definitionLink 241454095 - Disclosure - Geographic Information Revenue by Country (Details) link:presentationLink link:calculationLink link:definitionLink 241464096 - Disclosure - Geographic Information Net Property by Country (Details) link:presentationLink link:calculationLink link:definitionLink 211471026 - Disclosure - Segment Reporting (Notes) link:presentationLink link:calculationLink link:definitionLink 231483022 - Disclosure - Segment Reporting (Tables) link:presentationLink link:calculationLink link:definitionLink 241494097 - Disclosure - Segment Reporting Segment Information (Details) link:presentationLink link:calculationLink link:definitionLink 241504098 - Disclosure - Segment Reporting Segment Reconciliation (Details) link:presentationLink link:calculationLink link:definitionLink 241514099 - Disclosure - Segment Reporting Segment Assets (Details) link:presentationLink link:calculationLink link:definitionLink 241524100 - Disclosure - Segment Reporting Other Items (Details) link:presentationLink link:calculationLink link:definitionLink 241534101 - Disclosure - Segment Reporting Sig Items (Details) link:presentationLink link:calculationLink link:definitionLink 211541027 - Disclosure - Quaterly Financial Data link:presentationLink link:calculationLink link:definitionLink 231553023 - Disclosure - Quaterly Financial Data (Tables) link:presentationLink link:calculationLink link:definitionLink 241564102 - Disclosure - Quaterly Financial Data Quarterly Financial Data (Details) link:presentationLink link:calculationLink link:definitionLink 241574103 - Disclosure - Quaterly Financial Data Quarterly Financial Data (Parentheticals) (Details) link:presentationLink link:calculationLink link:definitionLink 211581028 - Disclosure - Subsequent Events (Notes) link:presentationLink link:calculationLink link:definitionLink 241594104 - Disclosure - Subsequent Events (Details) link:presentationLink link:calculationLink link:definitionLink 211601029 - Disclosure - EID Basis of Presentation (Notes) link:presentationLink link:calculationLink link:definitionLink 241614105 - Disclosure - EID Basis of Presentation (Details) link:presentationLink link:calculationLink link:definitionLink 211621030 - Disclosure - EID Related Party (Notes) link:presentationLink link:calculationLink link:definitionLink 231633024 - Disclosure - EID Related Party (Tables) link:presentationLink link:calculationLink link:definitionLink 241644106 - Disclosure - EID Related Party (Details) link:presentationLink link:calculationLink link:definitionLink 211651031 - Disclosure - EID Income Taxes (Notes) link:presentationLink link:calculationLink link:definitionLink 231663025 - Disclosure - EID Income Taxes (Tables) link:presentationLink link:calculationLink link:definitionLink 241674107 - Disclosure - EID Income Taxes Geographic Allocation (Details) link:presentationLink link:calculationLink link:definitionLink 241684108 - Disclosure - EID Income Taxes Rate Reconciliation (Details) link:presentationLink link:calculationLink link:definitionLink 211691032 - Disclosure - EID Segment FN (Notes) link:presentationLink link:calculationLink link:definitionLink 231703026 - Disclosure - EID Segment FN (Tables) link:presentationLink link:calculationLink link:definitionLink 241714109 - Disclosure - EID Segment FN Segment Reconciliation (Details) link:presentationLink link:calculationLink link:definitionLink 241724110 - Disclosure - EID Segment FN Segment Asset Reconciliation (Details) link:presentationLink link:calculationLink link:definitionLink 211731033 - Disclosure - EID Quarterly FN (Notes) link:presentationLink link:calculationLink link:definitionLink 231743027 - Disclosure - EID Quarterly FN (Tables) link:presentationLink link:calculationLink link:definitionLink 241754111 - Disclosure - EID Quarterly FN (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 10 ctva-20211231_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 11 ctva-20211231_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 12 ctva-20211231_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Unrealized gain (loss) on investments AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Parent [Member] Agreements with lenders to provide financing for select customers [Member] Agreements with lenders to provide financing for select customers [Member] Agreements with lenders to provide financing for select customers Actuarial (gain) loss Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss) Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax MDL Settlement [Member] MDL Settlement [Member] MDL Settlement RSUs and PSUs vested during the period Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period Current State and Local Tax Expense (Benefit) Current State and Local Tax Expense (Benefit) Sale of JV [Member] Sale of JV [Member] Sale of JV [Member] Reconciliation of Other Significant Reconciling Items from Segments to Consolidated [Table] Reconciliation of Other Significant Reconciling Items from Segments to Consolidated [Table] Other Intangible Assets [Member] Other Intangible Assets [Member] Capital Expenditures Capital Expenditure, Discontinued Operations Short Term Borrowings and finance lease obligations Disposal Group, Including Discontinued Operation, Other Liabilities, Current Derivative Liability, Net Derivative Liability Scheduled for Trial [Member] Scheduled for Trial [Member] Scheduled for Trial Corporate Expenses Segment Reporting Reconciling Item Corporate Expenses Segment Reporting Reconciling Item Corporate Expenses Security Exchange Name Security Exchange Name Equity Securities Equity Securities, FV-NI, Current Quarterly Financial Information Disclosure [Abstract] Quarterly Financial Information Disclosure [Abstract] EMEA EMEA [Member] Weighted Average Grant Date Fair Value, RSUs and PSUs forfeited during the period Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Escrow Account Balance Escrow Account Balance Amount by which if escrow is below, on December 31, 2028, then Chemours will make 50% of the deposits and DuPont and Corteva together will make 50% of the deposits necessary to restore the balance of the escrow account to $700MM. Restructuring and asset related charges- net Restructuring and asset related charges- net Amount of restructuring charges, remediation cost, and asset impairment loss Beginning Balance Ending Balance Cash Flow Hedges Derivative Instruments at Fair Value, Net Schedule of Noncontrolling Interests Represented by Preferred Stock [Table Text Block] Schedule of Noncontrolling Interests Represented by Preferred Stock [Table Text Block] Schedule of Noncontrolling Interests Represented by Preferred Stock [Table Text Block] Contract Balances [Table Text Block] Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block] Dividends, Preferred Stock Dividends, Preferred Stock Operating Lease, Weighted Average Remaining Lease Term Operating Lease, Weighted Average Remaining Lease Term Foreign Currency Translation Foreign Currency Transactions and Translations Policy [Policy Text Block] Geographic Information [Text Block] Geographic Information [Text Block] Geographic Information [Text Block] Balance Sheet [Member] Balance Sheet [Member] Balance Sheet [Member] Current liabilities Liability, Defined Benefit Plan, Current Notes receivable - trade Financing Receivable, after Allowance for Credit Loss, Current Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Derivative Instruments Derivatives, Policy [Policy Text Block] Soybean [Member] Soybean [Member] Soybean [Member] Shares available for grant Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant Contract Termination [Member] Contract Termination [Member] Interest income Interest Income, Operating Increase (decrease) on cash, cash equivalents and restricted cash Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Intangible Assets [Line Items] Acquired Finite-Lived Intangible Assets [Line Items] Expected Volatility Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate Intrinsic value of stock options Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value Cash, Cash Equivalents, and Restricted Cash [Abstract] Cash, Cash Equivalents, and Restricted Cash [Abstract] Cash, Cash Equivalents, and Restricted Cash [Abstract] Effect of Fourth Quarter Events [Table] Effect of Fourth Quarter Events [Table] Reclassification out of Accumulated Other Comprehensive Income [Table Text Block] Reclassification out of Accumulated Other Comprehensive Income [Table Text Block] (Loss) Gain on sale or disposition of assets Gain (Loss) on Disposition of Assets Gain (Loss) on Disposition of Assets Non-U.S. plans with plan assets [Member] Non-U.S. plans with plan assets [Member] Non-U.S. plans with plan assets [Member] Firefighting Foam [Member] Firefighting Foam [Member] Firefighting Foam [Member] Additions charged to expenses SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense Intended Business Separations [Abstract] Intended Business Separations [Abstract] Intended Business Separations [Abstract] Other Comprehensive Income, Other, Net of Tax Other Comprehensive Income, Other, Net of Tax Amortization of Intangibles Amortization expense Amortization of Intangible Assets Schedule of Restructuring Reserve by Type of Cost [Table Text Block] Schedule of Restructuring Reserve by Type of Cost [Table Text Block] Insurance and Self Insurance Insurance and Self Insurance [Policy Text Block] Insurance and Self Insurance [Policy Text Block] Increases related to positions taken on items from prior years Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions Operating Lease, Weighted Average Discount Rate, Percent Operating Lease, Weighted Average Discount Rate, Percent Schedule of Inventory, Current [Table Text Block] Schedule of Inventory, Current [Table Text Block] Percentage of outstanding amounts borrowed utilized as collateral Percentage of outstanding amounts borrowed utilized as collateral Percentage of outstanding amounts borrowed utilized as collateral Geographic Area, Revenues from External Customers [Abstract] Geographic Area, Revenues from External Customers [Abstract] Geographic Area, Revenues from External Customers [Abstract] Finance Lease, Right-Of-Use Asset, Accumulated Depreciation Finance Lease, Right-Of-Use Asset, Accumulated Depreciation Amount of accumulated depreciation of finance lease right-of-use assets Subsequent Events [Abstract] Subsequent Events [Abstract] Schedule of Effect of Significant Unobservable Inputs, Changes in Plan Assets [Table Text Block] Schedule of Effect of Significant Unobservable Inputs, Changes in Plan Assets [Table Text Block] CTVA Related Party Liability CTVA Related Party Liability Payables to Corteva, Inc. related to Corteva's indemnification liabilities to Dow and DuPont per the Separation Agreements. Deferred Tax Assets, Net of Valuation Allowance Deferred Tax Assets, Net of Valuation Allowance Restricted Cash Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block] Business Acquisition [Axis] Business Acquisition [Axis] Income (Loss), Including Portion Attributable to Noncontrolling Interest, before Tax Income (Loss), Including Portion Attributable to Noncontrolling Interest, before Tax Exchange gains/losses Effective Income Tax Rate Reconciliation, Foreign Currency Exchange Gains (Losses), Percent Effective Income Tax Rate Reconciliation, Foreign Currency Exchange Gains (Losses), Percent Cash Flow Hedging [Member] Cash Flow Hedging [Member] Conversion - Corteva Distribution Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Converted, Number Amount of RSU’s and PSU’s that were converted into Corteva-denominated awards under the “Employer Method,” or into DuPont-denominated awards under the “Shareholder Method,” using a formula designed to preserve the intrinsic value of the awards immediately prior to and subsequent to the Corteva Distribution and moved to the OIP. Proceeds from the sale of property, businesses, and consolidated companies, net of cash divested Proceeds from the sale of property, businesses, and consolidated companies, net of cash divested Proceeds from the sale of property, businesses, and consolidated companies, net of cash divested Valuation Allowance [Line Items] Valuation Allowance [Line Items] 2016 Global Cost Savings and Restructuring Plan [Member] 2016 Global Cost Savings and Restructuring Plan [Member] 2016 Global Cost Savings and Restructuring Plan [Member] 2.800% Notes due 2023 [Member] 2.800% Notes due 2023 [Member] 2.800% Notes due 2023 [Member] Award Type [Domain] Award Type [Domain] Local Phone Number Local Phone Number Schedule of Available-for-sale Securities Reconciliation Schedule of Available-for-sale Securities Reconciliation [Table Text Block] Swiss Tax Reform [Member] Swiss Tax Reform [Member] Swiss Tax Reform [Member] Fair Value, Nonrecurring [Member] Fair Value, Nonrecurring [Member] Stock options exercisable at end of period Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number Amortization of unrecognized loss (gain) Defined Benefit Plan, Amortization of Gain (Loss) Operating Loss Carryforwards [Line Items] Operating Loss Carryforwards [Line Items] Goodwill and Other Intangible Assets Goodwill and Intangible Assets, Policy [Policy Text Block] Preferred stock, without par value – cumulative; 23,000,000 shares authorized; issued at December 31, 2020 and December 31, 2019 Preferred Stock, Value, Issued Superfund Sites [Member] Superfund Sites [Member] Superfund Sites [Member] Disease Categories for MDL Disease Categories for MDL Disease Categories for MDL La Porte La Porte [Member] La Porte Successor Period [Member] Successor Period [Member] Successor Period [Member] Corteva and DuPont stray liability sharing percentage for PFAS Corteva and DuPont stray liability sharing percentage for PFAS Corteva and DuPont stray liability sharing percentage for PFAS Retained Earnings [Member] Retained Earnings [Member] Proceeds from sale of ownership interest in nonconsolidated affiliates Proceeds from Divestiture of Businesses and Interests in Affiliates Contributions from Dow and DowDuPont Proceeds from Contributions from Parent Loss Contingency, Limited Sharing of Potential Future Liabilities, Period Loss Contingency, Limited Sharing of Potential Future Liabilities, Period Loss Contingency, Limited Sharing of Potential Future Liabilities, Period Utility Plant [Domain] Utility Plant [Domain] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] 12 months or more, Gross unrealized Losses Available-for-sale Securities, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss Investments, All Other Investments [Abstract] Investments, All Other Investments [Abstract] Costs Related To Contract Termination [Member] Costs Related To Contract Termination [Member] Costs Related To Contract Termination [Member] Deferred Tax Liabilities, Inventory Deferred Tax Liabilities, Inventory Derivative Instruments and Hedging Activities Disclosure [Abstract] Derivative Instruments and Hedging Activities Disclosure [Abstract] Senior Subordinated Notes [Member] Senior Subordinated Notes [Member] Property, Plant and Equipment [Line Items] Property, Plant and Equipment [Line Items] Entity Well-known Seasoned Issuer Entity Well-known Seasoned Issuer Within One Year Short-term Debt [Member] Integration and Separation Costs Business Combination, Integration And Separation Related Costs Integration and separation costs includes costs incurred to prepare for and close the Merger, post-Merger integration expenses and costs incurred to prepare for the Intended Business Separations. These costs primarily consist of financial advisory, information technology, legal, accounting, consulting and other professional advisory fees associated with preparation and execution of these activities. Debt, Weighted Average Interest Rate Debt, Weighted Average Interest Rate Fungicides [Member] Fungicides [Member] Fungicides [Member] Comprehensive Income (Loss) Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest Maturing in One to Five Years Other Long-term Investments [Member] Net periodic pension and OPEB benefit, net Pension and Other Postretirement Benefits Cost (Reversal of Cost) Property, Plant and Equipment - Net Disposal Group, Including Discontinued Operation, Property, Plant and Equipment Financing cash outflows from finance leases Finance Lease, Principal Payments U.S. state blended tax rate changes [Member] U.S. state blended tax rate changes [Member] U.S. state blended tax rate changes associated with the Internal Reorganizations De minimis threshold De minimis threshold De minimis requirement for which certain stray liabilities will be subject to for sharing arrangement between DuPont and Corteva. Other Tax (Benefit) Expense Other Tax Expense (Benefit) Deferred Revenue Increase (Decrease) in Deferred Revenue Interest Expense, Related Party Interest Expense, Related Party BRAZIL BRAZIL Other Income (Expense) - net Other Nonoperating Income (Expense) [Member] Basic earnings (loss) per share of common stock Earnings Per Share, Basic Loss of Consortium [Member] Loss of Consortium [Member] Loss of Consortium Revenue Revenue from Contract with Customer [Text Block] Exchange Ratio Exchange Ratio Exchange Ratio Document Information [Line Items] Document Information [Line Items] Due from Nonconsolidated Affiliates Due from Affiliates Change in cash classified as held for sale Disposal Group, Including Discontinued Operation, Cash and Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Amount of increase (decrease) in cash and cash equivalents attributable to disposal group held for sale or disposed of; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Nonvested RSUs and PSUs at beginning of period Nonvested RSUs and PSUs at end of period Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number Residual Value Guarantee [Member] Residual Value Guarantee [Member] Residual Value Guarantee [Member] Deferred Tax Assets, Tax Loss And Tax Credit Carryforwards Deferred Tax Assets, Operating Loss And Tax Credit Carryforwards Deferred Tax Assets, Operating Loss And Tax Credit Carryforwards CANADA CANADA Equity award conversion ratio Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Award Conversion Ratio Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Award Conversion Ratio Required Time to Remove Assets Required Time to Remove Assets Amount of time, from operations being ceased, that lease agreement requires assets to be removed. Foreign Currency Exchange Gain (Loss) [Table] Foreign Currency Exchange Gain (Loss) [Table] Foreign Currency Exchange Gain (Loss) [Table] Reporting Unit [Domain] Reporting Unit [Domain] Net Property By Geographic Area Schedule of Disclosure on Geographic Areas, Long-Lived Assets in Individual Foreign Countries by Country [Table Text Block] Impact of Internal Reorganizations Share-based Compensation Arrangement by Share-based Payment Award, Awards other than Options, Impact of Internal Reorganizations Number of RSU's and PSU's that were impacted by the Internal Reorganizations. Stray liability threshold Stray liability threshold Amount over and above specified amounts of liability, for which Corteva and DuPont are responsible for strays. SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block] SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block] Accounts Payable Disposal Group, Including Discontinued Operation, Accounts Payable DowDuPont Cost Synergy Program [Member] DowDuPont Cost Synergy Program [Member] DowDuPont Cost Synergy Program [Member] Other Assets Assets for Plan Benefits, Defined Benefit Plan Machinery and Equipment [Member] Machinery and Equipment [Member] Unrealized Exchange Gains / Losses Deferred Tax Assets, Unrealized Currency Losses Net Deferred Tax Liability Deferred Tax Liabilities, Net Other net loss Other Noncash Income (Expense) Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Changes, Purchase of Interest by Parent Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Changes, Purchase of Interest by Parent Deferred Tax Liabilities, Property Deferred Tax Liabilities, Property, Plant and Equipment Withdrawal Amount after Year 6 Withdrawal Amount after Year 6 Withdrawal Amount after Year 6 Investments measured at net asset value [Member] Investments measured at net asset value [Member] Investments measured at net asset value [Member] Accounts Payable, Other Accounts Payable, Other Accounts and notes receivable - net Total accounts and notes receivable - net Receivables, Net, Current Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] Disposal Groups, Including Discontinued Operations [Table] Disposal Groups, Including Discontinued Operations [Table] Entity Voluntary Filers Entity Voluntary Filers Defined Benefit Plan, Plan Assets, Category [Domain] Defined Benefit Plan, Plan Assets, Category [Domain] Total Escrow Deposit Amount Total Escrow Deposit Amount From September 30, 2021 through September 30, 2028, Chemours will deposit a total of $500 million in the escrow account and DuPont and Corteva will deposit an additional $500 million pursuant to the terms of the Letter Agreement. Plan Name [Axis] Plan Name [Axis] Derivative Liability, Counterparty and Cash Collateral Netting Derivative Liability, Fair Value, Gross Asset and Right to Reclaim Cash, Offset Seed [Member] Seed [Member] Seed [Member] Discontinued Operations, Policy [Policy Text Block] Discontinued Operations, Policy [Policy Text Block] Fair Value, Inputs, Level 1 [Member] Fair Value, Inputs, Level 1 [Member] Goodwill Impairment Charge Goodwill, Impairment Loss Execute to Win Productivity Program [Domain] Execute to Win Productivity Program [Domain] Execute to Win Productivity Program [Domain] Income Tax Disclosure [Abstract] Income Tax Disclosure [Abstract] Entity Small Business Entity Small Business Cash and Cash Equivalents [Member] Cash and Cash Equivalents [Member] Marketable securities Short Term Investments, Fair Value Disclosure Short Term Investments, Fair Value Disclosure Increases related to positions taken in the current year Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions Finite-Lived Intangible Assets [Line Items] Finite-Lived Intangible Assets [Line Items] Accounts Receivable, after Allowance for Credit Loss Accounts Receivable, after Allowance for Credit Loss Other [Member] Other [Member] Other [Member] Cash Transferred to DowDuPont at Internal Reorganizations Cash transferred at Internal Reorganization Cash transferred at Internal Reorganization Other Income - net Disposal Group, Including Discontinued Operation, Nonoperating Income (Expense) Amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business), attributable to the disposal group including, but not limited to, discontinued operations. Income (loss) from continuing operations attributable to Corteva common stockholders Net Income (Loss) from Continuing Operations Available to Common Shareholders, Basic and Diluted Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) from continuing operations available to common shareholders. Scenario [Axis] Scenario [Axis] Plan amendments Defined Benefit Plan, Benefit Obligation, Increase (Decrease) for Plan Amendment Additional Paid in Capital Additional Paid in Capital Schedule of Pension Plans and Other Postemployment Benefits [Table Text Block] Schedule of Defined Benefit Plans Disclosures [Table Text Block] Business Combination, Fair Value, Amortized to Stock Comp Expense Business Combination, Consideration Transferred, Equity Interests Issued and Issuable, Converted But Not Yet Earned Business Combination, Consideration Transferred, Equity Interests Issued and Issuable, Converted But Not Yet Earned Schedule of Supplemental Cash Flow Information Related to Leases [Table Text Block] Schedule of Supplemental Cash Flow Information Related to Leases [Table Text Block] Schedule of supplemental cash flow information related to leases Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) Assets at Fair Value Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) Total unrecognized tax benefits that, if recognized, would impact the effective tax rate Unrecognized Tax Benefits that Would Impact Effective Tax Rate Accounts Payable Increase (Decrease) in Accounts Payable Hedging Relationship [Domain] Hedging Relationship [Domain] Amount of Employer and Related Party Securities Included in Plan Assets, Percent Defined Benefit Plan, Amount of Employer and Related Party Securities Included in Plan Assets, Percent Defined Benefit Plan, Amount of Employer and Related Party Securities Included in Plan Assets, Percent Foreign currency exchange contract settlements Payments for (Proceeds from) Derivative Instrument, Investing Activities SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table] SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table] After-Tax Effect of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) [Table Text Block] Entity Interactive Data Current Entity Interactive Data Current 2025 Finite-Lived Intangible Asset, Expected Amortization, Year Four U.S. research and development credit Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent Additional Financial Information Disclosure [Text Block] Additional Financial Information Disclosure [Text Block] Senior Notes Due 2030 [Member] Senior Notes Due 2030 [Member] Senior Notes Due 2030 Settlement of uncertain tax positions with tax authorities Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities Royalty Expense Royalty Expense, Policy [Policy Text Block] Royalty Expense, Policy [Policy Text Block] Preferred Stock, Redemption Amount Preferred Stock, Redemption Amount Settlement loss Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Reconciliation of Assets from Segment to Consolidated [Table Text Block] Reconciliation of Assets from Segment to Consolidated [Table Text Block] Retirement Plan Name [Axis] Retirement Plan Name [Axis] Other Asset Related [Member] Other Asset Related [Member] Other Asset Related Fair Value, Assets Measured on Nonrecurring Basis [Table Text Block] Fair Value, Assets Measured on Recurring and Nonrecurring Basis [Table Text Block] Balance Sheet Location [Domain] Balance Sheet Location [Domain] Comprehensive Income Attributable to Noncontrolling Interest- net of tax Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest Reconciliation of Common Stock Share Activity Schedule of Stock by Class [Table Text Block] Share Count Information [Table Text Block] Share Count Information [Table Text Block] [Table Text Block] for Share Count Information [Table] Unrecognized Tax Benefits, Beginning Balance Unrecognized Tax Benefits, Ending Balance Unrecognized Tax Benefits Subsidiary Monetary Position Subsidiaries [Member] Income Tax Authority [Domain] Income Tax Authority [Domain] Deferred Tax Assets, Gross Deferred Tax Assets, Gross Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Entity Address, State or Province Entity Address, State or Province Environmental Matters Environmental Costs, Policy [Policy Text Block] Restructuring Reserve, Beginning Balance Restructuring Reserve, Ending Balance Restructuring Reserve Leases of Lessee Disclosure [Text Block] Leases of Lessee Disclosure [Text Block] Deferred Tax Liabilities, Unrealized Exchange Gains/Losses Deferred Tax Liabilities, Unrealized Currency Transaction Gains Execute to Win Productivity Program Execute to Win Productivity Program [Member] Execute to Win Productivity Program Deferred Income Taxes Deferred Income Tax Assets, Net Quarterly Financial Data [Abstract] Quarterly Financial Data [Abstract] Restatement [Axis] Revision of Prior Period [Axis] Restructuring Plan [Domain] Restructuring Plan [Domain] Stock options exercisable, weighted average exercise price Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price Business Combination, Conversion Ratio Business Combination, Consideration Transferred, Equity Interests Issued and Issuable, Conversion Ratio Business Combination, Consideration Transferred, Equity Interests Issued and Issuable, Conversion Ratio Loss Contingency, Threatened Claims, Number Loss Contingency, Threatened Claims, Number Loss Contingency, Threatened Claims, Number Other Comprehensive Income Location [Domain] Other Comprehensive Income Location [Domain] Inventory Disclosure [Text Block] Inventory Disclosure [Text Block] Tax benefits (expenses) on exchange (loss) gain Foreign Currency Transaction Gain (Loss) Tax Foreign Currency Transaction Gain (Loss) Tax Equity Securities [Member] Equity Securities [Member] Total accrual for interest and penalties associated with unrecognized tax benefits Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued Amortization of Intangibles Disposal Group Including Discontinued Operation Amortization of Intangible Assets Amount of restructuring charges, remediation cost, and asset impairment loss attributable to the disposal group including, but not limited to, discontinued operations. Accounting Policies [Abstract] Accounting Policies [Abstract] 2023 Defined Benefit Plan, Expected Future Benefit Payment, Year Four Derivative Instrument [Axis] Derivative Instrument [Axis] Stock options outstanding, weighted average remaining contractual term Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Total operating lease liabilities Operating Lease, Liability Current Federal Tax (Benefit) Expense Current Federal Tax Expense (Benefit) Document Transition Report Document Transition Report Common stock Common Stock, Value, Issued Finance Lease, Weighted Average Discount Rate, Percent Finance Lease, Weighted Average Discount Rate, Percent Amortization of inventory step-up Business Combinations Inventory Fair Value Adjustment Business Combinations Inventory Fair Value Adjustment Total Liabilities of discontinued operations Disposal Group, Including Discontinued Operation, Liabilities Remaining Weighted-Average Recognition Period Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Weighted average grant date fair value, nonvested RSUs and PSUs beginning of period Weighted average grant date fair value, nonvested RSUs and PSUs end of period Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Finance Lease, Right-of-Use Asset, Amortization Finance Lease, Right-of-Use Asset, Amortization Defined Benefit Plan, Unfunded Status of Plan Funded (unfunded) status of plan Defined Benefit Plan, Funded (Unfunded) Status of Plan Operating Leases, Future Minimum Payments 2021 Operating Leases, Future Minimum Payments, Due in Three Years Weighted Average Assumptions - Stock Option Awards Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Prior service cost (benefit) Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), before Tax Revolving Credit Facilities due 2024 [Member] Revolving Credit Facilities due 2024 [Member] Revolving Credit Facilities due 2024 [Member] Deferred Foreign Income Tax Expense (Benefit) Deferred Foreign Income Tax Expense (Benefit) Pension and OPEB contributions Payment for Pension and Other Postretirement Benefits Legal Entity [Axis] Legal Entity [Axis] Goodwill [Line Items] Goodwill [Line Items] ECP Disposal [Member] ECP Disposal [Member] ECP Disposal [Member] Health care cost trend rate assumed for next year Defined Benefit Plan, Health Care Cost Trend Rate Assumed, Next Fiscal Year Marketable Securities Marketable Securities, Policy [Policy Text Block] Class of Stock [Axis] Class of Stock [Axis] Defined Benefit Plans and Other Postretirement Benefit Plans [Domain] Defined Benefit Plans & Other Postretirement Benefit Plans [Domain] [Domain] for Information by defined benefits pension or other postretirement plan or groupings of similar plans. Income Tax Contingency [Line Items] Income Tax Contingency [Line Items] Revenue Recognition, Services, Licensing Fees Revenue Recognition, Services, Licensing Fees [Policy Text Block] Income Tax Authority [Axis] Income Tax Authority [Axis] Alabama Water Utility [Member] Alabama Water Utility [Member] Alabama Water Utility Loss Contingency, Number of Property Owners Loss Contingency, Number of Property Owners Loss Contingency, Number of Property Owners Final Maturity 2018 Promissory Notes and Debentures, Final Maturity Current Year [Member] Promissory Notes and Debentures, Final Maturity Current Year [Member] Capital expenditures Payments to Acquire Productive Assets Noncontrolling Interest [Line Items] Noncontrolling Interest [Line Items] Finance Lease, Due After Year Five Finance Lease, Liability, to be Paid, after Year Five DowDuPont Agriculture Division Restructuring Program [Member] DowDuPont Agriculture Division Restructuring Program [Member] DowDuPont Agriculture Division Restructuring Program [Member] Common Stock Dividends Common Stock, Dividends, Per Share, Declared Accrued and other current liabilities Accrued Liabilities, Current Entity [Domain] Entity [Domain] Asset sale [Member] Asset sale [Member] Asset sale [Member] Accounts and Notes Receivables, Net Loans, Notes, Trade and Other Receivables Disclosure [Text Block] Share-based Payment Arrangement, Option [Member] Share-based Payment Arrangement, Option [Member] Equity [Abstract] Equity [Abstract] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Consolidation Items [Domain] Consolidation Items [Domain] Deferred Tax Assets, Property, Plant and Equipment Deferred Tax Assets, Property, Plant and Equipment Dow [Member] Dow [Member] Dow [Member] Once $300 million threshold is met [Member] Once $300 million threshold is met [Member] Once $300 million threshold is met [Member] Fair Value of Plan Assets, Excluding Trust Receivables and payables and assets measured at NAV Defined Benefit Plan, Fair Value of Plan Assets, Excluding Net Asset Value Investments Defined Benefit Plan, Fair Value of Plan Assets, Excluding Net Asset Value Investments $3.50 Series Preferred Stock [Member] $3.50 Series Preferred Stock [Member] $3.50 Series Preferred Stock [Member] Developed technology, other, and IPR&D [Member] Developed technology, other, and IPR&D [Member] Developed technology, other, and IPR&D Operating Loss Carryforwards [Table] Operating Loss Carryforwards [Table] Variable Rate [Axis] Variable Rate [Axis] Other discontinued operations [Member] Other discontinued operations [Member] Other discontinued operations [Member] Senior Note Floating Rate Due 2020 [Member] Senior Note Floating Rate Due 2020 [Member] Senior Note Floating Rate Due 2020 [Member] Segment Reporting Disclosure [Text Block] Segment Reporting Disclosure [Text Block] Finance Lease, Weighted Average Remaining Lease Term Finance Lease, Weighted Average Remaining Lease Term Property, Plant and Equipment - Depreciation Expense [Table Text Block] Property, Plant and Equipment - Depreciation Expense [Table Text Block] Property, Plant and Equipment - Depreciation Expense [Table Text Block] Unrecognized Tax Benefits, Impact of Internal Reorganizations Unrecognized Tax Benefits, Impact of Internal Reorganizations Unrecognized Tax Benefits, Impact of Internal Reorganizations Acquisition of a noncontrolling interest in consolidated subsidiaries Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests Property, Plant and Equipment [Table] Property, Plant and Equipment [Table] Debt Securities, Available-for-sale [Line Items] Debt Securities, Available-for-sale [Line Items] Inventories and Other Operating Assets Increase (Decrease) in Inventories and Other Operating Assets DAS Divested Ag Business [Member] [Member] DAS Divested Ag Business [Member] [Member] DAS Divested Ag Business [Member] [Member] Document Fiscal Year Focus Document Fiscal Year Focus Property, Plant and Equipment [Abstract] Property, Plant and Equipment [Abstract] Variable Rate [Domain] Variable Rate [Domain] Additional Paid-in Capital [Member] Additional Paid-in Capital [Member] Performance Chemicals [Member] Performance Chemicals [Member] Performance Chemicals [Member] Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table] Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table] 2025-2029 Defined Benefit Plan, Expected Future Benefit Payment, after Year Five for Next Five Years Tax Cuts and Jobs Act of 2017, Incomplete Accounting, Transition Tax for Accumulated Foreign Earnings, Provisional Income Tax Expense Tax Cuts and Jobs Act of 2017, Incomplete Accounting, Transition Tax for Accumulated Foreign Earnings, Provisional Income Tax Expense (Benefit) Tax Cuts and Jobs Act of 2017, Incomplete Accounting, Transition Tax for Accumulated Foreign Earnings, Provisional Income Tax Expense (Benefit) Long-term Debt, Type [Domain] Long-term Debt, Type [Domain] Derivative Asset, Counterparty and Cash Collateral Netting Derivative Asset, Fair Value, Gross Liability and Obligation to Return Cash, Offset Non-PFAS Non-PFAS [Member] Non-PFAS Entity Information [Line Items] Entity Information [Line Items] Grants between 2013 and 2015 [Member] Grants between 2013 and 2015 [Member] Grants between 2013 and 2015 [Member] Environmental Remediation Site [Domain] Environmental Remediation Site [Domain] Foreign Currency Loans [Member] Foreign Currency Loans [Member] Foreign Currency Loans [Member] Other Assets [Member] Other Assets [Member] Other Pension Plan [Member] Other Pension Plan [Member] Long-term Debt, Fair Value Long-term Debt, Fair Value Audit Information [Abstract] Audit Information Stock Repurchased and Retired During Period, Shares Stock Repurchased and Retired During Period, Shares Equity earning effect Effective Income Tax Rate Reconciliation, Equity in Earnings (Losses) of Unconsolidated Subsidiary, Percent Other investing activities - net Payments for (Proceeds from) Other Investing Activities Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Table] Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Table] Business Combinations [Abstract] Business Combinations [Abstract] Maximum [Member] Maximum [Member] Share-based Payment Arrangement [Abstract] Share-based Payment Arrangement [Abstract] Other Discontinued or Divested Business Obligations Other Discontinued or Divested Business Obligations [Member] Other Discontinued or Divested Business Obligations Guarantor Obligations, Nature [Axis] Guarantor Obligations, Nature [Axis] Loss Contingency, Nature [Domain] Loss Contingency, Nature [Domain] Payment Timing [Domain] Payment Timing [Domain] [Domain] for Payment Timing [Axis] Total recognized in net periodic benefit cost and other comprehensive (income) loss Defined Benefit Plan, Amount Recognized in Net Periodic Benefit Cost (Credit) and Other Comprehensive (Income) Loss, before Tax Provision for (Benefit from) Deferred Income Tax Deferred Income Tax Expense (Benefit), Continuing Operations and Discontinued Operations Deferred Income Tax Expense (Benefit), Continuing Operations and Discontinued Operations Schedule of Guarantor Obligations [Table] Schedule of Guarantor Obligations [Table] Award Type [Axis] Award Type [Axis] SAB 118 Impact of Enactment of U.S. Tax Reform Effective Income Tax Rate Reconciliation Tax Cuts And Jobs Act Of 2017 Percentage Effective Income Tax Rate Reconciliation Tax Cuts And Jobs Act Of 2017 Percentage Net effects of acquisitions / divestitures / other Defined Benefit Plan, Business Combinations And Acquisitions And Divestitures, Plan Assets Defined Benefit Plan, Business Combinations And Acquisitions And Divestitures, Plan Assets Non-operating benefits - net Non-operating (benefits) costs - net Non-operating (benefits) costs - net Total Company Stockholders' Equity Stockholders' Equity Attributable to Parent Settled Litigation [Member] Settled Litigation [Member] Accounts and Notes Receivable Increase (Decrease) in Accounts and Notes Receivable Asset Retirement Obligation Costs [Member] Asset Retirement Obligation Costs [Member] Effect of Fourth Quarter Events [Line Items] Effect of Fourth Quarter Events [Line Items] City Area Code City Area Code Stock options exercisable, intrinsic value Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value Environmental Remediation Stray Liabilities [Domain] Environmental Remediation Stray Liabilities [Domain] [Domain] for Environmental Remediation Stray Liabilities [Axis] Request for Remediation Funding Source ("RFS") Request for Remediation Funding Source ("RFS") On January 28, 2022, the State of New Jersey filed a request for a preliminary injunction against EID and Chemours seeking an establishment of a Request for Remediation Funding Source ("RFS") for environmental remediation at EID's former Chambers Works facility in New Jersey. Designated as Hedging Instrument [Member] Designated as Hedging Instrument [Member] Management [Member] Management [Member] DAS [Member] DAS [Member] DAS [Member] Goodwill and Intangible Assets Disclosure [Abstract] Goodwill and Intangible Assets Disclosure [Abstract] SMR notes [Member] SMR notes [Member] SMR notes [Member] Repurchase of Common Stock Payments for Repurchase of Common Stock Payments for Repurchase of Common Stock Payments for Repurchase of Common Stock Property, Plant and Equipment, Useful Life Property, Plant and Equipment, Useful Life Deferred Tax Assets, Other Accruals and Reversals Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Other Pre-tax gain on disposal Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal Equity, Class of Treasury Stock [Line Items] Equity, Class of Treasury Stock [Line Items] 2021 Restructuring Actions [Member] 2021 Restructuring Actions [Member] 2021 Restructuring Actions Accrued and Other Current Liabilities [Member] Accrued and Other Current Liabilities [Member] Accrued and Other Current Liabilities [Member] Noncurrent operating lease liabilities Operating Lease, Liability, Noncurrent Contributions to Trust Employer contribution to trust Contribution to Trust Finance Lease, Total Payments Finance Lease, Liability, Payment, Due Debt Instrument, Face Amount Debt Instrument, Face Amount Total current tax expense (benefit) Current Income Tax Expense (Benefit) Gain (Loss) on Investments [Member] Gain (Loss) on Investments [Member] Net periodic benefit cost (credit) Defined Benefit Plan, Net Periodic Benefit Cost (Credit) Assets of discontinued operations - current [Member] Assets of discontinued operations [Member] Assets of discontinued operations [Member] U.S. Retirement Savings Plan [Member] U.S. Retirement Savings Plan [Member] U.S. Retirement Savings Plan [Member] Tax Benefit from Compensation Expense Share-based Payment Arrangement, Expense, Tax Benefit Shares of DowDuPont Common Stock Held [Member] Shares of DowDuPont Common Stock Held [Member] Shares of DowDuPont Common Stock Held [Member] Operating Segments [Member] Operating Segments [Member] Schedule of Defined Benefit Plans Disclosures [Table] Schedule of Defined Benefit Plans Disclosures [Table] Stray liability sharing percentage Stray liability sharing percentage Stray liability sharing percentage Restricted Stock Units (RSUs) [Member] Restricted Stock Units (RSUs) [Member] Selling, General and Administrative Expenses Selling, General and Administrative Expenses, Policy [Policy Text Block] Corn [Member] Corn [Member] Corn [Member] Restatement [Domain] Revision of Prior Period [Domain] Finance Lease, Liability Finance Lease, Liability Fair value of plan assets Defined Benefit Plan, Plan with Accumulated Benefit Obligation in Excess of Plan Assets, Plan Assets Employer Matching Contribution, Percent of Match Defined Contribution Plan, Employer Matching Contribution, Percent of Match Deferred Tax Liabilities, Gross Deferred Tax Liabilities, Gross Business Acquisition [Line Items] Business Acquisition [Line Items] Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items] Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items] Share Repurchase Program [Axis] Share Repurchase Program [Axis] Restrictions on Cash and Cash Equivalents Restrictions on Cash and Cash Equivalents [Table Text Block] Investments in nonconsolidated affiliates Equity Method Investments Income Statement [Abstract] Income Statement [Abstract] RSU and PSU Activity Share-based Payment Arrangement, Outstanding Award, Activity, Excluding Option [Table Text Block] Entity Registrant Name Entity Registrant Name Company [Domain] Company [Domain] Company Number of Countries in which Entity Operates Number of Countries in which Entity Operates Proceeds from Dividends Received Proceeds from Dividends Received Finance Lease, Year Three Finance Lease, Liability, to be Paid, Year Three Finance Lease, Year Four Finance Lease, Liability, to be Paid, Year Four Deductions from reserves SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction Plan participants' contributions Defined Benefit Plan, Benefit Obligation, Contributions by Plan Participant Real Estate [Member] Real Estate [Member] Senior Note 2.20 Percent Due 2020 [Member] Senior Note 2.20 Percent Due 2020 [Member] Senior Note 2.20 Percent Due 2020 [Member] Provision for (benefit from) income taxes on continuing operations Income Tax Expense (Benefit) Income Tax Expense (Benefit) Other Commitments [Domain] Other Commitments [Domain] Other goodwill adjustments and acquisitions Goodwill, Other Increase (Decrease) Net Income (Loss) Attributable to Nonredeemable Noncontrolling Interest Net Income (Loss) Attributable to Nonredeemable Noncontrolling Interest 2022 Defined Benefit Plan, Expected Future Benefit Payment, Year Three Accounts receivable - trade Accounts Receivable, after Allowance for Credit Loss, Current Deferred Tax Assets, Inventory Deferred Tax Assets, Inventory Asia Pacific Asia Pacific [Member] Accumulated Other Comprehensive Income (Loss) [Table] Accumulated Other Comprehensive Income (Loss) [Table] Current Portion [Member] Current Portion [Member] Current Portion [Member] Selling, General and Administrative Disposal Group, Including Discontinued Operation, General and Administrative Expense Entity Tax Identification Number Entity Tax Identification Number Hedge Funds [Member] Hedge Funds [Member] 6.500% Debentures due 2028 [Member] 6.500% Debentures due 2028 [Member] 6.500% Debentures due 2028 [Member] Investment Type [Axis] Investment Type [Axis] Document Fiscal Period Focus Document Fiscal Period Focus Total current assets Assets, Current Compensatory Damages [Member] Compensatory Damages [Member] Compensatory Damages Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] Operating Lease, Total Payments Lessee, Operating Lease, Liability, to be Paid RSUs and PSUs forfeited during the period Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period Class of Treasury Stock [Table] Schedule of Stock by Class [Table] Document and Entity Information [Abstract] Document and Entity Information [Abstract] Document and Entity Information [Abstract] DuPont and Chemours Payment [Member] DuPont and Chemours Payment [Member] DuPont and Chemours Payment Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract] SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract] Long-term Debt Disposal Group, Including Discontinued Operation, Other Liabilities Fair Value Measurements Fair Value Measurement, Policy [Policy Text Block] Unrecognized Pretax Compensation Expense Related to Stock Options Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount Long-term debt payable within one year Long-term Debt, Current Maturities Operating Leases, Future Minimum Payments 2023 Operating Leases, Future Minimum Payments, Due in Five Years Property, Plant and Equipment, Type [Domain] Long-Lived Tangible Asset [Domain] Derivative Instruments, Gain (Loss) [Line Items] Derivative Instruments, Gain (Loss) [Line Items] Restructuring Plan [Axis] Restructuring Plan [Axis] Segment Reporting, Asset Reconciling Item [Line Items] Segment Reporting, Asset Reconciling Item [Line Items] Unrecognized Pretax Compensation Expense Related to RSUs and PSUs Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount Weighted Average Grant Date Fair Value Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 4.250% Notes due 2021 [Member] 4.250% Notes due 2021 [Member] 4.250% Notes due 2021 [Member] Equity Component [Domain] Equity Component [Domain] Defined Benefit Plans and Other Postretirement Benefit Plans [Axis] Defined Benefit Plans and Other Postretirement Benefit Plans [Axis] Information by defined benefits pension or other postretirement plan or groupings of similar plans. Stockholders' Equity, Other Stockholders' Equity, Other Operating Lease, Year One Lessee, Operating Lease, Liability, to be Paid, Year One Schedule of Accounts, Notes, Loans and Financing Receivable [Table] Schedule of Accounts, Notes, Loans and Financing Receivable [Table] Disposal Group Name [Domain] Disposal Group Name [Domain] Revenue Recognition, Sales of Goods Revenue Recognition, Sales of Goods [Policy Text Block] Defined Benefit Plan, Plan Assets, Category [Axis] Defined Benefit Plan, Plan Assets, Category [Axis] Impact of Internal Reorganizations Share-based Compensation Arrangement by Share-based Payment Award, Options, Impact of Internal Reorganizations Number of stock options that were impacted by the Internal Reorganizations. Business Combination, Fair Value, Consideration Transferred Business Combination, Consideration Transferred, Equity Interests Issued and Issuable Assets Components of Deferred Tax Assets [Abstract] Litigation Case [Axis] Litigation Case [Axis] Lawsuits alleging personal injury filed Lawsuits alleging personal injury filed Lawsuits alleging personal injury which were filed. Remaining Performance Obligation Revenue, Remaining Performance Obligation, Amount Impact of Internal Reorganizations, Weighted Average Exercise Price Share-based Compensation Arrangements by Share-based Payment Award, Options, Impact of Internal Reorganizations, Weighted Average Exercise Price Weighted average exercise price of options that were impacted by the Internal Reorganizations. Indemnification Asset Indemnification Asset Indemnification asset for indemnified liabilities related to environmental remediation. Short-term Debt, Type [Axis] Short-term Debt, Type [Axis] Assets Transferred into (out of) Level 3 Defined Benefit Plan, Plan Assets Level 3 Reconciliation, Increase (Decrease) for Assets Transferred into (out of) Level 3 Schedule of Allocation of Plan Assets [Table Text Block] Schedule of Allocation of Plan Assets [Table Text Block] Maturity Within One Year Short-term Investments [Member] Rounded Amount [Member] Rounded Amount [Member] Rounded Amount Counterparty Name [Domain] Counterparty Name [Domain] Loss Contingency, Number of Additional Plaintiffs Loss Contingency, Number of Additional Plaintiffs Loss Contingency, Number of Additional Plaintiffs Total Operating Loss and Tax Credit Carryforwards Total Operating Loss and Tax Credit Carryforwards Total Operating Loss and Tax Credit Carryforwards Operating Lease, Year Four Lessee, Operating Lease, Liability, to be Paid, Year Four Total Intangible Assets, Gross Intangible Assets, Gross (Excluding Goodwill) Brazil Valuation Allowance [Member] Brazil Valuation Allowance [Member] Brazil Valuation Allowance [Member] Operating Leases, Future Minimum Payments Due Operating Leases, Future Minimum Payments Due Weighted Average [Member] Weighted Average [Member] EID [Member] EID [Member] EID [Member] Finance Lease, Liability, Current Finance Lease, Liability, Current Purchases of investments Payments to Acquire Marketable Securities Income (loss) from continuing operations before income taxes Income (loss) from continuing operations before income taxes Income (loss) from Continuing Operations before Income Taxes Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Fair Value, Inputs, Level 2 [Member] Fair Value, Inputs, Level 2 [Member] Geographic Distribution [Domain] Geographic Distribution [Domain] Decrease in Other Post Employment Benefit Obligations Decrease in Other Post Employment Benefit Obligations Decrease in Other Post Employment Benefit Obligations due to changes made to the plans. Expiration Period [Domain] Expiration Period [Domain] [Domain] for Expiration Period [Axis] Auditor Location Auditor Location (Loss) Gain on Hedging Activity Derivative, Gain (Loss) on Derivative, Net Plans of Discontinued Operations [Member] Plans of Discontinued Operations [Member] Plans of Discontinued Operations [Member] Segment Reporting [Abstract] Segment Reporting [Abstract] Type of Restructuring [Domain] Type of Restructuring [Domain] Net gain on sales of property, businesses, consolidated companies, and investments Net gain on sales of property, businesses, consolidated companies, and investments Gain (loss) from sale or disposal of an organization or integrated set of activities (for example, but not limited to, a partnership or corporation) engaged in providing a product or service in a commercial, industrial, or professional environment. Also includes amount of gain (loss) on sale or disposal of assets, including but not limited to property, plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee. DuPont de Nemours and Corteva Contribution to MDL Settlement [Member] DuPont de Nemours and Corteva Contribution to MDL Settlement [Member] DuPont de Nemours and Corteva Contribution to MDL Settlement Operating Leases, Future Minimum Payments 2019 Operating Leases, Future Minimum Payments Due, Next Twelve Months Definite-Lived Intangible Asset, Useful Life Finite-Lived Intangible Asset, Useful Life Deferred Tax Assets, Accrued Employee Benefits Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits Commodity Contract [Member] Commodity Contract [Member] Finance Lease, Interest Expense Finance Lease, Interest Expense Use of Estimates Use of Estimates, Policy [Policy Text Block] Earnings Per Share of Common Stock Reconciliation Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Final Maturity 2024 and thereafter Promissory Notes and Debentures, Final Maturity Year Six and Thereafter [Member] Promissory Notes and Debentures, Final Maturity Year Six and Thereafter [Member] Restructuring and Asset Related Charges - Net Restructuring, Settlement and Impairment Provisions Tax Year Subject to Examination Summary of Income Tax Examinations [Table Text Block] Title of 12(b) Security Title of 12(b) Security Developed Technology [Member] Developed Technology [Member] Developed Technology Expiring After Five Years Or Having Indefinite Expiration [Member] Expiring After Five Years Or Having Indefinite Expiration [Member] Expiring After Five Years Or Having Indefinite Expiration [Member] Payment for acquisition of subsidiary's interest from the non-controlling interest Payments to Noncontrolling Interests Common Stock, Shares Authorized Common Stock, Shares Authorized Maturities of Lease Liabilities [Table Text Block] Maturities of Lease Liabilities [Table Text Block] Tabular disclosure of undiscounted cash flows of lessee's operating and finance lease liabilities. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating and finance lease liabilities recognized in statement of financial position. Factoring Agreement [Member] Factoring Agreement [Member] Factoring Agreement [Member] Cost Sharing Arrangement Term Cost Sharing Arrangement Term Term of cost sharing arrangement under the MOU. Ratio of Indebtedness to Net Capital Ratio of Indebtedness to Net Capital Diluted (loss) earnings per share of common stock Net Income (Loss) Available to Common Stockholders, Diluted Tax settlements and expiration of statue of limitations Effective Income Tax Rate Reconciliation, Tax Settlement, Percent Title of Individual [Axis] Title of Individual [Axis] Basic (loss) earnings per share of common stock Net Income (Loss) Available to Common Stockholders, Basic Document Type Document Type Preferred Stock, Dividends Per Share Preferred Stock, Dividends Per Share, Declared Retirement Plan Tax Status [Axis] Retirement Plan Tax Status [Axis] Final Maturity 2023 Promissory Notes and Debentures, Final Maturity Year Five [Member] Promissory Notes and Debentures, Final Maturity Year Five [Member] Product and Service [Domain] Product and Service [Domain] Corteva and Dupont stray liability threshold for PFAS Corteva and Dupont stray liability threshold for PFAS Amount by which DuPont and Corteva will share PFAS costs. After threshold is exceeded, companies will share proportionally on basis of 29% (Corteva) and 71% (DuPont). Research and Development Expense Disposal Group, Including Discontinued Operation, Research And Development Expenses Disposal Group, Including Discontinued Operation, Research And Development Expenses Debt Instrument, Interest Rate, Stated Percentage Debt Instrument, Interest Rate, Stated Percentage U.S. Plans with Plan Assets [Member] U.S. Plans with Plan Assets [Member] U.S. Plans with Plan Assets [Member] Net income (loss) attributable to noncontrolling interests Net Income (Loss) Attributable to Noncontrolling Interest Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Revolving Credit Facilities due 2022 [Member] Revolving Credit Facilities due 2022 [Member] Revolving Credit Facilities due 2022 [Member] Discontinued Operations [Member] Discontinued Operations [Member] Binding Settlement Agreement Class Size Binding Settlement Agreement Class Size Binding settlement agreement, class size Revolving Credit Facility [Member] Revolving Credit Facility [Member] Exchange (gain) loss Unrecognized Tax Benefits, Increase Resulting from Foreign Currency Translation Fair Value of plan assets Defined Benefit Plan, Pension Plan with Projected Benefit Obligation in Excess of Plan Assets, Plan Assets Corteva and DuPont Share of NRST Trust Payment Corteva and DuPont Share of NRST Trust Payment Corteva and DuPont Share of NRST Trust Payment Measurement Frequency [Axis] Measurement Frequency [Axis] SEC Schedule, 12-09, Valuation Allowance, Deferred Tax Asset [Member] SEC Schedule, 12-09, Valuation Allowance, Deferred Tax Asset [Member] Lease, Cost [Table Text Block] Lease, Cost [Table Text Block] Tax benefit (charge) related to The Act [Member] Tax charge (benefit) related to The Act [Member] Tax charge (benefit) related to The Act [Member] Geographical [Axis] Geographical [Axis] Net effects of acquisitions / divestitures / other Defined Benefit Plan, Business Combinations And Acquisitions And Divestitures, Benefit Obligation Defined Benefit Plan, Business Combinations And Acquisitions And Divestitures, Benefit Obligation Other Investments [Member] Derivative, Asset [Member] Other Investments [Member] Vesting [Domain] Vesting [Domain] Net Investment Hedging Net Investment Hedging [Member] Hedging Relationship [Axis] Hedging Relationship [Axis] Long-term Debt, Weighted Average Interest Rate Long-term Debt, Weighted Average Interest Rate, at Point in Time Subsequent Events [Text Block] Subsequent Events [Text Block] Remaining Lease Term Lessee Operating and Finance Leases, Remaining Lease Term Lessee, operating and financing leases remaining lease term Amortization of prior service benefit Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, before Tax DuPont and Corteva Contribution [Member] DuPont and Corteva Contribution [Member] DuPont and Corteva Contribution Corporate Segment [Member] Corporate Segment [Member] Unrealized Gain (Loss) on Investments Unrealized Gain (Loss) on Investments Prior Service Benefit Accumulated Defined Benefit Plans Adjustment, Net Prior Service Attributable to Parent [Member] Income Taxes Payable Disposal Group, Including Discontinued Operation, Accrued Income Tax Payable, Current Cash provided by (used for) financing activities Net Cash Provided by (Used in) Financing Activities Stock Option Award Vesting Period RSU and PSU Award Vesting Period Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period Related Party Transaction [Line Items] Related Party Transaction [Line Items] Total amount of interest and penalties (benefit) recognized in Provision for income taxes on continuing operations Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense Principal U.S. Pension Plan [Member] Principal U.S. Pension Plan [Member] Principal U.S. Pension Plan [Member] Senior Notes Due 2025 [Member] Senior Notes Due 2025 [Member] Senior Notes Due 2025 Equity in earnings (losses) of affiliates - net Income (Loss) from Equity Method Investments DuPont de Nemours and Corteva [Member] DuPont de Nemours and Corteva [Member] DuPont de Nemours and Corteva Other Operating Charges Other Cost and Expense, Operating Trade Receivables Sold Trade Receivables Sold Trade Receivables Sold Fair Value Disclosures [Text Block] Fair Value Disclosures [Text Block] Defined Benefit Plan, Expected Future Benefit Payment [Abstract] Defined Benefit Plan, Expected Future Benefit Payment [Abstract] 2024 Finite-Lived Intangible Asset, Expected Amortization, Year Three Basic earnings (loss) per share of common stock from discontinued operations Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Basic Share Derivative, Liability [Member] Derivative, Liability [Member] Derivative, Liability [Member] Net after-tax exchange (loss) gain Foreign Currency Transaction Gain (Loss) After Tax Foreign Currency Transaction Gain (Loss) After Tax Divested Ag Business [Member] Divested Ag Business [Member] Divested Ag Business [Member] Available-for-sale Securities Available-for-sale Securities [Member] Funded Pension Plans other than Principal U.S. Plan and Remaining Plans with no Plan Assets [Member] Funded Pension Plans other than Principal U.S. Plan and Remaining Plans with no Plan Assets [Member] Funded Pension Plans other than Principal U.S. Plan and Remaining Plans with no Plan Assets [Member] Continuing Involvement with Derecognized Transferred Financial Assets, Amount Outstanding Continuing Involvement with Derecognized Transferred Financial Assets, Amount Outstanding Derivative [Table] Derivative [Table] Investments Measured at Net Asset Value Alternative Investment Total company [Member] Total company [Member] Total company [Member] Trade receivables sold that remain outstanding with an element of recourse Trade Receivables Held-for-sale, Reconciliation to Cash Flow, Additions to Held-for-sale Asset related charges Asset impairments and asset related charges Asset impairments and asset related charges Computer Software, Intangible Asset [Member] Computer Software, Intangible Asset [Member] Document Period End Date Document Period End Date Net gain on sales of businesses and other assets Net gain on sales of businesses and other assets Net gain on sales of businesses and other assets Combination of Entities under Common Control, Policy [Policy Text Block] Combination of Entities under Common Control, Policy [Policy Text Block] Stock options and restricted stock units excluded from EPS Stock options, restricted stock units and performance based restricted stock units excluded from EPS Stock options, restricted stock units and performance based restricted stock units excluded from EPS Unusual or Infrequent Item, or Both [Domain] Unusual or Infrequent Item, or Both [Domain] Schedule of Lease Assets and Liabilities [Table Text Block] Schedule of Lease Assets and Liabilities [Table Text Block] [Table Text Block] for Schedule of Lease Assets and Liabilities [Table] Loss Related To Litigation Settlement, Net Of Tax Gain (Loss) Related To Litigation Settlement, Net Of Tax Amount of gain (loss), after tax, recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process. Quarterly Financial Information Quarterly Financial Information [Table Text Block] Fixed Income Securities [Member] Fixed Income Securities [Member] RSUs and PSUs - EIP [Domain] RSUs and PSUs - EIP [Member] RSUs and PSUs - EIP State and Local Income Taxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent Deferred State and Local Income Tax Expense (Benefit) Deferred State and Local Income Tax Expense (Benefit) Interest Expense Interest and Debt Expense Award Date [Domain] Award Date [Domain] Property, Plant and Equipment [Table Text Block] Property, Plant and Equipment [Table Text Block] Debt Instrument, Term Debt Instrument, Term Income Statement Location [Domain] Income Statement Location [Domain] Debt Securities, Available-for-sale [Table] Debt Securities, Available-for-sale [Table] Goodwill and Intangible Asset Disclosure [Abstract] Goodwill and Intangible Asset Disclosure [Abstract] Goodwill and Intangible Asset Disclosure [Abstract] Business Combination Disclosure [Text Block] Combination of Entities under Common Control [Text Block] Combination of Entities under Common Control [Text Block] Indemnified Liabilities Indemnified Liabilities Indemnified Liabilities for liabilities indemnified by Corteva against certain litigation, environmental, workers compensation and other liabilities that arose prior to the spin-off of Corteva. Net Property, Plant and Equipment Property, Plant and Equipment, Net Net Property Property, Plant and Equipment, Net Land and Land Improvements [Member] Land and Land Improvements [Member] Hedging Program [Member] Hedging Program [Member] Hedging Program [Member] Expiring within Five Years [Member] Expiring within Five Years [Member] Expiring within Five Years [Member] Schedule of Finite-Lived Intangible Assets, Future Amortization Expense Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block] Payments on Debt Repayments of Long-term Debt Earnings Per Share [Abstract] Earnings Per Share [Abstract] Method of Disaggregation [Axis] Method of Disaggregation [Axis] Method of Disaggregation Diluted earnings (loss) per share of common stock from discontinued operations Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Diluted Share Accelerated Prepaid Royalty Amortization Expense Accelerated Prepaid Royalty Amortization Expense Asset related cost for non-cash accelerated prepaid royalty amortization expense Repayments of Related Party Debt Repayments of Related Party Debt Impact of Internal Reorganizations, Weighted Average Grant Date Fair Value Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Impact of Internal Reorganizations, Weighted Average Grant Date Fair Value Weighted average grant date fair value of RSU's and PSU's that were impacted by the Internal Reorganizations. Property, Plant and Equipment Property, Plant and Equipment, Gross Noncontrolling Interest [Table] Noncontrolling Interest [Table] Accounts and Notes Receivable [Member] Accounts and Notes Receivable [Member] Accounts and Notes Receivable [Member] Net Sales Revenues Amount credited to each company's threshold Amount credited to each company's threshold Amount credited to each company's threshold for PFAS costs shared between DuPont and Corteva. Employee Retention Credit Employee Retention Credit Employee Retention Credit Amounts Reclassified from Accumulated Other Comprehensive Income, Net of Tax Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax Trademarks [Member] Trademarks [Member] Other deductions against allowance Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease) Foreign Exchange Contract [Member] Foreign Exchange Contract [Member] Finished products Inventory, Finished Goods, Gross Hedging Program Gain (Loss) Type [Domain] Hedging Program Gain (Loss) Type [Domain] [Domain] for Hedging Program Gain (Loss) Type [Axis] Stock options outstanding, weighted average exercise price beginning of period Stock options outstanding, weighted average exercise price end of period Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price Schedule of Related Party Transactions, by Related Party [Table] Schedule of Related Party Transactions, by Related Party [Table] Conversion - Corteva Distribution Share-based Compensation Arrangement by Share-based Payment Award, Options, Converted, Number Amount of equity awards that were into Corteva-denominated awards under the “Employer Method,” or into DuPont-denominated awards under the “Shareholder Method,” using a formula designed to preserve the intrinsic value of the awards immediately prior to and subsequent to the Corteva Distribution and moved to the OIP. Chemours share of payment to NRST Trust, percentage Chemours share of payment to NRST Trust, percentage Chemours share of payment to NRST Trust, percentage Type of Disclosure [Domain] Type of Disclosure [Domain] [Domain] for Type of Disclosure [Axis] Entity Current Reporting Status Entity Current Reporting Status Accounts Payable and Other Operating Liabilities Increase (Decrease) in Other Accounts Payable and Accrued Liabilities Fair value of plan assets at beginning of period Fair value of plan assets at end of period Fair value of plan assets Defined Benefit Plan, Plan Assets, Amount Other Non-current Obligations Disposal Group, Including Discontinued Operation, Other Liabilities, Noncurrent Litigation Legal Costs, Policy [Policy Text Block] Effective Income Tax Rate Effective Income Tax Rate Reconciliation, Percent Indemnification Agreement [Member] Indemnification Agreement [Member] Expected Future Employer Contributions, Next Fiscal Year Defined Benefit Plan, Expected Future Employer Contributions, Next Fiscal Year Short-term borrowings and finance lease obligations Debt, Current Finance Lease, Cost Finance Lease, Cost Amount of total finance lease costs Counterparty Name [Axis] Counterparty Name [Axis] Proceeds from Sale and Maturities of Investments Proceeds from Sale and Maturity of Marketable Securities Contract assets - current Contract with Customer, Asset, after Allowance for Credit Loss, Current Annual escrow deposit, remainder of period Annual escrow deposit, remainder of period No later than September 30 of each subsequent year through and including 2028, Chemours shall deposit $50 million into an escrow account and DuPont and Corteva shall together deposit $50 million in the aggregate into an escrow account 12 months or more, Fair Value Available-for-sale Securities, Continuous Unrealized Loss Position, Twelve Months or Longer, Fair Value UNITED STATES UNITED STATES Award Date [Axis] Award Date [Axis] Leases [Abstract] Leases [Abstract] Cash and Cash Equivalents Cash and Cash Equivalents of discontinued operations Disposal Group, Including Discontinued Operation, Cash and Cash Equivalents Income Taxes Income Tax, Policy [Policy Text Block] Derivative Liability, Gross Derivative Liability, Foreign Currency Derivative Liability, Fair Value, Gross Liability Including Not Subject to Master Netting Arrangement Tender Notes [Member] Tender Notes [Member] Tender Notes [Member] Accumulated Other Comprehensive Income (Loss) [Line Items] Accumulated Other Comprehensive Income (Loss) [Line Items] Collective Threshold for Payments to Fund the NRST Trust Collective Threshold for Payments to Fund the NRST Trust Collective Threshold for Payments to Fund the NRST Trust Loss Contingency, Number Of Water Districts Receiving Water Treatment Loss Contingency, Number Of Water Districts Receiving Water Treatment Loss Contingency, Number Of Water Districts Receiving Water Treatment Disposal Group Classification [Domain] Disposal Group Classification [Domain] Entity Address, Postal Zip Code Entity Address, Postal Zip Code Accrual for Environmental Loss Contingencies, Potential Exposure in Excess of Accrual Accrual for Environmental Loss Contingencies, Potential Exposure in Excess of Accrual Accrual for Environmental Loss Contingencies, Potential Exposure in Excess of Accrual Weighted Average Number of Shares Outstanding, Diluted Weighted Average Number of Shares Outstanding, Diluted Conversion - Corteva Distribution, weighted average grant date fair value Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Converted, Weighted Average Exercise Price Weighted average grant date fair value of RSU’s and PSU’s that were converted into Corteva-denominated awards under the “Employer Method,” or into DuPont-denominated awards under the “Shareholder Method,” using a formula designed to preserve the intrinsic value of the awards immediately prior to and subsequent to the Corteva Distribution and moved to the OIP. Income (loss) from Continuing Operations before Income Taxes, Domestic Income (Loss) from Continuing Operations before Income Taxes, Domestic Specialty Products Disposal [Member] Specialty Products Disposal [Member] Specialty Products Disposal [Member] Income Tax Disclosure [Text Block] Income Tax Disclosure [Text Block] Non-current Liabilities - Discontinued Operations Disposal Group, Including Discontinued Operation, Liabilities, Noncurrent Related Party [Domain] Related Party [Domain] Long-term Debt, Type [Axis] Long-term Debt, Type [Axis] Stock Option Activity Share-based Payment Arrangement, Option, Activity [Table Text Block] Miscellaneous income (expenses) - net Miscellaneous income and expenses, net Miscellaneous income and expenses, net Schedule of Net Benefit Costs [Table Text Block] Schedule of Net Benefit Costs [Table Text Block] Deferred Tax Assets, Investments Deferred Tax Assets, Investments Depreciation Disposal Group Including Discontinued Operation Depreciation Amount of depreciation attributable to disposal group, including, but not limited to, discontinued operation. Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Other Loans [Member] Other Loans [Member] Other Loans [Member] Not Designated as Hedging Instrument [Member] Not Designated as Hedging Instrument [Member] Credit Facility [Axis] Credit Facility [Axis] Finite-Lived Intangible Assets, Major Class Name [Domain] Fair Value Measurement [Domain] Finite-Lived Intangible Assets, Major Class Name [Domain] Entity Address, Address Line One Entity Address, Address Line One Accumulated Depreciation Accumulated Depreciation Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Restricted Stock Units and Performance Deferred Stock Units [Member] Restricted Stock Units and Performance Share Units [Member] Restricted Stock Units and Performance Share Units Basis of Consolidation Consolidation, Policy [Policy Text Block] Entity Shell Company Entity Shell Company Short-Term Borrowings and Finance Lease Obligations Schedule of Short-term Debt [Table Text Block] Expected life of stock options granted during period Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term Total current liabilities Liabilities, Current Employee Stock [Member] Employee Stock [Member] Type of Disclosure [Axis] Type of Disclosure [Axis] Type of Disclosure [Axis] Litigation Status [Domain] Litigation Status [Domain] Schedule of Sundry Income (Expense) - Net [Line Items] Schedule of Sundry Income (Expense) - Net [Line Items] [Line Items] for Schedule of Sundry Income (Expense) - Net [Table] Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] Accounts Payable, Trade, Current Accounts Payable, Trade, Current Loss Contingencies [Table] Loss Contingencies [Table] Employer Matching Contribution, Percent of Employees' Gross Pay Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay Defined Benefit Plan, Plan with Projected Benefit Obligation in Excess of Plan Assets [Table Text Block] Defined Benefit Plan, Plan with Projected Benefit Obligation in Excess of Plan Assets [Table Text Block] Current Fiscal Year End Date Current Fiscal Year End Date Unamortized debt discount and issuance costs Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net Financial Instruments Disclosure [Text Block] Financial Instruments Disclosure [Text Block] Nonqualified Plan [Member] Nonqualified Plan [Member] Fair Value, Measured on Recurring Basis, Gain (Loss) Included in Earnings [Line Items] Fair Value, Measured on Recurring Basis, Gain (Loss) Included in Earnings [Line Items] Derivative Instruments, Gain (Loss) [Table] Derivative Instruments, Gain (Loss) [Table] Long-term Transition Bond Long-term Transition Bond Notes Maturing 2030 [Domain] Notes Maturing 2030 [Domain] Notes Maturing 2030 Net Income attributable to continuing operations - Noncontrolling Interest Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest Asset Related Charges [Member] Asset Related Charges [Member] Asset Related Charges Germplasm [Member] Germplasm [Member] Germplasm [Member] Repatriation Accrual [Member] Repatriation Accrual [Member] Repatriation Accrual [Member] DuPont de Nemours [Member] DuPont de Nemours [Member] DuPont de Nemours [Member] Tender Offer for Debt Securities Tender Offer for Debt Securities Tender Offer for Debt Securities Statement [Table] Statement [Table] Accrual for Environmental Loss Contingencies Accrual for Environmental Loss Contingencies Accumulated benefit obligations Defined Benefit Plan, Plan with Accumulated Benefit Obligation in Excess of Plan Assets, Accumulated Benefit Obligation Recent Accounting Guidance New Accounting Pronouncements, Policy [Policy Text Block] Loss on Sale of Accounts Receivable Gain (Loss) on Sale of Accounts Receivable Deferred Tax Assets, Other Deferred Tax Assets, Other 2024 Defined Benefit Plan, Expected Future Benefit Payment, Year Five Other Commitments [Axis] Other Commitments [Axis] State Tax Valuation Allowance [Member] State Tax Valuation Allowance [Member] State Tax Valuation Allowance Debt Instrument, Redemption, Period [Domain] Debt Instrument, Redemption, Period [Domain] Operating Loss and Tax Credit Carryforwards Summary of Operating Loss and Tax Credit Carryforwards [Table Text Block] Tabular disclosure of pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss and tax credit carryforwards, including an assessment of the likelihood of utilization. Statistical Measurement [Axis] Statistical Measurement [Axis] North America [Member] North America [Member] Finance Lease, Liability, Noncurrent Finance Lease, Liability, Noncurrent Income (Loss) from Discontinued Operation, before Income Tax (Loss) Income from Discontinued Operation, before Income Tax Discontinued Operation, Income (Loss) from Discontinued Operation, before Income Tax Definite-Lived Intangible Assets, Net Finite-Lived Intangible Assets, Net Goodwill Goodwill Beginning Balance Goodwill Ending Balance Goodwill Deferred Revenue Deferred Revenue Noncontrolling Interests Stockholders' Equity Attributable to Noncontrolling Interest DuPont [Member] DuPont [Member] DuPont [Member] Cash Flow [Member] Cash Flow [Member] Cash Flow [Member] Effective tax rates on international operations - net Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent Schedule of Goodwill Schedule of Goodwill [Table Text Block] Scenario [Domain] Scenario [Domain] Operating Lease, Cost Operating Lease, Cost Geographic Distribution [Axis] Geographic Distribution [Axis] Debt Instrument, Redemption, Period [Axis] Debt Instrument, Redemption, Period [Axis] Related Party Transactions Disclosure [Text Block] Related Party Transactions Disclosure [Text Block] Accumulated Defined Benefit Plans Adjustment Attributable to Parent Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member] Inventory [Line Items] Inventory [Line Items] Total deferred tax expense (benefit) Deferred Income Tax Expense (Benefit) Hedging Designation [Domain] Hedging Designation [Domain] Stock Repurchase Program, Authorized Amount Stock Repurchase Program, Authorized Amount Liabilities of discontinued operations - non-current [Member] Liabilities of discontinued operations - non-current [Member] Liabilities of discontinued operations - non-current [Member] Goodwill Disposal Group, Including Discontinued Operation, Goodwill Semi-finished products Inventory, Work in Process, Gross Statutory U.S. federal income tax rate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent Earnings Per Share, Policy [Policy Text Block] Earnings Per Share, Policy [Policy Text Block] Additional annual PFOA liabilities for the next five years paid by Chemours Additional annual PFOA liabilities for the next five years paid by Chemours Additional annual PFOA liabilities for the next five years paid by Chemours, up to $25 million per year. Accounts and notes receivable - net Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net Trademarks and Trade Names [Member] Trademarks and Trade Names [Member] PFOA Matters: Multi-District Litigation [Member] PFOA Matters: Multi-District Litigation [Member] PFOA Matters: Multi-District Litigation [Member] Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] Net income (loss) attributable to Corteva Net (loss) income attributable to Company Net Income (Loss) Attributable to Parent Deferred Income Tax Liabilities Disposal Group, Including Discontinued Operation, Deferred Tax Liabilities, Noncurrent Operating Lease, Right-of-Use Asset Operating Lease, Right-of-Use Asset Notional Amounts of Derivatives Schedule of Notional Amounts of Outstanding Derivative Positions [Table Text Block] Operating Loss Carryforwards Deferred Tax Assets, Operating Loss Carryforwards Severance Costs Costs Associated with Exit or Disposal Activities or Restructurings, Policy [Policy Text Block] Interest Cost Defined Benefit Plan, Interest Cost Compensation and other employee-related costs Employee-related Liabilities, Current Income Statement Location [Axis] Income Statement Location [Axis] Accumulated Amortization Finite-Lived Intangible Assets, Accumulated Amortization Argentina, Pesos Argentina, Pesos Statistical Measurement [Domain] Statistical Measurement [Domain] Pension Trust Receivables Defined Benefit Plan, Fair Value Of Plan Assets, Reconciling Items, Pension Trust Receivables Defined Benefit Plan, Fair Value Of Plan Assets, Reconciling Items, Pension Trust Receivables Net Sales by Geographic Area Schedule of Revenue from External Customers Attributed to Foreign Countries by Geographic Area [Table Text Block] Final Maturity 2019 Promissory Notes and Debentures, Final Maturity Year One [Member] Promissory Notes and Debentures, Final Maturity Year One [Member] Derivatives Instruments Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax Schedule of Additional Segment Details [Table Text Block] Schedule of Additional Segment Details [Table Text Block] Schedule of Additional Segment Details [Table Text Block] Segment Reporting Segment Reporting, Policy [Policy Text Block] Curtailment gain Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Curtailment Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Revenue from Contract with Customer [Abstract] Revenue from Contract with Customer [Abstract] Restructuring Type [Axis] Restructuring Type [Axis] Other Assets Other Assets, Noncurrent Expected return on plan assets Defined Benefit Plan, Expected Return (Loss) on Plan Assets Defined Benefit Plan, Ultimate Health Care Cost Trend Rate Defined Benefit Plan, Ultimate Health Care Cost Trend Rate Segments [Axis] Segments [Axis] Dividend yield Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate Retirement Benefits [Abstract] Retirement Benefits [Abstract] IPR&D [Member] In Process Research and Development [Member] Entity File Number Entity File Number Reallocation of goodwill [Member] Reallocation of goodwill [Member] Reallocation of goodwill [Member] Schedule of Other Nonoperating Income (Expense) Schedule of Other Nonoperating Income (Expense) [Table Text Block] Share-based compensation APIC, Share-based Payment Arrangement, Increase for Cost Recognition Common Control Combination [Table Text Block] Common Control Combination [Table Text Block] [Table Text Block] for Common Control Combination [Table] Disposal group, Including Discontinued Operation, Restricted Cash Disposal group, Including Discontinued Operation, Restricted Cash Disposal Group, Including Discontinued Operation, Restricted Cash Chemours [Member] Chemours [Member] Chemours [Member] Debt Securities, Available-for-sale Debt Securities, Available-for-sale [Table Text Block] Stock options forfeited/expired during the period Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period Disposal Groups, Including Discontinued Operations, Disclosure [Text Block] Disposal Groups, Including Discontinued Operations, Disclosure [Text Block] SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items] SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items] Retirement Plan Name [Domain] Retirement Plan Name [Domain] Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization, Consolidation and Presentation of Financial Statements [Abstract] Divisional Equity [Member] Divisional Equity [Member] Divisional Equity [Member] Internal Entity Restructuring [Member] Internal Entity Restructuring [Member] Internal Entity Restructuring [Member] RSUs and PSUs - OIP [Domain] RSUs and PSUs - OIP [Member] RSUs and PSUs - OIP Other Current Assets [Member] Other Current Assets [Member] Variable Lease, Cost Variable Lease, Cost Long-term Debt Long-term Debt Long-term Debt and Lease Obligation Cost of Goods Sold Disposal Group, Including Discontinued Operation, Costs of Goods Sold Assets at Fair Value Indefinite-lived Intangible Assets (Excluding Goodwill), Fair Value Disclosure 5.600% Senior Notes due 2036 [Member] 5.600% Senior Notes due 2036 [Member] 5.600% Senior Notes due 2036 [Member] Building [Member] Building [Member] Equity Method Investment, Other than Temporary Impairment Equity Method Investment, Other than Temporary Impairment Corteva [Member] Corteva [Member] Corteva [Member] Fair Value of RSUs and PSUs vested during the period Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value Weighted Average Grant Date Fair Value, RSUs and PSUs granted during the period Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Schedule of Lease Assets and Liabilities [Table] Schedule of Lease Assets and Liabilities [Table] Schedule of Lease Assets and Liabilities [Table] Actual return on plan assets Defined Benefit Plan, Plan Assets, Increase (Decrease) for Actual Return (Loss) Title of Individual [Domain] Title of Individual [Domain] Disposal Group Name [Axis] Disposal Group Name [Axis] Pension and other post employment benefits - noncurrent Noncurrent liabilities Liability, Defined Benefit Plan, Noncurrent Derivative Instruments Not Designated as Hedging Instruments, (Loss) Gain, Net Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net Restricted Cash and Cash Equivalents Items [Line Items] Restricted Cash and Cash Equivalents Items [Line Items] Share Repurchase Program [Domain] Share Repurchase Program [Domain] Equity Option [Member] Equity Option [Member] Asset write-offs Asset write-offs and adjustments Noncash activity affecting the restructuring reserve related to asset write-offs and adjustments. Credit Facility [Domain] Credit Facility [Domain] Related Party Transactions [Abstract] Related Party Transactions [Abstract] Conversion - Corteva Distribution, weighted average exercise price Share-based Compensation Arrangement by Share-based Payment Award, Options, Converted, Weighted Average Exercise Price Weighted average exercise price of equity awards that were into Corteva-denominated awards under the “Employer Method,” or into DuPont-denominated awards under the “Shareholder Method,” using a formula designed to preserve the intrinsic value of the awards immediately prior to and subsequent to the Corteva Distribution and moved to the OIP. Accumulated impairment losses on goodwill Goodwill, Impaired, Accumulated Impairment Loss Deferred Tax Assets, Operating Loss Carryforwards, Domestic Deferred Tax Assets, Operating Loss Carryforwards, Domestic Segment Reconciling Items [Member] Segment Reconciling Items [Member] Cash Equivalents [Member] Cash Equivalents [Member] RSUs and PSUs granted during the period Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period Restrictions on Cash and Cash Equivalents [Table] Restrictions on Cash and Cash Equivalents [Table] Goodwill and Intangible Assets Disclosure [Text Block] Goodwill and Intangible Assets Disclosure [Text Block] Property, Plant and Equipment Property, Plant and Equipment, Policy [Policy Text Block] Stock options outstanding at beginning of period Stock options outstanding at end of period Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number Discount Rate Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Discount Rate Debt Instrument [Axis] Debt Instrument [Axis] Accrued and Other Current Liabilities Disposal Group, Including Discontinued Operation, Accrued Liabilities Proceeds from Related Party Debt Proceeds from Related Party Debt Valuation Allowance [Table] Valuation Allowance [Table] Commitments and Contingencies Disclosure [Text Block] Commitments and Contingencies Disclosure [Text Block] Related Party [Axis] Related Party [Axis] Amortization of prior service benefit Defined Benefit Plan, Amortization of Prior Service Cost (Credit) Foreign Currency Exchange Gain (Loss) [Line Items] Foreign Currency Exchange Gain (Loss) [Line Items] [Line Items] for Foreign Currency Exchange Gain (Loss) [Table] Industrial Biosciences [Member] Industrial Biosciences [Member] Industrial Biosciences [Member] Foreign Currency Transaction Type [Domain] Foreign Currency Transaction Type [Domain] [Domain] for Foreign Currency Transaction Type [Axis] Inventory, Current [Table] Inventory, Current [Table] Schedule of Environmental Loss Contingencies by Site [Table Text Block] Schedule of Environmental Loss Contingencies by Site [Table Text Block] Provision for (Benefit from) Income Taxes, Discontinued Operation Provision for Income Taxes, Discontinued Operation Discontinued Operation, Tax Effect of Discontinued Operation Interest rate in addition to LIBOR Interest rate in addition to LIBOR Interest rate in addition to LIBOR on borrowings under the repurchase facility Deferred Tax Balances Schedule of Deferred Tax Assets and Liabilities [Table Text Block] PFOA Matters [Member] PFOA Matters [Member] PFOA Matters [Member] Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Abstract] Target Allocation for plan assets Defined Benefit Plan, Plan Assets, Target Allocation, Percentage Net loss (gain) Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, before Tax Schedule of Segment Reporting Information, by Segment [Table] Schedule of Segment Reporting Information, by Segment [Table] $4.50 Series Preferred Stock [Member] $4.50 Series Preferred Stock [Member] $4.50 preferred stock [Member] Line of Credit Facility, Remaining Borrowing Capacity Line of Credit Facility, Remaining Borrowing Capacity Indefinite-lived Intangible Assets, Major Class Name [Domain] Indefinite-lived Intangible Assets, Major Class Name [Domain] Loss Contingency, Pending Claims, Number Loss Contingency, Pending Claims, Number Foreign Exchange Impact on Income (Loss) from Continuing Operations Foreign Exchange Impact on Income (Loss) from Continuing Operations Impact to pre-tax earnings as a result of the deterioration of the Peso to USD exchange rate Adjustments to other benefit plans Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax US Treasury and Government [Member] US Treasury and Government [Member] Operating Lease, Year Three Lessee, Operating Lease, Liability, to be Paid, Year Three Derivative, Asset [Member] Derivative, Asset [Member] Derivative, Asset [Member] Public Utility [Axis] Public Utility [Axis] 4.150% Notes due 2043 [Member] 4.150% Notes due 2043 [Member] 4.150% Notes due 2043 [Member] Expiration Period [Axis] Expiration Period [Axis] Expiration Period [Axis] SEC Schedule, 12-09, Allowance, Credit Loss [Member] SEC Schedule, 12-09, Allowance, Credit Loss [Member] SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis] SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis] Other Operating Charges Disposal Group, Including Discontinued Operation, Other Expense Major Product Line [Member] Major Product Line [Member] Major Product Line Fair Value - H&N Business Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net Disaggregation of Revenue [Table Text Block] Disaggregation of Revenue [Table Text Block] Noncontrolling Interest in Joint Ventures Noncontrolling Interest in Joint Ventures Hedging Program Gain (Loss) Type [Axis] Hedging Program Gain (Loss) Type [Axis] Hedging Program Gain (Loss) Type [Axis] Tax Credit Carryforwards Deferred Tax Assets, Tax Credit Carryforwards Environmental Remediation Stray Liabilities [Axis] Environmental Remediation Stray Liabilities [Axis] Environmental Remediation Stray Liabilities [Axis] SEC Schedule, 12-09, Reserve, Inventory [Member] SEC Schedule, 12-09, Reserve, Inventory [Member] Shares authorized for future grants Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized Operating cash outflows from operating leases Operating Lease, Payments Net Change in borrowings (less than 90 days) Proceeds from (Repayments of) Short-term Debt Escrow Balance Escrow Deposit Personal injury cases [Member] Personal injury cases [Member] Personal injury cases [Member] 4.625% Notes due 2020 [Member] 4.625% Notes due 2020 [Member] 4.625% Notes due 2020 [Member] Excess tax benefits (tax deficiency) from stock-compensation Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Percent Research and Development Research and Development Expense, Policy [Policy Text Block] Debt Securities, Held-to-maturity [Table] Debt Securities, Held-to-maturity [Table] Litigation Settlement, Liability For Medical Monitoring Program, Threshold Litigation Settlement, Liability For Medical Monitoring Program, Threshold Litigation Settlement, Liability For Medical Monitoring Program, Threshold Geography [Member] Geography [Member] Geography Additions charged to expense Accounts Receivable, Credit Loss Expense (Reversal) Long-term Debt, Gross Long-term Debt, Gross Settlement loss Other Comprehensive Income (Loss), Finalization Of Pension And Other Postretirement Benefit Plan Valuation, Settlement Gain (Loss), Before Tax Other Comprehensive Income (Loss), Finalization Of Pension And Other Postretirement Benefit Plan Valuation, Settlement Gain (Loss), Before Tax Reporting Unit [Axis] Reporting Unit [Axis] Actual Return (Loss) on Plan Assets Sold Defined Benefit Plan, Plan Assets Level 3 Reconciliation, Increase (Decrease) for Actual Return (Loss) on Plan Assets Sold Diluted earnings (loss) per share of common stock from continuing operations (Loss) earnings per common share, continuing operations - diluted Income (Loss) from Continuing Operations, Per Diluted Share Finance Lease, Right-of-Use Asset Finance Lease, Right-of-Use Asset, after Accumulated Amortization Total assets at fair value Assets, Fair Value Disclosure Chemours Contribution [Member] Chemours Contribution [Member] Chemours Contribution Total Liabilities and Equity Liabilities and Equity Swiss VA [Member] Swiss VA [Member] Swiss VA [Member] Other, net Effective Income Tax Rate Reconciliation, Other Adjustments, Percent Curtailment (loss) gain Accumulated Defined Benefit Plans Adjustment, Curtailment Gain (Loss) Attributable to Parent [Member] Accumulated Defined Benefit Plans Adjustment, Curtailment Gain (Loss) Attributable to Parent [Member] Assets at Fair Value Finite-lived Intangible Assets, Fair Value Disclosure Escrow Account Deposit Percentage Escrow Account Deposit Percentage Percentage of deposits to be made to the escrow account as part of the cost sharing agreement under the MOU. Operating Lease, Year Five Lessee, Operating Lease, Liability, to be Paid, Year Five Operating Leases, Future Minimum Payments 2022 Operating Leases, Future Minimum Payments, Due in Four Years Corporate Assets Corporate Assets Corporate Assets Stock options exercised during the period, weighted average exercise price Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Restricted Cash Trust Asset Restricted Cash Benefits paid Defined Benefit Plan, Plan Assets, Benefits Paid Restructuring and Asset Related Activities [Abstract] Restructuring and Asset Related Activities [Abstract] Restructuring and Asset Related Activities [Abstract] Defined Benefit Plan, Accumulated Benefit Obligation, Increase (Decrease) for Plan Amendment Defined Benefit Plan, Accumulated Benefit Obligation, Increase (Decrease) for Plan Amendment Purchases, Sales, and Settlements Defined Benefit Plan, Plan Assets Level 3 Reconciliation, Increase (Decrease) for Purchase, Sale, and Settlement Environmental Remediation Site [Axis] Environmental Remediation Site [Axis] Liability relating to testing drinking water in and around certain former EID sites and offering treatment or alternative supply of drinking water. Liability relating to testing drinking water in and around certain former EID sites and offering treatment or alternative supply of drinking water. Liability relating to testing drinking water in and around certain former EID sites and offering treatment or alternative supply of drinking water. Derivative [Line items] Derivative [Line Items] Other Intangible Assets Schedule of Finite and Indefinite-Lived Intangible Assets [Table Text Block] Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite or indefinite life, by either major class or business segment. Schedule of Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Table Text Block] Schedule of Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Table Text Block] Litigation Settlement, Medical Monitoring Program, Escrow Account, Disbursements To Date Litigation Settlement, Medical Monitoring Program, Escrow Account, Disbursements To Date Litigation Settlement, Medical Monitoring Program, Escrow Account, Disbursements To Date Short-term Debt, Type [Domain] Short-term Debt, Type [Domain] Income Tax Contingency [Table] Income Tax Contingency [Table] Reclassification from AOCI, Current Period, Tax Reclassification from AOCI, Current Period, Tax Other Intangible Assets Disposal Group, Including Discontinued Operation, Intangible Assets Earnings Per Share [Text Block] Earnings Per Share [Text Block] Acquisitions, divestitures, and ownership restructuring activities Effective Income Tax Rate Reconciliation, Acquisitions, Divestitures, And Ownership Restructuring Activities, Percent Effective Income Tax Rate Reconciliation, Acquisitions, Divestitures, And Ownership Restructuring Activities, Percent Total Assets - Discontinued Operations Disposal Group, Including Discontinued Operation, Assets Common Stock Repurchase Treasury Stock, Value, Acquired, Cost Method Other loss on sale [Member] Other loss on sale [Member] Other loss on sale [Member] Cash and Cash Equivalents [Domain] Cash and Cash Equivalents [Domain] Accounting Changes and Error Corrections [Abstract] Accounting Changes and Error Corrections [Abstract] 2021 Defined Benefit Plan, Expected Future Benefit Payment, Year Two Minimum [Member] Minimum [Member] Environmental remediation liabilities primarily related to DuPont - subject to indemnity from DuPont [Member] Environmental remediation liabilities primarily related to DuPont - subject to indemnity from DuPont [Member] Environmental remediation liabilities primarily related to DuPont - subject to indemnity from DuPont [Member] Other Assets and Liabilities, Net Increase (Decrease) in Other Operating Assets and Liabilities, Net Merger with Dow [Member] Merger with Dow [Member] Merger with Dow [Member] Long-term Line of Credit Long-term Line of Credit Operating Lease, Year Two Lessee, Operating Lease, Liability, to be Paid, Year Two Effect of exchange rate changes on cash, cash equivalents and restricted cash equivalents Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Operating Leases, Future Minimum Payments 2020 Operating Leases, Future Minimum Payments, Due in Two Years Percentage of FIFO Inventory Percentage of FIFO Inventory Schedule of Revenues from External Customers and Long-Lived Assets [Table] Schedule of Revenues from External Customers and Long-Lived Assets [Table] Total Liabilities at fair value Financial and Nonfinancial Liabilities, Fair Value Disclosure DELAWARE DELAWARE Selling, General and Administrative Expense Selling, General and Administrative Expense Stock options forfeited/expired, weighted average price Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price EID - Basis of Presentation [Abstract] EID - Basis of Presentation Indefinite-lived Intangible Assets [Axis] Indefinite-lived Intangible Assets [Axis] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table] Changes in Accounting and Reporting Reclassification, Comparability Adjustment [Policy Text Block] Preferred Stock, Shares Authorized Preferred Stock, Shares Authorized Line Of Credit Facility, Remaining Borrowing Capacity, Uncommitted Amount Line Of Credit Facility, Remaining Borrowing Capacity, Uncommitted Amount Line Of Credit Facility, Remaining Borrowing Capacity, Uncommitted Amount Marketable Securities [Member] Marketable Securities [Member] Marketable Securities [Member] Finance Lease, Right-of-Use Asset, Gross Finance Lease, Right-of-Use Asset, Gross Amount before accumulated depreciation of lessee's right to use underlying asset under finance lease Revenue Recognition Revenue [Policy Text Block] Tax Reform Foreign Currency Exchange Impact [Member] Tax Reform Foreign Currency Exchange Impact [Member] Tax Reform Foreign Currency Exchange Impact [Member] Acquisitions of businesses - Net of Cash Acquired Payments to Acquire Businesses, Net of Cash Acquired Cumulative Translation Adjustment Accumulated Foreign Currency Adjustment Attributable to Parent [Member] Debt Disclosure [Text Block] Debt Disclosure [Text Block] Effect of foreign exchange rates Other Comprehensive Income (Loss), Defined Benefit Plan, Foreign Currency Impact, before Tax Other Comprehensive Income (Loss), Defined Benefit Plan, Foreign Currency Impact, before Tax Share-based Payment Arrangement [Text Block] Share-based Payment Arrangement [Text Block] Senior Notes [Member] Senior Notes [Member] Prepaid Royalties Prepaid Royalties Pension Trust Payables Defined Benefit Plan, Fair Value Of Plan Assets, Reconciling Items, Pension Trust Payables Defined Benefit Plan, Fair Value Of Plan Assets, Reconciling Items, Pension Trust Payables Fair Value, Inputs, Level 3 [Member] Fair Value, Inputs, Level 3 [Member] Settlement Agreement Settlement Agreement [Member] Settlement Agreement Leases Lessee, Leases [Policy Text Block] Stock Issued During Period, Shares, New Issues Stock Issued During Period, Shares, New Issues Deferred Tax Liabilities, Investments Deferred Tax Liabilities, Investments Number of Reportable Segments Number of Reportable Segments Letters of Credit Outstanding, Amount Letters of Credit Outstanding, Amount Net exchange losses Pre-tax exchange (loss) gain Foreign Currency Transaction Gain (Loss), before Tax Indemnified Liabilities for Liabilities Indemnified by Chemours Indemnified Liabilities for Liabilities Indemnified by Corteva indemnified Liabilities for liabilities indemnified by Corteva associated with environmental remediation related to PFAS. Preferred Stock Dividends and Other Adjustments Preferred Stock Dividends and Other Adjustments Disaggregation of Revenue [Line Items] Disaggregation of Revenue [Line Items] Other income (expense) - net Nonoperating Income (Expense) Inventory, Net [Abstract] Inventory, Net [Abstract] Basis of Accounting, Policy [Policy Text Block] Basis of Accounting, Policy [Policy Text Block] Performance Shares [Member] Performance Shares [Member] Other Benefit Plans Other Post Employment Benefits Plan Other Postretirement Benefits Plan [Member] Subsequent Event [Table] Subsequent Event [Table] Investment in nonconsolidated affiliates Disposal group, including discontinued operations, investment in nonconsolidated affiliates Disposal group, including discontinued operations, investment in nonconsolidated affiliates Accumulated other comprehensive income (loss) Accumulated Other Comprehensive Income (Loss), Net of Tax Entity Emerging Growth Company Entity Emerging Growth Company A/R trade and notes receivable - trade, allowance Accounts Receivable, Allowance for Credit Loss, Current Medium-term Notes [Member] Medium-term Notes [Member] Effect of foreign exchange rates Defined Benefit Plan, Benefit Obligation, Foreign Currency Translation Gain (Loss) Receivables [Abstract] Receivables [Abstract] Retirement Plan Tax Status [Domain] Retirement Plan Tax Status [Domain] Goodwill impairment Effective Income Tax Rate Reconciliation, Nondeductible Expense, Impairment Losses, Percent Disposal Group Classification [Axis] Disposal Group Classification [Axis] Common control combination [Axis] Common control combination [Axis] Common control combination [Axis] Natural Resources Damages [Member] Natural Resources Damages [Member] Natural Resources Damages [Member] Auditor Name Auditor Name Revenues from External Customers and Long-Lived Assets [Line Items] Revenues from External Customers and Long-Lived Assets [Line Items] Other Comprehensive Income (Loss), before Reclassifications, Net of Tax Other Comprehensive Income (Loss), before Reclassifications, Net of Tax Cash and Cash Equivalents Cash and Cash Equivalents, Policy [Policy Text Block] Employers Discretionary Contribution, Vesting Period Defined Contribution Plan, Employers Discretionary Contribution, Vesting Period Defined Contribution Plan, Employers Discretionary Contribution, Vesting Period Income Statement [Member] Income Statement [Member] Income Statement [Member] Operating Lease, Interest Lessee, Operating Lease, Liability, Undiscounted Excess Amount Rate of increase in future compensation levels Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Rate of Compensation Increase Operating Activities [Domain] Operating Activities [Domain] Other Significant Noncash Transaction, Name [Domain] Other Significant Noncash Transaction, Name [Domain] Deferred Revenue Recognized During the Period Deferred Revenue, Revenue Recognized Preferred Stock, Par Value Preferred Stock, No Par Value Method of Disaggregation [Domain] Method of Disaggregation [Domain] Method of Disaggregation Financial Instrument [Axis] Financial Instrument [Axis] Finance Lease, Interest Finance Lease, Liability, Undiscounted Excess Amount Argentine peso devaluation [Member] Argentine peso devaluation [Member] Argentine peso devaluation [Member] Dividends Paid to stockholders Payments of Dividends Performance Share Units [Member] Performance Share Units [Member] Performance Share Units Line of Credit Facility, Periodic Payment, Principal Line of Credit Facility, Periodic Payment, Principal 3.625% Notes due 2021 [Member] 3.625% Notes due 2021 [Member] 3.625% Notes due 2021 [Member] Derivative Asset, Gross Derivative Asset, Foreign Currency Derivative Asset, Fair Value, Gross Asset Including Not Subject to Master Netting Arrangement Document Information [Table] Document Information [Table] Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value [Table Text Block] Payments for Restructuring Payments for Restructuring PFOA Matters: Drinking Water Actions [Member] PFOA Matters: Drinking Water Actions [Member] PFOA Matters: Drinking Water Actions [Member] MOU Terms for Withdrawals MOU Terms for Withdrawals The MOU provides that no withdrawals from the MOU Escrow Account can be made before year six, except to fund mutually agreed upon third-party settlements in excess of $125 million. Finance Lease, Year Five Finance Lease, Liability, to be Paid, Year Five Common Stock [Member] Common Stock [Member] Inventories Disposal Group, Including Discontinued Operation, Inventory Income (Loss) from Continuing Operations before Income Taxes, Foreign Income (Loss) from Continuing Operations before Income Taxes, Foreign Total Defined Benefit Plan Expected Future Payments Total Total amount of benefits for defined benefit plan expected to be paid from 2018-2027. Defined Contribution Plan, Employer Contribution Defined Contribution Plan, Employer Discretionary Contribution Amount Current operating lease liabilities Operating Lease, Liability, Current Geographical Reporting [Abstract] Geographical Reporting [Abstract] Geographical Reporting [Abstract] 2023 Finite-Lived Intangible Asset, Expected Amortization, Year Two Hedging Designation [Axis] Hedging Designation [Axis] DowDuPont [Member] DowDuPont [Member] DowDuPont [Member] All other plans [Member] All other plans [Member] All other plans [Member] Long-term Debt [Member] Long-term Debt [Member] Restructuring and Related Activities Disclosure [Text Block] Restructuring and Related Activities Disclosure [Text Block] Estimated future annual amortization expense Finite-Lived Intangible Asset, Future Expected Annual Amortization Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized annually. Cash and Cash Equivalents Cash and Cash Equivalents, at Carrying Value Schedule of Environmental Loss Contingencies Schedule of Environmental Loss Contingencies [Table Text Block] Tabluar disclosure of environmental loss contingencies. Does not include loss contingencies that are not environmental in nature. Depreciation expense Depreciation Developed Technology Technology-Based Intangible Assets [Member] Loss from Discontinued Operations, Net of Tax, Attributable to Noncontrolling Interest Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Noncontrolling Interest Equity Securities Mark-to-Mark Gain Equity Securities Mark-to-Mark Gain Equity Securities Mark-to-Mark Gain Ownership interest in an entity Ownership interest in an entity Ownership interest in an entity Total, Gross Unrealized Losses Available-for-sale Securities, Continuous Unrealized Loss Position, Accumulated Loss Stock options restricted stock units excluded from EPS Stock options restricted stock units excluded from EPS Outstanding potential shares of common stock relating to stock options, restricted stock units and performance-based restricted stock units that were excluded from the calculation of diluted EPS because the effect of including them would have been anti-dilutive. APAC Business [Member] APAC Business [Member] APAC Business (Loss) Gain on Derivative Instruments, Net, Pretax Gain (Loss) on Derivative Instruments, Net, Pretax Actuarial Losses Accumulated Defined Benefit Plans Adjustment, Net Gain (Loss) Attributable to Parent [Member] Income Taxes Income Taxes Paid Asset Impairment Charges Asset Impairment Charges Schedule of New Accounting Pronouncements and Changes in Accounting Principles [Table Text Block] Accounting Standards Update and Change in Accounting Principle [Table Text Block] Derivative, Notional Amount Derivative, Notional Amount Not subject to indemnification [Member] Not subject to indemnification [Member] Not subject to indemnification [Member] Qualified Spend and Escrow Account Contribution Threshold Qualified Spend and Escrow Account Contribution Threshold Qualified Spend and Escrow Account Contribution Threshold Benefits Paid Defined Benefit Plan, Benefit Obligation, Benefits Paid Payments to Acquire Property, Plant, and Equipment Payments to Acquire Property, Plant, and Equipment Effect of foreign exchange rates Defined Benefit Plan, Plan Assets, Foreign Currency Translation Gain (Loss) Property, Plant and Equipment [Member] Property, Plant and Equipment [Member] Schedule of Minimum Lease Commitments [Table Text Block] Schedule of Minimum Lease Commitments [Table Text Block] [Table Text Block] for Schedule of Minimum Lease Commitments [Table] Deferred Income Taxes Disposal Group, Including Discontinued Operation, Deferred Tax Assets, Noncurrent Plan assets transferred due to sale, liquidation, spin-off, or divestiture Plan assets transferred due to sale, liquidation, spin-off, or divestiture Amount, measured using unobservable inputs, of change in plan assets of defined benefit plan, for assets transferred attributed to the sale, liquidation, spin-off or other divestiture of a corporate division or subsidiary Long-Term Debt - Related Party Notes Payable, Related Parties, Noncurrent Defined Benefit Plan, Accumulated Benefit Obligation Defined Benefit Plan, Accumulated Benefit Obligation Employer contributions Defined Benefit Plan, Plan Assets, Contributions by Employer Operating Leases, Rent Expense, Net Operating Leases, Rent Expense, Net Favorable Supply Contract [Member] Favorable Supply Contract [Member] Favorable Supply Contract [Member] Grants between June 2019 and 2020 [Member] Grants between June 2019 and 2020 [Member] Grants between June 2019 and 2020 Post-MDL Settlement PFOA Personal Injury Claims [Domain] Post-MDL Settlement PFOA Personal Injury Claims [Domain] Post-MDL Settlement PFOA Personal Injury Claims [Domain] Fair Value, Measured on Recurring Basis, Gain (Loss) Included in Earnings [Table] Fair Value, Measured on Recurring Basis, Gain (Loss) Included in Earnings [Table] Pension and other post employment benefits - noncurrent [Member] Pension and other post employment benefits - noncurrent [Member] Pension and other post employment benefits - noncurrent [Member] Debt Extinguishment Costs Payment for Debt Extinguishment or Debt Prepayment Cost 2022 Finite-Lived Intangible Asset, Expected Amortization, Year One Stock options granted, weighted average price Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Stock options outstanding, intrinsic value Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value Supplemental Payment Threshold Supplemental Payment Threshold Supplemental Payment Threshold Consolidation Items [Axis] Consolidation Items [Axis] Dilutive effect of equity compensation plans Dilutive effect of equity compensation plans Dilutive effect of equity compensation plans Common Stock, Shares, Issued Common Stock, Shares, Issued Interest Paid on Related Party Long-Term Debt Interest Paid on Related Party Loan Interest Paid on Related Party Loan Tax Cuts and Jobs Act, Incomplete Accounting, Change in Tax Rate, Provisional Income Tax Expense (Benefit) Tax Cuts and Jobs Act, Incomplete Accounting, Change in Tax Rate, Provisional Income Tax Expense (Benefit) Amount of reasonable estimate for income tax expense (benefit) for which accounting for tax effect for remeasurement of deferred tax from change in tax rate is incomplete pursuant to Tax Cuts and Jobs Act. Preferred Stock, Shares Issued Preferred Stock, Shares Issued Pretax balance in accumulated other comprehensive (income) loss at end of year Defined Benefit Plan, Accumulated Other Comprehensive (Income) Loss, before Tax Other current assets Disposal Group, Including Discontinued Operation, Other Assets, Current Total (benefit) loss recognized in other comprehensive loss, attributable to Corteva Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, before Tax Accounts and notes receivable - trade Accounts and notes receivable - trade Accounts and notes receivable - trade (does not include Other AR), net of allowance for doubtful accounts Defined Benefit Plan, Assumptions [Table Text Block] Defined Benefit Plan, Assumptions [Table Text Block] Entity Address, City or Town Entity Address, City or Town Loss on early Extinguishment of Debt Loss on Extinguishment of Debt Gain (Loss) on Extinguishment of Debt Operating Leases, Future Minimum Payments 2024 and Thereafter Operating Leases, Future Minimum Payments, Due Thereafter Defined Benefit Plan, Plan with Accumulated Benefit Obligation in Excess of Plan Assets [Table Text Block] Defined Benefit Plan, Plan with Accumulated Benefit Obligation in Excess of Plan Assets [Table Text Block] Schedule of Expected Benefit Payments [Table Text Block] Schedule of Expected Benefit Payments [Table Text Block] Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block] Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block] Debt Instrument, Repurchase Amount Debt Instrument, Repurchase Amount Retirement Plan Type [Axis] Retirement Plan Type [Axis] Total Gross Unrecognized Tax Benefits Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block] Indemnification Assets Indemnification Assets Indemnification asset for liabilities indemnified against certain litigation, environmental, workers' compensation and other liabilities that arose prior to the spin-off of Corteva. Balance Sheet Location [Axis] Balance Sheet Location [Axis] Measurement Frequency [Domain] Measurement Frequency [Domain] Repayments of Long-term Debt, including breakage fees and all applicable accrued and unpaid interest Repayments of Long-term Debt, including breakage fees and all applicable accrued and unpaid interest Amount paid to extinguish long term debt, including principal, breakage fees and all applicable accrued and unpaid interest on related debt Finance Lease, Year One Finance Lease, Liability, to be Paid, Year One Expected long-term rate of return on plan assets Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-term Rate of Return on Plan Assets Supplementary Information [Abstract] Supplementary Information [Abstract] Supplementary Information [Abstract] Intended Business Separations [Policy Text Block] Intended Business Separations [Policy Text Block] Intended Business Separations [Policy Text Block] Impact of Swiss Tax Reform Effective Income Tax Rate Reconciliation, Swiss Tax Reform, Percent Effective Income Tax Rate Reconciliation, Swiss Tax Reform, Percent Discontinued Operations and Disposal Groups [Abstract] Discontinued Operations and Disposal Groups [Abstract] Loss Contingency Nature [Axis] Loss Contingency Nature [Axis] 2020 Defined Benefit Plan, Expected Future Benefit Payment, Year One Retained earnings (accumulated deficit) Retained Earnings (Accumulated Deficit) Asset Retirement Obligation Asset Retirement Obligation Pushdown Accounting [Policy Text Block] Pushdown Accounting [Policy Text Block] Stock Option, Expiration Period Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period Recoveries collected Financing Receivable, Allowance for Credit Loss, Recovery Litigation Case [Domain] Litigation Case [Domain] Foreign Currency Exchange Gain (Loss) Foreign Currency Exchange Gain (Loss) [Table Text Block] Foreign Currency Exchange Gain (Loss) [Table Text Block] Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Accrued interest reversals [Member] Accrued interest reversals [Member] Accrued interest reversals [Member] Entity Filer Category Entity Filer Category Deferred Tax Assets, Research and Development Capitalization Deferred Tax Assets, Research and Development Capitalization Deferred Tax Assets, Research and Development Capitalization Notes Maturing 2025 [Domain] Notes Maturing 2025 [Domain] Notes Maturing 2025 Herbicides [Member] Herbicides [Member] Herbicides [Member] Retained Earnings, Share-based Compensation Retained Earnings, Share-based Payment Arrangement, Increase for Cost Recognition Retained Earnings, Share-based Payment Arrangement, Increase for Cost Recognition Effect of Derivative Instruments Derivative Instruments, Gain (Loss) [Table Text Block] Risk Free Interest Rate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Goodwill Impairment [Member] Goodwill Impairment [Member] Goodwill Impairment [Member] US Treasury Securities US Treasury Securities [Member] Final Maturity 2020 Promissory Notes and Debentures, Final Maturity Year Two [Member] Promissory Notes and Debentures, Final Maturity Year Two [Member] Final Maturity 2021 Promissory Notes and Debentures, Final Maturity Year Three [Member] Promissory Notes and Debentures, Final Maturity Year Three [Member] Inventory Disclosure [Abstract] Inventory Disclosure [Abstract] NORTH CAROLINA NORTH CAROLINA The Act's Foreign Tax Provisions [Member] The Act's Foreign Tax Provisions [Member] The Act's Foreign Tax Provisions Disposal Group, Including Discontinued Operation, Transaction Costs Disposal Group, Including Discontinued Operation, Transaction Costs Disposal Group, Including Discontinued Operation, Transaction Costs Recent Accounting Guidance Accounting Standards Update and Change in Accounting Principle [Text Block] Contract Termination Cost Contract Termination Cost Contract Termination Cost Indefinite-lived Intangible Assets Indefinite-lived Intangible Assets (Excluding Goodwill) Proceeds from Exercise of Stock Options Proceeds from Stock Options Exercised Marketable Securities Short-term Investments Finance Lease, Year Two Finance Lease, Liability, to be Paid, Year Two Definite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets by Major Class [Axis] Total Stockholders' Equity Beginning Balance Ending Balance Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest Shares in which vesting conditions were met Shares in which vesting conditions were met Shares in which vesting conditions were met Amendment Flag Amendment Flag Proceeds from Debt Proceeds from Issuance of Long-term Debt Equity Components [Axis] Equity Components [Axis] Fair Value Disclosures [Abstract] Fair Value Disclosures [Abstract] Derivative Instruments Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent [Member] Deconsolidation of a subsidiary [Member] Deconsolidation of a subsidiary [Member] Deconsolidation of a subsidiary [Member] Contract assets - noncurrent Contract with Customer, Asset, after Allowance for Credit Loss, Noncurrent Disaggregation of Revenue [Table] Disaggregation of Revenue [Table] Inventories Inventory, Net Schedule of Segment Reporting Information, by Segment [Table Text Block] Schedule of Segment Reporting Information, by Segment [Table Text Block] Business Combination, Fair Value of Equity Awards Business Combination, Consideration Transferred, Equity Interests Issued and Issuable Including Converted But Not Yet Earned Business Combination, Consideration Transferred, Equity Interests Issued and Issuable Including Converted But Not Yet Earned Divisional Equity Divisional Equity Divisional Equity Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Deferred Federal Income Tax Expense (Benefit) Deferred Federal Income Tax Expense (Benefit) Corteva Other Contribution Plans [Member] Corteva Other Contribution Plans [Member] Corteva Other Contribution Plans [Member] Operating Lease, Due After Year Five Lessee, Operating Lease, Liability, to be Paid, after Year Five Internal Reorganization [Member] Internal Reorganization [Member] Internal Reorganization [Member] Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount Deferred Tax Assets, Long-Term Debt Deferred Tax Assets, Long-Term Debt Deferred Tax Assets, Long-Term Debt Product and Service [Axis] Product and Service [Axis] Reconciliation of Other Significant Reconciling Items from Segments to Consolidated [Table Text Block] Reconciliation of Other Significant Reconciling Items from Segments to Consolidated [Table Text Block] Entity Public Float Entity Public Float Documents Incorporated by Reference [Text Block] Documents Incorporated by Reference [Text Block] Short-term Lease, Cost Short-term Lease, Cost Guarantor Obligations, Nature [Domain] Guarantor Obligations, Nature [Domain] Gross Unrealized Gain (Loss) Debt Securities, Available-for-sale, Unrealized Gain (Loss) Discontinued Operations, Disposed of by Sale [Member] Discontinued Operations, Disposed of by Sale [Member] Cumulative Translation Adjustments Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Segment Assets Segment Assets Segment Assets Schedule of Lease Assets and Liabilities [Line Items] Schedule of Lease Assets and Liabilities [Line Items] [Line Items] for Schedule of Lease Assets and Liabilities [Table] Incremental Expense Share-based Payment Arrangement, Plan Modification, Incremental Cost Other Operating Charges Other Operating Charges, Policy [Policy Text Block] Disclosure of accounting policy for other operating cost and expense items that are associated with the entity's normal revenue producing operation. Statement [Line Items] Statement [Line Items] SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain] SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain] Geographic Information Threshold Geographic Information Threshold Threshold as a percentage of consolidated amount used for determination of material locations. Litigation Settlement Amount Litigation Settlement, Amount Awarded to Other Party Fair Value of Derivatives Instruments Schedule of Derivatives Instruments Statements of Financial Performance and Financial Position, Location [Table Text Block] Related Party Transaction, Purchases from Related Party Related Party Transaction, Purchases from Related Party Retirement Plan Type [Domain] Retirement Plan Type [Domain] Available-for-sale securities Debt Securities, Available-for-sale Curtailment (loss) gain Other Comprehensive Income (Loss), Finalization Of Pension And Other Postretirement Benefit Plan Valuation, Curtailment Gain (Loss), Before Tax Other Comprehensive Income (Loss), Finalization Of Pension And Other Postretirement Benefit Plan Valuation, Curtailment Gain (Loss), Before Tax Accumulated Defined Benefit Plans Adjustment, Settlement Gain (Loss) [Member] Accumulated Defined Benefit Plans Adjustment, Settlement Gain (Loss) [Member] Accumulated Defined Benefit Plans Adjustment, Settlement Gain (Loss) [Member] Conversion of Stock, Name [Domain] Conversion of Stock, Name [Domain] Debt Disclosure [Abstract] Debt Disclosure [Abstract] Integration and Separation Costs Disposal Group Including Discontinued Operation Integration and Separation Costs Amount of Integration and separation costs attributable to the disposal group including, but not limited to, discontinued operations. Integration and separation costs includes costs incurred to prepare for and close the Merger, post-Merger integration expenses and costs incurred to prepare for the Intended Business Separations. These costs primarily consist of financial advisory, information technology, legal, accounting, consulting and other professional advisory fees associated with preparation and execution of these activities. Property, Plant and Equipment, Type [Axis] Long-Lived Tangible Asset [Axis] Deferred Tax Assets, Valuation Allowance Deferred Tax Assets, Valuation Allowance Total Current Liabilities - Discontinued Operations Disposal Group, Including Discontinued Operation, Liabilities, Current Segment Reporting, Other Significant Reconciling Item [Line Items] Segment Reporting, Other Significant Reconciling Item [Line Items] Corporate, Non-Segment [Member] Corporate, Non-Segment [Member] Net Sales Disposal Group, Including Discontinued Operation, Revenue Grants between 2016 and 2018 [Member] Grants between 2016 and 2018 [Member] Grants between 2016 and 2018 [Member] Restructuring Cost and Reserve [Line Items] Restructuring Cost and Reserve [Line Items] Pension and Other Postretirement Benefits Disclosure [Text Block] Retirement Benefits [Text Block] Stock options granted during the period Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross Schedule of Business Acquisitions, by Acquisition [Table] Schedule of Business Acquisitions, by Acquisition [Table] Document Annual Report Document Annual Report Years of Experience Years of Experience Years of Experience Forecast [Member] Forecast [Member] Vesting [Axis] Vesting [Axis] Accrued Interest and Income Taxes Increase (decrease) in accrued interest and income taxes Increase (decrease) in accrued interest and income taxes After-tax net gain to be reclassified from AOCL into earnings over the next twelve months Cash Flow Hedge Gain (Loss) to be Reclassified within Twelve Months Pension Resize [Member] Pension Resize [Member] Pension Resize [Member] Other Comprehensive Income (Loss), Tax Other Comprehensive Income (Loss), Tax Total Assets Assets Assets Plan Name [Domain] Plan Name [Domain] Liabilities Components of Deferred Tax Liabilities [Abstract] Interest, net of amounts capitalized Interest Paid, Excluding Capitalized Interest, Operating Activities Geographical [Domain] Geographical [Domain] Restructuring and Related Cost, Expected Cost Restructuring and Related Cost, Expected Cost Noncontrolling Interest [Member] Noncontrolling Interest [Member] Research and Development Expense Research and Development Expense Guarantor Obligations [Line Items] Guarantor Obligations [Line Items] Tax, Advance deposits made to foreign taxing authority Tax, Advance deposits made to foreign taxing authority Tax, Advance deposits made to foreign taxing authority Discontinued Operation, Gain (Loss) on Disposal of Discontinued Operation, Net of Tax Discontinued Operation, Gain (Loss) on Disposal of Discontinued Operation, Net of Tax Schedule of Accounts and Notes Receivable Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block] Derivative Contract [Domain] Derivative Contract [Domain] Prior service (benefit) cost Defined Benefit Plan, Accumulated Other Comprehensive (Income) Loss, Prior Service Cost (Credit), before Tax Royalty Income Royalty Income, Nonoperating Impairment of Intangible Assets Indefinite lived Excluding Goodwill After Tax Impairment of Intangible Assets Indefinite lived Excluding Goodwill After Tax Impairment of Intangible Assets Indefinite lived Excluding Goodwill After Tax Undistributed Earnings of Foreign Subsidiaries Undistributed Earnings of Foreign Subsidiaries Liabilities, Noncurrent Liabilities, Noncurrent Committed and Available Credit Facilities Schedule of Line of Credit Facilities [Table Text Block] Pre-tax cash requirements to cover actual net claims costs and related administrative expenses Pre-tax cash requirements to cover actual net claims costs and related administrative expenses Pre-tax cash requirements to cover actual net claims costs and related administrative expenses Significant Accounting Policies [Text Block] Significant Accounting Policies [Text Block] Remaining Performance Obligation, Expected Timing of Satisfaction Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period Short-term Debt Short-term Debt EIP [Member] EIP [Member] EIP [Member] Cash provided by (used for) operating activities Net Cash Provided by (Used in) Operating Activities Accounts, Notes, Loans and Financing Receivable [Line Items] Accounts, Notes, Loans and Financing Receivable [Line Items] Litigation Status [Axis] Litigation Status [Axis] OHIO OHIO Term Loan Facility due 2020 [Member] Term Loan Facility due 2020 [Member] Term Loan Facility due 2020 [Member] Fair Value, Recurring and Nonrecurring [Table] Fair Value, Recurring and Nonrecurring [Table] Chemours related obligation subject to indemnification [Member] Chemours related obligation subject to indemnification [Member] Chemours related obligation subject to indemnification [Member] Schedule of Long-term Debt Instruments [Table] Schedule of Long-term Debt Instruments [Table] Subsequent Event [Line Items] Subsequent Event [Line Items] Other Other Receivables, Net, Current (Loss) income from discontinued operations attributable to Corteva common stockholders Net Income (Loss) from Discontinued Operations Available to Common Shareholders, Basic Marketable Securities Disposal Group, Including Discontinued Operation, Other Assets Stock Conversion Description [Axis] Stock Conversion Description [Axis] Weighted Average Number of Shares Outstanding, Basic Weighted Average Number of Shares Outstanding, Basic Diluted earnings (loss) per share of common stock Earnings Per Share, Diluted NEW YORK NEW YORK Segments [Domain] Segments [Domain] Less than 12 months, Fair Value Available-for-sale Securities, Continuous Unrealized Loss Position, Less than Twelve Months, Fair Value Service Cost Defined Benefit Plan, Service Cost Clearance of hedge results to earnings Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net Net loss (gain) Defined Benefit Plan, Accumulated Other Comprehensive Income (Loss), Gain (Loss), before Tax Non-US [Member] Non-US [Member] Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table Text Block] Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table Text Block] Securities Sold under Agreements to Repurchase [Member] Securities Sold under Agreements to Repurchase [Member] NEW JERSEY NEW JERSEY Schedule of Restructuring and Related Costs [Table] Schedule of Restructuring and Related Costs [Table] Other intangible assets Total intangible assets - net Intangible Assets, Net (Excluding Goodwill) Comprehensive Income (Loss) Attributable to Corteva Comprehensive Income (Loss), Net of Tax, Attributable to Parent Quarterly Financial Information [Text Block] Quarterly Financial Information [Text Block] Future Cash Payments Future Cash Payments Future Cash Payments related to restructuring program Employee Severance [Member] Employee Severance [Member] Guarantee Payment Timing [Axis] Guarantee Payment Timing [Axis] Guarantee Payment Timing [Axis] Year that the rate reached the ultimate health care cost trend rate Defined Benefit Plan, Year Health Care Cost Trend Rate Reaches Ultimate Trend Rate Discontinued Operations and Other Adjustments [Member] Discontinued Operations and Other Adjustments [Member] Discontinued Operations and Other Adjustments [Member] Deferred Income Tax Liabilities Deferred Income Tax Liabilities, Net Share based compensation arrangement by share based payment award, equity instruments other than options, actual awards granted, percentage of performance target Share based compensation arrangement by share based payment award, equity instruments other than options, actual awards granted, percentage of performance target Share based compensation arrangement by share based payment award, equity instruments other than options, actual awards granted, percentage of performance target Loans Payable [Member] Loans Payable [Member] Other Noncurrent Obligations [Member] Other Noncurrent Liabilities [Member] Company [Axis] Company [Axis] Company [Axis] DuPont Other Contribution Plans [Member] DuPont Other Contribution Plans [Member] DuPont Other Contribution Plans [Member] Other Comprehensive Income (Loss) Comprehensive Income (Loss) [Table Text Block] Business Acquisition, Acquiree [Domain] Business Acquisition, Acquiree [Domain] Basic earnings (loss) per share of common stock from continuing operations (Loss) earnings per common share, continuing operations - basic Income (Loss) from Continuing Operations, Per Basic Share Shares of Corteva Stock [Member] Shares of Corteva Stock [Member] Shares of Corteva Stock [Member] (Loss) income from discontinued operations after income taxes Income (loss) from discontinued operations after income taxes Income (loss) from discontinued operations after income taxes Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest Corporate Debt Securities [Member] Corporate Debt Securities [Member] Reconciliation to US Statutory Rate Schedule of Effective Income Tax Rate Reconciliation [Table Text Block] Accounts Payable Accounts Payable, Current Pro forma adjustments Pro forma adjustments Pro forma adjustments Depreciation and Amortization Depreciation, Depletion and Amortization Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Lease Term and Discount Rate [Table Text Block] Lease Term and Discount Rate [Table Text Block] Weighted-average remaining lease terms and weighted average discount rate information for operating and finance leases Dividends, Common Stock Dividends, Common Stock Actual Return (Loss) on Plan Assets Still Held Defined Benefit Plan, Plan Assets Level 3 Reconciliation, Increase (Decrease) for Actual Return (Loss) on Plan Assets Still Held Common control combination [Domain] Common control combination [Domain] [Domain] for Common control combination [Axis] Costs Associated with Exit and Disposal Activities [Member] Costs Associated with Exit and Disposal Activities [Member] Costs Associated with Exit and Disposal Activities Accumulated Other Comp Loss AOCI Attributable to Parent AOCI Attributable to Parent [Member] Inventories Increase (Decrease) in Inventories Common Stock, Shares, Outstanding Common Stock, Shares, Outstanding Financial Instruments [Domain] Financial Instruments [Domain] Interest rate in addition to SOFR Interest rate in addition to SOFR Interest rate in addition to SOFR on borrowings under the repurchase facility Raw materials and supplies Inventory, Raw Materials and Supplies, Gross Historical EID [Member] Historical EID [Member] Historical EID [Member] Continuing Operations [Member] Continuing Operations [Member] Cost of Goods Sold Cost of Goods and Services Sold Restructuring and Related Activities [Abstract] Restructuring and Related Activities [Abstract] Additions and revaluations of derivatives designated as cash flow hedges Gain (Loss) Recognized in Other Comprehensive Income (Loss), Pre-Tax Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax Proceeds from Divestiture of Businesses Proceeds from Divestiture of Businesses Entity Central Index Key Entity Central Index Key Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Schedule of Held-to-maturity Securities [Line Items] Schedule of Held-to-maturity Securities [Line Items] Chemours Contribution to MDL Settlement [Member] Chemours Contribution to MDL Settlement [Member] Chemours Contribution to MDL Settlement Total Lease Cost Lease, Cost Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] Fair Value Step-up Business Combination, Fair Value Step Up Of Acquired Inventory Business Combination, Fair Value Step Up Of Acquired Inventory Net (Loss) Income attributable to common stockholders Net Income (Loss) Available to Common Stockholders, Basic and Diluted Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders. Decreases related to positions taken on items from prior years Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions Available-for-sale Securities, Gross Realized Gain (Loss) Available-for-sale Securities, Gross Realized Gain (Loss) Non-operating pension and other post employment benefit credit (cost) Defined Benefit Plan, Other Net Periodic Benefit Cost (Credit) Amount of other net periodic benefit cost (credit) for defined benefit plan. Includes non-operating cost components for defined benefit pension and other post employment benefit plans (interest cost, expected return on plan assets, amortization of unrecognized loss, amortization of prior service benefit) Other oilseeds [Member] Other oilseeds [Member] Other oilseeds [Member] Employer Discretionary Contribution Percent Defined Contribution Plan Employer Discretionary Contribution Percent Defined Contribution Plan Employer Discretionary Contribution Percent Loss Contingencies [Line Items] Loss Contingencies [Line Items] Segment Operating EBITDA Segment operating EBITDA Segment operating EBITDA Property, Plant and Equipment Disclosure [Text Block] Property, Plant and Equipment Disclosure [Text Block] Other noncurrent obligations Other Liabilities, Noncurrent Cost Sharing Arrangement under the MOU [Member] Cost Sharing Arrangement under the MOU [Member] Cost Sharing Arrangement under the MOU Operating Activities [Axis] Operating Activities [Axis] Significant items Segment Reporting Information Other Benefit (Charge) Segment Reporting Information Other Benefit (Charge) Benefit obligation at beginning of the period Benefit obligation at end of the period Defined Benefit Plan, Benefit Obligation Long-Term Debt Schedule of Long-term Debt Instruments [Table Text Block] Debt Instrument [Line Items] Debt Instrument [Line Items] Trading Symbol Trading Symbol Customer-Related Intangible Assets [Member] Customer-Related Intangible Assets [Member] Trust Asset Distribution Trust Asset Distribution Distribution from Trust Derivative Asset, Net Derivative Asset Percentage of Weighted Average Cost Inventory Percentage of Weighted Average Cost Inventory Additional annual PFOA liabilities for the next five years paid by Corteva Additional annual PFOA liabilities for the next five years paid by Corteva Additional amounts EID will pay annually, if Chemours $25 million is exceeded. EID will pay excess up to the next $25 million, with Chemours annually bearing excess liabilities above that amount. Total inventories Inventory, Gross Tax Cuts and Jobs Act of 2017, Indirect Impact on Inventory, Income Tax Expense Tax Cuts and Jobs Act of 2017, Indirect Impact on Inventory, Income Tax Expense Tax Cuts and Jobs Act of 2017, Incomplete Accounting, Indirect Impact on Inventory, Provisional Income Tax Expense Deferred Tax Liabilities, Other Deferred Tax Liabilities, Other Trust Agreement [Member] Trust Agreement [Member] Trust Agreement [Member] Projected benefit obligations Defined Benefit Plan, Plan With Benefit Obligation In Excess Of Plan Assets, Projected Benefit Obligation Defined Benefit Plan, Plan With Benefit Obligation In Excess Of Plan Assets, Projected Benefit Obligation Proceeds from Sale of Debt Securities, Available-for-sale Proceeds from Sale of Debt Securities, Available-for-sale Line of Credit Facility [Table] Line of Credit Facility [Table] Restructuring and Asset Related Charges - Net Disposal Group Including Discontinued Operation Restructuring Settlement And Impairment Provisions Disposal Group Including Discontinued Operation Restructuring Settlement And Impairment Provisions Amortization of unrecognized (loss) gain Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, before Tax Defined Benefit Plans and Other Postretirement Benefit Plans [Domain] Defined Benefit Plans and Other Postretirement Benefit Plans [Domain] Defined Benefit Plans and Other Postretirement Benefit Plans [Domain] Plan participants' contributions Defined Benefit Plan, Plan Assets, Contributions by Plan Participant Reclassification out of Accumulated Other Comprehensive Income [Table] Reclassification out of Accumulated Other Comprehensive Income [Table] Schedule of Restructuring Reserve by Segment Schedule of Restructuring Reserve by Segment [Table Text Block] Schedule of Restructuring Reserve by Segment Schedule of Goodwill [Table] Schedule of Goodwill [Table] Issuance of stock Stock Issued During Period, Value, Other Stock-based compensation expense Share-based Payment Arrangement, Expense Other Comprehensive Income Location [Axis] Other Comprehensive Income Location [Axis] Cost of Goods Sold Cost of Goods and Service [Policy Text Block] Unusual or Infrequent Item, or Both [Axis] Unusual or Infrequent Item, or Both [Axis] Stock options exercisable, weighted average remaining contractual term Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term Pension and Other Post Employment Benefits Obligation Noncurrent Disposal Group Including Discontinued Operation Pension and Other Post Employment Benefits Obligation Noncurrent Disposal Group Including Discontinued Operation Pension and Other Post Employment Benefits Obligation Noncurrent Eligible Employee Age Threshold Defined Benefit Plan, Eligible Employee Age Threshold Defined Benefit Plan, Eligible Employee Age Threshold Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners Impact of Internal Reorganizations Stockholders' Equity Note, Spinoff Transaction Cash equivalents and restricted cash equivalents Cash, cash equivalents and restricted cash equivalents, fair value disclosure Cash, cash equivalents and restricted cash equivalents, fair value disclosure Statement [Table] Entities [Table] OIP [Member] OIP [Member] OIP [Member] Net income (loss) Net income (loss) Net income (loss) from continuing operations after income taxes Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Less than 12 months, Gross Unrealized Losses Available-for-sale Securities, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss Investments [Domain] Investments [Domain] Change in accounting method [Member] Change in accounting method [Member] Elective change in accounting method that alters the 2019 impact of the business separation on the 2017 Tax Cuts and Jobs Act's foreign tax provision Schedule of Sundry Income (Expense) - Net [Table] Schedule of Sundry Income (Expense) - Net [Table] Schedule of Sundry Income (Expense) - Net [Table] Geographic Allocation of Income and Provision for Income Taxes Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block] Construction in Progress [Member] Construction in Progress [Member] Other Significant Noncash Transaction [Axis] Other Significant Noncash Transaction [Axis] Cash, Cash Equivalents, and Restricted Cash Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Common Stock, Par Value Common Stock, Par or Stated Value Per Share Amount of Employer and Related Party Securities Included in Plan Assets Defined Benefit Plan, Plan Assets, Employer, Related Party, Amount Defined Benefit and Contribution Disclosures [Line Items] Defined Benefit Plan Disclosure [Line Items] Defined Benefit Plan Disclosure [Line Items] Guarantee Obligations Guarantor Obligations, Maximum Exposure, Undiscounted Amortization of Fair Value Step-up Business Combination, Fair Value Step-Up Of Acquired Inventory, Amount recognized in Cost of Goods sold Business Combination, Fair Value Step-Up Of Acquired Inventory, Amount recognized in Cost of Goods sold Business Combination, Fair Value Step-Up Of Acquired Inventory, Amount recognized in Cost of Goods sold Land Improvements [Member] Land Improvements [Member] Statement of Comprehensive Income [Abstract] Statement of Comprehensive Income [Abstract] Other financing activities Proceeds from (Payments for) Other Financing Activities Finite-Lived Intangible Assets, Gross Definite-Lived Intangible Assets, Gross Finite-Lived Intangible Assets, Gross MOU Escrow Account Deposit Annual escrow deposit No later than each of September 30, 2021 and September 30, 2022, Chemours shall deposit $100 million into an escrow account and DuPont and Corteva shall together deposit $100 million in the aggregate into an escrow account. Impairment of Long-Lived Assets Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block] Deferred Revenue Deferred Revenue, Current Stock options exercised during the period Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period Remaining Plans with no Plan Assets [Member] Remaining Plans with no Plan Assets [Member] Remaining Plans with no Plan Assets [Member] Total other comprehensive income (loss) Net other comprehensive income (loss) Other Comprehensive Income (Loss), Net of Tax Fair Value, Recurring [Member] Fair Value, Recurring [Member] Argentine Peso Devaluation Argentine Peso Devaluation Argentine Peso Devaluation RSU Requisite Service Period Share-based Compensation Arrangement by Share-based Payment Award, Award Requisite Service Period Total Non-Current Assets - Discontinued Operations Disposal Group, Including Discontinued Operation, Assets, Noncurrent Stockholders' Equity Note Disclosure [Text Block] Stockholders' Equity Note Disclosure [Text Block] Write-offs charged against allowance Accounts Receivable, Allowance for Credit Loss, Writeoff Private Market Securities [Member] Private Equity Funds [Member] Disposal Groups, Including Discontinued Operations [Table Text Block] Disposal Groups, Including Discontinued Operations [Table Text Block] Decreases due to expiration of statutes of limitations Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations Tax Rate Reconciliation [Abstract] Tax Rate Reconciliation [Abstract] Tax Rate Reconciliation [Abstract] 2026 Finite-Lived Intangible Asset, Expected Amortization, Year Five Auditor Firm ID Auditor Firm ID PFAS [Member] PFAS [Member] PFAS [Member] Investments in and loans to nonconsolidated affiliates Payments to Acquire Equity Method Investments Indemnification Assets for Liabilities Indemnified by Chemours Indemnification Assets for Liabilities Indemnified by Chemours Indemnification asset for liabilities indemnified by Chemours against certain litigation, environmental, workers' compensation and other liabilities that arose prior to the spin-off of Chemours. Total, Fair Value Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value Insecticides [Member] Insecticides [Member] Insecticides [Member] Cash provided by (used for) investing activities Net Cash Provided by (Used in) Investing Activities Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block] Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block] Held-to-maturity securities Debt Securities, Held-to-Maturity, Amortized Cost, before Allowance for Credit Loss Weighted Average Grant Date Fair Value, vested RSUs and PSUs during the period Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value 4.900% Notes due 2041 [Member] 4.900% Notes due 2041 [Member] 4.900% Notes due 2041 [Member] Class of Stock [Domain] Class of Stock [Domain] Deferred Tax Liabilities, Intangible Assets Deferred Tax Liabilities, Goodwill and Intangible Assets 2019 share repurchase plan 2019 share repurchase plan [Member] 2019 share repurchase plan Line of Credit Facility, Maximum Borrowing Capacity Line of Credit Facility, Maximum Borrowing Capacity Operating cash outflows from finance leases Finance Lease, Interest Payment on Liability Currency Translation Adjustment Goodwill, Foreign Currency Translation Gain (Loss) Segment Reporting Information [Line Items] Segment Reporting Information [Line Items] Latin America Latin America [Member] Foreign Currency Transaction Type [Axis] Foreign Currency Transaction Type [Axis] Foreign Currency Transaction Type [Axis] Tax benefit related to an internal legal entity restructuring associated with the Business Separations Tax charge (benefit) related to an internal legal entity restructuring associated with the Business Separations Tax charge (benefit) related to an internal legal entity restructuring associated with the Business Separations Payments for Legal Settlements Payments for Legal Settlements Net Periodic Benefit, Discount Rate Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate Line of Credit Facility [Line Items] Line of Credit Facility [Line Items] Total Current Assets - Discontinued Operations Disposal Group, Including Discontinued Operation, Assets, Current Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Other current assets Other Assets, Current Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Rate of Compensation Increase Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Rate of Compensation Increase Asset-backed Securities [Member] Asset-backed Securities [Member] Net amount recognized Defined Benefit Plan, Amounts for Asset (Liability) Recognized in Statement of Financial Position Disposal Group, Including Discontinued Operation, Pension Plan Benefit Obligation Disposal Group, Including Discontinued Operation, Pension Plan Benefit Obligation Restructuring and Related Cost, Cost Incurred to Date Restructuring and Related Cost, Cost Incurred to Date Reclassification of Divisional Equity to Additional Paid in Capital Adjustments to Additional Paid in Capital, Other Derivative, Remaining Maturity Derivative, Remaining Maturity Other Assets Disposal Group, Including Discontinued Operation, Other Assets, Noncurrent Prepaid Royalties - Long-Term Prepaid Royalties - Long-Term Amount of asset related to consideration paid in advance for royalties that provide economic benefits within a future period of greater than one year or normal reporting cycle, if longer. Cash, cash equivalents and restricted cash equivalents at beginning of period Cash, cash equivalents and restricted cash equivalents at end of period Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations Preferred Stock [Member] Preferred Stock [Member] Distributions to Dow and DowDuPont Distributions to DowDuPont Payments of Distributions to Affiliates Extinguishment of Debt, Amount Extinguishment of Debt, Amount Other Comprehensive Income (Loss), Defined Benefit Plan, Settlement and Curtailment Gain (Loss), after Tax Other Comprehensive Income (Loss), Defined Benefit Plan, Settlement and Curtailment Gain (Loss), after Tax Balance at beginning of period Balance at end of period SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount Cost of Goods Sold Cost of Sales [Member] Income Taxes Payable Accrued Income Taxes, Current Income (loss) from continuing operations after income taxes Income (loss) from continuing operations after income taxes Income (Loss) from Continuing Operations After Taxes Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest Crop Protection [Member] Crop Protection [Member] Crop Protection [Member] Inventories Inventory, Policy [Policy Text Block] Current Foreign Tax Expense (Benefit) Current Foreign Tax Expense (Benefit) Integration and Separation Costs Integration and Separation Costs, Policy [Policy Text Block] Integration and Separation Costs, Policy [Policy Text Block] Pension Plan Pension Plan [Member] Developed Technology Rights [Member] Developed Technology Rights [Member] Accounts Receivable, Allowance for Credit Loss Accounts Receivable, Allowance for Credit Loss [Table Text Block] Schedule of Finite-Lived Intangible Assets [Table] Schedule of Finite-Lived Intangible Assets [Table] EX-101.PRE 13 ctva-20211231_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT GRAPHIC 14 ctva-20211231_g1.jpg begin 644 ctva-20211231_g1.jpg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
U6NO M:U5UDO=7I';YN[[6/=/V&_VJI/V>?B')IGBNZD;POKTBIJNXB66">%PR2(PRK*1P000017XP5]#_L? M?MW^(_@$8O GCR*XU?PDTG[M$;=<:;D\F+)PR=S&2.>5(.0WYQX/>+=+AN*R M;.9/ZLVW">_LVW=J77D;UO\ 9;;>CT_<>&.)(X!?5<4_W?1_R^3\OR]-OT=H MK"^'GQ,\!_%?PY%XL^'GBBUU6QE _>VTG,;?W74_-&W^RP!]JW:_L?#XC#XN MA&M0FIPDKJ46FFNZ:T:/U"$X5(*4'=/9K8****V*"BBL+XA_$SP'\*/#DOBS MXA^*+72K&('][16]M;Q-+<3S.%2-%&69B> 22>E?FG^W/^ MU0W[1/Q!32/"]PX\+:$[QZ6#E?MY8'UQA0>0O/!9A6I^V#^W?XD^/AF\ M"> X[C2/"2R?O$=MMQJ6#P9<'Y4[B,$\\L2WM&G=)?W$];OXFET7O?E_$_$D<>OJN%?[OJ_YO)>7YORW****_G@^)"BB MB@ K]0?V"_AD?AC^S)H%M

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end GRAPHIC 15 ctva-20211231_g2.jpg begin 644 ctva-20211231_g2.jpg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end GRAPHIC 16 ctva-20211231_g3.jpg begin 644 ctva-20211231_g3.jpg M_]C_X 02D9)1@ ! @$ 8 !@ #_[@ .061O8F4 90 !_]L 0P " 0$! M 0$" 0$! @(" @($ P(" @(%! 0#! 8%!@8&!08&!@<)" 8'"0<&!@@+" D* M"@H*"@8("PP+"@P)"@H*_]L 0P$" @(" @(% P,%"@<&!PH*"@H*"@H*"@H* M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*_\ $0@" M% )X P$B (1 0,1 ?_$ !\ $% 0$! 0$! ! @,$!08'" D* M"__$ +40 (! P,"! ,%!00$ !?0$" P $$042(3%!!A-180'EZ@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>H MJ:JRL[2UMK>XN;K"P\3%QL?(R;GZ.GJ\?+S]/7V M]_CY^O_$ !\! ,! 0$! 0$! 0$ ! @,$!08'" D*"__$ +41 (! M @0$ P0'!00$ $"=P ! @,1! 4A,08205$'87$3(C*!"!1"D:&QP0DC,U+P M%6)RT0H6)#3A)?$7&!D:)BH*#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6V MM[BYNL+#Q,7&Q\C)RM+3U-76U]C9VN+CY.7FY^CIZO+S]/7V]_CY^O_: P# M 0 "$0,1 #\ _?RBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ MHHHH **** "BBB@ HHHH ***K:U9W^H:-=V&EZHUCI$KFWD92%D" MMPQ4D'!X..: /S0_X*6_\'3/[#?_ 3W^->H?LX^'/!'B'XI>,=!N3;^*(?# M=S!;Z?I-POW[62ZE)\RX3HR1HRHM>!O$RQBY%J6"?:K>2)F2Y@#LJ,PVNC,N]%#H6Z;PO\ M\$3/^"9&B?L[3?LX^(?V2/!WB.SU&P>+7_%/B#1(+C7M6NY 3-J$VI%?M'VM MW+2>:CJ48_)L4 #\$O\ @V2_9V\7:-_P7_N]+^%.KW=]X4^%U53A+S M31'<:;;>85^4E[B:VD"]S&2!\IP ?T9?MX_M\_LT_P#!-_\ 9^OOVD/VHO&+ MZ9HEM.MK865E")K[5KQU9H[2UAR/,E8*QY*JJJS.RJK,/FK6/^"\7AGX$W_P MPU[]O/\ 9!\9?!/P+\9$4^!/'FLZ[I^I6L3,D=Y"=JQJ@ M+%B< #.<5^/OQG_X/2_V$? GQ6N?!OPI_9U\?^-_#EG=F&3Q=#/;6"W2AL&6 MVMYB9'0CE?-,+'NJUZW_ ,$7=.T;_@J]_P $"?AC\&OV@_$FJ7&E:=8H(#YJ'_@X _X)4?\ !/5O^"3O MQ*\?^$?V8O ?@77OAMX;_M?PCK_A'PQ::9<6TL,B 6K-;HGFQ3*3$8WW#+A@ M ZJP /MO]A#]O3]FW_@H[^SWI_[2G[+_ (NEU+0;R=[6]M+Z#R;W2KU IDM+ MJ+)\N50Z' +*RNKHS*RL5_;$_P""@W[&?[ G@S_A-_VMOV@_#_@Z"2)I+'3[ MVY,NH7X'46UG$&GN.>#Y:,!W(K\GO^#(CX7_ !)T']G+XY?%S6Q=)X5\2>+M M(T_P]'+D1O=V5O2Q@]6B%AP3%C.5('T3_P='_LL_LUG_@D)\:_CZGP M%\(1^.;74/#E]%XQA\.VR:H;A];TZR:1KH)YK$VTLD/+'Y&QT H ^D?^"67_ M 5J^!__ 5I\+^/?B#^S_X%\1:1X?\ !7BB/1H+SQ*D4<^I%K=9O/$,;OY2 M?-@!F+$8)"D[1]5U^)O_ 9&?\F=?&?_ +*9:_\ IOCK]LJ /)/VR_VH_$'[ M(7PAO_C58_LT>._B5I6C65Q>Z]:?#\:?+>V-M$JLTOD7=U \XVEFVPB1P(V) M7IGXB_8G_P"#K?\ X)R?MK?M(^'?V9=*\'?$'P-JOBNX-IH>K^.+'3X=/FO3 M_JK5I+>\E9))3\B;E"LY5<@LN?T=^)G_ "3?Q!_V [O_ -$O7\D__!1S_@BY MXO\ V:/V#_@+_P %-/@!:WU]X#\>_##PU>^/88W:27PUKMQ8P,UR6^\+6YE; M%: /ZV/B+XF\2>#_"%WXA\(_#G4O%E_;A3!H.D7EI!<7.2 0CW MDT,(('/SR+TKYL_80_X*F-^WSX]\6^#_ 1^Q'\7/"-EX!\5W?ACQGXA\;KH MMM:Z7K%LFZ6RV0ZC+-/(N8P3%&Z+YJ$L P-?*?\ P;._\%R(?^"A/P=C_9+_ M &E/%:'XT^!=+7R+^\E&_P 7:3& JW8)^]=1#:LXZN"LPSND$?U3_P $KHHH MM;_:A$4:KN_:Q\3LVT8R39:7DT ?6-%?(/[77_!7_P"%7P _:U\*?\$]O@?\ M--2^+7QW\7$20>!M#U.&RMM'MO):X-QJ5[*&6U7R$>;8J22>6H8H \9>']C3 M_@L%\/?VB_VN_&?_ 3Q^.OPBU'X2_'7P2IGN?!>J:Q#J-IJ]IY23"XT^^B5 M!<#R98YBC1QOY;[@K!9/+ /J7XJ?%+X>?!#X;:[\8/BSXML]!\,^&M+FU'7= M9OY-L-I;1(7>1L9)P < DG )(%;]?S6?\ !UU_P5Q_:?\ B7\3Y?\ @G+8 M?";Q%\-/AY8^5J>IC7E6&^\:A9I%@N2B,PCL!+"[11D[I&C61PI5$3]V/V*? MVPOC)^U3<^(X/BO^PA\2O@NNAQVC6,OQ :S(U6N[=C_ %JX MSS0![W7QO\6/^"P7AN;]K#6OV&/V(?V;_$WQ[^)WA.V\_P ZG>.(UGR0/*C61MP9/OHR#[(K^3+_@DY_P5S^+'_!#;]OWXO>&OVLOA M7J?B&T\8^(FT_P"+=I"535[74K.ZN2+V RD+,0]S_$;X0^(IM/GE\'6\P@US1?%5VB%DL;75M-,L44 M[' *W*0[%.\Y%?>U?#OQ$^)'_!/[_@X>_P"">/C[X'?LZ_&_PYXCEUO0&>QB MO4:+4O"NL(-]E=W%HX%Q ([@+EPNV1!(J.RL<_3G[5G[5OP+_8G^ >O?M*?M M)^.(?#_A3PY;K)?WK1M(\DCL$C@AC4%I99'945%&23S@ D 'HU4_$6HZCH^@ M7NK:1H%QJUU;6DDMMI=I+%'+=R*I*PHTSI&K,0%!=E4$\D#)K\WOCU_P^*=4^ ^MO:R6WB^\^)NDP:E%:7,HAM[F73K<7!C62 M0H@4RY5G57V$U]@_\$^OV_?V??\ @I7^S1I?[47[-^JWDNBWUS+9:AIVJ0"* M]TF_B"F6SN$5F59%#HV59E9)$920P- 'RE^S-_PF MR\$> _#-NL^K:_<@J"L,;,H6-2\8>5B "ZJ-SLJ, ?2U%?"DO_!:R3X#_M7^ M /V2_P#@HM^RCJ'P1U+XK6:2?#_Q*/&=KKNDW-RTBQ&RNYX8XC:3K(\:'"R1 MAI4)D"L'KM_^"EG_ 5N^%G_ 3O\5_#GX(6?PUU7XB?%CXN:[#I7P^^'FB: MA!9O=R23QVZRW-U.?+M83+*D:N0Q9B<#:DC( ?6E%?&?@+_@JS\4+;]M#X:? ML%?M/?L"^,/AGXW^)?\ :MQI&LOXFL-6\/36=CIT]Y*]M?VY#SSAH4C:W>&) MD$HD)P5#_9E 'QU_P52_X++?"?\ X)'6?AWQ-^T'^SM\1==\-^)[IK/3/$OA M!=+FM_MBH9&MGCGO8ID?8"P;R]A .&R"*]I_82_;&^'G_!0#]E#PA^U]\*?# MNM:3X?\ &=O)?"ZB/Q)\/=;EBAO[*Y=': >8&,;PS&-Q'. M" =K!@C*RCY1_P"(K#X66G[7=M^PSXB_8%^)^C?$FX\

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

"_B5JNC:WH/B/X=:5 =:^'' MBB#S-.UW2Y[&\4 9\N5"A(ST89R#V(!K9HK2E5J4*L:E-VE%IIKHUJF9U:5. MO2E3J*\9)II[-/1KYG\^GQ:^&GB/X-_$W7?A9XM@*:CH.IRV=S\I ?8Q D7/ M\++AE/<,#7/5^C'_ 6T_9/FE-A^UIX,TPL$2+3O&"Q+T'"VUTWYB%C_ -<1 MZU^<]?Z$<$<3T.+N&Z&8P:YFK37\LU\2^_5?W6F?YS<=<+5^#N)Z^6S3Y4[P M?\U-ZQ?W:/\ O)H****^L/D K5\#^./%WPU\6V'COP'X@N=+U?2[@3V-_:/M M>)Q^A!&05.002"""165145*=.M3=.HDXM6:>J:>Z:ZIETZE2C452G)J2=TT[ M--;-/HT?KG^PU_P56^&7[0]C9_#_ .,=[9^&/&^%B4S/Y=CJK= T+L<1R$_\ MLF/)(V%LX'US7\Z=?0/[//\ P4T_:R_9UM8-"T;QLGB#1+=0D6B^)XVNHXD' M18Y-RRQ@#@*'VC^[7\W<9> T,36EBN'ZBA?5TIWY?^W):V7:,E;^\EH?TWP5 M](&>&H1PG$5-SMHJL$N9_P"..EWWE%W?\K>K_:NBOA;X)?\ !;3POX\>33OB M!\"=1TZ>WMQ)+M?LY^0)3X5\8[N M\8TVVR/_ "9Q^M?R1QIG63^'F?2R;B'$0P^)C%2<)23?++X7>-UK;O?R/Z#R MGCCA;.\&L5@\2I0?5J4=5OI))GTU17QYXP_X*W^%X(WB\ _""_N7((BFUC4$ M@"GU*1B3/TW#ZU\__&+]NC]HCXS6TND:KXL72-,F!$FF:"AMT=3_ N^3(XQ MU!;:?2ORG/O'C@3*:3^J5)8FIT4(M*_G*:2MYQYO0>,XPR?#1?LY.H^R6GWN MWX7/KC]JW_@H#X%^#%K<^#_AM=6VO>*<&,^4^^UT]NF964_.X_YYJ>H^8KT/ MY[>*_%?B/QSXCO/%WB[6)K_4K^8RW=W<-EI&/\@!@ #@ "L^BOY0XZ\0\ M^X]QJJ8Q\E*/P4X_#'S?\TN\G\DEH?G.;YWC,XJ\U72*VBME_F_/\@HHHKX, M\<**** -KX<^!=:^)OCO2?A_X=B+WFKWT=M#QD)N/+G_ &5&6)[!37Z[^#/" M>C^!/"6F>"_#\'EV6E6,5I:H>NR-0H)]2<9)[DFOD/\ X):_L]20K=_M$>); M/&]9+'PXLB]1G$UP/R,0/_73VK[/K^UO 'A">2\.3S;$1M5Q5G&^ZI1^'_P- MMR\URL_5N#$P+Q,U[U3;_ K;[]_2P4445^_'V04444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% 'RS_ ,%,_P#@I_I'_!,3PMX9^('Q&_9R M\6^+O#_BOQ5:>&M,U#PG?V'F+JES'+)#!)%+3WGVAV$_VA?V]?V9?^"P MGP\_8V_:/_:4T3XI>"?C=X US5](BL_ %MH3^%M3TT><\=N8I)9)K9XOE N) M99 6'S_*2_$1?\%"OC'^T]\5?VB?V9/AA^W#_P *A_:*\!>,==T3X4?!K7O# M^BQV&O6ELF-,NP^HVK3WKWH!E+0W*+$)48PM&F9@#]-J*^0?VKOVX-4L/VV= M._8/\%>-/&/A,6OPV_X3/QCXM\!?#6[\4:O%%->M9V5E:P16%]#;%VAN)99[ MB"10J11HNZ7?'XM\*/\ @IU^UW^RC\-OVG_&?[<7PX\:>+O 'P;TF/7?A/\ M%CQ#\.)_"ESXUMIE")IMS;RVUO''=1W,D,'FI;QJP9W\O:J[@#])ZS[KQ9X: ML?%-CX'O-55ZE4:YMU8]C,GJ*^,_'.D_P#! M832_AC\)/VC/@;\7M*\=>*=:U_2;CXJ?"#4M+TC3O#=MHMW&7NQIMTT"WZ2V MI:,*\MW,90'?RB<1'QOQ-X*_:!US_@YUN?!.G?M=^*;"S/[(L^OZ/ NCZ;/# MI%M-XGM[>73H(9;=D$26: M6>1(Q,I97BB;S<^2I5<9'PK^/'[:/_!2[]G/XH_M1_L@_M#3?#R'3/$&OZ+\ M#?#EAH.DW5OK\FEO);QW6LS:A:SN$N[N)U$=LUOY$)4EY')8 'U#^UY\:?C? M\!OA+%XZ_9__ &7=3^+VO/K]A8OX3TG7X--E2UGF$'M'^*.@6FB1Z MP(9[RY$$OV*X>X>WB'\15H[C&_:LGR[F]M_:P_:]^(UW^W=\,?\ @F;^SUXJ MB\-^)O&7A>_\9>.?&9L(;NYT#PW:N8(Q903JT+W=S= Q+),DD<*1R,8I"5 M-?3_ /@HI>7/_!4S_AV5JO[/&L:5.WPJN/'-KXWU'7;4PWUI'?I9(L%M 96V MO)YWS2O%(OE#,6'!'TQ7Y=_#CP+\8OAW_P '0NG>'_BS\;KSQ_"?V/+N;PYK M>KZ196FH1V3>(0#;W0L88+>5UG$S+)'#%F.2-6!9&=K6H?\ !0C]IO\ ;'_9 M2\6_M8_LB_&OXH>%]=^V:X_P?\">&/V=+[7M#UZWT^ZN+:VAU+4)-(N!++>O M;%C):7=O':B=$;>T,C. ?IU17YM_'+_@K/\ %GX8_#+]E/7OVR;;Q#^S-IWQ MCM]8A^*WBMO#44DWA76[**)+73R-0M[F*S@O)6FE66>&1A#".5!DF3Z]_8IG M^-5]X3\6ZO\ %/\ :"TWXH^'[_QD;GX6>-]-ATY1J/AM]-L&C,ATY5@DD6\^ MWH9551)M#JJ(R(H![/1110!F^,O"'AOX@>%-1\#^,-)BO]*U:SDM=0LYAE98 MG4JRGTX/4<@\CFOQ$_;7_9+\5_L@?&B[\!:JLUSHMV6N?#.KNGRWEH3P"1QY MJ9"N/7!QM92?W-KS+]K']EGX??M;_":Z^&OCB+R+A29]$UB*,--IUT 0LB_W ME/1DSAE.." P_3O##C^IP3G#C7N\+5LJBWY7TFEW75=8^:5ORSQ4\/*?'63* M5"RQ5&[IMZC8Z]005(# @<57]QX7%8;'8:&(P\U.$TG&2=TT]FF?P= MB\)B$;)[F*..3 MOF-7+#_R(E=W7-_"*P>P^']I(9=RWD\UR!C[IW>41_Y"!_&NDK_ 3Z7.?_ZP M_2&SVLG>-*I"BO+V-*%.2_\ XR?JV?TYP7AOJO"^&AWCS?^!-R_)A1117\W M'U 4444 %%%% !7I/[+?[.OB']I#XG6_A.P22'2[8K/KNHJ.+:WSR >GF/@J MH] =+-Q=3G=/,V1%:Q C=+(W\*C/U)P "2 ? MU!_9[^ 7@W]G7X>P>!_"<7FRDB75-2D0"2]GQ@NWH.RKT4>IR3^P>$WAGB>- MLT6+Q<6L%2?O/;G:U]G'_P!N:V6FC:/IN&\AGFV(52HK4HO7S?9?KV7F=;X; M\.:)X0\/V7A;PWIT=I8:?;);V=M$,+'&HPH'X#KWJ[117]XTZ=.E34()**5D MEHDELDNQ^PQBHI)+1!1115C"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** " MBBB@ HHHH _/#_@X8_9N_;!_;$^"/PR^#_[)7[*^M^.+WPO\9M$\8ZMJ,7B; M0].M$L[*&\5X5-]?PRM,S3QX CV8#$N, '1_X*N_"3]KK]J'QO\ LH^+_@E^ MQGXOU2W^&OQ]T;QYXWM[CQ+X;MIM-L+-Y8Y( )=5"37!5O,58F:,J0#(&RH^ M_J* /@C]IWX-?M9^/?\ @L[^S=^UAX+_ &1O%%_\/?AOX/\ $>F^+-?'B/P_ M$T$^J6?EQ".WDU)9I1$X D(3N2GF #/F7_!0C]C_ .(__!13X"_$;X5?M&_\ M$UMC^*?$%K\ _B_HFH:+!$+$:G%[+XY^+-"^"]A\-OCMX$ MO=L?$/X#?MC?\ !6#]B3XM M?"S]K[X26OP*M?'W@TZ-X(\!OXCAUN[L+M9!_V&['P=K'AK3K?P_K?[1;?$.RN M=.DTN!5B_M&SL8@\\^H/ O[M&*QB8B67RUS!74_M!_ ']LOX>?\ !<;PM^WC M\"_VFKX>OQKC:BMY=+.WFR6Q38I^SQRR??PA M(57^]:* /@WPM\#OVK;/_@X#\0_MD7_[+'B&+X5ZA^S_ !?#^U\8GQ%H15K^ M/6([W[2;4:@;H6QC# 'RO-W 9C .1XQ^R#\-?^"L'_!'KXD_$']D'X,?L(Q_ M'KX->)_'=_XC^$_BW3OB)8Z*WAY+U]\EAJ N0S+'&=K%U3[WF,GF^8(X_P!6 M:* /SO\ ^"Q7[+O[>'[1?_!-[PI^S]X ^$EQ\4_B7<>/M(\1>*KG0-:TO3=- ML3;W[7T\$+:G=V[M#'N%O;C#N8XT,A!R3!^W_P#LU_MI>#?^"AGP;_X+$_L@ M? "\\;:AX?\ T_@GXI_!^ZUNQL]6FT26>>X2:VE,[6TD\4MQ(S(LIW&*$*6 M5G*?HO10!^#=2E\4^-=+%] MICRZS-=[YX;26=3-A,O+&S-&GGG['7@W_@L-_P $>M6\1?L(_"3] M@>T^/_P:?Q7?ZC\'/&MA\2++0VT*SO+A[AK+4%N%=@D;R,[,(P=[2;#,&54_ M5^B@#Y(^-^E?M/VMI\._A/\ M#?LM6O[0'PZ\4^%-=3XY6VC6>ES6^F:O+=6 M4]@;>RU*:*6[LHP]];HB;YA''%(P9U^;F/\ @C)^P;XL_8;N/C=!H7A36_!/ MPG\:_$*+5?A)\+O$.KK=W?AVS%JJ74K[)9EA%Q.2R0^8TB10Q>9B0LH^WJ* M"BBB@ HHHH \Q_:G_9-^$_[7'P^;P/\ $K3"MQ!N?1]:M5 NM.F(QO1CU4X& MY#\K #/(4C\?_P!K3]BGXT?L@>*SI/C[23=Z-<3%=(\3643&TO!R0"?^64N! MS&W(P2-RX8_N=69XP\&>$_B#X;N_!WCGPY9:MI5]%Y=WI^H6ZRQ2K[JP(X/( M/4$ CD5^G< >)^;\$U/827M<*WK3;UC?=P?1]U\+\GJ?EGB'X5Y-QU3]O%^Q MQ26E1+25ME-?:79_$NEUH_YYJ*_1?]K#_@B4TDUSXR_9+UY%#%I&\(:U@ZBF3]FU*T:,N!_$A/$B^C* M2#V-?U]PQQMPWQ=04\NKIRMK!Z3CZQW^:O'LS^-.*>!>)N#J[AF5!J-])K6G M+TDM/D[2[HYZBBIM/L;G4[^#3;--TUQ,L42^K,0 /S-?5RE&,7)NR1\DDY.R MW/<_"EE!I_A72[2W4JHTZ%F4]G9 [CV^=FJ_4ET\4ES))!'L1I"43^Z,\"HZ M_P"9KC7/7Q1QEF6)Q%:M_P"#*DI_^W']=8+#K"8.G06T(J/W)(****^9 M.D***VO OPY\>?$[6E\/?#_PE?ZO>-C,-C;E]@/\3GHB_P"TQ ]ZUH4*^*K1 MI48N4Y:))-MOLDM65"$ZDE&*NWT1BUZ3^SM^RW\3_P!I#7Q8^$=.-MI<$H74 MM=ND(M[8=2!_ST?'1%YY&=HY'T7^SU_P2V$4EOXG_:'U=7P0X\-:9-Q_NS3K M^JQ_]]]J^PO#GAKP]X0T6W\-^%=%M=.L+1-EM9V<*QQQKZ!5X]_4OY%W^WTM'<^VR;@[$8B2JXWW(_R_:?KV7X^AR?P# M_9Z^'?[.O@Y?"O@73R99=K:EJP&3A1PN3W))[JBBOZ\P&7X+* ML'#"82FJ=."M&,59)?UN]V]7J?I=&C2P])4Z4;16R04445V&H4444 %%%% ! M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %% M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444 M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !6-X[^'7@'XH:#)X6^(_@ MS2]=TZ7[]EJMBD\>?[P#@X/H1R.QK9HK2E5JT*BJ4Y.,EJFG9I^31G5I4J]- MTZD5*+T::NFO-,^/OC!_P16_95\?22ZC\.]0UKP7=R$E8K"Y^UV@)[F*?+_@ MLB@>E>#7W_!#[X\>"_%UEKW@GXK>&= MM?IU17W5'Q/XYI9;5P,L9*=.I&4'S)2DE)--J;7,FD]'?1]#\YS'PBX S'$+ M$/!JG--.]-N"T=_A3Y/_ "4_,?6/^">'[6^DR%8_ABEX@_Y:V>LVC _@TH;] M*R6_8>_:N5BA^"VIY!QQ-"1^>^OU.HK^/JOT<.#92O#$UTNW-3?_ +C/6EP- ME;>E2:^'[6^JNH?X8):(Q_UMYK-HH'U E+?I7?>#_^"3WQ MAU-U?QK\0-!TF(XR+-9;N5?JI6-?R8U]]45Z.!^CYP!A)*5;VM;RE-)?^21@ M_P 3:CP5DU-WES2]7_DD?-WPV_X)@?L^^#WCO?&=UJGB>Y0@LEY/]GMR1Z1Q M8;\&=A7O_A7P;X2\"Z2FA>"_#-AI-DGW;73K1(4SZX4#)]SR:TJ*_4 GRAPHIC 17 ctva-20211231_g4.jpg begin 644 ctva-20211231_g4.jpg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end GRAPHIC 18 ctva-20211231_g5.gif begin 644 ctva-20211231_g5.gif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�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ctva-20211231_g6.jpg begin 644 ctva-20211231_g6.jpg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end GRAPHIC 20 ctva-20211231_g7.jpg begin 644 ctva-20211231_g7.jpg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

R>7_P ?)^1DPT^UAL;&VC6*"VMXPD<: 8"JHX ["H]#T+3O#.D6NE:186^F: M9:1B*WL[2)8HHD'1550 !]*OT %%%% &+XR\8:3X \*ZIXCUV\CL-(TV!KBY MN),X10/;DD\
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end XML 21 R1.htm IDEA: XBRL DOCUMENT v3.22.0.1
DEI Document - USD ($)
12 Months Ended
Dec. 31, 2021
Feb. 03, 2022
Jun. 30, 2021
Dec. 31, 2020
Document Information [Line Items]        
Document Annual Report true      
Document Type 10-K      
Amendment Flag false      
Document Period End Date Dec. 31, 2021      
Entity Registrant Name Corteva, Inc.      
Entity Incorporation, State or Country Code DE      
Entity Central Index Key 0001755672      
Current Fiscal Year End Date --12-31      
Document Fiscal Year Focus 2021      
Document Fiscal Period Focus FY      
Entity Well-known Seasoned Issuer Yes      
Entity Voluntary Filers No      
Entity Current Reporting Status Yes      
Entity Interactive Data Current Yes      
Entity Filer Category Large Accelerated Filer      
Entity Emerging Growth Company false      
Entity Public Float     $ 20,000,000,000  
Entity Common Stock, Shares Outstanding   727,021,000    
Common Stock, Par Value $ 0.01 $ 0.01   $ 0.01
Entity Small Business false      
Entity Shell Company false      
Document Transition Report false      
Entity File Number 001-38710      
Entity Tax Identification Number 82-4979096      
Entity Address, Address Line One 9330 Zionsville Road,      
Entity Address, City or Town Indianapolis,      
Entity Address, State or Province IN      
Entity Address, Postal Zip Code 46268      
City Area Code (833)      
Local Phone Number 267-8382      
Documents Incorporated by Reference [Text Block] Information pertaining to certain Items in Part III of this report is incorporated herein by reference to portions of Corteva, Inc.'s definitive 2022 Annual Meeting Proxy Statement to be filed within 120 days after the end of the year covered by this Annual Report on Form 10-K, pursuant to Regulation 14A (the Proxy).      
Common Stock [Member]        
Document Information [Line Items]        
Title of 12(b) Security Common Stock, par value $0.01 per share      
Trading Symbol CTVA      
Security Exchange Name NYSE      
EID [Member]        
Document Information [Line Items]        
Document Type 10-K      
Amendment Flag false      
Document Period End Date Dec. 31, 2021      
Entity Registrant Name E. I. du Pont de Nemours and Company      
Entity Incorporation, State or Country Code DE      
Entity Central Index Key 0000030554      
Current Fiscal Year End Date --12-31      
Document Fiscal Year Focus 2021      
Document Fiscal Period Focus FY      
Entity Well-known Seasoned Issuer Yes      
Entity Voluntary Filers No      
Entity Current Reporting Status Yes      
Entity Interactive Data Current Yes      
Entity Filer Category Non-accelerated Filer      
Entity Emerging Growth Company false      
Entity Common Stock, Shares Outstanding   200    
Common Stock, Par Value $ 0.30 $ 0.30   $ 0.30
Entity Small Business false      
Entity Shell Company false      
Entity File Number 1-815      
Entity Tax Identification Number 51-0014090      
Entity Address, Address Line One 9330 Zionsville Road,      
Entity Address, City or Town Indianapolis,      
Entity Address, State or Province IN      
Entity Address, Postal Zip Code 46268      
City Area Code (833)      
Local Phone Number 267-8382      
EID [Member] | $3.50 Series Preferred Stock [Member]        
Document Information [Line Items]        
Title of 12(b) Security $3.50 Series Preferred Stock      
Trading Symbol CTAPrA      
Security Exchange Name NYSE      
EID [Member] | $4.50 Series Preferred Stock [Member]        
Document Information [Line Items]        
Title of 12(b) Security $4.50 Series Preferred Stock      
Trading Symbol CTAPrB      
Security Exchange Name NYSE      
XML 22 R2.htm IDEA: XBRL DOCUMENT v3.22.0.1
Audit Information
12 Months Ended
Dec. 31, 2021
Audit Information [Abstract]  
Auditor Name PricewaterhouseCoopers LLP
Auditor Location Philadelphia, Pennsylvania
Auditor Firm ID 238
XML 23 R3.htm IDEA: XBRL DOCUMENT v3.22.0.1
Consolidated Statements of Income - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Net Sales $ 15,655 $ 14,217 $ 13,846
Cost of Goods Sold 9,220 8,507 8,575
Research and Development Expense 1,187 1,142 1,147
Selling, General and Administrative Expense 3,209 3,043 3,065
Amortization of Intangibles 722 682 475
Restructuring and asset related charges- net 289 335 222
Integration and Separation Costs 0 0 744
Other income (expense) - net 1,348 212 215
Loss on early Extinguishment of Debt 0 0 13 [1]
Interest Expense 30 45 136
Income (loss) from continuing operations before income taxes 2,346 675 (316)
Provision for (benefit from) income taxes on continuing operations 524 (81) (46)
Income (loss) from continuing operations after income taxes 1,822 756 (270)
(Loss) income from discontinued operations after income taxes (53) (55) (671)
Net income (loss) 1,769 701 (941) [1]
Net income (loss) attributable to noncontrolling interests 10 20 18
Net income (loss) attributable to Corteva $ 1,759 $ 681 $ (959)
Basic earnings (loss) per share of common stock from continuing operations $ 2.46 $ 0.98 $ (0.38)
Basic earnings (loss) per share of common stock from discontinued operations (0.07) (0.07) (0.90)
Basic earnings (loss) per share of common stock 2.39 0.91 (1.28)
Diluted earnings (loss) per share of common stock from continuing operations 2.44 0.98 (0.38)
Diluted earnings (loss) per share of common stock from discontinued operations (0.07) (0.07) (0.90)
Diluted earnings (loss) per share of common stock $ 2.37 $ 0.91 $ (1.28)
EID [Member]      
Net Sales $ 15,655 $ 14,217 $ 13,846
Cost of Goods Sold 9,220 8,507 8,575
Research and Development Expense 1,187 1,142 1,147
Selling, General and Administrative Expense 3,209 3,043 3,065
Amortization of Intangibles 722 682 475
Restructuring and asset related charges- net 289 335 222
Integration and Separation Costs 0 0 744
Other income (expense) - net 1,348 212 215
Loss on early Extinguishment of Debt 0 0 13 [2]
Interest Expense 80 145 242
Income (loss) from continuing operations before income taxes 2,296 575 (422)
Provision for (benefit from) income taxes on continuing operations 512 (105) (71)
Income (loss) from continuing operations after income taxes 1,784 680 (351)
(Loss) income from discontinued operations after income taxes (53) (55) (671)
Net income (loss) 1,731 625 (1,022) [2]
Net income (loss) attributable to noncontrolling interests 0 10 8
Net income (loss) attributable to Corteva $ 1,731 $ 615 $ (1,030)
[1] The cash flows for the year ended December 31, 2019 includes cash flows of EID's ECP and Specialty Products Entities.
[2] The cash flows for the year ended December 31, 2019 includes cash flows of EID's ECP and Specialty Products Entities
XML 24 R4.htm IDEA: XBRL DOCUMENT v3.22.0.1
Consolidated Statements of Comprehensive Income - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Net income (loss) $ 1,769 $ 701 $ (941) [1]
Cumulative Translation Adjustments (573) (26) (274)
Unrealized Gain (Loss) on Investments 10 (10) 0
Derivatives Instruments 139 (69) 28
Total other comprehensive income (loss) (8) 380 (1,124)
Comprehensive Income (Loss) 1,761 1,081 (2,065)
Comprehensive Income Attributable to Noncontrolling Interest- net of tax 10 20 18
Comprehensive Income (Loss) Attributable to Corteva 1,751 1,061 (2,083)
Pension Plan      
Adjustments to other benefit plans 1,037 (186) (718)
Other Benefit Plans      
Adjustments to other benefit plans (621) 671 (160)
EID [Member]      
Net income (loss) 1,731 625 (1,022) [2]
Cumulative Translation Adjustments (573) (26) (274)
Unrealized Gain (Loss) on Investments 10 (10) 0
Derivatives Instruments 139 (69) 28
Total other comprehensive income (loss) (8) 380 (1,124)
Comprehensive Income (Loss) 1,723 1,005 (2,146)
Comprehensive Income Attributable to Noncontrolling Interest- net of tax 0 10 8
Comprehensive Income (Loss) Attributable to Corteva 1,723 995 (2,154)
EID [Member] | Pension Plan      
Adjustments to other benefit plans 1,037 (186) (718)
EID [Member] | Other Benefit Plans      
Adjustments to other benefit plans $ (621) $ 671 $ (160)
[1] The cash flows for the year ended December 31, 2019 includes cash flows of EID's ECP and Specialty Products Entities.
[2] The cash flows for the year ended December 31, 2019 includes cash flows of EID's ECP and Specialty Products Entities
XML 25 R5.htm IDEA: XBRL DOCUMENT v3.22.0.1
Consolidated Balance Sheets - USD ($)
$ in Millions
Dec. 31, 2021
Dec. 31, 2020
Cash and Cash Equivalents $ 4,459 $ 3,526
Marketable Securities 86 269
Accounts and notes receivable - net 4,811 4,926
Inventories 5,180 4,882
Other current assets 1,010 1,165
Total current assets 15,546 14,768
Investments in nonconsolidated affiliates 76 66
Property, Plant and Equipment 8,364 8,253
Accumulated Depreciation 4,035 3,857
Net Property, Plant and Equipment 4,329 4,396
Goodwill 10,107 10,269
Other intangible assets 10,044 10,747
Deferred Income Taxes 438 464
Other Assets 1,804 1,939
Total Assets 42,344 42,649
Short-term borrowings and finance lease obligations 17 3
Accounts Payable 4,126 3,615
Income Taxes Payable 146 123
Deferred Revenue 3,201 2,662
Accrued and other current liabilities 2,068 2,145
Total current liabilities 9,558 8,548
Long-term Debt 1,100 1,102
Deferred Income Tax Liabilities 1,220 893
Pension and other post employment benefits - noncurrent 3,124 5,176
Other noncurrent obligations 1,719 1,867
Liabilities, Noncurrent 7,163 9,038
Common stock 7 7
Additional Paid in Capital 27,751 27,707
Retained earnings (accumulated deficit) 524 0
Accumulated other comprehensive income (loss) (2,898) (2,890)
Total Company Stockholders' Equity 25,384 24,824
Noncontrolling Interests 239 239
Total Stockholders' Equity 25,623 25,063
Total Liabilities and Equity 42,344 42,649
EID [Member]    
Cash and Cash Equivalents 4,459 3,526
Marketable Securities 86 269
Accounts and notes receivable - net 4,811 4,926
Inventories 5,180 4,882
Other current assets 1,010 1,165
Total current assets 15,546 14,768
Investments in nonconsolidated affiliates 76 66
Property, Plant and Equipment 8,364 8,253
Accumulated Depreciation 4,035 3,857
Net Property, Plant and Equipment 4,329 4,396
Goodwill 10,107 10,269
Other intangible assets 10,044 10,747
Deferred Income Taxes 438 464
Other Assets 1,804 1,939
Total Assets 42,344 42,649
Short-term borrowings and finance lease obligations 17 3
Accounts Payable 4,126 3,615
Income Taxes Payable 146 123
Deferred Revenue 3,201 2,662
Accrued and other current liabilities 2,070 2,148
Total current liabilities 9,560 8,551
Long-term Debt 1,100 1,102
Long-Term Debt - Related Party 2,162 3,459
Deferred Income Tax Liabilities 1,220 893
Pension and other post employment benefits - noncurrent 3,124 5,176
Other noncurrent obligations 1,719 1,867
Liabilities, Noncurrent 9,325 12,497
Common stock 0 0
Additional Paid in Capital 24,196 24,049
Retained earnings (accumulated deficit) 1,922 203
Accumulated other comprehensive income (loss) (2,898) (2,890)
Total Company Stockholders' Equity 23,459 21,601
Noncontrolling Interests 0 0
Total Stockholders' Equity 23,459 21,601
Total Liabilities and Equity 42,344 42,649
EID [Member] | $4.50 Series Preferred Stock [Member]    
Preferred stock, without par value – cumulative; 23,000,000 shares authorized; issued at December 31, 2020 and December 31, 2019 169 169
EID [Member] | $3.50 Series Preferred Stock [Member]    
Preferred stock, without par value – cumulative; 23,000,000 shares authorized; issued at December 31, 2020 and December 31, 2019 $ 70 $ 70
XML 26 R6.htm IDEA: XBRL DOCUMENT v3.22.0.1
Consolidated Balance Sheets (Parentheticals) - USD ($)
Dec. 31, 2021
Dec. 31, 2020
Common Stock, Par Value $ 0.01 $ 0.01
Common Stock, Shares Authorized 1,666,667,000 1,666,667,000
Common Stock, Shares, Outstanding 726,527,000 743,458,000
EID [Member]    
Common Stock, Par Value $ 0.30 $ 0.30
Common Stock, Shares Authorized 1,800,000,000 1,800,000,000
Common Stock, Shares, Outstanding 200 200
EID [Member] | $4.50 Series Preferred Stock [Member]    
Preferred Stock, Par Value $ 0 $ 0
Preferred Stock, Shares Authorized 23,000,000 23,000,000
Preferred Stock, Shares Issued 1,673,000 1,673,000
Preferred Stock, Redemption Amount $ 120 $ 120
EID [Member] | $3.50 Series Preferred Stock [Member]    
Preferred Stock, Par Value $ 0 $ 0
Preferred Stock, Shares Authorized 23,000,000 23,000,000
Preferred Stock, Shares Issued 700,000 700,000
Preferred Stock, Redemption Amount $ 102 $ 102
XML 27 R7.htm IDEA: XBRL DOCUMENT v3.22.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Net income (loss) $ 1,769 $ 701 $ (941) [1]
Depreciation and Amortization     1,599
Provision for (Benefit from) Deferred Income Tax 174 (330) (477) [1]
Net periodic pension and OPEB benefit, net (1,292) (340) (177) [1]
Pension and OPEB contributions 247 269 323 [1]
Net gain on sales of property, businesses, consolidated companies, and investments (21) 3 (142) [1]
Restructuring and asset related charges- net 289 335 222
Amortization of inventory step-up 0 0 272 [1]
Loss on early Extinguishment of Debt 0 0 13 [1]
Other net loss 156 290 246 [1]
Accounts and Notes Receivable (113) 187 (361) [1]
Inventories (422) 104 74 [1]
Accounts Payable 524 (118) 149 [1]
Deferred Revenue 574 71 632 [1]
Other Assets and Liabilities, Net 93 253 (935) [1]
Cash provided by (used for) operating activities 2,727 2,064 1,070 [1]
Capital expenditures (573) (475) (1,163) [1]
Proceeds from the sale of property, businesses, and consolidated companies, net of cash divested 75 83 249 [1]
Acquisitions of businesses - Net of Cash Acquired 0 0 (10) [1]
Investments in and loans to nonconsolidated affiliates (4) (1) (10) [1]
Proceeds from sale of ownership interest in nonconsolidated affiliates 0 0 21 [1]
Purchases of investments (204) (995) (138) [1]
Proceeds from Sale and Maturities of Investments 345 721 160 [1]
Other investing activities - net (1) (7) (13) [1]
Cash provided by (used for) investing activities (362) (674) (904) [1]
Net Change in borrowings (less than 90 days) 13 0 (1,868) [1]
Proceeds from Debt 419 2,439 1,001 [1]
Payments on Debt (421) (1,441) (6,804) [1]
Repurchase of Common Stock (950) (275) (25) [1]
Proceeds from Exercise of Stock Options 100 56 47 [1]
Dividends Paid to stockholders (397) (388) (194) [1]
Payment for acquisition of subsidiary's interest from the non-controlling interest 0 (60) 0 [1]
Distributions to Dow and DowDuPont 0 0 (317) [1]
Cash Transferred to DowDuPont at Internal Reorganizations 0 0 (2,053) [1]
Contributions from Dow and DowDuPont 0 0 7,396 [1]
Debt Extinguishment Costs 0 0 (79) [1]
Other financing activities (30) (28) (33) [1]
Cash provided by (used for) financing activities (1,266) 303 (2,929) [1]
Effect of exchange rate changes on cash, cash equivalents and restricted cash equivalents (136) 7 (88) [1]
Increase (decrease) on cash, cash equivalents and restricted cash 963 1,700 (2,851) [1]
Cash, cash equivalents and restricted cash equivalents at beginning of period 3,873 [2] 2,173 [1],[2] 5,024 [1]
Cash, cash equivalents and restricted cash equivalents at end of period [2] 4,836 3,873 2,173 [1]
Interest, net of amounts capitalized 30 36 263 [1]
Income Taxes 341 229 234 [1]
EID [Member]      
Net income (loss) 1,731 625 (1,022) [3]
Depreciation and Amortization 1,243 1,177 1,000
Provision for (Benefit from) Deferred Income Tax 174 (330) (477) [3]
Net periodic pension and OPEB benefit, net (1,292) (340) (177) [3]
Pension and OPEB contributions 247 269 323 [3]
Net gain on sales of property, businesses, consolidated companies, and investments (21) 3 (142) [3]
Restructuring and asset related charges- net 289 335 222
Amortization of inventory step-up 0 0 272 [3]
Loss on early Extinguishment of Debt 0 0 13 [3]
Other net loss 156 290 246 [3]
Accounts and Notes Receivable (113) 187 (361) [3]
Inventories (422) 104 74 [3]
Accounts Payable 524 (118) 149 [3]
Deferred Revenue 574 71 632
Other Assets and Liabilities, Net 93 251 (928) [3]
Cash provided by (used for) operating activities 2,689 1,986 996 [3]
Capital expenditures (573) (475) (1,163) [3]
Proceeds from the sale of property, businesses, and consolidated companies, net of cash divested 75 83 249 [3]
Acquisitions of businesses - Net of Cash Acquired 0 0 (10) [3]
Investments in and loans to nonconsolidated affiliates (4) (1) (10) [3]
Proceeds from sale of ownership interest in nonconsolidated affiliates 0 0 21 [3]
Purchases of investments (204) (995) (138) [3]
Proceeds from Sale and Maturities of Investments 345 721 160 [3]
Other investing activities - net (1) (7) (13) [3]
Cash provided by (used for) investing activities (362) (674) (904) [3]
Net Change in borrowings (less than 90 days) 13 0 (1,868) [3]
Proceeds from Related Party Debt 52 103 4,240 [3]
Repayments of Related Party Debt (1,349) (665) (219) [3]
Proceeds from Debt 419 2,439 1,001 [3]
Payments on Debt (421) (1,441) (6,804) [3]
Proceeds from Exercise of Stock Options 100 56 47 [3]
Payment for acquisition of subsidiary's interest from the non-controlling interest 0 (60) 0 [3]
Distributions to Dow and DowDuPont 0 0 (317) [3]
Cash Transferred to DowDuPont at Internal Reorganizations 0 0 (2,053) [3]
Contributions from Dow and DowDuPont 0 0 3,255 [3]
Debt Extinguishment Costs 0 0 (79) [3]
Other financing activities (42) (51) (58) [3]
Cash provided by (used for) financing activities (1,228) 381 (2,855) [3]
Effect of exchange rate changes on cash, cash equivalents and restricted cash equivalents (136) 7 (88) [3]
Increase (decrease) on cash, cash equivalents and restricted cash 963 1,700 (2,851) [3]
Cash, cash equivalents and restricted cash equivalents at beginning of period 3,873 2,173 [3] 5,024 [3]
Cash, cash equivalents and restricted cash equivalents at end of period 4,836 3,873 2,173 [3]
Interest, net of amounts capitalized [4] 30 36 263 [3]
Income Taxes 341 229 234 [3]
Total company [Member]      
Depreciation and Amortization 1,243 1,177 1,599 [1]
Restructuring and asset related charges- net 289 335 339 [1]
Goodwill Impairment Charge 0 0 1,102 [1]
Total company [Member] | EID [Member]      
Depreciation and Amortization 1,243 1,177 1,599 [3]
Restructuring and asset related charges- net 289 335 339 [3]
Goodwill Impairment Charge $ 0 $ 0 $ 1,102 [3]
[1] The cash flows for the year ended December 31, 2019 includes cash flows of EID's ECP and Specialty Products Entities.
[2] See page F-30 for reconciliation of cash and cash equivalents and restricted cash equivalents presented in the Consolidated Balance Sheets to total cash, cash equivalents and restricted cash equivalents presented in the Consolidated Statements of Cash Flows.
[3] The cash flows for the year ended December 31, 2019 includes cash flows of EID's ECP and Specialty Products Entities
[4] Reflects interest, net of amounts capitalized, paid to external parties. For information associated with interest paid on related party debt refer to EID's Note 2 - Related Party Transactions, of the EID Consolidated Financial Statements.
XML 28 R8.htm IDEA: XBRL DOCUMENT v3.22.0.1
Consolidated Statements of Equity - USD ($)
$ in Millions
Total
Common Stock [Member]
Additional Paid-in Capital [Member]
Divisional Equity [Member]
Retained Earnings [Member]
Accumulated Other Comp Loss
Noncontrolling Interest [Member]
EID [Member]
EID [Member]
Preferred Stock [Member]
EID [Member]
Common Stock [Member]
EID [Member]
Additional Paid-in Capital [Member]
EID [Member]
Divisional Equity [Member]
EID [Member]
Retained Earnings [Member]
EID [Member]
Accumulated Other Comp Loss
EID [Member]
Noncontrolling Interest [Member]
DowDuPont [Member]
DowDuPont [Member]
Divisional Equity [Member]
DowDuPont [Member]
EID [Member]
DowDuPont [Member]
EID [Member]
Divisional Equity [Member]
Beginning Balance at Dec. 31, 2018 $ 75,153 $ 0 $ 0 $ 78,020 $ 0 $ (3,360) $ 493 $ 75,153 $ 0 $ 0 $ 0 $ 78,259 $ 0 $ (3,360) $ 254        
Net income (loss) (941) [1]     (641) (318)   18 (1,022) [2]       (640) (390)   8        
Net other comprehensive income (loss) (1,124)         (1,124)   (1,124)           (1,124)          
Dividends, Common Stock (194)   (97)   (97)                            
Dividends, Preferred Stock               (10)     (2) (2) (6)            
Distributions to Dow and DowDuPont (317) [1]     (317)       (317) [2]       (317)       $ 317      
Issuance of stock 8   8         8     8         $ 39 $ 39 $ 39 $ 39
Share-based compensation 103   41 62       103     41 62              
Common Stock Repurchase (25)   (25)                                
Contributions from Dow and DowDuPont 7,396 [1]     7,396       3,255 [2]       3,255              
Impact of Internal Reorganizations (55,496)     (56,479)   1,214 (231) (55,496)       (56,479)   1,214 (231)        
Reclassification of Divisional Equity to Additional Paid in Capital   7 28,070 (28,077)       0 239   23,936 (24,175)              
Stockholders' Equity, Other (47)     (3) (10)   (34) (61)     (25) $ (2) (10)   (24)        
Ending Balance at Dec. 31, 2019 24,555 7 27,997 $ 0 (425) (3,270) 246 20,528 239 0 23,958   (406) (3,270) 7        
Net income (loss) 701       681   20 625         615   10        
Net other comprehensive income (loss) 380         380   380           380          
Dividends, Common Stock (388)   (194)   (194)                            
Dividends, Preferred Stock               (10)     (5)   (5)            
Distributions to Dow and DowDuPont 0             0                      
Issuance of stock 56   56         56     56                
Share-based compensation 59   60         59     60                
Retained Earnings, Share-based Compensation         (1)               (1)            
Common Stock Repurchase (275)   (216)   (59)                            
Contributions from Dow and DowDuPont 0             0                      
Acquisition of a noncontrolling interest in consolidated subsidiaries (52)   (37)       (15) (52)     (37)       (15)        
Stockholders' Equity, Other 27   41   (2)   (12) 15     17       (2)        
Ending Balance at Dec. 31, 2020 25,063 7 27,707   0 (2,890) 239 21,601 239 0 24,049   203 (2,890) 0        
Net income (loss) 1,769       1,759   10 1,731         1,731            
Net other comprehensive income (loss) (8)         (8)   (8)           (8)          
Dividends, Common Stock (397)   (97)   (300)                            
Dividends, Preferred Stock               (10)         (10)            
Distributions to Dow and DowDuPont 0             0                      
Issuance of stock 100   100         100     100                
Share-based compensation 56   59         56     59                
Retained Earnings, Share-based Compensation         (3)               (3)            
Common Stock Repurchase (950)   (18)   (932)                            
Contributions from Dow and DowDuPont 0             0                      
Stockholders' Equity, Other (10)           (10) (11)     (12)   1            
Ending Balance at Dec. 31, 2021 $ 25,623 $ 7 $ 27,751   $ 524 $ (2,898) $ 239 $ 23,459 $ 239 $ 0 $ 24,196   $ 1,922 $ (2,898) $ 0        
[1] The cash flows for the year ended December 31, 2019 includes cash flows of EID's ECP and Specialty Products Entities.
[2] The cash flows for the year ended December 31, 2019 includes cash flows of EID's ECP and Specialty Products Entities
XML 29 R9.htm IDEA: XBRL DOCUMENT v3.22.0.1
Consolidated Statements of Equity (Parentheticals) - $ / shares
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Common Stock Dividends $ 0.54 $ 0.52 $ 0.26
$3.50 Series Preferred Stock [Member] | EID [Member]      
Preferred Stock, Dividends Per Share 3.50 3.50 3.50
$4.50 Series Preferred Stock [Member] | EID [Member]      
Preferred Stock, Dividends Per Share $ 4.50 $ 4.50 $ 4.50
XML 30 R10.htm IDEA: XBRL DOCUMENT v3.22.0.1
Schedule II - Valuation and Qualifying Accounts (Notes)
12 Months Ended
Dec. 31, 2021
SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]  
SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]
Schedule II—Valuation and Qualifying Accounts (EID and Corteva, Inc.)
(Dollars in millions)
For the Year Ended December 31,
202120202019
Accounts Receivable—Allowance for Doubtful Receivables 
Balance at beginning of period$208 $174 $127 
Additions charged to expenses1
52 69 
Deductions from reserves1,2
(4)(18)(22)
Balance at end of period$210 $208 $174 
Deferred Tax Assets—Valuation Allowance  
Balance at beginning of period$453 $457 $669 
Additions charged to expenses97 56 20 
Deductions from reserves3
(184)(60)(232)
Balance at end of period$366 $453 $457 
1.    Classifications in the changes in the allowance for doubtful receivables for the period ended December 31, 2020 have been adjusted from their previous presentation. Adjustments did not impact the amount of the provision or the allowance for doubtful receivables recorded in the Consolidated Statements of Operations or the Consolidated Balance Sheets.
2.    Deductions include write-offs, recoveries collected and currency translation adjustments.
3.     Deductions include currency translation adjustments.
XML 31 R11.htm IDEA: XBRL DOCUMENT v3.22.0.1
Background and Basis of Presentation (Notes)
12 Months Ended
Dec. 31, 2021
Intended Business Separations [Abstract]  
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] BACKGROUND AND BASIS OF PRESENTATION
Corteva, Inc. is a leading global provider of seed and crop protection solutions focused on the agriculture industry. The company intends to leverage its rich heritage of scientific achievement to advance its robust innovation pipeline and continue to shape the future of responsible agriculture. The company's broad portfolio of agriculture solutions fuels farmer productivity around the globe. Corteva has two reportable segments: seed and crop protection. See Note 25 - Segment Information, to the Consolidated Financial Statements, for additional information on the company's reportable segments.

Throughout these financial statements, except as otherwise noted by the context, the terms "Corteva" or "company" used herein mean Corteva, Inc. and its consolidated subsidiaries (including EID) and the term “EID” used herein means E. I. du Pont de Nemours and Company and its consolidated subsidiaries or E. I. du Pont de Nemours and Company excluding its consolidated subsidiaries, as the context may indicate. Additionally, on June 1, 2019, DowDuPont Inc. changed its registered name to DuPont de Nemours, Inc. (“DuPont”), for certain events prior to, or on, June 1, 2019, DuPont may be referred to as DowDuPont.

Principles of Consolidation and Basis of Presentation
On June 1, 2019, Corteva, Inc. became an independent, publicly traded company through the completed separation (the “Separation”) of the agriculture business of DuPont de Nemours, Inc. (formerly known as DowDuPont Inc.) (“DowDuPont” or “DuPont”). The separation was effectuated through a pro rata distribution (the “Corteva Distribution”) of all of the then-issued and outstanding shares of common stock, par value $0.01 per share, of Corteva, Inc., which was then a wholly-owned subsidiary of DowDuPont, to holders of record of DowDuPont common stock as of the close of business on May 24, 2019.

Previously, DowDuPont was formed on December 9, 2015, to effect an all-stock merger of equals strategic combination between The Dow Chemical Company ("Historical Dow") and EID. On August 31, 2017 at 11:59 pm ET (the “Merger Effectiveness Time”) pursuant to the Agreement and Plan of Merger, dated as of December 11, 2015, as amended March 31, 2017 (the "Merger Agreement"), Historical Dow and EID each merged with wholly-owned subsidiaries of DowDuPont and became subsidiaries of DowDuPont (the “Merger”). Prior to the Merger, DowDuPont did not conduct any business activities other than those required for its formation and matters contemplated by the Merger Agreement.

Subsequent to the Merger, Historical Dow and EID engaged in a series of internal reorganization and realignment steps to realign their businesses into three subgroups: agriculture, materials science and specialty products through a series of tax-efficient transactions (collectively, the "Business Separations”). Effective as of 5:00 pm ET on April 1, 2019, DowDuPont completed the separation of its materials science business into a separate and independent public company by way of a distribution of Dow Inc. (“Dow”) through a pro rata dividend in-kind of all of the then-issued and outstanding shares of Dow’s common stock, par value $0.01 per share, to holders of DowDuPont's common stock, as of the close of business on March 21, 2019 (the “Dow Distribution” and together with the Corteva Distribution, the “Distributions”).

Prior to the Dow Distribution, Historical Dow conveyed or transferred the assets and liabilities aligned with Historical Dow’s agriculture business to separate legal entities (“Dow Ag Entities”) and the assets and liabilities associated with its specialty products business to separate legal entities (the “Dow SP Entities”). On April 1, 2019, Dow Ag Entities and the Dow SP Entities were transferred and conveyed to DowDuPont.

In furtherance of the Business Separations, EID engaged in a series of internal reorganization and realignment steps (the “Internal Reorganization” and the "Business Realignment," respectively) to realign its businesses into three subgroups: agriculture, materials science and specialty products. As part of the Internal Reorganization:

the assets and liabilities aligned with EID’s materials science business (“EID ECP”) were transferred or conveyed to separate legal entities that were ultimately conveyed by DowDuPont to Dow on April 1, 2019;

the assets and liabilities aligned with EID’s specialty products business were transferred or conveyed to separate legal entities (“EID Specialty Products Entities”) that were ultimately distributed to DowDuPont on May 1, 2019;

on May 2, 2019, DowDuPont conveyed Dow Ag Entities to EID and in connection with the foregoing, EID issued additional shares of its Common Stock to DowDuPont; and

on May 31, 2019, DowDuPont contributed EID to Corteva, Inc.

On May 6, 2019, the Board of Directors of DowDuPont approved the distribution of all the then issued and outstanding shares of common stock of Corteva, Inc., then a wholly-owned subsidiary of DowDuPont, to DowDuPont stockholders. On June 1,
2019, DowDuPont completed the Separation. Each DowDuPont stockholder received one share of Corteva common stock for every three shares of DowDuPont common stock held at the close of business on May 24, 2019, the record date of distribution. Corteva, Inc.'s common stock began trading the "regular way" under the ticker symbol "CTVA" on June 3, 2019, the first business day after June 1, 2019. Upon becoming an independent company, the capital structure of Corteva consisted of 748,815,000 authorized shares of common stock (par value of $0.01 per share), which represents the number of common shares issued on June 3, 2019. Information related to the Corteva Distribution and its effect on the company's financial statements is discussed throughout these Notes to the Consolidated Financial Statements.

As a result of the Business Realignment and the Internal Reorganization discussed above, Corteva owns 100% of the outstanding common stock of EID. EID is a subsidiary of Corteva, Inc. and continues to be a reporting company, subject to the requirements of the Securities Exchange Act of 1934, as amended.

DAS Common Control Business Combination
The transfer or conveyance of DAS to Corteva was treated as a transfer of entities under common control. As such, the company recorded the assets, liabilities, and equity of DAS on its balance sheet at their historical basis. Transfers of businesses between entities under common control requires the financial statements to be presented as if the transaction had occurred at the point at which common control first existed (the Merger Effectiveness Time). As a result, the accompanying Consolidated Financial Statements and Notes thereto include the results of DAS as of the Merger Effectiveness Time. See Note 4 - Common Control Business Combination, to the Consolidated Financial Statements, for additional information.

For periods prior to the Corteva Distribution, the combined results of operations and assets and liabilities of EID and DAS were derived from the Consolidated Financial Statements and accounting records of EID as well as the carve-out financial statements of DAS. The DAS carve-out financial statements reflect the historical results of operations, financial position, and cash flows of Historical Dow's Agricultural Sciences Business and include allocations of certain expenses for services from Historical Dow, including, but not limited to, general corporate expenses related to finance, legal, information technology, human resources, ethics and compliance, shared services, employee benefits and incentives, insurance, and stock-based compensation. These expenses were allocated on the basis of direct usage when identifiable, with the remainder allocated under the basis of headcount or other measures.

The company's Consolidated Balance Sheets for all periods presented consist of Corteva, Inc. and its consolidated subsidiaries.

The company's Consolidated Statements of Operations (the "Consolidated Statements of Operations") for all periods prior to the Corteva Distribution consist of the combined results of operations for Historical EID and DAS. The Consolidated Statements of Operations for all periods after the Corteva Distribution represent the consolidated balances of the company. Intercompany balances and transactions with Historical EID and DAS have been eliminated.

During the first quarter 2020, the company recorded an increase of $40 million to APIC relating to net assets recorded as
transferred as part of the 2019 Internal Reorganizations that were retained.

Divestiture of EID ECP and EID Specialty Products Entities
The transfer of EID ECP and EID Specialty Products Entities meets the criteria for discontinued operations and as such, results of operations are presented as discontinued operations and have been excluded from continuing operations for all periods presented. The comprehensive income (loss), stockholder's equity and cash flows related to EID ECP and EID Specialty Products Entities have not been segregated and are included in the Consolidated Statements of Comprehensive Income (Loss), Consolidated Statements of Equity and Consolidated Statements of Cash Flows, respectively, for 2019. Amounts related to EID ECP and EID Specialty Products Entities are consistently included or excluded from the Notes to the Consolidated Financial Statements based on the respective financial statement line item. See Note 5 - Divestitures and Other Transactions, to the Consolidated Financial Statements, for additional information.

Certain reclassifications of prior year's data have been made to conform to current year's presentation.

Since 2018, Argentina has been considered a hyper-inflationary economy under U.S. GAAP and therefore the U.S. Dollar (“USD”) is the functional currency for our related subsidiaries. Argentina contributes approximately 5 percent to both the company's annual Sales and EBITDA. We remeasure net monetary assets and translate our financial statements utilizing the official Argentine Peso (“Peso”) to USD exchange rate. The ability to draw down Peso cash balances is limited at this time due to government restrictions and market availability of U.S. Dollars. The devaluation of the Peso relative to the USD over the last several years has resulted in the recognition of exchange losses (refer to Note 9 – Supplementary Information, to the Consolidated Financial Statements). As of December 31, 2021, a further 10 percent deterioration in the official Peso to USD
exchange rate would reduce the USD value of our net monetary assets and negatively impact pre-tax earnings by approximately $15 million. We will continue to assess the implications to our operations and financial reporting.
XML 32 R12.htm IDEA: XBRL DOCUMENT v3.22.0.1
Summary of Significant Accounting Policies
12 Months Ended
Dec. 31, 2021
Accounting Policies [Abstract]  
Significant Accounting Policies [Text Block] SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
The Consolidated Financial Statements include the accounts of the company and subsidiaries in which a controlling interest is maintained. For those consolidated subsidiaries in which the company's ownership is less than 100 percent, the outside stockholders' interests are shown as noncontrolling interests. Investments in affiliates over which the company has the ability to exercise significant influence but does not have a controlling interest are accounted for under the equity method.

The company is also involved with certain joint ventures accounted for under the equity method of accounting that are variable interest entities ("VIEs"). The company is not the primary beneficiary, as the nature of the company's involvement with the VIEs does not provide it the power to direct the VIEs significant activities. Future events may require these VIEs to be consolidated if the company becomes the primary beneficiary. At December 31, 2021 and 2020, the maximum exposure to loss related to the nonconsolidated VIEs is not considered material to the Consolidated Financial Statements.

Use of Estimates in Financial Statement Preparation
The preparation of financial statements in accordance with U.S. GAAP requires the use of estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. The company’s consolidated financial statements include amounts that are based on management’s best estimates and judgments. Actual results could differ from those estimates.

Cash and Cash Equivalents
Cash equivalents represent investments with maturities of three months or less from time of purchase. They are carried at cost plus accrued interest.
 
Restricted Cash Equivalents
Restricted cash equivalents primarily consist of trust assets and contributions to the MOU Escrow Account of $377 million and $347 million as of December 31, 2021 and 2020, respectively. The trust assets are classified as current and the contributions to the MOU Escrow Account are classified as noncurrent and included within other current assets and other assets, respectively, in the Consolidated Balance Sheets. See Note 9 - Supplementary Information, to the Consolidated Financial Statements, for further information.

Marketable Securities
Marketable securities represent investments in fixed and floating rate financial instruments with maturities greater than three months and up to twelve months at time of purchase. Investments classified as held-to-maturity are recorded at amortized cost. The carrying value approximates fair value due to the short-term nature of the investments. Investments classified as debt securities that are available-for-sale are carried at estimated fair value with unrealized gains and losses recorded as a component of accumulated other comprehensive income (loss) or current period earnings if an allowance for credit losses has been established. The cost of investments sold is determined by specific identification.

Fair Value Measurements
Under the accounting guidance for fair value measurements and disclosures, a fair value hierarchy was established that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). A financial instrument's level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement.
The company uses the following valuation techniques to measure fair value for its assets and liabilities:
Level 1Quoted market prices in active markets for identical assets or liabilities;
Level 2Significant other observable inputs (e.g. quoted prices for similar items in active markets, quoted prices for identical or similar items in markets that are not active, inputs other than quoted prices that are observable such as interest rate and yield curves, and market-corroborated inputs);
Level 3Unobservable inputs for the asset or liability, which are valued based on management's estimates of assumptions that market participants would use in pricing the asset or liability.

Foreign Currency Translation
The company's worldwide operations utilize the U.S. dollar ("USD") or a related foreign currency as the functional currency, where applicable. The company identifies its separate and distinct foreign entities and groups the foreign entities into two categories: 1) extension of the parent or foreign subsidiaries operating in a hyper-inflationary environment (USD functional currency) and 2) self-contained (related foreign functional currency). If a foreign entity does not align with either category, factors are evaluated and a judgment is made to determine the functional currency. 

For foreign entities where the USD is the functional currency, all foreign currency-denominated asset and liability amounts are re-measured into USD at end-of-period exchange rates, except for inventories, prepaid expenses, property, plant and equipment, goodwill and other intangible assets, which are re-measured at historical rates. Foreign currency income and expenses are re-measured at average exchange rates in effect during each month, except for expenses related to balance sheet amounts re-measured at historical exchange rates. Exchange gains and losses arising from re-measurement of foreign currency-denominated monetary assets and liabilities are included in income in the period in which they occur.

For foreign entities where a related foreign currency is the functional currency, assets and liabilities denominated in the related foreign currencies are translated into USD at end-of-period exchange rates and the resultant translation adjustments are reported, net of their related tax effects, as a component of accumulated other comprehensive income (loss) in equity. Assets and liabilities denominated in other than the functional currency are re-measured into the functional currency prior to translation into USD and the resultant exchange gains or losses are included in income in the period in which they occur. Income and expenses are translated into USD at average exchange rates in effect during each month.

The company changes the functional currency of its separate and distinct foreign entities only when significant changes in economic facts and circumstances indicate clearly that the functional currency has changed.

Inventories
The company's inventories are valued at the lower of cost or net realizable value. Elements of cost in inventories include raw materials, direct labor and manufacturing overhead. Stores and supplies are valued at cost or net realizable value, whichever is lower; cost is generally determined by the average cost method.

As of December 31, 2021 and December 31, 2020, approximately 60% and 40% of the company's inventories were accounted for under the first-in, first-out ("FIFO") and average cost methods, respectively. Inventories accounted for under the FIFO method are primarily comprised of products with shorter shelf lives such as seeds. See Note 13 - Inventories, to the Consolidated Financial Statements, for further information.

The company establishes an obsolescence reserve for inventory based upon quality considerations and assumptions about future demand and market conditions.

Property, Plant and Equipment
Property, plant and equipment are carried at cost less accumulated depreciation. In connection with the Merger, the fair value of property, plant and equipment was determined using a market approach and a replacement cost approach. Depreciation is based on the estimated service lives of depreciable assets and is calculated using the straight-line method. Fully depreciated assets are retained in property and accumulated depreciation accounts until they are removed from service. When assets are surrendered, retired, sold, or otherwise disposed of, their gross carrying values and related accumulated depreciation are removed from the Consolidated Balance Sheets and included in determining gain or loss on such disposals.
Goodwill and Other Intangible Assets
The company records goodwill when the purchase price of a business acquisition exceeds the estimated fair value of net identified tangible and intangible assets acquired. Goodwill is tested for impairment at the reporting unit level at least annually, or more frequently when events or changes in circumstances indicate that the fair value of a reporting unit has more likely than not declined below its carrying value. The company performs an annual goodwill impairment test in the fourth quarter.

When testing goodwill for impairment, the company has the option to first perform qualitative testing to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying value. If the company chooses not to complete a qualitative assessment for a given reporting unit or if the initial assessment indicates that it is more likely than not that the carrying value of a reporting unit exceeds its estimated fair value, additional quantitative testing is required. If additional quantitative testing is required, the reporting unit's fair value is compared with its carrying amount, and an impairment charge, if any, is recognized for the amount by which the carrying amount exceeds the reporting unit's fair value, limited to the amount of goodwill associated with the reporting unit. The company determines fair values for each of the reporting units using a discounted cash flow model (a form of the income approach) or the market approach. Under the income approach, fair value is determined based on the present value of estimated future cash flows, discounted at an appropriate risk-adjusted rate. The company's significant assumptions in this analysis included future cash flow projections, weighted average cost of capital, the terminal growth rate, and the tax rate. Under the market approach, the company uses metrics of publicly traded companies or historically completed transactions for comparable companies. See Note 15 - Goodwill and Other Intangible Assets, to the Consolidated Financial Statements, for further information on goodwill.

Indefinite-lived intangible assets are tested for impairment at least annually; however, these tests are performed more frequently when events or changes in circumstances indicate that the asset may be impaired. Impairment exists when carrying value exceeds fair value. The company performs an impairment assessment using the relief from royalty method (a form of the income approach) using Level 3 inputs within the fair value hierarchy. The significant assumptions used in the calculation included projected revenue, the royalty rate, the discount rate, and the terminal growth rate. These significant assumptions involve management judgment and estimates relating to future operating performance and economic conditions that may differ from actual cash flows.

Definite-lived intangible assets are amortized over their estimated useful lives, generally on a straight-line basis for periods ranging primarily from 2 years to 25 years. The company continually evaluates the reasonableness of the useful lives of these assets. Once these assets are fully amortized, they are removed from the Consolidated Balance Sheets.

Leases
The company determines whether an arrangement is a lease at the inception of the arrangement based on the terms and conditions in the contract. A contract contains a lease if there is an identified asset and the company has the right to control the asset. Operating lease right-of-use ("ROU") assets are included in other assets on the company’s Consolidated Balance Sheets. Operating lease liabilities are included in accrued and other current liabilities and other noncurrent obligations on the company’s Consolidated Balance Sheets. Finance lease assets are included in property, plant and equipment on the company’s Consolidated Balance Sheets. Finance lease liabilities are included in short-term borrowings and finance lease obligations and long-term debt on the company’s Consolidated Balance Sheets.  

Operating lease ROU assets represent the company’s right to use an underlying asset for the lease term and lease liabilities represent the company’s obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at the commencement date based on the present value of lease payments over the lease term. As most of the company’s leases do not provide the lessor's implicit rate, the company uses its incremental borrowing rate at the commencement date in determining the present value of lease payments. Lease terms include options to extend the lease when it is reasonably certain those options will be exercised. Leases with an initial term of 12 months or less are not recorded on the balance sheet. The company recognizes lease expense for these leases on a straight-line basis over the lease term.

The company has lease agreements with lease and non-lease components, which are accounted for as a single lease component for all asset classes. In the Consolidated Statements of Operations, lease expense for operating leases is recognized on a straight-line basis over the lease term. For finance leases, interest expense is recognized on the lease liability and the ROU asset is amortized over the lease term. See Note 16 - Leases, to the Consolidated Financial Statements, for further information.

Impairment of Long-Lived Assets
The company evaluates the carrying value of long-lived assets to be held and used when events or changes in circumstances indicate the carrying value may not be recoverable. The carrying value of a long-lived asset group is considered impaired when the total projected undiscounted cash flows from the assets are separately identifiable and are less than its carrying value. In that event, a loss is recognized based on the amount by which the carrying value exceeds the fair value of the long-lived asset. The
company's fair value methodology is an estimate of fair market value which is made based on prices of similar assets or other valuation methodologies including present value techniques. Long-lived assets to be disposed of by sale, if material, are classified as held for sale and reported at the lower of carrying amount or fair value less cost to sell, and depreciation is ceased. Long-lived assets to be disposed of other than by sale are classified as held and used until they are disposed of and reported at the lower of carrying amount or fair value. Depreciation is recognized over the remaining useful life of the assets.

Derivative Instruments
Derivative instruments are reported in the Consolidated Balance Sheets at their fair values. The company utilizes derivatives to manage exposures to foreign currency exchange rates and commodity prices. Changes in the fair values of derivative instruments that are not designated as hedges are recorded in current period earnings. For derivative instruments designated as cash flow hedges, the gain (loss) is reported in accumulated other comprehensive income (loss) until it is cleared to earnings during the same period in which the hedged item affects earnings. For derivative instruments designated as net investment hedges, the gain (loss) is reported within accumulated other comprehensive income (loss) until the subsidiary is divested.

In the event that a derivative designated as a hedge of a firm commitment or an anticipated transaction is terminated prior to the maturation of the hedged transaction, the net gain or loss in accumulated other comprehensive income (loss) generally remains in accumulated other comprehensive income (loss) until the item that was hedged affects earnings. If a hedged transaction matures, or is sold, extinguished, or terminated prior to the maturity of a derivative designated as a hedge of such transaction, gains or losses associated with the derivative through the date the transaction matured are included in the measurement of the hedged transaction and the derivative is reclassified as for trading purposes. Derivatives designated as hedges of anticipated transactions are reclassified as for trading purposes if the anticipated transaction is no longer probable.

The company included foreign currency exchange contract settlements within cash flows from operating activities, regardless of hedge accounting qualification. See Note 22 - Financial Instruments, to the Consolidated Financial Statements, for additional discussion regarding the company's objectives and strategies for derivative instruments.

Environmental Matters
Accruals for environmental matters are recorded when it is probable that a liability has been incurred and the amount of the liability can be reasonably estimated. These accruals are adjusted periodically as assessment and remediation efforts progress or as additional technical or legal information becomes available. Accruals for environmental liabilities are included in the Consolidated Balance Sheets in accrued and other current liabilities and other noncurrent obligations at undiscounted amounts. Accruals for related insurance or other third-party recoveries for environmental liabilities are recorded when it is probable that a recovery will be realized and are included in the Consolidated Balance Sheets as accounts and notes receivable - net.

Environmental costs are capitalized if the costs extend the life of the property, increase its capacity, and/or mitigate or prevent contamination from future operations. Environmental costs are also capitalized in recognition of legal asset retirement obligations resulting from the acquisition, construction and/or normal operation of a long-lived asset. Costs related to environmental contamination treatment and cleanup are charged to expense. Estimated future incremental operations, maintenance and management costs directly related to remediation are accrued when such costs are probable and reasonably estimable.

Revenue Recognition
The company recognizes revenue when its customer obtains control of promised goods or services, in an amount that reflects the consideration which the company expects to receive in exchange for those goods or services. To determine revenue recognition for the arrangements that the company determines are within the scope of FASB ASU No. 2014-09, Revenue from Contracts with Customers (Topic 606), the company performs the following five steps: (1) identify the contract(s) with a customer, (2) identify the performance obligations in the contract, (3) determine the transaction price, (4) allocate the transaction price to the performance obligations in the contract, and (5) recognize revenue when (or as) the entity satisfies a performance obligation. See Note 6 - Revenue, to the Consolidated Financial Statements, for additional information on revenue recognition.

Prepaid Royalties
The company currently has certain third-party biotechnology trait license agreements, which require up-front and variable payments subject to the licensor meeting certain conditions. These payments are reflected as other current assets and other assets and are amortized to cost of goods sold as seeds containing the respective trait technology are utilized over the life of the license. The rate of royalty amortization expense recognized is based on the company’s strategic plans which include various assumptions and estimates including product portfolio, market dynamics, farmer preferences, growth rates and projected planted acres. Changes in factors and assumptions included in the strategic plans, including potential changes to the product portfolio in favor of internally developed biotechnology, could impact the rate of recognition of the relevant prepaid royalty.
At December 31, 2021, the balance of prepaid royalties reflected in other current assets and other assets was $303 million and $256 million, respectively. The majority of the balance of prepaid royalties relates to the company’s wholly owned subsidiary, Pioneer Hi-Bred International, Inc.’s (“Pioneer”) non-exclusive license in the United States and Canada for the Monsanto Company's Genuity® Roundup Ready 2 Yield® glyphosate tolerance trait and Roundup Ready 2 Xtend® glyphosate and dicamba tolerance trait for soybeans (“Roundup Ready 2 License Agreement”). Each of these licensed technologies are now trademarks of the Bayer Group, which acquired the Monsanto Company in 2018. The prepaid royalty asset relates to a series of up-front, fixed and variable royalty payments to utilize the traits in Pioneer’s soybean product mix.The company’s historical expectation has been that the technology licensed under the Roundup Ready 2 License Agreement would be used as the primary herbicide tolerance trait platform in the Pioneer® brand soybean through the term of the agreement. DAS and MS Technologies, L.L.C. jointly developed and own the Enlist E3TM herbicide tolerance trait for soybeans which provides tolerance to 2, 4-D choline in Enlist Duo® and Enlist One® herbicides, as well as glyphosate and glufosinate herbicides. In connection with the validation of breeding plans and large-scale product development timelines, during the fourth quarter of 2019, the company accelerated the ramp up of the Enlist E3TM trait platform in the company’s soybean portfolio mix across all brands, including Pioneer® brands, over the subsequent five years. During the ramp-up period, the company is expected to significantly reduce the volume of products with the Roundup Ready 2 Yield® and Roundup Ready 2 Xtend® herbicide tolerance traits beginning in 2021, with expected minimal use of the trait platform thereafter for the remainder of the Roundup Ready 2 License Agreement (the “Transition Plan”). The rate of royalty expense has therefore increased significantly through higher amortization of the prepaid royalty as fewer seeds containing the respective trait are expected to be utilized.

In connection with the departure from these traits, beginning January 1, 2020 the company presents and discloses the non-cash accelerated prepaid royalty amortization expense as a component of restructuring and asset related charges - net, in the Consolidated Statement of Operations. The accelerated prepaid royalty amortization expense represents the difference between the rate of amortization based on the revised number of units expected to contain the Roundup Ready 2 Yield® and Roundup Ready 2 Xtend® trait technology and the variable cash rate per the Roundup Ready 2 License Agreement.

Further changes in factors and assumptions associated with usage of the trait platform licensed under the Roundup Ready 2 License Agreement, including the Transition Plan, could further impact the rate of recognition of the prepaid royalty and Consolidated Statement of Operations presentation of the accelerated prepaid royalty amortization expense.

Cost of Goods Sold
Cost of goods sold primarily includes the cost of manufacture and delivery, ingredients or raw materials, direct salaries, wages and benefits and overhead, non-capitalizable costs associated with capital projects, royalties and other operational expenses. No amortization of intangibles is included within cost of goods sold.

Research and Development
Research and development costs are expensed as incurred. Research and development expense includes costs (primarily consisting of employee costs, materials, contract services, research agreements, and other external spend) relating to the discovery and development of new products.

Selling, General and Administrative Expenses
Selling, general and administrative expenses primarily include selling and marketing expenses, commissions, functional costs, and business management expenses.

Integration and Separation Costs
Integration and separation costs includes costs incurred to prepare for and close the Merger, post-Merger integration expenses, and costs incurred to prepare for the Business Separations. These costs primarily consist of financial advisory, information technology, legal, accounting, consulting and other professional advisory fees associated with preparation and execution of these activities.

Litigation and Other Contingencies
Accruals for legal matters and other contingencies are recorded when it is probable that a liability has been incurred and the amount of the liability can be reasonably estimated. Legal costs, such as outside counsel fees and expenses, are charged to expense in the period incurred.

Severance Costs
Severance benefits are provided to employees under the company's ongoing benefit arrangements. Severance costs are accrued when management commits to a plan of termination and it becomes probable that employees will be entitled to benefits at amounts that can be reasonably estimated.
Insurance/Self-Insurance
The company self-insures certain risks where permitted by law or regulation, including workers' compensation, vehicle liability and employee related benefits. Liabilities associated with these risks are estimated in part by considering historical claims experience, demographic factors and other actuarial assumptions. For other risks, the company uses a combination of insurance and self-insurance, reflecting comprehensive reviews of relevant risks. A receivable for an insurance recovery is generally recognized when the loss has occurred and collection is considered probable.

Income Taxes
The company accounts for income taxes using the asset and liability method. Under this method, deferred tax assets and liabilities are recognized for the future tax consequences of temporary differences between the carrying amounts and tax bases of assets and liabilities using enacted tax rates. The effect of a change in tax rates on deferred tax assets or liabilities is recognized in income in the period that includes the enactment date.

The company recognizes the financial statement effects of an uncertain income tax position when it is more likely than not, based on the technical merits, that the position will be sustained upon examination. The current portion of uncertain income tax positions is included in income taxes payable or income tax receivable, and the long-term portion is included in other noncurrent obligations or other noncurrent assets in the Consolidated Balance Sheets.

Income tax related penalties are included in the provision for (benefit from) income taxes in the Consolidated Statements of Operations. Interest accrued related to unrecognized tax benefits is included within the provision for (benefit from) income taxes from continuing operations in the Consolidated Statements of Operations.

Earnings per Common Share
The calculation of earnings per common share is based on the weighted-average number of the company’s common shares outstanding for the applicable period. The calculation of diluted earnings per common share reflects the effect of all potential common shares that were outstanding during the respective periods, unless the effect of doing so is antidilutive.
XML 33 R13.htm IDEA: XBRL DOCUMENT v3.22.0.1
Recent Accounting Guidance
12 Months Ended
Dec. 31, 2021
Accounting Changes and Error Corrections [Abstract]  
Recent Accounting Guidance RECENT ACCOUNTING GUIDANCE
Recently Adopted Accounting Guidance
In January 2021, the FASB issued ASU 2021-01, Reference Rate Reform (Topic 848): Scope, which provides certain optional expedients that allow derivative instruments impacted by changes in the interest rate used for margining, discounting or contract price alignment to qualify for certain optional relief. The amendments in this Update are effective immediately for all entities and may be applied retrospectively as of any date from the beginning of any interim period that includes March 12, 2020 or prospectively to new modifications subsequent to the issuance of this Update. The adoption of ASU 2021-01 did not have a material impact on the company’s financial position, results of operation or cash flows.

In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes, which is part of the FASB’s Simplification Initiative to identify, evaluate, and improve areas of U.S. GAAP for which cost and complexity can be reduced, while maintaining or improving the usefulness of the information provided to users of financial statements. This ASU amends ASC 740, Income Taxes, by removing certain exceptions to the general principles, and clarifying and amending current guidance. The new standard is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020. The company adopted this guidance on January 1, 2021 and it did not have a material impact on the company’s financial position, results of operation or cash flows.

Accounting Guidance Issued But Not Adopted as of December 31, 2021
In November 2021, the FASB issued ASU 2021-10, Government Assistance (Topic 832): Disclosures by Business Entities about Government Assistance, which requires business entities to disclose transactions with a governmental entity for which a grant or contribution accounting model is used in recognizing and measuring such transactions. This standard is effective for fiscal years beginning after December 15, 2021, and early adoption is permitted. The company is currently evaluating the impact of adopting this guidance.
XML 34 R14.htm IDEA: XBRL DOCUMENT v3.22.0.1
Common Control Business Combinations
12 Months Ended
Dec. 31, 2021
Business Combinations [Abstract]  
Business Combination Disclosure [Text Block] COMMON CONTROL BUSINESS COMBINATIONS
DAS Common Control Combination
Based on an evaluation of the provisions of ASC 805 (Business Combinations), Corteva and DAS represented entities under common control, as both shared DowDuPont as their parent company. As a result, the assets, liabilities and operations of
Corteva and DAS were combined at their historical carrying amounts, and periods prior to the Internal Reorganizations are adjusted as if Corteva and DAS had been combined since the Merger Effectiveness Time, when the entities were first under common control. Accordingly, in 2019, the accompanying Consolidated Financial Statements and Notes thereto were retrospectively revised to include the transferred net assets and results of operations of DAS beginning on September 1, 2017. Refer to Note 1 - Background and Basis of Presentation, for additional information on the common control combination.

Intercompany balances and transactions with Historical EID and DAS have been eliminated.
XML 35 R15.htm IDEA: XBRL DOCUMENT v3.22.0.1
Divestitures and Other Transactions
12 Months Ended
Dec. 31, 2021
Discontinued Operations and Disposal Groups [Abstract]  
Disposal Groups, Including Discontinued Operations, Disclosure [Text Block] DIVESTITURES AND OTHER TRANSACTIONS
Separation Agreements
In connection with the Distributions, DuPont, Corteva, and Dow (together, the “Parties” and each a “Party”) entered into certain agreements to effect the separation, provide for the allocation of DowDuPont’s assets, employees, liabilities and obligations (including its investments, property and employee benefits and tax-related assets and liabilities) among the Parties, and provide a framework for Corteva's relationship with Dow and DuPont following the separations and Distributions (collectively, the "Separation Agreements"). Effective April 1, 2019, the Parties entered into the following agreements referred to herein as: the Separation and Distribution Agreement (the “Corteva Separation Agreement”); the Tax Matters Agreement; the Employee Matters Agreement; and the Intellectual Property Cross-License Agreement.

Effective June 1, 2019, in connection with the Corteva Distribution, Corteva and DuPont entered into the following agreements: the Intellectual Property Cross-License Agreement (the “Corteva-DuPont IP Cross-License Agreement”); the Letter Agreement; and the Amended and Restated Tax Matters Agreement.

DuPont
Pursuant to the Separation Agreements, DuPont and Corteva indemnifies the other against certain litigation, environmental, tax, workers' compensation and other liabilities that arose prior to the Corteva Distribution. The term of this indemnification is generally indefinite and includes defense costs and expenses, as well as monetary and non-monetary settlements and judgments. In connection with the recognition of liabilities related to these matters, the company records an indemnification asset when recovery is deemed probable. At December 31, 2021, the indemnification assets are $25 million within accounts and notes receivable - net and $75 million within other assets in the Consolidated Balance Sheet. At December 31, 2021, the indemnification liabilities are $75 million within other noncurrent obligations in the Consolidated Balance Sheet.

Dow
Pursuant to the Separation Agreements, Dow and Corteva indemnifies the other against certain litigation, environmental, tax and other liabilities that arose prior to the Corteva Distribution. The term of this indemnification is generally indefinite and includes defense costs and expenses, as well as monetary and non-monetary settlements and judgments. In connection with the recognition of liabilities related to these matters, the company records an indemnification asset when recovery is deemed probable. At December 31, 2021, the indemnification liabilities are $20 million within accrued and other current liabilities and $42 million within other noncurrent obligations in the Consolidated Balance Sheet.
EID ECP Divestiture
As discussed in Note 1 - Background and Basis of Presentation, on April 1, 2019, EID completed the transfer of the entities and related assets and liabilities of EID ECP to DowDuPont.

As a result, the financial results of EID ECP are reflected as discontinued operations, as summarized below:
(In millions)For the Year Ended December 31, 2019
Net sales$362 
Cost of goods sold
259 
Research and development expense
Selling, general and administrative expenses
Amortization of intangibles
23 
Restructuring and asset related charges - net
Integration and separation costs
44 
Other income - net
(Loss) income from discontinued operations before income taxes23 
Provision for (benefit from) income taxes on discontinued operations
(Loss) income from discontinued operations after income taxes$19 

The following table presents the depreciation, amortization of intangibles, and capital expenditures of the discontinued operations related to EID ECP:
(In millions)For the Year Ended December 31, 2019
Depreciation$28 
Amortization of intangibles23 
Capital expenditures16 
EID Specialty Products Divestiture
As discussed in Note 1 - Background and Basis of Presentation, on May 1, 2019, the company completed the transfer of the entities and related assets and liabilities of the EID Specialty Products Entities to DowDuPont.

As a result, the financial results of the EID Specialty Products Entities are reflected as discontinued operations, as summarized below:
(In millions)For the Year Ended December 31, 2019
Net sales$5,030 
Cost of goods sold3,352 
Research and development expense204 
Selling, general and administrative expenses573 
Amortization of intangibles267 
Restructuring and asset related charges - net115 
Integration and separation costs253 
Goodwill impairment1,102 
Other income - net57 
(Loss) income from discontinued operations before income taxes(779)
Provision for (benefit from) income taxes on discontinued operations80 
(Loss) income from discontinued operations after income taxes$(859)

EID Specialty Products Impairment    
As a result of the Merger and related acquisition method of accounting, Historical DuPont's assets and liabilities were measured at fair value resulting in increases to the company’s goodwill and other intangible assets. The fair value valuation increased the risk that any declines in financial projections, including changes to key assumptions, could have a material, negative impact on the fair value of the company’s reporting units and assets, and therefore could result in an impairment.

As a result of the Internal Reorganization, in the second quarter of 2019, EID assessed the recoverability of the goodwill within the electronics and communications, protection solutions, nutrition and health, transportation and advanced polymers, packaging and specialty plastics, industrial biosciences, and clean technologies reporting units, and the overall carrying value of the net assets in the disposal group that was distributed to DowDuPont on May 1, 2019. As a result of this analysis, the company determined that the fair value of certain reporting units related to the EID specialty products businesses were below carrying value resulting in pre-tax, non-cash goodwill impairment charges totaling $1,102 million reflected in (loss) income from discontinued operations after income taxes. Revised financial projections reflect unfavorable market conditions, driven by slowed demand in the biomaterials business unit, coupled with challenging conditions in U.S. bioethanol markets. These revised financial projections resulted in a reduction in the long-term forecasts of sales and profitability as compared to prior projections.
The company’s analyses above using discounted cash flow models (a form of the income approach) utilized Level 3 unobservable inputs. The company’s significant assumptions in these analyses include, but are not limited to, future cash flow projections, the weighted average cost of capital, the terminal growth rate, and the tax rate. The company’s estimates of future cash flows are based on current regulatory and economic climates, recent operating results, and planned business strategies. These estimates could be negatively affected by changes in federal, state, or local regulations or economic downturns. Future cash flow estimates are, by their nature, subjective and actual results may differ materially from the company’s estimates. The company also used a form of the market approach (utilizes Level 3 unobservable inputs), which is derived from metrics of publicly traded companies or historically completed transactions of comparable businesses. The selection of comparable businesses is based on the markets in which the reporting units operate giving consideration to risk profiles, size, geography, and diversity of products and services. As such, the company believes the current assumptions and estimates utilized are both reasonable and appropriate.

In addition, the company performed an impairment analysis related to the equity method investments held by the EID specialty products businesses, as of May 1, 2019. The company applied the net asset value method under the cost approach to determine the fair value of the equity method investments in the EID specialty products businesses. Based on updated projections, the company determined the fair value of an equity method investment was below the carrying value and had no expectation the fair value would recover in the short-term due to the current economic environment. As a result, management concluded the impairment was other-than-temporary and recorded an impairment charge of $63 million, reflected in (loss) income from discontinued operations after income taxes. Additionally, this impairment is reflected within restructuring and asset related charges - net in the year ended December 31, 2019, within the table above.

The following table presents the depreciation, amortization of intangibles, and capital expenditures of the discontinued operations related to the EID Specialty Products Entities:
For the Year Ended December 31,
(In millions)2019
Depreciation$281 
Amortization of intangibles267 
Capital expenditures
481 

Merger Remedy - Divested Ag Business
As a condition of the regulatory approval for the Merger, including by the European Commission, EID was required to divest (the “Divested Ag Business”) certain assets related to its crop protection business and research and development ("R&D") organization, specifically EID’s Cereal Broadleaf Herbicides and Chewing Insecticides portfolios, including Rynaxypyr®, Cyazypyr® and Indoxacarb as well as the crop protection R&D pipeline and organization, excluding seed treatment, nematicides, and late-stage R&D programs. On March 31, 2017, EID and FMC Corporation (“FMC”) entered into a definitive agreement (the "FMC Transaction Agreement"), and on November 1, 2017 FMC acquired the Divested Ag Business. As a result of the agreement, EID entered into favorable contracts with FMC of $495 million, which were recorded as intangible assets recognized at the fair value of off-market contracts.

For the year ended December 31, 2019, the company recorded income from discontinued operations after income taxes related to the Divested Ag Business of $80 million related to changes in accruals for certain prior year tax positions.

Other Discontinued Operations Activity
For the year ended December 31, 2020, the company recorded income from discontinued operations after income taxes of $10 million related to the adjustment of certain prior year tax positions for previously divested businesses. For the year ended December 31, 2019, the company recorded income from discontinued operations after income taxes of $89 million related to the adjustment of certain unrecognized tax benefits for positions taken on items from prior years from previously divested businesses.
XML 36 R16.htm IDEA: XBRL DOCUMENT v3.22.0.1
Revenue (Notes)
12 Months Ended
Dec. 31, 2021
Revenue from Contract with Customer [Abstract]  
Revenue REVENUE
Revenue Recognition
Products
Substantially all of Corteva's revenue is derived from product sales. Product sales consist of sales of Corteva's products to farmers, distributors, and manufacturers. Corteva considers purchase orders, which in some cases are governed by master supply agreements, to be a contract with a customer. Contracts with customers are considered to be short-term when the time between order confirmation and satisfaction of the performance obligations is equal to or less than one year. However, the company has some long-term contracts which can span multiple years.

Revenue from product sales is recognized when the customer obtains control of the company's product, which occurs at a point in time according to shipping terms. Payment terms are generally less than one year from invoicing. The company elected the practical expedient and does not adjust the promised amount of consideration for the effects of a significant financing component when the company expects it will be one year or less between when a customer obtains control of the company's product and when payment is due. When the company performs shipping and handling activities after the transfer of control to the customer (e.g., when control transfers prior to or at shipment), these are considered fulfillment activities, and accordingly, the costs are accrued when the related revenue is recognized. Taxes collected from customers relating to product sales and remitted to governmental authorities are excluded from revenues. In addition, the company elected the practical expedient to expense any costs to obtain contracts as incurred, as the amortization period for these costs would have been one year or less.

The transaction price includes estimates of variable consideration, such as rights of return, rebates, and discounts, that are reductions in revenue. All estimates are based on the company's historical experience, anticipated performance, and the company's best judgment at the time the estimate is made. Estimates of variable consideration included in the transaction price primarily utilize the expected value method based on historical experience. These estimates are reassessed each reporting period and are included in the transaction price to the extent it is probable that a significant reversal of cumulative revenue recognized will not occur upon resolution of uncertainty associated with the variable consideration. The majority of contracts have a single performance obligation satisfied at a point in time and the transaction price is stated in the contract, usually as quantity times price per unit. For contracts with multiple performance obligations, the company allocates the transaction price to each performance obligation based on the relative standalone selling price. The standalone selling price is the observable price which depicts the price as if sold to a similar customer in similar circumstances.

Licenses of Intellectual Property
Corteva enters into licensing arrangements with customers under which it licenses its intellectual property. Revenue from the majority of intellectual property licenses is derived from sales-based royalties. Revenue for licensing agreements that contain sales-based royalties is recognized at the later of (i) when the subsequent sale occurs or (ii) when the performance obligation to which some or all of the royalty has been allocated is satisfied.

Remaining Performance Obligations
Remaining performance obligations represent the transaction price allocated to unsatisfied or partially unsatisfied performance obligations. The company applies the practical expedient to disclose the transaction price allocated to remaining performance obligations for only those contracts with an original duration of one year or more. The transaction price allocated to remaining performance obligations with an original duration of more than one year related to material rights granted to customers for contract renewal options were $123 million and $115 million at December 31, 2021 and December 31, 2020, respectively. The company expects revenue to be recognized for the remaining performance obligations evenly over the period of 1 year to 6 years.

Contract Balances
Contract liabilities primarily reflect deferred revenue from prepayments under contracts with customers where the company receives advance payments for products to be delivered in future periods. Corteva classifies deferred revenue as current or noncurrent based on the timing of when the company expects to recognize revenue. Contract assets primarily include amounts related to conditional rights to consideration for completed performance not yet invoiced. Accounts receivable are recorded when the right to consideration becomes unconditional.
Contract BalancesDecember 31, 2021December 31, 2020
(In millions)
Accounts and notes receivable - trade1
$3,561 $3,917 
Contract assets - current2
$24 $22 
Contract assets - noncurrent3
$58 $54 
Deferred revenue - current$3,201 $2,662 
Deferred revenue - noncurrent4
$120 $116 
1.Included in accounts and notes receivable - net in the Consolidated Balance Sheets.
2.Included in other current assets in the Consolidated Balance Sheets.
3.Included in other assets in the Consolidated Balance Sheets.
4.Included in other noncurrent obligations in the Consolidated Balance Sheets.

Revenue recognized during the year ended December 31, 2021, December 31, 2020, and December 31, 2019 from amounts included in deferred revenue at the beginning of the period was $2,613 million, $2,540 million, and $2,146 million, respectively.

Disaggregation of Revenue
Corteva's operations are classified into two reportable segments: Seed and Crop Protection. The company disaggregates its revenue by major product line and geographic region, as the company believes it best depicts the nature, amount and timing of its revenue and cash flows. Net sales by major product line are included below:

For the Year Ended December 31,
(In millions)202120202019
    Corn$5,618 $5,182 $5,126 
    Soybean1,568 1,445 1,387 
    Other oilseeds752 619 593 
    Other464 510 484 
Seed8,402 7,756 7,590 
    Herbicides3,815 3,280 3,206 
    Insecticides1,730 1,764 1,652 
    Fungicides1,310 1,032 1,072 
    Other398 385 326 
Crop Protection7,253 6,461 6,256 
Total$15,655 $14,217 $13,846 
Sales are attributed to geographic regions based on customer location. Net sales by geographic region and segment are included below:
SeedFor the Year Ended December 31,
(In millions)202120202019
North America1
$5,004 $4,795 $4,724 
EMEA2
1,599 1,468 1,378 
Latin America1,420 1,117 1,130 
Asia Pacific379 376 358 
Total$8,402 $7,756 $7,590 
Crop ProtectionFor the Year Ended December 31,
(In millions)202120202019
North America1
$2,532 $2,373 $2,205 
EMEA2
1,524 1,374 1,362 
Latin America2,125 1,688 1,759 
Asia Pacific1,072 1,026 930 
Total$7,253 $6,461 $6,256 
1.Represents U.S. & Canada.
2.Europe, Middle East, and Africa ("EMEA").
Refer to Note 24 - Geographic Information, for the breakout of consolidated net sales by geographic area.
XML 37 R17.htm IDEA: XBRL DOCUMENT v3.22.0.1
Restructuring and Asset Related Charges
12 Months Ended
Dec. 31, 2021
Restructuring and Related Activities [Abstract]  
Restructuring and Related Activities Disclosure [Text Block] RESTRUCTURING AND ASSET RELATED CHARGES - NET
2021 Restructuring Actions
During the first quarter of 2021, Corteva approved restructuring actions designed to right-size and optimize its footprint and organizational structure according to the business needs in each region with the focus on driving continued cost improvement and productivity. The company recorded net pre-tax restructuring charges in 2021 under the 2021 Restructuring Actions, as disclosed in the tables below. The company does not anticipate any additional material charges from the 2021 Restructuring Actions as actions associated with this charge are substantially complete.

The charges related to the 2021 Restructuring Actions related to the segments, as well as corporate expenses, were as follows:
(In millions)For the Year Ended December 31, 2021
Seed$31 
Crop Protection55 
Corporate expenses81 
Total$167 

The following table is a summary of charges incurred related to 2021 Restructuring Actions for the year ended December 31, 2021:
(In millions)For the Year Ended December 31, 2021
Severance and related benefit costs$74 
Asset related charges51 
Contract termination charges42 
Total restructuring and asset charges - net$167 
A reconciliation of the December 31, 2020 to the December 31, 2021 liability balances related to the 2021 Restructuring Actions is summarized below:
(In millions)Severance and Related Benefit Costs
Asset Related1
Contract Termination2
Total
Balance at December 31, 2020$— $— $— $— 
Charges to income from continuing operations74 51 42 167 
Payments(22)— (30)(52)
Asset write-offs— (51)— (51)
Balance at December 31, 2021$52 $— $12 $64 
1.In addition, the company has a liability recorded for asset retirement obligations of $6 million as of December 31, 2021.
2.The liability for contract terminations includes lease obligations. The cash impact of these obligations will be substantially complete by the end of 2022.

Execute to Win Productivity Program
During the first quarter of 2020, Corteva approved restructuring actions designed to improve productivity through optimizing certain operational and organizational structures primarily related to the Execute to Win Productivity Program. The company recorded net pre-tax restructuring charges of $185 million inception-to-date under the Execute to Win Productivity Program, consisting of $124 million of asset related charges and $61 million of severance and related benefit costs. Actions associated with the Execute to Win Productivity Program were substantially complete by the end of 2020.

The Execute to Win Productivity Program charges related to the segments, as well as corporate expenses, were as follows:
For the Year Ended December 31,
(In millions)20212020
Seed$— $15 
Crop Protection11 98 
Corporate expenses(2)63 
Total$$176 
The below is a summary of charges incurred related to the Execute to Win Productivity Program for the year ended December 31, 2020:
For the Year Ended December 31,
(In millions)20212020
Severance and related benefit costs - net$(2)$63 
Asset related charges11 113 
Total restructuring and asset related charges - net$$176 

A reconciliation of the December 31, 2020 to the December 31, 2021 liability balances related to the Execute to Win Productivity Program is summarized below:
(In millions)Severance and Related Benefit (Credits) Costs
Asset Related1
Total
Balance at December 31, 2020$53 $$56 
Charges to income from continuing operations for the year ended December 31, 2021(2)11 
Payments(27)(3)(30)
Asset write-offs— (11)(11)
Balance at December 31, 2021$24 $— $24 
1.In addition, the company has a liability recorded for asset retirement obligations of $13 million as of December 31, 2021.
DowDuPont Cost Synergy Program
In September and November 2017, DowDuPont and EID approved post-merger restructuring actions under the DowDuPont Cost Synergy Program (the “Synergy Program”), adopted at the time by the DowDuPont Board of Directors. The Synergy Program was designed to integrate and optimize the organization following the Merger and in preparation for the Business Separations. The company recorded net pre-tax restructuring charges of $833 million inception-to-date under the Synergy Program, consisting of severance and related benefit costs of $316 million, contract termination costs of $190 million, and asset related charges of $327 million. Actions associated with the Synergy Program, including employee separations, were substantially complete by the end of 2019.

The Synergy Program net charges (benefits) related to the segments, as well as corporate expenses, were as follows:
For the Year Ended December 31,
(In millions)202120202019
Seed$(8)$(9)$66 
Crop Protection(3)11 27 
Corporate expenses(1)(2)(1)
Total$(12)$— $92 

The below is a summary of net charges (benefits) incurred related to the Synergy Program for the years ended December 31, 2021, 2020 and 2019:
For the Year Ended December 31,
(In millions)202120202019
Severance and related benefit (credits) costs - net$(1)$(2)$(7)
Contract termination charges(3)— 69 
Asset related charges(8)30 
Total restructuring and asset related charges - net$(12)$— $92 

Other Asset Related Charges
For the years ended December 31, 2021 and 2020, the company recognized $125 million and $159 million, respectively, in restructuring and asset related charges - net in the Consolidated Statements of Operations, from non-cash accelerated prepaid royalty amortization expense related to Roundup Ready 2 Yield® and Roundup Ready 2 Xtend® herbicide tolerance traits.

Asset Impairment
During the year ended December 31, 2019, the company recognized non-cash impairment charges of $144 million pre-tax ($110 million after-tax) in restructuring and asset related charges - net in the company's Consolidated Statements of Operations related to certain in-process research and development ("IPR&D") assets within the seed segment. Refer to Note 15 - Goodwill and Other Intangible Assets, and Note 23 - Fair Value Measurements, for further information.
XML 38 R18.htm IDEA: XBRL DOCUMENT v3.22.0.1
Related Parties (Notes)
12 Months Ended
Dec. 31, 2021
Related Party Transactions [Abstract]  
Related Party Transactions Disclosure [Text Block] RELATED PARTY TRANSACTIONS
Services Provided by and to Historical Dow and its affiliates
Following the Merger and prior to the Dow Distribution, Corteva reported transactions with Historical Dow and its affiliates as related party transactions.

Transactions with DowDuPont
In 2019 DowDuPont contributed cash to Corteva to fund portions of the company's debt redemption/repayment transactions. See Note 17 - Long-Term Debt and Available Credit Facilities, to the Consolidated Financial Statements, for additional information.
In February 2019, the DowDuPont Board declared first quarter dividends per share of DowDuPont common stock payable on March 15, 2019. EID declared and paid distributions to DowDuPont of about $317 million for the year ended December 31, 2019 to fund a portion of DowDuPont’s dividend payments.
XML 39 R19.htm IDEA: XBRL DOCUMENT v3.22.0.1
Supplementary Information
12 Months Ended
Dec. 31, 2021
Supplementary Information [Abstract]  
Additional Financial Information Disclosure [Text Block] SUPPLEMENTARY INFORMATION
Other Income - NetFor the Year Ended December 31,
(In millions)202120202019
Interest income$77 $56 $59 
Equity in earnings (losses) of affiliates - net14 — (9)
Net gain (loss) on sales of businesses and other assets1
21 (2)64 
Net exchange gains (losses)2
(54)(174)(99)
Non-operating pension and other post employment benefit credit (costs)3
1,318 368 191 
Miscellaneous income (expenses) - net4
(28)(36)
Other income - net$1,348 $212 $215 
1.    The year ended December 31, 2021 includes a gain of $19 million relating to the sale of a business in Asia Pacific in the crop protection segment. The year ended December 31, 2020 includes a loss of $(53) million and a gain of $27 million relating to the expected sale of the La Porte site, for which the company signed an agreement in 2020, and the sale of a business in Asia Pacific in the crop protection segment, respectively.
2.    Includes net pre-tax exchange gains (losses) of $(67) million, $(82) million and $(51) million associated with the devaluation of the Argentine peso for the years ended December 31, 2021, 2020 and 2019, respectively.
3.    Includes non-service related components of net periodic benefit credits (costs) (interest cost, expected long-term rate of return on plan assets, amortization of unrecognized gain (loss), amortization of prior service benefit and settlement gain (loss)). 
4.    Miscellaneous income (expenses) - net, includes losses from sale of receivables, tax indemnification adjustments related to changes in indemnification balances as a result of the application of the terms of the Tax Matters Agreement between Corteva and Dow and/or DuPont, and other items. The year ended December 31, 2021 also includes the Employee Retention Credit of $60 million pursuant to the Coronavirus Aid, Relief, and Economic Security (“CARES”) Act as enhanced by the Consolidated Appropriations Act (“CAA”) and American Rescue Plan Act (“ARPA”), a gain from the remeasurement of an equity investment of $47 million, a charge related to a contract termination with a third-party service provider of $(54) million and the 2021 officer indemnification payment. 
The following table summarizes the impacts of the company's foreign currency hedging program on the company's results of operations. The company routinely uses foreign currency exchange contracts to offset its net exposures, by currency, related to the foreign currency-denominated monetary assets and liabilities. The objective of this program is to maintain an approximately balanced position in foreign currencies in order to minimize, on an after-tax basis, the effects of exchange rate changes on net monetary asset positions. The hedging program gains (losses) are largely taxable (tax deductible) in the United States (U.S.), whereas the offsetting exchange gains (losses) on the remeasurement of the net monetary asset positions are often not taxable (tax deductible) in their local jurisdictions. The net pre-tax exchange gains (losses) are recorded in other income - net and the related tax impact is recorded in provision for (benefit from) income taxes on continuing operations in the Consolidated Statements of Operations.
For the Year Ended December 31,
(In millions)202120202019
Subsidiary Monetary Position Gain (Loss)
Pre-tax exchange gain (loss) $(72)$(263)$(41)
Local tax (expenses) benefits (30)34 
Net after-tax impact from subsidiary exchange gain (loss) $(102)$(229)$(39)
Hedging Program Gain (Loss)
Pre-tax exchange gain (loss) $18 $89 $(58)
Tax (expenses) benefits (4)(21)13 
Net after-tax impact from hedging program exchange gain (loss) $14 $68 $(45)
Total Exchange Gain (Loss)
Pre-tax exchange gain (loss) $(54)$(174)$(99)
Tax (expenses) benefits(34)13 15 
Net after-tax exchange gain (loss) $(88)$(161)$(84)


Cash, cash equivalents and restricted cash equivalents
The following table provides a reconciliation of cash and cash equivalents and restricted cash equivalents presented in the Consolidated Balance Sheets to the total cash, cash equivalents and restricted cash equivalents presented in the Consolidated Statements of Cash Flows. Corteva classifies restricted cash equivalents as current or noncurrent based on the nature of the restrictions, which are included in other current assets and other assets, respectively, in the Consolidated Balance Sheets.
(In millions)December 31, 2021December 31, 2020
Cash and cash equivalents$4,459 $3,526 
Restricted cash equivalents377 347 
Total cash, cash equivalents and restricted cash equivalents$4,836 $3,873 

Restricted cash equivalents primarily relates to (i) a trust funded by EID for cash obligations under certain non-qualified benefit and deferred compensation plans due to the Merger, which was a change in control event, and is classified as current; and (ii) contributions to the MOU Escrow Account as further described in Note 18 - Commitments and Contingent Liabilities, to the Consolidated Financial Statements, which is classified as noncurrent.

Accounts payable
Accounts payable was $4,126 million and $3,615 million at December 31, 2021 and December 31, 2020, respectively. Accounts payable - trade, which is a component of accounts payable, was $3,023 million and $2,557 million at December 31, 2021 and December 31, 2020, respectively. Accounts payable - other, which is a component of accounts payable, was $1,103 million and $1,058 million at December 31, 2021 and December 31, 2020, respectively. No other components of accounts payable were more than 5 percent of total current liabilities.
XML 40 R20.htm IDEA: XBRL DOCUMENT v3.22.0.1
Income Taxes
12 Months Ended
Dec. 31, 2021
Income Tax Disclosure [Abstract]  
Income Tax Disclosure [Text Block] INCOME TAXES
Domestic and foreign components of the income (loss) from continuing operations before income taxes and the provision for (benefit from) current and deferred tax expense (benefit) are shown below:
Geographic Allocation of Income (Loss) and Provision for (Benefit from) Income Taxes For the Year Ended December 31,
(In millions)202120202019
Income (loss) from continuing operations before income taxes
Domestic$941 $(83)$(1,352)
Foreign1,405 758 1,036 
Income (loss) from continuing operations before income taxes$2,346 $675 $(316)
Current tax expense (benefit)
Federal$(13)$28 $(11)
State and local
Foreign329 222 317 
Total current tax expense (benefit)$322 $259 $307 
Deferred tax expense (benefit)
Federal$164 $(116)$(392)
State and local55 27 156 
Foreign(17)(251)(117)
Total deferred tax expense (benefit)$202 $(340)$(353)
Provision for (benefit from) income taxes on continuing operations524 (81)(46)
Net income (loss) from continuing operations after taxes$1,822 $756 $(270)

The effective income tax rate applicable to income (loss) from continuing operations before income taxes was different from the statutory U.S. federal income tax rate due to the factors listed in the following table:
Reconciliation to U.S. Statutory RateFor the Year Ended December 31,
202120202019
Statutory U.S. federal income tax rate21.0 %21.0 %21.0 %
Effective tax rates on international operations - net 1
(2.5)(13.9)(18.4)
Acquisitions, divestitures and ownership restructuring activities 2
(0.1)(0.3)(10.7)
U.S. research and development credit(2.4)(2.9)7.0 
Exchange gains/losses 3
1.9 3.5 (1.8)
State and local incomes taxes - net2.1 4.0 3.2 
Impact of Swiss Tax Reform4
0.2 (27.0)11.9 
Excess tax benefits/deficiencies from stock compensation(0.2)1.0 (0.6)
Tax settlements and expiration of statute of limitations— 0.4 3.9 
Other - net2.3 2.2 (0.9)
Effective tax rate on income from continuing operations22.3 %(12.0)%14.6 %
1.    Includes the effects of local and U.S. taxes related to earnings of non-U.S. subsidiaries, changes in the amount of unrecognized tax benefits associated with these earnings, losses at non-U.S. subsidiaries without local tax benefits due to valuation allowances, and other permanent differences between tax and U.S. GAAP results. Includes a tax benefit of $(51) million for the year ended December 31, 2020, related to a return to accrual adjustment associated with an elective change in accounting method for the 2019 tax year impact of foreign tax provisions.
2.    See Notes 4 - Common Control Business Combination, and Note 5 - Divestitures and Other Transactions, to the Consolidated Financial Statements, for additional information.
3.    Principally reflects the impact of foreign exchange gains and losses on net monetary assets for which no corresponding tax impact is realized. Further information about the company's foreign currency hedging program is included in Note 9 - Supplementary Information, and Note 22 - Financial Instruments, under the heading Foreign Currency Risk.
4.    Reflects tax benefits of $(182) million primarily driven by the recognition of an elective cantonal component of the recent enactment of the Federal Act on Tax Reform and AHV Financing ("Swiss Tax Reform") for the year ended December 31, 2020. Reflects tax benefits of $(38) million associated with the enactment of the Federal Act on Tax Reform and AHV Financing ("Swiss Tax Reform"), for the year ended December 31, 2019.
Significant components of our net deferred tax asset (liability) were attributable to:
Deferred Tax Balances at December 31,20212020
(In millions)AssetsLiabilitiesAssetsLiabilities
Property1
$— $341 $— $297 
Tax loss and credit carryforwards2,3
464 — 497 — 
Accrued employee benefits904 — 1,415 — 
Other accruals and reserves1
309 — 365 — 
Intangibles— 2,260 — 2,418 
Inventory153 — 127 — 
Research and development capitalization224 — 186 — 
Investments36 — 56 — 
Unrealized exchange gains/losses— 10 — 
Other – net105 — 91 — 
Subtotal$2,195 $2,611 $2,739 $2,715 
Valuation allowances3
(366)— (453)— 
Total$1,829 $2,611 $2,286 $2,715 
Net Deferred Tax Asset (Liability)$(782)$(429)
1.    Prior year classifications in property and other accruals and reserves have been adjusted from their previous presentation. Adjustments did not impact the amount of the net deferred tax asset (liability) recorded in the Consolidated Balance Sheets.    
2.    Primarily related to the realization of recorded tax benefits on tax loss and credit carryforwards from operations in the United States, Brazil, and Spain.    
3.    In connection with the company's 2021 internal legal entity restructuring, the company reduced various state net operating loss carryforwards and corresponding full valuation allowances by $61 million. There was no impact on the statement of operations. During the year ended December 31, 2020, the company established a $19 million state tax valuation allowance in the U.S. based on a change in judgement about the realizability of a deferred tax asset.

Details of the company’s operating loss and tax credit carryforwards are shown in the following table:
Operating Loss and Tax Credit CarryforwardsDeferred Tax Asset
(In millions)20212020
Operating loss carryforwards
Expire within 5 years$123 $99 
Expire after 5 years or indefinite expiration210 343 
Total operating loss carryforwards$333 $442 
Tax credit carryforwards
Expire within 5 years$14 $14 
Expire after 5 years or indefinite expiration117 41 
Total tax credit carryforwards$131 $55 
Total Operating Loss and Tax Credit Carryforwards$464 $497 
A reconciliation of the beginning and ending amount of gross unrecognized tax benefits is as follows:
Total Gross Unrecognized Tax BenefitsFor the Year Ended December 31,
(In millions)202120202019
Total unrecognized tax benefits as of beginning of period$395 $426 $749 
Decreases related to positions taken on items from prior years(7)(14)(167)
Increases related to positions taken on items from prior years13 77 
Increases related to positions taken in the current year54 
Settlement of uncertain tax positions with tax authorities(17)(18)(9)
Impact of Internal Reorganizations— — (278)
Decreases due to expiration of statutes of limitations(16)(7)— 
Exchange (gain) loss— (3)— 
Total unrecognized tax benefits as of end of period$377 $395 $426 
Total unrecognized tax benefits that, if recognized, would impact the effective tax rate$157 $156 $188 
Total amount of interest and penalties (benefits) recognized in provision for (benefit from) income taxes on continuing operations$$(2)$(4)
Total accrual for interest and penalties associated with unrecognized tax benefits at end of period$11 $18 $24 

Each year the company files hundreds of tax returns in the various national, state and local income taxing jurisdictions in which it operates. These tax returns are subject to examination and possible challenge by the tax authorities. Positions challenged by the tax authorities may be settled or appealed by the company. As a result, there is an uncertainty in income taxes recognized in the company's financial statements in accordance with accounting for income taxes and accounting for uncertainty in income taxes. It is reasonably possible that changes to the company’s global unrecognized tax benefits could be significant; however, due to the uncertainty regarding the timing of completion of audits and possible outcomes, a current estimate of the range of increases or decreases that may occur within the next twelve months cannot be made. As of December 31, 2021, the company has made advance deposits of approximately $102 million to a foreign taxing authority, partially as a prerequisite to petition the court related to an open tax examination. These payments are accounted for as a prepaid asset, included in other assets in the Consolidated Balance Sheets.

Tax years that remain subject to examination for the company’s major tax jurisdictions are shown below:
Tax Years Subject to Examination by Major Tax Jurisdiction at December 31, 2021Earliest Open Year
Jurisdiction
Argentina2015
Brazil2014
Canada2012
China2014
France2019
India2015
Italy2016
Switzerland2016
United States:
Federal income tax2012
State and local income tax2008

Undistributed earnings of foreign subsidiaries and related companies that are deemed to be indefinitely invested amounted to $3,681 million at December 31, 2021. Distributions of profits from non-U.S. subsidiaries are not expected to cause a significant incremental U.S. tax impact in the future; however, those distributions may still be subject to certain taxes upon repatriation, primarily where foreign withholding taxes apply. The company is asserting indefinite reinvestment related to certain investments in foreign subsidiaries. Determination of the amount of unrecognized deferred tax liability related to indefinitely reinvested profits is not feasible primarily due to our legal entity structure and the complexity of U.S. and local tax laws.

For periods between the Merger Effectiveness Time and the Corteva Distribution, Corteva and its subsidiaries were included in DowDuPont's consolidated federal income tax group and consolidated tax return. Generally, the consolidated tax liability of the
DowDuPont U.S. tax group for each year was apportioned among the members of the consolidated group based on each member’s separate taxable income. Corteva, DuPont and Dow intend that to the extent Federal and/or State corporate income tax liabilities are reduced through the utilization of tax attributes of the other, settlement of any receivable and payable generated from the use of the other party’s sub-group attributes will be in accordance with a tax sharing agreement and/or tax matters agreement. See Note 5 - Divestitures and Other Transactions, to the Consolidated Financial Statements for further information related to indemnifications between Corteva, Dow and DuPont.
XML 41 R21.htm IDEA: XBRL DOCUMENT v3.22.0.1
Earnings Per Share of Common Stock (Notes)
12 Months Ended
Dec. 31, 2021
Earnings Per Share [Abstract]  
Earnings Per Share [Text Block] EARNINGS PER SHARE OF COMMON STOCK
On June 1, 2019, the date of the Corteva Distribution, 748,815,000 shares of the company’s common stock were distributed to DowDuPont shareholders of record as of May 24, 2019.

The following tables provide earnings per share calculations for the periods indicated below:
Net Income (Loss) for Earnings Per Share Calculations - Basic and DilutedFor the Year Ended December 31,
(In millions)202120202019
Income (loss) from continuing operations after income taxes$1,822 $756 $(270)
Net income (loss) attributable to continuing operations noncontrolling interests10 20 13 
Income (loss) from continuing operations attributable to Corteva common stockholders1,812 736 (283)
(Loss) income from discontinued operations, net of tax(53)(55)(671)
Net income (loss) attributable to discontinued operations noncontrolling interests— — 
(Loss) income from discontinued operations attributable to Corteva common stockholders(53)(55)(676)
Net income (loss) attributable to common stockholders$1,759 $681 $(959)

Earnings (Loss) Per Share Calculations - BasicFor the Year Ended December 31,
(Dollars per share)202120202019
Earnings (loss) per share of common stock from continuing operations$2.46 $0.98 $(0.38)
(Loss) earnings per share of common stock from discontinued operations(0.07)(0.07)(0.90)
Earnings (loss) per share of common stock$2.39 $0.91 $(1.28)

Earnings (Loss) Per Share Calculations - DilutedFor the Year Ended December 31,
(Dollars per share)202120202019
Earnings (loss) per share of common stock from continuing operations$2.44 $0.98 $(0.38)
(Loss) earnings per share of common stock from discontinued operations(0.07)(0.07)(0.90)
Earnings (loss) per share of common stock$2.37 $0.91 $(1.28)

Share Count InformationFor the Year Ended December 31,
(Shares in millions)202120202019
Weighted-average common shares - basic1
735.9 748.7 749.5 
Plus dilutive effect of equity compensation plans2
5.7 2.5 — 
Weighted-average common shares - diluted741.6 751.2 749.5 
Potential shares of common stock excluded from EPS calculations3
2.8 9.4 14.4 
1.Share amounts for all periods prior to the Corteva Distribution were based on 748.8 million shares of Corteva, Inc. common stock distributed to holders of DowDuPont's common stock on June 1, 2019, plus 0.6 million of additional shares in which accelerated vesting conditions have been met.
2.Diluted earnings (loss) per share considers the impact of potentially dilutive securities except in periods in which there is a loss because the inclusion of the potential common shares would have an anti-dilutive effect.
3.These outstanding potential shares of common stock relating to stock options, restricted stock units and performance-based restricted stock units were excluded from the calculation of diluted earnings (loss) per share because (i) the effect of including stock options and restricted stock units would have been anti-dilutive; and (ii) the performance metrics have not yet been achieved for the outstanding potential shares relating to performance-based restricted stock units, which are deemed to be contingently issuable.
XML 42 R22.htm IDEA: XBRL DOCUMENT v3.22.0.1
Accounts and Notes Receivable, Net
12 Months Ended
Dec. 31, 2021
Receivables [Abstract]  
Accounts and Notes Receivables, Net ACCOUNTS AND NOTES RECEIVABLE - NET
(In millions)December 31, 2021December 31, 2020
Accounts receivable – trade1
$3,441 $3,754 
Notes receivable – trade1,2
120 163 
Other3
1,250 1,009 
Total accounts and notes receivable - net$4,811 $4,926 
1.Accounts receivable – trade and notes receivable – trade are net of allowances of $210 million and $208 million at December 31, 2021 and December 31, 2020, respectively. Allowances are equal to the estimated uncollectible amounts and are based on the expected credit losses and were developed using a loss-rate method.
2.Notes receivable – trade primarily consists of receivables for deferred payment loan programs for the sale of seed products to customers. These loans have terms of one year or less and are primarily concentrated in North America. The company maintains a rigid pre-approval process for extending credit to customers in order to manage overall risk and exposure associated with credit losses. As of December 31, 2021 and 2020, there were no significant impairments related to current loan agreements.
3.Other includes receivables in relation to indemnification assets, value added tax, general sales tax and other taxes. No individual group represents more than 10 percent of total receivables. In addition, Other includes amounts due from nonconsolidated affiliates of $104 million and $106 million as of December 31, 2021 and 2020, respectively.

Accounts and notes receivable are carried at the expected amount to be collected, which approximates fair value. The company establishes the allowance for doubtful receivables using a loss-rate method where the loss rate is developed using past events, historical experience, current conditions and forecasts that affect the collectability of the financial assets.

The following table summarizes changes in the allowance for doubtful receivables for the year ended December 31, 2021 and 2020, respectively:
(In millions)
2020
Balance at December 31, 2019$174 
Net provision for credit losses1
52 
Write-offs charged against allowance / other1
(18)
Balance at December 31, 2020$208 
2021
Balance at December 31, 2020$208 
Net provision for credit losses
Write-offs charged against allowance / other
Balance at December 31, 2021$210 
1. Prior year classifications in the changes in the allowance for doubtful receivables have been adjusted from their previous presentation. Adjustments did not impact the amount of the provision or the allowance for doubtful receivables recorded in the Consolidated Statements of Operations or the Consolidated Balance Sheets.

The company enters into various factoring agreements with third-party financial institutions to sell its trade receivables under both recourse and non-recourse agreements in exchange for cash proceeds. These financing arrangements result in a transfer of the company's receivables and risks to the third-party. As these transfers qualify as true sales under the applicable accounting guidance, the receivables are derecognized from the Consolidated Balance Sheets upon transfer, and the company receives a payment for the receivables from the third-party within a mutually agreed upon time period. For arrangements involving an element of recourse, which is typically provided through a guarantee of accounts in the event of customer default, the guarantee obligation is measured using market data from similar transactions and reported as a current liability in the Consolidated Balance Sheets.

Trade receivables sold under these agreements were $272 million, $255 million, and $328 million for the years ended December 31, 2021, 2020 and 2019, respectively. The trade receivables sold that remained outstanding under these agreements which include an element of recourse as of December 31, 2021 and December 31, 2020 were $166 million and $157 million, respectively. The net proceeds received were included in cash provided by (used for) operating activities in the Consolidated
Statements of Cash Flows. The difference between the carrying amount of the trade receivables sold and the sum of the cash received is recorded as a loss on sale of receivables in other income - net in the Consolidated Statements of Operations. The loss on sale of receivables were $54 million, $55 million, and $44 million for the years ended December 31, 2021, 2020 and 2019, respectively. See Note 18 - Commitments and Contingent Liabilities, to the Consolidated Financial Statements, for additional information on the company’s guarantees.
XML 43 R23.htm IDEA: XBRL DOCUMENT v3.22.0.1
Inventories
12 Months Ended
Dec. 31, 2021
Inventory Disclosure [Abstract]  
Inventory Disclosure [Text Block] INVENTORIES
(In millions)December 31, 2021December 31, 2020
Finished products$2,497 $2,584 
Semi-finished products2,076 1,813 
Raw materials and supplies607 485 
Total inventories$5,180 $4,882 

As a result of the Merger, a fair value step-up of $2,297 million was recorded for inventories. This fair value step-up was fully
amortized, as of December 31, 2019. During the year ended December 31, 2019, the company recognized $272 million in cost of goods sold in the Consolidated Statements of Operations related to the amortization of the step-up.
XML 44 R24.htm IDEA: XBRL DOCUMENT v3.22.0.1
Property, Plant and Equipment
12 Months Ended
Dec. 31, 2021
Property, Plant and Equipment [Abstract]  
Property, Plant and Equipment Disclosure [Text Block] PROPERTY, PLANT AND EQUIPMENT
(In millions)December 31, 2021December 31, 2020
Land and land improvements$420 $451 
Buildings1,487 1,525 
Machinery and equipment5,729 5,556 
Construction in progress728 721 
Total property, plant and equipment8,364 8,253 
Accumulated depreciation(4,035)(3,857)
Total property, plant and equipment - net$4,329 $4,396 

Buildings, machinery and equipment and land improvements are depreciated over useful lives on a straight-line basis ranging from 2 to 25 years. Capitalizable costs associated with computer software for internal use are amortized on a straight-line basis over 2 to 7 years.

For the Year Ended December 31,
(In millions)202120202019
Depreciation expense$521 $495 $525 
XML 45 R25.htm IDEA: XBRL DOCUMENT v3.22.0.1
Goodwill and Other Intangible Assets
12 Months Ended
Dec. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill and Intangible Assets Disclosure [Text Block] GOODWILL AND OTHER INTANGIBLE ASSETS
Goodwill
The following table summarizes changes in the carrying amount of goodwill by segment for the years ended December 31, 2021 and 2020, respectively.
(In millions)Crop ProtectionSeedTotal
Balance as of December 31, 2019$4,743 $5,486 $10,229 
Currency translation adjustment31 38 69 
Other goodwill adjustments and acquisitions1
(29)— (29)
Balance as of December 31, 2020$4,745 $5,524 $10,269 
Currency translation adjustment(73)(87)(160)
Other goodwill adjustments and acquisitions2
— (2)(2)
Balance as of December 31, 2021$4,672 $5,435 $10,107 
1.Primarily consists of the goodwill included in the sale of businesses in the crop protection segment.
2.Consists of the goodwill included in the sale of a business in the seed segment.

The company tests goodwill for impairment annually (during the fourth quarter), or more frequently when events or changes in circumstances indicate it is more likely than not that the fair value of a reporting unit has declined below its carrying value. As mentioned in Note 2 - Summary of Significant Accounting Policies, as a result of the Internal Reorganizations and Business Realignments, the company changed its reportable segments to seed and crop protection to reflect the manner in which the company's chief operating decision maker assesses performance and allocates resources. The change in reportable segments resulted in changes to the company's reporting units for goodwill impairment testing to align with the level at which discrete financial information is available for review by management. The company’s reporting units include seed, crop protection and digital.

During the second quarter of 2020, the company determined a triggering event had occurred as a result of changes in the company's long-term projections driven largely by the impacts of the COVID-19 pandemic on the mid-term forecasted cash flows of the business, including, but not limited to currency fluctuations, expectations of future planted area (as influenced by consumer demand, ethanol markets and government policies and regulations) and relative commodity prices, which required an interim impairment assessment for its seed and crop protection reporting units and trade name indefinite lived intangible asset. Based on the impairment analysis performed over the company’s trade name indefinite lived intangible asset it was determined that the fair value approximated the carrying value, and no impairment charge was necessary.

The company performed quantitative testing on all of its reporting units and determined that no goodwill impairments existed in 2021 and 2020. As of December 31, 2021, accumulated impairment losses on goodwill were $4,503 million.
Other Intangible Assets
The gross carrying amounts and accumulated amortization of other intangible assets by major class are as follows: 
(In millions)December 31, 2021December 31, 2020
 GrossAccumulated
Amortization
NetGrossAccumulated
Amortization
Net
Intangible assets subject to amortization (Definite-lived):
      
Germplasm$6,265 $(571)$5,694 $6,265 $(317)$5,948 
Customer-related
1,953 (487)1,466 1,984 (380)1,604 
Developed technology1,485 (679)806 1,451 (525)926 
Trademarks/trade names1
2,012 (172)1,840 2,019 (99)1,920 
Favorable supply contracts
475 (396)79 475 (302)173 
Other2
405 (256)149 405 (239)166 
Total other intangible assets with finite lives
12,595 (2,561)10,034 12,599 (1,862)10,737 
Intangible assets not subject to amortization (Indefinite-lived):
      
IPR&D10 — 10 10 — 10 
Total other intangible assets
10 — 10 10 — 10 
Total$12,605 $(2,561)$10,044 $12,609 $(1,862)$10,747 
1.Beginning on October 1, 2020, the company changed its indefinite life assertion of its trade name asset to definite lived with a useful life of 25 years. This change is the result of the launch of BrevantTM seed in the retail channel in the U.S. Prior to changing the useful life of the trade name asset, the company tested the asset for impairment under ASC 350 - Intangibles, Goodwill and Other, concluding the asset was not impaired.
2.Primarily consists of sales and farmer networks, marketing and manufacturing alliances and noncompetition agreements.

During the third quarter of 2019, and in connection with strategic product and portfolio reviews, the company determined that the fair value of certain intangible assets classified as developed technology, other intangible assets and IPR&D within the seed segment that primarily relate to heritage DAS intangibles previously acquired from Cooperativa Central de Pesquisa Agrícola's ("Coodetec") was less than the carrying value due to the company’s focus on advancing more competitive products and eliminating redundancy and complexity across the breeding programs. For IPR&D and developed technology, the company concluded these projects were abandoned. For other intangible assets, the company performed an impairment assessment using the relief from royalty method (a form of the income approach) using Level 3 inputs within the fair value hierarchy. The significant assumptions used in the calculation included projected revenue, royalty rates and discount rates. These significant assumptions involve management judgment and estimates relating to future operating performance and economic conditions that may differ from actual cash flows. As a result, the company recorded a pre-tax, non-cash intangible asset impairment charge of $54 million ($41 million after-tax), which is reflected in restructuring and asset related charges - net, in the company's Consolidated Statements of Operations for the year ended December 31, 2019.

There were no indicators of impairment for the company’s other intangible assets that suggested that the fair value was less than its carrying value at December 31, 2019, except for IPR&D. As a result of the company’s decision, during the fourth quarter of 2019, to accelerate the ramp up of the Enlist E3TM trait platform in the company’s soybean portfolio mix across all brands over the subsequent five years with minimal use of the Roundup Ready 2 Yield® and Roundup Ready 2 Xtend® traits thereafter for the remainder of the Roundup Ready 2 License Agreement, the company determined that certain IPR&D projects associated with Roundup Ready 2 Xtend® were not recoverable and were impaired. These IPR&D projects were either abandoned or tested for impairment using the relief from royalty method (a form of the income approach) using Level 3 inputs within the fair value hierarchy. The key assumptions used in the relief from royalty method calculation included projected revenue, royalty rates and discount rates. These key assumptions involve management judgment and estimates relating to future operating performance and economic conditions that may differ from actual cash flows. As a result, the company recorded a pre-tax, non-cash intangible asset charge of $90 million ($69 million after-tax), which is reflected in restructuring and asset related charges - net, in the company's Consolidated Statements of Operations for the year ended December 31, 2019.

The aggregate pre-tax amortization expense from continuing operations for definite-lived intangible assets was $722 million, $682 million, and $475 million, for the year ended December 31, 2021, December 31, 2020, and December 31, 2019, respectively.
Total estimated amortization expense for the next five fiscal years is as follows:
(In millions)
2022$700 
2023$620 
2024$606 
2025$569 
2026$558 
XML 46 R26.htm IDEA: XBRL DOCUMENT v3.22.0.1
Leases (Notes)
12 Months Ended
Dec. 31, 2021
Leases [Abstract]  
Leases of Lessee Disclosure [Text Block] LEASES
The company has operating and finance leases for real estate, transportation, certain machinery and equipment, and information technology assets. The company’s leases have remaining lease terms of 1 to 50 years. For purposes of calculating operating lease liabilities, lease terms may be deemed to include options to extend the lease when it is reasonably certain that the company will exercise that option. Some leasing arrangements require variable payments that are dependent on usage, output, or may vary for other reasons, such as insurance and tax payments. The variable lease payments are not presented as part of the initial ROU asset or lease liability.

Certain of the company's leases include residual value guarantees. These residual value guarantees are based on a percentage of the lessor's asset acquisition price and the amount of such guarantee declines over the course of the lease term. The portion of residual value guarantees that are probable of payment are included in the related lease liability. At December 31, 2021, the company has future maximum payments for residual value guarantees in operating leases of $193 million with final expirations through 2028. The company's lease agreements do not contain any material restrictive covenants. The components of lease cost are as follows:
For the Year Ended December 31,
(In millions)20212020
Operating lease cost$158 $197 
Finance lease cost
Amortization of right-of-use assets1
Interest on lease liabilities— — 
Total finance lease cost1
Short-term lease cost1414 
Variable lease cost8
Total lease cost$181 $220 

New leases entered into during the years ended December 31, 2021 and December 31, 2020 were not material, on an individual basis.

Supplemental cash flow information related to leases is as follows:
For the Year Ended December 31,
(In millions)20212020
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash outflows from operating leases$169 $202 
Operating cash outflows from finance leases$— $— 
Financing cash outflows from finance leases$$
Supplemental balance sheet information related to leases is as follows:
(In millions)December 31, 2021December 31, 2020
Operating Leases
 
Operating lease right-of-use assets1
$458 $521 
Current operating lease liabilities2
121 138 
Noncurrent operating lease liabilities3
338 391 
Total operating lease liabilities
$459 $529 
Finance Leases
 
Property, plant, and equipment, gross
$15 $15 
Accumulated depreciation
(11)(10)
Property, plant, and equipment, net
Short-term borrowings and finance lease obligations
Long-Term Debt
Total finance lease liabilities$$
1.Included in other assets in the Consolidated Balance Sheet.
2.Included in accrued and other current liabilities in the Consolidated Balance Sheet.
3.Included in other noncurrent obligations in the Consolidated Balance Sheet.

The company utilizes the incremental borrowing rate in determining the present value of lease payments unless the implicit rate is readily determinable.
Lease Term and Discount RateDecember 31, 2021December 31, 2020
Weighted-average remaining lease term (years)
Operating leases7.417.71
Financing leases3.364.26
Weighted average discount rate
Operating leases2.75 %3.06 %
Financing leases3.29 %3.28 %

Maturities of lease liabilities are as follows:
Maturity of Lease Liabilities at December 31, 2021Operating LeasesFinancing Leases
(In millions)
2022$132 $
202394 
202471 
202560 
202649 — 
2027 and thereafter106 — 
Total lease payments512 
Less: Interest53 — 
Present value of lease liabilities$459 $
Maturity of Lease Liabilities at December 31, 2020Operating LeasesFinancing Leases
(In millions)
2021$152 $
2022114 
202383 
202461 
202551 
2026 and thereafter137 — 
Total lease payments598 
Less: Interest69 — 
Present value of lease liabilities$529 $
XML 47 R27.htm IDEA: XBRL DOCUMENT v3.22.0.1
Long-Term Debt and Available Credit Facilities
12 Months Ended
Dec. 31, 2021
Debt Disclosure [Abstract]  
Debt Disclosure [Text Block] LONG-TERM DEBT AND AVAILABLE CREDIT FACILITIES
Long-Term Debt
December 31, 2021December 31, 2020
(In millions)AmountWeighted Average RateAmountWeighted Average Rate
Promissory notes and debentures:
  Maturing in 2025500 1.70 %500 1.70 %
  Maturing in 2030500 2.30 %500 2.30 %
Other loans:
Foreign currency loans, various rates and maturities
Medium-term notes, varying maturities through 2041107 — %109 — %
Finance lease obligations
Less: Unamortized debt discount and issuance costs10 11 
Less: Long-term debt due within one year
Total$1,100 $1,102 

Principal payments of long-term debt are $500 million for long-term debt maturing in 2025.

The estimated fair value of the company's long-term borrowings, was determined using Level 2 inputs within the fair value hierarchy, as described in Note 2 - Summary of Significant Accounting Policies. Based on quoted market prices for the same or similar issues, or on current rates offered to the company for debt of the same remaining maturities, the fair value of the company's long-term borrowings, not including long-term debt due within one year, was $1,120 million and $1,166 million at December 31, 2021 and 2020, respectively.

Debt Offering
In May 2020, EID issued $500 million of 1.70 percent Senior Notes due 2025 and $500 million of 2.30 percent Senior Notes due 2030 (the May 2020 Debt Offering). The proceeds of this offering are intended to be used for general corporate purposes.

Available Committed Credit Facilities
The following table summarizes the company's credit facilities:
Committed and Available Credit Facilities at December 31, 2021
(In millions)Effective DateCommitted CreditCredit AvailableMaturity DateInterest
Revolving Credit FacilityMay 2019$3,000 $3,000 May 2024Floating Rate
Revolving Credit FacilityMay 20193,000 3,000 May 2023Floating Rate
Total Committed and Available Credit Facilities$6,000 $6,000 
Revolving Credit Facilities
In November 2018, EID entered into a $3.0 billion, 5 year revolving credit facility and a $3.0 billion, 3-year revolving credit facility (the "Revolving Credit Facilities”). The Revolving Credit Facilities became effective May 2019. Corteva, Inc. became a party at the time of the Corteva Distribution. In May 2021, the company entered into an amendment that extended the maturity date of the 3-year revolving credit facility from May 2022 to May 2023. Other than the change in maturity date, there were no material modifications to the terms of the credit facility. The Revolving Credit Facilities may serve as a substitute to the company's commercial paper program, and can be used from time to time, for general corporate purposes including, but not limited to, the funding of seasonal working capital needs. The Revolving Credit Facilities contain customary representations and warranties, affirmative and negative covenants and events of default that are typical for companies with similar credit ratings. Additionally, the Revolving Credit Facilities contain a financial covenant requiring that the ratio of total indebtedness to total capitalization for Corteva and its consolidated subsidiaries not exceed 0.60.

In March 2020, the company drew down $500 million under the $3.0 billion 3-year revolving credit facility as a result of the volatility and increased borrowing costs of commercial paper resulting from the unstable market conditions caused by the COVID-19 pandemic and repaid that borrowing in full in June 2020. There were no additional borrowings and the unused commitments under the 3-year revolving credit facility were $3.0 billion as of December 31, 2021.

Debt Redemptions/Repayments
On March 22, 2019, EID issued notices of redemption in full of all of its outstanding notes (the “Make Whole Notes”) listed in the table below:
(in millions)Amount
4.625% Notes due 2020$474 
3.625% Notes due 2021296 
4.250% Notes due 2021163 
2.800% Notes due 2023381 
6.500% Debentures due 202857 
5.600% Senior Notes due 203642 
4.900% Notes due 204148 
4.150% Notes due 204369 
Total$1,530 

The Make Whole Notes were redeemed on April 22, 2019 at the make-whole redemption prices set forth in the respective Make Whole Notes. On and after the date of redemption, the Make Whole Notes were no longer deemed outstanding, interest on the Make Whole Notes ceased to accrue and all rights of the holders of the Make Whole Notes were terminated.

In March 2016, EID entered into a credit agreement that provided for a 3-year, senior unsecured term loan facility in the aggregate principal amount of $4.5 billion (as amended, from time to time, the "Term Loan Facility") under which EID could make up to seven term loan borrowings and amounts repaid or prepaid were not available for subsequent borrowings. On May 2, 2019, EID terminated its Term Loan Facility and repaid the aggregate outstanding principal amount of $3 billion plus accrued and unpaid interest through and including May 1, 2019.

In connection with the repayment of the Make Whole Notes and the Term Loan Facility, EID paid a total of $4.6 billion in the second quarter 2019, which included breakage fees and accrued and unpaid interest on the Make Whole Notes and Term Loan Facility. The repayment of the Make Whole Notes and Term Loan Facility was funded with cash from operations and a contribution from DowDuPont.

On May 7, 2019, DowDuPont publicly announced the record date in connection with the Corteva Distribution. In connection with such announcement, EID was required to redeem $1.25 billion aggregate principal amount of 2.20% Notes due 2020 and $750 million aggregate principal amount of Floating Rate Notes due 2020 (collectively, the Special Mandatory Redemption, or “SMR Notes”) setting forth the date of redemption of the SMR Notes. On May 17, 2019 EID redeemed and paid a total of $2 billion, which included accrued and unpaid interest on the SMR Notes. EID funded the payment with a contribution from DowDuPont. Following the redemption, the SMR Notes are no longer outstanding and no longer bear interest, and all rights of the holders of the SMR Notes have terminated.
EID recorded a loss on the early extinguishment of debt of $13 million for the year ended December 31, 2019, related to the difference between the redemption price and the par value of the Make Whole Notes, the Term Loan Facility, and the SMR Notes, partially offset by the write-off of unamortized step-up related to the fair value step-up of EID’s debt.

Uncommitted Credit Facilities and Outstanding Letters of Credit
Unused bank credit lines on uncommitted credit facilities were $389 million at December 31, 2021. These lines are available to support short-term liquidity needs and general corporate purposes, including letters of credit. Outstanding letters of credit were $127 million at December 31, 2021. These letters of credit support commitments made in the ordinary course of business.
XML 48 R28.htm IDEA: XBRL DOCUMENT v3.22.0.1
Stockholders' Equity
12 Months Ended
Dec. 31, 2021
Equity [Abstract]  
Stockholders' Equity Note Disclosure [Text Block] STOCKHOLDERS' EQUITY
Common Stock
As discussed in Note 1 - Background and Basis of Presentation, on June 1, 2019, Corteva, Inc.'s common stock was distributed to DowDuPont stockholders by way of a pro rata distribution. Each DowDuPont stockholder received one share of Corteva, Inc. common stock for every three shares of DowDuPont common stock held at the close of business on May 24, 2019, the record date of distribution. Corteva, Inc.'s common stock began trading the "regular way" under the ticker symbol "CTVA" on June 3, 2019, the first business day after June 1, 2019. The number of Corteva, Inc. common shares issued on June 1, 2019 was 748,815,000 (par value of $0.01 per share). Information related to the Corteva Distribution and its effect on the company's financial statements are discussed throughout these Notes to the Consolidated Financial Statements.

Set forth below is a reconciliation of common stock share activity for the years ended December 31, 2021, 2020, and 2019:
Shares of common stockIssued
Balance June 1, 2019748,815,000 
Issued586,000 
Repurchased and retired(824,000)
Balance December 31, 2019748,577,000 
Issued3,384,000 
Repurchased and retired(8,503,000)
Balance December 31, 2020743,458,000 
Issued4,019,000 
Repurchased and retired(20,950,000)
Balance December 31, 2021726,527,000 

Share Buyback Plan
On August 5, 2021, Corteva, Inc. announced that its Board of Directors authorized a $1.5 billion share repurchase program to purchase Corteva, Inc.'s common stock, par value $0.01 per share, without an expiration date ("2021 Share Buyback Plan"). The timing, price and volume of purchases will be based on market conditions, relevant securities laws and other factors. In connection with the 2021 Share Buyback Plan, the company purchased and retired 5,572,000 shares during the year ended December 31, 2021 in the open market for a total cost of $250 million.

On June 26, 2019, Corteva, Inc. announced that its Board of Directors authorized a $1 billion share repurchase program to purchase Corteva, Inc.'s common stock, par value $0.01 per share, without an expiration date ("2019 Share Buyback Plan").

In connection with the 2019 Share Buyback Plan, the company repurchased and retired 15,378,000 shares, 8,503,000 shares, and 824,000 shares in the open market for a total cost of $700 million, $275 million, and $25 million during the years ended December 31, 2021, 2020, and 2019, respectively. Repurchases under the 2019 Share Buyback Plan were completed during the third quarter of 2021.

Shares repurchased pursuant to Corteva's share buyback plan are immediately retired upon repurchase. Repurchased common stock is reflected as a reduction of stockholders' equity. The company's accounting policy related to its share repurchases is to reduce its common stock based on the par value of the shares and to reduce its retained earnings for the excess of the repurchase price over the par value. When Corteva has an accumulated deficit balance, the excess over the par value is applied to APIC. When Corteva has retained earnings, the excess is charged entirely to retained earnings.

Noncontrolling Interest
In June 2020, the company completed the acquisition of the remaining 46.5 percent interest in the Phytogen Seed Company, LLC joint venture from J. G. Boswell Company. As the purchase of the remaining interest did not result in a change of control, the difference between the carrying value of the noncontrolling interest and the consideration paid, net of taxes was recorded within equity.

Corteva, Inc. owns 100 percent of the outstanding common shares of EID. However, EID has preferred stock outstanding to third parties which is accounted for as a noncontrolling interest in Corteva's Consolidated Balance Sheets. Each share of EID
Preferred Stock - $4.50 Series and EID Preferred Stock - $3.50 Series issued and outstanding at the effective date of the Corteva Distribution remains issued and outstanding as to EID and was unaffected by the Corteva Distribution.

Below is a summary of the EID Preferred Stock at December 31, 2021 and December 31, 2020 which is classified as noncontrolling interests in the Corteva Consolidated Balance Sheets.

(Shares in thousands)Number of Shares
Authorized23,000
$4.50 Series, callable at $1201,673
$3.50 Series, callable at $102700

Other Comprehensive Income (Loss)
The changes and after-tax balances of components comprising accumulated other comprehensive income (loss) are summarized below:
(In millions)
Cumulative Translation Adjustment1
Derivative InstrumentsPension Benefit PlansOther Benefit PlansUnrealized Gain (Loss) on InvestmentsTotal
2019
Balance January 1, 2019$(2,793)$(26)$(620)$79 $— $(3,360)
Other comprehensive income (loss) before reclassifications(274)16 (723)(159)— (1,140)
Amounts reclassified from accumulated other comprehensive income (loss)— 12 (1)— 16 
Net other comprehensive income (loss) (274)28 (718)(160)— (1,124)
Impact of Internal Reorganizations
1,123 — 91 — — 1,214 
Balance December 31, 2019$(1,944)$$(1,247)$(81)$— $(3,270)
2020
Other comprehensive income (loss) before reclassifications$(26)$(81)$(191)$670 $(10)$362 
Amounts reclassified from accumulated other comprehensive income (loss)— 12 — 18 
Net other comprehensive income (loss) (26)(69)(186)671 (10)380 
Balance December 31, 2020$(1,970)$(67)$(1,433)$590 $(10)$(2,890)
2021
Other comprehensive income (loss) before reclassifications$(573)$143 $996 $25 $$594 
Amounts reclassified from accumulated other comprehensive income (loss)— (4)41 (646)(602)
Net other comprehensive income (loss)(573)139 1,037 (621)10 (8)
Balance December 31, 2021$(2,543)$72 $(396)$(31)$— $(2,898)
1.The cumulative translation adjustment losses for the year ended December 31, 2021 was primarily driven by the strengthening of the U.S. Dollar ("USD") against the European Euro ("EUR"), Swiss franc ("CHF") and Turkish Lira (“TRY”). The cumulative translation adjustment losses for the year ended December 31, 2020 was primarily driven by the strengthening of the U.S. Dollar ("USD") against the Brazilian Real ("BRL"), partially offset by the weakening of the U.S. Dollar against the Swiss franc ("CHF") and European Euro ("EUR").

The tax (expense) benefit on the net activity related to each component of other comprehensive income (loss) was as follows:
For the Year Ended December 31,
(In millions)202120202019
Derivative instruments$(41)$24 $(8)
Pension benefit plans - net(319)54 231 
Other benefit plans - net188 (211)52 
(Provision for) benefit from income taxes related to other comprehensive income (loss) items$(172)$(133)$275 
A summary of the reclassifications out of accumulated other comprehensive loss is provided as follows:
(In millions)For the Year Ended December 31,
202120202019
Derivative Instruments1:
$(13)$18 $13 
Tax (benefit) expense2
(6)(1)
After-tax$(4)$12 $12 
Amortization of pension benefit plans:
  Prior service (benefit) cost3,4
$(2)$(1)$(1)
  Actuarial (gains) losses3,4,5
55 
  Settlement (gain) loss3,4,5
Total before tax54 
Tax (benefit) expense2
(13)(1)— 
After-tax$41 $$
Amortization of other benefit plans:
  Prior service (benefit) cost3,4
$(922)$— $— 
  Actuarial (gains) losses3,4
81 (1)
  Curtailment (gain) loss(1)— — 
Total before tax(842)(1)
Tax (benefit) expense2
196 — — 
After-tax$(646)$$(1)
Unrealized (Gain) Loss on Investments4
$$— $— 
Tax (benefit) expense2
— — — 
After-tax
$$— $— 
Total reclassifications for the period, after-tax$(602)$18 $16 
1.Reflected in cost of goods sold in the Consolidated Statements of Operations.
2.Reflected in provision for (benefit from) income taxes from continuing operations in the Consolidated Statements of Operations.
3.These accumulated other comprehensive (loss) income components are included in the computation of net periodic benefit (credit) cost of the company's pension and other benefit plans. See Note 20 - Pension Plans and Other Post Employment Benefits, to the Consolidated Financial Statements, for additional information.
4.Reflected in other income - net in the Consolidated Statements of Operations.
5.A portion reflected in (loss) income from discontinued operations after income taxes for the year ended December 31, 2019.
XML 49 R29.htm IDEA: XBRL DOCUMENT v3.22.0.1
Pension Plans and Other Post Employment Benefit Plans
12 Months Ended
Dec. 31, 2021
Retirement Benefits [Abstract]  
Pension and Other Postretirement Benefits Disclosure [Text Block] PENSION PLANS AND OTHER POST EMPLOYMENT BENEFITS
The company offers various long-term benefits to its employees. Where permitted by applicable law, the company reserves the right to change, modify or discontinue the plans.

Defined Benefit Pension Plans
The company has both funded and unfunded noncontributory defined benefit pension plans covering a majority of the U.S. employees and employees in a number of other countries. The principal U.S. pension plan is the largest pension plan held by Corteva. Effective January 1, 2007, a majority of new hires are not eligible to participate in the U.S. defined benefit pension plans. The company froze the pay and service amounts used to calculate the pension benefits for active employees who participate in these plans on November 30, 2018, resulting in the participants no longer accruing additional benefits.

The company's funding policy is consistent with the funding requirements of federal laws and regulations. Pension coverage for employees of the company's non-U.S. consolidated subsidiaries is provided, to the extent deemed appropriate, through separate plans. Obligations under such plans are funded by depositing funds with trustees, covered by insurance contracts, or remain unfunded.

The company made total contributions of $49 million, $62 million, and $121 million to its pension plans other than the principal U.S. pension plan for the years ended December 31, 2021, 2020 and 2019, respectively. Corteva expects to contribute approximately $60 million to its pension plans other than the principal U.S. pension plan in 2022. The company does not anticipate making contributions to its principal U.S pension plan in 2022.

The weighted-average assumptions used to determine pension plan obligations for all pension plans are summarized in the table below:
Weighted-Average Assumptions used to Determine Benefit ObligationsDecember 31, 2021December 31, 2020
Discount rate
2.82 %2.44 %
Rate of increase in future compensation levels1
2.55 %2.54 %
1.The rate of compensation increase excludes U.S. pension plans since the employees who participate in the U.S. pension plans no longer accrue additional benefits for future service and eligible compensation.

The weighted-average assumptions used to determine net periodic benefit costs for all pension plans are summarized in the table below:
Weighted-Average Assumptions used to Determine Net Periodic Benefit CostFor the Year Ended December 31,
202120202019
Discount rate
2.44 %3.19 %4.19 %
Rate of increase in future compensation levels1
2.54 %2.60 %2.84 %
Expected long-term rate of return on plan assets
5.73 %6.25 %6.24 %
1.The rate of compensation increase excludes U.S. pension plans since the employees who participate in the U.S. pension plans no longer accrue additional benefits for future service and eligible compensation.

Other Post Employment Benefits
The company has historically provided medical, dental and life insurance benefits to certain pensioners and survivors. The majority of U.S. employees hired on or after January 1, 2007, and eligible employees under the age of 50 as of November 30, 2018, are not eligible to participate in the post-employment medical, dental and life insurance plans. Substantially all of the cost and liabilities for these retiree benefit plans are attributable to the U.S. benefit plans. The non-Medicare eligible retiree medical plan is contributory with costs shared between the company and pensioners and survivors. For Medicare eligible pensioners and survivors, Corteva provides a company-funded Health Reimbursement Arrangement ("HRA"). In December 2020, the company amended its retiree medical, dental and life insurance plans resulting in the company no longer providing retiree dental and life insurance benefits effective January 1, 2022 and Corteva’s portion of the cost of non-Medicare retiree medical coverage no longer being adjusted for cost increases, which capped the Corteva cost at the level in effect as of December 31, 2021 ("2020 OPEB Plan Amendments"). As a result of these changes, the company recorded a $(939) million decrease in OPEB benefit obligations as of December 31, 2020 with a corresponding prior service benefit within other comprehensive income for the year ended December 31, 2020. During 2021, a substantial amount of the prior service benefit within other comprehensive income (loss) in 2020 was recognized in other income - net in the Consolidated Statement of Operations.
The company also provides disability benefits to employees. Employee disability benefit plans are insured in many countries. However, primarily in the U.S., such plans are generally self-insured. Obligations and expenses for self-insured plans are reflected in the change in projected benefit obligations table on page F-56.

The company's OPEB plans are unfunded and the cost of the approved claims is paid from operating cash flows. Pre-tax cash requirements to cover actual net claims costs and related administrative expenses were $198 million, $207 million, and $202 million for the years ended December 31, 2021, 2020 and 2019, respectively. Changes in cash requirements reflect the net impact of per capita health care costs, demographic changes, plan amendments and changes in participant premiums, co-pays and deductibles. In 2022, the company expects to contribute approximately $140 million for its OPEB plans.

The weighted-average assumptions used to determine benefit obligations for OPEB plans are summarized in the table below:
Weighted-Average Assumptions used to Determine Benefit ObligationsDecember 31, 2021December 31, 2020
Discount rate
2.59 %2.09 %

The weighted-average assumptions used to determine net periodic benefit costs for the OPEB plans are summarized in the two tables below:
Weighted-Average Assumptions used to Determine Net Periodic Benefit CostFor the Year Ended December 31,
202120202019
Discount rate
2.09 %3.07 %3.93 %

As of December 31, 2021, health care cost trend rates do not impact the benefit obligations for the OPEB plans because of the 2020 OPEB Plan Amendments. For the year ended December 31, 2020 and 2019, the health care cost trend rate was assumed to be 7.0 percent and 7.2 percent for next year, respectively.

Assumptions
Within the U.S., the company determines the expected long-term rate of return on plan assets by performing a detailed analysis of key economic and market factors driving historical returns for each asset class and formulating a projected return based on factors in the current environment. Factors considered include, but are not limited to, inflation, real economic growth, interest rate yield, interest rate spreads, and other valuation measures and market metrics. The expected long-term rate of return for each asset class is then weighted based on the strategic asset allocation approved by the governing body for the plan. The company's historical experience with the pension fund asset performance is also considered. For non-U.S. plans, assumptions reflect economic assumptions applicable to each country.

In the U.S., Corteva calculates service costs and interest costs by applying individual spot rates from a yield curve (based on high-quality corporate bond yields) to the separate expected cash flows components of service cost and interest cost. Service cost and interest cost for all other plans are determined on the basis of the single equivalent discount rates derived in determining those plan obligations.

The discount rates utilized to measure the pension and other post employment benefit obligations are based on the yield on high-quality corporate fixed income investments at the measurement date. Future expected actuarially determined cash flows are individually discounted at the spot rates under the Aon AA_Above Median yield curve (based on high-quality corporate bond yields) to arrive at the plan’s obligations as of the measurement date. For non-U.S. benefit plans, historically the company utilized prevailing long-term high quality corporate bond indices to determine the discount rate, applicable to each country, at the measurement date.

The company adopts the most recently published mortality tables and mortality improvement scale released by the Society of Actuaries in measuring its U.S. pension and other post employment benefit obligations. The effect of these adoptions is amortized into net periodic benefit cost for the years following the adoption.
Summarized information on the company's pension and other post employment benefit plans is as follows:
Change in Projected Benefit Obligations, Plan Assets and Funded Status
Defined Benefit Pension PlansOther Post Employment Benefits
(In millions)For the Year Ended December 31, 2021For the Year Ended December 31, 2020For the Year Ended December 31, 2021For the Year Ended December 31, 2020
Change in benefit obligations:
Benefit obligation at beginning of the period$21,682 $21,004 $1,571 $2,591 
Service cost25 26 
Interest cost364 559 21 66 
Plan participants' contributions35 34 
Actuarial (gain) loss(524)1,659 (33)59 
Benefits paid(1,490)(1,538)(233)(241)
Plan amendments(15)(3)— (939)
Other1
(240)— — — 
Effect of foreign exchange rates(30)(27)— (1)
Benefit obligations at end of the period$19,775 $21,682 $1,362 $1,571 
Change in plan assets:
Fair value of plan assets at beginning of the period$17,835 $16,941 $— $— 
Actual return on plan assets1,685 2,404 — — 
Employer contributions49 62 198 207 
Plan participants' contributions35 34 
Benefits paid(1,490)(1,538)(233)(241)
Other1
(240)— — — 
Effect of foreign exchange rates(15)(36)— — 
Fair value of plan assets at end of the period$17,827 $17,835 $— $— 
Funded status    
U.S. plan with plan assets$(1,471)$(3,301)$— $— 
Non-U.S. plans with plan assets(62)(98)— — 
All other plans 2,3
(415)(448)(1,362)(1,571)
Funded status at end of the period$(1,948)$(3,847)$(1,362)$(1,571)
1.Relates to the transfer of certain benefit obligations and related assets associated with the principal U.S. pension plan to an insurance company through the purchase of nonparticipating group annuity contracts.
2.As of December 31, 2021 and December 31, 2020, $219 million and $249 million, respectively, of the benefit obligations are supported by funding under the Trust agreement, defined in the "Trust Assets" section below.
3.Includes pension plans maintained around the world where funding is not customary.
Defined Benefit Pension PlansOther Post Employment Benefits
(In millions)December 31, 2021December 31, 2020December 31, 2021December 31, 2020
Amounts recognized in the Consolidated Balance Sheets:
Other Assets$$$— $— 
Accrued and other current liabilities(46)(32)(144)(217)
Pension and other post employment benefits - noncurrent (1,906)(3,822)(1,218)(1,354)
Net amount recognized$(1,948)$(3,847)$(1,362)$(1,571)
Pretax amounts recognized in accumulated other comprehensive income (loss):
Net gain (loss)$(543)$(1,886)$(50)$(163)
Prior service benefit (cost)27 14 17 939 
Pretax balance in accumulated other comprehensive income (loss) at end of year$(516)$(1,872)$(33)$776

The gain related to the change in pension and OPEB plan benefit obligations for the period ended December 31, 2021 is mainly due to an increase in discount rates.

The accumulated benefit obligation for all pensions plans was $19.7 billion and $21.6 billion at December 31, 2021 and 2020, respectively.

Pension Plans with Projected Benefit Obligations in Excess of Plan AssetsDecember 31, 2021December 31, 2020
(In millions)
Projected benefit obligations$19,519 $21,513 
Fair value of plan assets17,567 17,659 

Pension Plans with Accumulated Benefit Obligations in Excess of Plan AssetsDecember 31, 2021December 31, 2020
(In millions)
Accumulated benefit obligations$19,501 $21,369 
Fair value of plan assets17,567 17,550 
(In millions)Defined Benefit Pension PlansOther Post Employment Benefits
For the Year Ended December 31,For the Year Ended December 31,
Components of net periodic benefit (credit) cost and amounts recognized in other comprehensive income (loss)202120202019202120202019
Net Periodic Benefit (Credit) Cost:
Service cost$25 $26 $41 $$$
Interest cost364 559 769 21 66 84 
Expected return on plan assets(915)(1,000)(1,078)— — — 
Amortization of unrecognized loss (gain)55 81 (1)
Amortization of prior service (benefit) cost(2)(1)(1)(922)— — 
Curtailment loss (gain) — — (2)(1)— — 
Settlement loss— — — 
Net periodic benefit (credit) cost - Total$(472)$(409)$(264)$(820)$69 $87 
Less: Discontinued operations1
— — (14)— — — 
Net periodic benefit (credit) cost - continuing operations$(472)$(409)$(250)$(820)$69 $87 
Changes in plan assets and benefit obligations recognized in other comprehensive income (loss):
Net gain (loss)$1,284 $(247)$(970)$33 $(59)$(211)
Amortization of unrecognized (gain) loss55 81 (1)
Prior service benefit (cost)15 11 — 939 — 
Amortization of prior service (benefit) cost(2)(1)(1)(922)— — 
Curtailment (gain) loss— — — (1)— — 
Settlement loss— — — 
Effect of foreign exchange rates(2)— — 
Total benefit (loss) recognized in other comprehensive income (loss), attributable to Corteva$1,356 $(240)$(949)$(809)$882 $(212)
Total recognized in net periodic benefit (credit) cost and other comprehensive income (loss)$1,828 $169 $(685)$11 $813 $(299)
1.Includes non-service related components of net periodic benefit credit of $(31) million for the year ended December 31, 2019.

Estimated Future Benefit Payments
The estimated future benefit payments, reflecting expected future service, as appropriate, are presented in the following table:
Estimated Future Benefit Payments at December 31, 2021Defined Benefit Pension PlansOther Post Employment Benefits
(In millions)
2022$1,459 $144 
20231,409 134 
20241,378 126 
20251,341 118 
20261,305 112 
Years 2027-20315,913 399 
Total$12,805 $1,033 
Plan Assets
All pension plan assets in the U.S. are invested through a single master trust fund. The strategic asset allocation for this trust fund is approved by the Pension Investment Committee. The general principles guiding U.S. pension asset investment policies are those embodied in the Employee Retirement Income Security Act of 1974 ("ERISA"). These principles include discharging Corteva's investment responsibilities for the exclusive benefit of plan participants and in accordance with the "prudent expert" standard and other ERISA rules and regulations. Corteva establishes strategic asset allocation percentage targets and appropriate benchmarks for significant asset classes with the aim of achieving a prudent balance between return and risk. Strategic asset allocations in other countries are selected in accordance with the laws and practices of those countries. Where appropriate, asset liability studies are utilized in this process. U.S. plan assets are managed by investment professionals employed by Corteva. The remaining assets are managed by professional investment firms unrelated to the company. Corteva's pension investment professionals have discretion to manage the assets within established asset allocation ranges approved by the Pension Investment Committee. Additionally, pension trust funds are permitted to enter into certain contractual arrangements generally described as "derivatives." Derivatives are primarily used to reduce specific market risks, hedge currency and adjust portfolio duration and asset allocation in a cost-effective manner.

The weighted-average target allocation for plan assets of the company's pension plans is summarized as follows:
Target Allocation for Plan AssetsDecember 31, 2021December 31, 2020
Asset Category
U.S. equity securities11 %20 %
Non-U.S. equity securities11 16 
Fixed income securities58 51 
Hedge funds
Private market securities
Real estate
Cash and cash equivalents
Total 100 %100 %

U.S. equity investments are primarily large-cap companies. Global equity securities include varying market capitalization levels. Global fixed income investments include corporate-issued, government-issued and asset-backed securities. Corporate debt investments include a range of credit risk and industry diversification. U.S. fixed income investments are weighted heavier than non-U.S. fixed income securities. Other investments include cash and cash equivalents, hedge funds, real estate and private market securities such as interests in private equity and venture capital partnerships.

Fair value calculations may not be indicative of net realizable value or reflective of future fair values. Furthermore, although the company believes its valuation methods are appropriate and consistent with other market participants, the use of different methodologies or assumptions to determine the fair value of certain financial instruments could result in a different fair value measurement at the reporting date.

For pension plan assets classified as Level 1 measurements (measured using quoted prices in active markets), total fair value is either the price of the most recent trade at the time of the market close or the official close price, as defined by the exchange on which the asset is most actively traded on the last trading day of the period, multiplied by the number of units held without consideration of transaction costs.

For pension plan assets classified as Level 2 measurements, where the security is frequently traded in less active markets, fair value is based on the closing price at the end of the period; where the security is less frequently traded, fair value is based on the price a dealer would pay for the security or similar securities, adjusted for any terms specific to that asset or liability. Market inputs are obtained from well-established and recognized vendors of market data and subjected to tolerance and quality checks. For derivative assets and liabilities, standard industry models are used to calculate the fair value of the various financial instruments based on significant observable market inputs, such as foreign exchange rates, commodity prices, swap rates, interest rates and implied volatilities obtained from various market sources.
For pension plan assets classified as Level 3 measurements, total fair value is based on significant unobservable inputs including assumptions where there is little, if any, market activity for the investment. Investment managers, fund managers, or investment contract issuers provide valuations of the investment on a monthly or quarterly basis. These valuations are reviewed for reasonableness based on applicable sector, benchmark and company performance. Adjustments to valuations are made where appropriate. Where available, audited financial statements are obtained and reviewed for the investments as support for the manager’s investment valuation.

The tables below present the fair values of the company's pension assets by level within the fair value hierarchy, as described in Note 2 - Summary of Significant Accounting Policies:
Basis of Fair Value MeasurementsTotalLevel 1Level 2Level 3
For the year ended December 31, 2021
(In millions)
Cash and cash equivalents$2,543 $2,543 $— $— 
U.S. equity securities 1
2,400 2,394 
Non-U.S. equity securities1,523 1,523 — — 
Debt – government-issued3,271 — 3,271 — 
Debt – corporate-issued4,591 — 4,589 
Debt – asset-backed682 — 682 — 
Private market securities— — 
Real estate26 — — 26 
Other78 — 75 
     Subtotal $15,117 $6,460 $8,547 $110 
Investments measured at net asset value
     Debt - government issued37 
     Debt - corporate issued
     U.S. equity securities33 
     Non-U.S. equity securities34 
     Hedge funds394 
     Private market securities1,822 
     Real estate funds759 
Total investments measured at net asset value$3,086 
Other items to reconcile to fair value of plan assets
     Pension trust receivables 2
655    
     Pension trust payables 3
(1,031)   
Total$17,827    
1.The Corteva pension plans directly held $201 million (approximately 1 percent of total plan assets) of Corteva, Inc. common stock at December 31, 2021.
2.Primarily receivables for investments securities sold.
3.Primarily payables for investment securities purchased.
Basis of Fair Value Measurements
For the year ended December 31, 2020
(In millions)TotalLevel 1Level 2Level 3
Cash and cash equivalents$2,616 $2,616 $— $— 
U.S. equity securities1
3,905 3,898 
Non-U.S. equity securities2,194 2,189 
Debt – government-issued3,569 — 3,569 — 
Debt – corporate-issued2,579 — 2,576 
Debt – asset-backed616 — 616 — 
Private market securities— — 
Real estate28 — — 28 
Other76 — 73 
     Subtotal $15,586 $8,703 $6,768 $115 
Investments measured at net asset value
     Debt - government issued36 
     Debt - corporate issued
     U.S. equity securities32 
     Non-U.S. equity securities32 
     Hedge funds391 
     Private market securities1,381 
     Real estate funds590 
Total investments measured at net asset value$2,469 
Other items to reconcile to fair value of plan assets
     Pension trust receivables2
214 
     Pension trust payables3
(434)   
Total$17,835    
1.The Corteva pension plans directly held $165 million (approximately 1 percent of total plan assets) of Corteva, Inc. at December 31, 2020.
2.Primarily receivables for investments securities sold.
3.Primarily payables for investment securities purchased.
The following table summarizes the changes in fair value of Level 3 pension plan assets for the years ended December 31, 2020 and 2019:
Fair Value Measurement of Level 3 Pension Plan AssetsU.S. equity securitiesNon-U.S. equity securitiesDebt – corporate-issuedPrivate market securitiesReal estateOtherTotal
(In millions)
Balance at January 1, 2020$$$$$33 $— $52 
Actual return on assets:
Relating to assets sold during the year ended December 31, 2020(25)(6)(7)— — — (38)
Relating to assets held at December 31, 202021 (5)34 
Purchases, sales and settlements, net— — — — — 
Transfers in or out of Level 3, net— — — — 61 62 
Balance at December 31, 2020$$$$$28 $73 $115 
Actual return on assets:
Relating to assets sold during the year ended December 31, 2021(1)(5)— — — (5)
Relating to assets held at December 31, 2021(3)(1)— (2)(2)(2)
Purchases, sales and settlements, net(1)(2)— — 
Balance at December 31, 2021$$— $$$26 $75 $110 

Trust Assets
EID entered into a trust agreement in 2013 (as amended and restated in 2017) that established and requires EID to fund the Trust for cash obligations under certain non-qualified benefit and deferred compensation plans upon a change in control event as defined in the Trust agreement. Under the Trust agreement, the consummation of the Merger was a change in control event. As a result, in November 2017, EID contributed $571 million to the Trust. At the Separation, Corteva transferred $39 million to DuPont. During the years ended December 31, 2021 and 2020, $43 million and $65 million, respectively, was distributed to EID according to the Trust agreement, and at December 31, 2021 and 2020, the balance in the Trust was $304 million and $347 million, respectively. The Trust Assets are classified as current restricted cash equivalents and included within other current assets in the Consolidated Balance Sheets. See Note 9 - Supplementary Information, to the Consolidated Financial Statements, for further information.

Defined Contribution Plans
Corteva provides defined contribution benefits to its employees. The most significant is the U.S. Retirement Savings Plan ("the Plan"), which covers almost all of the U.S. full-service employees. This Plan includes a non-leveraged Employee Stock Ownership Plan ("ESOP"). Employees are not required to participate in the ESOP and those who do are free to diversify out of the ESOP. The purpose of the Plan is to provide retirement savings benefits for employees and to provide employees an opportunity to become stockholders of the company. The Plan is a tax qualified contributory profit sharing plan, with cash or deferred arrangement and any eligible employee of Corteva may participate. Currently, Corteva contributes 100 percent of the first 6 percent of the employee's contribution election and also contributes 3 percent of each eligible employee's eligible compensation regardless of the employee's contribution.
Corteva's contributions to the Plan were $63 million, $94 million, and $142 million for the years ended December 31, 2021, 2020 and 2019, respectively. Corteva's matching contributions vest immediately upon contribution. The 3 percent nonmatching company contribution vests after employees complete three years of service. In addition, Corteva made contributions to other defined contribution plans of $29 million, $33 million, and $46 million for the years ended December 31, 2021, 2020 and 2019, respectively. Included in Corteva's contributions are amounts related to discontinued operations of $73 million for the year ended December 31, 2019
XML 50 R30.htm IDEA: XBRL DOCUMENT v3.22.0.1
Stock-Based Compensation
12 Months Ended
Dec. 31, 2021
Share-based Payment Arrangement [Abstract]  
Share-based Payment Arrangement [Text Block] STOCK-BASED COMPENSATION
Prior to the Corteva Distribution, Corteva employees held equity awards, including stock options, share appreciation rights (“SARs”), restricted stock units (“RSUs”) and performance-based restricted stock units (“PSUs”), which were denominated in DowDuPont common stock and, in some cases, in Dow Inc. common stock, and which had originally been issued under the DuPont Equity and Incentive Plan ("EIP"), the Dow Chemical Company 2012 Stock Incentive Plan or the Dow Chemical Company 1988 Award and Option Plan.

As discussed in Note 18 - Commitment and Contingent Liabilities, on April 1, 2019 the company entered into an employee matters agreement (the "EMA") with DuPont and Dow that identifies employees and employee-related liabilities (and attributable assets) to be allocated (either retained, transferred and accepted, or assigned and assumed, as applicable) to the Parties as part of the Distributions and describes when and how the relevant transfers and assignments will occur. With some exceptions, the EMA provides for the equitable adjustment of existing equity incentive compensation awards denominated in the common stock of DowDuPont to reflect the occurrence of the Distributions.

In connection with the Separation on June 1, 2019, outstanding DowDuPont-denominated stock options, SARs, RSU and PSU awards were converted into Corteva-denominated awards under the “Employer Method,” or into both DuPont-denominated awards and Corteva-denominated awards under the “Shareholder Method,” using a formula designed to preserve the intrinsic value of the awards immediately prior to and subsequent to the Corteva Separation. The awards have the same terms and conditions under the applicable plans and award agreements prior to the Separation transactions. The conversions of equity awards did not have a material impact to the company’s consolidated financial statements.

On June 1, 2019 (“Adoption Date”), in connection with the Separation, the Omnibus Incentive Plan (the "OIP") became effective. Under the OIP, the company may grant incentive awards, including stock options (both “incentive stock options” and nonqualified stock options), share appreciation rights, restricted shares, restricted stock units, other share-based awards and cash awards, to its and its subsidiaries’ eligible employees, non-employee directors, independent contractors and consultants following the Separation until the tenth anniversary of the Adoption Date, subject to an aggregate limit and annual individual limits. Under the OIP, the maximum number of shares reserved for the grant or settlement of awards is 20 million shares, excluding shares underlying certain exempt awards, such as the awards converted to Corteva-denominated awards pursuant to the Separation. At December 31, 2021, approximately 12 million shares were authorized for future grants under the OIP. The company generally satisfies stock option exercises and the vesting of RSUs and PSUs with newly issued shares of Corteva common stock, although RSU awards granted under Historical Dow plans in certain countries are settled in cash.

The compensation committee determines the long-term incentive mix, including stock options, RSUs and PSUs and may authorize new grants annually. The company estimates expected forfeitures.

The total stock-based compensation cost included in income (loss) from continuing operations before income taxes within the Consolidated Statement of Operations was $79 million, $73 million, and $84 million for the years ended December 31, 2021, 2020 and 2019, respectively. The income tax benefits related to stock-based compensation arrangements were $(15) million, $(15) million, and $(17) million for the years ended December 31, 2021, 2020 and 2019, respectively.

Stock Options

The exercise price of shares subject to option is equal to the market price of the company's stock on the date of grant. All options vest serially over a period of three years. Stock option awards granted under the OIP between June 2019 and 2020 expire 10 years after the grant date. Stock option awards granted under the EIP (previous plan) between 2014 and 2015 expire seven years after the grant date and options granted between 2016 and May 2019 expire 10 years after the grant date. Stock option awards granted under the Historical Dow plans subsequent to 2010 expire 10 years after the grant date.

To measure the fair value of the awards on the date of grant, the company used the Black-Scholes option pricing model and the assumptions set forth in the below table. Under the OIP, the weighted-average grant-date fair value of options granted for the years ended December 31, 2021 and 2020 was $11.77 and $6.06, respectively. Under the EIP, the weighted-average grant-date fair value of options granted for the years ended December 31, 2019 was $7.29.
Weighted-Average AssumptionsOIPEIP
For the year ended December 31, 2021For the year ended December 31, 2020For the year ended December 31, 2019
Dividend yield1.14 %1.67 %1.55 %
Expected volatility29.44 %23.14 %19.80 %
Risk-free interest rate1.0 %1.3 %2.4 %
Expected life of stock options granted during period (years)6.06.06.1

Under the OIP, the company determined the dividend yield by dividing the annualized dividend on Corteva’ s Common Stock by the option exercise price. A historical daily measurement of volatility is determined based on the expected life of the option granted. For the years ended December 31, 2021 and 2020, the measurement of volatility is based on the average volatility of eight of Corteva's peer companies. Corteva's peer volatility is based on the historical volatility of each business respectively. The risk-free interest rate is determined by reference to the yield on an outstanding U.S. Treasury note with a term equal to the expected life of the option granted. Expected life is determined by utilizing the simplified method for estimating expected term as referenced under ASC 718 – Share based Payments.

Under the EIP, the company determined the dividend yield by dividing the annualized dividend on DowDuPont's Common Stock by the option exercise price.

A historical daily measurement of volatility is determined based on the expected life of the option granted. For the year ended December 31, 2019, the measurement of volatility is based on weighted average of the individual peer volatilities of DuPont and Corteva based on the size of each business respectively. DuPont and Corteva peer volatility are based on a 50/50 blend of historical volatility and implied volatility. Both volatility measures are based on the average of five peer companies for DuPont and eight peer companies for Corteva.

The risk-free interest rate is determined by reference to the yield on an outstanding U.S. Treasury note with a term equal to the expected life of the option granted. Expected life is determined by reference to the company's historical experience.

The following table summarizes stock option activity for year ended December 31, 2021 under the OIP:
Stock OptionsFor the Year Ended December 31, 2021
Number of Shares
(in thousands)
Weighted Average Exercise Price (per share)Weighted Average Remaining Contractual Term (in years)Aggregate Intrinsic Value
(in thousands)
Outstanding at January 1, 20218,998 $34.21 5.27$50,077 
Granted849 45.37 
Exercised(3,206)32.44 
Forfeited/Expired(218)33.39 
Outstanding at December 31, 20216,423 $36.65 5.69$68,219 
Exercisable at December 31, 20214,739 $36.15 4.76$52,726 

The aggregate intrinsic values in the table above represent the total pre-tax intrinsic value (the difference between the closing stock price on the last trading day of the December 31, 2021 and the exercise price, multiplied by the number of in-the-money options) that would have been received by the option holders had all option holders exercised their in-the-money options at period end. Under the OIP, the total intrinsic value of options exercised for the years ended December 31, 2021 and 2020 were $43 million, and $21 million, respectively. The company recognized tax benefits from options exercised for the years ended December 31, 2021 and 2020 of $(8) million and $(4) million, respectively.

Under the EIP, the total intrinsic value of options exercised for the year ended December 31, 2019 was $16 million. The company recognized tax benefits from options exercised for the year ended December 31, 2019 of $(3) million.

As of December 31, 2021, $4 million of total unrecognized pre-tax compensation expense related to nonvested stock options is expected to be recognized over a weighted-average period of about 1.20 years.
Restricted Stock Units and Performance Share Units

RSUs granted under the EIP serially vest over 3 years. RSUs granted under the Historical Dow plans vest after a designated period, generally 1 year to 3 years. RSUs granted under the OIP serially vest over 3 years. Upon vesting, these RSUs convert one-for-one to Corteva Common Stock. A retirement-eligible employee retains any granted awards upon retirement provided the employee has rendered at least six months of service following the grant date. Additional RSUs are also granted periodically to key senior management employees. These RSUs generally vest over periods ranging from 3 years to 5 years. The fair value of all stock-settled RSUs is based upon the market price of the underlying common stock as of the grant date.

The company grants PSUs to senior leadership. In 2021, there were 343,632 PSUs granted. Vesting for PSUs granted in 2021 and 2020 is partially based on the realization of the Company’s improvement of its Return on Invested Capital (“ROIC”) and Operating Earnings Per Share (EPS) during the Performance Period. Vesting for PSUs granted in 2019 is partially based on the realization of the Company’s improvement of its Return on Invested Capital (“ROIC”) and Operating EBITDA during the Performance Period. Performance and payouts are determined independently for each metric. The actual award, delivered in Corteva Common Stock, can range from zero percent to 200 percent of the original grant. The weighted-average grant date fair value of the PSUs granted in 2021 of $45.37 was based upon the market price of the underlying common stock as of the grant date.

Nonvested awards of RSUs and PSUs are shown below.
RSUs & PSUsFor the Year Ended December 31, 2021
Number of Shares
(in thousands)
Weighted Average Grant Date Fair Value
(per share)
Nonvested at January 1, 20215,883 $31.54 
Granted1,536 $45.30 
Vested(1,583)$35.59 
Forfeited(234)$32.99 
Nonvested at December 31, 20215,602 $34.11 

The total fair value of stock units vested under the OIP for the years ended December 31, 2021 and 2020 was $56 million and $49 million, respectively. The weighted-average grant-date fair value of stock units granted under the OIP for the years ended December 31, 2021 and 2020 was $45.30 and $31.15, respectively.

The total fair value of stock units vested under the EIP during the years ended December 31, 2019 was $79 million. The weighted-average grant-date fair value of stock units granted under the EIP for the year ended December 31, 2019 was $52.19.

As of December 31, 2021, $45 million of total unrecognized pre-tax compensation expense related to RSUs and PSUs is expected to be recognized over a weighted average period of 1.13 years.
XML 51 R31.htm IDEA: XBRL DOCUMENT v3.22.0.1
Financial Instruments
12 Months Ended
Dec. 31, 2021
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Financial Instruments Disclosure [Text Block] FINANCIAL INSTRUMENTS
At December 31, 2021 and 2020, the company had $3,400 million and $2,511 million, respectively, of held-to-maturity securities (primarily time deposits and money market funds) classified as cash equivalents, as these securities had maturities of three months or less at the time of purchase; and $86 million and $43 million at December 31, 2021 and 2020, respectively, of held-to-maturity securities (primarily time deposits) classified as marketable securities as these securities had maturities of more than three months to less than one year at the time of purchase. The company’s investments in held-to-maturity securities are held at amortized cost, which approximates fair value. Additionally, at December 31, 2020, the company had $226 million of available-for-sale securities (see below "Debt Securities" for further discussion). The above noted securities are included in cash and cash equivalents, marketable securities, and other current assets in the Consolidated Balance Sheets.

Derivative Instruments
Objectives and Strategies for Holding Derivative Instruments
In the ordinary course of business, the company enters into contractual arrangements (derivatives) to reduce its exposure to foreign currency and commodity price risks. The company has established a variety of derivative programs to be utilized for financial risk management. These programs reflect varying levels of exposure coverage and time horizons based on an assessment of risk.
Derivative programs have procedures and controls and are approved by the Corporate Financial Risk Management Committee, consistent with the company's financial risk management policies and guidelines. Derivative instruments used are forwards, options, futures and swaps. The company has not designated any non-derivatives as hedging instruments.

The company's financial risk management procedures also address counterparty credit approval, limits and routine exposure monitoring and reporting. The counterparties to these contractual arrangements are major financial institutions and major commodity exchanges, and multinational grain exporters. The company is exposed to credit loss in the event of nonperformance by these counterparties. The company utilizes collateral support annex agreements with certain counterparties to limit its exposure to credit losses. The company anticipates performance by counterparties to these contracts and therefore no material loss is expected. Market and counterparty credit risks associated with these instruments are regularly reported to management.

The notional amounts of the company's derivative instruments were as follows:
Notional Amounts
(In millions)
December 31, 2021December 31, 2020
Derivatives designated as hedging instruments:
Foreign currency contracts$1,252 $1,164 
Commodity contracts
$845 $383 
Derivatives not designated as hedging instruments:
Foreign currency contracts
$103 $647 
Commodity contracts
$$— 

Foreign Currency Risk
The company's objective in managing exposure to foreign currency fluctuations is to reduce earnings and cash flow volatility associated with foreign currency rate changes and to mitigate the exposure of certain investments in foreign subsidiaries against
changes in the Euro/USD exchange rate. Accordingly, the company enters into various contracts that change in value as foreign exchange rates change to protect the value of its existing foreign currency-denominated assets, liabilities, commitments, investments and cash flows.

The company uses foreign exchange contracts to offset its net exposures, by currency, related to the foreign currency denominated monetary assets and liabilities of its operations. The primary business objective of this hedging program is to maintain an approximately balanced position in foreign currencies so that exchange gains and losses resulting from exchange rate changes, after related tax effects, are minimized. The company also uses foreign currency exchange contracts to offset a portion of the company's exposure to certain forecasted transactions as well as the translation of foreign currency-denominated earnings. The company also uses commodity contracts to offset risks associated with foreign currency devaluation in certain
countries.

Commodity Price Risk
Commodity price risk management programs serve to reduce exposure to price fluctuations on purchases of inventory such as corn and soybeans. The company enters into over-the-counter and exchange-traded derivative commodity instruments to hedge the commodity price risk associated with agricultural commodity exposures.

Derivatives Designated as Cash Flow Hedges
Commodity Contracts
The company enters into over-the-counter and exchange-traded derivative commodity instruments, including options, futures and swaps, to hedge the commodity price risk associated with agriculture commodity exposures.

While each risk management program has a different time maturity period, most programs currently do not extend beyond the next two years. Cash flow hedge results are reclassified into earnings during the same period in which the related exposure impacts earnings. Reclassifications are made sooner if it appears that a forecasted transaction is probable of not occurring.
The following table summarizes the after-tax effect of commodity contract cash flow hedges on accumulated other comprehensive loss:
For the Year Ended December 31,
(In millions)202120202019
Beginning balance$(16)$$(26)
Additions and revaluations of derivatives designated as cash flow hedges92 (44)16 
Clearance of hedge results to earnings(29)26 12 
Ending balance$47 $(16)$

At December 31, 2021, an after-tax net gain of $36 million is expected to be reclassified from accumulated other comprehensive loss into earnings over the next twelve months.

Foreign Currency Contracts
The company enters into forward contracts to hedge the foreign currency risk associated with forecasted transactions within certain foreign subsidiaries.

While each risk management program has a different time maturity period, most programs currently do not extend beyond the next two years. Cash flow hedge results are reclassified into earnings during the same period in which the related exposure impacts earnings. Reclassifications are made sooner if it appears that a forecasted transaction is not probable of occurring.

The following table summarizes the after-tax effect of foreign currency cash flow hedges on accumulated other comprehensive
loss:
(In millions)For the Year Ended December 31, 2021For the Year Ended December 31, 2020
Beginning balance$(17)$— 
Additions and revaluations of derivatives designated as cash flow hedges24 (3)
Clearance of hedges results to earnings25 (14)
Ending balance$32 $(17)

At December 31, 2021, an after-tax net gain of $32 million is expected to be reclassified from accumulated other comprehensive loss into earnings over the next twelve months.

Derivatives Designated as Net Investment Hedges
Foreign Currency Contracts
The company has designated €450 million of forward contracts to exchange EUR as net investment hedges. The purpose of these forward contracts is to mitigate FX exposure related to a portion of the company’s Euro net investments in certain foreign subsidiaries against changes in Euro/USD exchange rates. These hedges will expire and be settled in 2023, unless terminated early at the discretion of the company.

The company elected to apply the spot method in testing for effectiveness of the hedging relationship.

Derivatives not Designated in Hedging Relationships
Foreign Currency Contracts
The company uses foreign exchange contracts to reduce its net exposure, by currency, related to foreign currency-denominated monetary assets and liabilities of its operations so that exchange gains and losses resulting from exchange rate changes are minimized. The netting of such exposures precludes the use of hedge accounting; however, the required revaluation of the forward contracts and the associated foreign currency-denominated monetary assets and liabilities intends to achieve a minimal earnings impact, after taxes. The company also uses foreign currency exchange contracts to offset a portion of the company’s exposure to the translation of certain foreign currency-denominated earnings so that gains and losses on the contracts offset changes in the USD value of the related foreign currency-denominated earnings over the relevant aggregate period.

Commodity Contracts
The company utilizes options, futures and swaps that are not designated as hedging instruments to reduce exposure to commodity price fluctuations on purchases of inventory such as corn and soybeans. The company uses forward agreements,
with durations less than one year, to buy and sell USD priced commodities in order to reduce its exposure to currency devaluation for a portion of its local currency cash balances. Counterparties to the forward sales agreements are multinational grain exporters and subject to the company’s financial risk management procedures.

Fair Value of Derivative Instruments
Asset and liability derivatives subject to an enforceable master netting arrangement with the same counterparty are presented on a net basis in the Consolidated Balance Sheets. The presentation of the company's derivative assets and liabilities is as follows:
December 31, 2021
(In millions)Balance Sheet LocationGross
Counterparty and Cash Collateral Netting1
Net Amounts Included in the Consolidated Balance Sheet
Asset derivatives:   
Derivatives designated as hedging instruments:
Foreign currency contractsOther current assets$37 $— $37 
Derivatives not designated as hedging instruments:  
Foreign currency contracts
Other current assets31 (20)11 
Commodity contractsOther current assets— 
Total asset derivatives
 $71 $(20)$51 
Liability derivatives:  
Derivatives designated as hedging instruments:
Foreign currency contractsAccrued and other current liabilities$$— $
Derivatives not designated as hedging instruments:  
Foreign currency contracts
Accrued and other current liabilities23 $(20)
Commodity contractsAccrued and other current liabilities— 
Total liability derivatives
 $26 $(20)$
December 31, 2020
(In millions)Balance Sheet LocationGross
Counterparty and Cash Collateral Netting1
Net Amounts Included in the Consolidated Balance Sheet
Asset derivatives:   
Derivatives designated as hedging instruments:
Foreign currency contractsOther current assets$15 $— $15 
Derivatives not designated as hedging instruments:  
Foreign currency contracts
Other current assets40 (40)— 
Total asset derivatives
 $55 $(40)$15 
Liability derivatives:  
Derivatives designated as hedging instruments:
Foreign currency contractsAccrued and other current liabilities$38 $— $38 
Derivatives not designated as hedging instruments:  
Foreign currency contracts
Accrued and other current liabilities97 (40)57 
Total liability derivatives
 $135 $(40)$95 
1.    Counterparty and cash collateral amounts represent the estimated net settlement amount when applying netting and set-off rights included in master netting arrangements between the company and its counterparties and the payable or receivable for cash collateral held or placed with the same counterparty.

Effect of Derivative Instruments
Amount of Gain (Loss) Recognized in OCI1 - Pre-Tax
For the Year Ended December 31,
(In millions)202120202019
Derivatives designated as hedging instruments:
Net investment hedges:
Foreign currency contracts$37 $(45)$— 
Cash flow hedges:
Foreign currency contracts27 (4)— 
Commodity contracts129 (62)23 
Total derivatives designated as hedging instruments$193 $(111)$23 
1.OCI is defined as other comprehensive income (loss).
(in millions)
Amount of (Loss) Gain Recognized in Income - Pre-Tax1
For the Year Ended December 31,
202120202019
Derivatives designated as hedging instruments:
Cash flow hedges:
Foreign currency contracts2
$(29)$17 $— 
Commodity contracts2
42 (35)(13)
Total derivatives designated as hedging instruments
13 (18)(13)
Derivatives not designated as hedging instruments:
Foreign currency contracts3
18 89 (58)
Foreign currency contracts2
(14)14 — 
Commodity contracts2
(18)
Total derivatives not designated as hedging instruments
(14)112 (49)
Total derivatives$(1)$94 $(62)
1.For cash flow hedges, this represents the portion of the gain (loss) reclassified from accumulated OCI into income during the period.
2.Recorded in cost of goods sold.
3.Gain recognized in other income - net was partially offset by the related gain on the foreign currency-denominated monetary assets and liabilities of the company's operations. See Note 9 - Supplementary Information, to the Consolidated Financial Statements for additional information.

Debt Securities
The estimated fair value of the available-for-sale securities as of December 31, 2020 was determined using Level 1 inputs within the fair value hierarchy. Level 1 measurements were based on quoted market prices in active markets for identical assets and liabilities. The available-for-sale securities at of December 31, 2020 are held by certain foreign subsidiaries in which the USD is not the functional currency. The fluctuations in foreign exchange are recorded in accumulated other comprehensive loss within the Consolidated Statements of Equity. These fluctuations are subsequently reclassified from accumulated other comprehensive income (loss) to earnings in the period in which the marketable securities are sold and the gains and losses on these securities offset a portion of the foreign exchange fluctuations in earnings for the company.

The following table provides the investing results from available-for-sale securities for the year ended December 31,2021:
Investing ResultsFor the Year Ended December 31,
(In millions)2021
Proceeds from sales of available-for-sale securities$226 
Gross realized losses$(7)
XML 52 R32.htm IDEA: XBRL DOCUMENT v3.22.0.1
Fair Value Measurements
12 Months Ended
Dec. 31, 2021
Fair Value Disclosures [Abstract]  
Fair Value Disclosures [Text Block] FAIR VALUE MEASUREMENTS
The following tables summarize the basis used to measure certain assets and liabilities at fair value on a recurring basis:
December 31, 2021Significant Other Observable Inputs
(In millions)Level 1Level 2
Assets at fair value:
Marketable securities
$— $86 
Derivatives relating to:1
Foreign currency
— 68 
Equity securities2
48 — 
Total assets at fair value$48 $154 
Liabilities at fair value:
Derivatives relating to:1
Foreign currency
— 24 
Total liabilities at fair value$— $24 

December 31, 2020Significant Other Observable Inputs
(In millions)Level 1Level 2
Assets at fair value:
Marketable securities
$— $43 
Debt securities:
U.S. treasuries3
226 — 
Derivatives relating to:1
Foreign currency
— 55 
Total assets at fair value$226 $98 
Liabilities at fair value:
Derivatives relating to:1
Foreign currency
$— $135 
Total liabilities at fair value$— $135 
1.See Note 22 - Financial Instruments, to the Consolidated Financial Statements, for the classification of derivatives in the Consolidated Balance Sheets.
2.    The company's equity securities are included in "other assets" in the Consolidated Balance Sheets.
3.    The company's investments in U.S. treasuries, which are primarily available-for-sale, are included in "marketable securities" in the Consolidated Balance Sheets.

For assets and liabilities classified as Level 1 measurements (measured using quoted prices in active markets), total fair value is either the price of the most recent trade at the time of the market close or the official close price, as defined by the exchange on which the asset is most actively traded on the last trading day of the period, multiplied by the number of units held without consideration of transaction costs.

For assets and liabilities classified as Level 2 measurements, where the security is frequently traded in less active markets, fair value is based on the closing price at the end of the period; where the security is less frequently traded, fair value is based on the price a dealer would pay for the security or similar securities, adjusted for any terms specific to that asset or liability, or by using observable market data points of similar, more liquid securities to imply the price. For time deposits classified as held-to-maturity investments and reported at amortized cost, fair value is based on an observable interest rate for similar securities. Market inputs are obtained from well-established and recognized vendors of market data and subjected to tolerance and quality checks.
For derivative assets and liabilities, standard industry models are used to calculate the fair value of the various financial instruments based on significant observable market inputs, such as foreign exchange rates, commodity prices, swap rates and implied volatilities obtained from various market sources. Market inputs are obtained from well-established and recognized vendors of market data and subjected to tolerance/quality checks.

For all other assets and liabilities for which observable inputs are used, fair value is derived through the use of fair value models, such as a discounted cash flow model or other standard pricing models. See Note 22 - Financial Instruments, to the Consolidated Financial Statements, for further information on the types of instruments used by the company for risk management.

There were no transfers between Levels 1 and 2 during the years ended December 31, 2021 and 2020.

For assets classified as Level 3 measurements, the fair value is based on significant unobservable inputs including assumptions where there is little, if any, market activity. The fair value of the company’s interests held in trade receivable conduits is determined by calculating the expected amount of cash to be received using the key input of anticipated credit losses in the portfolio of receivables sold that have not yet been collected. Given the short-term nature of the underlying receivables, discount rate and prepayments are not factors in determining the fair value of the interests.

Fair Value Measurements on a Nonrecurring Basis
The following table summarizes the basis used to measure certain assets at fair value on a nonrecurring basis:
Basis of Fair Value Measurements on a Nonrecurring BasisSignificant Other Unobservable Inputs
(Level 3)
Total Losses
(In millions)
2019
Assets at fair value:
Developed technology
$— $(1)
Other intangible assets
$— $(6)
IPR&D
$— $(137)

During the third and fourth quarter of 2019, the company recorded impairment charges to developed technology, other intangible assets, and IPR&D. See Note 7 - Restructuring and Asset Related Charges - Net, and Note 15 - Goodwill and Other Intangible Assets, to the Consolidated Financial Statements, for further discussion of these fair value measurements.
XML 53 R33.htm IDEA: XBRL DOCUMENT v3.22.0.1
Geographic Information
12 Months Ended
Dec. 31, 2021
Geographical Reporting [Abstract]  
Geographic Information [Text Block] GEOGRAPHIC INFORMATION
Sales are attributed to geographic areas based on customer location; long-lived assets are attributed to geographic areas based on asset location.
 Net Sales
For the Year Ended December 31,
(In millions)202120202019
United States$6,782 $6,510 $6,255 
Canada754 658 674 
EMEA3,123 2,842 2,740 
Latin America1
3,545 2,805 2,889 
Asia Pacific1,451 1,402 1,288 
Total$15,655 $14,217 $13,846 
1.Net sales for Brazil for the years ended December 31, 2021, 2020 and 2019 were $2,315 million, $1,724 million and $1,794 million, respectively.

 Net Property
(In millions)202120202019
United States$3,051 $3,014 $3,069 
Canada114 122 125 
EMEA566 601 566 
Latin America468 510 608 
Asia Pacific130 149 178 
Total$4,329 $4,396 $4,546 
XML 54 R34.htm IDEA: XBRL DOCUMENT v3.22.0.1
Segment Reporting (Notes)
12 Months Ended
Dec. 31, 2021
Segment Reporting [Abstract]  
Segment Reporting Disclosure [Text Block] SEGMENT INFORMATION
Corteva’s reportable segments reflects the manner in which its chief operating decision maker ("CODM") allocates resources and assesses performance, which is at the operating segment level (seed and crop protection). For purposes of allocating resources to the segments and assessing segment performance, segment operating EBITDA is the primary measure used by Corteva’s CODM. The company defines segment operating EBITDA as earnings (loss) (i.e., income (loss) from continuing operations before income taxes) before interest, depreciation, amortization, corporate expenses, non-operating (benefits) costs, foreign exchange gains (losses), and net unrealized gain or loss from mark-to-market activity for certain foreign currency derivative instruments that do not qualify for hedge accounting, excluding the impact of significant items. Effective January 1, 2021, on a prospective basis, the company excludes from segment operating EBITDA net unrealized gain or loss from mark-to- market activity for certain foreign currency derivative instruments that do not qualify for hedge accounting. Non-operating (benefits) costs consists of non-operating pension and other post-employment benefit (OPEB) costs, tax indemnification adjustments, environmental remediation and legal costs associated with legacy EID businesses and sites, and the 2021 officer indemnification payment. Tax indemnification adjustments relate to changes in indemnification balances, as a result of the application of the terms of the Tax Matters Agreement, between Corteva and Dow and/or DuPont that are recorded by the company as pre-tax income or expense. Net unrealized gain or loss from mark-to-market activity for certain foreign currency derivative instruments that do not qualify for hedge accounting represents the non-cash net gain (loss) from changes in fair value of certain undesignated foreign currency derivative contracts. Upon settlement, which is within the same calendar year of execution of the contract, the realized gain (loss) from the changes in fair value of the non-qualified foreign currency derivative contracts will be reported in the respective segment results to reflect the economic effects of the foreign currency derivative contracts without the resulting unrealized mark to fair value volatility. For the year ended December 31, 2019, segment operating EBITDA is calculated on a pro forma basis, as this is the manner in which the CODM assesses performance and allocates resources or expense.

Pro forma adjustments used in the calculation of pro forma segment operating EBITDA for the year ended December 31, 2019 were determined in accordance with Article 11 of Regulation S-X that was in effect prior to recent amendments. These adjustments give effect to the Merger, the debt retirement transactions related to paying off or retiring portions of EID’s existing debt liabilities (as discussed in Note 17 - Long-Term Debt and Available Credit Facilities, to the Consolidated Financial Statements), and the separation and distribution to DowDuPont stockholders of all the outstanding shares of Corteva common stock as if they had been consummated on January 1, 2016.

Corporate Profile
The company conducts its global operations through the following reportable segments:

Seed
The company’s seed segment is a global leader in developing and supplying advanced germplasm and traits that produce optimum yield for farms around the world. The segment is a leader in many of the company’s key seed markets, including North America corn and soybeans, Europe corn and sunflower, as well as Brazil, India, South Africa and Argentina corn. The segment offers trait technologies that improve resistance to weather, disease, insects and herbicides used to control weeds, and trait technologies that enhance food and nutritional characteristics. In addition, the segment provides digital solutions that assist farmer decision-making with a view to optimize product selection and, ultimately, help maximize yield and profitability.

Crop Protection
The crop protection segment serves the global agricultural input industry with products that protect against weeds, insects and other pests, and disease, and that improve overall crop health both above and below ground via nitrogen management and seed-applied technologies. The segment is a leader in global herbicides, insecticides, nitrogen stabilizers and pasture and range management herbicides.

(In millions)
SeedCrop ProtectionTotal
As of and for the Year Ended December 31, 2021   
Net sales$8,402 $7,253 $15,655 
Segment operating EBITDA$1,512 $1,202 $2,714 
Depreciation and amortization$866 $377 $1,243 
Segment assets$23,270 $12,428 $35,698 
Investments in nonconsolidated affiliates$29 $47 $76 
Purchases of property, plant and equipment$237 $336 $573 
As of and for the Year Ended December 31, 2020   
Net sales$7,756 $6,461 $14,217 
Segment operating EBITDA$1,208 $1,004 $2,212 
Depreciation and amortization$798 $379 $1,177 
Segment assets$23,751 $13,099 $36,850 
Investments in nonconsolidated affiliates$22 $44 $66 
Purchases of property, plant and equipment$225 $250 $475 
As of and for the Year Ended December 31, 2019
Net sales$7,590 $6,256 $13,846 
Pro forma segment operating EBITDA$1,040 $1,066 $2,106 
Depreciation and amortization$628 $372 $1,000 
Segment assets1
$25,387 $13,492 $38,879 
Investments in nonconsolidated affiliates$27 $39 $66 
Purchase of property, plant and equipment$373 $293 $666 
1.On June 1, 2019, as a result of changes in reportable segments, $3,382 million of goodwill was reallocated from the seed reportable segment to the crop protection reportable segment. This change was not reflected in segment assets prior to June 1, 2019.

Reconciliation to Consolidated Financial Statements
Income (loss) from continuing operations after income taxes to segment operating EBITDA
For the Year Ended December 31,
(In millions)202120202019
Income (loss) from continuing operations after income taxes$1,822 $756 $(270)
Provision for (benefit from) income taxes on continuing operations524 (81)(46)
Income (loss) from continuing operations before income taxes2,346 675 (316)
Depreciation and amortization1,243 1,177 1,000 
Interest income(77)(56)(59)
Interest expense30 45 136 
Exchange (gains) losses - net 1
54 174 66 
Non-operating (benefits) costs - net(1,256)(316)(129)
Mark-to-market (gains) losses on certain foreign currency contracts not designated as hedges2
— 
Significant items236 388 991 
Pro forma adjustments298 
Corporate expenses138 125 119 
Segment operating EBITDA3
$2,714 $2,212 $2,106 
1.Excludes a $(33) million foreign exchange loss for the year ended December 31, 2019 associated with the devaluation of the Argentine peso. See Note 9 - Supplementary Information, to the Consolidated Financial Statements, for additional information.
2.Effective January 1, 2021, on a prospective basis, the company excludes net unrealized gain or loss from mark-to-market activity for certain foreign currency derivative instruments that do not qualify for hedge accounting. There were no unrealized mark-to-market (gains) losses for the years ended December 31, 2020 and 2019.
3.The year ended December 31, 2019 is presented on a pro forma basis, prepared in accordance with Article 11 of Regulation S-X that was in effect prior to recent amendments.
Segment assets to total assets (in millions)
December 31, 2021December 31, 2020
Total segment assets$35,698 $36,850 
Corporate assets6,646 5,799 
Total assets$42,344 $42,649 


Other Items (in millions)
Segment Totals
Adjustments 1
Consolidated Totals
For the Year Ended December 31, 2019
Depreciation and amortization$1,000 $599 $1,599 
Purchase of property, plant and equipment$666 $497 $1,163 
1.See Note 5 - Divestitures and Other Transactions, to the Consolidated Financial Statements, for additional information.
Significant Pre-tax (Charges) Benefits Not Included in Segment Operating EBITDA
The years ended December 31, 2021, 2020 and 2019, respectively, included the following significant pre-tax (charges) benefits which are excluded from segment operating EBITDA:
(In millions)SeedCrop ProtectionCorporateTotal
For the Year Ended December 31, 2021
Restructuring and Asset Related Charges - Net 1
$(152)$(59)$(78)$(289)
Equity securities mark-to-market gain (loss)47 — — 47 
Employee Retention Credit37 23 — 60 
Contract termination(30)(24)— (54)
Total$(98)$(60)$(78)$(236)
(In millions)SeedCrop ProtectionCorporateTotal
For the Year Ended December 31, 2020
Restructuring and Asset Related Charges - Net 1
$(165)$(109)$(61)$(335)
Loss on Divestiture 2
— (53)— (53)
Total$(165)$(162)$(61)$(388)
(In millions)SeedCrop ProtectionCorporateTotal
For the Year Ended December 31, 20193
Restructuring and Asset Related Charges - Net 1
$(213)$(23)$14 $(222)
Integration and Separation Costs 4
— — (632)(632)
Loss on Divestiture 5
(24)— — (24)
Amortization of Inventory Step Up 6
(67)— — (67)
Loss on Early Extinguishment of Debt 7
— — (13)(13)
Argentina Currency Devaluation 8
— — (33)(33)
Total$(304)$(23)$(664)$(991)
1.Includes Board approved restructuring plans and asset related charges as well as accelerated prepaid amortization. See Note 7 - Restructuring and Asset Related Charges - Net, to the Consolidated Financial Statements, for additional information.
2.Includes a loss recorded in other income - net related to the sale of the La Porte site.
3.The year ended December 31, 2019 is presented on a pro forma basis, prepared in accordance with Article 11 of Regulation S-X that was in effect prior to recent amendments.
4.Integration and separation costs include costs incurred to prepare for and close the Merger, post-Merger integration expenses, and costs incurred to prepare for the Internal Reorganizations. Beginning in the second quarter of 2019, this includes both integration and separation costs.
5.Includes a loss recorded in other income - net related to DAS's sale of a joint venture related to synergy actions.
6.Includes a charge related to the amortization of the inventory that was stepped up to fair value in connection with the Merger.
7.Includes a loss on early extinguishment of debt related to the difference between the redemption price and the par value of the Make Whole Notes and Term Loan Facility, partially offset by the write-off of unamortized step-up related to the fair value step-up of EID's debt.
8.Includes a charge included in other income - net associated with remeasuring the company’s Argentine Peso net monetary assets, resulting from an unexpected August primary election result in Argentina. Throughout the three months ended September 30, 2019, the Argentine Peso dropped approximately a third of its value against the US dollar and in September of 2019, the country’s central bank announced new restrictions on foreign currency transactions.
XML 55 R35.htm IDEA: XBRL DOCUMENT v3.22.0.1
Subsequent Events (Notes)
12 Months Ended
Dec. 31, 2021
Subsequent Events [Abstract]  
Subsequent Events [Text Block] SUBSEQUENT EVENTS In February 2022, the company entered into a new committed receivable repurchase facility of up to $500 million (the "2022 Repurchase Facility"), which expires in December 2022. Under the 2022 Repurchase Facility, Corteva may sell a portfolio of available and eligible outstanding customer notes receivables to participating institutions and simultaneously agree to repurchase at a future date. The 2022 Repurchase Facility is considered a secured borrowing with the customer notes receivables inclusive of those that are sold and repurchased, equal to 105 percent of the outstanding amounts borrowed utilized as collateral. Borrowings under the 2022 Repurchase Facility will have an interest rate equal to the Adjusted Term Secured Overnight Financing Rate ("SOFR") plus a margin of 0.75 percent.
XML 56 R36.htm IDEA: XBRL DOCUMENT v3.22.0.1
EID Basis of Presentation (Notes)
12 Months Ended
Dec. 31, 2021
Entity Information [Line Items]  
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] BACKGROUND AND BASIS OF PRESENTATION
Corteva, Inc. is a leading global provider of seed and crop protection solutions focused on the agriculture industry. The company intends to leverage its rich heritage of scientific achievement to advance its robust innovation pipeline and continue to shape the future of responsible agriculture. The company's broad portfolio of agriculture solutions fuels farmer productivity around the globe. Corteva has two reportable segments: seed and crop protection. See Note 25 - Segment Information, to the Consolidated Financial Statements, for additional information on the company's reportable segments.

Throughout these financial statements, except as otherwise noted by the context, the terms "Corteva" or "company" used herein mean Corteva, Inc. and its consolidated subsidiaries (including EID) and the term “EID” used herein means E. I. du Pont de Nemours and Company and its consolidated subsidiaries or E. I. du Pont de Nemours and Company excluding its consolidated subsidiaries, as the context may indicate. Additionally, on June 1, 2019, DowDuPont Inc. changed its registered name to DuPont de Nemours, Inc. (“DuPont”), for certain events prior to, or on, June 1, 2019, DuPont may be referred to as DowDuPont.

Principles of Consolidation and Basis of Presentation
On June 1, 2019, Corteva, Inc. became an independent, publicly traded company through the completed separation (the “Separation”) of the agriculture business of DuPont de Nemours, Inc. (formerly known as DowDuPont Inc.) (“DowDuPont” or “DuPont”). The separation was effectuated through a pro rata distribution (the “Corteva Distribution”) of all of the then-issued and outstanding shares of common stock, par value $0.01 per share, of Corteva, Inc., which was then a wholly-owned subsidiary of DowDuPont, to holders of record of DowDuPont common stock as of the close of business on May 24, 2019.

Previously, DowDuPont was formed on December 9, 2015, to effect an all-stock merger of equals strategic combination between The Dow Chemical Company ("Historical Dow") and EID. On August 31, 2017 at 11:59 pm ET (the “Merger Effectiveness Time”) pursuant to the Agreement and Plan of Merger, dated as of December 11, 2015, as amended March 31, 2017 (the "Merger Agreement"), Historical Dow and EID each merged with wholly-owned subsidiaries of DowDuPont and became subsidiaries of DowDuPont (the “Merger”). Prior to the Merger, DowDuPont did not conduct any business activities other than those required for its formation and matters contemplated by the Merger Agreement.

Subsequent to the Merger, Historical Dow and EID engaged in a series of internal reorganization and realignment steps to realign their businesses into three subgroups: agriculture, materials science and specialty products through a series of tax-efficient transactions (collectively, the "Business Separations”). Effective as of 5:00 pm ET on April 1, 2019, DowDuPont completed the separation of its materials science business into a separate and independent public company by way of a distribution of Dow Inc. (“Dow”) through a pro rata dividend in-kind of all of the then-issued and outstanding shares of Dow’s common stock, par value $0.01 per share, to holders of DowDuPont's common stock, as of the close of business on March 21, 2019 (the “Dow Distribution” and together with the Corteva Distribution, the “Distributions”).

Prior to the Dow Distribution, Historical Dow conveyed or transferred the assets and liabilities aligned with Historical Dow’s agriculture business to separate legal entities (“Dow Ag Entities”) and the assets and liabilities associated with its specialty products business to separate legal entities (the “Dow SP Entities”). On April 1, 2019, Dow Ag Entities and the Dow SP Entities were transferred and conveyed to DowDuPont.

In furtherance of the Business Separations, EID engaged in a series of internal reorganization and realignment steps (the “Internal Reorganization” and the "Business Realignment," respectively) to realign its businesses into three subgroups: agriculture, materials science and specialty products. As part of the Internal Reorganization:

the assets and liabilities aligned with EID’s materials science business (“EID ECP”) were transferred or conveyed to separate legal entities that were ultimately conveyed by DowDuPont to Dow on April 1, 2019;

the assets and liabilities aligned with EID’s specialty products business were transferred or conveyed to separate legal entities (“EID Specialty Products Entities”) that were ultimately distributed to DowDuPont on May 1, 2019;

on May 2, 2019, DowDuPont conveyed Dow Ag Entities to EID and in connection with the foregoing, EID issued additional shares of its Common Stock to DowDuPont; and

on May 31, 2019, DowDuPont contributed EID to Corteva, Inc.

On May 6, 2019, the Board of Directors of DowDuPont approved the distribution of all the then issued and outstanding shares of common stock of Corteva, Inc., then a wholly-owned subsidiary of DowDuPont, to DowDuPont stockholders. On June 1,
2019, DowDuPont completed the Separation. Each DowDuPont stockholder received one share of Corteva common stock for every three shares of DowDuPont common stock held at the close of business on May 24, 2019, the record date of distribution. Corteva, Inc.'s common stock began trading the "regular way" under the ticker symbol "CTVA" on June 3, 2019, the first business day after June 1, 2019. Upon becoming an independent company, the capital structure of Corteva consisted of 748,815,000 authorized shares of common stock (par value of $0.01 per share), which represents the number of common shares issued on June 3, 2019. Information related to the Corteva Distribution and its effect on the company's financial statements is discussed throughout these Notes to the Consolidated Financial Statements.

As a result of the Business Realignment and the Internal Reorganization discussed above, Corteva owns 100% of the outstanding common stock of EID. EID is a subsidiary of Corteva, Inc. and continues to be a reporting company, subject to the requirements of the Securities Exchange Act of 1934, as amended.

DAS Common Control Business Combination
The transfer or conveyance of DAS to Corteva was treated as a transfer of entities under common control. As such, the company recorded the assets, liabilities, and equity of DAS on its balance sheet at their historical basis. Transfers of businesses between entities under common control requires the financial statements to be presented as if the transaction had occurred at the point at which common control first existed (the Merger Effectiveness Time). As a result, the accompanying Consolidated Financial Statements and Notes thereto include the results of DAS as of the Merger Effectiveness Time. See Note 4 - Common Control Business Combination, to the Consolidated Financial Statements, for additional information.

For periods prior to the Corteva Distribution, the combined results of operations and assets and liabilities of EID and DAS were derived from the Consolidated Financial Statements and accounting records of EID as well as the carve-out financial statements of DAS. The DAS carve-out financial statements reflect the historical results of operations, financial position, and cash flows of Historical Dow's Agricultural Sciences Business and include allocations of certain expenses for services from Historical Dow, including, but not limited to, general corporate expenses related to finance, legal, information technology, human resources, ethics and compliance, shared services, employee benefits and incentives, insurance, and stock-based compensation. These expenses were allocated on the basis of direct usage when identifiable, with the remainder allocated under the basis of headcount or other measures.

The company's Consolidated Balance Sheets for all periods presented consist of Corteva, Inc. and its consolidated subsidiaries.

The company's Consolidated Statements of Operations (the "Consolidated Statements of Operations") for all periods prior to the Corteva Distribution consist of the combined results of operations for Historical EID and DAS. The Consolidated Statements of Operations for all periods after the Corteva Distribution represent the consolidated balances of the company. Intercompany balances and transactions with Historical EID and DAS have been eliminated.

During the first quarter 2020, the company recorded an increase of $40 million to APIC relating to net assets recorded as
transferred as part of the 2019 Internal Reorganizations that were retained.

Divestiture of EID ECP and EID Specialty Products Entities
The transfer of EID ECP and EID Specialty Products Entities meets the criteria for discontinued operations and as such, results of operations are presented as discontinued operations and have been excluded from continuing operations for all periods presented. The comprehensive income (loss), stockholder's equity and cash flows related to EID ECP and EID Specialty Products Entities have not been segregated and are included in the Consolidated Statements of Comprehensive Income (Loss), Consolidated Statements of Equity and Consolidated Statements of Cash Flows, respectively, for 2019. Amounts related to EID ECP and EID Specialty Products Entities are consistently included or excluded from the Notes to the Consolidated Financial Statements based on the respective financial statement line item. See Note 5 - Divestitures and Other Transactions, to the Consolidated Financial Statements, for additional information.

Certain reclassifications of prior year's data have been made to conform to current year's presentation.

Since 2018, Argentina has been considered a hyper-inflationary economy under U.S. GAAP and therefore the U.S. Dollar (“USD”) is the functional currency for our related subsidiaries. Argentina contributes approximately 5 percent to both the company's annual Sales and EBITDA. We remeasure net monetary assets and translate our financial statements utilizing the official Argentine Peso (“Peso”) to USD exchange rate. The ability to draw down Peso cash balances is limited at this time due to government restrictions and market availability of U.S. Dollars. The devaluation of the Peso relative to the USD over the last several years has resulted in the recognition of exchange losses (refer to Note 9 – Supplementary Information, to the Consolidated Financial Statements). As of December 31, 2021, a further 10 percent deterioration in the official Peso to USD
exchange rate would reduce the USD value of our net monetary assets and negatively impact pre-tax earnings by approximately $15 million. We will continue to assess the implications to our operations and financial reporting.
EID [Member]  
Entity Information [Line Items]  
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] BASIS OF PRESENTATION
As a result of the Business Realignment and the Internal Reorganization, Corteva, Inc. owns 100% of the outstanding common stock of EID. EID is a subsidiary of Corteva, Inc. and continues to be a reporting company, subject to the requirements of the Exchange Act. The primary differences between Corteva, Inc. and EID are outlined below:

Preferred Stock - EID has preferred stock outstanding to third parties which is accounted for as a noncontrolling interest at the Corteva, Inc. level. Each share of EID Preferred Stock - $4.50 Series and EID Preferred Stock - $3.50 Series issued and outstanding at the effective date of the Corteva Distribution remains issued and outstanding as to EID and was unaffected by the Corteva Distribution.
Related Party Loan - EID engaged in a series of debt redemptions during the second quarter of 2019 that were partially funded through an intercompany loan from Corteva, Inc. This was eliminated in consolidation at the Corteva, Inc. level but remains on EID's financial statements at the standalone level (including the associated interest).
Capital Structure - At December 31, 2021, Corteva, Inc.'s capital structure consists of 726,527,000 issued shares of common stock, par value $0.01 per share.

The accompanying footnotes relate to EID only, and not to Corteva, Inc., and are presented to show differences between EID and Corteva, Inc.

For the footnotes listed below, refer to the footnotes from the Corteva 10-K:
Note 1 - Background and Basis of Presentation - refer to page F-12 of the Corteva, Inc. Consolidated Financial Statements
Note 2 - Summary of Significant Accounting Policies - refer to page F-14 of the Corteva, Inc. Consolidated Financial Statements
Note 3 - Recent Accounting Guidance - refer to page F-19 of the Corteva, Inc. Consolidated Financial Statements
Note 4 - Common Control Business Combination - refer to page F-19 of the Corteva, Inc. Consolidated Financial Statements
Note 5 - Divestitures and Other Transactions - refer to page F-20 of the Corteva, Inc. Consolidated Financial Statements
Note 6 - Revenue - refer to page F-24 of the Corteva, Inc. Consolidated Financial Statements
Note 7 - Restructuring and Asset Related Charges - Net - refer to page F-26 of the Corteva, Inc. Consolidated Financial Statements
Note 8 - Related Party Transactions - Differences exist between Corteva, Inc. and EID; refer to EID Note 2 - Related Party Transactions, of the EID Consolidated Financial Statements, below
Note 9 - Supplementary Information - refer to page F-29 of the Corteva, Inc. Consolidated Financial Statements
Note 10 - Income Taxes - Differences exist between Corteva, Inc. and EID; refer to EID Note 3 - Income Taxes, of the EID Consolidated Financial Statements, below
Note 11 - Earnings Per Share of Common Stock - Not applicable for EID
Note 12 - Accounts and Notes Receivable - Net - refer to page F-36 of the Corteva, Inc. Consolidated Financial Statements
Note 13 - Inventories - refer to page F-37 of the Corteva, Inc. Consolidated Financial Statements
Note 14 - Property, Plant and Equipment - refer to page F-37 of the Corteva, Inc. Consolidated Financial Statements
Note 15 - Goodwill and Other Intangible Assets - refer to page F-38 of the Corteva, Inc. Consolidated Financial Statements
Note 16 - Leases - refer to page F-40 of the Corteva, Inc. Consolidated Financial Statements
Note 17 - Long-Term Debt and Available Credit Facilities - refer to page F-42 of the Corteva, Inc. Consolidated Financial Statements. In addition, EID has a related party loan payable to Corteva, Inc.; refer to EID Note 2 - Related Party Transactions, of the EID Consolidated Financial Statements, below
Note 18 - Commitments and Contingent Liabilities - refer to page F-44 of the Corteva, Inc. Consolidated Financial Statements
Note 19 - Stockholders' Equity - refer to page F-51 of the Corteva, Inc. Consolidated Financial Statements
Note 20 - Pension Plans and Other Post Employment Benefits - refer to page F-54 of the Corteva, Inc. Consolidated Financial Statements
Note 21 - Stock-Based Compensation - refer to page F-63 of the Corteva, Inc. Consolidated Financial Statements
Note 22 - Financial Instruments - refer to page F-65 of the Corteva, Inc. Consolidated Financial Statements
Note 23 - Fair Value Measurements - refer to page F-71 of the Corteva, Inc. Consolidated Financial Statements
Note 24 - Geographic Information - refer to page F-73 of the Corteva, Inc. Consolidated Financial Statements
Note 25 - Segment Information - Differences exist between Corteva, Inc. and EID; refer to EID Note 4 - Segment Information, of the EID Consolidated Financial Statements, below
Note 26 - Subsequent Events - Refers to page F-78 of the Corteva, Inc. Consolidated Financial Statements
XML 57 R37.htm IDEA: XBRL DOCUMENT v3.22.0.1
EID Related Party (Notes)
12 Months Ended
Dec. 31, 2021
Related Party Transaction [Line Items]  
Related Party Transactions Disclosure [Text Block] RELATED PARTY TRANSACTIONS
Services Provided by and to Historical Dow and its affiliates
Following the Merger and prior to the Dow Distribution, Corteva reported transactions with Historical Dow and its affiliates as related party transactions.

Transactions with DowDuPont
In 2019 DowDuPont contributed cash to Corteva to fund portions of the company's debt redemption/repayment transactions. See Note 17 - Long-Term Debt and Available Credit Facilities, to the Consolidated Financial Statements, for additional information.
In February 2019, the DowDuPont Board declared first quarter dividends per share of DowDuPont common stock payable on March 15, 2019. EID declared and paid distributions to DowDuPont of about $317 million for the year ended December 31, 2019 to fund a portion of DowDuPont’s dividend payments.
EID [Member]  
Related Party Transaction [Line Items]  
Related Party Transactions Disclosure [Text Block] RELATED PARTY TRANSACTIONS
Refer to page F-28 of the Corteva, Inc. Consolidated Financial Statements for discussion of related party transactions with Historical Dow and DowDuPont.

Transactions with Corteva
In the second quarter of 2019, EID entered into a related party revolving loan from Corteva, Inc., with a maturity date in 2024. As of December 31, 2021 and December 31, 2020, the outstanding related party loan balance was $2,162 million and $3,459 million respectively (which approximates fair value), with interest rates of 1.67% and 1.62%, respectively, and is reflected as long-term debt - related party on EID's Consolidated Balance Sheet. Additionally, EID has incurred tax deductible interest expense of $50 million and $100 million and paid interest of $51 million and $105 million for the years ended December 31, 2021 and 2020, respectively, associated with the related party loan to Corteva, Inc.

As of December 31, 2021, EID had payables to Corteva, Inc. of $27 million and $117 million included in accrued and other current liabilities and other noncurrent obligations, respectively, and $92 million included in both accrued and other current liabilities and other noncurrent obligations, respectively, at December 31, 2020, in the Consolidated Balance Sheet, related to Corteva's indemnification liabilities to Dow and DuPont per the Separation Agreements (refer to page F-20 of the Corteva, Inc. Consolidated Financial Statements for further details of the Separation Agreements).
XML 58 R38.htm IDEA: XBRL DOCUMENT v3.22.0.1
EID Income Taxes (Notes)
12 Months Ended
Dec. 31, 2021
Income Tax Disclosure [Text Block] INCOME TAXES
Domestic and foreign components of the income (loss) from continuing operations before income taxes and the provision for (benefit from) current and deferred tax expense (benefit) are shown below:
Geographic Allocation of Income (Loss) and Provision for (Benefit from) Income Taxes For the Year Ended December 31,
(In millions)202120202019
Income (loss) from continuing operations before income taxes
Domestic$941 $(83)$(1,352)
Foreign1,405 758 1,036 
Income (loss) from continuing operations before income taxes$2,346 $675 $(316)
Current tax expense (benefit)
Federal$(13)$28 $(11)
State and local
Foreign329 222 317 
Total current tax expense (benefit)$322 $259 $307 
Deferred tax expense (benefit)
Federal$164 $(116)$(392)
State and local55 27 156 
Foreign(17)(251)(117)
Total deferred tax expense (benefit)$202 $(340)$(353)
Provision for (benefit from) income taxes on continuing operations524 (81)(46)
Net income (loss) from continuing operations after taxes$1,822 $756 $(270)

The effective income tax rate applicable to income (loss) from continuing operations before income taxes was different from the statutory U.S. federal income tax rate due to the factors listed in the following table:
Reconciliation to U.S. Statutory RateFor the Year Ended December 31,
202120202019
Statutory U.S. federal income tax rate21.0 %21.0 %21.0 %
Effective tax rates on international operations - net 1
(2.5)(13.9)(18.4)
Acquisitions, divestitures and ownership restructuring activities 2
(0.1)(0.3)(10.7)
U.S. research and development credit(2.4)(2.9)7.0 
Exchange gains/losses 3
1.9 3.5 (1.8)
State and local incomes taxes - net2.1 4.0 3.2 
Impact of Swiss Tax Reform4
0.2 (27.0)11.9 
Excess tax benefits/deficiencies from stock compensation(0.2)1.0 (0.6)
Tax settlements and expiration of statute of limitations— 0.4 3.9 
Other - net2.3 2.2 (0.9)
Effective tax rate on income from continuing operations22.3 %(12.0)%14.6 %
1.    Includes the effects of local and U.S. taxes related to earnings of non-U.S. subsidiaries, changes in the amount of unrecognized tax benefits associated with these earnings, losses at non-U.S. subsidiaries without local tax benefits due to valuation allowances, and other permanent differences between tax and U.S. GAAP results. Includes a tax benefit of $(51) million for the year ended December 31, 2020, related to a return to accrual adjustment associated with an elective change in accounting method for the 2019 tax year impact of foreign tax provisions.
2.    See Notes 4 - Common Control Business Combination, and Note 5 - Divestitures and Other Transactions, to the Consolidated Financial Statements, for additional information.
3.    Principally reflects the impact of foreign exchange gains and losses on net monetary assets for which no corresponding tax impact is realized. Further information about the company's foreign currency hedging program is included in Note 9 - Supplementary Information, and Note 22 - Financial Instruments, under the heading Foreign Currency Risk.
4.    Reflects tax benefits of $(182) million primarily driven by the recognition of an elective cantonal component of the recent enactment of the Federal Act on Tax Reform and AHV Financing ("Swiss Tax Reform") for the year ended December 31, 2020. Reflects tax benefits of $(38) million associated with the enactment of the Federal Act on Tax Reform and AHV Financing ("Swiss Tax Reform"), for the year ended December 31, 2019.
Significant components of our net deferred tax asset (liability) were attributable to:
Deferred Tax Balances at December 31,20212020
(In millions)AssetsLiabilitiesAssetsLiabilities
Property1
$— $341 $— $297 
Tax loss and credit carryforwards2,3
464 — 497 — 
Accrued employee benefits904 — 1,415 — 
Other accruals and reserves1
309 — 365 — 
Intangibles— 2,260 — 2,418 
Inventory153 — 127 — 
Research and development capitalization224 — 186 — 
Investments36 — 56 — 
Unrealized exchange gains/losses— 10 — 
Other – net105 — 91 — 
Subtotal$2,195 $2,611 $2,739 $2,715 
Valuation allowances3
(366)— (453)— 
Total$1,829 $2,611 $2,286 $2,715 
Net Deferred Tax Asset (Liability)$(782)$(429)
1.    Prior year classifications in property and other accruals and reserves have been adjusted from their previous presentation. Adjustments did not impact the amount of the net deferred tax asset (liability) recorded in the Consolidated Balance Sheets.    
2.    Primarily related to the realization of recorded tax benefits on tax loss and credit carryforwards from operations in the United States, Brazil, and Spain.    
3.    In connection with the company's 2021 internal legal entity restructuring, the company reduced various state net operating loss carryforwards and corresponding full valuation allowances by $61 million. There was no impact on the statement of operations. During the year ended December 31, 2020, the company established a $19 million state tax valuation allowance in the U.S. based on a change in judgement about the realizability of a deferred tax asset.

Details of the company’s operating loss and tax credit carryforwards are shown in the following table:
Operating Loss and Tax Credit CarryforwardsDeferred Tax Asset
(In millions)20212020
Operating loss carryforwards
Expire within 5 years$123 $99 
Expire after 5 years or indefinite expiration210 343 
Total operating loss carryforwards$333 $442 
Tax credit carryforwards
Expire within 5 years$14 $14 
Expire after 5 years or indefinite expiration117 41 
Total tax credit carryforwards$131 $55 
Total Operating Loss and Tax Credit Carryforwards$464 $497 
A reconciliation of the beginning and ending amount of gross unrecognized tax benefits is as follows:
Total Gross Unrecognized Tax BenefitsFor the Year Ended December 31,
(In millions)202120202019
Total unrecognized tax benefits as of beginning of period$395 $426 $749 
Decreases related to positions taken on items from prior years(7)(14)(167)
Increases related to positions taken on items from prior years13 77 
Increases related to positions taken in the current year54 
Settlement of uncertain tax positions with tax authorities(17)(18)(9)
Impact of Internal Reorganizations— — (278)
Decreases due to expiration of statutes of limitations(16)(7)— 
Exchange (gain) loss— (3)— 
Total unrecognized tax benefits as of end of period$377 $395 $426 
Total unrecognized tax benefits that, if recognized, would impact the effective tax rate$157 $156 $188 
Total amount of interest and penalties (benefits) recognized in provision for (benefit from) income taxes on continuing operations$$(2)$(4)
Total accrual for interest and penalties associated with unrecognized tax benefits at end of period$11 $18 $24 

Each year the company files hundreds of tax returns in the various national, state and local income taxing jurisdictions in which it operates. These tax returns are subject to examination and possible challenge by the tax authorities. Positions challenged by the tax authorities may be settled or appealed by the company. As a result, there is an uncertainty in income taxes recognized in the company's financial statements in accordance with accounting for income taxes and accounting for uncertainty in income taxes. It is reasonably possible that changes to the company’s global unrecognized tax benefits could be significant; however, due to the uncertainty regarding the timing of completion of audits and possible outcomes, a current estimate of the range of increases or decreases that may occur within the next twelve months cannot be made. As of December 31, 2021, the company has made advance deposits of approximately $102 million to a foreign taxing authority, partially as a prerequisite to petition the court related to an open tax examination. These payments are accounted for as a prepaid asset, included in other assets in the Consolidated Balance Sheets.

Tax years that remain subject to examination for the company’s major tax jurisdictions are shown below:
Tax Years Subject to Examination by Major Tax Jurisdiction at December 31, 2021Earliest Open Year
Jurisdiction
Argentina2015
Brazil2014
Canada2012
China2014
France2019
India2015
Italy2016
Switzerland2016
United States:
Federal income tax2012
State and local income tax2008

Undistributed earnings of foreign subsidiaries and related companies that are deemed to be indefinitely invested amounted to $3,681 million at December 31, 2021. Distributions of profits from non-U.S. subsidiaries are not expected to cause a significant incremental U.S. tax impact in the future; however, those distributions may still be subject to certain taxes upon repatriation, primarily where foreign withholding taxes apply. The company is asserting indefinite reinvestment related to certain investments in foreign subsidiaries. Determination of the amount of unrecognized deferred tax liability related to indefinitely reinvested profits is not feasible primarily due to our legal entity structure and the complexity of U.S. and local tax laws.

For periods between the Merger Effectiveness Time and the Corteva Distribution, Corteva and its subsidiaries were included in DowDuPont's consolidated federal income tax group and consolidated tax return. Generally, the consolidated tax liability of the
DowDuPont U.S. tax group for each year was apportioned among the members of the consolidated group based on each member’s separate taxable income. Corteva, DuPont and Dow intend that to the extent Federal and/or State corporate income tax liabilities are reduced through the utilization of tax attributes of the other, settlement of any receivable and payable generated from the use of the other party’s sub-group attributes will be in accordance with a tax sharing agreement and/or tax matters agreement. See Note 5 - Divestitures and Other Transactions, to the Consolidated Financial Statements for further information related to indemnifications between Corteva, Dow and DuPont.
EID [Member]  
Income Tax Disclosure [Text Block]
Refer to page F-31 of the Corteva, Inc. Consolidated Financial Statements for discussion of tax items that do not differ between Corteva, Inc. and EID.
Geographic Allocation of Income (Loss) and Provision for (Benefit from) Income Taxes For the Year Ended December 31,
(In millions)202120202019
Income (loss) from continuing operations before income taxes
Domestic$892 $(183)$(1,458)
Foreign1,404 758 1,036 
Income (loss) from continuing operations before income taxes$2,296 $575 $(422)
Current tax expense (benefit)
Federal$(23)$$(11)
State and local
Foreign329 222 317 
Total current tax expense (benefit)$310 $235 $307 
Deferred tax (benefit) expense
Federal$164 $(116)$(417)
State and local55 27 156 
Foreign(17)(251)(117)
Total deferred tax expense (benefit)$202 $(340)$(378)
Provision for (benefit from) income taxes on continuing operations512 (105)(71)
Net income (loss) from continuing operations$1,784 $680 $(351)
Reconciliation to U.S. Statutory RateFor the Year Ended December 31,
202120202019
Statutory U.S. federal income tax rate21.0 %21.0 %21.0 %
Effective tax rates on international operations - net 1
(2.6)(16.4)(13.8)
Acquisitions, divestitures and ownership restructuring activities 2
(0.1)(0.3)(8.0)
U.S. research and development credit(2.5)(3.4)5.2 
Exchange gains/losses 3
1.9 4.1 (1.3)
State and local income taxes - net2.2 4.2 3.0 
Impact of Swiss Tax Reform 4
0.2 (31.7)8.9 
Excess tax benefits/deficiencies from stock compensation(0.2)1.2 (0.5)
Tax settlements and expiration of statute of limitations— 0.4 2.9 
Other - net2.3 2.6 (0.6)
Effective tax rate22.2 %(18.3)%16.8 %
1.    Includes the effects of local and U.S. taxes related to earnings of non-U.S. subsidiaries, changes in the amount of unrecognized tax benefits associated with these earnings, losses at non-U.S. subsidiaries without local tax benefits due to valuation allowances, and other permanent differences between tax and U.S. GAAP results. Includes a tax benefit of $(51) million for the year ended December 31, 2020, related to a return to accrual adjustment associated with an elective change in accounting method that alters the 2019 impact of foreign tax provisions.
2.    See Notes 4 - Common Control Business Combination, and Note 5 - Divestitures and Other Transactions, of the Corteva, Inc. Consolidated Financial Statements for additional information.
3.    Principally reflects the impact of foreign exchange gains and losses on net monetary assets for which no corresponding tax impact is realized. Further information about the company's foreign currency hedging program is included in Note 9 - Supplementary Information, and Note 22 - Financial Instruments, of the Corteva, Inc. Consolidated Financial Statements under the heading Foreign Currency Risk.
4.    Reflects tax benefits of $(182) million primarily driven by the recognition of an elective cantonal component of the recent enactment of the Federal Act on Tax Reform and AHV Financing ("Swiss Tax Reform") for the year ended December 31, 2020. Reflects tax benefits of $(38) million associated with the enactment of the Federal Act on Tax Reform and AHV Financing ("Swiss Tax Reform"), for the year ended December 31, 2019.
XML 59 R39.htm IDEA: XBRL DOCUMENT v3.22.0.1
EID Segment FN (Notes)
12 Months Ended
Dec. 31, 2021
Segment Reporting Information [Line Items]  
Segment Reporting Disclosure [Text Block] SEGMENT INFORMATION
Corteva’s reportable segments reflects the manner in which its chief operating decision maker ("CODM") allocates resources and assesses performance, which is at the operating segment level (seed and crop protection). For purposes of allocating resources to the segments and assessing segment performance, segment operating EBITDA is the primary measure used by Corteva’s CODM. The company defines segment operating EBITDA as earnings (loss) (i.e., income (loss) from continuing operations before income taxes) before interest, depreciation, amortization, corporate expenses, non-operating (benefits) costs, foreign exchange gains (losses), and net unrealized gain or loss from mark-to-market activity for certain foreign currency derivative instruments that do not qualify for hedge accounting, excluding the impact of significant items. Effective January 1, 2021, on a prospective basis, the company excludes from segment operating EBITDA net unrealized gain or loss from mark-to- market activity for certain foreign currency derivative instruments that do not qualify for hedge accounting. Non-operating (benefits) costs consists of non-operating pension and other post-employment benefit (OPEB) costs, tax indemnification adjustments, environmental remediation and legal costs associated with legacy EID businesses and sites, and the 2021 officer indemnification payment. Tax indemnification adjustments relate to changes in indemnification balances, as a result of the application of the terms of the Tax Matters Agreement, between Corteva and Dow and/or DuPont that are recorded by the company as pre-tax income or expense. Net unrealized gain or loss from mark-to-market activity for certain foreign currency derivative instruments that do not qualify for hedge accounting represents the non-cash net gain (loss) from changes in fair value of certain undesignated foreign currency derivative contracts. Upon settlement, which is within the same calendar year of execution of the contract, the realized gain (loss) from the changes in fair value of the non-qualified foreign currency derivative contracts will be reported in the respective segment results to reflect the economic effects of the foreign currency derivative contracts without the resulting unrealized mark to fair value volatility. For the year ended December 31, 2019, segment operating EBITDA is calculated on a pro forma basis, as this is the manner in which the CODM assesses performance and allocates resources or expense.

Pro forma adjustments used in the calculation of pro forma segment operating EBITDA for the year ended December 31, 2019 were determined in accordance with Article 11 of Regulation S-X that was in effect prior to recent amendments. These adjustments give effect to the Merger, the debt retirement transactions related to paying off or retiring portions of EID’s existing debt liabilities (as discussed in Note 17 - Long-Term Debt and Available Credit Facilities, to the Consolidated Financial Statements), and the separation and distribution to DowDuPont stockholders of all the outstanding shares of Corteva common stock as if they had been consummated on January 1, 2016.

Corporate Profile
The company conducts its global operations through the following reportable segments:

Seed
The company’s seed segment is a global leader in developing and supplying advanced germplasm and traits that produce optimum yield for farms around the world. The segment is a leader in many of the company’s key seed markets, including North America corn and soybeans, Europe corn and sunflower, as well as Brazil, India, South Africa and Argentina corn. The segment offers trait technologies that improve resistance to weather, disease, insects and herbicides used to control weeds, and trait technologies that enhance food and nutritional characteristics. In addition, the segment provides digital solutions that assist farmer decision-making with a view to optimize product selection and, ultimately, help maximize yield and profitability.

Crop Protection
The crop protection segment serves the global agricultural input industry with products that protect against weeds, insects and other pests, and disease, and that improve overall crop health both above and below ground via nitrogen management and seed-applied technologies. The segment is a leader in global herbicides, insecticides, nitrogen stabilizers and pasture and range management herbicides.

(In millions)
SeedCrop ProtectionTotal
As of and for the Year Ended December 31, 2021   
Net sales$8,402 $7,253 $15,655 
Segment operating EBITDA$1,512 $1,202 $2,714 
Depreciation and amortization$866 $377 $1,243 
Segment assets$23,270 $12,428 $35,698 
Investments in nonconsolidated affiliates$29 $47 $76 
Purchases of property, plant and equipment$237 $336 $573 
As of and for the Year Ended December 31, 2020   
Net sales$7,756 $6,461 $14,217 
Segment operating EBITDA$1,208 $1,004 $2,212 
Depreciation and amortization$798 $379 $1,177 
Segment assets$23,751 $13,099 $36,850 
Investments in nonconsolidated affiliates$22 $44 $66 
Purchases of property, plant and equipment$225 $250 $475 
As of and for the Year Ended December 31, 2019
Net sales$7,590 $6,256 $13,846 
Pro forma segment operating EBITDA$1,040 $1,066 $2,106 
Depreciation and amortization$628 $372 $1,000 
Segment assets1
$25,387 $13,492 $38,879 
Investments in nonconsolidated affiliates$27 $39 $66 
Purchase of property, plant and equipment$373 $293 $666 
1.On June 1, 2019, as a result of changes in reportable segments, $3,382 million of goodwill was reallocated from the seed reportable segment to the crop protection reportable segment. This change was not reflected in segment assets prior to June 1, 2019.

Reconciliation to Consolidated Financial Statements
Income (loss) from continuing operations after income taxes to segment operating EBITDA
For the Year Ended December 31,
(In millions)202120202019
Income (loss) from continuing operations after income taxes$1,822 $756 $(270)
Provision for (benefit from) income taxes on continuing operations524 (81)(46)
Income (loss) from continuing operations before income taxes2,346 675 (316)
Depreciation and amortization1,243 1,177 1,000 
Interest income(77)(56)(59)
Interest expense30 45 136 
Exchange (gains) losses - net 1
54 174 66 
Non-operating (benefits) costs - net(1,256)(316)(129)
Mark-to-market (gains) losses on certain foreign currency contracts not designated as hedges2
— 
Significant items236 388 991 
Pro forma adjustments298 
Corporate expenses138 125 119 
Segment operating EBITDA3
$2,714 $2,212 $2,106 
1.Excludes a $(33) million foreign exchange loss for the year ended December 31, 2019 associated with the devaluation of the Argentine peso. See Note 9 - Supplementary Information, to the Consolidated Financial Statements, for additional information.
2.Effective January 1, 2021, on a prospective basis, the company excludes net unrealized gain or loss from mark-to-market activity for certain foreign currency derivative instruments that do not qualify for hedge accounting. There were no unrealized mark-to-market (gains) losses for the years ended December 31, 2020 and 2019.
3.The year ended December 31, 2019 is presented on a pro forma basis, prepared in accordance with Article 11 of Regulation S-X that was in effect prior to recent amendments.
Segment assets to total assets (in millions)
December 31, 2021December 31, 2020
Total segment assets$35,698 $36,850 
Corporate assets6,646 5,799 
Total assets$42,344 $42,649 


Other Items (in millions)
Segment Totals
Adjustments 1
Consolidated Totals
For the Year Ended December 31, 2019
Depreciation and amortization$1,000 $599 $1,599 
Purchase of property, plant and equipment$666 $497 $1,163 
1.See Note 5 - Divestitures and Other Transactions, to the Consolidated Financial Statements, for additional information.
Significant Pre-tax (Charges) Benefits Not Included in Segment Operating EBITDA
The years ended December 31, 2021, 2020 and 2019, respectively, included the following significant pre-tax (charges) benefits which are excluded from segment operating EBITDA:
(In millions)SeedCrop ProtectionCorporateTotal
For the Year Ended December 31, 2021
Restructuring and Asset Related Charges - Net 1
$(152)$(59)$(78)$(289)
Equity securities mark-to-market gain (loss)47 — — 47 
Employee Retention Credit37 23 — 60 
Contract termination(30)(24)— (54)
Total$(98)$(60)$(78)$(236)
(In millions)SeedCrop ProtectionCorporateTotal
For the Year Ended December 31, 2020
Restructuring and Asset Related Charges - Net 1
$(165)$(109)$(61)$(335)
Loss on Divestiture 2
— (53)— (53)
Total$(165)$(162)$(61)$(388)
(In millions)SeedCrop ProtectionCorporateTotal
For the Year Ended December 31, 20193
Restructuring and Asset Related Charges - Net 1
$(213)$(23)$14 $(222)
Integration and Separation Costs 4
— — (632)(632)
Loss on Divestiture 5
(24)— — (24)
Amortization of Inventory Step Up 6
(67)— — (67)
Loss on Early Extinguishment of Debt 7
— — (13)(13)
Argentina Currency Devaluation 8
— — (33)(33)
Total$(304)$(23)$(664)$(991)
1.Includes Board approved restructuring plans and asset related charges as well as accelerated prepaid amortization. See Note 7 - Restructuring and Asset Related Charges - Net, to the Consolidated Financial Statements, for additional information.
2.Includes a loss recorded in other income - net related to the sale of the La Porte site.
3.The year ended December 31, 2019 is presented on a pro forma basis, prepared in accordance with Article 11 of Regulation S-X that was in effect prior to recent amendments.
4.Integration and separation costs include costs incurred to prepare for and close the Merger, post-Merger integration expenses, and costs incurred to prepare for the Internal Reorganizations. Beginning in the second quarter of 2019, this includes both integration and separation costs.
5.Includes a loss recorded in other income - net related to DAS's sale of a joint venture related to synergy actions.
6.Includes a charge related to the amortization of the inventory that was stepped up to fair value in connection with the Merger.
7.Includes a loss on early extinguishment of debt related to the difference between the redemption price and the par value of the Make Whole Notes and Term Loan Facility, partially offset by the write-off of unamortized step-up related to the fair value step-up of EID's debt.
8.Includes a charge included in other income - net associated with remeasuring the company’s Argentine Peso net monetary assets, resulting from an unexpected August primary election result in Argentina. Throughout the three months ended September 30, 2019, the Argentine Peso dropped approximately a third of its value against the US dollar and in September of 2019, the country’s central bank announced new restrictions on foreign currency transactions.
EID [Member]  
Segment Reporting Information [Line Items]  
Segment Reporting Disclosure [Text Block] SEGMENT INFORMATION
There are no differences in reporting structure or segments between Corteva, Inc. and EID. In addition, there are no differences between Corteva, Inc. and EID segment net sales, segment operating EBITDA or pro forma segment operating EBITDA, segment assets, or significant items by segment; refer to page F-74 of the Corteva, Inc. Consolidated Financial Statements for background information on the segments as well as further details regarding segment metrics. The tables below reconcile income (loss) from continuing operations after income taxes to segment operating EBITDA, as differences exist between Corteva, Inc. and EID.

Reconciliation to Consolidated Financial Statements
Income (loss) from continuing operations after income taxes to segment operating EBITDA
(In millions)
For the Year Ended December 31,
202120202019
Income (loss) from continuing operations after income taxes$1,784 $680 $(351)
Provision for (benefit from) income taxes on continuing operations512 (105)(71)
Income (loss) from continuing operations before income taxes2,296 575 (422)
Depreciation and amortization1,243 1,177 1,000 
Interest income(77)(56)(59)
Interest expense80 145 242 
Exchange losses - net1
54 174 66 
Non-operating (benefits) costs - net(1,256)(316)(129)
Mark-to-market (gains) losses on certain foreign currency contracts not designated as hedges2
— 
Significant items236 388 991 
Pro forma adjustments298 
Corporate expenses138 125 119 
Segment operating EBITDA3
$2,714 $2,212 $2,106 
1.Excludes a $(33) million foreign exchange loss for the year ended December 31, 2019 associated with the devaluation of the Argentine peso. See Note 9 - Supplementary Information, of the Corteva, Inc. Consolidated Financial Statements for additional information.
2.Effective January 1, 2021, on a prospective basis, the company excludes net unrealized gain or loss from mark-to-market activity for certain foreign currency derivative instruments that do not qualify for hedge accounting. There were no unrealized mark-to-market (gains) losses for the years ended December 31, 2020 and 2019.
3.The year ended December 31, 2019 is presented on a pro forma basis, prepared in accordance with Article 11 of Regulation S-X that was in effect prior to recent amendments.
XML 60 R40.htm IDEA: XBRL DOCUMENT v3.22.0.1
Background and Basis of Presentation (Policies)
12 Months Ended
Dec. 31, 2021
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]  
Intended Business Separations [Policy Text Block]
Subsequent to the Merger, Historical Dow and EID engaged in a series of internal reorganization and realignment steps to realign their businesses into three subgroups: agriculture, materials science and specialty products through a series of tax-efficient transactions (collectively, the "Business Separations”). Effective as of 5:00 pm ET on April 1, 2019, DowDuPont completed the separation of its materials science business into a separate and independent public company by way of a distribution of Dow Inc. (“Dow”) through a pro rata dividend in-kind of all of the then-issued and outstanding shares of Dow’s common stock, par value $0.01 per share, to holders of DowDuPont's common stock, as of the close of business on March 21, 2019 (the “Dow Distribution” and together with the Corteva Distribution, the “Distributions”).

Prior to the Dow Distribution, Historical Dow conveyed or transferred the assets and liabilities aligned with Historical Dow’s agriculture business to separate legal entities (“Dow Ag Entities”) and the assets and liabilities associated with its specialty products business to separate legal entities (the “Dow SP Entities”). On April 1, 2019, Dow Ag Entities and the Dow SP Entities were transferred and conveyed to DowDuPont.

In furtherance of the Business Separations, EID engaged in a series of internal reorganization and realignment steps (the “Internal Reorganization” and the "Business Realignment," respectively) to realign its businesses into three subgroups: agriculture, materials science and specialty products. As part of the Internal Reorganization:

the assets and liabilities aligned with EID’s materials science business (“EID ECP”) were transferred or conveyed to separate legal entities that were ultimately conveyed by DowDuPont to Dow on April 1, 2019;

the assets and liabilities aligned with EID’s specialty products business were transferred or conveyed to separate legal entities (“EID Specialty Products Entities”) that were ultimately distributed to DowDuPont on May 1, 2019;

on May 2, 2019, DowDuPont conveyed Dow Ag Entities to EID and in connection with the foregoing, EID issued additional shares of its Common Stock to DowDuPont; and

on May 31, 2019, DowDuPont contributed EID to Corteva, Inc.

On May 6, 2019, the Board of Directors of DowDuPont approved the distribution of all the then issued and outstanding shares of common stock of Corteva, Inc., then a wholly-owned subsidiary of DowDuPont, to DowDuPont stockholders. On June 1,
2019, DowDuPont completed the Separation. Each DowDuPont stockholder received one share of Corteva common stock for every three shares of DowDuPont common stock held at the close of business on May 24, 2019, the record date of distribution. Corteva, Inc.'s common stock began trading the "regular way" under the ticker symbol "CTVA" on June 3, 2019, the first business day after June 1, 2019. Upon becoming an independent company, the capital structure of Corteva consisted of 748,815,000 authorized shares of common stock (par value of $0.01 per share), which represents the number of common shares issued on June 3, 2019. Information related to the Corteva Distribution and its effect on the company's financial statements is discussed throughout these Notes to the Consolidated Financial Statements.

As a result of the Business Realignment and the Internal Reorganization discussed above, Corteva owns 100% of the outstanding common stock of EID. EID is a subsidiary of Corteva, Inc. and continues to be a reporting company, subject to the requirements of the Securities Exchange Act of 1934, as amended.
Combination of Entities under Common Control, Policy [Policy Text Block]
DAS Common Control Business Combination
The transfer or conveyance of DAS to Corteva was treated as a transfer of entities under common control. As such, the company recorded the assets, liabilities, and equity of DAS on its balance sheet at their historical basis. Transfers of businesses between entities under common control requires the financial statements to be presented as if the transaction had occurred at the point at which common control first existed (the Merger Effectiveness Time). As a result, the accompanying Consolidated Financial Statements and Notes thereto include the results of DAS as of the Merger Effectiveness Time. See Note 4 - Common Control Business Combination, to the Consolidated Financial Statements, for additional information.
Basis of Accounting, Policy [Policy Text Block]
For periods prior to the Corteva Distribution, the combined results of operations and assets and liabilities of EID and DAS were derived from the Consolidated Financial Statements and accounting records of EID as well as the carve-out financial statements of DAS. The DAS carve-out financial statements reflect the historical results of operations, financial position, and cash flows of Historical Dow's Agricultural Sciences Business and include allocations of certain expenses for services from Historical Dow, including, but not limited to, general corporate expenses related to finance, legal, information technology, human resources, ethics and compliance, shared services, employee benefits and incentives, insurance, and stock-based compensation. These expenses were allocated on the basis of direct usage when identifiable, with the remainder allocated under the basis of headcount or other measures.

The company's Consolidated Balance Sheets for all periods presented consist of Corteva, Inc. and its consolidated subsidiaries.

The company's Consolidated Statements of Operations (the "Consolidated Statements of Operations") for all periods prior to the Corteva Distribution consist of the combined results of operations for Historical EID and DAS. The Consolidated Statements of Operations for all periods after the Corteva Distribution represent the consolidated balances of the company. Intercompany balances and transactions with Historical EID and DAS have been eliminated.

During the first quarter 2020, the company recorded an increase of $40 million to APIC relating to net assets recorded as
transferred as part of the 2019 Internal Reorganizations that were retained.
ECP Disposal [Member]  
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]  
Discontinued Operations, Policy [Policy Text Block]
Divestiture of EID ECP and EID Specialty Products Entities
The transfer of EID ECP and EID Specialty Products Entities meets the criteria for discontinued operations and as such, results of operations are presented as discontinued operations and have been excluded from continuing operations for all periods presented. The comprehensive income (loss), stockholder's equity and cash flows related to EID ECP and EID Specialty Products Entities have not been segregated and are included in the Consolidated Statements of Comprehensive Income (Loss), Consolidated Statements of Equity and Consolidated Statements of Cash Flows, respectively, for 2019. Amounts related to EID ECP and EID Specialty Products Entities are consistently included or excluded from the Notes to the Consolidated Financial Statements based on the respective financial statement line item. See Note 5 - Divestitures and Other Transactions, to the Consolidated Financial Statements, for additional information.
Specialty Products Disposal [Member]  
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]  
Discontinued Operations, Policy [Policy Text Block] Since 2018, Argentina has been considered a hyper-inflationary economy under U.S. GAAP and therefore the U.S. Dollar (“USD”) is the functional currency for our related subsidiaries. Argentina contributes approximately 5 percent to both the company's annual Sales and EBITDA. We remeasure net monetary assets and translate our financial statements utilizing the official Argentine Peso (“Peso”) to USD exchange rate. The ability to draw down Peso cash balances is limited at this time due to government restrictions and market availability of U.S. Dollars. The devaluation of the Peso relative to the USD over the last several years has resulted in the recognition of exchange losses (refer to Note 9 – Supplementary Information, to the Consolidated Financial Statements). As of December 31, 2021, a further 10 percent deterioration in the official Peso to USD exchange rate would reduce the USD value of our net monetary assets and negatively impact pre-tax earnings by approximately $15 million. We will continue to assess the implications to our operations and financial reporting.
XML 61 R41.htm IDEA: XBRL DOCUMENT v3.22.0.1
Summary of Significant Accounting Policies (Policies)
12 Months Ended
Dec. 31, 2021
Accounting Policies [Abstract]  
Basis of Consolidation The Consolidated Financial Statements include the accounts of the company and subsidiaries in which a controlling interest is maintained. For those consolidated subsidiaries in which the company's ownership is less than 100 percent, the outside stockholders' interests are shown as noncontrolling interests. Investments in affiliates over which the company has the ability to exercise significant influence but does not have a controlling interest are accounted for under the equity method. The company is also involved with certain joint ventures accounted for under the equity method of accounting that are variable interest entities ("VIEs"). The company is not the primary beneficiary, as the nature of the company's involvement with the VIEs does not provide it the power to direct the VIEs significant activities. Future events may require these VIEs to be consolidated if the company becomes the primary beneficiary. At December 31, 2021 and 2020, the maximum exposure to loss related to the nonconsolidated VIEs is not considered material to the Consolidated Financial Statements.
Use of Estimates Use of Estimates in Financial Statement PreparationThe preparation of financial statements in accordance with U.S. GAAP requires the use of estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. The company’s consolidated financial statements include amounts that are based on management’s best estimates and judgments. Actual results could differ from those estimates.
Cash and Cash Equivalents Cash and Cash EquivalentsCash equivalents represent investments with maturities of three months or less from time of purchase. They are carried at cost plus accrued interest.
Restricted Cash
Restricted Cash Equivalents
Restricted cash equivalents primarily consist of trust assets and contributions to the MOU Escrow Account of $377 million and $347 million as of December 31, 2021 and 2020, respectively. The trust assets are classified as current and the contributions to the MOU Escrow Account are classified as noncurrent and included within other current assets and other assets, respectively, in the Consolidated Balance Sheets. See Note 9 - Supplementary Information, to the Consolidated Financial Statements, for further information.
Marketable Securities
Marketable Securities
Marketable securities represent investments in fixed and floating rate financial instruments with maturities greater than three months and up to twelve months at time of purchase. Investments classified as held-to-maturity are recorded at amortized cost. The carrying value approximates fair value due to the short-term nature of the investments. Investments classified as debt securities that are available-for-sale are carried at estimated fair value with unrealized gains and losses recorded as a component of accumulated other comprehensive income (loss) or current period earnings if an allowance for credit losses has been established. The cost of investments sold is determined by specific identification.
Fair Value Measurements
Fair Value Measurements
Under the accounting guidance for fair value measurements and disclosures, a fair value hierarchy was established that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). A financial instrument's level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement.
The company uses the following valuation techniques to measure fair value for its assets and liabilities:
Level 1Quoted market prices in active markets for identical assets or liabilities;
Level 2Significant other observable inputs (e.g. quoted prices for similar items in active markets, quoted prices for identical or similar items in markets that are not active, inputs other than quoted prices that are observable such as interest rate and yield curves, and market-corroborated inputs);
Level 3Unobservable inputs for the asset or liability, which are valued based on management's estimates of assumptions that market participants would use in pricing the asset or liability.
Foreign Currency Translation
Foreign Currency Translation
The company's worldwide operations utilize the U.S. dollar ("USD") or a related foreign currency as the functional currency, where applicable. The company identifies its separate and distinct foreign entities and groups the foreign entities into two categories: 1) extension of the parent or foreign subsidiaries operating in a hyper-inflationary environment (USD functional currency) and 2) self-contained (related foreign functional currency). If a foreign entity does not align with either category, factors are evaluated and a judgment is made to determine the functional currency. 

For foreign entities where the USD is the functional currency, all foreign currency-denominated asset and liability amounts are re-measured into USD at end-of-period exchange rates, except for inventories, prepaid expenses, property, plant and equipment, goodwill and other intangible assets, which are re-measured at historical rates. Foreign currency income and expenses are re-measured at average exchange rates in effect during each month, except for expenses related to balance sheet amounts re-measured at historical exchange rates. Exchange gains and losses arising from re-measurement of foreign currency-denominated monetary assets and liabilities are included in income in the period in which they occur.

For foreign entities where a related foreign currency is the functional currency, assets and liabilities denominated in the related foreign currencies are translated into USD at end-of-period exchange rates and the resultant translation adjustments are reported, net of their related tax effects, as a component of accumulated other comprehensive income (loss) in equity. Assets and liabilities denominated in other than the functional currency are re-measured into the functional currency prior to translation into USD and the resultant exchange gains or losses are included in income in the period in which they occur. Income and expenses are translated into USD at average exchange rates in effect during each month.

The company changes the functional currency of its separate and distinct foreign entities only when significant changes in economic facts and circumstances indicate clearly that the functional currency has changed.
Inventories
Inventories
The company's inventories are valued at the lower of cost or net realizable value. Elements of cost in inventories include raw materials, direct labor and manufacturing overhead. Stores and supplies are valued at cost or net realizable value, whichever is lower; cost is generally determined by the average cost method.

As of December 31, 2021 and December 31, 2020, approximately 60% and 40% of the company's inventories were accounted for under the first-in, first-out ("FIFO") and average cost methods, respectively. Inventories accounted for under the FIFO method are primarily comprised of products with shorter shelf lives such as seeds. See Note 13 - Inventories, to the Consolidated Financial Statements, for further information.

The company establishes an obsolescence reserve for inventory based upon quality considerations and assumptions about future demand and market conditions.
Property, Plant and Equipment
Property, Plant and Equipment
Property, plant and equipment are carried at cost less accumulated depreciation. In connection with the Merger, the fair value of property, plant and equipment was determined using a market approach and a replacement cost approach. Depreciation is based on the estimated service lives of depreciable assets and is calculated using the straight-line method. Fully depreciated assets are retained in property and accumulated depreciation accounts until they are removed from service. When assets are surrendered, retired, sold, or otherwise disposed of, their gross carrying values and related accumulated depreciation are removed from the Consolidated Balance Sheets and included in determining gain or loss on such disposals.
Goodwill and Other Intangible Assets
Goodwill and Other Intangible Assets
The company records goodwill when the purchase price of a business acquisition exceeds the estimated fair value of net identified tangible and intangible assets acquired. Goodwill is tested for impairment at the reporting unit level at least annually, or more frequently when events or changes in circumstances indicate that the fair value of a reporting unit has more likely than not declined below its carrying value. The company performs an annual goodwill impairment test in the fourth quarter.

When testing goodwill for impairment, the company has the option to first perform qualitative testing to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying value. If the company chooses not to complete a qualitative assessment for a given reporting unit or if the initial assessment indicates that it is more likely than not that the carrying value of a reporting unit exceeds its estimated fair value, additional quantitative testing is required. If additional quantitative testing is required, the reporting unit's fair value is compared with its carrying amount, and an impairment charge, if any, is recognized for the amount by which the carrying amount exceeds the reporting unit's fair value, limited to the amount of goodwill associated with the reporting unit. The company determines fair values for each of the reporting units using a discounted cash flow model (a form of the income approach) or the market approach. Under the income approach, fair value is determined based on the present value of estimated future cash flows, discounted at an appropriate risk-adjusted rate. The company's significant assumptions in this analysis included future cash flow projections, weighted average cost of capital, the terminal growth rate, and the tax rate. Under the market approach, the company uses metrics of publicly traded companies or historically completed transactions for comparable companies. See Note 15 - Goodwill and Other Intangible Assets, to the Consolidated Financial Statements, for further information on goodwill.

Indefinite-lived intangible assets are tested for impairment at least annually; however, these tests are performed more frequently when events or changes in circumstances indicate that the asset may be impaired. Impairment exists when carrying value exceeds fair value. The company performs an impairment assessment using the relief from royalty method (a form of the income approach) using Level 3 inputs within the fair value hierarchy. The significant assumptions used in the calculation included projected revenue, the royalty rate, the discount rate, and the terminal growth rate. These significant assumptions involve management judgment and estimates relating to future operating performance and economic conditions that may differ from actual cash flows.

Definite-lived intangible assets are amortized over their estimated useful lives, generally on a straight-line basis for periods ranging primarily from 2 years to 25 years. The company continually evaluates the reasonableness of the useful lives of these assets. Once these assets are fully amortized, they are removed from the Consolidated Balance Sheets.
Leases
Leases
The company determines whether an arrangement is a lease at the inception of the arrangement based on the terms and conditions in the contract. A contract contains a lease if there is an identified asset and the company has the right to control the asset. Operating lease right-of-use ("ROU") assets are included in other assets on the company’s Consolidated Balance Sheets. Operating lease liabilities are included in accrued and other current liabilities and other noncurrent obligations on the company’s Consolidated Balance Sheets. Finance lease assets are included in property, plant and equipment on the company’s Consolidated Balance Sheets. Finance lease liabilities are included in short-term borrowings and finance lease obligations and long-term debt on the company’s Consolidated Balance Sheets.  

Operating lease ROU assets represent the company’s right to use an underlying asset for the lease term and lease liabilities represent the company’s obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at the commencement date based on the present value of lease payments over the lease term. As most of the company’s leases do not provide the lessor's implicit rate, the company uses its incremental borrowing rate at the commencement date in determining the present value of lease payments. Lease terms include options to extend the lease when it is reasonably certain those options will be exercised. Leases with an initial term of 12 months or less are not recorded on the balance sheet. The company recognizes lease expense for these leases on a straight-line basis over the lease term.
The company has lease agreements with lease and non-lease components, which are accounted for as a single lease component for all asset classes. In the Consolidated Statements of Operations, lease expense for operating leases is recognized on a straight-line basis over the lease term. For finance leases, interest expense is recognized on the lease liability and the ROU asset is amortized over the lease term. See Note 16 - Leases, to the Consolidated Financial Statements, for further information.
Impairment of Long-Lived Assets
Impairment of Long-Lived Assets
The company evaluates the carrying value of long-lived assets to be held and used when events or changes in circumstances indicate the carrying value may not be recoverable. The carrying value of a long-lived asset group is considered impaired when the total projected undiscounted cash flows from the assets are separately identifiable and are less than its carrying value. In that event, a loss is recognized based on the amount by which the carrying value exceeds the fair value of the long-lived asset. The
company's fair value methodology is an estimate of fair market value which is made based on prices of similar assets or other valuation methodologies including present value techniques. Long-lived assets to be disposed of by sale, if material, are classified as held for sale and reported at the lower of carrying amount or fair value less cost to sell, and depreciation is ceased. Long-lived assets to be disposed of other than by sale are classified as held and used until they are disposed of and reported at the lower of carrying amount or fair value. Depreciation is recognized over the remaining useful life of the assets.
Derivative Instruments
Derivative Instruments
Derivative instruments are reported in the Consolidated Balance Sheets at their fair values. The company utilizes derivatives to manage exposures to foreign currency exchange rates and commodity prices. Changes in the fair values of derivative instruments that are not designated as hedges are recorded in current period earnings. For derivative instruments designated as cash flow hedges, the gain (loss) is reported in accumulated other comprehensive income (loss) until it is cleared to earnings during the same period in which the hedged item affects earnings. For derivative instruments designated as net investment hedges, the gain (loss) is reported within accumulated other comprehensive income (loss) until the subsidiary is divested.

In the event that a derivative designated as a hedge of a firm commitment or an anticipated transaction is terminated prior to the maturation of the hedged transaction, the net gain or loss in accumulated other comprehensive income (loss) generally remains in accumulated other comprehensive income (loss) until the item that was hedged affects earnings. If a hedged transaction matures, or is sold, extinguished, or terminated prior to the maturity of a derivative designated as a hedge of such transaction, gains or losses associated with the derivative through the date the transaction matured are included in the measurement of the hedged transaction and the derivative is reclassified as for trading purposes. Derivatives designated as hedges of anticipated transactions are reclassified as for trading purposes if the anticipated transaction is no longer probable.

The company included foreign currency exchange contract settlements within cash flows from operating activities, regardless of hedge accounting qualification. See Note 22 - Financial Instruments, to the Consolidated Financial Statements, for additional discussion regarding the company's objectives and strategies for derivative instruments.
Environmental Matters
Environmental Matters
Accruals for environmental matters are recorded when it is probable that a liability has been incurred and the amount of the liability can be reasonably estimated. These accruals are adjusted periodically as assessment and remediation efforts progress or as additional technical or legal information becomes available. Accruals for environmental liabilities are included in the Consolidated Balance Sheets in accrued and other current liabilities and other noncurrent obligations at undiscounted amounts. Accruals for related insurance or other third-party recoveries for environmental liabilities are recorded when it is probable that a recovery will be realized and are included in the Consolidated Balance Sheets as accounts and notes receivable - net.

Environmental costs are capitalized if the costs extend the life of the property, increase its capacity, and/or mitigate or prevent contamination from future operations. Environmental costs are also capitalized in recognition of legal asset retirement obligations resulting from the acquisition, construction and/or normal operation of a long-lived asset. Costs related to environmental contamination treatment and cleanup are charged to expense. Estimated future incremental operations, maintenance and management costs directly related to remediation are accrued when such costs are probable and reasonably estimable.
Revenue Recognition
Revenue Recognition
The company recognizes revenue when its customer obtains control of promised goods or services, in an amount that reflects the consideration which the company expects to receive in exchange for those goods or services. To determine revenue recognition for the arrangements that the company determines are within the scope of FASB ASU No. 2014-09, Revenue from Contracts with Customers (Topic 606), the company performs the following five steps: (1) identify the contract(s) with a customer, (2) identify the performance obligations in the contract, (3) determine the transaction price, (4) allocate the transaction price to the performance obligations in the contract, and (5) recognize revenue when (or as) the entity satisfies a performance obligation. See Note 6 - Revenue, to the Consolidated Financial Statements, for additional information on revenue recognition.
Royalty Expense
Prepaid Royalties
The company currently has certain third-party biotechnology trait license agreements, which require up-front and variable payments subject to the licensor meeting certain conditions. These payments are reflected as other current assets and other assets and are amortized to cost of goods sold as seeds containing the respective trait technology are utilized over the life of the license. The rate of royalty amortization expense recognized is based on the company’s strategic plans which include various assumptions and estimates including product portfolio, market dynamics, farmer preferences, growth rates and projected planted acres. Changes in factors and assumptions included in the strategic plans, including potential changes to the product portfolio in favor of internally developed biotechnology, could impact the rate of recognition of the relevant prepaid royalty.
At December 31, 2021, the balance of prepaid royalties reflected in other current assets and other assets was $303 million and $256 million, respectively. The majority of the balance of prepaid royalties relates to the company’s wholly owned subsidiary, Pioneer Hi-Bred International, Inc.’s (“Pioneer”) non-exclusive license in the United States and Canada for the Monsanto Company's Genuity® Roundup Ready 2 Yield® glyphosate tolerance trait and Roundup Ready 2 Xtend® glyphosate and dicamba tolerance trait for soybeans (“Roundup Ready 2 License Agreement”). Each of these licensed technologies are now trademarks of the Bayer Group, which acquired the Monsanto Company in 2018. The prepaid royalty asset relates to a series of up-front, fixed and variable royalty payments to utilize the traits in Pioneer’s soybean product mix.The company’s historical expectation has been that the technology licensed under the Roundup Ready 2 License Agreement would be used as the primary herbicide tolerance trait platform in the Pioneer® brand soybean through the term of the agreement. DAS and MS Technologies, L.L.C. jointly developed and own the Enlist E3TM herbicide tolerance trait for soybeans which provides tolerance to 2, 4-D choline in Enlist Duo® and Enlist One® herbicides, as well as glyphosate and glufosinate herbicides. In connection with the validation of breeding plans and large-scale product development timelines, during the fourth quarter of 2019, the company accelerated the ramp up of the Enlist E3TM trait platform in the company’s soybean portfolio mix across all brands, including Pioneer® brands, over the subsequent five years. During the ramp-up period, the company is expected to significantly reduce the volume of products with the Roundup Ready 2 Yield® and Roundup Ready 2 Xtend® herbicide tolerance traits beginning in 2021, with expected minimal use of the trait platform thereafter for the remainder of the Roundup Ready 2 License Agreement (the “Transition Plan”). The rate of royalty expense has therefore increased significantly through higher amortization of the prepaid royalty as fewer seeds containing the respective trait are expected to be utilized.

In connection with the departure from these traits, beginning January 1, 2020 the company presents and discloses the non-cash accelerated prepaid royalty amortization expense as a component of restructuring and asset related charges - net, in the Consolidated Statement of Operations. The accelerated prepaid royalty amortization expense represents the difference between the rate of amortization based on the revised number of units expected to contain the Roundup Ready 2 Yield® and Roundup Ready 2 Xtend® trait technology and the variable cash rate per the Roundup Ready 2 License Agreement.
Further changes in factors and assumptions associated with usage of the trait platform licensed under the Roundup Ready 2 License Agreement, including the Transition Plan, could further impact the rate of recognition of the prepaid royalty and Consolidated Statement of Operations presentation of the accelerated prepaid royalty amortization expense.
Cost of Goods Sold Cost of Goods Sold Cost of goods sold primarily includes the cost of manufacture and delivery, ingredients or raw materials, direct salaries, wages and benefits and overhead, non-capitalizable costs associated with capital projects, royalties and other operational expenses. No amortization of intangibles is included within cost of goods sold.
Research and Development
Research and Development
Research and development costs are expensed as incurred. Research and development expense includes costs (primarily consisting of employee costs, materials, contract services, research agreements, and other external spend) relating to the discovery and development of new products.
Selling, General and Administrative Expenses Selling, General and Administrative Expenses Selling, general and administrative expenses primarily include selling and marketing expenses, commissions, functional costs, and business management expenses.
Integration and Separation Costs
Integration and Separation Costs
Integration and separation costs includes costs incurred to prepare for and close the Merger, post-Merger integration expenses, and costs incurred to prepare for the Business Separations. These costs primarily consist of financial advisory, information technology, legal, accounting, consulting and other professional advisory fees associated with preparation and execution of these activities.
Litigation Litigation and Other ContingenciesAccruals for legal matters and other contingencies are recorded when it is probable that a liability has been incurred and the amount of the liability can be reasonably estimated. Legal costs, such as outside counsel fees and expenses, are charged to expense in the period incurred.
Severance Costs Severance CostsSeverance benefits are provided to employees under the company's ongoing benefit arrangements. Severance costs are accrued when management commits to a plan of termination and it becomes probable that employees will be entitled to benefits at amounts that can be reasonably estimated.
Insurance and Self Insurance
Insurance/Self-Insurance
The company self-insures certain risks where permitted by law or regulation, including workers' compensation, vehicle liability and employee related benefits. Liabilities associated with these risks are estimated in part by considering historical claims experience, demographic factors and other actuarial assumptions. For other risks, the company uses a combination of insurance and self-insurance, reflecting comprehensive reviews of relevant risks. A receivable for an insurance recovery is generally recognized when the loss has occurred and collection is considered probable.
Income Taxes
Income Taxes
The company accounts for income taxes using the asset and liability method. Under this method, deferred tax assets and liabilities are recognized for the future tax consequences of temporary differences between the carrying amounts and tax bases of assets and liabilities using enacted tax rates. The effect of a change in tax rates on deferred tax assets or liabilities is recognized in income in the period that includes the enactment date.

The company recognizes the financial statement effects of an uncertain income tax position when it is more likely than not, based on the technical merits, that the position will be sustained upon examination. The current portion of uncertain income tax positions is included in income taxes payable or income tax receivable, and the long-term portion is included in other noncurrent obligations or other noncurrent assets in the Consolidated Balance Sheets.

Income tax related penalties are included in the provision for (benefit from) income taxes in the Consolidated Statements of Operations. Interest accrued related to unrecognized tax benefits is included within the provision for (benefit from) income taxes from continuing operations in the Consolidated Statements of Operations.
Earnings Per Share, Policy [Policy Text Block]
Earnings per Common Share
The calculation of earnings per common share is based on the weighted-average number of the company’s common shares outstanding for the applicable period. The calculation of diluted earnings per common share reflects the effect of all potential common shares that were outstanding during the respective periods, unless the effect of doing so is antidilutive.
Segment Reporting
XML 62 R42.htm IDEA: XBRL DOCUMENT v3.22.0.1
Recent Accounting Guidance Recent Accounting Guidance (Policies)
12 Months Ended
Dec. 31, 2021
Accounting Policies [Abstract]  
Recent Accounting Guidance RECENT ACCOUNTING GUIDANCE
Recently Adopted Accounting Guidance
In January 2021, the FASB issued ASU 2021-01, Reference Rate Reform (Topic 848): Scope, which provides certain optional expedients that allow derivative instruments impacted by changes in the interest rate used for margining, discounting or contract price alignment to qualify for certain optional relief. The amendments in this Update are effective immediately for all entities and may be applied retrospectively as of any date from the beginning of any interim period that includes March 12, 2020 or prospectively to new modifications subsequent to the issuance of this Update. The adoption of ASU 2021-01 did not have a material impact on the company’s financial position, results of operation or cash flows.

In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes, which is part of the FASB’s Simplification Initiative to identify, evaluate, and improve areas of U.S. GAAP for which cost and complexity can be reduced, while maintaining or improving the usefulness of the information provided to users of financial statements. This ASU amends ASC 740, Income Taxes, by removing certain exceptions to the general principles, and clarifying and amending current guidance. The new standard is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020. The company adopted this guidance on January 1, 2021 and it did not have a material impact on the company’s financial position, results of operation or cash flows.

Accounting Guidance Issued But Not Adopted as of December 31, 2021
In November 2021, the FASB issued ASU 2021-10, Government Assistance (Topic 832): Disclosures by Business Entities about Government Assistance, which requires business entities to disclose transactions with a governmental entity for which a grant or contribution accounting model is used in recognizing and measuring such transactions. This standard is effective for fiscal years beginning after December 15, 2021, and early adoption is permitted. The company is currently evaluating the impact of adopting this guidance.
XML 63 R43.htm IDEA: XBRL DOCUMENT v3.22.0.1
Revenue from Contract with Customer (Policies)
12 Months Ended
Dec. 31, 2021
Revenue from Contract with Customer [Abstract]  
Revenue Recognition, Sales of Goods
Products
Substantially all of Corteva's revenue is derived from product sales. Product sales consist of sales of Corteva's products to farmers, distributors, and manufacturers. Corteva considers purchase orders, which in some cases are governed by master supply agreements, to be a contract with a customer. Contracts with customers are considered to be short-term when the time between order confirmation and satisfaction of the performance obligations is equal to or less than one year. However, the company has some long-term contracts which can span multiple years.

Revenue from product sales is recognized when the customer obtains control of the company's product, which occurs at a point in time according to shipping terms. Payment terms are generally less than one year from invoicing. The company elected the practical expedient and does not adjust the promised amount of consideration for the effects of a significant financing component when the company expects it will be one year or less between when a customer obtains control of the company's product and when payment is due. When the company performs shipping and handling activities after the transfer of control to the customer (e.g., when control transfers prior to or at shipment), these are considered fulfillment activities, and accordingly, the costs are accrued when the related revenue is recognized. Taxes collected from customers relating to product sales and remitted to governmental authorities are excluded from revenues. In addition, the company elected the practical expedient to expense any costs to obtain contracts as incurred, as the amortization period for these costs would have been one year or less.

The transaction price includes estimates of variable consideration, such as rights of return, rebates, and discounts, that are reductions in revenue. All estimates are based on the company's historical experience, anticipated performance, and the company's best judgment at the time the estimate is made. Estimates of variable consideration included in the transaction price primarily utilize the expected value method based on historical experience. These estimates are reassessed each reporting period and are included in the transaction price to the extent it is probable that a significant reversal of cumulative revenue recognized will not occur upon resolution of uncertainty associated with the variable consideration. The majority of contracts have a single performance obligation satisfied at a point in time and the transaction price is stated in the contract, usually as quantity times price per unit. For contracts with multiple performance obligations, the company allocates the transaction price to each performance obligation based on the relative standalone selling price. The standalone selling price is the observable price which depicts the price as if sold to a similar customer in similar circumstances.
Revenue Recognition, Services, Licensing Fees Licenses of Intellectual PropertyCorteva enters into licensing arrangements with customers under which it licenses its intellectual property. Revenue from the majority of intellectual property licenses is derived from sales-based royalties. Revenue for licensing agreements that contain sales-based royalties is recognized at the later of (i) when the subsequent sale occurs or (ii) when the performance obligation to which some or all of the royalty has been allocated is satisfied.
XML 64 R44.htm IDEA: XBRL DOCUMENT v3.22.0.1
Divestitures and Other Transactions (Tables)
12 Months Ended
Dec. 31, 2021
Income Statement [Member] | ECP Disposal [Member]  
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]  
Disposal Groups, Including Discontinued Operations [Table Text Block]
(In millions)For the Year Ended December 31, 2019
Net sales$362 
Cost of goods sold
259 
Research and development expense
Selling, general and administrative expenses
Amortization of intangibles
23 
Restructuring and asset related charges - net
Integration and separation costs
44 
Other income - net
(Loss) income from discontinued operations before income taxes23 
Provision for (benefit from) income taxes on discontinued operations
(Loss) income from discontinued operations after income taxes$19 
Income Statement [Member] | Specialty Products Disposal [Member]  
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]  
Disposal Groups, Including Discontinued Operations [Table Text Block]
(In millions)For the Year Ended December 31, 2019
Net sales$5,030 
Cost of goods sold3,352 
Research and development expense204 
Selling, general and administrative expenses573 
Amortization of intangibles267 
Restructuring and asset related charges - net115 
Integration and separation costs253 
Goodwill impairment1,102 
Other income - net57 
(Loss) income from discontinued operations before income taxes(779)
Provision for (benefit from) income taxes on discontinued operations80 
(Loss) income from discontinued operations after income taxes$(859)
Cash Flow [Member] | ECP Disposal [Member]  
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]  
Disposal Groups, Including Discontinued Operations [Table Text Block]
(In millions)For the Year Ended December 31, 2019
Depreciation$28 
Amortization of intangibles23 
Capital expenditures16 
Cash Flow [Member] | Specialty Products Disposal [Member]  
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]  
Disposal Groups, Including Discontinued Operations [Table Text Block]
For the Year Ended December 31,
(In millions)2019
Depreciation$281 
Amortization of intangibles267 
Capital expenditures
481 
XML 65 R45.htm IDEA: XBRL DOCUMENT v3.22.0.1
Revenue (Tables)
12 Months Ended
Dec. 31, 2021
Disaggregation of Revenue [Line Items]  
Contract Balances [Table Text Block]
Contract BalancesDecember 31, 2021December 31, 2020
(In millions)
Accounts and notes receivable - trade1
$3,561 $3,917 
Contract assets - current2
$24 $22 
Contract assets - noncurrent3
$58 $54 
Deferred revenue - current$3,201 $2,662 
Deferred revenue - noncurrent4
$120 $116 
1.Included in accounts and notes receivable - net in the Consolidated Balance Sheets.
2.Included in other current assets in the Consolidated Balance Sheets.
3.Included in other assets in the Consolidated Balance Sheets.
4.Included in other noncurrent obligations in the Consolidated Balance Sheets.
Geography [Member]  
Disaggregation of Revenue [Line Items]  
Disaggregation of Revenue [Table Text Block]
SeedFor the Year Ended December 31,
(In millions)202120202019
North America1
$5,004 $4,795 $4,724 
EMEA2
1,599 1,468 1,378 
Latin America1,420 1,117 1,130 
Asia Pacific379 376 358 
Total$8,402 $7,756 $7,590 
Crop ProtectionFor the Year Ended December 31,
(In millions)202120202019
North America1
$2,532 $2,373 $2,205 
EMEA2
1,524 1,374 1,362 
Latin America2,125 1,688 1,759 
Asia Pacific1,072 1,026 930 
Total$7,253 $6,461 $6,256 
1.Represents U.S. & Canada.
2.Europe, Middle East, and Africa ("EMEA").
XML 66 R46.htm IDEA: XBRL DOCUMENT v3.22.0.1
Restructuring and Asset Related Charges (Tables)
12 Months Ended
Dec. 31, 2021
Restructuring Cost and Reserve [Line Items]  
Schedule of Restructuring Reserve by Type of Cost [Table Text Block]
A reconciliation of the December 31, 2020 to the December 31, 2021 liability balances related to the Execute to Win Productivity Program is summarized below:
(In millions)Severance and Related Benefit (Credits) Costs
Asset Related1
Total
Balance at December 31, 2020$53 $$56 
Charges to income from continuing operations for the year ended December 31, 2021(2)11 
Payments(27)(3)(30)
Asset write-offs— (11)(11)
Balance at December 31, 2021$24 $— $24 
1.In addition, the company has a liability recorded for asset retirement obligations of $13 million as of December 31, 2021.
DowDuPont Cost Synergy Program [Member]  
Restructuring Cost and Reserve [Line Items]  
Schedule of Restructuring Reserve by Type of Cost [Table Text Block]
For the Year Ended December 31,
(In millions)202120202019
Seed$(8)$(9)$66 
Crop Protection(3)11 27 
Corporate expenses(1)(2)(1)
Total$(12)$— $92 
For the Year Ended December 31,
(In millions)202120202019
Severance and related benefit (credits) costs - net$(1)$(2)$(7)
Contract termination charges(3)— 69 
Asset related charges(8)30 
Total restructuring and asset related charges - net$(12)$— $92 
2021 Restructuring Actions [Member]  
Restructuring Cost and Reserve [Line Items]  
Schedule of Restructuring Reserve by Segment
The charges related to the 2021 Restructuring Actions related to the segments, as well as corporate expenses, were as follows:
(In millions)For the Year Ended December 31, 2021
Seed$31 
Crop Protection55 
Corporate expenses81 
Total$167 
Schedule of Restructuring Reserve by Type of Cost [Table Text Block]
The following table is a summary of charges incurred related to 2021 Restructuring Actions for the year ended December 31, 2021:
(In millions)For the Year Ended December 31, 2021
Severance and related benefit costs$74 
Asset related charges51 
Contract termination charges42 
Total restructuring and asset charges - net$167 
A reconciliation of the December 31, 2020 to the December 31, 2021 liability balances related to the 2021 Restructuring Actions is summarized below:
(In millions)Severance and Related Benefit Costs
Asset Related1
Contract Termination2
Total
Balance at December 31, 2020$— $— $— $— 
Charges to income from continuing operations74 51 42 167 
Payments(22)— (30)(52)
Asset write-offs— (51)— (51)
Balance at December 31, 2021$52 $— $12 $64 
1.In addition, the company has a liability recorded for asset retirement obligations of $6 million as of December 31, 2021.
2.The liability for contract terminations includes lease obligations. The cash impact of these obligations will be substantially complete by the end of 2022
Execute to Win Productivity Program  
Restructuring Cost and Reserve [Line Items]  
Schedule of Restructuring Reserve by Segment
The Execute to Win Productivity Program charges related to the segments, as well as corporate expenses, were as follows:
For the Year Ended December 31,
(In millions)20212020
Seed$— $15 
Crop Protection11 98 
Corporate expenses(2)63 
Total$$176 
Schedule of Restructuring Reserve by Type of Cost [Table Text Block]
The below is a summary of charges incurred related to the Execute to Win Productivity Program for the year ended December 31, 2020:
For the Year Ended December 31,
(In millions)20212020
Severance and related benefit costs - net$(2)$63 
Asset related charges11 113 
Total restructuring and asset related charges - net$$176 
XML 67 R47.htm IDEA: XBRL DOCUMENT v3.22.0.1
Supplementary Information (Tables)
12 Months Ended
Dec. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule of Other Nonoperating Income (Expense)
Other Income - NetFor the Year Ended December 31,
(In millions)202120202019
Interest income$77 $56 $59 
Equity in earnings (losses) of affiliates - net14 — (9)
Net gain (loss) on sales of businesses and other assets1
21 (2)64 
Net exchange gains (losses)2
(54)(174)(99)
Non-operating pension and other post employment benefit credit (costs)3
1,318 368 191 
Miscellaneous income (expenses) - net4
(28)(36)
Other income - net$1,348 $212 $215 
1.    The year ended December 31, 2021 includes a gain of $19 million relating to the sale of a business in Asia Pacific in the crop protection segment. The year ended December 31, 2020 includes a loss of $(53) million and a gain of $27 million relating to the expected sale of the La Porte site, for which the company signed an agreement in 2020, and the sale of a business in Asia Pacific in the crop protection segment, respectively.
2.    Includes net pre-tax exchange gains (losses) of $(67) million, $(82) million and $(51) million associated with the devaluation of the Argentine peso for the years ended December 31, 2021, 2020 and 2019, respectively.
3.    Includes non-service related components of net periodic benefit credits (costs) (interest cost, expected long-term rate of return on plan assets, amortization of unrecognized gain (loss), amortization of prior service benefit and settlement gain (loss)). 
4.    Miscellaneous income (expenses) - net, includes losses from sale of receivables, tax indemnification adjustments related to changes in indemnification balances as a result of the application of the terms of the Tax Matters Agreement between Corteva and Dow and/or DuPont, and other items. The year ended December 31, 2021 also includes the Employee Retention Credit of $60 million pursuant to the Coronavirus Aid, Relief, and Economic Security (“CARES”) Act as enhanced by the Consolidated Appropriations Act (“CAA”) and American Rescue Plan Act (“ARPA”), a gain from the remeasurement of an equity investment of $47 million, a charge related to a contract termination with a third-party service provider of $(54) million and the 2021 officer indemnification payment.
Foreign Currency Exchange Gain (Loss)
For the Year Ended December 31,
(In millions)202120202019
Subsidiary Monetary Position Gain (Loss)
Pre-tax exchange gain (loss) $(72)$(263)$(41)
Local tax (expenses) benefits (30)34 
Net after-tax impact from subsidiary exchange gain (loss) $(102)$(229)$(39)
Hedging Program Gain (Loss)
Pre-tax exchange gain (loss) $18 $89 $(58)
Tax (expenses) benefits (4)(21)13 
Net after-tax impact from hedging program exchange gain (loss) $14 $68 $(45)
Total Exchange Gain (Loss)
Pre-tax exchange gain (loss) $(54)$(174)$(99)
Tax (expenses) benefits(34)13 15 
Net after-tax exchange gain (loss) $(88)$(161)$(84)
Restrictions on Cash and Cash Equivalents
(In millions)December 31, 2021December 31, 2020
Cash and cash equivalents$4,459 $3,526 
Restricted cash equivalents377 347 
Total cash, cash equivalents and restricted cash equivalents$4,836 $3,873 
XML 68 R48.htm IDEA: XBRL DOCUMENT v3.22.0.1
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2021
Income Tax Disclosure [Abstract]  
Geographic Allocation of Income and Provision for Income Taxes
Geographic Allocation of Income (Loss) and Provision for (Benefit from) Income Taxes For the Year Ended December 31,
(In millions)202120202019
Income (loss) from continuing operations before income taxes
Domestic$941 $(83)$(1,352)
Foreign1,405 758 1,036 
Income (loss) from continuing operations before income taxes$2,346 $675 $(316)
Current tax expense (benefit)
Federal$(13)$28 $(11)
State and local
Foreign329 222 317 
Total current tax expense (benefit)$322 $259 $307 
Deferred tax expense (benefit)
Federal$164 $(116)$(392)
State and local55 27 156 
Foreign(17)(251)(117)
Total deferred tax expense (benefit)$202 $(340)$(353)
Provision for (benefit from) income taxes on continuing operations524 (81)(46)
Net income (loss) from continuing operations after taxes$1,822 $756 $(270)
Reconciliation to US Statutory Rate
Reconciliation to U.S. Statutory RateFor the Year Ended December 31,
202120202019
Statutory U.S. federal income tax rate21.0 %21.0 %21.0 %
Effective tax rates on international operations - net 1
(2.5)(13.9)(18.4)
Acquisitions, divestitures and ownership restructuring activities 2
(0.1)(0.3)(10.7)
U.S. research and development credit(2.4)(2.9)7.0 
Exchange gains/losses 3
1.9 3.5 (1.8)
State and local incomes taxes - net2.1 4.0 3.2 
Impact of Swiss Tax Reform4
0.2 (27.0)11.9 
Excess tax benefits/deficiencies from stock compensation(0.2)1.0 (0.6)
Tax settlements and expiration of statute of limitations— 0.4 3.9 
Other - net2.3 2.2 (0.9)
Effective tax rate on income from continuing operations22.3 %(12.0)%14.6 %
1.    Includes the effects of local and U.S. taxes related to earnings of non-U.S. subsidiaries, changes in the amount of unrecognized tax benefits associated with these earnings, losses at non-U.S. subsidiaries without local tax benefits due to valuation allowances, and other permanent differences between tax and U.S. GAAP results. Includes a tax benefit of $(51) million for the year ended December 31, 2020, related to a return to accrual adjustment associated with an elective change in accounting method for the 2019 tax year impact of foreign tax provisions.
2.    See Notes 4 - Common Control Business Combination, and Note 5 - Divestitures and Other Transactions, to the Consolidated Financial Statements, for additional information.
3.    Principally reflects the impact of foreign exchange gains and losses on net monetary assets for which no corresponding tax impact is realized. Further information about the company's foreign currency hedging program is included in Note 9 - Supplementary Information, and Note 22 - Financial Instruments, under the heading Foreign Currency Risk.
4.    Reflects tax benefits of $(182) million primarily driven by the recognition of an elective cantonal component of the recent enactment of the Federal Act on Tax Reform and AHV Financing ("Swiss Tax Reform") for the year ended December 31, 2020. Reflects tax benefits of $(38) million associated with the enactment of the Federal Act on Tax Reform and AHV Financing ("Swiss Tax Reform"), for the year ended December 31, 2019.
Deferred Tax Balances
Deferred Tax Balances at December 31,20212020
(In millions)AssetsLiabilitiesAssetsLiabilities
Property1
$— $341 $— $297 
Tax loss and credit carryforwards2,3
464 — 497 — 
Accrued employee benefits904 — 1,415 — 
Other accruals and reserves1
309 — 365 — 
Intangibles— 2,260 — 2,418 
Inventory153 — 127 — 
Research and development capitalization224 — 186 — 
Investments36 — 56 — 
Unrealized exchange gains/losses— 10 — 
Other – net105 — 91 — 
Subtotal$2,195 $2,611 $2,739 $2,715 
Valuation allowances3
(366)— (453)— 
Total$1,829 $2,611 $2,286 $2,715 
Net Deferred Tax Asset (Liability)$(782)$(429)
1.    Prior year classifications in property and other accruals and reserves have been adjusted from their previous presentation. Adjustments did not impact the amount of the net deferred tax asset (liability) recorded in the Consolidated Balance Sheets.    
2.    Primarily related to the realization of recorded tax benefits on tax loss and credit carryforwards from operations in the United States, Brazil, and Spain.    
3.    In connection with the company's 2021 internal legal entity restructuring, the company reduced various state net operating loss carryforwards and corresponding full valuation allowances by $61 million. There was no impact on the statement of operations. During the year ended December 31, 2020, the company established a $19 million state tax valuation allowance in the U.S. based on a change in judgement about the realizability of a deferred tax asset.
Operating Loss and Tax Credit Carryforwards
Operating Loss and Tax Credit CarryforwardsDeferred Tax Asset
(In millions)20212020
Operating loss carryforwards
Expire within 5 years$123 $99 
Expire after 5 years or indefinite expiration210 343 
Total operating loss carryforwards$333 $442 
Tax credit carryforwards
Expire within 5 years$14 $14 
Expire after 5 years or indefinite expiration117 41 
Total tax credit carryforwards$131 $55 
Total Operating Loss and Tax Credit Carryforwards$464 $497 
Total Gross Unrecognized Tax Benefits
Total Gross Unrecognized Tax BenefitsFor the Year Ended December 31,
(In millions)202120202019
Total unrecognized tax benefits as of beginning of period$395 $426 $749 
Decreases related to positions taken on items from prior years(7)(14)(167)
Increases related to positions taken on items from prior years13 77 
Increases related to positions taken in the current year54 
Settlement of uncertain tax positions with tax authorities(17)(18)(9)
Impact of Internal Reorganizations— — (278)
Decreases due to expiration of statutes of limitations(16)(7)— 
Exchange (gain) loss— (3)— 
Total unrecognized tax benefits as of end of period$377 $395 $426 
Total unrecognized tax benefits that, if recognized, would impact the effective tax rate$157 $156 $188 
Total amount of interest and penalties (benefits) recognized in provision for (benefit from) income taxes on continuing operations$$(2)$(4)
Total accrual for interest and penalties associated with unrecognized tax benefits at end of period$11 $18 $24 
Tax Year Subject to Examination
Tax Years Subject to Examination by Major Tax Jurisdiction at December 31, 2021Earliest Open Year
Jurisdiction
Argentina2015
Brazil2014
Canada2012
China2014
France2019
India2015
Italy2016
Switzerland2016
United States:
Federal income tax2012
State and local income tax2008
XML 69 R49.htm IDEA: XBRL DOCUMENT v3.22.0.1
Earnings Per Share of Common Stock (Tables)
12 Months Ended
Dec. 31, 2021
Earnings Per Share [Abstract]  
Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table Text Block]
Earnings (Loss) Per Share Calculations - BasicFor the Year Ended December 31,
(Dollars per share)202120202019
Earnings (loss) per share of common stock from continuing operations$2.46 $0.98 $(0.38)
(Loss) earnings per share of common stock from discontinued operations(0.07)(0.07)(0.90)
Earnings (loss) per share of common stock$2.39 $0.91 $(1.28)
Schedule of Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Table Text Block]
Earnings (Loss) Per Share Calculations - DilutedFor the Year Ended December 31,
(Dollars per share)202120202019
Earnings (loss) per share of common stock from continuing operations$2.44 $0.98 $(0.38)
(Loss) earnings per share of common stock from discontinued operations(0.07)(0.07)(0.90)
Earnings (loss) per share of common stock$2.37 $0.91 $(1.28)
Share Count Information [Table Text Block]
Share Count InformationFor the Year Ended December 31,
(Shares in millions)202120202019
Weighted-average common shares - basic1
735.9 748.7 749.5 
Plus dilutive effect of equity compensation plans2
5.7 2.5 — 
Weighted-average common shares - diluted741.6 751.2 749.5 
Potential shares of common stock excluded from EPS calculations3
2.8 9.4 14.4 
1.Share amounts for all periods prior to the Corteva Distribution were based on 748.8 million shares of Corteva, Inc. common stock distributed to holders of DowDuPont's common stock on June 1, 2019, plus 0.6 million of additional shares in which accelerated vesting conditions have been met.
2.Diluted earnings (loss) per share considers the impact of potentially dilutive securities except in periods in which there is a loss because the inclusion of the potential common shares would have an anti-dilutive effect.
3.These outstanding potential shares of common stock relating to stock options, restricted stock units and performance-based restricted stock units were excluded from the calculation of diluted earnings (loss) per share because (i) the effect of including stock options and restricted stock units would have been anti-dilutive; and (ii) the performance metrics have not yet been achieved for the outstanding potential shares relating to performance-based restricted stock units, which are deemed to be contingently issuable.
Earnings Per Share of Common Stock Reconciliation
Net Income (Loss) for Earnings Per Share Calculations - Basic and DilutedFor the Year Ended December 31,
(In millions)202120202019
Income (loss) from continuing operations after income taxes$1,822 $756 $(270)
Net income (loss) attributable to continuing operations noncontrolling interests10 20 13 
Income (loss) from continuing operations attributable to Corteva common stockholders1,812 736 (283)
(Loss) income from discontinued operations, net of tax(53)(55)(671)
Net income (loss) attributable to discontinued operations noncontrolling interests— — 
(Loss) income from discontinued operations attributable to Corteva common stockholders(53)(55)(676)
Net income (loss) attributable to common stockholders$1,759 $681 $(959)
XML 70 R50.htm IDEA: XBRL DOCUMENT v3.22.0.1
Accounts and Notes Receivable, Net (Tables)
12 Months Ended
Dec. 31, 2021
Receivables [Abstract]  
Schedule of Accounts and Notes Receivable
(In millions)December 31, 2021December 31, 2020
Accounts receivable – trade1
$3,441 $3,754 
Notes receivable – trade1,2
120 163 
Other3
1,250 1,009 
Total accounts and notes receivable - net$4,811 $4,926 
1.Accounts receivable – trade and notes receivable – trade are net of allowances of $210 million and $208 million at December 31, 2021 and December 31, 2020, respectively. Allowances are equal to the estimated uncollectible amounts and are based on the expected credit losses and were developed using a loss-rate method.
2.Notes receivable – trade primarily consists of receivables for deferred payment loan programs for the sale of seed products to customers. These loans have terms of one year or less and are primarily concentrated in North America. The company maintains a rigid pre-approval process for extending credit to customers in order to manage overall risk and exposure associated with credit losses. As of December 31, 2021 and 2020, there were no significant impairments related to current loan agreements.
3.Other includes receivables in relation to indemnification assets, value added tax, general sales tax and other taxes. No individual group represents more than 10 percent of total receivables. In addition, Other includes amounts due from nonconsolidated affiliates of $104 million and $106 million as of December 31, 2021 and 2020, respectively.
Accounts Receivable, Allowance for Credit Loss
(In millions)
2020
Balance at December 31, 2019$174 
Net provision for credit losses1
52 
Write-offs charged against allowance / other1
(18)
Balance at December 31, 2020$208 
2021
Balance at December 31, 2020$208 
Net provision for credit losses
Write-offs charged against allowance / other
Balance at December 31, 2021$210 
1. Prior year classifications in the changes in the allowance for doubtful receivables have been adjusted from their previous presentation. Adjustments did not impact the amount of the provision or the allowance for doubtful receivables recorded in the Consolidated Statements of Operations or the Consolidated Balance Sheets.
XML 71 R51.htm IDEA: XBRL DOCUMENT v3.22.0.1
Inventories (Tables)
12 Months Ended
Dec. 31, 2021
Inventory, Net [Abstract]  
Schedule of Inventory, Current [Table Text Block]
(In millions)December 31, 2021December 31, 2020
Finished products$2,497 $2,584 
Semi-finished products2,076 1,813 
Raw materials and supplies607 485 
Total inventories$5,180 $4,882 
XML 72 R52.htm IDEA: XBRL DOCUMENT v3.22.0.1
Property, Plant and Equipment (Tables)
12 Months Ended
Dec. 31, 2021
Property, Plant and Equipment [Abstract]  
Property, Plant and Equipment [Table Text Block]
(In millions)December 31, 2021December 31, 2020
Land and land improvements$420 $451 
Buildings1,487 1,525 
Machinery and equipment5,729 5,556 
Construction in progress728 721 
Total property, plant and equipment8,364 8,253 
Accumulated depreciation(4,035)(3,857)
Total property, plant and equipment - net$4,329 $4,396 
Property, Plant and Equipment - Depreciation Expense [Table Text Block]
For the Year Ended December 31,
(In millions)202120202019
Depreciation expense$521 $495 $525 
XML 73 R53.htm IDEA: XBRL DOCUMENT v3.22.0.1
Goodwill and Other Intangible Assets (Tables)
12 Months Ended
Dec. 31, 2021
Goodwill and Intangible Asset Disclosure [Abstract]  
Schedule of Goodwill
(In millions)Crop ProtectionSeedTotal
Balance as of December 31, 2019$4,743 $5,486 $10,229 
Currency translation adjustment31 38 69 
Other goodwill adjustments and acquisitions1
(29)— (29)
Balance as of December 31, 2020$4,745 $5,524 $10,269 
Currency translation adjustment(73)(87)(160)
Other goodwill adjustments and acquisitions2
— (2)(2)
Balance as of December 31, 2021$4,672 $5,435 $10,107 
1.Primarily consists of the goodwill included in the sale of businesses in the crop protection segment.
2.Consists of the goodwill included in the sale of a business in the seed segment.
Other Intangible Assets
(In millions)December 31, 2021December 31, 2020
 GrossAccumulated
Amortization
NetGrossAccumulated
Amortization
Net
Intangible assets subject to amortization (Definite-lived):
      
Germplasm$6,265 $(571)$5,694 $6,265 $(317)$5,948 
Customer-related
1,953 (487)1,466 1,984 (380)1,604 
Developed technology1,485 (679)806 1,451 (525)926 
Trademarks/trade names1
2,012 (172)1,840 2,019 (99)1,920 
Favorable supply contracts
475 (396)79 475 (302)173 
Other2
405 (256)149 405 (239)166 
Total other intangible assets with finite lives
12,595 (2,561)10,034 12,599 (1,862)10,737 
Intangible assets not subject to amortization (Indefinite-lived):
      
IPR&D10 — 10 10 — 10 
Total other intangible assets
10 — 10 10 — 10 
Total$12,605 $(2,561)$10,044 $12,609 $(1,862)$10,747 
1.Beginning on October 1, 2020, the company changed its indefinite life assertion of its trade name asset to definite lived with a useful life of 25 years. This change is the result of the launch of BrevantTM seed in the retail channel in the U.S. Prior to changing the useful life of the trade name asset, the company tested the asset for impairment under ASC 350 - Intangibles, Goodwill and Other, concluding the asset was not impaired.
2.Primarily consists of sales and farmer networks, marketing and manufacturing alliances and noncompetition agreements.
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense
(In millions)
2022$700 
2023$620 
2024$606 
2025$569 
2026$558 
XML 74 R54.htm IDEA: XBRL DOCUMENT v3.22.0.1
Leases (Tables)
12 Months Ended
Dec. 31, 2021
Leases [Abstract]  
Lease, Cost [Table Text Block]
For the Year Ended December 31,
(In millions)20212020
Operating lease cost$158 $197 
Finance lease cost
Amortization of right-of-use assets1
Interest on lease liabilities— — 
Total finance lease cost1
Short-term lease cost1414 
Variable lease cost8
Total lease cost$181 $220 
Schedule of Supplemental Cash Flow Information Related to Leases [Table Text Block]
For the Year Ended December 31,
(In millions)20212020
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash outflows from operating leases$169 $202 
Operating cash outflows from finance leases$— $— 
Financing cash outflows from finance leases$$
Schedule of Lease Assets and Liabilities [Table Text Block]
(In millions)December 31, 2021December 31, 2020
Operating Leases
 
Operating lease right-of-use assets1
$458 $521 
Current operating lease liabilities2
121 138 
Noncurrent operating lease liabilities3
338 391 
Total operating lease liabilities
$459 $529 
Finance Leases
 
Property, plant, and equipment, gross
$15 $15 
Accumulated depreciation
(11)(10)
Property, plant, and equipment, net
Short-term borrowings and finance lease obligations
Long-Term Debt
Total finance lease liabilities$$
1.Included in other assets in the Consolidated Balance Sheet.
2.Included in accrued and other current liabilities in the Consolidated Balance Sheet.
3.Included in other noncurrent obligations in the Consolidated Balance Sheet.
Lease Term and Discount Rate [Table Text Block]
Lease Term and Discount RateDecember 31, 2021December 31, 2020
Weighted-average remaining lease term (years)
Operating leases7.417.71
Financing leases3.364.26
Weighted average discount rate
Operating leases2.75 %3.06 %
Financing leases3.29 %3.28 %
Maturities of Lease Liabilities [Table Text Block]
Maturity of Lease Liabilities at December 31, 2021Operating LeasesFinancing Leases
(In millions)
2022$132 $
202394 
202471 
202560 
202649 — 
2027 and thereafter106 — 
Total lease payments512 
Less: Interest53 — 
Present value of lease liabilities$459 $
Maturity of Lease Liabilities at December 31, 2020Operating LeasesFinancing Leases
(In millions)
2021$152 $
2022114 
202383 
202461 
202551 
2026 and thereafter137 — 
Total lease payments598 
Less: Interest69 — 
Present value of lease liabilities$529 $
XML 75 R55.htm IDEA: XBRL DOCUMENT v3.22.0.1
Long-Term Debt and Available Credit Facilities (Tables)
12 Months Ended
Dec. 31, 2021
Debt Disclosure [Abstract]  
Long-Term Debt
Long-Term Debt
December 31, 2021December 31, 2020
(In millions)AmountWeighted Average RateAmountWeighted Average Rate
Promissory notes and debentures:
  Maturing in 2025500 1.70 %500 1.70 %
  Maturing in 2030500 2.30 %500 2.30 %
Other loans:
Foreign currency loans, various rates and maturities
Medium-term notes, varying maturities through 2041107 — %109 — %
Finance lease obligations
Less: Unamortized debt discount and issuance costs10 11 
Less: Long-term debt due within one year
Total$1,100 $1,102 
(in millions)Amount
4.625% Notes due 2020$474 
3.625% Notes due 2021296 
4.250% Notes due 2021163 
2.800% Notes due 2023381 
6.500% Debentures due 202857 
5.600% Senior Notes due 203642 
4.900% Notes due 204148 
4.150% Notes due 204369 
Total$1,530 
Committed and Available Credit Facilities
Committed and Available Credit Facilities at December 31, 2021
(In millions)Effective DateCommitted CreditCredit AvailableMaturity DateInterest
Revolving Credit FacilityMay 2019$3,000 $3,000 May 2024Floating Rate
Revolving Credit FacilityMay 20193,000 3,000 May 2023Floating Rate
Total Committed and Available Credit Facilities$6,000 $6,000 
XML 76 R56.htm IDEA: XBRL DOCUMENT v3.22.0.1
Commitments and Contingent Liabilities (Tables)
12 Months Ended
Dec. 31, 2021
Commitments and Contingencies Disclosure [Abstract]  
Schedule of Environmental Loss Contingencies
As of December 31, 2021
(In millions)Indemnification Asset
Accrual balance3
Potential exposure above amount accrued3
Environmental Remediation Stray Liabilities
Chemours related obligations - subject to indemnity1,2
$159 $159 $262 
Other discontinued or divested businesses obligations1
15 75 187 
Environmental remediation liabilities primarily related to DuPont - subject to indemnity from DuPont2
37 37 66 
Environmental remediation liabilities not subject to indemnity— 82 49 
Indemnification liabilities related to the MOU4
99 28 
Total$220 $452 $592 
1.Represents liabilities that are subject the $200 million threshold and sharing arrangements as discussed on page F-46, under Corteva Separation Agreement.
2.The company has recorded an indemnification asset related to these accruals, including $40 million related to the Superfund sites.
3.Accrual balance represents management’s best estimate of the costs of remediation and restoration, although it is reasonably possible that the potential exposure, as indicated, could range above the amounts accrued, as there are inherent uncertainties in these estimates. Accrual balance includes $68 million for remediation of Superfund sites. Amounts do not include possible impacts from the remediation elements of the EPAs October 2021 PFAS Strategic Roadmap (as applicable) or possible revisions to Chemours’ Consent Order with the North Carolina Department of Environmental Quality, as any possible impacts, to the extent such items would be reimbursable under the MOU, are not yet determinable.
4.Represents liabilities that are subject to the $150 million threshold and sharing agreements as discussed on page F-44, under the header "Chemours / Performance Chemicals.
XML 77 R57.htm IDEA: XBRL DOCUMENT v3.22.0.1
Stockholders' Equity (Tables)
12 Months Ended
Dec. 31, 2021
Equity [Abstract]  
Reconciliation of Common Stock Share Activity
Shares of common stockIssued
Balance June 1, 2019748,815,000 
Issued586,000 
Repurchased and retired(824,000)
Balance December 31, 2019748,577,000 
Issued3,384,000 
Repurchased and retired(8,503,000)
Balance December 31, 2020743,458,000 
Issued4,019,000 
Repurchased and retired(20,950,000)
Balance December 31, 2021726,527,000 
Schedule of Noncontrolling Interests Represented by Preferred Stock [Table Text Block]
(Shares in thousands)Number of Shares
Authorized23,000
$4.50 Series, callable at $1201,673
$3.50 Series, callable at $102700
Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]
(In millions)
Cumulative Translation Adjustment1
Derivative InstrumentsPension Benefit PlansOther Benefit PlansUnrealized Gain (Loss) on InvestmentsTotal
2019
Balance January 1, 2019$(2,793)$(26)$(620)$79 $— $(3,360)
Other comprehensive income (loss) before reclassifications(274)16 (723)(159)— (1,140)
Amounts reclassified from accumulated other comprehensive income (loss)— 12 (1)— 16 
Net other comprehensive income (loss) (274)28 (718)(160)— (1,124)
Impact of Internal Reorganizations
1,123 — 91 — — 1,214 
Balance December 31, 2019$(1,944)$$(1,247)$(81)$— $(3,270)
2020
Other comprehensive income (loss) before reclassifications$(26)$(81)$(191)$670 $(10)$362 
Amounts reclassified from accumulated other comprehensive income (loss)— 12 — 18 
Net other comprehensive income (loss) (26)(69)(186)671 (10)380 
Balance December 31, 2020$(1,970)$(67)$(1,433)$590 $(10)$(2,890)
2021
Other comprehensive income (loss) before reclassifications$(573)$143 $996 $25 $$594 
Amounts reclassified from accumulated other comprehensive income (loss)— (4)41 (646)(602)
Net other comprehensive income (loss)(573)139 1,037 (621)10 (8)
Balance December 31, 2021$(2,543)$72 $(396)$(31)$— $(2,898)
1.The cumulative translation adjustment losses for the year ended December 31, 2021 was primarily driven by the strengthening of the U.S. Dollar ("USD") against the European Euro ("EUR"), Swiss franc ("CHF") and Turkish Lira (“TRY”). The cumulative translation adjustment losses for the year ended December 31, 2020 was primarily driven by the strengthening of the U.S. Dollar ("USD") against the Brazilian Real ("BRL"), partially offset by the weakening of the U.S. Dollar against the Swiss franc ("CHF") and European Euro ("EUR").
Other Comprehensive Income (Loss)
For the Year Ended December 31,
(In millions)202120202019
Derivative instruments$(41)$24 $(8)
Pension benefit plans - net(319)54 231 
Other benefit plans - net188 (211)52 
(Provision for) benefit from income taxes related to other comprehensive income (loss) items$(172)$(133)$275 
Reclassification out of Accumulated Other Comprehensive Income [Table Text Block]
(In millions)For the Year Ended December 31,
202120202019
Derivative Instruments1:
$(13)$18 $13 
Tax (benefit) expense2
(6)(1)
After-tax$(4)$12 $12 
Amortization of pension benefit plans:
  Prior service (benefit) cost3,4
$(2)$(1)$(1)
  Actuarial (gains) losses3,4,5
55 
  Settlement (gain) loss3,4,5
Total before tax54 
Tax (benefit) expense2
(13)(1)— 
After-tax$41 $$
Amortization of other benefit plans:
  Prior service (benefit) cost3,4
$(922)$— $— 
  Actuarial (gains) losses3,4
81 (1)
  Curtailment (gain) loss(1)— — 
Total before tax(842)(1)
Tax (benefit) expense2
196 — — 
After-tax$(646)$$(1)
Unrealized (Gain) Loss on Investments4
$$— $— 
Tax (benefit) expense2
— — — 
After-tax
$$— $— 
Total reclassifications for the period, after-tax$(602)$18 $16 
1.Reflected in cost of goods sold in the Consolidated Statements of Operations.
2.Reflected in provision for (benefit from) income taxes from continuing operations in the Consolidated Statements of Operations.
3.These accumulated other comprehensive (loss) income components are included in the computation of net periodic benefit (credit) cost of the company's pension and other benefit plans. See Note 20 - Pension Plans and Other Post Employment Benefits, to the Consolidated Financial Statements, for additional information.
4.Reflected in other income - net in the Consolidated Statements of Operations.
5.A portion reflected in (loss) income from discontinued operations after income taxes for the year ended December 31, 2019.
XML 78 R58.htm IDEA: XBRL DOCUMENT v3.22.0.1
Pension Plans and Other Post Employment Benefit Plans (Tables)
12 Months Ended
Dec. 31, 2021
Retirement Benefits [Abstract]  
Defined Benefit Plan, Assumptions [Table Text Block]
The weighted-average assumptions used to determine pension plan obligations for all pension plans are summarized in the table below:
Weighted-Average Assumptions used to Determine Benefit ObligationsDecember 31, 2021December 31, 2020
Discount rate
2.82 %2.44 %
Rate of increase in future compensation levels1
2.55 %2.54 %
1.The rate of compensation increase excludes U.S. pension plans since the employees who participate in the U.S. pension plans no longer accrue additional benefits for future service and eligible compensation.

The weighted-average assumptions used to determine net periodic benefit costs for all pension plans are summarized in the table below:
Weighted-Average Assumptions used to Determine Net Periodic Benefit CostFor the Year Ended December 31,
202120202019
Discount rate
2.44 %3.19 %4.19 %
Rate of increase in future compensation levels1
2.54 %2.60 %2.84 %
Expected long-term rate of return on plan assets
5.73 %6.25 %6.24 %
1.The rate of compensation increase excludes U.S. pension plans since the employees who participate in the U.S. pension plans no longer accrue additional benefits for future service and eligible compensation.
The weighted-average assumptions used to determine benefit obligations for OPEB plans are summarized in the table below:
Weighted-Average Assumptions used to Determine Benefit ObligationsDecember 31, 2021December 31, 2020
Discount rate
2.59 %2.09 %

The weighted-average assumptions used to determine net periodic benefit costs for the OPEB plans are summarized in the two tables below:
Weighted-Average Assumptions used to Determine Net Periodic Benefit CostFor the Year Ended December 31,
202120202019
Discount rate
2.09 %3.07 %3.93 %

As of December 31, 2021, health care cost trend rates do not impact the benefit obligations for the OPEB plans because of the 2020 OPEB Plan Amendments. For the year ended December 31, 2020 and 2019, the health care cost trend rate was assumed to be 7.0 percent and 7.2 percent for next year, respectively.
Schedule of Pension Plans and Other Postemployment Benefits [Table Text Block]
Summarized information on the company's pension and other post employment benefit plans is as follows:
Change in Projected Benefit Obligations, Plan Assets and Funded Status
Defined Benefit Pension PlansOther Post Employment Benefits
(In millions)For the Year Ended December 31, 2021For the Year Ended December 31, 2020For the Year Ended December 31, 2021For the Year Ended December 31, 2020
Change in benefit obligations:
Benefit obligation at beginning of the period$21,682 $21,004 $1,571 $2,591 
Service cost25 26 
Interest cost364 559 21 66 
Plan participants' contributions35 34 
Actuarial (gain) loss(524)1,659 (33)59 
Benefits paid(1,490)(1,538)(233)(241)
Plan amendments(15)(3)— (939)
Other1
(240)— — — 
Effect of foreign exchange rates(30)(27)— (1)
Benefit obligations at end of the period$19,775 $21,682 $1,362 $1,571 
Change in plan assets:
Fair value of plan assets at beginning of the period$17,835 $16,941 $— $— 
Actual return on plan assets1,685 2,404 — — 
Employer contributions49 62 198 207 
Plan participants' contributions35 34 
Benefits paid(1,490)(1,538)(233)(241)
Other1
(240)— — — 
Effect of foreign exchange rates(15)(36)— — 
Fair value of plan assets at end of the period$17,827 $17,835 $— $— 
Funded status    
U.S. plan with plan assets$(1,471)$(3,301)$— $— 
Non-U.S. plans with plan assets(62)(98)— — 
All other plans 2,3
(415)(448)(1,362)(1,571)
Funded status at end of the period$(1,948)$(3,847)$(1,362)$(1,571)
1.Relates to the transfer of certain benefit obligations and related assets associated with the principal U.S. pension plan to an insurance company through the purchase of nonparticipating group annuity contracts.
2.As of December 31, 2021 and December 31, 2020, $219 million and $249 million, respectively, of the benefit obligations are supported by funding under the Trust agreement, defined in the "Trust Assets" section below.
3.Includes pension plans maintained around the world where funding is not customary.
Defined Benefit Pension PlansOther Post Employment Benefits
(In millions)December 31, 2021December 31, 2020December 31, 2021December 31, 2020
Amounts recognized in the Consolidated Balance Sheets:
Other Assets$$$— $— 
Accrued and other current liabilities(46)(32)(144)(217)
Pension and other post employment benefits - noncurrent (1,906)(3,822)(1,218)(1,354)
Net amount recognized$(1,948)$(3,847)$(1,362)$(1,571)
Pretax amounts recognized in accumulated other comprehensive income (loss):
Net gain (loss)$(543)$(1,886)$(50)$(163)
Prior service benefit (cost)27 14 17 939 
Pretax balance in accumulated other comprehensive income (loss) at end of year$(516)$(1,872)$(33)$776
Defined Benefit Plan, Plan with Projected Benefit Obligation in Excess of Plan Assets [Table Text Block]
Pension Plans with Projected Benefit Obligations in Excess of Plan AssetsDecember 31, 2021December 31, 2020
(In millions)
Projected benefit obligations$19,519 $21,513 
Fair value of plan assets17,567 17,659 
Defined Benefit Plan, Plan with Accumulated Benefit Obligation in Excess of Plan Assets [Table Text Block]
Pension Plans with Accumulated Benefit Obligations in Excess of Plan AssetsDecember 31, 2021December 31, 2020
(In millions)
Accumulated benefit obligations$19,501 $21,369 
Fair value of plan assets17,567 17,550 
Schedule of Net Benefit Costs [Table Text Block]
(In millions)Defined Benefit Pension PlansOther Post Employment Benefits
For the Year Ended December 31,For the Year Ended December 31,
Components of net periodic benefit (credit) cost and amounts recognized in other comprehensive income (loss)202120202019202120202019
Net Periodic Benefit (Credit) Cost:
Service cost$25 $26 $41 $$$
Interest cost364 559 769 21 66 84 
Expected return on plan assets(915)(1,000)(1,078)— — — 
Amortization of unrecognized loss (gain)55 81 (1)
Amortization of prior service (benefit) cost(2)(1)(1)(922)— — 
Curtailment loss (gain) — — (2)(1)— — 
Settlement loss— — — 
Net periodic benefit (credit) cost - Total$(472)$(409)$(264)$(820)$69 $87 
Less: Discontinued operations1
— — (14)— — — 
Net periodic benefit (credit) cost - continuing operations$(472)$(409)$(250)$(820)$69 $87 
Changes in plan assets and benefit obligations recognized in other comprehensive income (loss):
Net gain (loss)$1,284 $(247)$(970)$33 $(59)$(211)
Amortization of unrecognized (gain) loss55 81 (1)
Prior service benefit (cost)15 11 — 939 — 
Amortization of prior service (benefit) cost(2)(1)(1)(922)— — 
Curtailment (gain) loss— — — (1)— — 
Settlement loss— — — 
Effect of foreign exchange rates(2)— — 
Total benefit (loss) recognized in other comprehensive income (loss), attributable to Corteva$1,356 $(240)$(949)$(809)$882 $(212)
Total recognized in net periodic benefit (credit) cost and other comprehensive income (loss)$1,828 $169 $(685)$11 $813 $(299)
1.Includes non-service related components of net periodic benefit credit of $(31) million for the year ended December 31, 2019.
Schedule of Expected Benefit Payments [Table Text Block]
Estimated Future Benefit Payments at December 31, 2021Defined Benefit Pension PlansOther Post Employment Benefits
(In millions)
2022$1,459 $144 
20231,409 134 
20241,378 126 
20251,341 118 
20261,305 112 
Years 2027-20315,913 399 
Total$12,805 $1,033 
Schedule of Allocation of Plan Assets [Table Text Block]
Target Allocation for Plan AssetsDecember 31, 2021December 31, 2020
Asset Category
U.S. equity securities11 %20 %
Non-U.S. equity securities11 16 
Fixed income securities58 51 
Hedge funds
Private market securities
Real estate
Cash and cash equivalents
Total 100 %100 %
Basis of Fair Value MeasurementsTotalLevel 1Level 2Level 3
For the year ended December 31, 2021
(In millions)
Cash and cash equivalents$2,543 $2,543 $— $— 
U.S. equity securities 1
2,400 2,394 
Non-U.S. equity securities1,523 1,523 — — 
Debt – government-issued3,271 — 3,271 — 
Debt – corporate-issued4,591 — 4,589 
Debt – asset-backed682 — 682 — 
Private market securities— — 
Real estate26 — — 26 
Other78 — 75 
     Subtotal $15,117 $6,460 $8,547 $110 
Investments measured at net asset value
     Debt - government issued37 
     Debt - corporate issued
     U.S. equity securities33 
     Non-U.S. equity securities34 
     Hedge funds394 
     Private market securities1,822 
     Real estate funds759 
Total investments measured at net asset value$3,086 
Other items to reconcile to fair value of plan assets
     Pension trust receivables 2
655    
     Pension trust payables 3
(1,031)   
Total$17,827    
1.The Corteva pension plans directly held $201 million (approximately 1 percent of total plan assets) of Corteva, Inc. common stock at December 31, 2021.
2.Primarily receivables for investments securities sold.
3.Primarily payables for investment securities purchased.
Basis of Fair Value Measurements
For the year ended December 31, 2020
(In millions)TotalLevel 1Level 2Level 3
Cash and cash equivalents$2,616 $2,616 $— $— 
U.S. equity securities1
3,905 3,898 
Non-U.S. equity securities2,194 2,189 
Debt – government-issued3,569 — 3,569 — 
Debt – corporate-issued2,579 — 2,576 
Debt – asset-backed616 — 616 — 
Private market securities— — 
Real estate28 — — 28 
Other76 — 73 
     Subtotal $15,586 $8,703 $6,768 $115 
Investments measured at net asset value
     Debt - government issued36 
     Debt - corporate issued
     U.S. equity securities32 
     Non-U.S. equity securities32 
     Hedge funds391 
     Private market securities1,381 
     Real estate funds590 
Total investments measured at net asset value$2,469 
Other items to reconcile to fair value of plan assets
     Pension trust receivables2
214 
     Pension trust payables3
(434)   
Total$17,835    
1.The Corteva pension plans directly held $165 million (approximately 1 percent of total plan assets) of Corteva, Inc. at December 31, 2020.
2.Primarily receivables for investments securities sold.
3.Primarily payables for investment securities purchased.
Schedule of Effect of Significant Unobservable Inputs, Changes in Plan Assets [Table Text Block]
Fair Value Measurement of Level 3 Pension Plan AssetsU.S. equity securitiesNon-U.S. equity securitiesDebt – corporate-issuedPrivate market securitiesReal estateOtherTotal
(In millions)
Balance at January 1, 2020$$$$$33 $— $52 
Actual return on assets:
Relating to assets sold during the year ended December 31, 2020(25)(6)(7)— — — (38)
Relating to assets held at December 31, 202021 (5)34 
Purchases, sales and settlements, net— — — — — 
Transfers in or out of Level 3, net— — — — 61 62 
Balance at December 31, 2020$$$$$28 $73 $115 
Actual return on assets:
Relating to assets sold during the year ended December 31, 2021(1)(5)— — — (5)
Relating to assets held at December 31, 2021(3)(1)— (2)(2)(2)
Purchases, sales and settlements, net(1)(2)— — 
Balance at December 31, 2021$$— $$$26 $75 $110 
XML 79 R59.htm IDEA: XBRL DOCUMENT v3.22.0.1
Stock-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Weighted Average Assumptions - Stock Option Awards
Weighted-Average AssumptionsOIPEIP
For the year ended December 31, 2021For the year ended December 31, 2020For the year ended December 31, 2019
Dividend yield1.14 %1.67 %1.55 %
Expected volatility29.44 %23.14 %19.80 %
Risk-free interest rate1.0 %1.3 %2.4 %
Expected life of stock options granted during period (years)6.06.06.1
OIP [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Stock Option Activity
Stock OptionsFor the Year Ended December 31, 2021
Number of Shares
(in thousands)
Weighted Average Exercise Price (per share)Weighted Average Remaining Contractual Term (in years)Aggregate Intrinsic Value
(in thousands)
Outstanding at January 1, 20218,998 $34.21 5.27$50,077 
Granted849 45.37 
Exercised(3,206)32.44 
Forfeited/Expired(218)33.39 
Outstanding at December 31, 20216,423 $36.65 5.69$68,219 
Exercisable at December 31, 20214,739 $36.15 4.76$52,726 
RSU and PSU Activity
RSUs & PSUsFor the Year Ended December 31, 2021
Number of Shares
(in thousands)
Weighted Average Grant Date Fair Value
(per share)
Nonvested at January 1, 20215,883 $31.54 
Granted1,536 $45.30 
Vested(1,583)$35.59 
Forfeited(234)$32.99 
Nonvested at December 31, 20215,602 $34.11 
XML 80 R60.htm IDEA: XBRL DOCUMENT v3.22.0.1
Financial Instruments (Tables)
12 Months Ended
Dec. 31, 2021
Derivative [Line items]  
Notional Amounts of Derivatives
Notional Amounts
(In millions)
December 31, 2021December 31, 2020
Derivatives designated as hedging instruments:
Foreign currency contracts$1,252 $1,164 
Commodity contracts
$845 $383 
Derivatives not designated as hedging instruments:
Foreign currency contracts
$103 $647 
Commodity contracts
$$— 
Fair Value of Derivatives Instruments
December 31, 2021
(In millions)Balance Sheet LocationGross
Counterparty and Cash Collateral Netting1
Net Amounts Included in the Consolidated Balance Sheet
Asset derivatives:   
Derivatives designated as hedging instruments:
Foreign currency contractsOther current assets$37 $— $37 
Derivatives not designated as hedging instruments:  
Foreign currency contracts
Other current assets31 (20)11 
Commodity contractsOther current assets— 
Total asset derivatives
 $71 $(20)$51 
Liability derivatives:  
Derivatives designated as hedging instruments:
Foreign currency contractsAccrued and other current liabilities$$— $
Derivatives not designated as hedging instruments:  
Foreign currency contracts
Accrued and other current liabilities23 $(20)
Commodity contractsAccrued and other current liabilities— 
Total liability derivatives
 $26 $(20)$
December 31, 2020
(In millions)Balance Sheet LocationGross
Counterparty and Cash Collateral Netting1
Net Amounts Included in the Consolidated Balance Sheet
Asset derivatives:   
Derivatives designated as hedging instruments:
Foreign currency contractsOther current assets$15 $— $15 
Derivatives not designated as hedging instruments:  
Foreign currency contracts
Other current assets40 (40)— 
Total asset derivatives
 $55 $(40)$15 
Liability derivatives:  
Derivatives designated as hedging instruments:
Foreign currency contractsAccrued and other current liabilities$38 $— $38 
Derivatives not designated as hedging instruments:  
Foreign currency contracts
Accrued and other current liabilities97 (40)57 
Total liability derivatives
 $135 $(40)$95 
1.    Counterparty and cash collateral amounts represent the estimated net settlement amount when applying netting and set-off rights included in master netting arrangements between the company and its counterparties and the payable or receivable for cash collateral held or placed with the same counterparty.
Effect of Derivative Instruments
Amount of Gain (Loss) Recognized in OCI1 - Pre-Tax
For the Year Ended December 31,
(In millions)202120202019
Derivatives designated as hedging instruments:
Net investment hedges:
Foreign currency contracts$37 $(45)$— 
Cash flow hedges:
Foreign currency contracts27 (4)— 
Commodity contracts129 (62)23 
Total derivatives designated as hedging instruments$193 $(111)$23 
1.OCI is defined as other comprehensive income (loss).
(in millions)
Amount of (Loss) Gain Recognized in Income - Pre-Tax1
For the Year Ended December 31,
202120202019
Derivatives designated as hedging instruments:
Cash flow hedges:
Foreign currency contracts2
$(29)$17 $— 
Commodity contracts2
42 (35)(13)
Total derivatives designated as hedging instruments
13 (18)(13)
Derivatives not designated as hedging instruments:
Foreign currency contracts3
18 89 (58)
Foreign currency contracts2
(14)14 — 
Commodity contracts2
(18)
Total derivatives not designated as hedging instruments
(14)112 (49)
Total derivatives$(1)$94 $(62)
1.For cash flow hedges, this represents the portion of the gain (loss) reclassified from accumulated OCI into income during the period.
2.Recorded in cost of goods sold.
3.Gain recognized in other income - net was partially offset by the related gain on the foreign currency-denominated monetary assets and liabilities of the company's operations. See Note 9 - Supplementary Information, to the Consolidated Financial Statements for additional information.
Schedule of Available-for-sale Securities Reconciliation
Investing ResultsFor the Year Ended December 31,
(In millions)2021
Proceeds from sales of available-for-sale securities$226 
Gross realized losses$(7)
Commodity Contract [Member]  
Derivative [Line items]  
After-Tax Effect of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss)
For the Year Ended December 31,
(In millions)202120202019
Beginning balance$(16)$$(26)
Additions and revaluations of derivatives designated as cash flow hedges92 (44)16 
Clearance of hedge results to earnings(29)26 12 
Ending balance$47 $(16)$
Foreign Exchange Contract [Member]  
Derivative [Line items]  
After-Tax Effect of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss)
(In millions)For the Year Ended December 31, 2021For the Year Ended December 31, 2020
Beginning balance$(17)$— 
Additions and revaluations of derivatives designated as cash flow hedges24 (3)
Clearance of hedges results to earnings25 (14)
Ending balance$32 $(17)
XML 81 R61.htm IDEA: XBRL DOCUMENT v3.22.0.1
Fair Value Measurements (Tables)
12 Months Ended
Dec. 31, 2021
Fair Value Disclosures [Abstract]  
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]
December 31, 2021Significant Other Observable Inputs
(In millions)Level 1Level 2
Assets at fair value:
Marketable securities
$— $86 
Derivatives relating to:1
Foreign currency
— 68 
Equity securities2
48 — 
Total assets at fair value$48 $154 
Liabilities at fair value:
Derivatives relating to:1
Foreign currency
— 24 
Total liabilities at fair value$— $24 

December 31, 2020Significant Other Observable Inputs
(In millions)Level 1Level 2
Assets at fair value:
Marketable securities
$— $43 
Debt securities:
U.S. treasuries3
226 — 
Derivatives relating to:1
Foreign currency
— 55 
Total assets at fair value$226 $98 
Liabilities at fair value:
Derivatives relating to:1
Foreign currency
$— $135 
Total liabilities at fair value$— $135 
1.See Note 22 - Financial Instruments, to the Consolidated Financial Statements, for the classification of derivatives in the Consolidated Balance Sheets.
2.    The company's equity securities are included in "other assets" in the Consolidated Balance Sheets.
3.    The company's investments in U.S. treasuries, which are primarily available-for-sale, are included in "marketable securities" in the Consolidated Balance Sheets.
Fair Value, Assets Measured on Nonrecurring Basis [Table Text Block]
Basis of Fair Value Measurements on a Nonrecurring BasisSignificant Other Unobservable Inputs
(Level 3)
Total Losses
(In millions)
2019
Assets at fair value:
Developed technology
$— $(1)
Other intangible assets
$— $(6)
IPR&D
$— $(137)
XML 82 R62.htm IDEA: XBRL DOCUMENT v3.22.0.1
Geographic Information (Tables)
12 Months Ended
Dec. 31, 2021
Geographic Area, Revenues from External Customers [Abstract]  
Net Sales by Geographic Area
 Net Sales
For the Year Ended December 31,
(In millions)202120202019
United States$6,782 $6,510 $6,255 
Canada754 658 674 
EMEA3,123 2,842 2,740 
Latin America1
3,545 2,805 2,889 
Asia Pacific1,451 1,402 1,288 
Total$15,655 $14,217 $13,846 
1.Net sales for Brazil for the years ended December 31, 2021, 2020 and 2019 were $2,315 million, $1,724 million and $1,794 million, respectively.
Net Property By Geographic Area
 Net Property
(In millions)202120202019
United States$3,051 $3,014 $3,069 
Canada114 122 125 
EMEA566 601 566 
Latin America468 510 608 
Asia Pacific130 149 178 
Total$4,329 $4,396 $4,546 
XML 83 R63.htm IDEA: XBRL DOCUMENT v3.22.0.1
Segment Reporting (Tables)
12 Months Ended
Dec. 31, 2021
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information, by Segment [Table Text Block]

(In millions)
SeedCrop ProtectionTotal
As of and for the Year Ended December 31, 2021   
Net sales$8,402 $7,253 $15,655 
Segment operating EBITDA$1,512 $1,202 $2,714 
Depreciation and amortization$866 $377 $1,243 
Segment assets$23,270 $12,428 $35,698 
Investments in nonconsolidated affiliates$29 $47 $76 
Purchases of property, plant and equipment$237 $336 $573 
As of and for the Year Ended December 31, 2020   
Net sales$7,756 $6,461 $14,217 
Segment operating EBITDA$1,208 $1,004 $2,212 
Depreciation and amortization$798 $379 $1,177 
Segment assets$23,751 $13,099 $36,850 
Investments in nonconsolidated affiliates$22 $44 $66 
Purchases of property, plant and equipment$225 $250 $475 
As of and for the Year Ended December 31, 2019
Net sales$7,590 $6,256 $13,846 
Pro forma segment operating EBITDA$1,040 $1,066 $2,106 
Depreciation and amortization$628 $372 $1,000 
Segment assets1
$25,387 $13,492 $38,879 
Investments in nonconsolidated affiliates$27 $39 $66 
Purchase of property, plant and equipment$373 $293 $666 
1.On June 1, 2019, as a result of changes in reportable segments, $3,382 million of goodwill was reallocated from the seed reportable segment to the crop protection reportable segment. This change was not reflected in segment assets prior to June 1, 2019.
Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]
Income (loss) from continuing operations after income taxes to segment operating EBITDA
For the Year Ended December 31,
(In millions)202120202019
Income (loss) from continuing operations after income taxes$1,822 $756 $(270)
Provision for (benefit from) income taxes on continuing operations524 (81)(46)
Income (loss) from continuing operations before income taxes2,346 675 (316)
Depreciation and amortization1,243 1,177 1,000 
Interest income(77)(56)(59)
Interest expense30 45 136 
Exchange (gains) losses - net 1
54 174 66 
Non-operating (benefits) costs - net(1,256)(316)(129)
Mark-to-market (gains) losses on certain foreign currency contracts not designated as hedges2
— 
Significant items236 388 991 
Pro forma adjustments298 
Corporate expenses138 125 119 
Segment operating EBITDA3
$2,714 $2,212 $2,106 
1.Excludes a $(33) million foreign exchange loss for the year ended December 31, 2019 associated with the devaluation of the Argentine peso. See Note 9 - Supplementary Information, to the Consolidated Financial Statements, for additional information.
2.Effective January 1, 2021, on a prospective basis, the company excludes net unrealized gain or loss from mark-to-market activity for certain foreign currency derivative instruments that do not qualify for hedge accounting. There were no unrealized mark-to-market (gains) losses for the years ended December 31, 2020 and 2019.
3.The year ended December 31, 2019 is presented on a pro forma basis, prepared in accordance with Article 11 of Regulation S-X that was in effect prior to recent amendments.
Reconciliation of Assets from Segment to Consolidated [Table Text Block]
Segment assets to total assets (in millions)
December 31, 2021December 31, 2020
Total segment assets$35,698 $36,850 
Corporate assets6,646 5,799 
Total assets$42,344 $42,649 
Reconciliation of Other Significant Reconciling Items from Segments to Consolidated [Table Text Block]
Other Items (in millions)
Segment Totals
Adjustments 1
Consolidated Totals
For the Year Ended December 31, 2019
Depreciation and amortization$1,000 $599 $1,599 
Purchase of property, plant and equipment$666 $497 $1,163 
1.See Note 5 - Divestitures and Other Transactions, to the Consolidated Financial Statements, for additional information
Schedule of Additional Segment Details [Table Text Block]
(In millions)SeedCrop ProtectionCorporateTotal
For the Year Ended December 31, 2021
Restructuring and Asset Related Charges - Net 1
$(152)$(59)$(78)$(289)
Equity securities mark-to-market gain (loss)47 — — 47 
Employee Retention Credit37 23 — 60 
Contract termination(30)(24)— (54)
Total$(98)$(60)$(78)$(236)
(In millions)SeedCrop ProtectionCorporateTotal
For the Year Ended December 31, 2020
Restructuring and Asset Related Charges - Net 1
$(165)$(109)$(61)$(335)
Loss on Divestiture 2
— (53)— (53)
Total$(165)$(162)$(61)$(388)
(In millions)SeedCrop ProtectionCorporateTotal
For the Year Ended December 31, 20193
Restructuring and Asset Related Charges - Net 1
$(213)$(23)$14 $(222)
Integration and Separation Costs 4
— — (632)(632)
Loss on Divestiture 5
(24)— — (24)
Amortization of Inventory Step Up 6
(67)— — (67)
Loss on Early Extinguishment of Debt 7
— — (13)(13)
Argentina Currency Devaluation 8
— — (33)(33)
Total$(304)$(23)$(664)$(991)
1.Includes Board approved restructuring plans and asset related charges as well as accelerated prepaid amortization. See Note 7 - Restructuring and Asset Related Charges - Net, to the Consolidated Financial Statements, for additional information.
2.Includes a loss recorded in other income - net related to the sale of the La Porte site.
3.The year ended December 31, 2019 is presented on a pro forma basis, prepared in accordance with Article 11 of Regulation S-X that was in effect prior to recent amendments.
4.Integration and separation costs include costs incurred to prepare for and close the Merger, post-Merger integration expenses, and costs incurred to prepare for the Internal Reorganizations. Beginning in the second quarter of 2019, this includes both integration and separation costs.
5.Includes a loss recorded in other income - net related to DAS's sale of a joint venture related to synergy actions.
6.Includes a charge related to the amortization of the inventory that was stepped up to fair value in connection with the Merger.
7.Includes a loss on early extinguishment of debt related to the difference between the redemption price and the par value of the Make Whole Notes and Term Loan Facility, partially offset by the write-off of unamortized step-up related to the fair value step-up of EID's debt.
8.Includes a charge included in other income - net associated with remeasuring the company’s Argentine Peso net monetary assets, resulting from an unexpected August primary election result in Argentina. Throughout the three months ended September 30, 2019, the Argentine Peso dropped approximately a third of its value against the US dollar and in September of 2019, the country’s central bank announced new restrictions on foreign currency transactions.
XML 84 R64.htm IDEA: XBRL DOCUMENT v3.22.0.1
EID Income Taxes (Tables)
12 Months Ended
Dec. 31, 2021
Geographic Allocation of Income and Provision for Income Taxes
Geographic Allocation of Income (Loss) and Provision for (Benefit from) Income Taxes For the Year Ended December 31,
(In millions)202120202019
Income (loss) from continuing operations before income taxes
Domestic$941 $(83)$(1,352)
Foreign1,405 758 1,036 
Income (loss) from continuing operations before income taxes$2,346 $675 $(316)
Current tax expense (benefit)
Federal$(13)$28 $(11)
State and local
Foreign329 222 317 
Total current tax expense (benefit)$322 $259 $307 
Deferred tax expense (benefit)
Federal$164 $(116)$(392)
State and local55 27 156 
Foreign(17)(251)(117)
Total deferred tax expense (benefit)$202 $(340)$(353)
Provision for (benefit from) income taxes on continuing operations524 (81)(46)
Net income (loss) from continuing operations after taxes$1,822 $756 $(270)
Reconciliation to US Statutory Rate
Reconciliation to U.S. Statutory RateFor the Year Ended December 31,
202120202019
Statutory U.S. federal income tax rate21.0 %21.0 %21.0 %
Effective tax rates on international operations - net 1
(2.5)(13.9)(18.4)
Acquisitions, divestitures and ownership restructuring activities 2
(0.1)(0.3)(10.7)
U.S. research and development credit(2.4)(2.9)7.0 
Exchange gains/losses 3
1.9 3.5 (1.8)
State and local incomes taxes - net2.1 4.0 3.2 
Impact of Swiss Tax Reform4
0.2 (27.0)11.9 
Excess tax benefits/deficiencies from stock compensation(0.2)1.0 (0.6)
Tax settlements and expiration of statute of limitations— 0.4 3.9 
Other - net2.3 2.2 (0.9)
Effective tax rate on income from continuing operations22.3 %(12.0)%14.6 %
1.    Includes the effects of local and U.S. taxes related to earnings of non-U.S. subsidiaries, changes in the amount of unrecognized tax benefits associated with these earnings, losses at non-U.S. subsidiaries without local tax benefits due to valuation allowances, and other permanent differences between tax and U.S. GAAP results. Includes a tax benefit of $(51) million for the year ended December 31, 2020, related to a return to accrual adjustment associated with an elective change in accounting method for the 2019 tax year impact of foreign tax provisions.
2.    See Notes 4 - Common Control Business Combination, and Note 5 - Divestitures and Other Transactions, to the Consolidated Financial Statements, for additional information.
3.    Principally reflects the impact of foreign exchange gains and losses on net monetary assets for which no corresponding tax impact is realized. Further information about the company's foreign currency hedging program is included in Note 9 - Supplementary Information, and Note 22 - Financial Instruments, under the heading Foreign Currency Risk.
4.    Reflects tax benefits of $(182) million primarily driven by the recognition of an elective cantonal component of the recent enactment of the Federal Act on Tax Reform and AHV Financing ("Swiss Tax Reform") for the year ended December 31, 2020. Reflects tax benefits of $(38) million associated with the enactment of the Federal Act on Tax Reform and AHV Financing ("Swiss Tax Reform"), for the year ended December 31, 2019.
EID [Member]  
Geographic Allocation of Income and Provision for Income Taxes
Geographic Allocation of Income (Loss) and Provision for (Benefit from) Income Taxes For the Year Ended December 31,
(In millions)202120202019
Income (loss) from continuing operations before income taxes
Domestic$892 $(183)$(1,458)
Foreign1,404 758 1,036 
Income (loss) from continuing operations before income taxes$2,296 $575 $(422)
Current tax expense (benefit)
Federal$(23)$$(11)
State and local
Foreign329 222 317 
Total current tax expense (benefit)$310 $235 $307 
Deferred tax (benefit) expense
Federal$164 $(116)$(417)
State and local55 27 156 
Foreign(17)(251)(117)
Total deferred tax expense (benefit)$202 $(340)$(378)
Provision for (benefit from) income taxes on continuing operations512 (105)(71)
Net income (loss) from continuing operations$1,784 $680 $(351)
Reconciliation to US Statutory Rate
Reconciliation to U.S. Statutory RateFor the Year Ended December 31,
202120202019
Statutory U.S. federal income tax rate21.0 %21.0 %21.0 %
Effective tax rates on international operations - net 1
(2.6)(16.4)(13.8)
Acquisitions, divestitures and ownership restructuring activities 2
(0.1)(0.3)(8.0)
U.S. research and development credit(2.5)(3.4)5.2 
Exchange gains/losses 3
1.9 4.1 (1.3)
State and local income taxes - net2.2 4.2 3.0 
Impact of Swiss Tax Reform 4
0.2 (31.7)8.9 
Excess tax benefits/deficiencies from stock compensation(0.2)1.2 (0.5)
Tax settlements and expiration of statute of limitations— 0.4 2.9 
Other - net2.3 2.6 (0.6)
Effective tax rate22.2 %(18.3)%16.8 %
1.    Includes the effects of local and U.S. taxes related to earnings of non-U.S. subsidiaries, changes in the amount of unrecognized tax benefits associated with these earnings, losses at non-U.S. subsidiaries without local tax benefits due to valuation allowances, and other permanent differences between tax and U.S. GAAP results. Includes a tax benefit of $(51) million for the year ended December 31, 2020, related to a return to accrual adjustment associated with an elective change in accounting method that alters the 2019 impact of foreign tax provisions.
2.    See Notes 4 - Common Control Business Combination, and Note 5 - Divestitures and Other Transactions, of the Corteva, Inc. Consolidated Financial Statements for additional information.
3.    Principally reflects the impact of foreign exchange gains and losses on net monetary assets for which no corresponding tax impact is realized. Further information about the company's foreign currency hedging program is included in Note 9 - Supplementary Information, and Note 22 - Financial Instruments, of the Corteva, Inc. Consolidated Financial Statements under the heading Foreign Currency Risk.
4.    Reflects tax benefits of $(182) million primarily driven by the recognition of an elective cantonal component of the recent enactment of the Federal Act on Tax Reform and AHV Financing ("Swiss Tax Reform") for the year ended December 31, 2020. Reflects tax benefits of $(38) million associated with the enactment of the Federal Act on Tax Reform and AHV Financing ("Swiss Tax Reform"), for the year ended December 31, 2019.
XML 85 R65.htm IDEA: XBRL DOCUMENT v3.22.0.1
EID Segment FN (Tables)
12 Months Ended
Dec. 31, 2021
Segment Reporting, Asset Reconciling Item [Line Items]  
Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]
Income (loss) from continuing operations after income taxes to segment operating EBITDA
For the Year Ended December 31,
(In millions)202120202019
Income (loss) from continuing operations after income taxes$1,822 $756 $(270)
Provision for (benefit from) income taxes on continuing operations524 (81)(46)
Income (loss) from continuing operations before income taxes2,346 675 (316)
Depreciation and amortization1,243 1,177 1,000 
Interest income(77)(56)(59)
Interest expense30 45 136 
Exchange (gains) losses - net 1
54 174 66 
Non-operating (benefits) costs - net(1,256)(316)(129)
Mark-to-market (gains) losses on certain foreign currency contracts not designated as hedges2
— 
Significant items236 388 991 
Pro forma adjustments298 
Corporate expenses138 125 119 
Segment operating EBITDA3
$2,714 $2,212 $2,106 
1.Excludes a $(33) million foreign exchange loss for the year ended December 31, 2019 associated with the devaluation of the Argentine peso. See Note 9 - Supplementary Information, to the Consolidated Financial Statements, for additional information.
2.Effective January 1, 2021, on a prospective basis, the company excludes net unrealized gain or loss from mark-to-market activity for certain foreign currency derivative instruments that do not qualify for hedge accounting. There were no unrealized mark-to-market (gains) losses for the years ended December 31, 2020 and 2019.
3.The year ended December 31, 2019 is presented on a pro forma basis, prepared in accordance with Article 11 of Regulation S-X that was in effect prior to recent amendments.
Reconciliation of Assets from Segment to Consolidated [Table Text Block]
Segment assets to total assets (in millions)
December 31, 2021December 31, 2020
Total segment assets$35,698 $36,850 
Corporate assets6,646 5,799 
Total assets$42,344 $42,649 
EID [Member]  
Segment Reporting, Asset Reconciling Item [Line Items]  
Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]
Income (loss) from continuing operations after income taxes to segment operating EBITDA
(In millions)
For the Year Ended December 31,
202120202019
Income (loss) from continuing operations after income taxes$1,784 $680 $(351)
Provision for (benefit from) income taxes on continuing operations512 (105)(71)
Income (loss) from continuing operations before income taxes2,296 575 (422)
Depreciation and amortization1,243 1,177 1,000 
Interest income(77)(56)(59)
Interest expense80 145 242 
Exchange losses - net1
54 174 66 
Non-operating (benefits) costs - net(1,256)(316)(129)
Mark-to-market (gains) losses on certain foreign currency contracts not designated as hedges2
— 
Significant items236 388 991 
Pro forma adjustments298 
Corporate expenses138 125 119 
Segment operating EBITDA3
$2,714 $2,212 $2,106 
1.Excludes a $(33) million foreign exchange loss for the year ended December 31, 2019 associated with the devaluation of the Argentine peso. See Note 9 - Supplementary Information, of the Corteva, Inc. Consolidated Financial Statements for additional information.
2.Effective January 1, 2021, on a prospective basis, the company excludes net unrealized gain or loss from mark-to-market activity for certain foreign currency derivative instruments that do not qualify for hedge accounting. There were no unrealized mark-to-market (gains) losses for the years ended December 31, 2020 and 2019.
3.The year ended December 31, 2019 is presented on a pro forma basis, prepared in accordance with Article 11 of Regulation S-X that was in effect prior to recent amendments.
XML 86 R66.htm IDEA: XBRL DOCUMENT v3.22.0.1
Schedule II - Valuation and Qualifying Accounts (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
SEC Schedule, 12-09, Allowance, Credit Loss [Member]      
SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]      
Balance at beginning of period $ 208 $ 174 $ 127
Additions charged to expenses [1] 6 52 69
Deductions from reserves [1],[2] (4) (18) (22)
Balance at end of period 210 208 174
SEC Schedule, 12-09, Valuation Allowance, Deferred Tax Asset [Member]      
SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]      
Balance at beginning of period 453 457 669
Additions charged to expenses 97 56 20
Deductions from reserves [3] (184) (60) (232)
Balance at end of period $ 366 $ 453 $ 457
[1] Classifications in the changes in the allowance for doubtful receivables for the period ended December 31, 2020 have been adjusted from their previous presentation. Adjustments did not impact the amount of the provision or the allowance for doubtful receivables recorded in the Consolidated Statements of Operations or the Consolidated Balance Sheets.
[2] Deductions include write-offs, recoveries collected and currency translation adjustments.
[3] Deductions include currency translation adjustments.
XML 87 R67.htm IDEA: XBRL DOCUMENT v3.22.0.1
Background and Basis of Presentation (Details)
$ / shares in Units, $ in Millions
3 Months Ended 12 Months Ended
Mar. 31, 2020
USD ($)
Dec. 31, 2021
$ / shares
shares
Dec. 31, 2019
USD ($)
Feb. 03, 2022
$ / shares
Dec. 31, 2020
$ / shares
shares
Jun. 26, 2019
$ / shares
Jun. 03, 2019
$ / shares
shares
Jun. 01, 2019
Apr. 01, 2019
$ / shares
Common Stock, Par Value   $ 0.01   $ 0.01 $ 0.01        
Common Stock, Shares Authorized | shares   1,666,667,000     1,666,667,000        
Internal Reorganization [Member]                  
Reclassification of Divisional Equity to Additional Paid in Capital | $ $ 40                
EID [Member]                  
Common Stock, Par Value   $ 0.30   $ 0.30 $ 0.30        
Common Stock, Shares Authorized | shares   1,800,000,000     1,800,000,000        
Reclassification of Divisional Equity to Additional Paid in Capital | $     $ 0            
EID [Member] | Corteva [Member]                  
Ownership interest in an entity   100.00%              
Dow [Member]                  
Common Stock, Par Value                 $ 0.01
Corteva [Member]                  
Number of Reportable Segments   2              
Common Stock, Par Value           $ 0.01 $ 0.01    
Common Stock, Shares Authorized | shares             748,815,000    
Shares of DowDuPont Common Stock Held [Member] | Corteva [Member]                  
Exchange Ratio               3  
Shares of Corteva Stock [Member] | Corteva [Member]                  
Exchange Ratio               1  
XML 88 R68.htm IDEA: XBRL DOCUMENT v3.22.0.1
Summary of Significant Accounting Policies (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Integration and Separation Costs $ 0 $ 0 $ 744
Percentage of FIFO Inventory 60.00%    
Percentage of Weighted Average Cost Inventory 40.00%    
Minimum [Member]      
Definite-Lived Intangible Asset, Useful Life 2 years    
Maximum [Member]      
Definite-Lived Intangible Asset, Useful Life 25 years    
Other Current Assets [Member]      
Prepaid Royalties $ 303    
Restricted Cash 377 $ 347  
Other Assets [Member]      
Prepaid Royalties - Long-Term $ 256    
XML 89 R69.htm IDEA: XBRL DOCUMENT v3.22.0.1
Business Combinations DAS Common Control Transfer Income Statement (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Business Acquisition [Line Items]      
Net Sales $ 15,655 $ 14,217 $ 13,846
Income (loss) from continuing operations before income taxes 2,346 675 (316)
Income (loss) from continuing operations after income taxes $ 1,822 $ 756 $ (270)
XML 90 R70.htm IDEA: XBRL DOCUMENT v3.22.0.1
Divestitures and Other Transactions Divestitures and Other Transactions - Narrative (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]      
Income (loss) from discontinued operations after income taxes $ (53) $ (55) $ (671)
Specialty Products Disposal [Member]      
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]      
Goodwill Impairment Charge   1,102  
Equity Method Investment, Other than Temporary Impairment   63  
Income (loss) from discontinued operations after income taxes   (859)  
Divested Ag Business [Member]      
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]      
Income (loss) from discontinued operations after income taxes   80  
Other discontinued operations [Member]      
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]      
Income (loss) from discontinued operations after income taxes 10 $ 89  
Accounts and Notes Receivable [Member] | DuPont de Nemours [Member]      
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]      
Indemnification Assets 25    
Other Assets [Member] | DuPont de Nemours [Member]      
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]      
Indemnification Assets 75    
Accrued and Other Current Liabilities [Member] | Dow [Member]      
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]      
Indemnified Liabilities 20    
Other Noncurrent Obligations [Member] | DuPont de Nemours [Member]      
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]      
Indemnified Liabilities 75    
Other Noncurrent Obligations [Member] | Dow [Member]      
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]      
Indemnified Liabilities $ 42    
XML 91 R71.htm IDEA: XBRL DOCUMENT v3.22.0.1
Divestitures and Other Transactions ECP Divestiture (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]      
Income (loss) from discontinued operations after income taxes $ (53) $ (55) $ (671)
ECP Disposal [Member]      
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]      
Net Sales   362  
Cost of Goods Sold   259  
Research and Development Expense   4  
Selling, General and Administrative   9  
Amortization of Intangibles   23  
Restructuring and Asset Related Charges - Net   2  
Integration and Separation Costs   44  
Other Income - net   2  
Income (Loss) from Discontinued Operation, before Income Tax   23  
Provision for (Benefit from) Income Taxes, Discontinued Operation   4  
Income (loss) from discontinued operations after income taxes   19  
Depreciation   28  
Capital Expenditures   $ 16  
XML 92 R72.htm IDEA: XBRL DOCUMENT v3.22.0.1
Divestitures and Other Transactions SP Divestiture (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]      
(Loss) income from discontinued operations after income taxes $ (53) $ (55) $ (671)
Specialty Products Disposal [Member]      
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]      
Net Sales   5,030  
Cost of Goods Sold   3,352  
Research and Development Expense   204  
Selling, General and Administrative   573  
Amortization of Intangibles   267  
Restructuring and Asset Related Charges - Net   115  
Integration and Separation Costs   253  
Goodwill Impairment Charge   1,102  
Other Income - net   57  
(Loss) Income from Discontinued Operation, before Income Tax   (779)  
Provision for Income Taxes, Discontinued Operation   80  
(Loss) income from discontinued operations after income taxes   (859)  
Depreciation   281  
Capital Expenditures   $ 481  
XML 93 R73.htm IDEA: XBRL DOCUMENT v3.22.0.1
Divestitures and Other Transactions Divestitures and Other Transactions - Divested Ag Business Results of Operations (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Nov. 01, 2017
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]        
Finite-Lived Intangible Assets, Gross $ 12,595 $ 12,599    
Income (loss) from discontinued operations after income taxes (53) (55) $ (671)  
Divested Ag Business [Member]        
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]        
Income (loss) from discontinued operations after income taxes   80    
Favorable Supply Contract [Member]        
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]        
Finite-Lived Intangible Assets, Gross $ 475 $ 475    
Favorable Supply Contract [Member] | Divested Ag Business [Member]        
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]        
Finite-Lived Intangible Assets, Gross       $ 495
XML 94 R74.htm IDEA: XBRL DOCUMENT v3.22.0.1
Divestitures and Other Transactions Divestitures and Other Transactions - PChem Results of Operations (Details) - USD ($)
3 Months Ended 12 Months Ended
Jun. 30, 2017
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]        
Income (loss) from discontinued operations after income taxes   $ 53,000,000 $ 55,000,000 $ 671,000,000
Chemours Contribution to MDL Settlement [Member]        
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]        
Litigation Settlement Amount   29,000,000    
MDL Settlement [Member]        
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]        
Litigation Settlement Amount   83,000,000    
PFOA Matters: Multi-District Litigation [Member]        
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]        
Litigation Settlement Amount $ 670,700,000      
Post-MDL Settlement PFOA Personal Injury Claims [Domain] | PFOA Matters: Drinking Water Actions [Member] | Compensatory Damages [Member]        
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]        
Litigation Settlement Amount   $ 40,000,000    
Post-MDL Settlement PFOA Personal Injury Claims [Domain] | Settled Litigation [Member] | PFOA Matters: Drinking Water Actions [Member]        
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]        
Loss Contingency, Pending Claims, Number   95    
Performance Chemicals [Member]        
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]        
(Loss) Income from Discontinued Operation, before Income Tax   $ 48,000,000 $ 65,000,000  
DuPont de Nemours [Member] | Accounts and Notes Receivable [Member]        
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]        
Indemnification Assets   25,000,000    
DuPont de Nemours [Member] | Other Assets [Member]        
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]        
Indemnification Assets   75,000,000    
DuPont de Nemours [Member] | Other Noncurrent Obligations [Member]        
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]        
Indemnified Liabilities   $ 75,000,000    
XML 95 R75.htm IDEA: XBRL DOCUMENT v3.22.0.1
Revenue Narrative (Details) - USD ($)
$ in Millions
Dec. 31, 2021
Dec. 31, 2020
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]    
Remaining Performance Obligation $ 123 $ 115
Minimum [Member]    
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]    
Remaining Performance Obligation, Expected Timing of Satisfaction 1 year  
Maximum [Member]    
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]    
Remaining Performance Obligation, Expected Timing of Satisfaction 6 years  
XML 96 R76.htm IDEA: XBRL DOCUMENT v3.22.0.1
Revenue Contract Balances (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Disaggregation of Revenue [Line Items]      
Accounts and notes receivable - trade [1] $ 3,561 $ 3,917  
Contract assets - current [2] 24 22  
Contract assets - noncurrent [3] 58 54  
Deferred Revenue 3,201 2,662  
Deferred Revenue Recognized During the Period 2,613 2,540 $ 2,146
Other Noncurrent Obligations [Member]      
Disaggregation of Revenue [Line Items]      
Deferred Revenue [4] $ 120 $ 116  
[1] Included in accounts and notes receivable - net in the Consolidated Balance Sheets.
[2] Included in other current assets in the Consolidated Balance Sheets.
[3] Included in other assets in the Consolidated Balance Sheets.
[4] Included in other noncurrent obligations in the Consolidated Balance Sheets.
XML 97 R77.htm IDEA: XBRL DOCUMENT v3.22.0.1
Revenue Disaggregation of Revenue - Products (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Disaggregation of Revenue [Line Items]      
Net Sales $ 15,655 $ 14,217 $ 13,846
Seed [Member]      
Disaggregation of Revenue [Line Items]      
Net Sales 8,402 7,756 7,590
Seed [Member] | Corn [Member]      
Disaggregation of Revenue [Line Items]      
Net Sales 5,618 5,182 5,126
Seed [Member] | Soybean [Member]      
Disaggregation of Revenue [Line Items]      
Net Sales 1,568 1,445 1,387
Seed [Member] | Other oilseeds [Member]      
Disaggregation of Revenue [Line Items]      
Net Sales 752 619 593
Seed [Member] | Other [Member]      
Disaggregation of Revenue [Line Items]      
Net Sales 464 510 484
Crop Protection [Member]      
Disaggregation of Revenue [Line Items]      
Net Sales 7,253 6,461 6,256
Crop Protection [Member] | Other [Member]      
Disaggregation of Revenue [Line Items]      
Net Sales 398 385 326
Crop Protection [Member] | Herbicides [Member]      
Disaggregation of Revenue [Line Items]      
Net Sales 3,815 3,280 3,206
Crop Protection [Member] | Insecticides [Member]      
Disaggregation of Revenue [Line Items]      
Net Sales 1,730 1,764 1,652
Crop Protection [Member] | Fungicides [Member]      
Disaggregation of Revenue [Line Items]      
Net Sales $ 1,310 $ 1,032 $ 1,072
XML 98 R78.htm IDEA: XBRL DOCUMENT v3.22.0.1
Revenue Disaggregation of Revenue - Geo (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Disaggregation of Revenue [Line Items]      
Net Sales $ 15,655 $ 14,217 $ 13,846
EMEA      
Disaggregation of Revenue [Line Items]      
Net Sales 3,123 2,842 2,740
Asia Pacific      
Disaggregation of Revenue [Line Items]      
Net Sales 1,451 1,402 1,288
Latin America      
Disaggregation of Revenue [Line Items]      
Net Sales [1] 3,545 2,805 2,889
Seed [Member]      
Disaggregation of Revenue [Line Items]      
Net Sales 8,402 7,756 7,590
Seed [Member] | North America [Member]      
Disaggregation of Revenue [Line Items]      
Net Sales [2] 5,004 4,795 4,724
Seed [Member] | EMEA      
Disaggregation of Revenue [Line Items]      
Net Sales [3] 1,599 1,468 1,378
Seed [Member] | Asia Pacific      
Disaggregation of Revenue [Line Items]      
Net Sales 379 376 358
Seed [Member] | Latin America      
Disaggregation of Revenue [Line Items]      
Net Sales 1,420 1,117 1,130
Crop Protection [Member]      
Disaggregation of Revenue [Line Items]      
Net Sales 7,253 6,461 6,256
Crop Protection [Member] | North America [Member]      
Disaggregation of Revenue [Line Items]      
Net Sales [2] 2,532 2,373 2,205
Crop Protection [Member] | EMEA      
Disaggregation of Revenue [Line Items]      
Net Sales [3] 1,524 1,374 1,362
Crop Protection [Member] | Asia Pacific      
Disaggregation of Revenue [Line Items]      
Net Sales 1,072 1,026 930
Crop Protection [Member] | Latin America      
Disaggregation of Revenue [Line Items]      
Net Sales $ 2,125 $ 1,688 $ 1,759
[1] Net sales for Brazil for the years ended December 31, 2021, 2020 and 2019 were $2,315 million, $1,724 million and $1,794 million, respectively.
[2] Represents U.S. & Canada.
[3] Europe, Middle East, and Africa ("EMEA")
XML 99 R79.htm IDEA: XBRL DOCUMENT v3.22.0.1
Restructuring and Asset Related Charges 2021 Restructuring Actions (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Restructuring Cost and Reserve [Line Items]      
Restructuring and asset related charges- net $ 289 $ 335 $ 222
Asset Related Charges [Member]      
Restructuring Cost and Reserve [Line Items]      
Restructuring and asset related charges- net   176  
2021 Restructuring Actions [Member]      
Restructuring Cost and Reserve [Line Items]      
Restructuring Reserve, Beginning Balance 0    
Restructuring and asset related charges- net 167 167  
Payments for Restructuring (52)    
Asset write-offs (51)    
Restructuring Reserve, Ending Balance 64 0  
Asset Retirement Obligation 6    
2021 Restructuring Actions [Member] | Employee Severance [Member]      
Restructuring Cost and Reserve [Line Items]      
Restructuring Reserve, Beginning Balance 0    
Restructuring and asset related charges- net 74 74  
Payments for Restructuring (22)    
Asset write-offs 0    
Restructuring Reserve, Ending Balance 52 0  
2021 Restructuring Actions [Member] | Asset Related Charges [Member]      
Restructuring Cost and Reserve [Line Items]      
Restructuring Reserve, Beginning Balance 0    
Restructuring and asset related charges- net 51    
Payments for Restructuring 0    
Asset write-offs (51)    
Restructuring Reserve, Ending Balance 0 0  
2021 Restructuring Actions [Member] | Contract Termination [Member]      
Restructuring Cost and Reserve [Line Items]      
Restructuring Reserve, Beginning Balance 0    
Restructuring and asset related charges- net 42    
Payments for Restructuring (30)    
Asset write-offs 0    
Restructuring Reserve, Ending Balance $ 12 0  
Seed [Member] | 2021 Restructuring Actions [Member]      
Restructuring Cost and Reserve [Line Items]      
Restructuring and asset related charges- net   31  
Crop Protection [Member] | 2021 Restructuring Actions [Member]      
Restructuring Cost and Reserve [Line Items]      
Restructuring and asset related charges- net   55  
Corporate, Non-Segment [Member] | 2021 Restructuring Actions [Member]      
Restructuring Cost and Reserve [Line Items]      
Restructuring and asset related charges- net   $ 81  
XML 100 R80.htm IDEA: XBRL DOCUMENT v3.22.0.1
Restructuring and Asset Related Charges Execute to Win Productivity Program (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Restructuring Cost and Reserve [Line Items]      
Restructuring and asset related charges- net $ 289 $ 335 $ 222
Asset Related Charges [Member]      
Restructuring Cost and Reserve [Line Items]      
Restructuring and asset related charges- net   176  
Execute to Win Productivity Program      
Restructuring Cost and Reserve [Line Items]      
Restructuring and Related Cost, Cost Incurred to Date 185    
Restructuring Reserve, Beginning Balance 56    
Restructuring and asset related charges- net 9 176  
Payments for Restructuring (30)    
Asset write-offs (11)    
Restructuring Reserve, Ending Balance 24 56  
Asset Retirement Obligation 13    
Execute to Win Productivity Program | Employee Severance [Member]      
Restructuring Cost and Reserve [Line Items]      
Restructuring and Related Cost, Cost Incurred to Date 61    
Restructuring Reserve, Beginning Balance 53    
Restructuring and asset related charges- net (2) 63  
Payments for Restructuring (27)    
Asset write-offs 0    
Restructuring Reserve, Ending Balance 24 53  
Execute to Win Productivity Program | Asset Related Charges [Member]      
Restructuring Cost and Reserve [Line Items]      
Restructuring and Related Cost, Cost Incurred to Date 124    
Restructuring Reserve, Beginning Balance 3    
Restructuring and asset related charges- net 11 113  
Payments for Restructuring (3)    
Asset write-offs (11)    
Restructuring Reserve, Ending Balance 0 3  
Execute to Win Productivity Program | Crop Protection [Member]      
Restructuring Cost and Reserve [Line Items]      
Restructuring and asset related charges- net 11 98  
Execute to Win Productivity Program | Seed [Member]      
Restructuring Cost and Reserve [Line Items]      
Restructuring and asset related charges- net 0 15  
Execute to Win Productivity Program | Corporate, Non-Segment [Member]      
Restructuring Cost and Reserve [Line Items]      
Restructuring and asset related charges- net $ (2) $ 63  
XML 101 R81.htm IDEA: XBRL DOCUMENT v3.22.0.1
Restructuring and Asset Related Charges DowDuPont Cost Synergy Program (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Restructuring Cost and Reserve [Line Items]      
Restructuring and asset related charges- net $ 289 $ 335 $ 222
Asset Related Charges [Member]      
Restructuring Cost and Reserve [Line Items]      
Restructuring and asset related charges- net   176  
DowDuPont Cost Synergy Program [Member]      
Restructuring Cost and Reserve [Line Items]      
Restructuring and Related Cost, Cost Incurred to Date 833    
Restructuring and Asset Related Charges - Net (12) 0 92
DowDuPont Cost Synergy Program [Member] | Employee Severance [Member]      
Restructuring Cost and Reserve [Line Items]      
Restructuring and Related Cost, Cost Incurred to Date 316    
Restructuring and Asset Related Charges - Net (1) (2) (7)
DowDuPont Cost Synergy Program [Member] | Costs Related To Contract Termination [Member]      
Restructuring Cost and Reserve [Line Items]      
Restructuring and Related Cost, Cost Incurred to Date 190    
Restructuring and Asset Related Charges - Net (3) 0 69
DowDuPont Cost Synergy Program [Member] | Asset Related Charges [Member]      
Restructuring Cost and Reserve [Line Items]      
Restructuring and Related Cost, Cost Incurred to Date 327    
Restructuring and Asset Related Charges - Net (8) 2 30
DowDuPont Cost Synergy Program [Member] | Seed [Member]      
Restructuring Cost and Reserve [Line Items]      
Restructuring and Asset Related Charges - Net (8) (9) 66
DowDuPont Cost Synergy Program [Member] | Crop Protection [Member]      
Restructuring Cost and Reserve [Line Items]      
Restructuring and Asset Related Charges - Net (3) 11 27
DowDuPont Cost Synergy Program [Member] | Corporate Segment [Member]      
Restructuring Cost and Reserve [Line Items]      
Restructuring and Asset Related Charges - Net $ (1) $ (2) $ (1)
XML 102 R82.htm IDEA: XBRL DOCUMENT v3.22.0.1
Restructuring and Asset Related Charges Asset Impairments (Details) - USD ($)
$ in Millions
3 Months Ended 12 Months Ended
Dec. 31, 2019
Sep. 30, 2019
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Other Asset Related [Member]          
Restructuring Cost and Reserve [Line Items]          
Accelerated Prepaid Royalty Amortization Expense     $ 125 $ 159  
IPR&D [Member]          
Restructuring Cost and Reserve [Line Items]          
Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) $ 90 $ 54     $ 144
Impairment of Intangible Assets Indefinite lived Excluding Goodwill After Tax $ 69 $ 41     $ 110
XML 103 R83.htm IDEA: XBRL DOCUMENT v3.22.0.1
Related Parties Transactions with DowDuPont (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Jun. 26, 2019
Related Party Transaction [Line Items]        
Stock Repurchase Program, Authorized Amount       $ 1,000
Distributions to DowDuPont $ 0 $ 0 $ (317) [1]  
DowDuPont [Member]        
Related Party Transaction [Line Items]        
Distributions to DowDuPont     $ 317  
[1] The cash flows for the year ended December 31, 2019 includes cash flows of EID's ECP and Specialty Products Entities.
XML 104 R84.htm IDEA: XBRL DOCUMENT v3.22.0.1
Supplementary Information Other Income (Expense) - Net (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Schedule of Sundry Income (Expense) - Net [Line Items]      
Interest income $ 77 $ 56 $ 59
Equity in earnings (losses) of affiliates - net 14 0 (9)
Net gain on sales of businesses and other assets [1] 21 (2) 64
Net exchange losses [2] (54) (174) (99)
Non-operating pension and other post employment benefit credit (cost) [3] 1,318 368 191
Miscellaneous income (expenses) - net [4] (28) (36) 9
Other income (expense) - net 1,348 212 215
Segment Reconciling Items [Member]      
Schedule of Sundry Income (Expense) - Net [Line Items]      
Interest income (77) (56) (59)
Net exchange losses [5] 54 174 66
Non-operating pension and other post employment benefit credit (cost) (1,256) (316) (129)
(Loss) Gain on sale or disposition of assets [6],[7]   (388)  
Employee Retention Credit 60    
Contract Termination Cost (54)    
Segment Reconciling Items [Member] | Crop Protection [Member]      
Schedule of Sundry Income (Expense) - Net [Line Items]      
Employee Retention Credit 23    
Contract Termination Cost (24)    
Deconsolidation of a subsidiary [Member] | Segment Reconciling Items [Member]      
Schedule of Sundry Income (Expense) - Net [Line Items]      
(Loss) Gain on sale or disposition of assets [7]     (67)
La Porte | Segment Reconciling Items [Member] | Crop Protection [Member]      
Schedule of Sundry Income (Expense) - Net [Line Items]      
(Loss) Gain on sale or disposition of assets (53)    
APAC Business [Member] | Segment Reconciling Items [Member] | Crop Protection [Member]      
Schedule of Sundry Income (Expense) - Net [Line Items]      
(Loss) Gain on sale or disposition of assets 27    
Hedging Program [Member]      
Schedule of Sundry Income (Expense) - Net [Line Items]      
Net exchange losses 18 89 (58)
Hedging Program [Member] | Argentine peso devaluation [Member]      
Schedule of Sundry Income (Expense) - Net [Line Items]      
Net exchange losses $ (67) (82) (51)
Hedging Program [Member] | Argentine peso devaluation [Member] | Segment Reconciling Items [Member]      
Schedule of Sundry Income (Expense) - Net [Line Items]      
Net exchange losses   $ (33)  
Hedging Program [Member] | Tax Reform Foreign Currency Exchange Impact [Member] | Segment Reconciling Items [Member]      
Schedule of Sundry Income (Expense) - Net [Line Items]      
Net exchange losses [7]     $ (33)
[1] The year ended December 31, 2020 includes a loss of $(53) million and a gain of $27 million relating to the expected sale of the La Porte site, for which the company signed an agreement in 2020, and the sale of a business in Asia Pacific in the crop protection segment, respectively.
[2] Includes net pre-tax exchange gains (losses) of $(67) million, $(82) million and $(51) million associated with the devaluation of the Argentine peso for the years ended December 31, 2021, 2020 and 2019, respectively.
[3] Includes non-service related components of net periodic benefit credits (costs) (interest cost, expected long-term rate of return on plan assets, amortization of unrecognized gain (loss), amortization of prior service benefit and settlement gain (loss)). 
[4] Miscellaneous income (expenses) - net, includes losses from sale of receivables, tax indemnification adjustments related to changes in indemnification balances as a result of the application of the terms of the Tax Matters Agreement between Corteva and Dow and/or DuPont, and other items. The year ended December 31, 2021 also includes the Employee Retention Credit of $60 million pursuant to the Coronavirus Aid, Relief, and Economic Security (“CARES”) Act as enhanced by the Consolidated Appropriations Act (“CAA”) and American Rescue Plan Act (“ARPA”), a gain from the remeasurement of an equity investment of $47 million, a charge related to a contract termination with a third-party service provider of $(54) million and the 2021 officer indemnification payment. 
[5] Excludes a $(33) million foreign exchange loss for the year ended December 31, 2019 associated with the devaluation of the Argentine peso. See Note 9 - Supplementary Information, to the Consolidated Financial Statements, for additional information.2.Effective January 1, 2021, on a prospective basis, the company excludes net unrealized gain or loss from mark-to-market activity for certain foreign currency derivative instruments that do not qualify for hedge accounting. There were no unrealized mark-to-market (gains) losses for the years ended December 31, 2020 and 2019.
[6] Includes a loss recorded in other income - net related to DAS's sale of a joint venture related to synergy actions.
[7] The year ended December 31, 2019 is presented on a pro forma basis, prepared in accordance with Article 11 of Regulation S-X that was in effect prior to recent amendments.
XML 105 R85.htm IDEA: XBRL DOCUMENT v3.22.0.1
Supplementary Information Foreign Currency Exchange Gain (Loss) (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Foreign Currency Exchange Gain (Loss) [Line Items]      
Pre-tax exchange (loss) gain [1] $ (54) $ (174) $ (99)
Tax benefits (expenses) on exchange (loss) gain (34) 13 15
Net after-tax exchange (loss) gain (88) (161) (84)
Subsidiary Monetary Position      
Foreign Currency Exchange Gain (Loss) [Line Items]      
Pre-tax exchange (loss) gain (72) (263) (41)
Tax benefits (expenses) on exchange (loss) gain (30) 34 2
Net after-tax exchange (loss) gain (102) (229) (39)
Hedging Program [Member]      
Foreign Currency Exchange Gain (Loss) [Line Items]      
Pre-tax exchange (loss) gain 18 89 (58)
Tax benefits (expenses) on exchange (loss) gain (4) (21) 13
Net after-tax exchange (loss) gain 14 68 (45)
Argentine peso devaluation [Member] | Hedging Program [Member]      
Foreign Currency Exchange Gain (Loss) [Line Items]      
Pre-tax exchange (loss) gain $ (67) $ (82) $ (51)
[1] Includes net pre-tax exchange gains (losses) of $(67) million, $(82) million and $(51) million associated with the devaluation of the Argentine peso for the years ended December 31, 2021, 2020 and 2019, respectively.
XML 106 R86.htm IDEA: XBRL DOCUMENT v3.22.0.1
Supplementary Information Reconciliation of Cash, Cash Equivalents and Restricted Cash (Details) - USD ($)
$ in Millions
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
[1],[2]
Dec. 31, 2018
[2]
Restricted Cash and Cash Equivalents Items [Line Items]        
Cash and Cash Equivalents $ 4,459 $ 3,526    
Cash, Cash Equivalents, and Restricted Cash 4,836 3,873    
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations 4,836 [1] 3,873 [1] $ 2,173 $ 5,024
Other Current Assets [Member]        
Restricted Cash and Cash Equivalents Items [Line Items]        
Restricted Cash $ 377 $ 347    
[1] See page F-30 for reconciliation of cash and cash equivalents and restricted cash equivalents presented in the Consolidated Balance Sheets to total cash, cash equivalents and restricted cash equivalents presented in the Consolidated Statements of Cash Flows.
[2] The cash flows for the year ended December 31, 2019 includes cash flows of EID's ECP and Specialty Products Entities.
XML 107 R87.htm IDEA: XBRL DOCUMENT v3.22.0.1
Supplementary Information Supplementary Information (Narrative) (Details) - USD ($)
$ in Millions
Dec. 31, 2021
Dec. 31, 2020
Accrued and other current liabilities $ 2,068 $ 2,145
Accounts Payable 4,126 3,615
Accounts Payable, Trade, Current 3,023 2,557
Accounts Payable, Other $ 1,103 $ 1,058
XML 108 R88.htm IDEA: XBRL DOCUMENT v3.22.0.1
Income Taxes Income Taxes - Geographic Allocation of Income and Provision for Income Taxes (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Income (loss) from Continuing Operations before Income Taxes $ 2,346 $ 675 $ (316)
Provision for (benefit from) income taxes on continuing operations 524 (81) (46)
Income (loss) from continuing operations after income taxes 1,822 756 (270)
Continuing Operations [Member]      
Income (loss) from Continuing Operations before Income Taxes, Domestic 941 (83) (1,352)
Income (Loss) from Continuing Operations before Income Taxes, Foreign 1,405 758 1,036
Income (loss) from Continuing Operations before Income Taxes 2,346 675 (316)
Current Federal Tax (Benefit) Expense (13) 28 (11)
Current State and Local Tax Expense (Benefit) 6 9 1
Current Foreign Tax Expense (Benefit) 329 222 317
Total current tax expense (benefit) 322 259 307
Deferred Federal Income Tax Expense (Benefit) 164 (116) (392)
Deferred State and Local Income Tax Expense (Benefit) 55 27 156
Deferred Foreign Income Tax Expense (Benefit) (17) (251) (117)
Total deferred tax expense (benefit) 202 (340) (353)
Provision for (benefit from) income taxes on continuing operations 524 (81) (46)
Income (loss) from continuing operations after income taxes $ 1,822 $ 756 $ (270)
XML 109 R89.htm IDEA: XBRL DOCUMENT v3.22.0.1
Income Taxes Income Taxes - Reconciliation to US Statutory Rate (Details) - Continuing Operations [Member] - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Statutory U.S. federal income tax rate 21.00% 21.00% 21.00%
Effective tax rates on international operations - net [1] (2.50%) (13.90%) (18.40%)
Acquisitions, divestitures, and ownership restructuring activities [2] (0.10%) (0.30%) (10.70%)
U.S. research and development credit (2.40%) (2.90%) 7.00%
Exchange gains/losses [3] 1.90% 3.50% (1.80%)
State and Local Income Taxes 2.10% 4.00% 3.20%
Impact of Swiss Tax Reform [4] 0.20% (27.00%) 11.90%
Excess tax benefits (tax deficiency) from stock-compensation (0.20%) 1.00% (0.60%)
Tax settlements and expiration of statue of limitations 0.00% 0.40% 3.90%
Other, net 2.30% 2.20% (0.90%)
Effective Income Tax Rate 22.30% (12.00%) 14.60%
Swiss Tax Reform [Member]      
Other Tax (Benefit) Expense   $ (182) $ (38)
Change in accounting method [Member]      
Other Tax (Benefit) Expense   $ (51)  
[1] Includes the effects of local and U.S. taxes related to earnings of non-U.S. subsidiaries, changes in the amount of unrecognized tax benefits associated with these earnings, losses at non-U.S. subsidiaries without local tax benefits due to valuation allowances, and other permanent differences between tax and U.S. GAAP results. Includes a tax benefit of $(51) million for the year ended December 31, 2020, related to a return to accrual adjustment associated with an elective change in accounting method for the 2019 tax year impact of foreign tax provisions.
[2] See Notes 4 - Common Control Business Combination, and Note 5 - Divestitures and Other Transactions, to the Consolidated Financial Statements, for additional information.
[3] Principally reflects the impact of foreign exchange gains and losses on net monetary assets for which no corresponding tax impact is realized. Further information about the company's foreign currency hedging program is included in Note 9 - Supplementary Information, and Note 22 - Financial Instruments, under the heading Foreign Currency Risk.
[4] Reflects tax benefits of $(182) million primarily driven by the recognition of an elective cantonal component of the recent enactment of the Federal Act on Tax Reform and AHV Financing ("Swiss Tax Reform") for the year ended December 31, 2020. Reflects tax benefits of $(38) million associated with the enactment of the Federal Act on Tax Reform and AHV Financing ("Swiss Tax Reform"), for the year ended December 31, 2019.
XML 110 R90.htm IDEA: XBRL DOCUMENT v3.22.0.1
Income Taxes Income Taxes - Deferred Tax Balances (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2020
Dec. 31, 2021
Assets    
Deferred Tax Assets, Tax Loss And Tax Credit Carryforwards [1],[2] $ 497 $ 464
Deferred Tax Assets, Accrued Employee Benefits 1,415 904
Deferred Tax Assets, Other Accruals and Reversals 365 [3] 309
Deferred Tax Assets, Inventory 127 153
Deferred Tax Assets, Research and Development Capitalization 186 224
Deferred Tax Assets, Investments 56 36
Unrealized Exchange Gains / Losses 2 0
Deferred Tax Liabilities, Other 0 0
Deferred Tax Assets, Other 91 105
Deferred Tax Assets, Gross 2,739 2,195
Deferred Tax Assets, Valuation Allowance [1] (453) (366)
Deferred Tax Assets, Net of Valuation Allowance 2,286 1,829
Liabilities    
Deferred Tax Liabilities, Property 297 [3] 341
Deferred Tax Liabilities, Intangible Assets 2,418 2,260
Deferred Tax Liabilities, Unrealized Exchange Gains/Losses 0 10
Deferred Tax Liabilities, Gross 2,715 2,611
Net Deferred Tax Liability (429) (782)
Deferred Tax Assets, Operating Loss Carryforwards, Domestic   $ 61
Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount $ 19  
[1] In connection with the company's 2021 internal legal entity restructuring, the company reduced various state net operating loss carryforwards and corresponding full valuation allowances by $61 million. There was no impact on the statement of operations. During the year ended December 31, 2020, the company established a $19 million state tax valuation allowance in the U.S. based on a change in judgement about the realizability of a deferred tax asset.
[2] Primarily related to the realization of recorded tax benefits on tax loss and credit carryforwards from operations in the United States, Brazil, and Spain.
[3] Prior year classifications in property and other accruals and reserves have been adjusted from their previous presentation. Adjustments did not impact the amount of the net deferred tax asset (liability) recorded in the Consolidated Balance Sheets.
XML 111 R91.htm IDEA: XBRL DOCUMENT v3.22.0.1
Income Taxes Income Taxes - Operating Loss and Tax Credit Carryforwards (Details) - USD ($)
$ in Millions
Dec. 31, 2021
Dec. 31, 2020
Operating Loss Carryforwards [Line Items]    
Operating Loss Carryforwards $ 333 $ 442
Tax Credit Carryforwards 131 55
Total Operating Loss and Tax Credit Carryforwards 464 497
Expiring within Five Years [Member]    
Operating Loss Carryforwards [Line Items]    
Operating Loss Carryforwards 123 99
Tax Credit Carryforwards 14 14
Expiring After Five Years Or Having Indefinite Expiration [Member]    
Operating Loss Carryforwards [Line Items]    
Operating Loss Carryforwards 210 343
Tax Credit Carryforwards $ 117 $ 41
XML 112 R92.htm IDEA: XBRL DOCUMENT v3.22.0.1
Income Taxes Income Taxes - Gross Unrecognized Tax Benefits (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Income Tax Contingency [Line Items]      
Unrecognized Tax Benefits, Beginning Balance $ 395 $ 426 $ 749
Decreases related to positions taken on items from prior years (7) (14) (167)
Increases related to positions taken on items from prior years 13 5 77
Increases related to positions taken in the current year 9 6 54
Settlement of uncertain tax positions with tax authorities (17) (18) (9)
Unrecognized Tax Benefits, Impact of Internal Reorganizations 0 0 (278)
Decreases due to expiration of statutes of limitations (16) (7) 0
Exchange (gain) loss 0 (3) 0
Unrecognized Tax Benefits, Ending Balance 377 395 426
Total unrecognized tax benefits that, if recognized, would impact the effective tax rate 157 156 188
Total amount of interest and penalties (benefit) recognized in Provision for income taxes on continuing operations 1 (2) (4)
Total accrual for interest and penalties associated with unrecognized tax benefits 11 $ 18 $ 24
Tax, Advance deposits made to foreign taxing authority 102    
Undistributed Earnings of Foreign Subsidiaries $ 3,681    
XML 113 R93.htm IDEA: XBRL DOCUMENT v3.22.0.1
Earnings Per Share Narrative (Details)
Jun. 01, 2019
shares
Corteva [Member]  
Earnings Per Share [Line Items]  
Common Stock, Shares, Issued 748,815,000
XML 114 R94.htm IDEA: XBRL DOCUMENT v3.22.0.1
Earnings Per Share Net Income for Earnings Per Share Calculations - Basic and Diluted (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Earnings Per Share [Abstract]      
Income (Loss) from Continuing Operations After Taxes $ 1,822 $ 756 $ (270)
Income (loss) from continuing operations attributable to Corteva common stockholders 1,812 736 (283)
(Loss) income from discontinued operations after income taxes (53) (55) (671)
Loss from Discontinued Operations, Net of Tax, Attributable to Noncontrolling Interest 0 0 5
(Loss) income from discontinued operations attributable to Corteva common stockholders (53) (55) (676)
Net (Loss) Income attributable to common stockholders 1,759 681 (959)
Net Income attributable to continuing operations - Noncontrolling Interest $ 10 $ 20 $ 13
XML 115 R95.htm IDEA: XBRL DOCUMENT v3.22.0.1
Earnings Per Share of Common Stock EPS Calculation - Basic (Details) - USD ($)
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Earnings Per Share [Abstract]      
Basic earnings (loss) per share of common stock from continuing operations $ 2.46 $ 0.98 $ (0.38)
Basic earnings (loss) per share of common stock from discontinued operations $ (0.07) $ (0.07) $ (0.90)
Basic (loss) earnings per share of common stock $ 2.39 $ 0.91 $ (1.28)
XML 116 R96.htm IDEA: XBRL DOCUMENT v3.22.0.1
Earnings Per Share of Common Stock EPS Calculation - Diluted (Details) - USD ($)
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Earnings Per Share [Abstract]      
Diluted earnings (loss) per share of common stock from continuing operations $ 2.44 $ 0.98 $ (0.38)
Diluted earnings (loss) per share of common stock from discontinued operations $ (0.07) $ (0.07) $ (0.90)
Diluted (loss) earnings per share of common stock $ 2.37 $ 0.91 $ (1.28)
XML 117 R97.htm IDEA: XBRL DOCUMENT v3.22.0.1
Earnings Per Share Share Count Information (Details) - shares
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Jun. 01, 2019
Earnings Per Share [Line Items]        
Weighted Average Number of Shares Outstanding, Basic [1] 735,900,000 748,700,000 749,500,000  
Dilutive effect of equity compensation plans [2] 5,700,000 2,500,000 0  
Weighted Average Number of Shares Outstanding, Diluted 741,600,000 751,200,000 749,500,000  
Common Stock, Shares Authorized 1,666,667,000 1,666,667,000    
Stock options and restricted stock units excluded from EPS [3] 2,800,000 9,400,000 14,400,000  
Corteva [Member]        
Earnings Per Share [Line Items]        
Shares in which vesting conditions were met       600,000
Common Stock, Shares, Issued       748,815,000
Corteva [Member] | Rounded Amount [Member]        
Earnings Per Share [Line Items]        
Common Stock, Shares, Issued       748,800,000
[1] Share amounts for all periods prior to the Corteva Distribution were based on 748.8 million shares of Corteva, Inc. common stock distributed to holders of DowDuPont's common stock on June 1, 2019, plus 0.6 million of additional shares in which accelerated vesting conditions have been met.
[2] Diluted earnings (loss) per share considers the impact of potentially dilutive securities except in periods in which there is a loss because the inclusion of the potential common shares would have an anti-dilutive effect.
[3] These outstanding potential shares of common stock relating to stock options, restricted stock units and performance-based restricted stock units were excluded from the calculation of diluted earnings (loss) per share because (i) the effect of including stock options and restricted stock units would have been anti-dilutive; and (ii) the performance metrics have not yet been achieved for the outstanding potential shares relating to performance-based restricted stock units, which are deemed to be contingently issuable.
XML 118 R98.htm IDEA: XBRL DOCUMENT v3.22.0.1
Accounts and Notes Receivable, Net (Schedule of Accounts and Notes Receivable, Net) (Details) - USD ($)
$ in Millions
Dec. 31, 2021
Dec. 31, 2020
Receivables [Abstract]    
Accounts receivable - trade [1] $ 3,441 $ 3,754
Notes receivable - trade [1],[2] 120 163
Other [3] 1,250 1,009
Total accounts and notes receivable - net 4,811 4,926
A/R trade and notes receivable - trade, allowance 210 208
Due from Nonconsolidated Affiliates $ 104 $ 106
[1] Accounts receivable – trade and notes receivable – trade are net of allowances of $210 million and $208 million at December 31, 2021 and December 31, 2020, respectively. Allowances are equal to the estimated uncollectible amounts and are based on the expected credit losses and were developed using a loss-rate method.
[2] Notes receivable – trade primarily consists of receivables for deferred payment loan programs for the sale of seed products to customers. These loans have terms of one year or less and are primarily concentrated in North America. The company maintains a rigid pre-approval process for extending credit to customers in order to manage overall risk and exposure associated with credit losses. As of December 31, 2021 and 2020, there were no significant impairments related to current loan agreements.
[3] Other includes receivables in relation to indemnification assets, value added tax, general sales tax and other taxes. No individual group represents more than 10 percent of total receivables. In addition, Other includes amounts due from nonconsolidated affiliates of $104 million and $106 million as of December 31, 2021 and 2020, respectively.
XML 119 R99.htm IDEA: XBRL DOCUMENT v3.22.0.1
Accounts and Notes Receivable Allowance Rollforward (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Receivables [Abstract]    
A/R trade and notes receivable - trade, allowance $ 210 $ 208
Additions charged to expense 1  
Write-offs charged against allowance $ 1  
XML 120 R100.htm IDEA: XBRL DOCUMENT v3.22.0.1
Accounts and Notes Receivable, Net Customer Financing (Details) - Factoring Agreement [Member] - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Accounts, Notes, Loans and Financing Receivable [Line Items]      
Trade Receivables Sold $ 272 $ 255 $ 328
Loss on Sale of Accounts Receivable 54 55 $ 44
Continuing Involvement with Derecognized Transferred Financial Assets, Amount Outstanding $ 166 $ 157  
XML 121 R101.htm IDEA: XBRL DOCUMENT v3.22.0.1
Inventories Schedule of Inventory (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2019
Dec. 31, 2021
Dec. 31, 2020
Sep. 01, 2017
Inventory [Line Items]        
Finished products   $ 2,497 $ 2,584  
Semi-finished products   2,076 1,813  
Raw materials and supplies   607 485  
Total inventories   $ 5,180 $ 4,882  
Merger with Dow [Member]        
Inventory [Line Items]        
Fair Value Step-up       $ 2,297
Amortization of Fair Value Step-up $ 272      
XML 122 R102.htm IDEA: XBRL DOCUMENT v3.22.0.1
Property, Plant and Equipment Schedule of Property, Plant and Equipment (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Property, Plant and Equipment [Line Items]      
Property, Plant and Equipment $ 8,364 $ 8,253  
Accumulated Depreciation (4,035) (3,857)  
Property, Plant and Equipment, Net 4,329 4,396 $ 4,546
Land and Land Improvements [Member]      
Property, Plant and Equipment [Line Items]      
Property, Plant and Equipment 420 451  
Building [Member]      
Property, Plant and Equipment [Line Items]      
Property, Plant and Equipment $ 1,487 1,525  
Building [Member] | Minimum [Member]      
Property, Plant and Equipment [Line Items]      
Property, Plant and Equipment, Useful Life 2 years    
Building [Member] | Maximum [Member]      
Property, Plant and Equipment [Line Items]      
Property, Plant and Equipment, Useful Life 25 years    
Machinery and Equipment [Member]      
Property, Plant and Equipment [Line Items]      
Property, Plant and Equipment $ 5,729 5,556  
Machinery and Equipment [Member] | Minimum [Member]      
Property, Plant and Equipment [Line Items]      
Property, Plant and Equipment, Useful Life 1 year    
Machinery and Equipment [Member] | Maximum [Member]      
Property, Plant and Equipment [Line Items]      
Property, Plant and Equipment, Useful Life 25 years    
Construction in Progress [Member]      
Property, Plant and Equipment [Line Items]      
Property, Plant and Equipment $ 728 $ 721  
Computer Software, Intangible Asset [Member] | Minimum [Member]      
Property, Plant and Equipment [Line Items]      
Property, Plant and Equipment, Useful Life 2 years    
Computer Software, Intangible Asset [Member] | Maximum [Member]      
Property, Plant and Equipment [Line Items]      
Property, Plant and Equipment, Useful Life 7 years    
Land Improvements [Member] | Minimum [Member]      
Property, Plant and Equipment [Line Items]      
Property, Plant and Equipment, Useful Life 1 year    
Land Improvements [Member] | Maximum [Member]      
Property, Plant and Equipment [Line Items]      
Property, Plant and Equipment, Useful Life 25 years    
XML 123 R103.htm IDEA: XBRL DOCUMENT v3.22.0.1
Property, Plant and Equipment Schedule of Depreciation (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Property, Plant and Equipment [Abstract]      
Depreciation expense $ 521 $ 495 $ 525
XML 124 R104.htm IDEA: XBRL DOCUMENT v3.22.0.1
Goodwill and Other Intangible Assets Goodwill by Segment (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Goodwill [Line Items]    
Goodwill Beginning Balance $ 10,269 $ 10,229
Currency Translation Adjustment (160) 69
Other goodwill adjustments and acquisitions (2) [1] (29) [2]
Goodwill Ending Balance 10,107 10,269
Accumulated impairment losses on goodwill 4,503  
Crop Protection [Member]    
Goodwill [Line Items]    
Goodwill Beginning Balance 4,745 4,743
Currency Translation Adjustment (73) 31
Other goodwill adjustments and acquisitions 0 (29) [2]
Goodwill Ending Balance 4,672 4,745
Seed [Member]    
Goodwill [Line Items]    
Goodwill Beginning Balance 5,524 5,486
Currency Translation Adjustment (87) 38
Other goodwill adjustments and acquisitions (2) [1] 0
Goodwill Ending Balance $ 5,435 $ 5,524
[1] Consists of the goodwill included in the sale of a business in the seed segment.
[2] Primarily consists of the goodwill included in the sale of businesses in the crop protection segment.
XML 125 R105.htm IDEA: XBRL DOCUMENT v3.22.0.1
Goodwill and Other Intangible Assets Other Intangible Assets (Details) - USD ($)
$ in Millions
3 Months Ended 12 Months Ended
Dec. 31, 2019
Sep. 30, 2019
Dec. 31, 2019
Dec. 31, 2021
Dec. 31, 2020
Intangible Assets [Line Items]          
Definite-Lived Intangible Assets, Gross       $ 12,595 $ 12,599
Accumulated Amortization       (2,561) (1,862)
Definite-Lived Intangible Assets, Net       10,034 10,737
Indefinite-lived Intangible Assets       10 10
Total Intangible Assets, Gross       12,605 12,609
Total intangible assets - net       10,044 10,747
IPR&D [Member]          
Intangible Assets [Line Items]          
Indefinite-lived Intangible Assets       10 10
Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) $ 90 $ 54 $ 144    
Impairment of Intangible Assets Indefinite lived Excluding Goodwill After Tax $ 69 $ 41 $ 110    
Germplasm [Member]          
Intangible Assets [Line Items]          
Definite-Lived Intangible Assets, Gross       6,265 6,265
Accumulated Amortization       (571) (317)
Definite-Lived Intangible Assets, Net       5,694 5,948
Customer-Related Intangible Assets [Member]          
Intangible Assets [Line Items]          
Definite-Lived Intangible Assets, Gross       1,953 1,984
Accumulated Amortization       (487) (380)
Definite-Lived Intangible Assets, Net       1,466 1,604
Developed Technology [Member]          
Intangible Assets [Line Items]          
Definite-Lived Intangible Assets, Gross       1,485 1,451
Accumulated Amortization       (679) (525)
Definite-Lived Intangible Assets, Net       806 926
Trademarks and Trade Names [Member]          
Intangible Assets [Line Items]          
Definite-Lived Intangible Assets, Gross [1]       2,012 2,019
Accumulated Amortization [1]       (172) (99)
Definite-Lived Intangible Assets, Net [1]       1,840 1,920
Favorable Supply Contract [Member]          
Intangible Assets [Line Items]          
Definite-Lived Intangible Assets, Gross       475 475
Accumulated Amortization       (396) (302)
Definite-Lived Intangible Assets, Net       79 173
Other Intangible Assets [Member]          
Intangible Assets [Line Items]          
Definite-Lived Intangible Assets, Gross [2]       405 405
Accumulated Amortization [2]       (256) (239)
Definite-Lived Intangible Assets, Net [2]       $ 149 $ 166
[1] Beginning on October 1, 2020, the company changed its indefinite life assertion of its trade name asset to definite lived with a useful life of 25 years. This change is the result of the launch of BrevantTM seed in the retail channel in the U.S. Prior to changing the useful life of the trade name asset, the company tested the asset for impairment under ASC 350 - Intangibles, Goodwill and Other, concluding the asset was not impaired.
[2] Primarily consists of sales and farmer networks, marketing and manufacturing alliances and noncompetition agreements.
XML 126 R106.htm IDEA: XBRL DOCUMENT v3.22.0.1
Goodwill and Other Intangible Assets Amortization Expense (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Finite-Lived Intangible Assets [Line Items]      
Amortization expense $ 722 $ 682 $ 475
Continuing Operations [Member]      
Finite-Lived Intangible Assets [Line Items]      
2022 700    
2023 620    
2024 606    
2025 569    
2026 $ 558    
XML 127 R107.htm IDEA: XBRL DOCUMENT v3.22.0.1
Leases Narrative (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Guarantee Obligations $ 105 $ 94
Residual Value Guarantee [Member]    
Guarantee Obligations $ 193  
Minimum [Member]    
Remaining Lease Term 1 year  
Maximum [Member]    
Remaining Lease Term 50 years  
XML 128 R108.htm IDEA: XBRL DOCUMENT v3.22.0.1
Leases Lease Costs (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Leases [Abstract]    
Operating Lease, Cost $ 158 $ 197
Finance Lease, Right-of-Use Asset, Amortization 1 2
Finance Lease, Interest Expense 0 0
Finance Lease, Cost 1 2
Short-term Lease, Cost 14 14
Variable Lease, Cost 8 7
Total Lease Cost $ 181 $ 220
XML 129 R109.htm IDEA: XBRL DOCUMENT v3.22.0.1
Leases Supplemental Cash Flow Information (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Leases [Abstract]    
Operating cash outflows from operating leases $ 169 $ 202
Operating cash outflows from finance leases 0 0
Financing cash outflows from finance leases $ 1 $ 1
XML 130 R110.htm IDEA: XBRL DOCUMENT v3.22.0.1
Leases Supplemental Balance Sheet Information (Details) - USD ($)
$ in Millions
Dec. 31, 2021
Dec. 31, 2020
Schedule of Lease Assets and Liabilities [Line Items]    
Operating Lease, Right-of-Use Asset [1] $ 458 $ 521
Current operating lease liabilities [2] 121 138
Noncurrent operating lease liabilities [3] 338 391
Total operating lease liabilities 459 529
Finance Lease, Right-of-Use Asset, Gross 15 15
Finance Lease, Right-Of-Use Asset, Accumulated Depreciation (11) (10)
Finance Lease, Liability, Noncurrent 3 4
Finance Lease, Liability 4 5
Property, Plant and Equipment [Member]    
Schedule of Lease Assets and Liabilities [Line Items]    
Finance Lease, Right-of-Use Asset 4 5
Within One Year    
Schedule of Lease Assets and Liabilities [Line Items]    
Finance Lease, Liability, Current 1 1
Long-term Debt [Member]    
Schedule of Lease Assets and Liabilities [Line Items]    
Finance Lease, Liability, Noncurrent $ 3 $ 4
[1] Included in other assets in the Consolidated Balance Sheet.
[2] Included in accrued and other current liabilities in the Consolidated Balance Sheet.
[3] Included in other noncurrent obligations in the Consolidated Balance Sheet.
XML 131 R111.htm IDEA: XBRL DOCUMENT v3.22.0.1
Leases Lease Term and Discount Rate (Details)
Dec. 31, 2021
Dec. 31, 2020
Leases [Abstract]    
Operating Lease, Weighted Average Remaining Lease Term 7 years 4 months 28 days 7 years 8 months 15 days
Finance Lease, Weighted Average Remaining Lease Term 3 years 4 months 9 days 4 years 3 months 3 days
Operating Lease, Weighted Average Discount Rate, Percent 2.75% 3.06%
Finance Lease, Weighted Average Discount Rate, Percent 3.29% 3.28%
XML 132 R112.htm IDEA: XBRL DOCUMENT v3.22.0.1
Leases Maturity of Lease Liabilities (Details) - USD ($)
$ in Millions
Dec. 31, 2021
Dec. 31, 2020
Leases [Abstract]    
Operating Lease, Year One $ 132 $ 152
Operating Lease, Year Two 94 114
Operating Lease, Year Three 71 83
Operating Lease, Year Four 60 61
Operating Lease, Year Five 49 51
Operating Lease, Due After Year Five 106 137
Operating Lease, Total Payments 512 598
Operating Lease, Interest 53 69
Total operating lease liabilities 459 529
Finance Lease, Year One 1 1
Finance Lease, Year Two 1 1
Finance Lease, Year Three 1 1
Finance Lease, Year Four 1 1
Finance Lease, Year Five 0 1
Finance Lease, Due After Year Five 0 0
Finance Lease, Total Payments 4 5
Finance Lease, Interest 0 0
Finance Lease, Liability $ 4 $ 5
XML 133 R113.htm IDEA: XBRL DOCUMENT v3.22.0.1
Long-Term Debt and Available Credit Facilities Long Term Debt (Details) - USD ($)
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
May 31, 2020
Mar. 22, 2019
Debt Instrument [Line Items]        
Long-term Debt, Gross       $ 1,530,000,000
Finance Lease, Liability, Noncurrent $ 3,000,000 $ 4,000,000    
Unamortized debt discount and issuance costs 10,000,000 11,000,000    
Long-term debt payable within one year 1,000,000 1,000,000    
Long-term Debt 1,100,000,000 1,102,000,000    
Loans Payable [Member] | Notes Maturing 2025 [Domain]        
Debt Instrument [Line Items]        
Long-term Debt, Gross $ 500,000,000 $ 500,000,000    
Long-term Debt, Weighted Average Interest Rate 1.70% 1.70%    
Loans Payable [Member] | Notes Maturing 2030 [Domain]        
Debt Instrument [Line Items]        
Long-term Debt, Gross $ 500,000,000 $ 500,000,000    
Long-term Debt, Weighted Average Interest Rate 2.30% 2.30%    
Loans Payable [Member] | Foreign Currency Loans [Member]        
Debt Instrument [Line Items]        
Long-term Debt, Gross $ 1,000,000 $ 1,000,000    
Medium-term Notes [Member]        
Debt Instrument [Line Items]        
Long-term Debt, Gross $ 107,000,000 $ 109,000,000    
Long-term Debt, Weighted Average Interest Rate 0.00% 0.00%    
Senior Notes Due 2025 [Member]        
Debt Instrument [Line Items]        
Long-term Debt, Gross     $ 500,000,000  
Debt Instrument, Interest Rate, Stated Percentage     1.70%  
Senior Notes Due 2030 [Member]        
Debt Instrument [Line Items]        
Long-term Debt, Gross     $ 500,000,000  
Debt Instrument, Interest Rate, Stated Percentage     2.30%  
Notes Maturing 2025 [Domain]        
Debt Instrument [Line Items]        
Line of Credit Facility, Periodic Payment, Principal $ 500,000,000      
Fair Value, Inputs, Level 2 [Member]        
Debt Instrument [Line Items]        
Long-term Debt, Fair Value $ 1,120,000,000 $ 1,166,000,000    
XML 134 R114.htm IDEA: XBRL DOCUMENT v3.22.0.1
Long-Term Debt and Available Credit Facilities Available Committed Credit Facilities (Narrative) (Details)
$ in Millions
36 Months Ended 37 Months Ended 60 Months Ended
Nov. 13, 2021
Mar. 31, 2019
Nov. 13, 2023
Dec. 31, 2021
USD ($)
Nov. 13, 2018
USD ($)
Line of Credit Facility [Line Items]          
Line of Credit Facility, Maximum Borrowing Capacity       $ 6,000  
Line of Credit Facility, Remaining Borrowing Capacity       6,000  
Revolving Credit Facilities due 2024 [Member]          
Line of Credit Facility [Line Items]          
Line of Credit Facility, Maximum Borrowing Capacity       3,000 $ 3,000
Line of Credit Facility, Remaining Borrowing Capacity       3,000  
Debt Instrument, Term     5 years    
Revolving Credit Facilities due 2022 [Member]          
Line of Credit Facility [Line Items]          
Line of Credit Facility, Maximum Borrowing Capacity       3,000 $ 3,000
Line of Credit Facility, Remaining Borrowing Capacity       $ 3,000  
Debt Instrument, Term 3 years        
Term Loan Facility due 2020 [Member]          
Line of Credit Facility [Line Items]          
Debt Instrument, Term   3 years      
Revolving Credit Facilities due 2022 [Member]          
Line of Credit Facility [Line Items]          
Ratio of Indebtedness to Net Capital         0.60
XML 135 R115.htm IDEA: XBRL DOCUMENT v3.22.0.1
Long-Term Debt and Available Credit Facilities Debt Redemptions/Repayments (Details) - USD ($)
$ in Millions
12 Months Ended 36 Months Ended 37 Months Ended
May 02, 2019
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
[1]
Nov. 13, 2021
Mar. 31, 2019
Mar. 31, 2021
May 17, 2019
Mar. 22, 2019
Nov. 13, 2018
Mar. 22, 2016
Debt Instrument [Line Items]                      
Long-term Debt, Gross                 $ 1,530    
Repayments of Long-term Debt, including breakage fees and all applicable accrued and unpaid interest $ 4,600                    
Loss on Extinguishment of Debt   $ 0 $ 0 $ (13)              
Line of Credit Facility, Maximum Borrowing Capacity   6,000                  
Long-term Line of Credit $ 3,000                    
Term Loan Facility due 2020 [Member]                      
Debt Instrument [Line Items]                      
Debt Instrument, Term           3 years          
4.625% Notes due 2020 [Member]                      
Debt Instrument [Line Items]                      
Long-term Debt, Gross                 $ 474    
Debt Instrument, Interest Rate, Stated Percentage                 4.625%    
3.625% Notes due 2021 [Member]                      
Debt Instrument [Line Items]                      
Long-term Debt, Gross                 $ 296    
Debt Instrument, Interest Rate, Stated Percentage                 3.625%    
4.250% Notes due 2021 [Member]                      
Debt Instrument [Line Items]                      
Long-term Debt, Gross                 $ 163    
Debt Instrument, Interest Rate, Stated Percentage                 4.25%    
2.800% Notes due 2023 [Member]                      
Debt Instrument [Line Items]                      
Long-term Debt, Gross                 $ 381    
Debt Instrument, Interest Rate, Stated Percentage                 2.80%    
6.500% Debentures due 2028 [Member]                      
Debt Instrument [Line Items]                      
Long-term Debt, Gross                 $ 57    
Debt Instrument, Interest Rate, Stated Percentage                 6.50%    
5.600% Senior Notes due 2036 [Member]                      
Debt Instrument [Line Items]                      
Long-term Debt, Gross                 $ 42    
Debt Instrument, Interest Rate, Stated Percentage                 5.60%    
4.900% Notes due 2041 [Member]                      
Debt Instrument [Line Items]                      
Long-term Debt, Gross                 $ 48    
Debt Instrument, Interest Rate, Stated Percentage                 4.90%    
4.150% Notes due 2043 [Member]                      
Debt Instrument [Line Items]                      
Long-term Debt, Gross                 $ 69    
Debt Instrument, Interest Rate, Stated Percentage                 4.15%    
Senior Note 2.20 Percent Due 2020 [Member]                      
Debt Instrument [Line Items]                      
Debt Instrument, Interest Rate, Stated Percentage               2.20%      
Debt Instrument, Face Amount               $ 1,250      
Senior Note Floating Rate Due 2020 [Member]                      
Debt Instrument [Line Items]                      
Debt Instrument, Face Amount               750      
SMR notes [Member]                      
Debt Instrument [Line Items]                      
Debt Instrument, Repurchase Amount               $ 2,000      
Revolving Credit Facilities due 2022 [Member]                      
Debt Instrument [Line Items]                      
Debt Instrument, Term         3 years            
Line of Credit Facility, Maximum Borrowing Capacity   $ 3,000               $ 3,000  
Long-term Line of Credit             $ 500        
EID [Member] | Term Loan Facility due 2020 [Member]                      
Debt Instrument [Line Items]                      
Line of Credit Facility, Maximum Borrowing Capacity                     $ 4,500
[1] The cash flows for the year ended December 31, 2019 includes cash flows of EID's ECP and Specialty Products Entities.
XML 136 R116.htm IDEA: XBRL DOCUMENT v3.22.0.1
Long-Term Debt and Available Credit Facilities Uncommitted Credit Facilities and Outstanding Letters of Credit (Details)
$ in Millions
Dec. 31, 2021
USD ($)
Debt Instrument [Line Items]  
Line Of Credit Facility, Remaining Borrowing Capacity, Uncommitted Amount $ 389
Letters of Credit Outstanding, Amount $ 127
XML 137 R117.htm IDEA: XBRL DOCUMENT v3.22.0.1
Commitments and Contingent Liabilities Guarantee Narrative (Details) - USD ($)
$ in Millions
Dec. 31, 2021
Dec. 31, 2020
Guarantor Obligations [Line Items]    
Guarantee Obligations $ 105 $ 94
Factoring Agreement [Member]    
Guarantor Obligations [Line Items]    
Guarantee Obligations 21 17
Agreements with lenders to provide financing for select customers [Member]    
Guarantor Obligations [Line Items]    
Accounts Receivable, after Allowance for Credit Loss $ 15 $ 16
XML 138 R118.htm IDEA: XBRL DOCUMENT v3.22.0.1
Commitments and Contingent Liabilities Litigation - Chemours (Details)
3 Months Ended 12 Months Ended
Jun. 30, 2017
USD ($)
Dec. 31, 2021
USD ($)
Dec. 31, 2020
USD ($)
Sep. 30, 2029
USD ($)
Dec. 31, 2028
USD ($)
Sep. 30, 2023
USD ($)
Jan. 28, 2022
USD ($)
Dec. 31, 2018
lawsuits
Performance Chemicals [Member]                
Loss Contingencies [Line Items]                
(Loss) Income from Discontinued Operation, before Income Tax   $ 48,000,000 $ 65,000,000          
PFAS [Member]                
Loss Contingencies [Line Items]                
Escrow Account Balance         $ 700,000,000      
Withdrawal Amount after Year 6   200,000,000            
MOU Terms for Withdrawals   125,000,000            
PFAS [Member] | Maximum [Member]                
Loss Contingencies [Line Items]                
Qualified Spend and Escrow Account Contribution Threshold   $ 4,000,000,000            
Cost Sharing Arrangement Term   20 years            
Corteva and Dupont stray liability threshold for PFAS   $ 300,000,000            
PFAS [Member] | Minimum [Member]                
Loss Contingencies [Line Items]                
Corteva and Dupont stray liability threshold for PFAS   1            
PFAS [Member] | Minimum [Member] | Once $300 million threshold is met [Member]                
Loss Contingencies [Line Items]                
De minimis threshold   1,000,000            
DuPont de Nemours [Member]                
Loss Contingencies [Line Items]                
Amount credited to each company's threshold   $ 150,000,000            
PFOA Matters: Multi-District Litigation [Member]                
Loss Contingencies [Line Items]                
Litigation Settlement Amount $ 670,700,000              
Lawsuits alleging personal injury filed | lawsuits               3,550
Non-PFAS                
Loss Contingencies [Line Items]                
Request for Remediation Funding Source ("RFS")             $ 900,000,000  
Chemours [Member] | PFAS [Member]                
Loss Contingencies [Line Items]                
MOU Escrow Account Deposit           $ 100,000,000    
Escrow Account Deposit Percentage   50.00%            
Annual escrow deposit, remainder of period       $ 50,000,000        
Chemours [Member] | PFAS [Member] | Maximum [Member]                
Loss Contingencies [Line Items]                
Total Escrow Deposit Amount       500,000,000        
Corteva [Member]                
Loss Contingencies [Line Items]                
Stray liability sharing percentage   29.00%            
Corteva [Member] | PFAS [Member]                
Loss Contingencies [Line Items]                
Corteva and DuPont stray liability sharing percentage for PFAS   5000.00%            
Corteva [Member] | DuPont de Nemours [Member]                
Loss Contingencies [Line Items]                
Stray liability threshold   $ 200,000,000            
Corteva [Member] | DuPont de Nemours [Member] | PFAS [Member]                
Loss Contingencies [Line Items]                
MOU Escrow Account Deposit           $ 100,000,000    
Escrow Account Deposit Percentage   50.00%            
Corteva and DuPont stray liability sharing percentage for PFAS   50.00%            
Annual escrow deposit, remainder of period       50,000,000        
Corteva [Member] | DuPont de Nemours [Member] | PFAS [Member] | Maximum [Member]                
Loss Contingencies [Line Items]                
Qualified Spend and Escrow Account Contribution Threshold   $ 2,000,000,000            
Total Escrow Deposit Amount       $ 500,000,000        
DuPont de Nemours [Member]                
Loss Contingencies [Line Items]                
Stray liability sharing percentage   71.00%            
DuPont de Nemours [Member] | PFAS [Member]                
Loss Contingencies [Line Items]                
Corteva and DuPont stray liability sharing percentage for PFAS   5000.00%            
DuPont de Nemours [Member] | DuPont de Nemours [Member]                
Loss Contingencies [Line Items]                
Corteva and Dupont stray liability threshold for PFAS   $ 200,000,000            
Stray liability threshold   $ 200,000,000            
XML 139 R119.htm IDEA: XBRL DOCUMENT v3.22.0.1
Commitments and Contingent Liabilities Litigation - DuPont (Details)
Dec. 31, 2021
USD ($)
PFAS [Member] | Minimum [Member]  
Loss Contingencies [Line Items]  
Corteva and Dupont stray liability threshold for PFAS $ 1
PFAS [Member] | Minimum [Member] | Once $300 million threshold is met [Member]  
Loss Contingencies [Line Items]  
De minimis threshold 1,000,000
PFAS [Member] | Maximum [Member]  
Loss Contingencies [Line Items]  
Corteva and Dupont stray liability threshold for PFAS 300,000,000
DuPont de Nemours [Member]  
Loss Contingencies [Line Items]  
Amount credited to each company's threshold $ 150,000,000
Corteva [Member]  
Loss Contingencies [Line Items]  
Stray liability sharing percentage 29.00%
Corteva [Member] | PFAS [Member]  
Loss Contingencies [Line Items]  
Corteva and DuPont stray liability sharing percentage for PFAS 5000.00%
Corteva [Member] | DuPont de Nemours [Member]  
Loss Contingencies [Line Items]  
Stray liability threshold $ 200,000,000
Corteva [Member] | DuPont de Nemours [Member] | PFAS [Member]  
Loss Contingencies [Line Items]  
Corteva and DuPont stray liability sharing percentage for PFAS 50.00%
DuPont de Nemours [Member]  
Loss Contingencies [Line Items]  
Stray liability sharing percentage 71.00%
DuPont de Nemours [Member] | PFAS [Member]  
Loss Contingencies [Line Items]  
Corteva and DuPont stray liability sharing percentage for PFAS 5000.00%
DuPont de Nemours [Member] | DuPont de Nemours [Member]  
Loss Contingencies [Line Items]  
Stray liability threshold $ 200,000,000
Corteva and Dupont stray liability threshold for PFAS $ 200,000,000
XML 140 R120.htm IDEA: XBRL DOCUMENT v3.22.0.1
Commitments and Contingent Liabilities Litigation - Leach and MDL Settlement (Details)
3 Months Ended 12 Months Ended 108 Months Ended
Jun. 30, 2017
USD ($)
Dec. 31, 2021
USD ($)
Dec. 31, 2004
USD ($)
Dec. 31, 2020
USD ($)
Dec. 31, 2018
lawsuits
Jan. 01, 2012
PFOA Matters: Drinking Water Actions [Member]            
Loss Contingencies [Line Items]            
Binding Settlement Agreement Class Size     80,000      
Loss Contingency, Number Of Water Districts Receiving Water Treatment           6
Litigation Settlement, Liability For Medical Monitoring Program, Threshold     $ 235,000,000      
Litigation Settlement, Medical Monitoring Program, Escrow Account, Disbursements To Date       $ 2,000,000    
Escrow Balance   $ 1,000,000        
PFOA Matters: Multi-District Litigation [Member]            
Loss Contingencies [Line Items]            
Disease Categories for MDL   6        
Lawsuits alleging personal injury filed | lawsuits         3,550  
Litigation Settlement Amount $ 670,700,000          
DuPont de Nemours and Corteva Contribution to MDL Settlement [Member]            
Loss Contingencies [Line Items]            
Litigation Settlement Amount   $ 27,000,000        
Payments for Legal Settlements   27,000,000        
MDL Settlement [Member]            
Loss Contingencies [Line Items]            
Litigation Settlement Amount   83,000,000        
Chemours Contribution to MDL Settlement [Member]            
Loss Contingencies [Line Items]            
Litigation Settlement Amount   $ 29,000,000        
Post-MDL Settlement PFOA Personal Injury Claims [Domain] | PFOA Matters: Drinking Water Actions [Member] | Settled Litigation [Member]            
Loss Contingencies [Line Items]            
Loss Contingency, Pending Claims, Number   95        
Post-MDL Settlement PFOA Personal Injury Claims [Domain] | Compensatory Damages [Member] | PFOA Matters: Drinking Water Actions [Member]            
Loss Contingencies [Line Items]            
Litigation Settlement Amount   $ 40,000,000        
Post-MDL Settlement PFOA Personal Injury Claims [Domain] | Loss of Consortium [Member] | PFOA Matters: Drinking Water Actions [Member]            
Loss Contingencies [Line Items]            
Litigation Settlement Amount   $ 10,000,000        
XML 141 R121.htm IDEA: XBRL DOCUMENT v3.22.0.1
Commitments and Contingent Liabilities Litigation - Other PFOA Matters / Fayatteville (Details)
$ in Millions
12 Months Ended
Dec. 31, 2021
USD ($)
lawsuits
Settlement Agreement  
Loss Contingencies [Line Items]  
(Loss) Income from Discontinued Operation, before Income Tax $ 11.0
Firefighting Foam [Member]  
Loss Contingencies [Line Items]  
Loss Contingency, Pending Claims, Number | lawsuits 2,050
Firefighting Foam [Member] | Personal injury cases [Member]  
Loss Contingencies [Line Items]  
Loss Contingency, Pending Claims, Number 1,860
NORTH CAROLINA | PFOA Matters: Drinking Water Actions [Member]  
Loss Contingencies [Line Items]  
Loss Contingency, Number of Additional Plaintiffs | lawsuits 100
Loss Contingency, Number of Property Owners 100
NEW YORK | PFOA Matters: Drinking Water Actions [Member]  
Loss Contingencies [Line Items]  
Loss Contingency, Pending Claims, Number 50
NEW JERSEY | PFOA Matters: Drinking Water Actions [Member]  
Loss Contingencies [Line Items]  
Loss Contingency, Pending Claims, Number 2
NEW JERSEY | Natural Resources Damages [Member]  
Loss Contingencies [Line Items]  
Loss Contingency, Pending Claims, Number 4
OHIO | PFOA Matters: Drinking Water Actions [Member]  
Loss Contingencies [Line Items]  
Loss Contingency, Pending Claims, Number | lawsuits 3
DELAWARE | Natural Resources Damages [Member] | Corteva [Member]  
Loss Contingencies [Line Items]  
Collective Threshold for Payments to Fund the NRST Trust $ 25.0
DELAWARE | Natural Resources Damages [Member] | Chemours [Member]  
Loss Contingencies [Line Items]  
Chemours share of payment to NRST Trust, percentage 50.00%
DELAWARE | Natural Resources Damages [Member] | DuPont de Nemours [Member] | Corteva [Member]  
Loss Contingencies [Line Items]  
Collective Threshold for Payments to Fund the NRST Trust $ 50.0
Corteva and DuPont Share of NRST Trust Payment 12.5
Supplemental Payment Threshold $ 25.0
XML 142 R122.htm IDEA: XBRL DOCUMENT v3.22.0.1
Commitments and Contingent Liabilities Environmental (Details)
$ in Millions
Dec. 31, 2021
USD ($)
Loss Contingencies [Line Items]  
Accrual for Environmental Loss Contingencies $ 452 [1],[2]
Accrual for Environmental Loss Contingencies, Potential Exposure in Excess of Accrual 592 [1]
Indemnification Asset 220
Chemours related obligation subject to indemnification [Member]  
Loss Contingencies [Line Items]  
Accrual for Environmental Loss Contingencies 159 [1],[2],[3],[4]
Accrual for Environmental Loss Contingencies, Potential Exposure in Excess of Accrual 262 [1],[3],[4]
Indemnification Asset 159 [3],[4]
Discontinued Operations [Member]  
Loss Contingencies [Line Items]  
Indemnification Asset 15 [3]
Environmental remediation liabilities primarily related to DuPont - subject to indemnity from DuPont [Member]  
Loss Contingencies [Line Items]  
Accrual for Environmental Loss Contingencies 37 [1],[2],[4]
Accrual for Environmental Loss Contingencies, Potential Exposure in Excess of Accrual 66 [1],[4]
Indemnification Asset 37 [4]
Not subject to indemnification [Member]  
Loss Contingencies [Line Items]  
Accrual for Environmental Loss Contingencies 99 [1],[2]
Accrual for Environmental Loss Contingencies, Potential Exposure in Excess of Accrual 28 [1]
Indemnification Asset 9
Other Discontinued or Divested Business Obligations  
Loss Contingencies [Line Items]  
Accrual for Environmental Loss Contingencies 75 [1],[2],[3]
Accrual for Environmental Loss Contingencies, Potential Exposure in Excess of Accrual 187 [1],[3]
DuPont de Nemours [Member] | DuPont de Nemours [Member]  
Loss Contingencies [Line Items]  
Stray liability threshold 200
Superfund Sites [Member] | Chemours [Member] | Indemnification Agreement [Member]  
Loss Contingencies [Line Items]  
Indemnification Asset $ 40
[1] Accrual balance represents management’s best estimate of the costs of remediation and restoration, although it is reasonably possible that the potential exposure, as indicated, could range above the amounts accrued, as there are inherent uncertainties in these estimates. Accrual balance includes $68 million for remediation of Superfund sites. Amounts do not include possible impacts from the remediation elements of the EPAs October 2021 PFAS Strategic Roadmap (as applicable) or possible revisions to Chemours’ Consent Order with the North Carolina Department of Environmental Quality, as any possible impacts, to the extent such items would be reimbursable under the MOU, are not yet determinable.
[2] Represents liabilities that are subject to the $150 million threshold and sharing agreements as discussed on page F-44, under the header "Chemours / Performance Chemicals.
[3] Represents liabilities that are subject the $200 million threshold and sharing arrangements as discussed on page F-46, under Corteva Separation Agreement.
[4] The company has recorded an indemnification asset related to these accruals, including $40 million related to the Superfund sites.
XML 143 R123.htm IDEA: XBRL DOCUMENT v3.22.0.1
Stockholders' Equity Common Stock (Details)
$ / shares in Units, $ in Millions
12 Months Ended
Dec. 31, 2021
USD ($)
$ / shares
shares
Dec. 31, 2020
USD ($)
$ / shares
shares
Dec. 31, 2019
USD ($)
shares
Feb. 03, 2022
$ / shares
Jun. 26, 2019
USD ($)
$ / shares
Jun. 03, 2019
$ / shares
shares
Jun. 01, 2019
shares
Equity, Class of Treasury Stock [Line Items]              
Common Stock, Shares Authorized 1,666,667,000 1,666,667,000          
Common Stock, Par Value | $ / shares $ 0.01 $ 0.01   $ 0.01      
Common Stock, Shares, Outstanding 726,527,000 743,458,000 748,577,000       748,815,000
Stock Issued During Period, Shares, New Issues 4,019,000 3,384,000 586,000        
Stock Repurchased and Retired During Period, Shares (20,950,000) (8,503,000) (824,000)        
Stock Repurchase Program, Authorized Amount | $         $ 1,000    
Payments for Repurchase of Common Stock | $ $ 950 $ 275 $ 25 [1]        
Payments for Repurchase of Common Stock | $ 950 275 $ 25 [1]        
2019 share repurchase plan              
Equity, Class of Treasury Stock [Line Items]              
Payments for Repurchase of Common Stock | $ 700 275          
Payments for Repurchase of Common Stock | $ $ 700 $ 275          
Corteva [Member]              
Equity, Class of Treasury Stock [Line Items]              
Common Stock, Shares Authorized           748,815,000  
Common Stock, Par Value | $ / shares         $ 0.01 $ 0.01  
Common Stock, Shares, Issued             748,815,000
Corteva [Member] | Shares of Corteva Stock [Member]              
Equity, Class of Treasury Stock [Line Items]              
Exchange Ratio             1
Corteva [Member] | Shares of DowDuPont Common Stock Held [Member]              
Equity, Class of Treasury Stock [Line Items]              
Exchange Ratio             3
Corteva [Member]              
Equity, Class of Treasury Stock [Line Items]              
Stock Repurchased and Retired During Period, Shares 15,378,000 8,503,000          
Common Stock, Shares, Issued             748,815,000
[1] The cash flows for the year ended December 31, 2019 includes cash flows of EID's ECP and Specialty Products Entities.
XML 144 R124.htm IDEA: XBRL DOCUMENT v3.22.0.1
Stockholders' Equity Noncontrolling Interest (Details) - USD ($)
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Noncontrolling Interest [Line Items]      
Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners 46.50%    
Payment for acquisition of subsidiary's interest from the non-controlling interest $ 0 $ (60,000,000) $ 0 [1]
Net Deferred Tax Liability (782,000,000) (429,000,000)  
EID [Member]      
Noncontrolling Interest [Line Items]      
Payment for acquisition of subsidiary's interest from the non-controlling interest $ 0 $ (60,000,000) $ 0 [2]
$4.50 Series Preferred Stock [Member] | EID [Member]      
Noncontrolling Interest [Line Items]      
Preferred Stock, Shares Authorized 23,000,000 23,000,000  
Preferred Stock, Shares Issued 1,673,000 1,673,000  
Preferred Stock, Redemption Amount $ 120 $ 120  
$3.50 Series Preferred Stock [Member] | EID [Member]      
Noncontrolling Interest [Line Items]      
Preferred Stock, Shares Authorized 23,000,000 23,000,000  
Preferred Stock, Shares Issued 700,000 700,000  
Preferred Stock, Redemption Amount $ 102 $ 102  
Corteva [Member] | EID [Member]      
Noncontrolling Interest [Line Items]      
Ownership interest in an entity 100.00%    
[1] The cash flows for the year ended December 31, 2019 includes cash flows of EID's ECP and Specialty Products Entities.
[2] The cash flows for the year ended December 31, 2019 includes cash flows of EID's ECP and Specialty Products Entities
XML 145 R125.htm IDEA: XBRL DOCUMENT v3.22.0.1
Stockholders' Equity Other Comprehensive Income (Loss) (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Accumulated Other Comprehensive Income (Loss) [Line Items]      
Beginning Balance $ 25,063 $ 24,555 $ 75,153
Net other comprehensive income (loss) (8) 380 (1,124)
Ending Balance 25,623 25,063 24,555
Cumulative Translation Adjustment      
Accumulated Other Comprehensive Income (Loss) [Line Items]      
Beginning Balance (1,970) (1,944) (2,793)
Other Comprehensive Income (Loss), before Reclassifications, Net of Tax (573) (26) [1] (274) [1]
Amounts Reclassified from Accumulated Other Comprehensive Income, Net of Tax 0 0 0
Net other comprehensive income (loss) (573) (26) (274)
Ending Balance (2,543) (1,970) (1,944)
Derivative Instruments      
Accumulated Other Comprehensive Income (Loss) [Line Items]      
Beginning Balance (67) 2 (26)
Other Comprehensive Income (Loss), before Reclassifications, Net of Tax 143 (81) 16
Amounts Reclassified from Accumulated Other Comprehensive Income, Net of Tax (4) 12 12
Net other comprehensive income (loss) 139 (69) 28
Ending Balance 72 (67) 2
Unrealized gain (loss) on investments      
Accumulated Other Comprehensive Income (Loss) [Line Items]      
Beginning Balance (10) 0 0
Other Comprehensive Income (Loss), before Reclassifications, Net of Tax 3 (10) 0
Amounts Reclassified from Accumulated Other Comprehensive Income, Net of Tax 7 0 0
Net other comprehensive income (loss) 10 (10) 0
Ending Balance 0 (10) 0
Accumulated Other Comp Loss      
Accumulated Other Comprehensive Income (Loss) [Line Items]      
Beginning Balance (2,890) (3,270) (3,360)
Other Comprehensive Income (Loss), before Reclassifications, Net of Tax 594 362 (1,140)
Amounts Reclassified from Accumulated Other Comprehensive Income, Net of Tax (602) 18 16
Net other comprehensive income (loss) (8) 380 (1,124)
Ending Balance (2,898) (2,890) (3,270)
Internal Reorganization [Member] | Cumulative Translation Adjustment      
Accumulated Other Comprehensive Income (Loss) [Line Items]      
Other Comprehensive Income, Other, Net of Tax     1,123
Internal Reorganization [Member] | Derivative Instruments      
Accumulated Other Comprehensive Income (Loss) [Line Items]      
Other Comprehensive Income, Other, Net of Tax     0
Internal Reorganization [Member] | Unrealized gain (loss) on investments      
Accumulated Other Comprehensive Income (Loss) [Line Items]      
Other Comprehensive Income, Other, Net of Tax     0
Internal Reorganization [Member] | Accumulated Other Comp Loss      
Accumulated Other Comprehensive Income (Loss) [Line Items]      
Other Comprehensive Income, Other, Net of Tax     1,214
Pension Plan      
Accumulated Other Comprehensive Income (Loss) [Line Items]      
Beginning Balance (1,433) (1,247) (620)
Other Comprehensive Income (Loss), before Reclassifications, Net of Tax 996 (191) (723)
Amounts Reclassified from Accumulated Other Comprehensive Income, Net of Tax 41 5 5
Net other comprehensive income (loss) 1,037 (186) (718)
Ending Balance (396) (1,433) (1,247)
Pension Plan | Internal Reorganization [Member]      
Accumulated Other Comprehensive Income (Loss) [Line Items]      
Other Comprehensive Income, Other, Net of Tax     91
Other Benefit Plans      
Accumulated Other Comprehensive Income (Loss) [Line Items]      
Beginning Balance 590 (81) 79
Other Comprehensive Income (Loss), before Reclassifications, Net of Tax 25 670 (159)
Amounts Reclassified from Accumulated Other Comprehensive Income, Net of Tax (646) 1 (1)
Net other comprehensive income (loss) (621) 671 (160)
Ending Balance $ (31) $ 590 (81)
Other Benefit Plans | Internal Reorganization [Member]      
Accumulated Other Comprehensive Income (Loss) [Line Items]      
Other Comprehensive Income, Other, Net of Tax     $ 0
[1] The cumulative translation adjustment losses for the year ended December 31, 2021 was primarily driven by the strengthening of the U.S. Dollar ("USD") against the European Euro ("EUR"), Swiss franc ("CHF") and Turkish Lira (“TRY”). The cumulative translation adjustment losses for the year ended December 31, 2020 was primarily driven by the strengthening of the U.S. Dollar ("USD") against the Brazilian Real ("BRL"), partially offset by the weakening of the U.S. Dollar against the Swiss franc ("CHF") and European Euro ("EUR").
XML 146 R126.htm IDEA: XBRL DOCUMENT v3.22.0.1
Stockholders' Equity Tax Benefit (Expense) on Net Activity (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Accumulated Other Comprehensive Income (Loss) [Line Items]      
Other Comprehensive Income (Loss), Tax $ (172) $ (133) $ 275
Pension Plan      
Accumulated Other Comprehensive Income (Loss) [Line Items]      
Other Comprehensive Income (Loss), Tax (319) 54 231
Other Benefit Plans      
Accumulated Other Comprehensive Income (Loss) [Line Items]      
Other Comprehensive Income (Loss), Tax 188 (211) 52
Derivative Instruments      
Accumulated Other Comprehensive Income (Loss) [Line Items]      
Other Comprehensive Income (Loss), Tax $ (41) $ 24 $ (8)
XML 147 R127.htm IDEA: XBRL DOCUMENT v3.22.0.1
Stockholders' Equity Reclassifications out of AOCI (Details) - USD ($)
$ in Millions
4 Months Ended 12 Months Ended
Dec. 31, 2017
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]        
Income Tax Expense (Benefit)   $ 524 $ (81) $ (46)
Income (loss) from continuing operations after income taxes   1,822 756 (270)
Derivative Instruments        
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]        
Income Tax Expense (Benefit) [1]   9 (6) (1)
Income (loss) from continuing operations after income taxes   (4) 12 12
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax [2]   (13) 18 13
Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax   (4) 12 12
Gain (Loss) on Investments [Member]        
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]        
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax [3] $ 0 7 0  
Reclassification from AOCI, Current Period, Tax [1] $ 0 0 0  
AOCI Attributable to Parent        
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]        
Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax   (602) 18 16
Pension Plan        
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]        
Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax   41 5 5
Pension Plan | Prior Service Benefit        
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]        
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax [3],[4]   (2) (1) (1)
Pension Plan | Actuarial Losses        
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]        
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax [3],[4],[5]   55 4 2
Pension Plan | Accumulated Defined Benefit Plans Adjustment, Settlement Gain (Loss) [Member]        
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]        
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax [3],[4],[5]   1 3 4
Pension Plan | Accumulated Defined Benefit Plans Adjustment Attributable to Parent        
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]        
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax   54 6 5
Reclassification from AOCI, Current Period, Tax [1]   (13) (1) 0
Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax   41 5 5
Other Benefit Plans        
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]        
Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax   (646) 1 (1)
Other Benefit Plans | Prior Service Benefit        
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]        
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax [3],[4]   (922) 0 0
Other Benefit Plans | Actuarial Losses        
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]        
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax [3],[4]   81 1 (1)
Other Benefit Plans | Accumulated Defined Benefit Plans Adjustment Attributable to Parent        
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]        
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax   (842) 1 (1)
Reclassification from AOCI, Current Period, Tax [1]   196 0 0
Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax   $ (646) $ 1 $ (1)
[1] Reflected in provision for (benefit from) income taxes from continuing operations in the Consolidated Statements of Operations.
[2] Reflected in cost of goods sold in the Consolidated Statements of Operations.
[3] Reflected in other income - net in the Consolidated Statements of Operations.
[4] These accumulated other comprehensive (loss) income components are included in the computation of net periodic benefit (credit) cost of the company's pension and other benefit plans. See Note 20 - Pension Plans and Other Post Employment Benefits, to the Consolidated Financial Statements, for additional information.
[5] A portion reflected in (loss) income from discontinued operations after income taxes for the year ended December 31, 2019.
XML 148 R128.htm IDEA: XBRL DOCUMENT v3.22.0.1
Pension Plans and Other Post Employment Benefit Plans Additional Information (Details) - USD ($)
$ in Millions
1 Months Ended 5 Months Ended 12 Months Ended
Nov. 30, 2017
Jun. 01, 2019
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2022
Defined Benefit and Contribution Disclosures [Line Items]            
Pre-tax cash requirements to cover actual net claims costs and related administrative expenses     $ 198 $ 207 $ 202  
U.S. Retirement Savings Plan [Member]            
Defined Benefit and Contribution Disclosures [Line Items]            
Employer Matching Contribution, Percent of Match     100.00%      
Employer Matching Contribution, Percent of Employees' Gross Pay     6.00%      
Employer Discretionary Contribution Percent     3.00%      
Defined Contribution Plan, Employer Contribution     $ 63 94 142  
Employers Discretionary Contribution, Vesting Period     3 years      
Corteva Other Contribution Plans [Member]            
Defined Benefit and Contribution Disclosures [Line Items]            
Defined Contribution Plan, Employer Contribution     $ 29 33 $ 46  
Pension Plan            
Defined Benefit and Contribution Disclosures [Line Items]            
Defined Benefit Plan, Unfunded Status of Plan     (1,948) (3,847)    
Employer contributions     $ 49 $ 62    
Expected long-term rate of return on plan assets     5.73% 6.25% 6.24%  
Defined Benefit Plan, Expected Future Benefit Payment [Abstract]            
2021     $ 1,409      
Other Post Employment Benefits Plan            
Defined Benefit and Contribution Disclosures [Line Items]            
Defined Benefit Plan, Unfunded Status of Plan     (1,362) $ (1,571)    
Employer contributions     198 207    
Expected Future Employer Contributions, Next Fiscal Year           $ 140
Defined Benefit Plan, Expected Future Benefit Payment [Abstract]            
2021     134      
Defined Benefit Plan, Accumulated Benefit Obligation, Increase (Decrease) for Plan Amendment     (939)      
Other Pension Plan [Member]            
Defined Benefit and Contribution Disclosures [Line Items]            
Employer contributions     49 62 $ 121  
Expected Future Employer Contributions, Next Fiscal Year           $ 60
Nonqualified Plan [Member] | Trust Agreement [Member]            
Defined Benefit and Contribution Disclosures [Line Items]            
Contributions to Trust $ 571          
Trust Asset Distribution   $ 39 43 65    
Trust Asset     $ 304 $ 347    
Discontinued Operations [Member] | Corteva Other Contribution Plans [Member]            
Defined Benefit and Contribution Disclosures [Line Items]            
Defined Contribution Plan, Employer Contribution         $ 73  
XML 149 R129.htm IDEA: XBRL DOCUMENT v3.22.0.1
Pension Plans and Other Post Employment Benefit Plans Weighted Average Assumptions used to Determine Benefit Obligations - Pension (Details) - Pension Plan
Dec. 31, 2021
Dec. 31, 2020
Defined Benefit Plan Disclosure [Line Items]    
Discount Rate 2.82% 2.44%
Rate of increase in future compensation levels 2.55% 2.54%
XML 150 R130.htm IDEA: XBRL DOCUMENT v3.22.0.1
Pension Plans and Other Post Employment Benefit Plans Weighted Average Assumptions used to Determine Net Periodic Benefit Cost - Pension (Details) - Pension Plan
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Defined Benefit Plan Disclosure [Line Items]      
Net Periodic Benefit, Discount Rate 2.44% 3.19% 4.19%
Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Rate of Compensation Increase 2.54% 2.60% 2.84%
Expected long-term rate of return on plan assets 5.73% 6.25% 6.24%
XML 151 R131.htm IDEA: XBRL DOCUMENT v3.22.0.1
Pension Plans and Other Post Employment Benefit Plans Weighted Average Assumptions used to Determine Benefit Obligations and Periodic Benefit Cost - OPEB (Details) - Other Post Employment Benefits Plan
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]      
Discount Rate 2.59% 2.09%  
Net Periodic Benefit, Discount Rate 2.09% 3.07% 3.93%
XML 152 R132.htm IDEA: XBRL DOCUMENT v3.22.0.1
Pension Plans and Other Post Employment Benefit Plans Change in Projected Benefit Obligations, Plan Assets and Funded Status (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]      
Defined Benefit Plan, Accumulated Benefit Obligation $ 19,700 $ 21,600  
Trust Agreement [Member]      
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]      
Benefit obligation at beginning of the period 249    
Benefit obligation at end of the period 219 249  
Pension Plan      
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]      
Benefit obligation at beginning of the period 21,682 21,004  
Service Cost 25 26 $ 41
Interest Cost 364 559 769
Plan participants' contributions 3 2  
Actuarial (gain) loss (524) 1,659  
Benefits Paid (1,490) (1,538)  
Plan amendments (15) (3)  
Net effects of acquisitions / divestitures / other (240) 0  
Effect of foreign exchange rates (30) (27)  
Benefit obligation at end of the period 19,775 21,682 21,004
Fair value of plan assets at beginning of period 17,835 16,941  
Actual return on plan assets 1,685 2,404  
Employer contributions 49 62  
Plan participants' contributions 3 2  
Benefits paid (1,490) (1,538)  
Net effects of acquisitions / divestitures / other (240) 0  
Effect of foreign exchange rates (15) (36)  
Fair value of plan assets at end of period 17,827 17,835 16,941
Funded (unfunded) status of plan (1,948) (3,847)  
Pension Plan | U.S. Plans with Plan Assets [Member]      
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]      
Funded (unfunded) status of plan (1,471) (3,301)  
Pension Plan | Non-U.S. plans with plan assets [Member]      
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]      
Funded (unfunded) status of plan (62) (98)  
Pension Plan | All other plans [Member]      
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]      
Funded (unfunded) status of plan [1],[2] (415) (448)  
Other Post Employment Benefits Plan      
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]      
Benefit obligation at beginning of the period 1,571 2,591  
Service Cost 1 2 4
Interest Cost 21 66 84
Plan participants' contributions 35 34  
Actuarial (gain) loss (33) 59  
Benefits Paid (233) (241)  
Plan amendments 0 (939)  
Net effects of acquisitions / divestitures / other 0 0  
Effect of foreign exchange rates 0 (1)  
Benefit obligation at end of the period 1,362 1,571 2,591
Fair value of plan assets at beginning of period 0 0  
Actual return on plan assets 0 0  
Employer contributions 198 207  
Plan participants' contributions 35 34  
Benefits paid (233) (241)  
Net effects of acquisitions / divestitures / other 0 0  
Effect of foreign exchange rates 0 0  
Fair value of plan assets at end of period 0 0 0
Funded (unfunded) status of plan (1,362) (1,571)  
Other Comprehensive Income (Loss), Defined Benefit Plan, Settlement and Curtailment Gain (Loss), after Tax (1) 0 $ 0
Other Post Employment Benefits Plan | U.S. Plans with Plan Assets [Member]      
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]      
Funded (unfunded) status of plan 0 0  
Other Post Employment Benefits Plan | Non-U.S. plans with plan assets [Member]      
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]      
Funded (unfunded) status of plan 0 0  
Other Post Employment Benefits Plan | All other plans [Member]      
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]      
Funded (unfunded) status of plan [1],[2] $ (1,362) $ (1,571)  
[1] As of December 31, 2021 and December 31, 2020, $219 million and $249 million, respectively, of the benefit obligations are supported by funding under the Trust agreement, defined in the "Trust Assets" section below.
[2] Includes pension plans maintained around the world where funding is not customary.
XML 153 R133.htm IDEA: XBRL DOCUMENT v3.22.0.1
Pension Plans and Other Post Employment Benefit Plans Amounts Recognized in Consolidated Balance Sheets (Details) - USD ($)
$ in Millions
Dec. 31, 2021
Dec. 31, 2020
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]    
Defined Benefit Plan, Accumulated Benefit Obligation $ 19,700 $ 21,600
Noncurrent liabilities (3,124) (5,176)
Pension Plan    
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]    
Net amount recognized (1,948) (3,847)
Net loss (gain) (543) (1,886)
Prior service (benefit) cost 27 14
Pretax balance in accumulated other comprehensive (income) loss at end of year (516) (1,872)
Other Post Employment Benefits Plan    
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]    
Net amount recognized (1,362) (1,571)
Net loss (gain) (50) (163)
Prior service (benefit) cost 17 939
Pretax balance in accumulated other comprehensive (income) loss at end of year (33) 776
Other Assets [Member] | Pension Plan    
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]    
Other Assets 4 7
Other Assets [Member] | Other Post Employment Benefits Plan    
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]    
Other Assets 0 0
Accrued and Other Current Liabilities [Member] | Pension Plan    
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]    
Current liabilities (46) (32)
Accrued and Other Current Liabilities [Member] | Other Post Employment Benefits Plan    
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]    
Current liabilities (144) (217)
Pension and other post employment benefits - noncurrent [Member] | Pension Plan    
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]    
Noncurrent liabilities (1,906) (3,822)
Pension and other post employment benefits - noncurrent [Member] | Other Post Employment Benefits Plan    
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]    
Noncurrent liabilities $ (1,218) $ (1,354)
XML 154 R134.htm IDEA: XBRL DOCUMENT v3.22.0.1
Pension Plans and Other Post Employment Benefit Plans Pension Plans with Projected Benefit Obligations in Excess of Plan Assets (Details) - Pension Plan - USD ($)
$ in Millions
Dec. 31, 2021
Dec. 31, 2020
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]    
Projected benefit obligations $ 19,519 $ 21,513
Fair Value of plan assets $ 17,567 $ 17,659
XML 155 R135.htm IDEA: XBRL DOCUMENT v3.22.0.1
Pension Plans and Other Post Employment Benefit Plans Pension Plans with Accumulated Benefit Obligations in Excess of Plan Assets (Details) - Pension Plan - USD ($)
$ in Millions
Dec. 31, 2021
Dec. 31, 2020
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]    
Accumulated benefit obligations $ 19,501 $ 21,369
Fair value of plan assets $ 17,567 $ 17,550
XML 156 R136.htm IDEA: XBRL DOCUMENT v3.22.0.1
Pension Plans and Other Post Employment Benefit Plans Components of net periodic benefit cost (credit) and amounts recognized in other comprehensive loss (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]      
Discontinued Operation, Gain (Loss) on Disposal of Discontinued Operation, Net of Tax   $ (31)  
Pension Plan      
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]      
Service Cost $ 25 26 $ 41
Interest Cost 364 559 769
Expected return on plan assets (915) (1,000) (1,078)
Amortization of unrecognized loss (gain) 55 4 3
Amortization of prior service benefit (2) (1) (1)
Curtailment gain 0 0 (2)
Settlement loss 1 3 4
Net periodic benefit cost (credit) (472) (409) (264)
Net loss (gain) 1,284 (247) (970)
Amortization of unrecognized (loss) gain 55 4 2
Prior service cost (benefit) 15 3 11
Amortization of prior service benefit (2) (1) (1)
Settlement loss 1 3 4
Effect of foreign exchange rates 3 (2) 5
Total (benefit) loss recognized in other comprehensive loss, attributable to Corteva 1,356 (240) (949)
Total recognized in net periodic benefit cost and other comprehensive (income) loss 1,828 169 (685)
Other Post Employment Benefits Plan      
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]      
Service Cost 1 2 4
Interest Cost 21 66 84
Expected return on plan assets 0 0 0
Amortization of unrecognized loss (gain) 81 1 (1)
Amortization of prior service benefit (922) 0 0
Curtailment gain (1) 0 0
Settlement loss 0 0 0
Net periodic benefit cost (credit) (820) 69 87
Net loss (gain) 33 (59) (211)
Amortization of unrecognized (loss) gain 81 1 (1)
Prior service cost (benefit) 0 939 0
Amortization of prior service benefit (922) 0 0
Other Comprehensive Income (Loss), Defined Benefit Plan, Settlement and Curtailment Gain (Loss), after Tax (1) 0 0
Settlement loss 0 0 0
Effect of foreign exchange rates 0 1 0
Total (benefit) loss recognized in other comprehensive loss, attributable to Corteva (809) 882 (212)
Total recognized in net periodic benefit cost and other comprehensive (income) loss 11 813 (299)
Discontinued Operations [Member] | Pension Plan      
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]      
Net periodic benefit cost (credit) [1] 0 0 (14)
Discontinued Operations [Member] | Other Post Employment Benefits Plan      
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]      
Net periodic benefit cost (credit) [1] 0 0 0
Continuing Operations [Member] | Pension Plan      
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]      
Net periodic benefit cost (credit) (472) (409) (250)
Continuing Operations [Member] | Other Post Employment Benefits Plan      
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]      
Net periodic benefit cost (credit) $ (820) $ 69 $ 87
[1] Includes non-service related components of net periodic benefit credit of $(31) million for the year ended December 31, 2019.
XML 157 R137.htm IDEA: XBRL DOCUMENT v3.22.0.1
Pension Plans and Other Post Employment Benefit Plans Estimated Future Benefit Payments (Details)
$ in Millions
Dec. 31, 2021
USD ($)
Pension Plan  
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]  
2020 $ 1,459
2021 1,409
2022 1,378
2023 1,341
2024 1,305
2025-2029 5,913
Total 12,805
Other Post Employment Benefits Plan  
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]  
2020 144
2021 134
2022 126
2023 118
2024 112
2025-2029 399
Total $ 1,033
XML 158 R138.htm IDEA: XBRL DOCUMENT v3.22.0.1
Pension Plans and Other Post Employment Benefit Plans Target Allocation for Plan Assets (Details)
Dec. 31, 2021
Dec. 31, 2020
Defined Benefit Plan Disclosure [Line Items]    
Target Allocation for plan assets 100.00% 100.00%
Fixed Income Securities [Member]    
Defined Benefit Plan Disclosure [Line Items]    
Target Allocation for plan assets 58.00% 51.00%
Hedge Funds [Member]    
Defined Benefit Plan Disclosure [Line Items]    
Target Allocation for plan assets 2.00% 2.00%
Private Market Securities [Member]    
Defined Benefit Plan Disclosure [Line Items]    
Target Allocation for plan assets 8.00% 6.00%
Real Estate [Member]    
Defined Benefit Plan Disclosure [Line Items]    
Target Allocation for plan assets 5.00% 4.00%
Cash and Cash Equivalents [Member]    
Defined Benefit Plan Disclosure [Line Items]    
Target Allocation for plan assets 5.00% 1.00%
UNITED STATES | Equity Securities [Member]    
Defined Benefit Plan Disclosure [Line Items]    
Target Allocation for plan assets 11.00% 20.00%
Non-US [Member] | Equity Securities [Member]    
Defined Benefit Plan Disclosure [Line Items]    
Target Allocation for plan assets 11.00% 16.00%
XML 159 R139.htm IDEA: XBRL DOCUMENT v3.22.0.1
Pension Plans and Other Post Employment Benefit Plans Basis of Fair Value Measurement (Details) - USD ($)
$ in Millions
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Defined Benefit Plan Disclosure [Line Items]      
Pension Trust Receivables $ 655 [1] $ 214 [2]  
Pension Trust Payables (1,031) [3] (434) [4]  
Pension Plan      
Defined Benefit Plan Disclosure [Line Items]      
Fair value of plan assets 17,827 17,835 $ 16,941
Investments Measured at Net Asset Value 3,086 2,469  
Fair Value of Plan Assets, Excluding Trust Receivables and payables and assets measured at NAV 15,117 15,586  
Pension Plan | Fair Value, Inputs, Level 1 [Member]      
Defined Benefit Plan Disclosure [Line Items]      
Fair value of plan assets 6,460 8,703  
Pension Plan | Fair Value, Inputs, Level 2 [Member]      
Defined Benefit Plan Disclosure [Line Items]      
Fair value of plan assets 8,547 6,768  
Pension Plan | Fair Value, Inputs, Level 3 [Member]      
Defined Benefit Plan Disclosure [Line Items]      
Fair value of plan assets 110 115 52
Pension Plan | Cash and Cash Equivalents [Domain]      
Defined Benefit Plan Disclosure [Line Items]      
Fair value of plan assets 2,543 2,616  
Pension Plan | Cash and Cash Equivalents [Domain] | Fair Value, Inputs, Level 1 [Member]      
Defined Benefit Plan Disclosure [Line Items]      
Fair value of plan assets 2,543 2,616  
Pension Plan | Cash and Cash Equivalents [Domain] | Fair Value, Inputs, Level 2 [Member]      
Defined Benefit Plan Disclosure [Line Items]      
Fair value of plan assets 0 0  
Pension Plan | Cash and Cash Equivalents [Domain] | Fair Value, Inputs, Level 3 [Member]      
Defined Benefit Plan Disclosure [Line Items]      
Fair value of plan assets 0 0  
Pension Plan | US Treasury and Government [Member]      
Defined Benefit Plan Disclosure [Line Items]      
Fair value of plan assets 3,271 3,569  
Investments Measured at Net Asset Value 37 36  
Pension Plan | US Treasury and Government [Member] | Fair Value, Inputs, Level 1 [Member]      
Defined Benefit Plan Disclosure [Line Items]      
Fair value of plan assets 0 0  
Pension Plan | US Treasury and Government [Member] | Fair Value, Inputs, Level 2 [Member]      
Defined Benefit Plan Disclosure [Line Items]      
Fair value of plan assets 3,271 3,569  
Pension Plan | US Treasury and Government [Member] | Fair Value, Inputs, Level 3 [Member]      
Defined Benefit Plan Disclosure [Line Items]      
Fair value of plan assets 0 0  
Pension Plan | Corporate Debt Securities [Member]      
Defined Benefit Plan Disclosure [Line Items]      
Fair value of plan assets 4,591 2,579  
Investments Measured at Net Asset Value 7 7  
Pension Plan | Corporate Debt Securities [Member] | Fair Value, Inputs, Level 1 [Member]      
Defined Benefit Plan Disclosure [Line Items]      
Fair value of plan assets 0 0  
Pension Plan | Corporate Debt Securities [Member] | Fair Value, Inputs, Level 2 [Member]      
Defined Benefit Plan Disclosure [Line Items]      
Fair value of plan assets 4,589 2,576  
Pension Plan | Corporate Debt Securities [Member] | Fair Value, Inputs, Level 3 [Member]      
Defined Benefit Plan Disclosure [Line Items]      
Fair value of plan assets 2 3 4
Pension Plan | Asset-backed Securities [Member]      
Defined Benefit Plan Disclosure [Line Items]      
Fair value of plan assets 682 616  
Pension Plan | Asset-backed Securities [Member] | Fair Value, Inputs, Level 1 [Member]      
Defined Benefit Plan Disclosure [Line Items]      
Fair value of plan assets 0 0  
Pension Plan | Asset-backed Securities [Member] | Fair Value, Inputs, Level 2 [Member]      
Defined Benefit Plan Disclosure [Line Items]      
Fair value of plan assets 682 616  
Pension Plan | Asset-backed Securities [Member] | Fair Value, Inputs, Level 3 [Member]      
Defined Benefit Plan Disclosure [Line Items]      
Fair value of plan assets 0 0  
Pension Plan | Hedge Funds [Member]      
Defined Benefit Plan Disclosure [Line Items]      
Investments Measured at Net Asset Value 394 391  
Pension Plan | Private Market Securities [Member]      
Defined Benefit Plan Disclosure [Line Items]      
Fair value of plan assets 3 3  
Investments Measured at Net Asset Value 1,822 1,381  
Pension Plan | Private Market Securities [Member] | Fair Value, Inputs, Level 1 [Member]      
Defined Benefit Plan Disclosure [Line Items]      
Fair value of plan assets 0 0  
Pension Plan | Private Market Securities [Member] | Fair Value, Inputs, Level 2 [Member]      
Defined Benefit Plan Disclosure [Line Items]      
Fair value of plan assets 0 0  
Pension Plan | Private Market Securities [Member] | Fair Value, Inputs, Level 3 [Member]      
Defined Benefit Plan Disclosure [Line Items]      
Fair value of plan assets 3 3 2
Pension Plan | Real Estate [Member]      
Defined Benefit Plan Disclosure [Line Items]      
Fair value of plan assets 26 28  
Investments Measured at Net Asset Value 759 590  
Pension Plan | Real Estate [Member] | Fair Value, Inputs, Level 1 [Member]      
Defined Benefit Plan Disclosure [Line Items]      
Fair value of plan assets 0 0  
Pension Plan | Real Estate [Member] | Fair Value, Inputs, Level 2 [Member]      
Defined Benefit Plan Disclosure [Line Items]      
Fair value of plan assets 0 0  
Pension Plan | Real Estate [Member] | Fair Value, Inputs, Level 3 [Member]      
Defined Benefit Plan Disclosure [Line Items]      
Fair value of plan assets 26 28 33
Pension Plan | Other Investments [Member]      
Defined Benefit Plan Disclosure [Line Items]      
Fair value of plan assets 78 76  
Pension Plan | Other Investments [Member] | Fair Value, Inputs, Level 1 [Member]      
Defined Benefit Plan Disclosure [Line Items]      
Fair value of plan assets 0 0  
Pension Plan | Other Investments [Member] | Fair Value, Inputs, Level 2 [Member]      
Defined Benefit Plan Disclosure [Line Items]      
Fair value of plan assets 3 3  
Pension Plan | Other Investments [Member] | Fair Value, Inputs, Level 3 [Member]      
Defined Benefit Plan Disclosure [Line Items]      
Fair value of plan assets 75 73 0
Non-US [Member] | Pension Plan | Equity Securities [Member]      
Defined Benefit Plan Disclosure [Line Items]      
Fair value of plan assets 1,523 2,194  
Investments Measured at Net Asset Value 34 32  
Non-US [Member] | Pension Plan | Equity Securities [Member] | Fair Value, Inputs, Level 1 [Member]      
Defined Benefit Plan Disclosure [Line Items]      
Fair value of plan assets 1,523 2,189  
Non-US [Member] | Pension Plan | Equity Securities [Member] | Fair Value, Inputs, Level 2 [Member]      
Defined Benefit Plan Disclosure [Line Items]      
Fair value of plan assets 0 2  
Non-US [Member] | Pension Plan | Equity Securities [Member] | Fair Value, Inputs, Level 3 [Member]      
Defined Benefit Plan Disclosure [Line Items]      
Fair value of plan assets 0 3 4
UNITED STATES | Pension Plan | Equity Securities [Member]      
Defined Benefit Plan Disclosure [Line Items]      
Fair value of plan assets 2,400 [5] 3,905 [6]  
Investments Measured at Net Asset Value 33 32  
UNITED STATES | Pension Plan | Equity Securities [Member] | Fair Value, Inputs, Level 1 [Member]      
Defined Benefit Plan Disclosure [Line Items]      
Fair value of plan assets 2,394 [5] 3,898 [6]  
UNITED STATES | Pension Plan | Equity Securities [Member] | Fair Value, Inputs, Level 2 [Member]      
Defined Benefit Plan Disclosure [Line Items]      
Fair value of plan assets 2 [5] 2 [6]  
UNITED STATES | Pension Plan | Equity Securities [Member] | Fair Value, Inputs, Level 3 [Member]      
Defined Benefit Plan Disclosure [Line Items]      
Fair value of plan assets $ 4 [5] 5 [6] $ 9
Common Stock [Member]      
Defined Benefit Plan Disclosure [Line Items]      
Amount of Employer and Related Party Securities Included in Plan Assets, Percent 1.00%    
Common Stock [Member] | Pension Plan      
Defined Benefit Plan Disclosure [Line Items]      
Amount of Employer and Related Party Securities Included in Plan Assets $ 201 $ 165  
Amount of Employer and Related Party Securities Included in Plan Assets, Percent   1.00%  
[1] Primarily receivables for investments securities sold.
[2] Primarily receivables for investments securities sold.
[3] Primarily payables for investment securities purchased.
[4] Primarily payables for investment securities purchased.
[5] The Corteva pension plans directly held $201 million (approximately 1 percent of total plan assets) of Corteva, Inc. common stock at December 31, 2021.
[6] The Corteva pension plans directly held $165 million (approximately 1 percent of total plan assets) of Corteva, Inc. at December 31, 2020.
XML 160 R140.htm IDEA: XBRL DOCUMENT v3.22.0.1
Pension Plans and Other Post Employment Benefit Plans Summary of Fair Value Measurement of Level 3 Pension Plan Assets (Details) - Pension Plan - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Defined Benefit Plan Disclosure [Line Items]      
Fair value of plan assets $ 17,827 $ 17,835 $ 16,941
Fair Value, Inputs, Level 3 [Member]      
Defined Benefit Plan Disclosure [Line Items]      
Fair value of plan assets 110 115 52
Actual Return (Loss) on Plan Assets Sold (5) (38)  
Actual Return (Loss) on Plan Assets Still Held (2) 34  
Purchases, Sales, and Settlements 2 5  
Assets Transferred into (out of) Level 3   62  
Corporate Debt Securities [Member]      
Defined Benefit Plan Disclosure [Line Items]      
Fair value of plan assets 4,591 2,579  
Corporate Debt Securities [Member] | Fair Value, Inputs, Level 3 [Member]      
Defined Benefit Plan Disclosure [Line Items]      
Fair value of plan assets 2 3 4
Actual Return (Loss) on Plan Assets Sold (5) (7)  
Actual Return (Loss) on Plan Assets Still Held 6 5  
Purchases, Sales, and Settlements (2) 0  
Assets Transferred into (out of) Level 3   1  
Asset-backed Securities [Member]      
Defined Benefit Plan Disclosure [Line Items]      
Fair value of plan assets 682 616  
Asset-backed Securities [Member] | Fair Value, Inputs, Level 3 [Member]      
Defined Benefit Plan Disclosure [Line Items]      
Fair value of plan assets 0 0  
Private Market Securities [Member]      
Defined Benefit Plan Disclosure [Line Items]      
Fair value of plan assets 3 3  
Private Market Securities [Member] | Fair Value, Inputs, Level 3 [Member]      
Defined Benefit Plan Disclosure [Line Items]      
Fair value of plan assets 3 3 2
Actual Return (Loss) on Plan Assets Sold 0 0  
Actual Return (Loss) on Plan Assets Still Held 0 1  
Purchases, Sales, and Settlements 0 0  
Assets Transferred into (out of) Level 3   0  
Real Estate [Member]      
Defined Benefit Plan Disclosure [Line Items]      
Fair value of plan assets 26 28  
Real Estate [Member] | Fair Value, Inputs, Level 3 [Member]      
Defined Benefit Plan Disclosure [Line Items]      
Fair value of plan assets 26 28 33
Actual Return (Loss) on Plan Assets Sold 0 0  
Actual Return (Loss) on Plan Assets Still Held (2) (5)  
Purchases, Sales, and Settlements 0 0  
Assets Transferred into (out of) Level 3   0  
Derivative, Asset [Member]      
Defined Benefit Plan Disclosure [Line Items]      
Fair value of plan assets 78 76  
Derivative, Asset [Member] | Fair Value, Inputs, Level 3 [Member]      
Defined Benefit Plan Disclosure [Line Items]      
Fair value of plan assets 75 73 0
Actual Return (Loss) on Plan Assets Sold 0 0  
Actual Return (Loss) on Plan Assets Still Held (2) 7  
Purchases, Sales, and Settlements 4 5  
Assets Transferred into (out of) Level 3   61  
Non-US [Member] | Equity Securities [Member]      
Defined Benefit Plan Disclosure [Line Items]      
Fair value of plan assets 1,523 2,194  
Non-US [Member] | Equity Securities [Member] | Fair Value, Inputs, Level 3 [Member]      
Defined Benefit Plan Disclosure [Line Items]      
Fair value of plan assets 0 3 4
Actual Return (Loss) on Plan Assets Sold (1) (6)  
Actual Return (Loss) on Plan Assets Still Held (1) 5  
Purchases, Sales, and Settlements (1) 0  
Assets Transferred into (out of) Level 3   0  
UNITED STATES | Equity Securities [Member]      
Defined Benefit Plan Disclosure [Line Items]      
Fair value of plan assets 2,400 [1] 3,905 [2]  
UNITED STATES | Equity Securities [Member] | Fair Value, Inputs, Level 3 [Member]      
Defined Benefit Plan Disclosure [Line Items]      
Fair value of plan assets 4 [1] 5 [2] $ 9
Actual Return (Loss) on Plan Assets Sold 1 (25)  
Actual Return (Loss) on Plan Assets Still Held (3) 21  
Purchases, Sales, and Settlements $ 1 0  
Assets Transferred into (out of) Level 3   $ 0  
[1] The Corteva pension plans directly held $201 million (approximately 1 percent of total plan assets) of Corteva, Inc. common stock at December 31, 2021.
[2] The Corteva pension plans directly held $165 million (approximately 1 percent of total plan assets) of Corteva, Inc. at December 31, 2020.
XML 161 R141.htm IDEA: XBRL DOCUMENT v3.22.0.1
Stock-Based Compensation Stock Compensation (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Remaining Weighted-Average Recognition Period 1 year 2 months 12 days    
OIP [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Shares available for grant 20,000,000    
Shares authorized for future grants 12,000,000    
Tax Benefit from Compensation Expense $ (8) $ (4)  
Intrinsic value of stock options 43 21  
Share-based Payment Arrangement, Option [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Stock-based compensation expense 79 73 $ 84
Tax Benefit from Compensation Expense $ (15) $ (15) $ (17)
XML 162 R142.htm IDEA: XBRL DOCUMENT v3.22.0.1
Stock-Based Compensation Weighted Average Assumptions - Stock Options (Details) - $ / shares
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Equity Option [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Stock options outstanding, weighted average remaining contractual term 5 years 8 months 8 days 5 years 3 months 7 days  
EIP [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Dividend yield     1.55%
Expected Volatility     19.80%
Risk Free Interest Rate     2.40%
Expected life of stock options granted during period     6 years 1 month 6 days
EIP [Member] | Employee Stock [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Weighted Average Grant Date Fair Value   $ 7.29  
OIP [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Dividend yield 1.14% 1.67%  
Expected Volatility 29.44% 23.14%  
Risk Free Interest Rate 1.00% 1.30%  
Expected life of stock options granted during period 6 years 6 years  
OIP [Member] | Employee Stock [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Weighted Average Grant Date Fair Value $ 11.77 $ 6.06  
XML 163 R143.htm IDEA: XBRL DOCUMENT v3.22.0.1
Stock-Based Compensation Stock Options (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Stock Option Award Vesting Period 3 years    
Unrecognized Pretax Compensation Expense Related to Stock Options $ 4,000    
Remaining Weighted-Average Recognition Period 1 year 2 months 12 days    
Dow [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Stock Option, Expiration Period 10 years    
OIP [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Dividend yield 1.14% 1.67%  
EIP [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Dividend yield     1.55%
EIP [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Intrinsic value of stock options   $ 16,000  
Tax Benefit from Compensation Expense   (3,000)  
OIP [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Intrinsic value of stock options $ 43,000 21,000  
Tax Benefit from Compensation Expense $ (8,000) $ (4,000)  
Equity Option [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Stock options outstanding at beginning of period 8,998    
Stock options granted during the period 849    
Stock options forfeited/expired during the period (218)    
Stock options outstanding at end of period 6,423 8,998  
Stock options exercisable at end of period 4,739    
Stock options outstanding, weighted average exercise price beginning of period $ 34.21    
Stock options granted, weighted average price 45.37    
Stock options exercised during the period, weighted average exercise price $ 32.44    
Stock options exercised during the period (3,206)    
Stock options forfeited/expired, weighted average price $ 33.39    
Stock options outstanding, weighted average exercise price end of period 36.65 $ 34.21  
Stock options exercisable, weighted average exercise price $ 36.15    
Stock options outstanding, weighted average remaining contractual term 5 years 8 months 8 days 5 years 3 months 7 days  
Stock options exercisable, weighted average remaining contractual term 4 years 9 months 3 days    
Stock options outstanding, intrinsic value $ 68,219 $ 50,077  
Stock options exercisable, intrinsic value $ 52,726    
Employee Stock [Member] | OIP [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Weighted Average Grant Date Fair Value $ 11.77 $ 6.06  
Employee Stock [Member] | EIP [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Weighted Average Grant Date Fair Value   $ 7.29  
Grants between 2013 and 2015 [Member] | Equity Option [Member] | EIP [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Stock Option, Expiration Period 7 years    
Grants between 2016 and 2018 [Member] | Equity Option [Member] | EIP [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Stock Option, Expiration Period 10 years    
Grants between June 2019 and 2020 [Member] | Equity Option [Member] | OIP [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Stock Option, Expiration Period 10 years    
XML 164 R144.htm IDEA: XBRL DOCUMENT v3.22.0.1
Stock-Based Compensation Restricted Stock Units and Performance Deferred Stock (Details) - USD ($)
$ / shares in Units, $ in Millions
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
RSU and PSU Award Vesting Period 3 years  
Remaining Weighted-Average Recognition Period 1 year 2 months 12 days  
Minimum [Member]    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Share based compensation arrangement by share based payment award, equity instruments other than options, actual awards granted, percentage of performance target 0.00%  
Maximum [Member]    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Share based compensation arrangement by share based payment award, equity instruments other than options, actual awards granted, percentage of performance target 200.00%  
RSUs and PSUs - OIP [Domain]    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Weighted Average Grant Date Fair Value, RSUs and PSUs granted during the period $ 45.30 $ 31.15
Fair Value of RSUs and PSUs vested during the period $ 56 $ 49
Unrecognized Pretax Compensation Expense Related to RSUs and PSUs $ 45  
Remaining Weighted-Average Recognition Period 1 year 1 month 17 days  
RSUs and PSUs - EIP [Domain]    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Weighted Average Grant Date Fair Value, RSUs and PSUs granted during the period   $ 52.19
Fair Value of RSUs and PSUs vested during the period   $ 79
Restricted Stock Units (RSUs) [Member]    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Equity award conversion ratio 1  
Performance Shares [Member]    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
RSU Requisite Service Period 6 months  
Restricted Stock Units and Performance Deferred Stock Units [Member]    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Nonvested RSUs and PSUs at beginning of period 5,883,000  
RSUs and PSUs granted during the period 1,536,000  
RSUs and PSUs vested during the period (1,583,000)  
RSUs and PSUs forfeited during the period (234,000)  
Nonvested RSUs and PSUs at end of period 5,602,000 5,883,000
Weighted average grant date fair value, nonvested RSUs and PSUs beginning of period $ 31.54  
Weighted Average Grant Date Fair Value, RSUs and PSUs granted during the period 45.30  
Weighted Average Grant Date Fair Value, vested RSUs and PSUs during the period 35.59  
Weighted Average Grant Date Fair Value, RSUs and PSUs forfeited during the period 32.99  
Weighted average grant date fair value, nonvested RSUs and PSUs end of period $ 34.11 $ 31.54
Performance Share Units [Member]    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
RSUs and PSUs granted during the period 343,632  
Weighted Average Grant Date Fair Value, RSUs and PSUs granted during the period $ 45.37  
Minimum [Member] | Management [Member] | Restricted Stock Units (RSUs) [Member]    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
RSU and PSU Award Vesting Period 3 years  
Maximum [Member] | Management [Member] | Restricted Stock Units (RSUs) [Member]    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
RSU and PSU Award Vesting Period 5 years  
OIP [Member] | Restricted Stock Units (RSUs) [Member]    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
RSU and PSU Award Vesting Period 3 years  
EIP [Member] | Restricted Stock Units (RSUs) [Member]    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
RSU and PSU Award Vesting Period 3 years  
Dow [Member] | Minimum [Member] | Restricted Stock Units (RSUs) [Member]    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
RSU and PSU Award Vesting Period 1 year  
Dow [Member] | Maximum [Member] | Restricted Stock Units (RSUs) [Member]    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
RSU and PSU Award Vesting Period 3 years  
XML 165 R145.htm IDEA: XBRL DOCUMENT v3.22.0.1
Financial Instruments Financial Instruments (Narrative) (Details) - USD ($)
$ in Millions
Dec. 31, 2021
Dec. 31, 2020
Cash Equivalents [Member]    
Schedule of Held-to-maturity Securities [Line Items]    
Held-to-maturity securities $ 3,400 $ 2,511
Available-for-sale securities   226
Marketable Securities [Member]    
Schedule of Held-to-maturity Securities [Line Items]    
Held-to-maturity securities $ 86 $ 43
XML 166 R146.htm IDEA: XBRL DOCUMENT v3.22.0.1
Financial Instruments Notional Amounts (Details) - USD ($)
$ in Millions
Dec. 31, 2021
Dec. 31, 2020
Designated as Hedging Instrument [Member] | Commodity Contract [Member]    
Derivative Instruments, Gain (Loss) [Line Items]    
Derivative, Notional Amount $ 845 $ 383
Designated as Hedging Instrument [Member] | Foreign Exchange Contract [Member]    
Derivative Instruments, Gain (Loss) [Line Items]    
Derivative, Notional Amount 1,252 1,164
Not Designated as Hedging Instrument [Member] | Commodity Contract [Member]    
Derivative Instruments, Gain (Loss) [Line Items]    
Derivative, Notional Amount 4 0
Not Designated as Hedging Instrument [Member] | Foreign Exchange Contract [Member]    
Derivative Instruments, Gain (Loss) [Line Items]    
Derivative, Notional Amount $ 103 $ 647
XML 167 R147.htm IDEA: XBRL DOCUMENT v3.22.0.1
Financial Instruments Cash Flow Hedges Included in AOCI (Details)
€ in Millions, $ in Millions
12 Months Ended
Dec. 31, 2021
USD ($)
Dec. 31, 2020
USD ($)
Dec. 31, 2019
USD ($)
Dec. 31, 2021
EUR (€)
Designated as Hedging Instrument [Member]        
Derivative Instruments, Gain (Loss) [Line Items]        
Additions and revaluations of derivatives designated as cash flow hedges [1] $ 193 $ (111) $ 23  
Foreign Exchange Contract [Member] | Designated as Hedging Instrument [Member]        
Derivative Instruments, Gain (Loss) [Line Items]        
Derivative, Remaining Maturity 2 years      
Beginning Balance $ (17) 0    
Additions and revaluations of derivatives designated as cash flow hedges 24 (3)    
Clearance of hedge results to earnings 25 (14)    
Ending Balance 32 (17) 0  
After-tax net gain to be reclassified from AOCL into earnings over the next twelve months 32      
Derivative, Notional Amount $ 1,252 1,164    
Foreign Exchange Contract [Member] | Net Investment Hedging        
Derivative Instruments, Gain (Loss) [Line Items]        
Derivative, Notional Amount | €       € 450
Commodity Contract [Member] | Designated as Hedging Instrument [Member]        
Derivative Instruments, Gain (Loss) [Line Items]        
Derivative, Remaining Maturity 2 years      
Beginning Balance $ (16) 2 (26)  
Additions and revaluations of derivatives designated as cash flow hedges 92 (44) 16  
Clearance of hedge results to earnings (29) 26 12  
Ending Balance 47 (16) $ 2  
After-tax net gain to be reclassified from AOCL into earnings over the next twelve months 36      
Derivative, Notional Amount $ 845 $ 383    
[1] OCI is defined as other comprehensive income (loss).
XML 168 R148.htm IDEA: XBRL DOCUMENT v3.22.0.1
Financial Instruments Fair Value of Derivatives (Details) - USD ($)
$ in Millions
Dec. 31, 2021
Dec. 31, 2020
Derivative Instruments, Gain (Loss) [Line Items]    
Derivative Asset, Gross $ 71 $ 55
Derivative Asset, Counterparty and Cash Collateral Netting [1] (20) (40)
Derivative Asset, Net 51 15
Derivative Liability, Gross 26 135
Derivative Liability, Counterparty and Cash Collateral Netting [1] (20) (40)
Derivative Liability, Net 6 95
Not Designated as Hedging Instrument [Member] | Foreign Exchange Contract [Member] | Other Current Assets [Member]    
Derivative Instruments, Gain (Loss) [Line Items]    
Derivative Asset, Gross 31 40
Derivative Asset, Counterparty and Cash Collateral Netting [1] (20) (40)
Derivative Asset, Net 11 0
Not Designated as Hedging Instrument [Member] | Foreign Exchange Contract [Member] | Accrued and Other Current Liabilities [Member]    
Derivative Instruments, Gain (Loss) [Line Items]    
Derivative Liability, Gross 23 97
Derivative Liability, Counterparty and Cash Collateral Netting [1] (20) (40)
Derivative Liability, Net 3 57
Not Designated as Hedging Instrument [Member] | Commodity Contract [Member] | Other Current Assets [Member]    
Derivative Instruments, Gain (Loss) [Line Items]    
Derivative Asset, Gross 3  
Derivative Asset, Counterparty and Cash Collateral Netting 0  
Derivative Asset, Net 3  
Not Designated as Hedging Instrument [Member] | Commodity Contract [Member] | Accrued and Other Current Liabilities [Member]    
Derivative Instruments, Gain (Loss) [Line Items]    
Derivative Liability, Gross 2  
Derivative Liability, Counterparty and Cash Collateral Netting 0  
Derivative Liability, Net 2  
Designated as Hedging Instrument [Member] | Foreign Exchange Contract [Member] | Other Current Assets [Member]    
Derivative Instruments, Gain (Loss) [Line Items]    
Derivative Asset, Gross 37 15
Derivative Asset, Net 37 15
Derivative Liability, Counterparty and Cash Collateral Netting 0 [1] 0
Designated as Hedging Instrument [Member] | Foreign Exchange Contract [Member] | Accrued and Other Current Liabilities [Member]    
Derivative Instruments, Gain (Loss) [Line Items]    
Derivative Liability, Gross 1 38
Derivative Liability, Counterparty and Cash Collateral Netting 0 [1] 0
Derivative Liability, Net $ 1 $ 38
[1] Counterparty and cash collateral amounts represent the estimated net settlement amount when applying netting and set-off rights included in master netting arrangements between the company and its counterparties and the payable or receivable for cash collateral held or placed with the same counterparty.
XML 169 R149.htm IDEA: XBRL DOCUMENT v3.22.0.1
Financial Instruments Effect of Derivative Instruments (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Derivative Instruments, Gain (Loss) [Line Items]      
(Loss) Gain on Derivative Instruments, Net, Pretax [1] $ (1) $ 94 $ (62)
Designated as Hedging Instrument [Member]      
Derivative Instruments, Gain (Loss) [Line Items]      
Gain (Loss) Recognized in Other Comprehensive Income (Loss), Pre-Tax [2] 193 (111) 23
(Loss) Gain on Hedging Activity [1] 13 (18) (13)
Not Designated as Hedging Instrument [Member]      
Derivative Instruments, Gain (Loss) [Line Items]      
Derivative Instruments Not Designated as Hedging Instruments, (Loss) Gain, Net [1] (14) 112 (49)
Foreign Exchange Contract [Member] | Designated as Hedging Instrument [Member]      
Derivative Instruments, Gain (Loss) [Line Items]      
Gain (Loss) Recognized in Other Comprehensive Income (Loss), Pre-Tax 24 (3)  
Foreign Exchange Contract [Member] | Designated as Hedging Instrument [Member] | Net Investment Hedging      
Derivative Instruments, Gain (Loss) [Line Items]      
Gain (Loss) Recognized in Other Comprehensive Income (Loss), Pre-Tax [2] 37 (45) 0
Foreign Exchange Contract [Member] | Designated as Hedging Instrument [Member] | Cash Flow Hedging [Member]      
Derivative Instruments, Gain (Loss) [Line Items]      
Gain (Loss) Recognized in Other Comprehensive Income (Loss), Pre-Tax [2] 27 (4) 0
Foreign Exchange Contract [Member] | Cost of Goods Sold | Designated as Hedging Instrument [Member] | Cash Flow Hedging [Member]      
Derivative Instruments, Gain (Loss) [Line Items]      
(Loss) Gain on Hedging Activity [1],[3] (29) 17 0
Foreign Exchange Contract [Member] | Cost of Goods Sold | Not Designated as Hedging Instrument [Member]      
Derivative Instruments, Gain (Loss) [Line Items]      
Derivative Instruments Not Designated as Hedging Instruments, (Loss) Gain, Net [1],[3] (14) 14 0
Foreign Exchange Contract [Member] | Other Income (Expense) - net | Not Designated as Hedging Instrument [Member]      
Derivative Instruments, Gain (Loss) [Line Items]      
Derivative Instruments Not Designated as Hedging Instruments, (Loss) Gain, Net [1],[4] 18 89 (58)
Commodity Contract [Member] | Designated as Hedging Instrument [Member]      
Derivative Instruments, Gain (Loss) [Line Items]      
Gain (Loss) Recognized in Other Comprehensive Income (Loss), Pre-Tax 92 (44) 16
Commodity Contract [Member] | Designated as Hedging Instrument [Member] | Cash Flow Hedging [Member]      
Derivative Instruments, Gain (Loss) [Line Items]      
Gain (Loss) Recognized in Other Comprehensive Income (Loss), Pre-Tax [2] 129 (62) 23
Commodity Contract [Member] | Cost of Goods Sold | Designated as Hedging Instrument [Member] | Cash Flow Hedging [Member]      
Derivative Instruments, Gain (Loss) [Line Items]      
(Loss) Gain on Hedging Activity [1],[3] 42 (35) (13)
Commodity Contract [Member] | Cost of Goods Sold | Not Designated as Hedging Instrument [Member]      
Derivative Instruments, Gain (Loss) [Line Items]      
Derivative Instruments Not Designated as Hedging Instruments, (Loss) Gain, Net [1],[3] $ (18) $ 9 $ 9
[1] For cash flow hedges, this represents the portion of the gain (loss) reclassified from accumulated OCI into income during the period.
[2] OCI is defined as other comprehensive income (loss).
[3] Recorded in cost of goods sold.
[4] Gain recognized in other income - net was partially offset by the related gain on the foreign currency-denominated monetary assets and liabilities of the company's operations. See Note 9 - Supplementary Information, to the Consolidated Financial Statements for additional information.
XML 170 R150.htm IDEA: XBRL DOCUMENT v3.22.0.1
Financial Instruments Debt Securities (Details) - Available-for-sale Securities
$ in Millions
12 Months Ended
Dec. 31, 2021
USD ($)
Debt Securities, Available-for-sale [Line Items]  
Available-for-sale Securities, Gross Realized Gain (Loss) $ (7)
Proceeds from Sale of Debt Securities, Available-for-sale $ 226
XML 171 R151.htm IDEA: XBRL DOCUMENT v3.22.0.1
Fair Value Measurements Fair Value Measurement Recurring Basis (Details) - USD ($)
$ in Millions
Dec. 31, 2021
Dec. 31, 2020
Fair Value, Measured on Recurring Basis, Gain (Loss) Included in Earnings [Line Items]    
Derivative Asset, Foreign Currency $ 71 $ 55
Derivative Liability, Foreign Currency 26 135
Fair Value, Recurring [Member] | Fair Value, Inputs, Level 2 [Member]    
Fair Value, Measured on Recurring Basis, Gain (Loss) Included in Earnings [Line Items]    
Marketable securities 86 43
Total assets at fair value 154 98
Total Liabilities at fair value 24 135
Fair Value, Recurring [Member] | Fair Value, Inputs, Level 2 [Member] | Foreign Exchange Contract [Member]    
Fair Value, Measured on Recurring Basis, Gain (Loss) Included in Earnings [Line Items]    
Derivative Asset, Foreign Currency [1] 68 55
Derivative Liability, Foreign Currency [1] 24 135
Fair Value, Recurring [Member] | Fair Value, Inputs, Level 1 [Member]    
Fair Value, Measured on Recurring Basis, Gain (Loss) Included in Earnings [Line Items]    
Equity Securities [2] 48  
Total assets at fair value 48 226
Total Liabilities at fair value $ 0 0
Fair Value, Recurring [Member] | Fair Value, Inputs, Level 1 [Member] | US Treasury Securities    
Fair Value, Measured on Recurring Basis, Gain (Loss) Included in Earnings [Line Items]    
Available-for-sale securities [3]   $ 226
[1] See Note 22 - Financial Instruments, to the Consolidated Financial Statements, for the classification of derivatives in the Consolidated Balance Sheets.
[2] The company's equity securities are included in "other assets" in the Consolidated Balance Sheets.
[3] The company's investments in U.S. treasuries, which are primarily available-for-sale, are included in "marketable securities" in the Consolidated Balance Sheets.
XML 172 R152.htm IDEA: XBRL DOCUMENT v3.22.0.1
Fair Value Measurements Fair Value Measurement Nonrecurring Basis (Details)
$ in Millions
12 Months Ended
Dec. 31, 2020
USD ($)
Developed Technology  
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]  
Assets at Fair Value $ 0
Other Intangible Assets [Member]  
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]  
Assets at Fair Value 0
IPR&D [Member]  
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]  
Assets at Fair Value 0
Fair Value, Nonrecurring [Member] | Developed Technology  
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]  
Asset Impairment Charges (1)
Fair Value, Nonrecurring [Member] | Other Intangible Assets [Member]  
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]  
Asset Impairment Charges (6)
Fair Value, Nonrecurring [Member] | IPR&D [Member]  
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]  
Assets at Fair Value $ (137)
XML 173 R153.htm IDEA: XBRL DOCUMENT v3.22.0.1
Geographic Information Revenue by Country (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Revenues from External Customers and Long-Lived Assets [Line Items]      
Net Sales $ 15,655 $ 14,217 $ 13,846
UNITED STATES      
Revenues from External Customers and Long-Lived Assets [Line Items]      
Net Sales 6,782 6,510 6,255
CANADA      
Revenues from External Customers and Long-Lived Assets [Line Items]      
Net Sales 754 658 674
EMEA      
Revenues from External Customers and Long-Lived Assets [Line Items]      
Net Sales 3,123 2,842 2,740
Asia Pacific      
Revenues from External Customers and Long-Lived Assets [Line Items]      
Net Sales 1,451 1,402 1,288
Latin America      
Revenues from External Customers and Long-Lived Assets [Line Items]      
Net Sales [1] 3,545 2,805 2,889
BRAZIL      
Revenues from External Customers and Long-Lived Assets [Line Items]      
Net Sales $ 2,315 $ 1,724 $ 1,794
[1] Net sales for Brazil for the years ended December 31, 2021, 2020 and 2019 were $2,315 million, $1,724 million and $1,794 million, respectively.
XML 174 R154.htm IDEA: XBRL DOCUMENT v3.22.0.1
Geographic Information Net Property by Country (Details) - USD ($)
$ in Millions
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Revenues from External Customers and Long-Lived Assets [Line Items]      
Net Property $ 4,329 $ 4,396 $ 4,546
UNITED STATES      
Revenues from External Customers and Long-Lived Assets [Line Items]      
Net Property 3,051 3,014 3,069
CANADA      
Revenues from External Customers and Long-Lived Assets [Line Items]      
Net Property 114 122 125
EMEA      
Revenues from External Customers and Long-Lived Assets [Line Items]      
Net Property 566 601 566
Asia Pacific      
Revenues from External Customers and Long-Lived Assets [Line Items]      
Net Property 468 510 608
Latin America      
Revenues from External Customers and Long-Lived Assets [Line Items]      
Net Property $ 130 $ 149 $ 178
XML 175 R155.htm IDEA: XBRL DOCUMENT v3.22.0.1
Segment Reporting Segment Information (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Jun. 01, 2019
Segment Reporting Information [Line Items]        
Net Sales $ 15,655 $ 14,217 $ 13,846  
Segment Operating EBITDA [1] 2,714 2,212 2,106  
Depreciation and Amortization     1,599  
Segment Assets 35,698 36,850 [2] 38,879 [2]  
Investments in nonconsolidated affiliates 76 66    
Payments to Acquire Property, Plant, and Equipment     1,163  
Goodwill 10,107 10,269 10,229  
Reallocation of goodwill [Member]        
Segment Reporting Information [Line Items]        
Goodwill       $ 3,382
Operating Segments [Member]        
Segment Reporting Information [Line Items]        
Depreciation and Amortization 1,243 1,177 1,000  
Investments in nonconsolidated affiliates 76 66 66  
Payments to Acquire Property, Plant, and Equipment 573 475 666  
Seed [Member]        
Segment Reporting Information [Line Items]        
Net Sales 8,402 7,756 7,590  
Segment Operating EBITDA 1,512 1,208 1,040  
Depreciation and Amortization 866 798 628  
Segment Assets 23,270 23,751 [2] 25,387  
Investments in nonconsolidated affiliates 29 22 27  
Payments to Acquire Property, Plant, and Equipment 237 225 373  
Goodwill 5,435 5,524 5,486  
Crop Protection [Member]        
Segment Reporting Information [Line Items]        
Net Sales 7,253 6,461 6,256  
Segment Operating EBITDA 1,202 1,004 1,066  
Depreciation and Amortization 377 379 372  
Segment Assets 12,428 13,099 [2] 13,492  
Investments in nonconsolidated affiliates 47 44 39  
Payments to Acquire Property, Plant, and Equipment 336 250 293  
Goodwill $ 4,672 $ 4,745 $ 4,743  
[1] The year ended December 31, 2019 is presented on a pro forma basis, prepared in accordance with Article 11 of Regulation S-X that was in effect prior to recent amendments.
[2] On June 1, 2019, as a result of changes in reportable segments, $3,382 million of goodwill was reallocated from the seed reportable segment to the crop protection reportable segment. This change was not reflected in segment assets prior to June 1, 2019.
XML 176 R156.htm IDEA: XBRL DOCUMENT v3.22.0.1
Segment Reporting Segment Reconciliation (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Segment Reporting Information [Line Items]      
Income (Loss) from Continuing Operations After Taxes $ 1,822 $ 756 $ (270)
Provision for (benefit from) income taxes on continuing operations 524 (81) (46)
Income (loss) from Continuing Operations before Income Taxes 2,346 675 (316)
Depreciation and Amortization     1,599
Interest income 77 56 59
Interest Expense 30 45 136
Net exchange losses [1] (54) (174) (99)
Non-operating pension and other post employment benefit credit (cost) [2] 1,318 368 191
Significant items 236 388 991
Pro forma adjustments     298
Corporate Expenses 138 125 119
Segment Operating EBITDA [3] 2,714 2,212 2,106
Segment Reconciling Items [Member]      
Segment Reporting Information [Line Items]      
Interest income (77) (56) (59)
Net exchange losses [4] 54 174 66
Non-operating pension and other post employment benefit credit (cost) (1,256) (316) (129)
Significant items (236)   (991) [5]
Hedging Program [Member]      
Segment Reporting Information [Line Items]      
Net exchange losses 18 89 (58)
Hedging Program [Member] | Argentine peso devaluation [Member]      
Segment Reporting Information [Line Items]      
Net exchange losses (67) (82) (51)
Hedging Program [Member] | Argentine peso devaluation [Member] | Segment Reconciling Items [Member]      
Segment Reporting Information [Line Items]      
Net exchange losses   (33)  
Hedging Program [Member] | Tax Reform Foreign Currency Exchange Impact [Member] | Segment Reconciling Items [Member]      
Segment Reporting Information [Line Items]      
Net exchange losses [5]     (33)
Operating Segments [Member]      
Segment Reporting Information [Line Items]      
Depreciation and Amortization $ 1,243 $ 1,177 $ 1,000
[1] Includes net pre-tax exchange gains (losses) of $(67) million, $(82) million and $(51) million associated with the devaluation of the Argentine peso for the years ended December 31, 2021, 2020 and 2019, respectively.
[2] Includes non-service related components of net periodic benefit credits (costs) (interest cost, expected long-term rate of return on plan assets, amortization of unrecognized gain (loss), amortization of prior service benefit and settlement gain (loss)). 
[3] The year ended December 31, 2019 is presented on a pro forma basis, prepared in accordance with Article 11 of Regulation S-X that was in effect prior to recent amendments.
[4] Excludes a $(33) million foreign exchange loss for the year ended December 31, 2019 associated with the devaluation of the Argentine peso. See Note 9 - Supplementary Information, to the Consolidated Financial Statements, for additional information.2.Effective January 1, 2021, on a prospective basis, the company excludes net unrealized gain or loss from mark-to-market activity for certain foreign currency derivative instruments that do not qualify for hedge accounting. There were no unrealized mark-to-market (gains) losses for the years ended December 31, 2020 and 2019.
[5] The year ended December 31, 2019 is presented on a pro forma basis, prepared in accordance with Article 11 of Regulation S-X that was in effect prior to recent amendments.
XML 177 R157.htm IDEA: XBRL DOCUMENT v3.22.0.1
Segment Reporting Segment Assets (Details) - USD ($)
$ in Millions
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
[1]
Segment Reporting Information [Line Items]      
Segment Assets $ 35,698 $ 36,850 [1] $ 38,879
Corporate Assets 6,646 5,799  
Assets $ 42,344 $ 42,649  
[1] On June 1, 2019, as a result of changes in reportable segments, $3,382 million of goodwill was reallocated from the seed reportable segment to the crop protection reportable segment. This change was not reflected in segment assets prior to June 1, 2019.
XML 178 R158.htm IDEA: XBRL DOCUMENT v3.22.0.1
Segment Reporting Other Items (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Segment Reporting, Other Significant Reconciling Item [Line Items]      
Depreciation and Amortization     $ 1,599
Investments in nonconsolidated affiliates $ 76 $ 66  
Payments to Acquire Property, Plant, and Equipment     1,163
Operating Segments [Member]      
Segment Reporting, Other Significant Reconciling Item [Line Items]      
Depreciation and Amortization 1,243 1,177 1,000
Investments in nonconsolidated affiliates 76 66 66
Payments to Acquire Property, Plant, and Equipment $ 573 $ 475 666
Discontinued Operations [Member]      
Segment Reporting, Other Significant Reconciling Item [Line Items]      
Depreciation and Amortization [1]     599
Payments to Acquire Property, Plant, and Equipment [1]     $ 497
[1] See Note 5 - Divestitures and Other Transactions, to the Consolidated Financial Statements, for additional information
XML 179 R159.htm IDEA: XBRL DOCUMENT v3.22.0.1
Segment Reporting Sig Items (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Segment Reporting Information [Line Items]      
Integration and Separation Costs $ 0 $ 0 $ 744
Pre-tax exchange (loss) gain [1] (54) (174) (99)
Loss on Extinguishment of Debt 0 0 (13) [2]
Significant items 236 388 991
Restructuring and asset related charges- net 289 335 222
Hedging Program [Member]      
Segment Reporting Information [Line Items]      
Pre-tax exchange (loss) gain 18 89 (58)
Hedging Program [Member] | Argentine peso devaluation [Member]      
Segment Reporting Information [Line Items]      
Pre-tax exchange (loss) gain (67) (82) (51)
Segment Reconciling Items [Member]      
Segment Reporting Information [Line Items]      
Integration and Separation Costs [3],[4]   (53) (632)
Gain (Loss) on Disposition of Assets [4],[5]   (388)  
Pre-tax exchange (loss) gain [6] 54 174 66
Significant items (236)   (991) [4]
Restructuring and asset related charges- net [7] 47 (335) [4] (222) [4]
Employee Retention Credit 60    
Contract Termination Cost (54)    
Segment Reconciling Items [Member] | Seed [Member]      
Segment Reporting Information [Line Items]      
Significant items (98)   (304) [4]
Restructuring and asset related charges- net [7] (152) (165) [4] (213) [4]
Equity Securities Mark-to-Mark Gain 47    
Employee Retention Credit 37    
Contract Termination Cost (30)    
Segment Reconciling Items [Member] | Crop Protection [Member]      
Segment Reporting Information [Line Items]      
Significant items (60)   (23) [4]
Restructuring and asset related charges- net [7] (59) (109) [4] (23) [4]
Employee Retention Credit 23    
Contract Termination Cost (24)    
Segment Reconciling Items [Member] | Corporate, Non-Segment [Member]      
Segment Reporting Information [Line Items]      
Integration and Separation Costs [3],[4]   0 (632)
Loss on Extinguishment of Debt     (13)
Significant items (78)   (664) [4]
Restructuring and asset related charges- net [7] (78) (61) [4] 14 [4]
Segment Reconciling Items [Member] | Sale of JV [Member] | Crop Protection [Member]      
Segment Reporting Information [Line Items]      
Gain (Loss) on Disposition of Assets   (53)  
Segment Reconciling Items [Member] | Asset sale [Member]      
Segment Reporting Information [Line Items]      
Gain (Loss) on Disposition of Assets [4]     (24)
Segment Reconciling Items [Member] | Asset sale [Member] | Seed [Member]      
Segment Reporting Information [Line Items]      
Gain (Loss) on Disposition of Assets [4]     (24)
Segment Reconciling Items [Member] | Deconsolidation of a subsidiary [Member]      
Segment Reporting Information [Line Items]      
Gain (Loss) on Disposition of Assets [4]     (67)
Segment Reconciling Items [Member] | Deconsolidation of a subsidiary [Member] | Seed [Member]      
Segment Reporting Information [Line Items]      
Gain (Loss) on Disposition of Assets [4]     (67)
Segment Reconciling Items [Member] | Other loss on sale [Member]      
Segment Reporting Information [Line Items]      
Gain (Loss) on Disposition of Assets [4]     (13)
Segment Reconciling Items [Member] | Other loss on sale [Member] | Seed [Member]      
Segment Reporting Information [Line Items]      
Gain (Loss) on Disposition of Assets [4]     0
Segment Reconciling Items [Member] | La Porte | Crop Protection [Member]      
Segment Reporting Information [Line Items]      
Gain (Loss) on Disposition of Assets $ (53)    
Segment Reconciling Items [Member] | Hedging Program [Member] | Argentine peso devaluation [Member]      
Segment Reporting Information [Line Items]      
Pre-tax exchange (loss) gain   $ (33)  
Segment Reconciling Items [Member] | Hedging Program [Member] | Tax Reform Foreign Currency Exchange Impact [Member]      
Segment Reporting Information [Line Items]      
Pre-tax exchange (loss) gain [4]     (33)
Segment Reconciling Items [Member] | Hedging Program [Member] | Tax Reform Foreign Currency Exchange Impact [Member] | Corporate, Non-Segment [Member]      
Segment Reporting Information [Line Items]      
Pre-tax exchange (loss) gain [4]     $ (33)
[1] Includes net pre-tax exchange gains (losses) of $(67) million, $(82) million and $(51) million associated with the devaluation of the Argentine peso for the years ended December 31, 2021, 2020 and 2019, respectively.
[2] The cash flows for the year ended December 31, 2019 includes cash flows of EID's ECP and Specialty Products Entities.
[3] Integration and separation costs include costs incurred to prepare for and close the Merger, post-Merger integration expenses, and costs incurred to prepare for the Internal Reorganizations. Beginning in the second quarter of 2019, this includes both integration and separation costs.
[4] The year ended December 31, 2019 is presented on a pro forma basis, prepared in accordance with Article 11 of Regulation S-X that was in effect prior to recent amendments.
[5] Includes a loss recorded in other income - net related to DAS's sale of a joint venture related to synergy actions.
[6] Excludes a $(33) million foreign exchange loss for the year ended December 31, 2019 associated with the devaluation of the Argentine peso. See Note 9 - Supplementary Information, to the Consolidated Financial Statements, for additional information.2.Effective January 1, 2021, on a prospective basis, the company excludes net unrealized gain or loss from mark-to-market activity for certain foreign currency derivative instruments that do not qualify for hedge accounting. There were no unrealized mark-to-market (gains) losses for the years ended December 31, 2020 and 2019.
[7] Includes Board approved restructuring plans and asset related charges as well as accelerated prepaid amortization. See Note 7 - Restructuring and Asset Related Charges - Net, to the Consolidated Financial Statements, for additional information.
XML 180 R160.htm IDEA: XBRL DOCUMENT v3.22.0.1
Quaterly Financial Data Quarterly Financial Data (Details) - USD ($)
$ / shares in Units, $ in Millions
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Quarterly Financial Data [Abstract]      
Net Sales $ 15,655 $ 14,217 $ 13,846
Cost of Goods Sold 9,220 8,507 8,575
Restructuring and asset related charges- net 289 335 222
Integration and Separation Costs 0 0 744
Income (loss) from continuing operations after income taxes 1,822 756 (270)
Net (loss) income attributable to Company $ 1,759 $ 681 $ (959)
(Loss) earnings per common share, continuing operations - basic $ 2.46 $ 0.98 $ (0.38)
(Loss) earnings per common share, continuing operations - diluted $ 2.44 $ 0.98 $ (0.38)
XML 181 R161.htm IDEA: XBRL DOCUMENT v3.22.0.1
Quaterly Financial Data Quarterly Financial Data (Parentheticals) (Details) - USD ($)
$ in Millions
3 Months Ended 12 Months Ended
Sep. 30, 2020
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Loss on Extinguishment of Debt   $ 0 $ 0 $ (13) [1]
Net after-tax exchange (loss) gain   (88) (161) (84)
Hedging Program [Member]        
Net after-tax exchange (loss) gain   $ 14 68 (45)
Hedging Program [Member] | Argentine peso devaluation [Member]        
Other Tax (Benefit) Expense $ 33      
Merger with Dow [Member]        
Business Combination, Fair Value Step-Up Of Acquired Inventory, Amount recognized in Cost of Goods sold       $ 272
Segment Reconciling Items [Member]        
Gain (Loss) on Disposition of Assets [2],[3]     (388)  
Crop Protection [Member] | Segment Reconciling Items [Member] | Sale of JV [Member]        
Gain (Loss) on Disposition of Assets     $ (53)  
[1] The cash flows for the year ended December 31, 2019 includes cash flows of EID's ECP and Specialty Products Entities.
[2] Includes a loss recorded in other income - net related to DAS's sale of a joint venture related to synergy actions.
[3] The year ended December 31, 2019 is presented on a pro forma basis, prepared in accordance with Article 11 of Regulation S-X that was in effect prior to recent amendments.
XML 182 R162.htm IDEA: XBRL DOCUMENT v3.22.0.1
Subsequent Events (Details) - Securities Sold under Agreements to Repurchase [Member]
$ in Millions
Feb. 09, 2021
USD ($)
Subsequent Event [Line Items]  
Short-term Debt $ 500
Percentage of outstanding amounts borrowed utilized as collateral 105.00%
Interest rate in addition to SOFR 0.75%
XML 183 R163.htm IDEA: XBRL DOCUMENT v3.22.0.1
EID Basis of Presentation (Details) - $ / shares
12 Months Ended
Dec. 31, 2021
Feb. 03, 2022
Dec. 31, 2020
Dec. 31, 2019
Jun. 01, 2019
Common Stock, Shares, Outstanding 726,527,000   743,458,000 748,577,000 748,815,000
Common Stock, Par Value $ 0.01 $ 0.01 $ 0.01    
EID [Member]          
Common Stock, Shares, Outstanding 200   200    
Common Stock, Par Value $ 0.30 $ 0.30 $ 0.30    
Corteva [Member] | EID [Member]          
Ownership interest in an entity 100.00%        
XML 184 R164.htm IDEA: XBRL DOCUMENT v3.22.0.1
EID Related Party (Details) - EID [Member] - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Related Party Transaction [Line Items]    
Long-Term Debt - Related Party $ 2,162 $ 3,459
Corteva [Member]    
Related Party Transaction [Line Items]    
Debt, Weighted Average Interest Rate 1.67% 1.62%
Interest Expense, Related Party $ 50 $ 100
Interest Paid on Related Party Long-Term Debt 51 105
Accrued and Other Current Liabilities [Member] | Corteva [Member]    
Related Party Transaction [Line Items]    
CTVA Related Party Liability 92 27
Other Noncurrent Obligations [Member] | Corteva [Member]    
Related Party Transaction [Line Items]    
CTVA Related Party Liability $ 92 $ 117
XML 185 R165.htm IDEA: XBRL DOCUMENT v3.22.0.1
EID Income Taxes Geographic Allocation (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Income (loss) from Continuing Operations before Income Taxes $ 2,346 $ 675 $ (316)
Provision for (benefit from) income taxes on continuing operations 524 (81) (46)
Net income (loss) from continuing operations after income taxes 1,769 701 (941) [1]
Continuing Operations [Member]      
Income (loss) from Continuing Operations before Income Taxes, Domestic 941 (83) (1,352)
Income (Loss) from Continuing Operations before Income Taxes, Foreign 1,405 758 1,036
Income (loss) from Continuing Operations before Income Taxes 2,346 675 (316)
Current Federal Tax (Benefit) Expense (13) 28 (11)
Current State and Local Tax Expense (Benefit) 6 9 1
Current Foreign Tax Expense (Benefit) 329 222 317
Total current tax expense (benefit) 322 259 307
Deferred Federal Income Tax Expense (Benefit) 164 (116) (392)
Deferred State and Local Income Tax Expense (Benefit) 55 27 156
Deferred Foreign Income Tax Expense (Benefit) (17) (251) (117)
Total deferred tax expense (benefit) 202 (340) (353)
Provision for (benefit from) income taxes on continuing operations 524 (81) (46)
EID [Member]      
Income (loss) from Continuing Operations before Income Taxes 2,296 575 (422)
Provision for (benefit from) income taxes on continuing operations 512 (105) (71)
Net income (loss) from continuing operations after income taxes 1,731 625 (1,022) [2]
EID [Member] | Continuing Operations [Member]      
Income (loss) from Continuing Operations before Income Taxes, Domestic 892 (183) (1,458)
Income (Loss) from Continuing Operations before Income Taxes, Foreign 1,404 758 1,036
Income (loss) from Continuing Operations before Income Taxes 2,296 575 (422)
Current Federal Tax (Benefit) Expense (23) 8 (11)
Current State and Local Tax Expense (Benefit) 4 5 1
Current Foreign Tax Expense (Benefit) 329 222 317
Total current tax expense (benefit) 310 235 307
Deferred Federal Income Tax Expense (Benefit) 164 (116) (417)
Deferred State and Local Income Tax Expense (Benefit) 55 27 156
Deferred Foreign Income Tax Expense (Benefit) (17) (251) (117)
Total deferred tax expense (benefit) 202 (340) (378)
Provision for (benefit from) income taxes on continuing operations 512 (105) (71)
Net income (loss) from continuing operations after income taxes $ 1,784 $ 680 $ (351)
[1] The cash flows for the year ended December 31, 2019 includes cash flows of EID's ECP and Specialty Products Entities.
[2] The cash flows for the year ended December 31, 2019 includes cash flows of EID's ECP and Specialty Products Entities
XML 186 R166.htm IDEA: XBRL DOCUMENT v3.22.0.1
EID Income Taxes Rate Reconciliation (Details) - Continuing Operations [Member] - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Statutory U.S. federal income tax rate 21.00% 21.00% 21.00%
Effective tax rates on international operations - net [1] (2.50%) (13.90%) (18.40%)
Acquisitions, divestitures, and ownership restructuring activities [2] (0.10%) (0.30%) (10.70%)
U.S. research and development credit (2.40%) (2.90%) 7.00%
Exchange gains/losses [3] 1.90% 3.50% (1.80%)
State and Local Income Taxes 2.10% 4.00% 3.20%
Impact of Swiss Tax Reform [4] 0.20% (27.00%) 11.90%
Excess tax benefits (tax deficiency) from stock-compensation (0.20%) 1.00% (0.60%)
Tax settlements and expiration of statue of limitations 0.00% 0.40% 3.90%
Other, net 2.30% 2.20% (0.90%)
Effective Income Tax Rate 22.30% (12.00%) 14.60%
Swiss Tax Reform [Member]      
Other Tax (Benefit) Expense   $ (182) $ (38)
EID [Member]      
Statutory U.S. federal income tax rate 21.00% 21.00% 21.00%
Effective tax rates on international operations - net [5] (2.60%) (16.40%) (13.80%)
Acquisitions, divestitures, and ownership restructuring activities [6] (0.10%) (0.30%) (8.00%)
U.S. research and development credit (2.50%) (3.40%) 5.20%
Exchange gains/losses [7] 1.90% 4.10% (1.30%)
State and Local Income Taxes 2.20% 4.20% 3.00%
Impact of Swiss Tax Reform [8] 0.20% (31.70%) 8.90%
Excess tax benefits (tax deficiency) from stock-compensation (0.20%) 1.20% (0.50%)
Tax settlements and expiration of statue of limitations 0.00% 0.40% 2.90%
Other, net 2.30% 2.60% (0.60%)
Effective Income Tax Rate 22.20% (18.30%) 16.80%
EID [Member] | Tax benefit (charge) related to The Act [Member]      
Other Tax (Benefit) Expense $ (51)    
EID [Member] | Swiss Tax Reform [Member]      
Other Tax (Benefit) Expense $ (182) $ (38)  
[1] Includes the effects of local and U.S. taxes related to earnings of non-U.S. subsidiaries, changes in the amount of unrecognized tax benefits associated with these earnings, losses at non-U.S. subsidiaries without local tax benefits due to valuation allowances, and other permanent differences between tax and U.S. GAAP results. Includes a tax benefit of $(51) million for the year ended December 31, 2020, related to a return to accrual adjustment associated with an elective change in accounting method for the 2019 tax year impact of foreign tax provisions.
[2] See Notes 4 - Common Control Business Combination, and Note 5 - Divestitures and Other Transactions, to the Consolidated Financial Statements, for additional information.
[3] Principally reflects the impact of foreign exchange gains and losses on net monetary assets for which no corresponding tax impact is realized. Further information about the company's foreign currency hedging program is included in Note 9 - Supplementary Information, and Note 22 - Financial Instruments, under the heading Foreign Currency Risk.
[4] Reflects tax benefits of $(182) million primarily driven by the recognition of an elective cantonal component of the recent enactment of the Federal Act on Tax Reform and AHV Financing ("Swiss Tax Reform") for the year ended December 31, 2020. Reflects tax benefits of $(38) million associated with the enactment of the Federal Act on Tax Reform and AHV Financing ("Swiss Tax Reform"), for the year ended December 31, 2019.
[5] Includes the effects of local and U.S. taxes related to earnings of non-U.S. subsidiaries, changes in the amount of unrecognized tax benefits associated with these earnings, losses at non-U.S. subsidiaries without local tax benefits due to valuation allowances, and other permanent differences between tax and U.S. GAAP results. Includes a tax benefit of $(51) million for the year ended December 31, 2020, related to a return to accrual adjustment associated with an elective change in accounting method that alters the 2019 impact of foreign tax provisions.
[6] See Notes 4 - Common Control Business Combination, and Note 5 - Divestitures and Other Transactions, of the Corteva, Inc. Consolidated Financial Statements for additional information.
[7] Principally reflects the impact of foreign exchange gains and losses on net monetary assets for which no corresponding tax impact is realized. Further information about the company's foreign currency hedging program is included in Note 9 - Supplementary Information, and Note 22 - Financial Instruments, of the Corteva, Inc. Consolidated Financial Statements under the heading Foreign Currency Risk.
[8] Reflects tax benefits of $(182) million primarily driven by the recognition of an elective cantonal component of the recent enactment of the Federal Act on Tax Reform and AHV Financing ("Swiss Tax Reform") for the year ended December 31, 2020. Reflects tax benefits of $(38) million associated with the enactment of the Federal Act on Tax Reform and AHV Financing ("Swiss Tax Reform"), for the year ended December 31, 2019.
XML 187 R167.htm IDEA: XBRL DOCUMENT v3.22.0.1
EID Segment FN Segment Reconciliation (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]      
Income (Loss) from Continuing Operations After Taxes $ 1,822 $ 756 $ (270)
Provision for (benefit from) income taxes on continuing operations 524 (81) (46)
Income (loss) from Continuing Operations before Income Taxes 2,346 675 (316)
Depreciation and Amortization     1,599
Interest income 77 56 59
Interest Expense 30 45 136
Net exchange losses [1] (54) (174) (99)
Significant items 236 388 991
Pro forma adjustments     298
Corporate Expenses 138 125 119
Segment Operating EBITDA [2] 2,714 2,212 2,106
EID [Member]      
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]      
Income (Loss) from Continuing Operations After Taxes 1,784 680 (351)
Provision for (benefit from) income taxes on continuing operations 512 (105) (71)
Income (loss) from Continuing Operations before Income Taxes 2,296 575 (422)
Depreciation and Amortization 1,243 1,177 1,000
Interest Expense 80 145 242
Non-operating benefits - net (1,256) (316) (129)
Significant items 236 388 991
Pro forma adjustments     298
Corporate Expenses 138 125 119
Segment Operating EBITDA [3] 2,714 2,212 2,106
Segment Reconciling Items [Member]      
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]      
Interest income (77) (56) (59)
Net exchange losses [4] 54 174 66
Significant items (236)   (991) [5]
Segment Reconciling Items [Member] | EID [Member]      
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]      
Interest income (77) (56) (59)
Net exchange losses [6] 54 174 66
Hedging Program [Member]      
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]      
Net exchange losses 18 89 (58)
Hedging Program [Member] | Argentine peso devaluation [Member]      
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]      
Net exchange losses (67) (82) (51)
Hedging Program [Member] | Argentine peso devaluation [Member] | EID [Member]      
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]      
Net exchange losses   (33)  
Hedging Program [Member] | Argentine peso devaluation [Member] | Segment Reconciling Items [Member]      
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]      
Net exchange losses   (33)  
Hedging Program [Member] | Tax Reform Foreign Currency Exchange Impact [Member] | Segment Reconciling Items [Member]      
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]      
Net exchange losses [5]     (33)
Corporate, Non-Segment [Member] | Segment Reconciling Items [Member]      
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]      
Significant items (78)   (664) [5]
Corporate, Non-Segment [Member] | Hedging Program [Member] | Tax Reform Foreign Currency Exchange Impact [Member] | Segment Reconciling Items [Member]      
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]      
Net exchange losses [5]     (33)
Crop Protection [Member]      
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]      
Depreciation and Amortization 377 379 372
Segment Operating EBITDA 1,202 $ 1,004 1,066
Crop Protection [Member] | Segment Reconciling Items [Member]      
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]      
Significant items $ (60)   $ (23) [5]
[1] Includes net pre-tax exchange gains (losses) of $(67) million, $(82) million and $(51) million associated with the devaluation of the Argentine peso for the years ended December 31, 2021, 2020 and 2019, respectively.
[2] The year ended December 31, 2019 is presented on a pro forma basis, prepared in accordance with Article 11 of Regulation S-X that was in effect prior to recent amendments.
[3] The year ended December 31, 2019 is presented on a pro forma basis, prepared in accordance with Article 11 of Regulation S-X that was in effect prior to recent amendments.
[4] Excludes a $(33) million foreign exchange loss for the year ended December 31, 2019 associated with the devaluation of the Argentine peso. See Note 9 - Supplementary Information, to the Consolidated Financial Statements, for additional information.2.Effective January 1, 2021, on a prospective basis, the company excludes net unrealized gain or loss from mark-to-market activity for certain foreign currency derivative instruments that do not qualify for hedge accounting. There were no unrealized mark-to-market (gains) losses for the years ended December 31, 2020 and 2019.
[5] The year ended December 31, 2019 is presented on a pro forma basis, prepared in accordance with Article 11 of Regulation S-X that was in effect prior to recent amendments.
[6] Excludes a $(33) million foreign exchange loss for the year ended December 31, 2019 associated with the devaluation of the Argentine peso. See Note 9 - Supplementary Information, of the Corteva, Inc. Consolidated Financial Statements for additional information.2.Effective January 1, 2021, on a prospective basis, the company excludes net unrealized gain or loss from mark-to-market activity for certain foreign currency derivative instruments that do not qualify for hedge accounting. There were no unrealized mark-to-market (gains) losses for the years ended December 31, 2020 and 2019.
XML 188 R168.htm IDEA: XBRL DOCUMENT v3.22.0.1
EID Segment FN Segment Asset Reconciliation (Details) - USD ($)
$ in Millions
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
[1]
Segment Reporting Information [Line Items]      
Segment Assets $ 35,698 $ 36,850 [1] $ 38,879
Corporate Assets 6,646 5,799  
Assets 42,344 42,649  
EID [Member]      
Segment Reporting Information [Line Items]      
Assets $ 42,344 $ 42,649  
[1] On June 1, 2019, as a result of changes in reportable segments, $3,382 million of goodwill was reallocated from the seed reportable segment to the crop protection reportable segment. This change was not reflected in segment assets prior to June 1, 2019.
XML 189 R169.htm IDEA: XBRL DOCUMENT v3.22.0.1
EID Quarterly FN (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Effect of Fourth Quarter Events [Line Items]      
Income (loss) from continuing operations after income taxes $ 1,822 $ 756 $ (270)
Net (loss) income attributable to Company 1,759 681 (959)
EID [Member]      
Effect of Fourth Quarter Events [Line Items]      
Income (loss) from continuing operations after income taxes 1,784 680 (351)
Net (loss) income attributable to Company $ 1,731 $ 615 $ (1,030)
XML 190 ctva-20211231_htm.xml IDEA: XBRL DOCUMENT 0001755672 2021-01-01 2021-12-31 0001755672 ctva:EIDMember 2021-01-01 2021-12-31 0001755672 us-gaap:CommonStockMember 2021-01-01 2021-12-31 0001755672 ctva:A3.50SeriesPreferredStockMember ctva:EIDMember 2021-01-01 2021-12-31 0001755672 ctva:A4.50SeriesPreferredStockMember ctva:EIDMember 2021-01-01 2021-12-31 0001755672 2022-02-03 0001755672 ctva:EIDMember 2022-02-03 0001755672 2021-06-30 0001755672 us-gaap:AllowanceForCreditLossMember 2020-12-31 0001755672 us-gaap:AllowanceForCreditLossMember 2019-12-31 0001755672 us-gaap:AllowanceForCreditLossMember 2018-12-31 0001755672 us-gaap:AllowanceForCreditLossMember 2021-01-01 2021-12-31 0001755672 us-gaap:AllowanceForCreditLossMember 2020-01-01 2020-12-31 0001755672 us-gaap:AllowanceForCreditLossMember 2019-01-01 2019-12-31 0001755672 us-gaap:AllowanceForCreditLossMember 2021-12-31 0001755672 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2020-12-31 0001755672 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2019-12-31 0001755672 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2018-12-31 0001755672 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2021-01-01 2021-12-31 0001755672 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2020-01-01 2020-12-31 0001755672 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2019-01-01 2019-12-31 0001755672 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2021-12-31 0001755672 2020-01-01 2020-12-31 0001755672 2019-01-01 2019-12-31 0001755672 ctva:EIDMember 2019-01-01 2019-12-31 0001755672 us-gaap:PensionPlansDefinedBenefitMember 2021-01-01 2021-12-31 0001755672 us-gaap:PensionPlansDefinedBenefitMember 2020-01-01 2020-12-31 0001755672 us-gaap:PensionPlansDefinedBenefitMember 2019-01-01 2019-12-31 0001755672 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2021-01-01 2021-12-31 0001755672 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2020-01-01 2020-12-31 0001755672 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2019-01-01 2019-12-31 0001755672 2021-12-31 0001755672 2020-12-31 0001755672 ctva:TotalcompanyMember 2021-01-01 2021-12-31 0001755672 ctva:TotalcompanyMember 2020-01-01 2020-12-31 0001755672 ctva:TotalcompanyMember 2019-01-01 2019-12-31 0001755672 2019-12-31 0001755672 2018-12-31 0001755672 us-gaap:CommonStockMember 2018-12-31 0001755672 us-gaap:AdditionalPaidInCapitalMember 2018-12-31 0001755672 ctva:DivisionalEquityMember 2018-12-31 0001755672 us-gaap:RetainedEarningsMember 2018-12-31 0001755672 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-12-31 0001755672 us-gaap:NoncontrollingInterestMember 2018-12-31 0001755672 ctva:DivisionalEquityMember 2019-01-01 2019-12-31 0001755672 us-gaap:RetainedEarningsMember 2019-01-01 2019-12-31 0001755672 us-gaap:NoncontrollingInterestMember 2019-01-01 2019-12-31 0001755672 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-01-01 2019-12-31 0001755672 us-gaap:AdditionalPaidInCapitalMember 2019-01-01 2019-12-31 0001755672 ctva:DivisionalEquityMember ctva:DowDuPontMember 2019-01-01 2019-12-31 0001755672 ctva:DowDuPontMember 2019-01-01 2019-12-31 0001755672 us-gaap:CommonStockMember 2019-01-01 2019-12-31 0001755672 us-gaap:CommonStockMember 2019-12-31 0001755672 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0001755672 ctva:DivisionalEquityMember 2019-12-31 0001755672 us-gaap:RetainedEarningsMember 2019-12-31 0001755672 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-31 0001755672 us-gaap:NoncontrollingInterestMember 2019-12-31 0001755672 us-gaap:RetainedEarningsMember 2020-01-01 2020-12-31 0001755672 us-gaap:NoncontrollingInterestMember 2020-01-01 2020-12-31 0001755672 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-01-01 2020-12-31 0001755672 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-12-31 0001755672 us-gaap:CommonStockMember 2020-12-31 0001755672 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001755672 us-gaap:RetainedEarningsMember 2020-12-31 0001755672 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0001755672 us-gaap:NoncontrollingInterestMember 2020-12-31 0001755672 us-gaap:RetainedEarningsMember 2021-01-01 2021-12-31 0001755672 us-gaap:NoncontrollingInterestMember 2021-01-01 2021-12-31 0001755672 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-12-31 0001755672 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-12-31 0001755672 us-gaap:CommonStockMember 2021-12-31 0001755672 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001755672 us-gaap:RetainedEarningsMember 2021-12-31 0001755672 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0001755672 us-gaap:NoncontrollingInterestMember 2021-12-31 0001755672 ctva:CortevaMember 2021-01-01 2021-12-31 0001755672 ctva:CortevaMember 2019-06-26 0001755672 ctva:DowMember 2019-04-01 0001755672 ctva:SharesofCortevaStockMember ctva:CortevaMember 2019-06-01 0001755672 ctva:SharesofDowDuPontCommonStockHeldMember ctva:CortevaMember 2019-06-01 0001755672 ctva:CortevaMember 2019-06-03 0001755672 ctva:CortevaMember ctva:EIDMember 2021-01-01 2021-12-31 0001755672 ctva:InternalReorganizationMember 2020-01-01 2020-03-31 0001755672 ctva:ECPDisposalMember 2021-01-01 2021-12-31 0001755672 ctva:SpecialtyProductsDisposalMember 2021-01-01 2021-12-31 0001755672 us-gaap:OtherCurrentAssetsMember 2021-12-31 0001755672 us-gaap:OtherCurrentAssetsMember 2020-12-31 0001755672 srt:MinimumMember 2021-01-01 2021-12-31 0001755672 srt:MaximumMember 2021-01-01 2021-12-31 0001755672 us-gaap:OtherAssetsMember 2021-12-31 0001755672 ctva:DuPontdeNemoursMember ctva:AccountsandNotesReceivableMember 2021-12-31 0001755672 ctva:DuPontdeNemoursMember us-gaap:OtherAssetsMember 2021-12-31 0001755672 ctva:DuPontdeNemoursMember us-gaap:OtherNoncurrentLiabilitiesMember 2021-12-31 0001755672 ctva:DowMember ctva:AccruedandOtherCurrentLiabilitiesMember 2021-12-31 0001755672 ctva:DowMember us-gaap:OtherNoncurrentLiabilitiesMember 2021-12-31 0001755672 ctva:ECPDisposalMember ctva:IncomeStatementMember 2021-01-01 2021-12-31 0001755672 ctva:ECPDisposalMember 2020-01-01 2020-12-31 0001755672 ctva:ECPDisposalMember ctva:CashFlowMember 2021-01-01 2021-12-31 0001755672 ctva:SpecialtyProductsDisposalMember ctva:IncomeStatementMember 2021-01-01 2021-12-31 0001755672 ctva:SpecialtyProductsDisposalMember 2020-01-01 2020-12-31 0001755672 ctva:SpecialtyProductsDisposalMember ctva:CashFlowMember 2021-01-01 2021-12-31 0001755672 ctva:FavorableSupplyContractMember ctva:DivestedAgBusinessMember 2017-11-01 0001755672 ctva:DivestedAgBusinessMember 2020-01-01 2020-12-31 0001755672 ctva:OtherdiscontinuedoperationsMember 2021-01-01 2021-12-31 0001755672 ctva:OtherdiscontinuedoperationsMember 2020-01-01 2020-12-31 0001755672 srt:MinimumMember 2021-12-31 0001755672 srt:MaximumMember 2021-12-31 0001755672 us-gaap:OtherNoncurrentLiabilitiesMember 2021-12-31 0001755672 us-gaap:OtherNoncurrentLiabilitiesMember 2020-12-31 0001755672 ctva:CornMember ctva:SeedMember 2021-01-01 2021-12-31 0001755672 ctva:CornMember ctva:SeedMember 2020-01-01 2020-12-31 0001755672 ctva:CornMember ctva:SeedMember 2019-01-01 2019-12-31 0001755672 ctva:SoybeanMember ctva:SeedMember 2021-01-01 2021-12-31 0001755672 ctva:SoybeanMember ctva:SeedMember 2020-01-01 2020-12-31 0001755672 ctva:SoybeanMember ctva:SeedMember 2019-01-01 2019-12-31 0001755672 ctva:OtheroilseedsMember ctva:SeedMember 2021-01-01 2021-12-31 0001755672 ctva:OtheroilseedsMember ctva:SeedMember 2020-01-01 2020-12-31 0001755672 ctva:OtheroilseedsMember ctva:SeedMember 2019-01-01 2019-12-31 0001755672 ctva:OtherMember ctva:SeedMember 2021-01-01 2021-12-31 0001755672 ctva:OtherMember ctva:SeedMember 2020-01-01 2020-12-31 0001755672 ctva:OtherMember ctva:SeedMember 2019-01-01 2019-12-31 0001755672 ctva:SeedMember 2021-01-01 2021-12-31 0001755672 ctva:SeedMember 2020-01-01 2020-12-31 0001755672 ctva:SeedMember 2019-01-01 2019-12-31 0001755672 ctva:HerbicidesMember ctva:CropProtectionMember 2021-01-01 2021-12-31 0001755672 ctva:HerbicidesMember ctva:CropProtectionMember 2020-01-01 2020-12-31 0001755672 ctva:HerbicidesMember ctva:CropProtectionMember 2019-01-01 2019-12-31 0001755672 ctva:InsecticidesMember ctva:CropProtectionMember 2021-01-01 2021-12-31 0001755672 ctva:InsecticidesMember ctva:CropProtectionMember 2020-01-01 2020-12-31 0001755672 ctva:InsecticidesMember ctva:CropProtectionMember 2019-01-01 2019-12-31 0001755672 ctva:FungicidesMember ctva:CropProtectionMember 2021-01-01 2021-12-31 0001755672 ctva:FungicidesMember ctva:CropProtectionMember 2020-01-01 2020-12-31 0001755672 ctva:FungicidesMember ctva:CropProtectionMember 2019-01-01 2019-12-31 0001755672 ctva:OtherMember ctva:CropProtectionMember 2021-01-01 2021-12-31 0001755672 ctva:OtherMember ctva:CropProtectionMember 2020-01-01 2020-12-31 0001755672 ctva:OtherMember ctva:CropProtectionMember 2019-01-01 2019-12-31 0001755672 ctva:CropProtectionMember 2021-01-01 2021-12-31 0001755672 ctva:CropProtectionMember 2020-01-01 2020-12-31 0001755672 ctva:CropProtectionMember 2019-01-01 2019-12-31 0001755672 ctva:GeographyMember 2021-01-01 2021-12-31 0001755672 srt:NorthAmericaMember ctva:SeedMember 2021-01-01 2021-12-31 0001755672 srt:NorthAmericaMember ctva:SeedMember 2020-01-01 2020-12-31 0001755672 srt:NorthAmericaMember ctva:SeedMember 2019-01-01 2019-12-31 0001755672 us-gaap:EMEAMember ctva:SeedMember 2021-01-01 2021-12-31 0001755672 us-gaap:EMEAMember ctva:SeedMember 2020-01-01 2020-12-31 0001755672 us-gaap:EMEAMember ctva:SeedMember 2019-01-01 2019-12-31 0001755672 srt:LatinAmericaMember ctva:SeedMember 2021-01-01 2021-12-31 0001755672 srt:LatinAmericaMember ctva:SeedMember 2020-01-01 2020-12-31 0001755672 srt:LatinAmericaMember ctva:SeedMember 2019-01-01 2019-12-31 0001755672 srt:AsiaPacificMember ctva:SeedMember 2021-01-01 2021-12-31 0001755672 srt:AsiaPacificMember ctva:SeedMember 2020-01-01 2020-12-31 0001755672 srt:AsiaPacificMember ctva:SeedMember 2019-01-01 2019-12-31 0001755672 srt:NorthAmericaMember ctva:CropProtectionMember 2021-01-01 2021-12-31 0001755672 srt:NorthAmericaMember ctva:CropProtectionMember 2020-01-01 2020-12-31 0001755672 srt:NorthAmericaMember ctva:CropProtectionMember 2019-01-01 2019-12-31 0001755672 us-gaap:EMEAMember ctva:CropProtectionMember 2021-01-01 2021-12-31 0001755672 us-gaap:EMEAMember ctva:CropProtectionMember 2020-01-01 2020-12-31 0001755672 us-gaap:EMEAMember ctva:CropProtectionMember 2019-01-01 2019-12-31 0001755672 srt:LatinAmericaMember ctva:CropProtectionMember 2021-01-01 2021-12-31 0001755672 srt:LatinAmericaMember ctva:CropProtectionMember 2020-01-01 2020-12-31 0001755672 srt:LatinAmericaMember ctva:CropProtectionMember 2019-01-01 2019-12-31 0001755672 srt:AsiaPacificMember ctva:CropProtectionMember 2021-01-01 2021-12-31 0001755672 srt:AsiaPacificMember ctva:CropProtectionMember 2020-01-01 2020-12-31 0001755672 srt:AsiaPacificMember ctva:CropProtectionMember 2019-01-01 2019-12-31 0001755672 ctva:A2021RestructuringActionsMember 2021-01-01 2021-12-31 0001755672 ctva:A2021RestructuringActionsMember ctva:SeedMember 2020-01-01 2020-12-31 0001755672 ctva:A2021RestructuringActionsMember ctva:CropProtectionMember 2020-01-01 2020-12-31 0001755672 ctva:A2021RestructuringActionsMember us-gaap:CorporateNonSegmentMember 2020-01-01 2020-12-31 0001755672 ctva:A2021RestructuringActionsMember 2020-01-01 2020-12-31 0001755672 us-gaap:EmployeeSeveranceMember ctva:A2021RestructuringActionsMember 2020-01-01 2020-12-31 0001755672 ctva:AssetRelatedChargesMember ctva:A2021RestructuringActionsMember 2021-01-01 2021-12-31 0001755672 us-gaap:ContractTerminationMember ctva:A2021RestructuringActionsMember 2021-01-01 2021-12-31 0001755672 us-gaap:EmployeeSeveranceMember ctva:A2021RestructuringActionsMember 2020-12-31 0001755672 ctva:AssetRelatedChargesMember ctva:A2021RestructuringActionsMember 2020-12-31 0001755672 us-gaap:ContractTerminationMember ctva:A2021RestructuringActionsMember 2020-12-31 0001755672 ctva:A2021RestructuringActionsMember 2020-12-31 0001755672 us-gaap:EmployeeSeveranceMember ctva:A2021RestructuringActionsMember 2021-01-01 2021-12-31 0001755672 us-gaap:EmployeeSeveranceMember ctva:A2021RestructuringActionsMember 2021-12-31 0001755672 ctva:AssetRelatedChargesMember ctva:A2021RestructuringActionsMember 2021-12-31 0001755672 us-gaap:ContractTerminationMember ctva:A2021RestructuringActionsMember 2021-12-31 0001755672 ctva:A2021RestructuringActionsMember 2021-12-31 0001755672 ctva:ExecuteToWinProductivityProgramMember 2021-12-31 0001755672 ctva:AssetRelatedChargesMember ctva:ExecuteToWinProductivityProgramMember 2021-12-31 0001755672 us-gaap:EmployeeSeveranceMember ctva:ExecuteToWinProductivityProgramMember 2021-12-31 0001755672 ctva:ExecuteToWinProductivityProgramMember 2021-01-01 2021-12-31 0001755672 ctva:ExecuteToWinProductivityProgramMember ctva:SeedMember 2021-01-01 2021-12-31 0001755672 ctva:ExecuteToWinProductivityProgramMember ctva:SeedMember 2020-01-01 2020-12-31 0001755672 ctva:ExecuteToWinProductivityProgramMember ctva:CropProtectionMember 2021-01-01 2021-12-31 0001755672 ctva:ExecuteToWinProductivityProgramMember ctva:CropProtectionMember 2020-01-01 2020-12-31 0001755672 ctva:ExecuteToWinProductivityProgramMember us-gaap:CorporateNonSegmentMember 2021-01-01 2021-12-31 0001755672 ctva:ExecuteToWinProductivityProgramMember us-gaap:CorporateNonSegmentMember 2020-01-01 2020-12-31 0001755672 ctva:ExecuteToWinProductivityProgramMember 2020-01-01 2020-12-31 0001755672 us-gaap:EmployeeSeveranceMember ctva:ExecuteToWinProductivityProgramMember 2021-01-01 2021-12-31 0001755672 us-gaap:EmployeeSeveranceMember ctva:ExecuteToWinProductivityProgramMember 2020-01-01 2020-12-31 0001755672 ctva:AssetRelatedChargesMember ctva:ExecuteToWinProductivityProgramMember 2021-01-01 2021-12-31 0001755672 ctva:AssetRelatedChargesMember ctva:ExecuteToWinProductivityProgramMember 2020-01-01 2020-12-31 0001755672 ctva:AssetRelatedChargesMember 2020-01-01 2020-12-31 0001755672 us-gaap:EmployeeSeveranceMember ctva:ExecuteToWinProductivityProgramMember 2020-12-31 0001755672 ctva:AssetRelatedChargesMember ctva:ExecuteToWinProductivityProgramMember 2020-12-31 0001755672 ctva:ExecuteToWinProductivityProgramMember 2020-12-31 0001755672 ctva:DowDuPontCostSynergyProgramMember 2021-12-31 0001755672 us-gaap:EmployeeSeveranceMember ctva:DowDuPontCostSynergyProgramMember 2021-12-31 0001755672 ctva:CostsRelatedToContractTerminationMember ctva:DowDuPontCostSynergyProgramMember 2021-12-31 0001755672 ctva:AssetRelatedChargesMember ctva:DowDuPontCostSynergyProgramMember 2021-12-31 0001755672 ctva:DowDuPontCostSynergyProgramMember 2021-01-01 2021-12-31 0001755672 ctva:DowDuPontCostSynergyProgramMember ctva:SeedMember 2021-01-01 2021-12-31 0001755672 ctva:DowDuPontCostSynergyProgramMember ctva:SeedMember 2020-01-01 2020-12-31 0001755672 ctva:DowDuPontCostSynergyProgramMember ctva:SeedMember 2019-01-01 2019-12-31 0001755672 ctva:DowDuPontCostSynergyProgramMember ctva:CropProtectionMember 2021-01-01 2021-12-31 0001755672 ctva:DowDuPontCostSynergyProgramMember ctva:CropProtectionMember 2020-01-01 2020-12-31 0001755672 ctva:DowDuPontCostSynergyProgramMember ctva:CropProtectionMember 2019-01-01 2019-12-31 0001755672 ctva:DowDuPontCostSynergyProgramMember us-gaap:CorporateMember 2021-01-01 2021-12-31 0001755672 ctva:DowDuPontCostSynergyProgramMember us-gaap:CorporateMember 2020-01-01 2020-12-31 0001755672 ctva:DowDuPontCostSynergyProgramMember us-gaap:CorporateMember 2019-01-01 2019-12-31 0001755672 ctva:DowDuPontCostSynergyProgramMember 2020-01-01 2020-12-31 0001755672 ctva:DowDuPontCostSynergyProgramMember 2019-01-01 2019-12-31 0001755672 us-gaap:EmployeeSeveranceMember ctva:DowDuPontCostSynergyProgramMember 2021-01-01 2021-12-31 0001755672 us-gaap:EmployeeSeveranceMember ctva:DowDuPontCostSynergyProgramMember 2020-01-01 2020-12-31 0001755672 us-gaap:EmployeeSeveranceMember ctva:DowDuPontCostSynergyProgramMember 2019-01-01 2019-12-31 0001755672 ctva:CostsRelatedToContractTerminationMember ctva:DowDuPontCostSynergyProgramMember 2021-01-01 2021-12-31 0001755672 ctva:CostsRelatedToContractTerminationMember ctva:DowDuPontCostSynergyProgramMember 2020-01-01 2020-12-31 0001755672 ctva:CostsRelatedToContractTerminationMember ctva:DowDuPontCostSynergyProgramMember 2019-01-01 2019-12-31 0001755672 ctva:AssetRelatedChargesMember ctva:DowDuPontCostSynergyProgramMember 2021-01-01 2021-12-31 0001755672 ctva:AssetRelatedChargesMember ctva:DowDuPontCostSynergyProgramMember 2020-01-01 2020-12-31 0001755672 ctva:AssetRelatedChargesMember ctva:DowDuPontCostSynergyProgramMember 2019-01-01 2019-12-31 0001755672 ctva:OtherAssetRelatedMember 2021-01-01 2021-12-31 0001755672 ctva:OtherAssetRelatedMember 2020-01-01 2020-12-31 0001755672 us-gaap:InProcessResearchAndDevelopmentMember 2019-01-01 2019-12-31 0001755672 us-gaap:MaterialReconcilingItemsMember ctva:CropProtectionMember ctva:LaPorteMember 2021-01-01 2021-12-31 0001755672 us-gaap:MaterialReconcilingItemsMember ctva:CropProtectionMember ctva:APACBusinessMember 2021-01-01 2021-12-31 0001755672 ctva:HedgingProgramMember ctva:ArgentinepesodevaluationMember 2021-01-01 2021-12-31 0001755672 ctva:HedgingProgramMember ctva:ArgentinepesodevaluationMember 2020-01-01 2020-12-31 0001755672 ctva:HedgingProgramMember ctva:ArgentinepesodevaluationMember 2019-01-01 2019-12-31 0001755672 us-gaap:MaterialReconcilingItemsMember 2021-01-01 2021-12-31 0001755672 us-gaap:MaterialReconcilingItemsMember ctva:SeedMember 2021-01-01 2021-12-31 0001755672 srt:SubsidiariesMember 2021-01-01 2021-12-31 0001755672 srt:SubsidiariesMember 2020-01-01 2020-12-31 0001755672 srt:SubsidiariesMember 2019-01-01 2019-12-31 0001755672 ctva:HedgingProgramMember 2021-01-01 2021-12-31 0001755672 ctva:HedgingProgramMember 2020-01-01 2020-12-31 0001755672 ctva:HedgingProgramMember 2019-01-01 2019-12-31 0001755672 us-gaap:SegmentContinuingOperationsMember 2021-01-01 2021-12-31 0001755672 us-gaap:SegmentContinuingOperationsMember 2020-01-01 2020-12-31 0001755672 us-gaap:SegmentContinuingOperationsMember 2019-01-01 2019-12-31 0001755672 us-gaap:SegmentContinuingOperationsMember ctva:ChangeInAccountingMethodMember 2020-01-01 2020-12-31 0001755672 us-gaap:SegmentContinuingOperationsMember ctva:SwissTaxReformMember 2020-01-01 2020-12-31 0001755672 us-gaap:SegmentContinuingOperationsMember ctva:SwissTaxReformMember 2019-01-01 2019-12-31 0001755672 ctva:ExpiringwithinFiveYearsMember 2021-12-31 0001755672 ctva:ExpiringwithinFiveYearsMember 2020-12-31 0001755672 ctva:ExpiringAfterFiveYearsOrHavingIndefiniteExpirationMember 2021-12-31 0001755672 ctva:ExpiringAfterFiveYearsOrHavingIndefiniteExpirationMember 2020-12-31 0001755672 ctva:CortevaMember 2019-06-01 0001755672 ctva:RoundedAmountMember ctva:CortevaMember 2019-06-01 0001755672 ctva:FactoringAgreementMember 2021-01-01 2021-12-31 0001755672 ctva:FactoringAgreementMember 2020-01-01 2020-12-31 0001755672 ctva:FactoringAgreementMember 2019-01-01 2019-12-31 0001755672 ctva:FactoringAgreementMember 2021-12-31 0001755672 ctva:FactoringAgreementMember 2020-12-31 0001755672 ctva:MergerwithDowMember 2017-09-01 0001755672 ctva:MergerwithDowMember 2019-01-01 2019-12-31 0001755672 us-gaap:LandAndLandImprovementsMember 2021-12-31 0001755672 us-gaap:LandAndLandImprovementsMember 2020-12-31 0001755672 us-gaap:BuildingMember 2021-12-31 0001755672 us-gaap:BuildingMember 2020-12-31 0001755672 us-gaap:MachineryAndEquipmentMember 2021-12-31 0001755672 us-gaap:MachineryAndEquipmentMember 2020-12-31 0001755672 us-gaap:ConstructionInProgressMember 2021-12-31 0001755672 us-gaap:ConstructionInProgressMember 2020-12-31 0001755672 srt:MinimumMember us-gaap:BuildingMember 2021-01-01 2021-12-31 0001755672 srt:MaximumMember us-gaap:BuildingMember 2021-01-01 2021-12-31 0001755672 srt:MinimumMember us-gaap:ComputerSoftwareIntangibleAssetMember 2021-01-01 2021-12-31 0001755672 srt:MaximumMember us-gaap:ComputerSoftwareIntangibleAssetMember 2021-01-01 2021-12-31 0001755672 srt:MinimumMember us-gaap:MachineryAndEquipmentMember 2021-01-01 2021-12-31 0001755672 srt:MaximumMember us-gaap:MachineryAndEquipmentMember 2021-01-01 2021-12-31 0001755672 srt:MinimumMember us-gaap:LandImprovementsMember 2021-01-01 2021-12-31 0001755672 srt:MaximumMember us-gaap:LandImprovementsMember 2021-01-01 2021-12-31 0001755672 ctva:CropProtectionMember 2019-12-31 0001755672 ctva:SeedMember 2019-12-31 0001755672 ctva:CropProtectionMember 2020-12-31 0001755672 ctva:SeedMember 2020-12-31 0001755672 ctva:CropProtectionMember 2021-12-31 0001755672 ctva:SeedMember 2021-12-31 0001755672 ctva:GermplasmMember 2021-12-31 0001755672 ctva:GermplasmMember 2020-12-31 0001755672 us-gaap:CustomerRelatedIntangibleAssetsMember 2021-12-31 0001755672 us-gaap:CustomerRelatedIntangibleAssetsMember 2020-12-31 0001755672 ctva:DevelopedTechnologyMember 2021-12-31 0001755672 ctva:DevelopedTechnologyMember 2020-12-31 0001755672 us-gaap:TrademarksAndTradeNamesMember 2021-12-31 0001755672 us-gaap:TrademarksAndTradeNamesMember 2020-12-31 0001755672 ctva:FavorableSupplyContractMember 2021-12-31 0001755672 ctva:FavorableSupplyContractMember 2020-12-31 0001755672 us-gaap:OtherIntangibleAssetsMember 2021-12-31 0001755672 us-gaap:OtherIntangibleAssetsMember 2020-12-31 0001755672 us-gaap:InProcessResearchAndDevelopmentMember 2021-12-31 0001755672 us-gaap:InProcessResearchAndDevelopmentMember 2020-12-31 0001755672 us-gaap:InProcessResearchAndDevelopmentMember 2019-07-01 2019-09-30 0001755672 us-gaap:InProcessResearchAndDevelopmentMember 2019-10-01 2019-12-31 0001755672 us-gaap:SegmentContinuingOperationsMember 2021-12-31 0001755672 ctva:ResidualValueGuaranteeMember 2021-12-31 0001755672 us-gaap:PropertyPlantAndEquipmentMember 2021-12-31 0001755672 us-gaap:PropertyPlantAndEquipmentMember 2020-12-31 0001755672 us-gaap:ShortTermDebtMember 2021-12-31 0001755672 us-gaap:ShortTermDebtMember 2020-12-31 0001755672 us-gaap:LongTermDebtMember 2021-12-31 0001755672 us-gaap:LongTermDebtMember 2020-12-31 0001755672 ctva:NotesMaturing2025Domain us-gaap:LoansPayableMember 2021-12-31 0001755672 ctva:NotesMaturing2025Domain us-gaap:LoansPayableMember 2020-12-31 0001755672 ctva:NotesMaturing2030Domain us-gaap:LoansPayableMember 2021-12-31 0001755672 ctva:NotesMaturing2030Domain us-gaap:LoansPayableMember 2020-12-31 0001755672 ctva:ForeignCurrencyLoansMember us-gaap:LoansPayableMember 2021-12-31 0001755672 ctva:ForeignCurrencyLoansMember us-gaap:LoansPayableMember 2020-12-31 0001755672 us-gaap:MediumTermNotesMember 2021-12-31 0001755672 us-gaap:MediumTermNotesMember 2020-12-31 0001755672 ctva:NotesMaturing2025Domain 2021-01-01 2021-12-31 0001755672 us-gaap:FairValueInputsLevel2Member 2021-12-31 0001755672 us-gaap:FairValueInputsLevel2Member 2020-12-31 0001755672 ctva:SeniorNotesDue2025Member 2020-05-31 0001755672 ctva:SeniorNotesDue2030Member 2020-05-31 0001755672 ctva:RevolvingCreditFacilitiesdue2024Member 2021-12-31 0001755672 ctva:RevolvingCreditFacilitiesdue2022Member 2021-12-31 0001755672 ctva:RevolvingCreditFacilitiesdue2024Member 2018-11-13 0001755672 ctva:RevolvingCreditFacilitiesdue2024Member 2018-11-13 2023-11-13 0001755672 ctva:RevolvingCreditFacilitiesdue2022Member 2018-11-13 0001755672 ctva:RevolvingCreditFacilitiesdue2022Member 2018-11-13 2021-11-13 0001755672 ctva:RevolvingCreditFacilitiesdue2022Member 2018-11-13 0001755672 ctva:RevolvingCreditFacilitiesdue2022Member 2021-03-31 0001755672 ctva:A4.625Notesdue2020Member 2019-03-22 0001755672 ctva:A3.625Notesdue2021Member 2019-03-22 0001755672 ctva:A4.250Notesdue2021Member 2019-03-22 0001755672 ctva:A2.800Notesdue2023Member 2019-03-22 0001755672 ctva:A6.500Debenturesdue2028Member 2019-03-22 0001755672 ctva:A5.600SeniorNotesdue2036Member 2019-03-22 0001755672 ctva:A4.900Notesdue2041Member 2019-03-22 0001755672 ctva:A4.150Notesdue2043Member 2019-03-22 0001755672 2019-03-22 0001755672 ctva:TermLoanFacilitydue2020Member 2016-03-01 2019-03-31 0001755672 ctva:TermLoanFacilitydue2020Member ctva:EIDMember 2016-03-22 0001755672 2019-05-02 0001755672 2019-05-02 2019-05-02 0001755672 ctva:SeniorNote2.20PercentDue2020Member 2019-05-17 0001755672 ctva:SeniorNoteFloatingRateDue2020Member 2019-05-17 0001755672 ctva:SMRnotesMember 2019-05-17 0001755672 ctva:FactoringAgreementMember 2021-12-31 0001755672 ctva:FactoringAgreementMember 2020-12-31 0001755672 ctva:AgreementsWithLendersToProvideFinancingForSelectCustomersMember 2021-12-31 0001755672 ctva:AgreementsWithLendersToProvideFinancingForSelectCustomersMember 2020-12-31 0001755672 ctva:PFOAMattersMultiDistrictLitigationMember 2018-12-31 0001755672 ctva:PFASMember srt:MaximumMember 2021-01-01 2021-12-31 0001755672 ctva:PFASMember srt:MaximumMember 2021-12-31 0001755672 ctva:DuPontdeNemoursMember ctva:PFASMember ctva:CortevaMember 2021-12-31 0001755672 ctva:DuPontdeNemoursMember ctva:PFASMember srt:MaximumMember ctva:CortevaMember 2021-12-31 0001755672 ctva:DuPontdeNemoursMember 2021-12-31 0001755672 ctva:DuPontdeNemoursMember 2021-12-31 0001755672 ctva:CortevaMember 2021-12-31 0001755672 ctva:PFASMember ctva:ChemoursMember 2023-09-30 0001755672 ctva:DuPontdeNemoursMember ctva:PFASMember ctva:CortevaMember 2023-09-30 0001755672 ctva:PFASMember ctva:ChemoursMember 2029-09-30 0001755672 ctva:DuPontdeNemoursMember ctva:PFASMember ctva:CortevaMember 2029-09-30 0001755672 ctva:PFASMember srt:MaximumMember ctva:ChemoursMember 2029-09-30 0001755672 ctva:DuPontdeNemoursMember ctva:PFASMember srt:MaximumMember ctva:CortevaMember 2029-09-30 0001755672 ctva:PFASMember 2028-12-31 0001755672 ctva:PFASMember ctva:ChemoursMember 2021-12-31 0001755672 ctva:PFASMember 2021-12-31 0001755672 ctva:PerformanceChemicalsMember 2021-01-01 2021-12-31 0001755672 ctva:PerformanceChemicalsMember 2020-01-01 2020-12-31 0001755672 ctva:DuPontdeNemoursMember ctva:CortevaMember 2021-12-31 0001755672 ctva:DuPontdeNemoursMember ctva:DuPontdeNemoursMember 2021-12-31 0001755672 ctva:PFASMember ctva:CortevaMember 2021-12-31 0001755672 ctva:PFASMember ctva:DuPontdeNemoursMember 2021-12-31 0001755672 ctva:PFASMember srt:MinimumMember 2021-12-31 0001755672 ctva:PFASMember srt:MinimumMember ctva:Once300millionthresholdismetMember 2021-12-31 0001755672 ctva:PFOAMattersDrinkingWaterActionsMember 2004-01-01 2004-12-31 0001755672 ctva:PFOAMattersDrinkingWaterActionsMember 2012-01-01 0001755672 ctva:PFOAMattersDrinkingWaterActionsMember 2004-12-31 0001755672 ctva:PFOAMattersDrinkingWaterActionsMember 2012-01-01 2020-12-31 0001755672 ctva:PFOAMattersDrinkingWaterActionsMember 2021-12-31 0001755672 ctva:PFOAMattersMultiDistrictLitigationMember 2021-12-31 0001755672 ctva:PFOAMattersMultiDistrictLitigationMember 2017-04-01 2017-06-30 0001755672 ctva:CompensatoryDamagesMember ctva:PostMDLSettlementPFOAPersonalInjuryClaimsDomain ctva:PFOAMattersDrinkingWaterActionsMember 2021-01-01 2021-12-31 0001755672 ctva:LossOfConsortiumMember ctva:PostMDLSettlementPFOAPersonalInjuryClaimsDomain ctva:PFOAMattersDrinkingWaterActionsMember 2021-01-01 2021-12-31 0001755672 ctva:PostMDLSettlementPFOAPersonalInjuryClaimsDomain us-gaap:SettledLitigationMember ctva:PFOAMattersDrinkingWaterActionsMember 2021-12-31 0001755672 ctva:MDLSettlementMember 2021-01-01 2021-12-31 0001755672 ctva:ChemoursContributionToMDLSettlementMember 2021-01-01 2021-12-31 0001755672 ctva:DuPontDeNemoursAndCortevaContributionToMDLSettlementMember 2021-01-01 2021-12-31 0001755672 stpr:NY ctva:PFOAMattersDrinkingWaterActionsMember 2021-12-31 0001755672 stpr:NJ ctva:PFOAMattersDrinkingWaterActionsMember 2021-12-31 0001755672 stpr:NJ ctva:NaturalResourcesDamagesMember 2021-12-31 0001755672 stpr:OH ctva:PFOAMattersDrinkingWaterActionsMember 2021-12-31 0001755672 ctva:DuPontdeNemoursMember ctva:NaturalResourcesDamagesMember stpr:DE ctva:CortevaMember 2021-12-31 0001755672 ctva:NaturalResourcesDamagesMember stpr:DE ctva:ChemoursMember 2021-12-31 0001755672 ctva:NaturalResourcesDamagesMember stpr:DE ctva:CortevaMember 2021-12-31 0001755672 ctva:SettlementAgreementMember 2021-01-01 2021-12-31 0001755672 ctva:FirefightingFoamMember 2021-12-31 0001755672 ctva:PersonalinjurycasesMember ctva:FirefightingFoamMember 2021-12-31 0001755672 stpr:NC ctva:PFOAMattersDrinkingWaterActionsMember 2021-01-01 2021-12-31 0001755672 ctva:ChemoursrelatedobligationsubjecttoindemnificationMember 2021-12-31 0001755672 us-gaap:SegmentDiscontinuedOperationsMember 2021-12-31 0001755672 ctva:OtherDiscontinuedOrDivestedBusinessObligationsMember 2021-12-31 0001755672 ctva:EnvironmentalremediationliabilitiesprimarilyrelatedtoDuPontsubjecttoindemnityfromDuPontMember 2021-12-31 0001755672 ctva:NotsubjecttoindemnificationMember 2021-12-31 0001755672 ctva:ChemoursMember ctva:SuperfundSitesMember us-gaap:IndemnificationGuaranteeMember 2021-12-31 0001755672 ctva:NonPFASMember 2022-01-28 0001755672 ctva:CortevaMember 2019-06-01 0001755672 2019-06-01 0001755672 2019-06-26 0001755672 ctva:CortevaMember 2021-01-01 2021-12-31 0001755672 ctva:CortevaMember 2020-01-01 2020-12-31 0001755672 ctva:A2019ShareRepurchasePlanMember 2021-01-01 2021-12-31 0001755672 ctva:A2019ShareRepurchasePlanMember 2020-01-01 2020-12-31 0001755672 ctva:A4.50SeriesPreferredStockMember ctva:EIDMember 2021-12-31 0001755672 ctva:A3.50SeriesPreferredStockMember ctva:EIDMember 2021-12-31 0001755672 us-gaap:AccumulatedTranslationAdjustmentMember 2018-12-31 0001755672 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2018-12-31 0001755672 us-gaap:PensionPlansDefinedBenefitMember 2018-12-31 0001755672 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2018-12-31 0001755672 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2018-12-31 0001755672 us-gaap:AccumulatedTranslationAdjustmentMember 2019-01-01 2019-12-31 0001755672 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2019-01-01 2019-12-31 0001755672 us-gaap:PensionPlansDefinedBenefitMember 2019-01-01 2019-12-31 0001755672 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2019-01-01 2019-12-31 0001755672 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2019-01-01 2019-12-31 0001755672 ctva:InternalReorganizationMember us-gaap:AccumulatedTranslationAdjustmentMember 2019-01-01 2019-12-31 0001755672 ctva:InternalReorganizationMember us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2019-01-01 2019-12-31 0001755672 ctva:InternalReorganizationMember us-gaap:PensionPlansDefinedBenefitMember 2019-01-01 2019-12-31 0001755672 ctva:InternalReorganizationMember us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2019-01-01 2019-12-31 0001755672 ctva:InternalReorganizationMember us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2019-01-01 2019-12-31 0001755672 ctva:InternalReorganizationMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-01-01 2019-12-31 0001755672 us-gaap:AccumulatedTranslationAdjustmentMember 2019-12-31 0001755672 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2019-12-31 0001755672 us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0001755672 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2019-12-31 0001755672 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2019-12-31 0001755672 us-gaap:AccumulatedTranslationAdjustmentMember 2020-01-01 2020-12-31 0001755672 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2020-01-01 2020-12-31 0001755672 us-gaap:PensionPlansDefinedBenefitMember 2020-01-01 2020-12-31 0001755672 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2020-01-01 2020-12-31 0001755672 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2020-01-01 2020-12-31 0001755672 us-gaap:AccumulatedTranslationAdjustmentMember 2020-12-31 0001755672 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2020-12-31 0001755672 us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0001755672 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2020-12-31 0001755672 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2020-12-31 0001755672 us-gaap:AccumulatedTranslationAdjustmentMember 2021-01-01 2021-12-31 0001755672 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2021-01-01 2021-12-31 0001755672 us-gaap:PensionPlansDefinedBenefitMember 2021-01-01 2021-12-31 0001755672 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2021-01-01 2021-12-31 0001755672 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2021-01-01 2021-12-31 0001755672 us-gaap:AccumulatedTranslationAdjustmentMember 2021-12-31 0001755672 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2021-12-31 0001755672 us-gaap:PensionPlansDefinedBenefitMember 2021-12-31 0001755672 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2021-12-31 0001755672 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2021-12-31 0001755672 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember us-gaap:PensionPlansDefinedBenefitMember 2021-01-01 2021-12-31 0001755672 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember us-gaap:PensionPlansDefinedBenefitMember 2020-01-01 2020-12-31 0001755672 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember us-gaap:PensionPlansDefinedBenefitMember 2019-01-01 2019-12-31 0001755672 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember us-gaap:PensionPlansDefinedBenefitMember 2021-01-01 2021-12-31 0001755672 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember us-gaap:PensionPlansDefinedBenefitMember 2020-01-01 2020-12-31 0001755672 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember us-gaap:PensionPlansDefinedBenefitMember 2019-01-01 2019-12-31 0001755672 ctva:AccumulatedDefinedBenefitPlansAdjustmentSettlementGainLossMember us-gaap:PensionPlansDefinedBenefitMember 2021-01-01 2021-12-31 0001755672 ctva:AccumulatedDefinedBenefitPlansAdjustmentSettlementGainLossMember us-gaap:PensionPlansDefinedBenefitMember 2020-01-01 2020-12-31 0001755672 ctva:AccumulatedDefinedBenefitPlansAdjustmentSettlementGainLossMember us-gaap:PensionPlansDefinedBenefitMember 2019-01-01 2019-12-31 0001755672 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember us-gaap:PensionPlansDefinedBenefitMember 2021-01-01 2021-12-31 0001755672 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember us-gaap:PensionPlansDefinedBenefitMember 2020-01-01 2020-12-31 0001755672 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember us-gaap:PensionPlansDefinedBenefitMember 2019-01-01 2019-12-31 0001755672 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2021-01-01 2021-12-31 0001755672 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2020-01-01 2020-12-31 0001755672 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2019-01-01 2019-12-31 0001755672 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2021-01-01 2021-12-31 0001755672 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2020-01-01 2020-12-31 0001755672 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2019-01-01 2019-12-31 0001755672 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2021-01-01 2021-12-31 0001755672 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2020-01-01 2020-12-31 0001755672 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2019-01-01 2019-12-31 0001755672 us-gaap:GainLossOnInvestmentsMember1 2021-01-01 2021-12-31 0001755672 us-gaap:GainLossOnInvestmentsMember1 2020-01-01 2020-12-31 0001755672 us-gaap:GainLossOnInvestmentsMember1 2017-09-01 2017-12-31 0001755672 ctva:A4.50SeriesPreferredStockMember ctva:EIDMember 2020-12-31 0001755672 ctva:A3.50SeriesPreferredStockMember ctva:EIDMember 2020-12-31 0001755672 us-gaap:OtherPensionPlansDefinedBenefitMember 2021-01-01 2021-12-31 0001755672 us-gaap:OtherPensionPlansDefinedBenefitMember 2020-01-01 2020-12-31 0001755672 us-gaap:OtherPensionPlansDefinedBenefitMember 2019-01-01 2019-12-31 0001755672 us-gaap:OtherPensionPlansDefinedBenefitMember 2022-12-31 0001755672 us-gaap:PensionPlansDefinedBenefitMember 2021-12-31 0001755672 us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0001755672 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2022-12-31 0001755672 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2021-12-31 0001755672 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2020-12-31 0001755672 us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0001755672 us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0001755672 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2019-12-31 0001755672 us-gaap:PensionPlansDefinedBenefitMember 2021-12-31 0001755672 ctva:U.S.PlanswithPlanAssetsMember us-gaap:PensionPlansDefinedBenefitMember 2021-12-31 0001755672 ctva:U.S.PlanswithPlanAssetsMember us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0001755672 ctva:U.S.PlanswithPlanAssetsMember us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2021-12-31 0001755672 ctva:U.S.PlanswithPlanAssetsMember us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2020-12-31 0001755672 ctva:NonU.S.planswithplanassetsMember us-gaap:PensionPlansDefinedBenefitMember 2021-12-31 0001755672 ctva:NonU.S.planswithplanassetsMember us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0001755672 ctva:NonU.S.planswithplanassetsMember us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2021-12-31 0001755672 ctva:NonU.S.planswithplanassetsMember us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2020-12-31 0001755672 ctva:AllotherplansMember us-gaap:PensionPlansDefinedBenefitMember 2021-12-31 0001755672 ctva:AllotherplansMember us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0001755672 ctva:AllotherplansMember us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2021-12-31 0001755672 ctva:AllotherplansMember us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2020-12-31 0001755672 ctva:TrustAgreementMember 2021-12-31 0001755672 ctva:TrustAgreementMember 2020-12-31 0001755672 us-gaap:OtherAssetsMember us-gaap:PensionPlansDefinedBenefitMember 2021-12-31 0001755672 us-gaap:OtherAssetsMember us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0001755672 us-gaap:OtherAssetsMember us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2021-12-31 0001755672 us-gaap:OtherAssetsMember us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2020-12-31 0001755672 ctva:AccruedandOtherCurrentLiabilitiesMember us-gaap:PensionPlansDefinedBenefitMember 2021-12-31 0001755672 ctva:AccruedandOtherCurrentLiabilitiesMember us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0001755672 ctva:AccruedandOtherCurrentLiabilitiesMember us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2021-12-31 0001755672 ctva:AccruedandOtherCurrentLiabilitiesMember us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2020-12-31 0001755672 ctva:PensionandotherpostemploymentbenefitsnoncurrentMember us-gaap:PensionPlansDefinedBenefitMember 2021-12-31 0001755672 ctva:PensionandotherpostemploymentbenefitsnoncurrentMember us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0001755672 ctva:PensionandotherpostemploymentbenefitsnoncurrentMember us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2021-12-31 0001755672 ctva:PensionandotherpostemploymentbenefitsnoncurrentMember us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2020-12-31 0001755672 us-gaap:PensionPlansDefinedBenefitMember us-gaap:SegmentDiscontinuedOperationsMember 2021-01-01 2021-12-31 0001755672 us-gaap:PensionPlansDefinedBenefitMember us-gaap:SegmentDiscontinuedOperationsMember 2020-01-01 2020-12-31 0001755672 us-gaap:PensionPlansDefinedBenefitMember us-gaap:SegmentDiscontinuedOperationsMember 2019-01-01 2019-12-31 0001755672 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember us-gaap:SegmentDiscontinuedOperationsMember 2021-01-01 2021-12-31 0001755672 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember us-gaap:SegmentDiscontinuedOperationsMember 2020-01-01 2020-12-31 0001755672 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember us-gaap:SegmentDiscontinuedOperationsMember 2019-01-01 2019-12-31 0001755672 us-gaap:PensionPlansDefinedBenefitMember us-gaap:SegmentContinuingOperationsMember 2021-01-01 2021-12-31 0001755672 us-gaap:PensionPlansDefinedBenefitMember us-gaap:SegmentContinuingOperationsMember 2020-01-01 2020-12-31 0001755672 us-gaap:PensionPlansDefinedBenefitMember us-gaap:SegmentContinuingOperationsMember 2019-01-01 2019-12-31 0001755672 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember us-gaap:SegmentContinuingOperationsMember 2021-01-01 2021-12-31 0001755672 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember us-gaap:SegmentContinuingOperationsMember 2020-01-01 2020-12-31 0001755672 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember us-gaap:SegmentContinuingOperationsMember 2019-01-01 2019-12-31 0001755672 us-gaap:EquitySecuritiesMember country:US 2021-12-31 0001755672 us-gaap:EquitySecuritiesMember country:US 2020-12-31 0001755672 us-gaap:EquitySecuritiesMember us-gaap:NonUsMember 2021-12-31 0001755672 us-gaap:EquitySecuritiesMember us-gaap:NonUsMember 2020-12-31 0001755672 us-gaap:FixedIncomeSecuritiesMember 2021-12-31 0001755672 us-gaap:FixedIncomeSecuritiesMember 2020-12-31 0001755672 us-gaap:HedgeFundsMember 2021-12-31 0001755672 us-gaap:HedgeFundsMember 2020-12-31 0001755672 us-gaap:PrivateEquityFundsMember 2021-12-31 0001755672 us-gaap:PrivateEquityFundsMember 2020-12-31 0001755672 us-gaap:RealEstateMember 2021-12-31 0001755672 us-gaap:RealEstateMember 2020-12-31 0001755672 us-gaap:CashAndCashEquivalentsMember 2021-12-31 0001755672 us-gaap:CashAndCashEquivalentsMember 2020-12-31 0001755672 us-gaap:RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember us-gaap:PensionPlansDefinedBenefitMember 2021-12-31 0001755672 us-gaap:RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember us-gaap:FairValueInputsLevel1Member us-gaap:PensionPlansDefinedBenefitMember 2021-12-31 0001755672 us-gaap:RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember us-gaap:FairValueInputsLevel2Member us-gaap:PensionPlansDefinedBenefitMember 2021-12-31 0001755672 us-gaap:RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2021-12-31 0001755672 us-gaap:EquitySecuritiesMember country:US us-gaap:PensionPlansDefinedBenefitMember 2021-12-31 0001755672 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel1Member country:US us-gaap:PensionPlansDefinedBenefitMember 2021-12-31 0001755672 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel2Member country:US us-gaap:PensionPlansDefinedBenefitMember 2021-12-31 0001755672 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel3Member country:US us-gaap:PensionPlansDefinedBenefitMember 2021-12-31 0001755672 us-gaap:EquitySecuritiesMember us-gaap:NonUsMember us-gaap:PensionPlansDefinedBenefitMember 2021-12-31 0001755672 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel1Member us-gaap:NonUsMember us-gaap:PensionPlansDefinedBenefitMember 2021-12-31 0001755672 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel2Member us-gaap:NonUsMember us-gaap:PensionPlansDefinedBenefitMember 2021-12-31 0001755672 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel3Member us-gaap:NonUsMember us-gaap:PensionPlansDefinedBenefitMember 2021-12-31 0001755672 us-gaap:USTreasuryAndGovernmentMember us-gaap:PensionPlansDefinedBenefitMember 2021-12-31 0001755672 us-gaap:USTreasuryAndGovernmentMember us-gaap:FairValueInputsLevel1Member us-gaap:PensionPlansDefinedBenefitMember 2021-12-31 0001755672 us-gaap:USTreasuryAndGovernmentMember us-gaap:FairValueInputsLevel2Member us-gaap:PensionPlansDefinedBenefitMember 2021-12-31 0001755672 us-gaap:USTreasuryAndGovernmentMember us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2021-12-31 0001755672 us-gaap:CorporateDebtSecuritiesMember us-gaap:PensionPlansDefinedBenefitMember 2021-12-31 0001755672 us-gaap:CorporateDebtSecuritiesMember us-gaap:FairValueInputsLevel1Member us-gaap:PensionPlansDefinedBenefitMember 2021-12-31 0001755672 us-gaap:CorporateDebtSecuritiesMember us-gaap:FairValueInputsLevel2Member us-gaap:PensionPlansDefinedBenefitMember 2021-12-31 0001755672 us-gaap:CorporateDebtSecuritiesMember us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2021-12-31 0001755672 us-gaap:AssetBackedSecuritiesMember us-gaap:PensionPlansDefinedBenefitMember 2021-12-31 0001755672 us-gaap:AssetBackedSecuritiesMember us-gaap:FairValueInputsLevel1Member us-gaap:PensionPlansDefinedBenefitMember 2021-12-31 0001755672 us-gaap:AssetBackedSecuritiesMember us-gaap:FairValueInputsLevel2Member us-gaap:PensionPlansDefinedBenefitMember 2021-12-31 0001755672 us-gaap:AssetBackedSecuritiesMember us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2021-12-31 0001755672 us-gaap:PrivateEquityFundsMember us-gaap:PensionPlansDefinedBenefitMember 2021-12-31 0001755672 us-gaap:PrivateEquityFundsMember us-gaap:FairValueInputsLevel1Member us-gaap:PensionPlansDefinedBenefitMember 2021-12-31 0001755672 us-gaap:PrivateEquityFundsMember us-gaap:FairValueInputsLevel2Member us-gaap:PensionPlansDefinedBenefitMember 2021-12-31 0001755672 us-gaap:PrivateEquityFundsMember us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2021-12-31 0001755672 us-gaap:RealEstateMember us-gaap:PensionPlansDefinedBenefitMember 2021-12-31 0001755672 us-gaap:RealEstateMember us-gaap:FairValueInputsLevel1Member us-gaap:PensionPlansDefinedBenefitMember 2021-12-31 0001755672 us-gaap:RealEstateMember us-gaap:FairValueInputsLevel2Member us-gaap:PensionPlansDefinedBenefitMember 2021-12-31 0001755672 us-gaap:RealEstateMember us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2021-12-31 0001755672 us-gaap:OtherInvestmentsMember us-gaap:PensionPlansDefinedBenefitMember 2021-12-31 0001755672 us-gaap:OtherInvestmentsMember us-gaap:FairValueInputsLevel1Member us-gaap:PensionPlansDefinedBenefitMember 2021-12-31 0001755672 us-gaap:OtherInvestmentsMember us-gaap:FairValueInputsLevel2Member us-gaap:PensionPlansDefinedBenefitMember 2021-12-31 0001755672 us-gaap:OtherInvestmentsMember us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2021-12-31 0001755672 us-gaap:FairValueInputsLevel1Member us-gaap:PensionPlansDefinedBenefitMember 2021-12-31 0001755672 us-gaap:FairValueInputsLevel2Member us-gaap:PensionPlansDefinedBenefitMember 2021-12-31 0001755672 us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2021-12-31 0001755672 us-gaap:HedgeFundsMember us-gaap:PensionPlansDefinedBenefitMember 2021-12-31 0001755672 us-gaap:PensionPlansDefinedBenefitMember us-gaap:CommonStockMember 2021-12-31 0001755672 us-gaap:CommonStockMember 2021-12-31 0001755672 us-gaap:RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0001755672 us-gaap:RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember us-gaap:FairValueInputsLevel1Member us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0001755672 us-gaap:RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember us-gaap:FairValueInputsLevel2Member us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0001755672 us-gaap:RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0001755672 us-gaap:EquitySecuritiesMember country:US us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0001755672 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel1Member country:US us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0001755672 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel2Member country:US us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0001755672 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel3Member country:US us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0001755672 us-gaap:EquitySecuritiesMember us-gaap:NonUsMember us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0001755672 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel1Member us-gaap:NonUsMember us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0001755672 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel2Member us-gaap:NonUsMember us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0001755672 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel3Member us-gaap:NonUsMember us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0001755672 us-gaap:USTreasuryAndGovernmentMember us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0001755672 us-gaap:USTreasuryAndGovernmentMember us-gaap:FairValueInputsLevel1Member us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0001755672 us-gaap:USTreasuryAndGovernmentMember us-gaap:FairValueInputsLevel2Member us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0001755672 us-gaap:USTreasuryAndGovernmentMember us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0001755672 us-gaap:CorporateDebtSecuritiesMember us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0001755672 us-gaap:CorporateDebtSecuritiesMember us-gaap:FairValueInputsLevel1Member us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0001755672 us-gaap:CorporateDebtSecuritiesMember us-gaap:FairValueInputsLevel2Member us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0001755672 us-gaap:CorporateDebtSecuritiesMember us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0001755672 us-gaap:AssetBackedSecuritiesMember us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0001755672 us-gaap:AssetBackedSecuritiesMember us-gaap:FairValueInputsLevel1Member us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0001755672 us-gaap:AssetBackedSecuritiesMember us-gaap:FairValueInputsLevel2Member us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0001755672 us-gaap:AssetBackedSecuritiesMember us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0001755672 us-gaap:PrivateEquityFundsMember us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0001755672 us-gaap:PrivateEquityFundsMember us-gaap:FairValueInputsLevel1Member us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0001755672 us-gaap:PrivateEquityFundsMember us-gaap:FairValueInputsLevel2Member us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0001755672 us-gaap:PrivateEquityFundsMember us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0001755672 us-gaap:RealEstateMember us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0001755672 us-gaap:RealEstateMember us-gaap:FairValueInputsLevel1Member us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0001755672 us-gaap:RealEstateMember us-gaap:FairValueInputsLevel2Member us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0001755672 us-gaap:RealEstateMember us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0001755672 us-gaap:OtherInvestmentsMember us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0001755672 us-gaap:OtherInvestmentsMember us-gaap:FairValueInputsLevel1Member us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0001755672 us-gaap:OtherInvestmentsMember us-gaap:FairValueInputsLevel2Member us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0001755672 us-gaap:OtherInvestmentsMember us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0001755672 us-gaap:FairValueInputsLevel1Member us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0001755672 us-gaap:FairValueInputsLevel2Member us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0001755672 us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0001755672 us-gaap:HedgeFundsMember us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0001755672 us-gaap:PensionPlansDefinedBenefitMember us-gaap:CommonStockMember 2020-12-31 0001755672 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel3Member country:US us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0001755672 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel3Member us-gaap:NonUsMember us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0001755672 us-gaap:CorporateDebtSecuritiesMember us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0001755672 us-gaap:PrivateEquityFundsMember us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0001755672 us-gaap:RealEstateMember us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0001755672 us-gaap:OtherInvestmentsMember us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0001755672 us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0001755672 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel3Member country:US us-gaap:PensionPlansDefinedBenefitMember 2020-01-01 2020-12-31 0001755672 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel3Member us-gaap:NonUsMember us-gaap:PensionPlansDefinedBenefitMember 2020-01-01 2020-12-31 0001755672 us-gaap:CorporateDebtSecuritiesMember us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2020-01-01 2020-12-31 0001755672 us-gaap:PrivateEquityFundsMember us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2020-01-01 2020-12-31 0001755672 us-gaap:RealEstateMember us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2020-01-01 2020-12-31 0001755672 us-gaap:OtherInvestmentsMember us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2020-01-01 2020-12-31 0001755672 us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2020-01-01 2020-12-31 0001755672 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel3Member country:US us-gaap:PensionPlansDefinedBenefitMember 2021-01-01 2021-12-31 0001755672 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel3Member us-gaap:NonUsMember us-gaap:PensionPlansDefinedBenefitMember 2021-01-01 2021-12-31 0001755672 us-gaap:CorporateDebtSecuritiesMember us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2021-01-01 2021-12-31 0001755672 us-gaap:PrivateEquityFundsMember us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2021-01-01 2021-12-31 0001755672 us-gaap:RealEstateMember us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2021-01-01 2021-12-31 0001755672 us-gaap:OtherInvestmentsMember us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2021-01-01 2021-12-31 0001755672 us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2021-01-01 2021-12-31 0001755672 ctva:TrustAgreementMember us-gaap:NonqualifiedPlanMember 2017-11-01 2017-11-30 0001755672 ctva:TrustAgreementMember us-gaap:NonqualifiedPlanMember 2019-01-01 2019-06-01 0001755672 ctva:TrustAgreementMember us-gaap:NonqualifiedPlanMember 2021-01-01 2021-12-31 0001755672 ctva:TrustAgreementMember us-gaap:NonqualifiedPlanMember 2020-01-01 2020-12-31 0001755672 ctva:TrustAgreementMember us-gaap:NonqualifiedPlanMember 2021-12-31 0001755672 ctva:TrustAgreementMember us-gaap:NonqualifiedPlanMember 2020-12-31 0001755672 ctva:U.S.RetirementSavingsPlanMember 2021-01-01 2021-12-31 0001755672 ctva:U.S.RetirementSavingsPlanMember 2020-01-01 2020-12-31 0001755672 ctva:U.S.RetirementSavingsPlanMember 2019-01-01 2019-12-31 0001755672 ctva:CortevaOtherContributionPlansMember 2021-01-01 2021-12-31 0001755672 ctva:CortevaOtherContributionPlansMember 2020-01-01 2020-12-31 0001755672 ctva:CortevaOtherContributionPlansMember 2019-01-01 2019-12-31 0001755672 ctva:CortevaOtherContributionPlansMember us-gaap:SegmentDiscontinuedOperationsMember 2019-01-01 2019-12-31 0001755672 ctva:OIPMember 2021-12-31 0001755672 us-gaap:EmployeeStockOptionMember 2021-01-01 2021-12-31 0001755672 us-gaap:EmployeeStockOptionMember 2020-01-01 2020-12-31 0001755672 us-gaap:EmployeeStockOptionMember 2019-01-01 2019-12-31 0001755672 ctva:GrantsBetweenJune2019And2020Member us-gaap:StockOptionMember ctva:OIPMember 2021-01-01 2021-12-31 0001755672 ctva:Grantsbetween2013and2015Member us-gaap:StockOptionMember ctva:EIPMember 2021-01-01 2021-12-31 0001755672 ctva:Grantsbetween2016and2018Member us-gaap:StockOptionMember ctva:EIPMember 2021-01-01 2021-12-31 0001755672 ctva:DowMember 2021-01-01 2021-12-31 0001755672 us-gaap:EmployeeStockMember ctva:OIPMember 2021-01-01 2021-12-31 0001755672 us-gaap:EmployeeStockMember ctva:OIPMember 2020-01-01 2020-12-31 0001755672 us-gaap:EmployeeStockMember ctva:EIPMember 2020-01-01 2020-12-31 0001755672 ctva:OIPMember 2021-01-01 2021-12-31 0001755672 ctva:OIPMember 2020-01-01 2020-12-31 0001755672 ctva:EIPMember 2019-01-01 2019-12-31 0001755672 us-gaap:StockOptionMember 2020-12-31 0001755672 us-gaap:StockOptionMember 2020-01-01 2020-12-31 0001755672 us-gaap:StockOptionMember 2021-01-01 2021-12-31 0001755672 us-gaap:StockOptionMember 2021-12-31 0001755672 ctva:OIPMember 2021-01-01 2021-12-31 0001755672 ctva:OIPMember 2020-01-01 2020-12-31 0001755672 ctva:EIPMember 2020-01-01 2020-12-31 0001755672 us-gaap:RestrictedStockUnitsRSUMember ctva:EIPMember 2021-01-01 2021-12-31 0001755672 us-gaap:RestrictedStockUnitsRSUMember ctva:DowMember srt:MinimumMember 2021-01-01 2021-12-31 0001755672 us-gaap:RestrictedStockUnitsRSUMember ctva:DowMember srt:MaximumMember 2021-01-01 2021-12-31 0001755672 us-gaap:RestrictedStockUnitsRSUMember ctva:OIPMember 2021-01-01 2021-12-31 0001755672 us-gaap:RestrictedStockUnitsRSUMember 2021-01-01 2021-12-31 0001755672 us-gaap:PerformanceSharesMember 2021-01-01 2021-12-31 0001755672 srt:ManagementMember us-gaap:RestrictedStockUnitsRSUMember srt:MinimumMember 2021-01-01 2021-12-31 0001755672 srt:ManagementMember us-gaap:RestrictedStockUnitsRSUMember srt:MaximumMember 2021-01-01 2021-12-31 0001755672 ctva:PerformanceShareUnitsMember 2021-01-01 2021-12-31 0001755672 ctva:RestrictedStockUnitsAndPerformanceShareUnitsMember 2020-12-31 0001755672 ctva:RestrictedStockUnitsAndPerformanceShareUnitsMember 2021-01-01 2021-12-31 0001755672 ctva:RestrictedStockUnitsAndPerformanceShareUnitsMember 2021-12-31 0001755672 ctva:RSUsAndPSUsOIPMember 2021-01-01 2021-12-31 0001755672 ctva:RSUsAndPSUsOIPMember 2020-01-01 2020-12-31 0001755672 ctva:RSUsAndPSUsEIPMember 2020-01-01 2020-12-31 0001755672 ctva:RSUsAndPSUsOIPMember 2021-12-31 0001755672 us-gaap:CashEquivalentsMember 2021-12-31 0001755672 us-gaap:CashEquivalentsMember 2020-12-31 0001755672 ctva:MarketableSecuritiesMember 2021-12-31 0001755672 ctva:MarketableSecuritiesMember 2020-12-31 0001755672 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2021-12-31 0001755672 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-12-31 0001755672 us-gaap:CommodityContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2021-12-31 0001755672 us-gaap:CommodityContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-12-31 0001755672 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2021-12-31 0001755672 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2020-12-31 0001755672 us-gaap:CommodityContractMember us-gaap:NondesignatedMember 2021-12-31 0001755672 us-gaap:CommodityContractMember us-gaap:NondesignatedMember 2020-12-31 0001755672 us-gaap:CommodityContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2021-01-01 2021-12-31 0001755672 us-gaap:CommodityContractMember 2021-01-01 2021-12-31 0001755672 us-gaap:CommodityContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0001755672 us-gaap:CommodityContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-12-31 0001755672 us-gaap:CommodityContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-01-01 2020-12-31 0001755672 us-gaap:CommodityContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-01-01 2019-12-31 0001755672 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2021-01-01 2021-12-31 0001755672 us-gaap:ForeignExchangeContractMember 2021-01-01 2021-12-31 0001755672 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0001755672 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-01-01 2020-12-31 0001755672 us-gaap:ForeignExchangeContractMember us-gaap:NetInvestmentHedgingMember 2021-12-31 0001755672 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2021-12-31 0001755672 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2021-12-31 0001755672 us-gaap:OtherCurrentAssetsMember us-gaap:CommodityContractMember us-gaap:NondesignatedMember 2021-12-31 0001755672 ctva:AccruedandOtherCurrentLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2021-12-31 0001755672 ctva:AccruedandOtherCurrentLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2021-12-31 0001755672 ctva:AccruedandOtherCurrentLiabilitiesMember us-gaap:CommodityContractMember us-gaap:NondesignatedMember 2021-12-31 0001755672 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-12-31 0001755672 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2020-12-31 0001755672 ctva:AccruedandOtherCurrentLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-12-31 0001755672 ctva:AccruedandOtherCurrentLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2020-12-31 0001755672 us-gaap:ForeignExchangeContractMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2021-01-01 2021-12-31 0001755672 us-gaap:ForeignExchangeContractMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-01-01 2020-12-31 0001755672 us-gaap:ForeignExchangeContractMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-01-01 2019-12-31 0001755672 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2021-01-01 2021-12-31 0001755672 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-01-01 2020-12-31 0001755672 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-01-01 2019-12-31 0001755672 us-gaap:CommodityContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2021-01-01 2021-12-31 0001755672 us-gaap:CommodityContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-01-01 2020-12-31 0001755672 us-gaap:CommodityContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-01-01 2019-12-31 0001755672 us-gaap:DesignatedAsHedgingInstrumentMember 2021-01-01 2021-12-31 0001755672 us-gaap:DesignatedAsHedgingInstrumentMember 2020-01-01 2020-12-31 0001755672 us-gaap:DesignatedAsHedgingInstrumentMember 2019-01-01 2019-12-31 0001755672 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CostOfSalesMember 2021-01-01 2021-12-31 0001755672 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CostOfSalesMember 2020-01-01 2020-12-31 0001755672 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CostOfSalesMember 2019-01-01 2019-12-31 0001755672 us-gaap:CommodityContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CostOfSalesMember 2021-01-01 2021-12-31 0001755672 us-gaap:CommodityContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CostOfSalesMember 2020-01-01 2020-12-31 0001755672 us-gaap:CommodityContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CostOfSalesMember 2019-01-01 2019-12-31 0001755672 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember us-gaap:OtherNonoperatingIncomeExpenseMember 2021-01-01 2021-12-31 0001755672 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember us-gaap:OtherNonoperatingIncomeExpenseMember 2020-01-01 2020-12-31 0001755672 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember us-gaap:OtherNonoperatingIncomeExpenseMember 2019-01-01 2019-12-31 0001755672 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember us-gaap:CostOfSalesMember 2021-01-01 2021-12-31 0001755672 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember us-gaap:CostOfSalesMember 2020-01-01 2020-12-31 0001755672 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember us-gaap:CostOfSalesMember 2019-01-01 2019-12-31 0001755672 us-gaap:CommodityContractMember us-gaap:NondesignatedMember us-gaap:CostOfSalesMember 2021-01-01 2021-12-31 0001755672 us-gaap:CommodityContractMember us-gaap:NondesignatedMember us-gaap:CostOfSalesMember 2020-01-01 2020-12-31 0001755672 us-gaap:CommodityContractMember us-gaap:NondesignatedMember us-gaap:CostOfSalesMember 2019-01-01 2019-12-31 0001755672 us-gaap:NondesignatedMember 2021-01-01 2021-12-31 0001755672 us-gaap:NondesignatedMember 2020-01-01 2020-12-31 0001755672 us-gaap:NondesignatedMember 2019-01-01 2019-12-31 0001755672 us-gaap:AvailableforsaleSecuritiesMember 2021-01-01 2021-12-31 0001755672 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001755672 us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001755672 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001755672 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001755672 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasurySecuritiesMember 2020-12-31 0001755672 us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001755672 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001755672 us-gaap:TechnologyBasedIntangibleAssetsMember 2020-12-31 0001755672 us-gaap:FairValueMeasurementsNonrecurringMember us-gaap:TechnologyBasedIntangibleAssetsMember 2020-01-01 2020-12-31 0001755672 us-gaap:OtherIntangibleAssetsMember 2020-12-31 0001755672 us-gaap:FairValueMeasurementsNonrecurringMember us-gaap:OtherIntangibleAssetsMember 2020-01-01 2020-12-31 0001755672 us-gaap:InProcessResearchAndDevelopmentMember 2020-12-31 0001755672 us-gaap:FairValueMeasurementsNonrecurringMember us-gaap:InProcessResearchAndDevelopmentMember 2020-01-01 2020-12-31 0001755672 country:US 2021-01-01 2021-12-31 0001755672 country:US 2020-01-01 2020-12-31 0001755672 country:US 2019-01-01 2019-12-31 0001755672 country:CA 2021-01-01 2021-12-31 0001755672 country:CA 2020-01-01 2020-12-31 0001755672 country:CA 2019-01-01 2019-12-31 0001755672 us-gaap:EMEAMember 2021-01-01 2021-12-31 0001755672 us-gaap:EMEAMember 2020-01-01 2020-12-31 0001755672 us-gaap:EMEAMember 2019-01-01 2019-12-31 0001755672 srt:LatinAmericaMember 2021-01-01 2021-12-31 0001755672 srt:LatinAmericaMember 2020-01-01 2020-12-31 0001755672 srt:LatinAmericaMember 2019-01-01 2019-12-31 0001755672 srt:AsiaPacificMember 2021-01-01 2021-12-31 0001755672 srt:AsiaPacificMember 2020-01-01 2020-12-31 0001755672 srt:AsiaPacificMember 2019-01-01 2019-12-31 0001755672 country:BR 2021-01-01 2021-12-31 0001755672 country:BR 2020-01-01 2020-12-31 0001755672 country:BR 2019-01-01 2019-12-31 0001755672 country:US 2021-12-31 0001755672 country:US 2020-12-31 0001755672 country:US 2019-12-31 0001755672 country:CA 2021-12-31 0001755672 country:CA 2020-12-31 0001755672 country:CA 2019-12-31 0001755672 us-gaap:EMEAMember 2021-12-31 0001755672 us-gaap:EMEAMember 2020-12-31 0001755672 us-gaap:EMEAMember 2019-12-31 0001755672 srt:AsiaPacificMember 2021-12-31 0001755672 srt:AsiaPacificMember 2020-12-31 0001755672 srt:AsiaPacificMember 2019-12-31 0001755672 srt:LatinAmericaMember 2021-12-31 0001755672 srt:LatinAmericaMember 2020-12-31 0001755672 srt:LatinAmericaMember 2019-12-31 0001755672 us-gaap:OperatingSegmentsMember 2021-01-01 2021-12-31 0001755672 us-gaap:OperatingSegmentsMember 2021-12-31 0001755672 us-gaap:OperatingSegmentsMember 2020-01-01 2020-12-31 0001755672 us-gaap:OperatingSegmentsMember 2020-12-31 0001755672 us-gaap:OperatingSegmentsMember 2019-01-01 2019-12-31 0001755672 us-gaap:OperatingSegmentsMember 2019-12-31 0001755672 ctva:ReallocationofgoodwillMember 2019-06-01 0001755672 us-gaap:MaterialReconcilingItemsMember 2020-01-01 2020-12-31 0001755672 us-gaap:MaterialReconcilingItemsMember 2019-01-01 2019-12-31 0001755672 us-gaap:MaterialReconcilingItemsMember ctva:HedgingProgramMember ctva:ArgentinepesodevaluationMember 2020-01-01 2020-12-31 0001755672 us-gaap:SegmentDiscontinuedOperationsMember 2019-01-01 2019-12-31 0001755672 us-gaap:MaterialReconcilingItemsMember ctva:CropProtectionMember 2021-01-01 2021-12-31 0001755672 us-gaap:MaterialReconcilingItemsMember us-gaap:CorporateNonSegmentMember 2021-01-01 2021-12-31 0001755672 us-gaap:MaterialReconcilingItemsMember ctva:SeedMember 2020-01-01 2020-12-31 0001755672 us-gaap:MaterialReconcilingItemsMember ctva:CropProtectionMember 2020-01-01 2020-12-31 0001755672 us-gaap:MaterialReconcilingItemsMember us-gaap:CorporateNonSegmentMember 2020-01-01 2020-12-31 0001755672 us-gaap:MaterialReconcilingItemsMember ctva:CropProtectionMember ctva:SaleofJVMember 2020-01-01 2020-12-31 0001755672 us-gaap:MaterialReconcilingItemsMember ctva:SeedMember 2019-01-01 2019-12-31 0001755672 us-gaap:MaterialReconcilingItemsMember ctva:CropProtectionMember 2019-01-01 2019-12-31 0001755672 us-gaap:MaterialReconcilingItemsMember us-gaap:CorporateNonSegmentMember 2019-01-01 2019-12-31 0001755672 us-gaap:MaterialReconcilingItemsMember ctva:SeedMember ctva:AssetsaleMember 2019-01-01 2019-12-31 0001755672 us-gaap:MaterialReconcilingItemsMember ctva:AssetsaleMember 2019-01-01 2019-12-31 0001755672 us-gaap:MaterialReconcilingItemsMember ctva:SeedMember ctva:DeconsolidationofasubsidiaryMember 2019-01-01 2019-12-31 0001755672 us-gaap:MaterialReconcilingItemsMember ctva:DeconsolidationofasubsidiaryMember 2019-01-01 2019-12-31 0001755672 us-gaap:MaterialReconcilingItemsMember ctva:SeedMember ctva:OtherlossonsaleMember 2019-01-01 2019-12-31 0001755672 us-gaap:MaterialReconcilingItemsMember ctva:OtherlossonsaleMember 2019-01-01 2019-12-31 0001755672 us-gaap:MaterialReconcilingItemsMember us-gaap:CorporateNonSegmentMember ctva:HedgingProgramMember ctva:TaxReformForeignCurrencyExchangeImpactMember 2019-01-01 2019-12-31 0001755672 us-gaap:MaterialReconcilingItemsMember ctva:HedgingProgramMember ctva:TaxReformForeignCurrencyExchangeImpactMember 2019-01-01 2019-12-31 0001755672 ctva:HedgingProgramMember ctva:ArgentinepesodevaluationMember 2020-07-01 2020-09-30 0001755672 us-gaap:SecuritiesSoldUnderAgreementsToRepurchaseMember 2021-02-09 0001755672 ctva:EIDMember 2020-01-01 2020-12-31 0001755672 us-gaap:PensionPlansDefinedBenefitMember ctva:EIDMember 2021-01-01 2021-12-31 0001755672 us-gaap:PensionPlansDefinedBenefitMember ctva:EIDMember 2020-01-01 2020-12-31 0001755672 us-gaap:PensionPlansDefinedBenefitMember ctva:EIDMember 2019-01-01 2019-12-31 0001755672 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember ctva:EIDMember 2021-01-01 2021-12-31 0001755672 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember ctva:EIDMember 2020-01-01 2020-12-31 0001755672 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember ctva:EIDMember 2019-01-01 2019-12-31 0001755672 ctva:EIDMember 2021-12-31 0001755672 ctva:EIDMember 2020-12-31 0001755672 ctva:TotalcompanyMember ctva:EIDMember 2021-01-01 2021-12-31 0001755672 ctva:TotalcompanyMember ctva:EIDMember 2020-01-01 2020-12-31 0001755672 ctva:TotalcompanyMember ctva:EIDMember 2019-01-01 2019-12-31 0001755672 ctva:EIDMember 2019-12-31 0001755672 ctva:EIDMember 2018-12-31 0001755672 us-gaap:PreferredStockMember ctva:EIDMember 2018-12-31 0001755672 us-gaap:CommonStockMember ctva:EIDMember 2018-12-31 0001755672 us-gaap:AdditionalPaidInCapitalMember ctva:EIDMember 2018-12-31 0001755672 ctva:DivisionalEquityMember ctva:EIDMember 2018-12-31 0001755672 us-gaap:RetainedEarningsMember ctva:EIDMember 2018-12-31 0001755672 us-gaap:AccumulatedOtherComprehensiveIncomeMember ctva:EIDMember 2018-12-31 0001755672 us-gaap:NoncontrollingInterestMember ctva:EIDMember 2018-12-31 0001755672 ctva:DivisionalEquityMember ctva:EIDMember 2019-01-01 2019-12-31 0001755672 us-gaap:RetainedEarningsMember ctva:EIDMember 2019-01-01 2019-12-31 0001755672 us-gaap:NoncontrollingInterestMember ctva:EIDMember 2019-01-01 2019-12-31 0001755672 us-gaap:AccumulatedOtherComprehensiveIncomeMember ctva:EIDMember 2019-01-01 2019-12-31 0001755672 us-gaap:AdditionalPaidInCapitalMember ctva:EIDMember 2019-01-01 2019-12-31 0001755672 ctva:DivisionalEquityMember ctva:DowDuPontMember ctva:EIDMember 2019-01-01 2019-12-31 0001755672 ctva:DowDuPontMember ctva:EIDMember 2019-01-01 2019-12-31 0001755672 us-gaap:PreferredStockMember ctva:EIDMember 2019-01-01 2019-12-31 0001755672 us-gaap:PreferredStockMember ctva:EIDMember 2019-12-31 0001755672 us-gaap:CommonStockMember ctva:EIDMember 2019-12-31 0001755672 us-gaap:AdditionalPaidInCapitalMember ctva:EIDMember 2019-12-31 0001755672 us-gaap:RetainedEarningsMember ctva:EIDMember 2019-12-31 0001755672 us-gaap:AccumulatedOtherComprehensiveIncomeMember ctva:EIDMember 2019-12-31 0001755672 us-gaap:NoncontrollingInterestMember ctva:EIDMember 2019-12-31 0001755672 us-gaap:RetainedEarningsMember ctva:EIDMember 2020-01-01 2020-12-31 0001755672 us-gaap:NoncontrollingInterestMember ctva:EIDMember 2020-01-01 2020-12-31 0001755672 us-gaap:AccumulatedOtherComprehensiveIncomeMember ctva:EIDMember 2020-01-01 2020-12-31 0001755672 us-gaap:AdditionalPaidInCapitalMember ctva:EIDMember 2020-01-01 2020-12-31 0001755672 us-gaap:PreferredStockMember ctva:EIDMember 2020-12-31 0001755672 us-gaap:CommonStockMember ctva:EIDMember 2020-12-31 0001755672 us-gaap:AdditionalPaidInCapitalMember ctva:EIDMember 2020-12-31 0001755672 us-gaap:RetainedEarningsMember ctva:EIDMember 2020-12-31 0001755672 us-gaap:AccumulatedOtherComprehensiveIncomeMember ctva:EIDMember 2020-12-31 0001755672 us-gaap:NoncontrollingInterestMember ctva:EIDMember 2020-12-31 0001755672 us-gaap:RetainedEarningsMember ctva:EIDMember 2021-01-01 2021-12-31 0001755672 us-gaap:AccumulatedOtherComprehensiveIncomeMember ctva:EIDMember 2021-01-01 2021-12-31 0001755672 us-gaap:AdditionalPaidInCapitalMember ctva:EIDMember 2021-01-01 2021-12-31 0001755672 us-gaap:PreferredStockMember ctva:EIDMember 2021-12-31 0001755672 us-gaap:CommonStockMember ctva:EIDMember 2021-12-31 0001755672 us-gaap:AdditionalPaidInCapitalMember ctva:EIDMember 2021-12-31 0001755672 us-gaap:RetainedEarningsMember ctva:EIDMember 2021-12-31 0001755672 us-gaap:AccumulatedOtherComprehensiveIncomeMember ctva:EIDMember 2021-12-31 0001755672 us-gaap:NoncontrollingInterestMember ctva:EIDMember 2021-12-31 0001755672 ctva:A4.50SeriesPreferredStockMember ctva:EIDMember 2020-01-01 2020-12-31 0001755672 ctva:A4.50SeriesPreferredStockMember ctva:EIDMember 2019-01-01 2019-12-31 0001755672 ctva:A3.50SeriesPreferredStockMember ctva:EIDMember 2020-01-01 2020-12-31 0001755672 ctva:A3.50SeriesPreferredStockMember ctva:EIDMember 2019-01-01 2019-12-31 0001755672 ctva:CortevaMember ctva:EIDMember 2021-12-31 0001755672 ctva:CortevaMember ctva:EIDMember 2020-12-31 0001755672 ctva:CortevaMember ctva:EIDMember 2021-01-01 2021-12-31 0001755672 ctva:CortevaMember ctva:EIDMember 2020-01-01 2020-12-31 0001755672 ctva:AccruedandOtherCurrentLiabilitiesMember ctva:CortevaMember ctva:EIDMember 2020-12-31 0001755672 us-gaap:OtherNoncurrentLiabilitiesMember ctva:CortevaMember ctva:EIDMember 2020-12-31 0001755672 ctva:AccruedandOtherCurrentLiabilitiesMember ctva:CortevaMember ctva:EIDMember 2021-12-31 0001755672 us-gaap:OtherNoncurrentLiabilitiesMember ctva:CortevaMember ctva:EIDMember 2021-12-31 0001755672 us-gaap:SegmentContinuingOperationsMember ctva:EIDMember 2021-01-01 2021-12-31 0001755672 us-gaap:SegmentContinuingOperationsMember ctva:EIDMember 2020-01-01 2020-12-31 0001755672 us-gaap:SegmentContinuingOperationsMember ctva:EIDMember 2019-01-01 2019-12-31 0001755672 us-gaap:SegmentContinuingOperationsMember ctva:TaxChargeBenefitRelatedToTheActMember ctva:EIDMember 2021-01-01 2021-12-31 0001755672 us-gaap:SegmentContinuingOperationsMember ctva:SwissTaxReformMember ctva:EIDMember 2021-01-01 2021-12-31 0001755672 us-gaap:SegmentContinuingOperationsMember ctva:SwissTaxReformMember ctva:EIDMember 2020-01-01 2020-12-31 0001755672 us-gaap:MaterialReconcilingItemsMember ctva:EIDMember 2021-01-01 2021-12-31 0001755672 us-gaap:MaterialReconcilingItemsMember ctva:EIDMember 2020-01-01 2020-12-31 0001755672 us-gaap:MaterialReconcilingItemsMember ctva:EIDMember 2019-01-01 2019-12-31 0001755672 ctva:HedgingProgramMember ctva:ArgentinepesodevaluationMember ctva:EIDMember 2020-01-01 2020-12-31 shares iso4217:USD shares iso4217:USD pure ctva:lawsuits iso4217:EUR 10-K 10-K false false 2021-12-31 2021-12-31 0001755672 0000030554 --12-31 --12-31 2021 2021 FY FY Yes Yes No No Yes Yes Large Accelerated Filer Non-accelerated Filer false false false false 20000000000 false false 0.01 0.01 1666667000 1666667000 726527000 743458000 0.54 0.52 0.26 P1Y P25Y P1Y P25Y 0.04625 0.03625 0.04250 0.02800 0.06500 0.05600 0.04900 0.04150 120 120 102 102 33000000 33000000 0.30 0.30 1800000000 1800000000 200 200 0 0 23000000 23000000 1673000 1673000 120 120 0 0 23000000 23000000 700000 700000 102 102 4.50 4.50 4.50 3.50 3.50 3.50 92000000 10-K true 2021-12-31 false 001-38710 Corteva, Inc. DE 82-4979096 9330 Zionsville Road, Indianapolis, IN 46268 (833) 267-8382 1-815 E. I. du Pont de Nemours and Company DE 51-0014090 9330 Zionsville Road, Indianapolis, IN 46268 (833) 267-8382 Common Stock, par value $0.01 per share CTVA NYSE $3.50 Series Preferred Stock CTAPrA NYSE $4.50 Series Preferred Stock CTAPrB NYSE Yes Yes No No Yes Yes Yes Yes Large Accelerated Filer Non-accelerated Filer 727021000 0.01 200 0.30 Information pertaining to certain Items in Part III of this report is incorporated herein by reference to portions of Corteva, Inc.'s definitive 2022 Annual Meeting Proxy Statement to be filed within 120 days after the end of the year covered by this Annual Report on Form 10-K, pursuant to Regulation 14A (the Proxy). <div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Schedule II—Valuation and Qualifying Accounts (EID and Corteva, Inc.)</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(Dollars in millions)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.110%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.498%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Year Ended December 31, </span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accounts Receivable—Allowance for Doubtful Receivables</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of period</span></td><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">208 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions charged to expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deductions from reserves</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1,2</span></div></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of period</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">208 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deferred Tax Assets—Valuation Allowance</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of period</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">453 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">457 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">669 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions charged to expenses</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deductions from reserves</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">3</span></div></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(184)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(60)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(232)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of period</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">366 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">453 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">457 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">1.    </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Classifications in the changes in the allowance for doubtful receivables for the period ended December 31, 2020 have been adjusted from their previous presentation. Adjustments did not impact the amount of the provision or the allowance for doubtful receivables recorded in the Consolidated Statements of Operations or the Consolidated Balance Sheets.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">2.    </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Deductions include write-offs, recoveries collected and currency translation adjustments.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">     Deductions include currency translation adjustments.</span></div> 208000000 174000000 127000000 6000000 52000000 69000000 -4000000 -18000000 -22000000 210000000 208000000 174000000 453000000 457000000 669000000 97000000 56000000 20000000 -184000000 -60000000 -232000000 366000000 453000000 457000000 238 PricewaterhouseCoopers LLP Philadelphia, Pennsylvania 15655000000 14217000000 13846000000 9220000000 8507000000 8575000000 1187000000 1142000000 1147000000 3209000000 3043000000 3065000000 722000000 682000000 475000000 289000000 335000000 222000000 0 0 744000000 1348000000 212000000 215000000 0 0 -13000000 30000000 45000000 136000000 2346000000 675000000 -316000000 524000000 -81000000 -46000000 1822000000 756000000 -270000000 -53000000 -55000000 -671000000 1769000000 701000000 -941000000 10000000 20000000 18000000 1759000000 681000000 -959000000 2.46 0.98 -0.38 -0.07 -0.07 -0.90 2.39 0.91 -1.28 2.44 0.98 -0.38 -0.07 -0.07 -0.90 2.37 0.91 -1.28 1769000000 701000000 -941000000 -573000000 -26000000 -274000000 -1037000000 186000000 718000000 621000000 -671000000 160000000 10000000 -10000000 0 139000000 -69000000 28000000 -8000000 380000000 -1124000000 1761000000 1081000000 -2065000000 10000000 20000000 18000000 1751000000 1061000000 -2083000000 4459000000 3526000000 86000000 269000000 4811000000 4926000000 5180000000 4882000000 1010000000 1165000000 15546000000 14768000000 76000000 66000000 8364000000 8253000000 4035000000 3857000000 4329000000 4396000000 10107000000 10269000000 10044000000 10747000000 438000000 464000000 1804000000 1939000000 42344000000 42649000000 17000000 3000000 4126000000 3615000000 146000000 123000000 3201000000 2662000000 2068000000 2145000000 9558000000 8548000000 1100000000 1102000000 1220000000 893000000 3124000000 5176000000 1719000000 1867000000 7163000000 9038000000 7000000 7000000 27751000000 27707000000 524000000 0 -2898000000 -2890000000 25384000000 24824000000 239000000 239000000 25623000000 25063000000 42344000000 42649000000 1769000000 701000000 -941000000 1243000000 1177000000 1599000000 174000000 -330000000 -477000000 -1292000000 -340000000 -177000000 247000000 269000000 323000000 21000000 -3000000 142000000 289000000 335000000 339000000 0 0 272000000 0 0 1102000000 0 0 -13000000 -156000000 -290000000 -246000000 113000000 -187000000 361000000 422000000 -104000000 -74000000 524000000 -118000000 149000000 574000000 71000000 632000000 -93000000 -253000000 935000000 2727000000 2064000000 1070000000 573000000 475000000 1163000000 75000000 83000000 249000000 0 0 10000000 4000000 1000000 10000000 0 0 21000000 204000000 995000000 138000000 345000000 721000000 160000000 1000000 7000000 13000000 -362000000 -674000000 -904000000 13000000 0 -1868000000 419000000 2439000000 1001000000 421000000 1441000000 6804000000 950000000 275000000 25000000 100000000 56000000 47000000 -397000000 -388000000 -194000000 0 -60000000 0 0 0 -317000000 0 0 -2053000000 0 0 7396000000 0 0 -79000000 -30000000 -28000000 -33000000 -1266000000 303000000 -2929000000 -136000000 7000000 -88000000 963000000 1700000000 -2851000000 3873000000 2173000000 5024000000 4836000000 3873000000 2173000000 30000000 36000000 263000000 341000000 229000000 234000000 0 0 78020000000 0 -3360000000 493000000 75153000000 -641000000 -318000000 18000000 -941000000 -1124000000 -1124000000 -97000000 -97000000 -194000000 -317000000 -317000000 39000000 39000000 8000000 8000000 41000000 62000000 103000000 -25000000 -25000000 7396000000 7396000000 -56479000000 1214000000 -231000000 -55496000000 7000000 28070000000 -28077000000 -3000000 -10000000 -34000000 -47000000 7000000 27997000000 0 -425000000 -3270000000 246000000 24555000000 681000000 20000000 701000000 380000000 380000000 60000000 -1000000 59000000 -194000000 -194000000 -388000000 -216000000 -59000000 -275000000 56000000 56000000 -37000000 -15000000 -52000000 41000000 -2000000 -12000000 27000000 7000000 27707000000 0 -2890000000 239000000 25063000000 1759000000 10000000 1769000000 -8000000 -8000000 59000000 -3000000 56000000 -97000000 -300000000 -397000000 -18000000 -932000000 -950000000 100000000 100000000 -10000000 -10000000 7000000 27751000000 524000000 -2898000000 239000000 25623000000 BACKGROUND AND BASIS OF PRESENTATION<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corteva, Inc. is a leading global provider of seed and crop protection solutions focused on the agriculture industry. The company intends to leverage its rich heritage of scientific achievement to advance its robust innovation pipeline and continue to shape the future of responsible agriculture. The company's broad portfolio of agriculture solutions fuels farmer productivity around the globe. Corteva has two reportable segments: seed and crop protection. See Note 25 - Segment Information, to the Consolidated Financial Statements, for additional information on the company's reportable segments.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Throughout these financial statements, except as otherwise noted by the context, the terms "Corteva" or "company" used herein mean Corteva, Inc. and its consolidated subsidiaries (including EID) and the term “EID” used herein means E. I. du Pont de Nemours and Company and its consolidated subsidiaries or E. I. du Pont de Nemours and Company excluding its consolidated subsidiaries, as the context may indicate. Additionally, on June 1, 2019, DowDuPont Inc. changed its registered name to DuPont de Nemours, Inc. (“DuPont”), for certain events prior to, or on, June 1, 2019, DuPont may be referred to as DowDuPont. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Principles of Consolidation and Basis of Presentation</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 1, 2019, Corteva, Inc. became an independent, publicly traded company through the completed separation (the “Separation”) of the agriculture business of DuPont de Nemours, Inc. (formerly known as DowDuPont Inc.) (“DowDuPont” or “DuPont”). The separation was effectuated through a pro rata distribution (the “Corteva Distribution”) of all of the then-issued and outstanding shares of common stock, par value $0.01 per share, of Corteva, Inc., which was then a wholly-owned subsidiary of DowDuPont, to holders of record of DowDuPont common stock as of the close of business on May 24, 2019. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Previously, DowDuPont was formed on December 9, 2015, to effect an all-stock merger of equals strategic combination between The Dow Chemical Company ("Historical Dow") and EID. On August 31, 2017 at 11:59 pm ET (the “Merger Effectiveness Time”) pursuant to the Agreement and Plan of Merger, dated as of December 11, 2015, as amended March 31, 2017 (the "Merger Agreement"), Historical Dow and EID each merged with wholly-owned subsidiaries of DowDuPont and became subsidiaries of DowDuPont (the “Merger”). Prior to the Merger, DowDuPont did not conduct any business activities other than those required for its formation and matters contemplated by the Merger Agreement.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subsequent to the Merger, Historical Dow and EID engaged in a series of internal reorganization and realignment steps to realign their businesses into three subgroups: agriculture, materials science and specialty products through a series of tax-efficient transactions (collectively, the "Business Separations”). Effective as of 5:00 pm ET on April 1, 2019, DowDuPont completed the separation of its materials science business into a separate and independent public company by way of a distribution of Dow Inc. (“Dow”) through a pro rata dividend in-kind of all of the then-issued and outstanding shares of Dow’s common stock, par value $0.01 per share, to holders of DowDuPont's common stock, as of the close of business on March 21, 2019 (the “Dow Distribution” and together with the Corteva Distribution, the “Distributions”).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the Dow Distribution, Historical Dow conveyed or transferred the assets and liabilities aligned with Historical Dow’s agriculture business to separate legal entities (“Dow Ag Entities”) and the assets and liabilities associated with its specialty products business to separate legal entities (the “Dow SP Entities”). On April 1, 2019, Dow Ag Entities and the Dow SP Entities were transferred and conveyed to DowDuPont.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In furtherance of the Business Separations, EID engaged in a series of internal reorganization and realignment steps (the “Internal Reorganization” and the "Business Realignment," respectively) to realign its businesses into three subgroups: agriculture, materials science and specialty products. As part of the Internal Reorganization:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the assets and liabilities aligned with EID’s materials science business (“EID ECP”) were transferred or conveyed to separate legal entities that were ultimately conveyed by DowDuPont to Dow on April 1, 2019; </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the assets and liabilities aligned with EID’s specialty products business were transferred or conveyed to separate legal entities (“EID Specialty Products Entities”) that were ultimately distributed to DowDuPont on May 1, 2019;</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">on May 2, 2019, DowDuPont conveyed Dow Ag Entities to EID and in connection with the foregoing, EID issued additional shares of its Common Stock to DowDuPont; and</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">on May 31, 2019, DowDuPont contributed EID to Corteva, Inc.</span></div><div style="padding-left:54pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 6, 2019, the Board of Directors of DowDuPont approved the distribution of all the then issued and outstanding shares of common stock of Corteva, Inc., then a wholly-owned subsidiary of DowDuPont, to DowDuPont stockholders. On June 1, </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2019, DowDuPont completed the Separation. Each DowDuPont stockholder received one share of Corteva common stock for every three shares of DowDuPont common stock held at the close of business on May 24, 2019, the record date of distribution. Corteva, Inc.'s common stock began trading the "regular way" under the ticker symbol "CTVA" on June 3, 2019, the first business day after June 1, 2019. Upon becoming an independent company, the capital structure of Corteva consisted of 748,815,000 authorized shares of common stock (par value of $0.01 per share), which represents the number of common shares issued on June 3, 2019. Information related to the Corteva Distribution and its effect on the company's financial statements is discussed throughout these Notes to the Consolidated Financial Statements. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the Business Realignment and the Internal Reorganization discussed above, Corteva owns 100% of the outstanding common stock of EID. EID is a subsidiary of Corteva, Inc. and continues to be a reporting company, subject to the requirements of the Securities Exchange Act of 1934, as amended.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">DAS Common Control Business Combination </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The transfer or conveyance of DAS to Corteva was treated as a transfer of entities under common control. As such, the company recorded the assets, liabilities, and equity of DAS on its balance sheet at their historical basis. Transfers of businesses between entities under common control requires the financial statements to be presented as if the transaction had occurred at the point at which common control first existed (the Merger Effectiveness Time). As a result, the accompanying Consolidated Financial Statements and Notes thereto include the results of DAS as of the Merger Effectiveness Time. See Note 4 - Common Control Business Combination, to the Consolidated Financial Statements, for additional information.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For periods prior to the Corteva Distribution, the combined results of operations and assets and liabilities of EID and DAS were derived from the Consolidated Financial Statements and accounting records of EID as well as the carve-out financial statements of DAS. The DAS carve-out financial statements reflect the historical results of operations, financial position, and cash flows of Historical Dow's Agricultural Sciences Business and include allocations of certain expenses for services from Historical Dow, including, but not limited to, general corporate expenses related to finance, legal, information technology, human resources, ethics and compliance, shared services, employee benefits and incentives, insurance, and stock-based compensation. These expenses were allocated on the basis of direct usage when identifiable, with the remainder allocated under the basis of headcount or other measures. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company's Consolidated Balance Sheets for all periods presented consist of Corteva, Inc. and its consolidated subsidiaries.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company's Consolidated Statements of Operations (the "Consolidated Statements of Operations") for all periods prior to the Corteva Distribution consist of the combined results of operations for Historical EID and DAS. The Consolidated Statements of Operations for all periods after the Corteva Distribution represent the consolidated balances of the company. Intercompany balances and transactions with Historical EID and DAS have been eliminated.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter 2020, the company recorded an increase of $40 million to APIC relating to net assets recorded as</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">transferred as part of the 2019 Internal Reorganizations that were retained.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Divestiture of EID ECP and EID Specialty Products Entities</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The transfer of EID ECP and EID Specialty Products Entities meets the criteria for discontinued operations and as such, results of operations are presented as discontinued operations and have been excluded from continuing operations for all periods presented. The comprehensive income (loss), stockholder's equity and cash flows related to EID ECP and EID Specialty Products Entities have not been segregated and are included in the Consolidated Statements of Comprehensive Income (Loss), Consolidated Statements of Equity and Consolidated Statements of Cash Flows, respectively, for 2019. Amounts related to EID ECP and EID Specialty Products Entities are consistently included or excluded from the Notes to the Consolidated Financial Statements based on the respective financial statement line item. See Note 5 - Divestitures and Other Transactions, to the Consolidated Financial Statements, for additional information.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain reclassifications of prior year's data have been made to conform to current year's presentation.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since 2018, Argentina has been considered a hyper-inflationary economy under U.S. GAAP and therefore the U.S. Dollar (“USD”) is the functional currency for our related subsidiaries. Argentina contributes approximately 5 percent to both the company's annual Sales and EBITDA. We remeasure net monetary assets and translate our financial statements utilizing the official Argentine Peso (“Peso”) to USD exchange rate. The ability to draw down Peso cash balances is limited at this time due to government restrictions and market availability of U.S. Dollars. The devaluation of the Peso relative to the USD over the last several years has resulted in the recognition of exchange losses (refer to Note 9 – Supplementary Information, to the Consolidated Financial Statements). As of December 31, 2021, a further 10 percent deterioration in the official Peso to USD </span></div>exchange rate would reduce the USD value of our net monetary assets and negatively impact pre-tax earnings by approximately $15 million. We will continue to assess the implications to our operations and financial reporting. 2 0.01 <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subsequent to the Merger, Historical Dow and EID engaged in a series of internal reorganization and realignment steps to realign their businesses into three subgroups: agriculture, materials science and specialty products through a series of tax-efficient transactions (collectively, the "Business Separations”). Effective as of 5:00 pm ET on April 1, 2019, DowDuPont completed the separation of its materials science business into a separate and independent public company by way of a distribution of Dow Inc. (“Dow”) through a pro rata dividend in-kind of all of the then-issued and outstanding shares of Dow’s common stock, par value $0.01 per share, to holders of DowDuPont's common stock, as of the close of business on March 21, 2019 (the “Dow Distribution” and together with the Corteva Distribution, the “Distributions”).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the Dow Distribution, Historical Dow conveyed or transferred the assets and liabilities aligned with Historical Dow’s agriculture business to separate legal entities (“Dow Ag Entities”) and the assets and liabilities associated with its specialty products business to separate legal entities (the “Dow SP Entities”). On April 1, 2019, Dow Ag Entities and the Dow SP Entities were transferred and conveyed to DowDuPont.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In furtherance of the Business Separations, EID engaged in a series of internal reorganization and realignment steps (the “Internal Reorganization” and the "Business Realignment," respectively) to realign its businesses into three subgroups: agriculture, materials science and specialty products. As part of the Internal Reorganization:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the assets and liabilities aligned with EID’s materials science business (“EID ECP”) were transferred or conveyed to separate legal entities that were ultimately conveyed by DowDuPont to Dow on April 1, 2019; </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the assets and liabilities aligned with EID’s specialty products business were transferred or conveyed to separate legal entities (“EID Specialty Products Entities”) that were ultimately distributed to DowDuPont on May 1, 2019;</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">on May 2, 2019, DowDuPont conveyed Dow Ag Entities to EID and in connection with the foregoing, EID issued additional shares of its Common Stock to DowDuPont; and</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">on May 31, 2019, DowDuPont contributed EID to Corteva, Inc.</span></div><div style="padding-left:54pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 6, 2019, the Board of Directors of DowDuPont approved the distribution of all the then issued and outstanding shares of common stock of Corteva, Inc., then a wholly-owned subsidiary of DowDuPont, to DowDuPont stockholders. On June 1, </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2019, DowDuPont completed the Separation. Each DowDuPont stockholder received one share of Corteva common stock for every three shares of DowDuPont common stock held at the close of business on May 24, 2019, the record date of distribution. Corteva, Inc.'s common stock began trading the "regular way" under the ticker symbol "CTVA" on June 3, 2019, the first business day after June 1, 2019. Upon becoming an independent company, the capital structure of Corteva consisted of 748,815,000 authorized shares of common stock (par value of $0.01 per share), which represents the number of common shares issued on June 3, 2019. Information related to the Corteva Distribution and its effect on the company's financial statements is discussed throughout these Notes to the Consolidated Financial Statements. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the Business Realignment and the Internal Reorganization discussed above, Corteva owns 100% of the outstanding common stock of EID. EID is a subsidiary of Corteva, Inc. and continues to be a reporting company, subject to the requirements of the Securities Exchange Act of 1934, as amended.</span></div> 0.01 1 3 748815000 0.01 1 <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">DAS Common Control Business Combination </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The transfer or conveyance of DAS to Corteva was treated as a transfer of entities under common control. As such, the company recorded the assets, liabilities, and equity of DAS on its balance sheet at their historical basis. Transfers of businesses between entities under common control requires the financial statements to be presented as if the transaction had occurred at the point at which common control first existed (the Merger Effectiveness Time). As a result, the accompanying Consolidated Financial Statements and Notes thereto include the results of DAS as of the Merger Effectiveness Time. See Note 4 - Common Control Business Combination, to the Consolidated Financial Statements, for additional information.</span></div> <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For periods prior to the Corteva Distribution, the combined results of operations and assets and liabilities of EID and DAS were derived from the Consolidated Financial Statements and accounting records of EID as well as the carve-out financial statements of DAS. The DAS carve-out financial statements reflect the historical results of operations, financial position, and cash flows of Historical Dow's Agricultural Sciences Business and include allocations of certain expenses for services from Historical Dow, including, but not limited to, general corporate expenses related to finance, legal, information technology, human resources, ethics and compliance, shared services, employee benefits and incentives, insurance, and stock-based compensation. These expenses were allocated on the basis of direct usage when identifiable, with the remainder allocated under the basis of headcount or other measures. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company's Consolidated Balance Sheets for all periods presented consist of Corteva, Inc. and its consolidated subsidiaries.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company's Consolidated Statements of Operations (the "Consolidated Statements of Operations") for all periods prior to the Corteva Distribution consist of the combined results of operations for Historical EID and DAS. The Consolidated Statements of Operations for all periods after the Corteva Distribution represent the consolidated balances of the company. Intercompany balances and transactions with Historical EID and DAS have been eliminated.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter 2020, the company recorded an increase of $40 million to APIC relating to net assets recorded as</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">transferred as part of the 2019 Internal Reorganizations that were retained.</span></div> 40000000 <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Divestiture of EID ECP and EID Specialty Products Entities</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The transfer of EID ECP and EID Specialty Products Entities meets the criteria for discontinued operations and as such, results of operations are presented as discontinued operations and have been excluded from continuing operations for all periods presented. The comprehensive income (loss), stockholder's equity and cash flows related to EID ECP and EID Specialty Products Entities have not been segregated and are included in the Consolidated Statements of Comprehensive Income (Loss), Consolidated Statements of Equity and Consolidated Statements of Cash Flows, respectively, for 2019. Amounts related to EID ECP and EID Specialty Products Entities are consistently included or excluded from the Notes to the Consolidated Financial Statements based on the respective financial statement line item. See Note 5 - Divestitures and Other Transactions, to the Consolidated Financial Statements, for additional information.</span></div> Since 2018, Argentina has been considered a hyper-inflationary economy under U.S. GAAP and therefore the U.S. Dollar (“USD”) is the functional currency for our related subsidiaries. Argentina contributes approximately 5 percent to both the company's annual Sales and EBITDA. We remeasure net monetary assets and translate our financial statements utilizing the official Argentine Peso (“Peso”) to USD exchange rate. The ability to draw down Peso cash balances is limited at this time due to government restrictions and market availability of U.S. Dollars. The devaluation of the Peso relative to the USD over the last several years has resulted in the recognition of exchange losses (refer to Note 9 – Supplementary Information, to the Consolidated Financial Statements). As of December 31, 2021, a further 10 percent deterioration in the official Peso to USD exchange rate would reduce the USD value of our net monetary assets and negatively impact pre-tax earnings by approximately $15 million. We will continue to assess the implications to our operations and financial reporting. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Consolidated Financial Statements include the accounts of the company and subsidiaries in which a controlling interest is maintained. For those consolidated subsidiaries in which the company's ownership is less than 100 percent, the outside stockholders' interests are shown as noncontrolling interests. Investments in affiliates over which the company has the ability to exercise significant influence but does not have a controlling interest are accounted for under the equity method. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company is also involved with certain joint ventures accounted for under the equity method of accounting that are variable interest entities ("VIEs"). The company is not the primary beneficiary, as the nature of the company's involvement with the VIEs does not provide it the power to direct the VIEs significant activities. Future events may require these VIEs to be consolidated if the company becomes the primary beneficiary. At December 31, 2021 and 2020, the maximum exposure to loss related to the nonconsolidated VIEs is not considered material to the Consolidated Financial Statements. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates in Financial Statement Preparation</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in accordance with U.S. GAAP requires the use of estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. The company’s consolidated financial statements include amounts that are based on management’s best estimates and judgments. Actual results could differ from those estimates. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash and Cash Equivalents</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash equivalents represent investments with maturities of three months or less from time of purchase. They are carried at cost plus accrued interest. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Restricted Cash Equivalents</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted cash equivalents primarily consist of trust assets and contributions to the MOU Escrow Account of $377 million and $347 million as of December 31, 2021 and 2020, respectively. The trust assets are classified as current and the contributions to the MOU Escrow Account are classified as noncurrent and included within other current assets and other assets, respectively, in the Consolidated Balance Sheets. See Note 9 - Supplementary Information, to the Consolidated Financial Statements, for further information.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Marketable Securities</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Marketable securities represent investments in fixed and floating rate financial instruments with maturities greater than three months and up to twelve months at time of purchase. Investments classified as held-to-maturity are recorded at amortized cost. The carrying value approximates fair value due to the short-term nature of the investments. Investments classified as debt securities that are available-for-sale are carried at estimated fair value with unrealized gains and losses recorded as a component of accumulated other comprehensive income (loss) or current period earnings if an allowance for credit losses has been established. The cost of investments sold is determined by specific identification.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fair Value Measurements</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the accounting guidance for fair value measurements and disclosures, a fair value hierarchy was established that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). A financial instrument's level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company uses the following valuation techniques to measure fair value for its assets and liabilities:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:9.880%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.317%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:82.503%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 1</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">–</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Quoted market prices in active markets for identical assets or liabilities;</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">–</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Significant other observable inputs (e.g. quoted prices for similar items in active markets, quoted prices for identical or similar items in markets that are not active, inputs other than quoted prices that are observable such as interest rate and yield curves, and market-corroborated inputs);</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 3</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">–</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unobservable inputs for the asset or liability, which are valued based on management's estimates of assumptions that market participants would use in pricing the asset or liability.</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Foreign Currency Translation</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company's worldwide operations utilize the U.S. dollar ("USD") or a related foreign currency as the functional currency, where applicable. The company identifies its separate and distinct foreign entities and groups the foreign entities into two categories: 1) extension of the parent or foreign subsidiaries operating in a hyper-inflationary environment (USD functional currency) and 2) self-contained (related foreign functional currency). If a foreign entity does not align with either category, factors are evaluated and a judgment is made to determine the functional currency.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For foreign entities where the USD is the functional currency, all foreign currency-denominated asset and liability amounts are re-measured into USD at end-of-period exchange rates, except for inventories, prepaid expenses, property, plant and equipment, goodwill and other intangible assets, which are re-measured at historical rates. Foreign currency income and expenses are re-measured at average exchange rates in effect during each month, except for expenses related to balance sheet amounts re-measured at historical exchange rates. Exchange gains and losses arising from re-measurement of foreign currency-denominated monetary assets and liabilities are included in income in the period in which they occur. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For foreign entities where a related foreign currency is the functional currency, assets and liabilities denominated in the related foreign currencies are translated into USD at end-of-period exchange rates and the resultant translation adjustments are reported, net of their related tax effects, as a component of accumulated other comprehensive income (loss) in equity. Assets and liabilities denominated in other than the functional currency are re-measured into the functional currency prior to translation into USD and the resultant exchange gains or losses are included in income in the period in which they occur. Income and expenses are translated into USD at average exchange rates in effect during each month. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company changes the functional currency of its separate and distinct foreign entities only when significant changes in economic facts and circumstances indicate clearly that the functional currency has changed.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Inventories</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company's inventories are valued at the lower of cost or net realizable value. Elements of cost in inventories include raw materials, direct labor and manufacturing overhead. Stores and supplies are valued at cost or net realizable value, whichever is lower; cost is generally determined by the average cost method.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2021 and December 31, 2020, approximately 60% and 40% of the company's inventories were accounted for under the first-in, first-out ("FIFO") and average cost methods, respectively. Inventories accounted for under the FIFO method are primarily comprised of products with shorter shelf lives such as seeds. See Note 13 - Inventories, to the Consolidated Financial Statements, for further information. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company establishes an obsolescence reserve for inventory based upon quality considerations and assumptions about future demand and market conditions.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Property, Plant and Equipment</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant and equipment are carried at cost less accumulated depreciation. In connection with the Merger, the fair value of property, plant and equipment was determined using a market approach and a replacement cost approach. Depreciation is based on the estimated service lives of depreciable assets and is calculated using the straight-line method. Fully depreciated assets are retained in property and accumulated depreciation accounts until they are removed from service. When assets are surrendered, retired, sold, or otherwise disposed of, their gross carrying values and related accumulated depreciation are removed from the Consolidated Balance Sheets and included in determining gain or loss on such disposals.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Goodwill and Other Intangible Assets</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company records goodwill when the purchase price of a business acquisition exceeds the estimated fair value of net identified tangible and intangible assets acquired. Goodwill is tested for impairment at the reporting unit level at least annually, or more frequently when events or changes in circumstances indicate that the fair value of a reporting unit has more likely than not declined below its carrying value. The company performs an annual goodwill impairment test in the fourth quarter. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When testing goodwill for impairment, the company has the option to first perform qualitative testing to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying value. If the company chooses not to complete a qualitative assessment for a given reporting unit or if the initial assessment indicates that it is more likely than not that the carrying value of a reporting unit exceeds its estimated fair value, additional quantitative testing is required. If additional quantitative testing is required, the reporting unit's fair value is compared with its carrying amount, and an impairment charge, if any, is recognized for the amount by which the carrying amount exceeds the reporting unit's fair value, limited to the amount of goodwill associated with the reporting unit. The company determines fair values for each of the reporting units using a discounted cash flow model (a form of the income approach) or the market approach. Under the income approach, fair value is determined based on the present value of estimated future cash flows, discounted at an appropriate risk-adjusted rate. The company's significant assumptions in this analysis included future cash flow projections, weighted average cost of capital, the terminal growth rate, and the tax rate. Under the market approach, the company uses metrics of publicly traded companies or historically completed transactions for comparable companies. See Note 15 - Goodwill and Other Intangible Assets, to the Consolidated Financial Statements, for further information on goodwill.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Indefinite-lived intangible assets are tested for impairment at least annually; however, these tests are performed more frequently when events or changes in circumstances indicate that the asset may be impaired. Impairment exists when carrying value exceeds fair value. The company performs an impairment assessment using the relief from royalty method (a form of the income approach) using Level 3 inputs within the fair value hierarchy. The significant assumptions used in the calculation included projected revenue, the royalty rate, the discount rate, and the terminal growth rate. These significant assumptions involve management judgment and estimates relating to future operating performance and economic conditions that may differ from actual cash flows.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Definite-lived intangible assets are amortized over their estimated useful lives, generally on a straight-line basis for periods ranging primarily from 2 years to 25 years. The company continually evaluates the reasonableness of the useful lives of these assets. Once these assets are fully amortized, they are removed from the Consolidated Balance Sheets.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Leases</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company determines whether an arrangement is a lease at the inception of the arrangement based on the terms and conditions in the contract. A contract contains a lease if there is an identified asset and the company has the right to control the asset. Operating lease right-of-use ("ROU") assets are included in other assets on the company’s Consolidated Balance Sheets. Operating lease liabilities are included in accrued and other current liabilities and other noncurrent obligations on the company’s Consolidated Balance Sheets. Finance lease assets are included in property, plant and equipment on the company’s Consolidated Balance Sheets. Finance lease liabilities are included in short-term borrowings and finance lease obligations and long-term debt on the company’s Consolidated Balance Sheets.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease ROU assets represent the company’s right to use an underlying asset for the lease term and lease liabilities represent the company’s obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at the commencement date based on the present value of lease payments over the lease term. As most of the company’s leases do not provide the lessor's implicit rate, the company uses its incremental borrowing rate at the commencement date in determining the present value of lease payments. Lease terms include options to extend the lease when it is reasonably certain those options will be exercised. Leases with an initial term of 12 months or less are not recorded on the balance sheet. The company recognizes lease expense for these leases on a straight-line basis over the lease term. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company has lease agreements with lease and non-lease components, which are accounted for as a single lease component for all asset classes. In the Consolidated Statements of Operations, lease expense for operating leases is recognized on a straight-line basis over the lease term. For finance leases, interest expense is recognized on the lease liability and the ROU asset is amortized over the lease term. See Note 16 - Leases, to the Consolidated Financial Statements, for further information. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Impairment of Long-Lived Assets</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company evaluates the carrying value of long-lived assets to be held and used when events or changes in circumstances indicate the carrying value may not be recoverable. The carrying value of a long-lived asset group is considered impaired when the total projected undiscounted cash flows from the assets are separately identifiable and are less than its carrying value. In that event, a loss is recognized based on the amount by which the carrying value exceeds the fair value of the long-lived asset. The </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">company's fair value methodology is an estimate of fair market value which is made based on prices of similar assets or other valuation methodologies including present value techniques. Long-lived assets to be disposed of by sale, if material, are classified as held for sale and reported at the lower of carrying amount or fair value less cost to sell, and depreciation is ceased. Long-lived assets to be disposed of other than by sale are classified as held and used until they are disposed of and reported at the lower of carrying amount or fair value. Depreciation is recognized over the remaining useful life of the assets.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Derivative Instruments</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Derivative instruments are reported in the Consolidated Balance Sheets at their fair values. The company utilizes derivatives to manage exposures to foreign currency exchange rates and commodity prices. Changes in the fair values of derivative instruments that are not designated as hedges are recorded in current period earnings. For derivative instruments designated as cash flow hedges, the gain (loss) is reported in accumulated other comprehensive income (loss) until it is cleared to earnings during the same period in which the hedged item affects earnings. For derivative instruments designated as net investment hedges, the gain (loss) is reported within accumulated other comprehensive income (loss) until the subsidiary is divested.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event that a derivative designated as a hedge of a firm commitment or an anticipated transaction is terminated prior to the maturation of the hedged transaction, the net gain or loss in accumulated other comprehensive income (loss) generally remains in accumulated other comprehensive income (loss) until the item that was hedged affects earnings. If a hedged transaction matures, or is sold, extinguished, or terminated prior to the maturity of a derivative designated as a hedge of such transaction, gains or losses associated with the derivative through the date the transaction matured are included in the measurement of the hedged transaction and the derivative is reclassified as for trading purposes. Derivatives designated as hedges of anticipated transactions are reclassified as for trading purposes if the anticipated transaction is no longer probable.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company included foreign currency exchange contract settlements within cash flows from operating activities, regardless of hedge accounting qualification. See Note 22 - Financial Instruments, to the Consolidated Financial Statements, for additional discussion regarding the company's objectives and strategies for derivative instruments.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Environmental Matters</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accruals for environmental matters are recorded when it is probable that a liability has been incurred and the amount of the liability can be reasonably estimated. These accruals are adjusted periodically as assessment and remediation efforts progress or as additional technical or legal information becomes available. Accruals for environmental liabilities are included in the Consolidated Balance Sheets in accrued and other current liabilities and other noncurrent obligations at undiscounted amounts. Accruals for related insurance or other third-party recoveries for environmental liabilities are recorded when it is probable that a recovery will be realized and are included in the Consolidated Balance Sheets as accounts and notes receivable - net. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Environmental costs are capitalized if the costs extend the life of the property, increase its capacity, and/or mitigate or prevent contamination from future operations. Environmental costs are also capitalized in recognition of legal asset retirement obligations resulting from the acquisition, construction and/or normal operation of a long-lived asset. Costs related to environmental contamination treatment and cleanup are charged to expense. Estimated future incremental operations, maintenance and management costs directly related to remediation are accrued when such costs are probable and reasonably estimable.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company recognizes revenue when its customer obtains control of promised goods or services, in an amount that reflects the consideration which the company expects to receive in exchange for those goods or services. To determine revenue recognition for the arrangements that the company determines are within the scope of FASB ASU No. 2014-09, Revenue from Contracts with Customers (Topic 606), the company performs the following five steps: (1) identify the contract(s) with a customer, (2) identify the performance obligations in the contract, (3) determine the transaction price, (4) allocate the transaction price to the performance obligations in the contract, and (5) recognize revenue when (or as) the entity satisfies a performance obligation. See Note 6 - Revenue, to the Consolidated Financial Statements, for additional information on revenue recognition.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Prepaid Royalties</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company currently has certain third-party biotechnology trait license agreements, which require up-front and variable payments subject to the licensor meeting certain conditions. These payments are reflected as other current assets and other assets and are amortized to cost of goods sold as seeds containing the respective trait technology are utilized over the life of the license. The rate of royalty amortization expense recognized is based on the company’s strategic plans which include various assumptions and estimates including product portfolio, market dynamics, farmer preferences, growth rates and projected planted acres. Changes in factors and assumptions included in the strategic plans, including potential changes to the product portfolio in favor of internally developed biotechnology, could impact the rate of recognition of the relevant prepaid royalty. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December 31, 2021, the balance of prepaid royalties reflected in other current assets and other assets was $303 million and $256 million, respectively. The majority of the balance of prepaid royalties relates to the company’s wholly owned subsidiary, Pioneer Hi-Bred International, Inc.’s (“Pioneer”) non-exclusive license in the United States and Canada for the Monsanto Company's Genuity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">®</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Roundup Ready 2 Yield</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">®</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> glyphosate tolerance trait and Roundup Ready 2 Xtend</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">®</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> glyphosate and dicamba tolerance trait for soybeans (“Roundup Ready 2 License Agreement”). Each of these licensed technologies are now trademarks of the Bayer Group, which acquired the Monsanto Company in 2018. The prepaid royalty asset relates to a series of up-front, fixed and variable royalty payments to utilize the traits in Pioneer’s soybean product mix.The company’s historical expectation has been that the technology licensed under the Roundup Ready 2 License Agreement would be used as the primary herbicide tolerance trait platform in the Pioneer</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">® </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">brand soybean through the term of the agreement. DAS and MS Technologies, L.L.C. jointly developed and own the Enlist E3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">herbicide tolerance trait for soybeans which provides tolerance to 2, 4-D choline in Enlist Duo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">®</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and Enlist One</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">®</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> herbicides, as well as glyphosate and glufosinate herbicides. In connection with the validation of breeding plans and large-scale product development timelines, during the fourth quarter of 2019, the company accelerated the ramp up of the Enlist E3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> trait platform in the company’s soybean portfolio mix across all brands, including Pioneer</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">®</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> brands, over the subsequent five years. During the ramp-up period, the company is expected to significantly reduce the volume of products with the Roundup Ready 2 Yield</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">®</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and Roundup Ready 2 Xtend</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">® </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">herbicide tolerance traits beginning in 2021, with expected minimal use of the trait platform thereafter for the remainder of the Roundup Ready 2 License Agreement (the “Transition Plan”). The rate of royalty expense has therefore increased significantly through higher amortization of the prepaid royalty as fewer seeds containing the respective trait are expected to be utilized.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the departure from these traits, beginning January 1, 2020 the company presents and discloses the non-cash accelerated prepaid royalty amortization expense as a component of restructuring and asset related charges - net, in the Consolidated Statement of Operations. The accelerated prepaid royalty amortization expense represents the difference between the rate of amortization based on the revised number of units expected to contain the Roundup Ready 2 Yield</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">®</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and Roundup Ready 2 Xtend</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">®</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> trait technology and the variable cash rate per the Roundup Ready 2 License Agreement. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further changes in factors and assumptions associated with usage of the trait platform licensed under the Roundup Ready 2 License Agreement, including the Transition Plan, could further impact the rate of recognition of the prepaid royalty and Consolidated Statement of Operations presentation of the accelerated prepaid royalty amortization expense. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cost of Goods Sold </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of goods sold primarily includes the cost of manufacture and delivery, ingredients or raw materials, direct salaries, wages and benefits and overhead, non-capitalizable costs associated with capital projects, royalties and other operational expenses. No amortization of intangibles is included within cost of goods sold. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Research and Development</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development costs are expensed as incurred. Research and development expense includes costs (primarily consisting of employee costs, materials, contract services, research agreements, and other external spend) relating to the discovery and development of new products.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Selling, General and Administrative Expenses </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selling, general and administrative expenses primarily include selling and marketing expenses, commissions, functional costs, and business management expenses. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Integration and Separation Costs </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Integration and separation costs includes costs incurred to prepare for and close the Merger, post-Merger integration expenses, and costs incurred to prepare for the Business Separations. These costs primarily consist of financial advisory, information technology, legal, accounting, consulting and other professional advisory fees associated with preparation and execution of these activities.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Litigation and Other Contingencies</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accruals for legal matters and other contingencies are recorded when it is probable that a liability has been incurred and the amount of the liability can be reasonably estimated. Legal costs, such as outside counsel fees and expenses, are charged to expense in the period incurred. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Severance Costs</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Severance benefits are provided to employees under the company's ongoing benefit arrangements. Severance costs are accrued when management commits to a plan of termination and it becomes probable that employees will be entitled to benefits at amounts that can be reasonably estimated. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Insurance/Self-Insurance</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company self-insures certain risks where permitted by law or regulation, including workers' compensation, vehicle liability and employee related benefits. Liabilities associated with these risks are estimated in part by considering historical claims experience, demographic factors and other actuarial assumptions. For other risks, the company uses a combination of insurance and self-insurance, reflecting comprehensive reviews of relevant risks. A receivable for an insurance recovery is generally recognized when the loss has occurred and collection is considered probable.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Income Taxes </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company accounts for income taxes using the asset and liability method. Under this method, deferred tax assets and liabilities are recognized for the future tax consequences of temporary differences between the carrying amounts and tax bases of assets and liabilities using enacted tax rates. The effect of a change in tax rates on deferred tax assets or liabilities is recognized in income in the period that includes the enactment date.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company recognizes the financial statement effects of an uncertain income tax position when it is more likely than not, based on the technical merits, that the position will be sustained upon examination. The current portion of uncertain income tax positions is included in income taxes payable or income tax receivable, and the long-term portion is included in other noncurrent obligations or other noncurrent assets in the Consolidated Balance Sheets.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income tax related penalties are included in the provision for (benefit from) income taxes in the Consolidated Statements of Operations. Interest accrued related to unrecognized tax benefits is included within the provision for (benefit from) income taxes from continuing operations in the Consolidated Statements of Operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Earnings per Common Share</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The calculation of earnings per common share is based on the weighted-average number of the company’s common shares outstanding for the applicable period. The calculation of diluted earnings per common share reflects the effect of all potential common shares that were outstanding during the respective periods, unless the effect of doing so is antidilutive.</span></div> The Consolidated Financial Statements include the accounts of the company and subsidiaries in which a controlling interest is maintained. For those consolidated subsidiaries in which the company's ownership is less than 100 percent, the outside stockholders' interests are shown as noncontrolling interests. Investments in affiliates over which the company has the ability to exercise significant influence but does not have a controlling interest are accounted for under the equity method. The company is also involved with certain joint ventures accounted for under the equity method of accounting that are variable interest entities ("VIEs"). The company is not the primary beneficiary, as the nature of the company's involvement with the VIEs does not provide it the power to direct the VIEs significant activities. Future events may require these VIEs to be consolidated if the company becomes the primary beneficiary. At December 31, 2021 and 2020, the maximum exposure to loss related to the nonconsolidated VIEs is not considered material to the Consolidated Financial Statements. Use of Estimates in Financial Statement PreparationThe preparation of financial statements in accordance with U.S. GAAP requires the use of estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. The company’s consolidated financial statements include amounts that are based on management’s best estimates and judgments. Actual results could differ from those estimates. Cash and Cash EquivalentsCash equivalents represent investments with maturities of three months or less from time of purchase. They are carried at cost plus accrued interest. <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Restricted Cash Equivalents</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted cash equivalents primarily consist of trust assets and contributions to the MOU Escrow Account of $377 million and $347 million as of December 31, 2021 and 2020, respectively. The trust assets are classified as current and the contributions to the MOU Escrow Account are classified as noncurrent and included within other current assets and other assets, respectively, in the Consolidated Balance Sheets. See Note 9 - Supplementary Information, to the Consolidated Financial Statements, for further information.</span></div> 377000000 347000000 <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Marketable Securities</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Marketable securities represent investments in fixed and floating rate financial instruments with maturities greater than three months and up to twelve months at time of purchase. Investments classified as held-to-maturity are recorded at amortized cost. The carrying value approximates fair value due to the short-term nature of the investments. Investments classified as debt securities that are available-for-sale are carried at estimated fair value with unrealized gains and losses recorded as a component of accumulated other comprehensive income (loss) or current period earnings if an allowance for credit losses has been established. The cost of investments sold is determined by specific identification.</span></div> <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fair Value Measurements</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the accounting guidance for fair value measurements and disclosures, a fair value hierarchy was established that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). A financial instrument's level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company uses the following valuation techniques to measure fair value for its assets and liabilities:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:9.880%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.317%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:82.503%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 1</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">–</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Quoted market prices in active markets for identical assets or liabilities;</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">–</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Significant other observable inputs (e.g. quoted prices for similar items in active markets, quoted prices for identical or similar items in markets that are not active, inputs other than quoted prices that are observable such as interest rate and yield curves, and market-corroborated inputs);</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 3</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">–</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unobservable inputs for the asset or liability, which are valued based on management's estimates of assumptions that market participants would use in pricing the asset or liability.</span></td></tr></table></div> <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Foreign Currency Translation</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company's worldwide operations utilize the U.S. dollar ("USD") or a related foreign currency as the functional currency, where applicable. The company identifies its separate and distinct foreign entities and groups the foreign entities into two categories: 1) extension of the parent or foreign subsidiaries operating in a hyper-inflationary environment (USD functional currency) and 2) self-contained (related foreign functional currency). If a foreign entity does not align with either category, factors are evaluated and a judgment is made to determine the functional currency.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For foreign entities where the USD is the functional currency, all foreign currency-denominated asset and liability amounts are re-measured into USD at end-of-period exchange rates, except for inventories, prepaid expenses, property, plant and equipment, goodwill and other intangible assets, which are re-measured at historical rates. Foreign currency income and expenses are re-measured at average exchange rates in effect during each month, except for expenses related to balance sheet amounts re-measured at historical exchange rates. Exchange gains and losses arising from re-measurement of foreign currency-denominated monetary assets and liabilities are included in income in the period in which they occur. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For foreign entities where a related foreign currency is the functional currency, assets and liabilities denominated in the related foreign currencies are translated into USD at end-of-period exchange rates and the resultant translation adjustments are reported, net of their related tax effects, as a component of accumulated other comprehensive income (loss) in equity. Assets and liabilities denominated in other than the functional currency are re-measured into the functional currency prior to translation into USD and the resultant exchange gains or losses are included in income in the period in which they occur. Income and expenses are translated into USD at average exchange rates in effect during each month. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company changes the functional currency of its separate and distinct foreign entities only when significant changes in economic facts and circumstances indicate clearly that the functional currency has changed.</span></div> <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Inventories</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company's inventories are valued at the lower of cost or net realizable value. Elements of cost in inventories include raw materials, direct labor and manufacturing overhead. Stores and supplies are valued at cost or net realizable value, whichever is lower; cost is generally determined by the average cost method.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2021 and December 31, 2020, approximately 60% and 40% of the company's inventories were accounted for under the first-in, first-out ("FIFO") and average cost methods, respectively. Inventories accounted for under the FIFO method are primarily comprised of products with shorter shelf lives such as seeds. See Note 13 - Inventories, to the Consolidated Financial Statements, for further information. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company establishes an obsolescence reserve for inventory based upon quality considerations and assumptions about future demand and market conditions.</span></div> 0.60 0.40 <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Property, Plant and Equipment</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant and equipment are carried at cost less accumulated depreciation. In connection with the Merger, the fair value of property, plant and equipment was determined using a market approach and a replacement cost approach. Depreciation is based on the estimated service lives of depreciable assets and is calculated using the straight-line method. Fully depreciated assets are retained in property and accumulated depreciation accounts until they are removed from service. When assets are surrendered, retired, sold, or otherwise disposed of, their gross carrying values and related accumulated depreciation are removed from the Consolidated Balance Sheets and included in determining gain or loss on such disposals.</span></div> <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Goodwill and Other Intangible Assets</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company records goodwill when the purchase price of a business acquisition exceeds the estimated fair value of net identified tangible and intangible assets acquired. Goodwill is tested for impairment at the reporting unit level at least annually, or more frequently when events or changes in circumstances indicate that the fair value of a reporting unit has more likely than not declined below its carrying value. The company performs an annual goodwill impairment test in the fourth quarter. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When testing goodwill for impairment, the company has the option to first perform qualitative testing to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying value. If the company chooses not to complete a qualitative assessment for a given reporting unit or if the initial assessment indicates that it is more likely than not that the carrying value of a reporting unit exceeds its estimated fair value, additional quantitative testing is required. If additional quantitative testing is required, the reporting unit's fair value is compared with its carrying amount, and an impairment charge, if any, is recognized for the amount by which the carrying amount exceeds the reporting unit's fair value, limited to the amount of goodwill associated with the reporting unit. The company determines fair values for each of the reporting units using a discounted cash flow model (a form of the income approach) or the market approach. Under the income approach, fair value is determined based on the present value of estimated future cash flows, discounted at an appropriate risk-adjusted rate. The company's significant assumptions in this analysis included future cash flow projections, weighted average cost of capital, the terminal growth rate, and the tax rate. Under the market approach, the company uses metrics of publicly traded companies or historically completed transactions for comparable companies. See Note 15 - Goodwill and Other Intangible Assets, to the Consolidated Financial Statements, for further information on goodwill.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Indefinite-lived intangible assets are tested for impairment at least annually; however, these tests are performed more frequently when events or changes in circumstances indicate that the asset may be impaired. Impairment exists when carrying value exceeds fair value. The company performs an impairment assessment using the relief from royalty method (a form of the income approach) using Level 3 inputs within the fair value hierarchy. The significant assumptions used in the calculation included projected revenue, the royalty rate, the discount rate, and the terminal growth rate. These significant assumptions involve management judgment and estimates relating to future operating performance and economic conditions that may differ from actual cash flows.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Definite-lived intangible assets are amortized over their estimated useful lives, generally on a straight-line basis for periods ranging primarily from 2 years to 25 years. The company continually evaluates the reasonableness of the useful lives of these assets. Once these assets are fully amortized, they are removed from the Consolidated Balance Sheets.</span></div> P2Y P25Y <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Leases</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company determines whether an arrangement is a lease at the inception of the arrangement based on the terms and conditions in the contract. A contract contains a lease if there is an identified asset and the company has the right to control the asset. Operating lease right-of-use ("ROU") assets are included in other assets on the company’s Consolidated Balance Sheets. Operating lease liabilities are included in accrued and other current liabilities and other noncurrent obligations on the company’s Consolidated Balance Sheets. Finance lease assets are included in property, plant and equipment on the company’s Consolidated Balance Sheets. Finance lease liabilities are included in short-term borrowings and finance lease obligations and long-term debt on the company’s Consolidated Balance Sheets.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease ROU assets represent the company’s right to use an underlying asset for the lease term and lease liabilities represent the company’s obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at the commencement date based on the present value of lease payments over the lease term. As most of the company’s leases do not provide the lessor's implicit rate, the company uses its incremental borrowing rate at the commencement date in determining the present value of lease payments. Lease terms include options to extend the lease when it is reasonably certain those options will be exercised. Leases with an initial term of 12 months or less are not recorded on the balance sheet. The company recognizes lease expense for these leases on a straight-line basis over the lease term. </span></div>The company has lease agreements with lease and non-lease components, which are accounted for as a single lease component for all asset classes. In the Consolidated Statements of Operations, lease expense for operating leases is recognized on a straight-line basis over the lease term. For finance leases, interest expense is recognized on the lease liability and the ROU asset is amortized over the lease term. See Note 16 - Leases, to the Consolidated Financial Statements, for further information. <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Impairment of Long-Lived Assets</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company evaluates the carrying value of long-lived assets to be held and used when events or changes in circumstances indicate the carrying value may not be recoverable. The carrying value of a long-lived asset group is considered impaired when the total projected undiscounted cash flows from the assets are separately identifiable and are less than its carrying value. In that event, a loss is recognized based on the amount by which the carrying value exceeds the fair value of the long-lived asset. The </span></div>company's fair value methodology is an estimate of fair market value which is made based on prices of similar assets or other valuation methodologies including present value techniques. Long-lived assets to be disposed of by sale, if material, are classified as held for sale and reported at the lower of carrying amount or fair value less cost to sell, and depreciation is ceased. Long-lived assets to be disposed of other than by sale are classified as held and used until they are disposed of and reported at the lower of carrying amount or fair value. Depreciation is recognized over the remaining useful life of the assets. <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Derivative Instruments</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Derivative instruments are reported in the Consolidated Balance Sheets at their fair values. The company utilizes derivatives to manage exposures to foreign currency exchange rates and commodity prices. Changes in the fair values of derivative instruments that are not designated as hedges are recorded in current period earnings. For derivative instruments designated as cash flow hedges, the gain (loss) is reported in accumulated other comprehensive income (loss) until it is cleared to earnings during the same period in which the hedged item affects earnings. For derivative instruments designated as net investment hedges, the gain (loss) is reported within accumulated other comprehensive income (loss) until the subsidiary is divested.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event that a derivative designated as a hedge of a firm commitment or an anticipated transaction is terminated prior to the maturation of the hedged transaction, the net gain or loss in accumulated other comprehensive income (loss) generally remains in accumulated other comprehensive income (loss) until the item that was hedged affects earnings. If a hedged transaction matures, or is sold, extinguished, or terminated prior to the maturity of a derivative designated as a hedge of such transaction, gains or losses associated with the derivative through the date the transaction matured are included in the measurement of the hedged transaction and the derivative is reclassified as for trading purposes. Derivatives designated as hedges of anticipated transactions are reclassified as for trading purposes if the anticipated transaction is no longer probable.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company included foreign currency exchange contract settlements within cash flows from operating activities, regardless of hedge accounting qualification. See Note 22 - Financial Instruments, to the Consolidated Financial Statements, for additional discussion regarding the company's objectives and strategies for derivative instruments.</span></div> <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Environmental Matters</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accruals for environmental matters are recorded when it is probable that a liability has been incurred and the amount of the liability can be reasonably estimated. These accruals are adjusted periodically as assessment and remediation efforts progress or as additional technical or legal information becomes available. Accruals for environmental liabilities are included in the Consolidated Balance Sheets in accrued and other current liabilities and other noncurrent obligations at undiscounted amounts. Accruals for related insurance or other third-party recoveries for environmental liabilities are recorded when it is probable that a recovery will be realized and are included in the Consolidated Balance Sheets as accounts and notes receivable - net. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Environmental costs are capitalized if the costs extend the life of the property, increase its capacity, and/or mitigate or prevent contamination from future operations. Environmental costs are also capitalized in recognition of legal asset retirement obligations resulting from the acquisition, construction and/or normal operation of a long-lived asset. Costs related to environmental contamination treatment and cleanup are charged to expense. Estimated future incremental operations, maintenance and management costs directly related to remediation are accrued when such costs are probable and reasonably estimable.</span></div> <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company recognizes revenue when its customer obtains control of promised goods or services, in an amount that reflects the consideration which the company expects to receive in exchange for those goods or services. To determine revenue recognition for the arrangements that the company determines are within the scope of FASB ASU No. 2014-09, Revenue from Contracts with Customers (Topic 606), the company performs the following five steps: (1) identify the contract(s) with a customer, (2) identify the performance obligations in the contract, (3) determine the transaction price, (4) allocate the transaction price to the performance obligations in the contract, and (5) recognize revenue when (or as) the entity satisfies a performance obligation. See Note 6 - Revenue, to the Consolidated Financial Statements, for additional information on revenue recognition.</span></div> <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Prepaid Royalties</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company currently has certain third-party biotechnology trait license agreements, which require up-front and variable payments subject to the licensor meeting certain conditions. These payments are reflected as other current assets and other assets and are amortized to cost of goods sold as seeds containing the respective trait technology are utilized over the life of the license. The rate of royalty amortization expense recognized is based on the company’s strategic plans which include various assumptions and estimates including product portfolio, market dynamics, farmer preferences, growth rates and projected planted acres. Changes in factors and assumptions included in the strategic plans, including potential changes to the product portfolio in favor of internally developed biotechnology, could impact the rate of recognition of the relevant prepaid royalty. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December 31, 2021, the balance of prepaid royalties reflected in other current assets and other assets was $303 million and $256 million, respectively. The majority of the balance of prepaid royalties relates to the company’s wholly owned subsidiary, Pioneer Hi-Bred International, Inc.’s (“Pioneer”) non-exclusive license in the United States and Canada for the Monsanto Company's Genuity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">®</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Roundup Ready 2 Yield</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">®</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> glyphosate tolerance trait and Roundup Ready 2 Xtend</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">®</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> glyphosate and dicamba tolerance trait for soybeans (“Roundup Ready 2 License Agreement”). Each of these licensed technologies are now trademarks of the Bayer Group, which acquired the Monsanto Company in 2018. The prepaid royalty asset relates to a series of up-front, fixed and variable royalty payments to utilize the traits in Pioneer’s soybean product mix.The company’s historical expectation has been that the technology licensed under the Roundup Ready 2 License Agreement would be used as the primary herbicide tolerance trait platform in the Pioneer</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">® </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">brand soybean through the term of the agreement. DAS and MS Technologies, L.L.C. jointly developed and own the Enlist E3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">herbicide tolerance trait for soybeans which provides tolerance to 2, 4-D choline in Enlist Duo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">®</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and Enlist One</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">®</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> herbicides, as well as glyphosate and glufosinate herbicides. In connection with the validation of breeding plans and large-scale product development timelines, during the fourth quarter of 2019, the company accelerated the ramp up of the Enlist E3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> trait platform in the company’s soybean portfolio mix across all brands, including Pioneer</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">®</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> brands, over the subsequent five years. During the ramp-up period, the company is expected to significantly reduce the volume of products with the Roundup Ready 2 Yield</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">®</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and Roundup Ready 2 Xtend</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">® </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">herbicide tolerance traits beginning in 2021, with expected minimal use of the trait platform thereafter for the remainder of the Roundup Ready 2 License Agreement (the “Transition Plan”). The rate of royalty expense has therefore increased significantly through higher amortization of the prepaid royalty as fewer seeds containing the respective trait are expected to be utilized.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the departure from these traits, beginning January 1, 2020 the company presents and discloses the non-cash accelerated prepaid royalty amortization expense as a component of restructuring and asset related charges - net, in the Consolidated Statement of Operations. The accelerated prepaid royalty amortization expense represents the difference between the rate of amortization based on the revised number of units expected to contain the Roundup Ready 2 Yield</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">®</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and Roundup Ready 2 Xtend</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">®</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> trait technology and the variable cash rate per the Roundup Ready 2 License Agreement. </span></div>Further changes in factors and assumptions associated with usage of the trait platform licensed under the Roundup Ready 2 License Agreement, including the Transition Plan, could further impact the rate of recognition of the prepaid royalty and Consolidated Statement of Operations presentation of the accelerated prepaid royalty amortization expense. 303000000 256000000 Cost of Goods Sold Cost of goods sold primarily includes the cost of manufacture and delivery, ingredients or raw materials, direct salaries, wages and benefits and overhead, non-capitalizable costs associated with capital projects, royalties and other operational expenses. No amortization of intangibles is included within cost of goods sold. <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Research and Development</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development costs are expensed as incurred. Research and development expense includes costs (primarily consisting of employee costs, materials, contract services, research agreements, and other external spend) relating to the discovery and development of new products.</span></div> Selling, General and Administrative Expenses Selling, general and administrative expenses primarily include selling and marketing expenses, commissions, functional costs, and business management expenses. <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Integration and Separation Costs </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Integration and separation costs includes costs incurred to prepare for and close the Merger, post-Merger integration expenses, and costs incurred to prepare for the Business Separations. These costs primarily consist of financial advisory, information technology, legal, accounting, consulting and other professional advisory fees associated with preparation and execution of these activities.</span></div> Litigation and Other ContingenciesAccruals for legal matters and other contingencies are recorded when it is probable that a liability has been incurred and the amount of the liability can be reasonably estimated. Legal costs, such as outside counsel fees and expenses, are charged to expense in the period incurred. Severance CostsSeverance benefits are provided to employees under the company's ongoing benefit arrangements. Severance costs are accrued when management commits to a plan of termination and it becomes probable that employees will be entitled to benefits at amounts that can be reasonably estimated. <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Insurance/Self-Insurance</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company self-insures certain risks where permitted by law or regulation, including workers' compensation, vehicle liability and employee related benefits. Liabilities associated with these risks are estimated in part by considering historical claims experience, demographic factors and other actuarial assumptions. For other risks, the company uses a combination of insurance and self-insurance, reflecting comprehensive reviews of relevant risks. A receivable for an insurance recovery is generally recognized when the loss has occurred and collection is considered probable.</span></div> <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Income Taxes </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company accounts for income taxes using the asset and liability method. Under this method, deferred tax assets and liabilities are recognized for the future tax consequences of temporary differences between the carrying amounts and tax bases of assets and liabilities using enacted tax rates. The effect of a change in tax rates on deferred tax assets or liabilities is recognized in income in the period that includes the enactment date.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company recognizes the financial statement effects of an uncertain income tax position when it is more likely than not, based on the technical merits, that the position will be sustained upon examination. The current portion of uncertain income tax positions is included in income taxes payable or income tax receivable, and the long-term portion is included in other noncurrent obligations or other noncurrent assets in the Consolidated Balance Sheets.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income tax related penalties are included in the provision for (benefit from) income taxes in the Consolidated Statements of Operations. Interest accrued related to unrecognized tax benefits is included within the provision for (benefit from) income taxes from continuing operations in the Consolidated Statements of Operations.</span></div> <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Earnings per Common Share</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The calculation of earnings per common share is based on the weighted-average number of the company’s common shares outstanding for the applicable period. The calculation of diluted earnings per common share reflects the effect of all potential common shares that were outstanding during the respective periods, unless the effect of doing so is antidilutive.</span></div> RECENT ACCOUNTING GUIDANCE<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recently Adopted Accounting Guidance </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2021, the FASB issued ASU 2021-01, Reference Rate Reform (Topic 848): Scope, which provides certain optional expedients that allow derivative instruments impacted by changes in the interest rate used for margining, discounting or contract price alignment to qualify for certain optional relief. The amendments in this Update are effective immediately for all entities and may be applied retrospectively as of any date from the beginning of any interim period that includes March 12, 2020 or prospectively to new modifications subsequent to the issuance of this Update. The adoption of ASU 2021-01 did not have a material impact on the company’s financial position, results of operation or cash flows.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes, which is part of the FASB’s Simplification Initiative to identify, evaluate, and improve areas of U.S. GAAP for which cost and complexity can be reduced, while maintaining or improving the usefulness of the information provided to users of financial statements. This ASU amends ASC 740, Income Taxes, by removing certain exceptions to the general principles, and clarifying and amending current guidance. The new standard is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020. The company adopted this guidance on January 1, 2021 and it did not have a material impact on the company’s financial position, results of operation or cash flows.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounting Guidance Issued But Not Adopted as of December 31, 2021</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2021, the FASB issued ASU 2021-10, </span><span style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Government Assistance (Topic 832): Disclosures by Business Entities about Government Assistance, which </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">requires business entities to disclose transactions with a governmental entity for which a grant or contribution accounting model is used in recognizing and measuring such transactions. This standard is effective for fiscal years beginning after December 15, 2021, and early adoption is permitted. The company is currently evaluating the impact of adopting this guidance.</span></div> RECENT ACCOUNTING GUIDANCE<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recently Adopted Accounting Guidance </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2021, the FASB issued ASU 2021-01, Reference Rate Reform (Topic 848): Scope, which provides certain optional expedients that allow derivative instruments impacted by changes in the interest rate used for margining, discounting or contract price alignment to qualify for certain optional relief. The amendments in this Update are effective immediately for all entities and may be applied retrospectively as of any date from the beginning of any interim period that includes March 12, 2020 or prospectively to new modifications subsequent to the issuance of this Update. The adoption of ASU 2021-01 did not have a material impact on the company’s financial position, results of operation or cash flows.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes, which is part of the FASB’s Simplification Initiative to identify, evaluate, and improve areas of U.S. GAAP for which cost and complexity can be reduced, while maintaining or improving the usefulness of the information provided to users of financial statements. This ASU amends ASC 740, Income Taxes, by removing certain exceptions to the general principles, and clarifying and amending current guidance. The new standard is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020. The company adopted this guidance on January 1, 2021 and it did not have a material impact on the company’s financial position, results of operation or cash flows.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounting Guidance Issued But Not Adopted as of December 31, 2021</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2021, the FASB issued ASU 2021-10, </span><span style="color:#2d2d2d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Government Assistance (Topic 832): Disclosures by Business Entities about Government Assistance, which </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">requires business entities to disclose transactions with a governmental entity for which a grant or contribution accounting model is used in recognizing and measuring such transactions. This standard is effective for fiscal years beginning after December 15, 2021, and early adoption is permitted. The company is currently evaluating the impact of adopting this guidance.</span></div> COMMON CONTROL BUSINESS COMBINATIONS<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAS Common Control Combination </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on an evaluation of the provisions of ASC 805 (Business Combinations), Corteva and DAS represented entities under common control, as both shared DowDuPont as their parent company. As a result, the assets, liabilities and operations of </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corteva and DAS were combined at their historical carrying amounts, and periods prior to the Internal Reorganizations are adjusted as if Corteva and DAS had been combined since the Merger Effectiveness Time, when the entities were first under common control. Accordingly, in 2019, the accompanying Consolidated Financial Statements and Notes thereto were retrospectively revised to include the transferred net assets and results of operations of DAS beginning on September 1, 2017. Refer to Note 1 - Background and Basis of Presentation, for additional information on the common control combination.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intercompany balances and transactions with Historical EID and DAS have been eliminated.</span></div> DIVESTITURES AND OTHER TRANSACTIONS <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Separation Agreements</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Distributions, DuPont, Corteva, and Dow (together, the “Parties” and each a “Party”) entered into certain agreements to effect the separation, provide for the allocation of DowDuPont’s assets, employees, liabilities and obligations (including its investments, property and employee benefits and tax-related assets and liabilities) among the Parties, and provide a framework for Corteva's relationship with Dow and DuPont following the separations and Distributions (collectively, the "Separation Agreements"). Effective April 1, 2019, the Parties entered into the following agreements referred to herein as: the Separation and Distribution Agreement (the “Corteva Separation Agreement”); the Tax Matters Agreement; the Employee Matters Agreement; and the Intellectual Property Cross-License Agreement. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective June 1, 2019, in connection with the Corteva Distribution, Corteva and DuPont entered into the following agreements: the Intellectual Property Cross-License Agreement (the “Corteva-DuPont IP Cross-License Agreement”); the Letter Agreement; and the Amended and Restated Tax Matters Agreement.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">DuPont</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the Separation Agreements, DuPont and Corteva indemnifies the other against certain litigation, environmental, tax, workers' compensation and other liabilities that arose prior to the Corteva Distribution. The term of this indemnification is generally indefinite and includes defense costs and expenses, as well as monetary and non-monetary settlements and judgments. In connection with the recognition of liabilities related to these matters, the company records an indemnification asset when recovery is deemed probable. At December 31, 2021, the indemnification assets are $25 million within accounts and notes receivable - net and $75 million within other assets in the Consolidated Balance Sheet. At December 31, 2021, the indemnification liabilities are $75 million within other noncurrent obligations in the Consolidated Balance Sheet.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Dow</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the Separation Agreements, Dow and Corteva indemnifies the other against certain litigation, environmental, tax and other liabilities that arose prior to the Corteva Distribution. The term of this indemnification is generally indefinite and includes defense costs and expenses, as well as monetary and non-monetary settlements and judgments. In connection with the recognition of liabilities related to these matters, the company records an indemnification asset when recovery is deemed probable. At December 31, 2021, the indemnification liabilities are $20 million within accrued and other current liabilities and $42 million within other noncurrent obligations in the Consolidated Balance Sheet.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EID ECP Divestiture</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As discussed in Note 1 - Background and Basis of Presentation, on April 1, 2019, EID completed the transfer of the entities and related assets and liabilities of EID ECP to DowDuPont. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result, the financial results of EID ECP are reflected as discontinued operations, as summarized below:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.139%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.661%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Year Ended December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">362 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of goods sold</span></div></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">259 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expense</span></div></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></div></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangibles</span></div></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring and asset related charges - net</span></div></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integration and separation costs</span></div></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income - net</span></div></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Loss) income from discontinued operations before income taxes</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for (benefit from) income taxes on discontinued operations</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Loss) income from discontinued operations after income taxes</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the depreciation, amortization of intangibles, and capital expenditures of the discontinued operations related to EID ECP:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.139%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.661%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Year Ended December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangibles</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital expenditures</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EID Specialty Products Divestiture</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As discussed in Note 1 - Background and Basis of Presentation, on May 1, 2019, the company completed the transfer of the entities and related assets and liabilities of the EID Specialty Products Entities to DowDuPont. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result, the financial results of the EID Specialty Products Entities are reflected as discontinued operations, as summarized below:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:79.016%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.784%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Year Ended December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,030 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of goods sold</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,352 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expense</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">204 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">573 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangibles</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">267 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring and asset related charges - net</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integration and separation costs</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill impairment</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,102 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income - net</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Loss) income from discontinued operations before income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(779)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for (benefit from) income taxes on discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Loss) income from discontinued operations after income taxes</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(859)</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">EID Specialty Products Impairment    </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the Merger and related acquisition method of accounting, Historical DuPont's assets and liabilities were measured at fair value resulting in increases to the company’s goodwill and other intangible assets. The fair value valuation increased the risk that any declines in financial projections, including changes to key assumptions, could have a material, negative impact on the fair value of the company’s reporting units and assets, and therefore could result in an impairment.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the Internal Reorganization, in the second quarter of 2019, EID assessed the recoverability of the goodwill within the electronics and communications, protection solutions, nutrition and health, transportation and advanced polymers, packaging and specialty plastics, industrial biosciences, and clean technologies reporting units, and the overall carrying value of the net assets in the disposal group that was distributed to DowDuPont on May 1, 2019. As a result of this analysis, the company determined that the fair value of certain reporting units related to the EID specialty products businesses were below carrying value resulting in pre-tax, non-cash goodwill impairment charges totaling $1,102 million reflected in (loss) income from discontinued operations after income taxes. Revised financial projections reflect unfavorable market conditions, driven by slowed demand in the biomaterials business unit, coupled with challenging conditions in U.S. bioethanol markets. These revised financial projections resulted in a reduction in the long-term forecasts of sales and profitability as compared to prior projections. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company’s analyses above using discounted cash flow models (a form of the income approach) utilized Level 3 unobservable inputs. The company’s significant assumptions in these analyses include, but are not limited to, future cash flow projections, the weighted average cost of capital, the terminal growth rate, and the tax rate. The company’s estimates of future cash flows are based on current regulatory and economic climates, recent operating results, and planned business strategies. These estimates could be negatively affected by changes in federal, state, or local regulations or economic downturns. Future cash flow estimates are, by their nature, subjective and actual results may differ materially from the company’s estimates. The company also used a form of the market approach (utilizes Level 3 unobservable inputs), which is derived from metrics of publicly traded companies or historically completed transactions of comparable businesses. The selection of comparable businesses is based on the markets in which the reporting units operate giving consideration to risk profiles, size, geography, and diversity of products and services. As such, the company believes the current assumptions and estimates utilized are both reasonable and appropriate.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the company performed an impairment analysis related to the equity method investments held by the EID specialty products businesses, as of May 1, 2019. The company applied the net asset value method under the cost approach to determine the fair value of the equity method investments in the EID specialty products businesses. Based on updated projections, the company determined the fair value of an equity method investment was below the carrying value and had no expectation the fair value would recover in the short-term due to the current economic environment. As a result, management concluded the impairment was other-than-temporary and recorded an impairment charge of $63 million, reflected in (loss) income from discontinued operations after income taxes. Additionally, this impairment is reflected within restructuring and asset related charges - net in the year ended December 31, 2019, within the table above.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the depreciation, amortization of intangibles, and capital expenditures of the discontinued operations related to the EID Specialty Products Entities:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:79.747%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.053%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">281 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangibles</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">267 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital expenditures</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">481 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Merger Remedy - Divested Ag Business</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a condition of the regulatory approval for the Merger, including by the European Commission, EID was required to divest (the “Divested Ag Business”) certain assets related to its crop protection business and research and development ("R&amp;D") organization, specifically EID’s Cereal Broadleaf Herbicides and Chewing Insecticides portfolios, including Rynaxypyr®, Cyazypyr® and Indoxacarb as well as the crop protection R&amp;D pipeline and organization, excluding seed treatment, nematicides, and late-stage R&amp;D programs. On March 31, 2017, EID and FMC Corporation (“FMC”) entered into a definitive agreement (the "FMC Transaction Agreement"), and on November 1, 2017 FMC acquired the Divested Ag Business. As a result of the agreement, EID entered into favorable contracts with FMC of $495 million, which were recorded as intangible assets recognized at the fair value of off-market contracts. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December 31, 2019, the company recorded income from discontinued operations after income taxes related to the Divested Ag Business of $80 million related to changes in accruals for certain prior year tax positions. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Discontinued Operations Activity</span></div>For the year ended December 31, 2020, the company recorded income from discontinued operations after income taxes of $10 million related to the adjustment of certain prior year tax positions for previously divested businesses. For the year ended December 31, 2019, the company recorded income from discontinued operations after income taxes of $89 million related to the adjustment of certain unrecognized tax benefits for positions taken on items from prior years from previously divested businesses. 25000000 75000000 75000000 20000000 42000000 <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.139%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.661%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Year Ended December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">362 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of goods sold</span></div></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">259 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expense</span></div></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></div></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangibles</span></div></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring and asset related charges - net</span></div></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integration and separation costs</span></div></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income - net</span></div></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Loss) income from discontinued operations before income taxes</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for (benefit from) income taxes on discontinued operations</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Loss) income from discontinued operations after income taxes</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 362000000 259000000 4000000 9000000 23000000 2000000 44000000 2000000 23000000 4000000 19000000 <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.139%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.661%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Year Ended December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangibles</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital expenditures</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table> 28000000 23000000 16000000 <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:79.016%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.784%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Year Ended December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,030 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of goods sold</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,352 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expense</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">204 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">573 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangibles</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">267 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring and asset related charges - net</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integration and separation costs</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill impairment</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,102 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income - net</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Loss) income from discontinued operations before income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(779)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for (benefit from) income taxes on discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Loss) income from discontinued operations after income taxes</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(859)</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 5030000000 3352000000 204000000 573000000 267000000 115000000 253000000 1102000000 57000000 -779000000 80000000 -859000000 1102000000 63000000 <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:79.747%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.053%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">281 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangibles</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">267 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital expenditures</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">481 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 281000000 267000000 481000000 495000000 80000000 10000000 89000000 REVENUE<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Products</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Substantially all of Corteva's revenue is derived from product sales. Product sales consist of sales of Corteva's products to farmers, distributors, and manufacturers. Corteva considers purchase orders, which in some cases are governed by master supply agreements, to be a contract with a customer. Contracts with customers are considered to be short-term when the time between order confirmation and satisfaction of the performance obligations is equal to or less than one year. However, the company has some long-term contracts which can span multiple years.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue from product sales is recognized when the customer obtains control of the company's product, which occurs at a point in time according to shipping terms. Payment terms are generally less than one year from invoicing. The company elected the practical expedient and does not adjust the promised amount of consideration for the effects of a significant financing component when the company expects it will be one year or less between when a customer obtains control of the company's product and when payment is due. When the company performs shipping and handling activities after the transfer of control to the customer (e.g., when control transfers prior to or at shipment), these are considered fulfillment activities, and accordingly, the costs are accrued when the related revenue is recognized. Taxes collected from customers relating to product sales and remitted to governmental authorities are excluded from revenues. In addition, the company elected the practical expedient to expense any costs to obtain contracts as incurred, as the amortization period for these costs would have been one year or less.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The transaction price includes estimates of variable consideration, such as rights of return, rebates, and discounts, that are reductions in revenue. All estimates are based on the company's historical experience, anticipated performance, and the company's best judgment at the time the estimate is made. Estimates of variable consideration included in the transaction price primarily utilize the expected value method based on historical experience. These estimates are reassessed each reporting period and are included in the transaction price to the extent it is probable that a significant reversal of cumulative revenue recognized will not occur upon resolution of uncertainty associated with the variable consideration. The majority of contracts have a single performance obligation satisfied at a point in time and the transaction price is stated in the contract, usually as quantity times price per unit. For contracts with multiple performance obligations, the company allocates the transaction price to each performance obligation based on the relative standalone selling price. The standalone selling price is the observable price which depicts the price as if sold to a similar customer in similar circumstances.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Licenses of Intellectual Property</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corteva enters into licensing arrangements with customers under which it licenses its intellectual property. Revenue from the majority of intellectual property licenses is derived from sales-based royalties. Revenue for licensing agreements that contain sales-based royalties is recognized at the later of (i) when the subsequent sale occurs or (ii) when the performance obligation to which some or all of the royalty has been allocated is satisfied. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Remaining Performance Obligations</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Remaining performance obligations represent the transaction price allocated to unsatisfied or partially unsatisfied performance obligations. The company applies the practical expedient to disclose the transaction price allocated to remaining performance obligations for only those contracts with an original duration of one year or more. The transaction price allocated to remaining performance obligations with an original duration of more than one year related to material rights granted to customers for contract renewal options were $123 million and $115 million at December 31, 2021 and December 31, 2020, respectively. The company expects revenue to be recognized for the remaining performance obligations evenly over the period of 1 year to 6 years.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contract Balances</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract liabilities primarily reflect deferred revenue from prepayments under contracts with customers where the company receives advance payments for products to be delivered in future periods. Corteva classifies deferred revenue as current or noncurrent based on the timing of when the company expects to recognize revenue. Contract assets primarily include amounts related to conditional rights to consideration for completed performance not yet invoiced. Accounts receivable are recorded when the right to consideration becomes unconditional.</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:64.735%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.055%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.910%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Contract Balances</span></td><td colspan="3" rowspan="2" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" rowspan="2" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-right:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts and notes receivable - trade</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,561 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,917 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract assets - current</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">2</span></div></td><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract assets - noncurrent</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">3</span></div></td><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue - current</span></td><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,201 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,662 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue - noncurrent</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">4</span></div></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:14.1pt">Included in accounts and notes receivable - net in the Consolidated Balance Sheets.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:14.1pt">Included in other current assets in the Consolidated Balance Sheets. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:14.1pt">Included in other assets in the Consolidated Balance Sheets. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">4.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:14.1pt">Included in other noncurrent obligations in the Consolidated Balance Sheets. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue recognized during the year ended December 31, 2021, December 31, 2020, and December 31, 2019 from amounts included in deferred revenue at the beginning of the period was $2,613 million, $2,540 million, and $2,146 million, respectively. </span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Disaggregation of Revenue</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corteva's operations are classified into two reportable segments: Seed and Crop Protection. The company disaggregates its revenue by major product line and geographic region, as the company believes it best depicts the nature, amount and timing of its revenue and cash flows. Net sales by major product line are included below:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:39.543%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.783%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.636%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.638%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">    Corn</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,618 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,182 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,126 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">    Soybean</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,568 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,445 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,387 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">    Other oilseeds</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">752 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">619 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">593 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">    Other</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">464 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">510 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">484 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Seed</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,402 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,756 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,590 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">    Herbicides</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,815 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,280 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,206 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">    Insecticides</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,730 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,764 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,652 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">    Fungicides</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,310 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,032 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,072 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">    Other</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">398 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">385 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">326 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Crop Protection</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,253 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,461 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,256 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,655 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,217 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,846 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales are attributed to geographic regions based on customer location. Net sales by geographic region and segment are included below:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:39.250%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.783%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.783%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.784%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Seed</span></td><td colspan="9" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Year Ended December 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,004 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,795 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,724 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EMEA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">2</span></div></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,599 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,468 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,378 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Latin America</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,420 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,117 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,130 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia Pacific</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">379 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">376 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">358 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,402 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,756 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,590 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:39.250%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.783%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.783%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.784%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Crop Protection</span></td><td colspan="9" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,532 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,373 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,205 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EMEA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">2</span></div></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,524 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,374 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,362 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Latin America</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,125 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,688 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,759 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia Pacific</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,072 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,026 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">930 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,253 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,461 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,256 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt;padding-left:18pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:7.5pt">Represents U.S. &amp; Canada.</span></div><div style="padding-left:18pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:7.5pt">Europe, Middle East, and Africa ("EMEA").</span></div>Refer to Note 24 - Geographic Information, for the breakout of consolidated net sales by geographic area. <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Products</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Substantially all of Corteva's revenue is derived from product sales. Product sales consist of sales of Corteva's products to farmers, distributors, and manufacturers. Corteva considers purchase orders, which in some cases are governed by master supply agreements, to be a contract with a customer. Contracts with customers are considered to be short-term when the time between order confirmation and satisfaction of the performance obligations is equal to or less than one year. However, the company has some long-term contracts which can span multiple years.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue from product sales is recognized when the customer obtains control of the company's product, which occurs at a point in time according to shipping terms. Payment terms are generally less than one year from invoicing. The company elected the practical expedient and does not adjust the promised amount of consideration for the effects of a significant financing component when the company expects it will be one year or less between when a customer obtains control of the company's product and when payment is due. When the company performs shipping and handling activities after the transfer of control to the customer (e.g., when control transfers prior to or at shipment), these are considered fulfillment activities, and accordingly, the costs are accrued when the related revenue is recognized. Taxes collected from customers relating to product sales and remitted to governmental authorities are excluded from revenues. In addition, the company elected the practical expedient to expense any costs to obtain contracts as incurred, as the amortization period for these costs would have been one year or less.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The transaction price includes estimates of variable consideration, such as rights of return, rebates, and discounts, that are reductions in revenue. All estimates are based on the company's historical experience, anticipated performance, and the company's best judgment at the time the estimate is made. Estimates of variable consideration included in the transaction price primarily utilize the expected value method based on historical experience. These estimates are reassessed each reporting period and are included in the transaction price to the extent it is probable that a significant reversal of cumulative revenue recognized will not occur upon resolution of uncertainty associated with the variable consideration. The majority of contracts have a single performance obligation satisfied at a point in time and the transaction price is stated in the contract, usually as quantity times price per unit. For contracts with multiple performance obligations, the company allocates the transaction price to each performance obligation based on the relative standalone selling price. The standalone selling price is the observable price which depicts the price as if sold to a similar customer in similar circumstances.</span></div> Licenses of Intellectual PropertyCorteva enters into licensing arrangements with customers under which it licenses its intellectual property. Revenue from the majority of intellectual property licenses is derived from sales-based royalties. Revenue for licensing agreements that contain sales-based royalties is recognized at the later of (i) when the subsequent sale occurs or (ii) when the performance obligation to which some or all of the royalty has been allocated is satisfied. 123000000 115000000 P1Y P6Y <div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:64.735%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.055%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.910%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Contract Balances</span></td><td colspan="3" rowspan="2" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" rowspan="2" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-right:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts and notes receivable - trade</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,561 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,917 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract assets - current</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">2</span></div></td><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract assets - noncurrent</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">3</span></div></td><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue - current</span></td><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,201 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,662 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue - noncurrent</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">4</span></div></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:14.1pt">Included in accounts and notes receivable - net in the Consolidated Balance Sheets.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:14.1pt">Included in other current assets in the Consolidated Balance Sheets. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:14.1pt">Included in other assets in the Consolidated Balance Sheets. </span></div>4.Included in other noncurrent obligations in the Consolidated Balance Sheets. 3561000000 3917000000 24000000 22000000 58000000 54000000 3201000000 2662000000 120000000 116000000 2613000000 2540000000 2146000000 5618000000 5182000000 5126000000 1568000000 1445000000 1387000000 752000000 619000000 593000000 464000000 510000000 484000000 8402000000 7756000000 7590000000 3815000000 3280000000 3206000000 1730000000 1764000000 1652000000 1310000000 1032000000 1072000000 398000000 385000000 326000000 7253000000 6461000000 6256000000 15655000000 14217000000 13846000000 <div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:39.250%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.783%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.783%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.784%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Seed</span></td><td colspan="9" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Year Ended December 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,004 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,795 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,724 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EMEA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">2</span></div></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,599 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,468 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,378 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Latin America</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,420 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,117 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,130 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia Pacific</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">379 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">376 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">358 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,402 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,756 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,590 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:39.250%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.783%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.783%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.784%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Crop Protection</span></td><td colspan="9" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,532 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,373 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,205 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EMEA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">2</span></div></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,524 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,374 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,362 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Latin America</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,125 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,688 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,759 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia Pacific</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,072 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,026 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">930 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,253 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,461 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,256 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt;padding-left:18pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:7.5pt">Represents U.S. &amp; Canada.</span></div><div style="padding-left:18pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:7.5pt">Europe, Middle East, and Africa ("EMEA").</span></div> 5004000000 4795000000 4724000000 1599000000 1468000000 1378000000 1420000000 1117000000 1130000000 379000000 376000000 358000000 8402000000 7756000000 7590000000 2532000000 2373000000 2205000000 1524000000 1374000000 1362000000 2125000000 1688000000 1759000000 1072000000 1026000000 930000000 7253000000 6461000000 6256000000 RESTRUCTURING AND ASSET RELATED CHARGES - NET<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2021 Restructuring Actions</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2021, Corteva approved restructuring actions designed to right-size and optimize its footprint and organizational structure according to the business needs in each region with the focus on driving continued cost improvement and productivity. The company recorded net pre-tax restructuring charges in 2021 under the 2021 Restructuring Actions, as disclosed in the tables below. The company does not anticipate any additional material charges from the 2021 Restructuring Actions as actions associated with this charge are substantially complete.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The charges related to the 2021 Restructuring Actions related to the segments, as well as corporate expenses, were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:79.747%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.053%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Year Ended December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Seed</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Crop Protection</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate expenses</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt"><span><br/></span></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of charges incurred related to 2021 Restructuring Actions for the year ended December 31, 2021:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:79.747%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.053%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Year Ended December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance and related benefit costs</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset related charges</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract termination charges</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total restructuring and asset charges - net</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the December 31, 2020 to the December 31, 2021 liability balances related to the 2021 Restructuring Actions is summarized below:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:37.057%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.052%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.473%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.981%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.937%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Severance and Related Benefit Costs</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Asset Related</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-style:italic;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">1</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Contract Termination</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-style:italic;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">2</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charges to income from continuing operations</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset write-offs</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(51)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(51)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-right:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:22.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:7.5pt">In addition, the company has a liability recorded for asset retirement obligations of $6 million as of December 31, 2021. </span></div><div style="padding-left:22.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:7.5pt">The liability for contract terminations includes lease obligations. The cash impact of these obligations will be substantially complete by the end of 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Execute to Win Productivity Program</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2020, Corteva approved restructuring actions designed to improve productivity through optimizing certain operational and organizational structures primarily related to the Execute to Win Productivity Program. The company recorded net pre-tax restructuring charges of $185 million inception-to-date under the Execute to Win Productivity Program, consisting of $124 million of asset related charges and $61 million of severance and related benefit costs. Actions associated with the Execute to Win Productivity Program were substantially complete by the end of 2020.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Execute to Win Productivity Program charges related to the segments, as well as corporate expenses, were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:67.475%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.612%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.613%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="6" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Year Ended December 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Seed</span></td><td style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Crop Protection</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate expenses</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9 </span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">176 </span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The below is a summary of charges incurred related to the Execute to Win Productivity Program for the year ended December 31, 2020: </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.613%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.544%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="6" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance and related benefit costs - net</span></td><td style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset related charges</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total restructuring and asset related charges - net</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">176 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the December 31, 2020 to the December 31, 2021 liability balances related to the Execute to Win Productivity Program is summarized below:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.198%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.198%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.054%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Severance and Related Benefit (Credits) Costs</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Asset Related</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-style:italic;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">1</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charges to income from continuing operations for the year ended December 31, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset write-offs</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24 </span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24 </span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.25pt">In addition, the company has a liability recorded for asset retirement obligations of $13 million as of December 31, 2021.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DowDuPont Cost Synergy Program </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September and November 2017, DowDuPont and EID approved post-merger restructuring actions under the DowDuPont Cost Synergy Program (the “Synergy Program”), adopted at the time by the DowDuPont Board of Directors. The Synergy Program was designed to integrate and optimize the organization following the Merger and in preparation for the Business Separations. The company recorded net pre-tax restructuring charges of $833 million inception-to-date under the Synergy Program, consisting of severance and related benefit costs of $316 million, contract termination costs of $190 million, and asset related charges of $327 million. Actions associated with the Synergy Program, including employee separations, were substantially complete by the end of 2019.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Synergy Program net charges (benefits) related to the segments, as well as corporate expenses, were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.038%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.520%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.520%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.522%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-left:1pt solid #000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Seed</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Crop Protection</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27 </span></td><td style="border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate expenses</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92 </span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The below is a summary of net charges (benefits) incurred related to the Synergy Program for the years ended December 31, 2021, 2020 and 2019:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.038%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.520%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.520%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.522%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-left:1pt solid #000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance and related benefit (credits) costs - net</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract termination charges</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69 </span></td><td style="border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset related charges</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total restructuring and asset related charges - net</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92 </span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt;text-align:center"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Asset Related Charges</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December 31, 2021 and 2020, the company recognized $125 million and $159 million, respectively, in restructuring and asset related charges - net in the Consolidated Statements of Operations, from non-cash accelerated prepaid royalty amortization expense related to Roundup Ready 2 Yield® and Roundup Ready 2 Xtend® herbicide tolerance traits.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Asset Impairment</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2019, the company recognized non-cash impairment charges of $144 million pre-tax ($110 million after-tax) in restructuring and asset related charges - net in the company's Consolidated Statements of Operations related to certain in-process research and development ("IPR&amp;D") assets within the seed segment. Refer to Note 15 - Goodwill and Other Intangible Assets, and Note 23 - Fair Value Measurements, for further information.</span></div> <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The charges related to the 2021 Restructuring Actions related to the segments, as well as corporate expenses, were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:79.747%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.053%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Year Ended December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Seed</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Crop Protection</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate expenses</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 31000000 55000000 81000000 167000000 <div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of charges incurred related to 2021 Restructuring Actions for the year ended December 31, 2021:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:79.747%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.053%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Year Ended December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance and related benefit costs</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset related charges</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract termination charges</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total restructuring and asset charges - net</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the December 31, 2020 to the December 31, 2021 liability balances related to the 2021 Restructuring Actions is summarized below:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:37.057%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.052%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.473%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.981%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.937%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Severance and Related Benefit Costs</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Asset Related</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-style:italic;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">1</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Contract Termination</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-style:italic;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">2</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charges to income from continuing operations</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset write-offs</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(51)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(51)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-right:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:22.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:7.5pt">In addition, the company has a liability recorded for asset retirement obligations of $6 million as of December 31, 2021. </span></div>2.The liability for contract terminations includes lease obligations. The cash impact of these obligations will be substantially complete by the end of 2022 74000000 51000000 42000000 167000000 0 0 0 0 74000000 51000000 42000000 167000000 -22000000 0 -30000000 -52000000 0 -51000000 0 -51000000 52000000 0 12000000 64000000 6000000 185000000 124000000 61000000 <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Execute to Win Productivity Program charges related to the segments, as well as corporate expenses, were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:67.475%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.612%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.613%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="6" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Year Ended December 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Seed</span></td><td style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Crop Protection</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate expenses</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9 </span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">176 </span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 0 15000000 11000000 98000000 -2000000 63000000 9000000 176000000 <div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The below is a summary of charges incurred related to the Execute to Win Productivity Program for the year ended December 31, 2020: </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.613%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.544%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="6" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance and related benefit costs - net</span></td><td style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset related charges</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total restructuring and asset related charges - net</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">176 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> -2000000 63000000 11000000 113000000 9000000 176000000 <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the December 31, 2020 to the December 31, 2021 liability balances related to the Execute to Win Productivity Program is summarized below:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.198%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.198%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.054%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Severance and Related Benefit (Credits) Costs</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Asset Related</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-style:italic;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">1</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charges to income from continuing operations for the year ended December 31, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset write-offs</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24 </span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24 </span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.25pt">In addition, the company has a liability recorded for asset retirement obligations of $13 million as of December 31, 2021.</span></div> 53000000 3000000 56000000 -2000000 11000000 9000000 -27000000 -3000000 -30000000 0 -11000000 -11000000 24000000 0 24000000 13000000 833000000 316000000 190000000 327000000 <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.038%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.520%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.520%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.522%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-left:1pt solid #000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Seed</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Crop Protection</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27 </span></td><td style="border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate expenses</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92 </span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.038%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.520%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.520%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.522%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-left:1pt solid #000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance and related benefit (credits) costs - net</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract termination charges</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69 </span></td><td style="border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset related charges</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total restructuring and asset related charges - net</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92 </span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> -8000000 -9000000 66000000 -3000000 11000000 27000000 -1000000 -2000000 -1000000 -12000000 0 92000000 -1000000 -2000000 -7000000 -3000000 0 69000000 -8000000 2000000 30000000 -12000000 0 92000000 125000000 159000000 144000000 110000000 RELATED PARTY TRANSACTIONS<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Services Provided by and to Historical Dow and its affiliates</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following the Merger and prior to the Dow Distribution, Corteva reported transactions with Historical Dow and its affiliates as related party transactions. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Transactions with DowDuPont </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2019 DowDuPont contributed cash to Corteva to fund portions of the company's debt redemption/repayment transactions. See Note 17 - Long-Term Debt and Available Credit Facilities, to the Consolidated Financial Statements, for additional information. </span></div>In February 2019, the DowDuPont Board declared first quarter dividends per share of DowDuPont common stock payable on March 15, 2019. EID declared and paid distributions to DowDuPont of about $317 million for the year ended December 31, 2019 to fund a portion of DowDuPont’s dividend payments. 317000000 SUPPLEMENTARY INFORMATION<div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.987%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.205%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other Income - Net</span></td><td colspan="9" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity in earnings (losses) of affiliates - net</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net gain (loss) on sales of businesses and other assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net exchange gains (losses)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">2</span></div></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(174)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(99)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-operating pension and other post employment benefit credit (costs)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">3</span></div></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,318 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">368 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">191 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Miscellaneous income (expenses) - net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">4</span></div></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income - net</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,348 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">212 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">215 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1.    The year ended December 31, 2021 includes a gain of $19 million relating to the sale of a business in Asia Pacific in the crop protection segment. The year ended December 31, 2020 includes a loss of $(53) million and a gain of $27 million relating to the expected sale of the La Porte site, for which the company signed an agreement in 2020, and the sale of a business in Asia Pacific in the crop protection segment, respectively. </span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2.    Includes net pre-tax exchange gains (losses) of $(67) million, $(82) million and $(51) million associated with the devaluation of the Argentine peso for the years ended December 31, 2021, 2020 and 2019, respectively.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">3.    Includes non-service related components of net periodic benefit credits (costs) (interest cost, expected long-term rate of return on plan assets, amortization of unrecognized gain (loss), amortization of prior service benefit and settlement gain (loss)). </span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">4.    Miscellaneous income (expenses) - net, includes losses from sale of receivables, tax indemnification adjustments related to changes in indemnification balances as a result of the application of the terms of the Tax Matters Agreement between Corteva and Dow and/or DuPont, and other items. The year ended December 31, 2021 also includes the Employee Retention Credit of $60 million pursuant to the Coronavirus Aid, Relief, and Economic Security (“CARES”) Act as enhanced by the Consolidated Appropriations Act (“CAA”) and American Rescue Plan Act (“ARPA”), a gain from the remeasurement of an equity investment of $47 million, a charge related to a contract termination with a third-party service provider of $(54) million and the 2021 officer indemnification payment. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the impacts of the company's foreign currency hedging program on the company's results of operations. The company routinely uses foreign currency exchange contracts to offset its net exposures, by currency, related to the foreign currency-denominated monetary assets and liabilities. The objective of this program is to maintain an approximately balanced position in foreign currencies in order to minimize, on an after-tax basis, the effects of exchange rate changes on net monetary asset positions. The hedging program gains (losses) are largely taxable (tax deductible) in the United States (U.S.), whereas the offsetting exchange gains (losses) on the remeasurement of the net monetary asset positions are often not taxable (tax deductible) in their local jurisdictions. The net pre-tax exchange gains (losses) are recorded in other income - net and the related tax impact is recorded in provision for (benefit from) income taxes on continuing operations in the Consolidated Statements of Operations. </span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.987%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.205%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Subsidiary Monetary Position Gain (Loss) </span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pre-tax exchange gain (loss) </span></td><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(72)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(263)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Local tax (expenses) benefits </span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(30)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net after-tax impact from subsidiary exchange gain (loss) </span></td><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(102)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(229)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(39)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Hedging Program Gain (Loss) </span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pre-tax exchange gain (loss) </span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">89 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(58)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Tax (expenses) benefits </span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net after-tax impact from hedging program exchange gain (loss) </span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">68 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(45)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Exchange Gain (Loss) </span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pre-tax exchange gain (loss) </span></td><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(54)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(174)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(99)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Tax (expenses) benefits</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net after-tax exchange gain (loss) </span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(88)</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(161)</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(84)</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash, cash equivalents and restricted cash equivalents</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a reconciliation of cash and cash equivalents and restricted cash equivalents presented in the Consolidated Balance Sheets to the total cash, cash equivalents and restricted cash equivalents presented in the Consolidated Statements of Cash Flows. Corteva classifies restricted cash equivalents as current or noncurrent based on the nature of the restrictions, which are included in other current assets and other assets, respectively, in the Consolidated Balance Sheets.</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:52.858%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.920%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.922%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,459 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,526 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">377 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">347 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents and restricted cash equivalents</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,836 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,873 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%">Restricted cash equivalents primarily relates to (i) a trust funded by EID for cash obligations under certain non-qualified benefit</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%">and deferred compensation plans due to the Merger, which was a change in control event, and is classified as current; and (ii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%">contributions to the MOU Escrow Account as further described in Note 18 - Commitments and Contingent Liabilities, to the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%">Consolidated Financial</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%">Statements, which</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%">is</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%">classified</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%">as</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%">noncurrent.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounts payable</span></div>Accounts payable was $4,126 million and $3,615 million at December 31, 2021 and December 31, 2020, respectively. Accounts payable - trade, which is a component of accounts payable, was $3,023 million and $2,557 million at December 31, 2021 and December 31, 2020, respectively. Accounts payable - other, which is a component of accounts payable, was $1,103 million and $1,058 million at December 31, 2021 and December 31, 2020, respectively. No other components of accounts payable were more than 5 percent of total current liabilities. <div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.987%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.205%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other Income - Net</span></td><td colspan="9" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity in earnings (losses) of affiliates - net</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net gain (loss) on sales of businesses and other assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net exchange gains (losses)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">2</span></div></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(174)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(99)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-operating pension and other post employment benefit credit (costs)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">3</span></div></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,318 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">368 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">191 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Miscellaneous income (expenses) - net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">4</span></div></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income - net</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,348 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">212 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">215 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1.    The year ended December 31, 2021 includes a gain of $19 million relating to the sale of a business in Asia Pacific in the crop protection segment. The year ended December 31, 2020 includes a loss of $(53) million and a gain of $27 million relating to the expected sale of the La Porte site, for which the company signed an agreement in 2020, and the sale of a business in Asia Pacific in the crop protection segment, respectively. </span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2.    Includes net pre-tax exchange gains (losses) of $(67) million, $(82) million and $(51) million associated with the devaluation of the Argentine peso for the years ended December 31, 2021, 2020 and 2019, respectively.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">3.    Includes non-service related components of net periodic benefit credits (costs) (interest cost, expected long-term rate of return on plan assets, amortization of unrecognized gain (loss), amortization of prior service benefit and settlement gain (loss)). </span></div>4.    Miscellaneous income (expenses) - net, includes losses from sale of receivables, tax indemnification adjustments related to changes in indemnification balances as a result of the application of the terms of the Tax Matters Agreement between Corteva and Dow and/or DuPont, and other items. The year ended December 31, 2021 also includes the Employee Retention Credit of $60 million pursuant to the Coronavirus Aid, Relief, and Economic Security (“CARES”) Act as enhanced by the Consolidated Appropriations Act (“CAA”) and American Rescue Plan Act (“ARPA”), a gain from the remeasurement of an equity investment of $47 million, a charge related to a contract termination with a third-party service provider of $(54) million and the 2021 officer indemnification payment. 77000000 56000000 59000000 14000000 0 -9000000 21000000 -2000000 64000000 -54000000 -174000000 -99000000 1318000000 368000000 191000000 -28000000 -36000000 9000000 1348000000 212000000 215000000 -53000000 27000000 -67000000 -82000000 -51000000 60000000 47000000 -54000000 <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.987%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.205%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Subsidiary Monetary Position Gain (Loss) </span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pre-tax exchange gain (loss) </span></td><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(72)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(263)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Local tax (expenses) benefits </span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(30)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net after-tax impact from subsidiary exchange gain (loss) </span></td><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(102)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(229)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(39)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Hedging Program Gain (Loss) </span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pre-tax exchange gain (loss) </span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">89 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(58)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Tax (expenses) benefits </span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net after-tax impact from hedging program exchange gain (loss) </span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">68 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(45)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Exchange Gain (Loss) </span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pre-tax exchange gain (loss) </span></td><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(54)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(174)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(99)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Tax (expenses) benefits</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net after-tax exchange gain (loss) </span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(88)</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(161)</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(84)</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> -72000000 -263000000 -41000000 -30000000 34000000 2000000 -102000000 -229000000 -39000000 18000000 89000000 -58000000 -4000000 -21000000 13000000 14000000 68000000 -45000000 -54000000 -174000000 -99000000 -34000000 13000000 15000000 -88000000 -161000000 -84000000 <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:52.858%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.920%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.922%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,459 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,526 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">377 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">347 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents and restricted cash equivalents</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,836 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,873 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 4459000000 3526000000 377000000 347000000 4836000000 3873000000 4126000000 3615000000 3023000000 2557000000 1103000000 1058000000 INCOME TAXES <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Domestic and foreign components of the income (loss) from continuing operations before income taxes and the provision for (benefit from) current and deferred tax expense (benefit) are shown below:</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:51.677%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.689%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.691%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Geographic Allocation of Income (Loss) and Provision for (Benefit from) Income Taxes </span></td><td colspan="9" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Year Ended December 31,</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss) from continuing operations before income taxes</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Domestic</span></td><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">941 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(83)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,352)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,405 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">758 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,036 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss) from continuing operations before income taxes</span></td><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,346 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">675 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(316)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current tax expense (benefit)</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">State and local</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">329 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">222 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">317 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current tax expense (benefit)</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">322 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">259 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">307 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax expense (benefit) </span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">164 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(116)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(392)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">State and local</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">156 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(251)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(117)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total deferred tax expense (benefit)</span></td><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">202 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(340)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(353)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Provision for (benefit from) income taxes on continuing operations</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">524 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(81)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(46)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss) from continuing operations after taxes</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,822 </span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">756 </span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(270)</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effective income tax rate applicable to income (loss) from continuing operations before income taxes was different from the statutory U.S. federal income tax rate due to the factors listed in the following table:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.285%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.104%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.104%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.107%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reconciliation to U.S. Statutory Rate</span></td><td colspan="9" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Year Ended December 31,</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Statutory U.S. federal income tax rate</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective tax rates on international operations - net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> 1</span></div></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18.4)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions, divestitures and ownership restructuring activities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> 2</span></div></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.7)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. research and development credit</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.0 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exchange gains/losses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> 3</span></div></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and local incomes taxes - net</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of Swiss Tax Reform</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">4</span></div></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.9 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Excess tax benefits/deficiencies from stock compensation</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax settlements and expiration of statute of limitations</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other - net</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective tax rate on income from continuing operations</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.3 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.0)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.6 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">1.    Includes the effects of local and U.S. taxes related to earnings of non-U.S. subsidiaries, changes in the amount of unrecognized tax benefits associated with these earnings, losses at non-U.S. subsidiaries without local tax benefits due to valuation allowances, and other permanent differences between tax and U.S. GAAP results. Includes a tax benefit of $(51) million for the year ended December 31, 2020, related to a return to accrual adjustment associated with an elective change in accounting method for the 2019 tax year impact of foreign tax provisions.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2.    See Notes 4 - Common Control Business Combination, and Note 5 - Divestitures and Other Transactions, to the Consolidated Financial Statements, for additional information.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">3.    Principally reflects the impact of foreign exchange gains and losses on net monetary assets for which no corresponding tax impact is realized. Further information about the company's foreign currency hedging program is included in Note 9 - Supplementary Information, and Note 22 - Financial Instruments, under the heading Foreign Currency Risk.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">4.    Reflects tax benefits of $(182) million primarily driven by the recognition of an elective cantonal component of the recent enactment of the Federal Act on Tax Reform and AHV Financing ("Swiss Tax Reform") for the year ended December 31, 2020. Reflects tax benefits of $(38) million associated with the enactment of the Federal Act on Tax Reform and AHV Financing ("Swiss Tax Reform"), for the year ended December 31, 2019.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Significant components of our net deferred tax asset (liability) were attributable to:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:112%"> </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.718%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.697%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deferred Tax Balances at December 31,</span></td><td colspan="6" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="6" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Assets</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Liabilities</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Assets</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Liabilities</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">341 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">297 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax loss and credit carryforwards</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">2,3</span></div></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">464 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">497 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued employee benefits</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">904 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,415 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accruals and reserves</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">309 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">365 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangibles</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,260 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,418 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development capitalization</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized exchange gains/losses</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other – net</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subtotal</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,195 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,611 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,739 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,715 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowances</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">3</span></div></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(366)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(453)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,829 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,611 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,286 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,715 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Deferred Tax Asset (Liability)</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(782)</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(429)</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1.    Prior year classifications in property and other accruals and reserves have been adjusted from their previous presentation. Adjustments did not impact the amount of the net deferred tax asset (liability) recorded in the Consolidated Balance Sheets.    </span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2.    Primarily related to the realization of recorded tax benefits on tax loss and credit carryforwards from operations in the United States, Brazil, and Spain.    </span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">3.    In connection with the company's 2021 internal legal entity restructuring, the company reduced various state net operating loss carryforwards and corresponding full valuation allowances by $61 million. There was no impact on the statement of operations. During the year ended December 31, 2020, the company established a $19 million state tax valuation allowance in the U.S. based on a change in judgement about the realizability of a deferred tax asset. </span></div><div style="padding-left:9pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Details of the company’s operating loss and tax credit carryforwards are shown in the following table: </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:112%"> </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:61.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.028%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.053%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating Loss and Tax Credit Carryforwards</span></td><td colspan="6" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Deferred Tax Asset</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating loss carryforwards</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expire within 5 years</span></td><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expire after 5 years or indefinite expiration</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">343 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating loss carryforwards</span></td><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">442 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax credit carryforwards</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expire within 5 years</span></td><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expire after 5 years or indefinite expiration</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total tax credit carryforwards</span></td><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Operating Loss and Tax Credit Carryforwards</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">464 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">497 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">A reconciliation of the beginning and ending amount of gross unrecognized tax benefits is as follows: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.913%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Gross Unrecognized Tax Benefits</span></td><td colspan="9" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total unrecognized tax benefits as of beginning of period</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">395 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">426 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">749 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decreases related to positions taken on items from prior years</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(167)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increases related to positions taken on items from prior years</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increases related to positions taken in the current year</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlement of uncertain tax positions with tax authorities</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of Internal Reorganizations</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(278)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decreases due to expiration of statutes of limitations</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exchange (gain) loss</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total unrecognized tax benefits as of end of period</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">377 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">395 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">426 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total unrecognized tax benefits that, if recognized, would impact the effective tax rate</span></td><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total amount of interest and penalties (benefits) recognized in provision for (benefit from) income taxes on continuing operations</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total accrual for interest and penalties associated with unrecognized tax benefits at end of period</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 </span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18 </span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24 </span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each year the company files hundreds of tax returns in the various national, state and local income taxing jurisdictions in which it operates. These tax returns are subject to examination and possible challenge by the tax authorities. Positions challenged by the tax authorities may be settled or appealed by the company. As a result, there is an uncertainty in income taxes recognized in the company's financial statements in accordance with accounting for income taxes and accounting for uncertainty in income taxes. It is reasonably possible that changes to the company’s global unrecognized tax benefits could be significant; however, due to the uncertainty regarding the timing of completion of audits and possible outcomes, a current estimate of the range of increases or decreases that may occur within the next twelve months cannot be made. As of December 31, 2021, the company has made advance deposits of approximately $102 million to a foreign taxing authority, partially as a prerequisite to petition the court related to an open tax examination. These payments are accounted for as a prepaid asset, included in other assets in the Consolidated Balance Sheets. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Tax years that remain subject to examination for the company’s major tax jurisdictions are shown below: </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:89.090%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.710%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Tax Years Subject to Examination by Major Tax Jurisdiction at December 31, 2021</span></td><td colspan="3" rowspan="2" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Earliest Open Year</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Jurisdiction</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Argentina</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2015</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazil</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2014</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canada</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2012</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">China</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2014</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">France</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">India</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2015</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Italy</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2016</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Switzerland</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2016</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States:</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal income tax</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2012</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and local income tax</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2008</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Undistributed earnings of foreign subsidiaries and related companies that are deemed to be indefinitely invested amounted to $3,681 million at December 31, 2021. Distributions of profits from non-U.S. subsidiaries are not expected to cause a significant incremental U.S. tax impact in the future; however, those distributions may still be subject to certain taxes upon repatriation, primarily where foreign withholding taxes apply. The company is asserting indefinite reinvestment related to certain investments in foreign subsidiaries. Determination of the amount of unrecognized deferred tax liability related to indefinitely reinvested profits is not feasible primarily due to our legal entity structure and the complexity of U.S. and local tax laws.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For periods between the Merger Effectiveness Time and the Corteva Distribution, Corteva and its subsidiaries were included in DowDuPont's consolidated federal income tax group and consolidated tax return. Generally, the consolidated tax liability of the </span></div>DowDuPont U.S. tax group for each year was apportioned among the members of the consolidated group based on each member’s separate taxable income. Corteva, DuPont and Dow intend that to the extent Federal and/or State corporate income tax liabilities are reduced through the utilization of tax attributes of the other, settlement of any receivable and payable generated from the use of the other party’s sub-group attributes will be in accordance with a tax sharing agreement and/or tax matters agreement. See Note 5 - Divestitures and Other Transactions, to the Consolidated Financial Statements for further information related to indemnifications between Corteva, Dow and DuPont. <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:51.677%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.689%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.691%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Geographic Allocation of Income (Loss) and Provision for (Benefit from) Income Taxes </span></td><td colspan="9" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Year Ended December 31,</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss) from continuing operations before income taxes</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Domestic</span></td><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">941 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(83)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,352)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,405 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">758 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,036 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss) from continuing operations before income taxes</span></td><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,346 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">675 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(316)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current tax expense (benefit)</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">State and local</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">329 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">222 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">317 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current tax expense (benefit)</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">322 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">259 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">307 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax expense (benefit) </span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">164 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(116)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(392)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">State and local</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">156 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(251)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(117)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total deferred tax expense (benefit)</span></td><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">202 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(340)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(353)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Provision for (benefit from) income taxes on continuing operations</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">524 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(81)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(46)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss) from continuing operations after taxes</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,822 </span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">756 </span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(270)</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 941000000 -83000000 -1352000000 1405000000 758000000 1036000000 2346000000 675000000 -316000000 -13000000 28000000 -11000000 6000000 9000000 1000000 329000000 222000000 317000000 322000000 259000000 307000000 164000000 -116000000 -392000000 55000000 27000000 156000000 -17000000 -251000000 -117000000 202000000 -340000000 -353000000 524000000 -81000000 -46000000 1822000000 756000000 -270000000 <div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.285%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.104%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.104%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.107%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reconciliation to U.S. Statutory Rate</span></td><td colspan="9" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Year Ended December 31,</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Statutory U.S. federal income tax rate</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective tax rates on international operations - net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> 1</span></div></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18.4)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions, divestitures and ownership restructuring activities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> 2</span></div></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.7)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. research and development credit</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.0 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exchange gains/losses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> 3</span></div></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and local incomes taxes - net</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of Swiss Tax Reform</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">4</span></div></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.9 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Excess tax benefits/deficiencies from stock compensation</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax settlements and expiration of statute of limitations</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other - net</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective tax rate on income from continuing operations</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.3 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.0)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.6 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">1.    Includes the effects of local and U.S. taxes related to earnings of non-U.S. subsidiaries, changes in the amount of unrecognized tax benefits associated with these earnings, losses at non-U.S. subsidiaries without local tax benefits due to valuation allowances, and other permanent differences between tax and U.S. GAAP results. Includes a tax benefit of $(51) million for the year ended December 31, 2020, related to a return to accrual adjustment associated with an elective change in accounting method for the 2019 tax year impact of foreign tax provisions.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2.    See Notes 4 - Common Control Business Combination, and Note 5 - Divestitures and Other Transactions, to the Consolidated Financial Statements, for additional information.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">3.    Principally reflects the impact of foreign exchange gains and losses on net monetary assets for which no corresponding tax impact is realized. Further information about the company's foreign currency hedging program is included in Note 9 - Supplementary Information, and Note 22 - Financial Instruments, under the heading Foreign Currency Risk.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">4.    Reflects tax benefits of $(182) million primarily driven by the recognition of an elective cantonal component of the recent enactment of the Federal Act on Tax Reform and AHV Financing ("Swiss Tax Reform") for the year ended December 31, 2020. Reflects tax benefits of $(38) million associated with the enactment of the Federal Act on Tax Reform and AHV Financing ("Swiss Tax Reform"), for the year ended December 31, 2019.</span></div> 0.210 0.210 0.210 -0.025 -0.139 -0.184 -0.001 -0.003 -0.107 -0.024 -0.029 0.070 0.019 0.035 -0.018 0.021 0.040 0.032 0.002 -0.270 0.119 -0.002 0.010 -0.006 0 0.004 0.039 0.023 0.022 -0.009 0.223 -0.120 0.146 -51000000 -182000000 -38000000 <div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.718%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.697%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deferred Tax Balances at December 31,</span></td><td colspan="6" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="6" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Assets</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Liabilities</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Assets</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Liabilities</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">341 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">297 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax loss and credit carryforwards</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">2,3</span></div></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">464 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">497 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued employee benefits</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">904 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,415 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accruals and reserves</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">309 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">365 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangibles</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,260 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,418 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development capitalization</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized exchange gains/losses</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other – net</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subtotal</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,195 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,611 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,739 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,715 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowances</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">3</span></div></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(366)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(453)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,829 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,611 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,286 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,715 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Deferred Tax Asset (Liability)</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(782)</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(429)</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1.    Prior year classifications in property and other accruals and reserves have been adjusted from their previous presentation. Adjustments did not impact the amount of the net deferred tax asset (liability) recorded in the Consolidated Balance Sheets.    </span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2.    Primarily related to the realization of recorded tax benefits on tax loss and credit carryforwards from operations in the United States, Brazil, and Spain.    </span></div>3.    In connection with the company's 2021 internal legal entity restructuring, the company reduced various state net operating loss carryforwards and corresponding full valuation allowances by $61 million. There was no impact on the statement of operations. During the year ended December 31, 2020, the company established a $19 million state tax valuation allowance in the U.S. based on a change in judgement about the realizability of a deferred tax asset. 341000000 297000000 464000000 497000000 904000000 1415000000 309000000 365000000 2260000000 2418000000 153000000 127000000 224000000 186000000 36000000 56000000 0 10000000 2000000 0 105000000 0 91000000 0 2195000000 2611000000 2739000000 2715000000 -366000000 -453000000 1829000000 2611000000 2286000000 2715000000 -782000000 -429000000 61000000 19000000 <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:61.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.028%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.053%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating Loss and Tax Credit Carryforwards</span></td><td colspan="6" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Deferred Tax Asset</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating loss carryforwards</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expire within 5 years</span></td><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expire after 5 years or indefinite expiration</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">343 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating loss carryforwards</span></td><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">442 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax credit carryforwards</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expire within 5 years</span></td><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expire after 5 years or indefinite expiration</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total tax credit carryforwards</span></td><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Operating Loss and Tax Credit Carryforwards</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">464 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">497 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 123000000 99000000 210000000 343000000 333000000 442000000 14000000 14000000 117000000 41000000 131000000 55000000 464000000 497000000 <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.913%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Gross Unrecognized Tax Benefits</span></td><td colspan="9" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total unrecognized tax benefits as of beginning of period</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">395 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">426 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">749 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decreases related to positions taken on items from prior years</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(167)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increases related to positions taken on items from prior years</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increases related to positions taken in the current year</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlement of uncertain tax positions with tax authorities</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of Internal Reorganizations</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(278)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decreases due to expiration of statutes of limitations</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exchange (gain) loss</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total unrecognized tax benefits as of end of period</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">377 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">395 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">426 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total unrecognized tax benefits that, if recognized, would impact the effective tax rate</span></td><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total amount of interest and penalties (benefits) recognized in provision for (benefit from) income taxes on continuing operations</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total accrual for interest and penalties associated with unrecognized tax benefits at end of period</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 </span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18 </span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24 </span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 395000000 426000000 749000000 -7000000 -14000000 -167000000 13000000 5000000 77000000 9000000 6000000 54000000 -17000000 -18000000 -9000000 0 0 -278000000 -16000000 -7000000 0 0 -3000000 0 377000000 395000000 426000000 157000000 156000000 188000000 1000000 -2000000 -4000000 11000000 18000000 24000000 102000000 <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:89.090%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.710%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Tax Years Subject to Examination by Major Tax Jurisdiction at December 31, 2021</span></td><td colspan="3" rowspan="2" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Earliest Open Year</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Jurisdiction</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Argentina</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2015</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazil</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2014</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canada</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2012</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">China</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2014</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">France</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">India</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2015</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Italy</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2016</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Switzerland</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2016</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States:</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal income tax</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2012</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and local income tax</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2008</span></td></tr></table> 3681000000 EARNINGS PER SHARE OF COMMON STOCK<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 1, 2019, the date of the Corteva Distribution, 748,815,000 shares of the company’s common stock were distributed to DowDuPont shareholders of record as of May 24, 2019. </span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables provide earnings per share calculations for the periods indicated below: </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.987%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.205%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Income (Loss) for Earnings Per Share Calculations - Basic and Diluted</span></td><td colspan="9" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Year Ended December 31,</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from continuing operations after income taxes</span></td><td style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,822 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">756 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(270)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) attributable to continuing operations noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from continuing operations attributable to Corteva common stockholders</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,812 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">736 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(283)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Loss) income from discontinued operations, net of tax</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(671)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) attributable to discontinued operations noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Loss) income from discontinued operations attributable to Corteva common stockholders</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(676)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) attributable to common stockholders</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,759 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">681 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(959)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.987%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.205%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Earnings (Loss) Per Share Calculations - Basic</span></td><td colspan="9" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Year Ended December 31,</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Dollars per share)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (loss) per share of common stock from continuing operations</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.46 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.98 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.38)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Loss) earnings per share of common stock from discontinued operations</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.07)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.07)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.90)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (loss) per share of common stock</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.39 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.91 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.28)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.987%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.205%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Earnings (Loss) Per Share Calculations - Diluted</span></td><td colspan="9" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Year Ended December 31,</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Dollars per share)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (loss) per share of common stock from continuing operations</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.44 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.98 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.38)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Loss) earnings per share of common stock from discontinued operations</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.07)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.07)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.90)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (loss) per share of common stock</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.37 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.91 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.28)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.987%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.205%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Share Count Information</span></td><td colspan="9" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Year Ended December 31,</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Shares in millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average common shares - basic</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">735.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">748.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">749.5 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plus dilutive effect of equity compensation plans</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">2</span></div></td><td colspan="2" style="border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.7 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average common shares - diluted</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">741.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">751.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">749.5 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Potential shares of common stock excluded from EPS calculations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">3</span></div></td><td colspan="2" style="border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8 </span></td><td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.4 </span></td><td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.4 </span></td><td style="border-bottom:1.5pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:3pt">Share amounts for all periods prior to the Corteva Distribution were based on 748.8 million shares of Corteva, Inc. common stock distributed to holders of DowDuPont's common stock on June 1, 2019, plus 0.6 million of additional shares in which accelerated vesting conditions have been met. </span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:3pt">Diluted earnings (loss) per share considers the impact of potentially dilutive securities except in periods in which there is a loss because the inclusion of the potential common shares would have an anti-dilutive effect.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:3pt">These outstanding potential shares of common stock relating to stock options, restricted stock units and performance-based restricted stock units were excluded from the calculation of diluted earnings (loss) per share because (i) the effect of including stock options and restricted stock units would have been anti-dilutive; and (ii) the performance metrics have not yet been achieved for the outstanding potential shares relating to performance-based restricted stock units, which are deemed to be contingently issuable.</span></div> 748815000 <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.987%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.205%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Income (Loss) for Earnings Per Share Calculations - Basic and Diluted</span></td><td colspan="9" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Year Ended December 31,</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from continuing operations after income taxes</span></td><td style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,822 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">756 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(270)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) attributable to continuing operations noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from continuing operations attributable to Corteva common stockholders</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,812 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">736 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(283)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Loss) income from discontinued operations, net of tax</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(671)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) attributable to discontinued operations noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Loss) income from discontinued operations attributable to Corteva common stockholders</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(676)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) attributable to common stockholders</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,759 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">681 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(959)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 1822000000 756000000 -270000000 10000000 20000000 13000000 1812000000 736000000 -283000000 -53000000 -55000000 -671000000 0 0 5000000 -53000000 -55000000 -676000000 1759000000 681000000 -959000000 <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.987%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.205%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Earnings (Loss) Per Share Calculations - Basic</span></td><td colspan="9" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Year Ended December 31,</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Dollars per share)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (loss) per share of common stock from continuing operations</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.46 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.98 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.38)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Loss) earnings per share of common stock from discontinued operations</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.07)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.07)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.90)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (loss) per share of common stock</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.39 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.91 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.28)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 2.46 0.98 -0.38 -0.07 -0.07 -0.90 2.39 0.91 -1.28 <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.987%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.205%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Earnings (Loss) Per Share Calculations - Diluted</span></td><td colspan="9" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Year Ended December 31,</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Dollars per share)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (loss) per share of common stock from continuing operations</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.44 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.98 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.38)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Loss) earnings per share of common stock from discontinued operations</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.07)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.07)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.90)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (loss) per share of common stock</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.37 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.91 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.28)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 2.44 0.98 -0.38 -0.07 -0.07 -0.90 2.37 0.91 -1.28 <div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.987%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.205%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Share Count Information</span></td><td colspan="9" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Year Ended December 31,</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Shares in millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average common shares - basic</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">735.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">748.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">749.5 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plus dilutive effect of equity compensation plans</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">2</span></div></td><td colspan="2" style="border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.7 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average common shares - diluted</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">741.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">751.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">749.5 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Potential shares of common stock excluded from EPS calculations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">3</span></div></td><td colspan="2" style="border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8 </span></td><td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.4 </span></td><td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.4 </span></td><td style="border-bottom:1.5pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:3pt">Share amounts for all periods prior to the Corteva Distribution were based on 748.8 million shares of Corteva, Inc. common stock distributed to holders of DowDuPont's common stock on June 1, 2019, plus 0.6 million of additional shares in which accelerated vesting conditions have been met. </span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:3pt">Diluted earnings (loss) per share considers the impact of potentially dilutive securities except in periods in which there is a loss because the inclusion of the potential common shares would have an anti-dilutive effect.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:3pt">These outstanding potential shares of common stock relating to stock options, restricted stock units and performance-based restricted stock units were excluded from the calculation of diluted earnings (loss) per share because (i) the effect of including stock options and restricted stock units would have been anti-dilutive; and (ii) the performance metrics have not yet been achieved for the outstanding potential shares relating to performance-based restricted stock units, which are deemed to be contingently issuable.</span></div> 735900000 748700000 749500000 5700000 2500000 0 741600000 751200000 749500000 2800000 9400000 14400000 748800000 600000 ACCOUNTS AND NOTES RECEIVABLE - NET <div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.291%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.205%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable – trade</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,441 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,754 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notes receivable – trade</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1,2</span></div></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">3</span></div></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,250 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,009 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total accounts and notes receivable - net</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,811 </span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,926 </span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:9.6pt">Accounts receivable – trade and notes receivable – trade are net of allowances of $210 million and $208 million at December 31, 2021 and December 31, 2020, respectively. Allowances are equal to the estimated uncollectible amounts and are based on the expected credit losses and were developed using a loss-rate method. </span></div><div style="padding-left:18pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:9.6pt">Notes receivable – trade primarily consists of receivables for deferred payment loan programs for the sale of seed products to customers. These loans have terms of one year or less and are primarily concentrated in North America. The company maintains a rigid pre-approval process for extending credit to customers in order to manage overall risk and exposure associated with credit losses. As of December 31, 2021 and 2020, there were no significant impairments related to current loan agreements.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:9.6pt">Other includes receivables in relation to indemnification assets, value added tax, general sales tax and other taxes. No individual group represents more than 10 percent of total receivables. In addition, Other includes amounts due from nonconsolidated affiliates of $104 million and $106 million as of December 31, 2021 and 2020, respectively. </span></div><div style="padding-left:18pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Accounts and notes receivable are carried at the expected amount to be collected, which approximates fair value. The company establishes the allowance for doubtful receivables using a loss-rate method where the loss rate is developed using past events, historical experience, current conditions and forecasts that affect the collectability of the financial assets.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes changes in the allowance for doubtful receivables for the year ended December 31, 2021 and 2020, respectively:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.958%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:33.842%"/><td style="width:0.1%"/></tr><tr><td colspan="6" style="border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2019</span></td><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net provision for credit losses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Write-offs charged against allowance / other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">208 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;border-right:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">208 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net provision for credit losses</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Write-offs charged against allowance / other</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-right:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1. Prior year classifications in the changes in the allowance for doubtful receivables have been adjusted from their previous presentation. Adjustments did not impact the amount of the provision or the allowance for doubtful receivables recorded in the Consolidated Statements of Operations or the Consolidated Balance Sheets.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company enters into various factoring agreements with third-party financial institutions to sell its trade receivables under both recourse and non-recourse agreements in exchange for cash proceeds. These financing arrangements result in a transfer of the company's receivables and risks to the third-party. As these transfers qualify as true sales under the applicable accounting guidance, the receivables are derecognized from the Consolidated Balance Sheets upon transfer, and the company receives a payment for the receivables from the third-party within a mutually agreed upon time period. For arrangements involving an element of recourse, which is typically provided through a guarantee of accounts in the event of customer default, the guarantee obligation is measured using market data from similar transactions and reported as a current liability in the Consolidated Balance Sheets. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trade receivables sold under these agreements were $272 million, $255 million, and $328 million for the years ended December 31, 2021, 2020 and 2019, respectively. The trade receivables sold that remained outstanding under these agreements which include an element of recourse as of December 31, 2021 and December 31, 2020 were $166 million and $157 million, respectively. The net proceeds received were included in cash provided by (used for) operating activities in the Consolidated </span></div>Statements of Cash Flows. The difference between the carrying amount of the trade receivables sold and the sum of the cash received is recorded as a loss on sale of receivables in other income - net in the Consolidated Statements of Operations. The loss on sale of receivables were $54 million, $55 million, and $44 million for the years ended December 31, 2021, 2020 and 2019, respectively. See Note 18 - Commitments and Contingent Liabilities, to the Consolidated Financial Statements, for additional information on the company’s guarantees. <div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.291%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.205%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable – trade</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,441 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,754 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notes receivable – trade</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1,2</span></div></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">3</span></div></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,250 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,009 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total accounts and notes receivable - net</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,811 </span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,926 </span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:9.6pt">Accounts receivable – trade and notes receivable – trade are net of allowances of $210 million and $208 million at December 31, 2021 and December 31, 2020, respectively. Allowances are equal to the estimated uncollectible amounts and are based on the expected credit losses and were developed using a loss-rate method. </span></div><div style="padding-left:18pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:9.6pt">Notes receivable – trade primarily consists of receivables for deferred payment loan programs for the sale of seed products to customers. These loans have terms of one year or less and are primarily concentrated in North America. The company maintains a rigid pre-approval process for extending credit to customers in order to manage overall risk and exposure associated with credit losses. As of December 31, 2021 and 2020, there were no significant impairments related to current loan agreements.</span></div>3.Other includes receivables in relation to indemnification assets, value added tax, general sales tax and other taxes. No individual group represents more than 10 percent of total receivables. In addition, Other includes amounts due from nonconsolidated affiliates of $104 million and $106 million as of December 31, 2021 and 2020, respectively. 3441000000 3754000000 120000000 163000000 1250000000 1009000000 4811000000 4926000000 210000000 208000000 104000000 106000000 <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.958%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:33.842%"/><td style="width:0.1%"/></tr><tr><td colspan="6" style="border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2019</span></td><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net provision for credit losses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Write-offs charged against allowance / other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">208 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;border-right:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">208 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net provision for credit losses</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Write-offs charged against allowance / other</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-right:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1. Prior year classifications in the changes in the allowance for doubtful receivables have been adjusted from their previous presentation. Adjustments did not impact the amount of the provision or the allowance for doubtful receivables recorded in the Consolidated Statements of Operations or the Consolidated Balance Sheets.</span> 208000000 1000000 1000000 210000000 272000000 255000000 328000000 166000000 157000000 54000000 55000000 44000000 INVENTORIES<div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.876%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.911%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.913%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished products</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,497 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,584 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Semi-finished products</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,076 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,813 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials and supplies</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">607 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">485 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventories</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,180 </span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,882 </span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the Merger, a fair value step-up of $2,297 million was recorded for inventories. This fair value step-up was fully</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">amortized, as of December 31, 2019. During the year ended December 31, 2019, the company recognized $272 million in cost of goods sold in the Consolidated Statements of Operations related to the amortization of the step-up.</span></div> <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.876%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.911%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.913%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished products</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,497 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,584 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Semi-finished products</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,076 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,813 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials and supplies</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">607 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">485 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventories</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,180 </span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,882 </span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 2497000000 2584000000 2076000000 1813000000 607000000 485000000 5180000000 4882000000 2297000000 272000000 PROPERTY, PLANT AND EQUIPMENT<div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.876%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.911%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.913%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land and land improvements</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">420 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">451 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,487 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,525 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,729 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,556 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">728 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">721 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property, plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,364 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,253 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,035)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,857)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property, plant and equipment - net</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,329 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,396 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-right:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Buildings, machinery and equipment and land improvements are depreciated over useful lives on a straight-line basis ranging from 2 to 25 years. Capitalizable costs associated with computer software for internal use are amortized on a straight-line basis over 2 to 7 years. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:56.231%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.122%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.122%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.125%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-left:1pt solid #000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Year Ended December 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation expense</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">521 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">495 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">525 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.876%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.911%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.913%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land and land improvements</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">420 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">451 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,487 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,525 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,729 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,556 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">728 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">721 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property, plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,364 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,253 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,035)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,857)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property, plant and equipment - net</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,329 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,396 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-right:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 420000000 451000000 1487000000 1525000000 5729000000 5556000000 728000000 721000000 8364000000 8253000000 4035000000 3857000000 4329000000 4396000000 P2Y P25Y P2Y P7Y <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:56.231%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.122%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.122%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.125%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-left:1pt solid #000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Year Ended December 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation expense</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">521 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">495 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">525 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 521000000 495000000 525000000 GOODWILL AND OTHER INTANGIBLE ASSETS<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Goodwill</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes changes in the carrying amount of goodwill by segment for the years ended December 31, 2021 and 2020, respectively.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:51.970%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.544%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Crop Protection</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Seed</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2019</span></td><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,743 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,486 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,229 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation adjustment</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other goodwill adjustments and acquisitions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2020</span></td><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,745 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,524 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,269 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation adjustment</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(73)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(87)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(160)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other goodwill adjustments and acquisitions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">2</span></div></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2021</span></td><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,672 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,435 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,107 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-right:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></div><div style="padding-left:18pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:9.12pt">Primarily consists of the goodwill included in the sale of businesses in the crop protection segment.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:9.12pt">Consists of the goodwill included in the sale of a business in the seed segment.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company tests goodwill for impairment annually (during the fourth quarter), or more frequently when events or changes in circumstances indicate it is more likely than not that the fair value of a reporting unit has declined below its carrying value. As mentioned in Note 2 - Summary of Significant Accounting Policies, as a result of the Internal Reorganizations and Business Realignments, the company changed its reportable segments to seed and crop protection to reflect the manner in which the company's chief operating decision maker assesses performance and allocates resources. The change in reportable segments resulted in changes to the company's reporting units for goodwill impairment testing to align with the level at which discrete financial information is available for review by management. The company’s reporting units include seed, crop protection and digital.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the second quarter of 2020, the company determined a triggering event had occurred as a result of changes in the company's long-term projections driven largely by the impacts of the COVID-19 pandemic on the mid-term forecasted cash flows of the business, including, but not limited to currency fluctuations, expectations of future planted area (as influenced by consumer demand, ethanol markets and government policies and regulations) and relative commodity prices, which required an interim impairment assessment for its seed and crop protection reporting units and trade name indefinite lived intangible asset. Based on the impairment analysis performed over the company’s trade name indefinite lived intangible asset it was determined that the fair value approximated the carrying value, and no impairment charge was necessary. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company performed quantitative testing on all of its reporting units and determined that no goodwill impairments existed in 2021 and 2020. As of December 31, 2021, accumulated impairment losses on goodwill were $4,503 million. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Intangible Assets</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The gross carrying amounts and accumulated amortization of other intangible assets by major class are as follows: </span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:31.058%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.206%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.206%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.206%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.206%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.206%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.212%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="9" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="9" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intangible assets subject to amortization (Definite-lived):</span></div></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-4.5pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Germplasm</span></td><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,265 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(571)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,694 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,265 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(317)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,948 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:15.75pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer-related</span></div></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,953 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(487)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,466 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,984 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(380)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,604 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-4.5pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,485 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(679)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">806 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,451 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(525)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">926 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks/trade names</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,012 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(172)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,840 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,019 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(99)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,920 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Favorable supply contracts</span></div></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">475 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(396)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">475 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(302)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">2</span></div></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">405 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(256)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">405 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(239)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other intangible assets with finite lives</span></div></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,595 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,561)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,034 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,599 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,862)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,737 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intangible assets not subject to amortization (Indefinite-lived):</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IPR&amp;D</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other intangible assets</span></div></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,605 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,561)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,044 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,609 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,862)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,747 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-right:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:7.5pt">Beginning on October 1, 2020, the company changed its indefinite life assertion of its trade name asset to definite lived with a useful life of 25 years. This change is the result of the launch of Brevant</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> seed in the retail channel in the U.S. Prior to changing the useful life of the trade name asset, the company tested the asset for impairment under ASC 350 - Intangibles, Goodwill and Other, concluding the asset was not impaired.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:7.5pt">Primarily consists of sales and farmer networks, marketing and manufacturing alliances and noncompetition agreements.</span></div><div style="padding-left:18pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third quarter of 2019, and in connection with strategic product and portfolio reviews, the company determined that the fair value of certain intangible assets classified as developed technology, other intangible assets and IPR&amp;D within the seed segment that primarily relate to heritage DAS intangibles previously acquired from Cooperativa Central de Pesquisa Agrícola's ("Coodetec") was less than the carrying value due to the company’s focus on advancing more competitive products and eliminating redundancy and complexity across the breeding programs. For IPR&amp;D and developed technology, the company concluded these projects were abandoned. For other intangible assets, the company performed an impairment assessment using the relief from royalty method (a form of the income approach) using Level 3 inputs within the fair value hierarchy. The significant assumptions used in the calculation included projected revenue, royalty rates and discount rates. These significant assumptions involve management judgment and estimates relating to future operating performance and economic conditions that may differ from actual cash flows. As a result, the company recorded a pre-tax, non-cash intangible asset impairment charge of $54 million ($41 million after-tax), which is reflected in restructuring and asset related charges - net, in the company's Consolidated Statements of Operations for the year ended December 31, 2019.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no indicators of impairment for the company’s other intangible assets that suggested that the fair value was less than its carrying value at December 31, 2019, except for IPR&amp;D. As a result of the company’s decision, during the fourth quarter of 2019, to accelerate the ramp up of the Enlist E3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> trait platform in the company’s soybean portfolio mix across all brands over the subsequent five years with minimal use of the Roundup Ready 2 Yield</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">®</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and Roundup Ready 2 Xtend</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">®</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> traits thereafter for the remainder of the Roundup Ready 2 License Agreement, the company determined that certain IPR&amp;D projects associated with Roundup Ready 2 Xtend</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">®</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> were not recoverable and were impaired. These IPR&amp;D projects were either abandoned or tested for impairment using the relief from royalty method (a form of the income approach) using Level 3 inputs within the fair value hierarchy. The key assumptions used in the relief from royalty method calculation included projected revenue, royalty rates and discount rates. These key assumptions involve management judgment and estimates relating to future operating performance and economic conditions that may differ from actual cash flows. As a result, the company recorded a pre-tax, non-cash intangible asset charge of $90 million ($69 million after-tax), which is reflected in restructuring and asset related charges - net, in the company's Consolidated Statements of Operations for the year ended December 31, 2019.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate pre-tax amortization expense from continuing operations for definite-lived intangible assets was $722 million, $682 million, and $475 million, for the year ended December 31, 2021, December 31, 2020, and December 31, 2019, respectively. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total estimated amortization expense for the next five fiscal years is as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:79.455%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.345%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">700 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">620 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">606 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">569 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">558 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> <div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:51.970%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.544%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Crop Protection</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Seed</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2019</span></td><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,743 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,486 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,229 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation adjustment</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other goodwill adjustments and acquisitions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2020</span></td><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,745 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,524 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,269 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation adjustment</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(73)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(87)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(160)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other goodwill adjustments and acquisitions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">2</span></div></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2021</span></td><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,672 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,435 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,107 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-right:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></div><div style="padding-left:18pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:9.12pt">Primarily consists of the goodwill included in the sale of businesses in the crop protection segment.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:9.12pt">Consists of the goodwill included in the sale of a business in the seed segment.</span></div> 4743000000 5486000000 10229000000 31000000 38000000 69000000 -29000000 0 -29000000 4745000000 5524000000 10269000000 -73000000 -87000000 -160000000 0 -2000000 -2000000 4672000000 5435000000 10107000000 4503000000 <div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:31.058%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.206%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.206%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.206%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.206%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.206%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.212%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="9" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="9" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intangible assets subject to amortization (Definite-lived):</span></div></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-4.5pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Germplasm</span></td><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,265 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(571)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,694 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,265 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(317)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,948 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:15.75pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer-related</span></div></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,953 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(487)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,466 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,984 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(380)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,604 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-4.5pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,485 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(679)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">806 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,451 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(525)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">926 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks/trade names</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,012 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(172)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,840 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,019 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(99)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,920 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Favorable supply contracts</span></div></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">475 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(396)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">475 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(302)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">2</span></div></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">405 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(256)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">405 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(239)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other intangible assets with finite lives</span></div></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,595 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,561)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,034 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,599 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,862)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,737 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intangible assets not subject to amortization (Indefinite-lived):</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IPR&amp;D</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other intangible assets</span></div></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,605 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,561)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,044 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,609 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,862)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,747 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-right:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:7.5pt">Beginning on October 1, 2020, the company changed its indefinite life assertion of its trade name asset to definite lived with a useful life of 25 years. This change is the result of the launch of Brevant</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> seed in the retail channel in the U.S. Prior to changing the useful life of the trade name asset, the company tested the asset for impairment under ASC 350 - Intangibles, Goodwill and Other, concluding the asset was not impaired.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:7.5pt">Primarily consists of sales and farmer networks, marketing and manufacturing alliances and noncompetition agreements.</span></div> 6265000000 -571000000 5694000000 6265000000 -317000000 5948000000 1953000000 -487000000 1466000000 1984000000 -380000000 1604000000 1485000000 -679000000 806000000 1451000000 -525000000 926000000 2012000000 -172000000 1840000000 2019000000 -99000000 1920000000 475000000 -396000000 79000000 475000000 -302000000 173000000 405000000 -256000000 149000000 405000000 -239000000 166000000 12595000000 -2561000000 10034000000 12599000000 -1862000000 10737000000 10000000 10000000 10000000 10000000 10000000 10000000 10000000 10000000 12605000000 -2561000000 10044000000 12609000000 -1862000000 10747000000 54000000 41000000 90000000 69000000 722000000 682000000 475000000 <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:79.455%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.345%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">700 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">620 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">606 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">569 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">558 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 700000000 620000000 606000000 569000000 558000000 LEASES<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company has operating and finance leases for real estate, transportation, certain machinery and equipment, and information technology assets. The company’s leases have remaining lease terms of 1 to 50 years. For purposes of calculating operating lease liabilities, lease terms may be deemed to include options to extend the lease when it is reasonably certain that the company will exercise that option. Some leasing arrangements require variable payments that are dependent on usage, output, or may vary for other reasons, such as insurance and tax payments. The variable lease payments are not presented as part of the initial ROU asset or lease liability. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of the company's leases include residual value guarantees. These residual value guarantees are based on a percentage of the lessor's asset acquisition price and the amount of such guarantee declines over the course of the lease term. The portion of residual value guarantees that are probable of payment are included in the related lease liability. At December 31, 2021, the company has future maximum payments for residual value guarantees in operating leases of $193 million with final expirations through 2028. The company's lease agreements do not contain any material restrictive covenants. The components of lease cost are as follows: </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.274%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.712%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.714%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="6" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Year Ended December 31,</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease cost</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of right-of-use assets</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest on lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total finance lease cost</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term lease cost</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable lease cost</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease cost</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181 </span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">220 </span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">New leases entered into during the years ended December 31, 2021 and December 31, 2020 were not material, on an individual basis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information related to leases is as follows: </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.028%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.837%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="6" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash outflows from operating leases</span></td><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash outflows from finance leases</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing cash outflows from finance leases</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental balance sheet information related to leases is as follows: </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.133%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.783%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.784%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating Leases</span></div></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">458 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">521 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:15.75pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current operating lease liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">2</span></div></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent operating lease liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">3</span></div></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">338 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">391 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease liabilities</span></div></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">459 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">529 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Finance Leases</span></div></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant, and equipment, gross</span></div></td><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation</span></div></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant, and equipment, net</span></div></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term borrowings and finance lease obligations</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-Term Debt</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total finance lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:9.6pt">Included in other assets in the Consolidated Balance Sheet.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:9.6pt">Included in accrued and other current liabilities in the Consolidated Balance Sheet.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:9.6pt">Included in other noncurrent obligations in the Consolidated Balance Sheet.</span></div><div style="padding-left:18pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company utilizes the incremental borrowing rate in determining the present value of lease payments unless the implicit rate is readily determinable.</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.133%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.783%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.784%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Lease Term and Discount Rate</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average remaining lease term (years)</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.41</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.71</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing leases</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.36</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.26</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average discount rate</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.75 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.06 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing leases</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.29 </span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.28 </span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of lease liabilities are as follows: </span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:78.987%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.856%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.857%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Maturity of Lease Liabilities at December 31, 2021</span></td><td colspan="3" rowspan="2" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Operating Leases</span></td><td colspan="3" rowspan="2" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Financing Leases</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-right:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027 and thereafter</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">512 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Interest</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value of lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">459 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:78.987%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.856%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.857%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Maturity of Lease Liabilities at December 31, 2020</span></td><td colspan="3" rowspan="2" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Operating Leases</span></td><td colspan="3" rowspan="2" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Financing Leases</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-right:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026 and thereafter</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">598 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Interest</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value of lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">529 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> P1Y P50Y 193000000 <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.274%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.712%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.714%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="6" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Year Ended December 31,</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease cost</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of right-of-use assets</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest on lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total finance lease cost</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term lease cost</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable lease cost</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease cost</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181 </span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">220 </span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 158000000 197000000 1000000 2000000 0 0 1000000 2000000 14000000 14000000 8000000 7000000 181000000 220000000 <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.028%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.837%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="6" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash outflows from operating leases</span></td><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash outflows from finance leases</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing cash outflows from finance leases</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 169000000 202000000 0 0 1000000 1000000 <div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.133%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.783%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.784%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating Leases</span></div></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">458 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">521 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:15.75pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current operating lease liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">2</span></div></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent operating lease liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">3</span></div></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">338 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">391 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease liabilities</span></div></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">459 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">529 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Finance Leases</span></div></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant, and equipment, gross</span></div></td><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation</span></div></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant, and equipment, net</span></div></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term borrowings and finance lease obligations</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-Term Debt</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total finance lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:9.6pt">Included in other assets in the Consolidated Balance Sheet.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:9.6pt">Included in accrued and other current liabilities in the Consolidated Balance Sheet.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:9.6pt">Included in other noncurrent obligations in the Consolidated Balance Sheet.</span></div> 458000000 521000000 121000000 138000000 338000000 391000000 459000000 529000000 15000000 15000000 -11000000 -10000000 4000000 5000000 1000000 1000000 3000000 4000000 4000000 5000000 <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.133%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.783%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.784%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Lease Term and Discount Rate</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average remaining lease term (years)</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.41</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.71</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing leases</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.36</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.26</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average discount rate</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.75 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.06 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing leases</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.29 </span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.28 </span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table> P7Y4M28D P7Y8M15D P3Y4M9D P4Y3M3D 0.0275 0.0306 0.0329 0.0328 <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:78.987%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.856%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.857%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Maturity of Lease Liabilities at December 31, 2021</span></td><td colspan="3" rowspan="2" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Operating Leases</span></td><td colspan="3" rowspan="2" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Financing Leases</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-right:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027 and thereafter</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">512 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Interest</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value of lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">459 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:78.987%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.856%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.857%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Maturity of Lease Liabilities at December 31, 2020</span></td><td colspan="3" rowspan="2" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Operating Leases</span></td><td colspan="3" rowspan="2" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Financing Leases</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-right:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026 and thereafter</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">598 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Interest</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value of lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">529 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 132000000 1000000 94000000 1000000 71000000 1000000 60000000 1000000 49000000 0 106000000 0 512000000 4000000 53000000 0 459000000 4000000 152000000 1000000 114000000 1000000 83000000 1000000 61000000 1000000 51000000 1000000 137000000 0 598000000 5000000 69000000 0 529000000 5000000 LONG-TERM DEBT AND AVAILABLE CREDIT FACILITIES<div style="margin-top:5pt;padding-left:9pt;text-indent:-9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.098%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.350%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.350%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:12.350%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.352%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Long-Term Debt</span></td><td colspan="6" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="6" style="border-bottom:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="6" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"/><td colspan="6" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Amount</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Weighted Average Rate</span></td><td colspan="3" style="display:none"/><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Amount</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Weighted Average Rate</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Promissory notes and debentures:</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  Maturing in 2025</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.70 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.70 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  Maturing in 2030</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.30 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.30 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other loans:</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency loans, various rates and maturities</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medium-term notes, varying maturities through 2041</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease obligations</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Unamortized debt discount and issuance costs</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Long-term debt due within one year</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,100 </span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,102 </span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Principal payments of long-term debt are $500 million for long-term debt maturing in 2025. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value of the company's long-term borrowings, was determined using Level 2 inputs within the fair value hierarchy, as described in Note 2 - Summary of Significant Accounting Policies. Based on quoted market prices for the same or similar issues, or on current rates offered to the company for debt of the same remaining maturities, the fair value of the company's long-term borrowings, not including long-term debt due within one year, was $1,120 million and $1,166 million at December 31, 2021 and 2020, respectively.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt Offering</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2020, EID issued $500 million of 1.70 percent Senior Notes due 2025 and $500 million of 2.30 percent Senior Notes due 2030 (the May 2020 Debt Offering). The proceeds of this offering are intended to be used for general corporate purposes.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Available Committed Credit Facilities </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the company's credit facilities:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:38.024%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.600%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.681%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.681%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.666%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.748%"/><td style="width:0.1%"/></tr><tr><td colspan="12" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Committed and Available Credit Facilities at December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Effective Date</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Committed Credit</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Credit Available</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Maturity Date</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Interest</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revolving Credit Facility</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2019</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,000 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,000 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2024</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Floating Rate</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revolving Credit Facility</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2019</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2023</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Floating Rate</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Committed and Available Credit Facilities</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,000 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,000 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revolving Credit Facilities</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2018, EID entered into a $3.0 billion, 5 year revolving credit facility and a $3.0 billion, 3-year revolving credit facility (the "Revolving Credit Facilities”). The Revolving Credit Facilities became effective May 2019. Corteva, Inc. became a party at the time of the Corteva Distribution. In May 2021, the company entered into an amendment that extended the maturity date of the 3-year revolving credit facility from May 2022 to May 2023. Other than the change in maturity date, there were no material modifications to the terms of the credit facility. The Revolving Credit Facilities may serve as a substitute to the company's commercial paper program, and can be used from time to time, for general corporate purposes including, but not limited to, the funding of seasonal working capital needs. The Revolving Credit Facilities contain customary representations and warranties, affirmative and negative covenants and events of default that are typical for companies with similar credit ratings. Additionally, the Revolving Credit Facilities contain a financial covenant requiring that the ratio of total indebtedness to total capitalization for Corteva and its consolidated subsidiaries not exceed 0.60. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the company drew down $500 million under the $3.0 billion 3-year revolving credit facility as a result of the volatility and increased borrowing costs of commercial paper resulting from the unstable market conditions caused by the COVID-19 pandemic and repaid that borrowing in full in June 2020. There were no additional borrowings and the unused commitments under the 3-year revolving credit facility were $3.0 billion as of December 31, 2021. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt Redemptions/Repayments</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 22, 2019, EID issued notices of redemption in full of all of its outstanding notes (the “Make Whole Notes”) listed in the table below:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:78.987%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.813%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.625% Notes due 2020</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">474 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.625% Notes due 2021</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">296 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.250% Notes due 2021</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.800% Notes due 2023</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">381 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.500% Debentures due 2028</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.600% Senior Notes due 2036</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.900% Notes due 2041</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.150% Notes due 2043</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,530 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Make Whole Notes were redeemed on April 22, 2019 at the make-whole redemption prices set forth in the respective Make Whole Notes. On and after the date of redemption, the Make Whole Notes were no longer deemed outstanding, interest on the Make Whole Notes ceased to accrue and all rights of the holders of the Make Whole Notes were terminated. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2016, EID entered into a credit agreement that provided for a 3-year, senior unsecured term loan facility in the aggregate principal amount of $4.5 billion (as amended, from time to time, the "Term Loan Facility") under which EID could make up to seven term loan borrowings and amounts repaid or prepaid were not available for subsequent borrowings. On May 2, 2019, EID terminated its Term Loan Facility and repaid the aggregate outstanding principal amount of $3 billion plus accrued and unpaid interest through and including May 1, 2019.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the repayment of the Make Whole Notes and the Term Loan Facility, EID paid a total of $4.6 billion in the second quarter 2019, which included breakage fees and accrued and unpaid interest on the Make Whole Notes and Term Loan Facility. The repayment of the Make Whole Notes and Term Loan Facility was funded with cash from operations and a contribution from DowDuPont. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 7, 2019, DowDuPont publicly announced the record date in connection with the Corteva Distribution. In connection with such announcement, EID was required to redeem $1.25 billion aggregate principal amount of 2.20% Notes due 2020 and $750 million aggregate principal amount of Floating Rate Notes due 2020 (collectively, the Special Mandatory Redemption, or “SMR Notes”) setting forth the date of redemption of the SMR Notes. On May 17, 2019 EID redeemed and paid a total of $2 billion, which included accrued and unpaid interest on the SMR Notes. EID funded the payment with a contribution from DowDuPont. Following the redemption, the SMR Notes are no longer outstanding and no longer bear interest, and all rights of the holders of the SMR Notes have terminated.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EID recorded a loss on the early extinguishment of debt of $13 million for the year ended December 31, 2019, related to the difference between the redemption price and the par value of the Make Whole Notes, the Term Loan Facility, and the SMR Notes, partially offset by the write-off of unamortized step-up related to the fair value step-up of EID’s debt.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Uncommitted Credit Facilities and Outstanding Letters of Credit</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unused bank credit lines on uncommitted credit facilities were $389 million at December 31, 2021. These lines are available to support short-term liquidity needs and general corporate purposes, including letters of credit. Outstanding letters of credit were $127 million at December 31, 2021. These letters of credit support commitments made in the ordinary course of business.</span></div> <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.098%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.350%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.350%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:12.350%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.352%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Long-Term Debt</span></td><td colspan="6" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="6" style="border-bottom:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="6" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"/><td colspan="6" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Amount</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Weighted Average Rate</span></td><td colspan="3" style="display:none"/><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Amount</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Weighted Average Rate</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Promissory notes and debentures:</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  Maturing in 2025</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.70 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.70 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  Maturing in 2030</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.30 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.30 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other loans:</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency loans, various rates and maturities</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medium-term notes, varying maturities through 2041</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease obligations</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Unamortized debt discount and issuance costs</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Long-term debt due within one year</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,100 </span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,102 </span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:78.987%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.813%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.625% Notes due 2020</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">474 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.625% Notes due 2021</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">296 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.250% Notes due 2021</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.800% Notes due 2023</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">381 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.500% Debentures due 2028</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.600% Senior Notes due 2036</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.900% Notes due 2041</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.150% Notes due 2043</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,530 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 500000000 0.0170 500000000 0.0170 500000000 0.0230 500000000 0.0230 1000000 1000000 107000000 0 109000000 0 3000000 4000000 10000000 11000000 1000000 1000000 1100000000 1102000000 500000000 1120000000 1166000000 500000000 0.017 500000000 0.023 <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:38.024%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.600%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.681%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.681%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.666%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.748%"/><td style="width:0.1%"/></tr><tr><td colspan="12" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Committed and Available Credit Facilities at December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Effective Date</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Committed Credit</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Credit Available</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Maturity Date</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Interest</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revolving Credit Facility</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2019</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,000 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,000 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2024</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Floating Rate</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revolving Credit Facility</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2019</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2023</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Floating Rate</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Committed and Available Credit Facilities</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,000 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,000 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/></tr></table> 3000000000 3000000000 3000000000 3000000000 6000000000 6000000000 3000000000 P5Y 3000000000 P3Y 0.60 500000000 3000000000 P3Y P3Y 3000000000 474000000 296000000 163000000 381000000 57000000 42000000 48000000 69000000 1530000000 P3Y 4500000000 3000000000 4600000000 1250000000 0.0220 750000000 2000000000 -13000000 389000000 127000000 105000000 94000000 21000000 17000000 15000000 16000000 3550 P20Y 4000000000 0.50 2000000000 0.50 300000000 150000000 0.71 0.29 100000000 100000000 50000000 50000000 500000000 500000000 700000000 0.50 0.50 700000000 125000000 200000000 48000000 65000000 200000000 200000000 200000000 0.29 0.71 50 50 1 300000000 150000000 200000000 300000000 0.29 0.71 1000000 80000 6 235000000 2000000 1000000 6 3550 670700000 40000000 10000000 95 83000000 29000000 27000000 27000000 50 2 4 3 50000000 50000000 50000000 25000000 0.50 25000000 50000000 12500000 11000000 2050 1860 100 100 <div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:53.219%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.687%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.027%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.667%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2021</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Indemnification Asset</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accrual balance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">3</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Potential exposure above amount accrued</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">3</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Environmental Remediation Stray Liabilities</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chemours related obligations - subject to indemnity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1,2</span></div></td><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">262 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other discontinued or divested businesses obligations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Environmental remediation liabilities primarily related to DuPont - subject to indemnity from DuPont</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">2</span></div></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Environmental remediation liabilities not subject to indemnity</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indemnification liabilities related to the MOU</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">4</span></div></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">220 </span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">452 </span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">592 </span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:9.6pt">Represents liabilities that are subject the $200 million threshold and sharing arrangements as discussed on page F-46, under Corteva Separation Agreement.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:9.6pt">The company has recorded an indemnification asset related to these accruals, including $40 million related to the Superfund sites.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:9.56pt">Accrual balance represents management’s best estimate of the costs of remediation and restoration, although it is reasonably possible that the potential exposure, as indicated, could range above the amounts accrued, as there are inherent uncertainties in these estimates. Accrual balance includes $68 million for remediation of Superfund sites. Amounts do not include possible impacts from the remediation elements of the EPAs October 2021 PFAS Strategic Roadmap (as applicable) or possible revisions to Chemours’ Consent Order with the North Carolina Department of Environmental Quality, as any possible impacts, to the extent such items would be reimbursable under the MOU, are not yet determinable.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">4.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:9.6pt">Represents liabilities that are subject to the $150 million threshold and sharing agreements as discussed on page F-44, under the header "Chemours / Performance Chemicals.</span></div> 159000000 159000000 262000000 15000000 75000000 187000000 37000000 37000000 66000000 9000000 99000000 28000000 220000000 452000000 592000000 200000000 40000000 900000000 STOCKHOLDERS' EQUITY<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Common Stock</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As discussed in Note 1 - Background and Basis of Presentation, on June 1, 2019, Corteva, Inc.'s common stock was distributed to DowDuPont stockholders by way of a pro rata distribution</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Each DowDuPont stockholder received one share of Corteva, Inc. common stock for every three shares of DowDuPont common stock held at the close of business on May 24, 2019, the record date of distribution. Corteva, Inc.'s common stock began trading the "regular way" under the ticker symbol "CTVA" on June 3, 2019, the first business day after June 1, 2019. The number of Corteva, Inc. common shares issued on June 1, 2019 was 748,815,000 (par value of $0.01 per share). Information related to the Corteva Distribution and its effect on the company's financial statements are discussed throughout these Notes to the Consolidated Financial Statements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Set forth below is a reconciliation of common stock share activity for the years ended December 31, 2021, 2020, and 2019:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.391%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:27.409%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares of common stock</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Issued</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance June 1, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">748,815,000 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issued</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">586,000 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repurchased and retired</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(824,000)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance December 31, 2019</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">748,577,000 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issued</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,384,000 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repurchased and retired</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,503,000)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">743,458,000 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issued</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,019,000 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repurchased and retired</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20,950,000)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance December 31, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">726,527,000 </span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-right:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Share Buyback Plan</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 5, 2021, Corteva, Inc. announced that its Board of Directors authorized a $1.5 billion share repurchase program to purchase Corteva, Inc.'s common stock, par value $0.01 per share, without an expiration date ("2021 Share Buyback Plan"). The timing, price and volume of purchases will be based on market conditions, relevant securities laws and other factors. In connection with the 2021 Share Buyback Plan, the company purchased and retired 5,572,000 shares during the year ended December 31, 2021 in the open market for a total cost of $250 million.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 26, 2019, Corteva, Inc. announced that its Board of Directors authorized a $1 billion share repurchase program to purchase Corteva, Inc.'s common stock, par value $0.01 per share, without an expiration date ("2019 Share Buyback Plan").</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the 2019 Share Buyback Plan, the company repurchased and retired 15,378,000 shares, 8,503,000 shares, and 824,000 shares in the open market for a total cost of $700 million, $275 million, and $25 million during the years ended December 31, 2021, 2020, and 2019, respectively. Repurchases under the 2019 Share Buyback Plan were completed during the third quarter of 2021. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shares repurchased pursuant to Corteva's share buyback plan are immediately retired upon repurchase. Repurchased common stock is reflected as a reduction of stockholders' equity. The company's accounting policy related to its share repurchases is to reduce its common stock based on the par value of the shares and to reduce its retained earnings for the excess of the repurchase price over the par value. When Corteva has an accumulated deficit balance, the excess over the par value is applied to APIC. When Corteva has retained earnings, the excess is charged entirely to retained earnings.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Noncontrolling Interest</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2020, the company completed the acquisition of the remaining 46.5 percent interest in the Phytogen Seed Company, LLC joint venture from J. G. Boswell Company. As the purchase of the remaining interest did not result in a change of control, the difference between the carrying value of the noncontrolling interest and the consideration paid, net of taxes was recorded within equity.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corteva, Inc. owns 100 percent of the outstanding common shares of EID. However, EID has preferred stock outstanding to third parties which is accounted for as a noncontrolling interest in Corteva's Consolidated Balance Sheets. Each share of EID </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Preferred Stock - $4.50 Series and EID Preferred Stock - $3.50 Series issued and outstanding at the effective date of the Corteva Distribution remains issued and outstanding as to EID and was unaffected by the Corteva Distribution.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Below is a summary of the EID Preferred Stock at December 31, 2021 and December 31, 2020 which is classified as noncontrolling interests in the Corteva Consolidated Balance Sheets.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:75.292%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.508%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(Shares in thousands)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of Shares</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Authorized</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,000</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$4.50 Series, callable at $120</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,673</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$3.50 Series, callable at $102</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">700</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Comprehensive Income (Loss)</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes and after-tax balances of components comprising accumulated other comprehensive income (loss) are summarized below:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:33.302%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.832%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.832%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.832%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.832%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.832%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.838%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Cumulative Translation Adjustment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">1 </span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Derivative Instruments</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Pension Benefit Plans</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other Benefit Plans</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Unrealized Gain (Loss) on Investments</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance January 1, 2019</span></td><td style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,793)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(620)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,360)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(274)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(723)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(159)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,140)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net other comprehensive income (loss) </span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(274)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(718)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(160)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,124)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of Internal Reorganizations</span></div></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,123 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,214 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance December 31, 2019</span></td><td style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,944)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,247)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(81)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,270)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(81)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(191)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">670 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">362 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net other comprehensive income (loss) </span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(69)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(186)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">671 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">380 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance December 31, 2020</span></td><td style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,970)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(67)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,433)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">590 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,890)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(573)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">996 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">594 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(646)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(602)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(573)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,037 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(621)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance December 31, 2021</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,543)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(396)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,898)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:9.6pt">The cumulative translation adjustment losses for the year ended December 31, 2021 was primarily driven by the strengthening of the U.S. Dollar ("USD") against the European Euro ("EUR"), Swiss franc ("CHF") and Turkish Lira (“TRY”). The cumulative translation adjustment losses for the year ended December 31, 2020 was primarily driven by the strengthening of the U.S. Dollar ("USD") against the Brazilian Real ("BRL"), partially offset by the weakening of the U.S. Dollar against the Swiss franc ("CHF") and European Euro ("EUR"). </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tax (expense) benefit on the net activity related to each component of other comprehensive income (loss) was as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.987%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.205%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative instruments</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension benefit plans - net</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(319)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">231 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other benefit plans - net</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(211)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Provision for) benefit from income taxes related to other comprehensive income (loss) items</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(172)</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(133)</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">275 </span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the reclassifications out of accumulated other comprehensive loss is provided as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.036%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="9" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Year Ended December 31,</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Derivative Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">:</span></div></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax (benefit) expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">2</span></div></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">After-tax</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortization of pension benefit plans:</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  Prior service (benefit) cost</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">3,4</span></div></td><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  Actuarial (gains) losses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">3,4,5</span></div></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  Settlement (gain) loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">3,4,5</span></div></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total before tax</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax (benefit) expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">2</span></div></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">After-tax</span></td><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortization of other benefit plans:</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  Prior service (benefit) cost</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">3,4</span></div></td><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(922)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  Actuarial (gains) losses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">3,4</span></div></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  Curtailment (gain) loss</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total before tax</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(842)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax (benefit) expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">2</span></div></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">After-tax</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(646)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized (Gain) Loss on Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">4</span></div></td><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax (benefit) expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">2</span></div></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">After-tax</span></div></td><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total reclassifications for the period, after-tax</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(602)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-right:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:9.6pt">Reflected in cost of goods sold in the Consolidated Statements of Operations.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:9.6pt">Reflected in provision for (benefit from) income taxes from continuing operations in the Consolidated Statements of Operations.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:9.6pt">These accumulated other comprehensive (loss) income components are included in the computation of net periodic benefit (credit) cost of the company's pension and other benefit plans. See Note 20 - Pension Plans and Other Post Employment Benefits, to the Consolidated Financial Statements, for additional information. </span></div><div style="padding-left:18pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">4.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:9.6pt">Reflected in other income - net in the Consolidated Statements of Operations.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">5.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:9.6pt">A portion reflected in (loss) income from discontinued operations after income taxes for the year ended December 31, 2019.</span></div> 1 3 748815000 0.01 <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.391%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:27.409%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares of common stock</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Issued</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance June 1, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">748,815,000 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issued</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">586,000 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repurchased and retired</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(824,000)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance December 31, 2019</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">748,577,000 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issued</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,384,000 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repurchased and retired</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,503,000)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">743,458,000 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issued</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,019,000 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repurchased and retired</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20,950,000)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance December 31, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">726,527,000 </span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-right:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table> 748815000 586000 -824000 748577000 3384000 -8503000 743458000 4019000 -20950000 726527000 1000000000 0.01 15378000 8503000 700000000 275000000 0.465 1 <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:75.292%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.508%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(Shares in thousands)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of Shares</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Authorized</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,000</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$4.50 Series, callable at $120</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,673</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$3.50 Series, callable at $102</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">700</span></td></tr></table> 23000000 1673000 700000 <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:33.302%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.832%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.832%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.832%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.832%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.832%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.838%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Cumulative Translation Adjustment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">1 </span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Derivative Instruments</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Pension Benefit Plans</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other Benefit Plans</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Unrealized Gain (Loss) on Investments</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance January 1, 2019</span></td><td style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,793)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(620)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,360)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(274)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(723)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(159)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,140)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net other comprehensive income (loss) </span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(274)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(718)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(160)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,124)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of Internal Reorganizations</span></div></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,123 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,214 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance December 31, 2019</span></td><td style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,944)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,247)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(81)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,270)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(81)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(191)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">670 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">362 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net other comprehensive income (loss) </span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(69)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(186)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">671 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">380 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance December 31, 2020</span></td><td style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,970)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(67)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,433)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">590 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,890)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(573)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">996 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">594 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(646)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(602)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(573)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,037 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(621)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance December 31, 2021</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,543)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(396)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,898)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table>1.The cumulative translation adjustment losses for the year ended December 31, 2021 was primarily driven by the strengthening of the U.S. Dollar ("USD") against the European Euro ("EUR"), Swiss franc ("CHF") and Turkish Lira (“TRY”). The cumulative translation adjustment losses for the year ended December 31, 2020 was primarily driven by the strengthening of the U.S. Dollar ("USD") against the Brazilian Real ("BRL"), partially offset by the weakening of the U.S. Dollar against the Swiss franc ("CHF") and European Euro ("EUR"). -2793000000 -26000000 -620000000 79000000 0 -3360000000 -274000000 16000000 -723000000 -159000000 0 -1140000000 0 12000000 5000000 -1000000 0 16000000 -274000000 28000000 -718000000 -160000000 0 -1124000000 1123000000 0 91000000 0 0 1214000000 -1944000000 2000000 -1247000000 -81000000 0 -3270000000 -26000000 -81000000 -191000000 670000000 -10000000 362000000 0 12000000 5000000 1000000 0 18000000 -26000000 -69000000 -186000000 671000000 -10000000 380000000 -1970000000 -67000000 -1433000000 590000000 -10000000 -2890000000 -573000000 143000000 996000000 25000000 3000000 594000000 0 -4000000 41000000 -646000000 7000000 -602000000 -573000000 139000000 1037000000 -621000000 10000000 -8000000 -2543000000 72000000 -396000000 -31000000 0 -2898000000 <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.987%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.205%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative instruments</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension benefit plans - net</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(319)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">231 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other benefit plans - net</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(211)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Provision for) benefit from income taxes related to other comprehensive income (loss) items</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(172)</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(133)</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">275 </span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> -41000000 24000000 -8000000 -319000000 54000000 231000000 188000000 -211000000 52000000 -172000000 -133000000 275000000 <div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.036%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="9" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Year Ended December 31,</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Derivative Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">:</span></div></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax (benefit) expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">2</span></div></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">After-tax</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortization of pension benefit plans:</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  Prior service (benefit) cost</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">3,4</span></div></td><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  Actuarial (gains) losses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">3,4,5</span></div></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  Settlement (gain) loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">3,4,5</span></div></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total before tax</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax (benefit) expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">2</span></div></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">After-tax</span></td><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortization of other benefit plans:</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  Prior service (benefit) cost</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">3,4</span></div></td><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(922)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  Actuarial (gains) losses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">3,4</span></div></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  Curtailment (gain) loss</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total before tax</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(842)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax (benefit) expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">2</span></div></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">After-tax</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(646)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized (Gain) Loss on Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">4</span></div></td><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax (benefit) expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">2</span></div></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">After-tax</span></div></td><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total reclassifications for the period, after-tax</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(602)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-right:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:9.6pt">Reflected in cost of goods sold in the Consolidated Statements of Operations.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:9.6pt">Reflected in provision for (benefit from) income taxes from continuing operations in the Consolidated Statements of Operations.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:9.6pt">These accumulated other comprehensive (loss) income components are included in the computation of net periodic benefit (credit) cost of the company's pension and other benefit plans. See Note 20 - Pension Plans and Other Post Employment Benefits, to the Consolidated Financial Statements, for additional information. </span></div><div style="padding-left:18pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">4.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:9.6pt">Reflected in other income - net in the Consolidated Statements of Operations.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">5.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:9.6pt">A portion reflected in (loss) income from discontinued operations after income taxes for the year ended December 31, 2019.</span></div> -13000000 18000000 13000000 9000000 -6000000 -1000000 -4000000 12000000 12000000 -2000000 -1000000 -1000000 55000000 4000000 2000000 1000000 3000000 4000000 54000000 6000000 5000000 -13000000 -1000000 0 41000000 5000000 5000000 -922000000 0 0 81000000 1000000 -1000000 -842000000 1000000 -1000000 196000000 0 0 -646000000 1000000 -1000000 7000000 0 0 0 0 0 -602000000 18000000 16000000 PENSION PLANS AND OTHER POST EMPLOYMENT BENEFITS<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company offers various long-term benefits to its employees. Where permitted by applicable law, the company reserves the right to change, modify or discontinue the plans.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Defined Benefit Pension Plans</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company has both funded and unfunded noncontributory defined benefit pension plans covering a majority of the U.S. employees and employees in a number of other countries. The principal U.S. pension plan is the largest pension plan held by Corteva. Effective January 1, 2007, a majority of new hires are not eligible to participate in the U.S. defined benefit pension plans. The company froze the pay and service amounts used to calculate the pension benefits for active employees who participate in these plans on November 30, 2018, resulting in the participants no longer accruing additional benefits. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company's funding policy is consistent with the funding requirements of federal laws and regulations. Pension coverage for employees of the company's non-U.S. consolidated subsidiaries is provided, to the extent deemed appropriate, through separate plans. Obligations under such plans are funded by depositing funds with trustees, covered by insurance contracts, or remain unfunded. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company made total contributions of $49 million, $62 million, and $121 million to its pension plans other than the principal U.S. pension plan for the years ended December 31, 2021, 2020 and 2019, respectively. Corteva expects to contribute approximately $60 million to its pension plans other than the principal U.S. pension plan in 2022. The company does not anticipate making contributions to its principal U.S pension plan in 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted-average assumptions used to determine pension plan obligations for all pension plans are summarized in the table below:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.812%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.445%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-Average Assumptions used to Determine Benefit Obligations</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></div></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.82 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.44 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rate of increase in future compensation levels</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.55 </span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.54 </span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:9.6pt">The rate of compensation increase excludes U.S. pension plans since the employees who participate in the U.S. pension plans no longer accrue additional benefits for future service and eligible compensation. </span></div><div style="text-align:justify;text-indent:4.5pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted-average assumptions used to determine net periodic benefit costs for all pension plans are summarized in the table below:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.791%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-Average Assumptions used to Determine Net Periodic Benefit Cost</span></td><td colspan="9" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Year Ended December 31,</span></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></div></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.44 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.19 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.19 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rate of increase in future compensation levels</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.54 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.60 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.84 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected long-term rate of return on plan assets</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.73 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.25 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.24 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:9.6pt">The rate of compensation increase excludes U.S. pension plans since the employees who participate in the U.S. pension plans no longer accrue additional benefits for future service and eligible compensation. </span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Post Employment Benefits</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The company has historically provided medical, dental and life insurance benefits to certain pensioners and survivors. The majority of U.S. employees hired on or after January 1, 2007, and eligible employees under the age of 50 as of November 30, 2018, are not eligible to participate in the post-employment medical, dental and life insurance plans. Substantially all of the cost and liabilities for these retiree benefit plans are attributable to the U.S. benefit plans. The non-Medicare eligible retiree medical plan is contributory with costs shared between the company and pensioners and survivors. For Medicare eligible pensioners and survivors, Corteva provides a company-funded Health Reimbursement Arrangement ("HRA"). In December 2020, the company amended its retiree medical, dental and life insurance plans resulting in the company no longer providing retiree dental and life insurance benefits effective January 1, 2022 and Corteva’s portion of the cost of non-Medicare retiree medical coverage no longer being adjusted for cost increases, which capped the Corteva cost at the level in effect as of December 31, 2021 ("2020 OPEB Plan Amendments"). As a result of these changes, the company recorded a $(939) million decrease in OPEB benefit obligations as of December 31, 2020 with a corresponding prior service benefit within other comprehensive income for the year ended December 31, 2020. During 2021, a substantial amount of the prior service benefit within other comprehensive income (loss) in 2020 was recognized in other income - net in the Consolidated Statement of Operations.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company also provides disability benefits to employees. Employee disability benefit plans are insured in many countries. However, primarily in the U.S., such plans are generally self-insured. Obligations and expenses for self-insured plans are reflected in the change in projected benefit obligations table on page F-56.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company's OPEB plans are unfunded and the cost of the approved claims is paid from operating cash flows. Pre-tax cash requirements to cover actual net claims costs and related administrative expenses were $198 million, $207 million, and $202 million for the years ended December 31, 2021, 2020 and 2019, respectively. Changes in cash requirements reflect the net impact of per capita health care costs, demographic changes, plan amendments and changes in participant premiums, co-pays and deductibles. In 2022, the company expects to contribute approximately $140 million for its OPEB plans.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted-average assumptions used to determine benefit obligations for OPEB plans are summarized in the table below:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:66.491%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.104%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.105%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-Average Assumptions used to Determine Benefit Obligations</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.59 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.09 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted-average assumptions used to determine net periodic benefit costs for the OPEB plans are summarized in the two tables below:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.791%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-Average Assumptions used to Determine Net Periodic Benefit Cost</span></td><td colspan="9" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Year Ended December 31,</span></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.09 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.07 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.93 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As of December 31, 2021, health care cost trend rates do not impact the benefit obligations for the OPEB plans because of the 2020 OPEB Plan Amendments. For the year ended December 31, 2020 and 2019, the health care cost trend rate was assumed to be 7.0 percent and 7.2 percent for next year, respectively.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Assumptions</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Within the U.S., the company determines the expected long-term rate of return on plan assets by performing a detailed analysis of key economic and market factors driving historical returns for each asset class and formulating a projected return based on factors in the current environment. Factors considered include, but are not limited to, inflation, real economic growth, interest rate yield, interest rate spreads, and other valuation measures and market metrics. The expected long-term rate of return for each asset class is then weighted based on the strategic asset allocation approved by the governing body for the plan. The company's historical experience with the pension fund asset performance is also considered. For non-U.S. plans, assumptions reflect economic assumptions applicable to each country.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the U.S., Corteva calculates service costs and interest costs by applying individual spot rates from a yield curve (based on high-quality corporate bond yields) to the separate expected cash flows components of service cost and interest cost. Service cost and interest cost for all other plans are determined on the basis of the single equivalent discount rates derived in determining those plan obligations. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The discount rates utilized to measure the pension and other post employment benefit obligations are based on the yield on high-quality corporate fixed income investments at the measurement date. Future expected actuarially determined cash flows are individually discounted at the spot rates under the Aon AA_Above Median yield curve (based on high-quality corporate bond yields) to arrive at the plan’s obligations as of the measurement date. For non-U.S. benefit plans, historically the company utilized prevailing long-term high quality corporate bond indices to determine the discount rate, applicable to each country, at the measurement date. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company adopts the most recently published mortality tables and mortality improvement scale released by the Society of Actuaries in measuring its U.S. pension and other post employment benefit obligations. The effect of these adoptions is amortized into net periodic benefit cost for the years following the adoption.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Summarized information on the company's pension and other post employment benefit plans is as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.736%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.792%"/><td style="width:0.1%"/></tr><tr><td colspan="18" style="border-bottom:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change in Projected Benefit Obligations, Plan Assets and Funded Status</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="6" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Defined Benefit Pension Plans</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="6" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Other Post Employment Benefits</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Year Ended December 31, 2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Year Ended December 31, 2020</span></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Year Ended December 31, 2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Year Ended December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Change in benefit obligations:</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefit obligation at beginning of the period</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,682 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,004 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,571 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,591 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">364 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">559 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">66 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Plan participants' contributions</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Actuarial (gain) loss</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(524)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,659 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">59 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,490)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,538)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(233)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(241)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Plan amendments</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(939)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">1</span></div></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(240)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effect of foreign exchange rates</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(30)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefit obligations at end of the period</span></td><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,775 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,682 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,362 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,571 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Change in plan assets:</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of plan assets at beginning of the period</span></td><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,835 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,941 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,685 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,404 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Employer contributions</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">62 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">198 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">207 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Plan participants' contributions</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,490)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,538)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(233)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(241)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">1</span></div></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(240)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effect of foreign exchange rates</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of plan assets at end of the period</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,827 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,835 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Funded status</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. plan with plan assets</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,471)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,301)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-U.S. plans with plan assets</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(62)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(98)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">All other plans </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">2,3</span></div></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(415)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(448)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,362)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,571)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Funded status at end of the period</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,948)</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,847)</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,362)</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,571)</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-right:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:3pt">Relates to the transfer of certain benefit obligations and related assets associated with the principal U.S. pension plan to an insurance company through the purchase of nonparticipating group annuity contracts.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:3pt">As of December 31, 2021 and December 31, 2020, $219 million and $249 million, respectively, of the benefit obligations are supported by funding under the Trust agreement, defined in the "Trust Assets" section below.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:3pt">Includes pension plans maintained around the world where funding is not customary.</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.761%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.184%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.184%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.184%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.187%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="6" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Defined Benefit Pension Plans</span></td><td colspan="6" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Other Post Employment Benefits</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.5pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Amounts recognized in the Consolidated Balance Sheets:</span></div></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Assets</span></td><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued and other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(144)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(217)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and other post employment benefits - noncurrent </span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,906)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,822)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,218)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,354)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net amount recognized</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,948)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,847)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,362)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,571)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Pretax amounts recognized in accumulated other comprehensive income (loss):</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net gain (loss)</span></td><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(543)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,886)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(163)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service benefit (cost)</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">939 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pretax balance in accumulated other comprehensive income (loss) at end of year</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 5.5pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(516)</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 5.5pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,872)</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 5.5pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 5.5pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">776</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The gain related to the change in pension and OPEB plan benefit obligations for the period ended December 31, 2021 is mainly due to an increase in discount rates.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accumulated benefit obligation for all pensions plans was $19.7 billion and $21.6 billion at December 31, 2021 and 2020, respectively. </span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.274%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.712%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.714%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pension Plans with Projected Benefit Obligations in Excess of Plan Assets</span></td><td colspan="3" rowspan="2" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" rowspan="2" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-right:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected benefit obligations</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,519 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,513 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,567 </span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,659 </span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.981%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.859%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.860%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pension Plans with Accumulated Benefit Obligations in Excess of Plan Assets</span></td><td colspan="3" rowspan="2" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" rowspan="2" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-right:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated benefit obligations</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,501 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,369 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:1.5pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,567 </span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,550 </span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:43.540%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.857%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.857%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.857%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.415%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.857%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.857%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.860%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="24" style="border-bottom:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="9" style="border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Defined Benefit Pension Plans</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Other Post Employment Benefits</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Year Ended December 31,</span></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Components of net periodic benefit (credit) cost and amounts recognized in other comprehensive income (loss)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Net Periodic Benefit (Credit) Cost:</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Service cost</span></td><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">364 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">559 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">769 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(915)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,078)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of unrecognized loss (gain)</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of prior service (benefit) cost</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(922)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Curtailment loss (gain) </span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Settlement loss</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net periodic benefit (credit) cost - Total</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(472)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(409)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(264)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(820)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Discontinued operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">1</span></div></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net periodic benefit (credit) cost - continuing operations</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(472)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(409)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(250)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(820)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Changes in plan assets and benefit obligations recognized in other comprehensive income (loss):</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net gain (loss)</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,284 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(247)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(970)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(211)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of unrecognized (gain) loss</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prior service benefit (cost)</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">939 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of prior service (benefit) cost</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(922)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Curtailment (gain) loss</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Settlement loss</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effect of foreign exchange rates</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total benefit (loss) recognized in other comprehensive income (loss), attributable to Corteva</span></td><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,356 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(240)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(949)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(809)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">882 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(212)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total recognized in net periodic benefit (credit) cost and other comprehensive income (loss)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,828 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(685)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-bottom:1.5pt solid #000;border-left:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">813 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(299)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:14.1pt">Includes non-service related components of net periodic benefit credit of $(31) million for the year ended December 31, 2019.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Estimated Future Benefit Payments</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated future benefit payments, reflecting expected future service, as appropriate, are presented in the following table:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:65.517%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.617%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Estimated Future Benefit Payments at December 31, 2021</span></td><td colspan="3" rowspan="2" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Defined Benefit Pension Plans</span></td><td colspan="3" rowspan="2" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Other Post Employment Benefits</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-right:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,459 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,409 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,378 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,341 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,305 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Years 2027-2031</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,913 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">399 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,805 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,033 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Plan Assets</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All pension plan assets in the U.S. are invested through a single master trust fund. The strategic asset allocation for this trust fund is approved by the Pension Investment Committee. The general principles guiding U.S. pension asset investment policies are those embodied in the Employee Retirement Income Security Act of 1974 ("ERISA"). These principles include discharging Corteva's investment responsibilities for the exclusive benefit of plan participants and in accordance with the "prudent expert" standard and other ERISA rules and regulations. Corteva establishes strategic asset allocation percentage targets and appropriate benchmarks for significant asset classes with the aim of achieving a prudent balance between return and risk. Strategic asset allocations in other countries are selected in accordance with the laws and practices of those countries. Where appropriate, asset liability studies are utilized in this process. U.S. plan assets are managed by investment professionals employed by Corteva. The remaining assets are managed by professional investment firms unrelated to the company. Corteva's pension investment professionals have discretion to manage the assets within established asset allocation ranges approved by the Pension Investment Committee. Additionally, pension trust funds are permitted to enter into certain contractual arrangements generally described as "derivatives." Derivatives are primarily used to reduce specific market risks, hedge currency and adjust portfolio duration and asset allocation in a cost-effective manner.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted-average target allocation for plan assets of the company's pension plans is summarized as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.981%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.859%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.860%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Target Allocation for Plan Assets</span></td><td colspan="3" rowspan="2" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" rowspan="2" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-right:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Asset Category</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. equity securities</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. equity securities</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed income securities</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hedge funds</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Private market securities</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Real estate</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total </span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100 </span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100 </span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. equity investments are primarily large-cap companies. Global equity securities include varying market capitalization levels. Global fixed income investments include corporate-issued, government-issued and asset-backed securities. Corporate debt investments include a range of credit risk and industry diversification. U.S. fixed income investments are weighted heavier than non-U.S. fixed income securities. Other investments include cash and cash equivalents, hedge funds, real estate and private market securities such as interests in private equity and venture capital partnerships.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value calculations may not be indicative of net realizable value or reflective of future fair values. Furthermore, although the company believes its valuation methods are appropriate and consistent with other market participants, the use of different methodologies or assumptions to determine the fair value of certain financial instruments could result in a different fair value measurement at the reporting date.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For pension plan assets classified as Level 1 measurements (measured using quoted prices in active markets), total fair value is either the price of the most recent trade at the time of the market close or the official close price, as defined by the exchange on which the asset is most actively traded on the last trading day of the period, multiplied by the number of units held without consideration of transaction costs.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For pension plan assets classified as Level 2 measurements, where the security is frequently traded in less active markets, fair value is based on the closing price at the end of the period; where the security is less frequently traded, fair value is based on the price a dealer would pay for the security or similar securities, adjusted for any terms specific to that asset or liability. Market inputs are obtained from well-established and recognized vendors of market data and subjected to tolerance and quality checks. For derivative assets and liabilities, standard industry models are used to calculate the fair value of the various financial instruments based on significant observable market inputs, such as foreign exchange rates, commodity prices, swap rates, interest rates and implied volatilities obtained from various market sources.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For pension plan assets classified as Level 3 measurements, total fair value is based on significant unobservable inputs including assumptions where there is little, if any, market activity for the investment. Investment managers, fund managers, or investment contract issuers provide valuations of the investment on a monthly or quarterly basis. These valuations are reviewed for reasonableness based on applicable sector, benchmark and company performance. Adjustments to valuations are made where appropriate. Where available, audited financial statements are obtained and reviewed for the investments as support for the manager’s investment valuation.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tables below present the fair values of the company's pension assets by level within the fair value hierarchy, as described in Note 2 - Summary of Significant Accounting Policies:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:44.274%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.558%"/><td style="width:0.1%"/></tr><tr style="height:11pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basis of Fair Value Measurements</span></td><td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Total</span></td><td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Level 1</span></td><td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Level 3</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-right:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the year ended December 31, 2021</span></td></tr><tr style="height:11pt"><td colspan="3" style="border-right:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,543 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,543 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. equity securities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,400 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,394 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. equity securities</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,523 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,523 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt – government-issued</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,271 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,271 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt – corporate-issued</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,591 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,589 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt – asset-backed</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">682 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">682 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Private market securities</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Real estate</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">     Subtotal </span></td><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,117 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,460 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,547 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments measured at net asset value</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">     Debt - government issued</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">     Debt - corporate issued</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">     U.S. equity securities</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">     Non-U.S. equity securities</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">     Hedge funds</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">394 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">     Private market securities</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,822 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">     Real estate funds</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">759 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total investments measured at net asset value</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,086 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other items to reconcile to fair value of plan assets</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">     Pension trust receivables </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">2</span></div></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">655 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">     Pension trust payables </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">3</span></div></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,031)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,827 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr></table></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:3pt">The Corteva pension plans directly held $201 million (approximately 1 percent of total plan assets) of Corteva, Inc. common stock at December 31, 2021. </span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:3pt">Primarily receivables for investments securities sold.</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:3pt">Primarily payables for investment securities purchased.</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:44.434%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.516%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.516%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.516%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.518%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basis of Fair Value Measurements</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the year ended December 31, 2020</span></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Level 1</span></td><td colspan="3" style="border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,616 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,616 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. equity securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,905 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,898 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. equity securities</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,194 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,189 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt – government-issued</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,569 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,569 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt – corporate-issued</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,579 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,576 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt – asset-backed</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">616 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">616 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Private market securities</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Real estate</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">     Subtotal </span></td><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,586 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,703 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,768 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments measured at net asset value</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">     Debt - government issued</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">     Debt - corporate issued</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">     U.S. equity securities</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">     Non-U.S. equity securities</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">     Hedge funds</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">391 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">     Private market securities</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,381 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">     Real estate funds</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">590 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total investments measured at net asset value</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,469 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other items to reconcile to fair value of plan assets</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">     Pension trust receivables</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">2</span></div></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">     Pension trust payables</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">3</span></div></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(434)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,835 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr></table></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:3pt">The Corteva pension plans directly held $165 million (approximately 1 percent of total plan assets) of Corteva, Inc. at December 31, 2020. </span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:3pt">Primarily receivables for investments securities sold.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:3pt">Primarily payables for investment securities purchased.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the changes in fair value of Level 3 pension plan assets for the years ended December 31, 2020 and 2019:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:38.227%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.525%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.063%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.945%"/><td style="width:0.1%"/></tr><tr style="height:21pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value Measurement of Level 3 Pension Plan Assets</span></td><td colspan="3" rowspan="2" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">U.S. equity securities</span></td><td colspan="3" rowspan="2" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Non-U.S. equity securities</span></td><td colspan="3" rowspan="2" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Debt – corporate-issued</span></td><td colspan="3" rowspan="2" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Private market securities</span></td><td colspan="3" rowspan="2" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Real estate</span></td><td colspan="3" rowspan="2" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Other</span></td><td colspan="3" rowspan="2" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Total</span></td></tr><tr style="height:20pt"><td colspan="3" style="border-right:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at January 1, 2020</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual return on assets:</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Relating to assets sold during the year ended December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Relating to assets held at December 31, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases, sales and settlements, net</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfers in or out of Level 3, net</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual return on assets:</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Relating to assets sold during the year ended December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Relating to assets held at December 31, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases, sales and settlements, net</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26 </span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75 </span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110 </span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-right:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Trust Assets</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EID entered into a trust agreement in 2013 (as amended and restated in 2017) that established and requires EID to fund the Trust for cash obligations under certain non-qualified benefit and deferred compensation plans upon a change in control event as defined in the Trust agreement. Under the Trust agreement, the consummation of the Merger was a change in control event. As a result, in November 2017, EID contributed $571 million to the Trust. At the Separation, Corteva transferred $39 million to DuPont. During the years ended December 31, 2021 and 2020, $43 million and $65 million, respectively, was distributed to EID according to the Trust agreement, and at December 31, 2021 and 2020, the balance in the Trust was $304 million and $347 million, respectively. The Trust Assets are classified as current restricted cash equivalents and included within other current assets in the Consolidated Balance Sheets. See Note 9 - Supplementary Information, to the Consolidated Financial Statements, for further information.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Defined Contribution Plans</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corteva provides defined contribution benefits to its employees. The most significant is the U.S. Retirement Savings Plan ("the Plan"), which covers almost all of the U.S. full-service employees. This Plan includes a non-leveraged Employee Stock Ownership Plan ("ESOP"). Employees are not required to participate in the ESOP and those who do are free to diversify out of the ESOP. The purpose of the Plan is to provide retirement savings benefits for employees and to provide employees an opportunity to become stockholders of the company. The Plan is a tax qualified contributory profit sharing plan, with cash or deferred arrangement and any eligible employee of Corteva may participate. Currently, Corteva contributes 100 percent of the first 6 percent of the employee's contribution election and also contributes 3 percent of each eligible employee's eligible compensation regardless of the employee's contribution.</span></div>Corteva's contributions to the Plan were $63 million, $94 million, and $142 million for the years ended December 31, 2021, 2020 and 2019, respectively. Corteva's matching contributions vest immediately upon contribution. The 3 percent nonmatching company contribution vests after employees complete three years of service. In addition, Corteva made contributions to other defined contribution plans of $29 million, $33 million, and $46 million for the years ended December 31, 2021, 2020 and 2019, respectively. Included in Corteva's contributions are amounts related to discontinued operations of $73 million for the year ended December 31, 2019 49000000 62000000 121000000 60000000 <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted-average assumptions used to determine pension plan obligations for all pension plans are summarized in the table below:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.812%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.445%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-Average Assumptions used to Determine Benefit Obligations</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></div></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.82 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.44 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rate of increase in future compensation levels</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.55 </span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.54 </span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:9.6pt">The rate of compensation increase excludes U.S. pension plans since the employees who participate in the U.S. pension plans no longer accrue additional benefits for future service and eligible compensation. </span></div><div style="text-align:justify;text-indent:4.5pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted-average assumptions used to determine net periodic benefit costs for all pension plans are summarized in the table below:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.791%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-Average Assumptions used to Determine Net Periodic Benefit Cost</span></td><td colspan="9" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Year Ended December 31,</span></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></div></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.44 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.19 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.19 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rate of increase in future compensation levels</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.54 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.60 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.84 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected long-term rate of return on plan assets</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.73 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.25 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.24 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:9.6pt">The rate of compensation increase excludes U.S. pension plans since the employees who participate in the U.S. pension plans no longer accrue additional benefits for future service and eligible compensation. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted-average assumptions used to determine benefit obligations for OPEB plans are summarized in the table below:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:66.491%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.104%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.105%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-Average Assumptions used to Determine Benefit Obligations</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.59 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.09 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted-average assumptions used to determine net periodic benefit costs for the OPEB plans are summarized in the two tables below:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.791%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-Average Assumptions used to Determine Net Periodic Benefit Cost</span></td><td colspan="9" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Year Ended December 31,</span></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.09 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.07 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.93 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As of December 31, 2021, health care cost trend rates do not impact the benefit obligations for the OPEB plans because of the 2020 OPEB Plan Amendments. For the year ended December 31, 2020 and 2019, the health care cost trend rate was assumed to be 7.0 percent and 7.2 percent for next year, respectively.</span></div> 0.0282 0.0244 0.0255 0.0254 0.0244 0.0319 0.0419 0.0254 0.0260 0.0284 0.0573 0.0625 0.0624 -939000000 198000000 207000000 202000000 140000000 0.0259 0.0209 0.0209 0.0307 0.0393 <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Summarized information on the company's pension and other post employment benefit plans is as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.736%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.792%"/><td style="width:0.1%"/></tr><tr><td colspan="18" style="border-bottom:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change in Projected Benefit Obligations, Plan Assets and Funded Status</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="6" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Defined Benefit Pension Plans</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="6" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Other Post Employment Benefits</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Year Ended December 31, 2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Year Ended December 31, 2020</span></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Year Ended December 31, 2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Year Ended December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Change in benefit obligations:</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefit obligation at beginning of the period</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,682 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,004 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,571 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,591 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">364 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">559 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">66 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Plan participants' contributions</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Actuarial (gain) loss</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(524)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,659 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">59 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,490)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,538)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(233)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(241)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Plan amendments</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(939)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">1</span></div></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(240)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effect of foreign exchange rates</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(30)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefit obligations at end of the period</span></td><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,775 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,682 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,362 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,571 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Change in plan assets:</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of plan assets at beginning of the period</span></td><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,835 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,941 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,685 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,404 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Employer contributions</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">62 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">198 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">207 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Plan participants' contributions</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,490)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,538)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(233)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(241)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">1</span></div></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(240)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effect of foreign exchange rates</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of plan assets at end of the period</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,827 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,835 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Funded status</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. plan with plan assets</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,471)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,301)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-U.S. plans with plan assets</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(62)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(98)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">All other plans </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">2,3</span></div></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(415)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(448)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,362)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,571)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Funded status at end of the period</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,948)</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,847)</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,362)</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,571)</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-right:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:3pt">Relates to the transfer of certain benefit obligations and related assets associated with the principal U.S. pension plan to an insurance company through the purchase of nonparticipating group annuity contracts.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:3pt">As of December 31, 2021 and December 31, 2020, $219 million and $249 million, respectively, of the benefit obligations are supported by funding under the Trust agreement, defined in the "Trust Assets" section below.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:3pt">Includes pension plans maintained around the world where funding is not customary.</span></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.761%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.184%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.184%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.184%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.187%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="6" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Defined Benefit Pension Plans</span></td><td colspan="6" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Other Post Employment Benefits</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.5pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Amounts recognized in the Consolidated Balance Sheets:</span></div></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Assets</span></td><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued and other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(144)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(217)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and other post employment benefits - noncurrent </span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,906)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,822)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,218)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,354)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net amount recognized</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,948)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,847)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,362)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,571)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Pretax amounts recognized in accumulated other comprehensive income (loss):</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net gain (loss)</span></td><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(543)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,886)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(163)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service benefit (cost)</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">939 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pretax balance in accumulated other comprehensive income (loss) at end of year</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 5.5pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(516)</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 5.5pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,872)</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 5.5pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 5.5pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">776</span></td></tr></table> 21682000000 21004000000 1571000000 2591000000 25000000 26000000 1000000 2000000 364000000 559000000 21000000 66000000 3000000 2000000 35000000 34000000 -524000000 1659000000 -33000000 59000000 -1490000000 -1538000000 -233000000 -241000000 -15000000 -3000000 0 -939000000 -240000000 0 0 0 -30000000 -27000000 0 -1000000 19775000000 21682000000 1362000000 1571000000 17835000000 16941000000 0 0 1685000000 2404000000 0 0 49000000 62000000 198000000 207000000 3000000 2000000 35000000 34000000 -1490000000 -1538000000 -233000000 -241000000 -240000000 0 0 0 -15000000 -36000000 0 0 17827000000 17835000000 0 0 -1471000000 -3301000000 0 0 -62000000 -98000000 0 0 -415000000 -448000000 -1362000000 -1571000000 -1948000000 -3847000000 -1362000000 -1571000000 219000000 249000000 4000000 7000000 0 0 46000000 32000000 144000000 217000000 1906000000 3822000000 1218000000 1354000000 -1948000000 -3847000000 -1362000000 -1571000000 -543000000 -1886000000 -50000000 -163000000 27000000 14000000 17000000 939000000 -516000000 -1872000000 -33000000 776000000 19700000000 21600000000 <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.274%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.712%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.714%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pension Plans with Projected Benefit Obligations in Excess of Plan Assets</span></td><td colspan="3" rowspan="2" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" rowspan="2" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-right:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected benefit obligations</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,519 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,513 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,567 </span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,659 </span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 19519000000 21513000000 17567000000 17659000000 <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.981%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.859%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.860%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pension Plans with Accumulated Benefit Obligations in Excess of Plan Assets</span></td><td colspan="3" rowspan="2" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" rowspan="2" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-right:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated benefit obligations</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,501 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,369 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:1.5pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,567 </span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,550 </span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 19501000000 21369000000 17567000000 17550000000 <div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:43.540%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.857%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.857%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.857%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.415%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.857%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.857%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.860%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="24" style="border-bottom:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="9" style="border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Defined Benefit Pension Plans</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Other Post Employment Benefits</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Year Ended December 31,</span></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Components of net periodic benefit (credit) cost and amounts recognized in other comprehensive income (loss)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Net Periodic Benefit (Credit) Cost:</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Service cost</span></td><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">364 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">559 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">769 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(915)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,078)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of unrecognized loss (gain)</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of prior service (benefit) cost</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(922)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Curtailment loss (gain) </span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Settlement loss</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net periodic benefit (credit) cost - Total</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(472)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(409)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(264)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(820)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Discontinued operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">1</span></div></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net periodic benefit (credit) cost - continuing operations</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(472)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(409)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(250)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(820)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Changes in plan assets and benefit obligations recognized in other comprehensive income (loss):</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net gain (loss)</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,284 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(247)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(970)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(211)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of unrecognized (gain) loss</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prior service benefit (cost)</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">939 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of prior service (benefit) cost</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(922)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Curtailment (gain) loss</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Settlement loss</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effect of foreign exchange rates</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total benefit (loss) recognized in other comprehensive income (loss), attributable to Corteva</span></td><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,356 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(240)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(949)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(809)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">882 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(212)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total recognized in net periodic benefit (credit) cost and other comprehensive income (loss)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,828 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(685)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-bottom:1.5pt solid #000;border-left:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">813 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(299)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:14.1pt">Includes non-service related components of net periodic benefit credit of $(31) million for the year ended December 31, 2019.</span></div> 25000000 26000000 41000000 1000000 2000000 4000000 364000000 559000000 769000000 21000000 66000000 84000000 915000000 1000000000 1078000000 0 0 0 -55000000 -4000000 -3000000 -81000000 -1000000 1000000 -2000000 -1000000 -1000000 -922000000 0 0 0 0 2000000 1000000 0 0 -1000000 -3000000 -4000000 0 0 0 -472000000 -409000000 -264000000 -820000000 69000000 87000000 0 0 -14000000 0 0 0 -472000000 -409000000 -250000000 -820000000 69000000 87000000 1284000000 -247000000 -970000000 33000000 -59000000 -211000000 55000000 4000000 2000000 81000000 1000000 -1000000 15000000 3000000 11000000 0 939000000 0 -2000000 -1000000 -1000000 -922000000 0 0 -1000000 0 0 1000000 3000000 4000000 0 0 0 3000000 -2000000 5000000 0 1000000 0 1356000000 -240000000 -949000000 -809000000 882000000 -212000000 1828000000 169000000 -685000000 11000000 813000000 -299000000 -31000000 <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:65.517%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.617%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Estimated Future Benefit Payments at December 31, 2021</span></td><td colspan="3" rowspan="2" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Defined Benefit Pension Plans</span></td><td colspan="3" rowspan="2" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Other Post Employment Benefits</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-right:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,459 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,409 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,378 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,341 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,305 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Years 2027-2031</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,913 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">399 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,805 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,033 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 1459000000 144000000 1409000000 134000000 1378000000 126000000 1341000000 118000000 1305000000 112000000 5913000000 399000000 12805000000 1033000000 <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.981%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.859%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.860%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Target Allocation for Plan Assets</span></td><td colspan="3" rowspan="2" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" rowspan="2" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-right:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Asset Category</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. equity securities</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. equity securities</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed income securities</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hedge funds</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Private market securities</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Real estate</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total </span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100 </span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100 </span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:44.274%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.558%"/><td style="width:0.1%"/></tr><tr style="height:11pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basis of Fair Value Measurements</span></td><td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Total</span></td><td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Level 1</span></td><td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" rowspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Level 3</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-right:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the year ended December 31, 2021</span></td></tr><tr style="height:11pt"><td colspan="3" style="border-right:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,543 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,543 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. equity securities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,400 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,394 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. equity securities</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,523 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,523 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt – government-issued</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,271 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,271 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt – corporate-issued</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,591 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,589 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt – asset-backed</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">682 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">682 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Private market securities</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Real estate</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">     Subtotal </span></td><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,117 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,460 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,547 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments measured at net asset value</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">     Debt - government issued</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">     Debt - corporate issued</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">     U.S. equity securities</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">     Non-U.S. equity securities</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">     Hedge funds</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">394 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">     Private market securities</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,822 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">     Real estate funds</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">759 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total investments measured at net asset value</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,086 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other items to reconcile to fair value of plan assets</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">     Pension trust receivables </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">2</span></div></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">655 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">     Pension trust payables </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">3</span></div></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,031)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,827 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr></table></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:3pt">The Corteva pension plans directly held $201 million (approximately 1 percent of total plan assets) of Corteva, Inc. common stock at December 31, 2021. </span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:3pt">Primarily receivables for investments securities sold.</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:3pt">Primarily payables for investment securities purchased.</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:44.434%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.516%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.516%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.516%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.518%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basis of Fair Value Measurements</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the year ended December 31, 2020</span></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Level 1</span></td><td colspan="3" style="border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,616 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,616 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. equity securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,905 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,898 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. equity securities</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,194 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,189 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt – government-issued</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,569 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,569 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt – corporate-issued</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,579 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,576 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt – asset-backed</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">616 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">616 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Private market securities</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Real estate</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">     Subtotal </span></td><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,586 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,703 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,768 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments measured at net asset value</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">     Debt - government issued</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">     Debt - corporate issued</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">     U.S. equity securities</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">     Non-U.S. equity securities</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">     Hedge funds</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">391 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">     Private market securities</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,381 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">     Real estate funds</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">590 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total investments measured at net asset value</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,469 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other items to reconcile to fair value of plan assets</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">     Pension trust receivables</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">2</span></div></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">     Pension trust payables</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">3</span></div></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(434)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,835 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr></table></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:3pt">The Corteva pension plans directly held $165 million (approximately 1 percent of total plan assets) of Corteva, Inc. at December 31, 2020. </span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:3pt">Primarily receivables for investments securities sold.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:3pt">Primarily payables for investment securities purchased.</span></div> 0.11 0.20 0.11 0.16 0.58 0.51 0.02 0.02 0.08 0.06 0.05 0.04 0.05 0.01 1 1 2543000000 2543000000 0 0 2400000000 2394000000 2000000 4000000 1523000000 1523000000 0 0 3271000000 0 3271000000 0 4591000000 0 4589000000 2000000 682000000 0 682000000 0 3000000 0 0 3000000 26000000 0 0 26000000 78000000 0 3000000 75000000 15117000000 6460000000 8547000000 110000000 37000000 7000000 33000000 34000000 394000000 1822000000 759000000 3086000000 655000000 1031000000 17827000000 201000000 0.01 2616000000 2616000000 0 0 3905000000 3898000000 2000000 5000000 2194000000 2189000000 2000000 3000000 3569000000 0 3569000000 0 2579000000 0 2576000000 3000000 616000000 0 616000000 0 3000000 0 0 3000000 28000000 0 0 28000000 76000000 0 3000000 73000000 15586000000 8703000000 6768000000 115000000 36000000 7000000 32000000 32000000 391000000 1381000000 590000000 2469000000 214000000 434000000 17835000000 165000000 0.01 <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:38.227%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.525%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.063%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.945%"/><td style="width:0.1%"/></tr><tr style="height:21pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value Measurement of Level 3 Pension Plan Assets</span></td><td colspan="3" rowspan="2" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">U.S. equity securities</span></td><td colspan="3" rowspan="2" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Non-U.S. equity securities</span></td><td colspan="3" rowspan="2" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Debt – corporate-issued</span></td><td colspan="3" rowspan="2" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Private market securities</span></td><td colspan="3" rowspan="2" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Real estate</span></td><td colspan="3" rowspan="2" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Other</span></td><td colspan="3" rowspan="2" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Total</span></td></tr><tr style="height:20pt"><td colspan="3" style="border-right:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at January 1, 2020</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual return on assets:</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Relating to assets sold during the year ended December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Relating to assets held at December 31, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases, sales and settlements, net</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfers in or out of Level 3, net</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual return on assets:</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Relating to assets sold during the year ended December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Relating to assets held at December 31, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases, sales and settlements, net</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26 </span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75 </span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110 </span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-right:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 9000000 4000000 4000000 2000000 33000000 0 52000000 -25000000 -6000000 -7000000 0 0 0 -38000000 21000000 5000000 5000000 1000000 -5000000 7000000 34000000 0 0 0 0 0 5000000 5000000 0 0 1000000 0 0 61000000 62000000 5000000 3000000 3000000 3000000 28000000 73000000 115000000 1000000 -1000000 -5000000 0 0 0 -5000000 -3000000 -1000000 6000000 0 -2000000 -2000000 -2000000 1000000 -1000000 -2000000 0 0 4000000 2000000 4000000 0 2000000 3000000 26000000 75000000 110000000 571000000 39000000 43000000 65000000 304000000 347000000 1 0.06 0.03 63000000 94000000 142000000 0.03 P3Y 29000000 33000000 46000000 73000000 STOCK-BASED COMPENSATION<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the Corteva Distribution, Corteva employees held equity awards, including stock options, share appreciation rights (“SARs”), restricted stock units (“RSUs”) and performance-based restricted stock units (“PSUs”), which were denominated in DowDuPont common stock and, in some cases, in Dow Inc. common stock, and which had originally been issued under the DuPont Equity and Incentive Plan ("EIP"), the Dow Chemical Company 2012 Stock Incentive Plan or the Dow Chemical Company 1988 Award and Option Plan. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As discussed in Note 18 - Commitment and Contingent Liabilities, on April 1, 2019 the company entered into an employee matters agreement (the "EMA") with DuPont and Dow that identifies employees and employee-related liabilities (and attributable assets) to be allocated (either retained, transferred and accepted, or assigned and assumed, as applicable) to the Parties as part of the Distributions and describes when and how the relevant transfers and assignments will occur. With some exceptions, the EMA provides for the equitable adjustment of existing equity incentive compensation awards denominated in the common stock of DowDuPont to reflect the occurrence of the Distributions.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Separation on June 1, 2019, outstanding DowDuPont-denominated stock options, SARs, RSU and PSU awards were converted into Corteva-denominated awards under the “Employer Method,” or into both DuPont-denominated awards and Corteva-denominated awards under the “Shareholder Method,” using a formula designed to preserve the intrinsic value of the awards immediately prior to and subsequent to the Corteva Separation. The awards have the same terms and conditions under the applicable plans and award agreements prior to the Separation transactions. The conversions of equity awards did not have a material impact to the company’s consolidated financial statements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 1, 2019 (“Adoption Date”), in connection with the Separation, the Omnibus Incentive Plan (the "OIP") became effective. Under the OIP, the company may grant incentive awards, including stock options (both “incentive stock options” and nonqualified stock options), share appreciation rights, restricted shares, restricted stock units, other share-based awards and cash awards, to its and its subsidiaries’ eligible employees, non-employee directors, independent contractors and consultants following the Separation until the tenth anniversary of the Adoption Date, subject to an aggregate limit and annual individual limits. Under the OIP, the maximum number of shares reserved for the grant or settlement of awards is 20 million shares, excluding shares underlying certain exempt awards, such as the awards converted to Corteva-denominated awards pursuant to the Separation. At December 31, 2021, approximately 12 million shares were authorized for future grants under the OIP. The company generally satisfies stock option exercises and the vesting of RSUs and PSUs with newly issued shares of Corteva common stock, although RSU awards granted under Historical Dow plans in certain countries are settled in cash.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The compensation committee determines the long-term incentive mix, including stock options, RSUs and PSUs and may authorize new grants annually. The company estimates expected forfeitures.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total stock-based compensation cost included in income (loss) from continuing operations before income taxes within the Consolidated Statement of Operations was $79 million, $73 million, and $84 million for the years ended December 31, 2021, 2020 and 2019, respectively. The income tax benefits related to stock-based compensation arrangements were $(15) million, $(15) million, and $(17) million for the years ended December 31, 2021, 2020 and 2019, respectively. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock Options</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The exercise price of shares subject to option is equal to the market price of the company's stock on the date of grant. All options vest serially over a period of three years. Stock option awards granted under the OIP between June 2019 and 2020 expire 10 years after the grant date. Stock option awards granted under the EIP (previous plan) between 2014 and 2015 expire seven years after the grant date and options granted between 2016 and May 2019 expire 10 years after the grant date. Stock option awards granted under the Historical Dow plans subsequent to 2010 expire 10 years after the grant date. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To measure the fair value of the awards on the date of grant, the company used the Black-Scholes option pricing model and the assumptions set forth in the below table. Under the OIP, the weighted-average grant-date fair value of options granted for the years ended December 31, 2021 and 2020 was $11.77 and $6.06, respectively. Under the EIP, the weighted-average grant-date fair value of options granted for the years ended December 31, 2019 was $7.29. </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.268%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.446%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-Average Assumptions</span></td><td colspan="6" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">OIP</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">EIP</span></td></tr><tr style="height:23pt"><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the year ended December 31, 2021</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the year ended December 31, 2020</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the year ended December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.14 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.67 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.55 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.44 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.14 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.80 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life of stock options granted during period (years)</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1</span></td></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the OIP, the company determined the dividend yield by dividing the annualized dividend on Corteva’ s Common Stock by the option exercise price. A historical daily measurement of volatility is determined based on the expected life of the option granted. For the years ended December 31, 2021 and 2020, the measurement of volatility is based on the average volatility of eight of Corteva's peer companies. Corteva's peer volatility is based on the historical volatility of each business respectively. The risk-free interest rate is determined by reference to the yield on an outstanding U.S. Treasury note with a term equal to the expected life of the option granted. Expected life is determined by utilizing the simplified method for estimating expected term as referenced under ASC 718 – Share based Payments.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the EIP, the company determined the dividend yield by dividing the annualized dividend on DowDuPont's Common Stock by the option exercise price. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A historical daily measurement of volatility is determined based on the expected life of the option granted. For the year ended December 31, 2019, the measurement of volatility is based on weighted average of the individual peer volatilities of DuPont and Corteva based on the size of each business respectively. DuPont and Corteva peer volatility are based on a 50/50 blend of historical volatility and implied volatility. Both volatility measures are based on the average of five peer companies for DuPont and eight peer companies for Corteva.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The risk-free interest rate is determined by reference to the yield on an outstanding U.S. Treasury note with a term equal to the expected life of the option granted. Expected life is determined by reference to the company's historical experience.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes stock option activity for year ended December 31, 2021 under the OIP:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:40.334%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.541%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.541%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.690%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stock Options</span></td><td colspan="12" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Year Ended December 31, 2021</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Number of Shares <br/>(in thousands)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Weighted Average Exercise Price (per share)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Weighted Average Remaining Contractual Term (in years)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Aggregate Intrinsic Value<br/>(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at January 1, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,998 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.21 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.27</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,077 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">849 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.37 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,206)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.44 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited/Expired</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(218)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.39 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,423 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.65 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.69</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,219 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at December 31, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,739 </span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.15 </span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.76</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,726 </span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate intrinsic values in the table above represent the total pre-tax intrinsic value (the difference between the closing stock price on the last trading day of the December 31, 2021 and the exercise price, multiplied by the number of in-the-money options) that would have been received by the option holders had all option holders exercised their in-the-money options at period end. Under the OIP, the total intrinsic value of options exercised for the years ended December 31, 2021 and 2020 were $43 million, and $21 million, respectively. The company recognized tax benefits from options exercised for the years ended December 31, 2021 and 2020 of $(8) million and $(4) million, respectively. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the EIP, the total intrinsic value of options exercised for the year ended December 31, 2019 was $16 million. The company recognized tax benefits from options exercised for the year ended December 31, 2019 of $(3) million.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2021, $4 million of total unrecognized pre-tax compensation expense related to nonvested stock options is expected to be recognized over a weighted-average period of about 1.20 years.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Restricted Stock Units and Performance Share Units</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RSUs granted under the EIP serially vest over 3 years. RSUs granted under the Historical Dow plans vest after a designated period, generally 1 year to 3 years. RSUs granted under the OIP serially vest over 3 years. Upon vesting, these RSUs convert one-for-one to Corteva Common Stock. A retirement-eligible employee retains any granted awards upon retirement provided the employee has rendered at least six months of service following the grant date. Additional RSUs are also granted periodically to key senior management employees. These RSUs generally vest over periods ranging from 3 years to 5 years. The fair value of all stock-settled RSUs is based upon the market price of the underlying common stock as of the grant date. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The company grants PSUs to senior leadership. In 2021, there were 343,632 PSUs granted. Vesting for PSUs granted in 2021 and 2020 is partially based on the realization of the Company’s improvement of its Return on Invested Capital (“ROIC”) and Operating Earnings Per Share (EPS) during the Performance Period. Vesting for PSUs granted in 2019 is partially based on the realization of the Company’s improvement of its Return on Invested Capital (“ROIC”) and Operating EBITDA during the Performance Period. Performance and payouts are determined independently for each metric. The actual award, delivered in Corteva Common Stock, can range from zero percent to 200 percent of the original grant. The weighted-average grant date fair value of the PSUs granted in 2021 of $45.37 was based upon the market price of the underlying common stock as of the grant date.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nonvested awards of RSUs and PSUs are shown below.</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:52.340%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.179%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.181%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">RSUs &amp; PSUs</span></td><td colspan="6" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Year Ended December 31, 2021</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Number of Shares <br/>(in thousands)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Weighted Average Grant Date Fair Value <br/>(per share)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at January 1, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,883 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.54 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,536 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.30 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,583)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.59 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(234)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.99 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,602 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.11 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total fair value of stock units vested under the OIP for the years ended December 31, 2021 and 2020 was $56 million and $49 million, respectively. The weighted-average grant-date fair value of stock units granted under the OIP for the years ended December 31, 2021 and 2020 was $45.30 and $31.15, respectively.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total fair value of stock units vested under the EIP during the years ended December 31, 2019 was $79 million. The weighted-average grant-date fair value of stock units granted under the EIP for the year ended December 31, 2019 was $52.19.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2021, $45 million of total unrecognized pre-tax compensation expense related to RSUs and PSUs is expected to be recognized over a weighted average period of 1.13 years.</span></div> 20000000 12000000 79000000 73000000 84000000 -15000000 -15000000 -17000000 P3Y P10Y P7Y P10Y P10Y 11.77 6.06 7.29 <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.268%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.446%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-Average Assumptions</span></td><td colspan="6" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">OIP</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">EIP</span></td></tr><tr style="height:23pt"><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the year ended December 31, 2021</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the year ended December 31, 2020</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the year ended December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.14 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.67 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.55 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.44 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.14 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.80 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life of stock options granted during period (years)</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1</span></td></tr></table> 0.0114 0.0167 0.0155 0.2944 0.2314 0.1980 0.010 0.013 0.024 P6Y P6Y P6Y1M6D <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:40.334%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.541%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.541%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.690%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stock Options</span></td><td colspan="12" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Year Ended December 31, 2021</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Number of Shares <br/>(in thousands)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Weighted Average Exercise Price (per share)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Weighted Average Remaining Contractual Term (in years)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Aggregate Intrinsic Value<br/>(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at January 1, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,998 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.21 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.27</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,077 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">849 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.37 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,206)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.44 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited/Expired</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(218)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.39 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,423 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.65 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.69</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,219 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at December 31, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,739 </span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.15 </span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.76</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,726 </span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 8998000 34.21 P5Y3M7D 50077000 849000 45.37 -3206000 32.44 -218000 33.39 6423000 36.65 P5Y8M8D 68219000 4739000 36.15 P4Y9M3D 52726000 43000000 21000000 -8000000 -4000000 16000000 -3000000 4000000 P1Y2M12D P3Y P1Y P3Y P3Y 1 P6M P3Y P5Y 343632 0 2 45.37 <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:52.340%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.179%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.181%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">RSUs &amp; PSUs</span></td><td colspan="6" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Year Ended December 31, 2021</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Number of Shares <br/>(in thousands)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Weighted Average Grant Date Fair Value <br/>(per share)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at January 1, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,883 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.54 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,536 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.30 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,583)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.59 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(234)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.99 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,602 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.11 </span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 5883000 31.54 1536000 45.30 -1583000 35.59 -234000 32.99 5602000 34.11 56000000 49000000 45.30 31.15 79000000 52.19 45000000 P1Y1M17D FINANCIAL INSTRUMENTS<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December 31, 2021 and 2020, the company had $3,400 million and $2,511 million, respectively, of held-to-maturity securities (primarily time deposits and money market funds) classified as cash equivalents, as these securities had maturities of three months or less at the time of purchase; and $86 million and $43 million at December 31, 2021 and 2020, respectively, of held-to-maturity securities (primarily time deposits) classified as marketable securities as these securities had maturities of more than three months to less than one year at the time of purchase. The company’s investments in held-to-maturity securities are held at amortized cost, which approximates fair value. Additionally, at December 31, 2020, the company had $226 million of available-for-sale securities (see below "Debt Securities" for further discussion). The above noted securities are included in cash and cash equivalents, marketable securities, and other current assets in the Consolidated Balance Sheets.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Derivative Instruments</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Objectives and Strategies for Holding Derivative Instruments</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the ordinary course of business, the company enters into contractual arrangements (derivatives) to reduce its exposure to foreign currency and commodity price risks. The company has established a variety of derivative programs to be utilized for financial risk management. These programs reflect varying levels of exposure coverage and time horizons based on an assessment of risk.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Derivative programs have procedures and controls and are approved by the Corporate Financial Risk Management Committee, consistent with the company's financial risk management policies and guidelines. Derivative instruments used are forwards, options, futures and swaps. The company has not designated any non-derivatives as hedging instruments.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company's financial risk management procedures also address counterparty credit approval, limits and routine exposure monitoring and reporting. The counterparties to these contractual arrangements are major financial institutions and major commodity exchanges, and multinational grain exporters. The company is exposed to credit loss in the event of nonperformance by these counterparties. The company utilizes collateral support annex agreements with certain counterparties to limit its exposure to credit losses. The company anticipates performance by counterparties to these contracts and therefore no material loss is expected. Market and counterparty credit risks associated with these instruments are regularly reported to management.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The notional amounts of the company's derivative instruments were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.148%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.775%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.777%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notional Amounts</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Derivatives designated as hedging instruments:</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,252 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,164 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity contracts</span></div></td><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">845 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">383 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Derivatives not designated as hedging instruments:</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></div></td><td style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">647 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity contracts</span></div></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Foreign Currency Risk</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company's objective in managing exposure to foreign currency fluctuations is to reduce earnings and cash flow volatility associated with foreign currency rate changes and to mitigate the exposure of certain investments in foreign subsidiaries against</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">changes in the Euro/USD exchange rate. Accordingly, the company enters into various contracts that change in value as foreign exchange rates change to protect the value of its existing foreign currency-denominated assets, liabilities, commitments, investments and cash flows.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company uses foreign exchange contracts to offset its net exposures, by currency, related to the foreign currency denominated monetary assets and liabilities of its operations. The primary business objective of this hedging program is to maintain an approximately balanced position in foreign currencies so that exchange gains and losses resulting from exchange rate changes, after related tax effects, are minimized. The company also uses foreign currency exchange contracts to offset a portion of the company's exposure to certain forecasted transactions as well as the translation of foreign currency-denominated earnings. The company also uses commodity contracts to offset risks associated with foreign currency devaluation in certain</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">countries.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commodity Price Risk</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commodity price risk management programs serve to reduce exposure to price fluctuations on purchases of inventory such as corn and soybeans. The company enters into over-the-counter and exchange-traded derivative commodity instruments to hedge the commodity price risk associated with agricultural commodity exposures.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Derivatives Designated as Cash Flow Hedges</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Commodity Contracts</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company enters into over-the-counter and exchange-traded derivative commodity instruments, including options, futures and swaps, to hedge the commodity price risk associated with agriculture commodity exposures.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While each risk management program has a different time maturity period, most programs currently do not extend beyond the next two years. Cash flow hedge results are reclassified into earnings during the same period in which the related exposure impacts earnings. Reclassifications are made sooner if it appears that a forecasted transaction is probable of not occurring.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the after-tax effect of commodity contract cash flow hedges on accumulated other comprehensive loss:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.666%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.666%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.667%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions and revaluations of derivatives designated as cash flow hedges</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(44)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Clearance of hedge results to earnings</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December 31, 2021, an after-tax net gain of $36 million is expected to be reclassified from accumulated other comprehensive loss into earnings over the next twelve months.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Foreign Currency Contracts</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company enters into forward contracts to hedge the foreign currency risk associated with forecasted transactions within certain foreign subsidiaries.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While each risk management program has a different time maturity period, most programs currently do not extend beyond the next two years. Cash flow hedge results are reclassified into earnings during the same period in which the related exposure impacts earnings. Reclassifications are made sooner if it appears that a forecasted transaction is not probable of occurring.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the after-tax effect of foreign currency cash flow hedges on accumulated other comprehensive</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">loss:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:18.783%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.783%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.783%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.783%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.784%"/><td style="width:0.1%"/></tr><tr style="height:8pt"><td colspan="12" rowspan="2" style="border-bottom:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" rowspan="2" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Year Ended December 31, 2021</span></td><td colspan="3" rowspan="2" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Year Ended December 31, 2020</span></td></tr><tr style="height:15pt"><td colspan="18" style="display:none"/></tr><tr><td colspan="12" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions and revaluations of derivatives designated as cash flow hedges</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="12" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Clearance of hedges results to earnings</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="12" style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December 31, 2021, an after-tax net gain of $32 million is expected to be reclassified from accumulated other comprehensive loss into earnings over the next twelve months.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Derivatives Designated as Net Investment Hedges</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Foreign Currency Contracts</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company has designated €450 million of forward contracts to exchange EUR as net investment hedges. The purpose of these forward contracts is to mitigate FX exposure related to a portion of the company’s Euro net investments in certain foreign subsidiaries against changes in Euro/USD exchange rates. These hedges will expire and be settled in 2023, unless terminated early at the discretion of the company.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company elected to apply the spot method in testing for effectiveness of the hedging relationship.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Derivatives not Designated in Hedging Relationships</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Foreign Currency Contracts</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company uses foreign exchange contracts to reduce its net exposure, by currency, related to foreign currency-denominated monetary assets and liabilities of its operations so that exchange gains and losses resulting from exchange rate changes are minimized. The netting of such exposures precludes the use of hedge accounting; however, the required revaluation of the forward contracts and the associated foreign currency-denominated monetary assets and liabilities intends to achieve a minimal earnings impact, after taxes. The company also uses foreign currency exchange contracts to offset a portion of the company’s exposure to the translation of certain foreign currency-denominated earnings so that gains and losses on the contracts offset changes in the USD value of the related foreign currency-denominated earnings over the relevant aggregate period.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Commodity Contracts</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company utilizes options, futures and swaps that are not designated as hedging instruments to reduce exposure to commodity price fluctuations on purchases of inventory such as corn and soybeans. The company uses forward agreements, </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">with durations less than one year, to buy and sell USD priced commodities in order to reduce its exposure to currency devaluation for a portion of its local currency cash balances. Counterparties to the forward sales agreements are multinational grain exporters and subject to the company’s financial risk management procedures.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fair Value of Derivative Instruments</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Asset and liability derivatives subject to an enforceable master netting arrangement with the same counterparty are presented on a net basis in the Consolidated Balance Sheets. The presentation of the company's derivative assets and liabilities is as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:28.225%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:28.372%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.656%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.817%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance Sheet Location</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Counterparty and Cash Collateral Netting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">1</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Amounts Included in the Consolidated Balance Sheet</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Asset derivatives:</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives designated as hedging instruments:</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives not designated as hedging instruments:</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></div></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity contracts</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total asset derivatives</span></div></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liability derivatives:</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives designated as hedging instruments:</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued and other current liabilities</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives not designated as hedging instruments:</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></div></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued and other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity contracts</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued and other current liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liability derivatives</span></div></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:28.225%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:28.372%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.656%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.817%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance Sheet Location</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Counterparty and Cash Collateral Netting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">1</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Amounts Included in the Consolidated Balance Sheet</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Asset derivatives:</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives designated as hedging instruments:</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives not designated as hedging instruments:</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></div></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total asset derivatives</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liability derivatives:</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives designated as hedging instruments:</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued and other current liabilities</span></td><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives not designated as hedging instruments:</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued and other current liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liability derivatives</span></div></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">    Counterparty and cash collateral amounts represent the estimated net settlement amount when applying netting and set-off rights included in master netting arrangements between the company and its counterparties and the payable or receivable for cash collateral held or placed with the same counterparty. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Effect of Derivative Instruments</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"/><td style="width:54.209%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.796%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.796%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.799%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount of Gain (Loss) Recognized in OCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"> - Pre-Tax</span></div></td></tr><tr style="height:14pt"><td colspan="9" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Year Ended December 31, </span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives designated as hedging instruments:</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment hedges:</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedges:</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity contracts</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(62)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total derivatives designated as hedging instruments</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(111)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:9.6pt">OCI is defined as other comprehensive income (loss).</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:54.471%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.709%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.709%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.711%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="9" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount of (Loss) Gain Recognized in Income - Pre-Tax</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">1</span></div></td></tr><tr style="height:14pt"><td colspan="9" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Year Ended December 31,</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives designated as hedging instruments:</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedges:</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">2</span></div></td><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity contracts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">2</span></div></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total derivatives designated as hedging instruments</span></div></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives not designated as hedging instruments:</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">3</span></div></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(58)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">2</span></div></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity contracts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">2</span></div></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total derivatives not designated as hedging instruments</span></div></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total derivatives</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(62)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:9.6pt">For cash flow hedges, this represents the portion of the gain (loss) reclassified from accumulated OCI into income during the period.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:9.6pt">Recorded in cost of goods sold.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:9.6pt">Gain recognized in other income - net was partially offset by the related gain on the foreign currency-denominated monetary assets and liabilities of the company's operations. See Note 9 - Supplementary Information, to the Consolidated Financial Statements for additional information.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Debt Securities</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value of the available-for-sale securities as of December 31, 2020 was determined using Level 1 inputs within the fair value hierarchy. Level 1 measurements were based on quoted market prices in active markets for identical assets and liabilities. The available-for-sale securities at of December 31, 2020 are held by certain foreign subsidiaries in which the USD is not the functional currency. The fluctuations in foreign exchange are recorded in accumulated other comprehensive loss within the Consolidated Statements of Equity. These fluctuations are subsequently reclassified from accumulated other comprehensive income (loss) to earnings in the period in which the marketable securities are sold and the gains and losses on these securities offset a portion of the foreign exchange fluctuations in earnings for the company.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides the investing results from available-for-sale securities for the year ended December 31,2021:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.367%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:28.433%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Investing Results</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sales of available-for-sale securities</span></td><td style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">226 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross realized losses</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 3400000000 2511000000 86000000 43000000 226000000 <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.148%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.775%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.777%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notional Amounts</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Derivatives designated as hedging instruments:</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,252 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,164 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity contracts</span></div></td><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">845 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">383 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Derivatives not designated as hedging instruments:</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></div></td><td style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">647 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity contracts</span></div></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 1252000000 1164000000 845000000 383000000 103000000 647000000 4000000 0 P2Y <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.666%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.666%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.667%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions and revaluations of derivatives designated as cash flow hedges</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(44)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Clearance of hedge results to earnings</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> -16000000 2000000 -26000000 92000000 -44000000 16000000 -29000000 26000000 12000000 47000000 -16000000 2000000 36000000 P2Y <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:18.783%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.783%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.783%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.783%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.784%"/><td style="width:0.1%"/></tr><tr style="height:8pt"><td colspan="12" rowspan="2" style="border-bottom:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" rowspan="2" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Year Ended December 31, 2021</span></td><td colspan="3" rowspan="2" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Year Ended December 31, 2020</span></td></tr><tr style="height:15pt"><td colspan="18" style="display:none"/></tr><tr><td colspan="12" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions and revaluations of derivatives designated as cash flow hedges</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="12" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Clearance of hedges results to earnings</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="12" style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> -17000000 0 24000000 -3000000 25000000 -14000000 32000000 -17000000 32000000 450000000 <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:28.225%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:28.372%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.656%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.817%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance Sheet Location</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Counterparty and Cash Collateral Netting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">1</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Amounts Included in the Consolidated Balance Sheet</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Asset derivatives:</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives designated as hedging instruments:</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives not designated as hedging instruments:</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></div></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity contracts</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total asset derivatives</span></div></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liability derivatives:</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives designated as hedging instruments:</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued and other current liabilities</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives not designated as hedging instruments:</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></div></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued and other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity contracts</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued and other current liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liability derivatives</span></div></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:28.225%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:28.372%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.656%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.817%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance Sheet Location</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Counterparty and Cash Collateral Netting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">1</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Amounts Included in the Consolidated Balance Sheet</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Asset derivatives:</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives designated as hedging instruments:</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives not designated as hedging instruments:</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></div></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total asset derivatives</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liability derivatives:</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives designated as hedging instruments:</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued and other current liabilities</span></td><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives not designated as hedging instruments:</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued and other current liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liability derivatives</span></div></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table>1.    Counterparty and cash collateral amounts represent the estimated net settlement amount when applying netting and set-off rights included in master netting arrangements between the company and its counterparties and the payable or receivable for cash collateral held or placed with the same counterparty. 37000000 0 37000000 31000000 -20000000 11000000 3000000 0 3000000 71000000 -20000000 51000000 1000000 0 1000000 23000000 -20000000 3000000 2000000 0 2000000 26000000 -20000000 6000000 15000000 0 15000000 40000000 -40000000 0 55000000 -40000000 15000000 38000000 0 38000000 97000000 -40000000 57000000 135000000 -40000000 95000000 <div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"/><td style="width:54.209%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.796%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.796%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.799%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount of Gain (Loss) Recognized in OCI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"> - Pre-Tax</span></div></td></tr><tr style="height:14pt"><td colspan="9" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Year Ended December 31, </span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives designated as hedging instruments:</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment hedges:</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedges:</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity contracts</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(62)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total derivatives designated as hedging instruments</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(111)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:9.6pt">OCI is defined as other comprehensive income (loss).</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:54.471%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.709%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.709%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.711%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="9" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount of (Loss) Gain Recognized in Income - Pre-Tax</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">1</span></div></td></tr><tr style="height:14pt"><td colspan="9" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Year Ended December 31,</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives designated as hedging instruments:</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedges:</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">2</span></div></td><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity contracts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">2</span></div></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total derivatives designated as hedging instruments</span></div></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives not designated as hedging instruments:</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">3</span></div></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(58)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">2</span></div></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commodity contracts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">2</span></div></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total derivatives not designated as hedging instruments</span></div></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total derivatives</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(62)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:9.6pt">For cash flow hedges, this represents the portion of the gain (loss) reclassified from accumulated OCI into income during the period.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:9.6pt">Recorded in cost of goods sold.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:9.6pt">Gain recognized in other income - net was partially offset by the related gain on the foreign currency-denominated monetary assets and liabilities of the company's operations. See Note 9 - Supplementary Information, to the Consolidated Financial Statements for additional information.</span></div> 37000000 -45000000 0 27000000 -4000000 0 129000000 -62000000 23000000 193000000 -111000000 23000000 -29000000 17000000 0 42000000 -35000000 -13000000 13000000 -18000000 -13000000 18000000 89000000 -58000000 -14000000 14000000 0 -18000000 9000000 9000000 -14000000 112000000 -49000000 -1000000 94000000 -62000000 <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.367%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:28.433%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Investing Results</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sales of available-for-sale securities</span></td><td style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">226 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross realized losses</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 226000000 -7000000 FAIR VALUE MEASUREMENTS<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the basis used to measure certain assets and liabilities at fair value on a recurring basis:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.537%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:13.081%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.082%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr style="height:29pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"/><td colspan="6" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Significant Other Observable Inputs</span></td><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Level 1</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Level 2</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets at fair value:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;margin-top:2pt;padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable securities</span></div></td><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;margin-top:2pt;padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives relating to:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency</span></div></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">2</span></div></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets at fair value</span></td><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities at fair value:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;margin-top:2pt;padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives relating to:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency</span></div></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities at fair value</span></td><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:70.203%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:13.248%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.249%"/><td style="width:0.1%"/></tr><tr style="height:23pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="display:none"/><td colspan="6" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Significant Other Observable Inputs</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Level 1</span></td><td colspan="3" style="border-right:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Level 2</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets at fair value:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;margin-top:2pt;padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable securities</span></div></td><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;margin-top:2pt;padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;margin-top:2pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. treasuries</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">3</span></div></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">226 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;margin-top:2pt;padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives relating to:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency</span></div></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets at fair value</span></td><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">226 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities at fair value:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;margin-top:2pt;padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives relating to:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency</span></div></td><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities at fair value</span></td><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:9.6pt">See Note 22 - Financial Instruments, to the Consolidated Financial Statements, for the classification of derivatives in the Consolidated Balance Sheets.</span></div><div style="padding-left:18pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">    The company's equity securities are included in "other assets" in the Consolidated Balance Sheets.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">    The company's investments in U.S. treasuries, which are primarily available-for-sale, are included in "marketable securities" in the Consolidated Balance Sheets. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For assets and liabilities classified as Level 1 measurements (measured using quoted prices in active markets), total fair value is either the price of the most recent trade at the time of the market close or the official close price, as defined by the exchange on which the asset is most actively traded on the last trading day of the period, multiplied by the number of units held without consideration of transaction costs.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For assets and liabilities classified as Level 2 measurements, where the security is frequently traded in less active markets, fair value is based on the closing price at the end of the period; where the security is less frequently traded, fair value is based on the price a dealer would pay for the security or similar securities, adjusted for any terms specific to that asset or liability, or by using observable market data points of similar, more liquid securities to imply the price. For time deposits classified as held-to-maturity investments and reported at amortized cost, fair value is based on an observable interest rate for similar securities. Market inputs are obtained from well-established and recognized vendors of market data and subjected to tolerance and quality checks. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For derivative assets and liabilities, standard industry models are used to calculate the fair value of the various financial instruments based on significant observable market inputs, such as foreign exchange rates, commodity prices, swap rates and implied volatilities obtained from various market sources. Market inputs are obtained from well-established and recognized vendors of market data and subjected to tolerance/quality checks.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For all other assets and liabilities for which observable inputs are used, fair value is derived through the use of fair value models, such as a discounted cash flow model or other standard pricing models. See Note 22 - Financial Instruments, to the Consolidated Financial Statements, for further information on the types of instruments used by the company for risk management.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no transfers between Levels 1 and 2 during the years ended December 31, 2021 and 2020.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For assets classified as Level 3 measurements, the fair value is based on significant unobservable inputs including assumptions where there is little, if any, market activity. The fair value of the company’s interests held in trade receivable conduits is determined by calculating the expected amount of cash to be received using the key input of anticipated credit losses in the portfolio of receivables sold that have not yet been collected. Given the short-term nature of the underlying receivables, discount rate and prepayments are not factors in determining the fair value of the interests.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fair Value Measurements on a Nonrecurring Basis</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the basis used to measure certain assets at fair value on a nonrecurring basis:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.116%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.291%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.293%"/><td style="width:0.1%"/></tr><tr style="height:21pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basis of Fair Value Measurements on a Nonrecurring Basis</span></td><td colspan="3" rowspan="2" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Significant Other Unobservable Inputs <br/>(Level 3)</span></td><td colspan="3" rowspan="2" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Total Losses</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets at fair value:</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></div></td><td style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets</span></div></td><td style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IPR&amp;D</span></div></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(137)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third and fourth quarter of 2019, the company recorded impairment charges to developed technology, other intangible assets, and IPR&amp;D. See Note 7 - Restructuring and Asset Related Charges - Net, and Note 15 - Goodwill and Other Intangible Assets, to the Consolidated Financial Statements, for further discussion of these fair value measurements.</span></div> <div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.537%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:13.081%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.082%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr style="height:29pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"/><td colspan="6" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Significant Other Observable Inputs</span></td><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Level 1</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Level 2</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets at fair value:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;margin-top:2pt;padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable securities</span></div></td><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;margin-top:2pt;padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives relating to:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency</span></div></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">2</span></div></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets at fair value</span></td><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities at fair value:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;margin-top:2pt;padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives relating to:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency</span></div></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities at fair value</span></td><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:70.203%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:13.248%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.249%"/><td style="width:0.1%"/></tr><tr style="height:23pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="display:none"/><td colspan="6" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Significant Other Observable Inputs</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Level 1</span></td><td colspan="3" style="border-right:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Level 2</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets at fair value:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;margin-top:2pt;padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable securities</span></div></td><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;margin-top:2pt;padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;margin-top:2pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. treasuries</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">3</span></div></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">226 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;margin-top:2pt;padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives relating to:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency</span></div></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets at fair value</span></td><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">226 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities at fair value:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;margin-top:2pt;padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives relating to:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency</span></div></td><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities at fair value</span></td><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:9.6pt">See Note 22 - Financial Instruments, to the Consolidated Financial Statements, for the classification of derivatives in the Consolidated Balance Sheets.</span></div><div style="padding-left:18pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">    The company's equity securities are included in "other assets" in the Consolidated Balance Sheets.</span></div>3.    The company's investments in U.S. treasuries, which are primarily available-for-sale, are included in "marketable securities" in the Consolidated Balance Sheets. 86000000 68000000 48000000 48000000 154000000 24000000 0 24000000 43000000 226000000 55000000 226000000 98000000 135000000 0 135000000 <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.116%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.291%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.293%"/><td style="width:0.1%"/></tr><tr style="height:21pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basis of Fair Value Measurements on a Nonrecurring Basis</span></td><td colspan="3" rowspan="2" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Significant Other Unobservable Inputs <br/>(Level 3)</span></td><td colspan="3" rowspan="2" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Total Losses</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets at fair value:</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></div></td><td style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets</span></div></td><td style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IPR&amp;D</span></div></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(137)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table> 0 -1000000 0 -6000000 0 -137000000 GEOGRAPHIC INFORMATION<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales are attributed to geographic areas based on customer location; long-lived assets are attributed to geographic areas based on asset location.</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.952%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.882%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.882%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.884%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="border-bottom:1pt solid #000;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Sales</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Year Ended December 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,782 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,510 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,255 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canada</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">754 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">658 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">674 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EMEA</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,123 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,842 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,740 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Latin America</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,545 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,805 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,889 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia Pacific</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,451 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,402 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,288 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,655 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,217 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,846 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:7.5pt">Net sales for Brazil for the years ended December 31, 2021, 2020 and 2019 were $2,315 million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$1,724 million and $1,794 million, respectively. </span></div><div style="padding-left:18pt"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:26.864%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.911%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.911%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.914%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Property</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,051 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,014 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,069 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canada</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EMEA</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">566 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">601 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">566 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Latin America</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">468 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">510 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">608 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia Pacific</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,329 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,396 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,546 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.952%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.882%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.882%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.884%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="border-bottom:1pt solid #000;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Sales</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Year Ended December 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,782 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,510 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,255 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canada</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">754 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">658 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">674 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EMEA</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,123 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,842 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,740 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Latin America</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,545 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,805 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,889 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia Pacific</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,451 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,402 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,288 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,655 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,217 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,846 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:7.5pt">Net sales for Brazil for the years ended December 31, 2021, 2020 and 2019 were $2,315 million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span>$1,724 million and $1,794 million, respectively. 6782000000 6510000000 6255000000 754000000 658000000 674000000 3123000000 2842000000 2740000000 3545000000 2805000000 2889000000 1451000000 1402000000 1288000000 15655000000 14217000000 13846000000 2315000000 1724000000 1794000000 <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:26.864%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.911%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.911%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.914%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Property</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,051 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,014 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,069 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canada</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EMEA</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">566 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">601 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">566 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Latin America</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">468 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">510 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">608 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia Pacific</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,329 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,396 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,546 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 3051000000 3014000000 3069000000 114000000 122000000 125000000 566000000 601000000 566000000 468000000 510000000 608000000 130000000 149000000 178000000 4329000000 4396000000 4546000000 SEGMENT INFORMATION<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Corteva’s reportable segments reflects the manner in which its chief operating decision maker ("CODM") allocates resources and assesses performance, which is at the operating segment level (seed and crop protection). For purposes of allocating resources to the segments and assessing segment performance, segment operating EBITDA is the primary measure used by Corteva’s CODM. The company defines segment operating EBITDA as earnings (loss) (i.e., income (loss) from continuing operations before income taxes) before interest, depreciation, amortization, corporate expenses, non-operating (benefits) costs, foreign exchange gains (losses), and net unrealized gain or loss from mark-to-market activity for certain foreign currency derivative instruments that do not qualify for hedge accounting, excluding the impact of significant items. Effective January 1, 2021, on a prospective basis, the company excludes from segment operating EBITDA net unrealized gain or loss from mark-to- market activity for certain foreign currency derivative instruments that do not qualify for hedge accounting. Non-operating (benefits) costs consists of non-operating pension and other post-employment benefit (OPEB) costs, tax indemnification adjustments, environmental remediation and legal costs associated with legacy EID businesses and sites, and the 2021 officer indemnification payment. Tax indemnification adjustments relate to changes in indemnification balances, as a result of the application of the terms of the Tax Matters Agreement, between Corteva and Dow and/or DuPont that are recorded by the company as pre-tax income or expense. Net unrealized gain or loss from mark-to-market activity for certain foreign currency derivative instruments that do not qualify for hedge accounting represents the non-cash net gain (loss) from changes in fair value of certain undesignated foreign currency derivative contracts. Upon settlement, which is within the same calendar year of execution of the contract, the realized gain (loss) from the changes in fair value of the non-qualified foreign currency derivative contracts will be reported in the respective segment results to reflect the economic effects of the foreign currency derivative contracts without the resulting unrealized mark to fair value volatility. For the year ended December 31, 2019, segment operating EBITDA is calculated on a pro forma basis, as this is the manner in which the CODM assesses performance and allocates resources or expense.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pro forma adjustments used in the calculation of pro forma segment operating EBITDA for the year ended December 31, 2019 were determined in accordance with Article 11 of Regulation S-X that was in effect prior to recent amendments. These adjustments give effect to the Merger, the debt retirement transactions related to paying off or retiring portions of EID’s existing debt liabilities (as discussed in Note 17 - Long-Term Debt and Available Credit Facilities, to the Consolidated Financial Statements), and the separation and distribution to DowDuPont stockholders of all the outstanding shares of Corteva common stock as if they had been consummated on January 1, 2016.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Corporate Profile</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company conducts its global operations through the following reportable segments:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Seed</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company’s seed segment is a global leader in developing and supplying advanced germplasm and traits that produce optimum yield for farms around the world. The segment is a leader in many of the company’s key seed markets, including North America corn and soybeans, Europe corn and sunflower, as well as Brazil, India, South Africa and Argentina corn. The segment offers trait technologies that improve resistance to weather, disease, insects and herbicides used to control weeds, and trait technologies that enhance food and nutritional characteristics. In addition, the segment provides digital solutions that assist farmer decision-making with a view to optimize product selection and, ultimately, help maximize yield and profitability. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Crop Protection</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The crop protection segment serves the global agricultural input industry with products that protect against weeds, insects and other pests, and disease, and that improve overall crop health both above and below ground via nitrogen management and seed-applied technologies. The segment is a leader in global herbicides, insecticides, nitrogen stabilizers and pasture and range management herbicides.</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:44.434%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.055%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.055%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.056%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></div></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Seed</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Crop Protection</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of and for the Year Ended December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,402 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,253 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,655 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment operating EBITDA</span></td><td style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,512 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,202 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,714 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">866 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">377 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,243 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment assets</span></td><td style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,270 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,428 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,698 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments in nonconsolidated affiliates</span></td><td style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of property, plant and equipment</span></td><td style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">237 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">336 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">573 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of and for the Year Ended December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,756 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,461 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,217 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment operating EBITDA</span></td><td style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,208 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,004 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,212 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">798 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">379 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,177 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment assets</span></td><td style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,751 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,099 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,850 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments in nonconsolidated affiliates</span></td><td style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of property, plant and equipment</span></td><td style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">225 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">475 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of and for the Year Ended December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;border-right:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,590 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,256 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,846 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pro forma segment operating EBITDA</span></td><td style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,040 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,066 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,106 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">628 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">372 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,387 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,492 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,879 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments in nonconsolidated affiliates</span></td><td style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase of property, plant and equipment</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">373 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">293 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">666 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:7.5pt">On June 1, 2019, as a result of changes in reportable segments, $3,382 million of goodwill was reallocated from the seed reportable segment to the crop protection reportable segment. This change was not reflected in segment assets prior to June 1, 2019. </span></div><div style="padding-left:9pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reconciliation to Consolidated Financial Statements</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:54.911%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.562%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.562%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.565%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income (loss) from continuing operations after income taxes to segment operating EBITDA<br/></span></td><td colspan="9" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Year Ended December 31,</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from continuing operations after income taxes</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,822 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">756 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(270)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for (benefit from) income taxes on continuing operations</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">524 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(81)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from continuing operations before income taxes</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,346 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">675 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(316)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,243 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,177 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(77)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(56)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exchange (gains) losses - net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> 1</span></div></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-operating (benefits) costs - net</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,256)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(316)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(129)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mark-to-market (gains) losses on certain foreign currency contracts not designated as hedges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">2</span></div></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;border-left:1pt solid #000000;border-right:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Significant items</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">236 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">388 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">991 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pro forma adjustments</span></td><td colspan="3" style="background-color:#b6b6b6;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">298 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate expenses</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment operating EBITDA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">3</span></div></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,714 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,212 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,106 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:3pt">Excludes a $(33) million foreign exchange loss for the year ended December 31, 2019 associated with the devaluation of the Argentine peso. See Note 9 - Supplementary Information, to the Consolidated Financial Statements, for additional information.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:2.25pt">Effective January 1, 2021, on a prospective basis, the company excludes net unrealized gain or loss from mark-to-market activity for certain foreign currency derivative instruments that do not qualify for hedge accounting. There were no unrealized mark-to-market (gains) losses for the years ended December 31, 2020 and 2019.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:3pt">The year ended December 31, 2019 is presented on a pro forma basis, prepared in accordance with Article 11 of Regulation S-X that was in effect prior to recent amendments.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.426%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.636%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.638%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment assets to total assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment assets</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,698 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,850 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate assets</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,646 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,799 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,344 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,649 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify;text-indent:9pt"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.198%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.467%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.467%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.468%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other Items </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></div></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment Totals</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjustments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated Totals</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Year Ended December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">599 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,599 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase of property, plant and equipment</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">666 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">497 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,163 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:3pt">See Note 5 - Divestitures and Other Transactions, to the Consolidated Financial Statements, for additional information.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Significant Pre-tax (Charges) Benefits Not Included in Segment Operating EBITDA</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The years ended December 31, 2021, 2020 and 2019, respectively, included the following significant pre-tax (charges) benefits which are excluded from segment operating EBITDA:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:38.666%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.960%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Seed</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Crop Protection</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Corporate</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Year Ended December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring and Asset Related Charges - Net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(152)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(78)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(289)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities mark-to-market gain (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee Retention Credit</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract termination</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(98)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(60)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(78)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(236)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:38.666%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.960%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Seed</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Crop Protection</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Corporate</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Year Ended December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring and Asset Related Charges - Net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> 1</span></div></td><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(165)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(109)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(335)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on Divestiture </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">2</span></div></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(165)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(162)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(388)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-right:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:38.666%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.960%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Seed</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Crop Protection</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Corporate</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Year Ended December 31, 2019</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">3</span></div></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring and Asset Related Charges - Net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> 1</span></div></td><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(213)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(222)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integration and Separation Costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">4</span></div></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(632)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(632)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on Divestiture </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">5</span></div></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of Inventory Step Up</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> 6</span></div></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(67)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(67)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on Early Extinguishment of Debt </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">7</span></div></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Argentina Currency Devaluation </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">8</span></div></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(304)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(664)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(991)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:31.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:16.5pt">Includes Board approved restructuring plans and asset related charges as well as accelerated prepaid amortization. See Note 7 - Restructuring and Asset Related Charges - Net, to the Consolidated Financial Statements, for additional information.</span></div><div style="padding-left:31.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:16.5pt">Includes a loss recorded in other income - net related to the sale of the La Porte site.</span></div><div style="padding-left:31.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:16.5pt">The year ended December 31, 2019 is presented on a pro forma basis, prepared in accordance with Article 11 of Regulation S-X that was in effect prior to recent amendments.</span></div><div style="padding-left:31.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">4.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:16.5pt">Integration and separation costs include costs incurred to prepare for and close the Merger, post-Merger integration expenses, and costs incurred to prepare for the Internal Reorganizations. Beginning in the second quarter of 2019, this includes both integration and separation costs.</span></div><div style="padding-left:31.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">5.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:16.5pt">Includes a loss recorded in other income - net related to DAS's sale of a joint venture related to synergy actions.</span></div><div style="padding-left:31.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">6.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:16.5pt">Includes a charge related to the amortization of the inventory that was stepped up to fair value in connection with the Merger.</span></div><div style="padding-left:31.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">7.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:16.5pt">Includes a loss on early extinguishment of debt related to the difference between the redemption price and the par value of the Make Whole Notes and Term Loan Facility, partially offset by the write-off of unamortized step-up related to the fair value step-up of EID's debt.</span></div><div style="padding-left:31.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">8.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:16.5pt">Includes a charge included in other income - net associated with remeasuring the company’s Argentine Peso net monetary assets, resulting from an unexpected August primary election result in Argentina. Throughout the three months ended September 30, 2019, the Argentine Peso dropped approximately a third of its value against the US dollar and in September of 2019, the country’s central bank announced new restrictions on foreign currency transactions.</span></div> <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:44.434%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.055%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.055%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.056%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></div></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Seed</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Crop Protection</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of and for the Year Ended December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,402 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,253 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,655 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment operating EBITDA</span></td><td style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,512 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,202 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,714 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">866 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">377 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,243 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment assets</span></td><td style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,270 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,428 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,698 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments in nonconsolidated affiliates</span></td><td style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of property, plant and equipment</span></td><td style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">237 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">336 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">573 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of and for the Year Ended December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,756 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,461 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,217 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment operating EBITDA</span></td><td style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,208 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,004 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,212 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">798 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">379 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,177 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment assets</span></td><td style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,751 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,099 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,850 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments in nonconsolidated affiliates</span></td><td style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of property, plant and equipment</span></td><td style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">225 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">475 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of and for the Year Ended December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;border-right:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,590 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,256 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,846 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pro forma segment operating EBITDA</span></td><td style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,040 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,066 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,106 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">628 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">372 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,387 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,492 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,879 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments in nonconsolidated affiliates</span></td><td style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase of property, plant and equipment</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">373 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">293 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">666 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table>1.On June 1, 2019, as a result of changes in reportable segments, $3,382 million of goodwill was reallocated from the seed reportable segment to the crop protection reportable segment. This change was not reflected in segment assets prior to June 1, 2019. 8402000000 7253000000 15655000000 1512000000 1202000000 2714000000 866000000 377000000 1243000000 23270000000 12428000000 35698000000 29000000 47000000 76000000 237000000 336000000 573000000 7756000000 6461000000 14217000000 1208000000 1004000000 2212000000 798000000 379000000 1177000000 23751000000 13099000000 36850000000 22000000 44000000 66000000 225000000 250000000 475000000 7590000000 6256000000 13846000000 1040000000 1066000000 2106000000 628000000 372000000 1000000000 25387000000 13492000000 38879000000 27000000 39000000 66000000 373000000 293000000 666000000 3382000000 <div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:54.911%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.562%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.562%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.565%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income (loss) from continuing operations after income taxes to segment operating EBITDA<br/></span></td><td colspan="9" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Year Ended December 31,</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from continuing operations after income taxes</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,822 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">756 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(270)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for (benefit from) income taxes on continuing operations</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">524 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(81)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from continuing operations before income taxes</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,346 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">675 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(316)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,243 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,177 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(77)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(56)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exchange (gains) losses - net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> 1</span></div></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-operating (benefits) costs - net</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,256)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(316)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(129)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mark-to-market (gains) losses on certain foreign currency contracts not designated as hedges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">2</span></div></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;border-left:1pt solid #000000;border-right:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Significant items</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">236 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">388 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">991 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pro forma adjustments</span></td><td colspan="3" style="background-color:#b6b6b6;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">298 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate expenses</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment operating EBITDA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">3</span></div></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,714 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,212 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,106 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:3pt">Excludes a $(33) million foreign exchange loss for the year ended December 31, 2019 associated with the devaluation of the Argentine peso. See Note 9 - Supplementary Information, to the Consolidated Financial Statements, for additional information.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:2.25pt">Effective January 1, 2021, on a prospective basis, the company excludes net unrealized gain or loss from mark-to-market activity for certain foreign currency derivative instruments that do not qualify for hedge accounting. There were no unrealized mark-to-market (gains) losses for the years ended December 31, 2020 and 2019.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:3pt">The year ended December 31, 2019 is presented on a pro forma basis, prepared in accordance with Article 11 of Regulation S-X that was in effect prior to recent amendments.</span></div> 1822000000 756000000 -270000000 524000000 -81000000 -46000000 2346000000 675000000 -316000000 1243000000 1177000000 1000000000 -77000000 -56000000 -59000000 30000000 45000000 136000000 54000000 174000000 66000000 -1256000000 -316000000 -129000000 236000000 388000000 991000000 298000000 138000000 125000000 119000000 2714000000 2212000000 2106000000 -33000000 <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.426%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.636%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.638%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment assets to total assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment assets</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,698 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,850 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate assets</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,646 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,799 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,344 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,649 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 35698000000 36850000000 6646000000 5799000000 42344000000 42649000000 <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.198%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.467%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.467%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.468%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other Items </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></div></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment Totals</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjustments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated Totals</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Year Ended December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">599 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,599 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase of property, plant and equipment</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">666 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">497 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,163 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table>1.See Note 5 - Divestitures and Other Transactions, to the Consolidated Financial Statements, for additional information 1000000000 599000000 1599000000 666000000 497000000 1163000000 <div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:38.666%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.960%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Seed</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Crop Protection</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Corporate</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Year Ended December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring and Asset Related Charges - Net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(152)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(78)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(289)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities mark-to-market gain (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee Retention Credit</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract termination</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(98)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(60)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(78)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(236)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:38.666%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.960%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Seed</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Crop Protection</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Corporate</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Year Ended December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring and Asset Related Charges - Net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> 1</span></div></td><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(165)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(109)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(335)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on Divestiture </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">2</span></div></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(165)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(162)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(388)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-right:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:38.666%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.960%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Seed</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Crop Protection</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Corporate</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Year Ended December 31, 2019</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">3</span></div></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring and Asset Related Charges - Net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> 1</span></div></td><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(213)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(222)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integration and Separation Costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">4</span></div></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(632)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(632)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on Divestiture </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">5</span></div></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of Inventory Step Up</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> 6</span></div></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(67)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(67)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on Early Extinguishment of Debt </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">7</span></div></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Argentina Currency Devaluation </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">8</span></div></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(304)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(664)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(991)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:31.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:16.5pt">Includes Board approved restructuring plans and asset related charges as well as accelerated prepaid amortization. See Note 7 - Restructuring and Asset Related Charges - Net, to the Consolidated Financial Statements, for additional information.</span></div><div style="padding-left:31.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:16.5pt">Includes a loss recorded in other income - net related to the sale of the La Porte site.</span></div><div style="padding-left:31.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:16.5pt">The year ended December 31, 2019 is presented on a pro forma basis, prepared in accordance with Article 11 of Regulation S-X that was in effect prior to recent amendments.</span></div><div style="padding-left:31.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">4.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:16.5pt">Integration and separation costs include costs incurred to prepare for and close the Merger, post-Merger integration expenses, and costs incurred to prepare for the Internal Reorganizations. Beginning in the second quarter of 2019, this includes both integration and separation costs.</span></div><div style="padding-left:31.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">5.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:16.5pt">Includes a loss recorded in other income - net related to DAS's sale of a joint venture related to synergy actions.</span></div><div style="padding-left:31.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">6.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:16.5pt">Includes a charge related to the amortization of the inventory that was stepped up to fair value in connection with the Merger.</span></div><div style="padding-left:31.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">7.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:16.5pt">Includes a loss on early extinguishment of debt related to the difference between the redemption price and the par value of the Make Whole Notes and Term Loan Facility, partially offset by the write-off of unamortized step-up related to the fair value step-up of EID's debt.</span></div><div style="padding-left:31.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">8.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:16.5pt">Includes a charge included in other income - net associated with remeasuring the company’s Argentine Peso net monetary assets, resulting from an unexpected August primary election result in Argentina. Throughout the three months ended September 30, 2019, the Argentine Peso dropped approximately a third of its value against the US dollar and in September of 2019, the country’s central bank announced new restrictions on foreign currency transactions.</span></div> -152000000 -59000000 -78000000 47000000 47000000 37000000 23000000 60000000 -30000000 -24000000 -54000000 -98000000 -60000000 -78000000 -236000000 -165000000 -109000000 -61000000 -335000000 -53000000 0 -53000000 -388000000 -213000000 -23000000 14000000 -222000000 -632000000 -632000000 -24000000 -24000000 -67000000 -67000000 0 -13000000 -13000000 -33000000 -33000000 -304000000 -23000000 -664000000 -991000000 SUBSEQUENT EVENTS In February 2022, the company entered into a new committed receivable repurchase facility of up to $500 million (the "2022 Repurchase Facility"), which expires in December 2022. Under the 2022 Repurchase Facility, Corteva may sell a portfolio of available and eligible outstanding customer notes receivables to participating institutions and simultaneously agree to repurchase at a future date. The 2022 Repurchase Facility is considered a secured borrowing with the customer notes receivables inclusive of those that are sold and repurchased, equal to 105 percent of the outstanding amounts borrowed utilized as collateral. Borrowings under the 2022 Repurchase Facility will have an interest rate equal to the Adjusted Term Secured Overnight Financing Rate ("SOFR") plus a margin of 0.75 percent. 500000000 1.05 0.0075 238 PricewaterhouseCoopers LLP Philadelphia, Pennsylvania 15655000000 14217000000 13846000000 9220000000 8507000000 8575000000 1187000000 1142000000 1147000000 3209000000 3043000000 3065000000 722000000 682000000 475000000 289000000 335000000 222000000 0 0 744000000 1348000000 212000000 215000000 0 0 -13000000 80000000 145000000 242000000 2296000000 575000000 -422000000 512000000 -105000000 -71000000 1784000000 680000000 -351000000 -53000000 -55000000 -671000000 1731000000 625000000 -1022000000 0 10000000 8000000 1731000000 615000000 -1030000000 1731000000 625000000 -1022000000 -573000000 -26000000 -274000000 -1037000000 186000000 718000000 621000000 -671000000 160000000 10000000 -10000000 0 139000000 -69000000 28000000 -8000000 380000000 -1124000000 1723000000 1005000000 -2146000000 0 10000000 8000000 1723000000 995000000 -2154000000 4459000000 3526000000 86000000 269000000 4811000000 4926000000 5180000000 4882000000 1010000000 1165000000 15546000000 14768000000 76000000 66000000 8364000000 8253000000 4035000000 3857000000 4329000000 4396000000 10107000000 10269000000 10044000000 10747000000 438000000 464000000 1804000000 1939000000 42344000000 42649000000 17000000 3000000 4126000000 3615000000 146000000 123000000 3201000000 2662000000 2070000000 2148000000 9560000000 8551000000 1100000000 1102000000 2162000000 3459000000 1220000000 893000000 3124000000 5176000000 1719000000 1867000000 9325000000 12497000000 169000000 169000000 70000000 70000000 0 0 24196000000 24049000000 1922000000 203000000 -2898000000 -2890000000 23459000000 21601000000 0 0 23459000000 21601000000 42344000000 42649000000 1731000000 625000000 -1022000000 1243000000 1177000000 1599000000 174000000 -330000000 -477000000 -1292000000 -340000000 -177000000 247000000 269000000 323000000 21000000 -3000000 142000000 289000000 335000000 339000000 0 0 272000000 0 0 1102000000 0 0 -13000000 -156000000 -290000000 -246000000 113000000 -187000000 361000000 422000000 -104000000 -74000000 524000000 -118000000 149000000 574000000 71000000 632000000 -93000000 -251000000 928000000 2689000000 1986000000 996000000 573000000 475000000 1163000000 75000000 83000000 249000000 0 0 10000000 4000000 1000000 10000000 0 0 21000000 204000000 995000000 138000000 345000000 721000000 160000000 1000000 7000000 13000000 -362000000 -674000000 -904000000 13000000 0 -1868000000 52000000 103000000 4240000000 1349000000 665000000 219000000 419000000 2439000000 1001000000 421000000 1441000000 6804000000 100000000 56000000 47000000 0 -60000000 0 0 0 -317000000 0 0 -2053000000 0 0 3255000000 0 0 -79000000 -42000000 -51000000 -58000000 -1228000000 381000000 -2855000000 -136000000 7000000 -88000000 963000000 1700000000 -2851000000 3873000000 2173000000 5024000000 4836000000 3873000000 2173000000 30000000 36000000 263000000 341000000 229000000 234000000 0 0 0 78259000000 0 -3360000000 254000000 75153000000 -640000000 -390000000 8000000 -1022000000 -1124000000 -1124000000 -2000000 -2000000 -6000000 -10000000 -317000000 -317000000 3255000000 3255000000 39000000 39000000 8000000 8000000 41000000 62000000 103000000 -56479000000 1214000000 -231000000 -55496000000 239000000 23936000000 -24175000000 0 -25000000 -2000000 -10000000 -24000000 -61000000 239000000 0 23958000000 -406000000 -3270000000 7000000 20528000000 615000000 10000000 625000000 380000000 380000000 56000000 56000000 -5000000 -5000000 -10000000 60000000 -1000000 59000000 -37000000 -15000000 -52000000 17000000 -2000000 15000000 239000000 0 24049000000 203000000 -2890000000 0 21601000000 1731000000 1731000000 -8000000 -8000000 100000000 100000000 -10000000 -10000000 59000000 -3000000 56000000 -12000000 1000000 -11000000 239000000 0 24196000000 1922000000 -2898000000 0 23459000000 BASIS OF PRESENTATION<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the Business Realignment and the Internal Reorganization, Corteva, Inc. owns 100% of the outstanding common stock of EID. EID is a subsidiary of Corteva, Inc. and continues to be a reporting company, subject to the requirements of the Exchange Act. The primary differences between Corteva, Inc. and EID are outlined below: </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Preferred Stock</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - EID has preferred stock outstanding to third parties which is accounted for as a noncontrolling interest at the Corteva, Inc. level. Each share of EID Preferred Stock - $4.50 Series and EID Preferred Stock - $3.50 Series issued and outstanding at the effective date of the Corteva Distribution remains issued and outstanding as to EID and was unaffected by the Corteva Distribution.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Related Party Loan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - EID engaged in a series of debt redemptions during the second quarter of 2019 that were partially funded through an intercompany loan from Corteva, Inc. This was eliminated in consolidation at the Corteva, Inc. level but remains on EID's financial statements at the standalone level (including the associated interest).</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Capital Structure</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - At December 31, 2021, Corteva, Inc.'s capital structure consists of 726,527,000 issued shares of common stock, par value $0.01 per share. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying footnotes relate to EID only, and not to Corteva, Inc., and are presented to show differences between EID and Corteva, Inc. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the footnotes listed below, refer to the footnotes from the Corteva 10-K:</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Note 1 - Background and Basis of Presentation - refer to page F-12 of the Corteva, Inc. Consolidated Financial Statements</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Note 2 - Summary of Significant Accounting Policies - refer to page F-14 of the Corteva, Inc. Consolidated Financial Statements</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Note 3 - Recent Accounting Guidance - refer to page F-19 of the Corteva, Inc. Consolidated Financial Statements</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Note 4 - Common Control Business Combination - refer to page F-19 of the Corteva, Inc. Consolidated Financial Statements</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Note 5 - Divestitures and Other Transactions - refer to page F-20 of the Corteva, Inc. Consolidated Financial Statements</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Note 6 - Revenue - refer to page F-24 of the Corteva, Inc. Consolidated Financial Statements</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Note 7 - Restructuring and Asset Related Charges - Net - refer to page F-26 of the Corteva, Inc. Consolidated Financial Statements</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Note 8 - Related Party Transactions - Differences exist between Corteva, Inc. and EID; refer to EID Note 2 - Related Party Transactions, of the EID Consolidated Financial Statements, below</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Note 9 - Supplementary Information - refer to page F-29 of the Corteva, Inc. Consolidated Financial Statements</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Note 10 - Income Taxes - Differences exist between Corteva, Inc. and EID; refer to EID Note 3 - Income Taxes, of the EID Consolidated Financial Statements, below</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Note 11 - Earnings Per Share of Common Stock - Not applicable for EID</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Note 12 - Accounts and Notes Receivable - Net - refer to page F-36 of the Corteva, Inc. Consolidated Financial Statements</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Note 13 - Inventories - refer to page F-37 of the Corteva, Inc. Consolidated Financial Statements</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Note 14 - Property, Plant and Equipment - refer to page F-37 of the Corteva, Inc. Consolidated Financial Statements</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Note 15 - Goodwill and Other Intangible Assets - refer to page F-38 of the Corteva, Inc. Consolidated Financial Statements</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Note 16 - Leases - refer to page F-40 of the Corteva, Inc. Consolidated Financial Statements</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Note 17 - Long-Term Debt and Available Credit Facilities - refer to page F-42 of the Corteva, Inc. Consolidated Financial Statements. In addition, EID has a related party loan payable to Corteva, Inc.; refer to EID Note 2 - Related Party Transactions, of the EID Consolidated Financial Statements, below</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Note 18 - Commitments and Contingent Liabilities - refer to page F-44 of the Corteva, Inc. Consolidated Financial Statements</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Note 19 - Stockholders' Equity - refer to page F-51 of the Corteva, Inc. Consolidated Financial Statements</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Note 20 - Pension Plans and Other Post Employment Benefits - refer to page F-54 of the Corteva, Inc. Consolidated Financial Statements</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Note 21 - Stock-Based Compensation - refer to page F-63 of the Corteva, Inc. Consolidated Financial Statements</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Note 22 - Financial Instruments - refer to page F-65 of the Corteva, Inc. Consolidated Financial Statements</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Note 23 - Fair Value Measurements - refer to page F-71 of the Corteva, Inc. Consolidated Financial Statements</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Note 24 - Geographic Information - refer to page F-73 of the Corteva, Inc. Consolidated Financial Statements</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Note 25 - Segment Information - Differences exist between Corteva, Inc. and EID; refer to EID Note 4 - Segment Information, of the EID Consolidated Financial Statements, below</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Note 26 - Subsequent Events - Refers to page F-78 of the Corteva, Inc. Consolidated Financial Statements</span> 1 726527000 0.01 RELATED PARTY TRANSACTIONS<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to page F-28 of the Corteva, Inc. Consolidated Financial Statements for discussion of related party transactions with Historical Dow and DowDuPont.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Transactions with Corteva</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the second quarter of 2019, EID entered into a related party revolving loan from Corteva, Inc., with a maturity date in 2024. As of December 31, 2021 and December 31, 2020, the outstanding related party loan balance was $2,162 million and $3,459 million respectively (which approximates fair value), with interest rates of 1.67% and 1.62%, respectively, and is reflected as long-term debt - related party on EID's Consolidated Balance Sheet. Additionally, EID has incurred tax deductible interest expense of $50 million and $100 million and paid interest of $51 million and $105 million for the years ended December 31, 2021 and 2020, respectively, associated with the related party loan to Corteva, Inc. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2021, EID had payables to Corteva, Inc. of $27 million and $117 million included in accrued and other current liabilities and other noncurrent obligations, respectively, and $92 million included in both accrued and other current liabilities and other noncurrent obligations, respectively, at December 31, 2020, in the Consolidated Balance Sheet, related to Corteva's indemnification liabilities to Dow and DuPont per the Separation Agreements (refer to page F-20 of the Corteva, Inc. Consolidated Financial Statements for further details of the Separation Agreements).</span></div> 2162000000 3459000000 0.0167 0.0162 50000000 100000000 51000000 105000000 27000000 117000000 92000000 <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to page F-31 of the Corteva, Inc. Consolidated Financial Statements for discussion of tax items that do not differ between Corteva, Inc. and EID.</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:51.677%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.689%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.691%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Geographic Allocation of Income (Loss) and Provision for (Benefit from) Income Taxes </span></td><td colspan="9" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Year Ended December 31,</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss) from continuing operations before income taxes</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Domestic</span></td><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">892 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(183)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,458)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,404 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">758 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,036 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss) from continuing operations before income taxes</span></td><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,296 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">575 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(422)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current tax expense (benefit)</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">State and local</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">329 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">222 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">317 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current tax expense (benefit)</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">310 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">235 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">307 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax (benefit) expense</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">164 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(116)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(417)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">State and local</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">156 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(251)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(117)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total deferred tax expense (benefit)</span></td><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">202 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(340)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(378)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Provision for (benefit from) income taxes on continuing operations</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">512 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(105)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(71)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss) from continuing operations</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,784 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">680 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(351)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.285%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.104%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.104%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.107%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reconciliation to U.S. Statutory Rate</span></td><td colspan="9" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Year Ended December 31,</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Statutory U.S. federal income tax rate</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective tax rates on international operations - net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> 1</span></div></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.8)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions, divestitures and ownership restructuring activities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> 2</span></div></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.0)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. research and development credit</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exchange gains/losses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> 3</span></div></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and local income taxes - net</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of Swiss Tax Reform </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">4</span></div></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.9 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Excess tax benefits/deficiencies from stock compensation</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax settlements and expiration of statute of limitations</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other - net</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective tax rate</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.2 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18.3)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.8 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1.    Includes the effects of local and U.S. taxes related to earnings of non-U.S. subsidiaries, changes in the amount of unrecognized tax benefits associated with these earnings, losses at non-U.S. subsidiaries without local tax benefits due to valuation allowances, and other permanent differences between tax and U.S. GAAP results. Includes a tax benefit of $(51) million for the year ended December 31, 2020, related to a return to accrual adjustment associated with an elective change in accounting method that alters the 2019 impact of foreign tax provisions. </span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2.    See Notes 4 - Common Control Business Combination, and Note 5 - Divestitures and Other Transactions, of the Corteva, Inc. Consolidated Financial Statements for additional information.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">3.    Principally reflects the impact of foreign exchange gains and losses on net monetary assets for which no corresponding tax impact is realized. Further information about the company's foreign currency hedging program is included in Note 9 - Supplementary Information, and Note 22 - Financial Instruments, of the Corteva, Inc. Consolidated Financial Statements under the heading Foreign Currency Risk.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">4.    Reflects tax benefits of $(182) million primarily driven by the recognition of an elective cantonal component of the recent enactment of the Federal Act on Tax Reform and AHV Financing ("Swiss Tax Reform") for the year ended December 31, 2020. Reflects tax benefits of $(38) million associated with the enactment of the Federal Act on Tax Reform and AHV Financing ("Swiss Tax Reform"), for the year ended December 31, 2019.</span></div> <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:51.677%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.689%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.691%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Geographic Allocation of Income (Loss) and Provision for (Benefit from) Income Taxes </span></td><td colspan="9" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Year Ended December 31,</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss) from continuing operations before income taxes</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Domestic</span></td><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">892 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(183)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,458)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,404 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">758 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,036 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss) from continuing operations before income taxes</span></td><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,296 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">575 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(422)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current tax expense (benefit)</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">State and local</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">329 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">222 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">317 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current tax expense (benefit)</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">310 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">235 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">307 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax (benefit) expense</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">164 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(116)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(417)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">State and local</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">156 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(251)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(117)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total deferred tax expense (benefit)</span></td><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">202 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(340)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(378)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Provision for (benefit from) income taxes on continuing operations</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">512 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(105)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(71)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss) from continuing operations</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,784 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">680 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(351)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 892000000 -183000000 -1458000000 1404000000 758000000 1036000000 2296000000 575000000 -422000000 -23000000 8000000 -11000000 4000000 5000000 1000000 329000000 222000000 317000000 310000000 235000000 307000000 164000000 -116000000 -417000000 55000000 27000000 156000000 -17000000 -251000000 -117000000 202000000 -340000000 -378000000 512000000 -105000000 -71000000 1784000000 680000000 -351000000 <div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.285%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.104%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.104%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.107%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reconciliation to U.S. Statutory Rate</span></td><td colspan="9" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Year Ended December 31,</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Statutory U.S. federal income tax rate</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective tax rates on international operations - net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> 1</span></div></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.8)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions, divestitures and ownership restructuring activities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> 2</span></div></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.0)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. research and development credit</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exchange gains/losses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> 3</span></div></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and local income taxes - net</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of Swiss Tax Reform </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">4</span></div></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.9 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Excess tax benefits/deficiencies from stock compensation</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax settlements and expiration of statute of limitations</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other - net</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective tax rate</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.2 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18.3)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.8 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1.    Includes the effects of local and U.S. taxes related to earnings of non-U.S. subsidiaries, changes in the amount of unrecognized tax benefits associated with these earnings, losses at non-U.S. subsidiaries without local tax benefits due to valuation allowances, and other permanent differences between tax and U.S. GAAP results. Includes a tax benefit of $(51) million for the year ended December 31, 2020, related to a return to accrual adjustment associated with an elective change in accounting method that alters the 2019 impact of foreign tax provisions. </span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2.    See Notes 4 - Common Control Business Combination, and Note 5 - Divestitures and Other Transactions, of the Corteva, Inc. Consolidated Financial Statements for additional information.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">3.    Principally reflects the impact of foreign exchange gains and losses on net monetary assets for which no corresponding tax impact is realized. Further information about the company's foreign currency hedging program is included in Note 9 - Supplementary Information, and Note 22 - Financial Instruments, of the Corteva, Inc. Consolidated Financial Statements under the heading Foreign Currency Risk.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">4.    Reflects tax benefits of $(182) million primarily driven by the recognition of an elective cantonal component of the recent enactment of the Federal Act on Tax Reform and AHV Financing ("Swiss Tax Reform") for the year ended December 31, 2020. Reflects tax benefits of $(38) million associated with the enactment of the Federal Act on Tax Reform and AHV Financing ("Swiss Tax Reform"), for the year ended December 31, 2019.</span></div> 0.210 0.210 0.210 -0.026 -0.164 -0.138 -0.001 -0.003 -0.080 -0.025 -0.034 0.052 0.019 0.041 -0.013 0.022 0.042 0.030 0.002 -0.317 0.089 -0.002 0.012 -0.005 0 0.004 0.029 0.023 0.026 -0.006 0.222 -0.183 0.168 -51000000 -182000000 -38000000 SEGMENT INFORMATION <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are no differences in reporting structure or segments between Corteva, Inc. and EID. In addition, there are no differences between Corteva, Inc. and EID segment net sales, segment operating EBITDA or pro forma segment operating EBITDA, segment assets, or significant items by segment; refer to page F-74 of the Corteva, Inc. Consolidated Financial Statements for background information on the segments as well as further details regarding segment metrics. The tables below reconcile income (loss) from continuing operations after income taxes to segment operating EBITDA, as differences exist between Corteva, Inc. and EID.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reconciliation to Consolidated Financial Statements</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.549%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.350%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.350%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.351%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income (loss) from continuing operations after income taxes to segment operating EBITDA</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></div></td><td colspan="9" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Year Ended December 31,</span></td><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from continuing operations after income taxes</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,784 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">680 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(351)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for (benefit from) income taxes on continuing operations</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">512 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(105)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(71)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from continuing operations before income taxes</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,296 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">575 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(422)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,243 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,177 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(77)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(56)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">242 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exchange losses - net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-operating (benefits) costs - net</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,256)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(316)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(129)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mark-to-market (gains) losses on certain foreign currency contracts not designated as hedges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">2</span></div></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;border-left:1pt solid #000000;border-right:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Significant items</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">236 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">388 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">991 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pro forma adjustments</span></td><td colspan="3" style="background-color:#b6b6b6;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">298 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate expenses</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment operating EBITDA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">3</span></div></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,714 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,212 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,106 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:3pt">Excludes a $(33) million foreign exchange loss for the year ended December 31, 2019 associated with the devaluation of the Argentine peso. See Note 9 - Supplementary Information, of the Corteva, Inc. Consolidated Financial Statements for additional information.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:2.25pt">Effective January 1, 2021, on a prospective basis, the company excludes net unrealized gain or loss from mark-to-market activity for certain foreign currency derivative instruments that do not qualify for hedge accounting. There were no unrealized mark-to-market (gains) losses for the years ended December 31, 2020 and 2019.</span></div>3.The year ended December 31, 2019 is presented on a pro forma basis, prepared in accordance with Article 11 of Regulation S-X that was in effect prior to recent amendments. <div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.549%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.350%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.350%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.351%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income (loss) from continuing operations after income taxes to segment operating EBITDA</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(In millions)</span></div></td><td colspan="9" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Year Ended December 31,</span></td><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from continuing operations after income taxes</span></td><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,784 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">680 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(351)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for (benefit from) income taxes on continuing operations</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">512 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(105)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(71)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from continuing operations before income taxes</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,296 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">575 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(422)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,243 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,177 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(77)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(56)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59)</span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">242 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exchange losses - net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-operating (benefits) costs - net</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,256)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(316)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(129)</span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mark-to-market (gains) losses on certain foreign currency contracts not designated as hedges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">2</span></div></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#b6b6b6;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;border-left:1pt solid #000000;border-right:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Significant items</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">236 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">388 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">991 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pro forma adjustments</span></td><td colspan="3" style="background-color:#b6b6b6;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#b6b6b6;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">298 </span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate expenses</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119 </span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment operating EBITDA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">3</span></div></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,714 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,212 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,106 </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:3pt">Excludes a $(33) million foreign exchange loss for the year ended December 31, 2019 associated with the devaluation of the Argentine peso. See Note 9 - Supplementary Information, of the Corteva, Inc. Consolidated Financial Statements for additional information.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:2.25pt">Effective January 1, 2021, on a prospective basis, the company excludes net unrealized gain or loss from mark-to-market activity for certain foreign currency derivative instruments that do not qualify for hedge accounting. There were no unrealized mark-to-market (gains) losses for the years ended December 31, 2020 and 2019.</span></div>3.The year ended December 31, 2019 is presented on a pro forma basis, prepared in accordance with Article 11 of Regulation S-X that was in effect prior to recent amendments. 1784000000 680000000 -351000000 512000000 -105000000 -71000000 2296000000 575000000 -422000000 1243000000 1177000000 1000000000 -77000000 -56000000 -59000000 80000000 145000000 242000000 54000000 174000000 66000000 -1256000000 -316000000 -129000000 236000000 388000000 991000000 298000000 138000000 125000000 119000000 2714000000 2212000000 2106000000 -33000000 Classifications in the changes in the allowance for doubtful receivables for the period ended December 31, 2020 have been adjusted from their previous presentation. Adjustments did not impact the amount of the provision or the allowance for doubtful receivables recorded in the Consolidated Statements of Operations or the Consolidated Balance Sheets. Deductions include write-offs, recoveries collected and currency translation adjustments. For cash flow hedges, this represents the portion of the gain (loss) reclassified from accumulated OCI into income during the period. Recorded in cost of goods sold. Includes Board approved restructuring plans and asset related charges as well as accelerated prepaid amortization. See Note 7 - Restructuring and Asset Related Charges - Net, to the Consolidated Financial Statements, for additional information. The year ended December 31, 2019 is presented on a pro forma basis, prepared in accordance with Article 11 of Regulation S-X that was in effect prior to recent amendments. Reflected in other income - net in the Consolidated Statements of Operations. These accumulated other comprehensive (loss) income components are included in the computation of net periodic benefit (credit) cost of the company's pension and other benefit plans. See Note 20 - Pension Plans and Other Post Employment Benefits, to the Consolidated Financial Statements, for additional information. A portion reflected in (loss) income from discontinued operations after income taxes for the year ended December 31, 2019. As of December 31, 2021 and December 31, 2020, $219 million and $249 million, respectively, of the benefit obligations are supported by funding under the Trust agreement, defined in the "Trust Assets" section below. Includes pension plans maintained around the world where funding is not customary. Accrual balance represents management’s best estimate of the costs of remediation and restoration, although it is reasonably possible that the potential exposure, as indicated, could range above the amounts accrued, as there are inherent uncertainties in these estimates. Accrual balance includes $68 million for remediation of Superfund sites. Amounts do not include possible impacts from the remediation elements of the EPAs October 2021 PFAS Strategic Roadmap (as applicable) or possible revisions to Chemours’ Consent Order with the North Carolina Department of Environmental Quality, as any possible impacts, to the extent such items would be reimbursable under the MOU, are not yet determinable. Represents liabilities that are subject to the $150 million threshold and sharing agreements as discussed on page F-44, under the header "Chemours / Performance Chemicals. The company has recorded an indemnification asset related to these accruals, including $40 million related to the Superfund sites. Represents liabilities that are subject the $200 million threshold and sharing arrangements as discussed on page F-46, under Corteva Separation Agreement. Includes a loss recorded in other income - net related to DAS's sale of a joint venture related to synergy actions. In connection with the company's 2021 internal legal entity restructuring, the company reduced various state net operating loss carryforwards and corresponding full valuation allowances by $61 million. There was no impact on the statement of operations. During the year ended December 31, 2020, the company established a $19 million state tax valuation allowance in the U.S. based on a change in judgement about the realizability of a deferred tax asset. Primarily related to the realization of recorded tax benefits on tax loss and credit carryforwards from operations in the United States, Brazil, and Spain. Gain recognized in other income - net was partially offset by the related gain on the foreign currency-denominated monetary assets and liabilities of the company's operations. See Note 9 - Supplementary Information, to the Consolidated Financial Statements for additional information. The cash flows for the year ended December 31, 2019 includes cash flows of EID's ECP and Specialty Products Entities. See page F-30 for reconciliation of cash and cash equivalents and restricted cash equivalents presented in the Consolidated Balance Sheets to total cash, cash equivalents and restricted cash equivalents presented in the Consolidated Statements of Cash Flows. Integration and separation costs include costs incurred to prepare for and close the Merger, post-Merger integration expenses, and costs incurred to prepare for the Internal Reorganizations. Beginning in the second quarter of 2019, this includes both integration and separation costs. Reflects interest, net of amounts capitalized, paid to external parties. For information associated with interest paid on related party debt refer to EID's Note 2 - Related Party Transactions, of the EID Consolidated Financial Statements. The cash flows for the year ended December 31, 2019 includes cash flows of EID's ECP and Specialty Products Entities Notes receivable – trade primarily consists of receivables for deferred payment loan programs for the sale of seed products to customers. These loans have terms of one year or less and are primarily concentrated in North America. The company maintains a rigid pre-approval process for extending credit to customers in order to manage overall risk and exposure associated with credit losses. As of December 31, 2021 and 2020, there were no significant impairments related to current loan agreements. Accounts receivable – trade and notes receivable – trade are net of allowances of $210 million and $208 million at December 31, 2021 and December 31, 2020, respectively. Allowances are equal to the estimated uncollectible amounts and are based on the expected credit losses and were developed using a loss-rate method. The cumulative translation adjustment losses for the year ended December 31, 2021 was primarily driven by the strengthening of the U.S. Dollar ("USD") against the European Euro ("EUR"), Swiss franc ("CHF") and Turkish Lira (“TRY”). The cumulative translation adjustment losses for the year ended December 31, 2020 was primarily driven by the strengthening of the U.S. Dollar ("USD") against the Brazilian Real ("BRL"), partially offset by the weakening of the U.S. Dollar against the Swiss franc ("CHF") and European Euro ("EUR"). Reflects tax benefits of $(182) million primarily driven by the recognition of an elective cantonal component of the recent enactment of the Federal Act on Tax Reform and AHV Financing ("Swiss Tax Reform") for the year ended December 31, 2020. Reflects tax benefits of $(38) million associated with the enactment of the Federal Act on Tax Reform and AHV Financing ("Swiss Tax Reform"), for the year ended December 31, 2019. Included in other noncurrent obligations in the Consolidated Balance Sheets. Represents U.S. & Canada. The Corteva pension plans directly held $201 million (approximately 1 percent of total plan assets) of Corteva, Inc. common stock at December 31, 2021. Beginning on October 1, 2020, the company changed its indefinite life assertion of its trade name asset to definite lived with a useful life of 25 years. This change is the result of the launch of BrevantTM seed in the retail channel in the U.S. Prior to changing the useful life of the trade name asset, the company tested the asset for impairment under ASC 350 - Intangibles, Goodwill and Other, concluding the asset was not impaired. Included in accounts and notes receivable - net in the Consolidated Balance Sheets. See Note 22 - Financial Instruments, to the Consolidated Financial Statements, for the classification of derivatives in the Consolidated Balance Sheets. Prior year classifications in property and other accruals and reserves have been adjusted from their previous presentation. Adjustments did not impact the amount of the net deferred tax asset (liability) recorded in the Consolidated Balance Sheets. See Note 5 - Divestitures and Other Transactions, to the Consolidated Financial Statements, for additional information On June 1, 2019, as a result of changes in reportable segments, $3,382 million of goodwill was reallocated from the seed reportable segment to the crop protection reportable segment. This change was not reflected in segment assets prior to June 1, 2019. Includes the effects of local and U.S. taxes related to earnings of non-U.S. subsidiaries, changes in the amount of unrecognized tax benefits associated with these earnings, losses at non-U.S. subsidiaries without local tax benefits due to valuation allowances, and other permanent differences between tax and U.S. GAAP results. Includes a tax benefit of $(51) million for the year ended December 31, 2020, related to a return to accrual adjustment associated with an elective change in accounting method for the 2019 tax year impact of foreign tax provisions. The year ended December 31, 2020 includes a loss of $(53) million and a gain of $27 million relating to the expected sale of the La Porte site, for which the company signed an agreement in 2020, and the sale of a business in Asia Pacific in the crop protection segment, respectively. Included in other current assets in the Consolidated Balance Sheets. These outstanding potential shares of common stock relating to stock options, restricted stock units and performance-based restricted stock units were excluded from the calculation of diluted earnings (loss) per share because (i) the effect of including stock options and restricted stock units would have been anti-dilutive; and (ii) the performance metrics have not yet been achieved for the outstanding potential shares relating to performance-based restricted stock units, which are deemed to be contingently issuable. Included in accrued and other current liabilities in the Consolidated Balance Sheet. Primarily receivables for investments securities sold. Primarily payables for investment securities purchased. The company's equity securities are included in "other assets" in the Consolidated Balance Sheets. Net sales for Brazil for the years ended December 31, 2021, 2020 and 2019 were $2,315 million, $1,724 million and $1,794 million, respectively. Europe, Middle East, and Africa ("EMEA") Consists of the goodwill included in the sale of a business in the seed segment. Counterparty and cash collateral amounts represent the estimated net settlement amount when applying netting and set-off rights included in master netting arrangements between the company and its counterparties and the payable or receivable for cash collateral held or placed with the same counterparty. Reflected in provision for (benefit from) income taxes from continuing operations in the Consolidated Statements of Operations. Primarily consists of the goodwill included in the sale of businesses in the crop protection segment. Included in other assets in the Consolidated Balance Sheets. Principally reflects the impact of foreign exchange gains and losses on net monetary assets for which no corresponding tax impact is realized. Further information about the company's foreign currency hedging program is included in Note 9 - Supplementary Information, and Note 22 - Financial Instruments, of the Corteva, Inc. Consolidated Financial Statements under the heading Foreign Currency Risk. Includes the effects of local and U.S. taxes related to earnings of non-U.S. subsidiaries, changes in the amount of unrecognized tax benefits associated with these earnings, losses at non-U.S. subsidiaries without local tax benefits due to valuation allowances, and other permanent differences between tax and U.S. GAAP results. Includes a tax benefit of $(51) million for the year ended December 31, 2020, related to a return to accrual adjustment associated with an elective change in accounting method that alters the 2019 impact of foreign tax provisions. Included in other assets in the Consolidated Balance Sheet. Excludes a $(33) million foreign exchange loss for the year ended December 31, 2019 associated with the devaluation of the Argentine peso. See Note 9 - Supplementary Information, of the Corteva, Inc. Consolidated Financial Statements for additional information.2.Effective January 1, 2021, on a prospective basis, the company excludes net unrealized gain or loss from mark-to-market activity for certain foreign currency derivative instruments that do not qualify for hedge accounting. There were no unrealized mark-to-market (gains) losses for the years ended December 31, 2020 and 2019. Primarily payables for investment securities purchased. Included in other noncurrent obligations in the Consolidated Balance Sheet. The year ended December 31, 2019 is presented on a pro forma basis, prepared in accordance with Article 11 of Regulation S-X that was in effect prior to recent amendments. Includes non-service related components of net periodic benefit credits (costs) (interest cost, expected long-term rate of return on plan assets, amortization of unrecognized gain (loss), amortization of prior service benefit and settlement gain (loss)).  Includes non-service related components of net periodic benefit credit of $(31) million for the year ended December 31, 2019. The year ended December 31, 2019 is presented on a pro forma basis, prepared in accordance with Article 11 of Regulation S-X that was in effect prior to recent amendments. The company's investments in U.S. treasuries, which are primarily available-for-sale, are included in "marketable securities" in the Consolidated Balance Sheets. Primarily consists of sales and farmer networks, marketing and manufacturing alliances and noncompetition agreements. Principally reflects the impact of foreign exchange gains and losses on net monetary assets for which no corresponding tax impact is realized. Further information about the company's foreign currency hedging program is included in Note 9 - Supplementary Information, and Note 22 - Financial Instruments, under the heading Foreign Currency Risk. Other includes receivables in relation to indemnification assets, value added tax, general sales tax and other taxes. No individual group represents more than 10 percent of total receivables. In addition, Other includes amounts due from nonconsolidated affiliates of $104 million and $106 million as of December 31, 2021 and 2020, respectively. Excludes a $(33) million foreign exchange loss for the year ended December 31, 2019 associated with the devaluation of the Argentine peso. See Note 9 - Supplementary Information, to the Consolidated Financial Statements, for additional information.2.Effective January 1, 2021, on a prospective basis, the company excludes net unrealized gain or loss from mark-to-market activity for certain foreign currency derivative instruments that do not qualify for hedge accounting. There were no unrealized mark-to-market (gains) losses for the years ended December 31, 2020 and 2019. See Notes 4 - Common Control Business Combination, and Note 5 - Divestitures and Other Transactions, to the Consolidated Financial Statements, for additional information. Share amounts for all periods prior to the Corteva Distribution were based on 748.8 million shares of Corteva, Inc. common stock distributed to holders of DowDuPont's common stock on June 1, 2019, plus 0.6 million of additional shares in which accelerated vesting conditions have been met. See Notes 4 - Common Control Business Combination, and Note 5 - Divestitures and Other Transactions, of the Corteva, Inc. Consolidated Financial Statements for additional information. OCI is defined as other comprehensive income (loss). Reflected in cost of goods sold in the Consolidated Statements of Operations. Deductions include currency translation adjustments. Includes net pre-tax exchange gains (losses) of $(67) million, $(82) million and $(51) million associated with the devaluation of the Argentine peso for the years ended December 31, 2021, 2020 and 2019, respectively. Primarily receivables for investments securities sold. Diluted earnings (loss) per share considers the impact of potentially dilutive securities except in periods in which there is a loss because the inclusion of the potential common shares would have an anti-dilutive effect. The Corteva pension plans directly held $165 million (approximately 1 percent of total plan assets) of Corteva, Inc. at December 31, 2020. Reflects tax benefits of $(182) million primarily driven by the recognition of an elective cantonal component of the recent enactment of the Federal Act on Tax Reform and AHV Financing ("Swiss Tax Reform") for the year ended December 31, 2020. Reflects tax benefits of $(38) million associated with the enactment of the Federal Act on Tax Reform and AHV Financing ("Swiss Tax Reform"), for the year ended December 31, 2019. Miscellaneous income (expenses) - net, includes losses from sale of receivables, tax indemnification adjustments related to changes in indemnification balances as a result of the application of the terms of the Tax Matters Agreement between Corteva and Dow and/or DuPont, and other items. The year ended December 31, 2021 also includes the Employee Retention Credit of $60 million pursuant to the Coronavirus Aid, Relief, and Economic Security (“CARES”) Act as enhanced by the Consolidated Appropriations Act (“CAA”) and American Rescue Plan Act (“ARPA”), a gain from the remeasurement of an equity investment of $47 million, a charge related to a contract termination with a third-party service provider of $(54) million and the 2021 officer indemnification payment.  EXCEL 191 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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�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how.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 193 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 194 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.0.1 html 915 797 1 true 245 0 false 6 false false R1.htm 000010001 - Document - DEI Document Sheet http://www.corteva.com/role/DEIDocument DEI Document Cover 1 false false R2.htm 000020002 - Document - Audit Information Sheet http://www.corteva.com/role/AuditInformation Audit Information Notes 2 false false R3.htm 100010003 - Statement - Consolidated Statements of Income Sheet http://www.corteva.com/role/ConsolidatedStatementsofIncome Consolidated Statements of Income Uncategorized 3 false false R4.htm 100020004 - Statement - Consolidated Statements of Comprehensive Income Sheet http://www.corteva.com/role/ConsolidatedStatementsofComprehensiveIncome Consolidated Statements of Comprehensive Income Statements 4 false false R5.htm 100030005 - Statement - Consolidated Balance Sheets Sheet http://www.corteva.com/role/ConsolidatedBalanceSheets Consolidated Balance Sheets Statements 5 false false R6.htm 100040006 - Statement - Consolidated Balance Sheets (Parentheticals) Sheet http://www.corteva.com/role/ConsolidatedBalanceSheetsParentheticals Consolidated Balance Sheets (Parentheticals) Statements 6 false false R7.htm 100050007 - Statement - Consolidated Statements of Cash Flows Sheet http://www.corteva.com/role/ConsolidatedStatementsofCashFlows Consolidated Statements of Cash Flows Statements 7 false false R8.htm 100060008 - Statement - Consolidated Statements of Equity Sheet http://www.corteva.com/role/ConsolidatedStatementsofEquity Consolidated Statements of Equity Statements 8 false false R9.htm 100070009 - Statement - Consolidated Statements of Equity (Parentheticals) Sheet http://www.corteva.com/role/ConsolidatedStatementsofEquityParentheticals Consolidated Statements of Equity (Parentheticals) Statements 9 false false R10.htm 210011001 - Disclosure - Schedule II - Valuation and Qualifying Accounts (Notes) Notes http://www.corteva.com/role/ScheduleIIValuationandQualifyingAccountsNotes Schedule II - Valuation and Qualifying Accounts (Notes) Notes 10 false false R11.htm 210031002 - Disclosure - Background and Basis of Presentation (Notes) Notes http://www.corteva.com/role/BackgroundandBasisofPresentationNotes Background and Basis of Presentation (Notes) Notes 11 false false R12.htm 210061003 - Disclosure - Summary of Significant Accounting Policies Sheet http://www.corteva.com/role/SummaryofSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 12 false false R13.htm 210091004 - Disclosure - Recent Accounting Guidance Sheet http://www.corteva.com/role/RecentAccountingGuidance Recent Accounting Guidance Notes 13 false false R14.htm 210121005 - Disclosure - Common Control Business Combinations Sheet http://www.corteva.com/role/CommonControlBusinessCombinations Common Control Business Combinations Notes 14 false false R15.htm 210151006 - Disclosure - Divestitures and Other Transactions Sheet http://www.corteva.com/role/DivestituresandOtherTransactions Divestitures and Other Transactions Notes 15 false false R16.htm 210221007 - Disclosure - Revenue (Notes) Notes http://www.corteva.com/role/RevenueNotes Revenue (Notes) Notes 16 false false R17.htm 210291008 - Disclosure - Restructuring and Asset Related Charges Sheet http://www.corteva.com/role/RestructuringandAssetRelatedCharges Restructuring and Asset Related Charges Notes 17 false false R18.htm 210361009 - Disclosure - Related Parties (Notes) Notes http://www.corteva.com/role/RelatedPartiesNotes Related Parties (Notes) Notes 18 false false R19.htm 210391010 - Disclosure - Supplementary Information Sheet http://www.corteva.com/role/SupplementaryInformation Supplementary Information Notes 19 false false R20.htm 210451011 - Disclosure - Income Taxes Sheet http://www.corteva.com/role/IncomeTaxes Income Taxes Notes 20 false false R21.htm 210531012 - Disclosure - Earnings Per Share of Common Stock (Notes) Notes http://www.corteva.com/role/EarningsPerShareofCommonStockNotes Earnings Per Share of Common Stock (Notes) Notes 21 false false R22.htm 210601013 - Disclosure - Accounts and Notes Receivable, Net Notes http://www.corteva.com/role/AccountsandNotesReceivableNet Accounts and Notes Receivable, Net Notes 22 false false R23.htm 210651014 - Disclosure - Inventories Sheet http://www.corteva.com/role/Inventories Inventories Notes 23 false false R24.htm 210691015 - Disclosure - Property, Plant and Equipment Sheet http://www.corteva.com/role/PropertyPlantandEquipment Property, Plant and Equipment Notes 24 false false R25.htm 210731016 - Disclosure - Goodwill and Other Intangible Assets Sheet http://www.corteva.com/role/GoodwillandOtherIntangibleAssets Goodwill and Other Intangible Assets Notes 25 false false R26.htm 210781017 - Disclosure - Leases (Notes) Notes http://www.corteva.com/role/LeasesNotes Leases (Notes) Notes 26 false false R27.htm 210871018 - Disclosure - Long-Term Debt and Available Credit Facilities Sheet http://www.corteva.com/role/LongTermDebtandAvailableCreditFacilities Long-Term Debt and Available Credit Facilities Notes 27 false false R28.htm 211011020 - Disclosure - Stockholders' Equity Sheet http://www.corteva.com/role/StockholdersEquity Stockholders' Equity Notes 28 false false R29.htm 211081021 - Disclosure - Pension Plans and Other Post Employment Benefit Plans Sheet http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlans Pension Plans and Other Post Employment Benefit Plans Notes 29 false false R30.htm 211241022 - Disclosure - Stock-Based Compensation Sheet http://www.corteva.com/role/StockBasedCompensation Stock-Based Compensation Notes 30 false false R31.htm 211301023 - Disclosure - Financial Instruments Sheet http://www.corteva.com/role/FinancialInstruments Financial Instruments Notes 31 false false R32.htm 211391024 - Disclosure - Fair Value Measurements Sheet http://www.corteva.com/role/FairValueMeasurements Fair Value Measurements Notes 32 false false R33.htm 211431025 - Disclosure - Geographic Information Sheet http://www.corteva.com/role/GeographicInformation Geographic Information Notes 33 false false R34.htm 211471026 - Disclosure - Segment Reporting (Notes) Notes http://www.corteva.com/role/SegmentReportingNotes Segment Reporting (Notes) Notes 34 false false R35.htm 211581028 - Disclosure - Subsequent Events (Notes) Notes http://www.corteva.com/role/SubsequentEventsNotes Subsequent Events (Notes) Notes 35 false false R36.htm 211601029 - Disclosure - EID Basis of Presentation (Notes) Notes http://www.corteva.com/role/EIDBasisofPresentationNotes EID Basis of Presentation (Notes) Notes 36 false false R37.htm 211621030 - Disclosure - EID Related Party (Notes) Notes http://www.corteva.com/role/EIDRelatedPartyNotes EID Related Party (Notes) Notes 37 false false R38.htm 211651031 - Disclosure - EID Income Taxes (Notes) Notes http://www.corteva.com/role/EIDIncomeTaxesNotes EID Income Taxes (Notes) Notes 38 false false R39.htm 211691032 - Disclosure - EID Segment FN (Notes) Notes http://www.corteva.com/role/EIDSegmentFNNotes EID Segment FN (Notes) Notes 39 false false R40.htm 220042001 - Disclosure - Background and Basis of Presentation (Policies) Sheet http://www.corteva.com/role/BackgroundandBasisofPresentationPolicies Background and Basis of Presentation (Policies) Policies http://www.corteva.com/role/SummaryofSignificantAccountingPolicies 40 false false R41.htm 220072002 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://www.corteva.com/role/SummaryofSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://www.corteva.com/role/SummaryofSignificantAccountingPolicies 41 false false R42.htm 220102003 - Disclosure - Recent Accounting Guidance Recent Accounting Guidance (Policies) Sheet http://www.corteva.com/role/RecentAccountingGuidanceRecentAccountingGuidancePolicies Recent Accounting Guidance Recent Accounting Guidance (Policies) Policies http://www.corteva.com/role/SummaryofSignificantAccountingPolicies 42 false false R43.htm 220232004 - Disclosure - Revenue from Contract with Customer (Policies) Sheet http://www.corteva.com/role/RevenuefromContractwithCustomerPolicies Revenue from Contract with Customer (Policies) Policies http://www.corteva.com/role/SummaryofSignificantAccountingPolicies 43 false false R44.htm 230163003 - Disclosure - Divestitures and Other Transactions (Tables) Sheet http://www.corteva.com/role/DivestituresandOtherTransactionsTables Divestitures and Other Transactions (Tables) Tables http://www.corteva.com/role/DivestituresandOtherTransactions 44 false false R45.htm 230243004 - Disclosure - Revenue (Tables) Sheet http://www.corteva.com/role/RevenueTables Revenue (Tables) Tables http://www.corteva.com/role/RevenueNotes 45 false false R46.htm 230303005 - Disclosure - Restructuring and Asset Related Charges (Tables) Sheet http://www.corteva.com/role/RestructuringandAssetRelatedChargesTables Restructuring and Asset Related Charges (Tables) Tables http://www.corteva.com/role/RestructuringandAssetRelatedCharges 46 false false R47.htm 230403006 - Disclosure - Supplementary Information (Tables) Sheet http://www.corteva.com/role/SupplementaryInformationTables Supplementary Information (Tables) Tables http://www.corteva.com/role/SupplementaryInformation 47 false false R48.htm 230463007 - Disclosure - Income Taxes (Tables) Sheet http://www.corteva.com/role/IncomeTaxesTables Income Taxes (Tables) Tables http://www.corteva.com/role/IncomeTaxes 48 false false R49.htm 230543008 - Disclosure - Earnings Per Share of Common Stock (Tables) Sheet http://www.corteva.com/role/EarningsPerShareofCommonStockTables Earnings Per Share of Common Stock (Tables) Tables http://www.corteva.com/role/EarningsPerShareofCommonStockNotes 49 false false R50.htm 230613009 - Disclosure - Accounts and Notes Receivable, Net (Tables) Notes http://www.corteva.com/role/AccountsandNotesReceivableNetTables Accounts and Notes Receivable, Net (Tables) Tables http://www.corteva.com/role/AccountsandNotesReceivableNet 50 false false R51.htm 230663010 - Disclosure - Inventories (Tables) Sheet http://www.corteva.com/role/InventoriesTables Inventories (Tables) Tables http://www.corteva.com/role/Inventories 51 false false R52.htm 230703011 - Disclosure - Property, Plant and Equipment (Tables) Sheet http://www.corteva.com/role/PropertyPlantandEquipmentTables Property, Plant and Equipment (Tables) Tables http://www.corteva.com/role/PropertyPlantandEquipment 52 false false R53.htm 230743012 - Disclosure - Goodwill and Other Intangible Assets (Tables) Sheet http://www.corteva.com/role/GoodwillandOtherIntangibleAssetsTables Goodwill and Other Intangible Assets (Tables) Tables http://www.corteva.com/role/GoodwillandOtherIntangibleAssets 53 false false R54.htm 230793013 - Disclosure - Leases (Tables) Sheet http://www.corteva.com/role/LeasesTables Leases (Tables) Tables http://www.corteva.com/role/LeasesNotes 54 false false R55.htm 230883014 - Disclosure - Long-Term Debt and Available Credit Facilities (Tables) Sheet http://www.corteva.com/role/LongTermDebtandAvailableCreditFacilitiesTables Long-Term Debt and Available Credit Facilities (Tables) Tables http://www.corteva.com/role/LongTermDebtandAvailableCreditFacilities 55 false false R56.htm 230943015 - Disclosure - Commitments and Contingent Liabilities (Tables) Sheet http://www.corteva.com/role/CommitmentsandContingentLiabilitiesTables Commitments and Contingent Liabilities (Tables) Tables 56 false false R57.htm 231023016 - Disclosure - Stockholders' Equity (Tables) Sheet http://www.corteva.com/role/StockholdersEquityTables Stockholders' Equity (Tables) Tables http://www.corteva.com/role/StockholdersEquity 57 false false R58.htm 231093017 - Disclosure - Pension Plans and Other Post Employment Benefit Plans (Tables) Sheet http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansTables Pension Plans and Other Post Employment Benefit Plans (Tables) Tables http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlans 58 false false R59.htm 231253018 - Disclosure - Stock-Based Compensation (Tables) Sheet http://www.corteva.com/role/StockBasedCompensationTables Stock-Based Compensation (Tables) Tables http://www.corteva.com/role/StockBasedCompensation 59 false false R60.htm 231313019 - Disclosure - Financial Instruments (Tables) Sheet http://www.corteva.com/role/FinancialInstrumentsTables Financial Instruments (Tables) Tables http://www.corteva.com/role/FinancialInstruments 60 false false R61.htm 231403020 - Disclosure - Fair Value Measurements (Tables) Sheet http://www.corteva.com/role/FairValueMeasurementsTables Fair Value Measurements (Tables) Tables http://www.corteva.com/role/FairValueMeasurements 61 false false R62.htm 231443021 - Disclosure - Geographic Information (Tables) Sheet http://www.corteva.com/role/GeographicInformationTables Geographic Information (Tables) Tables http://www.corteva.com/role/GeographicInformation 62 false false R63.htm 231483022 - Disclosure - Segment Reporting (Tables) Sheet http://www.corteva.com/role/SegmentReportingTables Segment Reporting (Tables) Tables http://www.corteva.com/role/SegmentReportingNotes 63 false false R64.htm 231663025 - Disclosure - EID Income Taxes (Tables) Sheet http://www.corteva.com/role/EIDIncomeTaxesTables EID Income Taxes (Tables) Tables http://www.corteva.com/role/EIDIncomeTaxesNotes 64 false false R65.htm 231703026 - Disclosure - EID Segment FN (Tables) Sheet http://www.corteva.com/role/EIDSegmentFNTables EID Segment FN (Tables) Tables http://www.corteva.com/role/EIDSegmentFNNotes 65 false false R66.htm 240024001 - Disclosure - Schedule II - Valuation and Qualifying Accounts (Details) Sheet http://www.corteva.com/role/ScheduleIIValuationandQualifyingAccountsDetails Schedule II - Valuation and Qualifying Accounts (Details) Details http://www.corteva.com/role/ScheduleIIValuationandQualifyingAccountsNotes 66 false false R67.htm 240054002 - Disclosure - Background and Basis of Presentation (Details) Sheet http://www.corteva.com/role/BackgroundandBasisofPresentationDetails Background and Basis of Presentation (Details) Details http://www.corteva.com/role/BackgroundandBasisofPresentationPolicies 67 false false R68.htm 240084003 - Disclosure - Summary of Significant Accounting Policies (Details) Sheet http://www.corteva.com/role/SummaryofSignificantAccountingPoliciesDetails Summary of Significant Accounting Policies (Details) Details http://www.corteva.com/role/SummaryofSignificantAccountingPoliciesPolicies 68 false false R69.htm 240144004 - Disclosure - Business Combinations DAS Common Control Transfer Income Statement (Details) Sheet http://www.corteva.com/role/BusinessCombinationsDASCommonControlTransferIncomeStatementDetails Business Combinations DAS Common Control Transfer Income Statement (Details) Details 69 false false R70.htm 240174005 - Disclosure - Divestitures and Other Transactions Divestitures and Other Transactions - Narrative (Details) Sheet http://www.corteva.com/role/DivestituresandOtherTransactionsDivestituresandOtherTransactionsNarrativeDetails Divestitures and Other Transactions Divestitures and Other Transactions - Narrative (Details) Details 70 false false R71.htm 240184006 - Disclosure - Divestitures and Other Transactions ECP Divestiture (Details) Sheet http://www.corteva.com/role/DivestituresandOtherTransactionsECPDivestitureDetails Divestitures and Other Transactions ECP Divestiture (Details) Details 71 false false R72.htm 240194007 - Disclosure - Divestitures and Other Transactions SP Divestiture (Details) Sheet http://www.corteva.com/role/DivestituresandOtherTransactionsSPDivestitureDetails Divestitures and Other Transactions SP Divestiture (Details) Details 72 false false R73.htm 240204008 - Disclosure - Divestitures and Other Transactions Divestitures and Other Transactions - Divested Ag Business Results of Operations (Details) Sheet http://www.corteva.com/role/DivestituresandOtherTransactionsDivestituresandOtherTransactionsDivestedAgBusinessResultsofOperationsDetails Divestitures and Other Transactions Divestitures and Other Transactions - Divested Ag Business Results of Operations (Details) Details 73 false false R74.htm 240214009 - Disclosure - Divestitures and Other Transactions Divestitures and Other Transactions - PChem Results of Operations (Details) Sheet http://www.corteva.com/role/DivestituresandOtherTransactionsDivestituresandOtherTransactionsPChemResultsofOperationsDetails Divestitures and Other Transactions Divestitures and Other Transactions - PChem Results of Operations (Details) Details 74 false false R75.htm 240254010 - Disclosure - Revenue Narrative (Details) Sheet http://www.corteva.com/role/RevenueNarrativeDetails Revenue Narrative (Details) Details 75 false false R76.htm 240264011 - Disclosure - Revenue Contract Balances (Details) Sheet http://www.corteva.com/role/RevenueContractBalancesDetails Revenue Contract Balances (Details) Details 76 false false R77.htm 240274012 - Disclosure - Revenue Disaggregation of Revenue - Products (Details) Sheet http://www.corteva.com/role/RevenueDisaggregationofRevenueProductsDetails Revenue Disaggregation of Revenue - Products (Details) Details 77 false false R78.htm 240284013 - Disclosure - Revenue Disaggregation of Revenue - Geo (Details) Sheet http://www.corteva.com/role/RevenueDisaggregationofRevenueGeoDetails Revenue Disaggregation of Revenue - Geo (Details) Details 78 false false R79.htm 240314014 - Disclosure - Restructuring and Asset Related Charges 2021 Restructuring Actions (Details) Sheet http://www.corteva.com/role/RestructuringandAssetRelatedCharges2021RestructuringActionsDetails Restructuring and Asset Related Charges 2021 Restructuring Actions (Details) Details 79 false false R80.htm 240324015 - Disclosure - Restructuring and Asset Related Charges Execute to Win Productivity Program (Details) Sheet http://www.corteva.com/role/RestructuringandAssetRelatedChargesExecutetoWinProductivityProgramDetails Restructuring and Asset Related Charges Execute to Win Productivity Program (Details) Details 80 false false R81.htm 240334016 - Disclosure - Restructuring and Asset Related Charges DowDuPont Cost Synergy Program (Details) Sheet http://www.corteva.com/role/RestructuringandAssetRelatedChargesDowDuPontCostSynergyProgramDetails Restructuring and Asset Related Charges DowDuPont Cost Synergy Program (Details) Details 81 false false R82.htm 240354018 - Disclosure - Restructuring and Asset Related Charges Asset Impairments (Details) Sheet http://www.corteva.com/role/RestructuringandAssetRelatedChargesAssetImpairmentsDetails Restructuring and Asset Related Charges Asset Impairments (Details) Details 82 false false R83.htm 240384020 - Disclosure - Related Parties Transactions with DowDuPont (Details) Sheet http://www.corteva.com/role/RelatedPartiesTransactionswithDowDuPontDetails Related Parties Transactions with DowDuPont (Details) Details 83 false false R84.htm 240414021 - Disclosure - Supplementary Information Other Income (Expense) - Net (Details) Sheet http://www.corteva.com/role/SupplementaryInformationOtherIncomeExpenseNetDetails Supplementary Information Other Income (Expense) - Net (Details) Details 84 false false R85.htm 240424022 - Disclosure - Supplementary Information Foreign Currency Exchange Gain (Loss) (Details) Sheet http://www.corteva.com/role/SupplementaryInformationForeignCurrencyExchangeGainLossDetails Supplementary Information Foreign Currency Exchange Gain (Loss) (Details) Details 85 false false R86.htm 240434023 - Disclosure - Supplementary Information Reconciliation of Cash, Cash Equivalents and Restricted Cash (Details) Sheet http://www.corteva.com/role/SupplementaryInformationReconciliationofCashCashEquivalentsandRestrictedCashDetails Supplementary Information Reconciliation of Cash, Cash Equivalents and Restricted Cash (Details) Details 86 false false R87.htm 240444024 - Disclosure - Supplementary Information Supplementary Information (Narrative) (Details) Sheet http://www.corteva.com/role/SupplementaryInformationSupplementaryInformationNarrativeDetails Supplementary Information Supplementary Information (Narrative) (Details) Details 87 false false R88.htm 240484026 - Disclosure - Income Taxes Income Taxes - Geographic Allocation of Income and Provision for Income Taxes (Details) Sheet http://www.corteva.com/role/IncomeTaxesIncomeTaxesGeographicAllocationofIncomeandProvisionforIncomeTaxesDetails Income Taxes Income Taxes - Geographic Allocation of Income and Provision for Income Taxes (Details) Details 88 false false R89.htm 240494027 - Disclosure - Income Taxes Income Taxes - Reconciliation to US Statutory Rate (Details) Sheet http://www.corteva.com/role/IncomeTaxesIncomeTaxesReconciliationtoUSStatutoryRateDetails Income Taxes Income Taxes - Reconciliation to US Statutory Rate (Details) Details 89 false false R90.htm 240504028 - Disclosure - Income Taxes Income Taxes - Deferred Tax Balances (Details) Sheet http://www.corteva.com/role/IncomeTaxesIncomeTaxesDeferredTaxBalancesDetails Income Taxes Income Taxes - Deferred Tax Balances (Details) Details 90 false false R91.htm 240514029 - Disclosure - Income Taxes Income Taxes - Operating Loss and Tax Credit Carryforwards (Details) Sheet http://www.corteva.com/role/IncomeTaxesIncomeTaxesOperatingLossandTaxCreditCarryforwardsDetails Income Taxes Income Taxes - Operating Loss and Tax Credit Carryforwards (Details) Details 91 false false R92.htm 240524030 - Disclosure - Income Taxes Income Taxes - Gross Unrecognized Tax Benefits (Details) Sheet http://www.corteva.com/role/IncomeTaxesIncomeTaxesGrossUnrecognizedTaxBenefitsDetails Income Taxes Income Taxes - Gross Unrecognized Tax Benefits (Details) Details 92 false false R93.htm 240554031 - Disclosure - Earnings Per Share Narrative (Details) Sheet http://www.corteva.com/role/EarningsPerShareNarrativeDetails Earnings Per Share Narrative (Details) Details 93 false false R94.htm 240564032 - Disclosure - Earnings Per Share Net Income for Earnings Per Share Calculations - Basic and Diluted (Details) Sheet http://www.corteva.com/role/EarningsPerShareNetIncomeforEarningsPerShareCalculationsBasicandDilutedDetails Earnings Per Share Net Income for Earnings Per Share Calculations - Basic and Diluted (Details) Details 94 false false R95.htm 240574033 - Disclosure - Earnings Per Share of Common Stock EPS Calculation - Basic (Details) Sheet http://www.corteva.com/role/EarningsPerShareofCommonStockEPSCalculationBasicDetails Earnings Per Share of Common Stock EPS Calculation - Basic (Details) Details 95 false false R96.htm 240584034 - Disclosure - Earnings Per Share of Common Stock EPS Calculation - Diluted (Details) Sheet http://www.corteva.com/role/EarningsPerShareofCommonStockEPSCalculationDilutedDetails Earnings Per Share of Common Stock EPS Calculation - Diluted (Details) Details 96 false false R97.htm 240594035 - Disclosure - Earnings Per Share Share Count Information (Details) Sheet http://www.corteva.com/role/EarningsPerShareShareCountInformationDetails Earnings Per Share Share Count Information (Details) Details 97 false false R98.htm 240624036 - Disclosure - Accounts and Notes Receivable, Net (Schedule of Accounts and Notes Receivable, Net) (Details) Notes http://www.corteva.com/role/AccountsandNotesReceivableNetScheduleofAccountsandNotesReceivableNetDetails Accounts and Notes Receivable, Net (Schedule of Accounts and Notes Receivable, Net) (Details) Details http://www.corteva.com/role/AccountsandNotesReceivableNetTables 98 false false R99.htm 240634037 - Disclosure - Accounts and Notes Receivable Allowance Rollforward (Details) Notes http://www.corteva.com/role/AccountsandNotesReceivableAllowanceRollforwardDetails Accounts and Notes Receivable Allowance Rollforward (Details) Details 99 false false R100.htm 240644038 - Disclosure - Accounts and Notes Receivable, Net Customer Financing (Details) Notes http://www.corteva.com/role/AccountsandNotesReceivableNetCustomerFinancingDetails Accounts and Notes Receivable, Net Customer Financing (Details) Details 100 false false R101.htm 240674039 - Disclosure - Inventories Schedule of Inventory (Details) Sheet http://www.corteva.com/role/InventoriesScheduleofInventoryDetails Inventories Schedule of Inventory (Details) Details 101 false false R102.htm 240714041 - Disclosure - Property, Plant and Equipment Schedule of Property, Plant and Equipment (Details) Sheet http://www.corteva.com/role/PropertyPlantandEquipmentScheduleofPropertyPlantandEquipmentDetails Property, Plant and Equipment Schedule of Property, Plant and Equipment (Details) Details 102 false false R103.htm 240724042 - Disclosure - Property, Plant and Equipment Schedule of Depreciation (Details) Sheet http://www.corteva.com/role/PropertyPlantandEquipmentScheduleofDepreciationDetails Property, Plant and Equipment Schedule of Depreciation (Details) Details 103 false false R104.htm 240754043 - Disclosure - Goodwill and Other Intangible Assets Goodwill by Segment (Details) Sheet http://www.corteva.com/role/GoodwillandOtherIntangibleAssetsGoodwillbySegmentDetails Goodwill and Other Intangible Assets Goodwill by Segment (Details) Details 104 false false R105.htm 240764044 - Disclosure - Goodwill and Other Intangible Assets Other Intangible Assets (Details) Sheet http://www.corteva.com/role/GoodwillandOtherIntangibleAssetsOtherIntangibleAssetsDetails Goodwill and Other Intangible Assets Other Intangible Assets (Details) Details 105 false false R106.htm 240774045 - Disclosure - Goodwill and Other Intangible Assets Amortization Expense (Details) Sheet http://www.corteva.com/role/GoodwillandOtherIntangibleAssetsAmortizationExpenseDetails Goodwill and Other Intangible Assets Amortization Expense (Details) Details 106 false false R107.htm 240804046 - Disclosure - Leases Narrative (Details) Sheet http://www.corteva.com/role/LeasesNarrativeDetails Leases Narrative (Details) Details 107 false false R108.htm 240814047 - Disclosure - Leases Lease Costs (Details) Sheet http://www.corteva.com/role/LeasesLeaseCostsDetails Leases Lease Costs (Details) Details 108 false false R109.htm 240824048 - Disclosure - Leases Supplemental Cash Flow Information (Details) Sheet http://www.corteva.com/role/LeasesSupplementalCashFlowInformationDetails Leases Supplemental Cash Flow Information (Details) Details 109 false false R110.htm 240834049 - Disclosure - Leases Supplemental Balance Sheet Information (Details) Sheet http://www.corteva.com/role/LeasesSupplementalBalanceSheetInformationDetails Leases Supplemental Balance Sheet Information (Details) Details 110 false false R111.htm 240844050 - Disclosure - Leases Lease Term and Discount Rate (Details) Sheet http://www.corteva.com/role/LeasesLeaseTermandDiscountRateDetails Leases Lease Term and Discount Rate (Details) Details 111 false false R112.htm 240854051 - Disclosure - Leases Maturity of Lease Liabilities (Details) Sheet http://www.corteva.com/role/LeasesMaturityofLeaseLiabilitiesDetails Leases Maturity of Lease Liabilities (Details) Details 112 false false R113.htm 240894053 - Disclosure - Long-Term Debt and Available Credit Facilities Long Term Debt (Details) Sheet http://www.corteva.com/role/LongTermDebtandAvailableCreditFacilitiesLongTermDebtDetails Long-Term Debt and Available Credit Facilities Long Term Debt (Details) Details 113 false false R114.htm 240904054 - Disclosure - Long-Term Debt and Available Credit Facilities Available Committed Credit Facilities (Narrative) (Details) Sheet http://www.corteva.com/role/LongTermDebtandAvailableCreditFacilitiesAvailableCommittedCreditFacilitiesNarrativeDetails Long-Term Debt and Available Credit Facilities Available Committed Credit Facilities (Narrative) (Details) Details 114 false false R115.htm 240914055 - Disclosure - Long-Term Debt and Available Credit Facilities Debt Redemptions/Repayments (Details) Sheet http://www.corteva.com/role/LongTermDebtandAvailableCreditFacilitiesDebtRedemptionsRepaymentsDetails Long-Term Debt and Available Credit Facilities Debt Redemptions/Repayments (Details) Details 115 false false R116.htm 240924056 - Disclosure - Long-Term Debt and Available Credit Facilities Uncommitted Credit Facilities and Outstanding Letters of Credit (Details) Sheet http://www.corteva.com/role/LongTermDebtandAvailableCreditFacilitiesUncommittedCreditFacilitiesandOutstandingLettersofCreditDetails Long-Term Debt and Available Credit Facilities Uncommitted Credit Facilities and Outstanding Letters of Credit (Details) Details 116 false false R117.htm 240954057 - Disclosure - Commitments and Contingent Liabilities Guarantee Narrative (Details) Sheet http://www.corteva.com/role/CommitmentsandContingentLiabilitiesGuaranteeNarrativeDetails Commitments and Contingent Liabilities Guarantee Narrative (Details) Details 117 false false R118.htm 240964058 - Disclosure - Commitments and Contingent Liabilities Litigation - Chemours (Details) Sheet http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationChemoursDetails Commitments and Contingent Liabilities Litigation - Chemours (Details) Details 118 false false R119.htm 240974059 - Disclosure - Commitments and Contingent Liabilities Litigation - DuPont (Details) Sheet http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationDuPontDetails Commitments and Contingent Liabilities Litigation - DuPont (Details) Details 119 false false R120.htm 240984060 - Disclosure - Commitments and Contingent Liabilities Litigation - Leach and MDL Settlement (Details) Sheet http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationLeachandMDLSettlementDetails Commitments and Contingent Liabilities Litigation - Leach and MDL Settlement (Details) Details 120 false false R121.htm 240994061 - Disclosure - Commitments and Contingent Liabilities Litigation - Other PFOA Matters / Fayatteville (Details) Sheet http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationOtherPFOAMattersFayattevilleDetails Commitments and Contingent Liabilities Litigation - Other PFOA Matters / Fayatteville (Details) Details 121 false false R122.htm 241004062 - Disclosure - Commitments and Contingent Liabilities Environmental (Details) Sheet http://www.corteva.com/role/CommitmentsandContingentLiabilitiesEnvironmentalDetails Commitments and Contingent Liabilities Environmental (Details) Details 122 false false R123.htm 241034063 - Disclosure - Stockholders' Equity Common Stock (Details) Sheet http://www.corteva.com/role/StockholdersEquityCommonStockDetails Stockholders' Equity Common Stock (Details) Details 123 false false R124.htm 241044064 - Disclosure - Stockholders' Equity Noncontrolling Interest (Details) Sheet http://www.corteva.com/role/StockholdersEquityNoncontrollingInterestDetails Stockholders' Equity Noncontrolling Interest (Details) Details 124 false false R125.htm 241054065 - Disclosure - Stockholders' Equity Other Comprehensive Income (Loss) (Details) Sheet http://www.corteva.com/role/StockholdersEquityOtherComprehensiveIncomeLossDetails Stockholders' Equity Other Comprehensive Income (Loss) (Details) Details 125 false false R126.htm 241064066 - Disclosure - Stockholders' Equity Tax Benefit (Expense) on Net Activity (Details) Sheet http://www.corteva.com/role/StockholdersEquityTaxBenefitExpenseonNetActivityDetails Stockholders' Equity Tax Benefit (Expense) on Net Activity (Details) Details 126 false false R127.htm 241074067 - Disclosure - Stockholders' Equity Reclassifications out of AOCI (Details) Sheet http://www.corteva.com/role/StockholdersEquityReclassificationsoutofAOCIDetails Stockholders' Equity Reclassifications out of AOCI (Details) Details 127 false false R128.htm 241104068 - Disclosure - Pension Plans and Other Post Employment Benefit Plans Additional Information (Details) Sheet http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansAdditionalInformationDetails Pension Plans and Other Post Employment Benefit Plans Additional Information (Details) Details 128 false false R129.htm 241114069 - Disclosure - Pension Plans and Other Post Employment Benefit Plans Weighted Average Assumptions used to Determine Benefit Obligations - Pension (Details) Sheet http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansWeightedAverageAssumptionsusedtoDetermineBenefitObligationsPensionDetails Pension Plans and Other Post Employment Benefit Plans Weighted Average Assumptions used to Determine Benefit Obligations - Pension (Details) Details 129 false false R130.htm 241124070 - Disclosure - Pension Plans and Other Post Employment Benefit Plans Weighted Average Assumptions used to Determine Net Periodic Benefit Cost - Pension (Details) Sheet http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansWeightedAverageAssumptionsusedtoDetermineNetPeriodicBenefitCostPensionDetails Pension Plans and Other Post Employment Benefit Plans Weighted Average Assumptions used to Determine Net Periodic Benefit Cost - Pension (Details) Details 130 false false R131.htm 241134071 - Disclosure - Pension Plans and Other Post Employment Benefit Plans Weighted Average Assumptions used to Determine Benefit Obligations and Periodic Benefit Cost - OPEB (Details) Sheet http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansWeightedAverageAssumptionsusedtoDetermineBenefitObligationsandPeriodicBenefitCostOPEBDetails Pension Plans and Other Post Employment Benefit Plans Weighted Average Assumptions used to Determine Benefit Obligations and Periodic Benefit Cost - OPEB (Details) Details 131 false false R132.htm 241154073 - Disclosure - Pension Plans and Other Post Employment Benefit Plans Change in Projected Benefit Obligations, Plan Assets and Funded Status (Details) Sheet http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansChangeinProjectedBenefitObligationsPlanAssetsandFundedStatusDetails Pension Plans and Other Post Employment Benefit Plans Change in Projected Benefit Obligations, Plan Assets and Funded Status (Details) Details 132 false false R133.htm 241164074 - Disclosure - Pension Plans and Other Post Employment Benefit Plans Amounts Recognized in Consolidated Balance Sheets (Details) Sheet http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansAmountsRecognizedinConsolidatedBalanceSheetsDetails Pension Plans and Other Post Employment Benefit Plans Amounts Recognized in Consolidated Balance Sheets (Details) Details 133 false false R134.htm 241174075 - Disclosure - Pension Plans and Other Post Employment Benefit Plans Pension Plans with Projected Benefit Obligations in Excess of Plan Assets (Details) Sheet http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansPensionPlanswithProjectedBenefitObligationsinExcessofPlanAssetsDetails Pension Plans and Other Post Employment Benefit Plans Pension Plans with Projected Benefit Obligations in Excess of Plan Assets (Details) Details 134 false false R135.htm 241184076 - Disclosure - Pension Plans and Other Post Employment Benefit Plans Pension Plans with Accumulated Benefit Obligations in Excess of Plan Assets (Details) Sheet http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansPensionPlanswithAccumulatedBenefitObligationsinExcessofPlanAssetsDetails Pension Plans and Other Post Employment Benefit Plans Pension Plans with Accumulated Benefit Obligations in Excess of Plan Assets (Details) Details 135 false false R136.htm 241194077 - Disclosure - Pension Plans and Other Post Employment Benefit Plans Components of net periodic benefit cost (credit) and amounts recognized in other comprehensive loss (Details) Sheet http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansComponentsofnetperiodicbenefitcostcreditandamountsrecognizedinothercomprehensivelossDetails Pension Plans and Other Post Employment Benefit Plans Components of net periodic benefit cost (credit) and amounts recognized in other comprehensive loss (Details) Details 136 false false R137.htm 241204078 - Disclosure - Pension Plans and Other Post Employment Benefit Plans Estimated Future Benefit Payments (Details) Sheet http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansEstimatedFutureBenefitPaymentsDetails Pension Plans and Other Post Employment Benefit Plans Estimated Future Benefit Payments (Details) Details 137 false false R138.htm 241214079 - Disclosure - Pension Plans and Other Post Employment Benefit Plans Target Allocation for Plan Assets (Details) Sheet http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansTargetAllocationforPlanAssetsDetails Pension Plans and Other Post Employment Benefit Plans Target Allocation for Plan Assets (Details) Details 138 false false R139.htm 241224080 - Disclosure - Pension Plans and Other Post Employment Benefit Plans Basis of Fair Value Measurement (Details) Sheet http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansBasisofFairValueMeasurementDetails Pension Plans and Other Post Employment Benefit Plans Basis of Fair Value Measurement (Details) Details 139 false false R140.htm 241234081 - Disclosure - Pension Plans and Other Post Employment Benefit Plans Summary of Fair Value Measurement of Level 3 Pension Plan Assets (Details) Sheet http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansSummaryofFairValueMeasurementofLevel3PensionPlanAssetsDetails Pension Plans and Other Post Employment Benefit Plans Summary of Fair Value Measurement of Level 3 Pension Plan Assets (Details) Details 140 false false R141.htm 241264082 - Disclosure - Stock-Based Compensation Stock Compensation (Details) Sheet http://www.corteva.com/role/StockBasedCompensationStockCompensationDetails Stock-Based Compensation Stock Compensation (Details) Details 141 false false R142.htm 241274083 - Disclosure - Stock-Based Compensation Weighted Average Assumptions - Stock Options (Details) Sheet http://www.corteva.com/role/StockBasedCompensationWeightedAverageAssumptionsStockOptionsDetails Stock-Based Compensation Weighted Average Assumptions - Stock Options (Details) Details 142 false false R143.htm 241284084 - Disclosure - Stock-Based Compensation Stock Options (Details) Sheet http://www.corteva.com/role/StockBasedCompensationStockOptionsDetails Stock-Based Compensation Stock Options (Details) Details 143 false false R144.htm 241294085 - Disclosure - Stock-Based Compensation Restricted Stock Units and Performance Deferred Stock (Details) Sheet http://www.corteva.com/role/StockBasedCompensationRestrictedStockUnitsandPerformanceDeferredStockDetails Stock-Based Compensation Restricted Stock Units and Performance Deferred Stock (Details) Details 144 false false R145.htm 241324086 - Disclosure - Financial Instruments Financial Instruments (Narrative) (Details) Sheet http://www.corteva.com/role/FinancialInstrumentsFinancialInstrumentsNarrativeDetails Financial Instruments Financial Instruments (Narrative) (Details) Details 145 false false R146.htm 241334087 - Disclosure - Financial Instruments Notional Amounts (Details) Sheet http://www.corteva.com/role/FinancialInstrumentsNotionalAmountsDetails Financial Instruments Notional Amounts (Details) Details 146 false false R147.htm 241344088 - Disclosure - Financial Instruments Cash Flow Hedges Included in AOCI (Details) Sheet http://www.corteva.com/role/FinancialInstrumentsCashFlowHedgesIncludedinAOCIDetails Financial Instruments Cash Flow Hedges Included in AOCI (Details) Details 147 false false R148.htm 241354089 - Disclosure - Financial Instruments Fair Value of Derivatives (Details) Sheet http://www.corteva.com/role/FinancialInstrumentsFairValueofDerivativesDetails Financial Instruments Fair Value of Derivatives (Details) Details 148 false false R149.htm 241364090 - Disclosure - Financial Instruments Effect of Derivative Instruments (Details) Sheet http://www.corteva.com/role/FinancialInstrumentsEffectofDerivativeInstrumentsDetails Financial Instruments Effect of Derivative Instruments (Details) Details 149 false false R150.htm 241374091 - Disclosure - Financial Instruments Debt Securities (Details) Sheet http://www.corteva.com/role/FinancialInstrumentsDebtSecuritiesDetails Financial Instruments Debt Securities (Details) Details 150 false false R151.htm 241414093 - Disclosure - Fair Value Measurements Fair Value Measurement Recurring Basis (Details) Sheet http://www.corteva.com/role/FairValueMeasurementsFairValueMeasurementRecurringBasisDetails Fair Value Measurements Fair Value Measurement Recurring Basis (Details) Details 151 false false R152.htm 241424094 - Disclosure - Fair Value Measurements Fair Value Measurement Nonrecurring Basis (Details) Sheet http://www.corteva.com/role/FairValueMeasurementsFairValueMeasurementNonrecurringBasisDetails Fair Value Measurements Fair Value Measurement Nonrecurring Basis (Details) Details 152 false false R153.htm 241454095 - Disclosure - Geographic Information Revenue by Country (Details) Sheet http://www.corteva.com/role/GeographicInformationRevenuebyCountryDetails Geographic Information Revenue by Country (Details) Details 153 false false R154.htm 241464096 - Disclosure - Geographic Information Net Property by Country (Details) Sheet http://www.corteva.com/role/GeographicInformationNetPropertybyCountryDetails Geographic Information Net Property by Country (Details) Details 154 false false R155.htm 241494097 - Disclosure - Segment Reporting Segment Information (Details) Sheet http://www.corteva.com/role/SegmentReportingSegmentInformationDetails Segment Reporting Segment Information (Details) Details 155 false false R156.htm 241504098 - Disclosure - Segment Reporting Segment Reconciliation (Details) Sheet http://www.corteva.com/role/SegmentReportingSegmentReconciliationDetails Segment Reporting Segment Reconciliation (Details) Details 156 false false R157.htm 241514099 - Disclosure - Segment Reporting Segment Assets (Details) Sheet http://www.corteva.com/role/SegmentReportingSegmentAssetsDetails Segment Reporting Segment Assets (Details) Details 157 false false R158.htm 241524100 - Disclosure - Segment Reporting Other Items (Details) Sheet http://www.corteva.com/role/SegmentReportingOtherItemsDetails Segment Reporting Other Items (Details) Details 158 false false R159.htm 241534101 - Disclosure - Segment Reporting Sig Items (Details) Sheet http://www.corteva.com/role/SegmentReportingSigItemsDetails Segment Reporting Sig Items (Details) Details 159 false false R160.htm 241564102 - Disclosure - Quaterly Financial Data Quarterly Financial Data (Details) Sheet http://www.corteva.com/role/QuaterlyFinancialDataQuarterlyFinancialDataDetails Quaterly Financial Data Quarterly Financial Data (Details) Details 160 false false R161.htm 241574103 - Disclosure - Quaterly Financial Data Quarterly Financial Data (Parentheticals) (Details) Sheet http://www.corteva.com/role/QuaterlyFinancialDataQuarterlyFinancialDataParentheticalsDetails Quaterly Financial Data Quarterly Financial Data (Parentheticals) (Details) Details 161 false false R162.htm 241594104 - Disclosure - Subsequent Events (Details) Sheet http://www.corteva.com/role/SubsequentEventsDetails Subsequent Events (Details) Details http://www.corteva.com/role/SubsequentEventsNotes 162 false false R163.htm 241614105 - Disclosure - EID Basis of Presentation (Details) Sheet http://www.corteva.com/role/EIDBasisofPresentationDetails EID Basis of Presentation (Details) Details http://www.corteva.com/role/EIDBasisofPresentationNotes 163 false false R164.htm 241644106 - Disclosure - EID Related Party (Details) Sheet http://www.corteva.com/role/EIDRelatedPartyDetails EID Related Party (Details) Details http://www.corteva.com/role/EIDRelatedPartyNotes 164 false false R165.htm 241674107 - Disclosure - EID Income Taxes Geographic Allocation (Details) Sheet http://www.corteva.com/role/EIDIncomeTaxesGeographicAllocationDetails EID Income Taxes Geographic Allocation (Details) Details 165 false false R166.htm 241684108 - Disclosure - EID Income Taxes Rate Reconciliation (Details) Sheet http://www.corteva.com/role/EIDIncomeTaxesRateReconciliationDetails EID Income Taxes Rate Reconciliation (Details) Details 166 false false R167.htm 241714109 - Disclosure - EID Segment FN Segment Reconciliation (Details) Sheet http://www.corteva.com/role/EIDSegmentFNSegmentReconciliationDetails EID Segment FN Segment Reconciliation (Details) Details 167 false false R168.htm 241724110 - Disclosure - EID Segment FN Segment Asset Reconciliation (Details) Sheet http://www.corteva.com/role/EIDSegmentFNSegmentAssetReconciliationDetails EID Segment FN Segment Asset Reconciliation (Details) Details 168 false false R169.htm 241754111 - Disclosure - EID Quarterly FN (Details) Sheet http://www.corteva.com/role/EIDQuarterlyFNDetails EID Quarterly FN (Details) Details 169 false false All Reports Book All Reports ctva-20211231.htm ctva-12312021xex21.htm ctva-12312021xex231.htm ctva-12312021xex232.htm ctva-12312021xex311.htm ctva-12312021xex312.htm ctva-12312021xex321.htm ctva-12312021xex322.htm ctva-20211231.xsd ctva-20211231_cal.xml ctva-20211231_def.xml ctva-20211231_lab.xml ctva-20211231_pre.xml ctva-20211231_g1.jpg ctva-20211231_g2.jpg ctva-20211231_g3.jpg ctva-20211231_g4.jpg ctva-20211231_g5.gif ctva-20211231_g6.jpg ctva-20211231_g7.jpg http://fasb.org/srt/2021-01-31 http://fasb.org/us-gaap/2021-01-31 http://xbrl.sec.gov/dei/2021q4 true true JSON 197 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "ctva-20211231.htm": { "axisCustom": 8, "axisStandard": 52, "contextCount": 915, "dts": { "calculationLink": { "local": [ "ctva-20211231_cal.xml" ] }, "definitionLink": { "local": [ "ctva-20211231_def.xml" ] }, "inline": { "local": [ "ctva-20211231.htm" ] }, "labelLink": { "local": [ "ctva-20211231_lab.xml" ] }, "presentationLink": { "local": [ "ctva-20211231_pre.xml" ] }, "schema": { "local": [ "ctva-20211231.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd", "https://xbrl.sec.gov/country/2021/country-2021.xsd", "https://xbrl.sec.gov/currency/2021/currency-2021.xsd", "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd", "https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd" ] } }, "elementCount": 1412, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2021-01-31": 55, "http://www.corteva.com/20211231": 1, "http://xbrl.sec.gov/dei/2021q4": 29, "total": 85 }, "keyCustom": 131, "keyStandard": 666, "memberCustom": 119, "memberStandard": 98, "nsprefix": "ctva", "nsuri": "http://www.corteva.com/20211231", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentAnnualReport", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "000010001 - Document - DEI Document", "role": "http://www.corteva.com/role/DEIDocument", "shortName": "DEI Document", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentAnnualReport", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "210011001 - Disclosure - Schedule II - Valuation and Qualifying Accounts (Notes)", "role": "http://www.corteva.com/role/ScheduleIIValuationandQualifyingAccountsNotes", "shortName": "Schedule II - Valuation and Qualifying Accounts (Notes)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R100": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "ic028d8729d8d41afa48e665b448706d0_D20210101-20211231", "decimals": "-6", "first": true, "lang": "en-US", "name": "ctva:TradeReceivablesSold", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240644038 - Disclosure - Accounts and Notes Receivable, Net Customer Financing (Details)", "role": "http://www.corteva.com/role/AccountsandNotesReceivableNetCustomerFinancingDetails", "shortName": "Accounts and Notes Receivable, Net Customer Financing (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "ic028d8729d8d41afa48e665b448706d0_D20210101-20211231", "decimals": "-6", "first": true, "lang": "en-US", "name": "ctva:TradeReceivablesSold", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R101": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "id110b8058ec54269a2cb77f3badc9bac_I20211231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:InventoryFinishedGoods", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240674039 - Disclosure - Inventories Schedule of Inventory (Details)", "role": "http://www.corteva.com/role/InventoriesScheduleofInventoryDetails", "shortName": "Inventories Schedule of Inventory (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "id110b8058ec54269a2cb77f3badc9bac_I20211231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:InventoryFinishedGoods", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R102": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "id110b8058ec54269a2cb77f3badc9bac_I20211231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240714041 - Disclosure - Property, Plant and Equipment Schedule of Property, Plant and Equipment (Details)", "role": "http://www.corteva.com/role/PropertyPlantandEquipmentScheduleofPropertyPlantandEquipmentDetails", "shortName": "Property, Plant and Equipment Schedule of Property, Plant and Equipment (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "i4a938e204f244e028f82607272d519a8_I20211231", "decimals": "-6", "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R103": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ctva:PropertyPlantandEquipmentDepreciationExpenseTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:Depreciation", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240724042 - Disclosure - Property, Plant and Equipment Schedule of Depreciation (Details)", "role": "http://www.corteva.com/role/PropertyPlantandEquipmentScheduleofDepreciationDetails", "shortName": "Property, Plant and Equipment Schedule of Depreciation (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ctva:PropertyPlantandEquipmentDepreciationExpenseTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:Depreciation", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R104": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "ic3c0434c1aad407886edd72701605d70_I20201231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:Goodwill", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240754043 - Disclosure - Goodwill and Other Intangible Assets Goodwill by Segment (Details)", "role": "http://www.corteva.com/role/GoodwillandOtherIntangibleAssetsGoodwillbySegmentDetails", "shortName": "Goodwill and Other Intangible Assets Goodwill by Segment (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfGoodwillTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": "-6", "lang": "en-US", "name": "us-gaap:GoodwillForeignCurrencyTranslationGainLoss", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R105": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ctva:ScheduleofFiniteandIndefiniteLivedIntangibleAssetsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "id110b8058ec54269a2cb77f3badc9bac_I20211231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240764044 - Disclosure - Goodwill and Other Intangible Assets Other Intangible Assets (Details)", "role": "http://www.corteva.com/role/GoodwillandOtherIntangibleAssetsOtherIntangibleAssetsDetails", "shortName": "Goodwill and Other Intangible Assets Other Intangible Assets (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ctva:ScheduleofFiniteandIndefiniteLivedIntangibleAssetsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "id110b8058ec54269a2cb77f3badc9bac_I20211231", "decimals": "-6", "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R106": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:AmortizationOfIntangibleAssets", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240774045 - Disclosure - Goodwill and Other Intangible Assets Amortization Expense (Details)", "role": "http://www.corteva.com/role/GoodwillandOtherIntangibleAssetsAmortizationExpenseDetails", "shortName": "Goodwill and Other Intangible Assets Amortization Expense (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "ib050239d4a8a4e1bb383637ae1470e58_I20211231", "decimals": "-6", "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R107": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "id110b8058ec54269a2cb77f3badc9bac_I20211231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:GuaranteeObligationsMaximumExposure", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240804046 - Disclosure - Leases Narrative (Details)", "role": "http://www.corteva.com/role/LeasesNarrativeDetails", "shortName": "Leases Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "i40ced341ea0b4bd3a271590f77eac3df_I20211231", "decimals": "-6", "lang": "en-US", "name": "us-gaap:GuaranteeObligationsMaximumExposure", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R108": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:LeaseCostTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeaseCost", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240814047 - Disclosure - Leases Lease Costs (Details)", "role": "http://www.corteva.com/role/LeasesLeaseCostsDetails", "shortName": "Leases Lease Costs (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:LeaseCostTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeaseCost", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R109": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ctva:ScheduleofSupplementalCashFlowInformationRelatedtoLeasesTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeasePayments", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240824048 - Disclosure - Leases Supplemental Cash Flow Information (Details)", "role": "http://www.corteva.com/role/LeasesSupplementalCashFlowInformationDetails", "shortName": "Leases Supplemental Cash Flow Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ctva:ScheduleofSupplementalCashFlowInformationRelatedtoLeasesTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeasePayments", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "210031002 - Disclosure - Background and Basis of Presentation (Notes)", "role": "http://www.corteva.com/role/BackgroundandBasisofPresentationNotes", "shortName": "Background and Basis of Presentation (Notes)", "subGroupType": "", "uniqueAnchor": null }, "R110": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ctva:ScheduleofLeaseAssetsandLiabilitiesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "id110b8058ec54269a2cb77f3badc9bac_I20211231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeaseRightOfUseAsset", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240834049 - Disclosure - Leases Supplemental Balance Sheet Information (Details)", "role": "http://www.corteva.com/role/LeasesSupplementalBalanceSheetInformationDetails", "shortName": "Leases Supplemental Balance Sheet Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ctva:ScheduleofLeaseAssetsandLiabilitiesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "id110b8058ec54269a2cb77f3badc9bac_I20211231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeaseRightOfUseAsset", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R111": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ctva:LeaseTermandDiscountRateTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "id110b8058ec54269a2cb77f3badc9bac_I20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240844050 - Disclosure - Leases Lease Term and Discount Rate (Details)", "role": "http://www.corteva.com/role/LeasesLeaseTermandDiscountRateDetails", "shortName": "Leases Lease Term and Discount Rate (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ctva:LeaseTermandDiscountRateTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "id110b8058ec54269a2cb77f3badc9bac_I20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R112": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ctva:MaturitiesofLeaseLiabilitiesTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "id110b8058ec54269a2cb77f3badc9bac_I20211231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240854051 - Disclosure - Leases Maturity of Lease Liabilities (Details)", "role": "http://www.corteva.com/role/LeasesMaturityofLeaseLiabilitiesDetails", "shortName": "Leases Maturity of Lease Liabilities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ctva:MaturitiesofLeaseLiabilitiesTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "id110b8058ec54269a2cb77f3badc9bac_I20211231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R113": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "id065316d8e424564a2a9c6c77eb7384d_I20190322", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:DebtInstrumentCarryingAmount", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240894053 - Disclosure - Long-Term Debt and Available Credit Facilities Long Term Debt (Details)", "role": "http://www.corteva.com/role/LongTermDebtandAvailableCreditFacilitiesLongTermDebtDetails", "shortName": "Long-Term Debt and Available Credit Facilities Long Term Debt (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "id110b8058ec54269a2cb77f3badc9bac_I20211231", "decimals": "-6", "lang": "en-US", "name": "us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R114": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "id110b8058ec54269a2cb77f3badc9bac_I20211231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240904054 - Disclosure - Long-Term Debt and Available Credit Facilities Available Committed Credit Facilities (Narrative) (Details)", "role": "http://www.corteva.com/role/LongTermDebtandAvailableCreditFacilitiesAvailableCommittedCreditFacilitiesNarrativeDetails", "shortName": "Long-Term Debt and Available Credit Facilities Available Committed Credit Facilities (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "id110b8058ec54269a2cb77f3badc9bac_I20211231", "decimals": "-6", "lang": "en-US", "name": "us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R115": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "id065316d8e424564a2a9c6c77eb7384d_I20190322", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:DebtInstrumentCarryingAmount", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240914055 - Disclosure - Long-Term Debt and Available Credit Facilities Debt Redemptions/Repayments (Details)", "role": "http://www.corteva.com/role/LongTermDebtandAvailableCreditFacilitiesDebtRedemptionsRepaymentsDetails", "shortName": "Long-Term Debt and Available Credit Facilities Debt Redemptions/Repayments (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "i3d70c55caa594bf7aa2655af2f3670c1_D20190502-20190502", "decimals": "-8", "lang": "en-US", "name": "ctva:RepaymentsofLongtermDebtincludingbreakagefeesandallapplicableaccruedandunpaidinterest", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R116": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "id110b8058ec54269a2cb77f3badc9bac_I20211231", "decimals": "-6", "first": true, "lang": "en-US", "name": "ctva:LineOfCreditFacilityRemainingBorrowingCapacityUncommittedAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240924056 - Disclosure - Long-Term Debt and Available Credit Facilities Uncommitted Credit Facilities and Outstanding Letters of Credit (Details)", "role": "http://www.corteva.com/role/LongTermDebtandAvailableCreditFacilitiesUncommittedCreditFacilitiesandOutstandingLettersofCreditDetails", "shortName": "Long-Term Debt and Available Credit Facilities Uncommitted Credit Facilities and Outstanding Letters of Credit (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "id110b8058ec54269a2cb77f3badc9bac_I20211231", "decimals": "-6", "first": true, "lang": "en-US", "name": "ctva:LineOfCreditFacilityRemainingBorrowingCapacityUncommittedAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R117": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "id110b8058ec54269a2cb77f3badc9bac_I20211231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:GuaranteeObligationsMaximumExposure", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240954057 - Disclosure - Commitments and Contingent Liabilities Guarantee Narrative (Details)", "role": "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesGuaranteeNarrativeDetails", "shortName": "Commitments and Contingent Liabilities Guarantee Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "i6c63b3873bee49e69c6a46e333aa2f87_I20211231", "decimals": "-6", "lang": "en-US", "name": "us-gaap:GuaranteeObligationsMaximumExposure", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R118": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "i57288b9305f84a6e9284abc38de36130_D20210101-20211231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240964058 - Disclosure - Commitments and Contingent Liabilities Litigation - Chemours (Details)", "role": "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationChemoursDetails", "shortName": "Commitments and Contingent Liabilities Litigation - Chemours (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "i8e60cba9f75a4bde8708cf13dfc01f40_I20281231", "decimals": "-6", "lang": "en-US", "name": "ctva:EscrowAccountBalance", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R119": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "ia80b9212c7a7457ea32c4112cffea2c4_I20211231", "decimals": "0", "first": true, "lang": "en-US", "name": "ctva:CortevaAndDupontStrayLiabilityThresholdForPFAS", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240974059 - Disclosure - Commitments and Contingent Liabilities Litigation - DuPont (Details)", "role": "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationDuPontDetails", "shortName": "Commitments and Contingent Liabilities Litigation - DuPont (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R12": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "210061003 - Disclosure - Summary of Significant Accounting Policies", "role": "http://www.corteva.com/role/SummaryofSignificantAccountingPolicies", "shortName": "Summary of Significant Accounting Policies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R120": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "idd238bc374724acb848e44bb4528fc19_D20040101-20041231", "decimals": "0", "first": true, "lang": "en-US", "name": "ctva:BindingSettlementAgreementClassSize", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240984060 - Disclosure - Commitments and Contingent Liabilities Litigation - Leach and MDL Settlement (Details)", "role": "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationLeachandMDLSettlementDetails", "shortName": "Commitments and Contingent Liabilities Litigation - Leach and MDL Settlement (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "idd238bc374724acb848e44bb4528fc19_D20040101-20041231", "decimals": "0", "first": true, "lang": "en-US", "name": "ctva:BindingSettlementAgreementClassSize", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R121": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "i472456b06ead42b28f13615586b59c3a_D20210101-20211231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240994061 - Disclosure - Commitments and Contingent Liabilities Litigation - Other PFOA Matters / Fayatteville (Details)", "role": "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationOtherPFOAMattersFayattevilleDetails", "shortName": "Commitments and Contingent Liabilities Litigation - Other PFOA Matters / Fayatteville (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "i472456b06ead42b28f13615586b59c3a_D20210101-20211231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R122": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ctva:ScheduleOfEnvironmentalLossContingenciesTableTextBlock", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "id110b8058ec54269a2cb77f3badc9bac_I20211231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:AccrualForEnvironmentalLossContingencies", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "241004062 - Disclosure - Commitments and Contingent Liabilities Environmental (Details)", "role": "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesEnvironmentalDetails", "shortName": "Commitments and Contingent Liabilities Environmental (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ctva:ScheduleOfEnvironmentalLossContingenciesTableTextBlock", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "id110b8058ec54269a2cb77f3badc9bac_I20211231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:AccrualForEnvironmentalLossContingencies", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R123": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "id110b8058ec54269a2cb77f3badc9bac_I20211231", "decimals": "2", "first": true, "lang": "en-US", "name": "us-gaap:CommonStockParOrStatedValuePerShare", "reportCount": 1, "unitRef": "usdPerShare", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "241034063 - Disclosure - Stockholders' Equity Common Stock (Details)", "role": "http://www.corteva.com/role/StockholdersEquityCommonStockDetails", "shortName": "Stockholders' Equity Common Stock (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfStockByClassTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": "0", "lang": "en-US", "name": "us-gaap:StockIssuedDuringPeriodSharesNewIssues", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R124": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "id110b8058ec54269a2cb77f3badc9bac_I20211231", "decimals": "3", "first": true, "lang": "en-US", "name": "us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "241044064 - Disclosure - Stockholders' Equity Noncontrolling Interest (Details)", "role": "http://www.corteva.com/role/StockholdersEquityNoncontrollingInterestDetails", "shortName": "Stockholders' Equity Noncontrolling Interest (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "id110b8058ec54269a2cb77f3badc9bac_I20211231", "decimals": "3", "first": true, "lang": "en-US", "name": "us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R125": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "ic3c0434c1aad407886edd72701605d70_I20201231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "241054065 - Disclosure - Stockholders' Equity Other Comprehensive Income (Loss) (Details)", "role": "http://www.corteva.com/role/StockholdersEquityOtherComprehensiveIncomeLossDetails", "shortName": "Stockholders' Equity Other Comprehensive Income (Loss) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "i6c68dddbddcf4d46b4cdc0d9ddda2f2e_I20181231", "decimals": "-6", "lang": "en-US", "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R126": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:OtherComprehensiveIncomeLossTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "241064066 - Disclosure - Stockholders' Equity Tax Benefit (Expense) on Net Activity (Details)", "role": "http://www.corteva.com/role/StockholdersEquityTaxBenefitExpenseonNetActivityDetails", "shortName": "Stockholders' Equity Tax Benefit (Expense) on Net Activity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:OtherComprehensiveIncomeLossTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R127": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxExpenseBenefit", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "241074067 - Disclosure - Stockholders' Equity Reclassifications out of AOCI (Details)", "role": "http://www.corteva.com/role/StockholdersEquityReclassificationsoutofAOCIDetails", "shortName": "Stockholders' Equity Reclassifications out of AOCI (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "i56d7271a138d4a54ade27acf6e953b9a_D20210101-20211231", "decimals": "-6", "lang": "en-US", "name": "us-gaap:IncomeTaxExpenseBenefit", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R128": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": "-6", "first": true, "lang": "en-US", "name": "ctva:Pretaxcashrequirementstocoveractualnetclaimscostsandrelatedadministrativeexpenses", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "241104068 - Disclosure - Pension Plans and Other Post Employment Benefit Plans Additional Information (Details)", "role": "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansAdditionalInformationDetails", "shortName": "Pension Plans and Other Post Employment Benefit Plans Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": "-6", "first": true, "lang": "en-US", "name": "ctva:Pretaxcashrequirementstocoveractualnetclaimscostsandrelatedadministrativeexpenses", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R129": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAssumptionsUsedTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "ieca5ef77349f44fb8c18e2748f2ec548_I20211231", "decimals": "4", "first": true, "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "241114069 - Disclosure - Pension Plans and Other Post Employment Benefit Plans Weighted Average Assumptions used to Determine Benefit Obligations - Pension (Details)", "role": "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansWeightedAverageAssumptionsusedtoDetermineBenefitObligationsPensionDetails", "shortName": "Pension Plans and Other Post Employment Benefit Plans Weighted Average Assumptions used to Determine Benefit Obligations - Pension (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAssumptionsUsedTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "ieca5ef77349f44fb8c18e2748f2ec548_I20211231", "decimals": "4", "first": true, "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock", "span", "div", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "210091004 - Disclosure - Recent Accounting Guidance", "role": "http://www.corteva.com/role/RecentAccountingGuidance", "shortName": "Recent Accounting Guidance", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock", "span", "div", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R130": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAssumptionsUsedTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "i8a3126ddcc31456a965e9ff008b136b5_D20210101-20211231", "decimals": "4", "first": true, "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "241124070 - Disclosure - Pension Plans and Other Post Employment Benefit Plans Weighted Average Assumptions used to Determine Net Periodic Benefit Cost - Pension (Details)", "role": "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansWeightedAverageAssumptionsusedtoDetermineNetPeriodicBenefitCostPensionDetails", "shortName": "Pension Plans and Other Post Employment Benefit Plans Weighted Average Assumptions used to Determine Net Periodic Benefit Cost - Pension (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAssumptionsUsedTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "i8a3126ddcc31456a965e9ff008b136b5_D20210101-20211231", "decimals": "4", "first": true, "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R131": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "i73ad70cf94ce4a0db6ed67bc206e110b_I20211231", "decimals": "4", "first": true, "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "241134071 - Disclosure - Pension Plans and Other Post Employment Benefit Plans Weighted Average Assumptions used to Determine Benefit Obligations and Periodic Benefit Cost - OPEB (Details)", "role": "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansWeightedAverageAssumptionsusedtoDetermineBenefitObligationsandPeriodicBenefitCostOPEBDetails", "shortName": "Pension Plans and Other Post Employment Benefit Plans Weighted Average Assumptions used to Determine Benefit Obligations and Periodic Benefit Cost - OPEB (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "i73ad70cf94ce4a0db6ed67bc206e110b_I20211231", "decimals": "4", "first": true, "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R132": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "id110b8058ec54269a2cb77f3badc9bac_I20211231", "decimals": "-8", "first": true, "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "241154073 - Disclosure - Pension Plans and Other Post Employment Benefit Plans Change in Projected Benefit Obligations, Plan Assets and Funded Status (Details)", "role": "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansChangeinProjectedBenefitObligationsPlanAssetsandFundedStatusDetails", "shortName": "Pension Plans and Other Post Employment Benefit Plans Change in Projected Benefit Obligations, Plan Assets and Funded Status (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "link:footnote", "span", "div", "us-gaap:ScheduleOfDefinedBenefitPlansDisclosuresTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "i5d00959bdf844ddab92c8cbe1ecc5fb8_I20211231", "decimals": "-6", "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanBenefitObligation", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R133": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "id110b8058ec54269a2cb77f3badc9bac_I20211231", "decimals": "-8", "first": true, "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "241164074 - Disclosure - Pension Plans and Other Post Employment Benefit Plans Amounts Recognized in Consolidated Balance Sheets (Details)", "role": "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansAmountsRecognizedinConsolidatedBalanceSheetsDetails", "shortName": "Pension Plans and Other Post Employment Benefit Plans Amounts Recognized in Consolidated Balance Sheets (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "i6281cbe0261f4a08be030e9a21e49181_I20211231", "decimals": "-6", "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R134": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "i6281cbe0261f4a08be030e9a21e49181_I20211231", "decimals": "-6", "first": true, "lang": "en-US", "name": "ctva:DefinedBenefitPlanPlanWithBenefitObligationInExcessOfPlanAssetsProjectedBenefitObligation", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "241174075 - Disclosure - Pension Plans and Other Post Employment Benefit Plans Pension Plans with Projected Benefit Obligations in Excess of Plan Assets (Details)", "role": "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansPensionPlanswithProjectedBenefitObligationsinExcessofPlanAssetsDetails", "shortName": "Pension Plans and Other Post Employment Benefit Plans Pension Plans with Projected Benefit Obligations in Excess of Plan Assets (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "i6281cbe0261f4a08be030e9a21e49181_I20211231", "decimals": "-6", "first": true, "lang": "en-US", "name": "ctva:DefinedBenefitPlanPlanWithBenefitObligationInExcessOfPlanAssetsProjectedBenefitObligation", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R135": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "i6281cbe0261f4a08be030e9a21e49181_I20211231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "241184076 - Disclosure - Pension Plans and Other Post Employment Benefit Plans Pension Plans with Accumulated Benefit Obligations in Excess of Plan Assets (Details)", "role": "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansPensionPlanswithAccumulatedBenefitObligationsinExcessofPlanAssetsDetails", "shortName": "Pension Plans and Other Post Employment Benefit Plans Pension Plans with Accumulated Benefit Obligations in Excess of Plan Assets (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "i6281cbe0261f4a08be030e9a21e49181_I20211231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R136": { "firstAnchor": { "ancestors": [ "link:footnote", "span", "div", "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "ide618e77440343b78dcf01836238a3a3_D20200101-20201231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "241194077 - Disclosure - Pension Plans and Other Post Employment Benefit Plans Components of net periodic benefit cost (credit) and amounts recognized in other comprehensive loss (Details)", "role": "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansComponentsofnetperiodicbenefitcostcreditandamountsrecognizedinothercomprehensivelossDetails", "shortName": "Pension Plans and Other Post Employment Benefit Plans Components of net periodic benefit cost (credit) and amounts recognized in other comprehensive loss (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "link:footnote", "span", "div", "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "ide618e77440343b78dcf01836238a3a3_D20200101-20201231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R137": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "i6281cbe0261f4a08be030e9a21e49181_I20211231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "241204078 - Disclosure - Pension Plans and Other Post Employment Benefit Plans Estimated Future Benefit Payments (Details)", "role": "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansEstimatedFutureBenefitPaymentsDetails", "shortName": "Pension Plans and Other Post Employment Benefit Plans Estimated Future Benefit Payments (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "i6281cbe0261f4a08be030e9a21e49181_I20211231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R138": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfAllocationOfPlanAssetsTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "id110b8058ec54269a2cb77f3badc9bac_I20211231", "decimals": "2", "first": true, "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "241214079 - Disclosure - Pension Plans and Other Post Employment Benefit Plans Target Allocation for Plan Assets (Details)", "role": "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansTargetAllocationforPlanAssetsDetails", "shortName": "Pension Plans and Other Post Employment Benefit Plans Target Allocation for Plan Assets (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfAllocationOfPlanAssetsTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "id110b8058ec54269a2cb77f3badc9bac_I20211231", "decimals": "2", "first": true, "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R139": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "id110b8058ec54269a2cb77f3badc9bac_I20211231", "decimals": "-6", "first": true, "lang": "en-US", "name": "ctva:DefinedBenefitPlanFairValueOfPlanAssetsReconcilingItemsPensionTrustReceivables", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "241224080 - Disclosure - Pension Plans and Other Post Employment Benefit Plans Basis of Fair Value Measurement (Details)", "role": "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansBasisofFairValueMeasurementDetails", "shortName": "Pension Plans and Other Post Employment Benefit Plans Basis of Fair Value Measurement (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "id110b8058ec54269a2cb77f3badc9bac_I20211231", "decimals": "-6", "first": true, "lang": "en-US", "name": "ctva:DefinedBenefitPlanFairValueOfPlanAssetsReconcilingItemsPensionTrustReceivables", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "ctva:CombinationofEntitiesunderCommonControlTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "210121005 - Disclosure - Common Control Business Combinations", "role": "http://www.corteva.com/role/CommonControlBusinessCombinations", "shortName": "Common Control Business Combinations", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "ctva:CombinationofEntitiesunderCommonControlTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R140": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDefinedBenefitPlansDisclosuresTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "i6281cbe0261f4a08be030e9a21e49181_I20211231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanFairValueOfPlanAssets", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "241234081 - Disclosure - Pension Plans and Other Post Employment Benefit Plans Summary of Fair Value Measurement of Level 3 Pension Plan Assets (Details)", "role": "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansSummaryofFairValueMeasurementofLevel3PensionPlanAssetsDetails", "shortName": "Pension Plans and Other Post Employment Benefit Plans Summary of Fair Value Measurement of Level 3 Pension Plan Assets (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfEffectOfSignificantUnobservableInputsChangesInPlanAssetsTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "if50df84aacfb4e37a4ea6996a44689b6_D20210101-20211231", "decimals": "-6", "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanActualReturnOnPlanAssetsSoldDuringPeriod", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R141": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1", "reportCount": 1, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "241264082 - Disclosure - Stock-Based Compensation Stock Compensation (Details)", "role": "http://www.corteva.com/role/StockBasedCompensationStockCompensationDetails", "shortName": "Stock-Based Compensation Stock Compensation (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iab289e6a743348f2865908e406779bce_I20211231", "decimals": "0", "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R142": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "i677279dc7cd64b6db6e4d07babc198e1_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2", "reportCount": 1, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "241274083 - Disclosure - Stock-Based Compensation Weighted Average Assumptions - Stock Options (Details)", "role": "http://www.corteva.com/role/StockBasedCompensationWeightedAverageAssumptionsStockOptionsDetails", "shortName": "Stock-Based Compensation Weighted Average Assumptions - Stock Options (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "i76403b2f553f4dbbb0c9e69103723651_D20190101-20191231", "decimals": "3", "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R143": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1", "reportCount": 1, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "241284084 - Disclosure - Stock-Based Compensation Stock Options (Details)", "role": "http://www.corteva.com/role/StockBasedCompensationStockOptionsDetails", "shortName": "Stock-Based Compensation Stock Options (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "id110b8058ec54269a2cb77f3badc9bac_I20211231", "decimals": "-6", "lang": "en-US", "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R144": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1", "reportCount": 1, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "241294085 - Disclosure - Stock-Based Compensation Restricted Stock Units and Performance Deferred Stock (Details)", "role": "http://www.corteva.com/role/StockBasedCompensationRestrictedStockUnitsandPerformanceDeferredStockDetails", "shortName": "Stock-Based Compensation Restricted Stock Units and Performance Deferred Stock (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "ifccdd5543ef149d59ca9e5a25877fd15_D20210101-20211231", "decimals": "0", "lang": "en-US", "name": "ctva:Sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsactualawardsgrantedpercentageofperformancetarget", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R145": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "i890134565bcb4fdaac6d32d6da3f1fb1_I20211231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:HeldToMaturitySecurities", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "241324086 - Disclosure - Financial Instruments Financial Instruments (Narrative) (Details)", "role": "http://www.corteva.com/role/FinancialInstrumentsFinancialInstrumentsNarrativeDetails", "shortName": "Financial Instruments Financial Instruments (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "i890134565bcb4fdaac6d32d6da3f1fb1_I20211231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:HeldToMaturitySecurities", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R146": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "ic8e8d8949ac14f1ebcc56bf5a49a88f7_I20211231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:DerivativeNotionalAmount", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "241334087 - Disclosure - Financial Instruments Notional Amounts (Details)", "role": "http://www.corteva.com/role/FinancialInstrumentsNotionalAmountsDetails", "shortName": "Financial Instruments Notional Amounts (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "i73e60e56bd574554800d6bc9e980a1dd_I20211231", "decimals": "-6", "lang": "en-US", "name": "us-gaap:DerivativeNotionalAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R147": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "i3199f0ee0e5649748346b61d0b878232_D20210101-20211231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "241344088 - Disclosure - Financial Instruments Cash Flow Hedges Included in AOCI (Details)", "role": "http://www.corteva.com/role/FinancialInstrumentsCashFlowHedgesIncludedinAOCIDetails", "shortName": "Financial Instruments Cash Flow Hedges Included in AOCI (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "i34565b620233494aa6612274e85adbdd_D20210101-20211231", "decimals": null, "lang": "en-US", "name": "us-gaap:DerivativeRemainingMaturity1", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R148": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "id110b8058ec54269a2cb77f3badc9bac_I20211231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "241354089 - Disclosure - Financial Instruments Fair Value of Derivatives (Details)", "role": "http://www.corteva.com/role/FinancialInstrumentsFairValueofDerivativesDetails", "shortName": "Financial Instruments Fair Value of Derivatives (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "id110b8058ec54269a2cb77f3badc9bac_I20211231", "decimals": "-6", "lang": "en-US", "name": "us-gaap:DerivativeAssetFairValueGrossLiabilityAndObligationToReturnCashOffset", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R149": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:GainLossOnDerivativeInstrumentsNetPretax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "241364090 - Disclosure - Financial Instruments Effect of Derivative Instruments (Details)", "role": "http://www.corteva.com/role/FinancialInstrumentsEffectofDerivativeInstrumentsDetails", "shortName": "Financial Instruments Effect of Derivative Instruments (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:GainLossOnDerivativeInstrumentsNetPretax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "210151006 - Disclosure - Divestitures and Other Transactions", "role": "http://www.corteva.com/role/DivestituresandOtherTransactions", "shortName": "Divestitures and Other Transactions", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R150": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "icbbb25c9519949df9c937dc4c6373f36_D20210101-20211231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:AvailableForSaleSecuritiesGrossRealizedGainLossNet", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "241374091 - Disclosure - Financial Instruments Debt Securities (Details)", "role": "http://www.corteva.com/role/FinancialInstrumentsDebtSecuritiesDetails", "shortName": "Financial Instruments Debt Securities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "icbbb25c9519949df9c937dc4c6373f36_D20210101-20211231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:AvailableForSaleSecuritiesGrossRealizedGainLossNet", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R151": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "id110b8058ec54269a2cb77f3badc9bac_I20211231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "241414093 - Disclosure - Fair Value Measurements Fair Value Measurement Recurring Basis (Details)", "role": "http://www.corteva.com/role/FairValueMeasurementsFairValueMeasurementRecurringBasisDetails", "shortName": "Fair Value Measurements Fair Value Measurement Recurring Basis (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "i95248d35a86b4c0e989cae57385251de_I20211231", "decimals": "-6", "lang": "en-US", "name": "ctva:ShortTermInvestmentsFairValueDisclosure", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R152": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:FairValueAssetsMeasuredOnRecurringAndNonrecurringBasisTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "i1073440a8e6b43d383fb6ebaddd0b097_I20201231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetsFairValueDisclosure", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "241424094 - Disclosure - Fair Value Measurements Fair Value Measurement Nonrecurring Basis (Details)", "role": "http://www.corteva.com/role/FairValueMeasurementsFairValueMeasurementNonrecurringBasisDetails", "shortName": "Fair Value Measurements Fair Value Measurement Nonrecurring Basis (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:FairValueAssetsMeasuredOnRecurringAndNonrecurringBasisTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "i1073440a8e6b43d383fb6ebaddd0b097_I20201231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetsFairValueDisclosure", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R153": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:Revenues", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "241454095 - Disclosure - Geographic Information Revenue by Country (Details)", "role": "http://www.corteva.com/role/GeographicInformationRevenuebyCountryDetails", "shortName": "Geographic Information Revenue by Country (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "ib872004d32d44a9c850c74d92f968717_D20210101-20211231", "decimals": "-6", "lang": "en-US", "name": "us-gaap:Revenues", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R154": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "id110b8058ec54269a2cb77f3badc9bac_I20211231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentNet", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "241464096 - Disclosure - Geographic Information Net Property by Country (Details)", "role": "http://www.corteva.com/role/GeographicInformationNetPropertybyCountryDetails", "shortName": "Geographic Information Net Property by Country (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "i33b920e5400143d08607257d610bf79e_I20211231", "decimals": "-6", "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentNet", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R155": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:Revenues", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "241494097 - Disclosure - Segment Reporting Segment Information (Details)", "role": "http://www.corteva.com/role/SegmentReportingSegmentInformationDetails", "shortName": "Segment Reporting Segment Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "link:footnote", "ix:continuation", "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "i5472bde02ce347e49275c03293bcd718_I20190601", "decimals": "-6", "lang": "en-US", "name": "us-gaap:Goodwill", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R156": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "241504098 - Disclosure - Segment Reporting Segment Reconciliation (Details)", "role": "http://www.corteva.com/role/SegmentReportingSegmentReconciliationDetails", "shortName": "Segment Reporting Segment Reconciliation (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R157": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "id110b8058ec54269a2cb77f3badc9bac_I20211231", "decimals": "-6", "first": true, "lang": "en-US", "name": "ctva:SegmentAssets", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "241514099 - Disclosure - Segment Reporting Segment Assets (Details)", "role": "http://www.corteva.com/role/SegmentReportingSegmentAssetsDetails", "shortName": "Segment Reporting Segment Assets (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R158": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "i1f6fb23c7bb44e70a0a6b33ef453a294_D20190101-20191231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:DepreciationDepletionAndAmortization", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "241524100 - Disclosure - Segment Reporting Other Items (Details)", "role": "http://www.corteva.com/role/SegmentReportingOtherItemsDetails", "shortName": "Segment Reporting Other Items (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "i88bc46cbdee740d8b67867253dc8edf3_D20190101-20191231", "decimals": "-6", "lang": "en-US", "name": "us-gaap:DepreciationDepletionAndAmortization", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R159": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": "-6", "first": true, "lang": "en-US", "name": "ctva:BusinessCombinationIntegrationAndSeparationRelatedCosts", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "241534101 - Disclosure - Segment Reporting Sig Items (Details)", "role": "http://www.corteva.com/role/SegmentReportingSigItemsDetails", "shortName": "Segment Reporting Sig Items (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ctva:ScheduleofAdditionalSegmentDetailsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "i2e60464518c2475491e06aa1b53a3baa_D20200101-20201231", "decimals": "-6", "lang": "en-US", "name": "ctva:BusinessCombinationIntegrationAndSeparationRelatedCosts", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "210221007 - Disclosure - Revenue (Notes)", "role": "http://www.corteva.com/role/RevenueNotes", "shortName": "Revenue (Notes)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R160": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:Revenues", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "241564102 - Disclosure - Quaterly Financial Data Quarterly Financial Data (Details)", "role": "http://www.corteva.com/role/QuaterlyFinancialDataQuarterlyFinancialDataDetails", "shortName": "Quaterly Financial Data Quarterly Financial Data (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R161": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:GainsLossesOnExtinguishmentOfDebt", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "241574103 - Disclosure - Quaterly Financial Data Quarterly Financial Data (Parentheticals) (Details)", "role": "http://www.corteva.com/role/QuaterlyFinancialDataQuarterlyFinancialDataParentheticalsDetails", "shortName": "Quaterly Financial Data Quarterly Financial Data (Parentheticals) (Details)", "subGroupType": "parenthetical", "uniqueAnchor": null }, "R162": { "firstAnchor": { "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "i6d857b8de344495697120c3cce0b1ed4_I20210209", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:ShortTermBorrowings", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "241594104 - Disclosure - Subsequent Events (Details)", "role": "http://www.corteva.com/role/SubsequentEventsDetails", "shortName": "Subsequent Events (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "i6d857b8de344495697120c3cce0b1ed4_I20210209", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:ShortTermBorrowings", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R163": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfStockByClassTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "ib785b0d5d7cd4b318c64f47294f6242c_I20191231", "decimals": "0", "first": true, "lang": "en-US", "name": "us-gaap:CommonStockSharesOutstanding", "reportCount": 1, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "241614105 - Disclosure - EID Basis of Presentation (Details)", "role": "http://www.corteva.com/role/EIDBasisofPresentationDetails", "shortName": "EID Basis of Presentation (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R164": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "i85c6470e414c4387bd6d10dfb338b9b5_I20211231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:NotesPayableRelatedPartiesNoncurrent", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "241644106 - Disclosure - EID Related Party (Details)", "role": "http://www.corteva.com/role/EIDRelatedPartyDetails", "shortName": "EID Related Party (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "icdcb8a2cd12d4ab8b9dd8d5bd1dfe505_I20211231", "decimals": "INF", "lang": "en-US", "name": "us-gaap:DebtWeightedAverageInterestRate", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R165": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "241674107 - Disclosure - EID Income Taxes Geographic Allocation (Details)", "role": "http://www.corteva.com/role/EIDIncomeTaxesGeographicAllocationDetails", "shortName": "EID Income Taxes Geographic Allocation (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "div", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "if803e7f647d4403eb57dd33be9633b77_D20210101-20211231", "decimals": "-6", "lang": "en-US", "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R166": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "i2a184e6004274926830eca5cc2e2479b_D20210101-20211231", "decimals": "3", "first": true, "lang": "en-US", "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "reportCount": 1, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "241684108 - Disclosure - EID Income Taxes Rate Reconciliation (Details)", "role": "http://www.corteva.com/role/EIDIncomeTaxesRateReconciliationDetails", "shortName": "EID Income Taxes Rate Reconciliation (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "if803e7f647d4403eb57dd33be9633b77_D20210101-20211231", "decimals": "3", "lang": "en-US", "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R167": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "241714109 - Disclosure - EID Segment FN Segment Reconciliation (Details)", "role": "http://www.corteva.com/role/EIDSegmentFNSegmentReconciliationDetails", "shortName": "EID Segment FN Segment Reconciliation (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "i0a6e59408e1b436e8c76e23810ed2526_D20210101-20211231", "decimals": "-6", "lang": "en-US", "name": "ctva:Nonoperatingbenefitscostsnet", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R168": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "id110b8058ec54269a2cb77f3badc9bac_I20211231", "decimals": "-6", "first": true, "lang": "en-US", "name": "ctva:SegmentAssets", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "241724110 - Disclosure - EID Segment FN Segment Asset Reconciliation (Details)", "role": "http://www.corteva.com/role/EIDSegmentFNSegmentAssetReconciliationDetails", "shortName": "EID Segment FN Segment Asset Reconciliation (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R169": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "241754111 - Disclosure - EID Quarterly FN (Details)", "role": "http://www.corteva.com/role/EIDQuarterlyFNDetails", "shortName": "EID Quarterly FN (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R17": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "210291008 - Disclosure - Restructuring and Asset Related Charges", "role": "http://www.corteva.com/role/RestructuringandAssetRelatedCharges", "shortName": "Restructuring and Asset Related Charges", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "210361009 - Disclosure - Related Parties (Notes)", "role": "http://www.corteva.com/role/RelatedPartiesNotes", "shortName": "Related Parties (Notes)", "subGroupType": "", "uniqueAnchor": null }, "R19": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AdditionalFinancialInformationDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "210391010 - Disclosure - Supplementary Information", "role": "http://www.corteva.com/role/SupplementaryInformation", "shortName": "Supplementary Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AdditionalFinancialInformationDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "dei:AuditorName", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "false", "longName": "000020002 - Document - Audit Information", "role": "http://www.corteva.com/role/AuditInformation", "shortName": "Audit Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "dei:AuditorName", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "210451011 - Disclosure - Income Taxes", "role": "http://www.corteva.com/role/IncomeTaxes", "shortName": "Income Taxes", "subGroupType": "", "uniqueAnchor": null }, "R21": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "210531012 - Disclosure - Earnings Per Share of Common Stock (Notes)", "role": "http://www.corteva.com/role/EarningsPerShareofCommonStockNotes", "shortName": "Earnings Per Share of Common Stock (Notes)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "210601013 - Disclosure - Accounts and Notes Receivable, Net", "role": "http://www.corteva.com/role/AccountsandNotesReceivableNet", "shortName": "Accounts and Notes Receivable, Net", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InventoryDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "210651014 - Disclosure - Inventories", "role": "http://www.corteva.com/role/Inventories", "shortName": "Inventories", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InventoryDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "210691015 - Disclosure - Property, Plant and Equipment", "role": "http://www.corteva.com/role/PropertyPlantandEquipment", "shortName": "Property, Plant and Equipment", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "210731016 - Disclosure - Goodwill and Other Intangible Assets", "role": "http://www.corteva.com/role/GoodwillandOtherIntangibleAssets", "shortName": "Goodwill and Other Intangible Assets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LeasesOfLesseeDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "210781017 - Disclosure - Leases (Notes)", "role": "http://www.corteva.com/role/LeasesNotes", "shortName": "Leases (Notes)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LeasesOfLesseeDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "210871018 - Disclosure - Long-Term Debt and Available Credit Facilities", "role": "http://www.corteva.com/role/LongTermDebtandAvailableCreditFacilities", "shortName": "Long-Term Debt and Available Credit Facilities", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "211011020 - Disclosure - Stockholders' Equity", "role": "http://www.corteva.com/role/StockholdersEquity", "shortName": "Stockholders' Equity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "211081021 - Disclosure - Pension Plans and Other Post Employment Benefit Plans", "role": "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlans", "shortName": "Pension Plans and Other Post Employment Benefit Plans", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:Revenues", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "100010003 - Statement - Consolidated Statements of Income", "role": "http://www.corteva.com/role/ConsolidatedStatementsofIncome", "shortName": "Consolidated Statements of Income", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": "-6", "lang": "en-US", "name": "us-gaap:ResearchAndDevelopmentExpense", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "211241022 - Disclosure - Stock-Based Compensation", "role": "http://www.corteva.com/role/StockBasedCompensation", "shortName": "Stock-Based Compensation", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FinancialInstrumentsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "211301023 - Disclosure - Financial Instruments", "role": "http://www.corteva.com/role/FinancialInstruments", "shortName": "Financial Instruments", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FinancialInstrumentsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "211391024 - Disclosure - Fair Value Measurements", "role": "http://www.corteva.com/role/FairValueMeasurements", "shortName": "Fair Value Measurements", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "ctva:GeographicInformationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "211431025 - Disclosure - Geographic Information", "role": "http://www.corteva.com/role/GeographicInformation", "shortName": "Geographic Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "ctva:GeographicInformationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "211471026 - Disclosure - Segment Reporting (Notes)", "role": "http://www.corteva.com/role/SegmentReportingNotes", "shortName": "Segment Reporting (Notes)", "subGroupType": "", "uniqueAnchor": null }, "R35": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "211581028 - Disclosure - Subsequent Events (Notes)", "role": "http://www.corteva.com/role/SubsequentEventsNotes", "shortName": "Subsequent Events (Notes)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "211601029 - Disclosure - EID Basis of Presentation (Notes)", "role": "http://www.corteva.com/role/EIDBasisofPresentationNotes", "shortName": "EID Basis of Presentation (Notes)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "i0a6e59408e1b436e8c76e23810ed2526_D20210101-20211231", "decimals": null, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "211621030 - Disclosure - EID Related Party (Notes)", "role": "http://www.corteva.com/role/EIDRelatedPartyNotes", "shortName": "EID Related Party (Notes)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "i0a6e59408e1b436e8c76e23810ed2526_D20210101-20211231", "decimals": null, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "211651031 - Disclosure - EID Income Taxes (Notes)", "role": "http://www.corteva.com/role/EIDIncomeTaxesNotes", "shortName": "EID Income Taxes (Notes)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "i0a6e59408e1b436e8c76e23810ed2526_D20210101-20211231", "decimals": null, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "211691032 - Disclosure - EID Segment FN (Notes)", "role": "http://www.corteva.com/role/EIDSegmentFNNotes", "shortName": "EID Segment FN (Notes)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "i0a6e59408e1b436e8c76e23810ed2526_D20210101-20211231", "decimals": null, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:ProfitLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "100020004 - Statement - Consolidated Statements of Comprehensive Income", "role": "http://www.corteva.com/role/ConsolidatedStatementsofComprehensiveIncome", "shortName": "Consolidated Statements of Comprehensive Income", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": "-6", "lang": "en-US", "name": "us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "ctva:IntendedBusinessSeparationsPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "220042001 - Disclosure - Background and Basis of Presentation (Policies)", "role": "http://www.corteva.com/role/BackgroundandBasisofPresentationPolicies", "shortName": "Background and Basis of Presentation (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "ctva:IntendedBusinessSeparationsPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConsolidationPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "220072002 - Disclosure - Summary of Significant Accounting Policies (Policies)", "role": "http://www.corteva.com/role/SummaryofSignificantAccountingPoliciesPolicies", "shortName": "Summary of Significant Accounting Policies (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConsolidationPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "220102003 - Disclosure - Recent Accounting Guidance Recent Accounting Guidance (Policies)", "role": "http://www.corteva.com/role/RecentAccountingGuidanceRecentAccountingGuidancePolicies", "shortName": "Recent Accounting Guidance Recent Accounting Guidance (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueRecognitionSalesOfGoods", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "220232004 - Disclosure - Revenue from Contract with Customer (Policies)", "role": "http://www.corteva.com/role/RevenuefromContractwithCustomerPolicies", "shortName": "Revenue from Contract with Customer (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueRecognitionSalesOfGoods", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "ie4f8ad2a254a4f2184d1f550f3bf16af_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "230163003 - Disclosure - Divestitures and Other Transactions (Tables)", "role": "http://www.corteva.com/role/DivestituresandOtherTransactionsTables", "shortName": "Divestitures and Other Transactions (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "ie4f8ad2a254a4f2184d1f550f3bf16af_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "230243004 - Disclosure - Revenue (Tables)", "role": "http://www.corteva.com/role/RevenueTables", "shortName": "Revenue (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "230303005 - Disclosure - Restructuring and Asset Related Charges (Tables)", "role": "http://www.corteva.com/role/RestructuringandAssetRelatedChargesTables", "shortName": "Restructuring and Asset Related Charges (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R47": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "230403006 - Disclosure - Supplementary Information (Tables)", "role": "http://www.corteva.com/role/SupplementaryInformationTables", "shortName": "Supplementary Information (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R48": { "firstAnchor": { "ancestors": [ "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "reportCount": 1, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "230463007 - Disclosure - Income Taxes (Tables)", "role": "http://www.corteva.com/role/IncomeTaxesTables", "shortName": "Income Taxes (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": null, "lang": "en-US", "name": "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R49": { "firstAnchor": { "ancestors": [ "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicByCommonClassTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "230543008 - Disclosure - Earnings Per Share of Common Stock (Tables)", "role": "http://www.corteva.com/role/EarningsPerShareofCommonStockTables", "shortName": "Earnings Per Share of Common Stock (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicByCommonClassTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "id110b8058ec54269a2cb77f3badc9bac_I20211231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "100030005 - Statement - Consolidated Balance Sheets", "role": "http://www.corteva.com/role/ConsolidatedBalanceSheets", "shortName": "Consolidated Balance Sheets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "id110b8058ec54269a2cb77f3badc9bac_I20211231", "decimals": "-6", "lang": "en-US", "name": "us-gaap:ShortTermInvestments", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R50": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "230613009 - Disclosure - Accounts and Notes Receivable, Net (Tables)", "role": "http://www.corteva.com/role/AccountsandNotesReceivableNetTables", "shortName": "Accounts and Notes Receivable, Net (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R51": { "firstAnchor": { "ancestors": [ "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "230663010 - Disclosure - Inventories (Tables)", "role": "http://www.corteva.com/role/InventoriesTables", "shortName": "Inventories (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R52": { "firstAnchor": { "ancestors": [ "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "230703011 - Disclosure - Property, Plant and Equipment (Tables)", "role": "http://www.corteva.com/role/PropertyPlantandEquipmentTables", "shortName": "Property, Plant and Equipment (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R53": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfGoodwillTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "230743012 - Disclosure - Goodwill and Other Intangible Assets (Tables)", "role": "http://www.corteva.com/role/GoodwillandOtherIntangibleAssetsTables", "shortName": "Goodwill and Other Intangible Assets (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfGoodwillTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R54": { "firstAnchor": { "ancestors": [ "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LeaseCostTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "230793013 - Disclosure - Leases (Tables)", "role": "http://www.corteva.com/role/LeasesTables", "shortName": "Leases (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LeaseCostTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R55": { "firstAnchor": { "ancestors": [ "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "230883014 - Disclosure - Long-Term Debt and Available Credit Facilities (Tables)", "role": "http://www.corteva.com/role/LongTermDebtandAvailableCreditFacilitiesTables", "shortName": "Long-Term Debt and Available Credit Facilities (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R56": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "ctva:ScheduleOfEnvironmentalLossContingenciesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "230943015 - Disclosure - Commitments and Contingent Liabilities (Tables)", "role": "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesTables", "shortName": "Commitments and Contingent Liabilities (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "ctva:ScheduleOfEnvironmentalLossContingenciesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R57": { "firstAnchor": { "ancestors": [ "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfStockByClassTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "231023016 - Disclosure - Stockholders' Equity (Tables)", "role": "http://www.corteva.com/role/StockholdersEquityTables", "shortName": "Stockholders' Equity (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfStockByClassTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R58": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAssumptionsUsedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "231093017 - Disclosure - Pension Plans and Other Post Employment Benefit Plans (Tables)", "role": "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansTables", "shortName": "Pension Plans and Other Post Employment Benefit Plans (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAssumptionsUsedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R59": { "firstAnchor": { "ancestors": [ "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "231253018 - Disclosure - Stock-Based Compensation (Tables)", "role": "http://www.corteva.com/role/StockBasedCompensationTables", "shortName": "Stock-Based Compensation (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "id110b8058ec54269a2cb77f3badc9bac_I20211231", "decimals": "2", "first": true, "lang": "en-US", "name": "us-gaap:CommonStockParOrStatedValuePerShare", "reportCount": 1, "unitRef": "usdPerShare", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "100040006 - Statement - Consolidated Balance Sheets (Parentheticals)", "role": "http://www.corteva.com/role/ConsolidatedBalanceSheetsParentheticals", "shortName": "Consolidated Balance Sheets (Parentheticals)", "subGroupType": "parenthetical", "uniqueAnchor": null }, "R60": { "firstAnchor": { "ancestors": [ "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "231313019 - Disclosure - Financial Instruments (Tables)", "role": "http://www.corteva.com/role/FinancialInstrumentsTables", "shortName": "Financial Instruments (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R61": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "231403020 - Disclosure - Fair Value Measurements (Tables)", "role": "http://www.corteva.com/role/FairValueMeasurementsTables", "shortName": "Fair Value Measurements (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R62": { "firstAnchor": { "ancestors": [ "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "231443021 - Disclosure - Geographic Information (Tables)", "role": "http://www.corteva.com/role/GeographicInformationTables", "shortName": "Geographic Information (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R63": { "firstAnchor": { "ancestors": [ "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "231483022 - Disclosure - Segment Reporting (Tables)", "role": "http://www.corteva.com/role/SegmentReportingTables", "shortName": "Segment Reporting (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R64": { "firstAnchor": { "ancestors": [ "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "reportCount": 1, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "231663025 - Disclosure - EID Income Taxes (Tables)", "role": "http://www.corteva.com/role/EIDIncomeTaxesTables", "shortName": "EID Income Taxes (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "i0a6e59408e1b436e8c76e23810ed2526_D20210101-20211231", "decimals": null, "lang": "en-US", "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R65": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock", "reportCount": 1, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "231703026 - Disclosure - EID Segment FN (Tables)", "role": "http://www.corteva.com/role/EIDSegmentFNTables", "shortName": "EID Segment FN (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "i0a6e59408e1b436e8c76e23810ed2526_D20210101-20211231", "decimals": null, "lang": "en-US", "name": "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R66": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "ie9d459d54128432581cd84a373783deb_I20201231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:ValuationAllowancesAndReservesBalance", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240024001 - Disclosure - Schedule II - Valuation and Qualifying Accounts (Details)", "role": "http://www.corteva.com/role/ScheduleIIValuationandQualifyingAccountsDetails", "shortName": "Schedule II - Valuation and Qualifying Accounts (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "ic2777bc8a4674c19967c193066c3c6d4_I20181231", "decimals": "-6", "lang": "en-US", "name": "us-gaap:ValuationAllowancesAndReservesBalance", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R67": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "id110b8058ec54269a2cb77f3badc9bac_I20211231", "decimals": "2", "first": true, "lang": "en-US", "name": "us-gaap:CommonStockParOrStatedValuePerShare", "reportCount": 1, "unitRef": "usdPerShare", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240054002 - Disclosure - Background and Basis of Presentation (Details)", "role": "http://www.corteva.com/role/BackgroundandBasisofPresentationDetails", "shortName": "Background and Basis of Presentation (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "i4106444b271f4dd8ab7b28d470c3f9d9_D20200101-20200331", "decimals": "-6", "lang": "en-US", "name": "us-gaap:AdjustmentsToAdditionalPaidInCapitalOther", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R68": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": "-6", "first": true, "lang": "en-US", "name": "ctva:BusinessCombinationIntegrationAndSeparationRelatedCosts", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240084003 - Disclosure - Summary of Significant Accounting Policies (Details)", "role": "http://www.corteva.com/role/SummaryofSignificantAccountingPoliciesDetails", "shortName": "Summary of Significant Accounting Policies (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "us-gaap:InventoryPolicyTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "id110b8058ec54269a2cb77f3badc9bac_I20211231", "decimals": "2", "lang": "en-US", "name": "us-gaap:PercentageOfFIFOInventory", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R69": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:Revenues", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240144004 - Disclosure - Business Combinations DAS Common Control Transfer Income Statement (Details)", "role": "http://www.corteva.com/role/BusinessCombinationsDASCommonControlTransferIncomeStatementDetails", "shortName": "Business Combinations DAS Common Control Transfer Income Statement (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R7": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:ProfitLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "100050007 - Statement - Consolidated Statements of Cash Flows", "role": "http://www.corteva.com/role/ConsolidatedStatementsofCashFlows", "shortName": "Consolidated Statements of Cash Flows", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": "-6", "lang": "en-US", "name": "ctva:DeferredIncomeTaxExpenseBenefitContinuingOperationsandDiscontinuedOperations", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R70": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240174005 - Disclosure - Divestitures and Other Transactions Divestitures and Other Transactions - Narrative (Details)", "role": "http://www.corteva.com/role/DivestituresandOtherTransactionsDivestituresandOtherTransactionsNarrativeDetails", "shortName": "Divestitures and Other Transactions Divestitures and Other Transactions - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "i0f90a69257f6436bbb9da2ca83314153_D20200101-20201231", "decimals": "-6", "lang": "en-US", "name": "us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R71": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240184006 - Disclosure - Divestitures and Other Transactions ECP Divestiture (Details)", "role": "http://www.corteva.com/role/DivestituresandOtherTransactionsECPDivestitureDetails", "shortName": "Divestitures and Other Transactions ECP Divestiture (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "i986692ef5b084d1abc7b077b14d6658b_D20200101-20201231", "decimals": "-6", "lang": "en-US", "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R72": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240194007 - Disclosure - Divestitures and Other Transactions SP Divestiture (Details)", "role": "http://www.corteva.com/role/DivestituresandOtherTransactionsSPDivestitureDetails", "shortName": "Divestitures and Other Transactions SP Divestiture (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "i0f90a69257f6436bbb9da2ca83314153_D20200101-20201231", "decimals": "-6", "lang": "en-US", "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R73": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ctva:ScheduleofFiniteandIndefiniteLivedIntangibleAssetsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "id110b8058ec54269a2cb77f3badc9bac_I20211231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240204008 - Disclosure - Divestitures and Other Transactions Divestitures and Other Transactions - Divested Ag Business Results of Operations (Details)", "role": "http://www.corteva.com/role/DivestituresandOtherTransactionsDivestituresandOtherTransactionsDivestedAgBusinessResultsofOperationsDetails", "shortName": "Divestitures and Other Transactions Divestitures and Other Transactions - Divested Ag Business Results of Operations (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "i9634e411844d416c90b1a457136b5622_I20171101", "decimals": "-6", "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R74": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240214009 - Disclosure - Divestitures and Other Transactions Divestitures and Other Transactions - PChem Results of Operations (Details)", "role": "http://www.corteva.com/role/DivestituresandOtherTransactionsDivestituresandOtherTransactionsPChemResultsofOperationsDetails", "shortName": "Divestitures and Other Transactions Divestitures and Other Transactions - PChem Results of Operations (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R75": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "id110b8058ec54269a2cb77f3badc9bac_I20211231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:RevenueRemainingPerformanceObligation", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240254010 - Disclosure - Revenue Narrative (Details)", "role": "http://www.corteva.com/role/RevenueNarrativeDetails", "shortName": "Revenue Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "id110b8058ec54269a2cb77f3badc9bac_I20211231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:RevenueRemainingPerformanceObligation", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R76": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "id110b8058ec54269a2cb77f3badc9bac_I20211231", "decimals": "-6", "first": true, "lang": "en-US", "name": "ctva:Accountsandnotesreceivabletrade", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240264011 - Disclosure - Revenue Contract Balances (Details)", "role": "http://www.corteva.com/role/RevenueContractBalancesDetails", "shortName": "Revenue Contract Balances (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "id110b8058ec54269a2cb77f3badc9bac_I20211231", "decimals": "-6", "first": true, "lang": "en-US", "name": "ctva:Accountsandnotesreceivabletrade", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R77": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:Revenues", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240274012 - Disclosure - Revenue Disaggregation of Revenue - Products (Details)", "role": "http://www.corteva.com/role/RevenueDisaggregationofRevenueProductsDetails", "shortName": "Revenue Disaggregation of Revenue - Products (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "i3332fc6bd66d4ca4b416ae4bce2d2e16_D20210101-20211231", "decimals": "-6", "lang": "en-US", "name": "us-gaap:Revenues", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R78": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:Revenues", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240284013 - Disclosure - Revenue Disaggregation of Revenue - Geo (Details)", "role": "http://www.corteva.com/role/RevenueDisaggregationofRevenueGeoDetails", "shortName": "Revenue Disaggregation of Revenue - Geo (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:DisaggregationOfRevenueTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "i7db28ef069754a90be62e1660a3b3385_D20210101-20211231", "decimals": "-6", "lang": "en-US", "name": "us-gaap:Revenues", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R79": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": "-6", "first": true, "lang": "en-US", "name": "ctva:RestructuringAndAssetRelatedChargesNet", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240314014 - Disclosure - Restructuring and Asset Related Charges 2021 Restructuring Actions (Details)", "role": "http://www.corteva.com/role/RestructuringandAssetRelatedCharges2021RestructuringActionsDetails", "shortName": "Restructuring and Asset Related Charges 2021 Restructuring Actions (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "i93130df5f1ac4ab3b868d9026057750c_D20210101-20211231", "decimals": "-6", "lang": "en-US", "name": "ctva:RestructuringAndAssetRelatedChargesNet", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "i5a3c9d5bcb3a4d64b738ac0a84121974_I20181231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "100060008 - Statement - Consolidated Statements of Equity", "role": "http://www.corteva.com/role/ConsolidatedStatementsofEquity", "shortName": "Consolidated Statements of Equity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "i5defb46e9e744855bb86fc0ef8ce3c12_I20181231", "decimals": "-6", "lang": "en-US", "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R80": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": "-6", "first": true, "lang": "en-US", "name": "ctva:RestructuringAndAssetRelatedChargesNet", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240324015 - Disclosure - Restructuring and Asset Related Charges Execute to Win Productivity Program (Details)", "role": "http://www.corteva.com/role/RestructuringandAssetRelatedChargesExecutetoWinProductivityProgramDetails", "shortName": "Restructuring and Asset Related Charges Execute to Win Productivity Program (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "i81b37d6f64884f32ba3ac9e3004f2546_I20211231", "decimals": "-6", "lang": "en-US", "name": "us-gaap:RestructuringAndRelatedCostCostIncurredToDate1", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R81": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": "-6", "first": true, "lang": "en-US", "name": "ctva:RestructuringAndAssetRelatedChargesNet", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240334016 - Disclosure - Restructuring and Asset Related Charges DowDuPont Cost Synergy Program (Details)", "role": "http://www.corteva.com/role/RestructuringandAssetRelatedChargesDowDuPontCostSynergyProgramDetails", "shortName": "Restructuring and Asset Related Charges DowDuPont Cost Synergy Program (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "idb592200ef164b8c8dd5addd166c9ec3_I20211231", "decimals": "-6", "lang": "en-US", "name": "us-gaap:RestructuringAndRelatedCostCostIncurredToDate1", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R82": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "i44c1cfe32d244aa6ab07d540ab6312b5_D20210101-20211231", "decimals": "-6", "first": true, "lang": "en-US", "name": "ctva:AcceleratedPrepaidRoyaltyAmortizationExpense", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240354018 - Disclosure - Restructuring and Asset Related Charges Asset Impairments (Details)", "role": "http://www.corteva.com/role/RestructuringandAssetRelatedChargesAssetImpairmentsDetails", "shortName": "Restructuring and Asset Related Charges Asset Impairments (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "i44c1cfe32d244aa6ab07d540ab6312b5_D20210101-20211231", "decimals": "-6", "first": true, "lang": "en-US", "name": "ctva:AcceleratedPrepaidRoyaltyAmortizationExpense", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R83": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "i0ef78b273fed471392051b1ba27bf066_I20190626", "decimals": "-9", "first": true, "lang": "en-US", "name": "us-gaap:StockRepurchaseProgramAuthorizedAmount1", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240384020 - Disclosure - Related Parties Transactions with DowDuPont (Details)", "role": "http://www.corteva.com/role/RelatedPartiesTransactionswithDowDuPontDetails", "shortName": "Related Parties Transactions with DowDuPont (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R84": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:InterestIncomeOperating", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240414021 - Disclosure - Supplementary Information Other Income (Expense) - Net (Details)", "role": "http://www.corteva.com/role/SupplementaryInformationOtherIncomeExpenseNetDetails", "shortName": "Supplementary Information Other Income (Expense) - Net (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": "-6", "lang": "en-US", "name": "us-gaap:IncomeLossFromEquityMethodInvestments", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R85": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ctva:ForeignCurrencyExchangeGainLossTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:ForeignCurrencyTransactionGainLossBeforeTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240424022 - Disclosure - Supplementary Information Foreign Currency Exchange Gain (Loss) (Details)", "role": "http://www.corteva.com/role/SupplementaryInformationForeignCurrencyExchangeGainLossDetails", "shortName": "Supplementary Information Foreign Currency Exchange Gain (Loss) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ctva:ForeignCurrencyExchangeGainLossTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": "-6", "lang": "en-US", "name": "ctva:ForeignCurrencyTransactionGainLossTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R86": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "id110b8058ec54269a2cb77f3badc9bac_I20211231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240434023 - Disclosure - Supplementary Information Reconciliation of Cash, Cash Equivalents and Restricted Cash (Details)", "role": "http://www.corteva.com/role/SupplementaryInformationReconciliationofCashCashEquivalentsandRestrictedCashDetails", "shortName": "Supplementary Information Reconciliation of Cash, Cash Equivalents and Restricted Cash (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "id110b8058ec54269a2cb77f3badc9bac_I20211231", "decimals": "-6", "lang": "en-US", "name": "us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R87": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "id110b8058ec54269a2cb77f3badc9bac_I20211231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:AccruedLiabilitiesCurrent", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240444024 - Disclosure - Supplementary Information Supplementary Information (Narrative) (Details)", "role": "http://www.corteva.com/role/SupplementaryInformationSupplementaryInformationNarrativeDetails", "shortName": "Supplementary Information Supplementary Information (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "id110b8058ec54269a2cb77f3badc9bac_I20211231", "decimals": "-6", "lang": "en-US", "name": "us-gaap:AccountsPayableTradeCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R88": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240484026 - Disclosure - Income Taxes Income Taxes - Geographic Allocation of Income and Provision for Income Taxes (Details)", "role": "http://www.corteva.com/role/IncomeTaxesIncomeTaxesGeographicAllocationofIncomeandProvisionforIncomeTaxesDetails", "shortName": "Income Taxes Income Taxes - Geographic Allocation of Income and Provision for Income Taxes (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "i2a184e6004274926830eca5cc2e2479b_D20210101-20211231", "decimals": "-6", "lang": "en-US", "name": "us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R89": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "i2a184e6004274926830eca5cc2e2479b_D20210101-20211231", "decimals": "3", "first": true, "lang": "en-US", "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "reportCount": 1, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240494027 - Disclosure - Income Taxes Income Taxes - Reconciliation to US Statutory Rate (Details)", "role": "http://www.corteva.com/role/IncomeTaxesIncomeTaxesReconciliationtoUSStatutoryRateDetails", "shortName": "Income Taxes Income Taxes - Reconciliation to US Statutory Rate (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "link:footnote", "span", "div", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "i7a42e06786a640c597ee7e56a8093b55_D20200101-20201231", "decimals": "-6", "lang": "en-US", "name": "us-gaap:OtherTaxExpenseBenefit", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R9": { "firstAnchor": null, "groupType": "statement", "isDefault": "false", "longName": "100070009 - Statement - Consolidated Statements of Equity (Parentheticals)", "role": "http://www.corteva.com/role/ConsolidatedStatementsofEquityParentheticals", "shortName": "Consolidated Statements of Equity (Parentheticals)", "subGroupType": "parenthetical", "uniqueAnchor": null }, "R90": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "ic3c0434c1aad407886edd72701605d70_I20201231", "decimals": "-6", "first": true, "lang": "en-US", "name": "ctva:DeferredTaxAssetsOperatingLossAndTaxCreditCarryforwards", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240504028 - Disclosure - Income Taxes Income Taxes - Deferred Tax Balances (Details)", "role": "http://www.corteva.com/role/IncomeTaxesIncomeTaxesDeferredTaxBalancesDetails", "shortName": "Income Taxes Income Taxes - Deferred Tax Balances (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "ic3c0434c1aad407886edd72701605d70_I20201231", "decimals": "-6", "first": true, "lang": "en-US", "name": "ctva:DeferredTaxAssetsOperatingLossAndTaxCreditCarryforwards", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R91": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ctva:SummaryofOperatingLossandTaxCreditCarryforwardsTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "id110b8058ec54269a2cb77f3badc9bac_I20211231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240514029 - Disclosure - Income Taxes Income Taxes - Operating Loss and Tax Credit Carryforwards (Details)", "role": "http://www.corteva.com/role/IncomeTaxesIncomeTaxesOperatingLossandTaxCreditCarryforwardsDetails", "shortName": "Income Taxes Income Taxes - Operating Loss and Tax Credit Carryforwards (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ctva:SummaryofOperatingLossandTaxCreditCarryforwardsTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "id110b8058ec54269a2cb77f3badc9bac_I20211231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R92": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "ic3c0434c1aad407886edd72701605d70_I20201231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:UnrecognizedTaxBenefits", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240524030 - Disclosure - Income Taxes Income Taxes - Gross Unrecognized Tax Benefits (Details)", "role": "http://www.corteva.com/role/IncomeTaxesIncomeTaxesGrossUnrecognizedTaxBenefitsDetails", "shortName": "Income Taxes Income Taxes - Gross Unrecognized Tax Benefits (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "i5a3c9d5bcb3a4d64b738ac0a84121974_I20181231", "decimals": "-6", "lang": "en-US", "name": "us-gaap:UnrecognizedTaxBenefits", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R93": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "i3f265b2e894e48d698978a18e7f57d53_I20190601", "decimals": "0", "first": true, "lang": "en-US", "name": "us-gaap:CommonStockSharesIssued", "reportCount": 1, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240554031 - Disclosure - Earnings Per Share Narrative (Details)", "role": "http://www.corteva.com/role/EarningsPerShareNarrativeDetails", "shortName": "Earnings Per Share Narrative (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R94": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240564032 - Disclosure - Earnings Per Share Net Income for Earnings Per Share Calculations - Basic and Diluted (Details)", "role": "http://www.corteva.com/role/EarningsPerShareNetIncomeforEarningsPerShareCalculationsBasicandDilutedDetails", "shortName": "Earnings Per Share Net Income for Earnings Per Share Calculations - Basic and Diluted (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": "-6", "lang": "en-US", "name": "ctva:NetIncomeLossfromContinuingOperationsAvailabletoCommonShareholdersBasicandDiluted", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R95": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": "2", "first": true, "lang": "en-US", "name": "us-gaap:IncomeLossFromContinuingOperationsPerBasicShare", "reportCount": 1, "unitRef": "usdPerShare", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240574033 - Disclosure - Earnings Per Share of Common Stock EPS Calculation - Basic (Details)", "role": "http://www.corteva.com/role/EarningsPerShareofCommonStockEPSCalculationBasicDetails", "shortName": "Earnings Per Share of Common Stock EPS Calculation - Basic (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfEarningsPerShareBasicByCommonClassTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": "2", "lang": "en-US", "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R96": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": "2", "first": true, "lang": "en-US", "name": "us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare", "reportCount": 1, "unitRef": "usdPerShare", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240584034 - Disclosure - Earnings Per Share of Common Stock EPS Calculation - Diluted (Details)", "role": "http://www.corteva.com/role/EarningsPerShareofCommonStockEPSCalculationDilutedDetails", "shortName": "Earnings Per Share of Common Stock EPS Calculation - Diluted (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": "2", "lang": "en-US", "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R97": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ctva:ShareCountInformationTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:WeightedAverageNumberOfSharesOutstandingBasic", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240594035 - Disclosure - Earnings Per Share Share Count Information (Details)", "role": "http://www.corteva.com/role/EarningsPerShareShareCountInformationDetails", "shortName": "Earnings Per Share Share Count Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ctva:ShareCountInformationTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:WeightedAverageNumberOfSharesOutstandingBasic", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R98": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "id110b8058ec54269a2cb77f3badc9bac_I20211231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:AccountsReceivableNetCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240624036 - Disclosure - Accounts and Notes Receivable, Net (Schedule of Accounts and Notes Receivable, Net) (Details)", "role": "http://www.corteva.com/role/AccountsandNotesReceivableNetScheduleofAccountsandNotesReceivableNetDetails", "shortName": "Accounts and Notes Receivable, Net (Schedule of Accounts and Notes Receivable, Net) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "id110b8058ec54269a2cb77f3badc9bac_I20211231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:AccountsReceivableNetCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R99": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "id110b8058ec54269a2cb77f3badc9bac_I20211231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "240634037 - Disclosure - Accounts and Notes Receivable Allowance Rollforward (Details)", "role": "http://www.corteva.com/role/AccountsandNotesReceivableAllowanceRollforwardDetails", "shortName": "Accounts and Notes Receivable Allowance Rollforward (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "ctva-20211231.htm", "contextRef": "iaf610d50bf1c497d912c87112ca6e51c_D20210101-20211231", "decimals": "-6", "lang": "en-US", "name": "us-gaap:ProvisionForDoubtfulAccounts", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } } }, "segmentCount": 245, "tag": { "country_BR": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "BRAZIL", "terseLabel": "BRAZIL" } } }, "localname": "BR", "nsuri": "http://xbrl.sec.gov/country/2021", "presentation": [ "http://www.corteva.com/role/GeographicInformationRevenuebyCountryDetails" ], "xbrltype": "domainItemType" }, "country_CA": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CANADA", "terseLabel": "CANADA" } } }, "localname": "CA", "nsuri": "http://xbrl.sec.gov/country/2021", "presentation": [ "http://www.corteva.com/role/GeographicInformationNetPropertybyCountryDetails", "http://www.corteva.com/role/GeographicInformationRevenuebyCountryDetails" ], "xbrltype": "domainItemType" }, "country_US": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "UNITED STATES", "terseLabel": "UNITED STATES" } } }, "localname": "US", "nsuri": "http://xbrl.sec.gov/country/2021", "presentation": [ "http://www.corteva.com/role/GeographicInformationNetPropertybyCountryDetails", "http://www.corteva.com/role/GeographicInformationRevenuebyCountryDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansBasisofFairValueMeasurementDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansSummaryofFairValueMeasurementofLevel3PensionPlanAssetsDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansTargetAllocationforPlanAssetsDetails" ], "xbrltype": "domainItemType" }, "ctva_A2.800Notesdue2023Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "2.800% Notes due 2023 [Member]", "label": "2.800% Notes due 2023 [Member]", "terseLabel": "2.800% Notes due 2023 [Member]" } } }, "localname": "A2.800Notesdue2023Member", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/LongTermDebtandAvailableCreditFacilitiesDebtRedemptionsRepaymentsDetails" ], "xbrltype": "domainItemType" }, "ctva_A2016GlobalCostSavingsandRestructuringPlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "2016 Global Cost Savings and Restructuring Plan [Member]", "label": "2016 Global Cost Savings and Restructuring Plan [Member]", "terseLabel": "2016 Global Cost Savings and Restructuring Plan [Member]" } } }, "localname": "A2016GlobalCostSavingsandRestructuringPlanMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "ctva_A2019ShareRepurchasePlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "2019 share repurchase plan", "label": "2019 share repurchase plan [Member]", "terseLabel": "2019 share repurchase plan" } } }, "localname": "A2019ShareRepurchasePlanMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/StockholdersEquityCommonStockDetails" ], "xbrltype": "domainItemType" }, "ctva_A2021RestructuringActionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "2021 Restructuring Actions", "label": "2021 Restructuring Actions [Member]", "terseLabel": "2021 Restructuring Actions [Member]" } } }, "localname": "A2021RestructuringActionsMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/RestructuringandAssetRelatedCharges2021RestructuringActionsDetails", "http://www.corteva.com/role/RestructuringandAssetRelatedChargesTables" ], "xbrltype": "domainItemType" }, "ctva_A3.50SeriesPreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "$3.50 Series Preferred Stock [Member]", "label": "$3.50 Series Preferred Stock [Member]", "terseLabel": "$3.50 Series Preferred Stock [Member]" } } }, "localname": "A3.50SeriesPreferredStockMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/ConsolidatedBalanceSheets", "http://www.corteva.com/role/ConsolidatedBalanceSheetsParentheticals", "http://www.corteva.com/role/ConsolidatedStatementsofEquityParentheticals", "http://www.corteva.com/role/DEIDocument", "http://www.corteva.com/role/StockholdersEquityNoncontrollingInterestDetails" ], "xbrltype": "domainItemType" }, "ctva_A3.625Notesdue2021Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "3.625% Notes due 2021 [Member]", "label": "3.625% Notes due 2021 [Member]", "terseLabel": "3.625% Notes due 2021 [Member]" } } }, "localname": "A3.625Notesdue2021Member", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/LongTermDebtandAvailableCreditFacilitiesDebtRedemptionsRepaymentsDetails" ], "xbrltype": "domainItemType" }, "ctva_A4.150Notesdue2043Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "4.150% Notes due 2043 [Member]", "label": "4.150% Notes due 2043 [Member]", "terseLabel": "4.150% Notes due 2043 [Member]" } } }, "localname": "A4.150Notesdue2043Member", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/LongTermDebtandAvailableCreditFacilitiesDebtRedemptionsRepaymentsDetails" ], "xbrltype": "domainItemType" }, "ctva_A4.250Notesdue2021Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "4.250% Notes due 2021 [Member]", "label": "4.250% Notes due 2021 [Member]", "terseLabel": "4.250% Notes due 2021 [Member]" } } }, "localname": "A4.250Notesdue2021Member", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/LongTermDebtandAvailableCreditFacilitiesDebtRedemptionsRepaymentsDetails" ], "xbrltype": "domainItemType" }, "ctva_A4.50SeriesPreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "$4.50 preferred stock [Member]", "label": "$4.50 Series Preferred Stock [Member]", "terseLabel": "$4.50 Series Preferred Stock [Member]" } } }, "localname": "A4.50SeriesPreferredStockMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/ConsolidatedBalanceSheets", "http://www.corteva.com/role/ConsolidatedBalanceSheetsParentheticals", "http://www.corteva.com/role/ConsolidatedStatementsofEquityParentheticals", "http://www.corteva.com/role/DEIDocument", "http://www.corteva.com/role/StockholdersEquityNoncontrollingInterestDetails" ], "xbrltype": "domainItemType" }, "ctva_A4.625Notesdue2020Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "4.625% Notes due 2020 [Member]", "label": "4.625% Notes due 2020 [Member]", "terseLabel": "4.625% Notes due 2020 [Member]" } } }, "localname": "A4.625Notesdue2020Member", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/LongTermDebtandAvailableCreditFacilitiesDebtRedemptionsRepaymentsDetails" ], "xbrltype": "domainItemType" }, "ctva_A4.900Notesdue2041Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "4.900% Notes due 2041 [Member]", "label": "4.900% Notes due 2041 [Member]", "terseLabel": "4.900% Notes due 2041 [Member]" } } }, "localname": "A4.900Notesdue2041Member", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/LongTermDebtandAvailableCreditFacilitiesDebtRedemptionsRepaymentsDetails" ], "xbrltype": "domainItemType" }, "ctva_A5.600SeniorNotesdue2036Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "5.600% Senior Notes due 2036 [Member]", "label": "5.600% Senior Notes due 2036 [Member]", "terseLabel": "5.600% Senior Notes due 2036 [Member]" } } }, "localname": "A5.600SeniorNotesdue2036Member", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/LongTermDebtandAvailableCreditFacilitiesDebtRedemptionsRepaymentsDetails" ], "xbrltype": "domainItemType" }, "ctva_A6.500Debenturesdue2028Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "6.500% Debentures due 2028 [Member]", "label": "6.500% Debentures due 2028 [Member]", "terseLabel": "6.500% Debentures due 2028 [Member]" } } }, "localname": "A6.500Debenturesdue2028Member", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/LongTermDebtandAvailableCreditFacilitiesDebtRedemptionsRepaymentsDetails" ], "xbrltype": "domainItemType" }, "ctva_APACBusinessMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "APAC Business", "label": "APAC Business [Member]", "terseLabel": "APAC Business [Member]" } } }, "localname": "APACBusinessMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/SupplementaryInformationOtherIncomeExpenseNetDetails" ], "xbrltype": "domainItemType" }, "ctva_AcceleratedPrepaidRoyaltyAmortizationExpense": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Asset related cost for non-cash accelerated prepaid royalty amortization expense", "label": "Accelerated Prepaid Royalty Amortization Expense", "terseLabel": "Accelerated Prepaid Royalty Amortization Expense" } } }, "localname": "AcceleratedPrepaidRoyaltyAmortizationExpense", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/RestructuringandAssetRelatedChargesAssetImpairmentsDetails" ], "xbrltype": "monetaryItemType" }, "ctva_AccountsandNotesReceivableMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Accounts and Notes Receivable [Member]", "label": "Accounts and Notes Receivable [Member]", "terseLabel": "Accounts and Notes Receivable [Member]" } } }, "localname": "AccountsandNotesReceivableMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationChemoursDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsDivestituresandOtherTransactionsNarrativeDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsDivestituresandOtherTransactionsPChemResultsofOperationsDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsECPDivestitureDetails" ], "xbrltype": "domainItemType" }, "ctva_Accountsandnotesreceivabletrade": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Accounts and notes receivable - trade (does not include Other AR), net of allowance for doubtful accounts", "label": "Accounts and notes receivable - trade", "terseLabel": "Accounts and notes receivable - trade" } } }, "localname": "Accountsandnotesreceivabletrade", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/RevenueContractBalancesDetails" ], "xbrltype": "monetaryItemType" }, "ctva_AccrualforEnvironmentalLossContingenciesPotentialExposureinExcessofAccrual": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accrual for Environmental Loss Contingencies, Potential Exposure in Excess of Accrual", "label": "Accrual for Environmental Loss Contingencies, Potential Exposure in Excess of Accrual", "terseLabel": "Accrual for Environmental Loss Contingencies, Potential Exposure in Excess of Accrual" } } }, "localname": "AccrualforEnvironmentalLossContingenciesPotentialExposureinExcessofAccrual", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesEnvironmentalDetails" ], "xbrltype": "monetaryItemType" }, "ctva_AccruedandOtherCurrentLiabilitiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Accrued and Other Current Liabilities [Member]", "label": "Accrued and Other Current Liabilities [Member]", "terseLabel": "Accrued and Other Current Liabilities [Member]" } } }, "localname": "AccruedandOtherCurrentLiabilitiesMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationChemoursDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsDivestituresandOtherTransactionsNarrativeDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsDivestituresandOtherTransactionsPChemResultsofOperationsDetails", "http://www.corteva.com/role/EIDRelatedPartyDetails", "http://www.corteva.com/role/FinancialInstrumentsFairValueofDerivativesDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansAmountsRecognizedinConsolidatedBalanceSheetsDetails", "http://www.corteva.com/role/RevenueContractBalancesDetails", "http://www.corteva.com/role/SupplementaryInformationSupplementaryInformationNarrativeDetails" ], "xbrltype": "domainItemType" }, "ctva_AccruedinterestreversalsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Accrued interest reversals [Member]", "label": "Accrued interest reversals [Member]", "terseLabel": "Accrued interest reversals [Member]" } } }, "localname": "AccruedinterestreversalsMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/EIDIncomeTaxesRateReconciliationDetails", "http://www.corteva.com/role/IncomeTaxesIncomeTaxesReconciliationtoUSStatutoryRateDetails" ], "xbrltype": "domainItemType" }, "ctva_AccumulatedDefinedBenefitPlansAdjustmentCurtailmentGainLossAttributabletoParentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Accumulated Defined Benefit Plans Adjustment, Curtailment Gain (Loss) Attributable to Parent [Member]", "label": "Accumulated Defined Benefit Plans Adjustment, Curtailment Gain (Loss) Attributable to Parent [Member]", "terseLabel": "Curtailment (loss) gain" } } }, "localname": "AccumulatedDefinedBenefitPlansAdjustmentCurtailmentGainLossAttributabletoParentMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/StockholdersEquityReclassificationsoutofAOCIDetails" ], "xbrltype": "domainItemType" }, "ctva_AccumulatedDefinedBenefitPlansAdjustmentSettlementGainLossMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Accumulated Defined Benefit Plans Adjustment, Settlement Gain (Loss) [Member]", "label": "Accumulated Defined Benefit Plans Adjustment, Settlement Gain (Loss) [Member]", "terseLabel": "Accumulated Defined Benefit Plans Adjustment, Settlement Gain (Loss) [Member]" } } }, "localname": "AccumulatedDefinedBenefitPlansAdjustmentSettlementGainLossMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/StockholdersEquityReclassificationsoutofAOCIDetails" ], "xbrltype": "domainItemType" }, "ctva_AdditionalannualPFOAliabilitiesforthenextfiveyearspaidbyChemours": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Additional annual PFOA liabilities for the next five years paid by Chemours, up to $25 million per year.", "label": "Additional annual PFOA liabilities for the next five years paid by Chemours", "terseLabel": "Additional annual PFOA liabilities for the next five years paid by Chemours" } } }, "localname": "AdditionalannualPFOAliabilitiesforthenextfiveyearspaidbyChemours", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationChemoursDetails" ], "xbrltype": "monetaryItemType" }, "ctva_AdditionalannualPFOAliabilitiesforthenextfiveyearspaidbyCorteva": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Additional amounts EID will pay annually, if Chemours $25 million is exceeded. EID will pay excess up to the next $25 million, with Chemours annually bearing excess liabilities above that amount.", "label": "Additional annual PFOA liabilities for the next five years paid by Corteva", "terseLabel": "Additional annual PFOA liabilities for the next five years paid by Corteva" } } }, "localname": "AdditionalannualPFOAliabilitiesforthenextfiveyearspaidbyCorteva", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationChemoursDetails" ], "xbrltype": "monetaryItemType" }, "ctva_AgreementsWithLendersToProvideFinancingForSelectCustomersMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Agreements with lenders to provide financing for select customers", "label": "Agreements with lenders to provide financing for select customers [Member]", "terseLabel": "Agreements with lenders to provide financing for select customers [Member]" } } }, "localname": "AgreementsWithLendersToProvideFinancingForSelectCustomersMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesGuaranteeNarrativeDetails" ], "xbrltype": "domainItemType" }, "ctva_AlabamaWaterUtilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Alabama Water Utility", "label": "Alabama Water Utility [Member]", "terseLabel": "Alabama Water Utility [Member]" } } }, "localname": "AlabamaWaterUtilityMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationOtherPFOAMattersFayattevilleDetails" ], "xbrltype": "domainItemType" }, "ctva_AllotherplansMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "All other plans [Member]", "label": "All other plans [Member]", "terseLabel": "All other plans [Member]" } } }, "localname": "AllotherplansMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansChangeinProjectedBenefitObligationsPlanAssetsandFundedStatusDetails" ], "xbrltype": "domainItemType" }, "ctva_Amountcreditedtoeachcompanysthreshold": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount credited to each company's threshold for PFAS costs shared between DuPont and Corteva.", "label": "Amount credited to each company's threshold", "terseLabel": "Amount credited to each company's threshold" } } }, "localname": "Amountcreditedtoeachcompanysthreshold", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationChemoursDetails", "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationDuPontDetails" ], "xbrltype": "monetaryItemType" }, "ctva_AnnualEscrowDeposit": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "No later than each of September 30, 2021 and September 30, 2022, Chemours shall deposit $100 million into an escrow account and DuPont and Corteva shall together deposit $100 million in the aggregate into an escrow account.", "label": "Annual escrow deposit", "terseLabel": "MOU Escrow Account Deposit" } } }, "localname": "AnnualEscrowDeposit", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationChemoursDetails" ], "xbrltype": "monetaryItemType" }, "ctva_AnnualEscrowDepositRemainderOfPeriod": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "No later than September 30 of each subsequent year through and including 2028, Chemours shall deposit $50 million into an escrow account and DuPont and Corteva shall together deposit $50 million in the aggregate into an escrow account", "label": "Annual escrow deposit, remainder of period", "terseLabel": "Annual escrow deposit, remainder of period" } } }, "localname": "AnnualEscrowDepositRemainderOfPeriod", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationChemoursDetails" ], "xbrltype": "monetaryItemType" }, "ctva_ArgentinePesoDevaluation": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Argentine Peso Devaluation", "label": "Argentine Peso Devaluation", "terseLabel": "Argentine Peso Devaluation" } } }, "localname": "ArgentinePesoDevaluation", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/SegmentReportingSigItemsDetails" ], "xbrltype": "monetaryItemType" }, "ctva_ArgentinepesodevaluationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Argentine peso devaluation [Member]", "label": "Argentine peso devaluation [Member]", "terseLabel": "Argentine peso devaluation [Member]" } } }, "localname": "ArgentinepesodevaluationMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/EIDSegmentFNSegmentReconciliationDetails", "http://www.corteva.com/role/QuaterlyFinancialDataQuarterlyFinancialDataParentheticalsDetails", "http://www.corteva.com/role/SegmentReportingSegmentReconciliationDetails", "http://www.corteva.com/role/SegmentReportingSigItemsDetails", "http://www.corteva.com/role/SupplementaryInformationForeignCurrencyExchangeGainLossDetails", "http://www.corteva.com/role/SupplementaryInformationOtherIncomeExpenseNetDetails" ], "xbrltype": "domainItemType" }, "ctva_AssetRelatedChargesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Asset Related Charges", "label": "Asset Related Charges [Member]", "terseLabel": "Asset Related Charges [Member]" } } }, "localname": "AssetRelatedChargesMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/RestructuringandAssetRelatedCharges2021RestructuringActionsDetails", "http://www.corteva.com/role/RestructuringandAssetRelatedChargesDowDuPontAgricultureDivisionRestructuringProgramDetails", "http://www.corteva.com/role/RestructuringandAssetRelatedChargesDowDuPontCostSynergyProgramDetails", "http://www.corteva.com/role/RestructuringandAssetRelatedChargesExecutetoWinProductivityProgramDetails" ], "xbrltype": "domainItemType" }, "ctva_Assetimpairmentsandassetrelatedcharges": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Asset impairments and asset related charges", "label": "Asset impairments and asset related charges", "terseLabel": "Asset related charges" } } }, "localname": "Assetimpairmentsandassetrelatedcharges", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "ctva_AssetsOfDiscontinuedOperationsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Assets of discontinued operations [Member]", "label": "Assets of discontinued operations [Member]", "terseLabel": "Assets of discontinued operations - current [Member]" } } }, "localname": "AssetsOfDiscontinuedOperationsMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/EIDSegmentFNSegmentAssetReconciliationDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansAmountsRecognizedinConsolidatedBalanceSheetsDetails", "http://www.corteva.com/role/SegmentReportingSegmentAssetsDetails" ], "xbrltype": "domainItemType" }, "ctva_AssetsaleMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Asset sale [Member]", "label": "Asset sale [Member]", "terseLabel": "Asset sale [Member]" } } }, "localname": "AssetsaleMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/SegmentReportingSigItemsDetails" ], "xbrltype": "domainItemType" }, "ctva_Assetwriteoffsandadjustments": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Noncash activity affecting the restructuring reserve related to asset write-offs and adjustments.", "label": "Asset write-offs and adjustments", "terseLabel": "Asset write-offs" } } }, "localname": "Assetwriteoffsandadjustments", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/RestructuringandAssetRelatedCharges2021RestructuringActionsDetails", "http://www.corteva.com/role/RestructuringandAssetRelatedChargesDowDuPontCostSynergyProgramDetails", "http://www.corteva.com/role/RestructuringandAssetRelatedChargesExecutetoWinProductivityProgramDetails" ], "xbrltype": "monetaryItemType" }, "ctva_AuditInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Audit Information", "label": "Audit Information [Abstract]" } } }, "localname": "AuditInformationAbstract", "nsuri": "http://www.corteva.com/20211231", "xbrltype": "stringItemType" }, "ctva_BalanceSheetMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Balance Sheet [Member]", "label": "Balance Sheet [Member]", "terseLabel": "Balance Sheet [Member]" } } }, "localname": "BalanceSheetMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/CommonControlBusinessCombinationsTables", "http://www.corteva.com/role/DivestituresandOtherTransactionsTables" ], "xbrltype": "domainItemType" }, "ctva_BindingSettlementAgreementClassSize": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Binding settlement agreement, class size", "label": "Binding Settlement Agreement Class Size", "terseLabel": "Binding Settlement Agreement Class Size" } } }, "localname": "BindingSettlementAgreementClassSize", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationLeachandMDLSettlementDetails" ], "xbrltype": "integerItemType" }, "ctva_BrazilValuationAllowanceMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Brazil Valuation Allowance [Member]", "label": "Brazil Valuation Allowance [Member]", "terseLabel": "Brazil Valuation Allowance [Member]" } } }, "localname": "BrazilValuationAllowanceMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/EIDIncomeTaxesRateReconciliationDetails", "http://www.corteva.com/role/IncomeTaxesIncomeTaxesDeferredTaxBalancesDetails", "http://www.corteva.com/role/IncomeTaxesIncomeTaxesReconciliationtoUSStatutoryRateDetails" ], "xbrltype": "domainItemType" }, "ctva_BusinessCombinationConsiderationTransferredEquityInterestsIssuedandIssuableConversionRatio": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Business Combination, Consideration Transferred, Equity Interests Issued and Issuable, Conversion Ratio", "label": "Business Combination, Consideration Transferred, Equity Interests Issued and Issuable, Conversion Ratio", "terseLabel": "Business Combination, Conversion Ratio" } } }, "localname": "BusinessCombinationConsiderationTransferredEquityInterestsIssuedandIssuableConversionRatio", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/StockBasedCompensationStockCompensationDetails" ], "xbrltype": "sharesItemType" }, "ctva_BusinessCombinationConsiderationTransferredEquityInterestsIssuedandIssuableConvertedButNotYetEarned": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Business Combination, Consideration Transferred, Equity Interests Issued and Issuable, Converted But Not Yet Earned", "label": "Business Combination, Consideration Transferred, Equity Interests Issued and Issuable, Converted But Not Yet Earned", "terseLabel": "Business Combination, Fair Value, Amortized to Stock Comp Expense" } } }, "localname": "BusinessCombinationConsiderationTransferredEquityInterestsIssuedandIssuableConvertedButNotYetEarned", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/StockBasedCompensationStockCompensationDetails" ], "xbrltype": "monetaryItemType" }, "ctva_BusinessCombinationConsiderationTransferredEquityInterestsIssuedandIssuableIncludingConvertedButNotYetEarned": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Business Combination, Consideration Transferred, Equity Interests Issued and Issuable Including Converted But Not Yet Earned", "label": "Business Combination, Consideration Transferred, Equity Interests Issued and Issuable Including Converted But Not Yet Earned", "terseLabel": "Business Combination, Fair Value of Equity Awards" } } }, "localname": "BusinessCombinationConsiderationTransferredEquityInterestsIssuedandIssuableIncludingConvertedButNotYetEarned", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/StockBasedCompensationStockCompensationDetails" ], "xbrltype": "monetaryItemType" }, "ctva_BusinessCombinationFairValueStepUpOfAcquiredInventory": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Business Combination, Fair Value Step Up Of Acquired Inventory", "label": "Business Combination, Fair Value Step Up Of Acquired Inventory", "terseLabel": "Fair Value Step-up" } } }, "localname": "BusinessCombinationFairValueStepUpOfAcquiredInventory", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/InventoriesScheduleofInventoryDetails" ], "xbrltype": "monetaryItemType" }, "ctva_BusinessCombinationFairValueStepUpOfAcquiredInventoryAmountrecognizedinCostofGoodssold": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Business Combination, Fair Value Step-Up Of Acquired Inventory, Amount recognized in Cost of Goods sold", "label": "Business Combination, Fair Value Step-Up Of Acquired Inventory, Amount recognized in Cost of Goods sold", "terseLabel": "Business Combination, Fair Value Step-Up Of Acquired Inventory, Amount recognized in Cost of Goods sold", "verboseLabel": "Amortization of Fair Value Step-up" } } }, "localname": "BusinessCombinationFairValueStepUpOfAcquiredInventoryAmountrecognizedinCostofGoodssold", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/InventoriesScheduleofInventoryDetails", "http://www.corteva.com/role/QuaterlyFinancialDataQuarterlyFinancialDataParentheticalsDetails", "http://www.corteva.com/role/SegmentReportingSigItemsDetails" ], "xbrltype": "monetaryItemType" }, "ctva_BusinessCombinationIntegrationAndSeparationRelatedCosts": { "auth_ref": [], "calculation": { "http://www.corteva.com/role/ConsolidatedStatementsofIncome": { "order": 9.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Integration and separation costs includes costs incurred to prepare for and close the Merger, post-Merger integration expenses and costs incurred to prepare for the Intended Business Separations. These costs primarily consist of financial advisory, information technology, legal, accounting, consulting and other professional advisory fees associated with preparation and execution of these activities.", "label": "Business Combination, Integration And Separation Related Costs", "terseLabel": "Integration and Separation Costs" } } }, "localname": "BusinessCombinationIntegrationAndSeparationRelatedCosts", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/ConsolidatedStatementsofIncome", "http://www.corteva.com/role/QuaterlyFinancialDataQuarterlyFinancialDataDetails", "http://www.corteva.com/role/SegmentReportingSigItemsDetails", "http://www.corteva.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "ctva_BusinessCombinationsInventoryFairValueAdjustment": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Business Combinations Inventory Fair Value Adjustment", "label": "Business Combinations Inventory Fair Value Adjustment", "terseLabel": "Amortization of inventory step-up" } } }, "localname": "BusinessCombinationsInventoryFairValueAdjustment", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "ctva_CTVARelatedPartyLiability": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Payables to Corteva, Inc. related to Corteva's indemnification liabilities to Dow and DuPont per the Separation Agreements.", "label": "CTVA Related Party Liability", "terseLabel": "CTVA Related Party Liability" } } }, "localname": "CTVARelatedPartyLiability", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/EIDRelatedPartyDetails" ], "xbrltype": "monetaryItemType" }, "ctva_CashCashEquivalentsandRestrictedCashAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cash, Cash Equivalents, and Restricted Cash [Abstract]", "label": "Cash, Cash Equivalents, and Restricted Cash [Abstract]", "terseLabel": "Cash, Cash Equivalents, and Restricted Cash [Abstract]" } } }, "localname": "CashCashEquivalentsandRestrictedCashAbstract", "nsuri": "http://www.corteva.com/20211231", "xbrltype": "stringItemType" }, "ctva_CashFlowMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cash Flow [Member]", "label": "Cash Flow [Member]", "terseLabel": "Cash Flow [Member]" } } }, "localname": "CashFlowMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/DivestituresandOtherTransactionsTables" ], "xbrltype": "domainItemType" }, "ctva_Cashcashequivalentsandrestrictedcashequivalentsfairvaluedisclosure": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Cash, cash equivalents and restricted cash equivalents, fair value disclosure", "label": "Cash, cash equivalents and restricted cash equivalents, fair value disclosure", "terseLabel": "Cash equivalents and restricted cash equivalents" } } }, "localname": "Cashcashequivalentsandrestrictedcashequivalentsfairvaluedisclosure", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/FairValueMeasurementsFairValueMeasurementRecurringBasisDetails" ], "xbrltype": "monetaryItemType" }, "ctva_CashtransferredatInternalReorganization": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Cash transferred at Internal Reorganization", "label": "Cash transferred at Internal Reorganization", "terseLabel": "Cash Transferred to DowDuPont at Internal Reorganizations" } } }, "localname": "CashtransferredatInternalReorganization", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "ctva_ChangeInAccountingMethodMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Elective change in accounting method that alters the 2019 impact of the business separation on the 2017 Tax Cuts and Jobs Act's foreign tax provision", "label": "Change in accounting method [Member]", "terseLabel": "Change in accounting method [Member]" } } }, "localname": "ChangeInAccountingMethodMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/IncomeTaxesIncomeTaxesReconciliationtoUSStatutoryRateDetails", "http://www.corteva.com/role/QuaterlyFinancialDataQuarterlyFinancialDataParentheticalsDetails" ], "xbrltype": "domainItemType" }, "ctva_ChemoursContributionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Chemours Contribution", "label": "Chemours Contribution [Member]", "terseLabel": "Chemours Contribution [Member]" } } }, "localname": "ChemoursContributionMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationLeachandMDLSettlementDetails" ], "xbrltype": "domainItemType" }, "ctva_ChemoursContributionToMDLSettlementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Chemours Contribution to MDL Settlement", "label": "Chemours Contribution to MDL Settlement [Member]", "terseLabel": "Chemours Contribution to MDL Settlement [Member]" } } }, "localname": "ChemoursContributionToMDLSettlementMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationLeachandMDLSettlementDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsDivestituresandOtherTransactionsPChemResultsofOperationsDetails" ], "xbrltype": "domainItemType" }, "ctva_ChemoursMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Chemours [Member]", "label": "Chemours [Member]", "terseLabel": "Chemours [Member]" } } }, "localname": "ChemoursMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesEnvironmentalDetails", "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationChemoursDetails", "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationLeachandMDLSettlementDetails", "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationOtherPFOAMattersFayattevilleDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsDivestituresandOtherTransactionsPChemResultsofOperationsDetails" ], "xbrltype": "domainItemType" }, "ctva_ChemoursShareOfPaymentToNRSTTrustPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Chemours share of payment to NRST Trust, percentage", "label": "Chemours share of payment to NRST Trust, percentage", "terseLabel": "Chemours share of payment to NRST Trust, percentage" } } }, "localname": "ChemoursShareOfPaymentToNRSTTrustPercentage", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationOtherPFOAMattersFayattevilleDetails" ], "xbrltype": "percentItemType" }, "ctva_ChemoursrelatedobligationsubjecttoindemnificationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Chemours related obligation subject to indemnification [Member]", "label": "Chemours related obligation subject to indemnification [Member]", "terseLabel": "Chemours related obligation subject to indemnification [Member]" } } }, "localname": "ChemoursrelatedobligationsubjecttoindemnificationMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesEnvironmentalDetails" ], "xbrltype": "domainItemType" }, "ctva_CollectiveThresholdForPaymentsToFundTheNRSTTrust": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Collective Threshold for Payments to Fund the NRST Trust", "label": "Collective Threshold for Payments to Fund the NRST Trust", "terseLabel": "Collective Threshold for Payments to Fund the NRST Trust" } } }, "localname": "CollectiveThresholdForPaymentsToFundTheNRSTTrust", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationOtherPFOAMattersFayattevilleDetails" ], "xbrltype": "monetaryItemType" }, "ctva_CombinationofEntitiesunderCommonControlTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Combination of Entities under Common Control [Text Block]", "label": "Combination of Entities under Common Control [Text Block]", "terseLabel": "Business Combination Disclosure [Text Block]" } } }, "localname": "CombinationofEntitiesunderCommonControlTextBlock", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/CommonControlBusinessCombinations" ], "xbrltype": "textBlockItemType" }, "ctva_CommonControlCombinationTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "[Table Text Block] for Common Control Combination [Table]", "label": "Common Control Combination [Table Text Block]", "terseLabel": "Common Control Combination [Table Text Block]" } } }, "localname": "CommonControlCombinationTableTextBlock", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/CommonControlBusinessCombinationsTables" ], "xbrltype": "textBlockItemType" }, "ctva_CommoncontrolcombinationAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Common control combination [Axis]", "label": "Common control combination [Axis]", "terseLabel": "Common control combination [Axis]" } } }, "localname": "CommoncontrolcombinationAxis", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/BusinessCombinationsDASCommonControlTransferIncomeStatementDetails" ], "xbrltype": "stringItemType" }, "ctva_CommoncontrolcombinationDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "[Domain] for Common control combination [Axis]", "label": "Common control combination [Domain]", "terseLabel": "Common control combination [Domain]" } } }, "localname": "CommoncontrolcombinationDomain", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/BusinessCombinationsDASCommonControlTransferIncomeStatementDetails" ], "xbrltype": "domainItemType" }, "ctva_CompanyAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Company [Axis]", "label": "Company [Axis]", "terseLabel": "Company [Axis]" } } }, "localname": "CompanyAxis", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/BackgroundandBasisofPresentationDetails", "http://www.corteva.com/role/ConsolidatedStatementsofEquity", "http://www.corteva.com/role/EIDBasisofPresentationDetails", "http://www.corteva.com/role/EarningsPerShareNarrativeDetails", "http://www.corteva.com/role/EarningsPerShareShareCountInformationDetails", "http://www.corteva.com/role/LongTermDebtandAvailableCreditFacilitiesDebtRedemptionsRepaymentsDetails", "http://www.corteva.com/role/RelatedPartiesServicesProvidedbyandtoDowDetails", "http://www.corteva.com/role/RelatedPartiesTransactionswithDowDuPontDetails", "http://www.corteva.com/role/StockholdersEquityCommonStockDetails", "http://www.corteva.com/role/StockholdersEquityNoncontrollingInterestDetails" ], "xbrltype": "stringItemType" }, "ctva_CompanyDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Company", "label": "Company [Domain]", "terseLabel": "Company [Domain]" } } }, "localname": "CompanyDomain", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/BackgroundandBasisofPresentationDetails", "http://www.corteva.com/role/ConsolidatedStatementsofEquity", "http://www.corteva.com/role/EIDBasisofPresentationDetails", "http://www.corteva.com/role/EarningsPerShareNarrativeDetails", "http://www.corteva.com/role/EarningsPerShareShareCountInformationDetails", "http://www.corteva.com/role/LongTermDebtandAvailableCreditFacilitiesDebtRedemptionsRepaymentsDetails", "http://www.corteva.com/role/RelatedPartiesServicesProvidedbyandtoDowDetails", "http://www.corteva.com/role/RelatedPartiesTransactionswithDowDuPontDetails", "http://www.corteva.com/role/StockholdersEquityCommonStockDetails", "http://www.corteva.com/role/StockholdersEquityNoncontrollingInterestDetails" ], "xbrltype": "domainItemType" }, "ctva_CompensatoryDamagesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Compensatory Damages", "label": "Compensatory Damages [Member]", "terseLabel": "Compensatory Damages [Member]" } } }, "localname": "CompensatoryDamagesMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationLeachandMDLSettlementDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsDivestituresandOtherTransactionsPChemResultsofOperationsDetails" ], "xbrltype": "domainItemType" }, "ctva_ContractTerminationCost": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Contract Termination Cost", "label": "Contract Termination Cost", "terseLabel": "Contract Termination Cost" } } }, "localname": "ContractTerminationCost", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/SegmentReportingSigItemsDetails", "http://www.corteva.com/role/SupplementaryInformationOtherIncomeExpenseNetDetails" ], "xbrltype": "monetaryItemType" }, "ctva_CornMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Corn [Member]", "label": "Corn [Member]", "terseLabel": "Corn [Member]" } } }, "localname": "CornMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/RevenueDisaggregationofRevenueProductsDetails" ], "xbrltype": "domainItemType" }, "ctva_CorporateAssets": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Corporate Assets", "label": "Corporate Assets", "terseLabel": "Corporate Assets" } } }, "localname": "CorporateAssets", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/EIDSegmentFNSegmentAssetReconciliationDetails", "http://www.corteva.com/role/SegmentReportingSegmentAssetsDetails" ], "xbrltype": "monetaryItemType" }, "ctva_CortevaAndDuPontShareOfNRSTTrustPayment": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Corteva and DuPont Share of NRST Trust Payment", "label": "Corteva and DuPont Share of NRST Trust Payment", "terseLabel": "Corteva and DuPont Share of NRST Trust Payment" } } }, "localname": "CortevaAndDuPontShareOfNRSTTrustPayment", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationOtherPFOAMattersFayattevilleDetails" ], "xbrltype": "monetaryItemType" }, "ctva_CortevaAndDuPontStrayLiabilitySharingPercentageForPFAS": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Corteva and DuPont stray liability sharing percentage for PFAS", "label": "Corteva and DuPont stray liability sharing percentage for PFAS", "terseLabel": "Corteva and DuPont stray liability sharing percentage for PFAS" } } }, "localname": "CortevaAndDuPontStrayLiabilitySharingPercentageForPFAS", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationChemoursDetails", "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationDuPontDetails" ], "xbrltype": "percentItemType" }, "ctva_CortevaAndDupontStrayLiabilityThresholdForPFAS": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount by which DuPont and Corteva will share PFAS costs. After threshold is exceeded, companies will share proportionally on basis of 29% (Corteva) and 71% (DuPont).", "label": "Corteva and Dupont stray liability threshold for PFAS", "terseLabel": "Corteva and Dupont stray liability threshold for PFAS" } } }, "localname": "CortevaAndDupontStrayLiabilityThresholdForPFAS", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationChemoursDetails", "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationDuPontDetails" ], "xbrltype": "monetaryItemType" }, "ctva_CortevaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Corteva [Member]", "label": "Corteva [Member]", "terseLabel": "Corteva [Member]" } } }, "localname": "CortevaMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/BackgroundandBasisofPresentationDetails", "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationChemoursDetails", "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationDuPontDetails", "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationLeachandMDLSettlementDetails", "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationOtherPFOAMattersFayattevilleDetails", "http://www.corteva.com/role/ConsolidatedStatementsofEquity", "http://www.corteva.com/role/DivestituresandOtherTransactionsDivestituresandOtherTransactionsPChemResultsofOperationsDetails", "http://www.corteva.com/role/EIDBasisofPresentationDetails", "http://www.corteva.com/role/EIDRelatedPartyDetails", "http://www.corteva.com/role/EarningsPerShareNarrativeDetails", "http://www.corteva.com/role/EarningsPerShareShareCountInformationDetails", "http://www.corteva.com/role/StockBasedCompensationRestrictedStockUnitsandPerformanceDeferredStockDetails", "http://www.corteva.com/role/StockBasedCompensationStockOptionsDetails", "http://www.corteva.com/role/StockholdersEquityCommonStockDetails", "http://www.corteva.com/role/StockholdersEquityNoncontrollingInterestDetails" ], "xbrltype": "domainItemType" }, "ctva_CortevaOtherContributionPlansMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Corteva Other Contribution Plans [Member]", "label": "Corteva Other Contribution Plans [Member]", "terseLabel": "Corteva Other Contribution Plans [Member]" } } }, "localname": "CortevaOtherContributionPlansMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "ctva_CostSharingArrangementTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Term of cost sharing arrangement under the MOU.", "label": "Cost Sharing Arrangement Term", "terseLabel": "Cost Sharing Arrangement Term" } } }, "localname": "CostSharingArrangementTerm", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationChemoursDetails" ], "xbrltype": "durationItemType" }, "ctva_CostSharingArrangementUnderTheMOUMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cost Sharing Arrangement under the MOU", "label": "Cost Sharing Arrangement under the MOU [Member]", "terseLabel": "Cost Sharing Arrangement under the MOU [Member]" } } }, "localname": "CostSharingArrangementUnderTheMOUMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesEnvironmentalDetails" ], "xbrltype": "domainItemType" }, "ctva_CostsAssociatedWithExitAndDisposalActivitiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Costs Associated with Exit and Disposal Activities", "label": "Costs Associated with Exit and Disposal Activities [Member]", "terseLabel": "Costs Associated with Exit and Disposal Activities [Member]" } } }, "localname": "CostsAssociatedWithExitAndDisposalActivitiesMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/RestructuringandAssetRelatedChargesExecutetoWinProductivityProgramDetails" ], "xbrltype": "domainItemType" }, "ctva_CostsRelatedToContractTerminationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Costs Related To Contract Termination [Member]", "label": "Costs Related To Contract Termination [Member]", "terseLabel": "Costs Related To Contract Termination [Member]" } } }, "localname": "CostsRelatedToContractTerminationMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/RestructuringandAssetRelatedChargesDowDuPontCostSynergyProgramDetails" ], "xbrltype": "domainItemType" }, "ctva_CropProtectionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Crop Protection [Member]", "label": "Crop Protection [Member]", "terseLabel": "Crop Protection [Member]" } } }, "localname": "CropProtectionMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/DivestituresandOtherTransactionsECPDivestitureDetails", "http://www.corteva.com/role/EIDSegmentFNSegmentReconciliationDetails", "http://www.corteva.com/role/GoodwillandOtherIntangibleAssetsGoodwillbySegmentDetails", "http://www.corteva.com/role/QuaterlyFinancialDataQuarterlyFinancialDataParentheticalsDetails", "http://www.corteva.com/role/RestructuringandAssetRelatedCharges2021RestructuringActionsDetails", "http://www.corteva.com/role/RestructuringandAssetRelatedChargesDowDuPontAgricultureDivisionRestructuringProgramDetails", "http://www.corteva.com/role/RestructuringandAssetRelatedChargesDowDuPontCostSynergyProgramDetails", "http://www.corteva.com/role/RestructuringandAssetRelatedChargesExecutetoWinProductivityProgramDetails", "http://www.corteva.com/role/RevenueDisaggregationofRevenueGeoDetails", "http://www.corteva.com/role/RevenueDisaggregationofRevenueProductsDetails", "http://www.corteva.com/role/SegmentReportingSegmentInformationDetails", "http://www.corteva.com/role/SegmentReportingSigItemsDetails", "http://www.corteva.com/role/SupplementaryInformationOtherIncomeExpenseNetDetails" ], "xbrltype": "domainItemType" }, "ctva_CurrentPortionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Current Portion [Member]", "label": "Current Portion [Member]", "terseLabel": "Current Portion [Member]" } } }, "localname": "CurrentPortionMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesGuaranteeNarrativeDetails" ], "xbrltype": "domainItemType" }, "ctva_DASDivestedAgBusinessMemberMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "DAS Divested Ag Business [Member] [Member]", "label": "DAS Divested Ag Business [Member] [Member]", "terseLabel": "DAS Divested Ag Business [Member] [Member]" } } }, "localname": "DASDivestedAgBusinessMemberMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/DivestituresandOtherTransactionsDivestituresandOtherTransactionsNarrativeDetails", "http://www.corteva.com/role/SupplementaryInformationOtherIncomeExpenseNetDetails" ], "xbrltype": "domainItemType" }, "ctva_DASMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "DAS [Member]", "label": "DAS [Member]", "terseLabel": "DAS [Member]" } } }, "localname": "DASMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/BackgroundandBasisofPresentationDetails", "http://www.corteva.com/role/BusinessCombinationsDASCommonControlTransferIncomeStatementDetails" ], "xbrltype": "domainItemType" }, "ctva_DeMinimisThreshold": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "De minimis requirement for which certain stray liabilities will be subject to for sharing arrangement between DuPont and Corteva.", "label": "De minimis threshold", "terseLabel": "De minimis threshold" } } }, "localname": "DeMinimisThreshold", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationChemoursDetails", "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationDuPontDetails" ], "xbrltype": "monetaryItemType" }, "ctva_DeconsolidationofasubsidiaryMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Deconsolidation of a subsidiary [Member]", "label": "Deconsolidation of a subsidiary [Member]", "terseLabel": "Deconsolidation of a subsidiary [Member]" } } }, "localname": "DeconsolidationofasubsidiaryMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/SegmentReportingSigItemsDetails", "http://www.corteva.com/role/SupplementaryInformationOtherIncomeExpenseNetDetails" ], "xbrltype": "domainItemType" }, "ctva_DecreaseInOtherPostEmploymentBenefitObligations": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Decrease in Other Post Employment Benefit Obligations due to changes made to the plans.", "label": "Decrease in Other Post Employment Benefit Obligations", "terseLabel": "Decrease in Other Post Employment Benefit Obligations" } } }, "localname": "DecreaseInOtherPostEmploymentBenefitObligations", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansWeightedAverageAssumptionsusedtoDetermineBenefitObligationsandPeriodicBenefitCostOPEBDetails" ], "xbrltype": "monetaryItemType" }, "ctva_DeferredIncomeTaxExpenseBenefitContinuingOperationsandDiscontinuedOperations": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Deferred Income Tax Expense (Benefit), Continuing Operations and Discontinued Operations", "label": "Deferred Income Tax Expense (Benefit), Continuing Operations and Discontinued Operations", "terseLabel": "Provision for (Benefit from) Deferred Income Tax" } } }, "localname": "DeferredIncomeTaxExpenseBenefitContinuingOperationsandDiscontinuedOperations", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "ctva_DeferredTaxAssetsLongTermDebt": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Deferred Tax Assets, Long-Term Debt", "label": "Deferred Tax Assets, Long-Term Debt", "terseLabel": "Deferred Tax Assets, Long-Term Debt" } } }, "localname": "DeferredTaxAssetsLongTermDebt", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/IncomeTaxesIncomeTaxesDeferredTaxBalancesDetails" ], "xbrltype": "monetaryItemType" }, "ctva_DeferredTaxAssetsOperatingLossAndTaxCreditCarryforwards": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Deferred Tax Assets, Operating Loss And Tax Credit Carryforwards", "label": "Deferred Tax Assets, Operating Loss And Tax Credit Carryforwards", "terseLabel": "Deferred Tax Assets, Tax Loss And Tax Credit Carryforwards" } } }, "localname": "DeferredTaxAssetsOperatingLossAndTaxCreditCarryforwards", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/IncomeTaxesIncomeTaxesDeferredTaxBalancesDetails" ], "xbrltype": "monetaryItemType" }, "ctva_DeferredTaxAssetsResearchAndDevelopmentCapitalization": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Deferred Tax Assets, Research and Development Capitalization", "label": "Deferred Tax Assets, Research and Development Capitalization", "terseLabel": "Deferred Tax Assets, Research and Development Capitalization" } } }, "localname": "DeferredTaxAssetsResearchAndDevelopmentCapitalization", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/IncomeTaxesIncomeTaxesDeferredTaxBalancesDetails" ], "xbrltype": "monetaryItemType" }, "ctva_DefinedBenefitPlanAmountofEmployerandRelatedPartySecuritiesIncludedinPlanAssetsPercent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Defined Benefit Plan, Amount of Employer and Related Party Securities Included in Plan Assets, Percent", "label": "Defined Benefit Plan, Amount of Employer and Related Party Securities Included in Plan Assets, Percent", "terseLabel": "Amount of Employer and Related Party Securities Included in Plan Assets, Percent" } } }, "localname": "DefinedBenefitPlanAmountofEmployerandRelatedPartySecuritiesIncludedinPlanAssetsPercent", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansBasisofFairValueMeasurementDetails" ], "xbrltype": "percentItemType" }, "ctva_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsAndDivestituresBenefitObligation": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Defined Benefit Plan, Business Combinations And Acquisitions And Divestitures, Benefit Obligation", "label": "Defined Benefit Plan, Business Combinations And Acquisitions And Divestitures, Benefit Obligation", "terseLabel": "Net effects of acquisitions / divestitures / other" } } }, "localname": "DefinedBenefitPlanBusinessCombinationsAndAcquisitionsAndDivestituresBenefitObligation", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansChangeinProjectedBenefitObligationsPlanAssetsandFundedStatusDetails" ], "xbrltype": "monetaryItemType" }, "ctva_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsAndDivestituresPlanAssets": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Defined Benefit Plan, Business Combinations And Acquisitions And Divestitures, Plan Assets", "label": "Defined Benefit Plan, Business Combinations And Acquisitions And Divestitures, Plan Assets", "terseLabel": "Net effects of acquisitions / divestitures / other" } } }, "localname": "DefinedBenefitPlanBusinessCombinationsAndAcquisitionsAndDivestituresPlanAssets", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansChangeinProjectedBenefitObligationsPlanAssetsandFundedStatusDetails" ], "xbrltype": "monetaryItemType" }, "ctva_DefinedBenefitPlanEligibleEmployeeAgeThreshold": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Defined Benefit Plan, Eligible Employee Age Threshold", "label": "Defined Benefit Plan, Eligible Employee Age Threshold", "terseLabel": "Eligible Employee Age Threshold" } } }, "localname": "DefinedBenefitPlanEligibleEmployeeAgeThreshold", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansAdditionalInformationDetails" ], "xbrltype": "integerItemType" }, "ctva_DefinedBenefitPlanExpectedFuturePaymentsTotal": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total amount of benefits for defined benefit plan expected to be paid from 2018-2027.", "label": "Defined Benefit Plan Expected Future Payments Total", "terseLabel": "Total" } } }, "localname": "DefinedBenefitPlanExpectedFuturePaymentsTotal", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansEstimatedFutureBenefitPaymentsDetails" ], "xbrltype": "monetaryItemType" }, "ctva_DefinedBenefitPlanFairValueOfPlanAssetsReconcilingItemsPensionTrustPayables": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Defined Benefit Plan, Fair Value Of Plan Assets, Reconciling Items, Pension Trust Payables", "label": "Defined Benefit Plan, Fair Value Of Plan Assets, Reconciling Items, Pension Trust Payables", "negatedTerseLabel": "Pension Trust Payables" } } }, "localname": "DefinedBenefitPlanFairValueOfPlanAssetsReconcilingItemsPensionTrustPayables", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansBasisofFairValueMeasurementDetails" ], "xbrltype": "monetaryItemType" }, "ctva_DefinedBenefitPlanFairValueOfPlanAssetsReconcilingItemsPensionTrustReceivables": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Defined Benefit Plan, Fair Value Of Plan Assets, Reconciling Items, Pension Trust Receivables", "label": "Defined Benefit Plan, Fair Value Of Plan Assets, Reconciling Items, Pension Trust Receivables", "terseLabel": "Pension Trust Receivables" } } }, "localname": "DefinedBenefitPlanFairValueOfPlanAssetsReconcilingItemsPensionTrustReceivables", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansBasisofFairValueMeasurementDetails" ], "xbrltype": "monetaryItemType" }, "ctva_DefinedBenefitPlanFairValueofPlanAssetsExcludingNetAssetValueInvestments": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Defined Benefit Plan, Fair Value of Plan Assets, Excluding Net Asset Value Investments", "label": "Defined Benefit Plan, Fair Value of Plan Assets, Excluding Net Asset Value Investments", "terseLabel": "Fair Value of Plan Assets, Excluding Trust Receivables and payables and assets measured at NAV" } } }, "localname": "DefinedBenefitPlanFairValueofPlanAssetsExcludingNetAssetValueInvestments", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansBasisofFairValueMeasurementDetails" ], "xbrltype": "monetaryItemType" }, "ctva_DefinedBenefitPlanOtherNetPeriodicBenefitCostCredit": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of other net periodic benefit cost (credit) for defined benefit plan. Includes non-operating cost components for defined benefit pension and other post employment benefit plans (interest cost, expected return on plan assets, amortization of unrecognized loss, amortization of prior service benefit)", "label": "Defined Benefit Plan, Other Net Periodic Benefit Cost (Credit)", "terseLabel": "Non-operating pension and other post employment benefit credit (cost)" } } }, "localname": "DefinedBenefitPlanOtherNetPeriodicBenefitCostCredit", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/SegmentReportingSegmentReconciliationDetails", "http://www.corteva.com/role/SupplementaryInformationOtherIncomeExpenseNetDetails" ], "xbrltype": "monetaryItemType" }, "ctva_DefinedBenefitPlanPlanWithBenefitObligationInExcessOfPlanAssetsProjectedBenefitObligation": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Defined Benefit Plan, Plan With Benefit Obligation In Excess Of Plan Assets, Projected Benefit Obligation", "label": "Defined Benefit Plan, Plan With Benefit Obligation In Excess Of Plan Assets, Projected Benefit Obligation", "terseLabel": "Projected benefit obligations" } } }, "localname": "DefinedBenefitPlanPlanWithBenefitObligationInExcessOfPlanAssetsProjectedBenefitObligation", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansPensionPlanswithProjectedBenefitObligationsinExcessofPlanAssetsDetails" ], "xbrltype": "monetaryItemType" }, "ctva_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Defined Benefit Plans and Other Postretirement Benefit Plans [Domain]", "label": "Defined Benefit Plans and Other Postretirement Benefit Plans [Domain]", "terseLabel": "Defined Benefit Plans and Other Postretirement Benefit Plans [Domain]" } } }, "localname": "DefinedBenefitPlansAndOtherPostretirementBenefitPlansDomain", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/StockholdersEquityOtherComprehensiveIncomeLossDetails" ], "xbrltype": "domainItemType" }, "ctva_DefinedBenefitPlansOtherPostretirementBenefitPlansDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "[Domain] for Information by defined benefits pension or other postretirement plan or groupings of similar plans.", "label": "Defined Benefit Plans & Other Postretirement Benefit Plans [Domain]", "terseLabel": "Defined Benefit Plans and Other Postretirement Benefit Plans [Domain]" } } }, "localname": "DefinedBenefitPlansOtherPostretirementBenefitPlansDomain", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/StockholdersEquityOtherComprehensiveIncomeLossDetails", "http://www.corteva.com/role/StockholdersEquityReclassificationsoutofAOCIDetails", "http://www.corteva.com/role/StockholdersEquityTaxBenefitExpenseonNetActivityDetails" ], "xbrltype": "domainItemType" }, "ctva_DefinedBenefitPlansandOtherPostretirementBenefitPlansAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by defined benefits pension or other postretirement plan or groupings of similar plans.", "label": "Defined Benefit Plans and Other Postretirement Benefit Plans [Axis]", "terseLabel": "Defined Benefit Plans and Other Postretirement Benefit Plans [Axis]" } } }, "localname": "DefinedBenefitPlansandOtherPostretirementBenefitPlansAxis", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/StockholdersEquityOtherComprehensiveIncomeLossDetails", "http://www.corteva.com/role/StockholdersEquityReclassificationsoutofAOCIDetails", "http://www.corteva.com/role/StockholdersEquityTaxBenefitExpenseonNetActivityDetails" ], "xbrltype": "stringItemType" }, "ctva_DefinedContributionPlanEmployerDiscretionaryContributionPercent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Defined Contribution Plan Employer Discretionary Contribution Percent", "label": "Defined Contribution Plan Employer Discretionary Contribution Percent", "terseLabel": "Employer Discretionary Contribution Percent" } } }, "localname": "DefinedContributionPlanEmployerDiscretionaryContributionPercent", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "ctva_DefinedContributionPlanEmployersDiscretionaryContributionVestingPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Defined Contribution Plan, Employers Discretionary Contribution, Vesting Period", "label": "Defined Contribution Plan, Employers Discretionary Contribution, Vesting Period", "terseLabel": "Employers Discretionary Contribution, Vesting Period" } } }, "localname": "DefinedContributionPlanEmployersDiscretionaryContributionVestingPeriod", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansAdditionalInformationDetails" ], "xbrltype": "durationItemType" }, "ctva_DerivativeAssetMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Derivative, Asset [Member]", "label": "Derivative, Asset [Member]", "terseLabel": "Derivative, Asset [Member]" } } }, "localname": "DerivativeAssetMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansBasisofFairValueMeasurementDetails" ], "xbrltype": "domainItemType" }, "ctva_DerivativeLiabilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Derivative, Liability [Member]", "label": "Derivative, Liability [Member]", "terseLabel": "Derivative, Liability [Member]" } } }, "localname": "DerivativeLiabilityMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansBasisofFairValueMeasurementDetails" ], "xbrltype": "domainItemType" }, "ctva_DevelopedTechnologyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Developed Technology", "label": "Developed Technology [Member]", "terseLabel": "Developed Technology [Member]" } } }, "localname": "DevelopedTechnologyMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/GoodwillandOtherIntangibleAssetsOtherIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "ctva_DevelopedTechnologyOtherAndIPRDMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Developed technology, other, and IPR&D", "label": "Developed technology, other, and IPR&D [Member]", "terseLabel": "Developed technology, other, and IPR&D [Member]" } } }, "localname": "DevelopedTechnologyOtherAndIPRDMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/GoodwillandOtherIntangibleAssetsOtherIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "ctva_Dilutiveeffectofequitycompensationplans": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Dilutive effect of equity compensation plans", "label": "Dilutive effect of equity compensation plans", "terseLabel": "Dilutive effect of equity compensation plans" } } }, "localname": "Dilutiveeffectofequitycompensationplans", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/EarningsPerShareShareCountInformationDetails" ], "xbrltype": "sharesItemType" }, "ctva_DiscontinuedOperationsandOtherAdjustmentsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Discontinued Operations and Other Adjustments [Member]", "label": "Discontinued Operations and Other Adjustments [Member]", "terseLabel": "Discontinued Operations and Other Adjustments [Member]" } } }, "localname": "DiscontinuedOperationsandOtherAdjustmentsMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/BusinessCombinationsDASCommonControlTransferIncomeStatementDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansBasisofFairValueMeasurementDetails" ], "xbrltype": "domainItemType" }, "ctva_DiseaseCategoriesforMDL": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disease Categories for MDL", "label": "Disease Categories for MDL", "terseLabel": "Disease Categories for MDL" } } }, "localname": "DiseaseCategoriesforMDL", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationLeachandMDLSettlementDetails" ], "xbrltype": "integerItemType" }, "ctva_DisposalGroupIncludingDiscontinuedOperationAmortizationofIntangibleAssets": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of restructuring charges, remediation cost, and asset impairment loss attributable to the disposal group including, but not limited to, discontinued operations.", "label": "Disposal Group Including Discontinued Operation Amortization of Intangible Assets", "terseLabel": "Amortization of Intangibles" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationAmortizationofIntangibleAssets", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/DivestituresandOtherTransactionsECPDivestitureDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsSPDivestitureDetails" ], "xbrltype": "monetaryItemType" }, "ctva_DisposalGroupIncludingDiscontinuedOperationCashandCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash and cash equivalents attributable to disposal group held for sale or disposed of; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Disposal Group, Including Discontinued Operation, Cash and Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "terseLabel": "Change in cash classified as held for sale" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationCashandCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "ctva_DisposalGroupIncludingDiscontinuedOperationDepreciation": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of depreciation attributable to disposal group, including, but not limited to, discontinued operation.", "label": "Disposal Group Including Discontinued Operation Depreciation", "terseLabel": "Depreciation" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationDepreciation", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/DivestituresandOtherTransactionsECPDivestitureDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsSPDivestitureDetails" ], "xbrltype": "monetaryItemType" }, "ctva_DisposalGroupIncludingDiscontinuedOperationIntegrationandSeparationCosts": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of Integration and separation costs attributable to the disposal group including, but not limited to, discontinued operations. Integration and separation costs includes costs incurred to prepare for and close the Merger, post-Merger integration expenses and costs incurred to prepare for the Intended Business Separations. These costs primarily consist of financial advisory, information technology, legal, accounting, consulting and other professional advisory fees associated with preparation and execution of these activities.", "label": "Disposal Group Including Discontinued Operation Integration and Separation Costs", "terseLabel": "Integration and Separation Costs" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationIntegrationandSeparationCosts", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/DivestituresandOtherTransactionsECPDivestitureDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsSPDivestitureDetails" ], "xbrltype": "monetaryItemType" }, "ctva_DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business), attributable to the disposal group including, but not limited to, discontinued operations.", "label": "Disposal Group, Including Discontinued Operation, Nonoperating Income (Expense)", "verboseLabel": "Other Income - net" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/DivestituresandOtherTransactionsDivestituresandOtherTransactionsDivestedAgBusinessResultsofOperationsDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsDivestituresandOtherTransactionsPChemResultsofOperationsDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsECPDivestitureDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsSPDivestitureDetails" ], "xbrltype": "monetaryItemType" }, "ctva_DisposalGroupIncludingDiscontinuedOperationPensionandOtherPostEmploymentBenefitsObligationNoncurrent": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Disposal Group Including Discontinued Operation Pension and Other Post Employment Benefits Obligation Noncurrent", "label": "Disposal Group Including Discontinued Operation Pension and Other Post Employment Benefits Obligation Noncurrent", "terseLabel": "Pension and Other Post Employment Benefits Obligation Noncurrent" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationPensionandOtherPostEmploymentBenefitsObligationNoncurrent", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/DivestituresandOtherTransactionsECPDivestitureDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsSPDivestitureDetails" ], "xbrltype": "monetaryItemType" }, "ctva_DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopmentExpenses": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Disposal Group, Including Discontinued Operation, Research And Development Expenses", "label": "Disposal Group, Including Discontinued Operation, Research And Development Expenses", "terseLabel": "Research and Development Expense" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopmentExpenses", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/DivestituresandOtherTransactionsDivestituresandOtherTransactionsDivestedAgBusinessResultsofOperationsDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsECPDivestitureDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsSPDivestitureDetails" ], "xbrltype": "monetaryItemType" }, "ctva_DisposalGroupIncludingDiscontinuedOperationRestructuringSettlementAndImpairmentProvisions": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Disposal Group Including Discontinued Operation Restructuring Settlement And Impairment Provisions", "label": "Disposal Group Including Discontinued Operation Restructuring Settlement And Impairment Provisions", "terseLabel": "Restructuring and Asset Related Charges - Net" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationRestructuringSettlementAndImpairmentProvisions", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/DivestituresandOtherTransactionsECPDivestitureDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsSPDivestitureDetails" ], "xbrltype": "monetaryItemType" }, "ctva_DisposalGroupIncludingDiscontinuedOperationTransactionCosts": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Disposal Group, Including Discontinued Operation, Transaction Costs", "label": "Disposal Group, Including Discontinued Operation, Transaction Costs", "terseLabel": "Disposal Group, Including Discontinued Operation, Transaction Costs" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationTransactionCosts", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/DivestituresandOtherTransactionsDivestituresandOtherTransactionsDivestedAgBusinessResultsofOperationsDetails" ], "xbrltype": "monetaryItemType" }, "ctva_DisposalgroupIncludingDiscontinuedOperationRestrictedCash": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Disposal Group, Including Discontinued Operation, Restricted Cash", "label": "Disposal group, Including Discontinued Operation, Restricted Cash", "terseLabel": "Disposal group, Including Discontinued Operation, Restricted Cash" } } }, "localname": "DisposalgroupIncludingDiscontinuedOperationRestrictedCash", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/SupplementaryInformationReconciliationofCashCashEquivalentsandRestrictedCashDetails" ], "xbrltype": "monetaryItemType" }, "ctva_Disposalgroupincludingdiscontinuedoperationsinvestmentinnonconsolidatedaffiliates": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Disposal group, including discontinued operations, investment in nonconsolidated affiliates", "label": "Disposal group, including discontinued operations, investment in nonconsolidated affiliates", "terseLabel": "Investment in nonconsolidated affiliates" } } }, "localname": "Disposalgroupincludingdiscontinuedoperationsinvestmentinnonconsolidatedaffiliates", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/DivestituresandOtherTransactionsECPDivestitureDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsSPDivestitureDetails" ], "xbrltype": "monetaryItemType" }, "ctva_DivestedAgBusinessMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Divested Ag Business [Member]", "label": "Divested Ag Business [Member]", "terseLabel": "Divested Ag Business [Member]" } } }, "localname": "DivestedAgBusinessMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/BackgroundandBasisofPresentationPolicies", "http://www.corteva.com/role/DivestituresandOtherTransactionsDivestituresandOtherTransactionsDivestedAgBusinessResultsofOperationsDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsDivestituresandOtherTransactionsNarrativeDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsTables" ], "xbrltype": "domainItemType" }, "ctva_DivisionalEquity": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Divisional Equity", "label": "Divisional Equity", "terseLabel": "Divisional Equity" } } }, "localname": "DivisionalEquity", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "ctva_DivisionalEquityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Divisional Equity [Member]", "label": "Divisional Equity [Member]", "terseLabel": "Divisional Equity [Member]" } } }, "localname": "DivisionalEquityMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/ConsolidatedStatementsofEquity" ], "xbrltype": "domainItemType" }, "ctva_DocumentandEntityInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Document and Entity Information [Abstract]", "label": "Document and Entity Information [Abstract]", "terseLabel": "Document and Entity Information [Abstract]" } } }, "localname": "DocumentandEntityInformationAbstract", "nsuri": "http://www.corteva.com/20211231", "xbrltype": "stringItemType" }, "ctva_DowDuPontAgricultureDivisionRestructuringProgramMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "DowDuPont Agriculture Division Restructuring Program [Member]", "label": "DowDuPont Agriculture Division Restructuring Program [Member]", "terseLabel": "DowDuPont Agriculture Division Restructuring Program [Member]" } } }, "localname": "DowDuPontAgricultureDivisionRestructuringProgramMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/RestructuringandAssetRelatedChargesDowDuPontAgricultureDivisionRestructuringProgramDetails", "http://www.corteva.com/role/RestructuringandAssetRelatedChargesTables" ], "xbrltype": "domainItemType" }, "ctva_DowDuPontCostSynergyProgramMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "DowDuPont Cost Synergy Program [Member]", "label": "DowDuPont Cost Synergy Program [Member]", "terseLabel": "DowDuPont Cost Synergy Program [Member]" } } }, "localname": "DowDuPontCostSynergyProgramMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/RestructuringandAssetRelatedChargesDowDuPontCostSynergyProgramDetails", "http://www.corteva.com/role/RestructuringandAssetRelatedChargesTables" ], "xbrltype": "domainItemType" }, "ctva_DowDuPontMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "DowDuPont [Member]", "label": "DowDuPont [Member]", "terseLabel": "DowDuPont [Member]" } } }, "localname": "DowDuPontMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/ConsolidatedStatementsofEquity", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansBasisofFairValueMeasurementDetails", "http://www.corteva.com/role/RelatedPartiesTransactionswithDowDuPontDetails" ], "xbrltype": "domainItemType" }, "ctva_DowMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Dow [Member]", "label": "Dow [Member]", "terseLabel": "Dow [Member]" } } }, "localname": "DowMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/BackgroundandBasisofPresentationDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsDivestituresandOtherTransactionsNarrativeDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsECPDivestitureDetails", "http://www.corteva.com/role/RelatedPartiesServicesProvidedbyandtoDowDetails", "http://www.corteva.com/role/StockBasedCompensationRestrictedStockUnitsandPerformanceDeferredStockDetails", "http://www.corteva.com/role/StockBasedCompensationStockOptionsDetails" ], "xbrltype": "domainItemType" }, "ctva_DuPontAndChemoursPaymentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "DuPont and Chemours Payment", "label": "DuPont and Chemours Payment [Member]", "terseLabel": "DuPont and Chemours Payment [Member]" } } }, "localname": "DuPontAndChemoursPaymentMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationLeachandMDLSettlementDetails" ], "xbrltype": "domainItemType" }, "ctva_DuPontAndCortevaContributionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "DuPont and Corteva Contribution", "label": "DuPont and Corteva Contribution [Member]", "terseLabel": "DuPont and Corteva Contribution [Member]" } } }, "localname": "DuPontAndCortevaContributionMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationLeachandMDLSettlementDetails" ], "xbrltype": "domainItemType" }, "ctva_DuPontDeNemoursAndCortevaContributionToMDLSettlementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "DuPont de Nemours and Corteva Contribution to MDL Settlement", "label": "DuPont de Nemours and Corteva Contribution to MDL Settlement [Member]", "terseLabel": "DuPont de Nemours and Corteva Contribution to MDL Settlement [Member]" } } }, "localname": "DuPontDeNemoursAndCortevaContributionToMDLSettlementMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationLeachandMDLSettlementDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsDivestituresandOtherTransactionsPChemResultsofOperationsDetails" ], "xbrltype": "domainItemType" }, "ctva_DuPontDeNemoursAndCortevaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "DuPont de Nemours and Corteva", "label": "DuPont de Nemours and Corteva [Member]", "terseLabel": "DuPont de Nemours and Corteva [Member]" } } }, "localname": "DuPontDeNemoursAndCortevaMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationDuPontDetails" ], "xbrltype": "domainItemType" }, "ctva_DuPontMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "DuPont [Member]", "label": "DuPont [Member]", "terseLabel": "DuPont [Member]" } } }, "localname": "DuPontMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationChemoursDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansBasisofFairValueMeasurementDetails" ], "xbrltype": "domainItemType" }, "ctva_DuPontOtherContributionPlansMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "DuPont Other Contribution Plans [Member]", "label": "DuPont Other Contribution Plans [Member]", "terseLabel": "DuPont Other Contribution Plans [Member]" } } }, "localname": "DuPontOtherContributionPlansMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "ctva_DuPontdeNemoursMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "DuPont de Nemours [Member]", "label": "DuPont de Nemours [Member]", "terseLabel": "DuPont de Nemours [Member]" } } }, "localname": "DuPontdeNemoursMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesEnvironmentalDetails", "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationChemoursDetails", "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationDuPontDetails", "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationLeachandMDLSettlementDetails", "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationOtherPFOAMattersFayattevilleDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsDivestituresandOtherTransactionsNarrativeDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsDivestituresandOtherTransactionsPChemResultsofOperationsDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsSPDivestitureDetails" ], "xbrltype": "domainItemType" }, "ctva_ECPDisposalMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ECP Disposal [Member]", "label": "ECP Disposal [Member]", "terseLabel": "ECP Disposal [Member]" } } }, "localname": "ECPDisposalMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/BackgroundandBasisofPresentationPolicies", "http://www.corteva.com/role/DivestituresandOtherTransactionsECPDivestitureDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsTables" ], "xbrltype": "domainItemType" }, "ctva_EIDBasisOfPresentationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "EID - Basis of Presentation", "label": "EID - Basis of Presentation [Abstract]" } } }, "localname": "EIDBasisOfPresentationAbstract", "nsuri": "http://www.corteva.com/20211231", "xbrltype": "stringItemType" }, "ctva_EIDMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "EID [Member]", "label": "EID [Member]", "terseLabel": "EID [Member]" } } }, "localname": "EIDMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/BackgroundandBasisofPresentationDetails", "http://www.corteva.com/role/ConsolidatedBalanceSheets", "http://www.corteva.com/role/ConsolidatedBalanceSheetsParentheticals", "http://www.corteva.com/role/ConsolidatedStatementsofCashFlows", "http://www.corteva.com/role/ConsolidatedStatementsofComprehensiveIncome", "http://www.corteva.com/role/ConsolidatedStatementsofEquity", "http://www.corteva.com/role/ConsolidatedStatementsofEquityParentheticals", "http://www.corteva.com/role/ConsolidatedStatementsofIncome", "http://www.corteva.com/role/DEIDocument", "http://www.corteva.com/role/EIDBasisofPresentationDetails", "http://www.corteva.com/role/EIDBasisofPresentationNotes", "http://www.corteva.com/role/EIDIncomeTaxesGeographicAllocationDetails", "http://www.corteva.com/role/EIDIncomeTaxesNotes", "http://www.corteva.com/role/EIDIncomeTaxesRateReconciliationDetails", "http://www.corteva.com/role/EIDIncomeTaxesTables", "http://www.corteva.com/role/EIDQuarterlyFNDetails", "http://www.corteva.com/role/EIDQuarterlyFNNotes", "http://www.corteva.com/role/EIDQuarterlyFNTables", "http://www.corteva.com/role/EIDRelatedPartyDetails", "http://www.corteva.com/role/EIDRelatedPartyNotes", "http://www.corteva.com/role/EIDSegmentFNNotes", "http://www.corteva.com/role/EIDSegmentFNSegmentAssetReconciliationDetails", "http://www.corteva.com/role/EIDSegmentFNSegmentReconciliationDetails", "http://www.corteva.com/role/EIDSegmentFNTables", "http://www.corteva.com/role/LongTermDebtandAvailableCreditFacilitiesDebtRedemptionsRepaymentsDetails", "http://www.corteva.com/role/StockholdersEquityNoncontrollingInterestDetails" ], "xbrltype": "domainItemType" }, "ctva_EIPMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "EIP [Member]", "label": "EIP [Member]", "terseLabel": "EIP [Member]" } } }, "localname": "EIPMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/StockBasedCompensationRestrictedStockUnitsandPerformanceDeferredStockDetails", "http://www.corteva.com/role/StockBasedCompensationStockOptionsDetails", "http://www.corteva.com/role/StockBasedCompensationTables", "http://www.corteva.com/role/StockBasedCompensationWeightedAverageAssumptionsStockOptionsDetails" ], "xbrltype": "domainItemType" }, "ctva_EffectiveIncomeTaxRateReconciliationAcquisitionsDivestituresAndOwnershipRestructuringActivitiesPercent": { "auth_ref": [], "calculation": { "http://www.corteva.com/role/IncomeTaxesIncomeTaxesReconciliationtoUSStatutoryRateDetails": { "order": 4.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Effective Income Tax Rate Reconciliation, Acquisitions, Divestitures, And Ownership Restructuring Activities, Percent", "label": "Effective Income Tax Rate Reconciliation, Acquisitions, Divestitures, And Ownership Restructuring Activities, Percent", "terseLabel": "Acquisitions, divestitures, and ownership restructuring activities" } } }, "localname": "EffectiveIncomeTaxRateReconciliationAcquisitionsDivestituresAndOwnershipRestructuringActivitiesPercent", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/EIDIncomeTaxesRateReconciliationDetails", "http://www.corteva.com/role/IncomeTaxesIncomeTaxesReconciliationtoUSStatutoryRateDetails" ], "xbrltype": "percentItemType" }, "ctva_EffectiveIncomeTaxRateReconciliationForeignCurrencyExchangeGainsLossesPercent": { "auth_ref": [], "calculation": { "http://www.corteva.com/role/IncomeTaxesIncomeTaxesReconciliationtoUSStatutoryRateDetails": { "order": 6.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Effective Income Tax Rate Reconciliation, Foreign Currency Exchange Gains (Losses), Percent", "label": "Effective Income Tax Rate Reconciliation, Foreign Currency Exchange Gains (Losses), Percent", "terseLabel": "Exchange gains/losses" } } }, "localname": "EffectiveIncomeTaxRateReconciliationForeignCurrencyExchangeGainsLossesPercent", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/EIDIncomeTaxesRateReconciliationDetails", "http://www.corteva.com/role/IncomeTaxesIncomeTaxesReconciliationtoUSStatutoryRateDetails" ], "xbrltype": "percentItemType" }, "ctva_EffectiveIncomeTaxRateReconciliationSwissTaxReformPercent": { "auth_ref": [], "calculation": { "http://www.corteva.com/role/IncomeTaxesIncomeTaxesReconciliationtoUSStatutoryRateDetails": { "order": 11.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Effective Income Tax Rate Reconciliation, Swiss Tax Reform, Percent", "label": "Effective Income Tax Rate Reconciliation, Swiss Tax Reform, Percent", "terseLabel": "Impact of Swiss Tax Reform" } } }, "localname": "EffectiveIncomeTaxRateReconciliationSwissTaxReformPercent", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/EIDIncomeTaxesRateReconciliationDetails", "http://www.corteva.com/role/IncomeTaxesIncomeTaxesReconciliationtoUSStatutoryRateDetails" ], "xbrltype": "percentItemType" }, "ctva_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percentage": { "auth_ref": [], "calculation": { "http://www.corteva.com/role/IncomeTaxesIncomeTaxesReconciliationtoUSStatutoryRateDetails": { "order": 9.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Effective Income Tax Rate Reconciliation Tax Cuts And Jobs Act Of 2017 Percentage", "label": "Effective Income Tax Rate Reconciliation Tax Cuts And Jobs Act Of 2017 Percentage", "terseLabel": "SAB 118 Impact of Enactment of U.S. Tax Reform" } } }, "localname": "EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percentage", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/EIDIncomeTaxesRateReconciliationDetails", "http://www.corteva.com/role/IncomeTaxesIncomeTaxesReconciliationtoUSStatutoryRateDetails" ], "xbrltype": "percentItemType" }, "ctva_EmployeeRetentionCredit": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Employee Retention Credit", "label": "Employee Retention Credit", "terseLabel": "Employee Retention Credit" } } }, "localname": "EmployeeRetentionCredit", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/SegmentReportingSigItemsDetails", "http://www.corteva.com/role/SupplementaryInformationOtherIncomeExpenseNetDetails" ], "xbrltype": "monetaryItemType" }, "ctva_Employercontributiontotrust": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Contribution to Trust", "label": "Employer contribution to trust", "terseLabel": "Contributions to Trust" } } }, "localname": "Employercontributiontotrust", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "ctva_EnvironmentalRemediationStrayLiabilitiesAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Environmental Remediation Stray Liabilities [Axis]", "label": "Environmental Remediation Stray Liabilities [Axis]", "terseLabel": "Environmental Remediation Stray Liabilities [Axis]" } } }, "localname": "EnvironmentalRemediationStrayLiabilitiesAxis", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesEnvironmentalDetails" ], "xbrltype": "stringItemType" }, "ctva_EnvironmentalRemediationStrayLiabilitiesDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "[Domain] for Environmental Remediation Stray Liabilities [Axis]", "label": "Environmental Remediation Stray Liabilities [Domain]", "terseLabel": "Environmental Remediation Stray Liabilities [Domain]" } } }, "localname": "EnvironmentalRemediationStrayLiabilitiesDomain", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesEnvironmentalDetails" ], "xbrltype": "domainItemType" }, "ctva_EnvironmentalremediationliabilitiesprimarilyrelatedtoDuPontsubjecttoindemnityfromDuPontMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Environmental remediation liabilities primarily related to DuPont - subject to indemnity from DuPont [Member]", "label": "Environmental remediation liabilities primarily related to DuPont - subject to indemnity from DuPont [Member]", "terseLabel": "Environmental remediation liabilities primarily related to DuPont - subject to indemnity from DuPont [Member]" } } }, "localname": "EnvironmentalremediationliabilitiesprimarilyrelatedtoDuPontsubjecttoindemnityfromDuPontMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesEnvironmentalDetails" ], "xbrltype": "domainItemType" }, "ctva_EquitySecuritiesMarkToMarkGain": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Equity Securities Mark-to-Mark Gain", "label": "Equity Securities Mark-to-Mark Gain", "terseLabel": "Equity Securities Mark-to-Mark Gain" } } }, "localname": "EquitySecuritiesMarkToMarkGain", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/SegmentReportingSigItemsDetails" ], "xbrltype": "monetaryItemType" }, "ctva_EscrowAccountBalance": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount by which if escrow is below, on December 31, 2028, then Chemours will make 50% of the deposits and DuPont and Corteva together will make 50% of the deposits necessary to restore the balance of the escrow account to $700MM.", "label": "Escrow Account Balance", "terseLabel": "Escrow Account Balance" } } }, "localname": "EscrowAccountBalance", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationChemoursDetails" ], "xbrltype": "monetaryItemType" }, "ctva_EscrowAccountDepositPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of deposits to be made to the escrow account as part of the cost sharing agreement under the MOU.", "label": "Escrow Account Deposit Percentage", "terseLabel": "Escrow Account Deposit Percentage" } } }, "localname": "EscrowAccountDepositPercentage", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationChemoursDetails" ], "xbrltype": "percentItemType" }, "ctva_ExchangeRatio": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Exchange Ratio", "label": "Exchange Ratio", "terseLabel": "Exchange Ratio" } } }, "localname": "ExchangeRatio", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/BackgroundandBasisofPresentationDetails", "http://www.corteva.com/role/StockholdersEquityCommonStockDetails" ], "xbrltype": "integerItemType" }, "ctva_ExecuteToWinProductivityProgramDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Execute to Win Productivity Program [Domain]", "label": "Execute to Win Productivity Program [Domain]", "terseLabel": "Execute to Win Productivity Program [Domain]" } } }, "localname": "ExecuteToWinProductivityProgramDomain", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/DivestituresandOtherTransactionsECPDivestitureDetails" ], "xbrltype": "domainItemType" }, "ctva_ExecuteToWinProductivityProgramMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Execute to Win Productivity Program", "label": "Execute to Win Productivity Program [Member]", "terseLabel": "Execute to Win Productivity Program" } } }, "localname": "ExecuteToWinProductivityProgramMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/RestructuringandAssetRelatedChargesExecutetoWinProductivityProgramDetails", "http://www.corteva.com/role/RestructuringandAssetRelatedChargesTables" ], "xbrltype": "domainItemType" }, "ctva_ExpirationPeriodAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Expiration Period [Axis]", "label": "Expiration Period [Axis]", "terseLabel": "Expiration Period [Axis]" } } }, "localname": "ExpirationPeriodAxis", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/IncomeTaxesIncomeTaxesOperatingLossandTaxCreditCarryforwardsDetails" ], "xbrltype": "stringItemType" }, "ctva_ExpirationPeriodDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "[Domain] for Expiration Period [Axis]", "label": "Expiration Period [Domain]", "terseLabel": "Expiration Period [Domain]" } } }, "localname": "ExpirationPeriodDomain", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/IncomeTaxesIncomeTaxesOperatingLossandTaxCreditCarryforwardsDetails" ], "xbrltype": "domainItemType" }, "ctva_ExpiringAfterFiveYearsOrHavingIndefiniteExpirationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Expiring After Five Years Or Having Indefinite Expiration [Member]", "label": "Expiring After Five Years Or Having Indefinite Expiration [Member]", "terseLabel": "Expiring After Five Years Or Having Indefinite Expiration [Member]" } } }, "localname": "ExpiringAfterFiveYearsOrHavingIndefiniteExpirationMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/IncomeTaxesIncomeTaxesOperatingLossandTaxCreditCarryforwardsDetails" ], "xbrltype": "domainItemType" }, "ctva_ExpiringwithinFiveYearsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Expiring within Five Years [Member]", "label": "Expiring within Five Years [Member]", "terseLabel": "Expiring within Five Years [Member]" } } }, "localname": "ExpiringwithinFiveYearsMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/IncomeTaxesIncomeTaxesOperatingLossandTaxCreditCarryforwardsDetails" ], "xbrltype": "domainItemType" }, "ctva_FactoringAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Factoring Agreement [Member]", "label": "Factoring Agreement [Member]", "terseLabel": "Factoring Agreement [Member]" } } }, "localname": "FactoringAgreementMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/AccountsandNotesReceivableNetCustomerFinancingDetails", "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesGuaranteeNarrativeDetails" ], "xbrltype": "domainItemType" }, "ctva_FavorableSupplyContractMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Favorable Supply Contract [Member]", "label": "Favorable Supply Contract [Member]", "terseLabel": "Favorable Supply Contract [Member]" } } }, "localname": "FavorableSupplyContractMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/DivestituresandOtherTransactionsDivestituresandOtherTransactionsDivestedAgBusinessResultsofOperationsDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsDivestituresandOtherTransactionsNarrativeDetails", "http://www.corteva.com/role/GoodwillandOtherIntangibleAssetsOtherIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "ctva_FinanceLeaseCost": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of total finance lease costs", "label": "Finance Lease, Cost", "terseLabel": "Finance Lease, Cost" } } }, "localname": "FinanceLeaseCost", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/LeasesLeaseCostsDetails" ], "xbrltype": "monetaryItemType" }, "ctva_FinanceLeaseRightOfUseAssetAccumulatedDepreciation": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated depreciation of finance lease right-of-use assets", "label": "Finance Lease, Right-Of-Use Asset, Accumulated Depreciation", "terseLabel": "Finance Lease, Right-Of-Use Asset, Accumulated Depreciation" } } }, "localname": "FinanceLeaseRightOfUseAssetAccumulatedDepreciation", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/LeasesSupplementalBalanceSheetInformationDetails" ], "xbrltype": "monetaryItemType" }, "ctva_FinanceLeaseRightofUseAssetGross": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated depreciation of lessee's right to use underlying asset under finance lease", "label": "Finance Lease, Right-of-Use Asset, Gross", "terseLabel": "Finance Lease, Right-of-Use Asset, Gross" } } }, "localname": "FinanceLeaseRightofUseAssetGross", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/LeasesSupplementalBalanceSheetInformationDetails" ], "xbrltype": "monetaryItemType" }, "ctva_FiniteLivedIntangibleAssetFutureExpectedAnnualAmortization": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized annually.", "label": "Finite-Lived Intangible Asset, Future Expected Annual Amortization", "terseLabel": "Estimated future annual amortization expense" } } }, "localname": "FiniteLivedIntangibleAssetFutureExpectedAnnualAmortization", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/GoodwillandOtherIntangibleAssetsAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "ctva_FirefightingFoamMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Firefighting Foam [Member]", "label": "Firefighting Foam [Member]", "terseLabel": "Firefighting Foam [Member]" } } }, "localname": "FirefightingFoamMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationOtherPFOAMattersFayattevilleDetails" ], "xbrltype": "domainItemType" }, "ctva_ForeignCurrencyExchangeGainLossLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "[Line Items] for Foreign Currency Exchange Gain (Loss) [Table]", "label": "Foreign Currency Exchange Gain (Loss) [Line Items]", "terseLabel": "Foreign Currency Exchange Gain (Loss) [Line Items]" } } }, "localname": "ForeignCurrencyExchangeGainLossLineItems", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/SupplementaryInformationForeignCurrencyExchangeGainLossDetails" ], "xbrltype": "stringItemType" }, "ctva_ForeignCurrencyExchangeGainLossTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Foreign Currency Exchange Gain (Loss) [Table]", "label": "Foreign Currency Exchange Gain (Loss) [Table]", "terseLabel": "Foreign Currency Exchange Gain (Loss) [Table]" } } }, "localname": "ForeignCurrencyExchangeGainLossTable", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/SupplementaryInformationForeignCurrencyExchangeGainLossDetails" ], "xbrltype": "stringItemType" }, "ctva_ForeignCurrencyExchangeGainLossTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Foreign Currency Exchange Gain (Loss) [Table Text Block]", "label": "Foreign Currency Exchange Gain (Loss) [Table Text Block]", "terseLabel": "Foreign Currency Exchange Gain (Loss)" } } }, "localname": "ForeignCurrencyExchangeGainLossTableTextBlock", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/SupplementaryInformationTables" ], "xbrltype": "textBlockItemType" }, "ctva_ForeignCurrencyLoansMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Foreign Currency Loans [Member]", "label": "Foreign Currency Loans [Member]", "terseLabel": "Foreign Currency Loans [Member]" } } }, "localname": "ForeignCurrencyLoansMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/LongTermDebtandAvailableCreditFacilitiesLongTermDebtDetails" ], "xbrltype": "domainItemType" }, "ctva_ForeignCurrencyTransactionGainLossAfterTax": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Foreign Currency Transaction Gain (Loss) After Tax", "label": "Foreign Currency Transaction Gain (Loss) After Tax", "terseLabel": "Net after-tax exchange (loss) gain" } } }, "localname": "ForeignCurrencyTransactionGainLossAfterTax", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/QuaterlyFinancialDataQuarterlyFinancialDataParentheticalsDetails", "http://www.corteva.com/role/SupplementaryInformationForeignCurrencyExchangeGainLossDetails" ], "xbrltype": "monetaryItemType" }, "ctva_ForeignCurrencyTransactionGainLossTax": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Foreign Currency Transaction Gain (Loss) Tax", "label": "Foreign Currency Transaction Gain (Loss) Tax", "terseLabel": "Tax benefits (expenses) on exchange (loss) gain" } } }, "localname": "ForeignCurrencyTransactionGainLossTax", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/SupplementaryInformationForeignCurrencyExchangeGainLossDetails" ], "xbrltype": "monetaryItemType" }, "ctva_ForeignCurrencyTransactionTypeAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Foreign Currency Transaction Type [Axis]", "label": "Foreign Currency Transaction Type [Axis]", "terseLabel": "Foreign Currency Transaction Type [Axis]" } } }, "localname": "ForeignCurrencyTransactionTypeAxis", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/EIDSegmentFNSegmentReconciliationDetails", "http://www.corteva.com/role/QuaterlyFinancialDataQuarterlyFinancialDataParentheticalsDetails", "http://www.corteva.com/role/SegmentReportingSegmentReconciliationDetails", "http://www.corteva.com/role/SegmentReportingSigItemsDetails", "http://www.corteva.com/role/SupplementaryInformationForeignCurrencyExchangeGainLossDetails", "http://www.corteva.com/role/SupplementaryInformationOtherIncomeExpenseNetDetails" ], "xbrltype": "stringItemType" }, "ctva_ForeignCurrencyTransactionTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "[Domain] for Foreign Currency Transaction Type [Axis]", "label": "Foreign Currency Transaction Type [Domain]", "terseLabel": "Foreign Currency Transaction Type [Domain]" } } }, "localname": "ForeignCurrencyTransactionTypeDomain", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/EIDSegmentFNSegmentReconciliationDetails", "http://www.corteva.com/role/QuaterlyFinancialDataQuarterlyFinancialDataParentheticalsDetails", "http://www.corteva.com/role/SegmentReportingSegmentReconciliationDetails", "http://www.corteva.com/role/SegmentReportingSigItemsDetails", "http://www.corteva.com/role/SupplementaryInformationForeignCurrencyExchangeGainLossDetails", "http://www.corteva.com/role/SupplementaryInformationOtherIncomeExpenseNetDetails" ], "xbrltype": "domainItemType" }, "ctva_ForeignExchangeImpactOnIncomeLossFromContinuingOperations": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Impact to pre-tax earnings as a result of the deterioration of the Peso to USD exchange rate", "label": "Foreign Exchange Impact on Income (Loss) from Continuing Operations", "terseLabel": "Foreign Exchange Impact on Income (Loss) from Continuing Operations" } } }, "localname": "ForeignExchangeImpactOnIncomeLossFromContinuingOperations", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/BackgroundandBasisofPresentationDetails" ], "xbrltype": "monetaryItemType" }, "ctva_FundedPensionPlansotherthanPrincipalU.S.PlanandRemainingPlanswithnoPlanAssetsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Funded Pension Plans other than Principal U.S. Plan and Remaining Plans with no Plan Assets [Member]", "label": "Funded Pension Plans other than Principal U.S. Plan and Remaining Plans with no Plan Assets [Member]", "terseLabel": "Funded Pension Plans other than Principal U.S. Plan and Remaining Plans with no Plan Assets [Member]" } } }, "localname": "FundedPensionPlansotherthanPrincipalU.S.PlanandRemainingPlanswithnoPlanAssetsMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "ctva_FungicidesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fungicides [Member]", "label": "Fungicides [Member]", "terseLabel": "Fungicides [Member]" } } }, "localname": "FungicidesMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/RevenueDisaggregationofRevenueProductsDetails" ], "xbrltype": "domainItemType" }, "ctva_FutureCashPayments": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Future Cash Payments related to restructuring program", "label": "Future Cash Payments", "terseLabel": "Future Cash Payments" } } }, "localname": "FutureCashPayments", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/RestructuringandAssetRelatedChargesExecutetoWinProductivityProgramDetails" ], "xbrltype": "monetaryItemType" }, "ctva_GainLossRelatedToLitigationSettlementNetOfTax": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss), after tax, recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process.", "label": "Gain (Loss) Related To Litigation Settlement, Net Of Tax", "terseLabel": "Loss Related To Litigation Settlement, Net Of Tax" } } }, "localname": "GainLossRelatedToLitigationSettlementNetOfTax", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/DivestituresandOtherTransactionsDivestituresandOtherTransactionsPChemResultsofOperationsDetails" ], "xbrltype": "monetaryItemType" }, "ctva_GeographicAreaRevenuesfromExternalCustomersAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Geographic Area, Revenues from External Customers [Abstract]", "label": "Geographic Area, Revenues from External Customers [Abstract]", "terseLabel": "Geographic Area, Revenues from External Customers [Abstract]" } } }, "localname": "GeographicAreaRevenuesfromExternalCustomersAbstract", "nsuri": "http://www.corteva.com/20211231", "xbrltype": "stringItemType" }, "ctva_GeographicInformationTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Geographic Information [Text Block]", "label": "Geographic Information [Text Block]", "terseLabel": "Geographic Information [Text Block]" } } }, "localname": "GeographicInformationTextBlock", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/GeographicInformation" ], "xbrltype": "textBlockItemType" }, "ctva_GeographicInformationThreshold": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Threshold as a percentage of consolidated amount used for determination of material locations.", "label": "Geographic Information Threshold", "terseLabel": "Geographic Information Threshold" } } }, "localname": "GeographicInformationThreshold", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/GeographicInformationRevenuebyCountryDetails" ], "xbrltype": "percentItemType" }, "ctva_GeographicalReportingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Geographical Reporting [Abstract]", "label": "Geographical Reporting [Abstract]", "terseLabel": "Geographical Reporting [Abstract]" } } }, "localname": "GeographicalReportingAbstract", "nsuri": "http://www.corteva.com/20211231", "xbrltype": "stringItemType" }, "ctva_GeographyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Geography", "label": "Geography [Member]", "terseLabel": "Geography [Member]" } } }, "localname": "GeographyMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/RevenueTables" ], "xbrltype": "domainItemType" }, "ctva_GermplasmMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Germplasm [Member]", "label": "Germplasm [Member]", "terseLabel": "Germplasm [Member]" } } }, "localname": "GermplasmMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/GoodwillandOtherIntangibleAssetsAmortizationExpenseDetails", "http://www.corteva.com/role/GoodwillandOtherIntangibleAssetsOtherIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "ctva_GoodwillImpairmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Goodwill Impairment [Member]", "label": "Goodwill Impairment [Member]", "terseLabel": "Goodwill Impairment [Member]" } } }, "localname": "GoodwillImpairmentMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/GoodwillandOtherIntangibleAssetsGoodwillbySegmentDetails" ], "xbrltype": "domainItemType" }, "ctva_GoodwillandIntangibleAssetDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Goodwill and Intangible Asset Disclosure [Abstract]", "label": "Goodwill and Intangible Asset Disclosure [Abstract]", "terseLabel": "Goodwill and Intangible Asset Disclosure [Abstract]" } } }, "localname": "GoodwillandIntangibleAssetDisclosureAbstract", "nsuri": "http://www.corteva.com/20211231", "xbrltype": "stringItemType" }, "ctva_GrantsBetweenJune2019And2020Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Grants between June 2019 and 2020", "label": "Grants between June 2019 and 2020 [Member]", "terseLabel": "Grants between June 2019 and 2020 [Member]" } } }, "localname": "GrantsBetweenJune2019And2020Member", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/StockBasedCompensationStockOptionsDetails" ], "xbrltype": "domainItemType" }, "ctva_Grantsbetween2013and2015Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Grants between 2013 and 2015 [Member]", "label": "Grants between 2013 and 2015 [Member]", "terseLabel": "Grants between 2013 and 2015 [Member]" } } }, "localname": "Grantsbetween2013and2015Member", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/StockBasedCompensationStockOptionsDetails" ], "xbrltype": "domainItemType" }, "ctva_Grantsbetween2016and2018Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Grants between 2016 and 2018 [Member]", "label": "Grants between 2016 and 2018 [Member]", "terseLabel": "Grants between 2016 and 2018 [Member]" } } }, "localname": "Grantsbetween2016and2018Member", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/StockBasedCompensationStockOptionsDetails" ], "xbrltype": "domainItemType" }, "ctva_GuaranteePaymentTimingAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Guarantee Payment Timing [Axis]", "label": "Guarantee Payment Timing [Axis]", "terseLabel": "Guarantee Payment Timing [Axis]" } } }, "localname": "GuaranteePaymentTimingAxis", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesGuaranteeNarrativeDetails" ], "xbrltype": "stringItemType" }, "ctva_HedgingProgramGainLossTypeAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Hedging Program Gain (Loss) Type [Axis]", "label": "Hedging Program Gain (Loss) Type [Axis]", "terseLabel": "Hedging Program Gain (Loss) Type [Axis]" } } }, "localname": "HedgingProgramGainLossTypeAxis", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/EIDSegmentFNSegmentReconciliationDetails", "http://www.corteva.com/role/QuaterlyFinancialDataQuarterlyFinancialDataParentheticalsDetails", "http://www.corteva.com/role/SegmentReportingSegmentReconciliationDetails", "http://www.corteva.com/role/SegmentReportingSigItemsDetails", "http://www.corteva.com/role/SupplementaryInformationForeignCurrencyExchangeGainLossDetails", "http://www.corteva.com/role/SupplementaryInformationOtherIncomeExpenseNetDetails" ], "xbrltype": "stringItemType" }, "ctva_HedgingProgramGainLossTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "[Domain] for Hedging Program Gain (Loss) Type [Axis]", "label": "Hedging Program Gain (Loss) Type [Domain]", "terseLabel": "Hedging Program Gain (Loss) Type [Domain]" } } }, "localname": "HedgingProgramGainLossTypeDomain", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/EIDSegmentFNSegmentReconciliationDetails", "http://www.corteva.com/role/QuaterlyFinancialDataQuarterlyFinancialDataParentheticalsDetails", "http://www.corteva.com/role/SegmentReportingSegmentReconciliationDetails", "http://www.corteva.com/role/SegmentReportingSigItemsDetails", "http://www.corteva.com/role/SupplementaryInformationForeignCurrencyExchangeGainLossDetails", "http://www.corteva.com/role/SupplementaryInformationOtherIncomeExpenseNetDetails" ], "xbrltype": "domainItemType" }, "ctva_HedgingProgramMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Hedging Program [Member]", "label": "Hedging Program [Member]", "terseLabel": "Hedging Program [Member]" } } }, "localname": "HedgingProgramMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/EIDSegmentFNSegmentReconciliationDetails", "http://www.corteva.com/role/QuaterlyFinancialDataQuarterlyFinancialDataParentheticalsDetails", "http://www.corteva.com/role/SegmentReportingSegmentReconciliationDetails", "http://www.corteva.com/role/SegmentReportingSigItemsDetails", "http://www.corteva.com/role/SupplementaryInformationForeignCurrencyExchangeGainLossDetails", "http://www.corteva.com/role/SupplementaryInformationOtherIncomeExpenseNetDetails" ], "xbrltype": "domainItemType" }, "ctva_HerbicidesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Herbicides [Member]", "label": "Herbicides [Member]", "terseLabel": "Herbicides [Member]" } } }, "localname": "HerbicidesMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/RevenueDisaggregationofRevenueProductsDetails" ], "xbrltype": "domainItemType" }, "ctva_HistoricalEIDMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Historical EID [Member]", "label": "Historical EID [Member]", "terseLabel": "Historical EID [Member]" } } }, "localname": "HistoricalEIDMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/BusinessCombinationsDASCommonControlTransferIncomeStatementDetails" ], "xbrltype": "domainItemType" }, "ctva_ImpairmentofIntangibleAssetsIndefinitelivedExcludingGoodwillAfterTax": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Impairment of Intangible Assets Indefinite lived Excluding Goodwill After Tax", "label": "Impairment of Intangible Assets Indefinite lived Excluding Goodwill After Tax", "terseLabel": "Impairment of Intangible Assets Indefinite lived Excluding Goodwill After Tax" } } }, "localname": "ImpairmentofIntangibleAssetsIndefinitelivedExcludingGoodwillAfterTax", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/GoodwillandOtherIntangibleAssetsOtherIntangibleAssetsDetails", "http://www.corteva.com/role/RestructuringandAssetRelatedChargesAssetImpairmentsDetails" ], "xbrltype": "monetaryItemType" }, "ctva_IncomeStatementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Income Statement [Member]", "label": "Income Statement [Member]", "terseLabel": "Income Statement [Member]" } } }, "localname": "IncomeStatementMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/CommonControlBusinessCombinationsTables", "http://www.corteva.com/role/DivestituresandOtherTransactionsTables" ], "xbrltype": "domainItemType" }, "ctva_Increasedecreaseinaccruedinterestandincometaxes": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Increase (decrease) in accrued interest and income taxes", "label": "Increase (decrease) in accrued interest and income taxes", "negatedTerseLabel": "Accrued Interest and Income Taxes" } } }, "localname": "Increasedecreaseinaccruedinterestandincometaxes", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "ctva_IndemnificationAsset": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Indemnification asset for indemnified liabilities related to environmental remediation.", "label": "Indemnification Asset", "terseLabel": "Indemnification Asset" } } }, "localname": "IndemnificationAsset", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesEnvironmentalDetails" ], "xbrltype": "monetaryItemType" }, "ctva_IndemnificationAssets": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Indemnification asset for liabilities indemnified against certain litigation, environmental, workers' compensation and other liabilities that arose prior to the spin-off of Corteva.", "label": "Indemnification Assets", "terseLabel": "Indemnification Assets" } } }, "localname": "IndemnificationAssets", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationLeachandMDLSettlementDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsDivestituresandOtherTransactionsNarrativeDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsDivestituresandOtherTransactionsPChemResultsofOperationsDetails" ], "xbrltype": "monetaryItemType" }, "ctva_IndemnificationAssetsForLiabilitiesIndemnifiedByChemours": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Indemnification asset for liabilities indemnified by Chemours against certain litigation, environmental, workers' compensation and other liabilities that arose prior to the spin-off of Chemours.", "label": "Indemnification Assets for Liabilities Indemnified by Chemours", "terseLabel": "Indemnification Assets for Liabilities Indemnified by Chemours" } } }, "localname": "IndemnificationAssetsForLiabilitiesIndemnifiedByChemours", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationChemoursDetails", "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationLeachandMDLSettlementDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsDivestituresandOtherTransactionsPChemResultsofOperationsDetails" ], "xbrltype": "monetaryItemType" }, "ctva_IndemnifiedLiabilities": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Indemnified Liabilities for liabilities indemnified by Corteva against certain litigation, environmental, workers compensation and other liabilities that arose prior to the spin-off of Corteva.", "label": "Indemnified Liabilities", "terseLabel": "Indemnified Liabilities" } } }, "localname": "IndemnifiedLiabilities", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesEnvironmentalDetails", "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationLeachandMDLSettlementDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsDivestituresandOtherTransactionsNarrativeDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsDivestituresandOtherTransactionsPChemResultsofOperationsDetails", "http://www.corteva.com/role/EIDRelatedPartyDetails" ], "xbrltype": "monetaryItemType" }, "ctva_IndemnifiedLiabilitiesForLiabilitiesIndemnifiedByCorteva": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "indemnified Liabilities for liabilities indemnified by Corteva associated with environmental remediation related to PFAS.", "label": "Indemnified Liabilities for Liabilities Indemnified by Corteva", "terseLabel": "Indemnified Liabilities for Liabilities Indemnified by Chemours" } } }, "localname": "IndemnifiedLiabilitiesForLiabilitiesIndemnifiedByCorteva", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesEnvironmentalDetails", "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationChemoursDetails", "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationLeachandMDLSettlementDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsDivestituresandOtherTransactionsPChemResultsofOperationsDetails" ], "xbrltype": "monetaryItemType" }, "ctva_IndustrialBiosciencesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Industrial Biosciences [Member]", "label": "Industrial Biosciences [Member]", "terseLabel": "Industrial Biosciences [Member]" } } }, "localname": "IndustrialBiosciencesMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/DivestituresandOtherTransactionsDivestituresandOtherTransactionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "ctva_InsecticidesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Insecticides [Member]", "label": "Insecticides [Member]", "terseLabel": "Insecticides [Member]" } } }, "localname": "InsecticidesMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/RevenueDisaggregationofRevenueProductsDetails" ], "xbrltype": "domainItemType" }, "ctva_InsuranceandSelfInsurancePolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Insurance and Self Insurance [Policy Text Block]", "label": "Insurance and Self Insurance [Policy Text Block]", "terseLabel": "Insurance and Self Insurance" } } }, "localname": "InsuranceandSelfInsurancePolicyTextBlock", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "ctva_IntegrationandSeparationCostsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Integration and Separation Costs, Policy [Policy Text Block]", "label": "Integration and Separation Costs, Policy [Policy Text Block]", "terseLabel": "Integration and Separation Costs" } } }, "localname": "IntegrationandSeparationCostsPolicyPolicyTextBlock", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "ctva_IntendedBusinessSeparationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Intended Business Separations [Abstract]", "label": "Intended Business Separations [Abstract]", "terseLabel": "Intended Business Separations [Abstract]" } } }, "localname": "IntendedBusinessSeparationsAbstract", "nsuri": "http://www.corteva.com/20211231", "xbrltype": "stringItemType" }, "ctva_IntendedBusinessSeparationsPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Intended Business Separations [Policy Text Block]", "label": "Intended Business Separations [Policy Text Block]", "terseLabel": "Intended Business Separations [Policy Text Block]" } } }, "localname": "IntendedBusinessSeparationsPolicyTextBlock", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/BackgroundandBasisofPresentationPolicies" ], "xbrltype": "textBlockItemType" }, "ctva_InterestPaidOnRelatedPartyLoan": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Interest Paid on Related Party Loan", "label": "Interest Paid on Related Party Loan", "terseLabel": "Interest Paid on Related Party Long-Term Debt" } } }, "localname": "InterestPaidOnRelatedPartyLoan", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/EIDRelatedPartyDetails" ], "xbrltype": "monetaryItemType" }, "ctva_InterestRateInAdditionToSOFR": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest rate in addition to SOFR on borrowings under the repurchase facility", "label": "Interest rate in addition to SOFR", "terseLabel": "Interest rate in addition to SOFR" } } }, "localname": "InterestRateInAdditionToSOFR", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/SubsequentEventsDetails" ], "xbrltype": "percentItemType" }, "ctva_InterestrateinadditiontoLIBOR": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest rate in addition to LIBOR on borrowings under the repurchase facility", "label": "Interest rate in addition to LIBOR", "terseLabel": "Interest rate in addition to LIBOR" } } }, "localname": "InterestrateinadditiontoLIBOR", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/SubsequentEventsDetails" ], "xbrltype": "percentItemType" }, "ctva_InternalEntityRestructuringMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Internal Entity Restructuring [Member]", "label": "Internal Entity Restructuring [Member]", "terseLabel": "Internal Entity Restructuring [Member]" } } }, "localname": "InternalEntityRestructuringMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/EIDIncomeTaxesRateReconciliationDetails" ], "xbrltype": "domainItemType" }, "ctva_InternalReorganizationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Internal Reorganization [Member]", "label": "Internal Reorganization [Member]", "terseLabel": "Internal Reorganization [Member]" } } }, "localname": "InternalReorganizationMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/BackgroundandBasisofPresentationDetails", "http://www.corteva.com/role/StockBasedCompensationRestrictedStockUnitsandPerformanceDeferredStockDetails", "http://www.corteva.com/role/StockBasedCompensationStockOptionsDetails", "http://www.corteva.com/role/StockholdersEquityOtherComprehensiveIncomeLossDetails" ], "xbrltype": "domainItemType" }, "ctva_InvestmentsmeasuredatnetassetvalueMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Investments measured at net asset value [Member]", "label": "Investments measured at net asset value [Member]", "terseLabel": "Investments measured at net asset value [Member]" } } }, "localname": "InvestmentsmeasuredatnetassetvalueMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansBasisofFairValueMeasurementDetails" ], "xbrltype": "domainItemType" }, "ctva_LaPorteMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "La Porte", "label": "La Porte [Member]", "terseLabel": "La Porte" } } }, "localname": "LaPorteMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/QuaterlyFinancialDataQuarterlyFinancialDataParentheticalsDetails", "http://www.corteva.com/role/SegmentReportingSigItemsDetails", "http://www.corteva.com/role/SupplementaryInformationOtherIncomeExpenseNetDetails" ], "xbrltype": "domainItemType" }, "ctva_Lawsuitsallegingpersonalinjuryfiled": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Lawsuits alleging personal injury which were filed.", "label": "Lawsuits alleging personal injury filed", "terseLabel": "Lawsuits alleging personal injury filed" } } }, "localname": "Lawsuitsallegingpersonalinjuryfiled", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationChemoursDetails", "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationLeachandMDLSettlementDetails" ], "xbrltype": "integerItemType" }, "ctva_LeaseTermandDiscountRateTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted-average remaining lease terms and weighted average discount rate information for operating and finance leases", "label": "Lease Term and Discount Rate [Table Text Block]", "terseLabel": "Lease Term and Discount Rate [Table Text Block]" } } }, "localname": "LeaseTermandDiscountRateTableTextBlock", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/LeasesTables" ], "xbrltype": "textBlockItemType" }, "ctva_LesseeOperatingandFinanceLeasesRemainingLeaseTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Lessee, operating and financing leases remaining lease term", "label": "Lessee Operating and Finance Leases, Remaining Lease Term", "terseLabel": "Remaining Lease Term" } } }, "localname": "LesseeOperatingandFinanceLeasesRemainingLeaseTerm", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/LeasesNarrativeDetails" ], "xbrltype": "durationItemType" }, "ctva_LiabilitiesofdiscontinuedoperationsnoncurrentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Liabilities of discontinued operations - non-current [Member]", "label": "Liabilities of discontinued operations - non-current [Member]", "terseLabel": "Liabilities of discontinued operations - non-current [Member]" } } }, "localname": "LiabilitiesofdiscontinuedoperationsnoncurrentMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansAmountsRecognizedinConsolidatedBalanceSheetsDetails" ], "xbrltype": "domainItemType" }, "ctva_LiabilityRelatingToTestingDrinkingWaterInAndAroundCertainFormerEIDSitesAndOfferingTreatmentOrAlternativeSupplyOfDrinkingWater": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Liability relating to testing drinking water in and around certain former EID sites and offering treatment or alternative supply of drinking water.", "label": "Liability relating to testing drinking water in and around certain former EID sites and offering treatment or alternative supply of drinking water.", "terseLabel": "Liability relating to testing drinking water in and around certain former EID sites and offering treatment or alternative supply of drinking water." } } }, "localname": "LiabilityRelatingToTestingDrinkingWaterInAndAroundCertainFormerEIDSitesAndOfferingTreatmentOrAlternativeSupplyOfDrinkingWater", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationDuPontDetails", "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationLeachandMDLSettlementDetails" ], "xbrltype": "monetaryItemType" }, "ctva_LineOfCreditFacilityRemainingBorrowingCapacityUncommittedAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Line Of Credit Facility, Remaining Borrowing Capacity, Uncommitted Amount", "label": "Line Of Credit Facility, Remaining Borrowing Capacity, Uncommitted Amount", "terseLabel": "Line Of Credit Facility, Remaining Borrowing Capacity, Uncommitted Amount" } } }, "localname": "LineOfCreditFacilityRemainingBorrowingCapacityUncommittedAmount", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/LongTermDebtandAvailableCreditFacilitiesUncommittedCreditFacilitiesandOutstandingLettersofCreditDetails" ], "xbrltype": "monetaryItemType" }, "ctva_LitigationSettlementLiabilityForMedicalMonitoringProgramThreshold": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Litigation Settlement, Liability For Medical Monitoring Program, Threshold", "label": "Litigation Settlement, Liability For Medical Monitoring Program, Threshold", "terseLabel": "Litigation Settlement, Liability For Medical Monitoring Program, Threshold" } } }, "localname": "LitigationSettlementLiabilityForMedicalMonitoringProgramThreshold", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationLeachandMDLSettlementDetails" ], "xbrltype": "monetaryItemType" }, "ctva_LitigationSettlementMedicalMonitoringProgramEscrowAccountDisbursementsToDate": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Litigation Settlement, Medical Monitoring Program, Escrow Account, Disbursements To Date", "label": "Litigation Settlement, Medical Monitoring Program, Escrow Account, Disbursements To Date", "terseLabel": "Litigation Settlement, Medical Monitoring Program, Escrow Account, Disbursements To Date" } } }, "localname": "LitigationSettlementMedicalMonitoringProgramEscrowAccountDisbursementsToDate", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationLeachandMDLSettlementDetails" ], "xbrltype": "monetaryItemType" }, "ctva_LossContingencyLimitedSharingofPotentialFutureLiabilitiesPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Loss Contingency, Limited Sharing of Potential Future Liabilities, Period", "label": "Loss Contingency, Limited Sharing of Potential Future Liabilities, Period", "terseLabel": "Loss Contingency, Limited Sharing of Potential Future Liabilities, Period" } } }, "localname": "LossContingencyLimitedSharingofPotentialFutureLiabilitiesPeriod", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationChemoursDetails" ], "xbrltype": "durationItemType" }, "ctva_LossContingencyNumberOfPropertyOwners": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Loss Contingency, Number of Property Owners", "label": "Loss Contingency, Number of Property Owners", "terseLabel": "Loss Contingency, Number of Property Owners" } } }, "localname": "LossContingencyNumberOfPropertyOwners", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationOtherPFOAMattersFayattevilleDetails" ], "xbrltype": "integerItemType" }, "ctva_LossContingencyNumberOfWaterDistrictsReceivingWaterTreatment": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Loss Contingency, Number Of Water Districts Receiving Water Treatment", "label": "Loss Contingency, Number Of Water Districts Receiving Water Treatment", "terseLabel": "Loss Contingency, Number Of Water Districts Receiving Water Treatment" } } }, "localname": "LossContingencyNumberOfWaterDistrictsReceivingWaterTreatment", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationLeachandMDLSettlementDetails" ], "xbrltype": "integerItemType" }, "ctva_LossContingencyNumberofAdditionalPlaintiffs": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Loss Contingency, Number of Additional Plaintiffs", "label": "Loss Contingency, Number of Additional Plaintiffs", "terseLabel": "Loss Contingency, Number of Additional Plaintiffs" } } }, "localname": "LossContingencyNumberofAdditionalPlaintiffs", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationOtherPFOAMattersFayattevilleDetails" ], "xbrltype": "integerItemType" }, "ctva_LossContingencyThreatenedClaimsNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Loss Contingency, Threatened Claims, Number", "label": "Loss Contingency, Threatened Claims, Number", "terseLabel": "Loss Contingency, Threatened Claims, Number" } } }, "localname": "LossContingencyThreatenedClaimsNumber", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationLeachandMDLSettlementDetails" ], "xbrltype": "integerItemType" }, "ctva_LossOfConsortiumMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Loss of Consortium", "label": "Loss of Consortium [Member]", "terseLabel": "Loss of Consortium [Member]" } } }, "localname": "LossOfConsortiumMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationLeachandMDLSettlementDetails" ], "xbrltype": "domainItemType" }, "ctva_MDLSettlementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "MDL Settlement", "label": "MDL Settlement [Member]", "terseLabel": "MDL Settlement [Member]" } } }, "localname": "MDLSettlementMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationLeachandMDLSettlementDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsDivestituresandOtherTransactionsPChemResultsofOperationsDetails" ], "xbrltype": "domainItemType" }, "ctva_MOUTermsForWithdrawals": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The MOU provides that no withdrawals from the MOU Escrow Account can be made before year six, except to fund mutually agreed upon third-party settlements in excess of $125 million.", "label": "MOU Terms for Withdrawals", "terseLabel": "MOU Terms for Withdrawals" } } }, "localname": "MOUTermsForWithdrawals", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationChemoursDetails" ], "xbrltype": "monetaryItemType" }, "ctva_MajorProductLineMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Major Product Line", "label": "Major Product Line [Member]", "terseLabel": "Major Product Line [Member]" } } }, "localname": "MajorProductLineMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/RevenueTables" ], "xbrltype": "domainItemType" }, "ctva_MarketableSecuritiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Marketable Securities [Member]", "label": "Marketable Securities [Member]", "terseLabel": "Marketable Securities [Member]" } } }, "localname": "MarketableSecuritiesMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/FinancialInstrumentsFinancialInstrumentsNarrativeDetails" ], "xbrltype": "domainItemType" }, "ctva_MaturitiesofLeaseLiabilitiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating and finance lease liabilities. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating and finance lease liabilities recognized in statement of financial position.", "label": "Maturities of Lease Liabilities [Table Text Block]", "terseLabel": "Maturities of Lease Liabilities [Table Text Block]" } } }, "localname": "MaturitiesofLeaseLiabilitiesTableTextBlock", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/LeasesTables" ], "xbrltype": "textBlockItemType" }, "ctva_MergerwithDowMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Merger with Dow [Member]", "label": "Merger with Dow [Member]", "terseLabel": "Merger with Dow [Member]" } } }, "localname": "MergerwithDowMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/InventoriesScheduleofInventoryDetails", "http://www.corteva.com/role/QuaterlyFinancialDataQuarterlyFinancialDataParentheticalsDetails" ], "xbrltype": "domainItemType" }, "ctva_MethodOfDisaggregationAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Method of Disaggregation", "label": "Method of Disaggregation [Axis]", "terseLabel": "Method of Disaggregation [Axis]" } } }, "localname": "MethodOfDisaggregationAxis", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/RevenueTables" ], "xbrltype": "stringItemType" }, "ctva_MethodOfDisaggregationDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Method of Disaggregation", "label": "Method of Disaggregation [Domain]", "terseLabel": "Method of Disaggregation [Domain]" } } }, "localname": "MethodOfDisaggregationDomain", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/RevenueTables" ], "xbrltype": "domainItemType" }, "ctva_Miscellaneousincomeandexpensesnet": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Miscellaneous income and expenses, net", "label": "Miscellaneous income and expenses, net", "terseLabel": "Miscellaneous income (expenses) - net" } } }, "localname": "Miscellaneousincomeandexpensesnet", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/SupplementaryInformationOtherIncomeExpenseNetDetails" ], "xbrltype": "monetaryItemType" }, "ctva_NaturalResourcesDamagesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Natural Resources Damages [Member]", "label": "Natural Resources Damages [Member]", "terseLabel": "Natural Resources Damages [Member]" } } }, "localname": "NaturalResourcesDamagesMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationOtherPFOAMattersFayattevilleDetails" ], "xbrltype": "domainItemType" }, "ctva_NetIncomeLossAvailabletoCommonStockholdersBasicandDiluted": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.", "label": "Net Income (Loss) Available to Common Stockholders, Basic and Diluted", "terseLabel": "Net (Loss) Income attributable to common stockholders" } } }, "localname": "NetIncomeLossAvailabletoCommonStockholdersBasicandDiluted", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/EarningsPerShareNetIncomeforEarningsPerShareCalculationsBasicandDilutedDetails" ], "xbrltype": "monetaryItemType" }, "ctva_NetIncomeLossfromContinuingOperationsAvailabletoCommonShareholdersBasicandDiluted": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) from continuing operations available to common shareholders.", "label": "Net Income (Loss) from Continuing Operations Available to Common Shareholders, Basic and Diluted", "terseLabel": "Income (loss) from continuing operations attributable to Corteva common stockholders" } } }, "localname": "NetIncomeLossfromContinuingOperationsAvailabletoCommonShareholdersBasicandDiluted", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/EarningsPerShareNetIncomeforEarningsPerShareCalculationsBasicandDilutedDetails" ], "xbrltype": "monetaryItemType" }, "ctva_Netgainonsalesofbusinessesandotherassets": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Net gain on sales of businesses and other assets", "label": "Net gain on sales of businesses and other assets", "terseLabel": "Net gain on sales of businesses and other assets" } } }, "localname": "Netgainonsalesofbusinessesandotherassets", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/SupplementaryInformationOtherIncomeExpenseNetDetails" ], "xbrltype": "monetaryItemType" }, "ctva_Netgainonsalesofpropertybusinessesconsolidatedcompaniesandinvestments": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Gain (loss) from sale or disposal of an organization or integrated set of activities (for example, but not limited to, a partnership or corporation) engaged in providing a product or service in a commercial, industrial, or professional environment. Also includes amount of gain (loss) on sale or disposal of assets, including but not limited to property, plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee.", "label": "Net gain on sales of property, businesses, consolidated companies, and investments", "negatedTerseLabel": "Net gain on sales of property, businesses, consolidated companies, and investments" } } }, "localname": "Netgainonsalesofpropertybusinessesconsolidatedcompaniesandinvestments", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "ctva_NonPFASMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Non-PFAS", "label": "Non-PFAS [Member]", "terseLabel": "Non-PFAS" } } }, "localname": "NonPFASMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationChemoursDetails" ], "xbrltype": "domainItemType" }, "ctva_NonU.S.planswithplanassetsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Non-U.S. plans with plan assets [Member]", "label": "Non-U.S. plans with plan assets [Member]", "terseLabel": "Non-U.S. plans with plan assets [Member]" } } }, "localname": "NonU.S.planswithplanassetsMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansChangeinProjectedBenefitObligationsPlanAssetsandFundedStatusDetails" ], "xbrltype": "domainItemType" }, "ctva_Nonoperatingbenefitscostsnet": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Non-operating (benefits) costs - net", "label": "Non-operating (benefits) costs - net", "terseLabel": "Non-operating benefits - net" } } }, "localname": "Nonoperatingbenefitscostsnet", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/EIDSegmentFNSegmentReconciliationDetails" ], "xbrltype": "monetaryItemType" }, "ctva_NotesMaturing2025Domain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Notes Maturing 2025", "label": "Notes Maturing 2025 [Domain]", "terseLabel": "Notes Maturing 2025 [Domain]" } } }, "localname": "NotesMaturing2025Domain", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/LongTermDebtandAvailableCreditFacilitiesLongTermDebtDetails" ], "xbrltype": "domainItemType" }, "ctva_NotesMaturing2030Domain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Notes Maturing 2030", "label": "Notes Maturing 2030 [Domain]", "terseLabel": "Notes Maturing 2030 [Domain]" } } }, "localname": "NotesMaturing2030Domain", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/LongTermDebtandAvailableCreditFacilitiesLongTermDebtDetails" ], "xbrltype": "domainItemType" }, "ctva_NotsubjecttoindemnificationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Not subject to indemnification [Member]", "label": "Not subject to indemnification [Member]", "terseLabel": "Not subject to indemnification [Member]" } } }, "localname": "NotsubjecttoindemnificationMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesEnvironmentalDetails" ], "xbrltype": "domainItemType" }, "ctva_OIPMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "OIP [Member]", "label": "OIP [Member]", "terseLabel": "OIP [Member]" } } }, "localname": "OIPMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/StockBasedCompensationRestrictedStockUnitsandPerformanceDeferredStockDetails", "http://www.corteva.com/role/StockBasedCompensationStockCompensationDetails", "http://www.corteva.com/role/StockBasedCompensationStockOptionsDetails", "http://www.corteva.com/role/StockBasedCompensationTables", "http://www.corteva.com/role/StockBasedCompensationWeightedAverageAssumptionsStockOptionsDetails" ], "xbrltype": "domainItemType" }, "ctva_Once300millionthresholdismetMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Once $300 million threshold is met [Member]", "label": "Once $300 million threshold is met [Member]", "terseLabel": "Once $300 million threshold is met [Member]" } } }, "localname": "Once300millionthresholdismetMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationChemoursDetails", "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationDuPontDetails" ], "xbrltype": "domainItemType" }, "ctva_OtherAssetRelatedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Other Asset Related", "label": "Other Asset Related [Member]", "terseLabel": "Other Asset Related [Member]" } } }, "localname": "OtherAssetRelatedMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/RestructuringandAssetRelatedChargesAssetImpairmentsDetails" ], "xbrltype": "domainItemType" }, "ctva_OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyImpactbeforeTax": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Other Comprehensive Income (Loss), Defined Benefit Plan, Foreign Currency Impact, before Tax", "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Foreign Currency Impact, before Tax", "terseLabel": "Effect of foreign exchange rates" } } }, "localname": "OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyImpactbeforeTax", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansComponentsofnetperiodicbenefitcostcreditandamountsrecognizedinothercomprehensivelossDetails" ], "xbrltype": "monetaryItemType" }, "ctva_OtherComprehensiveIncomeLossFinalizationOfPensionAndOtherPostretirementBenefitPlanValuationCurtailmentGainLossBeforeTax": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Other Comprehensive Income (Loss), Finalization Of Pension And Other Postretirement Benefit Plan Valuation, Curtailment Gain (Loss), Before Tax", "label": "Other Comprehensive Income (Loss), Finalization Of Pension And Other Postretirement Benefit Plan Valuation, Curtailment Gain (Loss), Before Tax", "negatedTerseLabel": "Curtailment (loss) gain" } } }, "localname": "OtherComprehensiveIncomeLossFinalizationOfPensionAndOtherPostretirementBenefitPlanValuationCurtailmentGainLossBeforeTax", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansComponentsofnetperiodicbenefitcostcreditandamountsrecognizedinothercomprehensivelossDetails" ], "xbrltype": "monetaryItemType" }, "ctva_OtherComprehensiveIncomeLossFinalizationOfPensionAndOtherPostretirementBenefitPlanValuationSettlementGainLossBeforeTax": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Other Comprehensive Income (Loss), Finalization Of Pension And Other Postretirement Benefit Plan Valuation, Settlement Gain (Loss), Before Tax", "label": "Other Comprehensive Income (Loss), Finalization Of Pension And Other Postretirement Benefit Plan Valuation, Settlement Gain (Loss), Before Tax", "terseLabel": "Settlement loss" } } }, "localname": "OtherComprehensiveIncomeLossFinalizationOfPensionAndOtherPostretirementBenefitPlanValuationSettlementGainLossBeforeTax", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansComponentsofnetperiodicbenefitcostcreditandamountsrecognizedinothercomprehensivelossDetails" ], "xbrltype": "monetaryItemType" }, "ctva_OtherDiscontinuedOrDivestedBusinessObligationsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Other Discontinued or Divested Business Obligations", "label": "Other Discontinued or Divested Business Obligations [Member]", "terseLabel": "Other Discontinued or Divested Business Obligations" } } }, "localname": "OtherDiscontinuedOrDivestedBusinessObligationsMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesEnvironmentalDetails" ], "xbrltype": "domainItemType" }, "ctva_OtherLoansMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Other Loans [Member]", "label": "Other Loans [Member]", "terseLabel": "Other Loans [Member]" } } }, "localname": "OtherLoansMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/LongTermDebtandAvailableCreditFacilitiesLongTermDebtDetails" ], "xbrltype": "domainItemType" }, "ctva_OtherMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Other [Member]", "label": "Other [Member]", "terseLabel": "Other [Member]" } } }, "localname": "OtherMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/RevenueDisaggregationofRevenueProductsDetails" ], "xbrltype": "domainItemType" }, "ctva_OtherOperatingChargesPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for other operating cost and expense items that are associated with the entity's normal revenue producing operation.", "label": "Other Operating Charges, Policy [Policy Text Block]", "terseLabel": "Other Operating Charges" } } }, "localname": "OtherOperatingChargesPolicyPolicyTextBlock", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "ctva_OtherdiscontinuedoperationsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Other discontinued operations [Member]", "label": "Other discontinued operations [Member]", "terseLabel": "Other discontinued operations [Member]" } } }, "localname": "OtherdiscontinuedoperationsMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/DivestituresandOtherTransactionsDivestituresandOtherTransactionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "ctva_OtherlossonsaleMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Other loss on sale [Member]", "label": "Other loss on sale [Member]", "terseLabel": "Other loss on sale [Member]" } } }, "localname": "OtherlossonsaleMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/SegmentReportingSigItemsDetails" ], "xbrltype": "domainItemType" }, "ctva_OtheroilseedsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Other oilseeds [Member]", "label": "Other oilseeds [Member]", "terseLabel": "Other oilseeds [Member]" } } }, "localname": "OtheroilseedsMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/RevenueDisaggregationofRevenueProductsDetails" ], "xbrltype": "domainItemType" }, "ctva_Ownershipinterestinanentity": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Ownership interest in an entity", "label": "Ownership interest in an entity", "terseLabel": "Ownership interest in an entity" } } }, "localname": "Ownershipinterestinanentity", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/BackgroundandBasisofPresentationDetails", "http://www.corteva.com/role/EIDBasisofPresentationDetails", "http://www.corteva.com/role/StockholdersEquityNoncontrollingInterestDetails" ], "xbrltype": "percentItemType" }, "ctva_PFASMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "PFAS [Member]", "label": "PFAS [Member]", "terseLabel": "PFAS [Member]" } } }, "localname": "PFASMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationChemoursDetails", "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationDuPontDetails" ], "xbrltype": "domainItemType" }, "ctva_PFOAMattersDrinkingWaterActionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "PFOA Matters: Drinking Water Actions [Member]", "label": "PFOA Matters: Drinking Water Actions [Member]", "terseLabel": "PFOA Matters: Drinking Water Actions [Member]" } } }, "localname": "PFOAMattersDrinkingWaterActionsMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationLeachandMDLSettlementDetails", "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationOtherPFOAMattersFayattevilleDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsDivestituresandOtherTransactionsPChemResultsofOperationsDetails" ], "xbrltype": "domainItemType" }, "ctva_PFOAMattersMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "PFOA Matters [Member]", "label": "PFOA Matters [Member]", "terseLabel": "PFOA Matters [Member]" } } }, "localname": "PFOAMattersMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationLeachandMDLSettlementDetails" ], "xbrltype": "domainItemType" }, "ctva_PFOAMattersMultiDistrictLitigationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "PFOA Matters: Multi-District Litigation [Member]", "label": "PFOA Matters: Multi-District Litigation [Member]", "terseLabel": "PFOA Matters: Multi-District Litigation [Member]" } } }, "localname": "PFOAMattersMultiDistrictLitigationMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationChemoursDetails", "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationDuPontDetails", "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationLeachandMDLSettlementDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsDivestituresandOtherTransactionsPChemResultsofOperationsDetails" ], "xbrltype": "domainItemType" }, "ctva_PaymentTimingDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "[Domain] for Payment Timing [Axis]", "label": "Payment Timing [Domain]", "terseLabel": "Payment Timing [Domain]" } } }, "localname": "PaymentTimingDomain", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesGuaranteeNarrativeDetails" ], "xbrltype": "domainItemType" }, "ctva_PensionResizeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Pension Resize [Member]", "label": "Pension Resize [Member]", "terseLabel": "Pension Resize [Member]" } } }, "localname": "PensionResizeMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/IncomeTaxesIncomeTaxesNarrativeDetails" ], "xbrltype": "domainItemType" }, "ctva_PensionandotherpostemploymentbenefitsnoncurrentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Pension and other post employment benefits - noncurrent [Member]", "label": "Pension and other post employment benefits - noncurrent [Member]", "terseLabel": "Pension and other post employment benefits - noncurrent [Member]" } } }, "localname": "PensionandotherpostemploymentbenefitsnoncurrentMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansAmountsRecognizedinConsolidatedBalanceSheetsDetails" ], "xbrltype": "domainItemType" }, "ctva_Percentageofoutstandingamountsborrowedutilizedascollateral": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of outstanding amounts borrowed utilized as collateral", "label": "Percentage of outstanding amounts borrowed utilized as collateral", "terseLabel": "Percentage of outstanding amounts borrowed utilized as collateral" } } }, "localname": "Percentageofoutstandingamountsborrowedutilizedascollateral", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/SubsequentEventsDetails" ], "xbrltype": "percentItemType" }, "ctva_PerformanceChemicalsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Performance Chemicals [Member]", "label": "Performance Chemicals [Member]", "terseLabel": "Performance Chemicals [Member]" } } }, "localname": "PerformanceChemicalsMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesEnvironmentalDetails", "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationChemoursDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsDivestituresandOtherTransactionsPChemResultsofOperationsDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsTables" ], "xbrltype": "domainItemType" }, "ctva_PerformanceShareUnitsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Performance Share Units", "label": "Performance Share Units [Member]", "terseLabel": "Performance Share Units [Member]" } } }, "localname": "PerformanceShareUnitsMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/StockBasedCompensationRestrictedStockUnitsandPerformanceDeferredStockDetails" ], "xbrltype": "domainItemType" }, "ctva_PersonalinjurycasesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Personal injury cases [Member]", "label": "Personal injury cases [Member]", "terseLabel": "Personal injury cases [Member]" } } }, "localname": "PersonalinjurycasesMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationOtherPFOAMattersFayattevilleDetails" ], "xbrltype": "domainItemType" }, "ctva_Planassetstransferredduetosaleliquidationspinoffordivestiture": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, measured using unobservable inputs, of change in plan assets of defined benefit plan, for assets transferred attributed to the sale, liquidation, spin-off or other divestiture of a corporate division or subsidiary", "label": "Plan assets transferred due to sale, liquidation, spin-off, or divestiture", "terseLabel": "Plan assets transferred due to sale, liquidation, spin-off, or divestiture" } } }, "localname": "Planassetstransferredduetosaleliquidationspinoffordivestiture", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansSummaryofFairValueMeasurementofLevel3PensionPlanAssetsDetails" ], "xbrltype": "monetaryItemType" }, "ctva_PlansofDiscontinuedOperationsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Plans of Discontinued Operations [Member]", "label": "Plans of Discontinued Operations [Member]", "terseLabel": "Plans of Discontinued Operations [Member]" } } }, "localname": "PlansofDiscontinuedOperationsMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansChangeinProjectedBenefitObligationsPlanAssetsandFundedStatusDetails" ], "xbrltype": "domainItemType" }, "ctva_PostMDLSettlementPFOAPersonalInjuryClaimsDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Post-MDL Settlement PFOA Personal Injury Claims [Domain]", "label": "Post-MDL Settlement PFOA Personal Injury Claims [Domain]", "terseLabel": "Post-MDL Settlement PFOA Personal Injury Claims [Domain]" } } }, "localname": "PostMDLSettlementPFOAPersonalInjuryClaimsDomain", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationLeachandMDLSettlementDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsDivestituresandOtherTransactionsPChemResultsofOperationsDetails", "http://www.corteva.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "ctva_PrepaidRoyaltiesLongTerm": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for royalties that provide economic benefits within a future period of greater than one year or normal reporting cycle, if longer.", "label": "Prepaid Royalties - Long-Term", "terseLabel": "Prepaid Royalties - Long-Term" } } }, "localname": "PrepaidRoyaltiesLongTerm", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "ctva_Pretaxcashrequirementstocoveractualnetclaimscostsandrelatedadministrativeexpenses": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Pre-tax cash requirements to cover actual net claims costs and related administrative expenses", "label": "Pre-tax cash requirements to cover actual net claims costs and related administrative expenses", "terseLabel": "Pre-tax cash requirements to cover actual net claims costs and related administrative expenses" } } }, "localname": "Pretaxcashrequirementstocoveractualnetclaimscostsandrelatedadministrativeexpenses", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "ctva_PrincipalU.S.PensionPlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Principal U.S. Pension Plan [Member]", "label": "Principal U.S. Pension Plan [Member]", "terseLabel": "Principal U.S. Pension Plan [Member]" } } }, "localname": "PrincipalU.S.PensionPlanMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansAdditionalInformationDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansWeightedAverageAssumptionsusedtoDetermineNetPeriodicBenefitCostPensionDetails" ], "xbrltype": "domainItemType" }, "ctva_Proceedsfromthesaleofpropertybusinessesandconsolidatedcompaniesnetofcashdivested": { "auth_ref": [], "calculation": { "http://www.corteva.com/role/ConsolidatedStatementsofCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Proceeds from the sale of property, businesses, and consolidated companies, net of cash divested", "label": "Proceeds from the sale of property, businesses, and consolidated companies, net of cash divested", "terseLabel": "Proceeds from the sale of property, businesses, and consolidated companies, net of cash divested" } } }, "localname": "Proceedsfromthesaleofpropertybusinessesandconsolidatedcompaniesnetofcashdivested", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "ctva_Proformaadjustments": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Pro forma adjustments", "label": "Pro forma adjustments", "terseLabel": "Pro forma adjustments" } } }, "localname": "Proformaadjustments", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/EIDSegmentFNSegmentReconciliationDetails", "http://www.corteva.com/role/SegmentReportingSegmentReconciliationDetails" ], "xbrltype": "monetaryItemType" }, "ctva_PromissoryNotesandDebenturesFinalMaturityCurrentYearMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Promissory Notes and Debentures, Final Maturity Current Year [Member]", "label": "Promissory Notes and Debentures, Final Maturity Current Year [Member]", "terseLabel": "Final Maturity 2018" } } }, "localname": "PromissoryNotesandDebenturesFinalMaturityCurrentYearMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/LongTermDebtandAvailableCreditFacilitiesLongTermDebtDetails" ], "xbrltype": "domainItemType" }, "ctva_PromissoryNotesandDebenturesFinalMaturityYearFiveMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Promissory Notes and Debentures, Final Maturity Year Five [Member]", "label": "Promissory Notes and Debentures, Final Maturity Year Five [Member]", "terseLabel": "Final Maturity 2023" } } }, "localname": "PromissoryNotesandDebenturesFinalMaturityYearFiveMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/LongTermDebtandAvailableCreditFacilitiesLongTermDebtDetails" ], "xbrltype": "domainItemType" }, "ctva_PromissoryNotesandDebenturesFinalMaturityYearOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Promissory Notes and Debentures, Final Maturity Year One [Member]", "label": "Promissory Notes and Debentures, Final Maturity Year One [Member]", "terseLabel": "Final Maturity 2019" } } }, "localname": "PromissoryNotesandDebenturesFinalMaturityYearOneMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/LongTermDebtandAvailableCreditFacilitiesLongTermDebtDetails" ], "xbrltype": "domainItemType" }, "ctva_PromissoryNotesandDebenturesFinalMaturityYearSixandThereafterMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Promissory Notes and Debentures, Final Maturity Year Six and Thereafter [Member]", "label": "Promissory Notes and Debentures, Final Maturity Year Six and Thereafter [Member]", "terseLabel": "Final Maturity 2024 and thereafter" } } }, "localname": "PromissoryNotesandDebenturesFinalMaturityYearSixandThereafterMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/LongTermDebtandAvailableCreditFacilitiesLongTermDebtDetails" ], "xbrltype": "domainItemType" }, "ctva_PromissoryNotesandDebenturesFinalMaturityYearThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Promissory Notes and Debentures, Final Maturity Year Three [Member]", "label": "Promissory Notes and Debentures, Final Maturity Year Three [Member]", "terseLabel": "Final Maturity 2021" } } }, "localname": "PromissoryNotesandDebenturesFinalMaturityYearThreeMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/LongTermDebtandAvailableCreditFacilitiesLongTermDebtDetails" ], "xbrltype": "domainItemType" }, "ctva_PromissoryNotesandDebenturesFinalMaturityYearTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Promissory Notes and Debentures, Final Maturity Year Two [Member]", "label": "Promissory Notes and Debentures, Final Maturity Year Two [Member]", "terseLabel": "Final Maturity 2020" } } }, "localname": "PromissoryNotesandDebenturesFinalMaturityYearTwoMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/LongTermDebtandAvailableCreditFacilitiesLongTermDebtDetails" ], "xbrltype": "domainItemType" }, "ctva_PropertyPlantandEquipmentDepreciationExpenseTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Property, Plant and Equipment - Depreciation Expense [Table Text Block]", "label": "Property, Plant and Equipment - Depreciation Expense [Table Text Block]", "terseLabel": "Property, Plant and Equipment - Depreciation Expense [Table Text Block]" } } }, "localname": "PropertyPlantandEquipmentDepreciationExpenseTableTextBlock", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/PropertyPlantandEquipmentTables" ], "xbrltype": "textBlockItemType" }, "ctva_QualifiedSpendAndEscrowAccountContributionThreshold": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Qualified Spend and Escrow Account Contribution Threshold", "label": "Qualified Spend and Escrow Account Contribution Threshold", "terseLabel": "Qualified Spend and Escrow Account Contribution Threshold" } } }, "localname": "QualifiedSpendAndEscrowAccountContributionThreshold", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationChemoursDetails" ], "xbrltype": "monetaryItemType" }, "ctva_RSUsAndPSUsEIPMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "RSUs and PSUs - EIP", "label": "RSUs and PSUs - EIP [Member]", "terseLabel": "RSUs and PSUs - EIP [Domain]" } } }, "localname": "RSUsAndPSUsEIPMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/StockBasedCompensationRestrictedStockUnitsandPerformanceDeferredStockDetails" ], "xbrltype": "domainItemType" }, "ctva_RSUsAndPSUsOIPMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "RSUs and PSUs - OIP", "label": "RSUs and PSUs - OIP [Member]", "terseLabel": "RSUs and PSUs - OIP [Domain]" } } }, "localname": "RSUsAndPSUsOIPMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/StockBasedCompensationRestrictedStockUnitsandPerformanceDeferredStockDetails" ], "xbrltype": "domainItemType" }, "ctva_ReallocationofgoodwillMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Reallocation of goodwill [Member]", "label": "Reallocation of goodwill [Member]", "terseLabel": "Reallocation of goodwill [Member]" } } }, "localname": "ReallocationofgoodwillMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/SegmentReportingSegmentInformationDetails" ], "xbrltype": "domainItemType" }, "ctva_RemainingPlanswithnoPlanAssetsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Remaining Plans with no Plan Assets [Member]", "label": "Remaining Plans with no Plan Assets [Member]", "terseLabel": "Remaining Plans with no Plan Assets [Member]" } } }, "localname": "RemainingPlanswithnoPlanAssetsMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "ctva_RepatriationAccrualMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Repatriation Accrual [Member]", "label": "Repatriation Accrual [Member]", "terseLabel": "Repatriation Accrual [Member]" } } }, "localname": "RepatriationAccrualMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/EIDIncomeTaxesRateReconciliationDetails", "http://www.corteva.com/role/IncomeTaxesIncomeTaxesReconciliationtoUSStatutoryRateDetails" ], "xbrltype": "domainItemType" }, "ctva_RepaymentsofLongtermDebtincludingbreakagefeesandallapplicableaccruedandunpaidinterest": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount paid to extinguish long term debt, including principal, breakage fees and all applicable accrued and unpaid interest on related debt", "label": "Repayments of Long-term Debt, including breakage fees and all applicable accrued and unpaid interest", "terseLabel": "Repayments of Long-term Debt, including breakage fees and all applicable accrued and unpaid interest" } } }, "localname": "RepaymentsofLongtermDebtincludingbreakagefeesandallapplicableaccruedandunpaidinterest", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/LongTermDebtandAvailableCreditFacilitiesDebtRedemptionsRepaymentsDetails" ], "xbrltype": "monetaryItemType" }, "ctva_RequestForRemediationFundingSourceRFS": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "On January 28, 2022, the State of New Jersey filed a request for a preliminary injunction against EID and Chemours seeking an establishment of a Request for Remediation Funding Source (\"RFS\") for environmental remediation at EID's former Chambers Works facility in New Jersey.", "label": "Request for Remediation Funding Source (\"RFS\")", "terseLabel": "Request for Remediation Funding Source (\"RFS\")" } } }, "localname": "RequestForRemediationFundingSourceRFS", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationChemoursDetails" ], "xbrltype": "monetaryItemType" }, "ctva_RequiredTimeToRemoveAssets": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Amount of time, from operations being ceased, that lease agreement requires assets to be removed.", "label": "Required Time to Remove Assets", "terseLabel": "Required Time to Remove Assets" } } }, "localname": "RequiredTimeToRemoveAssets", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/RestructuringandAssetRelatedChargesExecutetoWinProductivityProgramDetails" ], "xbrltype": "durationItemType" }, "ctva_ResidualValueGuaranteeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Residual Value Guarantee [Member]", "label": "Residual Value Guarantee [Member]", "terseLabel": "Residual Value Guarantee [Member]" } } }, "localname": "ResidualValueGuaranteeMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/LeasesNarrativeDetails" ], "xbrltype": "domainItemType" }, "ctva_RestrictedStockUnitsAndPerformanceShareUnitsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Restricted Stock Units and Performance Share Units", "label": "Restricted Stock Units and Performance Share Units [Member]", "terseLabel": "Restricted Stock Units and Performance Deferred Stock Units [Member]" } } }, "localname": "RestrictedStockUnitsAndPerformanceShareUnitsMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/StockBasedCompensationRestrictedStockUnitsandPerformanceDeferredStockDetails" ], "xbrltype": "domainItemType" }, "ctva_RestructuringAndAssetRelatedChargesNet": { "auth_ref": [], "calculation": { "http://www.corteva.com/role/ConsolidatedStatementsofIncome": { "order": 5.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of restructuring charges, remediation cost, and asset impairment loss", "label": "Restructuring and asset related charges- net", "terseLabel": "Restructuring and asset related charges- net" } } }, "localname": "RestructuringAndAssetRelatedChargesNet", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/ConsolidatedStatementsofCashFlows", "http://www.corteva.com/role/ConsolidatedStatementsofIncome", "http://www.corteva.com/role/QuaterlyFinancialDataQuarterlyFinancialDataDetails", "http://www.corteva.com/role/RestructuringandAssetRelatedCharges2021RestructuringActionsDetails", "http://www.corteva.com/role/RestructuringandAssetRelatedChargesDowDuPontCostSynergyProgramDetails", "http://www.corteva.com/role/RestructuringandAssetRelatedChargesExecutetoWinProductivityProgramDetails", "http://www.corteva.com/role/SegmentReportingSigItemsDetails" ], "xbrltype": "monetaryItemType" }, "ctva_RestructuringandAssetRelatedActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Restructuring and Asset Related Activities [Abstract]", "label": "Restructuring and Asset Related Activities [Abstract]", "terseLabel": "Restructuring and Asset Related Activities [Abstract]" } } }, "localname": "RestructuringandAssetRelatedActivitiesAbstract", "nsuri": "http://www.corteva.com/20211231", "xbrltype": "stringItemType" }, "ctva_RetainedEarningsShareBasedPaymentArrangementIncreaseForCostRecognition": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Retained Earnings, Share-based Payment Arrangement, Increase for Cost Recognition", "label": "Retained Earnings, Share-based Payment Arrangement, Increase for Cost Recognition", "terseLabel": "Retained Earnings, Share-based Compensation" } } }, "localname": "RetainedEarningsShareBasedPaymentArrangementIncreaseForCostRecognition", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/ConsolidatedStatementsofEquity" ], "xbrltype": "monetaryItemType" }, "ctva_RevolvingCreditFacilitiesdue2022Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Revolving Credit Facilities due 2022 [Member]", "label": "Revolving Credit Facilities due 2022 [Member]", "terseLabel": "Revolving Credit Facilities due 2022 [Member]" } } }, "localname": "RevolvingCreditFacilitiesdue2022Member", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/LongTermDebtandAvailableCreditFacilitiesAvailableCommittedCreditFacilitiesNarrativeDetails", "http://www.corteva.com/role/LongTermDebtandAvailableCreditFacilitiesDebtRedemptionsRepaymentsDetails" ], "xbrltype": "domainItemType" }, "ctva_RevolvingCreditFacilitiesdue2024Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Revolving Credit Facilities due 2024 [Member]", "label": "Revolving Credit Facilities due 2024 [Member]", "terseLabel": "Revolving Credit Facilities due 2024 [Member]" } } }, "localname": "RevolvingCreditFacilitiesdue2024Member", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/LongTermDebtandAvailableCreditFacilitiesAvailableCommittedCreditFacilitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "ctva_RoundedAmountMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Rounded Amount", "label": "Rounded Amount [Member]", "terseLabel": "Rounded Amount [Member]" } } }, "localname": "RoundedAmountMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationLeachandMDLSettlementDetails", "http://www.corteva.com/role/EarningsPerShareShareCountInformationDetails" ], "xbrltype": "domainItemType" }, "ctva_RoyaltyExpensePolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Royalty Expense, Policy [Policy Text Block]", "label": "Royalty Expense, Policy [Policy Text Block]", "terseLabel": "Royalty Expense" } } }, "localname": "RoyaltyExpensePolicyPolicyTextBlock", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "ctva_SMRnotesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "SMR notes [Member]", "label": "SMR notes [Member]", "terseLabel": "SMR notes [Member]" } } }, "localname": "SMRnotesMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/LongTermDebtandAvailableCreditFacilitiesDebtRedemptionsRepaymentsDetails" ], "xbrltype": "domainItemType" }, "ctva_SaleofJVMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sale of JV [Member]", "label": "Sale of JV [Member]", "terseLabel": "Sale of JV [Member]" } } }, "localname": "SaleofJVMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/QuaterlyFinancialDataQuarterlyFinancialDataParentheticalsDetails", "http://www.corteva.com/role/SegmentReportingSigItemsDetails" ], "xbrltype": "domainItemType" }, "ctva_ScheduleOfEnvironmentalLossContingenciesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabluar disclosure of environmental loss contingencies. Does not include loss contingencies that are not environmental in nature.", "label": "Schedule of Environmental Loss Contingencies [Table Text Block]", "terseLabel": "Schedule of Environmental Loss Contingencies" } } }, "localname": "ScheduleOfEnvironmentalLossContingenciesTableTextBlock", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesTables" ], "xbrltype": "textBlockItemType" }, "ctva_ScheduleOfRestructuringReserveBySegmentTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of Restructuring Reserve by Segment", "label": "Schedule of Restructuring Reserve by Segment [Table Text Block]", "terseLabel": "Schedule of Restructuring Reserve by Segment" } } }, "localname": "ScheduleOfRestructuringReserveBySegmentTableTextBlock", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/RestructuringandAssetRelatedChargesTables" ], "xbrltype": "textBlockItemType" }, "ctva_ScheduledForTrialMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Scheduled for Trial", "label": "Scheduled for Trial [Member]", "terseLabel": "Scheduled for Trial [Member]" } } }, "localname": "ScheduledForTrialMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationLeachandMDLSettlementDetails" ], "xbrltype": "domainItemType" }, "ctva_ScheduleofAdditionalSegmentDetailsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of Additional Segment Details [Table Text Block]", "label": "Schedule of Additional Segment Details [Table Text Block]", "terseLabel": "Schedule of Additional Segment Details [Table Text Block]" } } }, "localname": "ScheduleofAdditionalSegmentDetailsTableTextBlock", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/SegmentReportingTables" ], "xbrltype": "textBlockItemType" }, "ctva_ScheduleofFiniteandIndefiniteLivedIntangibleAssetsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite or indefinite life, by either major class or business segment.", "label": "Schedule of Finite and Indefinite-Lived Intangible Assets [Table Text Block]", "terseLabel": "Other Intangible Assets" } } }, "localname": "ScheduleofFiniteandIndefiniteLivedIntangibleAssetsTableTextBlock", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/GoodwillandOtherIntangibleAssetsTables" ], "xbrltype": "textBlockItemType" }, "ctva_ScheduleofLeaseAssetsandLiabilitiesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "[Line Items] for Schedule of Lease Assets and Liabilities [Table]", "label": "Schedule of Lease Assets and Liabilities [Line Items]", "terseLabel": "Schedule of Lease Assets and Liabilities [Line Items]" } } }, "localname": "ScheduleofLeaseAssetsandLiabilitiesLineItems", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/LeasesSupplementalBalanceSheetInformationDetails" ], "xbrltype": "stringItemType" }, "ctva_ScheduleofLeaseAssetsandLiabilitiesTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of Lease Assets and Liabilities [Table]", "label": "Schedule of Lease Assets and Liabilities [Table]", "terseLabel": "Schedule of Lease Assets and Liabilities [Table]" } } }, "localname": "ScheduleofLeaseAssetsandLiabilitiesTable", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/LeasesSupplementalBalanceSheetInformationDetails" ], "xbrltype": "stringItemType" }, "ctva_ScheduleofLeaseAssetsandLiabilitiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "[Table Text Block] for Schedule of Lease Assets and Liabilities [Table]", "label": "Schedule of Lease Assets and Liabilities [Table Text Block]", "terseLabel": "Schedule of Lease Assets and Liabilities [Table Text Block]" } } }, "localname": "ScheduleofLeaseAssetsandLiabilitiesTableTextBlock", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/LeasesTables" ], "xbrltype": "textBlockItemType" }, "ctva_ScheduleofMinimumLeaseCommitmentsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "[Table Text Block] for Schedule of Minimum Lease Commitments [Table]", "label": "Schedule of Minimum Lease Commitments [Table Text Block]", "terseLabel": "Schedule of Minimum Lease Commitments [Table Text Block]" } } }, "localname": "ScheduleofMinimumLeaseCommitmentsTableTextBlock", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/LeasesTables" ], "xbrltype": "textBlockItemType" }, "ctva_ScheduleofNoncontrollingInterestsRepresentedbyPreferredStockTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of Noncontrolling Interests Represented by Preferred Stock [Table Text Block]", "label": "Schedule of Noncontrolling Interests Represented by Preferred Stock [Table Text Block]", "terseLabel": "Schedule of Noncontrolling Interests Represented by Preferred Stock [Table Text Block]" } } }, "localname": "ScheduleofNoncontrollingInterestsRepresentedbyPreferredStockTableTextBlock", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/StockholdersEquityTables" ], "xbrltype": "textBlockItemType" }, "ctva_ScheduleofSundryIncomeExpenseNetLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "[Line Items] for Schedule of Sundry Income (Expense) - Net [Table]", "label": "Schedule of Sundry Income (Expense) - Net [Line Items]", "terseLabel": "Schedule of Sundry Income (Expense) - Net [Line Items]" } } }, "localname": "ScheduleofSundryIncomeExpenseNetLineItems", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/SupplementaryInformationOtherIncomeExpenseNetDetails" ], "xbrltype": "stringItemType" }, "ctva_ScheduleofSundryIncomeExpenseNetTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of Sundry Income (Expense) - Net [Table]", "label": "Schedule of Sundry Income (Expense) - Net [Table]", "terseLabel": "Schedule of Sundry Income (Expense) - Net [Table]" } } }, "localname": "ScheduleofSundryIncomeExpenseNetTable", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/SupplementaryInformationOtherIncomeExpenseNetDetails" ], "xbrltype": "stringItemType" }, "ctva_ScheduleofSupplementalCashFlowInformationRelatedtoLeasesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of supplemental cash flow information related to leases", "label": "Schedule of Supplemental Cash Flow Information Related to Leases [Table Text Block]", "terseLabel": "Schedule of Supplemental Cash Flow Information Related to Leases [Table Text Block]" } } }, "localname": "ScheduleofSupplementalCashFlowInformationRelatedtoLeasesTableTextBlock", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/LeasesTables" ], "xbrltype": "textBlockItemType" }, "ctva_SeedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Seed [Member]", "label": "Seed [Member]", "terseLabel": "Seed [Member]" } } }, "localname": "SeedMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/DivestituresandOtherTransactionsECPDivestitureDetails", "http://www.corteva.com/role/GoodwillandOtherIntangibleAssetsGoodwillbySegmentDetails", "http://www.corteva.com/role/RestructuringandAssetRelatedCharges2021RestructuringActionsDetails", "http://www.corteva.com/role/RestructuringandAssetRelatedChargesDowDuPontAgricultureDivisionRestructuringProgramDetails", "http://www.corteva.com/role/RestructuringandAssetRelatedChargesDowDuPontCostSynergyProgramDetails", "http://www.corteva.com/role/RestructuringandAssetRelatedChargesExecutetoWinProductivityProgramDetails", "http://www.corteva.com/role/RevenueDisaggregationofRevenueGeoDetails", "http://www.corteva.com/role/RevenueDisaggregationofRevenueProductsDetails", "http://www.corteva.com/role/SegmentReportingSegmentInformationDetails", "http://www.corteva.com/role/SegmentReportingSigItemsDetails" ], "xbrltype": "domainItemType" }, "ctva_SegmentAssets": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Segment Assets", "label": "Segment Assets", "terseLabel": "Segment Assets" } } }, "localname": "SegmentAssets", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/EIDSegmentFNSegmentAssetReconciliationDetails", "http://www.corteva.com/role/SegmentReportingSegmentAssetsDetails", "http://www.corteva.com/role/SegmentReportingSegmentInformationDetails" ], "xbrltype": "monetaryItemType" }, "ctva_SegmentReportingInformationOtherBenefitCharge": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Segment Reporting Information Other Benefit (Charge)", "label": "Segment Reporting Information Other Benefit (Charge)", "terseLabel": "Significant items" } } }, "localname": "SegmentReportingInformationOtherBenefitCharge", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/EIDSegmentFNSegmentReconciliationDetails", "http://www.corteva.com/role/SegmentReportingSegmentReconciliationDetails", "http://www.corteva.com/role/SegmentReportingSigItemsDetails" ], "xbrltype": "monetaryItemType" }, "ctva_SegmentReportingReconcilingItemCorporateExpenses": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Segment Reporting Reconciling Item Corporate Expenses", "label": "Segment Reporting Reconciling Item Corporate Expenses", "terseLabel": "Corporate Expenses" } } }, "localname": "SegmentReportingReconcilingItemCorporateExpenses", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/EIDSegmentFNSegmentReconciliationDetails", "http://www.corteva.com/role/SegmentReportingSegmentReconciliationDetails" ], "xbrltype": "monetaryItemType" }, "ctva_SegmentoperatingEBITDA": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Segment operating EBITDA", "label": "Segment operating EBITDA", "terseLabel": "Segment Operating EBITDA" } } }, "localname": "SegmentoperatingEBITDA", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/EIDSegmentFNSegmentReconciliationDetails", "http://www.corteva.com/role/SegmentReportingSegmentInformationDetails", "http://www.corteva.com/role/SegmentReportingSegmentReconciliationDetails" ], "xbrltype": "monetaryItemType" }, "ctva_SeniorNote2.20PercentDue2020Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Senior Note 2.20 Percent Due 2020 [Member]", "label": "Senior Note 2.20 Percent Due 2020 [Member]", "terseLabel": "Senior Note 2.20 Percent Due 2020 [Member]" } } }, "localname": "SeniorNote2.20PercentDue2020Member", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/LongTermDebtandAvailableCreditFacilitiesAvailableCommittedCreditFacilitiesNarrativeDetails", "http://www.corteva.com/role/LongTermDebtandAvailableCreditFacilitiesDebtRedemptionsRepaymentsDetails" ], "xbrltype": "domainItemType" }, "ctva_SeniorNoteFloatingRateDue2020Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Senior Note Floating Rate Due 2020 [Member]", "label": "Senior Note Floating Rate Due 2020 [Member]", "terseLabel": "Senior Note Floating Rate Due 2020 [Member]" } } }, "localname": "SeniorNoteFloatingRateDue2020Member", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/LongTermDebtandAvailableCreditFacilitiesAvailableCommittedCreditFacilitiesNarrativeDetails", "http://www.corteva.com/role/LongTermDebtandAvailableCreditFacilitiesDebtRedemptionsRepaymentsDetails" ], "xbrltype": "domainItemType" }, "ctva_SeniorNotesDue2025Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Senior Notes Due 2025", "label": "Senior Notes Due 2025 [Member]", "terseLabel": "Senior Notes Due 2025 [Member]" } } }, "localname": "SeniorNotesDue2025Member", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/LongTermDebtandAvailableCreditFacilitiesLongTermDebtDetails" ], "xbrltype": "domainItemType" }, "ctva_SeniorNotesDue2030Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Senior Notes Due 2030", "label": "Senior Notes Due 2030 [Member]", "terseLabel": "Senior Notes Due 2030 [Member]" } } }, "localname": "SeniorNotesDue2030Member", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/LongTermDebtandAvailableCreditFacilitiesLongTermDebtDetails" ], "xbrltype": "domainItemType" }, "ctva_SettlementAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Settlement Agreement", "label": "Settlement Agreement [Member]", "terseLabel": "Settlement Agreement" } } }, "localname": "SettlementAgreementMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationOtherPFOAMattersFayattevilleDetails" ], "xbrltype": "domainItemType" }, "ctva_ShareBasedCompensationArrangementbyShareBasedPaymentAwardEquityAwardConversionRatio": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Award Conversion Ratio", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Award Conversion Ratio", "terseLabel": "Equity award conversion ratio" } } }, "localname": "ShareBasedCompensationArrangementbyShareBasedPaymentAwardEquityAwardConversionRatio", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/StockBasedCompensationRestrictedStockUnitsandPerformanceDeferredStockDetails" ], "xbrltype": "sharesItemType" }, "ctva_ShareCountInformationTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "[Table Text Block] for Share Count Information [Table]", "label": "Share Count Information [Table Text Block]", "terseLabel": "Share Count Information [Table Text Block]" } } }, "localname": "ShareCountInformationTableTextBlock", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/EarningsPerShareofCommonStockTables" ], "xbrltype": "textBlockItemType" }, "ctva_SharebasedCompensationArrangementbySharebasedPaymentAwardAwardsotherthanOptionsImpactofInternalReorganizations": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of RSU's and PSU's that were impacted by the Internal Reorganizations.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Awards other than Options, Impact of Internal Reorganizations", "terseLabel": "Impact of Internal Reorganizations" } } }, "localname": "SharebasedCompensationArrangementbySharebasedPaymentAwardAwardsotherthanOptionsImpactofInternalReorganizations", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/StockBasedCompensationRestrictedStockUnitsandPerformanceDeferredStockDetails" ], "xbrltype": "sharesItemType" }, "ctva_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsConvertedNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Amount of RSU\u2019s and PSU\u2019s that were converted into Corteva-denominated awards under the \u201cEmployer Method,\u201d or into DuPont-denominated awards under the \u201cShareholder Method,\u201d using a formula designed to preserve the intrinsic value of the awards immediately prior to and subsequent to the Corteva Distribution and moved to the OIP.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Converted, Number", "terseLabel": "Conversion - Corteva Distribution" } } }, "localname": "SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsConvertedNumber", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/StockBasedCompensationRestrictedStockUnitsandPerformanceDeferredStockDetails" ], "xbrltype": "sharesItemType" }, "ctva_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsConvertedWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average grant date fair value of RSU\u2019s and PSU\u2019s that were converted into Corteva-denominated awards under the \u201cEmployer Method,\u201d or into DuPont-denominated awards under the \u201cShareholder Method,\u201d using a formula designed to preserve the intrinsic value of the awards immediately prior to and subsequent to the Corteva Distribution and moved to the OIP.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Converted, Weighted Average Exercise Price", "terseLabel": "Conversion - Corteva Distribution, weighted average grant date fair value" } } }, "localname": "SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsConvertedWeightedAverageExercisePrice", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/StockBasedCompensationRestrictedStockUnitsandPerformanceDeferredStockDetails" ], "xbrltype": "perShareItemType" }, "ctva_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsImpactofInternalReorganizationsWeightedAverageGrantDateFairValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average grant date fair value of RSU's and PSU's that were impacted by the Internal Reorganizations.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Impact of Internal Reorganizations, Weighted Average Grant Date Fair Value", "terseLabel": "Impact of Internal Reorganizations, Weighted Average Grant Date Fair Value" } } }, "localname": "SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsImpactofInternalReorganizationsWeightedAverageGrantDateFairValue", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/StockBasedCompensationRestrictedStockUnitsandPerformanceDeferredStockDetails" ], "xbrltype": "perShareItemType" }, "ctva_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsConvertedNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Amount of equity awards that were into Corteva-denominated awards under the \u201cEmployer Method,\u201d or into DuPont-denominated awards under the \u201cShareholder Method,\u201d using a formula designed to preserve the intrinsic value of the awards immediately prior to and subsequent to the Corteva Distribution and moved to the OIP.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Converted, Number", "terseLabel": "Conversion - Corteva Distribution" } } }, "localname": "SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsConvertedNumber", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/StockBasedCompensationStockOptionsDetails" ], "xbrltype": "sharesItemType" }, "ctva_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsConvertedWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average exercise price of equity awards that were into Corteva-denominated awards under the \u201cEmployer Method,\u201d or into DuPont-denominated awards under the \u201cShareholder Method,\u201d using a formula designed to preserve the intrinsic value of the awards immediately prior to and subsequent to the Corteva Distribution and moved to the OIP.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Converted, Weighted Average Exercise Price", "terseLabel": "Conversion - Corteva Distribution, weighted average exercise price" } } }, "localname": "SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsConvertedWeightedAverageExercisePrice", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/StockBasedCompensationStockOptionsDetails" ], "xbrltype": "perShareItemType" }, "ctva_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsImpactofInternalReorganizations": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of stock options that were impacted by the Internal Reorganizations.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Impact of Internal Reorganizations", "terseLabel": "Impact of Internal Reorganizations" } } }, "localname": "SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsImpactofInternalReorganizations", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/StockBasedCompensationStockOptionsDetails" ], "xbrltype": "sharesItemType" }, "ctva_SharebasedCompensationArrangementsbySharebasedPaymentAwardOptionsImpactofInternalReorganizationsWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average exercise price of options that were impacted by the Internal Reorganizations.", "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Impact of Internal Reorganizations, Weighted Average Exercise Price", "terseLabel": "Impact of Internal Reorganizations, Weighted Average Exercise Price" } } }, "localname": "SharebasedCompensationArrangementsbySharebasedPaymentAwardOptionsImpactofInternalReorganizationsWeightedAverageExercisePrice", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/StockBasedCompensationStockOptionsDetails" ], "xbrltype": "perShareItemType" }, "ctva_Sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsactualawardsgrantedpercentageofperformancetarget": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share based compensation arrangement by share based payment award, equity instruments other than options, actual awards granted, percentage of performance target", "label": "Share based compensation arrangement by share based payment award, equity instruments other than options, actual awards granted, percentage of performance target", "terseLabel": "Share based compensation arrangement by share based payment award, equity instruments other than options, actual awards granted, percentage of performance target" } } }, "localname": "Sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsactualawardsgrantedpercentageofperformancetarget", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/StockBasedCompensationRestrictedStockUnitsandPerformanceDeferredStockDetails" ], "xbrltype": "percentItemType" }, "ctva_Sharesinwhichvestingconditionsweremet": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Shares in which vesting conditions were met", "label": "Shares in which vesting conditions were met", "terseLabel": "Shares in which vesting conditions were met" } } }, "localname": "Sharesinwhichvestingconditionsweremet", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/EarningsPerShareShareCountInformationDetails" ], "xbrltype": "sharesItemType" }, "ctva_SharesofCortevaStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Shares of Corteva Stock [Member]", "label": "Shares of Corteva Stock [Member]", "terseLabel": "Shares of Corteva Stock [Member]" } } }, "localname": "SharesofCortevaStockMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/BackgroundandBasisofPresentationDetails", "http://www.corteva.com/role/StockholdersEquityCommonStockDetails" ], "xbrltype": "domainItemType" }, "ctva_SharesofDowDuPontCommonStockHeldMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Shares of DowDuPont Common Stock Held [Member]", "label": "Shares of DowDuPont Common Stock Held [Member]", "terseLabel": "Shares of DowDuPont Common Stock Held [Member]" } } }, "localname": "SharesofDowDuPontCommonStockHeldMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/BackgroundandBasisofPresentationDetails", "http://www.corteva.com/role/StockholdersEquityCommonStockDetails" ], "xbrltype": "domainItemType" }, "ctva_ShortTermInvestmentsFairValueDisclosure": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Short Term Investments, Fair Value Disclosure", "label": "Short Term Investments, Fair Value Disclosure", "terseLabel": "Marketable securities" } } }, "localname": "ShortTermInvestmentsFairValueDisclosure", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/FairValueMeasurementsFairValueMeasurementRecurringBasisDetails" ], "xbrltype": "monetaryItemType" }, "ctva_SoybeanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Soybean [Member]", "label": "Soybean [Member]", "terseLabel": "Soybean [Member]" } } }, "localname": "SoybeanMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/RevenueDisaggregationofRevenueProductsDetails" ], "xbrltype": "domainItemType" }, "ctva_SpecialtyProductsDisposalMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Specialty Products Disposal [Member]", "label": "Specialty Products Disposal [Member]", "terseLabel": "Specialty Products Disposal [Member]" } } }, "localname": "SpecialtyProductsDisposalMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/BackgroundandBasisofPresentationPolicies", "http://www.corteva.com/role/DivestituresandOtherTransactionsDivestituresandOtherTransactionsNarrativeDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsSPDivestitureDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsTables" ], "xbrltype": "domainItemType" }, "ctva_StateTaxValuationAllowanceMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "State Tax Valuation Allowance", "label": "State Tax Valuation Allowance [Member]", "terseLabel": "State Tax Valuation Allowance [Member]" } } }, "localname": "StateTaxValuationAllowanceMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/QuaterlyFinancialDataQuarterlyFinancialDataParentheticalsDetails" ], "xbrltype": "domainItemType" }, "ctva_StockOptionsRestrictedStockUnitsAndPerformanceBasedRestrictedStockUnitsExcludedFromEPS": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stock options, restricted stock units and performance based restricted stock units excluded from EPS", "label": "Stock options, restricted stock units and performance based restricted stock units excluded from EPS", "terseLabel": "Stock options and restricted stock units excluded from EPS" } } }, "localname": "StockOptionsRestrictedStockUnitsAndPerformanceBasedRestrictedStockUnitsExcludedFromEPS", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/EarningsPerShareShareCountInformationDetails" ], "xbrltype": "sharesItemType" }, "ctva_StockOptionsRestrictedStockUnitsExcludedFromEPS": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Outstanding potential shares of common stock relating to stock options, restricted stock units and performance-based restricted stock units that were excluded from the calculation of diluted EPS because the effect of including them would have been anti-dilutive.", "label": "Stock options restricted stock units excluded from EPS", "terseLabel": "Stock options restricted stock units excluded from EPS" } } }, "localname": "StockOptionsRestrictedStockUnitsExcludedFromEPS", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/EarningsPerShareShareCountInformationDetails" ], "xbrltype": "sharesItemType" }, "ctva_Strayliabilitysharingpercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stray liability sharing percentage", "label": "Stray liability sharing percentage", "terseLabel": "Stray liability sharing percentage" } } }, "localname": "Strayliabilitysharingpercentage", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationChemoursDetails", "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationDuPontDetails" ], "xbrltype": "percentItemType" }, "ctva_Strayliabilitythreshold": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount over and above specified amounts of liability, for which Corteva and DuPont are responsible for strays.", "label": "Stray liability threshold", "terseLabel": "Stray liability threshold" } } }, "localname": "Strayliabilitythreshold", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesEnvironmentalDetails", "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationChemoursDetails", "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationDuPontDetails" ], "xbrltype": "monetaryItemType" }, "ctva_SuccessorPeriodMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Successor Period [Member]", "label": "Successor Period [Member]", "terseLabel": "Successor Period [Member]" } } }, "localname": "SuccessorPeriodMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/ConsolidatedStatementsofCashFlows", "http://www.corteva.com/role/FinancialInstrumentsCashFlowHedgesIncludedinAOCIDetails", "http://www.corteva.com/role/IncomeTaxesIncomeTaxesGrossUnrecognizedTaxBenefitsDetails", "http://www.corteva.com/role/ScheduleIIValuationandQualifyingAccountsDetails", "http://www.corteva.com/role/StockholdersEquityOtherComprehensiveIncomeLossDetails" ], "xbrltype": "domainItemType" }, "ctva_SummaryofOperatingLossandTaxCreditCarryforwardsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss and tax credit carryforwards, including an assessment of the likelihood of utilization.", "label": "Summary of Operating Loss and Tax Credit Carryforwards [Table Text Block]", "terseLabel": "Operating Loss and Tax Credit Carryforwards" } } }, "localname": "SummaryofOperatingLossandTaxCreditCarryforwardsTableTextBlock", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "ctva_SuperfundSitesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Superfund Sites [Member]", "label": "Superfund Sites [Member]", "terseLabel": "Superfund Sites [Member]" } } }, "localname": "SuperfundSitesMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesEnvironmentalDetails" ], "xbrltype": "domainItemType" }, "ctva_SupplementalPaymentThreshold": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Supplemental Payment Threshold", "label": "Supplemental Payment Threshold", "terseLabel": "Supplemental Payment Threshold" } } }, "localname": "SupplementalPaymentThreshold", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationOtherPFOAMattersFayattevilleDetails" ], "xbrltype": "monetaryItemType" }, "ctva_SupplementaryInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Supplementary Information [Abstract]", "label": "Supplementary Information [Abstract]", "terseLabel": "Supplementary Information [Abstract]" } } }, "localname": "SupplementaryInformationAbstract", "nsuri": "http://www.corteva.com/20211231", "xbrltype": "stringItemType" }, "ctva_SwissTaxReformMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Swiss Tax Reform [Member]", "label": "Swiss Tax Reform [Member]", "terseLabel": "Swiss Tax Reform [Member]" } } }, "localname": "SwissTaxReformMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/EIDIncomeTaxesRateReconciliationDetails", "http://www.corteva.com/role/IncomeTaxesIncomeTaxesReconciliationtoUSStatutoryRateDetails", "http://www.corteva.com/role/QuaterlyFinancialDataQuarterlyFinancialDataParentheticalsDetails" ], "xbrltype": "domainItemType" }, "ctva_SwissVAMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Swiss VA [Member]", "label": "Swiss VA [Member]", "terseLabel": "Swiss VA [Member]" } } }, "localname": "SwissVAMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/IncomeTaxesIncomeTaxesDeferredTaxBalancesDetails", "http://www.corteva.com/role/QuaterlyFinancialDataQuarterlyFinancialDataParentheticalsDetails" ], "xbrltype": "domainItemType" }, "ctva_TaxAdvanceDepositsMadeToForeignTaxingAuthority": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Tax, Advance deposits made to foreign taxing authority", "label": "Tax, Advance deposits made to foreign taxing authority", "terseLabel": "Tax, Advance deposits made to foreign taxing authority" } } }, "localname": "TaxAdvanceDepositsMadeToForeignTaxingAuthority", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/IncomeTaxesIncomeTaxesGrossUnrecognizedTaxBenefitsDetails" ], "xbrltype": "monetaryItemType" }, "ctva_TaxChargeBenefitRelatedToAnInternalLegalEntityRestructuringAssociatedWithTheBusinessSeparations": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Tax charge (benefit) related to an internal legal entity restructuring associated with the Business Separations", "label": "Tax charge (benefit) related to an internal legal entity restructuring associated with the Business Separations", "terseLabel": "Tax benefit related to an internal legal entity restructuring associated with the Business Separations" } } }, "localname": "TaxChargeBenefitRelatedToAnInternalLegalEntityRestructuringAssociatedWithTheBusinessSeparations", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/EIDIncomeTaxesRateReconciliationDetails", "http://www.corteva.com/role/IncomeTaxesIncomeTaxesReconciliationtoUSStatutoryRateDetails" ], "xbrltype": "monetaryItemType" }, "ctva_TaxChargeBenefitRelatedToTheActMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tax charge (benefit) related to The Act [Member]", "label": "Tax charge (benefit) related to The Act [Member]", "verboseLabel": "Tax benefit (charge) related to The Act [Member]" } } }, "localname": "TaxChargeBenefitRelatedToTheActMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/EIDIncomeTaxesRateReconciliationDetails", "http://www.corteva.com/role/IncomeTaxesIncomeTaxesReconciliationtoUSStatutoryRateDetails" ], "xbrltype": "domainItemType" }, "ctva_TaxCutsAndJobsActIncompleteAccountingChangeInTaxRateProvisionalIncomeTaxExpenseBenefit": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of reasonable estimate for income tax expense (benefit) for which accounting for tax effect for remeasurement of deferred tax from change in tax rate is incomplete pursuant to Tax Cuts and Jobs Act.", "label": "Tax Cuts and Jobs Act, Incomplete Accounting, Change in Tax Rate, Provisional Income Tax Expense (Benefit)", "terseLabel": "Tax Cuts and Jobs Act, Incomplete Accounting, Change in Tax Rate, Provisional Income Tax Expense (Benefit)" } } }, "localname": "TaxCutsAndJobsActIncompleteAccountingChangeInTaxRateProvisionalIncomeTaxExpenseBenefit", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/IncomeTaxesIncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ctva_TaxCutsandJobsActof2017IncompleteAccountingTransitionTaxforAccumulatedForeignEarningsProvisionalIncomeTaxExpenseBenefit": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Tax Cuts and Jobs Act of 2017, Incomplete Accounting, Transition Tax for Accumulated Foreign Earnings, Provisional Income Tax Expense (Benefit)", "label": "Tax Cuts and Jobs Act of 2017, Incomplete Accounting, Transition Tax for Accumulated Foreign Earnings, Provisional Income Tax Expense (Benefit)", "terseLabel": "Tax Cuts and Jobs Act of 2017, Incomplete Accounting, Transition Tax for Accumulated Foreign Earnings, Provisional Income Tax Expense" } } }, "localname": "TaxCutsandJobsActof2017IncompleteAccountingTransitionTaxforAccumulatedForeignEarningsProvisionalIncomeTaxExpenseBenefit", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/IncomeTaxesIncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ctva_TaxCutsandJobsActof2017IndirectImpactonInventoryIncomeTaxExpense": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Tax Cuts and Jobs Act of 2017, Incomplete Accounting, Indirect Impact on Inventory, Provisional Income Tax Expense", "label": "Tax Cuts and Jobs Act of 2017, Indirect Impact on Inventory, Income Tax Expense", "terseLabel": "Tax Cuts and Jobs Act of 2017, Indirect Impact on Inventory, Income Tax Expense" } } }, "localname": "TaxCutsandJobsActof2017IndirectImpactonInventoryIncomeTaxExpense", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/IncomeTaxesIncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "ctva_TaxRateReconciliationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tax Rate Reconciliation [Abstract]", "label": "Tax Rate Reconciliation [Abstract]", "terseLabel": "Tax Rate Reconciliation [Abstract]" } } }, "localname": "TaxRateReconciliationAbstract", "nsuri": "http://www.corteva.com/20211231", "xbrltype": "stringItemType" }, "ctva_TaxReformForeignCurrencyExchangeImpactMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tax Reform Foreign Currency Exchange Impact [Member]", "label": "Tax Reform Foreign Currency Exchange Impact [Member]", "terseLabel": "Tax Reform Foreign Currency Exchange Impact [Member]" } } }, "localname": "TaxReformForeignCurrencyExchangeImpactMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/EIDSegmentFNSegmentReconciliationDetails", "http://www.corteva.com/role/SegmentReportingSegmentReconciliationDetails", "http://www.corteva.com/role/SegmentReportingSigItemsDetails", "http://www.corteva.com/role/SupplementaryInformationForeignCurrencyExchangeGainLossDetails", "http://www.corteva.com/role/SupplementaryInformationOtherIncomeExpenseNetDetails" ], "xbrltype": "domainItemType" }, "ctva_TenderNotesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tender Notes [Member]", "label": "Tender Notes [Member]", "terseLabel": "Tender Notes [Member]" } } }, "localname": "TenderNotesMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/LongTermDebtandAvailableCreditFacilitiesDebtRedemptionsRepaymentsDetails" ], "xbrltype": "domainItemType" }, "ctva_TenderOfferforDebtSecurities": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Tender Offer for Debt Securities", "label": "Tender Offer for Debt Securities", "terseLabel": "Tender Offer for Debt Securities" } } }, "localname": "TenderOfferforDebtSecurities", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/LongTermDebtandAvailableCreditFacilitiesDebtRedemptionsRepaymentsDetails" ], "xbrltype": "monetaryItemType" }, "ctva_TermLoanFacilitydue2020Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Term Loan Facility due 2020 [Member]", "label": "Term Loan Facility due 2020 [Member]", "terseLabel": "Term Loan Facility due 2020 [Member]" } } }, "localname": "TermLoanFacilitydue2020Member", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/LongTermDebtandAvailableCreditFacilitiesAvailableCommittedCreditFacilitiesNarrativeDetails", "http://www.corteva.com/role/LongTermDebtandAvailableCreditFacilitiesDebtRedemptionsRepaymentsDetails", "http://www.corteva.com/role/LongTermDebtandAvailableCreditFacilitiesLongTermDebtDetails" ], "xbrltype": "domainItemType" }, "ctva_TheActsForeignTaxProvisionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The Act's Foreign Tax Provisions", "label": "The Act's Foreign Tax Provisions [Member]", "terseLabel": "The Act's Foreign Tax Provisions [Member]" } } }, "localname": "TheActsForeignTaxProvisionsMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/EIDIncomeTaxesRateReconciliationDetails" ], "xbrltype": "domainItemType" }, "ctva_TotalEscrowDepositAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "From September 30, 2021 through September 30, 2028, Chemours will deposit a total of $500 million in the escrow account and DuPont and Corteva will deposit an additional $500 million pursuant to the terms of the Letter Agreement.", "label": "Total Escrow Deposit Amount", "terseLabel": "Total Escrow Deposit Amount" } } }, "localname": "TotalEscrowDepositAmount", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationChemoursDetails" ], "xbrltype": "monetaryItemType" }, "ctva_TotalOperatingLossandTaxCreditCarryforwards": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Total Operating Loss and Tax Credit Carryforwards", "label": "Total Operating Loss and Tax Credit Carryforwards", "terseLabel": "Total Operating Loss and Tax Credit Carryforwards" } } }, "localname": "TotalOperatingLossandTaxCreditCarryforwards", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/IncomeTaxesIncomeTaxesOperatingLossandTaxCreditCarryforwardsDetails" ], "xbrltype": "monetaryItemType" }, "ctva_TotalcompanyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Total company [Member]", "label": "Total company [Member]", "terseLabel": "Total company [Member]" } } }, "localname": "TotalcompanyMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "domainItemType" }, "ctva_TradeReceivablesSold": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Trade Receivables Sold", "label": "Trade Receivables Sold", "terseLabel": "Trade Receivables Sold" } } }, "localname": "TradeReceivablesSold", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/AccountsandNotesReceivableNetCustomerFinancingDetails" ], "xbrltype": "monetaryItemType" }, "ctva_TrustAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trust Agreement [Member]", "label": "Trust Agreement [Member]", "terseLabel": "Trust Agreement [Member]" } } }, "localname": "TrustAgreementMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansAdditionalInformationDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansChangeinProjectedBenefitObligationsPlanAssetsandFundedStatusDetails" ], "xbrltype": "domainItemType" }, "ctva_TrustAssetDistribution": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Distribution from Trust", "label": "Trust Asset Distribution", "terseLabel": "Trust Asset Distribution" } } }, "localname": "TrustAssetDistribution", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "ctva_TypeofDisclosureAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Type of Disclosure [Axis]", "label": "Type of Disclosure [Axis]", "terseLabel": "Type of Disclosure [Axis]" } } }, "localname": "TypeofDisclosureAxis", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/CommonControlBusinessCombinationsTables", "http://www.corteva.com/role/DivestituresandOtherTransactionsTables" ], "xbrltype": "stringItemType" }, "ctva_TypeofDisclosureDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "[Domain] for Type of Disclosure [Axis]", "label": "Type of Disclosure [Domain]", "terseLabel": "Type of Disclosure [Domain]" } } }, "localname": "TypeofDisclosureDomain", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/CommonControlBusinessCombinationsTables", "http://www.corteva.com/role/DivestituresandOtherTransactionsTables" ], "xbrltype": "domainItemType" }, "ctva_U.S.PlanswithPlanAssetsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "U.S. Plans with Plan Assets [Member]", "label": "U.S. Plans with Plan Assets [Member]", "terseLabel": "U.S. Plans with Plan Assets [Member]" } } }, "localname": "U.S.PlanswithPlanAssetsMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansChangeinProjectedBenefitObligationsPlanAssetsandFundedStatusDetails" ], "xbrltype": "domainItemType" }, "ctva_U.S.RetirementSavingsPlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "U.S. Retirement Savings Plan [Member]", "label": "U.S. Retirement Savings Plan [Member]", "terseLabel": "U.S. Retirement Savings Plan [Member]" } } }, "localname": "U.S.RetirementSavingsPlanMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "ctva_USStateBlendedTaxRateChangesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "U.S. state blended tax rate changes associated with the Internal Reorganizations", "label": "U.S. state blended tax rate changes [Member]", "terseLabel": "U.S. state blended tax rate changes [Member]" } } }, "localname": "USStateBlendedTaxRateChangesMember", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/QuaterlyFinancialDataQuarterlyFinancialDataParentheticalsDetails" ], "xbrltype": "domainItemType" }, "ctva_UnrecognizedTaxBenefitsImpactofInternalReorganizations": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Unrecognized Tax Benefits, Impact of Internal Reorganizations", "label": "Unrecognized Tax Benefits, Impact of Internal Reorganizations", "terseLabel": "Unrecognized Tax Benefits, Impact of Internal Reorganizations" } } }, "localname": "UnrecognizedTaxBenefitsImpactofInternalReorganizations", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/IncomeTaxesIncomeTaxesGrossUnrecognizedTaxBenefitsDetails" ], "xbrltype": "monetaryItemType" }, "ctva_WithdrawalAmountAfterYear6": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Withdrawal Amount after Year 6", "label": "Withdrawal Amount after Year 6", "terseLabel": "Withdrawal Amount after Year 6" } } }, "localname": "WithdrawalAmountAfterYear6", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationChemoursDetails" ], "xbrltype": "monetaryItemType" }, "ctva_YearsofExperience": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Years of Experience", "label": "Years of Experience", "terseLabel": "Years of Experience" } } }, "localname": "YearsofExperience", "nsuri": "http://www.corteva.com/20211231", "presentation": [ "http://www.corteva.com/role/BackgroundandBasisofPresentationDetails" ], "xbrltype": "integerItemType" }, "currency_ARS": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Argentina, Pesos", "terseLabel": "Argentina, Pesos" } } }, "localname": "ARS", "nsuri": "http://xbrl.sec.gov/currency/2021", "presentation": [ "http://www.corteva.com/role/SupplementaryInformationForeignCurrencyExchangeGainLossDetails" ], "xbrltype": "domainItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.corteva.com/role/DEIDocument" ], "xbrltype": "booleanItemType" }, "dei_AuditorFirmId": { "auth_ref": [ "r1136", "r1137", "r1138" ], "lang": { "en-us": { "role": { "documentation": "PCAOB issued Audit Firm Identifier", "label": "Auditor Firm ID", "terseLabel": "Auditor Firm ID" } } }, "localname": "AuditorFirmId", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.corteva.com/role/AuditInformation" ], "xbrltype": "nonemptySequenceNumberItemType" }, "dei_AuditorLocation": { "auth_ref": [ "r1136", "r1137", "r1138" ], "lang": { "en-us": { "role": { "label": "Auditor Location", "terseLabel": "Auditor Location" } } }, "localname": "AuditorLocation", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.corteva.com/role/AuditInformation" ], "xbrltype": "internationalNameItemType" }, "dei_AuditorName": { "auth_ref": [ "r1136", "r1137", "r1138" ], "lang": { "en-us": { "role": { "label": "Auditor Name", "terseLabel": "Auditor Name" } } }, "localname": "AuditorName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.corteva.com/role/AuditInformation" ], "xbrltype": "internationalNameItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.corteva.com/role/DEIDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date", "terseLabel": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.corteva.com/role/DEIDocument" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r1136", "r1137", "r1138" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report", "terseLabel": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.corteva.com/role/DEIDocument" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus", "terseLabel": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.corteva.com/role/DEIDocument" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus", "terseLabel": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.corteva.com/role/DEIDocument" ], "xbrltype": "gYearItemType" }, "dei_DocumentInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Document Information [Line Items]", "terseLabel": "Document Information [Line Items]" } } }, "localname": "DocumentInformationLineItems", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.corteva.com/role/DEIDocument" ], "xbrltype": "stringItemType" }, "dei_DocumentInformationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.", "label": "Document Information [Table]", "terseLabel": "Document Information [Table]" } } }, "localname": "DocumentInformationTable", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.corteva.com/role/DEIDocument" ], "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.corteva.com/role/DEIDocument" ], "xbrltype": "dateItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r1139" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report", "terseLabel": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.corteva.com/role/DEIDocument" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.corteva.com/role/DEIDocument" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r1134" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]", "terseLabel": "Documents Incorporated by Reference [Text Block]" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.corteva.com/role/DEIDocument" ], "xbrltype": "textBlockItemType" }, "dei_EntitiesTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Container to assemble all relevant information about each entity associated with the document instance", "label": "Entities [Table]", "terseLabel": "Statement [Table]" } } }, "localname": "EntitiesTable", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.corteva.com/role/EIDBasisofPresentationNotes" ], "xbrltype": "stringItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.corteva.com/role/DEIDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.corteva.com/role/DEIDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.corteva.com/role/DEIDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.corteva.com/role/DEIDocument" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r1133" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.corteva.com/role/DEIDocument" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding", "terseLabel": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.corteva.com/role/DEIDocument" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status", "terseLabel": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.corteva.com/role/DEIDocument" ], "xbrltype": "yesNoItemType" }, "dei_EntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.", "label": "Entity [Domain]", "terseLabel": "Entity [Domain]" } } }, "localname": "EntityDomain", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.corteva.com/role/BackgroundandBasisofPresentationDetails", "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesEnvironmentalDetails", "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationChemoursDetails", "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationDuPontDetails", "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationLeachandMDLSettlementDetails", "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationOtherPFOAMattersFayattevilleDetails", "http://www.corteva.com/role/ConsolidatedBalanceSheets", "http://www.corteva.com/role/ConsolidatedBalanceSheetsParentheticals", "http://www.corteva.com/role/ConsolidatedStatementsofCashFlows", "http://www.corteva.com/role/ConsolidatedStatementsofComprehensiveIncome", "http://www.corteva.com/role/ConsolidatedStatementsofEquity", "http://www.corteva.com/role/ConsolidatedStatementsofEquityParentheticals", "http://www.corteva.com/role/ConsolidatedStatementsofIncome", "http://www.corteva.com/role/DEIDocument", "http://www.corteva.com/role/DivestituresandOtherTransactionsDivestituresandOtherTransactionsPChemResultsofOperationsDetails", "http://www.corteva.com/role/EIDBasisofPresentationDetails", "http://www.corteva.com/role/EIDBasisofPresentationNotes", "http://www.corteva.com/role/EIDIncomeTaxesGeographicAllocationDetails", "http://www.corteva.com/role/EIDIncomeTaxesNotes", "http://www.corteva.com/role/EIDIncomeTaxesRateReconciliationDetails", "http://www.corteva.com/role/EIDIncomeTaxesTables", "http://www.corteva.com/role/EIDQuarterlyFNDetails", "http://www.corteva.com/role/EIDQuarterlyFNNotes", "http://www.corteva.com/role/EIDQuarterlyFNTables", "http://www.corteva.com/role/EIDRelatedPartyDetails", "http://www.corteva.com/role/EIDRelatedPartyNotes", "http://www.corteva.com/role/EIDSegmentFNNotes", "http://www.corteva.com/role/EIDSegmentFNSegmentAssetReconciliationDetails", "http://www.corteva.com/role/EIDSegmentFNSegmentReconciliationDetails", "http://www.corteva.com/role/EIDSegmentFNTables", "http://www.corteva.com/role/StockBasedCompensationRestrictedStockUnitsandPerformanceDeferredStockDetails", "http://www.corteva.com/role/StockBasedCompensationStockOptionsDetails", "http://www.corteva.com/role/StockholdersEquityCommonStockDetails", "http://www.corteva.com/role/StockholdersEquityNoncontrollingInterestDetails" ], "xbrltype": "domainItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r1133" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.corteva.com/role/DEIDocument" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.corteva.com/role/DEIDocument" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r1133" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category", "terseLabel": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.corteva.com/role/DEIDocument" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.corteva.com/role/DEIDocument" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Entity Information [Line Items]", "terseLabel": "Entity Information [Line Items]" } } }, "localname": "EntityInformationLineItems", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.corteva.com/role/EIDBasisofPresentationNotes" ], "xbrltype": "stringItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r1158" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current", "terseLabel": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.corteva.com/role/DEIDocument" ], "xbrltype": "yesNoItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float", "terseLabel": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.corteva.com/role/DEIDocument" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r1133" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.corteva.com/role/DEIDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r1133" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company", "terseLabel": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.corteva.com/role/DEIDocument" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r1133" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business", "terseLabel": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.corteva.com/role/DEIDocument" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r1133" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.corteva.com/role/DEIDocument" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers", "terseLabel": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.corteva.com/role/DEIDocument" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r1183" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer", "terseLabel": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.corteva.com/role/DEIDocument" ], "xbrltype": "yesNoItemType" }, "dei_LegalEntityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The set of legal entities associated with a report.", "label": "Legal Entity [Axis]", "terseLabel": "Legal Entity [Axis]" } } }, "localname": "LegalEntityAxis", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.corteva.com/role/BackgroundandBasisofPresentationDetails", "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesEnvironmentalDetails", "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationChemoursDetails", "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationDuPontDetails", "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationLeachandMDLSettlementDetails", "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationOtherPFOAMattersFayattevilleDetails", "http://www.corteva.com/role/ConsolidatedBalanceSheets", "http://www.corteva.com/role/ConsolidatedBalanceSheetsParentheticals", "http://www.corteva.com/role/ConsolidatedStatementsofCashFlows", "http://www.corteva.com/role/ConsolidatedStatementsofComprehensiveIncome", "http://www.corteva.com/role/ConsolidatedStatementsofEquity", "http://www.corteva.com/role/ConsolidatedStatementsofEquityParentheticals", "http://www.corteva.com/role/ConsolidatedStatementsofIncome", "http://www.corteva.com/role/DEIDocument", "http://www.corteva.com/role/DivestituresandOtherTransactionsDivestituresandOtherTransactionsPChemResultsofOperationsDetails", "http://www.corteva.com/role/EIDBasisofPresentationDetails", "http://www.corteva.com/role/EIDBasisofPresentationNotes", "http://www.corteva.com/role/EIDIncomeTaxesGeographicAllocationDetails", "http://www.corteva.com/role/EIDIncomeTaxesNotes", "http://www.corteva.com/role/EIDIncomeTaxesRateReconciliationDetails", "http://www.corteva.com/role/EIDIncomeTaxesTables", "http://www.corteva.com/role/EIDQuarterlyFNDetails", "http://www.corteva.com/role/EIDQuarterlyFNNotes", "http://www.corteva.com/role/EIDQuarterlyFNTables", "http://www.corteva.com/role/EIDRelatedPartyDetails", "http://www.corteva.com/role/EIDRelatedPartyNotes", "http://www.corteva.com/role/EIDSegmentFNNotes", "http://www.corteva.com/role/EIDSegmentFNSegmentAssetReconciliationDetails", "http://www.corteva.com/role/EIDSegmentFNSegmentReconciliationDetails", "http://www.corteva.com/role/EIDSegmentFNTables", "http://www.corteva.com/role/StockBasedCompensationRestrictedStockUnitsandPerformanceDeferredStockDetails", "http://www.corteva.com/role/StockBasedCompensationStockOptionsDetails", "http://www.corteva.com/role/StockholdersEquityCommonStockDetails", "http://www.corteva.com/role/StockholdersEquityNoncontrollingInterestDetails" ], "xbrltype": "stringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.corteva.com/role/DEIDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r1132" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.corteva.com/role/DEIDocument" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r1135" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.corteva.com/role/DEIDocument" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.corteva.com/role/DEIDocument" ], "xbrltype": "tradingSymbolItemType" }, "srt_AsiaPacificMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region of Asia Pacific.", "label": "Asia Pacific [Member]", "terseLabel": "Asia Pacific" } } }, "localname": "AsiaPacificMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.corteva.com/role/GeographicInformationNetPropertybyCountryDetails", "http://www.corteva.com/role/GeographicInformationRevenuebyCountryDetails", "http://www.corteva.com/role/RevenueDisaggregationofRevenueGeoDetails" ], "xbrltype": "domainItemType" }, "srt_ConsolidationItemsAxis": { "auth_ref": [ "r221", "r298", "r317", "r318", "r319", "r320", "r322", "r324", "r328", "r480", "r481", "r482", "r483", "r484", "r485", "r487", "r488", "r490", "r492", "r493", "r1171", "r1172", "r1173", "r1174", "r1175", "r1176", "r1177", "r1178", "r1179", "r1180", "r1181" ], "lang": { "en-us": { "role": { "documentation": "Information by components, eliminations, non-segment corporate-level activity and reconciling items used in consolidating a parent entity and its subsidiaries or its operating segments.", "label": "Consolidation Items [Axis]", "terseLabel": "Consolidation Items [Axis]" } } }, "localname": "ConsolidationItemsAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.corteva.com/role/ConsolidatedStatementsofCashFlows", "http://www.corteva.com/role/EIDSegmentFNSegmentAssetReconciliationDetails", "http://www.corteva.com/role/RestructuringandAssetRelatedCharges2021RestructuringActionsDetails", "http://www.corteva.com/role/SegmentReportingOtherItemsDetails", "http://www.corteva.com/role/SegmentReportingSegmentAssetsDetails", "http://www.corteva.com/role/SegmentReportingSegmentInformationDetails", "http://www.corteva.com/role/SegmentReportingSegmentReconciliationDetails" ], "xbrltype": "stringItemType" }, "srt_ConsolidationItemsDomain": { "auth_ref": [ "r221", "r298", "r317", "r318", "r319", "r320", "r322", "r324", "r328", "r480", "r481", "r482", "r483", "r484", "r485", "r487", "r488", "r490", "r492", "r493", "r1171", "r1172", "r1173", "r1174", "r1175", "r1176", "r1177", "r1178", "r1179", "r1180", "r1181" ], "lang": { "en-us": { "role": { "documentation": "Components, elimination, non-segment corporate-level activity and reconciling items used in consolidating a parent entity and its subsidiaries or its operating segments.", "label": "Consolidation Items [Domain]", "terseLabel": "Consolidation Items [Domain]" } } }, "localname": "ConsolidationItemsDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.corteva.com/role/ConsolidatedStatementsofCashFlows", "http://www.corteva.com/role/EIDSegmentFNSegmentAssetReconciliationDetails", "http://www.corteva.com/role/RestructuringandAssetRelatedCharges2021RestructuringActionsDetails", "http://www.corteva.com/role/SegmentReportingOtherItemsDetails", "http://www.corteva.com/role/SegmentReportingSegmentAssetsDetails", "http://www.corteva.com/role/SegmentReportingSegmentInformationDetails", "http://www.corteva.com/role/SegmentReportingSegmentReconciliationDetails" ], "xbrltype": "domainItemType" }, "srt_CounterpartyNameAxis": { "auth_ref": [ "r115", "r117", "r218", "r219", "r499", "r541", "r1182" ], "lang": { "en-us": { "role": { "documentation": "Information by name of counterparty. A counterparty is the other party that participates in a financial transaction. Examples include, but not limited to, the name of the financial institution.", "label": "Counterparty Name [Axis]", "terseLabel": "Counterparty Name [Axis]" } } }, "localname": "CounterpartyNameAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesEnvironmentalDetails", "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationChemoursDetails", "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationDuPontDetails", "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationLeachandMDLSettlementDetails", "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationOtherPFOAMattersFayattevilleDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsDivestituresandOtherTransactionsNarrativeDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsDivestituresandOtherTransactionsPChemResultsofOperationsDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsECPDivestitureDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsSPDivestitureDetails" ], "xbrltype": "stringItemType" }, "srt_LatinAmericaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region of Latin America.", "label": "Latin America [Member]", "terseLabel": "Latin America" } } }, "localname": "LatinAmericaMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.corteva.com/role/GeographicInformationNetPropertybyCountryDetails", "http://www.corteva.com/role/GeographicInformationRevenuebyCountryDetails", "http://www.corteva.com/role/RevenueDisaggregationofRevenueGeoDetails" ], "xbrltype": "domainItemType" }, "srt_LitigationCaseAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of judicial proceeding, alternative dispute resolution or claim.", "label": "Litigation Case [Axis]", "terseLabel": "Litigation Case [Axis]" } } }, "localname": "LitigationCaseAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationChemoursDetails", "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationDuPontDetails", "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationLeachandMDLSettlementDetails", "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationOtherPFOAMattersFayattevilleDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsDivestituresandOtherTransactionsPChemResultsofOperationsDetails" ], "xbrltype": "stringItemType" }, "srt_LitigationCaseTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Judicial proceeding, alternative dispute resolution or claim. For example, but not limited to, name of case, category of litigation, or other differentiating information.", "label": "Litigation Case [Domain]", "terseLabel": "Litigation Case [Domain]" } } }, "localname": "LitigationCaseTypeDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationChemoursDetails", "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationDuPontDetails", "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationLeachandMDLSettlementDetails", "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationOtherPFOAMattersFayattevilleDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsDivestituresandOtherTransactionsPChemResultsofOperationsDetails" ], "xbrltype": "domainItemType" }, "srt_ManagementMember": { "auth_ref": [ "r337", "r947" ], "lang": { "en-us": { "role": { "documentation": "Person or persons designated as part of management.", "label": "Management [Member]", "terseLabel": "Management [Member]" } } }, "localname": "ManagementMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.corteva.com/role/StockBasedCompensationRestrictedStockUnitsandPerformanceDeferredStockDetails" ], "xbrltype": "domainItemType" }, "srt_MaximumMember": { "auth_ref": [ "r498", "r540", "r687", "r697", "r964", "r965", "r966", "r968", "r969", "r970", "r990", "r1079", "r1082", "r1127", "r1128" ], "lang": { "en-us": { "role": { "documentation": "Upper limit of the provided range.", "label": "Maximum [Member]", "terseLabel": "Maximum [Member]" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationChemoursDetails", "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationDuPontDetails", "http://www.corteva.com/role/LeasesNarrativeDetails", "http://www.corteva.com/role/PropertyPlantandEquipmentScheduleofPropertyPlantandEquipmentDetails", "http://www.corteva.com/role/RestructuringandAssetRelatedChargesExecutetoWinProductivityProgramDetails", "http://www.corteva.com/role/RevenueNarrativeDetails", "http://www.corteva.com/role/StockBasedCompensationRestrictedStockUnitsandPerformanceDeferredStockDetails", "http://www.corteva.com/role/SubsequentEventsDetails", "http://www.corteva.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r498", "r540", "r687", "r697", "r964", "r965", "r966", "r968", "r969", "r970", "r990", "r1079", "r1082", "r1127", "r1128" ], "lang": { "en-us": { "role": { "documentation": "Lower limit of the provided range.", "label": "Minimum [Member]", "terseLabel": "Minimum [Member]" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationChemoursDetails", "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationDuPontDetails", "http://www.corteva.com/role/LeasesNarrativeDetails", "http://www.corteva.com/role/PropertyPlantandEquipmentScheduleofPropertyPlantandEquipmentDetails", "http://www.corteva.com/role/RestructuringandAssetRelatedChargesExecutetoWinProductivityProgramDetails", "http://www.corteva.com/role/RevenueNarrativeDetails", "http://www.corteva.com/role/StockBasedCompensationRestrictedStockUnitsandPerformanceDeferredStockDetails", "http://www.corteva.com/role/SubsequentEventsDetails", "http://www.corteva.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "srt_NorthAmericaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Continent of North America.", "label": "North America [Member]", "terseLabel": "North America [Member]" } } }, "localname": "NorthAmericaMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.corteva.com/role/RevenueDisaggregationofRevenueGeoDetails" ], "xbrltype": "domainItemType" }, "srt_ProductOrServiceAxis": { "auth_ref": [ "r331", "r578", "r581", "r993", "r1078", "r1080" ], "lang": { "en-us": { "role": { "documentation": "Information by product and service, or group of similar products and similar services.", "label": "Product and Service [Axis]", "terseLabel": "Product and Service [Axis]" } } }, "localname": "ProductOrServiceAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.corteva.com/role/RevenueDisaggregationofRevenueProductsDetails" ], "xbrltype": "stringItemType" }, "srt_ProductsAndServicesDomain": { "auth_ref": [ "r331", "r578", "r581", "r993", "r1078", "r1080" ], "lang": { "en-us": { "role": { "documentation": "Product or service, or a group of similar products or similar services.", "label": "Product and Service [Domain]", "terseLabel": "Product and Service [Domain]" } } }, "localname": "ProductsAndServicesDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.corteva.com/role/RevenueDisaggregationofRevenueProductsDetails" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r498", "r540", "r622", "r687", "r697", "r964", "r965", "r966", "r968", "r969", "r970", "r990", "r1079", "r1082", "r1127", "r1128" ], "lang": { "en-us": { "role": { "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.", "label": "Statistical Measurement [Axis]", "terseLabel": "Statistical Measurement [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationChemoursDetails", "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationDuPontDetails", "http://www.corteva.com/role/LeasesNarrativeDetails", "http://www.corteva.com/role/LongTermDebtandAvailableCreditFacilitiesUncommittedCreditFacilitiesandOutstandingLettersofCreditDetails", "http://www.corteva.com/role/PropertyPlantandEquipmentScheduleofPropertyPlantandEquipmentDetails", "http://www.corteva.com/role/RestructuringandAssetRelatedChargesExecutetoWinProductivityProgramDetails", "http://www.corteva.com/role/RevenueNarrativeDetails", "http://www.corteva.com/role/StockBasedCompensationRestrictedStockUnitsandPerformanceDeferredStockDetails", "http://www.corteva.com/role/StockBasedCompensationStockCompensationDetails", "http://www.corteva.com/role/SubsequentEventsDetails", "http://www.corteva.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r498", "r540", "r622", "r687", "r697", "r964", "r965", "r966", "r968", "r969", "r970", "r990", "r1079", "r1082", "r1127", "r1128" ], "lang": { "en-us": { "role": { "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.", "label": "Statistical Measurement [Domain]", "terseLabel": "Statistical Measurement [Domain]" } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationChemoursDetails", "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationDuPontDetails", "http://www.corteva.com/role/LeasesNarrativeDetails", "http://www.corteva.com/role/LongTermDebtandAvailableCreditFacilitiesUncommittedCreditFacilitiesandOutstandingLettersofCreditDetails", "http://www.corteva.com/role/PropertyPlantandEquipmentScheduleofPropertyPlantandEquipmentDetails", "http://www.corteva.com/role/RestructuringandAssetRelatedChargesExecutetoWinProductivityProgramDetails", "http://www.corteva.com/role/RevenueNarrativeDetails", "http://www.corteva.com/role/StockBasedCompensationRestrictedStockUnitsandPerformanceDeferredStockDetails", "http://www.corteva.com/role/StockBasedCompensationStockCompensationDetails", "http://www.corteva.com/role/SubsequentEventsDetails", "http://www.corteva.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "srt_RepurchaseAgreementCounterpartyNameDomain": { "auth_ref": [ "r116", "r117", "r218", "r219", "r499", "r541" ], "lang": { "en-us": { "role": { "documentation": "Named other party that participates in a financial transaction. Examples include, but not limited to, the name of the financial institution.", "label": "Counterparty Name [Domain]", "terseLabel": "Counterparty Name [Domain]" } } }, "localname": "RepurchaseAgreementCounterpartyNameDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesEnvironmentalDetails", "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationChemoursDetails", "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationDuPontDetails", "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationLeachandMDLSettlementDetails", "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationOtherPFOAMattersFayattevilleDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsDivestituresandOtherTransactionsNarrativeDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsDivestituresandOtherTransactionsPChemResultsofOperationsDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsECPDivestitureDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsSPDivestitureDetails" ], "xbrltype": "domainItemType" }, "srt_RestatementAxis": { "auth_ref": [ "r1", "r230", "r231", "r232", "r235", "r236", "r240", "r241", "r242", "r243", "r245", "r246", "r247", "r248", "r249", "r250", "r272", "r366", "r367", "r739", "r784", "r878", "r880", "r881", "r882", "r1083", "r1084", "r1085", "r1086", "r1087", "r1088", "r1089", "r1090", "r1091", "r1092", "r1184", "r1185" ], "lang": { "en-us": { "role": { "documentation": "Information by adjustment to previously issued financial statements. Includes, but is not limited to, adjustment for retrospective application of amendment to accounting standards, other change in accounting principle, correction of error, and other revision.", "label": "Revision of Prior Period [Axis]", "terseLabel": "Restatement [Axis]" } } }, "localname": "RestatementAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.corteva.com/role/ConsolidatedStatementsofCashFlows", "http://www.corteva.com/role/EIDQuarterlyFNTables", "http://www.corteva.com/role/IncomeTaxesIncomeTaxesGrossUnrecognizedTaxBenefitsDetails", "http://www.corteva.com/role/QuaterlyFinancialDataTables", "http://www.corteva.com/role/ScheduleIIValuationandQualifyingAccountsDetails", "http://www.corteva.com/role/StockholdersEquityOtherComprehensiveIncomeLossDetails" ], "xbrltype": "stringItemType" }, "srt_RestatementDomain": { "auth_ref": [ "r1", "r230", "r231", "r232", "r235", "r236", "r240", "r241", "r242", "r243", "r245", "r246", "r247", "r248", "r249", "r250", "r272", "r366", "r367", "r739", "r784", "r878", "r880", "r881", "r882", "r1083", "r1084", "r1085", "r1086", "r1087", "r1088", "r1089", "r1090", "r1091", "r1092", "r1184", "r1185" ], "lang": { "en-us": { "role": { "documentation": "Adjustment to previously issued financial statements. Includes, but is not limited to, adjustment for retrospective application of amendment to accounting standards, other change in accounting principle, correction of error, and other revision.", "label": "Revision of Prior Period [Domain]", "terseLabel": "Restatement [Domain]" } } }, "localname": "RestatementDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.corteva.com/role/ConsolidatedStatementsofCashFlows", "http://www.corteva.com/role/EIDQuarterlyFNTables", "http://www.corteva.com/role/IncomeTaxesIncomeTaxesGrossUnrecognizedTaxBenefitsDetails", "http://www.corteva.com/role/QuaterlyFinancialDataTables", "http://www.corteva.com/role/ScheduleIIValuationandQualifyingAccountsDetails", "http://www.corteva.com/role/StockholdersEquityOtherComprehensiveIncomeLossDetails" ], "xbrltype": "domainItemType" }, "srt_ScenarioForecastMember": { "auth_ref": [ "r244", "r692", "r1159" ], "lang": { "en-us": { "role": { "documentation": "Information reported for future period. Excludes information expected to be reported in future period for effect on historical fact.", "label": "Forecast [Member]", "terseLabel": "Forecast [Member]" } } }, "localname": "ScenarioForecastMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.corteva.com/role/LongTermDebtandAvailableCreditFacilitiesAvailableCommittedCreditFacilitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_ScenarioUnspecifiedDomain": { "auth_ref": [ "r244", "r250", "r692" ], "lang": { "en-us": { "role": { "documentation": "Scenario reported, distinguishing information from actual fact. Includes, but is not limited to, pro forma and forecast. Excludes actual facts.", "label": "Scenario [Domain]", "terseLabel": "Scenario [Domain]" } } }, "localname": "ScenarioUnspecifiedDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationChemoursDetails", "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationDuPontDetails", "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationLeachandMDLSettlementDetails", "http://www.corteva.com/role/EIDSegmentFNSegmentReconciliationDetails", "http://www.corteva.com/role/EarningsPerShareShareCountInformationDetails", "http://www.corteva.com/role/FinancialInstrumentsCashFlowHedgesIncludedinAOCIDetails", "http://www.corteva.com/role/LongTermDebtandAvailableCreditFacilitiesAvailableCommittedCreditFacilitiesNarrativeDetails", "http://www.corteva.com/role/LongTermDebtandAvailableCreditFacilitiesDebtRedemptionsRepaymentsDetails", "http://www.corteva.com/role/QuaterlyFinancialDataQuarterlyFinancialDataParentheticalsDetails", "http://www.corteva.com/role/SegmentReportingOtherItemsDetails", "http://www.corteva.com/role/SegmentReportingSegmentInformationDetails", "http://www.corteva.com/role/SegmentReportingSegmentReconciliationDetails", "http://www.corteva.com/role/SegmentReportingSigItemsDetails", "http://www.corteva.com/role/StockBasedCompensationRestrictedStockUnitsandPerformanceDeferredStockDetails", "http://www.corteva.com/role/StockBasedCompensationStockOptionsDetails", "http://www.corteva.com/role/StockholdersEquityOtherComprehensiveIncomeLossDetails", "http://www.corteva.com/role/SupplementaryInformationOtherIncomeExpenseNetDetails" ], "xbrltype": "domainItemType" }, "srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock": { "auth_ref": [ "r228", "r1170" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for valuation and qualifying accounts and reserves.", "label": "SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]", "terseLabel": "SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]" } } }, "localname": "ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.corteva.com/role/ScheduleIIValuationandQualifyingAccountsNotes" ], "xbrltype": "textBlockItemType" }, "srt_SegmentGeographicalDomain": { "auth_ref": [ "r332", "r333", "r578", "r582", "r1081", "r1118", "r1119", "r1120", "r1121", "r1122", "r1123", "r1124", "r1125", "r1126", "r1160", "r1162", "r1163", "r1164", "r1165", "r1166", "r1167", "r1168", "r1169" ], "lang": { "en-us": { "role": { "documentation": "Geographical area.", "label": "Geographical [Domain]", "terseLabel": "Geographical [Domain]" } } }, "localname": "SegmentGeographicalDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationLeachandMDLSettlementDetails", "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationOtherPFOAMattersFayattevilleDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsDivestituresandOtherTransactionsPChemResultsofOperationsDetails", "http://www.corteva.com/role/GeographicInformationNetPropertybyCountryDetails", "http://www.corteva.com/role/GeographicInformationRevenuebyCountryDetails", "http://www.corteva.com/role/RevenueDisaggregationofRevenueGeoDetails", "http://www.corteva.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "srt_StatementGeographicalAxis": { "auth_ref": [ "r332", "r333", "r578", "r582", "r1081", "r1111", "r1118", "r1119", "r1120", "r1121", "r1122", "r1123", "r1124", "r1125", "r1126", "r1160", "r1161" ], "lang": { "en-us": { "role": { "documentation": "Information by geographical components.", "label": "Geographical [Axis]", "terseLabel": "Geographical [Axis]" } } }, "localname": "StatementGeographicalAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationLeachandMDLSettlementDetails", "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationOtherPFOAMattersFayattevilleDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsDivestituresandOtherTransactionsPChemResultsofOperationsDetails", "http://www.corteva.com/role/GeographicInformationNetPropertybyCountryDetails", "http://www.corteva.com/role/GeographicInformationRevenuebyCountryDetails", "http://www.corteva.com/role/RevenueDisaggregationofRevenueGeoDetails", "http://www.corteva.com/role/SubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "srt_StatementScenarioAxis": { "auth_ref": [ "r244", "r250", "r462", "r692", "r956" ], "lang": { "en-us": { "role": { "documentation": "Information by scenario reported, distinguishing information from actual fact. Includes, but is not limited to, pro forma and forecast. Excludes actual facts.", "label": "Scenario [Axis]", "terseLabel": "Scenario [Axis]" } } }, "localname": "StatementScenarioAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationChemoursDetails", "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationDuPontDetails", "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationLeachandMDLSettlementDetails", "http://www.corteva.com/role/EIDSegmentFNSegmentReconciliationDetails", "http://www.corteva.com/role/EarningsPerShareShareCountInformationDetails", "http://www.corteva.com/role/FinancialInstrumentsCashFlowHedgesIncludedinAOCIDetails", "http://www.corteva.com/role/LongTermDebtandAvailableCreditFacilitiesAvailableCommittedCreditFacilitiesNarrativeDetails", "http://www.corteva.com/role/LongTermDebtandAvailableCreditFacilitiesDebtRedemptionsRepaymentsDetails", "http://www.corteva.com/role/QuaterlyFinancialDataQuarterlyFinancialDataParentheticalsDetails", "http://www.corteva.com/role/SegmentReportingOtherItemsDetails", "http://www.corteva.com/role/SegmentReportingSegmentInformationDetails", "http://www.corteva.com/role/SegmentReportingSegmentReconciliationDetails", "http://www.corteva.com/role/SegmentReportingSigItemsDetails", "http://www.corteva.com/role/StockBasedCompensationRestrictedStockUnitsandPerformanceDeferredStockDetails", "http://www.corteva.com/role/StockBasedCompensationStockOptionsDetails", "http://www.corteva.com/role/StockholdersEquityOtherComprehensiveIncomeLossDetails", "http://www.corteva.com/role/SupplementaryInformationOtherIncomeExpenseNetDetails" ], "xbrltype": "stringItemType" }, "srt_SubsidiariesMember": { "auth_ref": [ "r650", "r944", "r945", "r948" ], "lang": { "en-us": { "role": { "documentation": "Entity owned or controlled by another entity.", "label": "Subsidiaries [Member]", "terseLabel": "Subsidiary Monetary Position" } } }, "localname": "SubsidiariesMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.corteva.com/role/SupplementaryInformationForeignCurrencyExchangeGainLossDetails" ], "xbrltype": "domainItemType" }, "srt_TitleOfIndividualAxis": { "auth_ref": [ "r337", "r947" ], "lang": { "en-us": { "role": { "documentation": "Information by title of individual or nature of relationship to individual or group of individuals.", "label": "Title of Individual [Axis]", "terseLabel": "Title of Individual [Axis]" } } }, "localname": "TitleOfIndividualAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.corteva.com/role/StockBasedCompensationRestrictedStockUnitsandPerformanceDeferredStockDetails" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Title of individual, or nature of relationship to individual or group of individuals.", "label": "Title of Individual [Domain]", "terseLabel": "Title of Individual [Domain]" } } }, "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.corteva.com/role/StockBasedCompensationRestrictedStockUnitsandPerformanceDeferredStockDetails" ], "xbrltype": "domainItemType" }, "srt_ValuationAndQualifyingAccountsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]", "terseLabel": "SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]" } } }, "localname": "ValuationAndQualifyingAccountsAbstract", "nsuri": "http://fasb.org/srt/2021-01-31", "xbrltype": "stringItemType" }, "srt_ValuationAndQualifyingAccountsDisclosureLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]", "terseLabel": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]" } } }, "localname": "ValuationAndQualifyingAccountsDisclosureLineItems", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.corteva.com/role/ScheduleIIValuationandQualifyingAccountsDetails" ], "xbrltype": "stringItemType" }, "srt_ValuationAndQualifyingAccountsDisclosureTable": { "auth_ref": [ "r222", "r223", "r224", "r226", "r227", "r1170" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of valuation and qualifying accounts and reserves.", "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]", "terseLabel": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]" } } }, "localname": "ValuationAndQualifyingAccountsDisclosureTable", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.corteva.com/role/ScheduleIIValuationandQualifyingAccountsDetails" ], "xbrltype": "stringItemType" }, "srt_WeightedAverageMember": { "auth_ref": [ "r964", "r966", "r970", "r1127", "r1128" ], "lang": { "en-us": { "role": { "documentation": "Average of a range of values, calculated with consideration of proportional relevance.", "label": "Weighted Average [Member]", "terseLabel": "Weighted Average [Member]" } } }, "localname": "WeightedAverageMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.corteva.com/role/StockBasedCompensationStockCompensationDetails" ], "xbrltype": "domainItemType" }, "stpr_DE": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "DELAWARE", "terseLabel": "DELAWARE" } } }, "localname": "DE", "nsuri": "http://xbrl.sec.gov/stpr/2021", "presentation": [ "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationOtherPFOAMattersFayattevilleDetails" ], "xbrltype": "domainItemType" }, "stpr_NC": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "NORTH CAROLINA", "terseLabel": "NORTH CAROLINA" } } }, "localname": "NC", "nsuri": "http://xbrl.sec.gov/stpr/2021", "presentation": [ "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationOtherPFOAMattersFayattevilleDetails" ], "xbrltype": "domainItemType" }, "stpr_NJ": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "NEW JERSEY", "terseLabel": "NEW JERSEY" } } }, "localname": "NJ", "nsuri": "http://xbrl.sec.gov/stpr/2021", "presentation": [ "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationOtherPFOAMattersFayattevilleDetails" ], "xbrltype": "domainItemType" }, "stpr_NY": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "NEW YORK", "terseLabel": "NEW YORK" } } }, "localname": "NY", "nsuri": "http://xbrl.sec.gov/stpr/2021", "presentation": [ "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationOtherPFOAMattersFayattevilleDetails" ], "xbrltype": "domainItemType" }, "stpr_OH": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "OHIO", "terseLabel": "OHIO" } } }, "localname": "OH", "nsuri": "http://xbrl.sec.gov/stpr/2021", "presentation": [ "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationOtherPFOAMattersFayattevilleDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingChangesAndErrorCorrectionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Changes and Error Corrections [Abstract]", "terseLabel": "Accounting Changes and Error Corrections [Abstract]" } } }, "localname": "AccountingChangesAndErrorCorrectionsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]", "terseLabel": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_AccountsNotesAndLoansReceivableLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Accounts, Notes, Loans and Financing Receivable [Line Items]", "terseLabel": "Accounts, Notes, Loans and Financing Receivable [Line Items]" } } }, "localname": "AccountsNotesAndLoansReceivableLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/AccountsandNotesReceivableNetCustomerFinancingDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableCurrent": { "auth_ref": [ "r88", "r953" ], "calculation": { "http://www.corteva.com/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts Payable, Current", "terseLabel": "Accounts Payable" } } }, "localname": "AccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/ConsolidatedBalanceSheets", "http://www.corteva.com/role/SupplementaryInformationSupplementaryInformationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsPayableOtherCurrentAndNoncurrent": { "auth_ref": [ "r1027", "r1064" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligations incurred and payable classified as other.", "label": "Accounts Payable, Other", "terseLabel": "Accounts Payable, Other" } } }, "localname": "AccountsPayableOtherCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/SupplementaryInformationSupplementaryInformationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsPayableTradeCurrent": { "auth_ref": [ "r45", "r88" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts Payable, Trade, Current", "terseLabel": "Accounts Payable, Trade, Current" } } }, "localname": "AccountsPayableTradeCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/SupplementaryInformationSupplementaryInformationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock": { "auth_ref": [ "r373" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of allowance for credit loss on accounts receivable.", "label": "Accounts Receivable, Allowance for Credit Loss [Table Text Block]", "terseLabel": "Accounts Receivable, Allowance for Credit Loss" } } }, "localname": "AccountsReceivableAllowanceForCreditLossTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/AccountsandNotesReceivableNetTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_AccountsReceivableNet": { "auth_ref": [ "r68", "r1050", "r1112" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business.", "label": "Accounts Receivable, after Allowance for Credit Loss", "terseLabel": "Accounts Receivable, after Allowance for Credit Loss" } } }, "localname": "AccountsReceivableNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesGuaranteeNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableNetCurrent": { "auth_ref": [ "r38", "r68", "r338", "r339" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Accounts Receivable, after Allowance for Credit Loss, Current", "terseLabel": "Accounts receivable - trade" } } }, "localname": "AccountsReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/AccountsandNotesReceivableNetScheduleofAccountsandNotesReceivableNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccrualForEnvironmentalLossContingencies": { "auth_ref": [ "r438", "r460", "r461" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total costs accrued as of the balance sheet date for environmental loss contingencies.", "label": "Accrual for Environmental Loss Contingencies", "terseLabel": "Accrual for Environmental Loss Contingencies" } } }, "localname": "AccrualForEnvironmentalLossContingencies", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesEnvironmentalDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedIncomeTaxesCurrent": { "auth_ref": [ "r58", "r1017", "r1055" ], "calculation": { "http://www.corteva.com/role/ConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.", "label": "Accrued Income Taxes, Current", "terseLabel": "Income Taxes Payable" } } }, "localname": "AccruedIncomeTaxesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedLiabilitiesCurrent": { "auth_ref": [ "r92" ], "calculation": { "http://www.corteva.com/role/ConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Liabilities, Current", "terseLabel": "Accrued and other current liabilities" } } }, "localname": "AccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/ConsolidatedBalanceSheets", "http://www.corteva.com/role/SupplementaryInformationSupplementaryInformationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember": { "auth_ref": [ "r127", "r134", "r144", "r145", "r146", "r835" ], "lang": { "en-us": { "role": { "documentation": "Accumulated other comprehensive (income) loss related to defined benefit plans attributable to the parent.", "label": "Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]", "terseLabel": "Accumulated Defined Benefit Plans Adjustment Attributable to Parent" } } }, "localname": "AccumulatedDefinedBenefitPlansAdjustmentMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/StockholdersEquityReclassificationsoutofAOCIDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember": { "auth_ref": [ "r129", "r134", "r144", "r145", "r146", "r835" ], "lang": { "en-us": { "role": { "documentation": "Accumulated other comprehensive (income) loss related to prior service cost (credit) component of defined benefit plans attributable to the parent.", "label": "Accumulated Defined Benefit Plans Adjustment, Net Prior Service Attributable to Parent [Member]", "terseLabel": "Prior Service Benefit" } } }, "localname": "AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/StockholdersEquityReclassificationsoutofAOCIDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember": { "auth_ref": [ "r126", "r134", "r144", "r145", "r146", "r835" ], "lang": { "en-us": { "role": { "documentation": "Accumulated other comprehensive income (loss) related to gain (loss) component of defined benefit plans attributable to the parent.", "label": "Accumulated Defined Benefit Plans Adjustment, Net Gain (Loss) Attributable to Parent [Member]", "terseLabel": "Actuarial Losses" } } }, "localname": "AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/StockholdersEquityReclassificationsoutofAOCIDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "auth_ref": [ "r86", "r423" ], "calculation": { "http://www.corteva.com/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.", "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment", "negatedTerseLabel": "Accumulated Depreciation", "terseLabel": "Accumulated Depreciation" } } }, "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/ConsolidatedBalanceSheets", "http://www.corteva.com/role/PropertyPlantandEquipmentScheduleofPropertyPlantandEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember": { "auth_ref": [ "r122", "r134", "r834" ], "lang": { "en-us": { "role": { "documentation": "Accumulated other comprehensive income (loss) resulting from gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges, attributable to the parent.", "label": "Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent [Member]", "terseLabel": "Derivative Instruments" } } }, "localname": "AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/StockholdersEquityOtherComprehensiveIncomeLossDetails", "http://www.corteva.com/role/StockholdersEquityReclassificationsoutofAOCIDetails", "http://www.corteva.com/role/StockholdersEquityTaxBenefitExpenseonNetActivityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember": { "auth_ref": [ "r123", "r124", "r125", "r134", "r144", "r145", "r146" ], "lang": { "en-us": { "role": { "documentation": "Accumulated unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), attributable to parent.", "label": "AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Parent [Member]", "terseLabel": "Unrealized gain (loss) on investments" } } }, "localname": "AccumulatedNetUnrealizedInvestmentGainLossMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/StockholdersEquityOtherComprehensiveIncomeLossDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]", "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/StockholdersEquityOtherComprehensiveIncomeLossDetails", "http://www.corteva.com/role/StockholdersEquityTaxBenefitExpenseonNetActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r71", "r131", "r133", "r134", "r1058", "r1088", "r1092" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.", "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax", "terseLabel": "Accumulated other comprehensive income (loss)" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": { "auth_ref": [ "r144", "r145", "r905", "r906", "r907", "r908", "r909", "r911" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).", "label": "Accumulated Other Comprehensive Income (Loss) [Table]", "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/StockholdersEquityOtherComprehensiveIncomeLossDetails", "http://www.corteva.com/role/StockholdersEquityTaxBenefitExpenseonNetActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "auth_ref": [ "r130", "r134", "r144", "r145", "r146", "r230", "r231", "r232", "r835", "r1083", "r1084", "r1185" ], "lang": { "en-us": { "role": { "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.", "label": "AOCI Attributable to Parent [Member]", "terseLabel": "AOCI Attributable to Parent", "verboseLabel": "Accumulated Other Comp Loss" } } }, "localname": "AccumulatedOtherComprehensiveIncomeMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/ConsolidatedStatementsofEquity", "http://www.corteva.com/role/StockholdersEquityOtherComprehensiveIncomeLossDetails", "http://www.corteva.com/role/StockholdersEquityReclassificationsoutofAOCIDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedTranslationAdjustmentMember": { "auth_ref": [ "r121", "r134", "r144", "r145", "r146", "r835", "r906", "r907", "r908", "r909", "r911" ], "lang": { "en-us": { "role": { "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent.", "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]", "terseLabel": "Cumulative Translation Adjustment" } } }, "localname": "AccumulatedTranslationAdjustmentMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/StockholdersEquityOtherComprehensiveIncomeLossDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Acquired Finite-Lived Intangible Assets [Line Items]", "terseLabel": "Intangible Assets [Line Items]" } } }, "localname": "AcquiredFiniteLivedIntangibleAssetsLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/GoodwillandOtherIntangibleAssetsOtherIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AdditionalFinancialInformationDisclosureTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosures of supplemental information, including descriptions and amounts, related to the balance sheet, income statement, and/or cash flow statement.", "label": "Additional Financial Information Disclosure [Text Block]", "terseLabel": "Additional Financial Information Disclosure [Text Block]" } } }, "localname": "AdditionalFinancialInformationDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/SupplementaryInformation" ], "xbrltype": "textBlockItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r69", "r739", "r953" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.", "label": "Additional Paid in Capital", "terseLabel": "Additional Paid in Capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r230", "r231", "r232", "r735", "r736", "r737", "r880" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]", "terseLabel": "Additional Paid-in Capital [Member]" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/ConsolidatedStatementsofEquity" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalOther": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of other increase (decrease) in additional paid in capital (APIC).", "label": "Adjustments to Additional Paid in Capital, Other", "terseLabel": "Reclassification of Divisional Equity to Additional Paid in Capital" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalOther", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/BackgroundandBasisofPresentationDetails", "http://www.corteva.com/role/ConsolidatedStatementsofEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": { "auth_ref": [ "r699", "r701", "r742", "r743" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.", "label": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition", "terseLabel": "Share-based compensation" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/ConsolidatedStatementsofEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllocatedShareBasedCompensationExpense": { "auth_ref": [ "r701", "r730", "r741" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.", "label": "Share-based Payment Arrangement, Expense", "terseLabel": "Stock-based compensation expense" } } }, "localname": "AllocatedShareBasedCompensationExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/StockBasedCompensationStockCompensationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllowanceForCreditLossMember": { "auth_ref": [ "r222", "r223", "r224", "r226", "r227" ], "lang": { "en-us": { "role": { "documentation": "Allowance for credit loss from right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.", "label": "SEC Schedule, 12-09, Allowance, Credit Loss [Member]", "terseLabel": "SEC Schedule, 12-09, Allowance, Credit Loss [Member]" } } }, "localname": "AllowanceForCreditLossMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/ScheduleIIValuationandQualifyingAccountsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": { "auth_ref": [ "r75", "r341", "r368" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.", "label": "Accounts Receivable, Allowance for Credit Loss, Current", "terseLabel": "A/R trade and notes receivable - trade, allowance" } } }, "localname": "AllowanceForDoubtfulAccountsReceivableCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/AccountsandNotesReceivableAllowanceRollforwardDetails", "http://www.corteva.com/role/AccountsandNotesReceivableNetScheduleofAccountsandNotesReceivableNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease": { "auth_ref": [ "r373" ], "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in allowance for credit loss on accounts receivable.", "label": "Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease)", "terseLabel": "Other deductions against allowance" } } }, "localname": "AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/AccountsandNotesReceivableAllowanceRollforwardDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs": { "auth_ref": [ "r371" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of direct write-downs of accounts receivable charged against the allowance.", "label": "Accounts Receivable, Allowance for Credit Loss, Writeoff", "terseLabel": "Write-offs charged against allowance" } } }, "localname": "AllowanceForDoubtfulAccountsReceivableWriteOffs", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/AccountsandNotesReceivableAllowanceRollforwardDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AlternativeInvestment": { "auth_ref": [ "r883", "r892" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value of investment other than investment in equity security, investment in debt security and equity method investment. Includes, but is not limited to, investment in certain entities that calculate net asset value per share. Example includes, but is not limited to, investment in hedge fund, venture capital fund, private equity fund, and real estate partnership or fund.", "label": "Alternative Investment", "terseLabel": "Investments Measured at Net Asset Value" } } }, "localname": "AlternativeInvestment", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansBasisofFairValueMeasurementDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfIntangibleAssets": { "auth_ref": [ "r193", "r402", "r410" ], "calculation": { "http://www.corteva.com/role/ConsolidatedStatementsofIncome": { "order": 8.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.", "label": "Amortization of Intangible Assets", "terseLabel": "Amortization of Intangibles", "verboseLabel": "Amortization expense" } } }, "localname": "AmortizationOfIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/ConsolidatedStatementsofIncome", "http://www.corteva.com/role/GoodwillandOtherIntangibleAssetsAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax": { "auth_ref": [ "r673" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount recognized in net periodic benefit cost (credit) and other comprehensive (income) loss.", "label": "Defined Benefit Plan, Amount Recognized in Net Periodic Benefit Cost (Credit) and Other Comprehensive (Income) Loss, before Tax", "terseLabel": "Total recognized in net periodic benefit cost and other comprehensive (income) loss" } } }, "localname": "AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansComponentsofnetperiodicbenefitcostcreditandamountsrecognizedinothercomprehensivelossDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]", "terseLabel": "Earnings Per Share [Line Items]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/EarningsPerShareNarrativeDetails", "http://www.corteva.com/role/EarningsPerShareShareCountInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AssetBackedSecuritiesMember": { "auth_ref": [ "r351", "r623" ], "lang": { "en-us": { "role": { "documentation": "Securities that are primarily serviced by the cash flows of a discrete pool of receivables or other financial assets for example, but not limited to, credit card receivables, car loans, recreational vehicle loans, and mobile home loans.", "label": "Asset-backed Securities [Member]", "terseLabel": "Asset-backed Securities [Member]" } } }, "localname": "AssetBackedSecuritiesMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansBasisofFairValueMeasurementDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansSummaryofFairValueMeasurementofLevel3PensionPlanAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AssetImpairmentCharges": { "auth_ref": [ "r193", "r418" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.", "label": "Asset Impairment Charges", "terseLabel": "Asset Impairment Charges" } } }, "localname": "AssetImpairmentCharges", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/FairValueMeasurementsFairValueMeasurementNonrecurringBasisDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetRetirementObligation": { "auth_ref": [ "r433" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The carrying amount of a liability for an asset retirement obligation. An asset retirement obligation is a legal obligation associated with the disposal or retirement of a tangible long-lived asset that results from the acquisition, construction or development, or the normal operations of a long-lived asset, except for certain obligations of lessees.", "label": "Asset Retirement Obligation", "terseLabel": "Asset Retirement Obligation" } } }, "localname": "AssetRetirementObligation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/RestructuringandAssetRelatedCharges2021RestructuringActionsDetails", "http://www.corteva.com/role/RestructuringandAssetRelatedChargesDowDuPontCostSynergyProgramDetails", "http://www.corteva.com/role/RestructuringandAssetRelatedChargesExecutetoWinProductivityProgramDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetRetirementObligationCostsMember": { "auth_ref": [ "r1129", "r1130" ], "lang": { "en-us": { "role": { "documentation": "Rate action of a regulator resulting in capitalization or accrual of costs for the retirement of long-lived assets.", "label": "Asset Retirement Obligation Costs [Member]", "terseLabel": "Asset Retirement Obligation Costs [Member]" } } }, "localname": "AssetRetirementObligationCostsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/RestructuringandAssetRelatedChargesExecutetoWinProductivityProgramDetails" ], "xbrltype": "domainItemType" }, "us-gaap_Assets": { "auth_ref": [ "r211", "r306", "r319", "r326", "r362", "r480", "r481", "r482", "r484", "r485", "r486", "r487", "r489", "r491", "r493", "r494", "r828", "r838", "r896", "r951", "r953", "r1015", "r1054" ], "calculation": { "http://www.corteva.com/role/ConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "terseLabel": "Assets", "totalLabel": "Total Assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/ConsolidatedBalanceSheets", "http://www.corteva.com/role/EIDSegmentFNSegmentAssetReconciliationDetails", "http://www.corteva.com/role/SegmentReportingSegmentAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r41", "r43", "r110", "r211", "r362", "r480", "r481", "r482", "r484", "r485", "r486", "r487", "r489", "r491", "r493", "r494", "r828", "r838", "r896", "r951", "r953" ], "calculation": { "http://www.corteva.com/role/ConsolidatedBalanceSheets": { "order": 7.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsFairValueDisclosure": { "auth_ref": [ "r884" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Fair Value Disclosure", "terseLabel": "Total assets at fair value" } } }, "localname": "AssetsFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/FairValueMeasurementsFairValueMeasurementRecurringBasisDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation": { "auth_ref": [ "r4", "r5", "r26", "r28", "r32", "r427" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount classified as assets attributable to disposal group held for sale or disposed of.", "label": "Disposal Group, Including Discontinued Operation, Assets", "terseLabel": "Total Assets - Discontinued Operations" } } }, "localname": "AssetsOfDisposalGroupIncludingDiscontinuedOperation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/DivestituresandOtherTransactionsECPDivestitureDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsSPDivestitureDetails", "http://www.corteva.com/role/SegmentReportingSegmentAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent": { "auth_ref": [ "r4", "r5", "r26", "r28", "r32", "r420", "r427" ], "calculation": { "http://www.corteva.com/role/ConsolidatedBalanceSheets": { "order": 6.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount classified as assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.", "label": "Disposal Group, Including Discontinued Operation, Assets, Current", "terseLabel": "Total Current Assets - Discontinued Operations" } } }, "localname": "AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/DivestituresandOtherTransactionsECPDivestitureDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsSPDivestitureDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated unrealized loss on investments in debt and equity securities classified as available-for-sale that have been in a continuous loss position for twelve months or longer.", "label": "Available-for-sale Securities, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss", "terseLabel": "12 months or more, Gross unrealized Losses" } } }, "localname": "AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/FinancialInstrumentsFairValueandGrossUnrealizedLossesofinvestmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss": { "auth_ref": [ "r354" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated unrealized loss on investments in debt and equity securities classified as available-for-sale in a continuous loss position.", "label": "Available-for-sale Securities, Continuous Unrealized Loss Position, Accumulated Loss", "terseLabel": "Total, Gross Unrealized Losses" } } }, "localname": "AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/FinancialInstrumentsFairValueandGrossUnrealizedLossesofinvestmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This item represents the aggregate fair value of investments in debt and equity securities in an unrealized loss position which are categorized neither as held-to-maturity nor trading securities.", "label": "Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value", "terseLabel": "Total, Fair Value" } } }, "localname": "AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/FinancialInstrumentsFairValueandGrossUnrealizedLossesofinvestmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of fair value of investments in debt and equity securities in an unrealized loss position categorized neither as held-to-maturity nor trading securities.", "label": "Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value [Table Text Block]", "terseLabel": "Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value" } } }, "localname": "AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/FinancialInstrumentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated unrealized loss on investments in debt and equity securities classified as available-for-sale that have been in a continuous loss position for less than twelve months.", "label": "Available-for-sale Securities, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss", "terseLabel": "Less than 12 months, Gross Unrealized Losses" } } }, "localname": "AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/FinancialInstrumentsFairValueandGrossUnrealizedLossesofinvestmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This item represents the aggregate fair value of investments in debt and equity securities categorized neither as held-to-maturity nor trading securities that have been in a continuous unrealized loss position for less than twelve months.", "label": "Available-for-sale Securities, Continuous Unrealized Loss Position, Less than Twelve Months, Fair Value", "terseLabel": "Less than 12 months, Fair Value" } } }, "localname": "AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/FinancialInstrumentsFairValueandGrossUnrealizedLossesofinvestmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This item represents the aggregate fair value of investments in debt and equity securities categorized neither as held-to-maturity nor trading securities that have been in a continuous unrealized loss position for twelve months or longer.", "label": "Available-for-sale Securities, Continuous Unrealized Loss Position, Twelve Months or Longer, Fair Value", "terseLabel": "12 months or more, Fair Value" } } }, "localname": "AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/FinancialInstrumentsFairValueandGrossUnrealizedLossesofinvestmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleSecuritiesDebtSecurities": { "auth_ref": [ "r347", "r349", "r379", "r1024" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).", "label": "Debt Securities, Available-for-sale", "terseLabel": "Available-for-sale securities" } } }, "localname": "AvailableForSaleSecuritiesDebtSecurities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/FairValueMeasurementsFairValueMeasurementRecurringBasisDetails", "http://www.corteva.com/role/FinancialInstrumentsFinancialInstrumentsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleSecuritiesGrossRealizedGainLossNet": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "This item represents the difference between the gross realized gains and losses realized on the sale of debt or equity securities categorized neither as held-to-maturity nor trading securities. Additionally, this item would include any losses recognized for other than temporary impairments (OTTI) of the subject investments in debt and equity securities.", "label": "Available-for-sale Securities, Gross Realized Gain (Loss)", "terseLabel": "Available-for-sale Securities, Gross Realized Gain (Loss)" } } }, "localname": "AvailableForSaleSecuritiesGrossRealizedGainLossNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/FinancialInstrumentsDebtSecuritiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableforsaleSecuritiesMember": { "auth_ref": [ "r355" ], "lang": { "en-us": { "role": { "documentation": "Investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).", "label": "Available-for-sale Securities [Member]", "terseLabel": "Available-for-sale Securities" } } }, "localname": "AvailableforsaleSecuritiesMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/FinancialInstrumentsDebtSecuritiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AwardDateAxis": { "auth_ref": [ "r702", "r733" ], "lang": { "en-us": { "role": { "documentation": "Information by date or year award under share-based payment arrangement is granted.", "label": "Award Date [Axis]", "terseLabel": "Award Date [Axis]" } } }, "localname": "AwardDateAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/StockBasedCompensationStockOptionsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AwardDateDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Date or year award under share-based payment arrangement is granted.", "label": "Award Date [Domain]", "terseLabel": "Award Date [Domain]" } } }, "localname": "AwardDateDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/StockBasedCompensationStockOptionsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AwardTypeAxis": { "auth_ref": [ "r702", "r733" ], "lang": { "en-us": { "role": { "documentation": "Information by type of award under share-based payment arrangement.", "label": "Award Type [Axis]", "terseLabel": "Award Type [Axis]" } } }, "localname": "AwardTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/StockBasedCompensationRestrictedStockUnitsandPerformanceDeferredStockDetails", "http://www.corteva.com/role/StockBasedCompensationStockCompensationDetails", "http://www.corteva.com/role/StockBasedCompensationStockOptionsDetails", "http://www.corteva.com/role/StockBasedCompensationWeightedAverageAssumptionsStockOptionsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetLocationAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by location on balance sheet (statement of financial position).", "label": "Balance Sheet Location [Axis]", "terseLabel": "Balance Sheet Location [Axis]" } } }, "localname": "BalanceSheetLocationAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationChemoursDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsDivestituresandOtherTransactionsNarrativeDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsDivestituresandOtherTransactionsPChemResultsofOperationsDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsECPDivestitureDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsSPDivestitureDetails", "http://www.corteva.com/role/EIDRelatedPartyDetails", "http://www.corteva.com/role/FinancialInstrumentsFairValueofDerivativesDetails", "http://www.corteva.com/role/FinancialInstrumentsFinancialInstrumentsNarrativeDetails", "http://www.corteva.com/role/LeasesSupplementalBalanceSheetInformationDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansAmountsRecognizedinConsolidatedBalanceSheetsDetails", "http://www.corteva.com/role/RevenueContractBalancesDetails", "http://www.corteva.com/role/SummaryofSignificantAccountingPoliciesDetails", "http://www.corteva.com/role/SupplementaryInformationReconciliationofCashCashEquivalentsandRestrictedCashDetails", "http://www.corteva.com/role/SupplementaryInformationSupplementaryInformationNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetLocationDomain": { "auth_ref": [ "r854", "r859" ], "lang": { "en-us": { "role": { "documentation": "Location in the balance sheet (statement of financial position).", "label": "Balance Sheet Location [Domain]", "terseLabel": "Balance Sheet Location [Domain]" } } }, "localname": "BalanceSheetLocationDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationChemoursDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsDivestituresandOtherTransactionsNarrativeDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsDivestituresandOtherTransactionsPChemResultsofOperationsDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsECPDivestitureDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsSPDivestitureDetails", "http://www.corteva.com/role/EIDRelatedPartyDetails", "http://www.corteva.com/role/FinancialInstrumentsFairValueofDerivativesDetails", "http://www.corteva.com/role/FinancialInstrumentsFinancialInstrumentsNarrativeDetails", "http://www.corteva.com/role/LeasesSupplementalBalanceSheetInformationDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansAmountsRecognizedinConsolidatedBalanceSheetsDetails", "http://www.corteva.com/role/RevenueContractBalancesDetails", "http://www.corteva.com/role/SummaryofSignificantAccountingPoliciesDetails", "http://www.corteva.com/role/SupplementaryInformationReconciliationofCashCashEquivalentsandRestrictedCashDetails", "http://www.corteva.com/role/SupplementaryInformationSupplementaryInformationNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Basis of Accounting, Policy [Policy Text Block]", "terseLabel": "Basis of Accounting, Policy [Policy Text Block]" } } }, "localname": "BasisOfAccountingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/BackgroundandBasisofPresentationPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_BuildingMember": { "auth_ref": [ "r422" ], "lang": { "en-us": { "role": { "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities.", "label": "Building [Member]", "terseLabel": "Building [Member]" } } }, "localname": "BuildingMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/PropertyPlantandEquipmentScheduleofPropertyPlantandEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "auth_ref": [ "r680", "r693" ], "lang": { "en-us": { "role": { "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.", "label": "Business Acquisition, Acquiree [Domain]", "terseLabel": "Business Acquisition, Acquiree [Domain]" } } }, "localname": "BusinessAcquisitionAcquireeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/InventoriesScheduleofInventoryDetails", "http://www.corteva.com/role/QuaterlyFinancialDataQuarterlyFinancialDataParentheticalsDetails", "http://www.corteva.com/role/RestructuringandAssetRelatedCharges2021RestructuringActionsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAxis": { "auth_ref": [ "r680", "r693", "r806", "r807" ], "lang": { "en-us": { "role": { "documentation": "Information by business combination or series of individually immaterial business combinations.", "label": "Business Acquisition [Axis]", "terseLabel": "Business Acquisition [Axis]" } } }, "localname": "BusinessAcquisitionAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/InventoriesScheduleofInventoryDetails", "http://www.corteva.com/role/QuaterlyFinancialDataQuarterlyFinancialDataParentheticalsDetails", "http://www.corteva.com/role/RestructuringandAssetRelatedCharges2021RestructuringActionsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Business Acquisition [Line Items]", "terseLabel": "Business Acquisition [Line Items]" } } }, "localname": "BusinessAcquisitionLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/BusinessCombinationsDASCommonControlTransferIncomeStatementDetails", "http://www.corteva.com/role/CommonControlBusinessCombinationsTables" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable": { "auth_ref": [ "r814", "r815" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination.", "label": "Business Combination, Consideration Transferred, Equity Interests Issued and Issuable", "terseLabel": "Business Combination, Fair Value, Consideration Transferred" } } }, "localname": "BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/StockBasedCompensationStockCompensationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet": { "auth_ref": [ "r808", "r809" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net", "terseLabel": "Fair Value - H&N Business" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/DivestituresandOtherTransactionsDivestituresandOtherTransactionsDivestedAgBusinessResultsofOperationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Business Combinations [Abstract]", "terseLabel": "Business Combinations [Abstract]" } } }, "localname": "BusinessCombinationsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_CapitalExpenditureDiscontinuedOperations": { "auth_ref": [ "r25" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of capital expenditure attributable to discontinued operations.", "label": "Capital Expenditure, Discontinued Operations", "terseLabel": "Capital Expenditures" } } }, "localname": "CapitalExpenditureDiscontinuedOperations", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/DivestituresandOtherTransactionsECPDivestitureDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsSPDivestitureDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r36", "r81", "r195" ], "calculation": { "http://www.corteva.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and Cash Equivalents, at Carrying Value", "terseLabel": "Cash and Cash Equivalents" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/ConsolidatedBalanceSheets", "http://www.corteva.com/role/SupplementaryInformationReconciliationofCashCashEquivalentsandRestrictedCashDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash and Cash Equivalents [Member]", "terseLabel": "Cash and Cash Equivalents [Member]" } } }, "localname": "CashAndCashEquivalentsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansBasisofFairValueMeasurementDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansTargetAllocationforPlanAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "auth_ref": [ "r50", "r196" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.", "label": "Cash and Cash Equivalents, Policy [Policy Text Block]", "terseLabel": "Cash and Cash Equivalents" } } }, "localname": "CashAndCashEquivalentsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy": { "auth_ref": [ "r50", "r196", "r1012" ], "lang": { "en-us": { "role": { "documentation": "Entity's cash and cash equivalents accounting policy with respect to restricted balances. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.", "label": "Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]", "terseLabel": "Restricted Cash" } } }, "localname": "CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r187", "r195", "r201" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents", "terseLabel": "Cash, Cash Equivalents, and Restricted Cash" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/SupplementaryInformationReconciliationofCashCashEquivalentsandRestrictedCashDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": { "auth_ref": [ "r187", "r195", "r201" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations", "periodEndLabel": "Cash, cash equivalents and restricted cash equivalents at end of period", "periodStartLabel": "Cash, cash equivalents and restricted cash equivalents at beginning of period", "terseLabel": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/ConsolidatedStatementsofCashFlows", "http://www.corteva.com/role/SupplementaryInformationReconciliationofCashCashEquivalentsandRestrictedCashDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r187", "r904" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "terseLabel": "Increase (decrease) on cash, cash equivalents and restricted cash" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashEquivalentsMember": { "auth_ref": [ "r50" ], "lang": { "en-us": { "role": { "documentation": "Short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash Equivalents [Member]", "terseLabel": "Cash Equivalents [Member]" } } }, "localname": "CashEquivalentsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/FinancialInstrumentsFinancialInstrumentsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths": { "auth_ref": [ "r876" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The estimated net amount of existing gains or losses on cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months.", "label": "Cash Flow Hedge Gain (Loss) to be Reclassified within Twelve Months", "terseLabel": "After-tax net gain to be reclassified from AOCL into earnings over the next twelve months" } } }, "localname": "CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/FinancialInstrumentsCashFlowHedgesIncludedinAOCIDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashFlowHedgesDerivativeInstrumentsAtFairValueNet": { "auth_ref": [ "r845" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Net fair value of all derivative instruments designated as cash flow hedging instruments, which is ordinarily reflected within other comprehensive income.", "label": "Cash Flow Hedges Derivative Instruments at Fair Value, Net", "periodEndLabel": "Ending Balance", "periodStartLabel": "Beginning Balance" } } }, "localname": "CashFlowHedgesDerivativeInstrumentsAtFairValueNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/FinancialInstrumentsCashFlowHedgesIncludedinAOCIDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashFlowHedgingMember": { "auth_ref": [ "r850" ], "lang": { "en-us": { "role": { "documentation": "Hedge of the exposure to variability in the cash flows of a recognized asset or liability, or of a forecasted transaction, that is attributable to a particular risk.", "label": "Cash Flow Hedging [Member]", "terseLabel": "Cash Flow Hedging [Member]" } } }, "localname": "CashFlowHedgingMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/FinancialInstrumentsCashFlowHedgesIncludedinAOCIDetails", "http://www.corteva.com/role/FinancialInstrumentsEffectofDerivativeInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [ "r208", "r211", "r256", "r257", "r262", "r265", "r267", "r283", "r284", "r285", "r362", "r480", "r485", "r486", "r487", "r493", "r494", "r538", "r539", "r543", "r547", "r896", "r1140" ], "lang": { "en-us": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.", "label": "Class of Stock [Domain]", "terseLabel": "Class of Stock [Domain]" } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/ConsolidatedBalanceSheets", "http://www.corteva.com/role/ConsolidatedBalanceSheetsParentheticals", "http://www.corteva.com/role/ConsolidatedStatementsofEquityParentheticals", "http://www.corteva.com/role/DEIDocument", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansBasisofFairValueMeasurementDetails", "http://www.corteva.com/role/StockholdersEquityNoncontrollingInterestDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]", "terseLabel": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r457", "r458", "r459", "r471", "r1113" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Commitments and Contingencies Disclosure [Text Block]", "terseLabel": "Commitments and Contingencies Disclosure [Text Block]" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/CommitmentsandContingentLiabilities" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommodityContractMember": { "auth_ref": [ "r623", "r866" ], "lang": { "en-us": { "role": { "documentation": "Derivative instrument whose primary underlying risk is tied to commodity prices.", "label": "Commodity Contract [Member]", "terseLabel": "Commodity Contract [Member]" } } }, "localname": "CommodityContractMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/FairValueMeasurementsFairValueMeasurementNonrecurringBasisDetails", "http://www.corteva.com/role/FairValueMeasurementsFairValueMeasurementRecurringBasisDetails", "http://www.corteva.com/role/FinancialInstrumentsCashFlowHedgesIncludedinAOCIDetails", "http://www.corteva.com/role/FinancialInstrumentsEffectofDerivativeInstrumentsDetails", "http://www.corteva.com/role/FinancialInstrumentsFairValueofDerivativesDetails", "http://www.corteva.com/role/FinancialInstrumentsNotionalAmountsDetails", "http://www.corteva.com/role/FinancialInstrumentsTables" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockDividendsPerShareDeclared": { "auth_ref": [ "r561" ], "lang": { "en-us": { "role": { "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding.", "label": "Common Stock, Dividends, Per Share, Declared", "terseLabel": "Common Stock Dividends" } } }, "localname": "CommonStockDividendsPerShareDeclared", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/ConsolidatedStatementsofEquityParentheticals" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r230", "r231", "r880" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]", "terseLabel": "Common Stock [Member]" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/ConsolidatedStatementsofEquity", "http://www.corteva.com/role/DEIDocument", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansBasisofFairValueMeasurementDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r66" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock, Par or Stated Value Per Share", "terseLabel": "Common Stock, Par Value" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/BackgroundandBasisofPresentationDetails", "http://www.corteva.com/role/ConsolidatedBalanceSheetsParentheticals", "http://www.corteva.com/role/DEIDocument", "http://www.corteva.com/role/EIDBasisofPresentationDetails", "http://www.corteva.com/role/StockholdersEquityCommonStockDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r66" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock, Shares Authorized", "terseLabel": "Common Stock, Shares Authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/BackgroundandBasisofPresentationDetails", "http://www.corteva.com/role/ConsolidatedBalanceSheetsParentheticals", "http://www.corteva.com/role/EarningsPerShareShareCountInformationDetails", "http://www.corteva.com/role/StockholdersEquityCommonStockDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r66" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock, Shares, Issued", "terseLabel": "Common Stock, Shares, Issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/EarningsPerShareNarrativeDetails", "http://www.corteva.com/role/EarningsPerShareShareCountInformationDetails", "http://www.corteva.com/role/StockholdersEquityCommonStockDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r66", "r554" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock, Shares, Outstanding", "terseLabel": "Common Stock, Shares, Outstanding" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/ConsolidatedBalanceSheetsParentheticals", "http://www.corteva.com/role/EIDBasisofPresentationDetails", "http://www.corteva.com/role/StockholdersEquityCommonStockDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r66", "r953" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock, Value, Issued", "terseLabel": "Common stock" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CompensationAndRetirementDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Retirement Benefits [Abstract]", "terseLabel": "Retirement Benefits [Abstract]" } } }, "localname": "CompensationAndRetirementDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_ComponentsOfDeferredTaxAssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Components of Deferred Tax Assets [Abstract]", "terseLabel": "Assets" } } }, "localname": "ComponentsOfDeferredTaxAssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/IncomeTaxesIncomeTaxesDeferredTaxBalancesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Components of Deferred Tax Liabilities [Abstract]", "terseLabel": "Liabilities" } } }, "localname": "ComponentsOfDeferredTaxLiabilitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/IncomeTaxesIncomeTaxesDeferredTaxBalancesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ComprehensiveIncomeNetOfTax": { "auth_ref": [ "r139", "r141", "r142", "r157", "r1037", "r1074" ], "calculation": { "http://www.corteva.com/role/ConsolidatedStatementsofComprehensiveIncome": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent", "totalLabel": "Comprehensive Income (Loss) Attributable to Corteva" } } }, "localname": "ComprehensiveIncomeNetOfTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/ConsolidatedStatementsofComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": { "auth_ref": [ "r139", "r141", "r156", "r824", "r825", "r842", "r1036", "r1073" ], "calculation": { "http://www.corteva.com/role/ConsolidatedStatementsofComprehensiveIncome": { "order": 2.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest", "terseLabel": "Comprehensive Income Attributable to Noncontrolling Interest- net of tax" } } }, "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/ConsolidatedStatementsofComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r139", "r141", "r155", "r823", "r842", "r1035", "r1072" ], "calculation": { "http://www.corteva.com/role/ConsolidatedStatementsofComprehensiveIncome": { "order": 1.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest", "totalLabel": "Comprehensive Income (Loss)" } } }, "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/ConsolidatedStatementsofComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComputerSoftwareIntangibleAssetMember": { "auth_ref": [ "r403", "r408", "r812" ], "lang": { "en-us": { "role": { "documentation": "Collection of computer programs and related data that provide instructions to a computer, for example, but not limited to, application program, control module or operating system, that perform one or more particular functions or tasks.", "label": "Computer Software, Intangible Asset [Member]", "terseLabel": "Computer Software, Intangible Asset [Member]" } } }, "localname": "ComputerSoftwareIntangibleAssetMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/PropertyPlantandEquipmentScheduleofPropertyPlantandEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesPurchaseOfInterestByParent": { "auth_ref": [ "r562", "r836", "r843" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Represents the purchase by the parent of an additional equity interest in a subsidiary during the period, thereby effecting a change in total (consolidated) equity attributable to the parent. The purchase of the additional equity interest represented by this element increases the parent's controlling interest in the subsidiary.", "label": "Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Changes, Purchase of Interest by Parent", "terseLabel": "Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Changes, Purchase of Interest by Parent" } } }, "localname": "ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesPurchaseOfInterestByParent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/StockholdersEquityNoncontrollingInterestDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConsolidationPolicyTextBlock": { "auth_ref": [ "r203", "r830" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.", "label": "Consolidation, Policy [Policy Text Block]", "terseLabel": "Basis of Consolidation" } } }, "localname": "ConsolidationPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConstructionInProgressMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.", "label": "Construction in Progress [Member]", "terseLabel": "Construction in Progress [Member]" } } }, "localname": "ConstructionInProgressMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/PropertyPlantandEquipmentScheduleofPropertyPlantandEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ContractTerminationMember": { "auth_ref": [ "r443", "r444", "r451", "r452" ], "lang": { "en-us": { "role": { "documentation": "Termination of a contract associated with exit from or disposal of business activities or restructurings pursuant to a plan.", "label": "Contract Termination [Member]", "terseLabel": "Contract Termination [Member]" } } }, "localname": "ContractTerminationMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/RestructuringandAssetRelatedCharges2021RestructuringActionsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock": { "auth_ref": [ "r568" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.", "label": "Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]", "terseLabel": "Contract Balances [Table Text Block]" } } }, "localname": "ContractWithCustomerAssetAndLiabilityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/RevenueTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ContractWithCustomerAssetNetCurrent": { "auth_ref": [ "r566", "r567", "r579" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current.", "label": "Contract with Customer, Asset, after Allowance for Credit Loss, Current", "terseLabel": "Contract assets - current" } } }, "localname": "ContractWithCustomerAssetNetCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/RevenueContractBalancesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerAssetNetNoncurrent": { "auth_ref": [ "r566", "r567", "r579" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as noncurrent.", "label": "Contract with Customer, Asset, after Allowance for Credit Loss, Noncurrent", "terseLabel": "Contract assets - noncurrent" } } }, "localname": "ContractWithCustomerAssetNetNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/RevenueContractBalancesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConversionOfStockByUniqueDescriptionAxis": { "auth_ref": [ "r198", "r199", "r200" ], "lang": { "en-us": { "role": { "documentation": "Information by description of stock conversions.", "label": "Stock Conversion Description [Axis]", "terseLabel": "Stock Conversion Description [Axis]" } } }, "localname": "ConversionOfStockByUniqueDescriptionAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/BackgroundandBasisofPresentationDetails", "http://www.corteva.com/role/StockholdersEquityCommonStockDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConversionOfStockNameDomain": { "auth_ref": [ "r198", "r199", "r200" ], "lang": { "en-us": { "role": { "documentation": "The unique name of a noncash or part noncash stock conversion.", "label": "Conversion of Stock, Name [Domain]", "terseLabel": "Conversion of Stock, Name [Domain]" } } }, "localname": "ConversionOfStockNameDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/BackgroundandBasisofPresentationDetails", "http://www.corteva.com/role/StockholdersEquityCommonStockDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CorporateDebtSecuritiesMember": { "auth_ref": [ "r623", "r673", "r1094" ], "lang": { "en-us": { "role": { "documentation": "Debt securities issued by domestic or foreign corporate business, banks and other entities with a promise of repayment.", "label": "Corporate Debt Securities [Member]", "terseLabel": "Corporate Debt Securities [Member]" } } }, "localname": "CorporateDebtSecuritiesMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansBasisofFairValueMeasurementDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansSummaryofFairValueMeasurementofLevel3PensionPlanAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CorporateMember": { "auth_ref": [ "r293" ], "lang": { "en-us": { "role": { "documentation": "Component of an entity that usually provides financial, operational and administrative support and is considered an operating segment. Excludes intersegment elimination and reconciling items.", "label": "Corporate Segment [Member]", "terseLabel": "Corporate Segment [Member]" } } }, "localname": "CorporateMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/RestructuringandAssetRelatedChargesDowDuPontAgricultureDivisionRestructuringProgramDetails", "http://www.corteva.com/role/RestructuringandAssetRelatedChargesDowDuPontCostSynergyProgramDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CorporateNonSegmentMember": { "auth_ref": [ "r317", "r318", "r319", "r320", "r322", "r328", "r330" ], "lang": { "en-us": { "role": { "documentation": "Corporate headquarters or functional department that may not earn revenues or may earn revenues that are only incidental to the activities of the entity and is not considered an operating segment.", "label": "Corporate, Non-Segment [Member]", "terseLabel": "Corporate, Non-Segment [Member]" } } }, "localname": "CorporateNonSegmentMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/EIDSegmentFNSegmentReconciliationDetails", "http://www.corteva.com/role/RestructuringandAssetRelatedCharges2021RestructuringActionsDetails", "http://www.corteva.com/role/RestructuringandAssetRelatedChargesExecutetoWinProductivityProgramDetails", "http://www.corteva.com/role/SegmentReportingSigItemsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CostOfGoodsAndServicesSold": { "auth_ref": [ "r164", "r993" ], "calculation": { "http://www.corteva.com/role/ConsolidatedStatementsofIncome": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.", "label": "Cost of Goods and Services Sold", "terseLabel": "Cost of Goods Sold" } } }, "localname": "CostOfGoodsAndServicesSold", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/ConsolidatedStatementsofIncome", "http://www.corteva.com/role/QuaterlyFinancialDataQuarterlyFinancialDataDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfSalesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing cost of sales.", "label": "Cost of Sales [Member]", "terseLabel": "Cost of Goods Sold" } } }, "localname": "CostOfSalesMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/FinancialInstrumentsEffectofDerivativeInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CostOfSalesPolicyTextBlock": { "auth_ref": [ "r593" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for cost of product sold and service rendered.", "label": "Cost of Goods and Service [Policy Text Block]", "terseLabel": "Cost of Goods Sold" } } }, "localname": "CostOfSalesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock": { "auth_ref": [ "r448", "r449", "r455" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for recognizing and reporting costs associated with exiting, disposing of, and restructuring certain operations.", "label": "Costs Associated with Exit or Disposal Activities or Restructurings, Policy [Policy Text Block]", "terseLabel": "Severance Costs" } } }, "localname": "CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CreditFacilityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Axis]", "terseLabel": "Credit Facility [Axis]" } } }, "localname": "CreditFacilityAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/LongTermDebtandAvailableCreditFacilitiesAvailableCommittedCreditFacilitiesNarrativeDetails", "http://www.corteva.com/role/LongTermDebtandAvailableCreditFacilitiesDebtRedemptionsRepaymentsDetails", "http://www.corteva.com/role/LongTermDebtandAvailableCreditFacilitiesLongTermDebtDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CreditFacilityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Domain]", "terseLabel": "Credit Facility [Domain]" } } }, "localname": "CreditFacilityDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/LongTermDebtandAvailableCreditFacilitiesAvailableCommittedCreditFacilitiesNarrativeDetails", "http://www.corteva.com/role/LongTermDebtandAvailableCreditFacilitiesDebtRedemptionsRepaymentsDetails", "http://www.corteva.com/role/LongTermDebtandAvailableCreditFacilitiesLongTermDebtDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CurrentFederalTaxExpenseBenefit": { "auth_ref": [ "r212", "r779", "r790" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Current Federal Tax Expense (Benefit)", "terseLabel": "Current Federal Tax (Benefit) Expense" } } }, "localname": "CurrentFederalTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/EIDIncomeTaxesGeographicAllocationDetails", "http://www.corteva.com/role/IncomeTaxesIncomeTaxesGeographicAllocationofIncomeandProvisionforIncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CurrentForeignTaxExpenseBenefit": { "auth_ref": [ "r212", "r779" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Current Foreign Tax Expense (Benefit)", "terseLabel": "Current Foreign Tax Expense (Benefit)" } } }, "localname": "CurrentForeignTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/EIDIncomeTaxesGeographicAllocationDetails", "http://www.corteva.com/role/IncomeTaxesIncomeTaxesGeographicAllocationofIncomeandProvisionforIncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CurrentIncomeTaxExpenseBenefit": { "auth_ref": [ "r212", "r779", "r790", "r792" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.", "label": "Current Income Tax Expense (Benefit)", "terseLabel": "Total current tax expense (benefit)" } } }, "localname": "CurrentIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/EIDIncomeTaxesGeographicAllocationDetails", "http://www.corteva.com/role/IncomeTaxesIncomeTaxesGeographicAllocationofIncomeandProvisionforIncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": { "auth_ref": [ "r212", "r779", "r790" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Current State and Local Tax Expense (Benefit)", "terseLabel": "Current State and Local Tax Expense (Benefit)" } } }, "localname": "CurrentStateAndLocalTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/EIDIncomeTaxesGeographicAllocationDetails", "http://www.corteva.com/role/IncomeTaxesIncomeTaxesGeographicAllocationofIncomeandProvisionforIncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CustomerRelatedIntangibleAssetsMember": { "auth_ref": [ "r810" ], "lang": { "en-us": { "role": { "documentation": "Customer-related asset, including, but not limited to, customer lists, and noncontractual customer relationships.", "label": "Customer-Related Intangible Assets [Member]", "terseLabel": "Customer-Related Intangible Assets [Member]" } } }, "localname": "CustomerRelatedIntangibleAssetsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/GoodwillandOtherIntangibleAssetsOtherIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtCurrent": { "auth_ref": [ "r91" ], "calculation": { "http://www.corteva.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of short-term debt and current maturity of long-term debt and capital lease obligations due within one year or the normal operating cycle, if longer.", "label": "Debt, Current", "terseLabel": "Short-term borrowings and finance lease obligations" } } }, "localname": "DebtCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Disclosure [Abstract]", "terseLabel": "Debt Disclosure [Abstract]" } } }, "localname": "DebtDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_DebtDisclosureTextBlock": { "auth_ref": [ "r207", "r501", "r502", "r503", "r504", "r505", "r506", "r507", "r512", "r519", "r520", "r522", "r531" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.", "label": "Debt Disclosure [Text Block]", "terseLabel": "Debt Disclosure [Text Block]" } } }, "localname": "DebtDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/LongTermDebtandAvailableCreditFacilities" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtInstrumentAxis": { "auth_ref": [ "r56", "r58", "r59", "r210", "r221", "r495", "r496", "r497", "r498", "r499", "r500", "r502", "r508", "r509", "r510", "r511", "r513", "r514", "r515", "r516", "r517", "r518", "r525", "r526", "r527", "r528", "r918", "r1016", "r1019", "r1049" ], "lang": { "en-us": { "role": { "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.", "label": "Debt Instrument [Axis]", "terseLabel": "Debt Instrument [Axis]" } } }, "localname": "DebtInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/LongTermDebtandAvailableCreditFacilitiesAvailableCommittedCreditFacilitiesNarrativeDetails", "http://www.corteva.com/role/LongTermDebtandAvailableCreditFacilitiesDebtRedemptionsRepaymentsDetails", "http://www.corteva.com/role/LongTermDebtandAvailableCreditFacilitiesLongTermDebtDetails", "http://www.corteva.com/role/LongTermDebtandAvailableCreditFacilitiesUncommittedCreditFacilitiesandOutstandingLettersofCreditDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentCarryingAmount": { "auth_ref": [ "r59", "r523", "r1019", "r1049" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.", "label": "Long-term Debt, Gross", "terseLabel": "Long-term Debt, Gross" } } }, "localname": "DebtInstrumentCarryingAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/LongTermDebtandAvailableCreditFacilitiesDebtRedemptionsRepaymentsDetails", "http://www.corteva.com/role/LongTermDebtandAvailableCreditFacilitiesLongTermDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentFaceAmount": { "auth_ref": [ "r495", "r525", "r526", "r916", "r918", "r919" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Face (par) amount of debt instrument at time of issuance.", "label": "Debt Instrument, Face Amount", "terseLabel": "Debt Instrument, Face Amount" } } }, "localname": "DebtInstrumentFaceAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/LongTermDebtandAvailableCreditFacilitiesDebtRedemptionsRepaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "auth_ref": [ "r95", "r496" ], "lang": { "en-us": { "role": { "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.", "label": "Debt Instrument, Interest Rate, Stated Percentage", "terseLabel": "Debt Instrument, Interest Rate, Stated Percentage" } } }, "localname": "DebtInstrumentInterestRateStatedPercentage", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/LongTermDebtandAvailableCreditFacilitiesDebtRedemptionsRepaymentsDetails", "http://www.corteva.com/role/LongTermDebtandAvailableCreditFacilitiesLongTermDebtDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Debt Instrument [Line Items]", "terseLabel": "Debt Instrument [Line Items]" } } }, "localname": "DebtInstrumentLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/LongTermDebtandAvailableCreditFacilitiesDebtRedemptionsRepaymentsDetails", "http://www.corteva.com/role/LongTermDebtandAvailableCreditFacilitiesLongTermDebtDetails", "http://www.corteva.com/role/LongTermDebtandAvailableCreditFacilitiesUncommittedCreditFacilitiesandOutstandingLettersofCreditDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentNameDomain": { "auth_ref": [ "r96", "r210", "r221", "r495", "r496", "r497", "r498", "r499", "r500", "r502", "r508", "r509", "r510", "r511", "r513", "r514", "r515", "r516", "r517", "r518", "r525", "r526", "r527", "r528", "r918" ], "lang": { "en-us": { "role": { "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.", "label": "Debt Instrument, Name [Domain]", "terseLabel": "Debt Instrument, Name [Domain]" } } }, "localname": "DebtInstrumentNameDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/LongTermDebtandAvailableCreditFacilitiesAvailableCommittedCreditFacilitiesNarrativeDetails", "http://www.corteva.com/role/LongTermDebtandAvailableCreditFacilitiesDebtRedemptionsRepaymentsDetails", "http://www.corteva.com/role/LongTermDebtandAvailableCreditFacilitiesLongTermDebtDetails", "http://www.corteva.com/role/LongTermDebtandAvailableCreditFacilitiesUncommittedCreditFacilitiesandOutstandingLettersofCreditDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentRedemptionPeriodAxis": { "auth_ref": [ "r1045" ], "lang": { "en-us": { "role": { "documentation": "Information about timing of debt redemption features under terms of the debt agreement.", "label": "Debt Instrument, Redemption, Period [Axis]", "terseLabel": "Debt Instrument, Redemption, Period [Axis]" } } }, "localname": "DebtInstrumentRedemptionPeriodAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/FinancialInstrumentsDebtSecuritiesDetails", "http://www.corteva.com/role/LongTermDebtandAvailableCreditFacilitiesUncommittedCreditFacilitiesandOutstandingLettersofCreditDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentRedemptionPeriodDomain": { "auth_ref": [ "r1045" ], "lang": { "en-us": { "role": { "documentation": "Period as defined under terms of the debt agreement for debt redemption features.", "label": "Debt Instrument, Redemption, Period [Domain]", "terseLabel": "Debt Instrument, Redemption, Period [Domain]" } } }, "localname": "DebtInstrumentRedemptionPeriodDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/FinancialInstrumentsDebtSecuritiesDetails", "http://www.corteva.com/role/LongTermDebtandAvailableCreditFacilitiesUncommittedCreditFacilitiesandOutstandingLettersofCreditDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentRepurchaseAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value amount of debt instrument that was repurchased.", "label": "Debt Instrument, Repurchase Amount", "terseLabel": "Debt Instrument, Repurchase Amount" } } }, "localname": "DebtInstrumentRepurchaseAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/LongTermDebtandAvailableCreditFacilitiesDebtRedemptionsRepaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentTable": { "auth_ref": [ "r96", "r210", "r221", "r495", "r496", "r497", "r498", "r499", "r500", "r502", "r508", "r509", "r510", "r511", "r513", "r514", "r515", "r516", "r517", "r518", "r521", "r525", "r526", "r527", "r528", "r555", "r558", "r559", "r560", "r915", "r916", "r918", "r919", "r1046" ], "lang": { "en-us": { "role": { "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Schedule of Long-term Debt Instruments [Table]", "terseLabel": "Schedule of Long-term Debt Instruments [Table]" } } }, "localname": "DebtInstrumentTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/LongTermDebtandAvailableCreditFacilitiesDebtRedemptionsRepaymentsDetails", "http://www.corteva.com/role/LongTermDebtandAvailableCreditFacilitiesLongTermDebtDetails", "http://www.corteva.com/role/LongTermDebtandAvailableCreditFacilitiesUncommittedCreditFacilitiesandOutstandingLettersofCreditDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Debt Instrument, Term", "terseLabel": "Debt Instrument, Term" } } }, "localname": "DebtInstrumentTerm", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/LongTermDebtandAvailableCreditFacilitiesAvailableCommittedCreditFacilitiesNarrativeDetails", "http://www.corteva.com/role/LongTermDebtandAvailableCreditFacilitiesDebtRedemptionsRepaymentsDetails" ], "xbrltype": "durationItemType" }, "us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet": { "auth_ref": [ "r508", "r524", "r525", "r526", "r917" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of unamortized debt discount (premium) and debt issuance costs.", "label": "Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net", "terseLabel": "Unamortized debt discount and issuance costs" } } }, "localname": "DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/LongTermDebtandAvailableCreditFacilitiesLongTermDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtSecuritiesAvailableForSaleTable": { "auth_ref": [ "r356" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).", "label": "Debt Securities, Available-for-sale [Table]", "terseLabel": "Debt Securities, Available-for-sale [Table]" } } }, "localname": "DebtSecuritiesAvailableForSaleTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/FinancialInstrumentsDebtSecuritiesDetails", "http://www.corteva.com/role/FinancialInstrumentsFairValueandGrossUnrealizedLossesofinvestmentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock": { "auth_ref": [ "r356" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).", "label": "Debt Securities, Available-for-sale [Table Text Block]", "terseLabel": "Debt Securities, Available-for-sale" } } }, "localname": "DebtSecuritiesAvailableForSaleTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/FinancialInstrumentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).", "label": "Debt Securities, Available-for-sale, Unrealized Gain (Loss)", "terseLabel": "Gross Unrealized Gain (Loss)" } } }, "localname": "DebtSecuritiesAvailableForSaleUnrealizedGainLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/FinancialInstrumentsDebtSecuritiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtWeightedAverageInterestRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average interest rate of debt outstanding.", "label": "Debt, Weighted Average Interest Rate", "terseLabel": "Debt, Weighted Average Interest Rate" } } }, "localname": "DebtWeightedAverageInterestRate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/EIDRelatedPartyDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": { "auth_ref": [ "r212", "r780", "r790" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Deferred Federal Income Tax Expense (Benefit)", "terseLabel": "Deferred Federal Income Tax Expense (Benefit)" } } }, "localname": "DeferredFederalIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/EIDIncomeTaxesGeographicAllocationDetails", "http://www.corteva.com/role/IncomeTaxesIncomeTaxesGeographicAllocationofIncomeandProvisionforIncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredForeignIncomeTaxExpenseBenefit": { "auth_ref": [ "r212", "r780", "r790" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Deferred Foreign Income Tax Expense (Benefit)", "terseLabel": "Deferred Foreign Income Tax Expense (Benefit)" } } }, "localname": "DeferredForeignIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/EIDIncomeTaxesGeographicAllocationDetails", "http://www.corteva.com/role/IncomeTaxesIncomeTaxesGeographicAllocationofIncomeandProvisionforIncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxAssetsNet": { "auth_ref": [ "r752", "r753" ], "calculation": { "http://www.corteva.com/role/ConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.", "label": "Deferred Income Tax Assets, Net", "terseLabel": "Deferred Income Taxes" } } }, "localname": "DeferredIncomeTaxAssetsNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxExpenseBenefit": { "auth_ref": [ "r193", "r212", "r780", "r790", "r791", "r792" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Deferred Income Tax Expense (Benefit)", "verboseLabel": "Total deferred tax expense (benefit)" } } }, "localname": "DeferredIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/EIDIncomeTaxesGeographicAllocationDetails", "http://www.corteva.com/role/IncomeTaxesIncomeTaxesGeographicAllocationofIncomeandProvisionforIncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxLiabilities": { "auth_ref": [ "r62", "r63", "r769", "r1018", "r1048" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences.", "label": "Deferred Tax Liabilities, Gross", "terseLabel": "Deferred Tax Liabilities, Gross" } } }, "localname": "DeferredIncomeTaxLiabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/IncomeTaxesIncomeTaxesDeferredTaxBalancesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxLiabilitiesNet": { "auth_ref": [ "r752", "r753" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.", "label": "Deferred Income Tax Liabilities, Net", "terseLabel": "Deferred Income Tax Liabilities" } } }, "localname": "DeferredIncomeTaxLiabilitiesNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredRevenue": { "auth_ref": [ "r77" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.", "label": "Deferred Revenue", "terseLabel": "Deferred Revenue" } } }, "localname": "DeferredRevenue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/RevenueContractBalancesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredRevenueCurrent": { "auth_ref": [ "r77" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.", "label": "Deferred Revenue, Current", "terseLabel": "Deferred Revenue" } } }, "localname": "DeferredRevenueCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredRevenueRevenueRecognized1": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue recognized that was previously reported as deferred or unearned revenue.", "label": "Deferred Revenue, Revenue Recognized", "terseLabel": "Deferred Revenue Recognized During the Period" } } }, "localname": "DeferredRevenueRevenueRecognized1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/RevenueContractBalancesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": { "auth_ref": [ "r212", "r780", "r790" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Deferred State and Local Income Tax Expense (Benefit)", "terseLabel": "Deferred State and Local Income Tax Expense (Benefit)" } } }, "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/EIDIncomeTaxesGeographicAllocationDetails", "http://www.corteva.com/role/IncomeTaxesIncomeTaxesGeographicAllocationofIncomeandProvisionforIncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsGross": { "auth_ref": [ "r770" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.", "label": "Deferred Tax Assets, Gross", "terseLabel": "Deferred Tax Assets, Gross" } } }, "localname": "DeferredTaxAssetsGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/IncomeTaxesIncomeTaxesDeferredTaxBalancesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsInventory": { "auth_ref": [ "r777", "r778" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from inventory.", "label": "Deferred Tax Assets, Inventory", "terseLabel": "Deferred Tax Assets, Inventory" } } }, "localname": "DeferredTaxAssetsInventory", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/IncomeTaxesIncomeTaxesDeferredTaxBalancesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsInvestments": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from investments (excludes investments in subsidiaries and equity method investments).", "label": "Deferred Tax Assets, Investments", "terseLabel": "Deferred Tax Assets, Investments" } } }, "localname": "DeferredTaxAssetsInvestments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/IncomeTaxesIncomeTaxesDeferredTaxBalancesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsNet": { "auth_ref": [ "r772" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.", "label": "Deferred Tax Assets, Net of Valuation Allowance", "terseLabel": "Deferred Tax Assets, Net of Valuation Allowance" } } }, "localname": "DeferredTaxAssetsNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/IncomeTaxesIncomeTaxesDeferredTaxBalancesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": { "auth_ref": [ "r777", "r778" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.", "label": "Deferred Tax Assets, Operating Loss Carryforwards", "terseLabel": "Operating Loss Carryforwards" } } }, "localname": "DeferredTaxAssetsOperatingLossCarryforwards", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/IncomeTaxesIncomeTaxesOperatingLossandTaxCreditCarryforwardsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic": { "auth_ref": [ "r777", "r778" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible domestic operating loss carryforwards. Excludes state and local operating loss carryforwards.", "label": "Deferred Tax Assets, Operating Loss Carryforwards, Domestic", "terseLabel": "Deferred Tax Assets, Operating Loss Carryforwards, Domestic" } } }, "localname": "DeferredTaxAssetsOperatingLossCarryforwardsDomestic", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/IncomeTaxesIncomeTaxesDeferredTaxBalancesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsOther": { "auth_ref": [ "r777", "r778" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.", "label": "Deferred Tax Assets, Other", "terseLabel": "Deferred Tax Assets, Other" } } }, "localname": "DeferredTaxAssetsOther", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/IncomeTaxesIncomeTaxesDeferredTaxBalancesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from property, plant, and equipment.", "label": "Deferred Tax Assets, Property, Plant and Equipment", "terseLabel": "Deferred Tax Assets, Property, Plant and Equipment" } } }, "localname": "DeferredTaxAssetsPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/IncomeTaxesIncomeTaxesDeferredTaxBalancesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsTaxCreditCarryforwards": { "auth_ref": [ "r775", "r777", "r778" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards.", "label": "Deferred Tax Assets, Tax Credit Carryforwards", "terseLabel": "Tax Credit Carryforwards" } } }, "localname": "DeferredTaxAssetsTaxCreditCarryforwards", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/IncomeTaxesIncomeTaxesOperatingLossandTaxCreditCarryforwardsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits": { "auth_ref": [ "r777", "r778" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from compensation and benefits costs.", "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits", "terseLabel": "Deferred Tax Assets, Accrued Employee Benefits" } } }, "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/IncomeTaxesIncomeTaxesDeferredTaxBalancesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther": { "auth_ref": [ "r777", "r778" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from reserves and accruals, classified as other.", "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Other", "terseLabel": "Deferred Tax Assets, Other Accruals and Reversals" } } }, "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/IncomeTaxesIncomeTaxesDeferredTaxBalancesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses": { "auth_ref": [ "r777", "r778" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from unrealized losses on foreign currency transactions.", "label": "Deferred Tax Assets, Unrealized Currency Losses", "terseLabel": "Unrealized Exchange Gains / Losses" } } }, "localname": "DeferredTaxAssetsUnrealizedCurrencyLosses", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/IncomeTaxesIncomeTaxesDeferredTaxBalancesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsValuationAllowance": { "auth_ref": [ "r771" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.", "label": "Deferred Tax Assets, Valuation Allowance", "terseLabel": "Deferred Tax Assets, Valuation Allowance" } } }, "localname": "DeferredTaxAssetsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/IncomeTaxesIncomeTaxesDeferredTaxBalancesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilities": { "auth_ref": [ "r753", "r772" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.", "label": "Deferred Tax Liabilities, Net", "terseLabel": "Net Deferred Tax Liability" } } }, "localname": "DeferredTaxLiabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/IncomeTaxesIncomeTaxesDeferredTaxBalancesDetails", "http://www.corteva.com/role/StockholdersEquityNoncontrollingInterestDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts": { "auth_ref": [ "r777", "r778" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax consequences attributable to taxable temporary differences derived from inventory.", "label": "Deferred Tax Liabilities, Inventory", "terseLabel": "Deferred Tax Liabilities, Inventory" } } }, "localname": "DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/IncomeTaxesIncomeTaxesDeferredTaxBalancesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets": { "auth_ref": [ "r777", "r778" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from intangible assets including goodwill.", "label": "Deferred Tax Liabilities, Goodwill and Intangible Assets", "terseLabel": "Deferred Tax Liabilities, Intangible Assets" } } }, "localname": "DeferredTaxLiabilitiesGoodwillAndIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/IncomeTaxesIncomeTaxesDeferredTaxBalancesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilitiesInvestments": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from investments (excludes investments in subsidiaries and equity method investments).", "label": "Deferred Tax Liabilities, Investments", "terseLabel": "Deferred Tax Liabilities, Investments" } } }, "localname": "DeferredTaxLiabilitiesInvestments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/IncomeTaxesIncomeTaxesDeferredTaxBalancesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilitiesOther": { "auth_ref": [ "r777", "r778" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences classified as other.", "label": "Deferred Tax Liabilities, Other", "terseLabel": "Deferred Tax Liabilities, Other" } } }, "localname": "DeferredTaxLiabilitiesOther", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/IncomeTaxesIncomeTaxesDeferredTaxBalancesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment": { "auth_ref": [ "r777", "r778" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.", "label": "Deferred Tax Liabilities, Property, Plant and Equipment", "terseLabel": "Deferred Tax Liabilities, Property" } } }, "localname": "DeferredTaxLiabilitiesPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/IncomeTaxesIncomeTaxesDeferredTaxBalancesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilitiesUnrealizedCurrencyTransactionGains": { "auth_ref": [ "r777", "r778" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from unrealized gains on foreign currency transactions.", "label": "Deferred Tax Liabilities, Unrealized Currency Transaction Gains", "terseLabel": "Deferred Tax Liabilities, Unrealized Exchange Gains/Losses" } } }, "localname": "DeferredTaxLiabilitiesUnrealizedCurrencyTransactionGains", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/IncomeTaxesIncomeTaxesDeferredTaxBalancesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation": { "auth_ref": [ "r631" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of actuarial present value of benefits attributed to employee service rendered, excluding assumptions about future compensation level.", "label": "Defined Benefit Plan, Accumulated Benefit Obligation", "terseLabel": "Defined Benefit Plan, Accumulated Benefit Obligation" } } }, "localname": "DefinedBenefitPlanAccumulatedBenefitObligation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansAmountsRecognizedinConsolidatedBalanceSheetsDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansChangeinProjectedBenefitObligationsPlanAssetsandFundedStatusDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanAccumulatedBenefitObligationIncreaseDecreaseForPlanAmendment": { "auth_ref": [ "r654" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in accumulated benefit obligation from change in existing term of defined benefit plan or initiation of new defined benefit plan.", "label": "Defined Benefit Plan, Accumulated Benefit Obligation, Increase (Decrease) for Plan Amendment", "terseLabel": "Defined Benefit Plan, Accumulated Benefit Obligation, Increase (Decrease) for Plan Amendment" } } }, "localname": "DefinedBenefitPlanAccumulatedBenefitObligationIncreaseDecreaseForPlanAmendment", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax": { "auth_ref": [ "r128", "r134", "r643" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before tax, of accumulated other comprehensive (income) loss for defined benefit plan, that has not been recognized in net periodic benefit cost (credit).", "label": "Defined Benefit Plan, Accumulated Other Comprehensive (Income) Loss, before Tax", "terseLabel": "Pretax balance in accumulated other comprehensive (income) loss at end of year" } } }, "localname": "DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansAmountsRecognizedinConsolidatedBalanceSheetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax": { "auth_ref": [ "r134", "r643" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, before tax, of accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.", "label": "Defined Benefit Plan, Accumulated Other Comprehensive Income (Loss), Gain (Loss), before Tax", "terseLabel": "Net loss (gain)" } } }, "localname": "DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansAmountsRecognizedinConsolidatedBalanceSheetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax": { "auth_ref": [ "r134", "r643" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before tax, of accumulated other comprehensive (income) loss for cost (credit) of benefit change attributable to participants' prior service from plan amendment or plan initiation of defined benefit plan, that has not been recognized in net periodic benefit cost (credit).", "label": "Defined Benefit Plan, Accumulated Other Comprehensive (Income) Loss, Prior Service Cost (Credit), before Tax", "terseLabel": "Prior service (benefit) cost" } } }, "localname": "DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansAmountsRecognizedinConsolidatedBalanceSheetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets": { "auth_ref": [ "r612", "r673" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in plan assets of defined benefit plan from actual return (loss) determined by change in fair value of plan assets adjusted for contributions, benefit payments, and other expenses.", "label": "Defined Benefit Plan, Plan Assets, Increase (Decrease) for Actual Return (Loss)", "terseLabel": "Actual return on plan assets" } } }, "localname": "DefinedBenefitPlanActualReturnOnPlanAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansChangeinProjectedBenefitObligationsPlanAssetsandFundedStatusDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanActualReturnOnPlanAssetsSoldDuringPeriod": { "auth_ref": [ "r627", "r673" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, measured using unobservable inputs, of increase (decrease) in plan assets of defined benefit plan from actual return (loss) on assets sold.", "label": "Defined Benefit Plan, Plan Assets Level 3 Reconciliation, Increase (Decrease) for Actual Return (Loss) on Plan Assets Sold", "terseLabel": "Actual Return (Loss) on Plan Assets Sold" } } }, "localname": "DefinedBenefitPlanActualReturnOnPlanAssetsSoldDuringPeriod", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansSummaryofFairValueMeasurementofLevel3PensionPlanAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld": { "auth_ref": [ "r627", "r673" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, measured using unobservable inputs, of increase (decrease) in plan assets of defined benefit plan from actual return (loss) on assets still held.", "label": "Defined Benefit Plan, Plan Assets Level 3 Reconciliation, Increase (Decrease) for Actual Return (Loss) on Plan Assets Still Held", "terseLabel": "Actual Return (Loss) on Plan Assets Still Held" } } }, "localname": "DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansSummaryofFairValueMeasurementofLevel3PensionPlanAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanActuarialGainLoss": { "auth_ref": [ "r605" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) from change in actuarial assumptions which (increases) decreases benefit obligation of defined benefit plan. Assumptions include, but are not limited to, interest, mortality, employee turnover, salary, and temporary deviation from substantive plan.", "label": "Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss)", "terseLabel": "Actuarial (gain) loss" } } }, "localname": "DefinedBenefitPlanActuarialGainLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansChangeinProjectedBenefitObligationsPlanAssetsandFundedStatusDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses": { "auth_ref": [ "r598", "r638", "r667", "r673", "r674" ], "calculation": { "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansComponentsofnetperiodicbenefitcostcreditandamountsrecognizedinothercomprehensivelossDetails": { "order": 4.0, "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit of defined benefit plan.", "label": "Defined Benefit Plan, Amortization of Gain (Loss)", "negatedTerseLabel": "Amortization of unrecognized loss (gain)" } } }, "localname": "DefinedBenefitPlanAmortizationOfGainsLosses", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansComponentsofnetperiodicbenefitcostcreditandamountsrecognizedinothercomprehensivelossDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit": { "auth_ref": [ "r598", "r639", "r668", "r673", "r674" ], "calculation": { "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansComponentsofnetperiodicbenefitcostcreditandamountsrecognizedinothercomprehensivelossDetails": { "order": 5.0, "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of prior service cost (credit) recognized in net periodic benefit cost (credit) of defined benefit plan.", "label": "Defined Benefit Plan, Amortization of Prior Service Cost (Credit)", "terseLabel": "Amortization of prior service benefit" } } }, "localname": "DefinedBenefitPlanAmortizationOfPriorServiceCostCredit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansComponentsofnetperiodicbenefitcostcreditandamountsrecognizedinothercomprehensivelossDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanAmountOfEmployerAndRelatedPartySecuritiesIncludedInPlanAssets": { "auth_ref": [ "r650", "r673" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of employer security in which defined benefit plan asset is invested. Includes, but is not limited to, security issued or managed by related party of employer.", "label": "Defined Benefit Plan, Plan Assets, Employer, Related Party, Amount", "terseLabel": "Amount of Employer and Related Party Securities Included in Plan Assets" } } }, "localname": "DefinedBenefitPlanAmountOfEmployerAndRelatedPartySecuritiesIncludedInPlanAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansBasisofFairValueMeasurementDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet": { "auth_ref": [ "r596", "r620" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset (liability), recognized in statement of financial position, for defined benefit pension and other postretirement plans.", "label": "Defined Benefit Plan, Amounts for Asset (Liability) Recognized in Statement of Financial Position", "terseLabel": "Net amount recognized" } } }, "localname": "DefinedBenefitPlanAmountsRecognizedInBalanceSheet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansAmountsRecognizedinConsolidatedBalanceSheetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent": { "auth_ref": [ "r54", "r596", "r597", "r620", "r673", "r1014", "r1053" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset, recognized in statement of financial position, for overfunded defined benefit pension and other postretirement plans.", "label": "Assets for Plan Benefits, Defined Benefit Plan", "terseLabel": "Other Assets" } } }, "localname": "DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansAmountsRecognizedinConsolidatedBalanceSheetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate": { "auth_ref": [ "r645" ], "lang": { "en-us": { "role": { "documentation": "Weighted average rate for present value of future retirement benefits cash flows, used to determine benefit obligation of defined benefit plan.", "label": "Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Discount Rate", "terseLabel": "Discount Rate" } } }, "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansWeightedAverageAssumptionsusedtoDetermineBenefitObligationsPensionDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansWeightedAverageAssumptionsusedtoDetermineBenefitObligationsandPeriodicBenefitCostOPEBDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease": { "auth_ref": [ "r646" ], "lang": { "en-us": { "role": { "documentation": "Weighted average rate increase of compensation, used to determine benefit obligation of defined benefit plan. Plan includes, but is not limited to, pay-related defined benefit plan.", "label": "Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Rate of Compensation Increase", "terseLabel": "Rate of increase in future compensation levels" } } }, "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansWeightedAverageAssumptionsusedtoDetermineBenefitObligationsPensionDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate": { "auth_ref": [ "r645" ], "lang": { "en-us": { "role": { "documentation": "Weighted average rate for present value of future retirement benefits cash flows, used to determine net periodic benefit cost of defined benefit plan.", "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate", "terseLabel": "Net Periodic Benefit, Discount Rate" } } }, "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansWeightedAverageAssumptionsusedtoDetermineBenefitObligationsandPeriodicBenefitCostOPEBDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansWeightedAverageAssumptionsusedtoDetermineNetPeriodicBenefitCostPensionDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets": { "auth_ref": [ "r647", "r672" ], "lang": { "en-us": { "role": { "documentation": "Weighted average rate of return on plan assets, reflecting average rate of earnings expected on existing plan assets and expected contributions, used to determine net periodic benefit cost of defined benefit plan.", "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-term Rate of Return on Plan Assets", "terseLabel": "Expected long-term rate of return on plan assets" } } }, "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansAdditionalInformationDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansWeightedAverageAssumptionsusedtoDetermineNetPeriodicBenefitCostPensionDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease": { "auth_ref": [ "r646" ], "lang": { "en-us": { "role": { "documentation": "Weighted average rate of compensation increase used to determine net periodic benefit cost of defined benefit plan. Plan includes, but is not limited to, pay-related defined benefit plan.", "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Rate of Compensation Increase", "terseLabel": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Rate of Compensation Increase" } } }, "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansWeightedAverageAssumptionsusedtoDetermineNetPeriodicBenefitCostPensionDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DefinedBenefitPlanBenefitObligation": { "auth_ref": [ "r600" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.", "label": "Defined Benefit Plan, Benefit Obligation", "periodEndLabel": "Benefit obligation at end of the period", "periodStartLabel": "Benefit obligation at beginning of the period" } } }, "localname": "DefinedBenefitPlanBenefitObligation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansChangeinProjectedBenefitObligationsPlanAssetsandFundedStatusDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid": { "auth_ref": [ "r607", "r677" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of payment to participant of defined benefit plan which decreases benefit obligation. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.", "label": "Defined Benefit Plan, Benefit Obligation, Benefits Paid", "terseLabel": "Benefits Paid" } } }, "localname": "DefinedBenefitPlanBenefitObligationBenefitsPaid", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansChangeinProjectedBenefitObligationsPlanAssetsandFundedStatusDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant": { "auth_ref": [ "r604" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of contributions received by defined benefit plan from participant which increase benefit obligation.", "label": "Defined Benefit Plan, Benefit Obligation, Contributions by Plan Participant", "terseLabel": "Plan participants' contributions" } } }, "localname": "DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansChangeinProjectedBenefitObligationsPlanAssetsandFundedStatusDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis": { "auth_ref": [ "r622", "r623", "r625", "r626", "r627", "r628", "r629", "r630", "r650", "r673" ], "lang": { "en-us": { "role": { "documentation": "Information by defined benefit plan asset investment.", "label": "Defined Benefit Plan, Plan Assets, Category [Axis]", "terseLabel": "Defined Benefit Plan, Plan Assets, Category [Axis]" } } }, "localname": "DefinedBenefitPlanByPlanAssetCategoriesAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansAdditionalInformationDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansBasisofFairValueMeasurementDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansSummaryofFairValueMeasurementofLevel3PensionPlanAssetsDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansTargetAllocationforPlanAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DefinedBenefitPlanContributionsByEmployer": { "auth_ref": [ "r614", "r623", "r625", "r671", "r673", "r674" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of contribution received by defined benefit plan from employer which increases plan assets.", "label": "Defined Benefit Plan, Plan Assets, Contributions by Employer", "terseLabel": "Employer contributions" } } }, "localname": "DefinedBenefitPlanContributionsByEmployer", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansAdditionalInformationDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansChangeinProjectedBenefitObligationsPlanAssetsandFundedStatusDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanDisclosureLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Defined Benefit Plan Disclosure [Line Items]", "terseLabel": "Defined Benefit Plan Disclosure [Line Items]", "verboseLabel": "Defined Benefit and Contribution Disclosures [Line Items]" } } }, "localname": "DefinedBenefitPlanDisclosureLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansAdditionalInformationDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansBasisofFairValueMeasurementDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansSummaryofFairValueMeasurementofLevel3PensionPlanAssetsDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansTargetAllocationforPlanAssetsDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansWeightedAverageAssumptionsusedtoDetermineBenefitObligationsPensionDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansWeightedAverageAssumptionsusedtoDetermineNetPeriodicBenefitCostPensionDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Defined Benefit Plan, Expected Future Benefit Payment [Abstract]", "terseLabel": "Defined Benefit Plan, Expected Future Benefit Payment [Abstract]" } } }, "localname": "DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansAdditionalInformationDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansEstimatedFutureBenefitPaymentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter": { "auth_ref": [ "r632" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of benefit for defined benefit plan expected to be paid in five fiscal years after fifth fiscal year following current fiscal year.", "label": "Defined Benefit Plan, Expected Future Benefit Payment, after Year Five for Next Five Years", "terseLabel": "2025-2029" } } }, "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansEstimatedFutureBenefitPaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths": { "auth_ref": [ "r632" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of benefit for defined benefit plan expected to be paid in next fiscal year following current fiscal year.", "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year One", "terseLabel": "2020" } } }, "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansEstimatedFutureBenefitPaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive": { "auth_ref": [ "r632" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of benefit for defined benefit plan expected to be paid in fifth fiscal year following current fiscal year.", "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Five", "terseLabel": "2024" } } }, "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansEstimatedFutureBenefitPaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour": { "auth_ref": [ "r632" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of benefit for defined benefit plan expected to be paid in fourth fiscal year following current fiscal year.", "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Four", "terseLabel": "2023" } } }, "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansEstimatedFutureBenefitPaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree": { "auth_ref": [ "r632" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of benefit for defined benefit plan expected to be paid in third fiscal year following current fiscal year.", "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Three", "terseLabel": "2022" } } }, "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansEstimatedFutureBenefitPaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo": { "auth_ref": [ "r632" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of benefit for defined benefit plan expected to be paid in second fiscal year following current fiscal year.", "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Two", "terseLabel": "2021" } } }, "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansAdditionalInformationDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansEstimatedFutureBenefitPaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear": { "auth_ref": [ "r633", "r674" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of contribution expected to be received by defined benefit plan from employer in next fiscal year following current fiscal year.", "label": "Defined Benefit Plan, Expected Future Employer Contributions, Next Fiscal Year", "terseLabel": "Expected Future Employer Contributions, Next Fiscal Year" } } }, "localname": "DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets": { "auth_ref": [ "r598", "r637", "r666", "r673", "r674" ], "calculation": { "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansComponentsofnetperiodicbenefitcostcreditandamountsrecognizedinothercomprehensivelossDetails": { "order": 3.0, "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.", "label": "Defined Benefit Plan, Expected Return (Loss) on Plan Assets", "negatedTerseLabel": "Expected return on plan assets" } } }, "localname": "DefinedBenefitPlanExpectedReturnOnPlanAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansComponentsofnetperiodicbenefitcostcreditandamountsrecognizedinothercomprehensivelossDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanFairValueOfPlanAssets": { "auth_ref": [ "r611", "r623", "r625", "r626", "r673" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.", "label": "Defined Benefit Plan, Plan Assets, Amount", "periodEndLabel": "Fair value of plan assets at end of period", "periodStartLabel": "Fair value of plan assets at beginning of period", "terseLabel": "Fair value of plan assets" } } }, "localname": "DefinedBenefitPlanFairValueOfPlanAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansBasisofFairValueMeasurementDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansChangeinProjectedBenefitObligationsPlanAssetsandFundedStatusDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansSummaryofFairValueMeasurementofLevel3PensionPlanAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation": { "auth_ref": [ "r606" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of foreign currency translation gain (loss) which (increases) decreases benefit obligation of defined benefit plan.", "label": "Defined Benefit Plan, Benefit Obligation, Foreign Currency Translation Gain (Loss)", "terseLabel": "Effect of foreign exchange rates" } } }, "localname": "DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansChangeinProjectedBenefitObligationsPlanAssetsandFundedStatusDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanFundedStatusOfPlan": { "auth_ref": [ "r596", "r620", "r673" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of funded (unfunded) status of defined benefit plan, measured as difference between fair value of plan assets and benefit obligation. Includes, but is not limited to, overfunded (underfunded) status.", "label": "Defined Benefit Plan, Funded (Unfunded) Status of Plan", "terseLabel": "Defined Benefit Plan, Unfunded Status of Plan", "verboseLabel": "Funded (unfunded) status of plan" } } }, "localname": "DefinedBenefitPlanFundedStatusOfPlan", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansAdditionalInformationDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansChangeinProjectedBenefitObligationsPlanAssetsandFundedStatusDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear": { "auth_ref": [ "r649" ], "lang": { "en-us": { "role": { "documentation": "Assumed rate, for next fiscal year, based on annual change in cost of health care cost benefits used to measure expected cost of benefits covered by defined benefit postretirement plan. Factors include, but are not limited to, estimate of health care inflation, change in health care utilization or delivery pattern, technological advances, and change in health status of participant. Excludes factors for change in composition of plan population by age and dependency status.", "label": "Defined Benefit Plan, Health Care Cost Trend Rate Assumed, Next Fiscal Year", "terseLabel": "Health care cost trend rate assumed for next year" } } }, "localname": "DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansAssumedHealthCareCostTrendRatesDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DefinedBenefitPlanInterestCost": { "auth_ref": [ "r598", "r603", "r636", "r665", "r673", "r674" ], "calculation": { "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansComponentsofnetperiodicbenefitcostcreditandamountsrecognizedinothercomprehensivelossDetails": { "order": 2.0, "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost recognized for passage of time related to defined benefit plan.", "label": "Defined Benefit Plan, Interest Cost", "terseLabel": "Interest Cost" } } }, "localname": "DefinedBenefitPlanInterestCost", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansChangeinProjectedBenefitObligationsPlanAssetsandFundedStatusDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansComponentsofnetperiodicbenefitcostcreditandamountsrecognizedinothercomprehensivelossDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost": { "auth_ref": [ "r634", "r663", "r673", "r674" ], "calculation": { "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansComponentsofnetperiodicbenefitcostcreditandamountsrecognizedinothercomprehensivelossDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of net periodic benefit cost (credit) for defined benefit plan.", "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit)", "totalLabel": "Net periodic benefit cost (credit)" } } }, "localname": "DefinedBenefitPlanNetPeriodicBenefitCost", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansComponentsofnetperiodicbenefitcostcreditandamountsrecognizedinothercomprehensivelossDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets": { "auth_ref": [ "r659", "r673" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of plan asset for defined benefit pension plan with projected benefit obligation in excess of plan assets.", "label": "Defined Benefit Plan, Pension Plan with Projected Benefit Obligation in Excess of Plan Assets, Plan Assets", "terseLabel": "Fair Value of plan assets" } } }, "localname": "DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansPensionPlanswithProjectedBenefitObligationsinExcessofPlanAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation": { "auth_ref": [ "r659", "r660", "r673" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated benefit obligation for defined benefit plan with accumulated benefit obligation in excess of plan assets.", "label": "Defined Benefit Plan, Plan with Accumulated Benefit Obligation in Excess of Plan Assets, Accumulated Benefit Obligation", "terseLabel": "Accumulated benefit obligations" } } }, "localname": "DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansPensionPlanswithAccumulatedBenefitObligationsinExcessofPlanAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets": { "auth_ref": [ "r659", "r660", "r673" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of plan asset for defined benefit plan with accumulated benefit obligation in excess of plan assets.", "label": "Defined Benefit Plan, Plan with Accumulated Benefit Obligation in Excess of Plan Assets, Plan Assets", "terseLabel": "Fair value of plan assets" } } }, "localname": "DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansPensionPlanswithAccumulatedBenefitObligationsinExcessofPlanAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanPlanAmendments": { "auth_ref": [ "r608" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in benefit obligation of defined benefit plan from change in terms of existing plan or initiation of new plan.", "label": "Defined Benefit Plan, Benefit Obligation, Increase (Decrease) for Plan Amendment", "terseLabel": "Plan amendments" } } }, "localname": "DefinedBenefitPlanPlanAmendments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansChangeinProjectedBenefitObligationsPlanAssetsandFundedStatusDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid": { "auth_ref": [ "r616", "r677" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of payment to participant under defined benefit plan which decreases plan assets. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.", "label": "Defined Benefit Plan, Plan Assets, Benefits Paid", "verboseLabel": "Benefits paid" } } }, "localname": "DefinedBenefitPlanPlanAssetsBenefitsPaid", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansChangeinProjectedBenefitObligationsPlanAssetsandFundedStatusDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant": { "auth_ref": [ "r615" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of contributions received by defined benefit plan from participant which increases plan assets.", "label": "Defined Benefit Plan, Plan Assets, Contributions by Plan Participant", "terseLabel": "Plan participants' contributions" } } }, "localname": "DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansChangeinProjectedBenefitObligationsPlanAssetsandFundedStatusDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss": { "auth_ref": [ "r613" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) plan assets of defined benefit plan.", "label": "Defined Benefit Plan, Plan Assets, Foreign Currency Translation Gain (Loss)", "terseLabel": "Effect of foreign exchange rates" } } }, "localname": "DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansChangeinProjectedBenefitObligationsPlanAssetsandFundedStatusDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage": { "auth_ref": [ "r622", "r673" ], "lang": { "en-us": { "role": { "documentation": "Percentage of target investment allocation to total plan assets. Includes, but is not limited to, percentage on weighted-average basis if more than one plan.", "label": "Defined Benefit Plan, Plan Assets, Target Allocation, Percentage", "terseLabel": "Target Allocation for plan assets" } } }, "localname": "DefinedBenefitPlanPlanAssetsTargetAllocationPercentage", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansTargetAllocationforPlanAssetsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DefinedBenefitPlanPurchasesSalesAndSettlements": { "auth_ref": [ "r628", "r673" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, measured using unobservable input, of increase (decrease) in plan asset of defined benefit plan from purchase, sale and settlement of trade associated with underlying investment.", "label": "Defined Benefit Plan, Plan Assets Level 3 Reconciliation, Increase (Decrease) for Purchase, Sale, and Settlement", "terseLabel": "Purchases, Sales, and Settlements" } } }, "localname": "DefinedBenefitPlanPurchasesSalesAndSettlements", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansSummaryofFairValueMeasurementofLevel3PensionPlanAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments": { "auth_ref": [ "r599", "r641", "r670" ], "calculation": { "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansComponentsofnetperiodicbenefitcostcreditandamountsrecognizedinothercomprehensivelossDetails": { "order": 6.0, "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit from event reducing expected years of future service of present employees or eliminating accrual of defined benefits for some or all future services of present employees.", "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Curtailment", "negatedTerseLabel": "Curtailment gain" } } }, "localname": "DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansComponentsofnetperiodicbenefitcostcreditandamountsrecognizedinothercomprehensivelossDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1": { "auth_ref": [ "r599", "r641", "r670" ], "calculation": { "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansComponentsofnetperiodicbenefitcostcreditandamountsrecognizedinothercomprehensivelossDetails": { "order": 7.0, "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit from irrevocable action relieving primary responsibility for benefit obligation and eliminating risk related to obligation and assets used to effect settlement.", "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement", "negatedTerseLabel": "Settlement loss" } } }, "localname": "DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansComponentsofnetperiodicbenefitcostcreditandamountsrecognizedinothercomprehensivelossDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanServiceCost": { "auth_ref": [ "r601", "r635", "r664", "r673", "r674" ], "calculation": { "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansComponentsofnetperiodicbenefitcostcreditandamountsrecognizedinothercomprehensivelossDetails": { "order": 1.0, "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.", "label": "Defined Benefit Plan, Service Cost", "terseLabel": "Service Cost" } } }, "localname": "DefinedBenefitPlanServiceCost", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansChangeinProjectedBenefitObligationsPlanAssetsandFundedStatusDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansComponentsofnetperiodicbenefitcostcreditandamountsrecognizedinothercomprehensivelossDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanTransfersBetweenMeasurementLevels": { "auth_ref": [ "r629", "r673" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, measured using unobservable inputs, of increase (decrease) in plan assets of defined benefit plan, for assets transferred into (out of) Level 3 of fair value hierarchy. Includes, but is not limited to, transfer due to change in observability of significant inputs.", "label": "Defined Benefit Plan, Plan Assets Level 3 Reconciliation, Increase (Decrease) for Assets Transferred into (out of) Level 3", "terseLabel": "Assets Transferred into (out of) Level 3" } } }, "localname": "DefinedBenefitPlanTransfersBetweenMeasurementLevels", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansSummaryofFairValueMeasurementofLevel3PensionPlanAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate1": { "auth_ref": [ "r649" ], "lang": { "en-us": { "role": { "documentation": "Ultimate trend rate for health care cost for defined benefit postretirement plan.", "label": "Defined Benefit Plan, Ultimate Health Care Cost Trend Rate", "terseLabel": "Defined Benefit Plan, Ultimate Health Care Cost Trend Rate" } } }, "localname": "DefinedBenefitPlanUltimateHealthCareCostTrendRate1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansAssumedHealthCareCostTrendRatesDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DefinedBenefitPlanYearHealthCareCostTrendRateReachesUltimateTrendRate": { "auth_ref": [ "r649" ], "lang": { "en-us": { "role": { "documentation": "Year ultimate health care cost trend rate is expected to be reached, in YYYY format.", "label": "Defined Benefit Plan, Year Health Care Cost Trend Rate Reaches Ultimate Trend Rate", "terseLabel": "Year that the rate reached the ultimate health care cost trend rate" } } }, "localname": "DefinedBenefitPlanYearHealthCareCostTrendRateReachesUltimateTrendRate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansAssumedHealthCareCostTrendRatesDetails" ], "xbrltype": "gYearListItemType" }, "us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable": { "auth_ref": [ "r657", "r658", "r661", "r662", "r673" ], "lang": { "en-us": { "role": { "documentation": "Disclosures and provisions pertaining to defined benefit pension plans or other postretirement defined benefit plans. The arrangements are generally based on terms and conditions stipulated by the entity, and which contain a promise by the employer to pay certain amounts or awards at designated future dates, including a period after retirement, upon compliance with stipulated requirements. Excludes disclosures pertaining to defined contribution plans.", "label": "Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Table]", "terseLabel": "Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Table]" } } }, "localname": "DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansAmountsRecognizedinConsolidatedBalanceSheetsDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansAssumedHealthCareCostTrendRatesDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansChangeinProjectedBenefitObligationsPlanAssetsandFundedStatusDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansComponentsofnetperiodicbenefitcostcreditandamountsrecognizedinothercomprehensivelossDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansEstimatedFutureBenefitPaymentsDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansPensionPlanswithAccumulatedBenefitObligationsinExcessofPlanAssetsDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansPensionPlanswithProjectedBenefitObligationsinExcessofPlanAssetsDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansWeightedAverageAssumptionsusedtoDetermineBenefitObligationsandPeriodicBenefitCostOPEBDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]", "terseLabel": "Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]" } } }, "localname": "DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansAmountsRecognizedinConsolidatedBalanceSheetsDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansAssumedHealthCareCostTrendRatesDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansChangeinProjectedBenefitObligationsPlanAssetsandFundedStatusDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansComponentsofnetperiodicbenefitcostcreditandamountsrecognizedinothercomprehensivelossDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansEstimatedFutureBenefitPaymentsDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansPensionPlanswithAccumulatedBenefitObligationsinExcessofPlanAssetsDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansPensionPlanswithProjectedBenefitObligationsinExcessofPlanAssetsDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansWeightedAverageAssumptionsusedtoDetermineBenefitObligationsandPeriodicBenefitCostOPEBDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of discretionary contributions made by an employer to a defined contribution plan.", "label": "Defined Contribution Plan, Employer Discretionary Contribution Amount", "terseLabel": "Defined Contribution Plan, Employer Contribution" } } }, "localname": "DefinedContributionPlanEmployerDiscretionaryContributionAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of employees' gross pay for which the employer contributes a matching contribution to a defined contribution plan.", "label": "Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay", "terseLabel": "Employer Matching Contribution, Percent of Employees' Gross Pay" } } }, "localname": "DefinedContributionPlanEmployerMatchingContributionPercent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage employer matches of the employee's percentage contribution matched.", "label": "Defined Contribution Plan, Employer Matching Contribution, Percent of Match", "terseLabel": "Employer Matching Contribution, Percent of Match" } } }, "localname": "DefinedContributionPlanEmployerMatchingContributionPercentOfMatch", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_Depreciation": { "auth_ref": [ "r193", "r421" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.", "label": "Depreciation", "terseLabel": "Depreciation expense" } } }, "localname": "Depreciation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/PropertyPlantandEquipmentScheduleofDepreciationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationDepletionAndAmortization": { "auth_ref": [ "r193", "r301" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.", "label": "Depreciation, Depletion and Amortization", "terseLabel": "Depreciation and Amortization" } } }, "localname": "DepreciationDepletionAndAmortization", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/ConsolidatedStatementsofCashFlows", "http://www.corteva.com/role/EIDSegmentFNSegmentReconciliationDetails", "http://www.corteva.com/role/SegmentReportingOtherItemsDetails", "http://www.corteva.com/role/SegmentReportingSegmentInformationDetails", "http://www.corteva.com/role/SegmentReportingSegmentReconciliationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerecognizedAssetsSecuritizedOrAssetbackedFinancingArrangementAssetsAndAnyOtherFinancialAssetsManagedTogetherPrincipalAmountOutstanding": { "auth_ref": [ "r967" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of transferred financial assets in which the transferor has continuing involvement with the assets underlying the transaction that have been derecognized. Continuing involvement includes, but is not limited to, servicing, recourse, and restrictions on transferor's interests in transferred financial assets.", "label": "Continuing Involvement with Derecognized Transferred Financial Assets, Amount Outstanding", "terseLabel": "Continuing Involvement with Derecognized Transferred Financial Assets, Amount Outstanding" } } }, "localname": "DerecognizedAssetsSecuritizedOrAssetbackedFinancingArrangementAssetsAndAnyOtherFinancialAssetsManagedTogetherPrincipalAmountOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/AccountsandNotesReceivableNetCustomerFinancingDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement": { "auth_ref": [ "r111", "r117" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and elected not to be offset.", "label": "Derivative Asset, Fair Value, Gross Asset Including Not Subject to Master Netting Arrangement", "terseLabel": "Derivative Asset, Foreign Currency", "verboseLabel": "Derivative Asset, Gross" } } }, "localname": "DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/FairValueMeasurementsFairValueMeasurementRecurringBasisDetails", "http://www.corteva.com/role/FinancialInstrumentsFairValueofDerivativesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeAssetFairValueGrossLiabilityAndObligationToReturnCashOffset": { "auth_ref": [ "r112", "r116", "r118", "r845" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of liability associated with financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, and obligation to return cash collateral under master netting arrangements.", "label": "Derivative Asset, Fair Value, Gross Liability and Obligation to Return Cash, Offset", "terseLabel": "Derivative Asset, Counterparty and Cash Collateral Netting" } } }, "localname": "DerivativeAssetFairValueGrossLiabilityAndObligationToReturnCashOffset", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/FinancialInstrumentsFairValueofDerivativesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeAssets": { "auth_ref": [ "r113", "r114", "r117", "r895" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.", "label": "Derivative Asset", "terseLabel": "Derivative Asset, Net" } } }, "localname": "DerivativeAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/FinancialInstrumentsFairValueofDerivativesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeContractTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.", "label": "Derivative Contract [Domain]", "terseLabel": "Derivative Contract [Domain]" } } }, "localname": "DerivativeContractTypeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/FairValueMeasurementsFairValueMeasurementNonrecurringBasisDetails", "http://www.corteva.com/role/FairValueMeasurementsFairValueMeasurementRecurringBasisDetails", "http://www.corteva.com/role/FinancialInstrumentsCashFlowHedgesIncludedinAOCIDetails", "http://www.corteva.com/role/FinancialInstrumentsEffectofDerivativeInstrumentsDetails", "http://www.corteva.com/role/FinancialInstrumentsFairValueofDerivativesDetails", "http://www.corteva.com/role/FinancialInstrumentsNotionalAmountsDetails", "http://www.corteva.com/role/FinancialInstrumentsTables" ], "xbrltype": "domainItemType" }, "us-gaap_DerivativeGainLossOnDerivativeNet": { "auth_ref": [ "r856" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.", "label": "Derivative, Gain (Loss) on Derivative, Net", "terseLabel": "(Loss) Gain on Hedging Activity" } } }, "localname": "DerivativeGainLossOnDerivativeNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/FinancialInstrumentsEffectofDerivativeInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeInstrumentRiskAxis": { "auth_ref": [ "r117", "r855", "r858", "r863", "r868" ], "lang": { "en-us": { "role": { "documentation": "Information by type of derivative contract.", "label": "Derivative Instrument [Axis]", "terseLabel": "Derivative Instrument [Axis]" } } }, "localname": "DerivativeInstrumentRiskAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/FairValueMeasurementsFairValueMeasurementNonrecurringBasisDetails", "http://www.corteva.com/role/FairValueMeasurementsFairValueMeasurementRecurringBasisDetails", "http://www.corteva.com/role/FinancialInstrumentsCashFlowHedgesIncludedinAOCIDetails", "http://www.corteva.com/role/FinancialInstrumentsEffectofDerivativeInstrumentsDetails", "http://www.corteva.com/role/FinancialInstrumentsFairValueofDerivativesDetails", "http://www.corteva.com/role/FinancialInstrumentsNotionalAmountsDetails", "http://www.corteva.com/role/FinancialInstrumentsTables" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]", "terseLabel": "Derivative Instruments and Hedging Activities Disclosure [Abstract]" } } }, "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": { "auth_ref": [ "r852", "r855", "r863" ], "lang": { "en-us": { "role": { "documentation": "Information by type of hedging relationship.", "label": "Hedging Relationship [Axis]", "terseLabel": "Hedging Relationship [Axis]" } } }, "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/FinancialInstrumentsEffectofDerivativeInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable": { "auth_ref": [ "r852", "r855", "r863", "r868", "r869", "r873", "r874" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.", "label": "Derivative Instruments, Gain (Loss) [Table]", "terseLabel": "Derivative Instruments, Gain (Loss) [Table]" } } }, "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/FinancialInstrumentsCashFlowHedgesIncludedinAOCIDetails", "http://www.corteva.com/role/FinancialInstrumentsEffectofDerivativeInstrumentsDetails", "http://www.corteva.com/role/FinancialInstrumentsFairValueofDerivativesDetails", "http://www.corteva.com/role/FinancialInstrumentsNotionalAmountsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsGainLossLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Derivative Instruments, Gain (Loss) [Line Items]", "terseLabel": "Derivative Instruments, Gain (Loss) [Line Items]" } } }, "localname": "DerivativeInstrumentsGainLossLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/FinancialInstrumentsCashFlowHedgesIncludedinAOCIDetails", "http://www.corteva.com/role/FinancialInstrumentsEffectofDerivativeInstrumentsDetails", "http://www.corteva.com/role/FinancialInstrumentsFairValueofDerivativesDetails", "http://www.corteva.com/role/FinancialInstrumentsNotionalAmountsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet": { "auth_ref": [ "r861", "r867" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The effective portion of net gain (loss) reclassified from accumulated other comprehensive income into income on derivative instruments designated and qualifying as hedging instruments.", "label": "Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net", "terseLabel": "Clearance of hedge results to earnings" } } }, "localname": "DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/FinancialInstrumentsCashFlowHedgesIncludedinAOCIDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet": { "auth_ref": [ "r862", "r864" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of realized and unrealized gain (loss) of derivative instruments not designated or qualifying as hedging instruments.", "label": "Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net", "terseLabel": "Derivative Instruments Not Designated as Hedging Instruments, (Loss) Gain, Net" } } }, "localname": "DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/FinancialInstrumentsEffectofDerivativeInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeLiabilities": { "auth_ref": [ "r113", "r114", "r117", "r895" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.", "label": "Derivative Liability", "terseLabel": "Derivative Liability, Net" } } }, "localname": "DerivativeLiabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/FinancialInstrumentsFairValueofDerivativesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeLiabilityFairValueGrossAssetAndRightToReclaimCashOffset": { "auth_ref": [ "r112", "r116", "r118", "r845" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value of asset associated with financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, and right to receive cash collateral under master netting arrangements.", "label": "Derivative Liability, Fair Value, Gross Asset and Right to Reclaim Cash, Offset", "verboseLabel": "Derivative Liability, Counterparty and Cash Collateral Netting" } } }, "localname": "DerivativeLiabilityFairValueGrossAssetAndRightToReclaimCashOffset", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/FinancialInstrumentsFairValueofDerivativesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement": { "auth_ref": [ "r111", "r117" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and elected not to be offset.", "label": "Derivative Liability, Fair Value, Gross Liability Including Not Subject to Master Netting Arrangement", "terseLabel": "Derivative Liability, Foreign Currency", "verboseLabel": "Derivative Liability, Gross" } } }, "localname": "DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/FairValueMeasurementsFairValueMeasurementRecurringBasisDetails", "http://www.corteva.com/role/FinancialInstrumentsFairValueofDerivativesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Derivative [Line Items]", "terseLabel": "Derivative [Line items]" } } }, "localname": "DerivativeLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/FinancialInstrumentsTables" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeNotionalAmount": { "auth_ref": [ "r847", "r849" ], "lang": { "en-us": { "role": { "documentation": "Nominal or face amount used to calculate payment on derivative.", "label": "Derivative, Notional Amount", "terseLabel": "Derivative, Notional Amount" } } }, "localname": "DerivativeNotionalAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/FinancialInstrumentsCashFlowHedgesIncludedinAOCIDetails", "http://www.corteva.com/role/FinancialInstrumentsNotionalAmountsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeRemainingMaturity1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Period remaining until the derivative contract matures, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Derivative, Remaining Maturity", "terseLabel": "Derivative, Remaining Maturity" } } }, "localname": "DerivativeRemainingMaturity1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/FinancialInstrumentsCashFlowHedgesIncludedinAOCIDetails" ], "xbrltype": "durationItemType" }, "us-gaap_DerivativeTable": { "auth_ref": [ "r846", "r848", "r849", "r852", "r853", "r860", "r863", "r870", "r872", "r874", "r877" ], "lang": { "en-us": { "role": { "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.", "label": "Derivative [Table]", "terseLabel": "Derivative [Table]" } } }, "localname": "DerivativeTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/FinancialInstrumentsTables" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativesPolicyTextBlock": { "auth_ref": [ "r220", "r846", "r848", "r852", "r853", "r871" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities.", "label": "Derivatives, Policy [Policy Text Block]", "terseLabel": "Derivative Instruments" } } }, "localname": "DerivativesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_DesignatedAsHedgingInstrumentMember": { "auth_ref": [ "r852" ], "lang": { "en-us": { "role": { "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).", "label": "Designated as Hedging Instrument [Member]", "terseLabel": "Designated as Hedging Instrument [Member]" } } }, "localname": "DesignatedAsHedgingInstrumentMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/FinancialInstrumentsCashFlowHedgesIncludedinAOCIDetails", "http://www.corteva.com/role/FinancialInstrumentsEffectofDerivativeInstrumentsDetails", "http://www.corteva.com/role/FinancialInstrumentsFairValueofDerivativesDetails", "http://www.corteva.com/role/FinancialInstrumentsNotionalAmountsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DevelopedTechnologyRightsMember": { "auth_ref": [ "r813" ], "lang": { "en-us": { "role": { "documentation": "Rights to developed technology, which can include the right to develop, use, market, sell, or offer for sale products, compounds, or intellectual property.", "label": "Developed Technology Rights [Member]", "terseLabel": "Developed Technology Rights [Member]" } } }, "localname": "DevelopedTechnologyRightsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/GoodwillandOtherIntangibleAssetsOtherIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DisaggregationOfRevenueLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Disaggregation of Revenue [Line Items]", "terseLabel": "Disaggregation of Revenue [Line Items]" } } }, "localname": "DisaggregationOfRevenueLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/RevenueContractBalancesDetails", "http://www.corteva.com/role/RevenueDisaggregationofRevenueGeoDetails", "http://www.corteva.com/role/RevenueDisaggregationofRevenueProductsDetails", "http://www.corteva.com/role/RevenueTables" ], "xbrltype": "stringItemType" }, "us-gaap_DisaggregationOfRevenueTable": { "auth_ref": [ "r578", "r581", "r582", "r583", "r584", "r585", "r586", "r587" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.", "label": "Disaggregation of Revenue [Table]", "terseLabel": "Disaggregation of Revenue [Table]" } } }, "localname": "DisaggregationOfRevenueTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/RevenueContractBalancesDetails", "http://www.corteva.com/role/RevenueDisaggregationofRevenueGeoDetails", "http://www.corteva.com/role/RevenueDisaggregationofRevenueProductsDetails", "http://www.corteva.com/role/RevenueTables" ], "xbrltype": "stringItemType" }, "us-gaap_DisaggregationOfRevenueTableTextBlock": { "auth_ref": [ "r578" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.", "label": "Disaggregation of Revenue [Table Text Block]", "terseLabel": "Disaggregation of Revenue [Table Text Block]" } } }, "localname": "DisaggregationOfRevenueTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/RevenueTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": { "auth_ref": [ "r745" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for share-based payment arrangement.", "label": "Share-based Payment Arrangement [Text Block]", "terseLabel": "Share-based Payment Arrangement [Text Block]" } } }, "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/StockBasedCompensation" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-based Payment Arrangement [Abstract]", "terseLabel": "Share-based Payment Arrangement [Abstract]" } } }, "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax": { "auth_ref": [ "r11", "r13", "r15", "r29" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of gain (loss) not previously recognized resulting from the disposal of a discontinued operation.", "label": "Discontinued Operation, Gain (Loss) on Disposal of Discontinued Operation, Net of Tax", "terseLabel": "Discontinued Operation, Gain (Loss) on Disposal of Discontinued Operation, Net of Tax" } } }, "localname": "DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansComponentsofnetperiodicbenefitcostcreditandamountsrecognizedinothercomprehensivelossDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax": { "auth_ref": [ "r11", "r12", "r13", "r14", "r15", "r23", "r152", "r1069" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before tax of income (loss) from a discontinued operation. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.", "label": "Discontinued Operation, Income (Loss) from Discontinued Operation, before Income Tax", "terseLabel": "(Loss) Income from Discontinued Operation, before Income Tax", "verboseLabel": "Income (Loss) from Discontinued Operation, before Income Tax" } } }, "localname": "DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationChemoursDetails", "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationOtherPFOAMattersFayattevilleDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsDivestituresandOtherTransactionsDivestedAgBusinessResultsofOperationsDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsDivestituresandOtherTransactionsPChemResultsofOperationsDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsECPDivestitureDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsSPDivestitureDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare": { "auth_ref": [], "calculation": { "http://www.corteva.com/role/ConsolidatedStatementsofIncome": { "order": 2.0, "parentTag": "us-gaap_EarningsPerShareBasic", "weight": 1.0 }, "http://www.corteva.com/role/EarningsPerShareofCommonStockEPSCalculationBasicDetails": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation.", "label": "Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Basic Share", "terseLabel": "Basic earnings (loss) per share of common stock from discontinued operations" } } }, "localname": "DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/ConsolidatedStatementsofIncome", "http://www.corteva.com/role/EarningsPerShareofCommonStockEPSCalculationBasicDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare": { "auth_ref": [], "calculation": { "http://www.corteva.com/role/ConsolidatedStatementsofIncome": { "order": 2.0, "parentTag": "us-gaap_EarningsPerShareDiluted", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Per diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation.", "label": "Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Diluted Share", "terseLabel": "Diluted earnings (loss) per share of common stock from discontinued operations" } } }, "localname": "DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/ConsolidatedStatementsofIncome", "http://www.corteva.com/role/EarningsPerShareofCommonStockEPSCalculationDilutedDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation": { "auth_ref": [ "r12", "r13", "r14", "r15", "r23", "r29", "r754", "r789", "r798" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of tax expense (benefit) related to a discontinued operation. Includes, but is not limited to, tax expense (benefit) related to income (loss) from operations during the phase-out period, tax expense (benefit) related to gain (loss) on disposal, tax expense (benefit) related to gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and tax expense (benefit) related to adjustments of a prior period gain (loss) on disposal.", "label": "Discontinued Operation, Tax Effect of Discontinued Operation", "terseLabel": "Provision for (Benefit from) Income Taxes, Discontinued Operation", "verboseLabel": "Provision for Income Taxes, Discontinued Operation" } } }, "localname": "DiscontinuedOperationTaxEffectOfDiscontinuedOperation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/DivestituresandOtherTransactionsDivestituresandOtherTransactionsDivestedAgBusinessResultsofOperationsDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsDivestituresandOtherTransactionsPChemResultsofOperationsDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsECPDivestitureDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsSPDivestitureDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Discontinued Operations and Disposal Groups [Abstract]", "terseLabel": "Discontinued Operations and Disposal Groups [Abstract]" } } }, "localname": "DiscontinuedOperationsAndDisposalGroupsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_DiscontinuedOperationsDisposedOfBySaleMember": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "Component or group of components disposed of by sale and representing a strategic shift that has or will have a major effect on operations and financial results.", "label": "Discontinued Operations, Disposed of by Sale [Member]", "terseLabel": "Discontinued Operations, Disposed of by Sale [Member]" } } }, "localname": "DiscontinuedOperationsDisposedOfBySaleMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/DivestituresandOtherTransactionsDivestituresandOtherTransactionsDivestedAgBusinessResultsofOperationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DiscontinuedOperationsPolicyTextBlock": { "auth_ref": [ "r17", "r33" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for discontinued operations. Includes, but is not limited to, method of interest allocation to a discontinued operation.", "label": "Discontinued Operations, Policy [Policy Text Block]", "terseLabel": "Discontinued Operations, Policy [Policy Text Block]" } } }, "localname": "DiscontinuedOperationsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/BackgroundandBasisofPresentationPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisposalGroupClassificationAxis": { "auth_ref": [ "r28" ], "lang": { "en-us": { "role": { "documentation": "Information by disposal group classification.", "label": "Disposal Group Classification [Axis]", "terseLabel": "Disposal Group Classification [Axis]" } } }, "localname": "DisposalGroupClassificationAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/DivestituresandOtherTransactionsDivestituresandOtherTransactionsDivestedAgBusinessResultsofOperationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisposalGroupClassificationDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Component or group of components disposed of, including but not limited to, disposal group held-for-sale or disposed of by sale, disposed of by means other than sale, and discontinued operations.", "label": "Disposal Group Classification [Domain]", "terseLabel": "Disposal Group Classification [Domain]" } } }, "localname": "DisposalGroupClassificationDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/DivestituresandOtherTransactionsDivestituresandOtherTransactionsDivestedAgBusinessResultsofOperationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet": { "auth_ref": [ "r4", "r5", "r26", "r427" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount classified as accounts, notes and loans receivable attributable to disposal group held for sale or disposed of.", "label": "Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net", "terseLabel": "Accounts and notes receivable - net" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/DivestituresandOtherTransactionsECPDivestitureDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsSPDivestitureDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayable": { "auth_ref": [ "r4", "r5", "r26", "r427" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount classified as accounts payable attributable to disposal group held for sale or disposed of.", "label": "Disposal Group, Including Discontinued Operation, Accounts Payable", "terseLabel": "Accounts Payable" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationAccountsPayable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/DivestituresandOtherTransactionsECPDivestitureDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsSPDivestitureDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedIncomeTaxesPayable": { "auth_ref": [ "r4", "r5", "r26", "r420", "r427" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount classified as income tax obligations attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.", "label": "Disposal Group, Including Discontinued Operation, Accrued Income Tax Payable, Current", "terseLabel": "Income Taxes Payable" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationAccruedIncomeTaxesPayable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/DivestituresandOtherTransactionsSPDivestitureDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities": { "auth_ref": [ "r4", "r5", "r26", "r427" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount classified as accrued liabilities attributable to disposal group held for sale or disposed of.", "label": "Disposal Group, Including Discontinued Operation, Accrued Liabilities", "terseLabel": "Accrued and Other Current Liabilities" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/DivestituresandOtherTransactionsECPDivestitureDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsSPDivestitureDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent": { "auth_ref": [ "r4", "r5", "r26", "r28", "r32", "r417", "r427" ], "calculation": { "http://www.corteva.com/role/ConsolidatedBalanceSheets": { "order": 8.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount classified as assets attributable to disposal group held for sale or disposed of, expected to be disposed of after one year or the normal operating cycle, if longer.", "label": "Disposal Group, Including Discontinued Operation, Assets, Noncurrent", "terseLabel": "Total Non-Current Assets - Discontinued Operations" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/DivestituresandOtherTransactionsECPDivestitureDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsSPDivestitureDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents": { "auth_ref": [ "r4", "r5", "r26", "r427" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount classified as cash and cash equivalents attributable to disposal group held for sale or disposed of.", "label": "Disposal Group, Including Discontinued Operation, Cash and Cash Equivalents", "terseLabel": "Cash and Cash Equivalents", "verboseLabel": "Cash and Cash Equivalents of discontinued operations" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/DivestituresandOtherTransactionsECPDivestitureDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsSPDivestitureDetails", "http://www.corteva.com/role/SupplementaryInformationReconciliationofCashCashEquivalentsandRestrictedCashDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold": { "auth_ref": [ "r24", "r32" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of costs of goods sold attributable to disposal group, including, but not limited to, discontinued operation.", "label": "Disposal Group, Including Discontinued Operation, Costs of Goods Sold", "terseLabel": "Cost of Goods Sold" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/DivestituresandOtherTransactionsDivestituresandOtherTransactionsDivestedAgBusinessResultsofOperationsDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsECPDivestitureDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsSPDivestitureDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssetsNoncurrent": { "auth_ref": [ "r4", "r5", "r26", "r417", "r427" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount classified as deferred tax assets attributable to disposal group held for sale or disposed of, expected to be disposed of after one year or the normal operating cycle, if longer.", "label": "Disposal Group, Including Discontinued Operation, Deferred Tax Assets, Noncurrent", "terseLabel": "Deferred Income Taxes" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/DivestituresandOtherTransactionsECPDivestitureDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsSPDivestitureDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilitiesNoncurrent": { "auth_ref": [ "r4", "r5", "r26", "r417", "r427" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount classified as deferred tax liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of beyond one year or the normal operating cycle, if longer.", "label": "Disposal Group, Including Discontinued Operation, Deferred Tax Liabilities, Noncurrent", "terseLabel": "Deferred Income Tax Liabilities" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/DivestituresandOtherTransactionsECPDivestitureDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsSPDivestitureDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense": { "auth_ref": [ "r24" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of general and administrative expense attributable to disposal group, including, but not limited to, discontinued operation.", "label": "Disposal Group, Including Discontinued Operation, General and Administrative Expense", "terseLabel": "Selling, General and Administrative" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/DivestituresandOtherTransactionsDivestituresandOtherTransactionsDivestedAgBusinessResultsofOperationsDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsECPDivestitureDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsSPDivestitureDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1": { "auth_ref": [ "r4", "r5", "r26", "r427" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount classified as goodwill attributable to disposal group held for sale or disposed of.", "label": "Disposal Group, Including Discontinued Operation, Goodwill", "terseLabel": "Goodwill" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationGoodwill1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/DivestituresandOtherTransactionsECPDivestitureDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsSPDivestitureDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets": { "auth_ref": [ "r4", "r5", "r26", "r427" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount classified as intangible assets, excluding goodwill, attributable to disposal group held for sale or disposed of.", "label": "Disposal Group, Including Discontinued Operation, Intangible Assets", "terseLabel": "Other Intangible Assets" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/DivestituresandOtherTransactionsECPDivestitureDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsSPDivestitureDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1": { "auth_ref": [ "r4", "r5", "r26", "r427" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount classified as inventory attributable to disposal group held for sale or disposed of.", "label": "Disposal Group, Including Discontinued Operation, Inventory", "terseLabel": "Inventories" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationInventory1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/DivestituresandOtherTransactionsECPDivestitureDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsSPDivestitureDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets": { "auth_ref": [ "r4", "r5", "r26", "r427" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount classified as other assets attributable to disposal group held for sale or disposed of.", "label": "Disposal Group, Including Discontinued Operation, Other Assets", "terseLabel": "Marketable Securities" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationOtherAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/DivestituresandOtherTransactionsSPDivestitureDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets": { "auth_ref": [ "r4", "r5", "r26", "r420", "r427" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount classified as other assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.", "label": "Disposal Group, Including Discontinued Operation, Other Assets, Current", "terseLabel": "Other current assets" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/DivestituresandOtherTransactionsECPDivestitureDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsSPDivestitureDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities": { "auth_ref": [ "r4", "r5", "r26", "r420", "r427" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount classified as other liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.", "label": "Disposal Group, Including Discontinued Operation, Other Liabilities, Current", "terseLabel": "Short Term Borrowings and finance lease obligations" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/DivestituresandOtherTransactionsECPDivestitureDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsSPDivestitureDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherExpense": { "auth_ref": [ "r24" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of other expense attributable to disposal group, including, but not limited to, discontinued operation.", "label": "Disposal Group, Including Discontinued Operation, Other Expense", "terseLabel": "Other Operating Charges" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationOtherExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/DivestituresandOtherTransactionsDivestituresandOtherTransactionsDivestedAgBusinessResultsofOperationsDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsDivestituresandOtherTransactionsPChemResultsofOperationsDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsSPDivestitureDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities": { "auth_ref": [ "r4", "r5", "r26", "r427" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount classified as other liabilities attributable to disposal group held for sale or disposed of.", "label": "Disposal Group, Including Discontinued Operation, Other Liabilities", "terseLabel": "Long-term Debt" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationOtherLiabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/DivestituresandOtherTransactionsECPDivestitureDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsSPDivestitureDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets": { "auth_ref": [ "r4", "r5", "r26", "r417", "r427" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount classified as other assets attributable to disposal group held for sale or disposed of, expected to be disposed of after one year or the normal operating cycle, if longer.", "label": "Disposal Group, Including Discontinued Operation, Other Assets, Noncurrent", "terseLabel": "Other Assets" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/DivestituresandOtherTransactionsECPDivestitureDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsSPDivestitureDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities": { "auth_ref": [ "r4", "r5", "r26", "r417", "r427" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount classified as other liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of beyond one year or the normal operating cycle, if longer.", "label": "Disposal Group, Including Discontinued Operation, Other Liabilities, Noncurrent", "terseLabel": "Other Non-current Obligations" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/DivestituresandOtherTransactionsECPDivestitureDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsSPDivestitureDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligation": { "auth_ref": [ "r5", "r26", "r427" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount classified as defined benefit plan benefit obligations attributable to disposal group held for sale or disposed of.", "label": "Disposal Group, Including Discontinued Operation, Pension Plan Benefit Obligation", "terseLabel": "Disposal Group, Including Discontinued Operation, Pension Plan Benefit Obligation" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansAmountsRecognizedinConsolidatedBalanceSheetsDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansChangeinProjectedBenefitObligationsPlanAssetsandFundedStatusDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment": { "auth_ref": [ "r4", "r5", "r26", "r427" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount classified as property, plant and equipment attributable to disposal group held for sale or disposed of.", "label": "Disposal Group, Including Discontinued Operation, Property, Plant and Equipment", "terseLabel": "Property, Plant and Equipment - Net" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/DivestituresandOtherTransactionsECPDivestitureDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsSPDivestitureDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue": { "auth_ref": [ "r24", "r32" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue attributable to disposal group, including, but not limited to, discontinued operation.", "label": "Disposal Group, Including Discontinued Operation, Revenue", "terseLabel": "Net Sales" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationRevenue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/DivestituresandOtherTransactionsDivestituresandOtherTransactionsDivestedAgBusinessResultsofOperationsDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsECPDivestitureDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsSPDivestitureDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal": { "auth_ref": [ "r193", "r419", "r425" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before tax of gain (loss) recognized on the sale or disposal of a disposal group. Excludes discontinued operations.", "label": "Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal", "terseLabel": "Pre-tax gain on disposal" } } }, "localname": "DisposalGroupNotDiscontinuedOperationGainLossOnDisposal", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/SupplementaryInformationOtherIncomeExpenseNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock": { "auth_ref": [ "r34", "r432" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.", "label": "Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]", "terseLabel": "Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]" } } }, "localname": "DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/DivestituresandOtherTransactions" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain": { "auth_ref": [ "r680", "r693" ], "lang": { "en-us": { "role": { "documentation": "Name of disposal group.", "label": "Disposal Group Name [Domain]", "terseLabel": "Disposal Group Name [Domain]" } } }, "localname": "DisposalGroupsIncludingDiscontinuedOperationsNameDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/BackgroundandBasisofPresentationPolicies", "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationChemoursDetails", "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationOtherPFOAMattersFayattevilleDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsDivestituresandOtherTransactionsDivestedAgBusinessResultsofOperationsDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsDivestituresandOtherTransactionsNarrativeDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsDivestituresandOtherTransactionsPChemResultsofOperationsDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsECPDivestitureDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsSPDivestitureDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsTables", "http://www.corteva.com/role/SupplementaryInformationOtherIncomeExpenseNetDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DividendsCommonStock": { "auth_ref": [ "r561", "r1044" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK).", "label": "Dividends, Common Stock", "terseLabel": "Dividends, Common Stock" } } }, "localname": "DividendsCommonStock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/ConsolidatedStatementsofEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_DividendsPreferredStock": { "auth_ref": [ "r561", "r1044" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of paid and unpaid preferred stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK).", "label": "Dividends, Preferred Stock", "terseLabel": "Dividends, Preferred Stock" } } }, "localname": "DividendsPreferredStock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/ConsolidatedStatementsofEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_DueFromAffiliates": { "auth_ref": [ "r945", "r947", "r1066" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "For an unclassified balance sheet, amount of receivables due from an entity that is affiliated with the reporting entity by means of direct or indirect ownership.", "label": "Due from Affiliates", "terseLabel": "Due from Nonconsolidated Affiliates" } } }, "localname": "DueFromAffiliates", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/AccountsandNotesReceivableNetScheduleofAccountsandNotesReceivableNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EMEAMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Regions of Europe, Middle East and Africa.", "label": "EMEA [Member]", "terseLabel": "EMEA" } } }, "localname": "EMEAMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/GeographicInformationNetPropertybyCountryDetails", "http://www.corteva.com/role/GeographicInformationRevenuebyCountryDetails", "http://www.corteva.com/role/RevenueDisaggregationofRevenueGeoDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share [Abstract]", "terseLabel": "Earnings Per Share [Abstract]" } } }, "localname": "EarningsPerShareAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r158", "r240", "r241", "r243", "r244", "r245", "r253", "r256", "r265", "r266", "r267", "r272", "r273", "r881", "r882", "r1038", "r1075" ], "calculation": { "http://www.corteva.com/role/ConsolidatedStatementsofIncome": { "order": null, "parentTag": null, "root": true, "weight": null } }, "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Earnings Per Share, Basic", "totalLabel": "Basic earnings (loss) per share of common stock" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/ConsolidatedStatementsofIncome" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r158", "r240", "r241", "r243", "r244", "r245", "r256", "r265", "r266", "r267", "r272", "r273", "r881", "r882", "r1038", "r1075" ], "calculation": { "http://www.corteva.com/role/ConsolidatedStatementsofIncome": { "order": null, "parentTag": null, "root": true, "weight": null } }, "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Earnings Per Share, Diluted", "totalLabel": "Diluted earnings (loss) per share of common stock" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/ConsolidatedStatementsofIncome" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerSharePolicyTextBlock": { "auth_ref": [ "r269", "r270" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.", "label": "Earnings Per Share, Policy [Policy Text Block]", "terseLabel": "Earnings Per Share, Policy [Policy Text Block]" } } }, "localname": "EarningsPerSharePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_EarningsPerShareTextBlock": { "auth_ref": [ "r269", "r270", "r271", "r274" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for earnings per share.", "label": "Earnings Per Share [Text Block]", "terseLabel": "Earnings Per Share [Text Block]" } } }, "localname": "EarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/EarningsPerShareofCommonStockNotes" ], "xbrltype": "textBlockItemType" }, "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r904" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents", "terseLabel": "Effect of exchange rate changes on cash, cash equivalents and restricted cash equivalents" } } }, "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_EffectOfFourthQuarterEventsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Effect of Fourth Quarter Events [Line Items]", "terseLabel": "Effect of Fourth Quarter Events [Line Items]" } } }, "localname": "EffectOfFourthQuarterEventsLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/EIDQuarterlyFNDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EffectiveIncomeTaxRateContinuingOperations": { "auth_ref": [ "r755" ], "calculation": { "http://www.corteva.com/role/IncomeTaxesIncomeTaxesReconciliationtoUSStatutoryRateDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "lang": { "en-us": { "role": { "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Effective Income Tax Rate Reconciliation, Percent", "totalLabel": "Effective Income Tax Rate" } } }, "localname": "EffectiveIncomeTaxRateContinuingOperations", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/EIDIncomeTaxesRateReconciliationDetails", "http://www.corteva.com/role/IncomeTaxesIncomeTaxesReconciliationtoUSStatutoryRateDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": { "auth_ref": [ "r214", "r755", "r794" ], "calculation": { "http://www.corteva.com/role/IncomeTaxesIncomeTaxesReconciliationtoUSStatutoryRateDetails": { "order": 1.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).", "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent", "terseLabel": "Statutory U.S. federal income tax rate" } } }, "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/EIDIncomeTaxesRateReconciliationDetails", "http://www.corteva.com/role/IncomeTaxesIncomeTaxesReconciliationtoUSStatutoryRateDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary": { "auth_ref": [ "r755", "r794" ], "calculation": { "http://www.corteva.com/role/IncomeTaxesIncomeTaxesReconciliationtoUSStatutoryRateDetails": { "order": 2.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to equity in earnings (loss) of unconsolidated subsidiaries exempt from income taxes.", "label": "Effective Income Tax Rate Reconciliation, Equity in Earnings (Losses) of Unconsolidated Subsidiary, Percent", "terseLabel": "Equity earning effect" } } }, "localname": "EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/EIDIncomeTaxesRateReconciliationDetails", "http://www.corteva.com/role/IncomeTaxesIncomeTaxesReconciliationtoUSStatutoryRateDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential": { "auth_ref": [ "r755", "r794" ], "calculation": { "http://www.corteva.com/role/IncomeTaxesIncomeTaxesReconciliationtoUSStatutoryRateDetails": { "order": 3.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile.", "label": "Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent", "terseLabel": "Effective tax rates on international operations - net" } } }, "localname": "EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/EIDIncomeTaxesRateReconciliationDetails", "http://www.corteva.com/role/IncomeTaxesIncomeTaxesReconciliationtoUSStatutoryRateDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses": { "auth_ref": [ "r755", "r794" ], "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to impairment loss.", "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Impairment Losses, Percent", "terseLabel": "Goodwill impairment" } } }, "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/EIDIncomeTaxesRateReconciliationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments": { "auth_ref": [ "r755", "r794" ], "calculation": { "http://www.corteva.com/role/IncomeTaxesIncomeTaxesReconciliationtoUSStatutoryRateDetails": { "order": 8.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.", "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Percent", "terseLabel": "Other, net" } } }, "localname": "EffectiveIncomeTaxRateReconciliationOtherAdjustments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/EIDIncomeTaxesRateReconciliationDetails", "http://www.corteva.com/role/IncomeTaxesIncomeTaxesReconciliationtoUSStatutoryRateDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent": { "auth_ref": [ "r744", "r755" ], "calculation": { "http://www.corteva.com/role/IncomeTaxesIncomeTaxesReconciliationtoUSStatutoryRateDetails": { "order": 10.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to expense for award under share-based payment arrangement. Excludes expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.", "label": "Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Percent", "terseLabel": "Excess tax benefits (tax deficiency) from stock-compensation" } } }, "localname": "EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/EIDIncomeTaxesRateReconciliationDetails", "http://www.corteva.com/role/IncomeTaxesIncomeTaxesReconciliationtoUSStatutoryRateDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes": { "auth_ref": [ "r755", "r794" ], "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).", "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent", "terseLabel": "State and Local Income Taxes" } } }, "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/EIDIncomeTaxesRateReconciliationDetails", "http://www.corteva.com/role/IncomeTaxesIncomeTaxesReconciliationtoUSStatutoryRateDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch": { "auth_ref": [ "r755", "r794" ], "calculation": { "http://www.corteva.com/role/IncomeTaxesIncomeTaxesReconciliationtoUSStatutoryRateDetails": { "order": 5.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.", "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent", "terseLabel": "U.S. research and development credit" } } }, "localname": "EffectiveIncomeTaxRateReconciliationTaxCreditsResearch", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/EIDIncomeTaxesRateReconciliationDetails", "http://www.corteva.com/role/IncomeTaxesIncomeTaxesReconciliationtoUSStatutoryRateDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlements": { "auth_ref": [ "r755", "r794" ], "calculation": { "http://www.corteva.com/role/IncomeTaxesIncomeTaxesReconciliationtoUSStatutoryRateDetails": { "order": 7.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to income tax settlements. Including, but not limited to, domestic tax settlement, foreign tax settlement, state and local tax settlement, and other tax settlements.", "label": "Effective Income Tax Rate Reconciliation, Tax Settlement, Percent", "terseLabel": "Tax settlements and expiration of statue of limitations" } } }, "localname": "EffectiveIncomeTaxRateReconciliationTaxSettlements", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/EIDIncomeTaxesRateReconciliationDetails", "http://www.corteva.com/role/IncomeTaxesIncomeTaxesReconciliationtoUSStatutoryRateDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EmployeeRelatedLiabilitiesCurrent": { "auth_ref": [ "r92" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Employee-related Liabilities, Current", "terseLabel": "Compensation and other employee-related costs" } } }, "localname": "EmployeeRelatedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/SupplementaryInformationSupplementaryInformationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": { "auth_ref": [ "r732" ], "lang": { "en-us": { "role": { "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition", "terseLabel": "Remaining Weighted-Average Recognition Period" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/StockBasedCompensationRestrictedStockUnitsandPerformanceDeferredStockDetails", "http://www.corteva.com/role/StockBasedCompensationStockCompensationDetails", "http://www.corteva.com/role/StockBasedCompensationStockOptionsDetails" ], "xbrltype": "durationItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions": { "auth_ref": [ "r732" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options.", "label": "Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount", "terseLabel": "Unrecognized Pretax Compensation Expense Related to RSUs and PSUs" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/StockBasedCompensationRestrictedStockUnitsandPerformanceDeferredStockDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": { "auth_ref": [ "r732" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost to be recognized for option under share-based payment arrangement.", "label": "Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount", "terseLabel": "Unrecognized Pretax Compensation Expense Related to Stock Options" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/StockBasedCompensationStockOptionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense": { "auth_ref": [ "r730" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of tax benefit for recognition of expense of award under share-based payment arrangement.", "label": "Share-based Payment Arrangement, Expense, Tax Benefit", "terseLabel": "Tax Benefit from Compensation Expense" } } }, "localname": "EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/StockBasedCompensationStockCompensationDetails", "http://www.corteva.com/role/StockBasedCompensationStockOptionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeSeveranceMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Termination of an employee associated with exit from or disposal of business activities or restructurings pursuant to a plan.", "label": "Employee Severance [Member]", "terseLabel": "Employee Severance [Member]" } } }, "localname": "EmployeeSeveranceMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/RestructuringandAssetRelatedCharges2021RestructuringActionsDetails", "http://www.corteva.com/role/RestructuringandAssetRelatedChargesDowDuPontAgricultureDivisionRestructuringProgramDetails", "http://www.corteva.com/role/RestructuringandAssetRelatedChargesDowDuPontCostSynergyProgramDetails", "http://www.corteva.com/role/RestructuringandAssetRelatedChargesExecutetoWinProductivityProgramDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EmployeeStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "An Employee Stock Purchase Plan is a tax-efficient means by which employees of a corporation can purchase the corporation's stock.", "label": "Employee Stock [Member]", "terseLabel": "Employee Stock [Member]" } } }, "localname": "EmployeeStockMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/StockBasedCompensationStockOptionsDetails", "http://www.corteva.com/role/StockBasedCompensationWeightedAverageAssumptionsStockOptionsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EmployeeStockOptionMember": { "auth_ref": [ "r729" ], "lang": { "en-us": { "role": { "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.", "label": "Share-based Payment Arrangement, Option [Member]", "terseLabel": "Share-based Payment Arrangement, Option [Member]" } } }, "localname": "EmployeeStockOptionMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/StockBasedCompensationStockCompensationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EnvironmentalCostsPolicy": { "auth_ref": [ "r437", "r439", "r440", "r441" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for obligations that resulted from improper or other-than normal operation of a long-lived asset in the past. This accounting policy may address (1) whether the related remediation costs are expensed or capitalized, (2) whether the obligation is measured on a discounted basis, (3) the event, situation, or set of circumstances that generally triggers recognition of loss contingencies arising from the entity's environmental remediation-related obligations, and (4) the timing of recognition of any recoveries.", "label": "Environmental Costs, Policy [Policy Text Block]", "terseLabel": "Environmental Matters" } } }, "localname": "EnvironmentalCostsPolicy", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_EnvironmentalRemediationSiteAxis": { "auth_ref": [ "r434", "r435", "r436", "r438", "r469" ], "lang": { "en-us": { "role": { "documentation": "Information by location or named area designated for environmental remediation.", "label": "Environmental Remediation Site [Axis]", "terseLabel": "Environmental Remediation Site [Axis]" } } }, "localname": "EnvironmentalRemediationSiteAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesEnvironmentalDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EnvironmentalRemediationSiteDomain": { "auth_ref": [ "r434" ], "lang": { "en-us": { "role": { "documentation": "Location or named area designated for environmental remediation.", "label": "Environmental Remediation Site [Domain]", "terseLabel": "Environmental Remediation Site [Domain]" } } }, "localname": "EnvironmentalRemediationSiteDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesEnvironmentalDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity [Abstract]", "terseLabel": "Equity [Abstract]" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_EquityClassOfTreasuryStockLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Equity, Class of Treasury Stock [Line Items]", "terseLabel": "Equity, Class of Treasury Stock [Line Items]" } } }, "localname": "EquityClassOfTreasuryStockLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/StockholdersEquityCommonStockDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r0", "r144", "r145", "r146", "r230", "r231", "r232", "r236", "r246", "r249", "r282", "r363", "r554", "r561", "r735", "r736", "r737", "r783", "r784", "r880", "r905", "r906", "r907", "r908", "r909", "r911", "r1083", "r1084", "r1085", "r1185" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]", "terseLabel": "Equity Component [Domain]" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/BackgroundandBasisofPresentationDetails", "http://www.corteva.com/role/ConsolidatedStatementsofEquity", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansBasisofFairValueMeasurementDetails", "http://www.corteva.com/role/StockholdersEquityOtherComprehensiveIncomeLossDetails", "http://www.corteva.com/role/StockholdersEquityReclassificationsoutofAOCIDetails", "http://www.corteva.com/role/StockholdersEquityTaxBenefitExpenseonNetActivityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment": { "auth_ref": [ "r360" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This item represents an other than temporary decline in value that has been recognized against an investment accounted for under the equity method of accounting. The excess of the carrying amount over the fair value of the investment represents the amount of the write down which is or was reflected in earnings. The written down value is a new cost basis with the adjusted value of the investment becoming its new carrying value subject to the equity accounting method. Evidence of a loss in value might include, but would not necessarily be limited to, absence of an ability to recover the carrying amount of the investment or inability of the investee to sustain an earnings capacity which would justify the carrying amount of the investment.", "label": "Equity Method Investment, Other than Temporary Impairment", "terseLabel": "Equity Method Investment, Other than Temporary Impairment" } } }, "localname": "EquityMethodInvestmentOtherThanTemporaryImpairment", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/DivestituresandOtherTransactionsDivestituresandOtherTransactionsNarrativeDetails", "http://www.corteva.com/role/RestructuringandAssetRelatedChargesAssetImpairmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquityMethodInvestments": { "auth_ref": [ "r82", "r307", "r361" ], "calculation": { "http://www.corteva.com/role/ConsolidatedBalanceSheets": { "order": 6.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.", "label": "Equity Method Investments", "terseLabel": "Investments in nonconsolidated affiliates" } } }, "localname": "EquityMethodInvestments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/ConsolidatedBalanceSheets", "http://www.corteva.com/role/SegmentReportingOtherItemsDetails", "http://www.corteva.com/role/SegmentReportingSegmentInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquitySecuritiesFvNi": { "auth_ref": [ "r894" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.", "label": "Equity Securities, FV-NI, Current", "terseLabel": "Equity Securities" } } }, "localname": "EquitySecuritiesFvNi", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/FairValueMeasurementsFairValueMeasurementRecurringBasisDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquitySecuritiesMember": { "auth_ref": [ "r51", "r57", "r356", "r1051", "r1108", "r1109", "r1110" ], "lang": { "en-us": { "role": { "documentation": "Ownership interest or right to acquire or dispose of ownership interest in corporations and other legal entities for which ownership interest is represented by shares of common or preferred stock, convertible securities, stock rights, or stock warrants.", "label": "Equity Securities [Member]", "terseLabel": "Equity Securities [Member]" } } }, "localname": "EquitySecuritiesMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansBasisofFairValueMeasurementDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansSummaryofFairValueMeasurementofLevel3PensionPlanAssetsDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansTargetAllocationforPlanAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EscrowDeposit": { "auth_ref": [ "r1026", "r1114" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The designation of funds furnished by a borrower to a lender to assure future payments of the borrower's real estate taxes and insurance obligations with respect to a mortgaged property. Escrow deposits may be made for a variety of other purposes such as earnest money and contingent payments. This element excludes replacement reserves which are an escrow separately provided for within the US GAAP taxonomy.", "label": "Escrow Deposit", "terseLabel": "Escrow Balance" } } }, "localname": "EscrowDeposit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationLeachandMDLSettlementDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ExtinguishmentOfDebtAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Gross amount of debt extinguished.", "label": "Extinguishment of Debt, Amount", "terseLabel": "Extinguishment of Debt, Amount" } } }, "localname": "ExtinguishmentOfDebtAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/LongTermDebtandAvailableCreditFacilitiesDebtRedemptionsRepaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]", "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/FairValueMeasurementsFairValueMeasurementNonrecurringBasisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": { "auth_ref": [ "r884", "r885", "r886", "r891" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.", "label": "Fair Value, Recurring and Nonrecurring [Table]", "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/FairValueMeasurementsFairValueMeasurementNonrecurringBasisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsMeasuredOnRecurringAndNonrecurringBasisTableTextBlock": { "auth_ref": [ "r884", "r885" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assets measured at fair value measured on a recurring or nonrecurring basis. Includes, but is not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2.", "label": "Fair Value, Assets Measured on Recurring and Nonrecurring Basis [Table Text Block]", "terseLabel": "Fair Value, Assets Measured on Nonrecurring Basis [Table Text Block]" } } }, "localname": "FairValueAssetsMeasuredOnRecurringAndNonrecurringBasisTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/FairValueMeasurementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "auth_ref": [ "r510", "r525", "r526", "r623", "r625", "r626", "r627", "r628", "r629", "r630", "r673", "r885", "r961", "r962", "r963" ], "lang": { "en-us": { "role": { "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.", "label": "Fair Value Hierarchy and NAV [Axis]", "terseLabel": "Fair Value Hierarchy and NAV [Axis]" } } }, "localname": "FairValueByFairValueHierarchyLevelAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/FairValueMeasurementsFairValueMeasurementNonrecurringBasisDetails", "http://www.corteva.com/role/FairValueMeasurementsFairValueMeasurementRecurringBasisDetails", "http://www.corteva.com/role/LongTermDebtandAvailableCreditFacilitiesLongTermDebtDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansBasisofFairValueMeasurementDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansSummaryofFairValueMeasurementofLevel3PensionPlanAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByMeasurementFrequencyAxis": { "auth_ref": [ "r884", "r885", "r887", "r888", "r893" ], "lang": { "en-us": { "role": { "documentation": "Information by measurement frequency.", "label": "Measurement Frequency [Axis]", "terseLabel": "Measurement Frequency [Axis]" } } }, "localname": "FairValueByMeasurementFrequencyAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/FairValueMeasurementsFairValueMeasurementNonrecurringBasisDetails", "http://www.corteva.com/role/FairValueMeasurementsFairValueMeasurementRecurringBasisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value Disclosures [Abstract]", "terseLabel": "Fair Value Disclosures [Abstract]" } } }, "localname": "FairValueDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresTextBlock": { "auth_ref": [ "r890" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.", "label": "Fair Value Disclosures [Text Block]", "terseLabel": "Fair Value Disclosures [Text Block]" } } }, "localname": "FairValueDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/FairValueMeasurements" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueInputsLevel1Member": { "auth_ref": [ "r510", "r623", "r625", "r630", "r673", "r885", "r961" ], "lang": { "en-us": { "role": { "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.", "label": "Fair Value, Inputs, Level 1 [Member]", "terseLabel": "Fair Value, Inputs, Level 1 [Member]" } } }, "localname": "FairValueInputsLevel1Member", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/FairValueMeasurementsFairValueMeasurementRecurringBasisDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansBasisofFairValueMeasurementDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel2Member": { "auth_ref": [ "r510", "r525", "r526", "r623", "r625", "r630", "r673", "r885", "r962" ], "lang": { "en-us": { "role": { "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.", "label": "Fair Value, Inputs, Level 2 [Member]", "terseLabel": "Fair Value, Inputs, Level 2 [Member]" } } }, "localname": "FairValueInputsLevel2Member", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/FairValueMeasurementsFairValueMeasurementRecurringBasisDetails", "http://www.corteva.com/role/LongTermDebtandAvailableCreditFacilitiesLongTermDebtDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansBasisofFairValueMeasurementDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel3Member": { "auth_ref": [ "r510", "r525", "r526", "r623", "r625", "r626", "r627", "r628", "r629", "r630", "r673", "r885", "r963" ], "lang": { "en-us": { "role": { "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Inputs, Level 3 [Member]", "terseLabel": "Fair Value, Inputs, Level 3 [Member]" } } }, "localname": "FairValueInputsLevel3Member", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansBasisofFairValueMeasurementDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansSummaryofFairValueMeasurementofLevel3PensionPlanAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasuredOnRecurringBasisGainLossIncludedInEarningsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Measured on Recurring Basis, Gain (Loss) Included in Earnings [Line Items]", "terseLabel": "Fair Value, Measured on Recurring Basis, Gain (Loss) Included in Earnings [Line Items]" } } }, "localname": "FairValueMeasuredOnRecurringBasisGainLossIncludedInEarningsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/FairValueMeasurementsFairValueMeasurementRecurringBasisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueMeasuredOnRecurringBasisGainLossIncludedInEarningsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about the gain (loss) of assets and liabilities measured at fair value on a recurring basis.", "label": "Fair Value, Measured on Recurring Basis, Gain (Loss) Included in Earnings [Table]", "terseLabel": "Fair Value, Measured on Recurring Basis, Gain (Loss) Included in Earnings [Table]" } } }, "localname": "FairValueMeasuredOnRecurringBasisGainLossIncludedInEarningsTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/FairValueMeasurementsFairValueMeasurementRecurringBasisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueMeasurementFrequencyDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement frequency.", "label": "Measurement Frequency [Domain]", "terseLabel": "Measurement Frequency [Domain]" } } }, "localname": "FairValueMeasurementFrequencyDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/FairValueMeasurementsFairValueMeasurementNonrecurringBasisDetails", "http://www.corteva.com/role/FairValueMeasurementsFairValueMeasurementRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.", "label": "Fair Value Measurement, Policy [Policy Text Block]", "terseLabel": "Fair Value Measurements" } } }, "localname": "FairValueMeasurementPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "auth_ref": [ "r510", "r525", "r526", "r623", "r625", "r626", "r627", "r628", "r629", "r630", "r673", "r961", "r962", "r963" ], "lang": { "en-us": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.", "label": "Fair Value Hierarchy and NAV [Domain]", "terseLabel": "Fair Value Hierarchy and NAV [Domain]" } } }, "localname": "FairValueMeasurementsFairValueHierarchyDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/FairValueMeasurementsFairValueMeasurementNonrecurringBasisDetails", "http://www.corteva.com/role/FairValueMeasurementsFairValueMeasurementRecurringBasisDetails", "http://www.corteva.com/role/LongTermDebtandAvailableCreditFacilitiesLongTermDebtDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansBasisofFairValueMeasurementDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansSummaryofFairValueMeasurementofLevel3PensionPlanAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementsNonrecurringMember": { "auth_ref": [ "r884", "r885", "r887", "r888", "r889", "r893" ], "lang": { "en-us": { "role": { "documentation": "Infrequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, not frequently measured at fair value.", "label": "Fair Value, Nonrecurring [Member]", "terseLabel": "Fair Value, Nonrecurring [Member]" } } }, "localname": "FairValueMeasurementsNonrecurringMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/FairValueMeasurementsFairValueMeasurementNonrecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementsRecurringMember": { "auth_ref": [ "r890", "r893" ], "lang": { "en-us": { "role": { "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.", "label": "Fair Value, Recurring [Member]", "terseLabel": "Fair Value, Recurring [Member]" } } }, "localname": "FairValueMeasurementsRecurringMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/FairValueMeasurementsFairValueMeasurementNonrecurringBasisDetails", "http://www.corteva.com/role/FairValueMeasurementsFairValueMeasurementRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FinanceLeaseInterestExpense": { "auth_ref": [ "r926", "r931", "r940" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of interest expense on finance lease liability.", "label": "Finance Lease, Interest Expense", "terseLabel": "Finance Lease, Interest Expense" } } }, "localname": "FinanceLeaseInterestExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/LeasesLeaseCostsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseInterestPaymentOnLiability": { "auth_ref": [ "r928", "r935" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of interest paid on finance lease liability.", "label": "Finance Lease, Interest Payment on Liability", "terseLabel": "Operating cash outflows from finance leases" } } }, "localname": "FinanceLeaseInterestPaymentOnLiability", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/LeasesSupplementalCashFlowInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiability": { "auth_ref": [ "r925", "r939" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease.", "label": "Finance Lease, Liability", "terseLabel": "Finance Lease, Liability" } } }, "localname": "FinanceLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/LeasesMaturityofLeaseLiabilitiesDetails", "http://www.corteva.com/role/LeasesSupplementalBalanceSheetInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityCurrent": { "auth_ref": [ "r925" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.", "label": "Finance Lease, Liability, Current", "terseLabel": "Finance Lease, Liability, Current" } } }, "localname": "FinanceLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/LeasesSupplementalBalanceSheetInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityNoncurrent": { "auth_ref": [ "r925" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.", "label": "Finance Lease, Liability, Noncurrent", "terseLabel": "Finance Lease, Liability, Noncurrent" } } }, "localname": "FinanceLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/LeasesSupplementalBalanceSheetInformationDetails", "http://www.corteva.com/role/LongTermDebtandAvailableCreditFacilitiesLongTermDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsDue": { "auth_ref": [ "r939" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments for finance lease.", "label": "Finance Lease, Liability, Payment, Due", "terseLabel": "Finance Lease, Total Payments" } } }, "localname": "FinanceLeaseLiabilityPaymentsDue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/LeasesMaturityofLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive": { "auth_ref": [ "r939" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finance Lease, Liability, to be Paid, after Year Five", "terseLabel": "Finance Lease, Due After Year Five" } } }, "localname": "FinanceLeaseLiabilityPaymentsDueAfterYearFive", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/LeasesMaturityofLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths": { "auth_ref": [ "r939" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finance Lease, Liability, to be Paid, Year One", "terseLabel": "Finance Lease, Year One" } } }, "localname": "FinanceLeaseLiabilityPaymentsDueNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/LeasesMaturityofLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive": { "auth_ref": [ "r939" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finance Lease, Liability, to be Paid, Year Five", "terseLabel": "Finance Lease, Year Five" } } }, "localname": "FinanceLeaseLiabilityPaymentsDueYearFive", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/LeasesMaturityofLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour": { "auth_ref": [ "r939" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finance Lease, Liability, to be Paid, Year Four", "terseLabel": "Finance Lease, Year Four" } } }, "localname": "FinanceLeaseLiabilityPaymentsDueYearFour", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/LeasesMaturityofLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree": { "auth_ref": [ "r939" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finance Lease, Liability, to be Paid, Year Three", "terseLabel": "Finance Lease, Year Three" } } }, "localname": "FinanceLeaseLiabilityPaymentsDueYearThree", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/LeasesMaturityofLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo": { "auth_ref": [ "r939" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finance Lease, Liability, to be Paid, Year Two", "terseLabel": "Finance Lease, Year Two" } } }, "localname": "FinanceLeaseLiabilityPaymentsDueYearTwo", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/LeasesMaturityofLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount": { "auth_ref": [ "r939" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease.", "label": "Finance Lease, Liability, Undiscounted Excess Amount", "terseLabel": "Finance Lease, Interest" } } }, "localname": "FinanceLeaseLiabilityUndiscountedExcessAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/LeasesMaturityofLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeasePrincipalPayments": { "auth_ref": [ "r927", "r935" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow for principal payment on finance lease.", "label": "Finance Lease, Principal Payments", "terseLabel": "Financing cash outflows from finance leases" } } }, "localname": "FinanceLeasePrincipalPayments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/LeasesSupplementalCashFlowInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseRightOfUseAsset": { "auth_ref": [ "r924" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated amortization, of right-of-use asset from finance lease.", "label": "Finance Lease, Right-of-Use Asset, after Accumulated Amortization", "terseLabel": "Finance Lease, Right-of-Use Asset" } } }, "localname": "FinanceLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/LeasesSupplementalBalanceSheetInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseRightOfUseAssetAmortization": { "auth_ref": [ "r926", "r931", "r940" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization expense attributable to right-of-use asset from finance lease.", "label": "Finance Lease, Right-of-Use Asset, Amortization", "terseLabel": "Finance Lease, Right-of-Use Asset, Amortization" } } }, "localname": "FinanceLeaseRightOfUseAssetAmortization", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/LeasesLeaseCostsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent": { "auth_ref": [ "r937", "r940" ], "lang": { "en-us": { "role": { "documentation": "Weighted average discount rate for finance lease calculated at point in time.", "label": "Finance Lease, Weighted Average Discount Rate, Percent", "terseLabel": "Finance Lease, Weighted Average Discount Rate, Percent" } } }, "localname": "FinanceLeaseWeightedAverageDiscountRatePercent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/LeasesLeaseTermandDiscountRateDetails" ], "xbrltype": "percentItemType" }, "us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1": { "auth_ref": [ "r936", "r940" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Finance Lease, Weighted Average Remaining Lease Term", "terseLabel": "Finance Lease, Weighted Average Remaining Lease Term" } } }, "localname": "FinanceLeaseWeightedAverageRemainingLeaseTerm1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/LeasesLeaseTermandDiscountRateDetails" ], "xbrltype": "durationItemType" }, "us-gaap_FinancialInstrumentAxis": { "auth_ref": [ "r351", "r352", "r357", "r358", "r359", "r369", "r373", "r374", "r375", "r376", "r380", "r381", "r382", "r383", "r521", "r552", "r877", "r958", "r959", "r960", "r961", "r962", "r963", "r964", "r965", "r966", "r968", "r969", "r970", "r971", "r973", "r974", "r975", "r976", "r977", "r978", "r979", "r980", "r981", "r982", "r983", "r984", "r985", "r986", "r987", "r988", "r989", "r1140", "r1141", "r1142", "r1143", "r1148", "r1149", "r1150" ], "lang": { "en-us": { "role": { "documentation": "Information by type of financial instrument.", "label": "Financial Instrument [Axis]", "terseLabel": "Financial Instrument [Axis]" } } }, "localname": "FinancialInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/FairValueMeasurementsFairValueMeasurementRecurringBasisDetails", "http://www.corteva.com/role/FinancialInstrumentsFairValueandGrossUnrealizedLossesofinvestmentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FinancialInstrumentsDisclosureTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for financial instruments. This disclosure includes, but is not limited to, fair value measurements of short and long term marketable securities, international currencies forward contracts, and auction rate securities. Financial instruments may include hedging and non-hedging currency exchange instruments, derivatives, securitizations and securities available for sale at fair value. Also included are investment results, realized and unrealized gains and losses as well as impairments and risk management disclosures.", "label": "Financial Instruments Disclosure [Text Block]", "terseLabel": "Financial Instruments Disclosure [Text Block]" } } }, "localname": "FinancialInstrumentsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/FinancialInstruments" ], "xbrltype": "textBlockItemType" }, "us-gaap_FinancingReceivableAllowanceForCreditLossesRecovery": { "auth_ref": [ "r340", "r372", "r378" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in allowance for credit loss on financing receivable from recovery.", "label": "Financing Receivable, Allowance for Credit Loss, Recovery", "terseLabel": "Recoveries collected" } } }, "localname": "FinancingReceivableAllowanceForCreditLossesRecovery", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/AccountsandNotesReceivableAllowanceRollforwardDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetUsefulLife": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Finite-Lived Intangible Asset, Useful Life", "terseLabel": "Definite-Lived Intangible Asset, Useful Life" } } }, "localname": "FiniteLivedIntangibleAssetUsefulLife", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "durationItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": { "auth_ref": [ "r409" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Accumulated Amortization", "terseLabel": "Accumulated Amortization" } } }, "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/GoodwillandOtherIntangibleAssetsOtherIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": { "auth_ref": [ "r411" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One", "terseLabel": "2022" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/GoodwillandOtherIntangibleAssetsAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": { "auth_ref": [ "r411" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five", "terseLabel": "2026" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/GoodwillandOtherIntangibleAssetsAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": { "auth_ref": [ "r411" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four", "terseLabel": "2025" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/GoodwillandOtherIntangibleAssetsAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": { "auth_ref": [ "r411" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three", "terseLabel": "2024" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/GoodwillandOtherIntangibleAssetsAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": { "auth_ref": [ "r411" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two", "terseLabel": "2023" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/GoodwillandOtherIntangibleAssetsAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "auth_ref": [ "r403", "r405", "r409", "r413", "r994", "r998" ], "lang": { "en-us": { "role": { "documentation": "Information by major type or class of finite-lived intangible assets.", "label": "Finite-Lived Intangible Assets by Major Class [Axis]", "terseLabel": "Definite-Lived Intangible Assets by Major Class [Axis]" } } }, "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/DivestituresandOtherTransactionsDivestituresandOtherTransactionsDivestedAgBusinessResultsofOperationsDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsDivestituresandOtherTransactionsNarrativeDetails", "http://www.corteva.com/role/FairValueMeasurementsFairValueMeasurementNonrecurringBasisDetails", "http://www.corteva.com/role/GoodwillandOtherIntangibleAssetsAmortizationExpenseDetails", "http://www.corteva.com/role/GoodwillandOtherIntangibleAssetsOtherIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosure": { "auth_ref": [ "r884" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of assets, excluding financial assets, that lack physical substance, having a limited useful life.", "label": "Finite-lived Intangible Assets, Fair Value Disclosure", "terseLabel": "Assets at Fair Value" } } }, "localname": "FiniteLivedIntangibleAssetsFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/FairValueMeasurementsFairValueMeasurementNonrecurringBasisDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsGross": { "auth_ref": [ "r409", "r998" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Gross", "terseLabel": "Finite-Lived Intangible Assets, Gross", "verboseLabel": "Definite-Lived Intangible Assets, Gross" } } }, "localname": "FiniteLivedIntangibleAssetsGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/DivestituresandOtherTransactionsDivestituresandOtherTransactionsDivestedAgBusinessResultsofOperationsDetails", "http://www.corteva.com/role/GoodwillandOtherIntangibleAssetsOtherIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Finite-Lived Intangible Assets [Line Items]", "terseLabel": "Finite-Lived Intangible Assets [Line Items]" } } }, "localname": "FiniteLivedIntangibleAssetsLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/GoodwillandOtherIntangibleAssetsAmortizationExpenseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "auth_ref": [ "r403", "r408" ], "lang": { "en-us": { "role": { "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.", "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]", "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]", "verboseLabel": "Fair Value Measurement [Domain]" } } }, "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/DivestituresandOtherTransactionsDivestituresandOtherTransactionsDivestedAgBusinessResultsofOperationsDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsDivestituresandOtherTransactionsNarrativeDetails", "http://www.corteva.com/role/FairValueMeasurementsFairValueMeasurementNonrecurringBasisDetails", "http://www.corteva.com/role/GoodwillandOtherIntangibleAssetsAmortizationExpenseDetails", "http://www.corteva.com/role/GoodwillandOtherIntangibleAssetsOtherIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FiniteLivedIntangibleAssetsNet": { "auth_ref": [ "r409", "r994" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Net", "verboseLabel": "Definite-Lived Intangible Assets, Net" } } }, "localname": "FiniteLivedIntangibleAssetsNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/GoodwillandOtherIntangibleAssetsOtherIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FixedIncomeSecuritiesMember": { "auth_ref": [ "r623", "r673" ], "lang": { "en-us": { "role": { "documentation": "Investment that provides a return in the form of fixed periodic payments and eventual return of principal at maturity.", "label": "Fixed Income Securities [Member]", "terseLabel": "Fixed Income Securities [Member]" } } }, "localname": "FixedIncomeSecuritiesMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansTargetAllocationforPlanAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ForeignCurrencyTransactionGainLossBeforeTax": { "auth_ref": [ "r900", "r901", "r902", "r903" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement.", "label": "Foreign Currency Transaction Gain (Loss), before Tax", "terseLabel": "Pre-tax exchange (loss) gain", "verboseLabel": "Net exchange losses" } } }, "localname": "ForeignCurrencyTransactionGainLossBeforeTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/EIDSegmentFNSegmentReconciliationDetails", "http://www.corteva.com/role/SegmentReportingSegmentReconciliationDetails", "http://www.corteva.com/role/SegmentReportingSigItemsDetails", "http://www.corteva.com/role/SupplementaryInformationForeignCurrencyExchangeGainLossDetails", "http://www.corteva.com/role/SupplementaryInformationOtherIncomeExpenseNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": { "auth_ref": [ "r913" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.", "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]", "terseLabel": "Foreign Currency Translation" } } }, "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ForeignExchangeContractMember": { "auth_ref": [ "r117", "r623", "r865" ], "lang": { "en-us": { "role": { "documentation": "Derivative instrument whose primary underlying risk is tied to foreign exchange rates.", "label": "Foreign Exchange Contract [Member]", "terseLabel": "Foreign Exchange Contract [Member]" } } }, "localname": "ForeignExchangeContractMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/FairValueMeasurementsFairValueMeasurementNonrecurringBasisDetails", "http://www.corteva.com/role/FairValueMeasurementsFairValueMeasurementRecurringBasisDetails", "http://www.corteva.com/role/FinancialInstrumentsCashFlowHedgesIncludedinAOCIDetails", "http://www.corteva.com/role/FinancialInstrumentsEffectofDerivativeInstrumentsDetails", "http://www.corteva.com/role/FinancialInstrumentsFairValueofDerivativesDetails", "http://www.corteva.com/role/FinancialInstrumentsNotionalAmountsDetails", "http://www.corteva.com/role/FinancialInstrumentsTables" ], "xbrltype": "domainItemType" }, "us-gaap_GainLossOnDerivativeInstrumentsNetPretax": { "auth_ref": [ "r855" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate net gain (loss) on all derivative instruments recognized in earnings during the period, before tax effects.", "label": "Gain (Loss) on Derivative Instruments, Net, Pretax", "terseLabel": "(Loss) Gain on Derivative Instruments, Net, Pretax" } } }, "localname": "GainLossOnDerivativeInstrumentsNetPretax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/FinancialInstrumentsEffectofDerivativeInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GainLossOnDispositionOfAssets1": { "auth_ref": [ "r193" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) on sale or disposal of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee.", "label": "Gain (Loss) on Disposition of Assets", "terseLabel": "Gain (Loss) on Disposition of Assets", "verboseLabel": "(Loss) Gain on sale or disposition of assets" } } }, "localname": "GainLossOnDispositionOfAssets1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/QuaterlyFinancialDataQuarterlyFinancialDataParentheticalsDetails", "http://www.corteva.com/role/SegmentReportingSigItemsDetails", "http://www.corteva.com/role/SupplementaryInformationOtherIncomeExpenseNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GainLossOnInvestmentsMember1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing gain (loss) on investments.", "label": "Gain (Loss) on Investments [Member]", "terseLabel": "Gain (Loss) on Investments [Member]" } } }, "localname": "GainLossOnInvestmentsMember1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/StockholdersEquityReclassificationsoutofAOCIDetails" ], "xbrltype": "domainItemType" }, "us-gaap_GainLossOnSaleOfAccountsReceivable": { "auth_ref": [ "r972" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) on sale of accounts receivable.", "label": "Gain (Loss) on Sale of Accounts Receivable", "terseLabel": "Loss on Sale of Accounts Receivable" } } }, "localname": "GainLossOnSaleOfAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/AccountsandNotesReceivableNetCustomerFinancingDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GainsLossesOnExtinguishmentOfDebt": { "auth_ref": [ "r193", "r529", "r530" ], "calculation": { "http://www.corteva.com/role/ConsolidatedStatementsofIncome": { "order": 12.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.", "label": "Gain (Loss) on Extinguishment of Debt", "negatedTerseLabel": "Loss on early Extinguishment of Debt", "terseLabel": "Loss on Extinguishment of Debt" } } }, "localname": "GainsLossesOnExtinguishmentOfDebt", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/ConsolidatedStatementsofCashFlows", "http://www.corteva.com/role/ConsolidatedStatementsofIncome", "http://www.corteva.com/role/LongTermDebtandAvailableCreditFacilitiesDebtRedemptionsRepaymentsDetails", "http://www.corteva.com/role/QuaterlyFinancialDataQuarterlyFinancialDataParentheticalsDetails", "http://www.corteva.com/role/SegmentReportingSigItemsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GeographicDistributionAxis": { "auth_ref": [ "r377", "r1039", "r1040", "r1140", "r1141", "r1142", "r1143", "r1144", "r1145", "r1146", "r1147", "r1148", "r1149", "r1150", "r1151", "r1152", "r1153", "r1154", "r1155", "r1156", "r1157" ], "lang": { "en-us": { "role": { "documentation": "Information by geographic distribution of business activity identified as either domestic or foreign. Excludes names of countries, states and provinces, and cities.", "label": "Geographic Distribution [Axis]", "terseLabel": "Geographic Distribution [Axis]" } } }, "localname": "GeographicDistributionAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansBasisofFairValueMeasurementDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansSummaryofFairValueMeasurementofLevel3PensionPlanAssetsDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansTargetAllocationforPlanAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_GeographicDistributionDomain": { "auth_ref": [ "r1039", "r1040", "r1140", "r1141", "r1142", "r1143", "r1144", "r1145", "r1146", "r1147", "r1148", "r1149", "r1150", "r1151", "r1152", "r1153", "r1154", "r1155", "r1156", "r1157" ], "lang": { "en-us": { "role": { "documentation": "Allocation of business activity identified as domestic or foreign. Excludes names of countries, states and provinces, and cities.", "label": "Geographic Distribution [Domain]", "terseLabel": "Geographic Distribution [Domain]" } } }, "localname": "GeographicDistributionDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansBasisofFairValueMeasurementDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansSummaryofFairValueMeasurementofLevel3PensionPlanAssetsDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansTargetAllocationforPlanAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_Goodwill": { "auth_ref": [ "r389", "r391", "r953", "r1013" ], "calculation": { "http://www.corteva.com/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill", "periodEndLabel": "Goodwill Ending Balance", "periodStartLabel": "Goodwill Beginning Balance", "terseLabel": "Goodwill" } } }, "localname": "Goodwill", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/ConsolidatedBalanceSheets", "http://www.corteva.com/role/GoodwillandOtherIntangibleAssetsGoodwillbySegmentDetails", "http://www.corteva.com/role/SegmentReportingSegmentInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Goodwill and Intangible Assets Disclosure [Abstract]", "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": { "auth_ref": [ "r415" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for goodwill and intangible assets.", "label": "Goodwill and Intangible Assets Disclosure [Text Block]", "terseLabel": "Goodwill and Intangible Assets Disclosure [Text Block]" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/GoodwillandOtherIntangibleAssets" ], "xbrltype": "textBlockItemType" }, "us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock": { "auth_ref": [ "r397", "r406" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.", "label": "Goodwill and Intangible Assets, Policy [Policy Text Block]", "terseLabel": "Goodwill and Other Intangible Assets" } } }, "localname": "GoodwillAndIntangibleAssetsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_GoodwillForeignCurrencyTranslationGainLoss": { "auth_ref": [ "r394" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill, Foreign Currency Translation Gain (Loss)", "terseLabel": "Currency Translation Adjustment" } } }, "localname": "GoodwillForeignCurrencyTranslationGainLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/GoodwillandOtherIntangibleAssetsGoodwillbySegmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillImpairedAccumulatedImpairmentLoss": { "auth_ref": [ "r392", "r396" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated impairment loss for an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill, Impaired, Accumulated Impairment Loss", "terseLabel": "Accumulated impairment losses on goodwill" } } }, "localname": "GoodwillImpairedAccumulatedImpairmentLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/GoodwillandOtherIntangibleAssetsGoodwillbySegmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillImpairmentLoss": { "auth_ref": [ "r193", "r390", "r393", "r399" ], "calculation": { "http://www.corteva.com/role/ConsolidatedStatementsofIncome": { "order": 11.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill, Impairment Loss", "terseLabel": "Goodwill Impairment Charge" } } }, "localname": "GoodwillImpairmentLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/ConsolidatedStatementsofCashFlows", "http://www.corteva.com/role/ConsolidatedStatementsofIncome", "http://www.corteva.com/role/DivestituresandOtherTransactionsDivestituresandOtherTransactionsNarrativeDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsSPDivestitureDetails", "http://www.corteva.com/role/GoodwillandOtherIntangibleAssetsGoodwillbySegmentDetails", "http://www.corteva.com/role/QuaterlyFinancialDataQuarterlyFinancialDataDetails", "http://www.corteva.com/role/SegmentReportingSegmentReconciliationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Goodwill [Line Items]", "terseLabel": "Goodwill [Line Items]" } } }, "localname": "GoodwillLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/GoodwillandOtherIntangibleAssetsGoodwillbySegmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_GoodwillOtherIncreaseDecrease": { "auth_ref": [ "r395" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease), classified as other, of an asset representing the future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill, Other Increase (Decrease)", "terseLabel": "Other goodwill adjustments and acquisitions" } } }, "localname": "GoodwillOtherIncreaseDecrease", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/GoodwillandOtherIntangibleAssetsGoodwillbySegmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GuaranteeObligationsByNatureAxis": { "auth_ref": [ "r477" ], "lang": { "en-us": { "role": { "documentation": "Information by nature of guarantee.", "label": "Guarantor Obligations, Nature [Axis]", "terseLabel": "Guarantor Obligations, Nature [Axis]" } } }, "localname": "GuaranteeObligationsByNatureAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesGuaranteeNarrativeDetails", "http://www.corteva.com/role/LeasesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_GuaranteeObligationsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Guarantor Obligations [Line Items]", "terseLabel": "Guarantor Obligations [Line Items]" } } }, "localname": "GuaranteeObligationsLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesGuaranteeNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_GuaranteeObligationsMaximumExposure": { "auth_ref": [ "r476" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Maximum potential amount of future payments (undiscounted) the guarantor could be required to make under the guarantee or each group of similar guarantees before reduction for potential recoveries under recourse or collateralization provisions.", "label": "Guarantor Obligations, Maximum Exposure, Undiscounted", "terseLabel": "Guarantee Obligations" } } }, "localname": "GuaranteeObligationsMaximumExposure", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesGuaranteeNarrativeDetails", "http://www.corteva.com/role/LeasesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GuaranteeObligationsNatureDomain": { "auth_ref": [ "r475" ], "lang": { "en-us": { "role": { "documentation": "Represents a description of the nature of the guarantee or each group of similar guarantees.", "label": "Guarantor Obligations, Nature [Domain]", "terseLabel": "Guarantor Obligations, Nature [Domain]" } } }, "localname": "GuaranteeObligationsNatureDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesGuaranteeNarrativeDetails", "http://www.corteva.com/role/LeasesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_HedgeFundsMember": { "auth_ref": [ "r623" ], "lang": { "en-us": { "role": { "documentation": "Investments in registered hedge funds.", "label": "Hedge Funds [Member]", "terseLabel": "Hedge Funds [Member]" } } }, "localname": "HedgeFundsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansBasisofFairValueMeasurementDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansSummaryofFairValueMeasurementofLevel3PensionPlanAssetsDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansTargetAllocationforPlanAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_HedgingDesignationAxis": { "auth_ref": [ "r852", "r869" ], "lang": { "en-us": { "role": { "documentation": "Information by designation of purpose of derivative instrument.", "label": "Hedging Designation [Axis]", "terseLabel": "Hedging Designation [Axis]" } } }, "localname": "HedgingDesignationAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/FinancialInstrumentsCashFlowHedgesIncludedinAOCIDetails", "http://www.corteva.com/role/FinancialInstrumentsEffectofDerivativeInstrumentsDetails", "http://www.corteva.com/role/FinancialInstrumentsFairValueofDerivativesDetails", "http://www.corteva.com/role/FinancialInstrumentsNotionalAmountsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_HedgingDesignationDomain": { "auth_ref": [ "r852" ], "lang": { "en-us": { "role": { "documentation": "Designation of purpose of derivative instrument.", "label": "Hedging Designation [Domain]", "terseLabel": "Hedging Designation [Domain]" } } }, "localname": "HedgingDesignationDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/FinancialInstrumentsCashFlowHedgesIncludedinAOCIDetails", "http://www.corteva.com/role/FinancialInstrumentsEffectofDerivativeInstrumentsDetails", "http://www.corteva.com/role/FinancialInstrumentsFairValueofDerivativesDetails", "http://www.corteva.com/role/FinancialInstrumentsNotionalAmountsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_HedgingRelationshipDomain": { "auth_ref": [ "r852" ], "lang": { "en-us": { "role": { "documentation": "Nature or intent of a hedge.", "label": "Hedging Relationship [Domain]", "terseLabel": "Hedging Relationship [Domain]" } } }, "localname": "HedgingRelationshipDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/FinancialInstrumentsEffectofDerivativeInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_HeldToMaturitySecurities": { "auth_ref": [ "r342", "r350", "r368", "r374" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity).", "label": "Debt Securities, Held-to-Maturity, Amortized Cost, before Allowance for Credit Loss", "terseLabel": "Held-to-maturity securities" } } }, "localname": "HeldToMaturitySecurities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/FinancialInstrumentsFinancialInstrumentsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill": { "auth_ref": [ "r193", "r414" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value.", "label": "Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)", "terseLabel": "Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)", "verboseLabel": "Assets at Fair Value" } } }, "localname": "ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/FairValueMeasurementsFairValueMeasurementNonrecurringBasisDetails", "http://www.corteva.com/role/GoodwillandOtherIntangibleAssetsOtherIntangibleAssetsDetails", "http://www.corteva.com/role/RestructuringandAssetRelatedChargesAssetImpairmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": { "auth_ref": [ "r416", "r431" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.", "label": "Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]", "terseLabel": "Impairment of Long-Lived Assets" } } }, "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_InProcessResearchAndDevelopmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "In process investigation of new knowledge useful in developing new product or service or new process or technique or improvement to existing product or process, and translation of knowledge into plan or design for new product or process or for improvement to existing product or process.", "label": "In Process Research and Development [Member]", "terseLabel": "IPR&D [Member]" } } }, "localname": "InProcessResearchAndDevelopmentMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/FairValueMeasurementsFairValueMeasurementNonrecurringBasisDetails", "http://www.corteva.com/role/GoodwillandOtherIntangibleAssetsOtherIntangibleAssetsDetails", "http://www.corteva.com/role/RestructuringandAssetRelatedChargesAssetImpairmentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": { "auth_ref": [ "r213", "r793" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.", "label": "Income (Loss) from Continuing Operations before Income Taxes, Domestic", "terseLabel": "Income (loss) from Continuing Operations before Income Taxes, Domestic" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/EIDIncomeTaxesGeographicAllocationDetails", "http://www.corteva.com/role/IncomeTaxesIncomeTaxesGeographicAllocationofIncomeandProvisionforIncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "auth_ref": [ "r150", "r306", "r318", "r322", "r325", "r328", "r1011", "r1031", "r1040", "r1076" ], "calculation": { "http://www.corteva.com/role/ConsolidatedStatementsofIncome": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.", "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "terseLabel": "Income (loss) from continuing operations before income taxes", "totalLabel": "Income (loss) from continuing operations before income taxes", "verboseLabel": "Income (loss) from Continuing Operations before Income Taxes" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/BusinessCombinationsDASCommonControlTransferIncomeStatementDetails", "http://www.corteva.com/role/ConsolidatedStatementsofIncome", "http://www.corteva.com/role/EIDIncomeTaxesGeographicAllocationDetails", "http://www.corteva.com/role/EIDSegmentFNSegmentReconciliationDetails", "http://www.corteva.com/role/IncomeTaxesIncomeTaxesGeographicAllocationofIncomeandProvisionforIncomeTaxesDetails", "http://www.corteva.com/role/SegmentReportingSegmentReconciliationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign": { "auth_ref": [ "r213", "r793" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.", "label": "Income (Loss) from Continuing Operations before Income Taxes, Foreign", "terseLabel": "Income (Loss) from Continuing Operations before Income Taxes, Foreign" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/EIDIncomeTaxesGeographicAllocationDetails", "http://www.corteva.com/role/IncomeTaxesIncomeTaxesGeographicAllocationofIncomeandProvisionforIncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r211", "r235", "r306", "r318", "r322", "r325", "r328", "r362", "r480", "r481", "r482", "r485", "r486", "r487", "r489", "r491", "r493", "r494", "r823", "r882", "r896" ], "calculation": { "http://www.corteva.com/role/ConsolidatedStatementsofIncome": { "order": 1.0, "parentTag": "us-gaap_ProfitLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest.", "label": "Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest", "terseLabel": "Income (Loss) from Continuing Operations After Taxes", "totalLabel": "Income (loss) from continuing operations after income taxes", "verboseLabel": "Income (loss) from continuing operations after income taxes" } } }, "localname": "IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/BusinessCombinationsDASCommonControlTransferIncomeStatementDetails", "http://www.corteva.com/role/ConsolidatedStatementsofIncome", "http://www.corteva.com/role/EIDQuarterlyFNDetails", "http://www.corteva.com/role/EIDSegmentFNSegmentReconciliationDetails", "http://www.corteva.com/role/EarningsPerShareNetIncomeforEarningsPerShareCalculationsBasicandDilutedDetails", "http://www.corteva.com/role/IncomeTaxesIncomeTaxesGeographicAllocationofIncomeandProvisionforIncomeTaxesDetails", "http://www.corteva.com/role/QuaterlyFinancialDataQuarterlyFinancialDataDetails", "http://www.corteva.com/role/SegmentReportingSegmentReconciliationDetails", "http://www.corteva.com/role/StockholdersEquityReclassificationsoutofAOCIDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsPerBasicShare": { "auth_ref": [ "r148", "r158", "r235", "r240", "r241", "r243", "r244", "r256", "r265", "r266", "r882", "r1029", "r1032", "r1038", "r1068" ], "calculation": { "http://www.corteva.com/role/ConsolidatedStatementsofIncome": { "order": 1.0, "parentTag": "us-gaap_EarningsPerShareBasic", "weight": 1.0 }, "http://www.corteva.com/role/EarningsPerShareofCommonStockEPSCalculationBasicDetails": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.", "label": "Income (Loss) from Continuing Operations, Per Basic Share", "terseLabel": "Basic earnings (loss) per share of common stock from continuing operations", "verboseLabel": "(Loss) earnings per common share, continuing operations - basic" } } }, "localname": "IncomeLossFromContinuingOperationsPerBasicShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/ConsolidatedStatementsofIncome", "http://www.corteva.com/role/EarningsPerShareofCommonStockEPSCalculationBasicDetails", "http://www.corteva.com/role/QuaterlyFinancialDataQuarterlyFinancialDataDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare": { "auth_ref": [ "r148", "r158", "r235", "r240", "r241", "r243", "r244", "r256", "r265", "r266", "r267", "r882", "r1038", "r1068", "r1071", "r1075" ], "calculation": { "http://www.corteva.com/role/ConsolidatedStatementsofIncome": { "order": 1.0, "parentTag": "us-gaap_EarningsPerShareDiluted", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Income (Loss) from Continuing Operations, Per Diluted Share", "terseLabel": "Diluted earnings (loss) per share of common stock from continuing operations", "verboseLabel": "(Loss) earnings per common share, continuing operations - diluted" } } }, "localname": "IncomeLossFromContinuingOperationsPerDilutedShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/ConsolidatedStatementsofIncome", "http://www.corteva.com/role/EarningsPerShareofCommonStockEPSCalculationDilutedDetails", "http://www.corteva.com/role/QuaterlyFinancialDataQuarterlyFinancialDataDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax": { "auth_ref": [ "r11", "r12", "r13", "r14", "r15", "r29", "r32", "r800", "r1069" ], "calculation": { "http://www.corteva.com/role/ConsolidatedStatementsofIncome": { "order": 2.0, "parentTag": "us-gaap_ProfitLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.", "label": "Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest", "negatedLabel": "Income (loss) from discontinued operations after income taxes", "terseLabel": "(Loss) income from discontinued operations after income taxes", "verboseLabel": "Income (loss) from discontinued operations after income taxes" } } }, "localname": "IncomeLossFromDiscontinuedOperationsNetOfTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/ConsolidatedStatementsofIncome", "http://www.corteva.com/role/DivestituresandOtherTransactionsDivestituresandOtherTransactionsDivestedAgBusinessResultsofOperationsDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsDivestituresandOtherTransactionsNarrativeDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsDivestituresandOtherTransactionsPChemResultsofOperationsDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsECPDivestitureDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsSPDivestitureDetails", "http://www.corteva.com/role/EarningsPerShareNetIncomeforEarningsPerShareCalculationsBasicandDilutedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToNoncontrollingInterest": { "auth_ref": [ "r11", "r12", "r13", "r14", "r15", "r23", "r29", "r821", "r823" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of income (loss) from a discontinued operation attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.", "label": "Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Noncontrolling Interest", "terseLabel": "Loss from Discontinued Operations, Net of Tax, Attributable to Noncontrolling Interest" } } }, "localname": "IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/EarningsPerShareNetIncomeforEarningsPerShareCalculationsBasicandDilutedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromEquityMethodInvestments": { "auth_ref": [ "r151", "r193", "r303", "r361", "r1030", "r1067" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss).", "label": "Income (Loss) from Equity Method Investments", "terseLabel": "Equity in earnings (losses) of affiliates - net" } } }, "localname": "IncomeLossFromEquityMethodInvestments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/SupplementaryInformationOtherIncomeExpenseNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r146", "r162" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, before tax, of income (loss) including portion attributable to noncontrolling interest. Includes, but is not limited to, income (loss) from continuing operations, discontinued operations and equity method investments.", "label": "Income (Loss), Including Portion Attributable to Noncontrolling Interest, before Tax", "terseLabel": "Income (Loss), Including Portion Attributable to Noncontrolling Interest, before Tax" } } }, "localname": "IncomeLossIncludingPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/DivestituresandOtherTransactionsDivestituresandOtherTransactionsDivestedAgBusinessResultsofOperationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]", "terseLabel": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis": { "auth_ref": [ "r680", "r693" ], "lang": { "en-us": { "role": { "documentation": "Information by name of disposal group.", "label": "Disposal Group Name [Axis]", "terseLabel": "Disposal Group Name [Axis]" } } }, "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/BackgroundandBasisofPresentationPolicies", "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationChemoursDetails", "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationOtherPFOAMattersFayattevilleDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsDivestituresandOtherTransactionsDivestedAgBusinessResultsofOperationsDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsDivestituresandOtherTransactionsNarrativeDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsDivestituresandOtherTransactionsPChemResultsofOperationsDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsECPDivestitureDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsSPDivestitureDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsTables", "http://www.corteva.com/role/SupplementaryInformationOtherIncomeExpenseNetDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]", "terseLabel": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]" } } }, "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/BackgroundandBasisofPresentationPolicies", "http://www.corteva.com/role/DivestituresandOtherTransactionsDivestituresandOtherTransactionsDivestedAgBusinessResultsofOperationsDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsDivestituresandOtherTransactionsNarrativeDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsDivestituresandOtherTransactionsPChemResultsofOperationsDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsECPDivestitureDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsSPDivestitureDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsTables" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable": { "auth_ref": [ "r5", "r17", "r18", "r19", "r20", "r21", "r22", "r27", "r30", "r31", "r32", "r429", "r430" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.", "label": "Disposal Groups, Including Discontinued Operations [Table]", "terseLabel": "Disposal Groups, Including Discontinued Operations [Table]" } } }, "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/BackgroundandBasisofPresentationPolicies", "http://www.corteva.com/role/DivestituresandOtherTransactionsDivestituresandOtherTransactionsDivestedAgBusinessResultsofOperationsDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsDivestituresandOtherTransactionsNarrativeDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsDivestituresandOtherTransactionsPChemResultsofOperationsDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsECPDivestitureDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsSPDivestitureDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsTables" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationAxis": { "auth_ref": [ "r426", "r445" ], "lang": { "en-us": { "role": { "documentation": "Information by location in the income statement.", "label": "Income Statement Location [Axis]", "terseLabel": "Income Statement Location [Axis]" } } }, "localname": "IncomeStatementLocationAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/FinancialInstrumentsEffectofDerivativeInstrumentsDetails", "http://www.corteva.com/role/RestructuringandAssetRelatedCharges2021RestructuringActionsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationDomain": { "auth_ref": [ "r445" ], "lang": { "en-us": { "role": { "documentation": "Location in the income statement.", "label": "Income Statement Location [Domain]", "terseLabel": "Income Statement Location [Domain]" } } }, "localname": "IncomeStatementLocationDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/FinancialInstrumentsEffectofDerivativeInstrumentsDetails", "http://www.corteva.com/role/RestructuringandAssetRelatedCharges2021RestructuringActionsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxAuthorityAxis": { "auth_ref": [ "r758" ], "lang": { "en-us": { "role": { "documentation": "Information by tax jurisdiction.", "label": "Income Tax Authority [Axis]", "terseLabel": "Income Tax Authority [Axis]" } } }, "localname": "IncomeTaxAuthorityAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/QuaterlyFinancialDataQuarterlyFinancialDataParentheticalsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxAuthorityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.", "label": "Income Tax Authority [Domain]", "terseLabel": "Income Tax Authority [Domain]" } } }, "localname": "IncomeTaxAuthorityDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/QuaterlyFinancialDataQuarterlyFinancialDataParentheticalsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxContingencyLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Income Tax Contingency [Line Items]", "terseLabel": "Income Tax Contingency [Line Items]" } } }, "localname": "IncomeTaxContingencyLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/IncomeTaxesIncomeTaxesGrossUnrecognizedTaxBenefitsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxContingencyTable": { "auth_ref": [ "r759", "r766", "r768", "r782" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about tax positions taken in the tax returns filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities and other income tax contingencies. Includes, but is not limited to, interest and penalties, reconciliation of unrecognized tax benefits, unrecognized tax benefits that would affect the effective tax rate, tax years that remain subject to examination by tax jurisdictions, and information about positions for which it is reasonably possible that amounts unrecognized will significantly change within 12 months.", "label": "Income Tax Contingency [Table]", "terseLabel": "Income Tax Contingency [Table]" } } }, "localname": "IncomeTaxContingencyTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/IncomeTaxesIncomeTaxesGrossUnrecognizedTaxBenefitsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Abstract]", "terseLabel": "Income Tax Disclosure [Abstract]" } } }, "localname": "IncomeTaxDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureTextBlock": { "auth_ref": [ "r214", "r756", "r767", "r774", "r788", "r795", "r801", "r802", "r804" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.", "label": "Income Tax Disclosure [Text Block]", "terseLabel": "Income Tax Disclosure [Text Block]" } } }, "localname": "IncomeTaxDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/EIDIncomeTaxesNotes", "http://www.corteva.com/role/IncomeTaxes" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r215", "r248", "r249", "r304", "r754", "r789", "r797", "r1077" ], "calculation": { "http://www.corteva.com/role/ConsolidatedStatementsofIncome": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income Tax Expense (Benefit)", "terseLabel": "Provision for (benefit from) income taxes on continuing operations", "verboseLabel": "Income Tax Expense (Benefit)" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/ConsolidatedStatementsofIncome", "http://www.corteva.com/role/EIDIncomeTaxesGeographicAllocationDetails", "http://www.corteva.com/role/EIDSegmentFNSegmentReconciliationDetails", "http://www.corteva.com/role/IncomeTaxesIncomeTaxesGeographicAllocationofIncomeandProvisionforIncomeTaxesDetails", "http://www.corteva.com/role/SegmentReportingSegmentReconciliationDetails", "http://www.corteva.com/role/StockholdersEquityReclassificationsoutofAOCIDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxPolicyTextBlock": { "auth_ref": [ "r143", "r750", "r751", "r767", "r768", "r773", "r781" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.", "label": "Income Tax, Policy [Policy Text Block]", "terseLabel": "Income Taxes" } } }, "localname": "IncomeTaxPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxesPaid": { "auth_ref": [ "r189", "r197" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.", "label": "Income Taxes Paid", "terseLabel": "Income Taxes" } } }, "localname": "IncomeTaxesPaid", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsAndNotesReceivable": { "auth_ref": [ "r192" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period of the sum of amounts due within one year (or one business cycle) from customers for the credit sale of goods and services; and from note holders for outstanding loans.", "label": "Increase (Decrease) in Accounts and Notes Receivable", "negatedTerseLabel": "Accounts and Notes Receivable" } } }, "localname": "IncreaseDecreaseInAccountsAndNotesReceivable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayable": { "auth_ref": [ "r192" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.", "label": "Increase (Decrease) in Accounts Payable", "terseLabel": "Accounts Payable" } } }, "localname": "IncreaseDecreaseInAccountsPayable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInDeferredRevenue": { "auth_ref": [ "r192" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.", "label": "Increase (Decrease) in Deferred Revenue", "terseLabel": "Deferred Revenue" } } }, "localname": "IncreaseDecreaseInDeferredRevenue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInInventories": { "auth_ref": [ "r192" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.", "label": "Increase (Decrease) in Inventories", "negatedTerseLabel": "Inventories" } } }, "localname": "IncreaseDecreaseInInventories", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInInventoriesAndOtherOperatingAssets": { "auth_ref": [ "r192" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in inventory, and assets classified as other.", "label": "Increase (Decrease) in Inventories and Other Operating Assets", "negatedTerseLabel": "Inventories and Other Operating Assets" } } }, "localname": "IncreaseDecreaseInInventoriesAndOtherOperatingAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities": { "auth_ref": [ "r192" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in other obligations or expenses incurred but not yet paid.", "label": "Increase (Decrease) in Other Accounts Payable and Accrued Liabilities", "terseLabel": "Accounts Payable and Other Operating Liabilities" } } }, "localname": "IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet": { "auth_ref": [ "r192" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.", "label": "Increase (Decrease) in Other Operating Assets and Liabilities, Net", "negatedTerseLabel": "Other Assets and Liabilities, Net" } } }, "localname": "IncreaseDecreaseInOtherOperatingCapitalNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": { "auth_ref": [ "r404", "r412" ], "lang": { "en-us": { "role": { "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.", "label": "Indefinite-lived Intangible Assets [Axis]", "terseLabel": "Indefinite-lived Intangible Assets [Axis]" } } }, "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/GoodwillandOtherIntangibleAssetsOtherIntangibleAssetsDetails", "http://www.corteva.com/role/RestructuringandAssetRelatedChargesAssetImpairmentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": { "auth_ref": [ "r412" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.", "label": "Indefinite-lived Intangible Assets (Excluding Goodwill)", "terseLabel": "Indefinite-lived Intangible Assets" } } }, "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/GoodwillandOtherIntangibleAssetsOtherIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillFairValueDisclosure": { "auth_ref": [ "r884" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of assets, excluding financial assets and goodwill, that lack physical substance, having a projected indefinite period of benefit.", "label": "Indefinite-lived Intangible Assets (Excluding Goodwill), Fair Value Disclosure", "terseLabel": "Assets at Fair Value" } } }, "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwillFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/FairValueMeasurementsFairValueMeasurementNonrecurringBasisDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": { "auth_ref": [ "r404", "r412" ], "lang": { "en-us": { "role": { "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company.", "label": "Indefinite-lived Intangible Assets, Major Class Name [Domain]", "terseLabel": "Indefinite-lived Intangible Assets, Major Class Name [Domain]" } } }, "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/GoodwillandOtherIntangibleAssetsOtherIntangibleAssetsDetails", "http://www.corteva.com/role/RestructuringandAssetRelatedChargesAssetImpairmentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IndemnificationGuaranteeMember": { "auth_ref": [ "r472", "r478" ], "lang": { "en-us": { "role": { "documentation": "An agreement (contract) that contingently requires the guarantor to make payments to the guaranteed party in compensation for that party's or parties' loss or injury attributable to specified events or actions, such as a patent infringement action against an entity that relied on certain representations as to ownership rights made by a software vendor.", "label": "Indemnification Agreement [Member]", "terseLabel": "Indemnification Agreement [Member]" } } }, "localname": "IndemnificationGuaranteeMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesEnvironmentalDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IntangibleAssetsGrossExcludingGoodwill": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated amortization of intangible assets, excluding goodwill.", "label": "Intangible Assets, Gross (Excluding Goodwill)", "terseLabel": "Total Intangible Assets, Gross" } } }, "localname": "IntangibleAssetsGrossExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/GoodwillandOtherIntangibleAssetsOtherIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "auth_ref": [ "r401", "r407" ], "calculation": { "http://www.corteva.com/role/ConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.", "label": "Intangible Assets, Net (Excluding Goodwill)", "terseLabel": "Other intangible assets", "verboseLabel": "Total intangible assets - net" } } }, "localname": "IntangibleAssetsNetExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/ConsolidatedBalanceSheets", "http://www.corteva.com/role/GoodwillandOtherIntangibleAssetsOtherIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestAndDebtExpense": { "auth_ref": [ "r914" ], "calculation": { "http://www.corteva.com/role/ConsolidatedStatementsofIncome": { "order": 7.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Interest and debt related expenses associated with nonoperating financing activities of the entity.", "label": "Interest and Debt Expense", "terseLabel": "Interest Expense" } } }, "localname": "InterestAndDebtExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/ConsolidatedStatementsofIncome", "http://www.corteva.com/role/EIDSegmentFNSegmentReconciliationDetails", "http://www.corteva.com/role/SegmentReportingSegmentReconciliationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpenseRelatedParty": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of interest expense incurred on a debt or other obligation to related party.", "label": "Interest Expense, Related Party", "terseLabel": "Interest Expense, Related Party" } } }, "localname": "InterestExpenseRelatedParty", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/EIDRelatedPartyDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestIncomeOperating": { "auth_ref": [ "r160" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of operating interest income, including, but not limited to, amortization and accretion of premiums and discounts on securities.", "label": "Interest Income, Operating", "terseLabel": "Interest income" } } }, "localname": "InterestIncomeOperating", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/EIDSegmentFNSegmentReconciliationDetails", "http://www.corteva.com/role/SegmentReportingSegmentReconciliationDetails", "http://www.corteva.com/role/SupplementaryInformationOtherIncomeExpenseNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaidNet": { "auth_ref": [ "r184", "r188", "r197" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.", "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities", "terseLabel": "Interest, net of amounts capitalized" } } }, "localname": "InterestPaidNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryCurrentTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about inventory expected to be sold or consumed within one year or operating cycle, if longer.", "label": "Inventory, Current [Table]", "terseLabel": "Inventory, Current [Table]" } } }, "localname": "InventoryCurrentTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/InventoriesScheduleofInventoryDetails" ], "xbrltype": "stringItemType" }, "us-gaap_InventoryDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Inventory Disclosure [Abstract]", "terseLabel": "Inventory Disclosure [Abstract]" } } }, "localname": "InventoryDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_InventoryDisclosureTextBlock": { "auth_ref": [ "r386" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.", "label": "Inventory Disclosure [Text Block]", "terseLabel": "Inventory Disclosure [Text Block]" } } }, "localname": "InventoryDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/Inventories" ], "xbrltype": "textBlockItemType" }, "us-gaap_InventoryFinishedGoods": { "auth_ref": [ "r104" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.", "label": "Inventory, Finished Goods, Gross", "terseLabel": "Finished products" } } }, "localname": "InventoryFinishedGoods", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/InventoriesScheduleofInventoryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryGross": { "auth_ref": [ "r107" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Gross amount, as of the balance sheet date, of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.", "label": "Inventory, Gross", "terseLabel": "Total inventories" } } }, "localname": "InventoryGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/InventoriesScheduleofInventoryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Inventory [Line Items]", "terseLabel": "Inventory [Line Items]" } } }, "localname": "InventoryLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/InventoriesScheduleofInventoryDetails" ], "xbrltype": "stringItemType" }, "us-gaap_InventoryNet": { "auth_ref": [ "r37", "r107", "r953" ], "calculation": { "http://www.corteva.com/role/ConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Inventory, Net", "terseLabel": "Inventories" } } }, "localname": "InventoryNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryNetAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Inventory, Net [Abstract]", "terseLabel": "Inventory, Net [Abstract]" } } }, "localname": "InventoryNetAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_InventoryPolicyTextBlock": { "auth_ref": [ "r46", "r108", "r204", "r277", "r384", "r385", "r386", "r991" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.", "label": "Inventory, Policy [Policy Text Block]", "terseLabel": "Inventories" } } }, "localname": "InventoryPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_InventoryRawMaterialsAndSupplies": { "auth_ref": [ "r106" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Gross amount of unprocessed materials to be used in manufacturing or production process and supplies that will be consumed.", "label": "Inventory, Raw Materials and Supplies, Gross", "terseLabel": "Raw materials and supplies" } } }, "localname": "InventoryRawMaterialsAndSupplies", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/InventoriesScheduleofInventoryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryValuationReserveMember": { "auth_ref": [ "r222", "r223", "r224", "r226", "r227" ], "lang": { "en-us": { "role": { "documentation": "Reserve to reduce inventory to lower of cost or net realizable value.", "label": "SEC Schedule, 12-09, Reserve, Inventory [Member]", "terseLabel": "SEC Schedule, 12-09, Reserve, Inventory [Member]" } } }, "localname": "InventoryValuationReserveMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/ScheduleIIValuationandQualifyingAccountsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_InventoryWorkInProcess": { "auth_ref": [ "r105" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer.", "label": "Inventory, Work in Process, Gross", "terseLabel": "Semi-finished products" } } }, "localname": "InventoryWorkInProcess", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/InventoriesScheduleofInventoryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentTypeAxis": { "auth_ref": [ "r1096", "r1097", "r1098", "r1099", "r1100", "r1101", "r1102", "r1103", "r1104", "r1105", "r1106", "r1107", "r1108", "r1109", "r1110" ], "lang": { "en-us": { "role": { "documentation": "Information by type of investments.", "label": "Investment Type [Axis]", "terseLabel": "Investment Type [Axis]" } } }, "localname": "InvestmentTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/FinancialInstrumentsDebtSecuritiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_InvestmentTypeCategorizationMember": { "auth_ref": [ "r1096", "r1097", "r1098", "r1099", "r1100", "r1101", "r1102", "r1103", "r1104", "r1105", "r1106", "r1107", "r1108", "r1109", "r1110" ], "lang": { "en-us": { "role": { "documentation": "Asset obtained to generate income or appreciate in value.", "label": "Investments [Domain]", "terseLabel": "Investments [Domain]" } } }, "localname": "InvestmentTypeCategorizationMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/FinancialInstrumentsDebtSecuritiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_InvestmentsAllOtherInvestmentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investments, All Other Investments [Abstract]", "terseLabel": "Investments, All Other Investments [Abstract]" } } }, "localname": "InvestmentsAllOtherInvestmentsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_LandAndLandImprovementsMember": { "auth_ref": [ "r44" ], "lang": { "en-us": { "role": { "documentation": "Real estate held and assets that are an addition or improvement to real estate held.", "label": "Land and Land Improvements [Member]", "terseLabel": "Land and Land Improvements [Member]" } } }, "localname": "LandAndLandImprovementsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/PropertyPlantandEquipmentScheduleofPropertyPlantandEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LandImprovementsMember": { "auth_ref": [ "r44" ], "lang": { "en-us": { "role": { "documentation": "Additions or improvements to real estate held.", "label": "Land Improvements [Member]", "terseLabel": "Land Improvements [Member]" } } }, "localname": "LandImprovementsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/PropertyPlantandEquipmentScheduleofPropertyPlantandEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LeaseCost": { "auth_ref": [ "r938", "r940" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lease cost recognized by lessee for lease contract.", "label": "Lease, Cost", "terseLabel": "Total Lease Cost" } } }, "localname": "LeaseCost", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/LeasesLeaseCostsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LeaseCostTableTextBlock": { "auth_ref": [ "r938" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.", "label": "Lease, Cost [Table Text Block]", "terseLabel": "Lease, Cost [Table Text Block]" } } }, "localname": "LeaseCostTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/LeasesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LeasesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Leases [Abstract]", "terseLabel": "Leases [Abstract]" } } }, "localname": "LeasesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_LeasesOfLesseeDisclosureTextBlock": { "auth_ref": [ "r923" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for lessee entity's leasing arrangements including, but not limited to, all of the following: (a.) The basis on which contingent rental payments are determined, (b.) The existence and terms of renewal or purchase options and escalation clauses, (c.) Restrictions imposed by lease agreements, such as those concerning dividends, additional debt, and further leasing.", "label": "Leases of Lessee Disclosure [Text Block]", "terseLabel": "Leases of Lessee Disclosure [Text Block]" } } }, "localname": "LeasesOfLesseeDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/LeasesNotes" ], "xbrltype": "textBlockItemType" }, "us-gaap_LegalCostsPolicyTextBlock": { "auth_ref": [ "r470" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for legal costs incurred to protect or defend the entity's assets and rights, or to obtain assets, including monetary damages, or to obtain rights.", "label": "Legal Costs, Policy [Policy Text Block]", "terseLabel": "Litigation" } } }, "localname": "LegalCostsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeLeasesPolicyTextBlock": { "auth_ref": [ "r930" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.", "label": "Lessee, Leases [Policy Text Block]", "terseLabel": "Leases" } } }, "localname": "LesseeLeasesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": { "auth_ref": [ "r939" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.", "label": "Lessee, Operating Lease, Liability, to be Paid", "terseLabel": "Operating Lease, Total Payments" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/LeasesMaturityofLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": { "auth_ref": [ "r939" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five", "terseLabel": "Operating Lease, Due After Year Five" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/LeasesMaturityofLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": { "auth_ref": [ "r939" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year One", "terseLabel": "Operating Lease, Year One" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/LeasesMaturityofLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": { "auth_ref": [ "r939" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five", "terseLabel": "Operating Lease, Year Five" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/LeasesMaturityofLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": { "auth_ref": [ "r939" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four", "terseLabel": "Operating Lease, Year Four" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/LeasesMaturityofLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": { "auth_ref": [ "r939" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three", "terseLabel": "Operating Lease, Year Three" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/LeasesMaturityofLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": { "auth_ref": [ "r939" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two", "terseLabel": "Operating Lease, Year Two" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/LeasesMaturityofLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": { "auth_ref": [ "r939" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.", "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount", "terseLabel": "Operating Lease, Interest" } } }, "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/LeasesMaturityofLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LettersOfCreditOutstandingAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.", "label": "Letters of Credit Outstanding, Amount", "terseLabel": "Letters of Credit Outstanding, Amount" } } }, "localname": "LettersOfCreditOutstandingAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/LongTermDebtandAvailableCreditFacilitiesUncommittedCreditFacilitiesandOutstandingLettersofCreditDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r74", "r211", "r362", "r896", "r953", "r1021", "r1061" ], "calculation": { "http://www.corteva.com/role/ConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total Liabilities and Equity" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r94", "r211", "r362", "r480", "r481", "r482", "r485", "r486", "r487", "r489", "r491", "r493", "r494", "r829", "r838", "r839", "r896", "r951", "r952", "r953" ], "calculation": { "http://www.corteva.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesFairValueDisclosure": { "auth_ref": [ "r884" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of financial and nonfinancial obligations.", "label": "Financial and Nonfinancial Liabilities, Fair Value Disclosure", "terseLabel": "Total Liabilities at fair value" } } }, "localname": "LiabilitiesFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/FairValueMeasurementsFairValueMeasurementRecurringBasisDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesNoncurrent": { "auth_ref": [ "r47", "r48", "r49", "r59", "r60", "r211", "r362", "r480", "r481", "r482", "r485", "r486", "r487", "r489", "r491", "r493", "r494", "r829", "r838", "r839", "r896", "r951", "r952" ], "calculation": { "http://www.corteva.com/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation due after one year or beyond the normal operating cycle, if longer.", "label": "Liabilities, Noncurrent", "totalLabel": "Liabilities, Noncurrent" } } }, "localname": "LiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation": { "auth_ref": [ "r4", "r5", "r26", "r28", "r32", "r427" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount classified as liabilities attributable to disposal group held for sale or disposed of.", "label": "Disposal Group, Including Discontinued Operation, Liabilities", "terseLabel": "Total Liabilities of discontinued operations" } } }, "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/DivestituresandOtherTransactionsECPDivestitureDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsSPDivestitureDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent": { "auth_ref": [ "r4", "r5", "r26", "r28", "r32", "r420", "r427" ], "calculation": { "http://www.corteva.com/role/ConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount classified as liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.", "label": "Disposal Group, Including Discontinued Operation, Liabilities, Current", "terseLabel": "Total Current Liabilities - Discontinued Operations" } } }, "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/DivestituresandOtherTransactionsECPDivestitureDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsSPDivestitureDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent": { "auth_ref": [ "r4", "r5", "r26", "r28", "r32", "r417", "r427" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount classified as liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of beyond one year or the normal operating cycle, if longer.", "label": "Disposal Group, Including Discontinued Operation, Liabilities, Noncurrent", "terseLabel": "Non-current Liabilities - Discontinued Operations" } } }, "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/DivestituresandOtherTransactionsECPDivestitureDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsSPDivestitureDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCredit": { "auth_ref": [ "r59", "r1019", "r1049" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.", "label": "Long-term Line of Credit", "terseLabel": "Long-term Line of Credit" } } }, "localname": "LineOfCredit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/LongTermDebtandAvailableCreditFacilitiesDebtRedemptionsRepaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Line of Credit Facility [Line Items]", "terseLabel": "Line of Credit Facility [Line Items]" } } }, "localname": "LineOfCreditFacilityLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/LongTermDebtandAvailableCreditFacilitiesAvailableCommittedCreditFacilitiesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": { "auth_ref": [ "r89" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.", "label": "Line of Credit Facility, Maximum Borrowing Capacity", "terseLabel": "Line of Credit Facility, Maximum Borrowing Capacity" } } }, "localname": "LineOfCreditFacilityMaximumBorrowingCapacity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/LongTermDebtandAvailableCreditFacilitiesAvailableCommittedCreditFacilitiesNarrativeDetails", "http://www.corteva.com/role/LongTermDebtandAvailableCreditFacilitiesDebtRedemptionsRepaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityPeriodicPaymentPrincipal": { "auth_ref": [ "r89" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the required periodic payment applied to principal.", "label": "Line of Credit Facility, Periodic Payment, Principal", "terseLabel": "Line of Credit Facility, Periodic Payment, Principal" } } }, "localname": "LineOfCreditFacilityPeriodicPaymentPrincipal", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/LongTermDebtandAvailableCreditFacilitiesLongTermDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity": { "auth_ref": [ "r89" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).", "label": "Line of Credit Facility, Remaining Borrowing Capacity", "terseLabel": "Line of Credit Facility, Remaining Borrowing Capacity" } } }, "localname": "LineOfCreditFacilityRemainingBorrowingCapacity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/LongTermDebtandAvailableCreditFacilitiesAvailableCommittedCreditFacilitiesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityTable": { "auth_ref": [ "r89", "r210" ], "lang": { "en-us": { "role": { "documentation": "A table or schedule providing information pertaining to short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.", "label": "Line of Credit Facility [Table]", "terseLabel": "Line of Credit Facility [Table]" } } }, "localname": "LineOfCreditFacilityTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/LongTermDebtandAvailableCreditFacilitiesAvailableCommittedCreditFacilitiesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LitigationSettlementAmountAwardedToOtherParty": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount awarded to other party in judgment or settlement of litigation.", "label": "Litigation Settlement, Amount Awarded to Other Party", "terseLabel": "Litigation Settlement Amount" } } }, "localname": "LitigationSettlementAmountAwardedToOtherParty", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationChemoursDetails", "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationLeachandMDLSettlementDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsDivestituresandOtherTransactionsPChemResultsofOperationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LitigationStatusAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by status of pending, threatened, or settled litigation.", "label": "Litigation Status [Axis]", "terseLabel": "Litigation Status [Axis]" } } }, "localname": "LitigationStatusAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationLeachandMDLSettlementDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsDivestituresandOtherTransactionsPChemResultsofOperationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LitigationStatusDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Status of pending, threatened, or settled litigation.", "label": "Litigation Status [Domain]", "terseLabel": "Litigation Status [Domain]" } } }, "localname": "LitigationStatusDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationLeachandMDLSettlementDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsDivestituresandOtherTransactionsPChemResultsofOperationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock": { "auth_ref": [ "r344" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for claims held for amounts due a entity, excluding financing receivables. Examples include, but are not limited to, trade accounts receivables, notes receivables, loans receivables. Includes disclosure for allowance for credit losses.", "label": "Loans, Notes, Trade and Other Receivables Disclosure [Text Block]", "terseLabel": "Accounts and Notes Receivables, Net" } } }, "localname": "LoansNotesTradeAndOtherReceivablesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/AccountsandNotesReceivableNet" ], "xbrltype": "textBlockItemType" }, "us-gaap_LoansPayableMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Borrowing supported by a written promise to pay an obligation.", "label": "Loans Payable [Member]", "terseLabel": "Loans Payable [Member]" } } }, "localname": "LoansPayableMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/LongTermDebtandAvailableCreditFacilitiesDebtRedemptionsRepaymentsDetails", "http://www.corteva.com/role/LongTermDebtandAvailableCreditFacilitiesLongTermDebtDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LongTermDebtAndCapitalLeaseObligations": { "auth_ref": [ "r59" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt and lease obligation, classified as noncurrent.", "label": "Long-term Debt and Lease Obligation", "terseLabel": "Long-term Debt", "verboseLabel": "Long-term Debt" } } }, "localname": "LongTermDebtAndCapitalLeaseObligations", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/ConsolidatedBalanceSheets", "http://www.corteva.com/role/LongTermDebtandAvailableCreditFacilitiesLongTermDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtCurrent": { "auth_ref": [ "r91" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.", "label": "Long-term Debt, Current Maturities", "terseLabel": "Long-term debt payable within one year" } } }, "localname": "LongTermDebtCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/LongTermDebtandAvailableCreditFacilitiesLongTermDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtFairValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission.", "label": "Long-term Debt, Fair Value", "terseLabel": "Long-term Debt, Fair Value" } } }, "localname": "LongTermDebtFairValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/LongTermDebtandAvailableCreditFacilitiesLongTermDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Debt arrangement having an initial term longer than one year or beyond the normal operating cycle, if longer.", "label": "Long-term Debt [Member]", "terseLabel": "Long-term Debt [Member]" } } }, "localname": "LongTermDebtMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/LeasesSupplementalBalanceSheetInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LongtermDebtTypeAxis": { "auth_ref": [ "r96" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-term debt.", "label": "Long-term Debt, Type [Axis]", "terseLabel": "Long-term Debt, Type [Axis]" } } }, "localname": "LongtermDebtTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/LongTermDebtandAvailableCreditFacilitiesAvailableCommittedCreditFacilitiesNarrativeDetails", "http://www.corteva.com/role/LongTermDebtandAvailableCreditFacilitiesDebtRedemptionsRepaymentsDetails", "http://www.corteva.com/role/LongTermDebtandAvailableCreditFacilitiesLongTermDebtDetails", "http://www.corteva.com/role/LongTermDebtandAvailableCreditFacilitiesUncommittedCreditFacilitiesandOutstandingLettersofCreditDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LongtermDebtTypeDomain": { "auth_ref": [ "r96", "r479" ], "lang": { "en-us": { "role": { "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Long-term Debt, Type [Domain]", "terseLabel": "Long-term Debt, Type [Domain]" } } }, "localname": "LongtermDebtTypeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/LongTermDebtandAvailableCreditFacilitiesAvailableCommittedCreditFacilitiesNarrativeDetails", "http://www.corteva.com/role/LongTermDebtandAvailableCreditFacilitiesDebtRedemptionsRepaymentsDetails", "http://www.corteva.com/role/LongTermDebtandAvailableCreditFacilitiesLongTermDebtDetails", "http://www.corteva.com/role/LongTermDebtandAvailableCreditFacilitiesUncommittedCreditFacilitiesandOutstandingLettersofCreditDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LongtermDebtWeightedAverageInterestRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average interest rate of long-term debt outstanding calculated at point in time.", "label": "Long-term Debt, Weighted Average Interest Rate, at Point in Time", "terseLabel": "Long-term Debt, Weighted Average Interest Rate" } } }, "localname": "LongtermDebtWeightedAverageInterestRate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/LongTermDebtandAvailableCreditFacilitiesLongTermDebtDetails" ], "xbrltype": "percentItemType" }, "us-gaap_LongtermTransitionBondCurrentAndNoncurrent": { "auth_ref": [ "r93", "r1028", "r1065" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Long-Term transition bonds are bonds under the Competition Act in which the proceeds of Transition Bonds are required to be used principally to reduce qualified stranded costs and the related capitalization of the utility. This represents the current and noncurrent portions. The initial maturity is beyond one year or beyond the normal operating cycle, if longer.", "label": "Long-term Transition Bond", "terseLabel": "Long-term Transition Bond" } } }, "localname": "LongtermTransitionBondCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/LongTermDebtandAvailableCreditFacilitiesDebtRedemptionsRepaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LossContingenciesByNatureOfContingencyAxis": { "auth_ref": [ "r461", "r462", "r463", "r465", "r466", "r467", "r468", "r473", "r474" ], "lang": { "en-us": { "role": { "documentation": "Information by type of existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur.", "label": "Loss Contingency Nature [Axis]", "terseLabel": "Loss Contingency Nature [Axis]" } } }, "localname": "LossContingenciesByNatureOfContingencyAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesEnvironmentalDetails", "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationChemoursDetails", "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationDuPontDetails", "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationLeachandMDLSettlementDetails", "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationOtherPFOAMattersFayattevilleDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsDivestituresandOtherTransactionsPChemResultsofOperationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LossContingenciesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Loss Contingencies [Line Items]", "terseLabel": "Loss Contingencies [Line Items]" } } }, "localname": "LossContingenciesLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesEnvironmentalDetails", "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationChemoursDetails", "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationDuPontDetails", "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationLeachandMDLSettlementDetails", "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationOtherPFOAMattersFayattevilleDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LossContingenciesTable": { "auth_ref": [ "r461", "r462", "r463", "r465", "r466", "r467", "r468", "r473", "r474" ], "lang": { "en-us": { "role": { "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.", "label": "Loss Contingencies [Table]", "terseLabel": "Loss Contingencies [Table]" } } }, "localname": "LossContingenciesTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesEnvironmentalDetails", "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationChemoursDetails", "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationDuPontDetails", "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationLeachandMDLSettlementDetails", "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationOtherPFOAMattersFayattevilleDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LossContingencyNatureDomain": { "auth_ref": [ "r461", "r462", "r463", "r465", "r466", "r467", "r468", "r473", "r474" ], "lang": { "en-us": { "role": { "documentation": "An existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur. Resolution of the uncertainty may confirm the incurrence of a loss or impairment of an asset or the incurrence of a liability.", "label": "Loss Contingency, Nature [Domain]", "terseLabel": "Loss Contingency, Nature [Domain]" } } }, "localname": "LossContingencyNatureDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesEnvironmentalDetails", "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationChemoursDetails", "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationDuPontDetails", "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationLeachandMDLSettlementDetails", "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationOtherPFOAMattersFayattevilleDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsDivestituresandOtherTransactionsPChemResultsofOperationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LossContingencyPendingClaimsNumber": { "auth_ref": [ "r464" ], "lang": { "en-us": { "role": { "documentation": "Number of pending claims pertaining to a loss contingency.", "label": "Loss Contingency, Pending Claims, Number", "terseLabel": "Loss Contingency, Pending Claims, Number" } } }, "localname": "LossContingencyPendingClaimsNumber", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationChemoursDetails", "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationLeachandMDLSettlementDetails", "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationOtherPFOAMattersFayattevilleDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsDivestituresandOtherTransactionsPChemResultsofOperationsDetails" ], "xbrltype": "integerItemType" }, "us-gaap_MachineryAndEquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.", "label": "Machinery and Equipment [Member]", "terseLabel": "Machinery and Equipment [Member]" } } }, "localname": "MachineryAndEquipmentMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/PropertyPlantandEquipmentScheduleofPropertyPlantandEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MarketableSecuritiesPolicy": { "auth_ref": [ "r1042" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for investment classified as marketable security.", "label": "Marketable Securities, Policy [Policy Text Block]", "terseLabel": "Marketable Securities" } } }, "localname": "MarketableSecuritiesPolicy", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_MaterialReconcilingItemsMember": { "auth_ref": [ "r322" ], "lang": { "en-us": { "role": { "documentation": "Items used in reconciling reportable segments' amounts to consolidated amount. Excludes corporate-level activity.", "label": "Segment Reconciling Items [Member]", "terseLabel": "Segment Reconciling Items [Member]" } } }, "localname": "MaterialReconcilingItemsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/EIDSegmentFNSegmentReconciliationDetails", "http://www.corteva.com/role/QuaterlyFinancialDataQuarterlyFinancialDataParentheticalsDetails", "http://www.corteva.com/role/SegmentReportingOtherItemsDetails", "http://www.corteva.com/role/SegmentReportingSegmentInformationDetails", "http://www.corteva.com/role/SegmentReportingSegmentReconciliationDetails", "http://www.corteva.com/role/SegmentReportingSigItemsDetails", "http://www.corteva.com/role/SupplementaryInformationOtherIncomeExpenseNetDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MediumTermNotesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Debt instruments with maturities ranging from five to ten years.", "label": "Medium-term Notes [Member]", "terseLabel": "Medium-term Notes [Member]" } } }, "localname": "MediumTermNotesMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/LongTermDebtandAvailableCreditFacilitiesLongTermDebtDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MinorityInterest": { "auth_ref": [ "r103", "r211", "r362", "r480", "r485", "r486", "r487", "r493", "r494", "r896", "r1020", "r1060" ], "calculation": { "http://www.corteva.com/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).", "label": "Stockholders' Equity Attributable to Noncontrolling Interest", "terseLabel": "Noncontrolling Interests" } } }, "localname": "MinorityInterest", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_MinorityInterestDecreaseFromRedemptions": { "auth_ref": [ "r561", "r826", "r827" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Decrease in noncontrolling interest (for example, but not limited to, redeeming or purchasing the interests of noncontrolling shareholders, issuance of shares (interests) by the non-wholly owned subsidiary to the parent entity for other than cash, and a buyback of shares (interest) by the non-wholly owned subsidiary from the noncontrolling interests).", "label": "Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests", "terseLabel": "Acquisition of a noncontrolling interest in consolidated subsidiaries" } } }, "localname": "MinorityInterestDecreaseFromRedemptions", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/ConsolidatedStatementsofEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_MinorityInterestInJointVentures": { "auth_ref": [ "r822" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount of the equity interests owned by noncontrolling shareholders, partners, or other equity holders in joint ventures included in the entity's consolidated financial statements.", "label": "Noncontrolling Interest in Joint Ventures", "terseLabel": "Noncontrolling Interest in Joint Ventures" } } }, "localname": "MinorityInterestInJointVentures", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/StockholdersEquityNoncontrollingInterestDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_MinorityInterestLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Noncontrolling Interest [Line Items]", "terseLabel": "Noncontrolling Interest [Line Items]" } } }, "localname": "MinorityInterestLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/StockholdersEquityNoncontrollingInterestDetails" ], "xbrltype": "stringItemType" }, "us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity.", "label": "Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners", "terseLabel": "Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners" } } }, "localname": "MinorityInterestOwnershipPercentageByNoncontrollingOwners", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/StockholdersEquityNoncontrollingInterestDetails" ], "xbrltype": "percentItemType" }, "us-gaap_MinorityInterestTable": { "auth_ref": [ "r103", "r163", "r822", "r837" ], "lang": { "en-us": { "role": { "documentation": "Schedule of noncontrolling interest disclosure which includes the name of the subsidiary, the ownership percentage held by the parent, the ownership percentage held by the noncontrolling owners, the amount of the noncontrolling interest, the location of this amount on the balance sheet (when not reported separately), an explanation of the increase or decrease in the amount of the noncontrolling interest, the noncontrolling interest share of the net Income or Loss of the subsidiary, the location of this amount on the income statement (when not reported separately), the nature of the noncontrolling interest such as background information and terms, the amount of the noncontrolling interest represented by preferred stock, a description of the preferred stock, and the dividend requirements of the preferred stock.", "label": "Noncontrolling Interest [Table]", "terseLabel": "Noncontrolling Interest [Table]" } } }, "localname": "MinorityInterestTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/StockholdersEquityNoncontrollingInterestDetails" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r187" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Cash provided by (used for) financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r187" ], "calculation": { "http://www.corteva.com/role/ConsolidatedStatementsofCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Cash provided by (used for) investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r187", "r191", "r194" ], "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "terseLabel": "Cash provided by (used for) operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r32", "r137", "r140", "r146", "r153", "r194", "r211", "r235", "r240", "r241", "r243", "r244", "r248", "r249", "r263", "r306", "r318", "r322", "r325", "r328", "r362", "r480", "r481", "r482", "r485", "r486", "r487", "r489", "r491", "r493", "r494", "r882", "r896", "r1033", "r1070" ], "calculation": { "http://www.corteva.com/role/ConsolidatedStatementsofIncome": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Income (Loss) Attributable to Parent", "terseLabel": "Net (loss) income attributable to Company", "totalLabel": "Net income (loss) attributable to Corteva" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/ConsolidatedStatementsofIncome", "http://www.corteva.com/role/EIDQuarterlyFNDetails", "http://www.corteva.com/role/QuaterlyFinancialDataQuarterlyFinancialDataDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": { "auth_ref": [ "r137", "r140", "r146", "r248", "r249", "r832", "r841" ], "calculation": { "http://www.corteva.com/role/ConsolidatedStatementsofIncome": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.", "label": "Net Income (Loss) Attributable to Noncontrolling Interest", "terseLabel": "Net income (loss) attributable to noncontrolling interests" } } }, "localname": "NetIncomeLossAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/ConsolidatedStatementsofIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAttributableToNonredeemableNoncontrollingInterest": { "auth_ref": [ "r163" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Portion of net income (loss) attributable to nonredeemable noncontrolling interest.", "label": "Net Income (Loss) Attributable to Nonredeemable Noncontrolling Interest", "terseLabel": "Net Income (Loss) Attributable to Nonredeemable Noncontrolling Interest" } } }, "localname": "NetIncomeLossAttributableToNonredeemableNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/EarningsPerShareNetIncomeforEarningsPerShareCalculationsBasicandDilutedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": { "auth_ref": [ "r240", "r241", "r243", "r244", "r253", "r254", "r264", "r267", "r306", "r318", "r322", "r325", "r328" ], "calculation": { "http://www.corteva.com/role/EarningsPerShareofCommonStockEPSCalculationBasicDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.", "label": "Net Income (Loss) Available to Common Stockholders, Basic", "totalLabel": "Basic (loss) earnings per share of common stock" } } }, "localname": "NetIncomeLossAvailableToCommonStockholdersBasic", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/EarningsPerShareofCommonStockEPSCalculationBasicDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted": { "auth_ref": [ "r255", "r258", "r259", "r260", "r261", "r264", "r267" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.", "label": "Net Income (Loss) Available to Common Stockholders, Diluted", "terseLabel": "Diluted (loss) earnings per share of common stock" } } }, "localname": "NetIncomeLossAvailableToCommonStockholdersDiluted", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/EarningsPerShareofCommonStockEPSCalculationDilutedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) from discontinued operations available to common shareholders.", "label": "Net Income (Loss) from Discontinued Operations Available to Common Shareholders, Basic", "terseLabel": "(Loss) income from discontinued operations attributable to Corteva common stockholders" } } }, "localname": "NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/EarningsPerShareNetIncomeforEarningsPerShareCalculationsBasicandDilutedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest": { "auth_ref": [ "r534", "r832", "r833" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after income tax of income (loss) including the portion attributable to nonredeemable noncontrolling interest. Excludes the portion attributable to redeemable noncontrolling interest recognized as temporary equity.", "label": "Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest", "terseLabel": "Net Income attributable to continuing operations - Noncontrolling Interest" } } }, "localname": "NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/EarningsPerShareNetIncomeforEarningsPerShareCalculationsBasicandDilutedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetInvestmentHedgingMember": { "auth_ref": [ "r851" ], "lang": { "en-us": { "role": { "documentation": "Hedges of a net investment in a foreign operation.", "label": "Net Investment Hedging [Member]", "terseLabel": "Net Investment Hedging" } } }, "localname": "NetInvestmentHedgingMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/FinancialInstrumentsCashFlowHedgesIncludedinAOCIDetails", "http://www.corteva.com/role/FinancialInstrumentsEffectofDerivativeInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock": { "auth_ref": [ "r2", "r233", "r234", "r237", "r238", "r250", "r251", "r252", "r345", "r346", "r364", "r365", "r588", "r589", "r590", "r591", "r738", "r785", "r786", "r787", "r879", "r897", "r898", "r899", "r941", "r995", "r996", "r997", "r1087", "r1088", "r1089", "r1090", "r1092", "r1186" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for change in accounting principle. Includes, but is not limited to, nature, reason, and method of adopting amendment to accounting standards or other change in accounting principle.", "label": "Accounting Standards Update and Change in Accounting Principle [Text Block]", "terseLabel": "Recent Accounting Guidance" } } }, "localname": "NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/RecentAccountingGuidance" ], "xbrltype": "textBlockItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "terseLabel": "Recent Accounting Guidance" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/RecentAccountingGuidanceRecentAccountingGuidancePolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NonUsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Countries excluding the United States of America (US).", "label": "Non-US [Member]", "terseLabel": "Non-US [Member]" } } }, "localname": "NonUsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansBasisofFairValueMeasurementDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansSummaryofFairValueMeasurementofLevel3PensionPlanAssetsDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansTargetAllocationforPlanAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_NoncontrollingInterestMember": { "auth_ref": [ "r230", "r231", "r232", "r561", "r821" ], "lang": { "en-us": { "role": { "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.", "label": "Noncontrolling Interest [Member]", "terseLabel": "Noncontrolling Interest [Member]" } } }, "localname": "NoncontrollingInterestMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/ConsolidatedStatementsofEquity" ], "xbrltype": "domainItemType" }, "us-gaap_NondesignatedMember": { "auth_ref": [ "r852" ], "lang": { "en-us": { "role": { "documentation": "Derivative instrument not designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).", "label": "Not Designated as Hedging Instrument [Member]", "terseLabel": "Not Designated as Hedging Instrument [Member]" } } }, "localname": "NondesignatedMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/FinancialInstrumentsEffectofDerivativeInstrumentsDetails", "http://www.corteva.com/role/FinancialInstrumentsFairValueofDerivativesDetails", "http://www.corteva.com/role/FinancialInstrumentsNotionalAmountsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_NonoperatingIncomeExpense": { "auth_ref": [ "r167" ], "calculation": { "http://www.corteva.com/role/ConsolidatedStatementsofIncome": { "order": 6.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).", "label": "Nonoperating Income (Expense)", "terseLabel": "Other income (expense) - net" } } }, "localname": "NonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/ConsolidatedStatementsofIncome", "http://www.corteva.com/role/SupplementaryInformationOtherIncomeExpenseNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NonqualifiedPlanMember": { "auth_ref": [ "r600", "r601", "r602", "r603", "r604", "r605", "r606", "r607", "r608", "r609", "r610", "r611", "r612", "r613", "r614", "r615", "r616", "r617", "r618", "r619", "r620", "r622", "r623", "r625", "r626", "r627", "r628", "r629", "r630", "r631", "r632", "r633", "r634", "r635", "r636", "r637", "r638", "r639", "r640", "r641", "r642", "r643", "r645", "r646", "r647", "r648", "r650", "r653", "r658", "r659", "r660", "r663", "r664", "r665", "r666", "r667", "r668", "r669", "r670", "r671", "r672" ], "lang": { "en-us": { "role": { "documentation": "Plan without tax-exempt status in accordance with applicable tax provision of designated taxing authority. Taxing authority includes, but is not limited to, U.S. Internal Revenue Service (IRS). Includes, but is not limited to, defined benefit and defined contribution plans.", "label": "Nonqualified Plan [Member]", "terseLabel": "Nonqualified Plan [Member]" } } }, "localname": "NonqualifiedPlanMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_NotesAndLoansReceivableNetCurrent": { "auth_ref": [ "r38", "r39", "r67", "r338", "r339", "r1025" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of financing receivable, classified as current. Includes, but is not limited to, notes and loan receivable.", "label": "Financing Receivable, after Allowance for Credit Loss, Current", "terseLabel": "Notes receivable - trade" } } }, "localname": "NotesAndLoansReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/AccountsandNotesReceivableNetScheduleofAccountsandNotesReceivableNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NotesPayableRelatedPartiesNoncurrent": { "auth_ref": [ "r97", "r216", "r945" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount for notes payable (written promise to pay), payable to related parties, which are due after one year (or one business cycle).", "label": "Notes Payable, Related Parties, Noncurrent", "terseLabel": "Long-Term Debt - Related Party" } } }, "localname": "NotesPayableRelatedPartiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/ConsolidatedBalanceSheets", "http://www.corteva.com/role/EIDRelatedPartyDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NumberOfCountriesInWhichEntityOperates": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of countries in which the entity operates as of balance sheet date.", "label": "Number of Countries in which Entity Operates", "terseLabel": "Number of Countries in which Entity Operates" } } }, "localname": "NumberOfCountriesInWhichEntityOperates", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/BackgroundandBasisofPresentationDetails" ], "xbrltype": "integerItemType" }, "us-gaap_NumberOfReportableSegments": { "auth_ref": [ "r294" ], "lang": { "en-us": { "role": { "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.", "label": "Number of Reportable Segments", "terseLabel": "Number of Reportable Segments" } } }, "localname": "NumberOfReportableSegments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/BackgroundandBasisofPresentationDetails" ], "xbrltype": "integerItemType" }, "us-gaap_OperatingLeaseCost": { "auth_ref": [ "r932", "r940" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.", "label": "Operating Lease, Cost", "terseLabel": "Operating Lease, Cost" } } }, "localname": "OperatingLeaseCost", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/LeasesLeaseCostsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiability": { "auth_ref": [ "r925" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.", "label": "Operating Lease, Liability", "terseLabel": "Total operating lease liabilities" } } }, "localname": "OperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/LeasesMaturityofLeaseLiabilitiesDetails", "http://www.corteva.com/role/LeasesSupplementalBalanceSheetInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityCurrent": { "auth_ref": [ "r925" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.", "label": "Operating Lease, Liability, Current", "terseLabel": "Current operating lease liabilities" } } }, "localname": "OperatingLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/LeasesSupplementalBalanceSheetInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "auth_ref": [ "r925" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.", "label": "Operating Lease, Liability, Noncurrent", "terseLabel": "Noncurrent operating lease liabilities" } } }, "localname": "OperatingLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/LeasesSupplementalBalanceSheetInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasePayments": { "auth_ref": [ "r929", "r935" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.", "label": "Operating Lease, Payments", "terseLabel": "Operating cash outflows from operating leases" } } }, "localname": "OperatingLeasePayments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/LeasesSupplementalCashFlowInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAsset": { "auth_ref": [ "r924" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's right to use underlying asset under operating lease.", "label": "Operating Lease, Right-of-Use Asset", "terseLabel": "Operating Lease, Right-of-Use Asset" } } }, "localname": "OperatingLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/LeasesSupplementalBalanceSheetInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": { "auth_ref": [ "r937", "r940" ], "lang": { "en-us": { "role": { "documentation": "Weighted average discount rate for operating lease calculated at point in time.", "label": "Operating Lease, Weighted Average Discount Rate, Percent", "terseLabel": "Operating Lease, Weighted Average Discount Rate, Percent" } } }, "localname": "OperatingLeaseWeightedAverageDiscountRatePercent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/LeasesLeaseTermandDiscountRateDetails" ], "xbrltype": "percentItemType" }, "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": { "auth_ref": [ "r936", "r940" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Operating Lease, Weighted Average Remaining Lease Term", "terseLabel": "Operating Lease, Weighted Average Remaining Lease Term" } } }, "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/LeasesLeaseTermandDiscountRateDetails" ], "xbrltype": "durationItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsDue": { "auth_ref": [ "r920", "r922" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of required minimum rental payments for leases having an initial or remaining non-cancelable letter-terms in excess of one year.", "label": "Operating Leases, Future Minimum Payments Due", "terseLabel": "Operating Leases, Future Minimum Payments Due" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/LeasesFutureMinimumLeaseCommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent": { "auth_ref": [ "r920", "r922" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Operating Leases, Future Minimum Payments Due, Next Twelve Months", "terseLabel": "Operating Leases, Future Minimum Payments 2019" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDueCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/LeasesFutureMinimumLeaseCommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears": { "auth_ref": [ "r920", "r922" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Operating Leases, Future Minimum Payments, Due in Five Years", "terseLabel": "Operating Leases, Future Minimum Payments 2023" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDueInFiveYears", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/LeasesFutureMinimumLeaseCommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears": { "auth_ref": [ "r920", "r922" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Operating Leases, Future Minimum Payments, Due in Four Years", "terseLabel": "Operating Leases, Future Minimum Payments 2022" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDueInFourYears", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/LeasesFutureMinimumLeaseCommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears": { "auth_ref": [ "r920", "r922" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Operating Leases, Future Minimum Payments, Due in Three Years", "terseLabel": "Operating Leases, Future Minimum Payments 2021" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDueInThreeYears", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/LeasesFutureMinimumLeaseCommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears": { "auth_ref": [ "r920", "r922" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Operating Leases, Future Minimum Payments, Due in Two Years", "terseLabel": "Operating Leases, Future Minimum Payments 2020" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDueInTwoYears", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/LeasesFutureMinimumLeaseCommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter": { "auth_ref": [ "r920", "r922" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due after the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Operating Leases, Future Minimum Payments, Due Thereafter", "terseLabel": "Operating Leases, Future Minimum Payments 2024 and Thereafter" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDueThereafter", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/LeasesFutureMinimumLeaseCommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasesRentExpenseNet": { "auth_ref": [ "r921" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Rental expense for the reporting period incurred under operating leases, including minimum and any contingent rent expense, net of related sublease income.", "label": "Operating Leases, Rent Expense, Net", "terseLabel": "Operating Leases, Rent Expense, Net" } } }, "localname": "OperatingLeasesRentExpenseNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/LeasesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLossCarryforwardsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Operating Loss Carryforwards [Line Items]", "terseLabel": "Operating Loss Carryforwards [Line Items]" } } }, "localname": "OperatingLossCarryforwardsLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/IncomeTaxesIncomeTaxesNarrativeDetails", "http://www.corteva.com/role/IncomeTaxesIncomeTaxesOperatingLossandTaxCreditCarryforwardsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingLossCarryforwardsTable": { "auth_ref": [ "r776" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss carryforwards, including an assessment of the likelihood of utilization.", "label": "Operating Loss Carryforwards [Table]", "terseLabel": "Operating Loss Carryforwards [Table]" } } }, "localname": "OperatingLossCarryforwardsTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/IncomeTaxesIncomeTaxesNarrativeDetails", "http://www.corteva.com/role/IncomeTaxesIncomeTaxesOperatingLossandTaxCreditCarryforwardsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingSegmentsMember": { "auth_ref": [ "r317", "r318", "r319", "r320", "r322", "r328" ], "lang": { "en-us": { "role": { "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.", "label": "Operating Segments [Member]", "terseLabel": "Operating Segments [Member]" } } }, "localname": "OperatingSegmentsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/SegmentReportingOtherItemsDetails", "http://www.corteva.com/role/SegmentReportingSegmentInformationDetails", "http://www.corteva.com/role/SegmentReportingSegmentReconciliationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]", "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": { "auth_ref": [ "r35", "r844" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.", "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]", "terseLabel": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/BackgroundandBasisofPresentationNotes", "http://www.corteva.com/role/EIDBasisofPresentationNotes" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherAssetsCurrent": { "auth_ref": [ "r109", "r953" ], "calculation": { "http://www.corteva.com/role/ConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current assets classified as other.", "label": "Other Assets, Current", "terseLabel": "Other current assets" } } }, "localname": "OtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsMember": { "auth_ref": [ "r854", "r873" ], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing other assets.", "label": "Other Assets [Member]", "terseLabel": "Other Assets [Member]" } } }, "localname": "OtherAssetsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationChemoursDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsDivestituresandOtherTransactionsNarrativeDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsDivestituresandOtherTransactionsPChemResultsofOperationsDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsECPDivestitureDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsSPDivestitureDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansAmountsRecognizedinConsolidatedBalanceSheetsDetails", "http://www.corteva.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherAssetsNoncurrent": { "auth_ref": [ "r87" ], "calculation": { "http://www.corteva.com/role/ConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncurrent assets classified as other.", "label": "Other Assets, Noncurrent", "terseLabel": "Other Assets" } } }, "localname": "OtherAssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherCommitmentsAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of other commitment.", "label": "Other Commitments [Axis]", "terseLabel": "Other Commitments [Axis]" } } }, "localname": "OtherCommitmentsAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/AccountsandNotesReceivableNetCustomerFinancingDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OtherCommitmentsDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Other future obligation.", "label": "Other Commitments [Domain]", "terseLabel": "Other Commitments [Domain]" } } }, "localname": "OtherCommitmentsDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/AccountsandNotesReceivableNetCustomerFinancingDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax": { "auth_ref": [ "r129", "r131", "r642" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before tax, of cost (credit) of benefit change attributable to participants' prior service from plan amendment or plan initiation of defined benefit plan, that has not been recognized in net periodic benefit cost (credit).", "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), before Tax", "terseLabel": "Prior service cost (benefit)" } } }, "localname": "OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansComponentsofnetperiodicbenefitcostcreditandamountsrecognizedinothercomprehensivelossDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLocationAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by location in other comprehensive income.", "label": "Other Comprehensive Income Location [Axis]", "terseLabel": "Other Comprehensive Income Location [Axis]" } } }, "localname": "OtherComprehensiveIncomeLocationAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/RestructuringandAssetRelatedCharges2021RestructuringActionsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OtherComprehensiveIncomeLocationDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Location in other comprehensive income.", "label": "Other Comprehensive Income Location [Domain]", "terseLabel": "Other Comprehensive Income Location [Domain]" } } }, "localname": "OtherComprehensiveIncomeLocationDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/RestructuringandAssetRelatedCharges2021RestructuringActionsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax": { "auth_ref": [ "r131", "r135", "r136", "r642" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, before tax, of reclassification adjustment from accumulated other comprehensive (income) loss for prior service cost (credit) of defined benefit plan.", "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, before Tax", "terseLabel": "Amortization of prior service benefit" } } }, "localname": "OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansComponentsofnetperiodicbenefitcostcreditandamountsrecognizedinothercomprehensivelossDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax": { "auth_ref": [ "r134", "r144", "r145", "r147", "r905", "r907", "r911" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax, before reclassification adjustments of other comprehensive income (loss).", "label": "Other Comprehensive Income (Loss), before Reclassifications, Net of Tax", "terseLabel": "Other Comprehensive Income (Loss), before Reclassifications, Net of Tax" } } }, "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/StockholdersEquityOtherComprehensiveIncomeLossDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax": { "auth_ref": [ "r122" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax and reclassification adjustments, of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss).", "label": "Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax", "terseLabel": "Derivatives Instruments" } } }, "localname": "OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/ConsolidatedStatementsofComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax": { "auth_ref": [ "r131", "r135", "r642" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax, of increase (decrease) to other comprehensive income from settlement and curtailment gain (loss) of defined benefit plan.", "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Settlement and Curtailment Gain (Loss), after Tax", "terseLabel": "Other Comprehensive Income (Loss), Defined Benefit Plan, Settlement and Curtailment Gain (Loss), after Tax" } } }, "localname": "OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansChangeinProjectedBenefitObligationsPlanAssetsandFundedStatusDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansComponentsofnetperiodicbenefitcostcreditandamountsrecognizedinothercomprehensivelossDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": { "auth_ref": [ "r120" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.", "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax", "terseLabel": "Cumulative Translation Adjustments" } } }, "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/ConsolidatedStatementsofComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r138", "r141", "r144", "r145", "r147", "r154", "r554", "r905", "r910", "r911", "r1034", "r1071" ], "calculation": { "http://www.corteva.com/role/ConsolidatedStatementsofComprehensiveIncome": { "order": 2.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).", "label": "Other Comprehensive Income (Loss), Net of Tax", "terseLabel": "Total other comprehensive income (loss)", "verboseLabel": "Net other comprehensive income (loss)" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/ConsolidatedStatementsofComprehensiveIncome", "http://www.corteva.com/role/ConsolidatedStatementsofEquity", "http://www.corteva.com/role/StockholdersEquityOtherComprehensiveIncomeLossDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax": { "auth_ref": [ "r128", "r131", "r642", "r673" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before tax, after reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.", "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, before Tax", "terseLabel": "Total (benefit) loss recognized in other comprehensive loss, attributable to Corteva" } } }, "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansComponentsofnetperiodicbenefitcostcreditandamountsrecognizedinothercomprehensivelossDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax": { "auth_ref": [ "r128", "r131" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.", "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax", "negatedTerseLabel": "Adjustments to other benefit plans" } } }, "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/ConsolidatedStatementsofComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax": { "auth_ref": [ "r126", "r131", "r642" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, before tax, of gain (loss) for (increase) decrease in value of benefit obligation for change in actuarial assumptions and increase (decrease) in value of plan assets from experience different from that assumed of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.", "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, before Tax", "terseLabel": "Net loss (gain)" } } }, "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansComponentsofnetperiodicbenefitcostcreditandamountsrecognizedinothercomprehensivelossDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax": { "auth_ref": [ "r131", "r135", "r136", "r642" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before tax, of reclassification adjustment from accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan.", "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, before Tax", "terseLabel": "Amortization of unrecognized (loss) gain" } } }, "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansComponentsofnetperiodicbenefitcostcreditandamountsrecognizedinothercomprehensivelossDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossTax": { "auth_ref": [ "r132", "r144", "r154", "r754", "r796", "r799", "r905", "r908", "r911", "r1034", "r1071" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of tax expense (benefit) allocated to other comprehensive income (loss).", "label": "Other Comprehensive Income (Loss), Tax", "terseLabel": "Other Comprehensive Income (Loss), Tax" } } }, "localname": "OtherComprehensiveIncomeLossTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/StockholdersEquityTaxBenefitExpenseonNetActivityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeOtherNetOfTax": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in other comprehensive income, after tax, from changes classified as other.", "label": "Other Comprehensive Income, Other, Net of Tax", "terseLabel": "Other Comprehensive Income, Other, Net of Tax" } } }, "localname": "OtherComprehensiveIncomeOtherNetOfTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/StockholdersEquityOtherComprehensiveIncomeLossDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax": { "auth_ref": [ "r122", "r131", "r875" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before tax of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss).", "label": "Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax", "terseLabel": "Gain (Loss) Recognized in Other Comprehensive Income (Loss), Pre-Tax", "verboseLabel": "Additions and revaluations of derivatives designated as cash flow hedges" } } }, "localname": "OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/FinancialInstrumentsCashFlowHedgesIncludedinAOCIDetails", "http://www.corteva.com/role/FinancialInstrumentsEffectofDerivativeInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherCostAndExpenseOperating": { "auth_ref": [ "r165" ], "calculation": { "http://www.corteva.com/role/ConsolidatedStatementsofIncome": { "order": 10.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The total amount of other operating cost and expense items that are associated with the entity's normal revenue producing operation.", "label": "Other Cost and Expense, Operating", "terseLabel": "Other Operating Charges" } } }, "localname": "OtherCostAndExpenseOperating", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/ConsolidatedStatementsofIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherCurrentAssetsMember": { "auth_ref": [ "r854", "r873" ], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing other current assets.", "label": "Other Current Assets [Member]", "terseLabel": "Other Current Assets [Member]" } } }, "localname": "OtherCurrentAssetsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/FinancialInstrumentsFairValueofDerivativesDetails", "http://www.corteva.com/role/SummaryofSignificantAccountingPoliciesDetails", "http://www.corteva.com/role/SupplementaryInformationReconciliationofCashCashEquivalentsandRestrictedCashDetails", "http://www.corteva.com/role/SupplementaryInformationSupplementaryInformationNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherIntangibleAssetsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Intangible assets classified as other.", "label": "Other Intangible Assets [Member]", "terseLabel": "Other Intangible Assets [Member]" } } }, "localname": "OtherIntangibleAssetsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/FairValueMeasurementsFairValueMeasurementNonrecurringBasisDetails", "http://www.corteva.com/role/GoodwillandOtherIntangibleAssetsOtherIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherInvestmentsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing other investments.", "label": "Other Investments [Member]", "terseLabel": "Other Investments [Member]", "verboseLabel": "Derivative, Asset [Member]" } } }, "localname": "OtherInvestmentsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansBasisofFairValueMeasurementDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansSummaryofFairValueMeasurementofLevel3PensionPlanAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherLiabilitiesNoncurrent": { "auth_ref": [ "r98" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.", "label": "Other Liabilities, Noncurrent", "terseLabel": "Other noncurrent obligations" } } }, "localname": "OtherLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherLongTermInvestmentsMember": { "auth_ref": [ "r1094" ], "lang": { "en-us": { "role": { "documentation": "Long-term investments classified as other.", "label": "Other Long-term Investments [Member]", "terseLabel": "Maturing in One to Five Years" } } }, "localname": "OtherLongTermInvestmentsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/FinancialInstrumentsDebtSecuritiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherNoncashIncomeExpense": { "auth_ref": [ "r194" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.", "label": "Other Noncash Income (Expense)", "negatedTerseLabel": "Other net loss" } } }, "localname": "OtherNoncashIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNoncurrentLiabilitiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing other noncurrent liabilities.", "label": "Other Noncurrent Liabilities [Member]", "terseLabel": "Other Noncurrent Obligations [Member]" } } }, "localname": "OtherNoncurrentLiabilitiesMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationChemoursDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsDivestituresandOtherTransactionsNarrativeDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsDivestituresandOtherTransactionsPChemResultsofOperationsDetails", "http://www.corteva.com/role/EIDRelatedPartyDetails", "http://www.corteva.com/role/RevenueContractBalancesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherNonoperatingIncomeExpenseMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing other nonoperating income (expense).", "label": "Other Nonoperating Income (Expense) [Member]", "terseLabel": "Other Income (Expense) - net" } } }, "localname": "OtherNonoperatingIncomeExpenseMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/FinancialInstrumentsEffectofDerivativeInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherPensionPlansDefinedBenefitMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Plan designed to provide retirement benefits, classified as other. Includes, but is not limited to, defined benefit and defined contribution plans.", "label": "Other Pension Plan [Member]", "terseLabel": "Other Pension Plan [Member]" } } }, "localname": "OtherPensionPlansDefinedBenefitMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember": { "auth_ref": [ "r595", "r596", "r600", "r601", "r602", "r603", "r604", "r605", "r606", "r607", "r608", "r609", "r610", "r611", "r612", "r613", "r614", "r615", "r616", "r617", "r618", "r619", "r620", "r622", "r623", "r625", "r626", "r627", "r628", "r629", "r630", "r632", "r633", "r634", "r635", "r636", "r637", "r638", "r639", "r640", "r641", "r642", "r643", "r645", "r647", "r648", "r650", "r653", "r658", "r663", "r664", "r665", "r666", "r667", "r668", "r669", "r670", "r671", "r672", "r673", "r674", "r678", "r679", "r680", "r681", "r682", "r683" ], "lang": { "en-us": { "role": { "documentation": "Plan designed to provide other postretirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes pension benefits.", "label": "Other Postretirement Benefits Plan [Member]", "terseLabel": "Other Post Employment Benefits Plan", "verboseLabel": "Other Benefit Plans" } } }, "localname": "OtherPostretirementBenefitPlansDefinedBenefitMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/ConsolidatedStatementsofComprehensiveIncome", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansAdditionalInformationDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansAmountsRecognizedinConsolidatedBalanceSheetsDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansAssumedHealthCareCostTrendRatesDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansChangeinProjectedBenefitObligationsPlanAssetsandFundedStatusDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansComponentsofnetperiodicbenefitcostcreditandamountsrecognizedinothercomprehensivelossDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansEstimatedFutureBenefitPaymentsDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansWeightedAverageAssumptionsusedtoDetermineBenefitObligationsandPeriodicBenefitCostOPEBDetails", "http://www.corteva.com/role/StockholdersEquityOtherComprehensiveIncomeLossDetails", "http://www.corteva.com/role/StockholdersEquityReclassificationsoutofAOCIDetails", "http://www.corteva.com/role/StockholdersEquityTaxBenefitExpenseonNetActivityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherReceivablesNetCurrent": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.", "label": "Other Receivables, Net, Current", "terseLabel": "Other" } } }, "localname": "OtherReceivablesNetCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/AccountsandNotesReceivableNetScheduleofAccountsandNotesReceivableNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherSignificantNoncashTransactionNameDomain": { "auth_ref": [ "r198", "r199", "r200" ], "lang": { "en-us": { "role": { "documentation": "The name of other significant noncash (or part noncash) investing and financing activities required to be supplementally disclosed to enable users of the financial information to fully understand the period cash flows of the Entity in relation to the statements of financial position, income statement, and statement of changes in shareholders' equity. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of a transaction not resulting in cash receipts or cash payments in the period.", "label": "Other Significant Noncash Transaction, Name [Domain]", "terseLabel": "Other Significant Noncash Transaction, Name [Domain]" } } }, "localname": "OtherSignificantNoncashTransactionNameDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/GoodwillandOtherIntangibleAssetsGoodwillbySegmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherSignificantNoncashTransactionsByUniqueDescriptionAxis": { "auth_ref": [ "r198", "r199", "r200" ], "lang": { "en-us": { "role": { "documentation": "Information by other significant noncash transactions.", "label": "Other Significant Noncash Transaction [Axis]", "terseLabel": "Other Significant Noncash Transaction [Axis]" } } }, "localname": "OtherSignificantNoncashTransactionsByUniqueDescriptionAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/GoodwillandOtherIntangibleAssetsGoodwillbySegmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OtherTaxExpenseBenefit": { "auth_ref": [ "r212", "r754", "r781" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of other income tax expense (benefit).", "label": "Other Tax Expense (Benefit)", "terseLabel": "Other Tax (Benefit) Expense" } } }, "localname": "OtherTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/EIDIncomeTaxesRateReconciliationDetails", "http://www.corteva.com/role/IncomeTaxesIncomeTaxesDeferredTaxBalancesDetails", "http://www.corteva.com/role/IncomeTaxesIncomeTaxesReconciliationtoUSStatutoryRateDetails", "http://www.corteva.com/role/QuaterlyFinancialDataQuarterlyFinancialDataParentheticalsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForLegalSettlements": { "auth_ref": [ "r190" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid for the settlement of litigation or for other legal issues during the period.", "label": "Payments for Legal Settlements", "terseLabel": "Payments for Legal Settlements" } } }, "localname": "PaymentsForLegalSettlements", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationLeachandMDLSettlementDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForProceedsFromDerivativeInstrumentInvestingActivities": { "auth_ref": [], "calculation": { "http://www.corteva.com/role/ConsolidatedStatementsofCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net cash outflow or inflow from derivative instruments during the period, which are classified as investing activities, excluding those designated as hedging instruments.", "label": "Payments for (Proceeds from) Derivative Instrument, Investing Activities", "negatedTerseLabel": "Foreign currency exchange contract settlements" } } }, "localname": "PaymentsForProceedsFromDerivativeInstrumentInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": { "auth_ref": [ "r172", "r175" ], "calculation": { "http://www.corteva.com/role/ConsolidatedStatementsofCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash (inflow) outflow from investing activities classified as other.", "label": "Payments for (Proceeds from) Other Investing Activities", "negatedTerseLabel": "Other investing activities - net" } } }, "localname": "PaymentsForProceedsFromOtherInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForRepurchaseOfCommonStock": { "auth_ref": [ "r179" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow to reacquire common stock during the period.", "label": "Payments for Repurchase of Common Stock", "negatedLabel": "Repurchase of Common Stock", "terseLabel": "Payments for Repurchase of Common Stock", "verboseLabel": "Payments for Repurchase of Common Stock" } } }, "localname": "PaymentsForRepurchaseOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/ConsolidatedStatementsofCashFlows", "http://www.corteva.com/role/StockholdersEquityCommonStockDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForRestructuring": { "auth_ref": [ "r185", "r444" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.", "label": "Payments for Restructuring", "terseLabel": "Payments for Restructuring" } } }, "localname": "PaymentsForRestructuring", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/RestructuringandAssetRelatedCharges2021RestructuringActionsDetails", "http://www.corteva.com/role/RestructuringandAssetRelatedChargesDowDuPontCostSynergyProgramDetails", "http://www.corteva.com/role/RestructuringandAssetRelatedChargesExecutetoWinProductivityProgramDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfDebtExtinguishmentCosts": { "auth_ref": [ "r181" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow for cost from early extinguishment and prepayment of debt. Includes, but is not limited to, third-party cost, premium paid, and other fee paid to lender directly for debt extinguishment or debt prepayment. Excludes accrued interest.", "label": "Payment for Debt Extinguishment or Debt Prepayment Cost", "terseLabel": "Debt Extinguishment Costs" } } }, "localname": "PaymentsOfDebtExtinguishmentCosts", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfDistributionsToAffiliates": { "auth_ref": [ "r179" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The distributions of earnings to an entity that is affiliated with the reporting entity by means of direct or indirect ownership.", "label": "Payments of Distributions to Affiliates", "terseLabel": "Distributions to Dow and DowDuPont", "verboseLabel": "Distributions to DowDuPont" } } }, "localname": "PaymentsOfDistributionsToAffiliates", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/ConsolidatedStatementsofCashFlows", "http://www.corteva.com/role/ConsolidatedStatementsofEquity", "http://www.corteva.com/role/RelatedPartiesTransactionswithDowDuPontDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfDividends": { "auth_ref": [ "r179" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.", "label": "Payments of Dividends", "terseLabel": "Dividends Paid to stockholders" } } }, "localname": "PaymentsOfDividends", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": { "auth_ref": [ "r173" ], "calculation": { "http://www.corteva.com/role/ConsolidatedStatementsofCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.", "label": "Payments to Acquire Businesses, Net of Cash Acquired", "negatedTerseLabel": "Acquisitions of businesses - Net of Cash Acquired" } } }, "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireEquityMethodInvestments": { "auth_ref": [ "r173" ], "calculation": { "http://www.corteva.com/role/ConsolidatedStatementsofCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.", "label": "Payments to Acquire Equity Method Investments", "negatedTerseLabel": "Investments in and loans to nonconsolidated affiliates" } } }, "localname": "PaymentsToAcquireEquityMethodInvestments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireMarketableSecurities": { "auth_ref": [ "r348" ], "calculation": { "http://www.corteva.com/role/ConsolidatedStatementsofCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow for purchase of marketable security.", "label": "Payments to Acquire Marketable Securities", "negatedTerseLabel": "Purchases of investments" } } }, "localname": "PaymentsToAcquireMarketableSecurities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireProductiveAssets": { "auth_ref": [ "r174", "r816", "r817", "r818" ], "calculation": { "http://www.corteva.com/role/ConsolidatedStatementsofCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets.", "label": "Payments to Acquire Productive Assets", "negatedTerseLabel": "Capital expenditures" } } }, "localname": "PaymentsToAcquireProductiveAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "auth_ref": [ "r174" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.", "label": "Payments to Acquire Property, Plant, and Equipment", "terseLabel": "Payments to Acquire Property, Plant, and Equipment" } } }, "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/SegmentReportingOtherItemsDetails", "http://www.corteva.com/role/SegmentReportingSegmentInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToMinorityShareholders": { "auth_ref": [ "r182" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow to a noncontrolling interest. Includes, but not limited to, reduction of noncontrolling interest ownership. Excludes dividends paid to the noncontrolling interest.", "label": "Payments to Noncontrolling Interests", "terseLabel": "Payment for acquisition of subsidiary's interest from the non-controlling interest" } } }, "localname": "PaymentsToMinorityShareholders", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/ConsolidatedStatementsofCashFlows", "http://www.corteva.com/role/StockholdersEquityNoncontrollingInterestDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PensionAndOtherPostretirementBenefitContributions": { "auth_ref": [ "r190" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow for pension and other postretirement benefits. Includes, but is not limited to, employer contribution to fund plan asset and payment to retiree.", "label": "Payment for Pension and Other Postretirement Benefits", "terseLabel": "Pension and OPEB contributions" } } }, "localname": "PensionAndOtherPostretirementBenefitContributions", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PensionAndOtherPostretirementBenefitExpense": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost (reversal of cost) for pension and other postretirement benefits.", "label": "Pension and Other Postretirement Benefits Cost (Reversal of Cost)", "terseLabel": "Net periodic pension and OPEB benefit, net" } } }, "localname": "PensionAndOtherPostretirementBenefitExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock": { "auth_ref": [ "r622", "r624", "r630", "r649", "r651", "r652", "r653", "r655", "r656", "r673", "r675", "r676", "r678", "r698" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for retirement benefits.", "label": "Retirement Benefits [Text Block]", "terseLabel": "Pension and Other Postretirement Benefits Disclosure [Text Block]" } } }, "localname": "PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlans" ], "xbrltype": "textBlockItemType" }, "us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities": { "auth_ref": [ "r58", "r596", "r597", "r620", "r673" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as current.", "label": "Liability, Defined Benefit Plan, Current", "negatedTerseLabel": "Current liabilities" } } }, "localname": "PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansAmountsRecognizedinConsolidatedBalanceSheetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent": { "auth_ref": [ "r61", "r596", "r597", "r620", "r673" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as noncurrent.", "label": "Liability, Defined Benefit Plan, Noncurrent", "negatedTerseLabel": "Noncurrent liabilities", "terseLabel": "Pension and other post employment benefits - noncurrent" } } }, "localname": "PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/ConsolidatedBalanceSheets", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansAmountsRecognizedinConsolidatedBalanceSheetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PensionPlansDefinedBenefitMember": { "auth_ref": [ "r594", "r596", "r600", "r601", "r602", "r603", "r604", "r605", "r606", "r607", "r608", "r609", "r610", "r611", "r612", "r613", "r614", "r615", "r616", "r617", "r618", "r619", "r620", "r622", "r623", "r625", "r626", "r627", "r628", "r629", "r630", "r631", "r632", "r633", "r634", "r635", "r636", "r637", "r638", "r639", "r640", "r641", "r642", "r643", "r645", "r647", "r648", "r650", "r653", "r658", "r663", "r664", "r665", "r666", "r667", "r668", "r669", "r670", "r671", "r672", "r673", "r674", "r678", "r679", "r693", "r694", "r695", "r696" ], "lang": { "en-us": { "role": { "documentation": "Plan designed to provide participant with pension benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes other postretirement benefits.", "label": "Pension Plan [Member]", "terseLabel": "Pension Plan" } } }, "localname": "PensionPlansDefinedBenefitMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/ConsolidatedStatementsofComprehensiveIncome", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansAdditionalInformationDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansAmountsRecognizedinConsolidatedBalanceSheetsDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansBasisofFairValueMeasurementDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansChangeinProjectedBenefitObligationsPlanAssetsandFundedStatusDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansComponentsofnetperiodicbenefitcostcreditandamountsrecognizedinothercomprehensivelossDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansEstimatedFutureBenefitPaymentsDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansPensionPlanswithAccumulatedBenefitObligationsinExcessofPlanAssetsDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansPensionPlanswithProjectedBenefitObligationsinExcessofPlanAssetsDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansSummaryofFairValueMeasurementofLevel3PensionPlanAssetsDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansTargetAllocationforPlanAssetsDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansWeightedAverageAssumptionsusedtoDetermineBenefitObligationsPensionDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansWeightedAverageAssumptionsusedtoDetermineNetPeriodicBenefitCostPensionDetails", "http://www.corteva.com/role/StockholdersEquityOtherComprehensiveIncomeLossDetails", "http://www.corteva.com/role/StockholdersEquityReclassificationsoutofAOCIDetails", "http://www.corteva.com/role/StockholdersEquityTaxBenefitExpenseonNetActivityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PercentageOfFIFOInventory": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The percentage of FIFO (first in first out) inventory to total inventory as of the balance sheet date if other than 100 percent.", "label": "Percentage of FIFO Inventory", "terseLabel": "Percentage of FIFO Inventory" } } }, "localname": "PercentageOfFIFOInventory", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "percentItemType" }, "us-gaap_PercentageOfWeightedAverageCostInventory": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The percentage of weighted average cost inventory present at the reporting date when inventory is valued using different valuation methods.", "label": "Percentage of Weighted Average Cost Inventory", "terseLabel": "Percentage of Weighted Average Cost Inventory" } } }, "localname": "PercentageOfWeightedAverageCostInventory", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "percentItemType" }, "us-gaap_PerformanceSharesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-based payment arrangement awarded for meeting performance target.", "label": "Performance Shares [Member]", "terseLabel": "Performance Shares [Member]" } } }, "localname": "PerformanceSharesMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/StockBasedCompensationRestrictedStockUnitsandPerformanceDeferredStockDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PlanAssetCategoriesDomain": { "auth_ref": [ "r622", "r623", "r625", "r626", "r627", "r628", "r629", "r630", "r650", "r673" ], "lang": { "en-us": { "role": { "documentation": "Defined benefit plan asset investment.", "label": "Defined Benefit Plan, Plan Assets, Category [Domain]", "terseLabel": "Defined Benefit Plan, Plan Assets, Category [Domain]" } } }, "localname": "PlanAssetCategoriesDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansAdditionalInformationDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansBasisofFairValueMeasurementDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansSummaryofFairValueMeasurementofLevel3PensionPlanAssetsDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansTargetAllocationforPlanAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PlanNameAxis": { "auth_ref": [ "r702", "r733" ], "lang": { "en-us": { "role": { "documentation": "Information by plan name for share-based payment arrangement.", "label": "Plan Name [Axis]", "terseLabel": "Plan Name [Axis]" } } }, "localname": "PlanNameAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/StockBasedCompensationRestrictedStockUnitsandPerformanceDeferredStockDetails", "http://www.corteva.com/role/StockBasedCompensationStockOptionsDetails", "http://www.corteva.com/role/StockBasedCompensationTables", "http://www.corteva.com/role/StockBasedCompensationWeightedAverageAssumptionsStockOptionsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PlanNameDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Plan name for share-based payment arrangement.", "label": "Plan Name [Domain]", "terseLabel": "Plan Name [Domain]" } } }, "localname": "PlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/StockBasedCompensationRestrictedStockUnitsandPerformanceDeferredStockDetails", "http://www.corteva.com/role/StockBasedCompensationStockOptionsDetails", "http://www.corteva.com/role/StockBasedCompensationTables", "http://www.corteva.com/role/StockBasedCompensationWeightedAverageAssumptionsStockOptionsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockDividendsAndOtherAdjustments": { "auth_ref": [ "r254", "r268" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate value of preferred stock dividends and other adjustments necessary to derive net income apportioned to common stockholders.", "label": "Preferred Stock Dividends and Other Adjustments", "terseLabel": "Preferred Stock Dividends and Other Adjustments" } } }, "localname": "PreferredStockDividendsAndOtherAdjustments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/EarningsPerShareNetIncomeforEarningsPerShareCalculationsBasicandDilutedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PreferredStockDividendsPerShareDeclared": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Aggregate dividends declared during the period for each share of preferred stock outstanding.", "label": "Preferred Stock, Dividends Per Share, Declared", "terseLabel": "Preferred Stock, Dividends Per Share" } } }, "localname": "PreferredStockDividendsPerShareDeclared", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/ConsolidatedStatementsofEquityParentheticals" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company.", "label": "Preferred Stock [Member]", "terseLabel": "Preferred Stock [Member]" } } }, "localname": "PreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/ConsolidatedStatementsofEquity" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockNoParValue": { "auth_ref": [ "r65", "r538" ], "lang": { "en-us": { "role": { "documentation": "Face amount per share of no-par value preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred Stock, No Par Value", "terseLabel": "Preferred Stock, Par Value" } } }, "localname": "PreferredStockNoParValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/ConsolidatedBalanceSheetsParentheticals" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockRedemptionAmount": { "auth_ref": [ "r99", "r537" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The redemption (or callable) amount of currently redeemable preferred stock. Includes amounts representing dividends not currently declared or paid but which will be payable under the redemption features or for which ultimate payment is solely within the control of the issuer.", "label": "Preferred Stock, Redemption Amount", "terseLabel": "Preferred Stock, Redemption Amount" } } }, "localname": "PreferredStockRedemptionAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/ConsolidatedBalanceSheetsParentheticals", "http://www.corteva.com/role/StockholdersEquityNoncontrollingInterestDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r65" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred Stock, Shares Authorized", "terseLabel": "Preferred Stock, Shares Authorized" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/ConsolidatedBalanceSheetsParentheticals", "http://www.corteva.com/role/StockholdersEquityNoncontrollingInterestDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r65", "r538" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred Stock, Shares Issued", "terseLabel": "Preferred Stock, Shares Issued" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/ConsolidatedBalanceSheetsParentheticals", "http://www.corteva.com/role/StockholdersEquityNoncontrollingInterestDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r65", "r953" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred Stock, Value, Issued", "terseLabel": "Preferred stock, without par value\u00a0\u2013 cumulative; 23,000,000 shares authorized; issued at December 31, 2020 and December 31, 2019" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidRoyalties": { "auth_ref": [ "r40", "r42", "r387", "r388" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for royalties that provide economic benefits within a future period of one year or the normal operating cycle, if longer.", "label": "Prepaid Royalties", "terseLabel": "Prepaid Royalties" } } }, "localname": "PrepaidRoyalties", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PriorPeriodReclassificationAdjustmentDescription": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.", "label": "Reclassification, Comparability Adjustment [Policy Text Block]", "terseLabel": "Changes in Accounting and Reporting" } } }, "localname": "PriorPeriodReclassificationAdjustmentDescription", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_PrivateEquityFundsMember": { "auth_ref": [ "r623" ], "lang": { "en-us": { "role": { "documentation": "Investments held in private equity funds.", "label": "Private Equity Funds [Member]", "terseLabel": "Private Market Securities [Member]" } } }, "localname": "PrivateEquityFundsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansAdditionalInformationDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansBasisofFairValueMeasurementDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansSummaryofFairValueMeasurementofLevel3PensionPlanAssetsDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansTargetAllocationforPlanAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ProceedsFromContributionsFromParent": { "auth_ref": [ "r178" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from parent as a source of financing that is recorded as additional paid in capital.", "label": "Proceeds from Contributions from Parent", "terseLabel": "Contributions from Dow and DowDuPont" } } }, "localname": "ProceedsFromContributionsFromParent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/ConsolidatedStatementsofCashFlows", "http://www.corteva.com/role/ConsolidatedStatementsofEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromDivestitureOfBusinesses": { "auth_ref": [ "r171" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.", "label": "Proceeds from Divestiture of Businesses", "terseLabel": "Proceeds from Divestiture of Businesses" } } }, "localname": "ProceedsFromDivestitureOfBusinesses", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/DivestituresandOtherTransactionsDivestituresandOtherTransactionsDivestedAgBusinessResultsofOperationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates": { "auth_ref": [ "r171" ], "calculation": { "http://www.corteva.com/role/ConsolidatedStatementsofCashFlows": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the amount received from the sale of a business segment or subsidiary or sale of an entity that is related to it but not strictly controlled during the period (for example, an unconsolidated subsidiary, affiliate, joint venture or equity method investment).", "label": "Proceeds from Divestiture of Businesses and Interests in Affiliates", "terseLabel": "Proceeds from sale of ownership interest in nonconsolidated affiliates" } } }, "localname": "ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromDividendsReceived": { "auth_ref": [ "r183" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Dividends received on equity and other investments during the current period.", "label": "Proceeds from Dividends Received", "terseLabel": "Proceeds from Dividends Received" } } }, "localname": "ProceedsFromDividendsReceived", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationChemoursDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfLongTermDebt": { "auth_ref": [ "r177" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.", "label": "Proceeds from Issuance of Long-term Debt", "terseLabel": "Proceeds from Debt" } } }, "localname": "ProceedsFromIssuanceOfLongTermDebt", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": { "auth_ref": [ "r178", "r182" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities classified as other.", "label": "Proceeds from (Payments for) Other Financing Activities", "terseLabel": "Other financing activities" } } }, "localname": "ProceedsFromPaymentsForOtherFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromRelatedPartyDebt": { "auth_ref": [ "r177" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates.", "label": "Proceeds from Related Party Debt", "terseLabel": "Proceeds from Related Party Debt" } } }, "localname": "ProceedsFromRelatedPartyDebt", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromRepaymentsOfShortTermDebt": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The net cash inflow or outflow for borrowing having initial term of repayment within one year or the normal operating cycle, if longer.", "label": "Proceeds from (Repayments of) Short-term Debt", "terseLabel": "Net Change in borrowings (less than 90 days)" } } }, "localname": "ProceedsFromRepaymentsOfShortTermDebt", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities": { "auth_ref": [], "calculation": { "http://www.corteva.com/role/ConsolidatedStatementsofCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities (held-to-maturity or available-for-sale) during the period.", "label": "Proceeds from Sale and Maturity of Marketable Securities", "terseLabel": "Proceeds from Sale and Maturities of Investments" } } }, "localname": "ProceedsFromSaleAndMaturityOfMarketableSecurities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt": { "auth_ref": [ "r169", "r170", "r348" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow from sale of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).", "label": "Proceeds from Sale of Debt Securities, Available-for-sale", "terseLabel": "Proceeds from Sale of Debt Securities, Available-for-sale" } } }, "localname": "ProceedsFromSaleOfAvailableForSaleSecuritiesDebt", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/FinancialInstrumentsDebtSecuritiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromStockOptionsExercised": { "auth_ref": [ "r176", "r734" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.", "label": "Proceeds from Stock Options Exercised", "terseLabel": "Proceeds from Exercise of Stock Options" } } }, "localname": "ProceedsFromStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProfitLoss": { "auth_ref": [ "r32", "r137", "r140", "r146", "r186", "r211", "r235", "r248", "r249", "r306", "r318", "r322", "r325", "r328", "r362", "r480", "r481", "r482", "r485", "r486", "r487", "r489", "r491", "r493", "r494", "r823", "r831", "r833", "r841", "r842", "r882", "r896", "r1040" ], "calculation": { "http://www.corteva.com/role/ConsolidatedStatementsofComprehensiveIncome": { "order": 1.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 }, "http://www.corteva.com/role/ConsolidatedStatementsofIncome": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.", "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest", "terseLabel": "Net income (loss)", "totalLabel": "Net income (loss)", "verboseLabel": "Net income (loss) from continuing operations after income taxes" } } }, "localname": "ProfitLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/ConsolidatedStatementsofCashFlows", "http://www.corteva.com/role/ConsolidatedStatementsofComprehensiveIncome", "http://www.corteva.com/role/ConsolidatedStatementsofEquity", "http://www.corteva.com/role/ConsolidatedStatementsofIncome", "http://www.corteva.com/role/EIDIncomeTaxesGeographicAllocationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Abstract]", "terseLabel": "Property, Plant and Equipment [Abstract]" } } }, "localname": "PropertyPlantAndEquipmentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "auth_ref": [ "r86", "r424" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.", "label": "Long-Lived Tangible Asset [Axis]", "terseLabel": "Property, Plant and Equipment, Type [Axis]" } } }, "localname": "PropertyPlantAndEquipmentByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/PropertyPlantandEquipmentScheduleofPropertyPlantandEquipmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": { "auth_ref": [ "r432", "r1115", "r1116", "r1117" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "Property, Plant and Equipment Disclosure [Text Block]", "terseLabel": "Property, Plant and Equipment Disclosure [Text Block]" } } }, "localname": "PropertyPlantAndEquipmentDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/PropertyPlantandEquipment" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentGross": { "auth_ref": [ "r85", "r422" ], "calculation": { "http://www.corteva.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Gross", "terseLabel": "Property, Plant and Equipment" } } }, "localname": "PropertyPlantAndEquipmentGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/ConsolidatedBalanceSheets", "http://www.corteva.com/role/PropertyPlantandEquipmentScheduleofPropertyPlantandEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Property, Plant and Equipment [Line Items]", "terseLabel": "Property, Plant and Equipment [Line Items]" } } }, "localname": "PropertyPlantAndEquipmentLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/PropertyPlantandEquipmentScheduleofPropertyPlantandEquipmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment [Member]", "terseLabel": "Property, Plant and Equipment [Member]" } } }, "localname": "PropertyPlantAndEquipmentMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/LeasesSupplementalBalanceSheetInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r52", "r53", "r424", "r953", "r1043", "r1063" ], "calculation": { "http://www.corteva.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Net", "terseLabel": "Property, Plant and Equipment, Net", "totalLabel": "Net Property, Plant and Equipment", "verboseLabel": "Net Property" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/ConsolidatedBalanceSheets", "http://www.corteva.com/role/GeographicInformationNetPropertybyCountryDetails", "http://www.corteva.com/role/PropertyPlantandEquipmentScheduleofPropertyPlantandEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": { "auth_ref": [ "r83", "r424", "r1115", "r1116" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "Property, Plant and Equipment, Policy [Policy Text Block]", "terseLabel": "Property, Plant and Equipment" } } }, "localname": "PropertyPlantAndEquipmentPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTextBlock": { "auth_ref": [ "r52", "r424" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table Text Block]", "terseLabel": "Property, Plant and Equipment [Table Text Block]" } } }, "localname": "PropertyPlantAndEquipmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/PropertyPlantandEquipmentTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "auth_ref": [ "r52", "r422" ], "lang": { "en-us": { "role": { "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.", "label": "Long-Lived Tangible Asset [Domain]", "terseLabel": "Property, Plant and Equipment, Type [Domain]" } } }, "localname": "PropertyPlantAndEquipmentTypeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/PropertyPlantandEquipmentScheduleofPropertyPlantandEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PropertyPlantAndEquipmentUsefulLife": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.", "label": "Property, Plant and Equipment, Useful Life", "terseLabel": "Property, Plant and Equipment, Useful Life" } } }, "localname": "PropertyPlantAndEquipmentUsefulLife", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/PropertyPlantandEquipmentScheduleofPropertyPlantandEquipmentDetails" ], "xbrltype": "durationItemType" }, "us-gaap_ProvisionForDoubtfulAccounts": { "auth_ref": [ "r159", "r370" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.", "label": "Accounts Receivable, Credit Loss Expense (Reversal)", "terseLabel": "Additions charged to expense" } } }, "localname": "ProvisionForDoubtfulAccounts", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/AccountsandNotesReceivableAllowanceRollforwardDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PublicUtilityAxis": { "auth_ref": [ "r84" ], "lang": { "en-us": { "role": { "documentation": "Information by type of utility plant.", "label": "Public Utility [Axis]", "terseLabel": "Public Utility [Axis]" } } }, "localname": "PublicUtilityAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationOtherPFOAMattersFayattevilleDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PurchaseTransactionPolicy": { "auth_ref": [ "r805" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for a combination of entities that is not accounted for using the purchase method (for example, exchange of shares between entities under common control).", "label": "Combination of Entities under Common Control, Policy [Policy Text Block]", "terseLabel": "Combination of Entities under Common Control, Policy [Policy Text Block]" } } }, "localname": "PurchaseTransactionPolicy", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/BackgroundandBasisofPresentationPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_PushdownAccountingPolicyTextBlock": { "auth_ref": [ "r819", "r820" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy by the acquiree for election of option to apply pushdown accounting when a change-in-control event has occurred.", "label": "Pushdown Accounting [Policy Text Block]", "terseLabel": "Pushdown Accounting [Policy Text Block]" } } }, "localname": "PushdownAccountingPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/BackgroundandBasisofPresentationPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_QuarterlyFinancialDataAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Quarterly Financial Data [Abstract]", "terseLabel": "Quarterly Financial Data [Abstract]" } } }, "localname": "QuarterlyFinancialDataAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_QuarterlyFinancialInformationDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Quarterly Financial Information Disclosure [Abstract]", "terseLabel": "Quarterly Financial Information Disclosure [Abstract]" } } }, "localname": "QuarterlyFinancialInformationDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_QuarterlyFinancialInformationTextBlock": { "auth_ref": [ "r279", "r281" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for quarterly financial data. Includes, but is not limited to, tabular presentation of financial information for fiscal quarters, effect of year-end adjustments, and an explanation of matters or transactions that affect comparability of the information.", "label": "Quarterly Financial Information [Text Block]", "terseLabel": "Quarterly Financial Information [Text Block]" } } }, "localname": "QuarterlyFinancialInformationTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/EIDQuarterlyFNNotes", "http://www.corteva.com/role/QuaterlyFinancialData" ], "xbrltype": "textBlockItemType" }, "us-gaap_RatioOfIndebtednessToNetCapital1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indebtedness divided by net capital.", "label": "Ratio of Indebtedness to Net Capital", "terseLabel": "Ratio of Indebtedness to Net Capital" } } }, "localname": "RatioOfIndebtednessToNetCapital1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/LongTermDebtandAvailableCreditFacilitiesAvailableCommittedCreditFacilitiesNarrativeDetails" ], "xbrltype": "pureItemType" }, "us-gaap_RealEstateMember": { "auth_ref": [ "r581" ], "lang": { "en-us": { "role": { "documentation": "Property consisting of land, land improvement and buildings.", "label": "Real Estate [Member]", "terseLabel": "Real Estate [Member]" } } }, "localname": "RealEstateMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansBasisofFairValueMeasurementDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansSummaryofFairValueMeasurementofLevel3PensionPlanAssetsDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansTargetAllocationforPlanAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ReceivablesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Receivables [Abstract]", "terseLabel": "Receivables [Abstract]" } } }, "localname": "ReceivablesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_ReceivablesNetCurrent": { "auth_ref": [ "r68", "r76", "r953", "r1062", "r1095" ], "calculation": { "http://www.corteva.com/role/ConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The total amount due to the entity within one year of the balance sheet date (or one operating cycle, if longer) from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value.", "label": "Receivables, Net, Current", "terseLabel": "Accounts and notes receivable - net", "verboseLabel": "Total accounts and notes receivable - net" } } }, "localname": "ReceivablesNetCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/AccountsandNotesReceivableNetScheduleofAccountsandNotesReceivableNetDetails", "http://www.corteva.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]", "terseLabel": "Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]" } } }, "localname": "ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/StockholdersEquityReclassificationsoutofAOCIDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax": { "auth_ref": [ "r134", "r144", "r145", "r905", "r909", "r911" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before tax of reclassification adjustments of other comprehensive income (loss).", "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax", "terseLabel": "Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax" } } }, "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/StockholdersEquityReclassificationsoutofAOCIDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax": { "auth_ref": [ "r134", "r144", "r145", "r147", "r905", "r909", "r911" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss).", "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax", "terseLabel": "Amounts Reclassified from Accumulated Other Comprehensive Income, Net of Tax", "verboseLabel": "Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax" } } }, "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/StockholdersEquityOtherComprehensiveIncomeLossDetails", "http://www.corteva.com/role/StockholdersEquityReclassificationsoutofAOCIDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReclassificationFromAociCurrentPeriodTax": { "auth_ref": [ "r132", "r136", "r144" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of tax expense (benefit) of reclassification adjustment from accumulated other comprehensive income (loss).", "label": "Reclassification from AOCI, Current Period, Tax", "terseLabel": "Reclassification from AOCI, Current Period, Tax" } } }, "localname": "ReclassificationFromAociCurrentPeriodTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/StockholdersEquityReclassificationsoutofAOCIDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable": { "auth_ref": [ "r146" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about items reclassified out of accumulated other comprehensive income (loss).", "label": "Reclassification out of Accumulated Other Comprehensive Income [Table]", "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income [Table]" } } }, "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/StockholdersEquityReclassificationsoutofAOCIDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of information about items reclassified out of accumulated other comprehensive income (loss).", "label": "Reclassification out of Accumulated Other Comprehensive Income [Table Text Block]", "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income [Table Text Block]" } } }, "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/StockholdersEquityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock": { "auth_ref": [ "r319", "r322" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of all significant reconciling items in the reconciliation of total assets from reportable segments to the entity's consolidated assets.", "label": "Reconciliation of Assets from Segment to Consolidated [Table Text Block]", "terseLabel": "Reconciliation of Assets from Segment to Consolidated [Table Text Block]" } } }, "localname": "ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/EIDSegmentFNTables", "http://www.corteva.com/role/SegmentReportingTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock": { "auth_ref": [ "r318", "r322" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment.", "label": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]", "terseLabel": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]" } } }, "localname": "ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/EIDSegmentFNTables", "http://www.corteva.com/role/SegmentReportingTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTable": { "auth_ref": [ "r320", "r322" ], "lang": { "en-us": { "role": { "documentation": "Identification, description, and amounts of all significant reconciling items in the reconciliation of a significant segment item of information disclosed (for example, liabilities) other than profit (loss), revenues, or assets, between reportable segments in total and the entity's consolidated total for that significant segment item disclosed.", "label": "Reconciliation of Other Significant Reconciling Items from Segments to Consolidated [Table]", "terseLabel": "Reconciliation of Other Significant Reconciling Items from Segments to Consolidated [Table]" } } }, "localname": "ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/SegmentReportingOtherItemsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock": { "auth_ref": [ "r320", "r322" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of each significant reconciling item, other than profit (loss), revenues, or assets, in the reconciliation of totals of such items in reportable segments to the entity's corresponding consolidated amount.", "label": "Reconciliation of Other Significant Reconciling Items from Segments to Consolidated [Table Text Block]", "terseLabel": "Reconciliation of Other Significant Reconciling Items from Segments to Consolidated [Table Text Block]" } } }, "localname": "ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/SegmentReportingTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_RelatedPartyDomain": { "auth_ref": [ "r650", "r944", "r945" ], "lang": { "en-us": { "role": { "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Domain]", "terseLabel": "Related Party [Domain]" } } }, "localname": "RelatedPartyDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/EIDRelatedPartyDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansBasisofFairValueMeasurementDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Related Party Transaction [Line Items]", "terseLabel": "Related Party Transaction [Line Items]" } } }, "localname": "RelatedPartyTransactionLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/EIDRelatedPartyDetails", "http://www.corteva.com/role/EIDRelatedPartyNotes", "http://www.corteva.com/role/RelatedPartiesServicesProvidedbyandtoDowDetails", "http://www.corteva.com/role/RelatedPartiesTransactionswithDowDuPontDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Purchases during the period (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.", "label": "Related Party Transaction, Purchases from Related Party", "terseLabel": "Related Party Transaction, Purchases from Related Party" } } }, "localname": "RelatedPartyTransactionPurchasesFromRelatedParty", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/RelatedPartiesServicesProvidedbyandtoDowDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedPartyTransactionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Transactions [Abstract]", "terseLabel": "Related Party Transactions [Abstract]" } } }, "localname": "RelatedPartyTransactionsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "auth_ref": [ "r650", "r944", "r948", "r999", "r1000", "r1001", "r1002", "r1003", "r1004", "r1005", "r1006", "r1007", "r1008", "r1009", "r1010" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Axis]", "terseLabel": "Related Party [Axis]" } } }, "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/EIDRelatedPartyDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansBasisofFairValueMeasurementDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "auth_ref": [ "r942", "r943", "r945", "r949", "r950" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Related Party Transactions Disclosure [Text Block]", "terseLabel": "Related Party Transactions Disclosure [Text Block]" } } }, "localname": "RelatedPartyTransactionsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/EIDRelatedPartyNotes", "http://www.corteva.com/role/RelatedPartiesNotes" ], "xbrltype": "textBlockItemType" }, "us-gaap_RepaymentsOfLongTermDebt": { "auth_ref": [ "r180" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.", "label": "Repayments of Long-term Debt", "negatedTerseLabel": "Payments on Debt" } } }, "localname": "RepaymentsOfLongTermDebt", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_RepaymentsOfRelatedPartyDebt": { "auth_ref": [ "r180" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for the payment of a long-term borrowing made from a related party where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Payments for Advances from Affiliates.", "label": "Repayments of Related Party Debt", "negatedLabel": "Repayments of Related Party Debt" } } }, "localname": "RepaymentsOfRelatedPartyDebt", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReportingUnitAxis": { "auth_ref": [ "r398", "r399" ], "lang": { "en-us": { "role": { "documentation": "Information by reporting unit.", "label": "Reporting Unit [Axis]", "terseLabel": "Reporting Unit [Axis]" } } }, "localname": "ReportingUnitAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/DivestituresandOtherTransactionsDivestituresandOtherTransactionsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ReportingUnitDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Level of reporting at which goodwill is tested for impairment.", "label": "Reporting Unit [Domain]", "terseLabel": "Reporting Unit [Domain]" } } }, "localname": "ReportingUnitDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/DivestituresandOtherTransactionsDivestituresandOtherTransactionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ResearchAndDevelopmentExpense": { "auth_ref": [ "r747", "r992", "r1131" ], "calculation": { "http://www.corteva.com/role/ConsolidatedStatementsofIncome": { "order": 3.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.", "label": "Research and Development Expense", "terseLabel": "Research and Development Expense" } } }, "localname": "ResearchAndDevelopmentExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/ConsolidatedStatementsofIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentExpensePolicy": { "auth_ref": [ "r747" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.", "label": "Research and Development Expense, Policy [Policy Text Block]", "terseLabel": "Research and Development" } } }, "localname": "ResearchAndDevelopmentExpensePolicy", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RestrictedCash": { "auth_ref": [ "r201", "r1012", "r1057" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.", "label": "Restricted Cash", "terseLabel": "Restricted Cash", "verboseLabel": "Trust Asset" } } }, "localname": "RestrictedCash", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansAdditionalInformationDetails", "http://www.corteva.com/role/SummaryofSignificantAccountingPoliciesDetails", "http://www.corteva.com/role/SupplementaryInformationReconciliationofCashCashEquivalentsandRestrictedCashDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Type of cash and cash equivalent. Cash is currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash and Cash Equivalents [Domain]", "terseLabel": "Cash and Cash Equivalents [Domain]" } } }, "localname": "RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansBasisofFairValueMeasurementDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Restricted Cash and Cash Equivalents Items [Line Items]", "terseLabel": "Restricted Cash and Cash Equivalents Items [Line Items]" } } }, "localname": "RestrictedCashAndCashEquivalentsItemsLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/SupplementaryInformationReconciliationofCashCashEquivalentsandRestrictedCashDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RestrictedStockUnitsRSUMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.", "label": "Restricted Stock Units (RSUs) [Member]", "terseLabel": "Restricted Stock Units (RSUs) [Member]" } } }, "localname": "RestrictedStockUnitsRSUMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/StockBasedCompensationRestrictedStockUnitsandPerformanceDeferredStockDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RestructuringAndRelatedActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Restructuring and Related Activities [Abstract]", "terseLabel": "Restructuring and Related Activities [Abstract]" } } }, "localname": "RestructuringAndRelatedActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock": { "auth_ref": [ "r442", "r444", "r447", "r454", "r456" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.", "label": "Restructuring and Related Activities Disclosure [Text Block]", "terseLabel": "Restructuring and Related Activities Disclosure [Text Block]" } } }, "localname": "RestructuringAndRelatedActivitiesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/RestructuringandAssetRelatedCharges" ], "xbrltype": "textBlockItemType" }, "us-gaap_RestructuringAndRelatedCostCostIncurredToDate1": { "auth_ref": [ "r443", "r446", "r451", "r453" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of costs incurred to date for the specified restructuring cost.", "label": "Restructuring and Related Cost, Cost Incurred to Date", "terseLabel": "Restructuring and Related Cost, Cost Incurred to Date" } } }, "localname": "RestructuringAndRelatedCostCostIncurredToDate1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/RestructuringandAssetRelatedChargesDowDuPontCostSynergyProgramDetails", "http://www.corteva.com/role/RestructuringandAssetRelatedChargesExecutetoWinProductivityProgramDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestructuringAndRelatedCostExpectedCost1": { "auth_ref": [ "r443", "r446", "r451", "r453" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount expected to be recognized in earnings for the specified restructuring cost.", "label": "Restructuring and Related Cost, Expected Cost", "terseLabel": "Restructuring and Related Cost, Expected Cost" } } }, "localname": "RestructuringAndRelatedCostExpectedCost1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/DivestituresandOtherTransactionsECPDivestitureDetails", "http://www.corteva.com/role/RestructuringandAssetRelatedChargesExecutetoWinProductivityProgramDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestructuringCostAndReserveAxis": { "auth_ref": [ "r443", "r444", "r451", "r452" ], "lang": { "en-us": { "role": { "documentation": "Information by type of restructuring cost.", "label": "Restructuring Type [Axis]", "terseLabel": "Restructuring Type [Axis]" } } }, "localname": "RestructuringCostAndReserveAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/RestructuringandAssetRelatedCharges2021RestructuringActionsDetails", "http://www.corteva.com/role/RestructuringandAssetRelatedChargesAssetImpairmentsDetails", "http://www.corteva.com/role/RestructuringandAssetRelatedChargesDowDuPontAgricultureDivisionRestructuringProgramDetails", "http://www.corteva.com/role/RestructuringandAssetRelatedChargesDowDuPontCostSynergyProgramDetails", "http://www.corteva.com/role/RestructuringandAssetRelatedChargesExecutetoWinProductivityProgramDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RestructuringCostAndReserveLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Restructuring Cost and Reserve [Line Items]", "terseLabel": "Restructuring Cost and Reserve [Line Items]" } } }, "localname": "RestructuringCostAndReserveLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/RestructuringandAssetRelatedCharges2021RestructuringActionsDetails", "http://www.corteva.com/role/RestructuringandAssetRelatedChargesAssetImpairmentsDetails", "http://www.corteva.com/role/RestructuringandAssetRelatedChargesDowDuPontAgricultureDivisionRestructuringProgramDetails", "http://www.corteva.com/role/RestructuringandAssetRelatedChargesDowDuPontCostSynergyProgramDetails", "http://www.corteva.com/role/RestructuringandAssetRelatedChargesExecutetoWinProductivityProgramDetails", "http://www.corteva.com/role/RestructuringandAssetRelatedChargesTables" ], "xbrltype": "stringItemType" }, "us-gaap_RestructuringPlanAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by individual restructuring plan.", "label": "Restructuring Plan [Axis]", "terseLabel": "Restructuring Plan [Axis]" } } }, "localname": "RestructuringPlanAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/DivestituresandOtherTransactionsECPDivestitureDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansAdditionalInformationDetails", "http://www.corteva.com/role/RestructuringandAssetRelatedCharges2021RestructuringActionsDetails", "http://www.corteva.com/role/RestructuringandAssetRelatedChargesDowDuPontAgricultureDivisionRestructuringProgramDetails", "http://www.corteva.com/role/RestructuringandAssetRelatedChargesDowDuPontCostSynergyProgramDetails", "http://www.corteva.com/role/RestructuringandAssetRelatedChargesExecutetoWinProductivityProgramDetails", "http://www.corteva.com/role/RestructuringandAssetRelatedChargesTables" ], "xbrltype": "stringItemType" }, "us-gaap_RestructuringPlanDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Identification of the individual restructuring plans.", "label": "Restructuring Plan [Domain]", "terseLabel": "Restructuring Plan [Domain]" } } }, "localname": "RestructuringPlanDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/DivestituresandOtherTransactionsECPDivestitureDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansAdditionalInformationDetails", "http://www.corteva.com/role/RestructuringandAssetRelatedCharges2021RestructuringActionsDetails", "http://www.corteva.com/role/RestructuringandAssetRelatedChargesDowDuPontAgricultureDivisionRestructuringProgramDetails", "http://www.corteva.com/role/RestructuringandAssetRelatedChargesDowDuPontCostSynergyProgramDetails", "http://www.corteva.com/role/RestructuringandAssetRelatedChargesExecutetoWinProductivityProgramDetails", "http://www.corteva.com/role/RestructuringandAssetRelatedChargesTables" ], "xbrltype": "domainItemType" }, "us-gaap_RestructuringReserve": { "auth_ref": [ "r444", "r450" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.", "label": "Restructuring Reserve", "periodEndLabel": "Restructuring Reserve, Ending Balance", "periodStartLabel": "Restructuring Reserve, Beginning Balance" } } }, "localname": "RestructuringReserve", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/RestructuringandAssetRelatedCharges2021RestructuringActionsDetails", "http://www.corteva.com/role/RestructuringandAssetRelatedChargesDowDuPontCostSynergyProgramDetails", "http://www.corteva.com/role/RestructuringandAssetRelatedChargesExecutetoWinProductivityProgramDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestructuringSettlementAndImpairmentProvisions": { "auth_ref": [ "r165" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of restructuring charges, remediation cost, and asset impairment loss.", "label": "Restructuring, Settlement and Impairment Provisions", "terseLabel": "Restructuring and Asset Related Charges - Net" } } }, "localname": "RestructuringSettlementAndImpairmentProvisions", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/RestructuringandAssetRelatedChargesDowDuPontAgricultureDivisionRestructuringProgramDetails", "http://www.corteva.com/role/RestructuringandAssetRelatedChargesDowDuPontCostSynergyProgramDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r70", "r561", "r739", "r953", "r1059", "r1087", "r1092" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings (Accumulated Deficit)", "terseLabel": "Retained earnings (accumulated deficit)" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r0", "r230", "r231", "r232", "r236", "r246", "r249", "r363", "r735", "r736", "r737", "r783", "r784", "r880", "r1083", "r1085" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]", "terseLabel": "Retained Earnings [Member]" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/ConsolidatedStatementsofEquity" ], "xbrltype": "domainItemType" }, "us-gaap_RetirementPlanNameAxis": { "auth_ref": [ "r600", "r601", "r602", "r603", "r604", "r605", "r606", "r607", "r608", "r609", "r610", "r611", "r612", "r613", "r614", "r615", "r616", "r617", "r618", "r619", "r620", "r622", "r623", "r625", "r626", "r627", "r628", "r629", "r630", "r631", "r632", "r633", "r634", "r635", "r636", "r637", "r638", "r639", "r640", "r641", "r642", "r643", "r645", "r646", "r647", "r648", "r650", "r653", "r658", "r659", "r660", "r663", "r664", "r665", "r666", "r667", "r668", "r669", "r670", "r671", "r672", "r684", "r685", "r686", "r687", "r688", "r689", "r690", "r691", "r692", "r697" ], "lang": { "en-us": { "role": { "documentation": "Information by name of plan designed to provide retirement benefits. Includes, but is not limited to, legal name of defined benefit and defined contribution plans.", "label": "Retirement Plan Name [Axis]", "terseLabel": "Retirement Plan Name [Axis]" } } }, "localname": "RetirementPlanNameAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansAdditionalInformationDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansChangeinProjectedBenefitObligationsPlanAssetsandFundedStatusDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansWeightedAverageAssumptionsusedtoDetermineBenefitObligationsPensionDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansWeightedAverageAssumptionsusedtoDetermineNetPeriodicBenefitCostPensionDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RetirementPlanNameDomain": { "auth_ref": [ "r600", "r601", "r602", "r603", "r604", "r605", "r606", "r607", "r608", "r609", "r610", "r611", "r612", "r613", "r614", "r615", "r616", "r617", "r618", "r619", "r620", "r622", "r623", "r625", "r626", "r627", "r628", "r629", "r630", "r631", "r632", "r633", "r634", "r635", "r636", "r637", "r638", "r639", "r640", "r641", "r642", "r643", "r645", "r646", "r647", "r648", "r650", "r653", "r658", "r659", "r660", "r663", "r664", "r665", "r666", "r667", "r668", "r669", "r670", "r671", "r672", "r684", "r685", "r686", "r687", "r688", "r689", "r690", "r691", "r692", "r697" ], "lang": { "en-us": { "role": { "documentation": "Name of plan designed to provide retirement benefits. Includes, but is not limited to, legal name of defined benefit and defined contribution plans.", "label": "Retirement Plan Name [Domain]", "terseLabel": "Retirement Plan Name [Domain]" } } }, "localname": "RetirementPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansAdditionalInformationDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansChangeinProjectedBenefitObligationsPlanAssetsandFundedStatusDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansWeightedAverageAssumptionsusedtoDetermineBenefitObligationsPensionDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansWeightedAverageAssumptionsusedtoDetermineNetPeriodicBenefitCostPensionDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RetirementPlanTaxStatusAxis": { "auth_ref": [ "r600", "r601", "r602", "r603", "r604", "r605", "r606", "r607", "r608", "r609", "r610", "r611", "r612", "r613", "r614", "r615", "r616", "r617", "r618", "r619", "r620", "r622", "r623", "r625", "r626", "r627", "r628", "r629", "r630", "r631", "r632", "r633", "r634", "r635", "r636", "r637", "r638", "r639", "r640", "r641", "r642", "r643", "r645", "r646", "r647", "r648", "r650", "r653", "r658", "r659", "r660", "r663", "r664", "r665", "r666", "r667", "r668", "r669", "r670", "r671", "r672" ], "lang": { "en-us": { "role": { "documentation": "Information by tax status of plan designed to provide retirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans.", "label": "Retirement Plan Tax Status [Axis]", "terseLabel": "Retirement Plan Tax Status [Axis]" } } }, "localname": "RetirementPlanTaxStatusAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RetirementPlanTaxStatusDomain": { "auth_ref": [ "r600", "r601", "r602", "r603", "r604", "r605", "r606", "r607", "r608", "r609", "r610", "r611", "r612", "r613", "r614", "r615", "r616", "r617", "r618", "r619", "r620", "r622", "r623", "r625", "r626", "r627", "r628", "r629", "r630", "r631", "r632", "r633", "r634", "r635", "r636", "r637", "r638", "r639", "r640", "r641", "r642", "r643", "r645", "r646", "r647", "r648", "r650", "r653", "r658", "r659", "r660", "r663", "r664", "r665", "r666", "r667", "r668", "r669", "r670", "r671", "r672" ], "lang": { "en-us": { "role": { "documentation": "Tax status of plan designed to provide retirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans.", "label": "Retirement Plan Tax Status [Domain]", "terseLabel": "Retirement Plan Tax Status [Domain]" } } }, "localname": "RetirementPlanTaxStatusDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RetirementPlanTypeAxis": { "auth_ref": [ "r594", "r595", "r596", "r600", "r601", "r602", "r603", "r604", "r605", "r606", "r607", "r608", "r609", "r610", "r611", "r612", "r613", "r614", "r615", "r616", "r617", "r618", "r619", "r620", "r622", "r623", "r625", "r626", "r627", "r628", "r629", "r630", "r631", "r632", "r633", "r634", "r635", "r636", "r637", "r638", "r639", "r640", "r641", "r642", "r643", "r645", "r647", "r648", "r650", "r653", "r658", "r663", "r664", "r665", "r666", "r667", "r668", "r669", "r670", "r671", "r672", "r673", "r674", "r678", "r679", "r680", "r681", "r682", "r683", "r693", "r694", "r695", "r696" ], "lang": { "en-us": { "role": { "documentation": "Information by type of retirement benefit plan. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.", "label": "Retirement Plan Type [Axis]", "terseLabel": "Retirement Plan Type [Axis]" } } }, "localname": "RetirementPlanTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/ConsolidatedStatementsofComprehensiveIncome", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansAdditionalInformationDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansAmountsRecognizedinConsolidatedBalanceSheetsDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansAssumedHealthCareCostTrendRatesDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansBasisofFairValueMeasurementDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansChangeinProjectedBenefitObligationsPlanAssetsandFundedStatusDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansComponentsofnetperiodicbenefitcostcreditandamountsrecognizedinothercomprehensivelossDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansEstimatedFutureBenefitPaymentsDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansPensionPlanswithAccumulatedBenefitObligationsinExcessofPlanAssetsDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansPensionPlanswithProjectedBenefitObligationsinExcessofPlanAssetsDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansSummaryofFairValueMeasurementofLevel3PensionPlanAssetsDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansTargetAllocationforPlanAssetsDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansWeightedAverageAssumptionsusedtoDetermineBenefitObligationsandPeriodicBenefitCostOPEBDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansWeightedAverageAssumptionsusedtoDetermineNetPeriodicBenefitCostPensionDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RetirementPlanTypeDomain": { "auth_ref": [ "r594", "r595", "r596", "r600", "r601", "r602", "r603", "r604", "r605", "r606", "r607", "r608", "r609", "r610", "r611", "r612", "r613", "r614", "r615", "r616", "r617", "r618", "r619", "r620", "r622", "r623", "r625", "r626", "r627", "r628", "r629", "r630", "r631", "r632", "r633", "r634", "r635", "r636", "r637", "r638", "r639", "r640", "r641", "r642", "r643", "r645", "r647", "r648", "r650", "r653", "r658", "r663", "r664", "r665", "r666", "r667", "r668", "r669", "r670", "r671", "r672", "r673", "r674", "r678", "r679", "r680", "r681", "r682", "r683", "r693", "r694", "r695", "r696" ], "lang": { "en-us": { "role": { "documentation": "Type of plan designed to provide participants with retirement benefits. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.", "label": "Retirement Plan Type [Domain]", "terseLabel": "Retirement Plan Type [Domain]" } } }, "localname": "RetirementPlanTypeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/ConsolidatedStatementsofComprehensiveIncome", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansAdditionalInformationDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansAmountsRecognizedinConsolidatedBalanceSheetsDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansAssumedHealthCareCostTrendRatesDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansBasisofFairValueMeasurementDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansChangeinProjectedBenefitObligationsPlanAssetsandFundedStatusDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansComponentsofnetperiodicbenefitcostcreditandamountsrecognizedinothercomprehensivelossDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansEstimatedFutureBenefitPaymentsDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansPensionPlanswithAccumulatedBenefitObligationsinExcessofPlanAssetsDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansPensionPlanswithProjectedBenefitObligationsinExcessofPlanAssetsDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansSummaryofFairValueMeasurementofLevel3PensionPlanAssetsDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansTargetAllocationforPlanAssetsDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansWeightedAverageAssumptionsusedtoDetermineBenefitObligationsandPeriodicBenefitCostOPEBDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansWeightedAverageAssumptionsusedtoDetermineNetPeriodicBenefitCostPensionDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Revenue from Contract with Customer [Abstract]", "terseLabel": "Revenue from Contract with Customer [Abstract]" } } }, "localname": "RevenueFromContractWithCustomerAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_RevenueFromContractWithCustomerTextBlock": { "auth_ref": [ "r568", "r569", "r570", "r571", "r572", "r573", "r576", "r577", "r580", "r592" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.", "label": "Revenue from Contract with Customer [Text Block]", "terseLabel": "Revenue" } } }, "localname": "RevenueFromContractWithCustomerTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/RevenueNotes" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenueRecognitionPolicyTextBlock": { "auth_ref": [ "r205", "r206" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.", "label": "Revenue [Policy Text Block]", "terseLabel": "Revenue Recognition" } } }, "localname": "RevenueRecognitionPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenueRecognitionSalesOfGoods": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for revenue recognition for the sale of goods, which is a transaction between an entity delivering a tangible good to a purchaser. The entity also may disclose its treatment of any unearned or deferred revenue that arises from the transaction.", "label": "Revenue Recognition, Sales of Goods [Policy Text Block]", "terseLabel": "Revenue Recognition, Sales of Goods" } } }, "localname": "RevenueRecognitionSalesOfGoods", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/RevenuefromContractwithCustomerPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenueRecognitionServicesLicensingFees": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for revenue recognition for licensing fees, which is consideration paid to the entity (licensor) by another party for the right to use, but not own, certain of the entity's intangible assets. Licensing arrangements include, but are not limited to, rights to use a patent, copyright, technology, manufacturing process, or trademark.", "label": "Revenue Recognition, Services, Licensing Fees [Policy Text Block]", "terseLabel": "Revenue Recognition, Services, Licensing Fees" } } }, "localname": "RevenueRecognitionServicesLicensingFees", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/RevenuefromContractwithCustomerPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenueRemainingPerformanceObligation": { "auth_ref": [ "r574" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of transaction price allocated to performance obligation that has not been recognized as revenue.", "label": "Revenue, Remaining Performance Obligation, Amount", "terseLabel": "Remaining Performance Obligation" } } }, "localname": "RevenueRemainingPerformanceObligation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/RevenueNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]", "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]" } } }, "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/RevenueNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1": { "auth_ref": [ "r575" ], "lang": { "en-us": { "role": { "documentation": "Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period", "terseLabel": "Remaining Performance Obligation, Expected Timing of Satisfaction" } } }, "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/RevenueNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about expected timing for satisfying remaining performance obligation.", "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]", "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]" } } }, "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/RevenueNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_Revenues": { "auth_ref": [ "r149", "r211", "r297", "r298", "r317", "r323", "r324", "r331", "r332", "r335", "r362", "r480", "r481", "r482", "r485", "r486", "r487", "r489", "r491", "r493", "r494", "r896", "r1040" ], "calculation": { "http://www.corteva.com/role/ConsolidatedStatementsofIncome": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).", "label": "Revenues", "terseLabel": "Net Sales" } } }, "localname": "Revenues", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/BusinessCombinationsDASCommonControlTransferIncomeStatementDetails", "http://www.corteva.com/role/ConsolidatedStatementsofIncome", "http://www.corteva.com/role/GeographicInformationRevenuebyCountryDetails", "http://www.corteva.com/role/QuaterlyFinancialDataQuarterlyFinancialDataDetails", "http://www.corteva.com/role/RevenueDisaggregationofRevenueGeoDetails", "http://www.corteva.com/role/RevenueDisaggregationofRevenueProductsDetails", "http://www.corteva.com/role/SegmentReportingSegmentInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Revenues from External Customers and Long-Lived Assets [Line Items]", "terseLabel": "Revenues from External Customers and Long-Lived Assets [Line Items]" } } }, "localname": "RevenuesFromExternalCustomersAndLongLivedAssetsLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/GeographicInformationNetPropertybyCountryDetails", "http://www.corteva.com/role/GeographicInformationRevenuebyCountryDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RevolvingCreditFacilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.", "label": "Revolving Credit Facility [Member]", "terseLabel": "Revolving Credit Facility [Member]" } } }, "localname": "RevolvingCreditFacilityMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/LongTermDebtandAvailableCreditFacilitiesAvailableCommittedCreditFacilitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RoyaltyIncomeNonoperating": { "auth_ref": [ "r167" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Ancillary revenue earned during the period from the consideration paid to the entity for the use of its rights and property by another party. Examples include licensing the use of copyrighted materials and leasing the extraction of natural resources.", "label": "Royalty Income, Nonoperating", "terseLabel": "Royalty Income" } } }, "localname": "RoyaltyIncomeNonoperating", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/SupplementaryInformationOtherIncomeExpenseNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable": { "auth_ref": [ "r102" ], "lang": { "en-us": { "role": { "documentation": "Schedule itemizing specific types of trade accounts and notes receivable, and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.", "label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table]", "terseLabel": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table]" } } }, "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/AccountsandNotesReceivableNetCustomerFinancingDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock": { "auth_ref": [ "r102" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.", "label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]", "terseLabel": "Schedule of Accounts and Notes Receivable" } } }, "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/AccountsandNotesReceivableNetTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock": { "auth_ref": [ "r659", "r660", "r673" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of benefit obligation and plan assets of defined benefit plan with accumulated benefit obligation in excess of plan assets.", "label": "Defined Benefit Plan, Plan with Accumulated Benefit Obligation in Excess of Plan Assets [Table Text Block]", "terseLabel": "Defined Benefit Plan, Plan with Accumulated Benefit Obligation in Excess of Plan Assets [Table Text Block]" } } }, "localname": "ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": { "auth_ref": [ "r134", "r910", "r911" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).", "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]", "terseLabel": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]" } } }, "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/StockholdersEquityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable": { "auth_ref": [ "r403" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the major classes of acquired finite-lived intangible assets showing the amount, any significant residual value, weighted average amortization period, and other characteristics. A major class is composed of intangible assets that can be grouped together because they are similar, either by nature or by their use in the operations of the company.", "label": "Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]", "terseLabel": "Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]" } } }, "localname": "ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/GoodwillandOtherIntangibleAssetsOtherIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock": { "auth_ref": [ "r621" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the major categories of plan assets of pension plans and/or other employee benefit plans. This information may include, but is not limited to, the target allocation of plan assets, the fair value of each major category of plan assets, and the level within the fair value hierarchy in which the fair value measurements fall.", "label": "Schedule of Allocation of Plan Assets [Table Text Block]", "terseLabel": "Schedule of Allocation of Plan Assets [Table Text Block]" } } }, "localname": "ScheduleOfAllocationOfPlanAssetsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": { "auth_ref": [ "r269" ], "lang": { "en-us": { "role": { "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.", "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]", "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]" } } }, "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/EarningsPerShareNarrativeDetails", "http://www.corteva.com/role/EarningsPerShareShareCountInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfAssumptionsUsedTableTextBlock": { "auth_ref": [ "r644" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assumption used to determine benefit obligation and net periodic benefit cost of defined benefit plan. Includes, but is not limited to, discount rate, rate of compensation increase, expected long-term rate of return on plan assets and interest crediting rate.", "label": "Defined Benefit Plan, Assumptions [Table Text Block]", "terseLabel": "Defined Benefit Plan, Assumptions [Table Text Block]" } } }, "localname": "ScheduleOfAssumptionsUsedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Debt Securities, Available-for-sale [Line Items]", "terseLabel": "Debt Securities, Available-for-sale [Line Items]" } } }, "localname": "ScheduleOfAvailableForSaleSecuritiesLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/FinancialInstrumentsDebtSecuritiesDetails", "http://www.corteva.com/role/FinancialInstrumentsFairValueandGrossUnrealizedLossesofinvestmentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the reconciliation of available-for-sale securities from cost basis to fair value.", "label": "Schedule of Available-for-sale Securities Reconciliation [Table Text Block]", "terseLabel": "Schedule of Available-for-sale Securities Reconciliation" } } }, "localname": "ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/FinancialInstrumentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock": { "auth_ref": [ "r659", "r673" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of benefit obligation and plan assets for defined benefit pension plan with projected benefit obligation in excess of plan assets.", "label": "Defined Benefit Plan, Plan with Projected Benefit Obligation in Excess of Plan Assets [Table Text Block]", "terseLabel": "Defined Benefit Plan, Plan with Projected Benefit Obligation in Excess of Plan Assets [Table Text Block]" } } }, "localname": "ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": { "auth_ref": [ "r806", "r807" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.", "label": "Schedule of Business Acquisitions, by Acquisition [Table]", "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]" } } }, "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/BusinessCombinationsDASCommonControlTransferIncomeStatementDetails", "http://www.corteva.com/role/CommonControlBusinessCombinationsTables" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock": { "auth_ref": [ "r861" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of gain (loss) on derivative and nonderivative instruments designated and qualifying as cash flow hedge recorded in accumulated other comprehensive income (AOCI) and reclassified into earnings.", "label": "Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) [Table Text Block]", "terseLabel": "After-Tax Effect of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss)" } } }, "localname": "ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/FinancialInstrumentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock": { "auth_ref": [ "r119" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of components of comprehensive income (loss). Includes, but is not limited to, foreign currency translation adjustments, foreign currency transactions designated as economic hedges of a net investment in foreign entity, gain (loss) and prior service cost (credit) for pension plans and other postretirement benefit plans.", "label": "Comprehensive Income (Loss) [Table Text Block]", "terseLabel": "Other Comprehensive Income (Loss)" } } }, "localname": "ScheduleOfComprehensiveIncomeLossTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/StockholdersEquityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDebtInstrumentsTextBlock": { "auth_ref": [ "r96", "r221", "r525", "r527", "r555", "r558", "r559", "r560", "r915", "r916", "r919", "r1046" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.", "label": "Schedule of Long-term Debt Instruments [Table Text Block]", "terseLabel": "Long-Term Debt" } } }, "localname": "ScheduleOfDebtInstrumentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/LongTermDebtandAvailableCreditFacilitiesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": { "auth_ref": [ "r772" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.", "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]", "terseLabel": "Deferred Tax Balances" } } }, "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": { "auth_ref": [ "r657", "r658", "r661", "r662", "r673" ], "lang": { "en-us": { "role": { "documentation": "Disclosures about an individual defined benefit pension plan or an other postretirement defined benefit plan. It may be appropriate to group certain similar plans. Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).", "label": "Schedule of Defined Benefit Plans Disclosures [Table]", "terseLabel": "Schedule of Defined Benefit Plans Disclosures [Table]" } } }, "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansAdditionalInformationDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansBasisofFairValueMeasurementDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansSummaryofFairValueMeasurementofLevel3PensionPlanAssetsDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansTargetAllocationforPlanAssetsDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansWeightedAverageAssumptionsusedtoDetermineBenefitObligationsPensionDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansWeightedAverageAssumptionsusedtoDetermineNetPeriodicBenefitCostPensionDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock": { "auth_ref": [ "r657", "r658", "r661", "r662", "r673" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of one or more of the entity's defined benefit pension plans or one or more other defined benefit postretirement plans, separately for pension plans and other postretirement benefit plans including the entity's schedule of fair value of plan assets for defined benefit or other postretirement plans.", "label": "Schedule of Defined Benefit Plans Disclosures [Table Text Block]", "terseLabel": "Schedule of Pension Plans and Other Postemployment Benefits [Table Text Block]" } } }, "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock": { "auth_ref": [ "r855", "r863", "r869" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.", "label": "Derivative Instruments, Gain (Loss) [Table Text Block]", "terseLabel": "Effect of Derivative Instruments" } } }, "localname": "ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/FinancialInstrumentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock": { "auth_ref": [ "r857" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of derivative instruments (including nonderivative instruments that are designated and qualify as hedging instruments) of (a) the location and amount of gains and losses reported in the statement of financial performance and (b) the location and fair value amounts of the instruments reported in the statement of financial position.", "label": "Schedule of Derivatives Instruments Statements of Financial Performance and Financial Position, Location [Table Text Block]", "terseLabel": "Fair Value of Derivatives Instruments" } } }, "localname": "ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/FinancialInstrumentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock": { "auth_ref": [ "r5", "r17", "r18", "r19", "r20", "r21", "r22", "r27", "r30", "r31", "r32", "r429", "r430" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.", "label": "Disposal Groups, Including Discontinued Operations [Table Text Block]", "terseLabel": "Disposal Groups, Including Discontinued Operations [Table Text Block]" } } }, "localname": "ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/DivestituresandOtherTransactionsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "auth_ref": [ "r267" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.", "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]", "terseLabel": "Earnings Per Share of Common Stock Reconciliation" } } }, "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/EarningsPerShareofCommonStockTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTextBlock": { "auth_ref": [ "r257", "r267", "r273" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the effect of income (loss) on basic earnings per share.", "label": "Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table Text Block]", "terseLabel": "Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table Text Block]" } } }, "localname": "ScheduleOfEarningsPerShareBasicByCommonClassTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/EarningsPerShareofCommonStockTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock": { "auth_ref": [ "r257", "r267", "r273" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the effect of income (loss) on an entity's diluted earnings per share.", "label": "Schedule of Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Table Text Block]", "terseLabel": "Schedule of Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Table Text Block]" } } }, "localname": "ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/EarningsPerShareofCommonStockTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEffectOfFourthQuarterEventsTable": { "auth_ref": [ "r280" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about transactions recognized in the fourth quarter, including, but not limited to, disposals of components of an entity, unusual or infrequently occurring items, or both, effect from changes in accounting estimates and effect of year-end adjustments.", "label": "Effect of Fourth Quarter Events [Table]", "terseLabel": "Effect of Fourth Quarter Events [Table]" } } }, "localname": "ScheduleOfEffectOfFourthQuarterEventsTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/EIDQuarterlyFNDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfEffectOfSignificantUnobservableInputsChangesInPlanAssetsTableTextBlock": { "auth_ref": [ "r626" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the effect of fair value measurements using significant unobservable inputs (Level 3) on changes in plan assets of pension plans and/or other employee benefit plans for the period.", "label": "Schedule of Effect of Significant Unobservable Inputs, Changes in Plan Assets [Table Text Block]", "terseLabel": "Schedule of Effect of Significant Unobservable Inputs, Changes in Plan Assets [Table Text Block]" } } }, "localname": "ScheduleOfEffectOfSignificantUnobservableInputsChangesInPlanAssetsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": { "auth_ref": [ "r755" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.", "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]", "terseLabel": "Reconciliation to US Statutory Rate" } } }, "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/EIDIncomeTaxesTables", "http://www.corteva.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock": { "auth_ref": [ "r333" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the names of foreign countries in which material long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets are located, and amount of such long-lived assets located in that country or foreign geographic area.", "label": "Schedule of Disclosure on Geographic Areas, Long-Lived Assets in Individual Foreign Countries by Country [Table Text Block]", "terseLabel": "Net Property By Geographic Area" } } }, "localname": "ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/GeographicInformationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEnvironmentalLossContingenciesBySiteTextBlock": { "auth_ref": [ "r434", "r435", "r436", "r438", "r469" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of environmental loss contingencies by individual site. Does not include loss contingencies that are not environmental in nature.", "label": "Schedule of Environmental Loss Contingencies by Site [Table Text Block]", "terseLabel": "Schedule of Environmental Loss Contingencies by Site [Table Text Block]" } } }, "localname": "ScheduleOfEnvironmentalLossContingenciesBySiteTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock": { "auth_ref": [ "r632" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of benefits expected to be paid by pension plans and/or other employee benefit plans in each of the next five fiscal years and in the aggregate for the five fiscal years thereafter.", "label": "Schedule of Expected Benefit Payments [Table Text Block]", "terseLabel": "Schedule of Expected Benefit Payments [Table Text Block]" } } }, "localname": "ScheduleOfExpectedBenefitPaymentsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": { "auth_ref": [ "r884", "r885" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).", "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]", "terseLabel": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]" } } }, "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/FairValueMeasurementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": { "auth_ref": [ "r403", "r408", "r994" ], "lang": { "en-us": { "role": { "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Schedule of Finite-Lived Intangible Assets [Table]", "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]" } } }, "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/GoodwillandOtherIntangibleAssetsAmortizationExpenseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfGoodwillTable": { "auth_ref": [ "r397", "r400" ], "lang": { "en-us": { "role": { "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.", "label": "Schedule of Goodwill [Table]", "terseLabel": "Schedule of Goodwill [Table]" } } }, "localname": "ScheduleOfGoodwillTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/GoodwillandOtherIntangibleAssetsGoodwillbySegmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfGoodwillTextBlock": { "auth_ref": [ "r397", "r400" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.", "label": "Schedule of Goodwill [Table Text Block]", "terseLabel": "Schedule of Goodwill" } } }, "localname": "ScheduleOfGoodwillTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/GoodwillandOtherIntangibleAssetsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfGuaranteeObligationsTable": { "auth_ref": [ "r477" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure about the type or nature of guarantees, for example performance, indemnification, payment and other guarantees, and related information such as term, origin and purpose, triggering event, maximum exposure, and carrying value. Represents the guarantor's disclosures which include the information about each guarantee, or each group of similar guarantees, even if the likelihood of the guarantor's need to make any payments under the guarantee is remote. This excludes disclosures for product warranties.", "label": "Schedule of Guarantor Obligations [Table]", "terseLabel": "Schedule of Guarantor Obligations [Table]" } } }, "localname": "ScheduleOfGuaranteeObligationsTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesGuaranteeNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfHeldToMaturitySecuritiesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Schedule of Held-to-maturity Securities [Line Items]", "terseLabel": "Schedule of Held-to-maturity Securities [Line Items]" } } }, "localname": "ScheduleOfHeldToMaturitySecuritiesLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/FinancialInstrumentsFinancialInstrumentsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfHeldToMaturitySecuritiesTable": { "auth_ref": [ "r351", "r352", "r353" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about investment in debt security measured at amortized cost (held-to-maturity).", "label": "Debt Securities, Held-to-maturity [Table]", "terseLabel": "Debt Securities, Held-to-maturity [Table]" } } }, "localname": "ScheduleOfHeldToMaturitySecuritiesTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/FinancialInstrumentsFinancialInstrumentsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock": { "auth_ref": [ "r212" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of income before income tax between domestic and foreign jurisdictions.", "label": "Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]", "terseLabel": "Geographic Allocation of Income and Provision for Income Taxes" } } }, "localname": "ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/EIDIncomeTaxesTables", "http://www.corteva.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": { "auth_ref": [ "r46", "r78", "r79", "r80" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.", "label": "Schedule of Inventory, Current [Table Text Block]", "terseLabel": "Schedule of Inventory, Current [Table Text Block]" } } }, "localname": "ScheduleOfInventoryCurrentTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/InventoriesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock": { "auth_ref": [ "r89" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.", "label": "Schedule of Line of Credit Facilities [Table Text Block]", "terseLabel": "Committed and Available Credit Facilities" } } }, "localname": "ScheduleOfLineOfCreditFacilitiesTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/LongTermDebtandAvailableCreditFacilitiesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfNetBenefitCostsTableTextBlock": { "auth_ref": [ "r634" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of net benefit costs for pension plans and/or other employee benefit plans including service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) recognized due to settlements or curtailments.", "label": "Schedule of Net Benefit Costs [Table Text Block]", "terseLabel": "Schedule of Net Benefit Costs [Table Text Block]" } } }, "localname": "ScheduleOfNetBenefitCostsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock": { "auth_ref": [ "r239", "r243", "r275", "r276" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of changes in accounting principles, including adoption of new accounting pronouncements, that describes the new methods, amount and effects on financial statement line items.", "label": "Accounting Standards Update and Change in Accounting Principle [Table Text Block]", "terseLabel": "Schedule of New Accounting Pronouncements and Changes in Accounting Principles [Table Text Block]" } } }, "localname": "ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/RecentAccountingGuidanceAccountingPronouncementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock": { "auth_ref": [ "r847" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the notional amounts of outstanding derivative positions.", "label": "Schedule of Notional Amounts of Outstanding Derivative Positions [Table Text Block]", "terseLabel": "Notional Amounts of Derivatives" } } }, "localname": "ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/FinancialInstrumentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of non-operating income or non-operating expense that may include amounts earned from dividends, interest on securities, gains (losses) on securities sold, equity earnings of unconsolidated affiliates, net gain (loss) on sales of business, interest expense and other miscellaneous income or expense items.", "label": "Schedule of Other Nonoperating Income (Expense) [Table Text Block]", "terseLabel": "Schedule of Other Nonoperating Income (Expense)" } } }, "localname": "ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/SupplementaryInformationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfOtherShareBasedCompensationActivityTableTextBlock": { "auth_ref": [ "r714" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of activity for outstanding award under share-based payment arrangement excluding share and unit options and nonvested award.", "label": "Share-based Payment Arrangement, Outstanding Award, Activity, Excluding Option [Table Text Block]", "terseLabel": "RSU and PSU Activity" } } }, "localname": "ScheduleOfOtherShareBasedCompensationActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/StockBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "auth_ref": [ "r86", "r424" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table]", "terseLabel": "Property, Plant and Equipment [Table]" } } }, "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/PropertyPlantandEquipmentScheduleofPropertyPlantandEquipmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock": { "auth_ref": [ "r278" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of quarterly financial data. Includes, but is not limited to, financial information for fiscal quarters, cumulative effect of a change in accounting principle and earnings per share data.", "label": "Quarterly Financial Information [Table Text Block]", "terseLabel": "Quarterly Financial Information" } } }, "localname": "ScheduleOfQuarterlyFinancialInformationTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/EIDQuarterlyFNTables", "http://www.corteva.com/role/QuaterlyFinancialDataTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": { "auth_ref": [ "r946", "r948" ], "lang": { "en-us": { "role": { "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Schedule of Related Party Transactions, by Related Party [Table]", "terseLabel": "Schedule of Related Party Transactions, by Related Party [Table]" } } }, "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/EIDRelatedPartyDetails", "http://www.corteva.com/role/EIDRelatedPartyNotes", "http://www.corteva.com/role/RelatedPartiesServicesProvidedbyandtoDowDetails", "http://www.corteva.com/role/RelatedPartiesTransactionswithDowDuPontDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTable": { "auth_ref": [ "r50", "r201", "r1012", "r1057" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about cash and cash equivalents restricted as to withdrawal or usage.", "label": "Restrictions on Cash and Cash Equivalents [Table]", "terseLabel": "Restrictions on Cash and Cash Equivalents [Table]" } } }, "localname": "ScheduleOfRestrictedCashAndCashEquivalentsTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/SupplementaryInformationReconciliationofCashCashEquivalentsandRestrictedCashDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock": { "auth_ref": [ "r50", "r201", "r1012", "r1057" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of cash and cash equivalents restricted as to withdrawal or usage.", "label": "Restrictions on Cash and Cash Equivalents [Table Text Block]", "terseLabel": "Restrictions on Cash and Cash Equivalents" } } }, "localname": "ScheduleOfRestrictedCashAndCashEquivalentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/SupplementaryInformationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": { "auth_ref": [ "r443", "r444", "r445", "r446", "r451", "r452", "r453" ], "lang": { "en-us": { "role": { "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring.", "label": "Schedule of Restructuring and Related Costs [Table]", "terseLabel": "Schedule of Restructuring and Related Costs [Table]" } } }, "localname": "ScheduleOfRestructuringAndRelatedCostsTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/RestructuringandAssetRelatedCharges2021RestructuringActionsDetails", "http://www.corteva.com/role/RestructuringandAssetRelatedChargesAssetImpairmentsDetails", "http://www.corteva.com/role/RestructuringandAssetRelatedChargesDowDuPontAgricultureDivisionRestructuringProgramDetails", "http://www.corteva.com/role/RestructuringandAssetRelatedChargesDowDuPontCostSynergyProgramDetails", "http://www.corteva.com/role/RestructuringandAssetRelatedChargesExecutetoWinProductivityProgramDetails", "http://www.corteva.com/role/RestructuringandAssetRelatedChargesTables" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock": { "auth_ref": [ "r444", "r452" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period.", "label": "Schedule of Restructuring Reserve by Type of Cost [Table Text Block]", "terseLabel": "Schedule of Restructuring Reserve by Type of Cost [Table Text Block]" } } }, "localname": "ScheduleOfRestructuringReserveByTypeOfCostTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/RestructuringandAssetRelatedChargesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock": { "auth_ref": [ "r161", "r332" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the names of foreign countries from which revenue is material and the amount of revenue from external customers attributed to those countries. An entity may also provide subtotals of geographic information about groups of countries.", "label": "Schedule of Revenue from External Customers Attributed to Foreign Countries by Geographic Area [Table Text Block]", "terseLabel": "Net Sales by Geographic Area" } } }, "localname": "ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/GeographicInformationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable": { "auth_ref": [ "r149", "r334" ], "lang": { "en-us": { "role": { "documentation": "Schedule of material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material. An entity may also provide subtotals of geographic information about groups of countries.", "label": "Schedule of Revenues from External Customers and Long-Lived Assets [Table]", "terseLabel": "Schedule of Revenues from External Customers and Long-Lived Assets [Table]" } } }, "localname": "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/GeographicInformationNetPropertybyCountryDetails", "http://www.corteva.com/role/GeographicInformationRevenuebyCountryDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": { "auth_ref": [ "r306", "r309", "r321", "r397" ], "lang": { "en-us": { "role": { "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "Schedule of Segment Reporting Information, by Segment [Table]", "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/EIDSegmentFNNotes", "http://www.corteva.com/role/EIDSegmentFNSegmentAssetReconciliationDetails", "http://www.corteva.com/role/EIDSegmentFNSegmentReconciliationDetails", "http://www.corteva.com/role/EIDSegmentFNTables", "http://www.corteva.com/role/SegmentReportingSegmentAssetsDetails", "http://www.corteva.com/role/SegmentReportingSegmentInformationDetails", "http://www.corteva.com/role/SegmentReportingSegmentReconciliationDetails", "http://www.corteva.com/role/SegmentReportingSigItemsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": { "auth_ref": [ "r306", "r309", "r321", "r397" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]", "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table Text Block]" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/SegmentReportingTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "auth_ref": [ "r702", "r733" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about share-based payment arrangement.", "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]", "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]" } } }, "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/StockBasedCompensationRestrictedStockUnitsandPerformanceDeferredStockDetails", "http://www.corteva.com/role/StockBasedCompensationStockCompensationDetails", "http://www.corteva.com/role/StockBasedCompensationStockOptionsDetails", "http://www.corteva.com/role/StockBasedCompensationTables", "http://www.corteva.com/role/StockBasedCompensationWeightedAverageAssumptionsStockOptionsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": { "auth_ref": [ "r707", "r719", "r722" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.", "label": "Share-based Payment Arrangement, Option, Activity [Table Text Block]", "terseLabel": "Stock Option Activity" } } }, "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/StockBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": { "auth_ref": [ "r724" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.", "label": "Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]", "terseLabel": "Weighted Average Assumptions - Stock Option Awards" } } }, "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/StockBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShortTermDebtTextBlock": { "auth_ref": [ "r90" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of short-term debt arrangements (having initial terms of repayment within one year or the normal operating cycle, if longer) including: (1) description of the short-term debt arrangement; (2) identification of the lender or type of lender; (3) repayment terms; (4) weighted average interest rate; (5) carrying amount of funds borrowed under the specified short-term debt arrangement as of the balance sheet date; (6) description of the refinancing of a short-term obligation when that obligation is excluded from current liabilities in the balance sheet; and (7) amount of a short-term obligation that has been excluded from current liabilities in the balance sheet because of a refinancing of the obligation.", "label": "Schedule of Short-term Debt [Table Text Block]", "terseLabel": "Short-Term Borrowings and Finance Lease Obligations" } } }, "localname": "ScheduleOfShortTermDebtTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/LongTermDebtandAvailableCreditFacilitiesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfStockByClassTable": { "auth_ref": [ "r100", "r208", "r283", "r284", "r532", "r535", "r536", "r538", "r539", "r540", "r541", "r543", "r547", "r552", "r555", "r556", "r557", "r558", "r559", "r560", "r561" ], "lang": { "en-us": { "role": { "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.", "label": "Schedule of Stock by Class [Table]", "terseLabel": "Class of Treasury Stock [Table]" } } }, "localname": "ScheduleOfStockByClassTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/StockholdersEquityCommonStockDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfStockByClassTextBlock": { "auth_ref": [ "r64", "r65", "r66", "r533", "r535", "r536", "r555", "r556", "r557", "r558", "r559", "r560", "r561" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of an entity's stock, including par or stated value per share, number and dollar amount of share subscriptions, shares authorized, shares issued, shares outstanding, number and dollar amount of shares held in an employee trust, dividend per share, total dividends, share conversion features, par value plus additional paid in capital, the value of treasury stock and other information necessary to a fair presentation, and EPS information. Stock by class includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. Includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity. If more than one issue is outstanding, state the title of each issue and the corresponding dollar amount; dollar amount of any shares subscribed but unissued and the deduction of subscriptions receivable there from; number of shares authorized, issued, and outstanding.", "label": "Schedule of Stock by Class [Table Text Block]", "terseLabel": "Reconciliation of Common Stock Share Activity" } } }, "localname": "ScheduleOfStockByClassTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/StockholdersEquityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock": { "auth_ref": [ "r766", "r782" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the change in unrecognized tax benefits.", "label": "Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]", "terseLabel": "Total Gross Unrecognized Tax Benefits" } } }, "localname": "ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": { "auth_ref": [ "r408" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.", "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]", "terseLabel": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense" } } }, "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/GoodwillandOtherIntangibleAssetsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SecuritiesSoldUnderAgreementsToRepurchaseMember": { "auth_ref": [ "r895" ], "lang": { "en-us": { "role": { "documentation": "The securities that an institution sells and agrees to repurchase (the identical or substantially the same securities) as a seller-borrower at a specified date for a specified price, also known as a repurchase agreement, or repo. Most repos involve obligations of the federal government or its agencies, but other financial instruments, such as commercial paper, banker's acceptances, and negotiable certificates of deposit, are sometimes used in repos.", "label": "Securities Sold under Agreements to Repurchase [Member]", "terseLabel": "Securities Sold under Agreements to Repurchase [Member]" } } }, "localname": "SecuritiesSoldUnderAgreementsToRepurchaseMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SegmentContinuingOperationsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Component of an entity expected to operate in the foreseeable future.", "label": "Continuing Operations [Member]", "terseLabel": "Continuing Operations [Member]" } } }, "localname": "SegmentContinuingOperationsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/EIDIncomeTaxesGeographicAllocationDetails", "http://www.corteva.com/role/EIDIncomeTaxesRateReconciliationDetails", "http://www.corteva.com/role/GoodwillandOtherIntangibleAssetsAmortizationExpenseDetails", "http://www.corteva.com/role/IncomeTaxesIncomeTaxesGeographicAllocationofIncomeandProvisionforIncomeTaxesDetails", "http://www.corteva.com/role/IncomeTaxesIncomeTaxesReconciliationtoUSStatutoryRateDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansComponentsofnetperiodicbenefitcostcreditandamountsrecognizedinothercomprehensivelossDetails", "http://www.corteva.com/role/SupplementaryInformationReconciliationofCashCashEquivalentsandRestrictedCashDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SegmentDiscontinuedOperationsMember": { "auth_ref": [ "r6", "r8", "r9", "r10" ], "lang": { "en-us": { "role": { "documentation": "Component or group of components disposed of or classified as held-for-sale and representing a strategic shift that has or will have a major effect on operations and financial results. Includes a business or nonprofit activity on acquisition classified as held-for-sale.", "label": "Discontinued Operations [Member]", "terseLabel": "Discontinued Operations [Member]" } } }, "localname": "SegmentDiscontinuedOperationsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesEnvironmentalDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansAdditionalInformationDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansAmountsRecognizedinConsolidatedBalanceSheetsDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansBasisofFairValueMeasurementDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansComponentsofnetperiodicbenefitcostcreditandamountsrecognizedinothercomprehensivelossDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansPensionPlanswithAccumulatedBenefitObligationsinExcessofPlanAssetsDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansPensionPlanswithProjectedBenefitObligationsinExcessofPlanAssetsDetails", "http://www.corteva.com/role/RelatedPartiesServicesProvidedbyandtoDowDetails", "http://www.corteva.com/role/SegmentReportingOtherItemsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SegmentDomain": { "auth_ref": [ "r293", "r297", "r298", "r299", "r300", "r301", "r302", "r303", "r304", "r305", "r306", "r307", "r308", "r317", "r318", "r319", "r320", "r322", "r323", "r324", "r325", "r326", "r328", "r335", "r446", "r453", "r1078" ], "lang": { "en-us": { "role": { "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.", "label": "Segments [Domain]", "terseLabel": "Segments [Domain]" } } }, "localname": "SegmentDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/DivestituresandOtherTransactionsECPDivestitureDetails", "http://www.corteva.com/role/EIDSegmentFNSegmentReconciliationDetails", "http://www.corteva.com/role/GoodwillandOtherIntangibleAssetsGoodwillbySegmentDetails", "http://www.corteva.com/role/QuaterlyFinancialDataQuarterlyFinancialDataParentheticalsDetails", "http://www.corteva.com/role/RestructuringandAssetRelatedCharges2021RestructuringActionsDetails", "http://www.corteva.com/role/RestructuringandAssetRelatedChargesDowDuPontAgricultureDivisionRestructuringProgramDetails", "http://www.corteva.com/role/RestructuringandAssetRelatedChargesDowDuPontCostSynergyProgramDetails", "http://www.corteva.com/role/RestructuringandAssetRelatedChargesExecutetoWinProductivityProgramDetails", "http://www.corteva.com/role/RevenueDisaggregationofRevenueGeoDetails", "http://www.corteva.com/role/RevenueDisaggregationofRevenueProductsDetails", "http://www.corteva.com/role/SegmentReportingSegmentInformationDetails", "http://www.corteva.com/role/SegmentReportingSigItemsDetails", "http://www.corteva.com/role/SupplementaryInformationOtherIncomeExpenseNetDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SegmentOperatingActivitiesDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Operations of an entity including continuing and discontinued operations.", "label": "Operating Activities [Domain]", "terseLabel": "Operating Activities [Domain]" } } }, "localname": "SegmentOperatingActivitiesDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/EIDIncomeTaxesGeographicAllocationDetails", "http://www.corteva.com/role/EIDIncomeTaxesRateReconciliationDetails", "http://www.corteva.com/role/GoodwillandOtherIntangibleAssetsAmortizationExpenseDetails", "http://www.corteva.com/role/IncomeTaxesIncomeTaxesGeographicAllocationofIncomeandProvisionforIncomeTaxesDetails", "http://www.corteva.com/role/IncomeTaxesIncomeTaxesReconciliationtoUSStatutoryRateDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansAdditionalInformationDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansAmountsRecognizedinConsolidatedBalanceSheetsDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansBasisofFairValueMeasurementDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansComponentsofnetperiodicbenefitcostcreditandamountsrecognizedinothercomprehensivelossDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansPensionPlanswithAccumulatedBenefitObligationsinExcessofPlanAssetsDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansPensionPlanswithProjectedBenefitObligationsinExcessofPlanAssetsDetails", "http://www.corteva.com/role/RelatedPartiesServicesProvidedbyandtoDowDetails", "http://www.corteva.com/role/SupplementaryInformationReconciliationofCashCashEquivalentsandRestrictedCashDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SegmentReportingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Segment Reporting [Abstract]", "terseLabel": "Segment Reporting [Abstract]" } } }, "localname": "SegmentReportingAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_SegmentReportingAssetReconcilingItemLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Segment Reporting, Asset Reconciling Item [Line Items]", "terseLabel": "Segment Reporting, Asset Reconciling Item [Line Items]" } } }, "localname": "SegmentReportingAssetReconcilingItemLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/EIDSegmentFNTables" ], "xbrltype": "stringItemType" }, "us-gaap_SegmentReportingDisclosureTextBlock": { "auth_ref": [ "r293", "r295", "r296", "r306", "r310", "r322", "r326", "r327", "r328", "r329", "r331", "r334", "r335", "r336" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.", "label": "Segment Reporting Disclosure [Text Block]", "terseLabel": "Segment Reporting Disclosure [Text Block]" } } }, "localname": "SegmentReportingDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/EIDSegmentFNNotes", "http://www.corteva.com/role/SegmentReportingNotes" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentReportingInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Segment Reporting Information [Line Items]", "terseLabel": "Segment Reporting Information [Line Items]" } } }, "localname": "SegmentReportingInformationLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/EIDSegmentFNNotes", "http://www.corteva.com/role/EIDSegmentFNSegmentAssetReconciliationDetails", "http://www.corteva.com/role/SegmentReportingSegmentAssetsDetails", "http://www.corteva.com/role/SegmentReportingSegmentInformationDetails", "http://www.corteva.com/role/SegmentReportingSegmentReconciliationDetails", "http://www.corteva.com/role/SegmentReportingSigItemsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Segment Reporting, Other Significant Reconciling Item [Line Items]", "terseLabel": "Segment Reporting, Other Significant Reconciling Item [Line Items]" } } }, "localname": "SegmentReportingOtherSignificantReconcilingItemLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/SegmentReportingOtherItemsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SegmentReportingPolicyPolicyTextBlock": { "auth_ref": [ "r311", "r312", "r313", "r314", "r315", "r316", "r332" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for segment reporting.", "label": "Segment Reporting, Policy [Policy Text Block]", "terseLabel": "Segment Reporting" } } }, "localname": "SegmentReportingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]", "terseLabel": "Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]" } } }, "localname": "SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/EIDSegmentFNSegmentReconciliationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SellingGeneralAndAdministrativeExpense": { "auth_ref": [ "r166" ], "calculation": { "http://www.corteva.com/role/ConsolidatedStatementsofIncome": { "order": 4.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.", "label": "Selling, General and Administrative Expense", "terseLabel": "Selling, General and Administrative Expense" } } }, "localname": "SellingGeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/ConsolidatedStatementsofIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock": { "auth_ref": [ "r746" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for inclusion of significant items in the selling, general and administrative (or similar) expense report caption.", "label": "Selling, General and Administrative Expenses, Policy [Policy Text Block]", "terseLabel": "Selling, General and Administrative Expenses" } } }, "localname": "SellingGeneralAndAdministrativeExpensesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_SeniorNotesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Bond that takes priority over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior debt holders receive priority for (must receive) repayment prior to (relative to) junior and unsecured (general) creditors.", "label": "Senior Notes [Member]", "terseLabel": "Senior Notes [Member]" } } }, "localname": "SeniorNotesMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/LongTermDebtandAvailableCreditFacilitiesLongTermDebtDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SeniorSubordinatedNotesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A senior subordinated note is a bond that takes priority over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior subordinated debt holders receive priority for [must receive] repayment [prior] relative to junior and unsecured (general) creditors. However senior subordinated notes are junior to Senior Notes and Senior bond holders.", "label": "Senior Subordinated Notes [Member]", "terseLabel": "Senior Subordinated Notes [Member]" } } }, "localname": "SeniorSubordinatedNotesMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/LongTermDebtandAvailableCreditFacilitiesDebtRedemptionsRepaymentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SettledLitigationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Agreement reached between parties in a litigation that occurs without judicial intervention, supervision or approval.", "label": "Settled Litigation [Member]", "terseLabel": "Settled Litigation [Member]" } } }, "localname": "SettledLitigationMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationLeachandMDLSettlementDetails", "http://www.corteva.com/role/DivestituresandOtherTransactionsDivestituresandOtherTransactionsPChemResultsofOperationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1": { "auth_ref": [ "r703" ], "lang": { "en-us": { "role": { "documentation": "Estimated period over which an employee is required to provide service in exchange for the equity-based payment award, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Requisite Service Period", "terseLabel": "RSU Requisite Service Period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/StockBasedCompensationRestrictedStockUnitsandPerformanceDeferredStockDetails" ], "xbrltype": "durationItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": { "auth_ref": [ "r703" ], "lang": { "en-us": { "role": { "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period", "terseLabel": "Stock Option Award Vesting Period", "verboseLabel": "RSU and PSU Award Vesting Period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/StockBasedCompensationRestrictedStockUnitsandPerformanceDeferredStockDetails", "http://www.corteva.com/role/StockBasedCompensationStockOptionsDetails" ], "xbrltype": "durationItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": { "auth_ref": [ "r712" ], "lang": { "en-us": { "role": { "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period", "terseLabel": "RSUs and PSUs forfeited during the period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/StockBasedCompensationRestrictedStockUnitsandPerformanceDeferredStockDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": { "auth_ref": [ "r718" ], "lang": { "en-us": { "role": { "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value", "terseLabel": "Weighted Average Grant Date Fair Value, RSUs and PSUs forfeited during the period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/StockBasedCompensationRestrictedStockUnitsandPerformanceDeferredStockDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": { "auth_ref": [ "r716" ], "lang": { "en-us": { "role": { "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period", "terseLabel": "RSUs and PSUs granted during the period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/StockBasedCompensationRestrictedStockUnitsandPerformanceDeferredStockDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r716" ], "lang": { "en-us": { "role": { "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value", "terseLabel": "Weighted Average Grant Date Fair Value, RSUs and PSUs granted during the period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/StockBasedCompensationRestrictedStockUnitsandPerformanceDeferredStockDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": { "auth_ref": [ "r715" ], "lang": { "en-us": { "role": { "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number", "periodEndLabel": "Nonvested RSUs and PSUs at end of period", "periodStartLabel": "Nonvested RSUs and PSUs at beginning of period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/StockBasedCompensationRestrictedStockUnitsandPerformanceDeferredStockDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": { "auth_ref": [ "r715" ], "lang": { "en-us": { "role": { "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value", "periodStartLabel": "Weighted average grant date fair value, nonvested RSUs and PSUs beginning of period", "terseLabel": "Weighted average grant date fair value, nonvested RSUs and PSUs end of period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/StockBasedCompensationRestrictedStockUnitsandPerformanceDeferredStockDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": { "auth_ref": [ "r717" ], "lang": { "en-us": { "role": { "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period", "terseLabel": "RSUs and PSUs vested during the period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/StockBasedCompensationRestrictedStockUnitsandPerformanceDeferredStockDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue": { "auth_ref": [ "r721" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value", "terseLabel": "Fair Value of RSUs and PSUs vested during the period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/StockBasedCompensationRestrictedStockUnitsandPerformanceDeferredStockDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r717" ], "lang": { "en-us": { "role": { "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value", "terseLabel": "Weighted Average Grant Date Fair Value, vested RSUs and PSUs during the period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/StockBasedCompensationRestrictedStockUnitsandPerformanceDeferredStockDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": { "auth_ref": [ "r727" ], "lang": { "en-us": { "role": { "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate", "terseLabel": "Dividend yield" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/StockBasedCompensationStockOptionsDetails", "http://www.corteva.com/role/StockBasedCompensationWeightedAverageAssumptionsStockOptionsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": { "auth_ref": [ "r726" ], "lang": { "en-us": { "role": { "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate", "terseLabel": "Expected Volatility" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/StockBasedCompensationWeightedAverageAssumptionsStockOptionsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": { "auth_ref": [ "r728" ], "lang": { "en-us": { "role": { "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate", "terseLabel": "Risk Free Interest Rate" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/StockBasedCompensationWeightedAverageAssumptionsStockOptionsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/StockBasedCompensationRestrictedStockUnitsandPerformanceDeferredStockDetails", "http://www.corteva.com/role/StockBasedCompensationStockCompensationDetails", "http://www.corteva.com/role/StockBasedCompensationStockOptionsDetails", "http://www.corteva.com/role/StockBasedCompensationTables", "http://www.corteva.com/role/StockBasedCompensationWeightedAverageAssumptionsStockOptionsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": { "auth_ref": [ "r705" ], "lang": { "en-us": { "role": { "documentation": "Number of shares authorized for issuance under share-based payment arrangement.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized", "terseLabel": "Shares authorized for future grants" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/StockBasedCompensationStockCompensationDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": { "auth_ref": [ "r733" ], "lang": { "en-us": { "role": { "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant", "terseLabel": "Shares available for grant" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/StockBasedCompensationStockCompensationDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": { "auth_ref": [ "r710" ], "lang": { "en-us": { "role": { "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number", "terseLabel": "Stock options exercisable at end of period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/StockBasedCompensationStockOptionsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": { "auth_ref": [ "r710" ], "lang": { "en-us": { "role": { "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price", "terseLabel": "Stock options exercisable, weighted average exercise price" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/StockBasedCompensationStockOptionsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": { "auth_ref": [ "r721" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value", "terseLabel": "Intrinsic value of stock options" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/StockBasedCompensationStockCompensationDetails", "http://www.corteva.com/role/StockBasedCompensationStockOptionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod": { "auth_ref": [ "r713" ], "lang": { "en-us": { "role": { "documentation": "For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period", "terseLabel": "Stock options forfeited/expired during the period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/StockBasedCompensationStockOptionsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r713" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price of options that were either forfeited or expired.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price", "terseLabel": "Stock options forfeited/expired, weighted average price" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/StockBasedCompensationStockOptionsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Gross number of share options (or share units) granted during the period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross", "terseLabel": "Stock options granted during the period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/StockBasedCompensationStockOptionsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r720" ], "lang": { "en-us": { "role": { "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value", "terseLabel": "Weighted Average Grant Date Fair Value" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/StockBasedCompensationStockOptionsDetails", "http://www.corteva.com/role/StockBasedCompensationWeightedAverageAssumptionsStockOptionsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": { "auth_ref": [ "r733" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value", "terseLabel": "Stock options outstanding, intrinsic value" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/StockBasedCompensationStockOptionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "auth_ref": [ "r709", "r733" ], "lang": { "en-us": { "role": { "documentation": "Number of options outstanding, including both vested and non-vested options.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number", "periodEndLabel": "Stock options outstanding at end of period", "periodStartLabel": "Stock options outstanding at beginning of period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/StockBasedCompensationStockOptionsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "auth_ref": [ "r708" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price", "periodEndLabel": "Stock options outstanding, weighted average exercise price end of period", "periodStartLabel": "Stock options outstanding, weighted average exercise price beginning of period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/StockBasedCompensationStockOptionsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost": { "auth_ref": [ "r731" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "An excess of the fair value of the modified award over the fair value of the award immediately before the modification.", "label": "Share-based Payment Arrangement, Plan Modification, Incremental Cost", "terseLabel": "Incremental Expense" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/StockBasedCompensationStockCompensationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "auth_ref": [ "r700", "r706" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement.", "label": "Award Type [Domain]", "terseLabel": "Award Type [Domain]" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/StockBasedCompensationRestrictedStockUnitsandPerformanceDeferredStockDetails", "http://www.corteva.com/role/StockBasedCompensationStockCompensationDetails", "http://www.corteva.com/role/StockBasedCompensationStockOptionsDetails", "http://www.corteva.com/role/StockBasedCompensationWeightedAverageAssumptionsStockOptionsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.", "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price", "terseLabel": "Stock options exercised during the period, weighted average exercise price" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/StockBasedCompensationStockOptionsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.", "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price", "terseLabel": "Stock options granted, weighted average price" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/StockBasedCompensationStockOptionsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareRepurchaseProgramAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by share repurchase program.", "label": "Share Repurchase Program [Axis]", "terseLabel": "Share Repurchase Program [Axis]" } } }, "localname": "ShareRepurchaseProgramAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/StockholdersEquityCommonStockDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareRepurchaseProgramDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the share repurchase program.", "label": "Share Repurchase Program [Domain]", "terseLabel": "Share Repurchase Program [Domain]" } } }, "localname": "ShareRepurchaseProgramDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/StockholdersEquityCommonStockDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": { "auth_ref": [ "r704" ], "lang": { "en-us": { "role": { "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period", "terseLabel": "Stock Option, Expiration Period" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/StockBasedCompensationStockOptionsDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": { "auth_ref": [ "r725", "r740" ], "lang": { "en-us": { "role": { "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term", "terseLabel": "Expected life of stock options granted during period" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/StockBasedCompensationWeightedAverageAssumptionsStockOptionsDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": { "auth_ref": [ "r733" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value", "terseLabel": "Stock options exercisable, intrinsic value" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/StockBasedCompensationStockOptionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": { "auth_ref": [ "r733" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term", "terseLabel": "Stock options exercisable, weighted average remaining contractual term" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/StockBasedCompensationStockOptionsDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": { "auth_ref": [ "r723" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term", "terseLabel": "Stock options outstanding, weighted average remaining contractual term" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/StockBasedCompensationStockOptionsDetails", "http://www.corteva.com/role/StockBasedCompensationWeightedAverageAssumptionsStockOptionsDetails" ], "xbrltype": "durationItemType" }, "us-gaap_ShortTermBorrowings": { "auth_ref": [ "r55", "r953", "r1016", "r1056" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.", "label": "Short-term Debt", "verboseLabel": "Short-term Debt" } } }, "localname": "ShortTermBorrowings", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/SubsequentEventsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShortTermDebtMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Debt arrangement having an initial term within one year or the normal operating cycle, if longer.", "label": "Short-term Debt [Member]", "terseLabel": "Within One Year" } } }, "localname": "ShortTermDebtMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/LeasesSupplementalBalanceSheetInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShortTermDebtTypeAxis": { "auth_ref": [ "r90" ], "lang": { "en-us": { "role": { "documentation": "Information by type of short-term debt arrangement.", "label": "Short-term Debt, Type [Axis]", "terseLabel": "Short-term Debt, Type [Axis]" } } }, "localname": "ShortTermDebtTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/LongTermDebtandAvailableCreditFacilitiesAvailableCommittedCreditFacilitiesNarrativeDetails", "http://www.corteva.com/role/SubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShortTermDebtTypeDomain": { "auth_ref": [ "r88" ], "lang": { "en-us": { "role": { "documentation": "Type of short-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing.", "label": "Short-term Debt, Type [Domain]", "terseLabel": "Short-term Debt, Type [Domain]" } } }, "localname": "ShortTermDebtTypeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/LongTermDebtandAvailableCreditFacilitiesAvailableCommittedCreditFacilitiesNarrativeDetails", "http://www.corteva.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShortTermInvestments": { "auth_ref": [ "r57", "r1022", "r1023", "r1052" ], "calculation": { "http://www.corteva.com/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.", "label": "Short-term Investments", "terseLabel": "Marketable Securities" } } }, "localname": "ShortTermInvestments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShortTermInvestmentsMember": { "auth_ref": [ "r1107", "r1108", "r1109", "r1110" ], "lang": { "en-us": { "role": { "documentation": "Investments which are not otherwise included in another category or item that the entity has the intent to sell or dispose of within one year from the date of the balance sheet.", "label": "Short-term Investments [Member]", "terseLabel": "Maturity Within One Year" } } }, "localname": "ShortTermInvestmentsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/FinancialInstrumentsDebtSecuritiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShortTermLeaseCost": { "auth_ref": [ "r933", "r940" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of short-term lease cost, excluding expense for lease with term of one month or less.", "label": "Short-term Lease, Cost", "terseLabel": "Short-term Lease, Cost" } } }, "localname": "ShortTermLeaseCost", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/LeasesLeaseCostsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r202", "r229" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.", "label": "Significant Accounting Policies [Text Block]", "terseLabel": "Significant Accounting Policies [Text Block]" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/SummaryofSignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_StatementBusinessSegmentsAxis": { "auth_ref": [ "r16", "r293", "r297", "r298", "r299", "r300", "r301", "r302", "r303", "r304", "r305", "r306", "r307", "r308", "r317", "r318", "r319", "r320", "r322", "r323", "r324", "r325", "r326", "r328", "r335", "r397", "r428", "r446", "r453", "r1078" ], "lang": { "en-us": { "role": { "documentation": "Information by business segments.", "label": "Segments [Axis]", "terseLabel": "Segments [Axis]" } } }, "localname": "StatementBusinessSegmentsAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/DivestituresandOtherTransactionsECPDivestitureDetails", "http://www.corteva.com/role/EIDSegmentFNSegmentReconciliationDetails", "http://www.corteva.com/role/GoodwillandOtherIntangibleAssetsGoodwillbySegmentDetails", "http://www.corteva.com/role/QuaterlyFinancialDataQuarterlyFinancialDataParentheticalsDetails", "http://www.corteva.com/role/RestructuringandAssetRelatedCharges2021RestructuringActionsDetails", "http://www.corteva.com/role/RestructuringandAssetRelatedChargesDowDuPontAgricultureDivisionRestructuringProgramDetails", "http://www.corteva.com/role/RestructuringandAssetRelatedChargesDowDuPontCostSynergyProgramDetails", "http://www.corteva.com/role/RestructuringandAssetRelatedChargesExecutetoWinProductivityProgramDetails", "http://www.corteva.com/role/RevenueDisaggregationofRevenueGeoDetails", "http://www.corteva.com/role/RevenueDisaggregationofRevenueProductsDetails", "http://www.corteva.com/role/SegmentReportingSegmentInformationDetails", "http://www.corteva.com/role/SegmentReportingSigItemsDetails", "http://www.corteva.com/role/SupplementaryInformationOtherIncomeExpenseNetDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [ "r64", "r65", "r66", "r208", "r211", "r256", "r257", "r262", "r265", "r267", "r283", "r284", "r285", "r362", "r480", "r485", "r486", "r487", "r493", "r494", "r538", "r539", "r543", "r547", "r554", "r896", "r1140" ], "lang": { "en-us": { "role": { "documentation": "Information by the different classes of stock of the entity.", "label": "Class of Stock [Axis]", "terseLabel": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/ConsolidatedBalanceSheets", "http://www.corteva.com/role/ConsolidatedBalanceSheetsParentheticals", "http://www.corteva.com/role/ConsolidatedStatementsofEquityParentheticals", "http://www.corteva.com/role/DEIDocument", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansBasisofFairValueMeasurementDetails", "http://www.corteva.com/role/StockholdersEquityNoncontrollingInterestDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r0", "r101", "r144", "r145", "r146", "r230", "r231", "r232", "r236", "r246", "r249", "r282", "r363", "r554", "r561", "r735", "r736", "r737", "r783", "r784", "r880", "r905", "r906", "r907", "r908", "r909", "r911", "r1083", "r1084", "r1085", "r1185" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]", "terseLabel": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/BackgroundandBasisofPresentationDetails", "http://www.corteva.com/role/ConsolidatedStatementsofEquity", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansBasisofFairValueMeasurementDetails", "http://www.corteva.com/role/StockholdersEquityOtherComprehensiveIncomeLossDetails", "http://www.corteva.com/role/StockholdersEquityReclassificationsoutofAOCIDetails", "http://www.corteva.com/role/StockholdersEquityTaxBenefitExpenseonNetActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]", "terseLabel": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/BackgroundandBasisofPresentationDetails", "http://www.corteva.com/role/ConsolidatedBalanceSheets", "http://www.corteva.com/role/ConsolidatedBalanceSheetsParentheticals", "http://www.corteva.com/role/ConsolidatedStatementsofCashFlows", "http://www.corteva.com/role/ConsolidatedStatementsofComprehensiveIncome", "http://www.corteva.com/role/ConsolidatedStatementsofEquity", "http://www.corteva.com/role/ConsolidatedStatementsofEquityParentheticals", "http://www.corteva.com/role/ConsolidatedStatementsofIncome", "http://www.corteva.com/role/EIDBasisofPresentationDetails", "http://www.corteva.com/role/EIDIncomeTaxesGeographicAllocationDetails", "http://www.corteva.com/role/EIDIncomeTaxesNotes", "http://www.corteva.com/role/EIDIncomeTaxesRateReconciliationDetails", "http://www.corteva.com/role/EIDIncomeTaxesTables", "http://www.corteva.com/role/EIDQuarterlyFNNotes", "http://www.corteva.com/role/EIDQuarterlyFNTables", "http://www.corteva.com/role/IncomeTaxesIncomeTaxesGeographicAllocationofIncomeandProvisionforIncomeTaxesDetails", "http://www.corteva.com/role/IncomeTaxesIncomeTaxesReconciliationtoUSStatutoryRateDetails", "http://www.corteva.com/role/LeasesNarrativeDetails", "http://www.corteva.com/role/QuaterlyFinancialDataQuarterlyFinancialDataParentheticalsDetails", "http://www.corteva.com/role/QuaterlyFinancialDataTables", "http://www.corteva.com/role/SummaryofSignificantAccountingPoliciesDetails", "http://www.corteva.com/role/SupplementaryInformationSupplementaryInformationNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]", "terseLabel": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]", "terseLabel": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Comprehensive Income [Abstract]", "terseLabel": "Statement of Comprehensive Income [Abstract]" } } }, "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Stockholders' Equity [Abstract]", "terseLabel": "Statement of Stockholders' Equity [Abstract]" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOperatingActivitiesSegmentAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by continuing and discontinuing operations.", "label": "Operating Activities [Axis]", "terseLabel": "Operating Activities [Axis]" } } }, "localname": "StatementOperatingActivitiesSegmentAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/EIDIncomeTaxesGeographicAllocationDetails", "http://www.corteva.com/role/EIDIncomeTaxesRateReconciliationDetails", "http://www.corteva.com/role/GoodwillandOtherIntangibleAssetsAmortizationExpenseDetails", "http://www.corteva.com/role/IncomeTaxesIncomeTaxesGeographicAllocationofIncomeandProvisionforIncomeTaxesDetails", "http://www.corteva.com/role/IncomeTaxesIncomeTaxesReconciliationtoUSStatutoryRateDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansAdditionalInformationDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansAmountsRecognizedinConsolidatedBalanceSheetsDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansBasisofFairValueMeasurementDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansComponentsofnetperiodicbenefitcostcreditandamountsrecognizedinothercomprehensivelossDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansPensionPlanswithAccumulatedBenefitObligationsinExcessofPlanAssetsDetails", "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansPensionPlanswithProjectedBenefitObligationsinExcessofPlanAssetsDetails", "http://www.corteva.com/role/RelatedPartiesServicesProvidedbyandtoDowDetails", "http://www.corteva.com/role/SupplementaryInformationReconciliationofCashCashEquivalentsandRestrictedCashDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r230", "r231", "r232", "r282", "r993" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]", "terseLabel": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/BackgroundandBasisofPresentationDetails", "http://www.corteva.com/role/ConsolidatedBalanceSheets", "http://www.corteva.com/role/ConsolidatedBalanceSheetsParentheticals", "http://www.corteva.com/role/ConsolidatedStatementsofCashFlows", "http://www.corteva.com/role/ConsolidatedStatementsofComprehensiveIncome", "http://www.corteva.com/role/ConsolidatedStatementsofEquity", "http://www.corteva.com/role/ConsolidatedStatementsofEquityParentheticals", "http://www.corteva.com/role/ConsolidatedStatementsofIncome", "http://www.corteva.com/role/EIDBasisofPresentationDetails", "http://www.corteva.com/role/EIDIncomeTaxesGeographicAllocationDetails", "http://www.corteva.com/role/EIDIncomeTaxesNotes", "http://www.corteva.com/role/EIDIncomeTaxesRateReconciliationDetails", "http://www.corteva.com/role/EIDIncomeTaxesTables", "http://www.corteva.com/role/EIDQuarterlyFNNotes", "http://www.corteva.com/role/EIDQuarterlyFNTables", "http://www.corteva.com/role/IncomeTaxesIncomeTaxesGeographicAllocationofIncomeandProvisionforIncomeTaxesDetails", "http://www.corteva.com/role/IncomeTaxesIncomeTaxesReconciliationtoUSStatutoryRateDetails", "http://www.corteva.com/role/LeasesNarrativeDetails", "http://www.corteva.com/role/QuaterlyFinancialDataQuarterlyFinancialDataParentheticalsDetails", "http://www.corteva.com/role/QuaterlyFinancialDataTables", "http://www.corteva.com/role/SummaryofSignificantAccountingPoliciesDetails", "http://www.corteva.com/role/SupplementaryInformationSupplementaryInformationNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "auth_ref": [ "r65", "r66", "r554", "r561" ], "lang": { "en-us": { "role": { "documentation": "Number of new stock issued during the period.", "label": "Stock Issued During Period, Shares, New Issues", "terseLabel": "Stock Issued During Period, Shares, New Issues" } } }, "localname": "StockIssuedDuringPeriodSharesNewIssues", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/StockholdersEquityCommonStockDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "auth_ref": [ "r65", "r66", "r554", "r561", "r711" ], "lang": { "en-us": { "role": { "documentation": "Number of share options (or share units) exercised during the current period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period", "terseLabel": "Stock options exercised during the period" } } }, "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/StockBasedCompensationStockOptionsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueOther": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of shares of stock issued attributable to transactions classified as other.", "label": "Stock Issued During Period, Value, Other", "terseLabel": "Issuance of stock" } } }, "localname": "StockIssuedDuringPeriodValueOther", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/ConsolidatedStatementsofEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockOptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Contracts conveying rights, but not obligations, to buy or sell a specific quantity of stock at a specified price during a specified period (an American option) or at a specified date (a European option).", "label": "Equity Option [Member]", "terseLabel": "Equity Option [Member]" } } }, "localname": "StockOptionMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/StockBasedCompensationStockOptionsDetails", "http://www.corteva.com/role/StockBasedCompensationWeightedAverageAssumptionsStockOptionsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_StockRepurchaseProgramAuthorizedAmount1": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of stock repurchase plan authorized.", "label": "Stock Repurchase Program, Authorized Amount", "terseLabel": "Stock Repurchase Program, Authorized Amount" } } }, "localname": "StockRepurchaseProgramAuthorizedAmount1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/RelatedPartiesTransactionswithDowDuPontDetails", "http://www.corteva.com/role/StockholdersEquityCommonStockDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockRepurchasedAndRetiredDuringPeriodShares": { "auth_ref": [ "r65", "r66", "r554", "r561" ], "lang": { "en-us": { "role": { "documentation": "Number of shares that have been repurchased and retired during the period.", "label": "Stock Repurchased and Retired During Period, Shares", "terseLabel": "Stock Repurchased and Retired During Period, Shares" } } }, "localname": "StockRepurchasedAndRetiredDuringPeriodShares", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/StockholdersEquityCommonStockDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r66", "r72", "r73", "r211", "r343", "r362", "r896", "r953" ], "calculation": { "http://www.corteva.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "terseLabel": "Total Company Stockholders' Equity" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r0", "r1", "r145", "r211", "r230", "r231", "r232", "r236", "r246", "r362", "r363", "r561", "r735", "r736", "r737", "r783", "r784", "r821", "r822", "r840", "r880", "r896", "r905", "r906", "r911", "r1084", "r1085", "r1185" ], "calculation": { "http://www.corteva.com/role/ConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.", "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest", "periodEndLabel": "Ending Balance", "periodStartLabel": "Beginning Balance", "totalLabel": "Total Stockholders' Equity" } } }, "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/ConsolidatedBalanceSheets", "http://www.corteva.com/role/ConsolidatedStatementsofEquity", "http://www.corteva.com/role/StockholdersEquityOtherComprehensiveIncomeLossDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r209", "r539", "r542", "r543", "r544", "r545", "r546", "r547", "r548", "r549", "r550", "r551", "r553", "r561", "r565" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.", "label": "Stockholders' Equity Note Disclosure [Text Block]", "terseLabel": "Stockholders' Equity Note Disclosure [Text Block]" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/StockholdersEquity" ], "xbrltype": "textBlockItemType" }, "us-gaap_StockholdersEquityNoteSpinoffTransaction": { "auth_ref": [ "r564" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The change in equity as a result of a spin-off transaction (a regular or reverse spin-off) which is based on the recorded amounts.", "label": "Stockholders' Equity Note, Spinoff Transaction", "terseLabel": "Impact of Internal Reorganizations" } } }, "localname": "StockholdersEquityNoteSpinoffTransaction", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/ConsolidatedStatementsofEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityOther": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This element represents movements included in the statement of changes in stockholders' equity which are not separately disclosed or provided for elsewhere in the taxonomy.", "label": "Stockholders' Equity, Other", "terseLabel": "Stockholders' Equity, Other" } } }, "localname": "StockholdersEquityOther", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/ConsolidatedStatementsofEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_SubsequentEventLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.", "label": "Subsequent Event [Line Items]", "terseLabel": "Subsequent Event [Line Items]" } } }, "localname": "SubsequentEventLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/SubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTable": { "auth_ref": [ "r912", "r955" ], "lang": { "en-us": { "role": { "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.", "label": "Subsequent Event [Table]", "terseLabel": "Subsequent Event [Table]" } } }, "localname": "SubsequentEventTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/SubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]", "terseLabel": "Subsequent Events [Abstract]" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r954", "r957" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "Subsequent Events [Text Block]", "terseLabel": "Subsequent Events [Text Block]" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/SubsequentEventsNotes" ], "xbrltype": "textBlockItemType" }, "us-gaap_SummaryOfIncomeTaxExaminationsTextBlock": { "auth_ref": [ "r759", "r782" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of income tax examinations that an enterprise is currently subject to or that have been completed in the current period typically including a description of the examination, the jurisdiction conducting the examination, the tax year(s) under examination, the likelihood of an unfavorable settlement, the range of possible losses, the liability recorded, the increase or decrease in the liability from the prior period, and any penalties and interest that have been recorded.", "label": "Summary of Income Tax Examinations [Table Text Block]", "terseLabel": "Tax Year Subject to Examination" } } }, "localname": "SummaryOfIncomeTaxExaminationsTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_TechnologyBasedIntangibleAssetsMember": { "auth_ref": [ "r810" ], "lang": { "en-us": { "role": { "documentation": "Technology-based intangible assets, including, but not limited to, patented technology, unpatented technology, and developed technology rights.", "label": "Technology-Based Intangible Assets [Member]", "terseLabel": "Developed Technology" } } }, "localname": "TechnologyBasedIntangibleAssetsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/FairValueMeasurementsFairValueMeasurementNonrecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TradeReceivablesHeldForSaleReconciliationToCashFlowAdditionsToHeldForSale": { "auth_ref": [ "r338" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of additions to trade receivables held-for-sale, after allowance for bad debt, that are not part of a disposal group.", "label": "Trade Receivables Held-for-sale, Reconciliation to Cash Flow, Additions to Held-for-sale", "terseLabel": "Trade receivables sold that remain outstanding with an element of recourse" } } }, "localname": "TradeReceivablesHeldForSaleReconciliationToCashFlowAdditionsToHeldForSale", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/AccountsandNotesReceivableNetCustomerFinancingDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_TrademarksAndTradeNamesMember": { "auth_ref": [ "r811" ], "lang": { "en-us": { "role": { "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style, or rights either acquired through registration of a business name to gain or protect exclusive use thereof.", "label": "Trademarks and Trade Names [Member]", "terseLabel": "Trademarks and Trade Names [Member]" } } }, "localname": "TrademarksAndTradeNamesMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/GoodwillandOtherIntangibleAssetsOtherIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TrademarksMember": { "auth_ref": [ "r811" ], "lang": { "en-us": { "role": { "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style.", "label": "Trademarks [Member]", "terseLabel": "Trademarks [Member]" } } }, "localname": "TrademarksMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/GoodwillandOtherIntangibleAssetsAmortizationExpenseDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": { "auth_ref": [ "r351", "r352", "r357", "r358", "r359", "r521", "r552", "r877", "r958", "r959", "r960", "r961", "r962", "r963", "r964", "r965", "r966", "r968", "r969", "r970", "r971", "r973", "r974", "r975", "r976", "r977", "r978", "r979", "r980", "r981", "r982", "r983", "r984", "r985", "r986", "r987", "r988", "r989", "r1140", "r1141", "r1142", "r1143", "r1148", "r1149", "r1150" ], "lang": { "en-us": { "role": { "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.", "label": "Financial Instruments [Domain]", "terseLabel": "Financial Instruments [Domain]" } } }, "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/FairValueMeasurementsFairValueMeasurementRecurringBasisDetails", "http://www.corteva.com/role/FinancialInstrumentsFairValueandGrossUnrealizedLossesofinvestmentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TreasuryStockValueAcquiredCostMethod": { "auth_ref": [ "r554", "r561", "r563" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.", "label": "Treasury Stock, Value, Acquired, Cost Method", "terseLabel": "Common Stock Repurchase" } } }, "localname": "TreasuryStockValueAcquiredCostMethod", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/ConsolidatedStatementsofEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_TypeOfRestructuringDomain": { "auth_ref": [ "r443", "r444", "r451", "r452" ], "lang": { "en-us": { "role": { "documentation": "Identification of the types of restructuring costs.", "label": "Type of Restructuring [Domain]", "terseLabel": "Type of Restructuring [Domain]" } } }, "localname": "TypeOfRestructuringDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/RestructuringandAssetRelatedCharges2021RestructuringActionsDetails", "http://www.corteva.com/role/RestructuringandAssetRelatedChargesAssetImpairmentsDetails", "http://www.corteva.com/role/RestructuringandAssetRelatedChargesDowDuPontAgricultureDivisionRestructuringProgramDetails", "http://www.corteva.com/role/RestructuringandAssetRelatedChargesDowDuPontCostSynergyProgramDetails", "http://www.corteva.com/role/RestructuringandAssetRelatedChargesExecutetoWinProductivityProgramDetails" ], "xbrltype": "domainItemType" }, "us-gaap_USTreasuryAndGovernmentMember": { "auth_ref": [ "r623", "r1041", "r1094" ], "lang": { "en-us": { "role": { "documentation": "This category includes investments in debt securities issued by the United States Department of the Treasury, US Government Agencies and US Government-sponsored Enterprises. Such securities may include treasury bills (short-term maturities - one year or less), treasury notes (intermediate term maturities - two to ten years), and treasury bonds (long-term maturities - ten to thirty years), debt securities issued by the Government National Mortgage Association (Ginnie Mae) and debt securities issued by the Federal National Mortgage Association (Fannie Mae) or the Federal Home Loan Mortgage Corporation (Freddie Mac).", "label": "US Treasury and Government [Member]", "terseLabel": "US Treasury and Government [Member]" } } }, "localname": "USTreasuryAndGovernmentMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/PensionPlansandOtherPostEmploymentBenefitPlansBasisofFairValueMeasurementDetails" ], "xbrltype": "domainItemType" }, "us-gaap_USTreasurySecuritiesMember": { "auth_ref": [ "r217", "r623", "r673", "r1041" ], "lang": { "en-us": { "role": { "documentation": "This category includes information about debt securities issued by the United States Department of the Treasury and backed by the United States government. Such securities primarily consist of treasury bills (short-term maturities - one year or less), treasury notes (intermediate term maturities - two to ten years), and treasury bonds (long-term maturities - ten to thirty years).", "label": "US Treasury Securities [Member]", "terseLabel": "US Treasury Securities" } } }, "localname": "USTreasurySecuritiesMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/FairValueMeasurementsFairValueMeasurementRecurringBasisDetails", "http://www.corteva.com/role/FinancialInstrumentsFairValueandGrossUnrealizedLossesofinvestmentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_UndistributedEarningsOfForeignSubsidiaries": { "auth_ref": [ "r748", "r803", "r1047", "r1093" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of undistributed earnings of foreign subsidiaries intended to be permanently reinvested outside the country of domicile.", "label": "Undistributed Earnings of Foreign Subsidiaries", "terseLabel": "Undistributed Earnings of Foreign Subsidiaries" } } }, "localname": "UndistributedEarningsOfForeignSubsidiaries", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/IncomeTaxesIncomeTaxesGrossUnrecognizedTaxBenefitsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrealizedGainLossOnInvestments": { "auth_ref": [ "r193" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unrealized gain (loss) on investment.", "label": "Unrealized Gain (Loss) on Investments", "terseLabel": "Unrealized Gain (Loss) on Investments" } } }, "localname": "UnrealizedGainLossOnInvestments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/ConsolidatedStatementsofComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefits": { "auth_ref": [ "r749", "r760" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unrecognized tax benefits.", "label": "Unrecognized Tax Benefits", "periodEndLabel": "Unrecognized Tax Benefits, Ending Balance", "periodStartLabel": "Unrecognized Tax Benefits, Beginning Balance" } } }, "localname": "UnrecognizedTaxBenefits", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/IncomeTaxesIncomeTaxesGrossUnrecognizedTaxBenefitsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions": { "auth_ref": [ "r761" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.", "label": "Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions", "terseLabel": "Decreases related to positions taken on items from prior years" } } }, "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/IncomeTaxesIncomeTaxesGrossUnrecognizedTaxBenefitsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities": { "auth_ref": [ "r763" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease in unrecognized tax benefits resulting from settlements with taxing authorities.", "label": "Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities", "terseLabel": "Settlement of uncertain tax positions with tax authorities" } } }, "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/IncomeTaxesIncomeTaxesGrossUnrecognizedTaxBenefitsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued": { "auth_ref": [ "r757" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.", "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued", "terseLabel": "Total accrual for interest and penalties associated with unrecognized tax benefits" } } }, "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/IncomeTaxesIncomeTaxesGrossUnrecognizedTaxBenefitsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense": { "auth_ref": [ "r757" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.", "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense", "terseLabel": "Total amount of interest and penalties (benefit) recognized in Provision for income taxes on continuing operations" } } }, "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/IncomeTaxesIncomeTaxesGrossUnrecognizedTaxBenefitsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions": { "auth_ref": [ "r762" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.", "label": "Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions", "terseLabel": "Increases related to positions taken in the current year" } } }, "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/IncomeTaxesIncomeTaxesGrossUnrecognizedTaxBenefitsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromForeignCurrencyTranslation": { "auth_ref": [ "r760" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in unrecognized tax benefits resulting from foreign currency translation.", "label": "Unrecognized Tax Benefits, Increase Resulting from Foreign Currency Translation", "terseLabel": "Exchange (gain) loss" } } }, "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromForeignCurrencyTranslation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/IncomeTaxesIncomeTaxesGrossUnrecognizedTaxBenefitsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions": { "auth_ref": [ "r761" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.", "label": "Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions", "terseLabel": "Increases related to positions taken on items from prior years" } } }, "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/IncomeTaxesIncomeTaxesGrossUnrecognizedTaxBenefitsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations": { "auth_ref": [ "r764" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.", "label": "Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations", "terseLabel": "Decreases due to expiration of statutes of limitations" } } }, "localname": "UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/IncomeTaxesIncomeTaxesGrossUnrecognizedTaxBenefitsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate": { "auth_ref": [ "r765" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.", "label": "Unrecognized Tax Benefits that Would Impact Effective Tax Rate", "terseLabel": "Total unrecognized tax benefits that, if recognized, would impact the effective tax rate" } } }, "localname": "UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/IncomeTaxesIncomeTaxesGrossUnrecognizedTaxBenefitsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnusualOrInfrequentItemAxis": { "auth_ref": [ "r168" ], "lang": { "en-us": { "role": { "documentation": "Information by an event or transaction that is unusual in nature or infrequent in occurrence, or both.", "label": "Unusual or Infrequent Item, or Both [Axis]", "terseLabel": "Unusual or Infrequent Item, or Both [Axis]" } } }, "localname": "UnusualOrInfrequentItemAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/EIDIncomeTaxesRateReconciliationDetails", "http://www.corteva.com/role/IncomeTaxesIncomeTaxesDeferredTaxBalancesDetails", "http://www.corteva.com/role/IncomeTaxesIncomeTaxesNarrativeDetails", "http://www.corteva.com/role/IncomeTaxesIncomeTaxesReconciliationtoUSStatutoryRateDetails", "http://www.corteva.com/role/QuaterlyFinancialDataQuarterlyFinancialDataParentheticalsDetails", "http://www.corteva.com/role/SegmentReportingSigItemsDetails", "http://www.corteva.com/role/SupplementaryInformationOtherIncomeExpenseNetDetails" ], "xbrltype": "stringItemType" }, "us-gaap_UnusualOrInfrequentItemDomain": { "auth_ref": [ "r168" ], "lang": { "en-us": { "role": { "documentation": "Event or transaction that is unusual in nature or infrequent in occurrence, or both.", "label": "Unusual or Infrequent Item, or Both [Domain]", "terseLabel": "Unusual or Infrequent Item, or Both [Domain]" } } }, "localname": "UnusualOrInfrequentItemDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/EIDIncomeTaxesRateReconciliationDetails", "http://www.corteva.com/role/IncomeTaxesIncomeTaxesDeferredTaxBalancesDetails", "http://www.corteva.com/role/IncomeTaxesIncomeTaxesNarrativeDetails", "http://www.corteva.com/role/IncomeTaxesIncomeTaxesReconciliationtoUSStatutoryRateDetails", "http://www.corteva.com/role/QuaterlyFinancialDataQuarterlyFinancialDataParentheticalsDetails", "http://www.corteva.com/role/SegmentReportingSigItemsDetails", "http://www.corteva.com/role/SupplementaryInformationOtherIncomeExpenseNetDetails" ], "xbrltype": "domainItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r286", "r287", "r288", "r289", "r290", "r291", "r292" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates, Policy [Policy Text Block]", "terseLabel": "Use of Estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_UtilityPlantDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Plant owned by a utility entity used in the operations of the entity.", "label": "Utility Plant [Domain]", "terseLabel": "Utility Plant [Domain]" } } }, "localname": "UtilityPlantDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/CommitmentsandContingentLiabilitiesLitigationOtherPFOAMattersFayattevilleDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount": { "auth_ref": [ "r772" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.", "label": "Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount", "terseLabel": "Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount" } } }, "localname": "ValuationAllowanceDeferredTaxAssetChangeInAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/IncomeTaxesIncomeTaxesDeferredTaxBalancesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ValuationAllowanceLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Valuation Allowance [Line Items]", "terseLabel": "Valuation Allowance [Line Items]" } } }, "localname": "ValuationAllowanceLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/IncomeTaxesIncomeTaxesDeferredTaxBalancesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember": { "auth_ref": [ "r222", "r223", "r224", "r226", "r227" ], "lang": { "en-us": { "role": { "documentation": "Valuation allowance of deferred tax asset attributable to deductible temporary difference and carryforward.", "label": "SEC Schedule, 12-09, Valuation Allowance, Deferred Tax Asset [Member]", "terseLabel": "SEC Schedule, 12-09, Valuation Allowance, Deferred Tax Asset [Member]" } } }, "localname": "ValuationAllowanceOfDeferredTaxAssetsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/ScheduleIIValuationandQualifyingAccountsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ValuationAllowanceTable": { "auth_ref": [ "r771" ], "lang": { "en-us": { "role": { "documentation": "A listing of an entity's valuation allowances to reduce deferred tax assets to amounts which it is more likely than not will not be realized, including a description of the deferred tax assets for which the valuation allowance has been recorded and the amount of the valuation allowance.", "label": "Valuation Allowance [Table]", "terseLabel": "Valuation Allowance [Table]" } } }, "localname": "ValuationAllowanceTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/IncomeTaxesIncomeTaxesDeferredTaxBalancesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ValuationAllowancesAndReservesBalance": { "auth_ref": [ "r222", "r227" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of valuation and qualifying accounts and reserves.", "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount", "periodEndLabel": "Balance at end of period", "periodStartLabel": "Balance at beginning of period", "terseLabel": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount" } } }, "localname": "ValuationAllowancesAndReservesBalance", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/AccountsandNotesReceivableNetScheduleofAccountsandNotesReceivableNetDetails", "http://www.corteva.com/role/ScheduleIIValuationandQualifyingAccountsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense": { "auth_ref": [ "r225" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in valuation and qualifying accounts and reserves from charge to cost and expense.", "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense", "terseLabel": "Additions charged to expenses" } } }, "localname": "ValuationAllowancesAndReservesChargedToCostAndExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/ScheduleIIValuationandQualifyingAccountsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ValuationAllowancesAndReservesDeductions": { "auth_ref": [ "r226" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease in valuation and qualifying accounts and reserves.", "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction", "terseLabel": "Deductions from reserves" } } }, "localname": "ValuationAllowancesAndReservesDeductions", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/ScheduleIIValuationandQualifyingAccountsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ValuationAllowancesAndReservesDomain": { "auth_ref": [ "r222", "r223", "r224", "r226", "r227" ], "lang": { "en-us": { "role": { "documentation": "Valuation and qualifying accounts and reserves.", "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]", "terseLabel": "SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]" } } }, "localname": "ValuationAllowancesAndReservesDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/ScheduleIIValuationandQualifyingAccountsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ValuationAllowancesAndReservesTypeAxis": { "auth_ref": [ "r222", "r223", "r224", "r226", "r227" ], "lang": { "en-us": { "role": { "documentation": "Information by valuation and qualifying accounts and reserves.", "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]", "terseLabel": "SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]" } } }, "localname": "ValuationAllowancesAndReservesTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/ScheduleIIValuationandQualifyingAccountsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_VariableLeaseCost": { "auth_ref": [ "r934", "r940" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.", "label": "Variable Lease, Cost", "terseLabel": "Variable Lease, Cost" } } }, "localname": "VariableLeaseCost", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/LeasesLeaseCostsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_VariableRateAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of variable rate.", "label": "Variable Rate [Axis]", "terseLabel": "Variable Rate [Axis]" } } }, "localname": "VariableRateAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/LongTermDebtandAvailableCreditFacilitiesUncommittedCreditFacilitiesandOutstandingLettersofCreditDetails" ], "xbrltype": "stringItemType" }, "us-gaap_VariableRateDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.", "label": "Variable Rate [Domain]", "terseLabel": "Variable Rate [Domain]" } } }, "localname": "VariableRateDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/LongTermDebtandAvailableCreditFacilitiesUncommittedCreditFacilitiesandOutstandingLettersofCreditDetails" ], "xbrltype": "domainItemType" }, "us-gaap_VestingAxis": { "auth_ref": [ "r733" ], "lang": { "en-us": { "role": { "documentation": "Information by vesting schedule of award under share-based payment arrangement.", "label": "Vesting [Axis]", "terseLabel": "Vesting [Axis]" } } }, "localname": "VestingAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/StockBasedCompensationRestrictedStockUnitsandPerformanceDeferredStockDetails" ], "xbrltype": "stringItemType" }, "us-gaap_VestingDomain": { "auth_ref": [ "r733" ], "lang": { "en-us": { "role": { "documentation": "Vesting schedule of award under share-based payment arrangement.", "label": "Vesting [Domain]", "terseLabel": "Vesting [Domain]" } } }, "localname": "VestingDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/StockBasedCompensationRestrictedStockUnitsandPerformanceDeferredStockDetails" ], "xbrltype": "domainItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r255", "r267" ], "lang": { "en-us": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Weighted Average Number of Shares Outstanding, Diluted", "terseLabel": "Weighted Average Number of Shares Outstanding, Diluted" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/EarningsPerShareShareCountInformationDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r253", "r267" ], "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted Average Number of Shares Outstanding, Basic", "terseLabel": "Weighted Average Number of Shares Outstanding, Basic" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.corteva.com/role/EarningsPerShareShareCountInformationDetails" ], "xbrltype": "sharesItemType" } }, "unitCount": 6 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "105", "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721503-107759" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.28,29)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r1000": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61929-109447" }, "r1001": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62059-109447" }, "r1002": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62059-109447" }, "r1003": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62395-109447" }, "r1004": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62395-109447" }, "r1005": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62479-109447" }, "r1006": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62479-109447" }, "r1007": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=SL6807758-109447" }, "r1008": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=SL6807758-109447" }, "r1009": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(1)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61872-109447" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r1010": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(2)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61872-109447" }, "r1011": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "940", "URI": "http://asc.fasb.org/extlink&oid=123384075&loc=d3e41242-110953" }, "r1012": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(1)(a))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r1013": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(10)(1))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r1014": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(10))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r1015": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r1016": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(13))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r1017": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(15)(1))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r1018": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(15)(2))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r1019": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.3,4)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r1020": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(22))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r1021": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r1022": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(4))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r1023": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(5))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r1024": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(6))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r1025": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(7))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r1026": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.10)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r1027": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.15(5))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r1028": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.16)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r1029": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(19))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.31)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r1030": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(13)(f))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r1031": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(15))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r1032": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(20))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r1033": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r1034": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(23))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r1035": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(24))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r1036": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(25))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r1037": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(26))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r1038": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r1039": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(1))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r1040": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884" }, "r1041": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "320", "Subparagraph": "(b)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=d3e62557-112803" }, "r1042": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "320", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=d3e62652-112803" }, "r1043": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630" }, "r1044": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "405", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6957935&loc=d3e64057-112817" }, "r1045": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Subparagraph": "e", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823" }, "r1046": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823" }, "r1047": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "740", "Subparagraph": "(b)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6479915&loc=d3e66715-112838" }, "r1048": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(15)(b)(2))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r1049": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(16))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(a)(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r1050": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(5))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r1051": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(1)(b))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r1052": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(1)(g))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r1053": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(10))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r1054": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r1055": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(15)(b)(1))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r1056": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16)(a)(1))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r1057": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(2))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r1058": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r1059": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(a)(4),(5))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r1060": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(24))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r1061": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r1062": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(5))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r1063": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r1064": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.15(a))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r1065": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.16)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r1066": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.3)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r1067": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(10))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r1068": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(11))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r1069": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(12))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r1070": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r1071": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(19))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r1072": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(20))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r1073": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(21))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r1074": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(22))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r1075": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r1076": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(8))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r1077": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r1078": { "Name": "Accounting Standards Codification", "Paragraph": "4H", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438" }, "r1079": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r1080": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441" }, "r1081": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441" }, "r1082": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819544-158441" }, "r1083": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r1084": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r1085": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r1086": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r1087": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r1088": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(ii)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r1089": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(iii)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.8)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r1090": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(iv)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r1091": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r1092": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r1093": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "740", "Subparagraph": "(b)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=6487024&loc=d3e29054-158556" }, "r1094": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(e)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124508989&loc=d3e19393-158473" }, "r1095": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-06(3))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401414&loc=d3e604059-122996" }, "r1096": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 1))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r1097": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 6))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r1098": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 7))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r1099": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 1))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=d3e957-107759" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.9)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r1100": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 6))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r1101": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 7))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r1102": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 1))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r1103": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 6))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r1104": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 7))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r1105": { "Name": "Accounting Standards Codification", "Paragraph": "5D", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13D(Column B)(Footnote 2))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010" }, "r1106": { "Name": "Accounting Standards Codification", "Paragraph": "5D", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13D(Column C)(Footnote 2))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010" }, "r1107": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column A))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010" }, "r1108": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column B))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010" }, "r1109": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column C))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312" }, "r1110": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column D))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010" }, "r1111": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "310", "Subparagraph": "(SX 210.12-29(Footnote 4))", "Topic": "948", "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014" }, "r1112": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "310", "Topic": "954", "URI": "http://asc.fasb.org/extlink&oid=123366838&loc=d3e3073-115593" }, "r1113": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(a)", "Topic": "954", "URI": "http://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629" }, "r1114": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(d)", "Topic": "954", "URI": "http://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629" }, "r1115": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Subparagraph": "(d)", "Topic": "958", "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99779-112916" }, "r1116": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99893-112916" }, "r1117": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=SL120174063-112916" }, "r1118": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column B))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r1119": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column C))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312" }, "r1120": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column D))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r1121": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column E))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r1122": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column F))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r1123": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column G))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r1124": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column H))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r1125": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column I))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r1126": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 2))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r1127": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(c)", "Topic": "976", "URI": "http://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663" }, "r1128": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "978", "URI": "http://asc.fasb.org/extlink&oid=123360121&loc=d3e27327-108691" }, "r1129": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "340", "Topic": "980", "URI": "http://asc.fasb.org/extlink&oid=123417213&loc=d3e43603-110378" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312" }, "r1130": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "25", "SubTopic": "410", "Topic": "980", "URI": "http://asc.fasb.org/extlink&oid=6500910&loc=d3e48636-110399" }, "r1131": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "985", "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756" }, "r1132": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1133": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r1134": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23" }, "r1135": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r1136": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310" }, "r1137": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f" }, "r1138": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f" }, "r1139": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226008-175313" }, "r1140": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402" }, "r1141": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(1)" }, "r1142": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)" }, "r1143": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(3)" }, "r1144": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(4)" }, "r1145": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(5)" }, "r1146": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(1)(i)" }, "r1147": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(1)(ii)" }, "r1148": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(i)" }, "r1149": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(ii)" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313" }, "r1150": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(iii)" }, "r1151": { "Name": "Regulation S-K (SK)", "Number": "229", "Publisher": "SEC", "Section": "1402", "Subsection": "Instruction 5" }, "r1152": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1406", "Subparagraph": "(1)" }, "r1153": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1406", "Subparagraph": "(2)" }, "r1154": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1406", "Subparagraph": "(3)" }, "r1155": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1406", "Subparagraph": "(4)" }, "r1156": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1406", "Subparagraph": "(5)" }, "r1157": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1406" }, "r1158": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r1159": { "Name": "Regulation S-X (SX)", "Number": "210", "Publisher": "SEC", "Section": "11", "Subsection": "03" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226049-175313" }, "r1160": { "Footnote": "2", "Name": "Regulation S-X (SX)", "Number": "210", "Publisher": "SEC", "Section": "12", "Subsection": "28" }, "r1161": { "Footnote": "4", "Name": "Regulation S-X (SX)", "Number": "210", "Publisher": "SEC", "Section": "12", "Subsection": "29" }, "r1162": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column B", "Publisher": "SEC", "Section": "12", "Subsection": "28" }, "r1163": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column C", "Publisher": "SEC", "Section": "12", "Subsection": "28" }, "r1164": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column D", "Publisher": "SEC", "Section": "12", "Subsection": "28" }, "r1165": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column E", "Publisher": "SEC", "Section": "12", "Subsection": "28" }, "r1166": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column F", "Publisher": "SEC", "Section": "12", "Subsection": "28" }, "r1167": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column G", "Publisher": "SEC", "Section": "12", "Subsection": "28" }, "r1168": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column H", "Publisher": "SEC", "Section": "12", "Subsection": "28" }, "r1169": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column I", "Publisher": "SEC", "Section": "12", "Subsection": "28" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313" }, "r1170": { "Name": "Regulation S-X (SX)", "Number": "210", "Publisher": "SEC", "Section": "12", "Subsection": "09" }, "r1171": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "(a)", "Publisher": "SEC", "Section": "13", "Subparagraph": "(4)(i)", "Subsection": "01" }, "r1172": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "(a)", "Publisher": "SEC", "Section": "13", "Subparagraph": "(4)(i)", "Subsection": "02" }, "r1173": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "(a)", "Publisher": "SEC", "Section": "13", "Subparagraph": "(4)(ii)", "Subsection": "01" }, "r1174": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "(a)", "Publisher": "SEC", "Section": "13", "Subparagraph": "(4)(iii)", "Subsection": "01" }, "r1175": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "(a)", "Publisher": "SEC", "Section": "13", "Subparagraph": "(4)(iii)(A)", "Subsection": "01" }, "r1176": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "(a)", "Publisher": "SEC", "Section": "13", "Subparagraph": "(4)(iii)(A)", "Subsection": "02" }, "r1177": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "(a)", "Publisher": "SEC", "Section": "13", "Subparagraph": "(4)(iii)(B)", "Subsection": "01" }, "r1178": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "(a)", "Publisher": "SEC", "Section": "13", "Subparagraph": "(4)(iii)(B)", "Subsection": "02" }, "r1179": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "(a)", "Publisher": "SEC", "Section": "13", "Subparagraph": "(4)(iii)(C)", "Subsection": "02" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226003-175313" }, "r1180": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "(a)", "Publisher": "SEC", "Section": "13", "Subparagraph": "(4)(iv)", "Subsection": "01" }, "r1181": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "(a)", "Publisher": "SEC", "Section": "13", "Subparagraph": "(4)(iv)", "Subsection": "02" }, "r1182": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "(m)", "Publisher": "SEC", "Section": "4", "Subparagraph": "(1)(iii)", "Subsection": "08" }, "r1183": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405" }, "r1184": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(01)", "Topic": "848" }, "r1185": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848" }, "r1186": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "848" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e526-108580" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721523-107759" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a),(b),(c)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(i),(j),(k)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(i-k)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(j)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "3B", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721525-107759" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e637-108580" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e640-108580" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e681-108580" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "14A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669686-108580" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e689-108580" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "17A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL34724391-108580" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=d3e1012-107759" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e557-108580" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(13))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868656-224227" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(1))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(10))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(12))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(14))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(21))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(22))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(23))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(24))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(5))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1(e))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.18)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.19)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2(a),(d))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.3)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=114868883&loc=SL114871943-224233" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3151-108585" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1474-107760" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3337-108585" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3367-108585" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3367-108585" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3000-108585" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721659-107760" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4273-108586" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4297-108586" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4304-108586" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4313-108586" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "105", "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721663-107760" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4332-108586" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=SL98516268-108586" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18726-107790" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(c))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(d))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721665-107760" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(f))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(2))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(k)(1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(m)(1)(ii)(A))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(m)(1)(iii))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(m)(2)(ii))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721671-107760" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(n))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09(Column B))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09(Column C(1)))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09(Column C(2)))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09(Column C)(1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09(Column D))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09(Column E))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09)", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690" }, "r229": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "http://asc.fasb.org/topic&trid=2122369" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(4)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=SL124452830-107794" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.M.Q2)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=122038215&loc=SL108384541-122693" }, "r252": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "250", "URI": "http://asc.fasb.org/topic&trid=2122394" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1448-109256" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1377-109256" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1505-109256" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1278-109256" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1930-109256" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1930-109256" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1930-109256" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1930-109256" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "55", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2626-109256" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e3842-109258" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e4984-109258" }, "r274": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "260", "URI": "http://asc.fasb.org/topic&trid=2144383" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "270", "URI": "http://asc.fasb.org/extlink&oid=124437754&loc=d3e725-108305" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "270", "URI": "http://asc.fasb.org/extlink&oid=124437754&loc=d3e765-108305" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "270", "URI": "http://asc.fasb.org/extlink&oid=124437754&loc=d3e543-108305" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "270", "URI": "http://asc.fasb.org/extlink&oid=124502072&loc=d3e1280-108306" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "270", "URI": "http://asc.fasb.org/extlink&oid=124502072&loc=SL124452896-108306" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "5C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(2)", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "270", "URI": "http://asc.fasb.org/extlink&oid=124502072&loc=d3e1570-108306" }, "r281": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "270", "URI": "http://asc.fasb.org/topic&trid=2126967" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "5C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8657-108599" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8672-108599" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=124429488&loc=d3e326-107755" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "5C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(j)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "5D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721677-107760" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "26", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8844-108599" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "34", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8981-108599" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=26872618&loc=d3e7436-122677" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8475-108599" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599" }, "r336": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "280", "URI": "http://asc.fasb.org/topic&trid=2134510" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522" }, "r34": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/subtopic&trid=2122178" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "11B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(4)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=SL6953423-111524" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=SL6953401-111524" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707" }, "r344": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/subtopic&trid=2196772" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(d)(1)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(d)(2)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=124260329&loc=d3e26610-111562" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=124260329&loc=d3e26853-111562" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(aa)", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563" }, "r35": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "205", "URI": "http://asc.fasb.org/topic&trid=2122149" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27232-111563" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27232-111563" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=SL120269820-111563" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=SL120269825-111563" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27337-111563" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "8B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=SL6284393-111563" }, "r356": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "320", "URI": "http://asc.fasb.org/topic&trid=2196928" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "321", "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "321", "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "321", "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=124268079&loc=d3e32787-111569" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(3)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(4)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919258-210447" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124267575&loc=SL82921835-210448" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "79", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124267575&loc=SL82922352-210448" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124258926&loc=SL82898722-210454" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4556-108314" }, "r386": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "330", "URI": "http://asc.fasb.org/topic&trid=2126998" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "340", "URI": "http://asc.fasb.org/extlink&oid=123349782&loc=d3e5879-108316" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "340", "URI": "http://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13777-109266" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=SL108378252-109267" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=d3e1107-107759" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)(5)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "((a)(1),(b))", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(2)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(3)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275" }, "r415": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "350", "URI": "http://asc.fasb.org/topic&trid=2144416" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226317&loc=d3e202-110218" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=123351718&loc=d3e2510-110228" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=123351718&loc=d3e2420-110228" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=123351718&loc=d3e2443-110228" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6787-107765" }, "r420": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=123351718&loc=d3e2473-110228" }, "r421": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r422": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r425": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r428": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r429": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765" }, "r430": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=SL51724579-110230" }, "r431": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.CC)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=27011434&loc=d3e125687-122742" }, "r432": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "360", "URI": "http://asc.fasb.org/topic&trid=2155823" }, "r433": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "410", "URI": "http://asc.fasb.org/extlink&oid=6392692&loc=d3e7535-110849" }, "r434": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "410", "URI": "http://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859" }, "r435": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "410", "URI": "http://asc.fasb.org/extlink&oid=6393242&loc=d3e13283-110859" }, "r436": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "410", "URI": "http://asc.fasb.org/extlink&oid=6393242&loc=d3e13296-110859" }, "r437": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "410", "URI": "http://asc.fasb.org/extlink&oid=6393242&loc=d3e13185-110859" }, "r438": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "410", "URI": "http://asc.fasb.org/extlink&oid=6393242&loc=d3e13207-110859" }, "r439": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "410", "URI": "http://asc.fasb.org/extlink&oid=6393242&loc=d3e13231-110859" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6812-107765" }, "r440": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "410", "URI": "http://asc.fasb.org/extlink&oid=6571209&loc=d3e13669-110860" }, "r441": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "30", "Topic": "410", "URI": "http://asc.fasb.org/subtopic&trid=2175709" }, "r442": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r443": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r444": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r445": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r446": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r447": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r448": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.3)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747" }, "r449": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765" }, "r450": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 5.P.4(b)(2))", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r451": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(b)(1))", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r452": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(b)(2))", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r453": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(d))", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r454": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(e))", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r455": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r456": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "420", "URI": "http://asc.fasb.org/topic&trid=2175745" }, "r457": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r458": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r459": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "http://asc.fasb.org/topic&trid=2144648" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766" }, "r460": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=6395460&loc=d3e13647-108346" }, "r461": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349" }, "r462": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349" }, "r463": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14394-108349" }, "r464": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349" }, "r465": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349" }, "r466": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14453-108349" }, "r467": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14472-108349" }, "r468": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349" }, "r469": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB TOPIC 5.Y.Q2)", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 201.5-02(24))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r470": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=27011672&loc=d3e149975-122751" }, "r471": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "http://asc.fasb.org/topic&trid=2127136" }, "r472": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "15", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=123389529&loc=d3e10037-110241" }, "r473": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248" }, "r474": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=124440162&loc=d3e12053-110248" }, "r475": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=124440162&loc=d3e12069-110248" }, "r476": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=124440162&loc=d3e12069-110248" }, "r477": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=124440162&loc=d3e12069-110248" }, "r478": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=123408193&loc=d3e13051-110250" }, "r479": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 201.5-02(25))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r480": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r481": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r482": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r483": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r484": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r485": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r486": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r487": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r488": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r489": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 201.5-02(26))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r490": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r491": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r492": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r493": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r494": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r495": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r496": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r497": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r498": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r499": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721533-107759" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r500": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r501": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r502": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r503": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(i)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r504": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r505": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r506": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r507": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r508": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r509": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(12))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r510": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r511": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r512": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r513": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r514": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r515": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r516": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r517": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r518": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r519": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(13))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r520": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r521": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r522": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r523": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870" }, "r524": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870" }, "r525": { "Name": "Accounting Standards Codification", "Paragraph": "69B", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612" }, "r526": { "Name": "Accounting Standards Codification", "Paragraph": "69C", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612" }, "r527": { "Name": "Accounting Standards Codification", "Paragraph": "69E", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612" }, "r528": { "Name": "Accounting Standards Codification", "Paragraph": "69F", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612" }, "r529": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "40", "SubTopic": "50", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123467658&loc=d3e12317-112629" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(14))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r530": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "40", "SubTopic": "50", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123467658&loc=d3e12355-112629" }, "r531": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "470", "URI": "http://asc.fasb.org/topic&trid=2208564" }, "r532": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(CFRR 211.02)", "Topic": "480", "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764" }, "r533": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Topic": "480", "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764" }, "r534": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(3)", "Topic": "480", "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764" }, "r535": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643" }, "r536": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21553-112644" }, "r537": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21564-112644" }, "r538": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r539": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r540": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r541": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r542": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r543": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r544": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r545": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r546": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644" }, "r547": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644" }, "r548": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644" }, "r549": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496180-112644" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19)(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r550": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644" }, "r551": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644" }, "r552": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644" }, "r553": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644" }, "r554": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644" }, "r555": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644" }, "r556": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21484-112644" }, "r557": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21488-112644" }, "r558": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644" }, "r559": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21521-112644" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r560": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21538-112644" }, "r561": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770" }, "r562": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770" }, "r563": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655" }, "r564": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "25", "SubTopic": "60", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=6406278&loc=d3e26268-112671" }, "r565": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "http://asc.fasb.org/topic&trid=2208762" }, "r566": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130531-203044" }, "r567": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130533-203044" }, "r568": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130551-203045" }, "r569": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(2))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r570": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045" }, "r571": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045" }, "r572": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045" }, "r573": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045" }, "r574": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130556-203045" }, "r575": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130556-203045" }, "r576": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130556-203045" }, "r577": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130558-203045" }, "r578": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045" }, "r579": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130549-203045" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r580": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130550-203045" }, "r581": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046" }, "r582": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046" }, "r583": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046" }, "r584": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046" }, "r585": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046" }, "r586": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046" }, "r587": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046" }, "r588": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(g)(2)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123338486&loc=SL49131195-203048" }, "r589": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123338486&loc=SL49131195-203048" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r590": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(i)(2)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123338486&loc=SL49131195-203048" }, "r591": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(j)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123338486&loc=SL49131195-203048" }, "r592": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "606", "URI": "http://asc.fasb.org/topic&trid=49130388" }, "r593": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "705", "URI": "http://asc.fasb.org/topic&trid=2122478" }, "r594": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "15", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "712", "URI": "http://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664" }, "r595": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "15", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "712", "URI": "http://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664" }, "r596": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123453770&loc=d3e1703-114919" }, "r597": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123453770&loc=d3e1731-114919" }, "r598": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123453770&loc=SL108413299-114919" }, "r599": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123453770&loc=SL108413299-114919" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721491-107759" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(23))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r600": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r601": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(1)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r602": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(10)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r603": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(2)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r604": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(3)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r605": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(4)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r606": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(5)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r607": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(6)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r608": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(7)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r609": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(8)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(24))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r610": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(9)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r611": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r612": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r613": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r614": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r615": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(4)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r616": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(5)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r617": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(6)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r618": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(7)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r619": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(8)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(26)(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r620": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r621": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(5)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r622": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r623": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r624": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iii)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r625": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r626": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r627": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(A)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r628": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(B)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r629": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(C)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(26)(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r630": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(03)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r631": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r632": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r633": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r634": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r635": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(1)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r636": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(2)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r637": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(3)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r638": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(4)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r639": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(5)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r640": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(6)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r641": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(7)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r642": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(i)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r643": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(j)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r644": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(k)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r645": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(k)(1)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r646": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(k)(2)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r647": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(k)(3)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r648": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(k)(4)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r649": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(l)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r650": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r651": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(o)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r652": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(p)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r653": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(q)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r654": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(r)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r655": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(r)(1)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r656": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(r)(2)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r657": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r658": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2410-114920" }, "r659": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r660": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920" }, "r661": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920" }, "r662": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2439-114920" }, "r663": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920" }, "r664": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(1)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920" }, "r665": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(2)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920" }, "r666": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(3)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920" }, "r667": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(4)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920" }, "r668": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(5)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920" }, "r669": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(6)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r670": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(7)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920" }, "r671": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920" }, "r672": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2919-114920" }, "r673": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921" }, "r674": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4587-114921" }, "r675": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=21916913&loc=d3e273930-122802" }, "r676": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "60", "Subparagraph": "(c)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=6414203&loc=d3e39689-114964" }, "r677": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "60", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=6414203&loc=d3e39716-114964" }, "r678": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "70", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942" }, "r679": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "35", "SubTopic": "80", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=29639808&loc=d3e29008-114946" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r680": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947" }, "r681": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(b)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947" }, "r682": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(c)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947" }, "r683": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947" }, "r684": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r685": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(b)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r686": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(c)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r687": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r688": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(e)(1)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r689": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(e)(2)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r690": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(f)(1)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r691": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(f)(2)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r692": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(f)(3)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r693": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947" }, "r694": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(b)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947" }, "r695": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(c)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947" }, "r696": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(b)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450691-114947" }, "r697": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948" }, "r698": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "715", "URI": "http://asc.fasb.org/topic&trid=2235017" }, "r699": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=123468992&loc=d3e4534-113899" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721494-107759" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r700": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r701": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r702": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r703": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r704": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r705": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r706": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a),(g)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r707": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r708": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r709": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)-(ii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r710": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r711": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r712": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(3)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r713": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(3)-(4)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r714": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r715": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)-(ii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r716": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r717": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r718": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(3)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r719": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r720": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r721": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r722": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r723": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r724": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r725": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r726": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r727": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r728": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r729": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r730": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r731": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(2)(iii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r732": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r733": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r734": { "Name": "Accounting Standards Codification", "Paragraph": "2A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901" }, "r735": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r736": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r737": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r738": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(g)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r739": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(g)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r740": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.D.2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809" }, "r741": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.F)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809" }, "r742": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11149-113907" }, "r743": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11178-113907" }, "r744": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "35", "SubTopic": "740", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120384911&loc=d3e23163-113944" }, "r745": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "718", "URI": "http://asc.fasb.org/topic&trid=2228938" }, "r746": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "35", "Subparagraph": "(a)", "Topic": "720", "URI": "http://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848" }, "r747": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "730", "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373" }, "r748": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123452999&loc=d3e28200-109314" }, "r749": { "Name": "Accounting Standards Codification", "Paragraph": "10B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=SL37586934-109318" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(4)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r750": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318" }, "r751": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318" }, "r752": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318" }, "r753": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318" }, "r754": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319" }, "r755": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319" }, "r756": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319" }, "r757": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319" }, "r758": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319" }, "r759": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(4))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r760": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319" }, "r761": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319" }, "r762": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319" }, "r763": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319" }, "r764": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(4)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319" }, "r765": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319" }, "r766": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319" }, "r767": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319" }, "r768": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319" }, "r769": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(5))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r770": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319" }, "r771": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319" }, "r772": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319" }, "r773": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319" }, "r774": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319" }, "r775": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319" }, "r776": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319" }, "r777": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319" }, "r778": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319" }, "r779": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r780": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319" }, "r781": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319" }, "r782": { "Name": "Accounting Standards Codification", "Paragraph": "217", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=124434304&loc=d3e36027-109320" }, "r783": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277" }, "r784": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277" }, "r785": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277" }, "r786": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277" }, "r787": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(3)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277" }, "r788": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r789": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r790": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.7)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r791": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.1)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r792": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.2)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r793": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.3)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r794": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.4)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r795": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.C)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817" }, "r796": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e39076-109324" }, "r797": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324" }, "r798": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324" }, "r799": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721494-107759" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(c))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r800": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "270", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=109227538&loc=d3e44648-109337" }, "r801": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "270", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338" }, "r802": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331" }, "r803": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331" }, "r804": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "740", "URI": "http://asc.fasb.org/topic&trid=2144680" }, "r805": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=123586518&loc=d3e873-128460" }, "r806": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r807": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463" }, "r808": { "Name": "Accounting Standards Codification", "Paragraph": "37", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=123455525&loc=d3e2207-128464" }, "r809": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=123413009&loc=d3e4845-128472" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.1)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r810": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5227-128473" }, "r811": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473" }, "r812": { "Name": "Accounting Standards Codification", "Paragraph": "38", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5504-128473" }, "r813": { "Name": "Accounting Standards Codification", "Paragraph": "38", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5504-128473" }, "r814": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "30", "SubTopic": "30", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6578-128477" }, "r815": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "30", "SubTopic": "30", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6613-128477" }, "r816": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "50", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=123385561&loc=d3e9135-128495" }, "r817": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "30", "SubTopic": "50", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=123362884&loc=d3e9212-128498" }, "r818": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "30", "SubTopic": "50", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=123362884&loc=d3e9215-128498" }, "r819": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=66013424&loc=SL58715849-205896" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.12)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r820": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=66013424&loc=SL58715852-205896" }, "r821": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4568447-111683" }, "r822": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4568740-111683" }, "r823": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569616-111683" }, "r824": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569643-111683" }, "r825": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4613674-111683" }, "r826": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569655-111683" }, "r827": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4616395-111683" }, "r828": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r829": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.13(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r830": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684" }, "r831": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r832": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r833": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r834": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(3)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r835": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c),(3)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r836": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r837": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r838": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r839": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.13(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r840": { "Name": "Accounting Standards Codification", "Paragraph": "4I", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686" }, "r841": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686" }, "r842": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686" }, "r843": { "Name": "Accounting Standards Codification", "Paragraph": "4M", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591554-111686" }, "r844": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "810", "URI": "http://asc.fasb.org/topic&trid=2197479" }, "r845": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=117331979&loc=d3e41228-113958" }, "r846": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959" }, "r847": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959" }, "r848": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959" }, "r849": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.13)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r850": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)(ii)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959" }, "r851": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)(iii)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959" }, "r852": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959" }, "r853": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959" }, "r854": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959" }, "r855": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959" }, "r856": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959" }, "r857": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959" }, "r858": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959" }, "r859": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.14)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r860": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959" }, "r861": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959" }, "r862": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959" }, "r863": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959" }, "r864": { "Name": "Accounting Standards Codification", "Paragraph": "4CC", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL109998890-113959" }, "r865": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959" }, "r866": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(4)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959" }, "r867": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959" }, "r868": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959" }, "r869": { "Name": "Accounting Standards Codification", "Paragraph": "4E", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624181-113959" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.17)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r870": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41641-113959" }, "r871": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41675-113959" }, "r872": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41678-113959" }, "r873": { "Name": "Accounting Standards Codification", "Paragraph": "182", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123421605&loc=SL5629052-113961" }, "r874": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "25", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986" }, "r875": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121558989&loc=d3e80720-113993" }, "r876": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121549185&loc=d3e80748-113994" }, "r877": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123477628&loc=d3e90205-114008" }, "r878": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(b)(2)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r879": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(1)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r880": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r881": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(4)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r882": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r883": { "Name": "Accounting Standards Codification", "Paragraph": "54B", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=122636397&loc=SL7495116-110257" }, "r884": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r885": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r886": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r887": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(1)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r888": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r889": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(b),22(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r890": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r891": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19279-110258" }, "r892": { "Name": "Accounting Standards Codification", "Paragraph": "6A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=SL6742756-110258" }, "r893": { "Name": "Accounting Standards Codification", "Paragraph": "6A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=SL6742756-110258" }, "r894": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123594786&loc=SL75136599-209740" }, "r895": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611" }, "r896": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612" }, "r897": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497" }, "r898": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497" }, "r899": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(3)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721501-107759" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r900": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=120253306&loc=d3e28228-110885" }, "r901": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "35", "SubTopic": "20", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=123602790&loc=d3e30226-110892" }, "r902": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=125521441&loc=d3e30690-110894" }, "r903": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=124440516&loc=d3e30840-110895" }, "r904": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906" }, "r905": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900" }, "r906": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r907": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r908": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r909": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19,20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r910": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r911": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901" }, "r912": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901" }, "r913": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "830", "URI": "http://asc.fasb.org/topic&trid=2175825" }, "r914": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391" }, "r915": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399" }, "r916": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399" }, "r917": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399" }, "r918": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629" }, "r919": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r920": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(Note 3)", "Topic": "840", "URI": "http://asc.fasb.org/extlink&oid=123403562&loc=d3e38371-112697" }, "r921": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "840", "URI": "http://asc.fasb.org/extlink&oid=123406913&loc=d3e41499-112717" }, "r922": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "840", "URI": "http://asc.fasb.org/extlink&oid=123406913&loc=d3e41502-112717" }, "r923": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "840", "URI": "http://asc.fasb.org/topic&trid=2208923" }, "r924": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977" }, "r925": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977" }, "r926": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977" }, "r927": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977" }, "r928": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977" }, "r929": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20,22)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r930": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918666-209980" }, "r931": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980" }, "r932": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980" }, "r933": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980" }, "r934": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980" }, "r935": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(1)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980" }, "r936": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(3)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980" }, "r937": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(4)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980" }, "r938": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980" }, "r939": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918701-209980" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r940": { "Name": "Accounting Standards Codification", "Paragraph": "53", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971" }, "r941": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "848", "URI": "http://asc.fasb.org/extlink&oid=122150657&loc=SL122150809-237846" }, "r942": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r943": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r944": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r945": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r946": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r947": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864" }, "r948": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864" }, "r949": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r950": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "850", "URI": "http://asc.fasb.org/topic&trid=2122745" }, "r951": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r952": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r953": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766" }, "r954": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r955": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r956": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662" }, "r957": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "http://asc.fasb.org/topic&trid=2122774" }, "r958": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)(i)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r959": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)(ii)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r960": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r961": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r962": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r963": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r964": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r965": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r966": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r967": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r968": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r969": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.23)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r970": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r971": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r972": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107425-111719" }, "r973": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728" }, "r974": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729" }, "r975": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746" }, "r976": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746" }, "r977": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746" }, "r978": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(4)(i)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746" }, "r979": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.24)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r980": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746" }, "r981": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746" }, "r982": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(4)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746" }, "r983": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(5)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746" }, "r984": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(6)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746" }, "r985": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(7)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746" }, "r986": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(b)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746" }, "r987": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746" }, "r988": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746" }, "r989": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.27(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r990": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733" }, "r991": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "330", "Topic": "912", "URI": "http://asc.fasb.org/extlink&oid=6471895&loc=d3e55923-109411" }, "r992": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "730", "Topic": "912", "URI": "http://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433" }, "r993": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856" }, "r994": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "926", "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959" }, "r995": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(f)(1)", "Topic": "926", "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079" }, "r996": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(f)(2)", "Topic": "926", "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079" }, "r997": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(f)(3)", "Topic": "926", "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079" }, "r998": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "340", "Topic": "928", "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004" }, "r999": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61929-109447" } }, "version": "2.1" } ZIP 198 0001755672-22-000005-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001755672-22-000005-xbrl.zip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�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

L4%KSD5"400']."70'71E-!?2PAD02'\'(;)*(0+5.\+U1'+ R?G98H2]!,/FDHPH*00 M$9%2,*TQ>6QSIA>>L'N^P'0Q8/I,6^@+3!\%TQ�@O&DE4>164PXEX19"WQ MR."D)(V:6A)S O4+"7L,&YC#B\2;^PT_U3=_A#C-3N\P=LK.E06T;.J96PN? M3[J]PK@/85P\9L-H+Y@V(=R7 M3' W7$@B'<">.=1T*9'/*$Z3(Q!42D$UI$IQRYIE=3 6J)G13(/@5D M1ZP9&X.DTB>4LK^!1TZ1BT$CK84-,D9MO M>3DS+)F#E",'.")(8P M(2IGIWMD>,Y.#S82K;0*/A=,:U_W 1[O)#I3E6FB+?JR*:NVDE_UK&O&874 M^#%\IL'K#2A(7Z60['=II+/^1XU6B*W>:Y2_-.T7T[>]%\WO15;ZLC'^,S-+ M:K=[K78O+B9B/_Y[B/W1WRW[CSG9^;S[>?^?W2];ZQMB:^^/P_V]]V1_SXO] MO;\;.^O[;)MN?M]>/VS O<[^_;X)[[+Q2?C(O-446<4HXI12!'0)J..4."R< M" SGK+O^&.VV\[0=]GK'KU^].CT]7?GF.LV5=N?@%2A[[%4'#K\:?G=I%0BS M>1)@&GN'L8HUC7;K;,RZ]%Y.V*S['/6+[]55*V*H>NTJVDX+9*O^+B =+//K7-9OO4 MMGQ^U+J9;AVEA84"1#EW< J#]M/P!;A*[S3&5GW%\S'Y?6WM76X ==+L=5>J M\X&TE^^;7_>GZ_7VDVX861DU%\8E23Q1EEN!M:;2,69%GFIFW"W.!"2OU=IK M?RNLC!O?#ZR^\O?;)4Z%@<#E2#H:4XQ"1DS0A97T@ MH)MHP3 MS^\_&48H>M,^.@)X M9"TIV\^>NT:I)N,^\^91*P!F7.T_61_J9,WL=$(4^[("K092S M=+]I=WKQJUW.Q+N2;U*K=C5JWL+56X"@9E571NOO/<@HS2*UGJ<-? M*R\0 :P@X!H$^$]*VV MMLCY7)!$$(D4 MA@Z Y+C=RB)9<_K@#HVLIH%,@FZU4KT]Z=0(NB3ME7590\K/E&L"V-;9_W3/ MG\D/JI%7AS$S4?.#;E[*N MDE*,2R6T4CQPS1GQ\&S^MH!AT?'O+A(;?'O]KT_8)DQ$-,A3GLO&)8X<#:#S M*"D(=AW,M_[@#P]\!)%>A VI*JW)G-?<,3-GAAL8KRKIM]6IE M(Q-MNS8J!U0')^6_8@MNMRU-D+O MVK/NTJLK;W74:*&149R? 5 3!V!CI=I,7PR]BK78^4Z:K2UV&Q MIGP:8'%A6-$H&9AKUH3(B8I&$VTQI?(3(WCIYOD8W/^Y)@06BMH[\I\KY#:R MLEH9A>%81^(X@V76*QDITP3'0 6\Y20%\>H2^B$>Y"G=C<=@5<%Z'LS+ MDT[<@]O\UFS[+\^]BNZM#5;1X\/]?S;%Q_6WS:V]CXVMO0,,WQ$[>YMB_WLX M_/CY/?[XS]]?/O[^_FSGS<@J>O3VYXO8^MS\ MO$W?'FVO[S8_PBK[<7V3@S+X'8Y_TB081ZU&B@9812T,HL;,(V=LHI('22+O M:SHU$-9R(0/#1(392,PYPX7/V^TQ458)XU-BT2U5$723XRQHG9/L"-OX?6MC M>Z_:W'Z[L[NUMK>YLUV-+V>W<\=569V$C)$EL3^EMS_NU=?C42I*&4LX>,ZX M==YHRA\'5]+T$^%IX"&[DH%LUG5D>P\KLWV:6U9Y>T"<=@![.?L'_NE7]72G^=V M#(>IG9UH60.YVC ,WOWZ\80GO#R?\5NCV[M%-*8#VWETD=TC:6^_/0_]J+WUR?&9%(RIQ 8AA%G M)()Z3SWRBG'#M/ *B]%5P3'CL?8A*A.Y4]1:E1,0-+=4@ *F1A>]*_J^[1R MRI_3;D2MV=7(OC"+ZJ0<$.RF/>[&U\-??AWN$&^T:O&L3_IU<*V!+36A4T:- MH/[A"ZMB!?DL&=!X=7ZD,C^4?]8T*O"&ZN/8Q7R+7';KHLH2M,7']X M'B][_:DCE[W?5O\1HYH,Y./J93KMT[%$S.LRN>Z[;0>N\#2M:<9HMM^:YG&+ MV;6KV34&V]-%)OHYZJ Y#?Q,W1$;U@?O](]:Z;R(]:Y!R:(WW>KQ>W[+.9N4']ZX-#<]O+SG?1^GZ#D0PS-JT') MJV9G7XR'UN6D+27]S-]LB&:/4[NUUNMU&NZD-E[VVMM@M/8SX."]#C8SO\5N M[VJ1U-;)$0KM'AH\Q_P$.A]HK?:WJ!PW/GX.AUMTZVQ[#RS4WS?Q]M%[MK_W M,0<]3W. =/_[7V"]_O9YNS&R1>7HCZ-MNO%]__LFV5Y?@^^^IQ_7PR&#.JDA"F3 S&6*8RA)8 B9 HN4->QM-0 M8&&Y^['<:#-QZBS#N1"T4!)8CC"D.?=(!D9=,-X(0I96I7YT<^+"<87CGK>^ MP80<2F49U2%PG"PL\-+RX)C"R5GGM2;ZEAW$-R2?%;:;#[8;:5!((Q6$!8\P MRSJ=L!II2A.2SC.;P_8^TJ55-FFGUC2+],Z#?;JG, MKH1?KOK%X2L3?0NEW.Y<6=%SG-*[$*RX-6;I,T?3TBK!4VA15L#XLFR. L9'@W'$:)""<&VT08P%GAW!!CD=,-*! M"!N2KA/F/4\<4&'EW>JA1OC#Q.KQ_2#U/P;2YBV<>FP[9YLY3[H$YF;-Q^_'S!7C K?".]"&I$2<4(><\1(E[Q17 MRFGAW-(J7:;FT5T%'L!JS]\T[0(6CV") H/W(\'1HPD)E6BT06D' ,> M""Z[+:Q 3 90UV!6@\I5M]2XD5188/%88)YLK,('<\$'(W::4\Y)+BS23GF4 MBQP@@X5'#@?!8Y N8K*TRNF$ AU/$MQ9 "ONJAUZ]U<@=(6*.;?HUN-Q)_K! MOK2\$<\>YPO7*'*$NU5LPP9W,C@67*I]5Z<6ZTKH+V)[:]"MJ?'.VC M8:A$<6U7D9CK&E,MD'&)(\:BMYH9'J7.:"=*%;3_6&B?@HE5T/[,:!^QGX0$ M;$N'$=+]A=G1@VLQ$6UE(8>B4%0:W;A MK 6DR/NXH8C&G%F1O%0*?K&6:V6"RQV+0O#]!D4/*]$ZG*&^F^F\B$FAP'M1 MX/Z8>:,QX3:IB)+1"G$G W+4"\05C\R'I!T32ZL3M)U[>Y#FSE_\PK%H/=@F MN5ZR$ !*!U9L%-Q[3@752AC]F!RX@L6I8''$^,#.2JM#1%APACCS'!EJ,++< M6FJL=]B!\2$>TX:Z8/%9L.B#"D0$'6D@W$1IIPXE9:X7UZ'J#[-[":??B-#^NZR>>V^(EA ,UB(-5A@R)%BEGHB,8 MEJ($NO[C-SZ7//L7$8TH*)P."D?K#P3JH[()1:4 A2Y04"J"1,))2:PE@5FY MM$KXHY.X"@Q?1)B@P' Z,!Q1\)EEPAK-D)&Y#(@!5=](01%1V(=$)*R(.:>: M3VL+Z *K^9.=!G=6[:_M<$%J$^&9(+TQ[",XZ!Z(< MID\*S2G$+PHTGPR:HWE4()K<<8Z2OI(AH^"Q[? MV&ZWT$6[BV$AL.XO\/+=WHC%4]P\]PSI3B'H,1+2];VO]C7,V?F4#2>LGBZ8 MJY(,.CU:_#)N35@1(YB"B)/HLD,(K GF;-9;;$P\&1-DO='C40D8Q2G[0@J" MW0&M!9#W ^2(#9$B5RYP@H07 G$6 ](P:X@23C2FQAKCEU89*7!<.#A.?[MZ M@>/4X3AB-GB>;$AY#Z3S%G%+'-*P9"(MI4DD2:N\A?61/B8E:M%B)9-.691O MEC!09JTMV_F">FUT!/_&7O7S@6VTP$(:!(5R@61X'?@LJ][90U'Y@8NB)K0L MX=VJU=[A[<> LK7YHC#0I+]Z:9\Y0K=7,0:_LW7B<-^KF>D;G M3=UWVZG=V[T=XQ"GGB!+ M14(F4[3#NAB#"YVW6K#Y!-C41 M)2>X<-1QR=32*M.Z8',1L3FU9-:"S2? YM95;#+AO2-"H$AP0-R3B*PF$DDC M>-14*T9@W31FO(Q[R7!=+#OA7:?=#PU6-GP^Z?8RRJZW%1; AKSU#C^B(^+9 M>!O$JY:N2\)5V/E^['PVQL["$8Z9!*5)$((X-@09DG(!5^QM<@Q3;<&J,8_6 MG$H:SC/C]DV[ PJ/[<7A/N/BQIE+-\YNA)OY1EVANA>/SJ=ML..J<-X].>_[ MF"='@[GH0"=%)&&!N$T):4%!-Z6"&<62<2H\XLHQE!TX*!'CA$Q48.%SA+_L3%Y(>,[6F5/@.75XCE@,T4BG M 80H<0?PY($C%R5&#@N7% ZP;@J )QE/P/E1_3F#-^C?%I[UP=6,[YGG\DS1 MXCXBJXN4_XW?-O?6UQ8O#85-3D.9TG3/I+3UW%F=/SW00?!XL-R#!^9\Q9R) MO7D.SSXZRZ:.*2Z:>,SD))PZ I.&L& 43$[ED0N)H.18]-Y8L$AQ;IVHR+2V MHDYST7GHNOJ89RPT^>BA^Y$X"B!( M'3PR6@]:QKQJ$E?]T>('.5!'.:02.= M]3]JM ((_&MDIK]'2-^&=9JQ3E9FXD&YR\U_O3)*K!X!D*_4;O=:[5Y<3#A_ M_/<0^Z._6_8?<[)S]/9P_W/SR]8_?WW;/MH$^ (D/W\16Y^;G[?IVZ/M]=WF MQW]VOWQ]CK';]^]>KT]'3EF^LT M5]J=@U>@Q;)7'3C\:OC=NHI@\R3 ;-OJI_ML@'4>:V,IXT%C;F)TDF.:# XX M6L^%?7ASCA^IDL[#)+F:9/ZTZAW&ZBS:3A6!OT*U'GT\]4GV(L=K.V#<5JCZ< M'!\W8U8(;.>LNI1/NSP\_4V[TX.++L-!OP)_M>H5H;[KVT;+MN )FM6''GQ0 MYW75CYXY)U\$CC0N+KE2#\-0]%>ONF@?3^QP[0%D^Z]?"^2ML)TR)YL[+0AT M7A8$.M@YNY%2]-F[7OUA8?Q %&HAH_ S=WZNCCOM[O'@&\YV&]WE6C9\^PB> M_RP+;Y_$6K$'I-6),%G?04#R7M@*Y*$OTYWV475T=;=LAL/71N^LEIIK-\J" M/M+X6CO_09RZO_9_3^"6J7^=>N\L7-J#6I0UW)5J[S!V M8G6:?[3:EQ_PZ,;-NY=1V)T,0XKKOM@9C^=S^FI$$L^C$'T2V(;'[S3\I.\M MI'8S&7@\2D4I8PD'SQFWSGDGA:?> &=&A\?65YT\5\D ,"D/T1D9E* X6,ZM MIHY?=Q_'#*R$/D1E(G>*6@O$"^82MU0H&M7H?:S1F+(@M/>:,P5L (J \-;! MNJD,R72],FD&QS^9"P"S&ZCO@2-Z^PC]Z!JD_Q0M)V#3&22L,8@397-E&8NH MMY@01T$?>[!&N'?;NM_H A_'+J >#@_I>9"^/R!G.'YL.W 8Z#0382? 0AW[ M:L):MLV:L2(D+_&[\>"DV9_]#^C?/J>>VFX^,=:+ ERKD7FP777@25K V<"^ MH6;@L07]=MA48ZM^'T*K_W&=5Q-4@EJZ0"-G@F& LV3<)VM"A"&/1A-M,:7R M$R-Y(;]9D>#B#B3*+^I(7/=$T[CV[)Q-:B)%;^YM;%5$KO1="?V?;W=VX3., M_E_UX:^MK;7=_=F\ZC7#^.1.-]JO9PCB"PIOPV>?PLH]97'PL(,K#+TZQ#I3ID][UIUP:Z(R]V'EZ;V4]<&^1&4VIN/S3 MM<,9_'/8.VJN_G]02P,$% @ ,(%*5+339XI5/@ @=T" !$ !C='9A M+3(P,C$Q,C,Q+GAS9.U]67/C.)+P^_P*?O7R]42,JRS+9\?T;*A\5'O"5=98 MKN[=IPV:A"1,4X0:)&VK?_UF KPDD@!(R6WL4C/A+EM")HY,)!*)//[^'Z^+ MP'DF/*(L_.G#X./A!X>$'O-I./OIP_?'FX/S#__QC[_\Y>__[^#@/S\_W#E7 MS$L6)(R=2T[O%TX?]M]J-_ MX?G>,;08')Y#,_?X^.!I." ')^CP\/!I__\>C<133^D;0,:_K;6^O6)!UG[ MX2?\^LF-2-;8>XS%Y=N'?!4 <#09'PT'6&%%1!7(:1K$;>CER/^8' M\6I)HGH8^/H3?HW]'!X<#@Z.UGKRXQRLW,W))_GE!\>-8TZ?DIC<,+ZX(E,W M"0 D"7]/W(!.*?&!#0*"A%YK4/HZ=OF,Q-_2?M)^-"5^'5Q<7'QZ10:L'T"H7;=- MO&G>-_QUD,'M8@S%YFLWA@QNRS'4[K2P)8[X2[*S9 G4@V1^"^3OUGW .YU&[ 91A\K\Z#\$G5&#Z_=BP M_P( ?SV0OW;I.8J7O,W$\_;BMYH)NV'(8H$!/TD_6RYI.&7R _@(-\R/V:YY M(-/L5*D$Q)5#Y8!8(Y)].?/N#Q>I"='O\= MN$\?8219DTH'ZUL?O_X$("2X*V:2P>+N^^E#!#0(B%P;FR>^Y*3MQ $D@I-; M$/I__?P]-V@[?P#QDN#_QO1],FT[?0"A(>TP>X1^A.\=ZO_TX>KZ-M/U/SCX MS?>'VT8E3_1;AL@09ZB+,?WC$/XWP!_GH+A-P*_7M_F??_^T";2!+HF(?Q_^ M0_R^R>TI<-I$ ;C!)L9PZ^M;"Y9^F"VH8IE'B4_C6Q# ?"%&8KC6%3#-@A_A MS_J""Q1."4>/5OV2A1$+J(\WV E,0MQT(C:]A:OO@AC20(-$09%!N@6&0(8< M$GXO8RR^B!PV=232/8FFEVP!$YN3,*+/9"?TJL.H(1YNIV-SXJWUT&]2?G8# MO!).YH3$40?"K<-KR#2$GQ,5F5)LCD2W)TD$ MQJLM*94BT9#I%'[.SY)E*[NUD)1BU)#OC/XN6A+OC[+1WS8\9. W-[^ MX@:)&(P;^O\2SQW!N;^&OO!<'NG&*?IRL(^<'T=6>KE4:7)'8I<9;M2U6%6U!B<&?[6F;=M8G MZGYVO=]F'.;OPZI\=B,*XG)Z\#7LH M12?)8N'R%9M.Z"RD4]#]PC@]5N"$:;D-#9%IY.CI0!H[UT]$B1II5D+N%-B= M#/V>>!OK_29$-)6H9TK5$'>![4F7O M-1-4]54OA6O3^I>$(6#P;#F6J*@:UGDKG7G M_" [[!.]+]EBP<)+%L;P\>M20>H#0^V:2BQ.JD M:)T,KU-&O"=6L1:M=J,I-LWV&PYK=%@3PO5QN]4M\]5HLD:*1^Z&T91PZ=R0 M/T>T-!=LWY%:RQT<']>H3O6$AHXW.2+K.W7A*#W']%'[O:+/)(II#(L8N:%_ M'\\)%ROD>FV$L!:-1@:?#*37P!I)RTB%>4B@= :GV4O[H5UWW_S>4KDE)KMEE'K<&FY >U07L>Y ;^5V>VK74&3R=L2N1:VA]<6Q=")K3>O)GM3; M2FGY/?%'LTP-?B!1$J"GTOV2\%0)_U,/CE9#4K/6$3J5GK_=H9(-U1G-BFM$ M.EJTFA?CW3-G!TX87\[)XMWY43<*#0L.CJ7SWANQH!C=GN=*QN!G$B:DC:_0 M&HCZNGF$)K_*694BZ*'73SIS3/TAK"3 EY@1Y#*)8K8@O/4#BQDV]7O*T?"H M]H%,TDAD*5-*:/A>A>HIF7?'#A9/WNR5DCPA;!= M4K2$3D/,&2(7!)Y0G1E$OR[AWLWTD'L&<00Z*-9IS"B,4C M(&PM3"^\!O[F7--R !I6.D;_A.U9J30H)QO5!IH]@RGI*SZZ72Q=RH7[\\X9 MJ*D##8.@>:WKC2/]M-1I3ZDO5F7LBNR([=YOJI#J&^(0(Q(KCW(975)$O7S. M*:_DA/!GZI$(9-(S]8G_M (>CAG*LY;;KAU6S5Y#0YN6=EDO3M:-\[026Q#4 M/NAJO\.B\CLR/H/EQ]0VQ-4BU=#V''TV=+1=>P$7+WC%$=M'NDZ2Y5)FZW?Y MJGTRT49PC0R]&-0\*:TAZVEZT:8%;65,TR!16]".T8)6N?LTTJ:/-K.F]15. M-C+ X_IU2<*(?",M16(GU&K!>#Q 3R)S@DI7H31.Y8>TM[^B&S39R\@R36X8 M)W067J9E JY?O;D;SL@7EX9W+&H=D;]5)QH6P'>IFL0+32R0=NIDO3I9MP[V MZ_R /?]USPNE)7L@'@L]&M#TU1"S5>(/YM-[=@.\F8$&*6YUU,,K(WRW&P;9 MIF<-UPR!:VH2.S1QS?I(LIR=?Y.9.TO#$;IT,2#Y_9Z9BI5L^KRCV\_6W6C8 MY!C8I/+NTLPF"E4B[[F?PD6>N8_NJ[&F5X90J]S')X,:/Z'TE!<(^KG0K13K M*IQ&E\98Q8KQM[SH?52?2ZM8^K6C<#-$IA%A9^CFJ*33VA]]#PFL7_0O!-\? MEG/JC8(@K3>5U;2 (U]8T_#9 @1^"6H7Y-ZN9PUOH%VI<\.=KWG@])&G1*XB/KP1SA.0OI'W+'DA Z;ON*WQV_AA/P :KRH*%4 M$K!/I]RIE UIM[VD_K7+0]@;T9CPR=SE1!386K!P$C/OMS:O^@:(U+?ED^&@ M)B(C0^L 7D<@3DMT8:8G@;N'[_[*M6YUNS;!I+YOGV"\8.5@-B%;_V[AFZO= M\?ZM1:,1G"?HN&U L7Y?N"NK3&)YGH"VL/G=93'@"%/;>Z!E7-$@B8F_)6FW MZU3#"*?HG&W"".CO)L]2O#K7M"B/163[A^$(52L=T)Z#-H7K]7A26C2Q8-NQ MBBEV#4^"/>&5I-F)E##'KR'^.3I/[X3X^WU?D$=*:TP( M77IYVX[B2I0:(E^@ [0!D5/)CIVL/QGVD*19H2\XTL1M W-_TV=48.%L-*T" MKL2AOAR='@YJ(ISS\F-XT@J<3H'T;WAL[TDDE[?5I<@$D_I2=(H)XRM6*CVY M^G@I4JYV5H>/397-V@G37?:HEK6G:*.J/&29\$%>@!".6GW[?OIN-!,(WP!? M1*T/%@2I=7=7/*+"K>&&(89#M.(&)^_-*76WI_;F=LQR@MW0$!8+%)D=2H1& MW!IJ'V. 1(>]G^C*$!IU"CVS*A>=$GP_U[FE8]8F MG$8G.AW6!*"4L/11^2E-OU \L@]7;1_:3'!IA!::?VJ>5PLBE163''G?!51G M1[IF#!HZG1\?'BLW4[^-]V/.EH3'JW'@PAQ"'UWAE^C_;$B99GC-P8)1=A7C M2H;M;X[ )\[^'..>*F&[Z[D.B_H8.CL MU,+R;( 1>>U(7C[F-,RQ%Z]U-+LB,$6/=K!U=T2NX0$1DM>=!\H]]I+D7QCS M7V@09"GW;Y$V,XH&$SRL\>TR(5L?SU[=DF??/ZTF9-;^P.V,7B-A3S!\M1.-\T9/*R?M M50N@O@OYLMMJ4,T M06O(@5:8)NDC_A&Y>_MYZ,ME**7I"#!#RTW 7CJ[#+9"J2&=B,EN(%VY!YE7 M!OOHO<=@=?G3&-3)G)#NCJ"MT6HH.\10:A/*IMTXHI\]=0L1^$A@(3#R(A*> M'>VCY,UP:>AXC"'22N&*N-.0#(F]OR'O#F!@IFR-$2+:E9PM]C$MXDF)S]*Z!=)(M4(5DL:-PAV7@+A!I" MGF)L<@,A)7XG[2!7>_(N^DE+%LY0.EV1)WSO&3W# N#]2(;HW[A>RNBFE#1% MI[XMGY\-:I+$(_(#(4H1O[;[9"J;^3GY\,:I[]V M!.WES=V0".5V+67O%CUHA/$%"..J%:8=S;&Y4S3?B^AF"A5?B#,-2Y.4QKC]P_$)XLE=AP]D*6[ZJ+Q[:H[ M#0,-,.7"E@PD&I4&\:D8Q9Y5%+3[CED+ZN4 /G\E<83@F)J*0!L>L:EL]C:< MM.UH-(PF4CILR6BE(=9\*Y[PBF$ZZ3A%/+ALW$=F+-W?8%VP_C>L#?Q5NJ,; M,I())O6MY0(=I"H&O?(-$VE88"X;$O8D*R]TJXN*.3[U'>4"':4JAX49^?IX M-S%8]R^)R]TP)EVS+6W5A49BH\VO\B1F2.V\TYZ_91K0YP[^*ZN_7\[)@B6\ MI::X51<:%D!K8<7*9,@"1:<(D_:[9P(=A;K43=NB PT#G&%*EETP0(]+JK6B MSAUQL;*.__7J;@+ZJWSA?$-N4/:G88[SX\/3RK->%^80@Q"M81A.,8X]N^C( M)UP6QS?WHZ^NN.SXUB7;=:ICG IBG\J+8A7FDUR8.QDE'XWQR MR@/: M7=12+LJ61=-,4&GDVQ#3+!G1:CT9]5Z8P9I\8Z$'HA]:0>O9;0@G/8G:5E-M MB55#SV-,I&1$S_5NG*R?/6G%\@@5#E@>YC4G842?B4SHW*%J:B?<&C*? )DK M9L]:,DM==*VWO'!NCVNDUAQM63V--)R*A=](//)B^@S?;DMR,^P:HI\"TF"\MZW5/>+%8#\0+W"BB4RJKH$4LB=ET=']YNRW1]9@U!#_# M!%-&!*]TY4!?(A3FF$7Q]6(9,.$)D&X0T<(TU48[ MI)HKR_F@INAYVH5(L!&58D"Q&Z?H)]_>HMV>K@TD:)]70F?SF/BC M9\+=&8;S)ZF_&/8?,UA PA Y<&GJIZST#[XQ%0.\?$TZ93[T4'F.';6)BHQ%J M&!ES:E1LP'\*(^.]*AM^C@DGL&?G/T?B80GM*OOUYWZ]-HF+3OR?B1O$\TM1KRB*'SD)?0P\;FEU?).N-1QYC&DC M=Z32R@$Y[/ :51':R:12 M@.XF"7WBBR+O;\IONQB7AAE/@!DK#UO=F%&.UJ&ADX^W3@;*I*A9ABY$+H?M MR''OV54OAA:BUL=#7F^:AI=H-@VH[R*3E#)WO*TX[# .#3N> CM6WN4ZRD8Y M.J<8'K)F>8#KR4?VG*>G>+GU"XWG"L%$P^M7CT01FQ8BZBV9<4=#T_#G&28D MW0U_KD/AD-5R$[E7CELD#R_)T#W?MF6.D>7 :WCW'7*IOQKNE M4>^Y=\?J*5LL68ANE&P:DGB9WA^?9!,/X#P1)0F87'GH\=*1S!"Y5W9L"%H[ M9]@S7@V/7V"ZV!VIL_DLD&-A'DXV$2>=B8-3<7Z0D_FK0)S.Q^%K2H>8DK,V M)P=]+2]=1S%=H%"1*8ZRKSI%YK]%SVI^/#H$?MS1\U4^GBS;4_YUGR/V MVSY&\QF)L?BE]/^8,O[GG/%&'6MX:0"\M*/W)SD@N+(L;3QG6S"JQVWT,'S:/*#^;(]5(TU/,H6Y,0QF2M$[6O0A,EZ+914&T MOY>_[X+8[7K2<, 9YEHWY@"E T,*YZ0#V//&^O;<(0=TH/,YYF)ON=/WA-Q< M^ <2Q9SB XOX_CMTESH8"7?@T"-79$HX3[_?!:T[=JEAAPM,[&[,#L484LX0 MH\A\D;)Q.-E >AR[>D-#6 J*CNJP9(DPJQF2OQ94K1J#!G9X5)'>.2*GA*GG M-&BE%2L0J'7B(5*D8F&KI4*Z=:W[K&-"O,[HU;)R*&HGF!&U@=0]SY]< M2P2&R-T@=;+9GM(-"#6T17-2Y;FOGHI9![E?T)Z4(K;&]C?&LE:V;[.G2/\43XF%=K]8EQ\SQ:0A[AO4)S @KTL<7'>SIN"E(X9K^ MA;,H^AYRX@;H4H3Y:$C$8 @[[H4)=M=?QH^.,?R :T%.AHFQ!"<8@R.' 0* M@-(P^LDM->^RQI2OA=68*2X&AT<5XV/]FVNO#!5U:]G.4J' H#95'!\.:_(X M-M"DE\:*NJ6M^_ !CQY.PYGP96DI1[?K1"T\X?^'%U7K8 .)&UP@\HY35YV] MO%10Z1N#X^9/X(;&?C0,@5P$T.4^^XQ3WPA;,;=Y9QZI50PAG2NAU6? MH<>8[[7R8E-@*F>DZ3L96AVA*@R:(_1X6)-7K)XD?3Q!:U?V@3R3,"%/JTLT MHO*6"1];H=0(PQ.L=-9C2OTK<6/"@U7^1';EQJXA?>IAU2K\"09G5720#%/II0YQ]9T. MK;1X%0:U*G]R,JSQ"FZ@21\5^MJEA0]Y]=-V$JX#8HW0.\7]94K*O*<*C?>2 M4$6+LP(3N'Y./8;- M;2JUL)JS$>N.5&]T.29'HNJC>6MC-5OJD0W0FIUT@57;#*C1PYUQ?7N59@49 ME^;19G^H,*AWR2G&,%6NS8"OR U21MG#W5*_MNWVC!J'>N><#K 07@L*]7,' M/1"1NQ!.6BPMV6KK5$$U>^8(E(**W0(IDF)R!*I^[I7R8K:Z<=7#JN]:I\-A MC6MC#27Z=\O:6,[6\JH.6".HCK%XHP$Q^BF@9#721_>5M%)]ZR UXND$Q%/% M5(=T2 NB"DS]E$ZEI6PKG*J@&MET.JQQ&:N2H9>BJ;28A6=(D M1OE"[L EQ1B=6HJ=X:6_UBQ3HM;>%T5%1>'@L6-2*G!JZ"EJX1K24_2RIZJ@ M:O&6T_9XJD"J#ZBS(1Q0E:<>I%#I6:>G1U1I*=L>4E50S3&%41VU.O@Z&7IY M4)46L[4HJX'5B*P3K)FLI\3_;;GT]T^OT8_N!X2RHN?W?_&*HZ3N8MA>B/.L; >?O\]] E_G).O]]^_DL43X1\<]RF*N>O% M/WV(>4(^.*&[(#]], 8/:1#@5LC 7Y]X0'^4E4YP%C]]\!.>1L=%"?1%XP3_ M^L)9LOSI@VQ.8[+XX,2R>

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

  •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end

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